Citrus Sinensis ID: 019433

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-
Protein Sequence
MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMSHDP
Secondary Structure (PSIPRED)
ccccccccEEcccccEEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHcccccccEEEEEEEcccEEEEEEEEcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccccccccccccccccccccHHHcccccccccccccHHHHHHHHHHHHccccccccccHHHHHHHHcccccEEEEccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccHHHHHHHHcccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccHHHHccccccccccc
Secondary Structure Prediction (SSPRO)
ccccEEEEEEccccccEEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEEccccccHcccccccccccccHccccHHHHcccccccccEEEEHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccEEccccEEccHHHHHHHHHHHcccccccEcHHHHHccHHHHccccHHHcccccccccccccccccccHHHHHHHHHHcccccccccccccHEHEcccccccccccHHHcccccccccccc
Coil and Loop (DISEMBL)
meeryepvkelgsgnfgvarlVRDKRTKELVAVKYIERGKKIDENVQREIINhrslrhpniirfkevlltpTHLAIVMEYAAGGELFARICsagrfsedEARFFFQQLISGVSYCHSMEICHRDLKLentlldgspqprlkicdfgysksgllhsqpkstvgtpayiapevlarkeydgkisdvwSCGVTLYVMLVgaypfedpedprnfrkTIDRIRNVQYFLPDYVRVSADCRHLLSQifvadpskripipeikkhpwflknlpKEIIEIEKTnykeagrdqptQSVEEIMRIIQEAkmpgeatkvagqgaagasdpddmegdieseidasgdymshdp
Flexible Loop (DISEMBL)
meeryepvkelgsgnfgvarlvrdkrtkelvavkyiergkkidenvqreiinhrslrhpniirFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLlhsqpkstvgtpAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAypfedpedprNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQifvadpskripipeikkhpwflknlpKEIIEIEKtnykeagrdqptqSVEEIMRIIQEAKMPGEATKVAGQGAagasdpddmeGDIESeidasgdymshdp
Low Complexity Region (SEG)
MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMSHDP
Disordered region (IsUnstruct)
**************NFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ*KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT******************************************************************
Disordered Region (DISOPRED)
**ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE****************************************GAAGASDPDDMEGDIESEIDASGDYM****
Disordered Region (DISEMBL)
*********ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGE******************EGDIESEIDASGDYMSHDP
Disordered Region (DISPRO)
**ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE************TQSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIES*************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMSHDP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	341	2.2.26 [Sep-21-2011]
P0C5D6	334	Serine/threonine-protein	yes	no	0.956	0.976	0.814	1e-157
A2ZAB5	334	Serine/threonine-protein	N/A	no	0.956	0.976	0.814	1e-157
Q0D4J7	339	Serine/threonine-protein	no	no	0.906	0.911	0.799	1e-149
A2YNT8	339	Serine/threonine-protein	N/A	no	0.982	0.988	0.749	1e-149
Q75LR7	342	Serine/threonine-protein	no	no	0.909	0.906	0.783	1e-147
Q940H6	362	Serine/threonine-protein	yes	no	0.935	0.881	0.755	1e-146
Q7XQP4	359	Serine/threonine-protein	no	no	0.935	0.888	0.743	1e-141
Q9C958	361	Serine/threonine-protein	no	no	0.920	0.869	0.743	1e-141
Q6ZI44	365	Serine/threonine-protein	no	no	0.935	0.873	0.733	1e-140
Q39193	361	Serine/threonine-protein	no	no	0.882	0.833	0.767	1e-140

>sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1

 Score =  555 bits (1431), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 268/329 (81%), Positives = 294/329 (89%), Gaps = 3/329 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYE +KELG+GNFGVARLVRDKR+KELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEV LTPTHLAIVMEYAAGGELF +IC+AGRFSEDEAR+FFQQLISGVSYCHS+EI
Sbjct: 61  IIRFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           ++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI  VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVADPSKRI IPEIKKH WFLKNLPKEI E EK +YK+     PTQ+VEEIMRIIQEAK
Sbjct: 241 IFVADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAK 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESE 329
           +PG+   +A    A  ++  +++ D E E
Sbjct: 301 VPGD---MAAADPALLAELAELKSDDEEE 326

May play a role in signal transduction of hyperosmotic response.
Oryza sativa subsp. japonica (taxid: 39947)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|A2ZAB5|SAPK3_ORYSI Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. indica GN=SAPK3 PE=1 SV=2

 Score =  555 bits (1431), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 268/329 (81%), Positives = 294/329 (89%), Gaps = 3/329 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYE +KELG+GNFGVARLVRDKR+KELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEV LTPTHLAIVMEYAAGGELF +IC+AGRFSEDEAR+FFQQLISGVSYCHS+EI
Sbjct: 61  IIRFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PR+KICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           ++DVWSCGVTLYVMLVG+YPFEDP DPRNFRKTI RI  VQY +PDYVRVS+DCR LLSQ
Sbjct: 181 VADVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQ 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVADPSKRI IPEIKKH WFLKNLPKEI E EK +YK+     PTQ+VEEIMRIIQEAK
Sbjct: 241 IFVADPSKRITIPEIKKHTWFLKNLPKEISEREKADYKDTDAAPPTQAVEEIMRIIQEAK 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESE 329
           +PG+   +A    A  ++  +++ D E E
Sbjct: 301 VPGD---MAAADPALLAELAELKSDDEEE 326

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 247/309 (79%), Positives = 279/309 (90%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ERYE +K++GSGNFGVA+LVRD RTKEL AVK+IERG+KIDENVQREI+NHRSLRHPNI+
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+ICH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGS  PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVLARKEYDGK++
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VA+P +RI IPEIK HPWFLKNLP E+ +  + + +    + P+Q +EEIM IIQEA+ P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 303 GEATKVAGQ 311
           G+ +K +GQ
Sbjct: 302 GDGSKFSGQ 310

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/335 (74%), Positives = 290/335 (86%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ERYE +K++GSGNFGVA+LVRD RTKEL AVK+IERG+KIDENVQREI+NHRSLRHPNI+
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+ICH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGS  PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVLARKEYDGK++
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDP++PRNFRKTI RI +VQY +PDYVRVS +CRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VA+P +RI IPEIK HPWFLKNLP E+ +  + + +    + P+Q +EEIM IIQEA+ P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 303 GEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 337
           G+ +K +GQ     S   D     + +++ SGD++
Sbjct: 302 GDGSKFSGQIPGLGSMELDDIDTDDIDVEDSGDFV 336

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1

 Score =  522 bits (1344), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 243/310 (78%), Positives = 278/310 (89%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ERYE ++++GSGNFGVA+LVRD  T  L AVK+IERG KIDE+VQREI+NHRSL+HPNII
Sbjct: 2   ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGVSYCHSM++CH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGS  PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL+RKEYDGK++
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDP+DPRNFRKTI RI +VQY +PDYVRVSADCRHLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           V +P +RI IPEIK HPWFLKNLP E+ +  + + + A  + P+QS+EE+M IIQEA+ P
Sbjct: 242 VGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKP 301

Query: 303 GEATKVAGQG 312
           G+A K+AG G
Sbjct: 302 GDAMKLAGAG 311

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  518 bits (1334), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 241/319 (75%), Positives = 278/319 (87%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+KRI IPEI+ H WFLKNLP +++       +    DQP QS+EEIM+II EA +P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318

Query: 303 GEATKVAGQGAAGASDPDD 321
              T+       G+ D DD
Sbjct: 319 PAGTQNLNHYLTGSLDIDD 337

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2

 Score =  501 bits (1291), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 240/323 (74%), Positives = 277/323 (85%), Gaps = 4/323 (1%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ERYE +K++G+GNFGVARL+R+K TKELVA+KYI RG KIDENV REIINHRSLRHPNII
Sbjct: 2   ERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV++TPTHLAIVMEYAAGGELF RIC+AGRFSEDEAR+FFQQLI GVSYCH M+ICH
Sbjct: 62  RFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQICH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKTA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RI ++QY +P+YV VS DCR LLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT---QSVEEIMRIIQEA 299
           VA+P+KRI I EI+ HPWFLKNLP+E+ E  +  Y +     PT   QSVEEIM+I++EA
Sbjct: 242 VANPAKRITIREIRNHPWFLKNLPRELTEAAQAMYYKKDNSAPTYSVQSVEEIMKIVEEA 301

Query: 300 KM-PGEATKVAGQGAAGASDPDD 321
           +  P  +T VAG G     + +D
Sbjct: 302 RTPPRSSTPVAGFGWQEEDEQED 324

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1

 Score =  500 bits (1287), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 238/320 (74%), Positives = 274/320 (85%), Gaps = 6/320 (1%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ++YE VK++G+GNFGVARL+R K +KELVA+KYIERG KIDENV REIINHRSLRHPNII
Sbjct: 2   DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTH+AI MEYAAGGELF RICSAGRFSEDEAR+FFQQLISGVSYCH+M+ICH
Sbjct: 62  RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS LLHS PKSTVGTPAYIAPEVL+R EYDGK++
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFED EDP+NF+KTI RI  V+Y +PDYV +S DC+HLLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT---QSVEEIMRIIQEA 299
           V + +KRI I +IKKHPWFLKNLP+E+ EI +  Y    ++ PT   QSVEEIM+I++EA
Sbjct: 242 VTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFR--KENPTFSLQSVEEIMKIVEEA 299

Query: 300 KMPGEATKVAGQ-GAAGASD 318
           K P   ++  G  G  G  D
Sbjct: 300 KTPARVSRSIGAFGWGGGED 319

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1

 Score =  498 bits (1283), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 237/323 (73%), Positives = 277/323 (85%), Gaps = 4/323 (1%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           E+YE +K++GSGNFGVARL+R++ TKELVA+KYI RG KIDENV REIINHRSLRHPNII
Sbjct: 2   EKYELLKDIGSGNFGVARLMRNRETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNII 61

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYAAGGELF RICSAGRFSEDE+R+FFQQLI GVSYCH M+ICH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFDRICSAGRFSEDESRYFFQQLICGVSYCHFMQICH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+R+EYDGK++
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKMA 181

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDP+DP+NFRKTI RI ++QY +P+YV +S DCR LLS+IF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIVSIQYKIPEYVHISQDCRQLLSRIF 241

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNY---KEAGRDQPTQSVEEIMRIIQEA 299
           VA+P+KRI I EI+ HPWF+KNLP+E+ E  +  Y     + R    Q+V+EIM+I+QEA
Sbjct: 242 VANPAKRITIREIRNHPWFMKNLPRELTEAAQAKYYKKDNSARTFSDQTVDEIMKIVQEA 301

Query: 300 KM-PGEATKVAGQGAAGASDPDD 321
           K  P  +T VAG G     + +D
Sbjct: 302 KTPPPSSTPVAGFGWTEEEEQED 324

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1

 Score =  498 bits (1281), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 231/301 (76%), Positives = 268/301 (89%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG KIDENVQREIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+ RI IPEIK H WFLKNLP +++    T  +    +QP QS++ IM+II EA +P
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319

Query: 303 G 303
            
Sbjct: 320 A 320

Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	341
255552916	336	Serine/threonine-protein kinase SAPK3, p	0.982	0.997	0.851	1e-170
225427681	340	PREDICTED: serine/threonine-protein kina	0.991	0.994	0.846	1e-169
449459014	340	PREDICTED: serine/threonine-protein kina	0.991	0.994	0.828	1e-167
224126431	338	predicted protein [Populus trichocarpa]	0.982	0.991	0.857	1e-166
147783296	367	hypothetical protein VITISV_005083 [Viti	0.970	0.901	0.854	1e-166
3811293	339	putative serine/threonine protein kinase	0.982	0.988	0.824	1e-164
356511001	336	PREDICTED: serine/threonine-protein kina	0.970	0.985	0.816	1e-162
356563403	336	PREDICTED: serine/threonine-protein kina	0.976	0.991	0.815	1e-162
329025156	339	serine/threonine protein kinase [Solanum	0.982	0.988	0.800	1e-162
404435145	339	sucrose non-fermenting 1-related protein	0.982	0.988	0.794	1e-161

>gi|255552916|ref|XP_002517501.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis] gi|223543512|gb|EEF45043.1| Serine/threonine-protein kinase SAPK3, putative [Ricinus communis]

 Score =  603 bits (1556), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 287/337 (85%), Positives = 311/337 (92%), Gaps = 2/337 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYEP+KELGSGNFGVARLVRDK++KELVAVKYIERG KIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYEPIKELGSGNFGVARLVRDKKSKELVAVKYIERGNKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVLL PTHLAIVMEYAAGGELFARIC+AGRFSEDEARFFFQQLISGVSYCHSMEI
Sbjct: 61  IVRFKEVLLAPTHLAIVMEYAAGGELFARICNAGRFSEDEARFFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPED RNFRKTI RI +VQY +PDYVRVSADC+HLLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDSRNFRKTIGRIMSVQYSIPDYVRVSADCKHLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+P+KRI IPEIK+HPWFLKNLPKE+IEIEKT Y E+ RDQP+QSVEEIMRIIQEAK
Sbjct: 241 IFVANPAKRITIPEIKQHPWFLKNLPKELIEIEKTTYAESERDQPSQSVEEIMRIIQEAK 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 337
            PGE  K +     G S  DD++ D+ESEID SG+++
Sbjct: 301 TPGEGAKFSELAVPGTS--DDLDADLESEIDISGEFV 335

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225427681|ref|XP_002262726.1| PREDICTED: serine/threonine-protein kinase SAPK3 [Vitis vinifera] gi|296083436|emb|CBI23389.3| unnamed protein product [Vitis vinifera]

 Score =  600 bits (1548), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 286/338 (84%), Positives = 308/338 (91%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERY+ +KELGSGNFGVARLVRDK+TKELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYDALKELGSGNFGVARLVRDKKTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVLLTPTHLAIVMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGVSYCHSMEI
Sbjct: 61  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKS VGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPMPRLKICDFGYSKSALLHSQPKSAVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYV VSA+CR LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVHVSAECRQLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+P+KRI IPEIK+HPWFLKN PKE+IE EKTNY E   DQ  QSVEEIMRIIQEA+
Sbjct: 241 IFVANPAKRITIPEIKQHPWFLKNFPKELIEGEKTNYGELHHDQLVQSVEEIMRIIQEAR 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMS 338
            PGE +KV G    GA D DD+E D+ESEID SG++M+
Sbjct: 301 TPGEGSKVDGHSLDGALDSDDLEADLESEIDVSGEFMA 338

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449459014|ref|XP_004147241.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus] gi|449515157|ref|XP_004164616.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Cucumis sativus]

 Score =  595 bits (1534), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 280/338 (82%), Positives = 310/338 (91%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           ME+RYEP+K+LGSGNFGVARLV+DK+T ELVAVKYIERGKKIDE VQREIINHRSLRHPN
Sbjct: 1   MEDRYEPLKDLGSGNFGVARLVKDKKTNELVAVKYIERGKKIDEKVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEV LTPTHLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCHSM+I
Sbjct: 61  IIRFKEVFLTPTHLAIVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVSYCHSMQI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP P+LKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPTPQLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYVRVS +CR+LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIARILSVQYSIPDYVRVSVECRNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+P+KRI I EIK+ PWF KNLPKE+IEIEKTN+K+   +Q +QSVEEIM+I+QEA 
Sbjct: 241 IFVANPAKRITIQEIKQLPWFFKNLPKELIEIEKTNFKQQEHNQLSQSVEEIMQIVQEAM 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYMS 338
            PGEA+KV  Q  AG S  DD+EGDI+SE+D SGDY++
Sbjct: 301 TPGEASKVGDQALAGGSGLDDLEGDIDSEVDVSGDYVT 338

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224126431|ref|XP_002329552.1| predicted protein [Populus trichocarpa] gi|222870261|gb|EEF07392.1| predicted protein [Populus trichocarpa]

 Score =  591 bits (1524), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 289/337 (85%), Positives = 311/337 (92%), Gaps = 2/337 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYE +KE+GSGNFGVARLVRDK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYETIKEIGSGNFGVARLVRDKKTMELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE RFFFQQLISGVSYCHSMEI
Sbjct: 61  IVRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDETRFFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPAPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYVRVSADC+HLLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVRVSADCKHLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+P+KRI IPEIK+HPWFLKNLPKE++EIEKTN+ ++ RDQP QSVEEIM IIQEAK
Sbjct: 241 IFVANPAKRITIPEIKQHPWFLKNLPKELVEIEKTNFTKSERDQPAQSVEEIMSIIQEAK 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDYM 337
            PGE  KVA    AG S  DD++ D++SE+D SGD M
Sbjct: 301 TPGEGGKVAEHAFAGTS--DDLDVDLDSEVDVSGDIM 335

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147783296|emb|CAN62023.1| hypothetical protein VITISV_005083 [Vitis vinifera]

 Score =  589 bits (1518), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 283/331 (85%), Positives = 301/331 (90%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERY+ +KELGSGNFGVARLVRDK+TKELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYDALKELGSGNFGVARLVRDKKTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVLLTPTHLAIVMEYAAGGELF RIC+AGRFSEDEARFFFQQLISGVSYCHSMEI
Sbjct: 61  IVRFKEVLLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKS LLHSQPKS VGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPMPRLKICDFGYSKSALLHSQPKSAVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI +VQY +PDYV VSA CR LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIMSVQYSIPDYVHVSAXCRQLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+P+KRI IPEIK+HPWFLKN PKE+IE EKTNY E   DQ  QSVEEIMRIIQEA+
Sbjct: 241 IFVANPAKRITIPEIKQHPWFLKNFPKELIEGEKTNYGELHHDQLVQSVEEIMRIIQEAR 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEID 331
            PGE +KV G    GA D DD+E D+ESEID
Sbjct: 301 TPGEGSKVDGHSLDGALDSDDLEADLESEID 331

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|3811293|gb|AAC69450.1| putative serine/threonine protein kinase [Nicotiana tabacum] gi|4098172|gb|AAD00239.1| PK11-C1 [Nicotiana tabacum]

 Score =  585 bits (1508), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 277/336 (82%), Positives = 310/336 (92%), Gaps = 1/336 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEE+YE +KELG+GNFGVARLV+DK+TKEL AVKYIERGKKIDENVQREIINHRSL HPN
Sbjct: 1   MEEKYELLKELGTGNFGVARLVKDKKTKELFAVKYIERGKKIDENVQREIINHRSLGHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEVL+TP+HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH+MEI
Sbjct: 61  IIRFKEVLVTPSHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHAMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGS  PR+KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSASPRVKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + QY +PDYVR+SADC++LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQYSIPDYVRISADCKNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+PSKRI IPEIKKHPWFLKNLPK++++ E + Y+EA  +Q  QSVEEIMRIIQEAK
Sbjct: 241 IFVANPSKRITIPEIKKHPWFLKNLPKDLMDGEHSKYEEAS-EQLQQSVEEIMRIIQEAK 299

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 336
           +PGE +K  GQ  AG ++PDD E D+ESEID+S D+
Sbjct: 300 IPGEVSKPEGQATAGTAEPDDTEDDLESEIDSSNDF 335

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356511001|ref|XP_003524220.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max]

 Score =  576 bits (1485), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 276/338 (81%), Positives = 305/338 (90%), Gaps = 7/338 (2%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYEP+KELG+GNFGVARL +DK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYEPLKELGAGNFGVARLAKDKKTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEVLLTPTHLAIV+EYA+GGELF RIC+AGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61  IIRFKEVLLTPTHLAIVLEYASGGELFERICTAGRFSEDEARYFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI  VQY +PDYVRVS+DCR+LLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGVQYSIPDYVRVSSDCRNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVADP+KRI IPEIK++PWFLKN+PKEIIE E+  ++E  +DQP+Q VEEIMRIIQEA+
Sbjct: 241 IFVADPAKRITIPEIKQYPWFLKNMPKEIIEAERKGFEETTKDQPSQKVEEIMRIIQEAR 300

Query: 301 MPGEATKVA--GQGAAGASDPDDMEGDIESEIDASGDY 336
           +PG+ +K    GQ   G+ D +D E     EID SGDY
Sbjct: 301 IPGQGSKAGEVGQVGTGSLDIEDDE-----EIDVSGDY 333

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563403|ref|XP_003549953.1| PREDICTED: serine/threonine-protein kinase SAPK3-like [Glycine max]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 274/336 (81%), Positives = 304/336 (90%), Gaps = 3/336 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEERYEP+KELG+GNFGVARL +DK+T ELVAVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEERYEPLKELGAGNFGVARLAKDKKTGELVAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIRFKEVLLTPTHLAIV+EYA+GGELF RIC+AGRFSEDEAR+FFQQLISGVSYCHSMEI
Sbjct: 61  IIRFKEVLLTPTHLAIVLEYASGGELFERICTAGRFSEDEARYFFQQLISGVSYCHSMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDG+P PRLKICDFGYSKS LLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGNPSPRLKICDFGYSKSALLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI RI  +QY +PDYVRVS+DCR+LLS+
Sbjct: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIGRIIGIQYSIPDYVRVSSDCRNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVADP+KRI IPEIK++PWFLKN+PKEIIE E+  ++E  +DQP Q VEEIMRIIQ A+
Sbjct: 241 IFVADPAKRITIPEIKQYPWFLKNMPKEIIEAERKGFEETTKDQPNQKVEEIMRIIQAAR 300

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 336
           +PG+ +K AG+G    +   D+E D   EID SGDY
Sbjct: 301 IPGQGSK-AGEGGQAGTGSLDIEDD--EEIDVSGDY 333

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|329025156|gb|AEB71561.1| serine/threonine protein kinase [Solanum chacoense]

 Score =  576 bits (1484), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 269/336 (80%), Positives = 309/336 (91%), Gaps = 1/336 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEE+YE +KELG GNFGVARLV+DK+TKEL+AVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEEKYELLKELGHGNFGVARLVKDKKTKELLAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVL+TP+HLAIVMEYAAGGELF RICSAGRFSEDEARFFFQQLISGVSYCH+MEI
Sbjct: 61  IVRFKEVLVTPSHLAIVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVSYCHTMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPSPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + Q+ +PDYVR++ DC++LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQHSIPDYVRITPDCKNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+PSKRI IPEIKKHPWFLKNLPKE++++E   ++E+  +Q  QSVEEIM++IQEAK
Sbjct: 241 IFVANPSKRITIPEIKKHPWFLKNLPKELMDVEHAKFEESS-EQLQQSVEEIMKMIQEAK 299

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 336
           +PG  +K  G+  AG ++ DD+E D+ESEID+S D+
Sbjct: 300 IPGVVSKSEGKDPAGTAEQDDLEEDLESEIDSSNDF 335

Source: Solanum chacoense

Species: Solanum chacoense

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|404435145|gb|AFR68939.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum]

 Score =  572 bits (1475), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 267/336 (79%), Positives = 308/336 (91%), Gaps = 1/336 (0%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
           MEE+YE +KELG+GNFGVARLV+DK+TKEL+AVKYIERGKKIDENVQREIINHRSLRHPN
Sbjct: 1   MEEKYELLKELGAGNFGVARLVKDKKTKELLAVKYIERGKKIDENVQREIINHRSLRHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+RFKEVL+TP+HLAIVMEYAAGGELF RICSAGRFS DEARFFFQQLISGVSYCH+MEI
Sbjct: 61  IVRFKEVLVTPSHLAIVMEYAAGGELFGRICSAGRFSGDEARFFFQQLISGVSYCHTMEI 120

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           CHRDLKLENTLLDGSP PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL+RKEYDGK
Sbjct: 121 CHRDLKLENTLLDGSPSPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLSRKEYDGK 180

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           I+DVWSCGVTLYVMLVGAYPFEDPEDP+NFRKTI RI + Q+ +PDYVR++ DC++LLS+
Sbjct: 181 IADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIGRIMSAQHSIPDYVRITPDCKNLLSR 240

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK 300
           IFVA+PSKRI IPE KKHPWFLKNLPKE++++E   ++E+  +Q  QSVEEIM++IQEAK
Sbjct: 241 IFVANPSKRITIPETKKHPWFLKNLPKELMDVEHAKFEESS-EQLQQSVEEIMKMIQEAK 299

Query: 301 MPGEATKVAGQGAAGASDPDDMEGDIESEIDASGDY 336
           +PG  +K  G+  AG ++ DD+E D+ESEID+S D+
Sbjct: 300 IPGVVSKSEGKDPAGTAEQDDLEEDLESEIDSSNDF 335

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	341
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.958	0.903	0.75	1.1e-135
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.958	0.905	0.726	3.5e-130
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.976	0.922	0.721	1.2e-129
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.988	0.954	0.690	1.4e-128
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.944	0.894	0.721	6.8e-127
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.964	0.959	0.717	6.1e-126
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.982	0.957	0.676	7.2e-123
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.958	0.964	0.661	5.8e-114
TAIR|locus:2179260	488	CIPK25 "CBL-interacting protei	0.791	0.553	0.423	3e-53
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.747	0.350	0.462	8e-53

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1329 (472.9 bits), Expect = 1.1e-135, P = 1.1e-135
 Identities = 249/332 (75%), Positives = 290/332 (87%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct:   199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK--TNYKEAGRDQPTQSVEEIMRIIQEAK 300
             VADP+KRI IPEI+ H WFLKNLP +++      T + E+  DQP QS+EEIM+II EA 
Sbjct:   259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES--DQPGQSIEEIMQIIAEAT 316

Query:   301 MPGEATKVAGQGAAGASD-PDDMEGDIESEID 331
             +P   T+       G+ D  DDME D+ES++D
Sbjct:   317 VPPAGTQNLNHYLTGSLDIDDDMEEDLESDLD 348

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1277 (454.6 bits), Expect = 3.5e-130, P = 3.5e-130
 Identities = 242/333 (72%), Positives = 281/333 (84%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ++YE VK++G+GNFGVARL+R K +KELVA+KYIERG KIDENV REIINHRSLRHPNII
Sbjct:     2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTH+AI MEYAAGGELF RICSAGRFSEDEAR+FFQQLISGVSYCH+M+ICH
Sbjct:    62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP PRLKICDFGYSKS LLHS PKSTVGTPAYIAPEVL+R EYDGK++
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFED EDP+NF+KTI RI  V+Y +PDYV +S DC+HLLS+IF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT---QSVEEIMRIIQEA 299
             V + +KRI I +IKKHPWFLKNLP+E+ EI +  Y    ++ PT   QSVEEIM+I++EA
Sbjct:   242 VTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFR--KENPTFSLQSVEEIMKIVEEA 299

Query:   300 KMPGEATKVAGQ-GAAGASDPDDMEGDIESEID 331
             K P   ++  G  G  G  D +  E D E E++
Sbjct:   300 KTPARVSRSIGAFGWGGGEDAEGKEEDAEEEVE 332

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1272 (452.8 bits), Expect = 1.2e-129, P = 1.2e-129
 Identities = 243/337 (72%), Positives = 284/337 (84%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             +RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG KIDENVQREIINHRSLRHPNI+
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct:   200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
             VADP+ RI IPEIK H WFLKNLP +++    T  +    +QP QS++ IM+II EA +P
Sbjct:   260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319

Query:   303 GEATKVAGQGAAGASD-PDDMEG-DIESEID--ASGD 335
                 +          D  DDM+  D ESEID  +SG+
Sbjct:   320 AVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGE 356

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1262 (449.3 bits), Expect = 1.4e-128, P = 1.4e-128
 Identities = 234/339 (69%), Positives = 280/339 (82%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ++Y+ VK+LG+GNFGVARL+R K TKELVA+KYIERG+KIDENV REIINHRSL+HPNII
Sbjct:     2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSE EAR+FFQQLI GV YCHS++ICH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP P LKICDFGYSKS +LHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFEDP DP+NFRKTI RI  VQY +PDYV +S +C+HLLS+IF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
             V + +KRI + EIK HPW+LKNLPKE++E  +  Y +       QSVE+IM+I+ EA+ P
Sbjct:   242 VTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDTSFSLQSVEDIMKIVGEARNP 301

Query:   303 GEATKVAGQGAAGASDPD--DMEGDIESEIDASGDYMSH 339
               +T       +GA + +  D+E ++E E D   +Y  H
Sbjct:   302 APSTSAVKSSGSGADEEEEEDVEAEVEEEEDDEDEYEKH 340

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1246 (443.7 bits), Expect = 6.8e-127, P = 6.8e-127
 Identities = 238/330 (72%), Positives = 280/330 (84%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ++YE VK+LG+GNFGVARL+R K TKELVA+KYIERG+KIDENV REIINHRSLRHPNII
Sbjct:     2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSE EAR+FFQQLI GV YCHS++ICH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP P LKICDFGYSKS LLHS+PKSTVGTPAYIAPEVL+R+EYDGK +
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVG YPFEDP+DPRNFRKTI RI  VQY +PDYV +S +CRHLLS+IF
Sbjct:   182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT---QSVEEIMRIIQEA 299
             V + +KRI + EIKKHPW+LKNLPKE+ E  +  Y +  R+ P+   QSVE+IM+I+ EA
Sbjct:   242 VTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYK--RETPSFSLQSVEDIMKIVGEA 299

Query:   300 KMPGEATKVAGQGAAGASDPDDMEGDIESE 329
             + P  ++  A +G     D +D+E ++E E
Sbjct:   300 RNPAPSSN-AVKGFD--DDEEDVEDEVEEE 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
 Identities = 249/347 (71%), Positives = 286/347 (82%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ERYE VK++GSGNFGVA+LVRDK +KEL AVK+IERG+KIDE+VQREI+NHRSL HPNII
Sbjct:     2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEVLLT THLA+VMEYAAGGELF RICSAGRFSEDEARFFFQQLISGV+YCHS++ICH
Sbjct:    62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGS  PR+KICDFGYSKSG+LHSQPK+TVGTPAYIAPEVL+ KEYDGKI+
Sbjct:   122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFEDP DP++FRKTI RI   QY +PDYVRVS +CRHLLS+IF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
             VA+P KRI I EIK H WFLKNLP E+ E    +    G    TQ+VEEI+ II+EA+ P
Sbjct:   242 VANPEKRITIEEIKNHSWFLKNLPVEMYE---GSLMMNGPS--TQTVEEIVWIIEEARKP 296

Query:   303 -GEATKVAGQGAAGAS----------DPDDMEGDIESEIDASGDYMS 338
                AT +AG G +G S          D DD++ D + +ID + D +S
Sbjct:   297 ITVATGLAGAGGSGGSSNGAIGSSSMDLDDLDTDFD-DIDTA-DLLS 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
 Identities = 234/346 (67%), Positives = 281/346 (81%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ERY+ +++LGSGNFGVA+LVR+K   E  AVKYIERG KIDE+VQREIINHR L+HPNII
Sbjct:     2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV +TPTHLAIVMEYAAGGELF RIC+AGRFSEDE R++F+QLISGVSYCH+M+ICH
Sbjct:    62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP   LKICDFGYSKS +LHSQPKSTVGTPAY+APEVL+RKEY+GKI+
Sbjct:   122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGVTLYVMLVGAYPFEDPEDPRN R TI RI +V Y +PDYVR+S++C+HLLS+IF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKN---LPKEIIEIEK-TNYKEAGRDQPTQSVEEIMRIIQE 298
             VADP KRI +PEI+KHPWFLK    +P E  + +     +E   ++  QSVEEI++II+E
Sbjct:   242 VADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIEE 301

Query:   299 AKMPGEAT-KVAGQGAA-GASDPDDME-GDIESEID----ASGDYM 337
             A+     T    G G   G+ D DD++  DI  ++D     +GD++
Sbjct:   302 ARKGVNGTDNNGGLGLIDGSIDLDDIDDADIYDDVDDDEERNGDFV 347

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1124 (400.7 bits), Expect = 5.8e-114, P = 5.8e-114
 Identities = 219/331 (66%), Positives = 256/331 (77%)

Query:     3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             E+YE VK+LG GNFG+ARL+R+K+T ELVAVK+I+RG KIDENV REIINHR+L HPNI+
Sbjct:     2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61

Query:    63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             RFKEV+LTPTHL IVMEYAAGGELF RI S GRFSE EAR+FFQQLI GV Y H+++ICH
Sbjct:    62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121

Query:   123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
             RDLKLENTLLDGSP PRLKICDFGYSKS +LHS PKSTVGTPAYIAPEV  R EYDGK  
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181

Query:   183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
             DVWSCGV LYVMLVGAYPFEDP+DPRNFRKT+ +I  V Y +P YV +S DCR LLS+IF
Sbjct:   182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241

Query:   243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQ---PTQSVEEIMRIIQEA 299
             VA+P  R  + EIK H WFLKNLP+E+ E  +  Y +   +      Q VEEIM+I+ EA
Sbjct:   242 VANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGEA 301

Query:   300 K-MPGEATKVAGQGAAGASDPDDMEGDIESE 329
             + +P  +  V   G+    D ++   D   E
Sbjct:   302 RTIPNLSRPVESLGSDKKDDDEEEYLDANDE 332

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 551 (199.0 bits), Expect = 3.0e-53, P = 3.0e-53
 Identities = 125/295 (42%), Positives = 174/295 (58%)

Query:     4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID---ENVQREIINHRSLRHP 59
             +YE  + LG G FG     ++  T E VA+K I + + K +   E ++REI   R +RHP
Sbjct:    42 KYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKREISIMRLVRHP 101

Query:    60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
             NI+  KEV+ T T +  +MEY  GGELF++I   G+  ED AR +FQQLIS V +CHS  
Sbjct:   102 NIVELKEVMATKTKIFFIMEYVKGGELFSKIVK-GKLKEDSARKYFQQLISAVDFCHSRG 160

Query:   120 ICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLLHSQPKSTVGTPAYIAPEVL 172
             + HRDLK EN L+D +    LK+ DFG S       + GLLH+Q     GTPAY+APEVL
Sbjct:   161 VSHRDLKPENLLVDENGD--LKVSDFGLSALPEQILQDGLLHTQ----CGTPAYVAPEVL 214

Query:   173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
              +K YDG   D+WSCG+ LYV+L G  PF+D     N  K   +I   ++  P +   S 
Sbjct:   215 RKKGYDGAKGDIWSCGIILYVLLAGFLPFQD----ENLMKMYRKIFKSEFEYPPWF--SP 268

Query:   233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI-IEIEKTNYKEAGRDQPT 286
             + + L+S++ V DP+KRI IP I + PWF KN+   I  +I++   +    + PT
Sbjct:   269 ESKRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPT 323

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 547 (197.6 bits), Expect = 8.0e-53, P = 8.0e-53
 Identities = 124/268 (46%), Positives = 157/268 (58%)

Query:     5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPN 60
             Y   K LG G+FG  +L    RT   VA+K + R K    K+DE ++REI N +  RHP+
Sbjct:    31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90

Query:    61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
             II+  EV+ T T + +VMEY  GGELF  I   G+  EDE+R  FQQ+ISGV YCH   +
Sbjct:    91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150

Query:   121 CHRDLKLENTLLDGSPQPR-LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
              HRDLK EN LLD  P  + +KI DFG S         K++ G+P Y APEV++ K Y G
Sbjct:   151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208

Query:   180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
                DVWSCGV LY  L    PF+D   P  F+K    IR   + +PD+V  S  C  L+ 
Sbjct:   209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKK----IREGVFSIPDFV--SPSCADLIK 262

Query:   240 QIFVADPSKRIPIPEIKKHPWFLKNLPK 267
             ++ V DP KRI I EI+ HPWF   LPK
Sbjct:   263 KMLVVDPVKRITIHEIRNHPWFQVKLPK 290

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7437	0.9208	0.8698	no	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.7524	0.8856	0.8388	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.8145	0.9560	0.9760	N/A	no
P0C5D6	SAPK3_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8145	0.9560	0.9760	yes	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7993	0.9061	0.9115	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7294	0.9560	0.9819	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.7774	0.8621	0.8571	no	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7430	0.9354	0.8885	no	no
Q9SMQ4	SRK2F_ARATH	2, ., 7, ., 1, 1, ., 1	0.7211	0.9032	0.88	no	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7838	0.9090	0.9064	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7220	0.9178	0.8866	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.7656	0.8739	0.8209	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.7674	0.8826	0.8337	no	no
Q39192	SRK2D_ARATH	2, ., 7, ., 1, 1, ., 1	0.7433	0.8797	0.8287	no	no
Q7XKA8	SAPK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7116	0.9090	0.8378	no	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.7554	0.9354	0.8812	yes	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.75	0.8914	0.8397	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7492	0.9824	0.9882	N/A	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7337	0.9354	0.8739	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7385	0.8973	0.8247	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7411	0.9061	0.8559	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	341
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-87
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-67
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-66
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-59
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-58
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-57
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-54
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-53
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-47
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-46
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	8e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-45
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-45
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	8e-45
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-44
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-43
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-43
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-42
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-42
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-41
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-41
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-41
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-40
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-40
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-39
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-39
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-39
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-39
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-38
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-38
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-38
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-38
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-38
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-37
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-37
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-36
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-36
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-36
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-36
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-36
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-36
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-36
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-36
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-36
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-36
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-36
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-36
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-35
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-35
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-35
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-34
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-33
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-33
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-32
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-32
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-32
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-32
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-32
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-32
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-32
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-32
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-32
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-31
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-31
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-31
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-31
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-30
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-30
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-30
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-29
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-29
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-29
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-28
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-28
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-28
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-28
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-27
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-27
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-27
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-27
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-27
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-26
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-26
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-26
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-26
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-25
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-25
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-25
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-25
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-25
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-25
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-24
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-24
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-24
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-24
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-23
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-23
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-22
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-22
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-22
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-22
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-22
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-22
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-22
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-22
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-22
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-22
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-22
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-21
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-21
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-21
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-21
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-20
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-20
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-20
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-20
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-19
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-18
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-17
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-16
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-16
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-16
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-12
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-11
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-09
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-08
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	8e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-05
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.001
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  297 bits (763), Expect = e-101
 Identities = 105/260 (40%), Positives = 150/260 (57%), Gaps = 9/260 (3%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
           YE +++LG G+FG   L RDK+T +LVA+K I  ++ KK  E + REI   + L+HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           R  +V      L +VMEY  GG+LF  +   GR SEDEARF+ +Q++S + Y HS  I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVL  K Y   + 
Sbjct: 121 RDLKPENILLDEDGH--VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCRHLLSQI 241
           D+WS GV LY +L G  PF   +      +   +I   +  F P    +S + + L+ ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 242 FVADPSKRIPIPEIKKHPWF 261
            V DP KR+   E  +HP+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  262 bits (673), Expect = 3e-87
 Identities = 108/263 (41%), Positives = 145/263 (55%), Gaps = 9/263 (3%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPNI 61
           YE +++LGSG+FG     + K T ++VAVK +       K D+  +REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +R  +      HL +VMEY  GG+LF  +   G  SEDEA+    Q++ G+ Y HS  I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGK 180
           HRDLK EN LLD +    +KI DFG +K  L  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDENGV--VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYFLPDYVRVSADCRHLL 238
             DVWS GV LY +L G  PF   E+  +  + I RI    +++  P +   S + + L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 239 SQIFVADPSKRIPIPEIKKHPWF 261
            +    DPSKR    EI +HPWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  211 bits (540), Expect = 2e-67
 Identities = 98/259 (37%), Positives = 141/259 (54%), Gaps = 17/259 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
           LG G+FG   LVR K T +L A+K +++ K I        +  R+    + HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
              T   L +V+EYA GGELF+ +   GRFSE+ ARF+  +++  + Y HS+ I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            EN LLD      +K+ DFG +K      S+  +  GTP Y+APEVL  K Y GK  D W
Sbjct: 121 PENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177

Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S GV LY ML G  PF       + ++  ++I       P++  +S + R L+S +   D
Sbjct: 178 SLGVLLYEMLTGKPPFYAE----DRKEIYEKILKDPLRFPEF--LSPEARDLISGLLQKD 231

Query: 246 PSKRI---PIPEIKKHPWF 261
           P+KR+      EIK HP+F
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  210 bits (537), Expect = 2e-67
 Identities = 92/253 (36%), Positives = 121/253 (47%), Gaps = 42/253 (16%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNIIRFKEVL 68
           LG G FG   L RDK+T + VA+K I++       E + REI   + L HPNI++   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 69  LTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
               HL +VMEY  GG L   +    G+ SEDE      Q++ G+ Y HS  I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 128 ENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
           EN LLD S   ++K+ DFG SK      S  K+ VGTPAY+APEVL  K Y  + SD+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246
            GV LY +                                      + + L+ ++   DP
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 247 SKRIPIPEIKKHP 259
            KR    EI +H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  208 bits (531), Expect = 6e-66
 Identities = 93/261 (35%), Positives = 137/261 (52%), Gaps = 18/261 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE +K++G G+FG   LVR K   +L  +K I      +K  E+   E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGR-FSEDEARFFFQQLISGVSYCH 116
           II++ E       L IVMEYA GG+L  +I      G+ F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLAR 174
           S +I HRD+K +N  L       +K+ DFG SK  L  +    K+ VGTP Y++PE+   
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKV-LSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           K Y+ K SD+WS G  LY +    +PFE      N  +   +I   QY  P   + S++ 
Sbjct: 178 KPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQY-PPIPSQYSSEL 231

Query: 235 RHLLSQIFVADPSKRIPIPEI 255
           R+L+S +   DP +R  I +I
Sbjct: 232 RNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  190 bits (486), Expect = 9e-59
 Identities = 96/273 (35%), Positives = 151/273 (55%), Gaps = 34/273 (12%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPN 60
           +E +K LG+G+FG   LVR K + +  A+K + + K +     E+V  E    +S+RHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 61  IIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           ++     F++     ++L +VMEY  GGELF+ +  +GRF E  ARF+  Q++  + Y H
Sbjct: 63  LVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118

Query: 117 SMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
           S++I +RDLK EN LLD  G     +KI DFG++K   +  +  +  GTP Y+APE++  
Sbjct: 119 SLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEIILS 172

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSAD 233
           K Y GK  D W+ G+ +Y ML G  PF D    + + K +  ++R   +F       S D
Sbjct: 173 KGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF-------SPD 224

Query: 234 CRHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
            + L+  +   D +KR+      + +IK HPWF
Sbjct: 225 AKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  188 bits (480), Expect = 3e-58
 Identities = 86/266 (32%), Positives = 133/266 (50%), Gaps = 14/266 (5%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPN 60
            +   + LG G+FG   L  DK T EL+AVK +E     +E +   +REI    SL+HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 61  IIRFK--EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I+R+   E       L I +EY +GG L + +   G+  E   R + +Q++ G++Y HS 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARK 175
            I HRD+K  N L+D      +K+ DFG +K            S  GTP ++APEV+ R 
Sbjct: 121 GIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RG 177

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           E  G+ +D+WS G T+  M  G  P+ +  +P      I         +P++  +S + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPE-IPEH--LSEEAK 234

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWF 261
             L +    DP KR    E+ +HP+ 
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  186 bits (475), Expect = 2e-57
 Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 14/261 (5%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
           +E ++++G G FG     R KRT + VA+K I    K+  E +  EI   +  +HPNI++
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICH 122
           +    L    L IVME+ +GG L   + S  +  +E +  +  ++L+ G+ Y HS  I H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 123 RDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           RD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV+  K YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHLLS 239
            +D+WS G+T   +  G  P+ +        K + +I  N    L +  + S + +  L 
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 240 QIFVADPSKRIPIPEIKKHPW 260
           +    +P KR    ++ KHP+
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  178 bits (453), Expect = 3e-54
 Identities = 91/267 (34%), Positives = 135/267 (50%), Gaps = 23/267 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKE 66
           +  G +G   L + K T ++ A+K I++   I +N   +++  R      + P +++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                 +L +VMEY  GG+L + + + G   ED AR +  +++  + Y HS  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---------TVGTPAYIAPEVLARKEY 177
            +N L+D +    LK+ DFG SK GL+  Q             VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K  D WS G  LY  LVG  PF   E P    +    I N +   P+ V VS +   L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 238 LSQIFVADPSKRI---PIPEIKKHPWF 261
           +S++ V DP KR+    I EIK HP+F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  176 bits (449), Expect = 2e-53
 Identities = 87/292 (29%), Positives = 133/292 (45%), Gaps = 49/292 (16%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVK-----YIERGKKIDE-NVQREIINHRSLRH 58
           ++  K +G G+F    L ++K T +  A+K      + + KK+    +++E++  R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61

Query: 59  PNIIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           P II+    F++      +L  V+EYA  GEL   I   G   E   RF+  +++  + Y
Sbjct: 62  PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------------SGLL 153
            HS  I HRDLK EN LLD      +KI DFG +K                         
Sbjct: 118 LHSKGIIHRDLKPENILLDK--DMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
             +  S VGT  Y++PE+L  K   GK SD+W+ G  +Y ML G  PF    +      T
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230

Query: 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI----PIPEIKKHPWF 261
             +I  ++Y  P       D + L+ ++ V DP  R+       E+K HP+F
Sbjct: 231 FQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  161 bits (410), Expect = 3e-47
 Identities = 93/298 (31%), Positives = 138/298 (46%), Gaps = 47/298 (15%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLR 57
            ++ +K LG G+ G   LVR K T +L A+K +++ + I  N       ++EI+   +L 
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATLD 59

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFA--RICSAGRFSEDEARFFFQQLISGVSYC 115
           HP +        T T+L +VM+Y  GGELF   +       SE+ ARF+  +++  + Y 
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 116 HSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHSQP- 157
           H + I +RDLK EN LL  S                 P P  K    G  +S +      
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 158 ----------KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
                      S VGT  YIAPEV++   +   + D W+ G+ LY ML G  PF+     
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG---- 234

Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI----PIPEIKKHPWF 261
            N  +T   I   +   P    VS+  R L+ ++ V DPSKR+       EIK+HP+F
Sbjct: 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  159 bits (405), Expect = 4e-47
 Identities = 84/262 (32%), Positives = 132/262 (50%), Gaps = 18/262 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
           LG G FG   LV+ K      A+K +++   ++   Q  I + +       HP I++   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                 ++ ++MEY  GGEL+  +   G F E  ARF+   ++    Y H+  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            EN LLD      +K+ DFG++K      +  +  GTP Y+APE++  K YD    D WS
Sbjct: 121 PENLLLDS--NGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 187 CGVTLYVMLVGAYPF-EDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
            G+ LY +L G  PF ED EDP   +   +     +++  P+Y+  +A  + L+ Q+   
Sbjct: 178 LGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAA--KDLIKQLLRR 233

Query: 245 DPSKRI-----PIPEIKKHPWF 261
           +P +R+      I +IKKH WF
Sbjct: 234 NPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  162 bits (409), Expect = 1e-46
 Identities = 89/281 (31%), Positives = 130/281 (46%), Gaps = 28/281 (9%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP- 59
           Y  +++LG G+FG   L RD++    VA+K + +  +          REI    SL HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCH 116
           NI++  +       L +VMEY  GG L   +      G  SE EA F   Q++S + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAP 169
           S  I HRD+K EN LLD      +K+ DFG +K       +  + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 170 EVL--ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------- 220
           EVL      Y    SD+WS G+TLY +L G  PFE  ++     +T+  I  +       
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                +   +S     LL ++   DP  R+       H   
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  158 bits (401), Expect = 8e-46
 Identities = 97/265 (36%), Positives = 136/265 (51%), Gaps = 22/265 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
           K LG G+FG   L   K T EL AVK +++   + D++V+  +   R L    +HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  VMEY  GG+L   I  +GRF E  ARF+  +++ G+ + H   I +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLKL+N LLD   +  +KI DFG  K G+L     ST  GTP YIAPE+L+ + Y G   
Sbjct: 121 DLKLDNVLLDS--EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177

Query: 183 DVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           D W+ GV LY ML G  PFE D ED     +    I   +   P ++   A  + +L   
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDEVRYPRWLSKEA--KSILKSF 230

Query: 242 FVADPSKRIPIP-----EIKKHPWF 261
              +P KR+        +IK HP+F
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  155 bits (395), Expect = 1e-45
 Identities = 78/260 (30%), Positives = 130/260 (50%), Gaps = 20/260 (7%)

Query: 12  GSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKEV 67
           G G FG   +V+ + TK++ A+KY+ + K +++   R ++N R     L HP ++     
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                ++ +V++   GG+L   +    +FSE++ +F+  +++  + Y HS  I HRD+K 
Sbjct: 69  FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128

Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDGKISDVW 185
           +N LLD   Q  + I DF  +    +     +T   GTP Y+APEVL R+ Y     D W
Sbjct: 129 DNILLD--EQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWW 183

Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDY-VRVSADCRHLLSQIFV 243
           S GVT Y  L G  P+       + R   D+IR  Q      Y    S +    ++++  
Sbjct: 184 SLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE 238

Query: 244 ADPSKRI--PIPEIKKHPWF 261
            DP KR+   + ++K HP+F
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  156 bits (397), Expect = 3e-45
 Identities = 92/268 (34%), Positives = 135/268 (50%), Gaps = 27/268 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSLRHPN 60
           K LG G FG   LVR+K T +  A+K +    K +  + ++ + H        ++ RHP 
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKIL----KKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS ++
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
            +RDLKLEN +LD      +KI DFG  K G+       T  GTP Y+APEVL   +Y G
Sbjct: 117 VYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 173

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           +  D W  GV +Y M+ G  PF +    ++  K  + I   +   P    +S + + LL+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEEIRFPR--TLSPEAKSLLA 227

Query: 240 QIFVADPSKRI-----PIPEIKKHPWFL 262
            +   DP +R+        EI +H +F 
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  154 bits (392), Expect = 8e-45
 Identities = 91/290 (31%), Positives = 133/290 (45%), Gaps = 41/290 (14%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
           YE +++LG G +GV    RDK+T E+VA+K I R    +E +     REI   + L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSME 119
           I++  +V+ T   L +V EY    +L   +    G  S +  +    QL+ G++YCHS  
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLAR- 174
           I HRDLK +N L++      LK+ DFG +++      P  T    V T  Y APE+L   
Sbjct: 119 ILHRDLKPQNILINRDGV--LKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFE------------------DPEDPRNFRKTIDR 216
           K Y   + D+WS G     M+ G   F                     E      K  D 
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 217 IRNVQYFLPDYV-----RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                 F P  +     R+  +   LLS++   +P+KRI   E  KHP+F
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  154 bits (392), Expect = 1e-44
 Identities = 99/263 (37%), Positives = 141/263 (53%), Gaps = 22/263 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL----RHPN 60
           K LG G+FG   L   K T E  A+K +   KK     D++V+  ++  R L     HP 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWEHPF 57

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +        T  HL  VMEY  GG+L   I S+GRF E  ARF+  ++I G+ + H   I
Sbjct: 58  LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
            +RDLKL+N LLD      +KI DFG  K  +      ST  GTP YIAPE+L  ++Y+ 
Sbjct: 118 IYRDLKLDNVLLD--KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNE 175

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
            + D WS GV LY ML+G  PF   ++   F    D I N +   P +  +S + +  LS
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFPRW--ISKEAKDCLS 228

Query: 240 QIFVADPSKRIPIP-EIKKHPWF 261
           ++F  DP+KR+ +  +I++HP+F
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 3e-44
 Identities = 95/303 (31%), Positives = 139/303 (45%), Gaps = 59/303 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
           + +E +K +G G FG   LVRDK T ++ A+K +   +K D   + +I + R+ R     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILAD 57

Query: 58  --HPNIIR----FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
              P I++    F++      HL +VMEY  GG+L   +     F E+ ARF+  +L+  
Sbjct: 58  ADSPWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---------------------- 149
           +   H +   HRD+K +N L+D      +K+ DFG  K                      
Sbjct: 114 LDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 150 ----SGLLHSQPK----STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
                   H Q +    STVGTP YIAPEVL    Y  +  D WS GV LY ML G  PF
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPF 230

Query: 202 EDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRI-PIPEIKKH 258
                    ++T ++I N +  L  P    VS +   L+ +  + DP  R+    EIK H
Sbjct: 231 YSD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSH 285

Query: 259 PWF 261
           P+F
Sbjct: 286 PFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 1e-43
 Identities = 83/259 (32%), Positives = 127/259 (49%), Gaps = 18/259 (6%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPNIIRFKE 66
            +G G FGV     +  T + VA+K I   K  +E    + +EI   ++L+HPNI+++  
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            + T   L I++EYA  G L   I   G F E     +  Q++ G++Y H   + HRD+K
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIK 126

Query: 127 LENTLL--DGSPQPRLKICDFGYS-KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
             N L   DG     +K+ DFG + K   +     S VGTP ++APEV+         SD
Sbjct: 127 AANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SD 181

Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHLLSQIF 242
           +WS G T+  +L G  P+ D     N    + RI ++    LP+   +S + +  L Q F
Sbjct: 182 IWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDHPPLPE--GISPELKDFLMQCF 235

Query: 243 VADPSKRIPIPEIKKHPWF 261
             DP+ R    ++ KHPW 
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 8e-43
 Identities = 87/268 (32%), Positives = 141/268 (52%), Gaps = 20/268 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           +  E +K +G+G FG   LVRD+ ++   A+K +   + I     ++V  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P IIR          L ++MEY  GGELF+ + ++GRFS     F+  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           EI +RDLK EN LLD   +  +K+ DFG++K   L  +  +  GTP Y+APEV+  K + 
Sbjct: 121 EIVYRDLKPENILLD--KEGHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K  D W+ G+ +Y MLVG  PF D     N     ++I   +   P ++ + A  + L+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPRHLDLYA--KDLI 229

Query: 239 SQIFVADPSKRI-----PIPEIKKHPWF 261
            ++ V D ++R+        ++K H WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  148 bits (376), Expect = 3e-42
 Identities = 93/264 (35%), Positives = 133/264 (50%), Gaps = 19/264 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-----LRHPNIIR 63
           K +G G+FG   L + K   +  AVK +++   + +  Q+ I+  R+     ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLK EN LLD   Q  + + DFG  K G+ HS+  ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D W  G  LY ML G  PF      R+  +  D I N    L   + VS   RHLL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYS----RDTAEMYDNILNKPLRLKPNISVS--ARHLLEGLL 231

Query: 243 VADPSKRI----PIPEIKKHPWFL 262
             D +KR+       EIK H +F 
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  146 bits (371), Expect = 3e-42
 Identities = 93/261 (35%), Positives = 126/261 (48%), Gaps = 12/261 (4%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE ++ +G G FG+  L R K  ++LV +K I   +  K      Q E    + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSM 118
           II + E  L    L IVMEYA GG L   I         ED    FF Q++  + + H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            I HRDLK +N LLD   +  +KI DFG SK     S+  + VGTP YI+PE+   K Y+
Sbjct: 121 LILHRDLKTQNILLD-KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K SD+W+ G  LY +      FE    P    K    +      + D  R S D R L+
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLPALVLKI---MSGTFAPISD--RYSPDLRQLI 233

Query: 239 SQIFVADPSKRIPIPEIKKHP 259
             +   DPSKR  + +I   P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  145 bits (369), Expect = 1e-41
 Identities = 83/271 (30%), Positives = 129/271 (47%), Gaps = 25/271 (9%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
           YE ++ +G G+FG  R VR K   +++  K I+ G  + E  ++++++     R L+HPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60

Query: 61  IIRF--KEVLLTPTHLAIVMEYAAGGELFARI--CSA--GRFSEDEARFFFQQLISGVSY 114
           I+R+  + +  +   L IVMEY  GG+L   I  C        E+       QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 115 CH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIA 168
           CH        + HRDLK  N  LD      +K+ DFG +K     S    T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE L    YD K SD+WS G  +Y +   + PF      RN  +   +I+  + F     
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGK-FRRIPY 232

Query: 229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHP 259
           R S++   ++  +   DP KR    E+ + P
Sbjct: 233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 1e-41
 Identities = 85/276 (30%), Positives = 137/276 (49%), Gaps = 30/276 (10%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFK 65
           ++G G +G   L + K T E+VA+K +++      N  R ++  R +    +   +++  
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                  +L + MEY  GG+    + + G  SED ARF+  ++   V   H +   HRDL
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           K EN L+D S    +K+ DFG SK  +  +   S VG+P Y+APEVL  K YD  + D W
Sbjct: 128 KPENFLIDASGH--IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTV-DYW 182

Query: 186 SCGVTLYVMLVGAYPF------EDPEDPRNFRKTIDRIRNVQYFLPDYVR----VSADCR 235
           S G  LY  L G  PF      E  E+ + +++T+ R        P Y      +S +  
Sbjct: 183 SLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFNLSDEAW 234

Query: 236 HLLSQIFVADPSKRI-PIPEIKKHPWFLKNLPKEII 270
            L++++ + DPS+R   + +IK HP+F K +    +
Sbjct: 235 DLITKL-INDPSRRFGSLEDIKNHPFF-KEVDWNEL 268

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  143 bits (364), Expect = 9e-41
 Identities = 87/275 (31%), Positives = 140/275 (50%), Gaps = 29/275 (10%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
            E Y+ ++++G G  G      D+ T + VA+K +   K+  E +  EI+  +  +HPNI
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           + + +  L    L +VMEY  GG L   I  +  R +E +  +  ++++ G+ Y HS  +
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARK 175
            HRD+K +N LL  DGS    +K+ DFG+  +  L    S+  S VGTP ++APEV+ RK
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGF--AAQLTKEKSKRNSVVGTPYWMAPEVIKRK 191

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYP-FEDPEDPRNFRKTID-----RIRNVQYFLPDYVR 229
           +Y  K+ D+WS G+    M  G  P   +P  P      I       ++N +       +
Sbjct: 192 DYGPKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKGIPPLKNPE-------K 241

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            S + +  L++  V DP KR    E+ +HP FLK 
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  144 bits (366), Expect = 1e-40
 Identities = 92/273 (33%), Positives = 133/273 (48%), Gaps = 41/273 (15%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERG--------------KKIDENVQREIINHRSL 56
           LG G+FG   L   K+T EL A+K +++G              K+I E    E       
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE------- 59

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           RHP ++       T  H+  VMEYAAGG+L   I     FSE  A F+   ++ G+ Y H
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLH 118

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 175
             +I +RDLKL+N LLD   +  +KI DFG  K G+      ST  GTP ++APEVL   
Sbjct: 119 ENKIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
            Y   + D W  GV +Y MLVG  PF  +D E+        D I N +   P +  +S +
Sbjct: 177 SYTRAV-DWWGLGVLIYEMLVGESPFPGDDEEE------VFDSIVNDEVRYPRF--LSRE 227

Query: 234 CRHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
              ++ ++   +P +R+        ++KK P+F
Sbjct: 228 AISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  143 bits (363), Expect = 3e-40
 Identities = 87/261 (33%), Positives = 135/261 (51%), Gaps = 22/261 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKY-----IERGKKIDENVQREIINHRSLRHPNIIRFK 65
           LG+G+FG  R+ + K T E  A+K      I + K++    Q + I    L HP I+   
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSI-LMELSHPFIVNMM 84

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                   +  ++E+  GGELF  +  AGRF  D A+F+  +L+    Y HS +I +RDL
Sbjct: 85  CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDL 144

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           K EN LLD   +  +K+ DFG++K   +  +  +  GTP Y+APEV+  K + GK  D W
Sbjct: 145 KPENLLLDN--KGHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSKGH-GKAVDWW 199

Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           + GV LY  + G  PF D + P  FR   ++I   +   P++    A  R L+  +   D
Sbjct: 200 TMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWFDGRA--RDLVKGLLQTD 253

Query: 246 PSKRI-----PIPEIKKHPWF 261
            +KR+      + ++K HP+F
Sbjct: 254 HTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  141 bits (358), Expect = 4e-40
 Identities = 79/269 (29%), Positives = 134/269 (49%), Gaps = 18/269 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGK-KIDENVQREIINHRSLRHPN 60
           R++   ++G G FG      +  T EL+AVK I  +    K  + +  E+     L+HPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEA--RFFFQQLISGVSYCHSM 118
           ++++  V +    + I MEY +GG L   +   GR   DE   R +  QL+ G++Y HS 
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLA 173
            I HRD+K  N  LD +    +K+ DFG +      +  +  + +S  GTPAY+APEV+ 
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 174 RKEYDGKI--SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
             +  G    +D+WS G  +  M  G  P+ + ++   F+         +  +PD +++S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQLS 234

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            + +  L +   +DP KR    E+ +HP+
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  142 bits (359), Expect = 5e-40
 Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 39/291 (13%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPN 60
           RY+ +  +G G  G+    +D+ T E VA+K +   +    I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           +++  +V    +   +VMEY     L   +    R   E + + + + L+ GV+Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVL--ARK 175
           I HRDLK  N L+       LKI DFG ++  S          V T  Y APE+L  ARK
Sbjct: 120 IMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------LPDY 227
            YD  + D+W+ G     +L G+ P    E+       + R               LPDY
Sbjct: 178 -YDPGV-DLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234

Query: 228 VRVS-------------ADCR----HLLSQIFVADPSKRIPIPEIKKHPWF 261
            +++              D       LL  + V DPSKR+   E  +HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  140 bits (354), Expect = 1e-39
 Identities = 81/264 (30%), Positives = 127/264 (48%), Gaps = 18/264 (6%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLR---HPNI 61
           E VK LG G+ GV   VR K T ++ A+K I      DE  +++++   ++LR    P +
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD--GDEEFRKQLLRELKTLRSCESPYV 61

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EI 120
           ++          ++IV+EY  GG L   +   G+  E    +  +Q++ G+ Y H+   I
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            HRD+K  N L+   G      KI DFG SK         +T VGT  Y++PE + + E 
Sbjct: 122 IHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGES 176

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRH 236
               +D+WS G+TL    +G +PF  P  P +F + +  I +     LP     S + R 
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRD 234

Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
            +S     DP KR    E+ +HP+
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  140 bits (355), Expect = 3e-39
 Identities = 88/260 (33%), Positives = 138/260 (53%), Gaps = 16/260 (6%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
           K LG G+FG   L   K T +  A+K +++   + D++V+  ++  R L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T  +L  VMEY  GG+L   I S  +F    A F+  ++I G+ + HS  I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLKL+N LLD      +KI DFG  K  +L      T  GTP YIAPE+L  ++Y+  + 
Sbjct: 121 DLKLDNILLD--TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV- 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D WS GV LY ML+G  PF   ++   F+     IR      P +  ++ + + +L ++F
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQS----IRMDNPCYPRW--LTREAKDILVKLF 231

Query: 243 VADPSKRIPIP-EIKKHPWF 261
           V +P +R+ +  +I++HP+F
Sbjct: 232 VREPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  140 bits (355), Expect = 4e-39
 Identities = 95/263 (36%), Positives = 140/263 (53%), Gaps = 19/263 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
           K LG G FG   LVR+K + +  A+K +++   I  + V   +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           K    T   L  VMEY  GGELF  +     FSED  RF+  +++S + Y HS +I +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYDGKISD 183
           LKLEN +LD      +KI DFG  K G+  +   K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 LKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
            W  GV +Y M+ G  PF + +  + F   +  + ++++  P    +SAD + LLS + +
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELIL--MEDIKF--PR--TLSADAKSLLSGLLI 231

Query: 244 ADPSKRI-----PIPEIKKHPWF 261
            DP+KR+        EI +H +F
Sbjct: 232 KDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 5e-39
 Identities = 82/294 (27%), Positives = 121/294 (41%), Gaps = 48/294 (16%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNI 61
           Y+ + ++G G +GV    RDK T E+VA+K I+   +   I +   REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARIC-----SAGRFSEDEARFFFQQLISGVSYCH 116
           I+  +V      L +V E+     +   +            E   + +  QL+ G+++CH
Sbjct: 61  IKLLDVFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLLHSQPKSTVGTPAYIAPEV 171
           S  I HRDLK EN L++      LK+ DFG      S            V T  Y APE+
Sbjct: 116 SHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHY----VVTRWYRAPEL 169

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDR 216
           L   +      D+WS G     +L     +P +   D             P  + K    
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229

Query: 217 IRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN ++  P    +         S     LLSQ+   DP KRI   +   HP+F
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  139 bits (351), Expect = 1e-38
 Identities = 90/262 (34%), Positives = 135/262 (51%), Gaps = 20/262 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSL----RHPNIIR 63
           K LG G+FG   L   K   E  AVK +++    ID++V+  ++  R L     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T  HL  VME+  GG+L   I   GRF    A F+  +++ G+ + HS  I +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLKL+N +LD      +KI DFG  K  +      ST  GTP YIAPE+L   +Y   + 
Sbjct: 121 DLKLDNVMLDR--DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177

Query: 183 DVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHLLSQ 240
           D WS GV LY ML+G  PF  D ED        +   +++   P Y R ++ + + +L +
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPRWITKESKDILEK 229

Query: 241 IFVADPSKRIPIP-EIKKHPWF 261
           +F  DP++R+ +   I+ HP+F
Sbjct: 230 LFERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  136 bits (345), Expect = 2e-38
 Identities = 85/267 (31%), Positives = 143/267 (53%), Gaps = 24/267 (8%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPN 60
           +Y  VK++G G+FG A LV+ K   +   +K I   K   K  E  ++E+    +++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHS 117
           I++++E      +L IVM+Y  GG+L+ +I +A R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 118 MEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVL 172
            +I HRD+K +N  L  DG+    +K+ DFG ++  +L+S     ++ +GTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
             + Y+ K SD+W+ G  LY M    + FE      N +  + +I    Y  P     S 
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSY-PPVSSHYSY 227

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHP 259
           D R+L+SQ+F  +P  R  +  I +  
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  138 bits (349), Expect = 3e-38
 Identities = 89/248 (35%), Positives = 129/248 (52%), Gaps = 16/248 (6%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
           K LG G FG   LVR+K T    A+K + +   I  + V   +   R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++ +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +KLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 IKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQIF 242
            W  GV +Y M+ G  PF + +  R F   + + IR      P    +S + + LL+ + 
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-----FPR--TLSPEAKSLLAGLL 230

Query: 243 VADPSKRI 250
             DP +R+
Sbjct: 231 KKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  136 bits (345), Expect = 3e-38
 Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 27/268 (10%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE----------RGKKIDENVQREIINHRSLRHPN 60
           +GSG+FG   L  +  + EL+AVK +E          R + + + + REI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+++    L   HL I +EY  GG + A + + G F E   R F +Q++ G++Y H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVLA 173
            HRD+K  N L+D   +  +KI DFG SK       S   +    S  G+  ++APEV+ 
Sbjct: 128 IHRDIKGANILVDN--KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSA 232
           +  Y  K +D+WS G  +  ML G +PF D        + I +I  N    +P  +   A
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPD----CTQLQAIFKIGENASPEIPSNISSEA 240

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                L + F  D +KR    E+ KHP+
Sbjct: 241 --IDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  136 bits (344), Expect = 4e-38
 Identities = 85/268 (31%), Positives = 134/268 (50%), Gaps = 19/268 (7%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
           E + ELG+GN GV   V  + T +++AVK I     I+E +Q++I     I H+    P 
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
           I+ F         ++I MEY  GG L    +    GR  E         ++ G++Y H  
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            +I HRD+K  N L++   Q  +K+CDFG S   L++S  K+ VGT +Y+APE +   +Y
Sbjct: 120 HKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNVQY-FLPDYVRVSADCR 235
             K SD+WS G++L  +  G +P+    D P    + +  I N     LP   + S D +
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQ 234

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLK 263
             ++   + DP +R    E+ +HP+  K
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  135 bits (343), Expect = 9e-38
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E +  ++ +G G+FG      DKRT ++VA+K I+  +  D  E++Q+EI      R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I ++    L  + L I+MEY  GG     +   G+  E    F  ++++ G+ Y H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
            HRD+K  N LL  S +  +K+ DFG S   L  +  K  + VGTP ++APEV+ +  YD
Sbjct: 120 IHRDIKAANILL--SEEGDVKLADFGVSGQ-LTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRVS 231
            K +D+WS G+T   +  G  P  D          P+N   +++             + S
Sbjct: 177 EK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NKFS 224

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-----LPKEIIEIEK 274
              +  +S     DP +R    E+ KH  F+K          +IE  K
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHK-FIKKAKKTSYLTLLIERIK 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  135 bits (340), Expect = 4e-37
 Identities = 85/262 (32%), Positives = 127/262 (48%), Gaps = 19/262 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFKE 66
           +G G+FG    VR + T+ + A+K I +   +  +     +  R++      P I+  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
              +P  L +V+ +  GGELF  +   GRF    ARF+  +L+  +   H   + +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDVW 185
            EN LLD   Q  + +CDFG  K  +      +T  GTP Y+APE+L    Y  K  D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177

Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           + GV LY ML G  PF D      +RK + + +R      PD      D + LL  +   
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR-----FPDGFD--RDAKDLLIGLLSR 230

Query: 245 DPSKRIPI---PEIKKHPWFLK 263
           DP++R+      EIK HP+F +
Sbjct: 231 DPTRRLGYNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  133 bits (336), Expect = 4e-37
 Identities = 87/270 (32%), Positives = 121/270 (44%), Gaps = 30/270 (11%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPN 60
            ++ +K+LG G++G    V+     +  A+K ++ G   +K  E+   EI    S+ HPN
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCH 116
           II +KE  L    L IVMEYA  G+L   I    +      E E    F QL+ G+   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLA 173
             +I HRDLK  N LL  +    +KI D G SK     +  +Q    +GTP Y+APEV  
Sbjct: 121 EQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKNMAKTQ----IGTPHYMAPEVWK 174

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFE--DPEDPRN--FRKTIDRIRNVQYFLPDYVR 229
            + Y  K SD+WS G  LY M   A PFE    +D R    R     I            
Sbjct: 175 GRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPP---------I 224

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHP 259
            S D ++ +  +    P  R    +I   P
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  134 bits (339), Expect = 1e-36
 Identities = 101/337 (29%), Positives = 143/337 (42%), Gaps = 54/337 (16%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDENVQREIINHRSL 56
           RYE +K +GSG +GV     DKRT   VA+K I          K+I     REI   R L
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI----LREIKLLRHL 56

Query: 57  RHPNIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
           RH NII   ++L  P+      + IV E     +L   I S    ++D  ++F  Q++ G
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYI 167
           + Y HS  + HRDLK  N L++ +    LKICDFG ++        K      V T  Y 
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 168 APEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRK 212
           APE+ L+   Y   I D+WS G     +L     +P  D  D                 K
Sbjct: 174 APELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232

Query: 213 TI--DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            I  ++ RN    LP   +          S +   LL ++ V DP KRI   E   HP+ 
Sbjct: 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Query: 262 --LKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRII 296
             L +   E +     ++     D+ T   EE+  +I
Sbjct: 293 AQLHDPEDEPVAKPPFDFDFFDDDELT--EEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  132 bits (335), Expect = 1e-36
 Identities = 84/274 (30%), Positives = 142/274 (51%), Gaps = 17/274 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNI 61
              +   ++G G+ G+  +  DK T   VAVK ++ R ++  E +  E++  R  +HPNI
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +      L    L +VME+  GG L   I +  R +E++       ++  +S+ H+  + 
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVI 137

Query: 122 HRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEY 177
           HRD+K ++ LL  DG    R+K+ DFG+  + +    P  KS VGTP ++APEV++R  Y
Sbjct: 138 HRDIKSDSILLTSDG----RVKLSDFGFC-AQVSKEVPRRKSLVGTPYWMAPEVISRLPY 192

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCRH 236
             ++ D+WS G+ +  M+ G  P+ + E P    + + RIR+     L +  +VS   R 
Sbjct: 193 GTEV-DIWSLGIMVIEMVDGEPPYFN-EPPL---QAMKRIRDNLPPKLKNLHKVSPRLRS 247

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
            L ++ V DP++R    E+  HP+  K  P   I
Sbjct: 248 FLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSI 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 2e-36
 Identities = 84/267 (31%), Positives = 132/267 (49%), Gaps = 26/267 (9%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--------HP 59
           +K +  G FG   L + + T +  A+K +   KK D   + ++ N ++ R         P
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVL---KKSDMIAKNQVTNVKAERAIMMIQGESP 57

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + +      +  +L +VMEY  GG+  + I + G   ED A+ +  +++ GV   H   
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I HRD+K EN L+D +    LK+ DFG S++GL     K  VGTP Y+APE +     D 
Sbjct: 118 IIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DD 171

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VSADCRHL 237
           K+SD WS G  ++  L G  PF   E P      I   R + +  P+ V+   S +   L
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILS-RRINW--PEEVKEFCSPEAVDL 227

Query: 238 LSQIFVADPSKRIP---IPEIKKHPWF 261
           ++++   DP+KR+      EIK HP+F
Sbjct: 228 INRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  131 bits (332), Expect = 2e-36
 Identities = 85/263 (32%), Positives = 125/263 (47%), Gaps = 16/263 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHP 59
            Y P++ LG G FG A L R      LV  K +    ++ E  +R+ +N       L+HP
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNL-TRLSEKERRDALNEIVILSLLQHP 59

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHS 117
           NII +    +    L I MEYA GG L+ +I       F E+   ++  Q++S VSY H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HRD+K  N  L  +    +K+ DFG SK  G  +S  ++ VGTP Y++PE+    +
Sbjct: 120 AGILHRDIKTLNIFLTKA--GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y+ K SD+W+ G  LY +L     F    D  N    + +I    Y  P     S++   
Sbjct: 178 YNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNY-TPVVSVYSSELIS 231

Query: 237 LLSQIFVADPSKRIPIPEIKKHP 259
           L+  +   DP KR    E+   P
Sbjct: 232 LVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  132 bits (334), Expect = 2e-36
 Identities = 81/273 (29%), Positives = 130/273 (47%), Gaps = 21/273 (7%)

Query: 5   YEPVKELGSGNFGVARLVRD---KRTKELVAVKY------IERGKKIDENVQREIINHRS 55
           +E ++ LG+G +G   LVR        +L A+K       +++ K  +       +    
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            R P ++       T T L ++++Y  GGELF  +     F+E E R +  +++  + + 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLA 173
           H + I +RD+KLEN LLD   +  + + DFG SK  L   + +  S  GT  Y+APEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 174 RKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVS 231
                  K  D WS GV  + +L GA PF   +  +N +  I  RI   +   P    +S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMS 236

Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
           A+ R  + ++   DP KR+      EIK HP+F
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  134 bits (339), Expect = 2e-36
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 24/274 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENV---QREIINHRSL 56
           E ++ +K +G G FG  +LVR K +K++ A+K +   E  K+ D      +R+I+ H + 
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
               I++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVL 172
           SM   HRD+K +N LLD S    LK+ DFG       +G++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEVL 215

Query: 173 ARKEYD---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
             +  D   G+  D WS GV LY MLVG  PF        + K +D   ++ +  PD + 
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDIE 273

Query: 230 VSADCRHLLSQIFVADPSK--RIPIPEIKKHPWF 261
           +S   + L+         +  R  + EIK HP+F
Sbjct: 274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  133 bits (336), Expect = 2e-36
 Identities = 89/306 (29%), Positives = 149/306 (48%), Gaps = 37/306 (12%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV------QREIINHRSLRHPNIIRF 64
           +G G+FG  ++VR+K T ++ A+K +++   + +        +R+I++  +   P I + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN--SPWIPQL 66

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
           +       +L +VMEY  GG+L + +     +F ED A+F+  +L+  +   H M   HR
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           D+K EN L+D +    +K+ DFG +   +       K  VGTP YIAPEVL     DGK 
Sbjct: 127 DIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 182 S-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234
           +     D WS GV  Y M+ G  PF   E      KT + I N Q FL  P+  +VS+D 
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWF-------LKNLPKEII-----EIEKTNYKEAGR 282
             L+ Q  +    +R+    +  HP+F       ++N     +     + + +N+ E  +
Sbjct: 241 LDLI-QSLLCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEK 299

Query: 283 DQPTQS 288
           +   +S
Sbjct: 300 NSTRRS 305

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (335), Expect = 4e-36
 Identities = 85/264 (32%), Positives = 135/264 (51%), Gaps = 21/264 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENV-QREIINHRSLRH-PNIIR 63
           +G G FG    VR K T+ + A+K +        K++   + +R I+    L   P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
            K    T + L +V +Y +GGELF  +   GRFSED A+F+  +L+  + + H  +I +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLK EN LLD +    + +CDFG SK+ L  ++  +T  GT  Y+APEVL  ++   K  
Sbjct: 121 DLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-TIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           D WS GV ++ M  G  PF   +  + +R     ++R      P  V +S + R  +  +
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR-----FPKNV-LSDEGRQFVKGL 232

Query: 242 FVADPSKRI----PIPEIKKHPWF 261
              +P  R+       E+K+HP+F
Sbjct: 233 LNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  132 bits (334), Expect = 4e-36
 Identities = 88/262 (33%), Positives = 134/262 (51%), Gaps = 20/262 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L   K T EL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T   L  VMEY  GG+L   I   G+F E  A F+  ++  G+ + HS  I +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
           KL+N +LD      +KI DFG  K  +   +   T  GTP YIAPE++A + Y GK  D 
Sbjct: 128 KLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PF+  ++   F+  ++   NV Y         + C+ LL++    
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLLTK---- 238

Query: 245 DPSKRIPI-----PEIKKHPWF 261
            P+KR+        +I++H +F
Sbjct: 239 HPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 7e-36
 Identities = 86/307 (28%), Positives = 139/307 (45%), Gaps = 60/307 (19%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVK------YIERGKKIDENVQREIINHRSLRH 58
           +E +K +G G FG  RLV+ K T  + A+K       +E+ +      +R+I+      +
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA--EADN 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L ++MEY  GG++   +     F+E+E RF+  + I  +   H +
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG-------------------------------- 146
              HRD+K +N LLD      +K+ DFG                                
Sbjct: 121 GYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178

Query: 147 YSKSGLLHSQPK-------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY 199
            S      +  +       STVGTP YIAPEV  +  Y  K  D WS GV +Y MLVG  
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYP 237

Query: 200 PF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP---E 254
           PF  ++P++   +RK I+    +Q+  PD V +S + + L+ +    +  +R+      E
Sbjct: 238 PFCSDNPQE--TYRKIINWKETLQF--PDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNE 292

Query: 255 IKKHPWF 261
           IK HP+F
Sbjct: 293 IKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  132 bits (332), Expect = 8e-36
 Identities = 92/263 (34%), Positives = 133/263 (50%), Gaps = 19/263 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
           K +G G+FG   L R K  ++  AVK +++   + +  ++ I++ R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLK EN LLD   Q  + + DFG  K  + H+   ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDS--QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D W  G  LY ML G  PF      RN  +  D I N    L   +  SA  RHLL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPNITNSA--RHLLEGLL 231

Query: 243 VADPSKRI----PIPEIKKHPWF 261
             D +KR+       EIK H +F
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  131 bits (331), Expect = 9e-36
 Identities = 94/275 (34%), Positives = 140/275 (50%), Gaps = 22/275 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL---RHPNIIRF 64
           K LG G FG   LV++K T    A+K +++   +  + V   +  +R L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHR 123
           K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   + +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           DLKLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y G+  
Sbjct: 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLLSQI 241
           D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + LLS +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP-------EAKSLLSGL 230

Query: 242 FVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
              DP +R+        EI +H +F   + +++ E
Sbjct: 231 LKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYE 265

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  131 bits (330), Expect = 1e-35
 Identities = 89/263 (33%), Positives = 127/263 (48%), Gaps = 19/263 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-----SLRHPNIIR 63
           K +G G+FG   L + K      AVK +++   + +  Q  I+  R     +L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLK EN LLD   Q  + + DFG  K G+   +  ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D W  G  LY ML G  PF      R+  +  D I +    LP   +  A C  LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYS----RDVSQMYDNILHKPLQLPG-GKTVAAC-DLLVGLL 231

Query: 243 VADPSKRI----PIPEIKKHPWF 261
             D  +R+       EIK H +F
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  131 bits (330), Expect = 1e-35
 Identities = 83/268 (30%), Positives = 147/268 (54%), Gaps = 25/268 (9%)

Query: 8   VKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK-KIDENV----QREIINHRSLRHP 59
           +K LG G+FG   LVR     +   L A+K +++   K+ + V    +R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            I++      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + HS+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           I +RDLK EN LLD      +K+ DFG SK  + H  +  S  GT  Y+APEV+ R+ + 
Sbjct: 119 IIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            + +D WS GV ++ ML G+ PF+     ++ ++T+  I   +  +P +  +S + + LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229

Query: 239 SQIFVADPSKRI-----PIPEIKKHPWF 261
             +F  +P+ R+      + EIK+HP+F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  131 bits (330), Expect = 2e-35
 Identities = 87/269 (32%), Positives = 133/269 (49%), Gaps = 24/269 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
           K LG G+FG   L   K T E+ A+K +++   + D++V   +   R L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  VMEY  GG+L  +I  + +F E  +RF+  ++   + + H   + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLKL+N LLD   +   K+ DFG  K G+L+    +T  GTP YIAPE+L   EY   + 
Sbjct: 121 DLKLDNILLDA--EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV- 177

Query: 183 DVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           D W+ GV +Y M+ G  PFE D ED        + I +     P  V +S +   +L   
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSILKAF 230

Query: 242 FVADPSKRIPI-------PEIKKHPWFLK 263
              +P+KR+           IK+HP+F +
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  128 bits (322), Expect = 4e-35
 Identities = 91/265 (34%), Positives = 133/265 (50%), Gaps = 15/265 (5%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPN 60
           RYE +K++G G+FG   L + K   E   +K I+  K   K  E  ++E+I    ++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHSM 118
           I+ F         L IVMEY  GG+L  RI       FSED+   +F Q+  G+ + H  
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAYIAPEVLARKE 176
           +I HRD+K +N  L  +     K+ DFG ++  L  S     + VGTP Y++PE+   + 
Sbjct: 121 KILHRDIKSQNIFLSKNGMVA-KLGDFGIARQ-LNDSMELAYTCVGTPYYLSPEICQNRP 178

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y+ K +D+WS G  LY +    +PFE      N  + + +I    YF P     S D R 
Sbjct: 179 YNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQ-GYFAPISPNFSRDLRS 232

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           L+SQ+F   P  R  I  I K P+ 
Sbjct: 233 LISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  130 bits (327), Expect = 4e-35
 Identities = 90/263 (34%), Positives = 130/263 (49%), Gaps = 21/263 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L R K +  L AVK +++   + D++V+  +   R L     HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               TP  L  VME+  GG+L   I  + RF E  ARF+  ++ S + + H   I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
           KL+N LLD   +   K+ DFG  K G+ + +  ST  GTP YIAPE+L    Y G   D 
Sbjct: 123 KLDNVLLDH--EGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PFE   +   F    + I N +   P +  +S D   +L      
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPTW--LSQDAVDILKAFMTK 233

Query: 245 DPSKRIPI------PEIKKHPWF 261
           +P+ R+          I +HP+F
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  129 bits (325), Expect = 5e-35
 Identities = 91/288 (31%), Positives = 141/288 (48%), Gaps = 39/288 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSL 56
           E +E +K + +G +G   LVR K T++  A+K I +   I  N      V+R+I+     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            +P ++       T  HL +VMEY  GG+    + + G    D AR +F + +  + Y H
Sbjct: 60  -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----------------QPKST 160
           +  I HRDLK +N L+  +    +K+ DFG SK GL+                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIR 218
            GTP YIAPEV+ R+ Y GK  D W+ G+ LY  LVG  PF  + PE+   F + I    
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229

Query: 219 NVQYFLPDYVR-VSADCRHLLSQIFVADPSKRIPIP---EIKKHPWFL 262
           +     P+    + AD + L+S++   +P +R+      E+K+H +FL
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 6e-35
 Identities = 86/265 (32%), Positives = 131/265 (49%), Gaps = 21/265 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERG------KKIDENVQREIINHRSLRHPNII 62
           K LG G FG   L  D  T   +AVK +         KK    ++ EI   ++L+H  I+
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           ++   L     L+I MEY  GG +  ++ + G  +E   R + +Q++ GV Y HS  I H
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQ---PKSTVGTPAYIAPEVLARKEYD 178
           RD+K  N L D +    +K+ DFG SK    + S     KS  GTP +++PEV++ + Y 
Sbjct: 128 RDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY- 184

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--RNVQYFLPDYVRVSADCRH 236
           G+ +DVWS G T+  ML    P+ + E        I +I  +     LP +  VS D R+
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNPQLPSH--VSPDARN 238

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
            L + FV +  KR    E+ +H + 
Sbjct: 239 FLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  128 bits (324), Expect = 1e-34
 Identities = 98/280 (35%), Positives = 142/280 (50%), Gaps = 26/280 (9%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L   K T EL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T   L  VMEY  GG+L  +I   GRF E  A F+  ++  G+ + HS  I +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           KL+N +LD   +  +KI DFG  K  +      K+  GTP YIAPE++A + Y GK  D 
Sbjct: 128 KLDNVMLDS--EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PFE  ++   F+  ++   NV Y         A C+ L+++    
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK---- 238

Query: 245 DPSKRIPI-PE----IKKHPWFLKNLPKEIIEIEKTNYKE 279
            P KR+   PE    IK+H +F        I+ EK   KE
Sbjct: 239 HPGKRLGCGPEGERDIKEHAFF------RYIDWEKLERKE 272

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  126 bits (320), Expect = 2e-34
 Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 52/296 (17%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQ-REIINHRSLR----H 58
           Y+ +K+LG G FG   L R+K T ELVA+K +++     +E +  RE+   +SLR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCH 116
           PNI++ KEV      L  V EY   G L+  +       FSE   R    Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
                HRDLK EN L+  S    +KI DFG ++   + S+P  T  V T  Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 175 -KEYDGKISDVWSCG---VTLYVM------------------LVGAYPFED--PEDPR-- 208
              Y   + D+W+ G     LY +                  ++G  P +   PE  +  
Sbjct: 173 STSYSSPV-DIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT-PTKQDWPEGYKLA 230

Query: 209 ---NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
               FR       ++   +P+    S +   L+  +   DP KR    +  +HP+F
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPN---ASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (314), Expect = 1e-33
 Identities = 73/254 (28%), Positives = 105/254 (41%), Gaps = 23/254 (9%)

Query: 9   KELGSGNFGV---ARLV-RDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNII 62
           K+LG G FG      L  +    +  VAVK ++        E   RE    R L HPNI+
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  S   
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-----LHSQPKSTVGTPAYIAPEVLARK 175
            HRDL   N L+       +KI DFG S+             K  +    ++APE L   
Sbjct: 125 IHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESLKEG 179

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           ++  K SDVWS GV L+ +       E+P    +  + ++ ++   Y LP       +  
Sbjct: 180 KFTSK-SDVWSFGVLLWEIFTLG---EEPYPGMSNAEVLEYLKK-GYRLPKPPNCPPELY 234

Query: 236 HLLSQIFVADPSKR 249
            L+ Q +  DP  R
Sbjct: 235 KLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  126 bits (318), Expect = 1e-33
 Identities = 83/271 (30%), Positives = 139/271 (51%), Gaps = 25/271 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKIDEN------VQREIINHRS 55
           E +  ++ LG+G+FG   L   K      VA+K  E+ K I +        +R+I+N+  
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + HP  +         ++L +V+E+  GGE F  +    RF  D   F+  Q++    Y 
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
            S+ I +RDLK EN LLD      +K+ DFG++K  ++ ++  +  GTP YIAPE+L   
Sbjct: 148 QSLNIVYRDLKPENLLLD--KDGFIKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNV 203

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            + GK +D W+ G+ +Y +LVG  PF   E    ++K ++ I     + P +  +  +C+
Sbjct: 204 GH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI----IYFPKF--LDNNCK 256

Query: 236 HLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           HL+ ++   D +KR          +K+HPWF
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  125 bits (316), Expect = 2e-33
 Identities = 89/268 (33%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHP 59
           +  +  LG G+FG   L   K T EL A+K +++   I D++V+  ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + +      T   L  VMEY  GG+L   I   G+F E +A F+  ++  G+ + H   
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
           I +RDLKL+N +LD   +  +KI DFG  K  ++      T  GTP YIAPE++A + Y 
Sbjct: 122 IIYRDLKLDNVMLDS--EGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           GK  D W+ GV LY ML G  PF+  ++   F+  ++   NV Y         + C+ L+
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLM 236

Query: 239 SQIFVADPSKRIPI-PE----IKKHPWF 261
           ++     PSKR+   PE    I++H +F
Sbjct: 237 TKH----PSKRLGCGPEGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  124 bits (313), Expect = 5e-33
 Identities = 91/289 (31%), Positives = 149/289 (51%), Gaps = 23/289 (7%)

Query: 5   YEPVKELGSGNFGVARLVRD---KRTKELVAVK------YIERGKKIDEN-VQREIINHR 54
           +E +K LG+G +G   LVR      T +L A+K       +++ K ++    +R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
             + P ++       T   L ++++Y +GGE+F  +     FSEDE RF+  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172
            H + I +RD+KLEN LLD   +  + + DFG SK  L   + +  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDS--EGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
             K   GK  D WS G+ ++ +L GA PF   E  RN +  + R R ++   P    +  
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSR-RILKCDPPFPSFIGP 236

Query: 233 DCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIEIEKTN 276
           + + LL ++   DP KR+        EIK+HP+F K L  E + + K N
Sbjct: 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLDWEALALRKVN 284

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  122 bits (309), Expect = 6e-33
 Identities = 75/253 (29%), Positives = 108/253 (42%), Gaps = 22/253 (8%)

Query: 9   KELGSGNFGV---ARLV-RDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNII 62
           K+LG G FG     +L  +  + K  VAVK ++        E   RE    R L HPN++
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   V      L IVMEY  GG+L  + R  +  + S  +   F  Q+  G+ Y  S   
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLESKNF 123

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEVLARKEYD 178
            HRDL   N L+       +KI DFG S+        +   G  P  ++APE L   ++ 
Sbjct: 124 IHRDLAARNCLVGE--NLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFT 181

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCRH 236
            K SDVWS GV L+ +      F   E P       + +  ++  Y LP       +   
Sbjct: 182 SK-SDVWSFGVLLWEI------FTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYD 234

Query: 237 LLSQIFVADPSKR 249
           L+ Q +  DP  R
Sbjct: 235 LMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  122 bits (307), Expect = 8e-33
 Identities = 85/254 (33%), Positives = 120/254 (47%), Gaps = 20/254 (7%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
           +E + ++G G+FGV   V  K  K + A+K I+   K++   + E I+       L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSM 118
           IIR+ E  L    L IVMEYA  G+L   +         ED+   FF Q++ G+++ HS 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARK 175
           +I HRD+K  N  LD      +KI D G +K  LL        + VGTP Y++PE+   K
Sbjct: 121 KILHRDIKSLNLFLDAYDN--VKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y+ K SDVW+ GV LY    G +PF+         K    IR V  F P     S    
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKI---IRGV--FPPVSQMYSQQLA 230

Query: 236 HLLSQIFVADPSKR 249
            L+ Q    D  +R
Sbjct: 231 QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  122 bits (308), Expect = 8e-33
 Identities = 83/267 (31%), Positives = 128/267 (47%), Gaps = 21/267 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE-----------RGKKIDENVQREIINHRSLRHP 59
           +G G +G   L  +  T E++AVK +E           R K + + ++ EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+++     T  +L+I +EY  GG + + + + GRF E   RFF +Q++ G++Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSG---LLHSQPKSTVGTPAYIAPEV--LAR 174
           I HRDLK +N L+D       KI DFG SK       + Q  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDA--DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-RVSAD 233
           + Y  K+ D+WS G  +  M  G  P+ D E      K +   R+     PD    +S  
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKRSAPPIPPDVSMNLSPV 244

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPW 260
               L+  F  +P  R    E+ +HP+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  122 bits (309), Expect = 1e-32
 Identities = 89/301 (29%), Positives = 132/301 (43%), Gaps = 48/301 (15%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLR 57
           RYE  K+LG G + V    RDK T  +VA+K I+ G++      I+    REI   + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
           HPNII   +V    +++ +V E+    +L   I   +   +  + + +    + G+ Y H
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIAPEVL 172
           S  I HRDLK  N L+       LK+ DFG ++S      P       V T  Y APE+L
Sbjct: 120 SNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPELL 174

Query: 173 --ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRK----TIDRIRNVQ 221
             AR  Y   + D+WS G     +L+   PF   +       + F      T +    V 
Sbjct: 175 FGARH-YGVGV-DMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231

Query: 222 YFLPDYVRV---------------SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
             LPDYV                 S D   LL ++   +P+KRI   +  +HP+F  N P
Sbjct: 232 S-LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDP 289

Query: 267 K 267
            
Sbjct: 290 A 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  123 bits (310), Expect = 1e-32
 Identities = 88/270 (32%), Positives = 134/270 (49%), Gaps = 27/270 (10%)

Query: 8   VKELGSGNFGVARLVR---DKRTKELVAVKYIERGKKIDE-------NVQREIINHRSLR 57
           +K LG G +G    VR      T ++ A+K +++   +           +R I+   +++
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNIL--EAVK 58

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP I+       T   L +++EY +GGELF  +   G F ED A F+  ++   + + H 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
             I +RDLK EN LLD   Q  +K+ DFG  K  +       T  GT  Y+APE+L R  
Sbjct: 119 QGIIYRDLKPENILLDA--QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG 176

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           + GK  D WS G  +Y ML GA PF       N +KTID+I   +  LP Y  ++ + R 
Sbjct: 177 H-GKAVDWWSLGALMYDMLTGAPPFT----AENRKKTIDKILKGKLNLPPY--LTPEARD 229

Query: 237 LLSQIFVADPSKRI-----PIPEIKKHPWF 261
           LL ++   +PS R+        E++ HP+F
Sbjct: 230 LLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  121 bits (304), Expect = 2e-32
 Identities = 82/254 (32%), Positives = 129/254 (50%), Gaps = 19/254 (7%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNI 61
           +Y  ++ +G G+FG A LV+   + +  A+K I   K     E+ ++E +    ++HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           + FKE      HL IVMEY  GG+L  +I    G+ F ED    +F Q+  GV + H   
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS----TVGTPAYIAPEVLARK 175
           + HRD+K +N  L  +   ++K+ DFG   S  L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y+ K SD+WS G  LY +    +PF+      +++  I ++    Y  P     S + R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSY-KPLPSHYSYELR 229

Query: 236 HLLSQIFVADPSKR 249
            L+ Q+F  +P  R
Sbjct: 230 SLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 2e-32
 Identities = 72/200 (36%), Positives = 106/200 (53%), Gaps = 17/200 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
           +E YE ++ +GSG +G     RD  T ELVA+K I  E G   +  +Q+EI   +  RHP
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHP 60

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           NI+ +    L    L IVMEY  GG   +++      G  SE +  +  ++ + G++Y H
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH 118

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLA- 173
                HRD+K  N LL       +K+ DFG S + L  +  K  S +GTP ++APEV A 
Sbjct: 119 ETGKIHRDIKGANILLTEDGD--VKLADFGVS-AQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 174 --RKEYDGKISDVWSCGVTL 191
             +  YDGK  D+W+ G+T 
Sbjct: 176 ERKGGYDGKC-DIWALGITA 194

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  122 bits (307), Expect = 3e-32
 Identities = 83/263 (31%), Positives = 131/263 (49%), Gaps = 19/263 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
           K +G G+FG   L + K   +  AVK +++   ++   Q+ I+  R++     +HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T   L  V+++  GGELF  +     F E  ARF+  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKIS 182
           DLK EN LLD   Q  + + DFG  K G+  S   +T  GTP Y+APEV+ ++ YD  + 
Sbjct: 121 DLKPENILLDS--QGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV- 177

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D W  G  LY ML G  PF      R+  +  D I +    L     ++A    +L ++ 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYC----RDVAEMYDNILHKPLVLRPGASLTA--WSILEELL 231

Query: 243 VADPSKRI----PIPEIKKHPWF 261
             D  +R+       EI++HP+F
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 3e-32
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 26/268 (9%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
           K+LG G FG     +L         VAVK ++     +E     +E    + L HPN++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS-------GVSY 114
              V      L +V+EY  GG+L  + R       S +++    + L+S       G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEV 171
             S +  HRDL   N L+       +KI DFG S+        +   G    I   APE 
Sbjct: 121 LASKKFVHRDLAARNCLVGE--DLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
           L    +  K SDVWS GV L+ +  +GA P+       +  + ++ +R   Y LP     
Sbjct: 179 LKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GYRLPKPEYC 232

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKH 258
             +   L+   +  DP  R    E+ + 
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  123 bits (310), Expect = 3e-32
 Identities = 87/312 (27%), Positives = 130/312 (41%), Gaps = 65/312 (20%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRH 58
           +  +K +G G FG   LVR   T  L A+K + +   +  N       +R+I+      +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--N 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
             +++         +L  VM+Y  GG++ + +   G F ED ARF+  +L   +   H M
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG------------YSKSGLLHSQ---------- 156
              HRD+K +N L+D      +K+ DFG            Y + G  H Q          
Sbjct: 121 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 157 ------PK----------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
                  K                S VGTP YIAPEVL R  Y  ++ D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237

Query: 195 LVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADPSKRI-- 250
           LVG  PF          +T  ++ N +  L  P   ++S +   L+ ++       R+  
Sbjct: 238 LVGQPPFLADTPA----ETQLKVINWETTLHIPSQAKLSREASDLILRL-CCGAEDRLGK 292

Query: 251 -PIPEIKKHPWF 261
               EIK HP+F
Sbjct: 293 NGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 4e-32
 Identities = 72/202 (35%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKY---IERGKKIDENVQREIINHRSLRHP 59
            +YE +  +G G +GV    R+K T E+VA+K     E  + + +   RE+   R LRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+  KE       L +V EY     L     S G    D  R +  QL+  ++YCHS  
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVLARK 175
           I HRD+K EN L+  S    LK+CDFG++++  L ++P S     V T  Y APE+L   
Sbjct: 121 IIHRDIKPENILVSESGV--LKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLVGD 176

Query: 176 EYDGKISDVWSCGVTLYVMLVG 197
              GK  DVW+ G  +  +L G
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  119 bits (301), Expect = 6e-32
 Identities = 76/257 (29%), Positives = 124/257 (48%), Gaps = 16/257 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVK---YIERGKKIDENVQ---REIINHRSLRHPNIIRF 64
           LGSG+FG      +    +  AVK     + G+   E V+   +EI     L+HPNI+++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                   +L I +E   GG L   +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           +K  N L+D +    +K+ DFG +K  +  S  KS  G+P ++APEV+A++   G  +D+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQIF 242
           WS G T+  M  G  P+   E        + +I   +    +PD+  +S + +  + +  
Sbjct: 186 WSLGCTVLEMATGKPPWSQLE----GVAAVFKIGRSKELPPIPDH--LSDEAKDFILKCL 239

Query: 243 VADPSKRIPIPEIKKHP 259
             DPS R    E+ +HP
Sbjct: 240 QRDPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  121 bits (306), Expect = 8e-32
 Identities = 89/309 (28%), Positives = 136/309 (44%), Gaps = 45/309 (14%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRH 58
             RY+P++ +GSG +GV     D R+ + VA+K I     +    +R   E+   R  +H
Sbjct: 4   GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH 63

Query: 59  PNIIRFKEVLLTP----THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            NII  +++L  P      + +VM+     +L   I S    +E+  R+F  QL+ G+ Y
Sbjct: 64  DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKY 122

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIA 168
            HS  + HRDLK  N L++   +  L+I DFG ++ GL  S  +        V T  Y A
Sbjct: 123 IHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMAR-GLSSSPTEHKYFMTEYVATRWYRA 179

Query: 169 PEVL-ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKT 213
           PE+L +  EY   I D+WS G     ML     +P ++                      
Sbjct: 180 PELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 214 I--DRIRNVQYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
           I  DR+R     LP          + + S +   LLSQ+   DP +RI + +  +HP FL
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-FL 297

Query: 263 KNLPKEIIE 271
                   E
Sbjct: 298 AQYHDPDDE 306

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 8e-32
 Identities = 80/294 (27%), Positives = 130/294 (44%), Gaps = 44/294 (14%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKK-IDENVQREIINHRSLRHPNI 61
           YE + ++G G +G     R+K+T ELVA+K I  E  K+       REI   + LRHPNI
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 62  IRFKEVLLTPTHLAI--VMEYA----AGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           +R KE++ +    +I  V EY      G           +F+E + + + +QL+ G+ Y 
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLD-SPEVKFTESQIKCYMKQLLEGLQYL 116

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL- 172
           HS  I HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE+L 
Sbjct: 117 HSNGILHRDIKGSNILINN--DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-----------RIRNVQ 221
               Y  ++ D+WS G  L  + +G   F+   +     K  +            +  + 
Sbjct: 175 GATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP 233

Query: 222 YF------------LPDYVR--VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +F            L ++ +  +      LL ++   DP KRI   +  +H +F
Sbjct: 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  120 bits (302), Expect = 1e-31
 Identities = 88/281 (31%), Positives = 134/281 (47%), Gaps = 25/281 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKEVL 68
           LG G  G     R K T  + A+K I      D   Q  RE+  ++S + P I+++    
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 69  LTP--THLAIVMEYAAGGEL---FARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           L    + + I MEY  GG L   + ++    GR  E       + ++ G+SY HS +I H
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RD+K  N LL    Q  +K+CDFG S   L++S   +  GT  Y+APE +  K Y    S
Sbjct: 129 RDIKPSNILLTRKGQ--VKLCDFGVSGE-LVNSLAGTFTGTSFYMAPERIQGKPYSIT-S 184

Query: 183 DVWSCGVTLYVMLVGAYPF----EDPEDPRNFRKTIDRIRNVQYFLPD----YVRVSADC 234
           DVWS G+TL  +    +PF    E P  P      I  + N +  L D     ++ S + 
Sbjct: 185 DVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE--LKDEPGNGIKWSEEF 242

Query: 235 RHLLSQIFVADPSKRIPIP-EIKKHPWFLKNLPKEIIEIEK 274
           +  + Q    DP++R P P ++ +HPW +K   K+ + + K
Sbjct: 243 KDFIKQCLEKDPTRR-PTPWDMLEHPW-IKAQMKKKVNMAK 281

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  118 bits (297), Expect = 3e-31
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 10/206 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           EE ++ +++LG G++G       K T ++VA+K +   + + + + +EI   +    P I
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +++       T L IVMEY   G +    +I +    +E+E      Q + G+ Y HS +
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL+   Q   K+ DFG S   L  +  K  + +GTP ++APEV+    Y
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
           + K  D+WS G+T   M  G  P+ D
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 3e-31
 Identities = 81/264 (30%), Positives = 128/264 (48%), Gaps = 18/264 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRH--- 58
           R E +   G G +G     +   T  +VA+K I      D+  ++QRE+     LR    
Sbjct: 5   RLELI---GRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR-KE 176
            + HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV+   K 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           YD K +D+WS G+T+Y M  G  P+ D  D   FR  +   ++    L D    S   R 
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSD-VDA--FRAMMLIPKSKPPRLEDN-GYSKLLRE 233

Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
            ++     +P +R+   E+ K  W
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 4e-31
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 36/290 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRH 58
            + +E + ELG G FG     + K T    A K I+   +    D  V+ +I++    +H
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKH 61

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHS 117
           PNI+   E       L I++E+  GG L + +    R  +E + R+  +Q++  +++ HS
Sbjct: 62  PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 118 MEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
            ++ HRDLK  N LL  DG     +K+ DFG S       Q + T +GTP ++APEV+A 
Sbjct: 122 HKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 174 ----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-------TIDRIRNVQY 222
                  YD K +D+WS G+TL  +     P  +    R   K       T+D+      
Sbjct: 178 ETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS---- 232

Query: 223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
                 + S+     L    V DP  R    E+ KHP+       + I+ 
Sbjct: 233 ------KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKD 276

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  117 bits (295), Expect = 5e-31
 Identities = 83/268 (30%), Positives = 126/268 (47%), Gaps = 21/268 (7%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE-------RGKKIDENVQREIINHRSLRHPNI 61
           ++LG+G F      RD +T  L+AVK +          +++ E +++EI     L HP+I
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           IR        +H  + +E+ AGG +   +   G F E     + +QL+ G+SY H  +I 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125

Query: 122 HRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           HRD+K  N L+D + Q RL+I DFG         + +G    Q    +GT A++APEVL 
Sbjct: 126 HRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQ---LLGTIAFMAPEVL- 180

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           R E  G+  DVWS G  +  M     P+ + E   N    I +I +          +S  
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPG 239

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            R +  +     P  R P  E+ KHP F
Sbjct: 240 LRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  119 bits (300), Expect = 6e-31
 Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 22/273 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E Y+ VK +G G FG  +LVR K ++++ A+K + + + I  +        R +      
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  A+F+  +++  +   HSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 161

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            + HRD+K +N LLD      LK+ DFG      ++G++     + VGTP YI+PEVL  
Sbjct: 162 GLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKS 217

Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV L+ MLVG  PF        + K +D   ++ +  P+ V +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEIS 275

Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
              ++L+   F+ D   R+    + EIK+HP+F
Sbjct: 276 KHAKNLICA-FLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  116 bits (293), Expect = 1e-30
 Identities = 79/265 (29%), Positives = 121/265 (45%), Gaps = 22/265 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------VQREIINHRSLRHPNIIR 63
           LG G FG     + K T ++ A K +++ K++ +         +++I+   S R   I+ 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDK-KRLKKRKGEQMALNEKKILEKVSSRF--IVS 57

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEIC 121
                 T   L +VM    GG+L   I + G   F E  A F+  Q+I G+ + H   I 
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIV 117

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           +RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL  + YD  +
Sbjct: 118 YRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175

Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            D ++ G TLY M+ G  PF   ++     +   R   +    PD  + S + + L   +
Sbjct: 176 -DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEAL 232

Query: 242 FVADPSKRI-----PIPEIKKHPWF 261
              DP KR+        E+++HP F
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  118 bits (297), Expect = 2e-30
 Identities = 89/273 (32%), Positives = 138/273 (50%), Gaps = 22/273 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E YE VK +G G FG  +LVR K T+++ A+K + + + I  +        R +      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   HSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
              HRD+K +N LLD S    LK+ DFG     +K G++     + VGTP YI+PEVL  
Sbjct: 162 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKS 217

Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 275

Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
            + ++L+   F+ D   R+    + EIK+H +F
Sbjct: 276 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 3e-30
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 41/284 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----H 58
             +E V+ +G G +G     R K+T +LVA+K ++  +  +E ++ E      LR    H
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSNH 62

Query: 59  PNIIRFKEVLLTPTH------LAIVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQL 108
           PNI  F    +          L +VME   GG   +L   +   G R  E+   +  ++ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-------V 161
           + G++Y H  ++ HRD+K +N LL  +    +K+ DFG S      +Q  ST       +
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILL--TKNAEVKLVDFGVS------AQLDSTLGRRNTFI 174

Query: 162 GTPAYIAPEVLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216
           GTP ++APEV+A  E     YD + SDVWS G+T   +  G  P  D    R   K    
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKI--- 230

Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            RN    L      S      +S+  + +  +R  + E+ +HP+
Sbjct: 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  115 bits (290), Expect = 4e-30
 Identities = 86/299 (28%), Positives = 139/299 (46%), Gaps = 56/299 (18%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHP 59
           +YE ++++G G +G     +++ T E+VA+K + R    DE V     REI   + L+H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 60  NIIRFKEVLLTPTHLAIVMEY----------AAGGELFARICSAGRFSEDEARFFFQQLI 109
           NI+R  +VL +   L +V EY          +  G++   I           + F  QL+
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIV----------KSFMFQLL 109

Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIA 168
            G+++CHS  + HRDLK +N L++ + +  LK+ DFG +++ G+      + V T  Y  
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRP 167

Query: 169 PEVL-ARKEYDGKISDVWSCGVTLYVMLVGA---YPFEDPEDP--RNFR----KTIDRIR 218
           P+VL   K Y   I D+WS G     +       +P  D +D   R FR     T +   
Sbjct: 168 PDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226

Query: 219 NVQYFLPDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            V   LPDY                 ++++  R LL  + V +P +RI   E  +HP+F
Sbjct: 227 GVSK-LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  112 bits (283), Expect = 6e-29
 Identities = 76/198 (38%), Positives = 105/198 (53%), Gaps = 17/198 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           E+ +  ++E+G G+FG     RD RT E+VA+K +   GK+ +E  Q   +E+   + LR
Sbjct: 14  EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYC 115
           HPN I +K   L      +VMEY  G    + I    +    E E        + G++Y 
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCLGSA--SDILEVHKKPLQEVEIAAICHGALQGLAYL 131

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LAR 174
           HS E  HRD+K  N LL  +    +K+ DFG   S  L S   S VGTP ++APEV LA 
Sbjct: 132 HSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAM 186

Query: 175 KE--YDGKISDVWSCGVT 190
            E  YDGK+ DVWS G+T
Sbjct: 187 DEGQYDGKV-DVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  111 bits (280), Expect = 6e-29
 Identities = 89/272 (32%), Positives = 131/272 (48%), Gaps = 28/272 (10%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERG-----KKIDENVQREIINHRS 55
           RY   + LG G+FG   LV+DK+      L  +K I  G     + +  N + ++++   
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----CSAGRFSEDEARFFFQQLISG 111
           L HP I++F    L      I+ EY  G +L  ++     +    SE++   +F QL+ G
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
           V Y H   I HRDLK +N  L  +    LKI DFG S+  L+ S   +T   GTP Y++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRL-LMGSCDLATTFTGTPYYMSP 174

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYV 228
           E L  + YD K SD+WS G  LY M   A+ FE     +NF   + RI       LP+  
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE-- 227

Query: 229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
             S     ++  +   DPS R    EI ++P+
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 7e-29
 Identities = 81/300 (27%), Positives = 125/300 (41%), Gaps = 56/300 (18%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLR-- 57
           YE + E+G G +G     RD  T   VA+K +     E G  I  +  REI   + L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 58  -HPNIIRFKEVLLTP-----THLAIVMEYA----AGGELFARICSAGRFSEDEARFFFQQ 107
            HPNI+R  +V   P       L +V E+     A    +   C       +  +   +Q
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPGLPPETIKDLMRQ 115

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
           L+ GV + HS  I HRDLK +N L+  +   ++KI DFG ++         S V T  Y 
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILV--TSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173

Query: 168 APEVLARKEYDGKISDVWSCGVTLYVM---------------------LVGAYPFED-PE 205
           APEVL +  Y   + D+WS G     +                     ++G    E+ P 
Sbjct: 174 APEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232

Query: 206 D----PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +      +F       R+ + F+P+   +  +   LL ++   +P KRI   E  +HP+F
Sbjct: 233 NVSLPRSSFPSY--TPRSFKSFVPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  112 bits (282), Expect = 9e-29
 Identities = 89/309 (28%), Positives = 134/309 (43%), Gaps = 70/309 (22%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ-------REIINHRS 55
           + YE +  +  G +GV    RDK+T E+VA+K +    K+++  +       REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 56  LRHPNIIRFKEVLL--TPTHLAIVMEYAAGGE-----LFARICSAGRFSEDEARFFFQQL 108
           L+HPNI+  KEV++      + +VMEY    E     L   +     F + E +    QL
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
           +SGV++ H   I HRDLK  N LL  + +  LKICDFG ++    +  P       V T 
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAR---EYGSPLKPYTQLVVTL 170

Query: 165 AYIAPEVL-ARKEYDGKISDVWSCG------VTLYVMLVGA--------------YPFED 203
            Y APE+L   KEY   I D+WS G      +T   +  G                P E 
Sbjct: 171 WYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK 229

Query: 204 --PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH---------LLSQIFVADPSKRIPI 252
             P     F + +   +   +    Y ++               LL+++   DP+KRI  
Sbjct: 230 IWPG----FSE-LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284

Query: 253 PEIKKHPWF 261
            +  KHP+F
Sbjct: 285 EDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  112 bits (280), Expect = 1e-28
 Identities = 80/278 (28%), Positives = 139/278 (50%), Gaps = 25/278 (8%)

Query: 5   YEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGKKIDE-------NVQREIINHR 54
           +E +K LG+G +G   LVR      + +L A+K +++   + +         +R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
             + P ++       T T L ++++Y  GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVL 172
            H + I +RD+KLEN LLD +    + + DFG SK        +  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 173 ARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
              +  +D K  D WS GV +Y +L GA PF    +  +  +   RI   +   P    +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235

Query: 231 SADCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLK 263
           SA  + ++ ++ + DP KR+        EIKKHP+F K
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 4e-28
 Identities = 94/291 (32%), Positives = 138/291 (47%), Gaps = 42/291 (14%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
           Y+ V+++G G +GV    RDK T E+VA+K I R +  DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSM 118
           I+R  +V+ +   L +V E+    +L   + S+     D      +  QL+ G++YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEV-LARKE 176
            + HRDLK +N L+D   +  LK+ DFG +++ G+        V T  Y APE+ L  ++
Sbjct: 119 RVLHRDLKPQNLLID--REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRI---------RNVQYFLPD 226
           Y   + D+WS G     M+     F  D E  + FR  I R            V   LPD
Sbjct: 177 YSTPV-DIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTS-LPD 232

Query: 227 YV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           Y                  +  D   LLS++ V DP+KRI      +HP+F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  110 bits (277), Expect = 5e-28
 Identities = 90/311 (28%), Positives = 135/311 (43%), Gaps = 65/311 (20%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRHPN 60
           +E +  +G G +G+    RD  + E+VA+K +    ER   I  +  REI    +LRHPN
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-IPISSLREITLLLNLRHPN 67

Query: 61  IIRFKEVLLTPTHLA---IVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCH 116
           I+  KEV+    HL    +VMEY    +L + + +    FSE + +    QL+ G+ Y H
Sbjct: 68  IVELKEVV-VGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVL-AR 174
              I HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+L   
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 175 KEYDGKISDVWSCG---------------------VTLYVMLVGA-----YP-------- 200
             Y   I D+W+ G                     + L + L+G      +P        
Sbjct: 184 TTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242

Query: 201 --FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
             F  P+ P N  K              +  +S     LL+ + + DP KR    E  + 
Sbjct: 243 GKFTLPKQPYNNLK------------HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290

Query: 259 PWFLKN-LPKE 268
            +F +  LP E
Sbjct: 291 SYFKEKPLPCE 301

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  111 bits (278), Expect = 6e-28
 Identities = 80/280 (28%), Positives = 140/280 (50%), Gaps = 27/280 (9%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREI-INHRSLRHPNIIRFK 65
           +G G++    LV  K+T+ + A+K I++    D+     VQ E  +   +  HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T + L  V+E+ +GG+L   +    +  E+ ARF+  ++   +++ H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
           KL+N LLD   +  +K+ D+G  K G+      ST  GTP YIAPE+L  ++Y   + D 
Sbjct: 123 KLDNVLLDA--EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DW 179

Query: 185 WSCGVTLYVMLVGAYPFE---DPEDPRNFRKTIDRIRNVQYFLPDYVRV----SADCRHL 237
           W+ GV ++ M+ G  PF+     ++P   + T D +   Q  L   +R+    S     +
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPD--QNTEDYL--FQVILEKQIRIPRSLSVKASSV 235

Query: 238 LSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
           L      DP +R+         +IK HP+F +N+  +++E
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFF-RNIDWDLLE 274

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  109 bits (273), Expect = 7e-28
 Identities = 92/268 (34%), Positives = 136/268 (50%), Gaps = 30/268 (11%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
           K LG G FG   L  D  T   +AVK +       E  K+++  ++ EI   ++LRH  I
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNLRHDRI 66

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +++   L  P    L+I +EY  GG +  ++ + G  +E+  R + +Q++ GVSY HS  
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVL 172
           I HRD+K  N L D +    +K+ DFG SK       SG   +  KS  GTP +++PEV+
Sbjct: 127 IVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSG---TGIKSVTGTPYWMSPEVI 181

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
           + + Y G+ +DVWS   T+  ML    P+ + E      K   +       LPD   VS 
Sbjct: 182 SGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPD--GVSD 236

Query: 233 DCRHLLSQIFVADPSKRIPIPE-IKKHP 259
            CR  L QIFV +  KR P  E + +HP
Sbjct: 237 ACRDFLKQIFVEE--KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (273), Expect = 1e-27
 Identities = 82/273 (30%), Positives = 124/273 (45%), Gaps = 24/273 (8%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID-ENVQREIINHRSLRHPNII 62
           YE ++ +G G   V          E VA+K I+  K +   + +++E+       HPN++
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELF---ARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           ++    +    L +VM Y +GG L          G   E       ++++ G+ Y HS  
Sbjct: 63  KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122

Query: 120 ICHRDLKLENTLL--DGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVL 172
             HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++APEV+
Sbjct: 123 QIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 173 A-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DYV 228
                YD K +D+WS G+T   +  GA P+      +    T   ++N    L    DY 
Sbjct: 179 EQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLT---LQNDPPSLETGADYK 234

Query: 229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           + S   R ++S     DPSKR    E+ KH +F
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  108 bits (272), Expect = 2e-27
 Identities = 79/280 (28%), Positives = 145/280 (51%), Gaps = 18/280 (6%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  + R+K +   VAVK ++ R ++  E +  E++  R  +H N++   +  
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L ++ME+  GG L   I S  R +E++     + ++  + Y HS  + HRD+K +
Sbjct: 88  LVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146

Query: 129 NTL--LDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDGKISDV 184
           + L  LDG    R+K+ DFG+  + +    PK  S VGTP ++APEV++R  Y  ++ D+
Sbjct: 147 SILLTLDG----RVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DI 200

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFV 243
           WS G+ +  M+ G  P+   + P    K   R+R+     L +  ++S   R  L ++  
Sbjct: 201 WSLGIMVIEMVDGEPPYFS-DSPVQAMK---RLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 244 ADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYKEAGR 282
            +P +R    E+  HP+ L+  LP+ ++ + +   K    
Sbjct: 257 REPQERATAQELLDHPFLLQTGLPECLVPLIQQYRKRTST 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  108 bits (272), Expect = 2e-27
 Identities = 80/296 (27%), Positives = 124/296 (41%), Gaps = 53/296 (17%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKKIDE-NVQREIINHRSLR-HPNI 61
           Y+ + ++G G F      + ++T +  A+K   +  K +++ N  REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCH 116
           +R  EVL       LA+V E      L+  I   GR     E   + +  QL+  + + H
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
              I HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE L  
Sbjct: 118 RNGIFHRDIKPENILIK---DDILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLT 172

Query: 175 KEYDGKISDVWSCGVTLYVM--LVGAYPFEDPEDPRNFRKTIDRIRNV------------ 220
             Y G   D+W+ G   + +  L   +P  +  D       I +I +V            
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD------QIAKIHDVLGTPDAEVLKKF 226

Query: 221 ------QYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                  Y  P              SA+   LL ++   DP +RI   +  +HP+F
Sbjct: 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  107 bits (269), Expect = 4e-27
 Identities = 86/286 (30%), Positives = 132/286 (46%), Gaps = 32/286 (11%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
           ++ V+++G G +GV    R+K T E+VA+K I R     E V     REI   + L HPN
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           I++  +V+ T   L +V E+     + F              + +  QL+ G+++CHS  
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y 
Sbjct: 121 VLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 179 GKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV--- 228
               D+WS G     M+     F  D E  + FR  +T+     V +     LPDY    
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238

Query: 229 -------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                         +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  106 bits (267), Expect = 7e-27
 Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 16/207 (7%)

Query: 9   KELGSGNFGV---ARLVRDKR-TKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
           K+LG G FG      L  D   T+  VAVK ++ G  ++  E    E    + L HPNI+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           R   V      L IV EY  GG+L  F R     + +  +      Q+  G+ Y  S   
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESKNF 123

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEY 177
            HRDL   N L+  +    +KI DFG S+        +   G      ++APE L   ++
Sbjct: 124 VHRDLAARNCLVTENLV--VKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKF 181

Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
             K SDVWS GV L+ +  +G  P+  
Sbjct: 182 TSK-SDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  106 bits (266), Expect = 8e-27
 Identities = 85/276 (30%), Positives = 132/276 (47%), Gaps = 26/276 (9%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHP 59
           EE +  ++ +G G+FG      D RT+++VA+K I+  +  DE  ++Q+EI        P
Sbjct: 3   EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +  AG F E +     ++++ G+ Y HS +
Sbjct: 63  YVTKYYGSYLKGTKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S Q  +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 122 KIHRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV------RVS 231
           D K +D+WS G+T   +  G  P  D    R           V + +P           S
Sbjct: 179 DSK-ADIWSLGITAIELAKGEPPNSDMHPMR-----------VLFLIPKNNPPTLTGEFS 226

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
              +  +      DPS R    E+ KH + +KN  K
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  107 bits (270), Expect = 8e-27
 Identities = 89/295 (30%), Positives = 132/295 (44%), Gaps = 43/295 (14%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKID-ENVQREIINHRSLRHPN 60
           +Y P+K +G G +G+    ++  T E VA+K I      +ID +   REI   R L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 61  IIRFKEVLLTPTH------LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           +I  K+++  P H      + IV E     +L   I S+   S+D  ++F  QL+ G+ Y
Sbjct: 66  VIAIKDIM-PPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-L 172
            HS  + HRDLK  N LL+ +    LKICDFG +++        +  V T  Y APE+ L
Sbjct: 124 IHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 173 ARKEYDGKISDVWSCG---------------------VTLYVMLVGA-----YPFEDPED 206
              EY   I DVWS G                     + L   L+G+       F   E 
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            R + +++        F   +   +     LL ++ V DPSKRI + E   HP+ 
Sbjct: 241 ARRYIRSLPYTPRQS-FARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  106 bits (265), Expect = 1e-26
 Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 24/252 (9%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           LG G +G+    RD  T+  +A+K I ER  +  + +  EI  H  L+H NI+++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 70  TPTHLAIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                 I ME   GG L A + S     + +E    F+ +Q++ G+ Y H  +I HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 127 LENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISD 183
            +N L++ +    +KI DFG SK    ++   ++  GT  Y+APEV+ +  + Y G  +D
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193

Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPR------NFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           +WS G T+  M  G  PF +  +P+         K    I       P+   +SA+ ++ 
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-------PE--SLSAEAKNF 244

Query: 238 LSQIFVADPSKR 249
           + + F  DP KR
Sbjct: 245 ILRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  106 bits (266), Expect = 1e-26
 Identities = 85/268 (31%), Positives = 136/268 (50%), Gaps = 18/268 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRH 58
           +++Y   +++G G  G      D  T + VA+K +   ++ KK  E +  EI+  R  +H
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK--ELIINEILVMRENKH 75

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS 
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 134

Query: 119 EICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 175
           ++ HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ RK
Sbjct: 135 QVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK 190

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y  K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R
Sbjct: 191 AYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFR 246

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLK 263
             L++    D  KR    E+ +HP FLK
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  105 bits (263), Expect = 2e-26
 Identities = 80/265 (30%), Positives = 126/265 (47%), Gaps = 11/265 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
           +E +E ++ +GSG +G     R+  T EL A+K I  E G+     VQ+EII  +  +H 
Sbjct: 8   QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHS 66

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+ +    L    L I ME+  GG L       G  SE +  +  ++ + G+ Y HS  
Sbjct: 67  NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLA--RKE 176
             HRD+K  N LL  +    +K+ DFG S       ++ KS +GTP ++APEV A  RK 
Sbjct: 127 KMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCR 235
              ++ D+W+ G+T   +     P  D    R  F  T    +  +  L D ++ S    
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK--LKDKMKWSNSFH 242

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPW 260
           H +      +P KR    ++ +HP+
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  106 bits (266), Expect = 2e-26
 Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 23/278 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHPNIIRFK 65
           +G G++    LVR K+T+ + A+K +++      + ID     + +  ++  HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
           KL+N LLD   +  +K+ D+G  K GL      ST  GTP YIAPE+L  ++Y G   D 
Sbjct: 123 KLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179

Query: 185 WSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           W+ GV ++ M+ G  PF+     D  D          I   Q  +P  + V A    +L 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA--ASVLK 237

Query: 240 QIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
                DP +R+         +I+ HP+F +N+  +++E
Sbjct: 238 SFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLME 274

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  105 bits (262), Expect = 4e-26
 Identities = 77/256 (30%), Positives = 137/256 (53%), Gaps = 10/256 (3%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +  +K T + VAVK ++ R ++  E +  E++  R   H N++      
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +SY H+  + HRD+K +
Sbjct: 89  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147

Query: 129 NTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSC 187
           + LL  +   R+K+ DFG+ ++      + KS VGTP ++APEV++R  Y  ++ D+WS 
Sbjct: 148 SILL--TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV-DIWSL 204

Query: 188 GVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 247
           G+ +  M+ G  P+ +    +  R+  D   N+   + D  +VS+  R  L  + V +PS
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDLMLVREPS 261

Query: 248 KRIPIPEIKKHPWFLK 263
           +R    E+ +HP FLK
Sbjct: 262 QRATAQELLQHP-FLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  105 bits (262), Expect = 4e-26
 Identities = 80/266 (30%), Positives = 141/266 (53%), Gaps = 15/266 (5%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   K + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 87  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145

Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + KS VGTP ++APE+++R  Y  ++ D+W
Sbjct: 146 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV-DIW 200

Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLLSQIFVA 244
           S G+ +  M+ G  P+ + E P    K +  IR N+   L +  +VS   +  L ++ V 
Sbjct: 201 SLGIMVIEMVDGEPPYFN-EPPL---KAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR 256

Query: 245 DPSKRIPIPEIKKHPWFLKNLPKEII 270
           DP++R    E+ KHP+  K  P   I
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPSCI 282

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  105 bits (264), Expect = 4e-26
 Identities = 86/324 (26%), Positives = 143/324 (44%), Gaps = 41/324 (12%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHP 59
            RY  ++ +G G FG+    RD+ T + VA+K I +      + +   RE+   + LRH 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 60  NIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NII   ++ ++P   +  V E    G    R+ ++    +   ++F  Q++ G+ Y HS 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKEY 177
            + HRDLK  N L++ +    LKICDFG ++  +   Q    V T  Y APE+ L  ++Y
Sbjct: 128 GVVHRDLKPSNILINENCD--LKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 178 DGKISDVWSCGVTLYVMLVGA--YPFEDP------------------------EDPRNFR 211
           D ++ D+WS G     ML G   +P +D                         E+   F 
Sbjct: 184 DVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF--LKNLPKEI 269
           +++ + R    F   +         LL ++ V DP KRI   E   HP+     +   E 
Sbjct: 243 QSLPK-REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301

Query: 270 IEIEKTNYKEAGRDQPTQSVEEIM 293
           +  EK ++     D P  + + +M
Sbjct: 302 VAEEKFDWSFNDADLPVDTWKVMM 325

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  104 bits (261), Expect = 6e-26
 Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 44/292 (15%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRHPN 60
           ++ +++LG G +      R++ T E+VA+K I    E G        REI   + L+H N
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHEN 59

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHS 117
           I+R  +V+ T   L +V EY    +L   + + G       +  + F  QL+ G+++CH 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARK 175
             + HRDLK +N L++   +  LK+ DFG +++ G+  +   + V T  Y AP+VL   +
Sbjct: 119 NRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 176 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN--FR-------KTIDRI------- 217
            Y   I D+WS G  +  M+ G   +P  + ED     FR        T   I       
Sbjct: 177 TYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 218 --------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                   +++Q   P    +  D   LL ++   +P  RI   +  +HPWF
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGID---LLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  103 bits (259), Expect = 1e-25
 Identities = 87/292 (29%), Positives = 139/292 (47%), Gaps = 39/292 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           ++YE V+++G G +GV    RD+ T E +A+K I R ++ DE V     REI   + ++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQQLISGVSYCH 116
            NI+R ++V+ +   L +V EY    +L   + S+  F+++    + +  Q++ G++YCH
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARK 175
           S  + HRDLK +N L+D      LK+ DFG +++ G+        V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQY--------FLP 225
            +     D+WS G  ++  +V   P    D E    F+  I RI              LP
Sbjct: 179 RHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLP 235

Query: 226 DYVR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           DY                  +      LLS++   DPSKRI      +H +F
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  105 bits (262), Expect = 1e-25
 Identities = 80/300 (26%), Positives = 131/300 (43%), Gaps = 49/300 (16%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN---- 60
           +E +K +G G FG  RLV+ K T  + A+K + +   +++     I   R +        
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++         +L ++ME+  GG++   +      SE+  +F+  + +  +   H +  
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKS-----------GLLHSQPK----------- 158
            HRD+K +N LLD   +  +K+ DFG                L H+ P            
Sbjct: 123 IHRDIKPDNLLLDA--KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 159 --------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP 204
                         STVGTP YIAPEV  +  Y+ K+ D WS GV +Y ML+G  PF   
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 205 EDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
                +RK ++    + +  P  V +S   + L+ + F  D   RI    + EIK HP+F
Sbjct: 240 TPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  103 bits (259), Expect = 3e-25
 Identities = 80/288 (27%), Positives = 127/288 (44%), Gaps = 51/288 (17%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVK--YIERGKKIDENVQREIINHRSLRHPNIIR 63
           E V  +GSG  G    V  + T  L A+K  Y      +   + REI   R + HPN+++
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
             ++      + +++E+  GG L     +  +F  D AR    Q++SG++Y H   I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV----LARKEYD 178
           D+K  N L++ +    +KI DFG S+       P  S+VGT AY++PE     L    YD
Sbjct: 193 DIKPSNLLINSA--KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 179 GKISDVWSCGVTLYVMLVGAYPF------------------EDPEDPRNFRKTIDRIRNV 220
           G   D+WS GV++    +G +PF                  + PE P             
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT----------- 299

Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
                     S + RH +S     +P+KR    ++ +HP+ L+  P +
Sbjct: 300 ---------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338

Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  102 bits (254), Expect = 3e-25
 Identities = 87/263 (33%), Positives = 132/263 (50%), Gaps = 22/263 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
           K LG G FG   L  D  T   +AVK +       E  K+++  ++ EI   ++L H  I
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLLHERI 66

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +++   L  P    L+I ME+  GG +  ++ S G  +E+  R + +Q++ GVSY HS  
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARK 175
           I HRD+K  N L D      +K+ DFG SK      L  +  KS  GTP +++PEV++ +
Sbjct: 127 IVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y G+ +D+WS G T+  ML    P+ + E      K   +  N    LP +  VS  CR
Sbjct: 185 GY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV--LPPH--VSDHCR 239

Query: 236 HLLSQIFVADPSKRIPIPEIKKH 258
             L +IFV +   R    E+ +H
Sbjct: 240 DFLKRIFV-EAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  101 bits (254), Expect = 4e-25
 Identities = 80/278 (28%), Positives = 121/278 (43%), Gaps = 29/278 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPN 60
           ++  K++G G F V           +VA+K ++       K  ++  +EI   + L HPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGR-FSEDEARFFFQQLISGVSYCH 116
           +I++    +    L IV+E A  G+L   I       R   E     +F QL S + + H
Sbjct: 64  VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH 123

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEV 171
           S  I HRD+K  N  +  +    +K+ D G      SK+   HS     VGTP Y++PE 
Sbjct: 124 SKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSPER 177

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y+ K SD+WS G  LY M     PF    D  N      +I    Y        S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADHYS 234

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
            + R L+S+    DP KR   P+I     ++  + KE+
Sbjct: 235 EELRDLVSRCINPDPEKR---PDI----SYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  103 bits (257), Expect = 4e-25
 Identities = 77/266 (28%), Positives = 128/266 (48%), Gaps = 20/266 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHPNIIRFK 65
           +G G++    LVR K+  ++ A+K +++      + ID     + +  ++  +P ++   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T + L +V+EY  GG+L   +    +  E+ ARF+  ++   +++ H   I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKISDV 184
           KL+N LLD      +K+ D+G  K GL      ST  GTP YIAPE+L  +EY G   D 
Sbjct: 123 KLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 185 WSCGVTLYVMLVGAYPFE---DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           W+ GV ++ M+ G  PF+   D  D          I      +P ++ V A   H+L   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKAS--HVLKGF 237

Query: 242 FVADPSKRI------PIPEIKKHPWF 261
              DP +R+         +IK H +F
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFF 263

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  102 bits (255), Expect = 4e-25
 Identities = 82/266 (30%), Positives = 134/266 (50%), Gaps = 14/266 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA+K +  + +   E +  EI+  R  ++PN
Sbjct: 18  KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPN 77

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ RK Y
Sbjct: 137 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  R+SA  R  
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPERLSAVFRDF 248

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  +R    E+ +HP FLK
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  101 bits (252), Expect = 8e-25
 Identities = 73/206 (35%), Positives = 107/206 (51%), Gaps = 9/206 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHP 59
           EE +  ++ +G G+FG      D RTKE+VA+K I+  +  D  E++Q+EI        P
Sbjct: 3   EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            I R+    L  T L I+MEY  GG     +   G   E       ++++ G+ Y HS  
Sbjct: 63  YITRYYGSYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S Q  +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 122 KIHRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
           D K +D+WS G+T   +  G  P  D
Sbjct: 179 DFK-ADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  100 bits (251), Expect = 1e-24
 Identities = 80/277 (28%), Positives = 132/277 (47%), Gaps = 28/277 (10%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I+  +  DE  ++Q+EI        P
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 63  YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S    +K+ DFG +   L  +Q K    VGTP ++APEV+ +  Y
Sbjct: 122 KIHRDIKAANVLL--SEHGEVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRV 230
           D K +D+WS G+T   +  G  P  +          P+N   T++   N    L ++V  
Sbjct: 179 DSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLE--GNYSKPLKEFVEA 235

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
             +           +PS R    E+ KH + ++   K
Sbjct: 236 CLN----------KEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  100 bits (251), Expect = 1e-24
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 22/272 (8%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNI 61
           E + ELG GN+G    V  + T   +A+K I    ++DE+   +II    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYI 61

Query: 62  IRFKEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYC-HS 117
           + F         + + MEY   G   +L+A   +     ED  R     ++ G+ +    
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
             I HRD+K  N L++G+ Q  +K+CDFG S   L+ S  K+ +G  +Y+APE +     
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQ--VKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178

Query: 178 DGKI-----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVS 231
           +        SDVWS G+++  M +G YP+  PE   N    +  I       LP     S
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLSAIVDGDPPTLPS--GYS 235

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            D +  +++     P++R    ++ +HPW +K
Sbjct: 236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  104 bits (259), Expect = 2e-24
 Identities = 82/247 (33%), Positives = 120/247 (48%), Gaps = 37/247 (14%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQR--EIINHRSLRHPNI 61
           YE +K++G+G FG   LV+ KRT+E    K I  RG K  E  Q   E+   R L+H NI
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYC 115
           +R+ +  L   +  L I+ME+   G+L   I       G+  E       +QL+  ++YC
Sbjct: 75  VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134

Query: 116 HSME-------ICHRDLKLENTLLDG---------------SPQPRLKICDFGYSKSGLL 153
           H+++       + HRDLK +N  L                 + +P  KI DFG SK+  +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194

Query: 154 HSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211
            S   S VGTP Y +PE+L    K YD K SD+W+ G  +Y +  G  PF       NF 
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKAN---NFS 250

Query: 212 KTIDRIR 218
           + I  ++
Sbjct: 251 QLISELK 257

Length = 1021

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  100 bits (250), Expect = 2e-24
 Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 23/270 (8%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNI 61
           E + +LG+GN G    V+   T  ++A K +  G K   +V+++I+    + H    P I
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYI 65

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EI 120
           + F    L   ++ + ME+   G L       G    +        ++ G++Y +++  I
Sbjct: 66  VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRD+K  N L++   Q  +K+CDFG S   L++S   + VGT  Y++PE +   +Y  K
Sbjct: 126 MHRDIKPSNILVNSRGQ--IKLCDFGVSGE-LINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPE-------DPRNFRKTIDRIRNVQY-FLPDYVRVSA 232
            SDVWS G+++  + +G +PF           DP      + +I       LP       
Sbjct: 183 -SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS-DFPE 240

Query: 233 DCRHLLSQIFVADPSKRIPIPE--IKKHPW 260
           D R  +    + DP++R P P+      P+
Sbjct: 241 DLRDFVDACLLKDPTER-PTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 99.8 bits (248), Expect = 4e-24
 Identities = 83/266 (31%), Positives = 134/266 (50%), Gaps = 14/266 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA+K I   K+   E +  EI+  + L++PN
Sbjct: 18  KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN 77

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ F +  L    L +VMEY AGG L   + +     E +     ++ +  + + H+ ++
Sbjct: 78  IVNFLDSFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ RK Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++S   R  
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSPIFRDF 248

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +HP FLK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 98.3 bits (245), Expect = 9e-24
 Identities = 84/270 (31%), Positives = 119/270 (44%), Gaps = 27/270 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRT-KELVAVKYI------------ERGKKIDENVQREII 51
           Y  ++ LGSG FG    VR K   + L+A+K I            ER K I + V    I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAG-RFSEDEARFFFQQ 107
               LRHPNI+R+ +  L    L IVM+   G   GE F  +     RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 108 LISGVSYCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
           ++  + Y H    I HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LP 225
             PE++  + Y G+ +DVW+ G  LY M     PF       N      +I    Y  LP
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234

Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
           + +  S D   +++     D   R  I ++
Sbjct: 235 EGM-YSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 98.2 bits (244), Expect = 1e-23
 Identities = 87/282 (30%), Positives = 136/282 (48%), Gaps = 20/282 (7%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
           EE +E + ELG G FG     ++K T  L A K I+   + + E+   EI    S  HPN
Sbjct: 4   EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 63

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++  +      +L I++E+ AGG + A +    R  +E + R   +Q +  ++Y H  +
Sbjct: 64  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123

Query: 120 ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVL---- 172
           I HRDLK  N L  LDG     +K+ DFG S       Q + S +GTP ++APEV+    
Sbjct: 124 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRV 230
              + YD K +DVWS G+TL  M       E P    N  + + +I ++    L    R 
Sbjct: 180 SKDRPYDYK-ADVWSLGITLIEMA----QIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 234

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           S++ +  L +    +   R    ++ +HP+   N  K I E+
Sbjct: 235 SSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIREL 276

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 98.2 bits (244), Expect = 2e-23
 Identities = 69/196 (35%), Positives = 100/196 (51%), Gaps = 13/196 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           E+ +  ++E+G G+FG     RD R  E+VA+K +   GK+ +E  Q   +E+   + LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I+++   L      +VMEY  G              E E        + G++Y HS
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
             + HRD+K  N LL       +K+ DFG   S  + +     VGTP ++APEV LA  E
Sbjct: 134 HNMIHRDVKAGNILLSEPGL--VKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDE 188

Query: 177 --YDGKISDVWSCGVT 190
             YDGK+ DVWS G+T
Sbjct: 189 GQYDGKV-DVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.9 bits (241), Expect = 2e-23
 Identities = 74/264 (28%), Positives = 121/264 (45%), Gaps = 21/264 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE-------RGKKIDENVQREIINHRSLRHPNIIR 63
           LG G +G           +L+AVK +E         +K  E +Q E+   +SL+H NI++
Sbjct: 8   LGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
           +    L    ++I ME+  GG + + +   G   E     + +Q++ GV+Y H+  + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK-------SGLLHSQPKSTVGTPAYIAPEVLARKE 176
           D+K  N +L   P   +K+ DFG ++        G   +  KS  GTP ++APEV+    
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y G+ SD+WS G T++ M  G  P     D       I   R +   LPD    SA    
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPLAS-MDRLAAMFYIGAHRGLMPRLPD--SFSAAAID 240

Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
            ++     D  +R    ++ +H +
Sbjct: 241 FVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 97.9 bits (243), Expect = 3e-23
 Identities = 72/196 (36%), Positives = 102/196 (52%), Gaps = 13/196 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           E+ +  ++E+G G+FG     RD RT E+VA+K +   GK+ +E  Q   +E+   + ++
Sbjct: 24  EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK 83

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I +K   L      +VMEY  G              E E        + G++Y HS
Sbjct: 84  HPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
             + HRD+K  N LL    Q  +K+ DFG   S  + S   S VGTP ++APEV LA  E
Sbjct: 144 HNMIHRDIKAGNILLTEPGQ--VKLADFG---SASIASPANSFVGTPYWMAPEVILAMDE 198

Query: 177 --YDGKISDVWSCGVT 190
             YDGK+ DVWS G+T
Sbjct: 199 GQYDGKV-DVWSLGIT 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.8 bits (241), Expect = 3e-23
 Identities = 81/267 (30%), Positives = 120/267 (44%), Gaps = 23/267 (8%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPN---IIRFKE 66
           LG G FG     + + T +L A K + + + K  +  +  ++  R L   +   I+    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICH 122
              T T L +VM    GG+L   I +       F E  A F+  Q+ISG+ + H   I +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           RDLK EN LLD     R  I D G +   K G   S+ K   GTP ++APE+L  +EYD 
Sbjct: 121 RDLKPENVLLDNDGNVR--ISDLGLAVELKDG--QSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
            + D ++ GVTLY M+    PF    +    ++   RI N     PD  + S   +    
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFCE 233

Query: 240 QIFVADPSKRIPI-----PEIKKHPWF 261
            +   DP KR+         ++ HP F
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 49/302 (16%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-- 60
           E +E +K +G G FG  RLV+ K T  + A+K + +   +++     I   R +      
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 61  --IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
             +++         +L ++ME+  GG++   +      +E+E +F+  + +  +   H +
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-----------GLLHSQPK--------- 158
              HRD+K +N LLD   +  +K+ DFG                L HS P          
Sbjct: 121 GFIHRDIKPDNLLLDS--KGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 159 ----------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
                           STVGTP YIAPEV  +  Y+ K+ D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 203 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP---EIKKHP 259
             E P+   K +   +    F P+ V +S   + L+ + F  +   RI  P   EIK +P
Sbjct: 238 S-ETPQETYKKVMNWKETLIFPPE-VPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNP 294

Query: 260 WF 261
           +F
Sbjct: 295 FF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 97.0 bits (242), Expect = 8e-23
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 42/295 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPN 60
            RY+ +  +G G +G+      K T   VA+K I   +     +   REI   R  +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 61  IIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           II   +++  P+      + IV E     +L+ ++      S D  ++F  Q++ G+ Y 
Sbjct: 65  IIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKYI 122

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
           HS  + HRDLK  N LL+ +    LKICDFG ++               V T  Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Query: 172 -LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNF---------RKTIDRIRN 219
            L  K Y   I D+WS G  L  ML     +P +D     N          ++ ++ I +
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239

Query: 220 VQ---YF--LPDYVRVS-------ADCR--HLLSQIFVADPSKRIPIPEIKKHPW 260
           ++   Y   LP   +V        AD +   LL ++   +P KRI + E   HP+
Sbjct: 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.3 bits (239), Expect = 8e-23
 Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 14/266 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +  + +   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+ ++     S+  + VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 249

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 95.8 bits (238), Expect = 9e-23
 Identities = 66/195 (33%), Positives = 99/195 (50%), Gaps = 12/195 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           ++E +  +G G +GV    R K TKE+VA+K     E  +++ E   RE+   R+L+  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I+  KE       L +V EY      EL   + +      ++ R +  QLI  + +CH  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKE 176
           +I HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+L    
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 177 YDGKISDVWSCGVTL 191
           Y GK  D+WS G  L
Sbjct: 178 Y-GKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 28/278 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
           + +E +K +G G FG   +V+ K T+ + A+K + + + +          +R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
           +    + +        +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QWITTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
           H +   HRD+K +N LLD +   RL   DFG     ++ G +  Q    VGTP YI+PE+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTV--QSSVAVGTPDYISPEI 174

Query: 172 LARKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           L   E      G   D WS GV +Y ML G  PF        + K ++     Q+  P +
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF--PSH 232

Query: 228 VR-VSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
           +  VS + + L+ Q  +    +R+    I + KKH +F
Sbjct: 233 ITDVSEEAKDLI-QRLICSRERRLGQNGIEDFKKHAFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 95.1 bits (236), Expect = 1e-22
 Identities = 83/265 (31%), Positives = 130/265 (49%), Gaps = 22/265 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYI-------ERGKKIDENVQREIINHRSLRHPNI 61
           K LG G FG   L  D  T   +A K +       E  K++   ++ EI   ++L+H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERI 66

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +++   L       L I MEY  GG +  ++ + G  +E   R + +Q++ G+SY HS  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARK 175
           I HRD+K  N L D +    +K+ DFG SK      +  +  +S  GTP +++PEV++ +
Sbjct: 127 IVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y G+ +DVWS G T+  ML    P+ + E      K   +  N Q  LP +  +S   R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQ--LPSH--ISEHAR 239

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPW 260
             L  IFV +   R    E+ +HP+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 30/269 (11%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L+ +++   GG+L   +   G FSE E RF+  ++I G+ + H+  + +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYD 178
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-IRNVQYFLPDYVRVSADCRHL 237
              +D +S G  L+ +L G  PF   +     +  IDR    +   LPD    S + R L
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTLTMAVELPD--SFSPELRSL 229

Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D ++R+        E+K+HP+F
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.9 bits (238), Expect = 1e-22
 Identities = 72/196 (36%), Positives = 98/196 (50%), Gaps = 13/196 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           EE +  + E+G G+FG      +  T E+VAVK +   GK+ +E  Q   +E+   + L+
Sbjct: 20  EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK 79

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I +K   L      +VMEY  G              E E        + G++Y HS
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LARKE 176
             + HRD+K  N LL    Q  +K+ DFG   S    S   S VGTP ++APEV LA  E
Sbjct: 140 HNMIHRDIKAGNILLTEPGQ--VKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDE 194

Query: 177 --YDGKISDVWSCGVT 190
             YDGK+ DVWS G+T
Sbjct: 195 GQYDGKV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 28/278 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVK------YIERGKKIDENVQREIINHRSL 56
           + +E +K +G G FG   +V+ K T ++ A+K       ++R +      +R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYC 115
           R   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
           H +   HRD+K +N LLD +   RL   DFG        G + S     VGTP YI+PE+
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFGSCLRLLADGTVQSN--VAVGTPDYISPEI 174

Query: 172 LARKEYDGKIS-----DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           L   E DGK       D WS GV +Y ML G  PF        + K ++   + Q F PD
Sbjct: 175 LQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-FPPD 232

Query: 227 YVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
              VS + + L+ ++ +  P  R+    + + K HP+F
Sbjct: 233 VTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 81/320 (25%), Positives = 136/320 (42%), Gaps = 73/320 (22%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDE----NVQREIINHRSL 56
           E +  VK +G G FG  RLV+ K T ++ A+K + + +  K D+      +R+++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
             P ++          +L ++ME+  GG+L   +     FSED  RF+  + +  +   H
Sbjct: 60  -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS----------------- 159
            +   HRD+K +N L+D      +K+ DFG S     H Q  S                 
Sbjct: 119 KLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTG--FHKQHDSAYYQKLLQGKSNKNRID 174

Query: 160 ---------------------------------TVGTPAYIAPEVLARKEYDGKISDVWS 186
                                            TVGTP YIAPE+  ++ Y G+  D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWS 233

Query: 187 CGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
            G  ++  L+G  PF  E+  +   +RK I+    + +  PD + +S +   L+ ++ + 
Sbjct: 234 LGAIMFECLIGWPPFCSENSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL-IT 288

Query: 245 DPSKRI---PIPEIKKHPWF 261
           +   R+      EIK HP+F
Sbjct: 289 NAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 86/301 (28%), Positives = 132/301 (43%), Gaps = 49/301 (16%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
           + +E + ELG+GN GV   V  + +  ++A K I    +I   ++ +II    + H    
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNS 58

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
           P I+ F     +   ++I ME+  GG L   +  AGR  E+        ++ G++Y    
Sbjct: 59  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKE 176
            +I HRD+K  N L++   +  +K+CDFG S  G L  S   S VGT +Y++PE L    
Sbjct: 119 HKIMHRDVKPSNILVNSRGE--IKLCDFGVS--GQLIDSMANSFVGTRSYMSPERLQGTH 174

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR----------IRNVQYFLPD 226
           Y  + SD+WS G++L  M +G YP   P D +       R           R V    PD
Sbjct: 175 YTVQ-SDIWSLGLSLVEMAIGRYPIP-PPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 227 YVRVSADCRHLLSQI-------------------FVA-----DPSKRIPIPEIKKHPWFL 262
             R  A    LL  I                   FV      +P +R  + E+ KHP+  
Sbjct: 233 SPRPMA-IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Query: 263 K 263
           +
Sbjct: 292 R 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 94.7 bits (235), Expect = 2e-22
 Identities = 64/193 (33%), Positives = 103/193 (53%), Gaps = 6/193 (3%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPN 60
           +  YE ++ +GSG +G     R+  T EL AVK I+     D + +Q+EI   +  +H N
Sbjct: 8   QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ +    L+   L I MEY  GG L       G  SE +  +  ++ + G++Y HS   
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
            HRD+K  N LL  +    +K+ DFG  +K     ++ KS +GTP ++APEV A ++  G
Sbjct: 128 MHRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 180 --KISDVWSCGVT 190
             ++ D+W+ G+T
Sbjct: 186 YNQLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 94.5 bits (236), Expect = 2e-22
 Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 36/274 (13%)

Query: 5   YEPVKELGS--GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
            E VK+L    G FG   +++ K T++L   K I+  K  +     E + H+ ++ +PN 
Sbjct: 16  CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKA-KNFNAI---EPMVHQLMKDNPNF 71

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           I+    + T     ++M+Y   G+LF  +   G+ SE E +   +QL+  ++  H   I 
Sbjct: 72  IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           H D+KLEN L D + + R+ +CD+G  K       P    GT  Y +PE +    YD  +
Sbjct: 132 HNDIKLENVLYDRA-KDRIYLCDYGLCKI---IGTPSCYDGTLDYFSPEKIKGHNYD--V 185

Query: 182 S-DVWSCGVTLYVMLVGAYPFEDPED---------PRNFRKTIDRIRNVQYFLPDYVRVS 231
           S D W+ GV  Y +L G +PF++ ED          R  +K +  I+NV     D+V+  
Sbjct: 186 SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-LPFIKNVSKNANDFVQ-- 242

Query: 232 ADCRHLLSQIFVADPSKR-IPIPEIKKHPWFLKN 264
                    +   + + R     EI KHP FLK 
Sbjct: 243 --------SMLKYNINYRLTNYNEIIKHP-FLKI 267

Length = 267

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 89/314 (28%), Positives = 129/314 (41%), Gaps = 65/314 (20%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRH 58
           +  +K LG G FG   L R   TK L A+K + +   +  N       +R+I+      +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD--N 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
             ++R         +L  VM+Y  GG++ + +   G F ED ARF+  +L   V   H M
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG------------YSKSGLLHSQ---------- 156
              HRD+K +N L+D      +K+ DFG            Y +SG    Q          
Sbjct: 121 GFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 157 --------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190
                                       S VGTP YIAPEVL R  Y  ++ D WS GV 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237

Query: 191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI 250
           LY MLVG  PF          K I+   ++   +P   ++S +   L+ ++    P  R+
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH--IPPQAKLSPEASDLIIKL-CRGPEDRL 294

Query: 251 ---PIPEIKKHPWF 261
                 EIK HP+F
Sbjct: 295 GKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 82/310 (26%), Positives = 128/310 (41%), Gaps = 63/310 (20%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRHPNI 61
           +K LG G FG   L     T  L A+K + +   ++ N       +R+I+      +  +
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++         +L  VM+Y  GG++ + +     F E  ARF+  +L   +   H M   
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 122 HRDLKLENTLLDGSPQPRLKICDFG-------------YSKSGLLHS---QPK------- 158
           HRD+K +N L+D      +K+ DFG             Y K   +     +P        
Sbjct: 124 HRDIKPDNILID--LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVS 181

Query: 159 -------------------------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYV 193
                                    S VGTP YIAPEVL RK Y  ++ D WS GV L+ 
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFE 240

Query: 194 MLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK--RIP 251
           MLVG  PF  P       K I+    +   +P  V++S +   L++++  +   +  R  
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNG 298

Query: 252 IPEIKKHPWF 261
             +IK HP+F
Sbjct: 299 ADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 39/290 (13%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRHPN 60
           Y  ++++G G +GV    R+K+T ++VA+K I R +  +E V     REI   + L+HPN
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I+  ++VL+  + L ++ E+ +    +    +        +  + +  Q++ G+ +CHS 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARKE 176
            + HRDLK +N L+D      +K+ DFG +++ G+        V T  Y APEVL     
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFR-------KTIDRIRNVQYFLPDY 227
           Y   + D+WS G T++  +    P    D E  + FR        T D    V   LPDY
Sbjct: 179 YSTPV-DIWSIG-TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS-LPDY 235

Query: 228 VR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                             +  D   LL ++ + DP+KRI   +   HP+F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 79/301 (26%), Positives = 120/301 (39%), Gaps = 56/301 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
           +RY+ +  +GSG +G      D +T   VA+K      K+    Q  I   R+ R     
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68

Query: 58  ----HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
               H N+I   +V    + L       +V     G +L   I    + S+D  +F   Q
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPA 165
           ++ G+ Y HS  I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRW 180

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFR 211
           Y APE++    +  +  D+WS G  +  +L G   +P  D  D                 
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240

Query: 212 KTID--RIRNVQYFLPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           + I     RN    LP   +          +     LL ++ V DP KRI   E   HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 261 F 261
            
Sbjct: 301 L 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 94.8 bits (236), Expect = 4e-22
 Identities = 85/308 (27%), Positives = 119/308 (38%), Gaps = 60/308 (19%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNII 62
           RY  ++ LG G+ G+     D    + VAVK I     +  ++  REI   R L H NI+
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 63  RFKEVLLT-----------PTHLA---IVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
           +  EVL              T L    IV EY       A +   G  SE+ AR F  QL
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMYQL 123

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG--------YSKSGLLHSQPKST 160
           + G+ Y HS  + HRDLK  N  ++ +    LKI DFG        YS  G L       
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYL----SEG 178

Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRN 209
           + T  Y +P +L       K  D+W+ G     ML G   F    +           P  
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 210 FRKTIDRIRNVQYFLPDYVR----------------VSADCRHLLSQIFVADPSKRIPIP 253
             +  + + NV   +P +VR                V+ +    L QI   +P  R+   
Sbjct: 239 REEDRNELLNV---IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295

Query: 254 EIKKHPWF 261
           E   HP+ 
Sbjct: 296 EALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 94.1 bits (234), Expect = 4e-22
 Identities = 86/308 (27%), Positives = 124/308 (40%), Gaps = 67/308 (21%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLRHP 59
           ++ + ++G G +G     RDK T ELVA+K +     + G  I     REI   R L H 
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPI--TAIREIKILRQLNHR 66

Query: 60  NIIRFKEVLLTPTH----------LAIVMEYAAG---GELFARICSAGRFSEDEARFFFQ 106
           NI+  KE++                 +V EY      G L + +     FSED  + F +
Sbjct: 67  NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFMK 123

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVG 162
           QL+ G++YCH     HRD+K  N LL+   Q  +K+ DFG ++  L +S+      + V 
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLAR--LYNSEESRPYTNKVI 179

Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE---------------DP 207
           T  Y  PE+L  +E  G   DVWSCG  L  +      F+  +                P
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239

Query: 208 RNFRKTID---------------RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI 252
             +   I                R+R    F+P           LL  +   DPSKR   
Sbjct: 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP------TPALDLLDHMLTLDPSKRCTA 293

Query: 253 PEIKKHPW 260
            E    PW
Sbjct: 294 EEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.5 bits (232), Expect = 5e-22
 Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 28/268 (10%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L  +++   GG+L   +   G FSE E RF+  ++I G+ + H+  + +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
             +D +S G  L+ +L G  PF   +     +  IDR+   V   LPD    S + + LL
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTVNVELPD--SFSPELKSLL 230

Query: 239 SQIFVADPSKRIPI-----PEIKKHPWF 261
             +   D SKR+        E+K+H +F
Sbjct: 231 EGLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 89/301 (29%), Positives = 131/301 (43%), Gaps = 49/301 (16%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLR- 57
             +YE +++LG G +G+     D+RTKE+VA+K I    +   + QR   EI+  + L  
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 58  HPNIIRFKEVLLTPTHLAI--VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           HPNI++   V+       I  V EY    +L A I  A    +   R+   QL+  + Y 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIMYQLLKALKYI 123

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTPAYIAP 169
           HS  + HRDLK  N LL+     R+K+ DFG ++S     +          V T  Y AP
Sbjct: 124 HSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 170 EVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPF---------------------EDPEDP 207
           E+L     Y  K  D+WS G  L  ML+G   F                     ED E  
Sbjct: 182 EILLGSTRYT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 208 R-NFRKTI------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           +  F  T+         + +   LP     S D   LL ++ V +P+KR+   E  +HP+
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKA---SDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 261 F 261
            
Sbjct: 298 V 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 93.6 bits (233), Expect = 5e-22
 Identities = 85/311 (27%), Positives = 137/311 (44%), Gaps = 48/311 (15%)

Query: 2   EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER--GKKIDENVQREIINHR 54
           E+R+ + +K+LG G+FG   L R       T E VAVK +     ++   + +REI   R
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61

Query: 55  SLRHPNIIRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
           +L H NI+++K V   P    L ++MEY   G L  + +     + +      F  Q+  
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICK 120

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G+ Y  S    HRDL   N L++   +  +KI DFG +K  L   +    V  P      
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVES--EDLVKISDFGLAKV-LPEDKDYYYVKEPGESPIF 177

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           + APE L   ++    SDVWS GVTLY +     P + P  P  F + I   +  Q  + 
Sbjct: 178 WYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMIGIAQG-QMIVT 233

Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQP 285
             +        LL         +R+P P          + P E+ ++ K  ++   +D+P
Sbjct: 234 RLLE-------LLK------EGERLPRPP---------SCPDEVYDLMKLCWEAEPQDRP 271

Query: 286 TQSVEEIMRII 296
             S  +++ I+
Sbjct: 272 --SFADLILIV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 94.3 bits (234), Expect = 6e-22
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 11/209 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V+ K +  ++A K I    +I   ++ +II    + H   
Sbjct: 4   DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECN 61

Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            P I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G++Y   
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121

Query: 118 M-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 122 KHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 178

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  + +G YP   P+
Sbjct: 179 YSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 93.2 bits (231), Expect = 2e-21
 Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 24/276 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
           E +E +K +G G FG   +V+ K   ++ A+K + + + +          +R+++ +   
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
           +    + +        +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QWITTLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVL 172
           H +   HRD+K +N L+D +   RL   DFG S   L+     Q    VGTP YI+PE+L
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRL--ADFG-SCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 173 ARKEYDGK-----ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
              E DGK       D WS GV +Y ML G  PF        + K ++     Q F    
Sbjct: 176 QAME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-FPAQV 233

Query: 228 VRVSADCRHLLSQIFVADPSK--RIPIPEIKKHPWF 261
             VS D + L+ ++  +   +  +  I + K+HP+F
Sbjct: 234 TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 69/202 (34%), Positives = 103/202 (50%), Gaps = 15/202 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
           E +E + ELG G FG     ++K T  L A K IE   + + E+   EI    +  HP I
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI 71

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEI 120
           ++          L I++E+  GG + A +    R  +E + +   +Q++  + Y HSM+I
Sbjct: 72  VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131

Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEV-----L 172
            HRDLK  N LL  DG     +K+ DFG S   +   Q + S +GTP ++APEV     +
Sbjct: 132 IHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 173 ARKEYDGKISDVWSCGVTLYVM 194
               YD K +D+WS G+TL  M
Sbjct: 188 KDTPYDYK-ADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 78/325 (24%), Positives = 130/325 (40%), Gaps = 76/325 (23%)

Query: 4   RYEPVKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQ----REIINHRSLR 57
           +YE    +G G +G     + K  +  +  A+K  +  K+    +     REI   R L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 58  HPNIIRFKEVLLTPTHLAIVM--EYAAGGELFARICSAGRFSEDEARFFFQ--------- 106
           H N++   EV L     ++ +  +YA   +L+  I    +F     R             
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII----KFHRQAKRVSIPPSMVKSLLW 115

Query: 107 QLISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS----- 159
           Q+++GV Y HS  + HRDLK  N L+  +G  +  +KI D G ++  L ++  K      
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLD 173

Query: 160 -TVGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRN-FRK 212
             V T  Y APE+ L  + Y   I D+W+ G  ++  L+   P     E      N F++
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAI-DIWAIGC-IFAELLTLEPIFKGREAKIKKSNPFQR 231

Query: 213 T-IDRIRNVQYF-----------LPDY------------------------VRVSADCRH 236
             ++RI  V              +P+Y                         +  +    
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           LL ++   DP+KRI   E  +HP+F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 41/293 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVK-YIERG-----KKIDENVQREIINHRSL 56
           E+YE + ++G G++GV    R++ T ++VA+K ++E       KKI     REI   + L
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           +HPN++   EV      L +V EY     L     +     E   +    Q +  V++CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYIAPEVLA 173
                HRD+K EN L+  + Q ++K+CDFG+++  +L          V T  Y APE+L 
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLV 173

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDP-----RNFRKTIDRIRNV----QY 222
                G   DVW+ G     +L G   +P +   D      +     I R + +    Q+
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233

Query: 223 F----LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           F    +P+          +  +S+     L      DP++R+   E+ +HP+F
Sbjct: 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 77/289 (26%), Positives = 124/289 (42%), Gaps = 33/289 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVK-YIER--GKKIDENVQREIINHRSLRHP 59
           E+YE +  +G G++G+    + K T ++VA+K ++E    K + +   REI   + LRH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           N++   EV      L +V E+     L           E   R +  Q++ G+ +CHS  
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
           I HRD+K EN L+  S    +K+CDFG++++ L       T  V T  Y APE+L     
Sbjct: 121 IIHRDIKPENILV--SQSGVVKLCDFGFART-LAAPGEVYTDYVATRWYRAPELLVGDTK 177

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQY-------- 222
            G+  D+W+ G  +  ML G   F    D        +     I R + +          
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237

Query: 223 FLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            LP+          + ++S     L  Q    DP  R    ++  H +F
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 33/280 (11%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIR 63
           +E ++ +G G +G    V +K+   L AVK ++    +DE ++ E    +SL  HPN+++
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 64  FKEVLLTPTHLA-----IVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQLISGVSY 114
           F  +      L      +V+E   GG   EL   +   G R  E    +     + G+ +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEV 171
            H+  I HRD+K  N LL  + +  +K+ DFG S    L S   +  ++VGTP ++APEV
Sbjct: 144 LHNNRIIHRDVKGNNILL--TTEGGVKLVDFGVSAQ--LTSTRLRRNTSVGTPFWMAPEV 199

Query: 172 LA-RKEYDGKIS---DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPD 226
           +A  ++YD       DVWS G+T   +  G  P  D        KT+ +I RN     P 
Sbjct: 200 IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTLFKIPRNPP---PT 252

Query: 227 YVRVSADCR---HLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            +     CR   H +SQ  + D   R  +  + +HP F+K
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 91.6 bits (227), Expect = 6e-21
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 11/209 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 4   DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECN 61

Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 118 M-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 122 KHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 178

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M +G YP   P+
Sbjct: 179 YSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 90.9 bits (226), Expect = 8e-21
 Identities = 81/312 (25%), Positives = 130/312 (41%), Gaps = 68/312 (21%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKK-IDENVQREIINHRSLRHPN 60
           +YE + ++G G FG     R K+TK++VA+K +  E  K+       REI   + L+H N
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72

Query: 61  IIRFKEVLLTPT--------HLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLIS 110
           ++   E+  T             +V E+       A + S    +F+  E +   + L++
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVMKMLLN 130

Query: 111 GVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-----VGT 163
           G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L    K       V T
Sbjct: 131 GLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 164 PAYIAPEVLARKEYDGKISDVWSCG---------------------VTLYVMLVGA---- 198
             Y  PE+L  +   G   D+W  G                     +TL   L G+    
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246

Query: 199 -YP-------FEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 249
            +P       F+  E P+   RK  +R++        YV+       L+ ++ V DP+KR
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPHALDLIDKLLVLDPAKR 298

Query: 250 IPIPEIKKHPWF 261
           I       H +F
Sbjct: 299 IDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 89.9 bits (223), Expect = 9e-21
 Identities = 61/195 (31%), Positives = 100/195 (51%), Gaps = 14/195 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNIIRFKE 66
           LG GN G         T+ ++AVK I     I   +Q++I++   + +    P II F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  ++I  E+  GG L        +  E         ++ G++Y  S++I HRD+K
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
             N L++   Q  +K+CDFG S   L++S  K+ VGT AY+APE ++ ++Y G  SDVWS
Sbjct: 123 PSNMLVNTRGQ--VKLCDFGVSTQ-LVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVWS 178

Query: 187 CGVTLYVMLVGAYPF 201
            G++   + +G +P+
Sbjct: 179 LGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 74/316 (23%), Positives = 119/316 (37%), Gaps = 69/316 (21%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ER-GKKIDENVQREIINHRSLR 57
             YE + +LG G FG     R  +T  +VA+K I    E+ G  I     REI   + L+
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI--TALREIKILKKLK 65

Query: 58  HPNIIRF--------KEVLLTPTHLAIVMEYAA---GGELF-ARICSAGRFSEDEARFFF 105
           HPN++           +       + +V  Y      G L    +    + +E + + + 
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV----KLTESQIKCYM 121

Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY------------SKSGLL 153
            QL+ G++Y H   I HRD+K  N L+D      LKI DFG                G  
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 154 HSQPKSTVGTPAYIAPE-VLARKEYDGKISDVWSCGVTLYVM------LVGAYPFE---- 202
             +  + V T  Y  PE +L  + Y   + D+W  G     M      L G    +    
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 203 --------DPEDPRNFRK---------TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
                     E    +R            +  R ++     + ++  +   LLS++   D
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLE---ERFGKLGPEGLDLLSKLLSLD 295

Query: 246 PSKRIPIPEIKKHPWF 261
           P KR+   +  +HP+F
Sbjct: 296 PYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 90.5 bits (225), Expect = 1e-20
 Identities = 90/312 (28%), Positives = 132/312 (42%), Gaps = 73/312 (23%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTK--ELVAVKYIERGKKIDENVQREIINHRSLR---- 57
           RYE +KELG G +G+    R+  T   E VA+K      KI     ++I+  R+LR    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54

Query: 58  ------HPNII-----------RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE 100
                 H NI             F E+ L       +ME     +L   I S    ++  
Sbjct: 55  LRHFRGHKNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAH 106

Query: 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQP 157
            + F  Q++ G+ Y HS  + HRDLK  N L++   +  LKICDFG ++        +  
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAG 164

Query: 158 KST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNF- 210
             T  V T  Y APE+ L+ + Y   I DVWS G  L   L+G  P    +D  D  N  
Sbjct: 165 FMTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCIL-AELLGRKPVFKGKDYVDQLNQI 222

Query: 211 --------RKTIDRI--RNVQYF---LPDYVRV---------SADCRHLLSQIFVADPSK 248
                    +T+ RI     Q +   LP+  +          +     LL ++   DP+K
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK 282

Query: 249 RIPIPEIKKHPW 260
           RI + E  +HP+
Sbjct: 283 RISVEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 87/336 (25%), Positives = 144/336 (42%), Gaps = 50/336 (14%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLR 57
           + +RY  +K++GSG +G      D+RT   VA+K + R  + +   +   RE+   + ++
Sbjct: 13  VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72

Query: 58  HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
           H N+I   +V      L       +VM +   G    ++    + SED  +F   Q++ G
Sbjct: 73  HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           + Y H+  I HRDLK  N  L  +    LKI DFG ++     S+    V T  Y APEV
Sbjct: 131 LKYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEV 186

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFE--------------------------DPE 205
           +    +  +  D+WS G  +  ML G   F+                            E
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246

Query: 206 DPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           D +N+ K + R R   +   LP+    +    ++L ++ V D   RI   E   HP+F +
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPN---ANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303

Query: 264 -NLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
            + P++  E    +      D+  QS+EE  R+   
Sbjct: 304 FHDPEDETEAPPYDDS---FDEVDQSLEEWKRLTFT 336

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 25/230 (10%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDEN---VQREIINHRSLRHPNIIRF 64
           LG G FG    V+ K T ++ A K +++    KK  E    +++EI+    +  P I+  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLISGVSYCHSMEICH 122
                + THL +VM    GG+L   I + G    +  R   +  Q+  G+ + HSM+I +
Sbjct: 59  AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           RD+K EN LLD     RL   D G +   K G   +Q     GT  Y+APE+L  + Y  
Sbjct: 119 RDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQ---RAGTNGYMAPEILKEEPYSY 173

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
            + D ++ G ++Y M+ G  PF      ++ ++ + +    +  L D V+
Sbjct: 174 PV-DWFAMGCSIYEMVAGRTPF------KDHKEKVAKEELKRRTLEDEVK 216

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 78/254 (30%), Positives = 121/254 (47%), Gaps = 27/254 (10%)

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
            H  I++  +   +   L ++MEY +GG+L  +I    +    F E E    F Q++  +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTPAYIAP 169
              HS ++ HRDLK  N  L   P   +K+ DFG+SK     +      S  GTP Y+AP
Sbjct: 183 DEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
           E+  RK Y  K +D+WS GV LY +L    PF+ P      R+ + ++   +Y  P    
Sbjct: 241 ELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCP 294

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK---NLPKEIIEIEKTNYKEAGRDQPT 286
           VS+  + LL  +   +P+ R P  +   H  FLK   NL ++I+   +T           
Sbjct: 295 VSSGMKALLDPLLSKNPALR-PTTQQLLHTEFLKYVANLFQDIVRHSETISP-------- 345

Query: 287 QSVEEIMRIIQEAK 300
              EEI+R +QE+ 
Sbjct: 346 HDREEILRQLQESG 359

Length = 478

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 88.1 bits (218), Expect = 6e-20
 Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 39/292 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           E Y  + +LG G +      R K T  LVA+K I  E  +       RE+   + L+H N
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I+   +++ T   L +V EY    +L   +   G   +    + F  QL+ G++YCH  +
Sbjct: 66  IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK 124

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
           + HRDLK +N L++   +  LK+ DFG +++  + ++  S  V T  Y  P++ L   +Y
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 178 DGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRI-------------RNVQY 222
             +I D+W  G   Y M  G   +P    E+  +F   I RI              N ++
Sbjct: 183 STQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEEF 238

Query: 223 FLPDYVRVSADCRH------------LLSQIFVADPSKRIPIPEIKKHPWFL 262
              +Y +  ADC H            LLS++   +  KRI   E  KHP+F 
Sbjct: 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.3 bits (216), Expect = 9e-20
 Identities = 74/228 (32%), Positives = 112/228 (49%), Gaps = 23/228 (10%)

Query: 2   EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER--GKKIDENVQREIINHR 54
            +RY + ++ LG G+FG   L      +  T E+VAVK ++R  G++     ++EI   +
Sbjct: 2   HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILK 61

Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
           +L H NI+++K          L ++MEY   G L   +    + +  +   F QQ+  G+
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGM 120

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPAY-I 167
           +Y HS    HRDL   N LLD     RL KI DFG +K+   G  + + +    +P +  
Sbjct: 121 AYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 168 APEVLARKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
           A E L  KE      SDVWS GVTLY +L      + P  P+ F + I
Sbjct: 178 AVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 87.4 bits (216), Expect = 9e-20
 Identities = 81/291 (27%), Positives = 128/291 (43%), Gaps = 39/291 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           E Y  + +LG G +      R K T+ LVA+K I  E  +       RE+   ++L+H N
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN 64

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSME 119
           I+   +++ T   L +V EY    +L   + + G   S    + F  QL+ G+SYCH  +
Sbjct: 65  IVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK 123

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
           I HRDLK +N L++   +  LK+ DFG +++  + ++  S  V T  Y  P+V L   EY
Sbjct: 124 ILHRDLKPQNLLIN--EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181

Query: 178 DGKISDVWSCGVTLYVMLVG--------------------AYPFEDP-------EDPRNF 210
              I D+W  G  LY M  G                      P E+        E+ R++
Sbjct: 182 STPI-DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240

Query: 211 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                R + +    P   R+  D   LLS + + +   RI      +H +F
Sbjct: 241 LFPQYRAQPLINHAP---RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 25/271 (9%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
           E ++ELG G +GV   +R   T  ++AVK I       E  Q+ +     I+ RS+  P 
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPY 61

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDE--ARFFFQQLISGVSYCH 116
            + F   L     + I ME       + + ++   G    ++   +     ++  + Y H
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALEYLH 120

Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPE---- 170
           S + + HRD+K  N L++ + Q  +K+CDFG S   L+ S  K+   G   Y+APE    
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGY-LVDSVAKTIDAGCKPYMAPERINP 177

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            L +K YD K SDVWS G+T+  +  G +P++  + P  F++    +      LP   + 
Sbjct: 178 ELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPAE-KF 233

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           S + +  +++    +  +R   PE+ +HP+F
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 84/304 (27%), Positives = 136/304 (44%), Gaps = 43/304 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           E Y  +++LG G +      R K T+ LVA+K I  E  +       RE+   + L+H N
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 65

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I+   +++ T   L +V EY    +L   +   G   S    + F  Q++ G++YCH  +
Sbjct: 66  IVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV-LARKEY 177
           + HRDLK +N L++   +  LK+ DFG +++  + ++  S  V T  Y  P+V L   EY
Sbjct: 125 VLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 178 DGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN--FR-------------KTIDRIRNV 220
             +I D+W  G   + M  G   +P    ED  +  FR              + D  +N 
Sbjct: 183 STQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN- 240

Query: 221 QYFLPDYV---------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LKNL 265
            Y  P Y          R+  +   LL++    +  KRI   E  KH +F      + +L
Sbjct: 241 -YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSL 299

Query: 266 PKEI 269
           P+ I
Sbjct: 300 PESI 303

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 33/264 (12%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRF 64
           K++G G F           ++ VA+K ++  + +D   +++ +      + L HPN+I++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLISGVSYCH 116
            +  +    L IV+E A  G+L   I    ++ + + R         +F QL S V + H
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMI----KYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEV 171
           S  + HRD+K  N  +  +    +K+ D G      SK+   H    S VGTP Y++PE 
Sbjct: 124 SRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPER 177

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y+ K SD+WS G  LY M     PF    D  N      +I    Y        S
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIEQCDYPPLPTEHYS 234

Query: 232 ADCRHLLSQIFVADPSKRIPIPEI 255
              R L+S     DP +R   P+I
Sbjct: 235 EKLRELVSMCIYPDPDQR---PDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 86.7 bits (215), Expect = 3e-19
 Identities = 77/323 (23%), Positives = 126/323 (39%), Gaps = 63/323 (19%)

Query: 1   MEERYEPV-KELGSGNFGVARLVRDKRTKELVA---VKYIERGKKIDENVQ--------- 47
           + ERY      LG G +G      D  T ++VA   VK IE    + ++ Q         
Sbjct: 6   ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHF 65

Query: 48  ---REIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFF 104
              RE+     ++H NI+   +V +    + +VM+  A  +L   +    R +E + +  
Sbjct: 66  TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI 124

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----------SGLL 153
             Q+++G++  H     HRDL   N  ++   +   KI DFG ++           S   
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINS--KGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 154 HSQPK----STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFED---- 203
             Q +    S V T  Y APE+L   E      D+WS G     +L G   +P E+    
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242

Query: 204 ----------PED---------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
                     P +         P     T  + ++++   P+    S D   LL  +   
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN---ASDDAIDLLQSLLKL 299

Query: 245 DPSKRIPIPEIKKHPWFLKNLPK 267
           +P +RI   E  KH +F K+ P 
Sbjct: 300 NPLERISAKEALKHEYF-KSDPL 321

Length = 335

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 85.5 bits (212), Expect = 5e-19
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)

Query: 10  ELGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRF 64
            +G       +  L + K T  LVAVK I       E++   Q+EII  R L+HPNI+ +
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 65  KEVLLTPTHLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
               +  + L +V    A G   +L       G   E    F  + +++ + Y HS    
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFI 123

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYS--------KSGLLHSQPKSTVGTPAYIAPEVLA 173
           HR +K  + LL G  +  + +    YS        +  ++H  PKS+V    +++PEVL 
Sbjct: 124 HRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181

Query: 174 R--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
           +  + Y+ K SD++S G+T   +  G  PF+D
Sbjct: 182 QNLQGYNEK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 86.3 bits (214), Expect = 6e-19
 Identities = 80/297 (26%), Positives = 119/297 (40%), Gaps = 51/297 (17%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRSLRHP 59
           EP + +G G FGV   V D R  + VA+K +     + +N      V RE+      +H 
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM---PNVFQNLVSCKRVFRELKMLCFFKHD 59

Query: 60  NIIRFKEVLLTP-----THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N++   ++L  P       + +V E     +L   I S    S D  + F  Q++ G+ Y
Sbjct: 60  NVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKY 118

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS  I HRD+K  N L++ +    LKICDFG ++          T  V T  Y APE+L
Sbjct: 119 LHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQEVVTQYYRAPEIL 176

Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFE----------------DP---------ED 206
              + Y   + D+WS G     +L     F+                 P         E 
Sbjct: 177 MGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235

Query: 207 PRNF---RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            R              V Y L    + + +  HLL ++ V DP KRI   +   HP+
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSS--QATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 85.7 bits (212), Expect = 8e-19
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           Y  +K L  G+ G   +       + V +K  ++G  + E +  + +NH     P++IR 
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNH-----PSVIRM 122

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
           K+ L++     +V+ + +  +L+  +   +     D+A    +Q++ G+ Y H+  I HR
Sbjct: 123 KDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR 181

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           D+K EN  ++   Q  + I D G ++  ++        GT    APEVLAR +Y+ K  D
Sbjct: 182 DVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA-D 238

Query: 184 VWSCGVTLYVMLVGAYP---FEDP 204
           +WS G+ L+ ML  AYP   FEDP
Sbjct: 239 IWSAGIVLFEML--AYPSTIFEDP 260

Length = 357

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 83/304 (27%), Positives = 120/304 (39%), Gaps = 62/304 (20%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
           E Y+ + +LG G++      R K T +LVA+K I    E G        RE    + L+H
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHS 117
            NI+   +++ T   L +V EY    +L   +   G   S    R F  QL+ G++YCH 
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 175
             + HRDLK +N L+  S +  LK+ DFG +++  + S+  S  V T  Y  P+VL    
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF---EDPED-------------------------- 206
           EY   + D+W  G   Y M  G   F    D ED                          
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 207 ---------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
                    PR       R+  +                L  +    +P KRI   E  K
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRI-----------PHGEELALKFLQYEPKKRISAAEAMK 287

Query: 258 HPWF 261
           HP+F
Sbjct: 288 HPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 83/306 (27%), Positives = 124/306 (40%), Gaps = 50/306 (16%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSLR 57
           RY+  + +G G++GV     D  T E VA+K I     + E+V       REI   R LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 58  HPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
           HP+I+  K ++L P+      + +V E     +L   I +    + +  +FF  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIA 168
            Y H+  + HRDLK +N L +     +LKICDFG ++     +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 169 PEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR-----------KTID 215
           PE+      +Y   I D+WS G     +L G   F                     +TI 
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 216 RIRNVQY--------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           R+RN +               F   +         LL ++   DP  R    E    P+F
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 262 LKNLPK 267
            K L K
Sbjct: 294 -KGLAK 298

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E      L H  +++   V
Sbjct: 9   LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + IV EY + G L   +   G+      RF   QL+        G++Y  S + 
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGK------RFQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEY 177
            HRDL   N L+D   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 122 IHRDLAARNCLVDD--QGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178

Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SDVW+ GV ++ V  +G  P+E
Sbjct: 179 SSK-SDVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 84.2 bits (208), Expect = 1e-18
 Identities = 82/298 (27%), Positives = 122/298 (40%), Gaps = 50/298 (16%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSLR- 57
           +YEPV E+G G +G     RD  +   VA+K +     E G  +  +  RE+   + L  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58

Query: 58  --HPNIIRFKEVLLT-----PTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLI 109
             HPNI+R  +V  T      T + +V E+       +           +  +   +Q +
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118

Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            G+ + H+  I HRDLK EN L+    Q  +K+ DFG ++           V T  Y AP
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMALTPVVVTLWYRAP 176

Query: 170 EVLARKEYDGKISDVWSCGVTLYVM---------------------LVGAYPFED-PED- 206
           EVL +  Y   + D+WS G     M                     L+G  P +D P D 
Sbjct: 177 EVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235

Query: 207 --PR-NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             PR  F       R VQ  +P+     A    LL ++   +P KRI      +HP+F
Sbjct: 236 TLPRGAFSPRGP--RPVQSVVPEIEESGAQ---LLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 62/214 (28%), Positives = 109/214 (50%), Gaps = 18/214 (8%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIR 63
           +E V+ +G+G +G     R  +T +L A+K ++  +  +E ++ EI +  +   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 64  FKEVLLT---PTH---LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYC 115
           +    +    P H   L +VME+   G +    +        ED   +  ++++ G+++ 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
           H+ ++ HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+A 
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 175 KE-----YDGKISDVWSCGVTLYVMLVGAYPFED 203
            E     YD + SD+WS G+T   M  GA P  D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 69/213 (32%), Positives = 100/213 (46%), Gaps = 34/213 (15%)

Query: 2   EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHRS 55
           EER+ + +++LG GNFG   L R       T E+VAVK ++        + +REI   +S
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61

Query: 56  LRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ------- 106
           L+H NI+++K V  +    +L +VMEY   G L           +   R   +       
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSL------RDYLQKHRERLDHRKLLLYAS 115

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS--TVGTP 164
           Q+  G+ Y  S    HRDL   N L++   + R+KI DFG +K   +  Q K    V  P
Sbjct: 116 QICKGMEYLGSKRYVHRDLATRNILVES--ENRVKIGDFGLTK---VLPQDKEYYKVREP 170

Query: 165 A-----YIAPEVLARKEYDGKISDVWSCGVTLY 192
                 + APE L   ++    SDVWS GV LY
Sbjct: 171 GESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 57/306 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VAVK + R    +   +   RE++  + + H 
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 80

Query: 60  NIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLIS 110
           NII    V  TP         + +VME      + A +C       D  R  +   Q++ 
Sbjct: 81  NIISLLNVF-TPQKSLEEFQDVYLVMEL-----MDANLCQVIHMELDHERMSYLLYQMLC 134

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           G+ + HS  I HRDLK  N ++       LKI DFG +++   +      V T  Y APE
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPE 192

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-------------- 216
           V+    Y   + D+WS G  +  ++ G+  F+  +    + K I++              
Sbjct: 193 VILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 217 -IRNV-----QY-------FLPDYVRVS---------ADCRHLLSQIFVADPSKRIPIPE 254
            +RN      QY         PD++  S         +  R LLS++ V DP KRI + E
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Query: 255 IKKHPW 260
             +HP+
Sbjct: 312 ALRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 90/332 (27%), Positives = 142/332 (42%), Gaps = 47/332 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           ERY  +K++GSG +G      DKRT E VA+K + R    +   +   RE+   + ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 60  NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           N+I   +V  +           +VM Y        +I      SED+ ++   Q++ G+ 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
           Y HS  I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APEV
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLAR----HADAEMTGYVVTRWYRAPEV 185

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDP------------RNFRKTIDRI 217
           +    +  +  D+WS G  +  ML G   F  +D  D               F + ++  
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 218 RNVQYF--LPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
               Y   LP Y R          S     LL ++   D  KR+   E  +HP+F  +  
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF-DSFR 304

Query: 267 KEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
               E E+  Y ++  +    SV+E  + I +
Sbjct: 305 DADEETEQQPYDDS-LENEKLSVDEWKKHIYK 335

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 68/262 (25%), Positives = 110/262 (41%), Gaps = 16/262 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIRFKE 66
           LG G FG     + + T ++ A K +E+ +      +   +N + +        ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I + G   F E+ A F+  ++  G+   H   I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD     R  I D G +         +  VGT  Y+APEV+  + Y     D 
Sbjct: 128 LKPENILLDDYGHIR--ISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDW 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W  G  +Y M+ G  PF   ++     +   R++  Q    +  + S   R +  Q+   
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTK 242

Query: 245 DPSKRI-----PIPEIKKHPWF 261
           DP  R+        E+K HP+F
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 71/243 (29%), Positives = 122/243 (50%), Gaps = 32/243 (13%)

Query: 74  LAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLEN 129
           +A+V++YA  G+L   I S  +    F E EA   F Q++  V + HS  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 130 TLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            LL       +K+ DFG+SK   + +     ++  GTP Y+APE+  RK Y  K +D++S
Sbjct: 174 ILL--CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230

Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVRVSADCRHLLSQIFVAD 245
            GV LY +L    PF    D  N  + + +    +Y  LP    +S + + +++ +  +D
Sbjct: 231 LGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284

Query: 246 PSKRIPIPEIKKHPWFLKNLP------KEIIEIEKTNYKEAG--RDQPTQSVEEIMRIIQ 297
           P +R   P   K    L N+P        ++EI +T    +G  RD  ++ +++  +++Q
Sbjct: 285 PKRR---PSSSK----LLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQ 337

Query: 298 EAK 300
             +
Sbjct: 338 VER 340

Length = 496

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.8 bits (204), Expect = 5e-18
 Identities = 75/263 (28%), Positives = 116/263 (44%), Gaps = 18/263 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
           LG G FG     + + T ++ A K +E+ +      +   +N + +      RF   L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 70  ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I   G   F E  A F+  ++  G+   H   I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     D 
Sbjct: 128 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-VRVSADCRHLLSQIFV 243
           W+ G  LY M+ G  PF+     +  R+ ++R+  V+    +Y  + S D R L   +  
Sbjct: 185 WALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL--VKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 244 ADPSKRI-----PIPEIKKHPWF 261
            DP +R+        E+K+HP F
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 82.1 bits (202), Expect = 7e-18
 Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 30/275 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIR 63
           +E V+ +G+G +G     R  +T +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 64  FKEVLLTPT------HLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYC 115
           +    +          L +VME+   G +    +        E+   +  ++++ G+S+ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
           H  ++ HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+A 
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 175 KE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----RKTIDRIRNVQYFLP 225
            E     YD K SD+WS G+T   M  GA P  D    R      R    R+++ ++   
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--- 241

Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                S   +  +    V + S+R    ++ KHP+
Sbjct: 242 -----SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 81.2 bits (200), Expect = 9e-18
 Identities = 71/267 (26%), Positives = 128/267 (47%), Gaps = 23/267 (8%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI------ERGKKIDENVQREIINHRSLRH 58
           Y  V+ +G G++G   LVR +   +   +K +       R +K  E  + ++++   L+H
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ-EAQLLSQ--LKH 58

Query: 59  PNIIRFKEVLL-TPTHLAIVMEYAAGGELFARI--CSAGRFSEDEARFFFQQLISGVSYC 115
           PNI+ ++E        L IVM +  GG+L+ ++         E++   +F Q+   + Y 
Sbjct: 59  PNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
           H   I HRDLK +N  L  +    +K+ D G ++         ST +GTP Y++PE+ + 
Sbjct: 119 HEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSAD 233
           K Y+ K SDVW+ G  +Y M    + F    + ++    + RI  ++  LP   +  S +
Sbjct: 177 KPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDYSPE 229

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPW 260
              L++ +    P KR  +  I + P+
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 2e-17
 Identities = 71/254 (27%), Positives = 106/254 (41%), Gaps = 22/254 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRF 64
           K++G G F              VA+K ++    +D   + + I      + L HPN+I++
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEI 120
               +    L IV+E A  G+L   I    +      E     +F QL S + + HS  +
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPEVLARK 175
            HRD+K  N  +  +    +K+ D G      SK+   H    S VGTP Y++PE +   
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y+ K SD+WS G  LY M     PF    D  N      +I    Y        S + R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 236 HLLSQIFVADPSKR 249
            L++     DP KR
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 80.5 bits (199), Expect = 3e-17
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 27/279 (9%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR--SLRH--PNI 61
           E + E+GSG  G    +R K+T  ++AVK + R    +EN +R +++       H  P I
Sbjct: 18  ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYI 76

Query: 62  IRFKEVLLTPTHLAIVMEYAAG--GELFARICSAGRFSEDEARFFFQQLISGVSYC---H 116
           ++     +T + + I ME  +    +L  RI   G   ED        ++  + Y    H
Sbjct: 77  VKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH 134

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVL--- 172
              + HRD+K  N LLD S    +K+CDFG S   L+ S+ K+ + G  AY+APE +   
Sbjct: 135 G--VIHRDVKPSNILLDASGN--VKLCDFGISGR-LVDSKAKTRSAGCAAYMAPERIDPP 189

Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRV 230
               +YD + +DVWS G++L  +  G +P+        F + + +I   +   LP     
Sbjct: 190 DPNPKYDIR-ADVWSLGISLVELATGQFPY--KNCKTEF-EVLTKILQEEPPSLPPNEGF 245

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           S D    +      D  KR    E+ +HP+  +    E+
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 5e-17
 Identities = 67/207 (32%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 9   KELGSGNFGVAR--LVRDKRTKEL-VAVKYIERGKKIDENVQREIINHRS----LRHPNI 61
           KELG GNFG     +   K  KE+ VAVK +++        ++E +   S    L HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMAQLDHPCI 58

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +R   V      L +VME A  G L   +         + +    Q+  G++Y  S    
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGT--P-AYIAPEVLARKEY 177
           HRDL   N LL    Q   KI DFG S++ G      ++T     P  + APE +   ++
Sbjct: 118 HRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 178 DGKISDVWSCGVTLYVML-VGAYPFED 203
             K SDVWS GVTL+     GA P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 79.7 bits (196), Expect = 6e-17
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 24/273 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
           + +E ++ +G G +G    V +K+     AVK ++    IDE ++ E    ++L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 62  IRF-----KEVLLTPTHLAIVMEYAAGG---ELFARICSAG-RFSEDEARFFFQQLISGV 112
           ++F     K+ +     L +V+E   GG   +L       G R  E    +   + + G+
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPE 170
            + H  +  HRD+K  N LL  + +  +K+ DFG S + L  ++ +  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPE 194

Query: 171 VLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           V+A ++     YD +  DVWS G+T   +  G  P  D    R   K     RN    L 
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKI---PRNPPPTLH 250

Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
                S +    + +    D  KR  + ++ +H
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 78.6 bits (194), Expect = 7e-17
 Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 23/201 (11%)

Query: 9   KELGSGNFGVARLVRDKRTKEL-----VAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
           K+LG G+FGV R  R + +        VAVK ++  K   I ++  +E     SL H N+
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSA-GRFSEDEARFFFQQLISGVSYCHSME 119
           IR   V+LT   L +V E A  G L  R+   A G F       +  Q+ +G+ Y  S  
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTP-AYIAPEVLA 173
             HRDL   N LL  +   ++KI DFG  ++   +      +    V  P A+ APE L 
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173

Query: 174 RKEYDGKISDVWSCGVTLYVM 194
            + +    SDVW  GVTL+ M
Sbjct: 174 TRTFS-HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 80.1 bits (197), Expect = 8e-17
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGA--YPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 250 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 1e-16
 Identities = 64/201 (31%), Positives = 91/201 (45%), Gaps = 12/201 (5%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELGSG FGV  L +  R K  VA+K I  G   +++   E      L HPN+++   V
Sbjct: 9   LKELGSGQFGVVHLGK-WRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                 + IV EY A G L  + R    G+   +        +   + Y  S    HRDL
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
              N L+       +K+ DFG ++  +L  Q  S+ GT   +    PEV     +  K S
Sbjct: 127 AARNCLV--GEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182

Query: 183 DVWSCGVTLY-VMLVGAYPFE 202
           DVWS GV ++ V   G  P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 84/316 (26%), Positives = 130/316 (41%), Gaps = 72/316 (22%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSLR 57
           RY+ +K +GSG  G+     D  T + VA+K + R     +NV       RE++  + + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73

Query: 58  HPNIIRFKEVLLTP-------THLAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQL 108
           H NII    V  TP         + +VME      + A +C   +   D  R  +   Q+
Sbjct: 74  HKNIIGLLNVF-TPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQM 127

Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
           + G+ + HS  I HRDLK  N ++  D +    LKI DFG +++          V T  Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFED--------------PED---- 206
            APEV+    Y   + D+WS G  +  M+ G   +P  D              P D    
Sbjct: 184 RAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 207 -------------PRNFRKTIDRIRNVQYFLPDYVRVS----ADCRHLLSQIFVADPSKR 249
                        P+    + + +     F PD    +    +  R LLS++ V DP KR
Sbjct: 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302

Query: 250 IPIPEIKKHP----WF 261
           I + +  +HP    W+
Sbjct: 303 ISVDDALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 71/267 (26%), Positives = 118/267 (44%), Gaps = 19/267 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
           LG G FG     + + T ++ A K +E+ +      +   +N + +      +F   L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 70  ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I + G   F E+ A F+  +++ G+   H     +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD      ++I D G +         +  VGT  Y+APEVL  + Y     D 
Sbjct: 128 LKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-VRVSADCRHLLSQIFV 243
           W  G  +Y M+ G  PF   ++ +  R+ +D  R V      Y  + S + + +   +  
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKE-KVKREEVD--RRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 244 ADPSKRIPIP-----EIKKHPWFLKNL 265
            DP +R+        E+K+HP F +N+
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHP-FFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.6 bits (191), Expect = 2e-16
 Identities = 66/201 (32%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELGSG FGV  L +  R +  VA+K I  G   +E+   E      L HP +++   V
Sbjct: 9   MKELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                 L IV E+   G L  + R    G+ S+D      Q +  G+ Y       HRDL
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
              N L+  S    +K+ DFG ++  +L  +  S+ G      +  PEV    +Y  K S
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182

Query: 183 DVWSCGVTLY-VMLVGAYPFE 202
           DVWS GV ++ V   G  PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.9 bits (192), Expect = 2e-16
 Identities = 82/305 (26%), Positives = 123/305 (40%), Gaps = 57/305 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           + YE ++++G G +G     RDK T +LVA+K   R +  +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59

Query: 59  -PNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGR-----FSEDEARFFFQQ 107
              I+R  +V           L +V EY    +L   + S GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KST--VGT 163
           L+ GV++CH   + HRDLK +N L+D   +  LKI D G  ++    S P    T  + T
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLGRA---FSIPVKSYTHEIVT 174

Query: 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR--------------- 208
             Y APEVL    +     D+WS G     M      F  P D                 
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF--PGDSELQQLLHIFKLLGTPT 232

Query: 209 --------NFRK----TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 256
                     R        + +++   +PD   +S +   LL ++   DP+KRI      
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAAL 289

Query: 257 KHPWF 261
            HP+F
Sbjct: 290 THPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 86/341 (25%), Positives = 135/341 (39%), Gaps = 45/341 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 195 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + E  +HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Query: 261 FLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKM 301
                    +E       +   D+   ++EE   +I +  M
Sbjct: 314 INVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 81/307 (26%), Positives = 126/307 (41%), Gaps = 59/307 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 60  NIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGRFSEDEAR--FFFQQLIS 110
           NII    V  TP         + IVME      + A +C   +   D  R  +   Q++ 
Sbjct: 84  NIIGLLNVF-TPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQMLC 137

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           G+ + HS  I HRDLK  N ++       LKI DFG +++          V T  Y APE
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------- 217
           V+    Y   + D+WS G  +  M+ G   F   +    + K I+++             
Sbjct: 196 VILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 254

Query: 218 --------------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIP 253
                          + +   PD V   AD  H          LLS++ V D SKRI + 
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 254 EIKKHPW 260
           E  +HP+
Sbjct: 314 EALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 77.8 bits (191), Expect = 3e-16
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 19/214 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
           + YE +++LG G++      + K   +LVA+K I    E G        RE    + L+H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLKH 62

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVS 113
            NI+   +++ T   L +V EY     +   +C       G    +  + F  QL+ G+S
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL 172
           Y H   I HRDLK +N L+  + +  LK+ DFG +++  + S   S  V T  Y  P+VL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
                     D+W  G     M+ G   F   +D
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 16/262 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
           LG G FG     + + T ++ A K +E+ +      +   +N + +      RF   L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 70  ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I + G   F E  A F+  +L  G+       I +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD   +  ++I D G +         +  VGT  Y+APEV+  ++Y     D 
Sbjct: 128 LKPENILLDD--RGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDW 184

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W  G  +Y M+ G  PF   ++     +   R++  Q    +  + S D + +   +   
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLTK 242

Query: 245 DPSKRIPI-----PEIKKHPWF 261
           +P +R+         +K+HP F
Sbjct: 243 NPKERLGCRGNGAAGVKQHPIF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 5e-16
 Identities = 59/186 (31%), Positives = 83/186 (44%), Gaps = 13/186 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G FG   L   +  K  VAVK ++      +    E     +LRHPN+++   V+L 
Sbjct: 14  IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 71  PTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
              L IV EY A G L   + S GR   +  +   F   +  G+ Y       HRDL   
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131

Query: 129 NTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA-YIAPEVLARKEYDGKISDVWS 186
           N L+  S     K+ DFG +K     +      G  P  + APE L  K++  K SDVWS
Sbjct: 132 NVLV--SEDLVAKVSDFGLAKE----ASQGQDSGKLPVKWTAPEALREKKFSTK-SDVWS 184

Query: 187 CGVTLY 192
            G+ L+
Sbjct: 185 FGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 6/151 (3%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E +  VK +  G FG   L R K   +L AVK +++   I++N+  ++   R      + 
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P I+     L +  ++ +VMEY  GG++ + +   G F E+ A  +  ++   + Y H  
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
            I HRDLK +N L+  S +  +K+ DFG SK
Sbjct: 124 GIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 71/278 (25%), Positives = 117/278 (42%), Gaps = 40/278 (14%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRFK 65
           E+G G FG    +  K +  ++AVK I R    ++  +R +++     RS   P I++F 
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFY 69

Query: 66  EVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYC--------- 115
             L       I ME      + F +        E       ++++  ++           
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
             ++I HRD+K  N LLD +    +K+CDFG S   L+ S  K+   G   Y+APE +  
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQ-LVDSIAKTRDAGCRPYMAPERIDP 181

Query: 174 --RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-----FLPD 226
             R  YD + SDVWS G+TLY +  G +P+        +    D++  V           
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPILSNS 234

Query: 227 YVR-VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
             R  S    + ++   + D SKR    E+ +HP+   
Sbjct: 235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.4 bits (185), Expect = 2e-15
 Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 27/273 (9%)

Query: 2   EERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYI--ERGKKIDENVQREIINHR 54
           E+R+ + +++LG G+FG   L R       T E VAVK +  E G     ++++EI   R
Sbjct: 2   EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 61

Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISG 111
           +L H NI+++K +        + ++ME+   G L   +  +  + +  +   +  Q+  G
Sbjct: 62  NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKG 121

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAY-I 167
           + Y  S +  HRDL   N L++   + ++KI DFG +K+     +    K  + +P +  
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVES--EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179

Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNV 220
           APE L + ++    SDVWS GVTLY +L        P         P + + T+ R+  V
Sbjct: 180 APECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238

Query: 221 ---QYFLPDYVRVSADCRHLLSQIFVADPSKRI 250
                 LP       +   L+ + +   PSKR 
Sbjct: 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT 271

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 14/178 (7%)

Query: 26  RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGG 84
           + + L+A K ++ G +    ++ EI+    L H NI++ +E+L +  +   I  +Y    
Sbjct: 191 KCERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247

Query: 85  ELFARICSAGRFSED-----EARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139
           +L++ +       +D     + R   +QL+  V Y H  ++ HRD+KLEN  L+   +  
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307

Query: 140 LKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
           L   DFG +       +      VGT A  +PE+LA   Y  +I+D+WSCG+ L  ML
Sbjct: 308 LG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 74.2 bits (182), Expect = 2e-15
 Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 12/202 (5%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K  VA+K I  G   +E+   E      L HP +++   V
Sbjct: 9   VQEIGSGQFGLVWL-GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               + + +V E+   G L  + R    G+FS++        +  G++Y  S  + HRDL
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
              N L+       +K+ DFG ++  +L  Q  S+ GT     + +PEV +  +Y  K S
Sbjct: 127 AARNCLV--GENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-S 182

Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
           DVWS GV ++ V   G  P+E+
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 11/206 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D R ++ VAVK + R  +         RE+   + ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 60  NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           N+I   +V    T +     + +     G     I    + S++  +F   QL+ G+ Y 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           HS  I HRDLK  N  ++   +  L+I DFG ++      +    V T  Y APE++   
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNW 190

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
            +  +  D+WS G  +  +L G   F
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 8e-15
 Identities = 63/219 (28%), Positives = 98/219 (44%), Gaps = 39/219 (17%)

Query: 8   VKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPN 60
            K +G G FG     RL    + +  VA+K ++ G    +  + + +   S+     HPN
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPN 66

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
           IIR + V+     + I+ EY   G L  F R        E++ +F   QL+       SG
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASG 118

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-----PA- 165
           + Y   M   HRDL   N L+  +     K+ DFG S+        ++T  T     P  
Sbjct: 119 MKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSR---RLEDSEATYTTKGGKIPIR 173

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           + APE +A +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 73.5 bits (181), Expect = 8e-15
 Identities = 73/293 (24%), Positives = 109/293 (37%), Gaps = 43/293 (14%)

Query: 1   MEERYEPVKELGSGNFGV----------------ARLVRDKRTKELVAVKYIERG--KKI 42
             +    V++LG G FG                      +     LVAVK +        
Sbjct: 3   PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA 62

Query: 43  DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSE 98
            E+  +E+     L  PNI R   V      L ++MEY   G+    L   +      + 
Sbjct: 63  REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 99  DEARFFFQQLI-------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
           +     F  L+       SG+ Y  S+   HRDL   N L+  +    +KI DFG S++ 
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179

Query: 152 LLHSQPKSTVG--TPAYI---APEVLARKEYDGKISDVWSCGVTLY--VMLVGAYPFEDP 204
            L+S     V    P  I   A E +   ++  K SDVW+ GVTL+  + L    P+E  
Sbjct: 180 -LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHL 237

Query: 205 EDPRNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
            D +         R+   Q +LP       D   L+ + +  D   R    EI
Sbjct: 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 73.1 bits (179), Expect = 9e-15
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 21/208 (10%)

Query: 5   YEPVKELGSGNF-----GVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRS 55
           Y  +++LG G++     G++R+       +LVA+K I    K +E V     RE    + 
Sbjct: 7   YLNLEKLGEGSYATVYKGISRI-----NGQLVALKVISM--KTEEGVPFTAIREASLLKG 59

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           L+H NI+   +++ T   L  V EY         I   G       R F  QL+ G++Y 
Sbjct: 60  LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-A 173
           H   I HRDLK +N L+  S    LK+ DFG +++  + SQ  S+ V T  Y  P+VL  
Sbjct: 120 HGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG 177

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
             +Y   + D+W  G     ML G   F
Sbjct: 178 ATDYSSAL-DIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 70.9 bits (174), Expect = 4e-14
 Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 20/255 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
           E +   ++LGSG FG   +     + +  VA+K ++    +  ++ Q+E+   + LRH +
Sbjct: 6   EEFTLERKLGSGYFG--EVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKH 63

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSM 118
           +I    V      + I+ E    G L A + S        A       Q+  G++Y    
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARK 175
              HRDL   N L+        K+ DFG ++  L+      +        + APE  +  
Sbjct: 124 NSIHRDLAARNILVG--EDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHG 179

Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
            +  K SDVWS G+ LY +   G  P+       N  +  D+I    Y +P   +   + 
Sbjct: 180 TFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQI-TAGYRMPCPAKCPQEI 233

Query: 235 RHLLSQIFVADPSKR 249
             ++ + + A+P  R
Sbjct: 234 YKIMLECWAAEPEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 83/318 (26%), Positives = 133/318 (41%), Gaps = 65/318 (20%)

Query: 5   YEPVKELGSGNFGVARLVR--DKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           YE  K +G G +G     +  D + ++  A+K IE G  I  +  REI   R L+HPN+I
Sbjct: 4   YEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNVI 61

Query: 63  RFKEVLLTPT--HLAIVMEYAAGGEL----FARICSAGR----FSEDEARFFFQQLISGV 112
             ++V L+ +   + ++ +YA         F R   A +          +    Q++ G+
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 113 SYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK------STVGTP 164
            Y H+  + HRDLK  N L+  +G  + R+KI D G+++  L +S  K        V T 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179

Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 219
            Y APE+L    +  K  D+W+ G     +L     F    ED +    F    +DRI +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239

Query: 220 VQYF-----------LPDYVRVSADCRH-------------------------LLSQIFV 243
           V  F           +P+Y  +  D R                          LL ++  
Sbjct: 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299

Query: 244 ADPSKRIPIPEIKKHPWF 261
            DP+KRI   +  + P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 28/207 (13%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G+G+FGV        T E VA+K + +  +      RE++  ++L H NII  K+   T
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130

Query: 71  PT--------HLAIVMEYAAGG-----ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
                      L +VME+         + +AR   A        + +  QL   ++Y HS
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA--LPLFLVKLYSYQLCRALAYIHS 188

Query: 118 MEICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV-LA 173
             ICHRDLK +N L+D    P    LK+CDFG +K+ L   +  S + +  Y APE+ L 
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYP 200
              Y   I D+WS G  +  M++G YP
Sbjct: 245 ATNYTTHI-DLWSLGCIIAEMILG-YP 269

Length = 440

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.8 bits (173), Expect = 7e-14
 Identities = 66/229 (28%), Positives = 99/229 (43%), Gaps = 18/229 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYI-----ERGKKIDENVQREIINH-RS 55
           ++YE V E+G G +G     RD K     VA+K +     E G  +    +  ++ H  +
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60

Query: 56  LRHPNIIRFKEVLLTP-----THLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQL 108
             HPN++R  +V         T L +V E+          ++   G  +E      FQ L
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 119

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
           + G+ + HS  + HRDLK +N L+  S Q  +K+ DFG ++         S V T  Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYRA 177

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
           PEVL +  Y   + D+WS G     M      F    D     K +D I
Sbjct: 178 PEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 31/221 (14%)

Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRS 55
           E   E +K LGSG FG       +   ++ K  VA+K +  E   K ++ +  E     S
Sbjct: 6   ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS----- 110
           + HP+++R   + L+     ++ +    G L   +         +     Q L++     
Sbjct: 66  VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV------RNHKDNIGSQYLLNWCVQI 118

Query: 111 --GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
             G+SY     + HRDL   N L+  +PQ  +KI DFG +K  LL    K          
Sbjct: 119 AKGMSYLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVP 174

Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
             ++A E +  + Y  K SDVWS GVT++ +M  GA P+E 
Sbjct: 175 IKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 85/318 (26%), Positives = 132/318 (41%), Gaps = 65/318 (20%)

Query: 5   YEPVKELGSGNFG-VARLVR-DKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           YE  K +G G +G V +  R D +     A+K IE G  I  +  REI   R L+HPN+I
Sbjct: 4   YEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVI 61

Query: 63  RFKEVLLTPT--HLAIVMEYAAGGEL----FARICSAGR----FSEDEARFFFQQLISGV 112
             ++V L+     + ++ +YA         F R   A +          +    Q++ G+
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 113 SYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPK------STVGTP 164
            Y H+  + HRDLK  N L+  +G  + R+KI D G+++  L +S  K        V T 
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVTF 179

Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNF-RKTIDRIRN 219
            Y APE+L    +  K  D+W+ G     +L     F    ED +    +    +DRI N
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239

Query: 220 VQYF-----------LPDYVRVSADCR-------------------------HLLSQIFV 243
           V  F           +P++  +  D R                         HLL ++  
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT 299

Query: 244 ADPSKRIPIPEIKKHPWF 261
            DP KRI   +  + P+F
Sbjct: 300 MDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 29/263 (11%)

Query: 9   KELGSGNFG-VAR--LVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG V R  L    R +  VA+K ++ G    E  +++ ++  S+     H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNI 68

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+       I+ EY   G L  + R    G FS  +     + + +G+ Y   M 
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++       K+ DFG S+  +L   P+ T  T        + APE +A
Sbjct: 128 YVHRDLAARNILVNS--NLECKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            +++    SDVWS G+ ++ VM  G  P+ D  +     K I    N  + LP  +   +
Sbjct: 184 YRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAI----NDGFRLPAPMDCPS 237

Query: 233 DCRHLLSQIFVADPSKRIPIPEI 255
               L+ Q +  D ++R    +I
Sbjct: 238 AVYQLMLQCWQQDRARRPRFVDI 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 54/236 (22%)

Query: 2   EERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS- 55
            E+   ++ELG G+FG     +A+ V     +  VA+K +     + E    E +N  S 
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASV 62

Query: 56  ---LRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARF------- 103
                  +++R   V+ T     +VME  A G+L  + R     R   +           
Sbjct: 63  MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQ 119

Query: 104 -FFQ---QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----------YSK 149
            F Q   ++  G++Y  + +  HRDL   N ++  +    +KI DFG          Y K
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--AEDLTVKIGDFGMTRDIYETDYYRK 177

Query: 150 SG--LLHSQPKSTVGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPF 201
            G  LL          P  ++APE L    +  K SDVWS GV L+ M  +   P+
Sbjct: 178 GGKGLL----------PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.4 bits (167), Expect = 4e-13
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 26/211 (12%)

Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIR 63
           +G+G FG     RL    + +  VA+K ++ G    E  +R+ ++  S+     HPNII 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
            + V+     + I+ E+   G L  F R  + G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE +A
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 67.5 bits (165), Expect = 5e-13
 Identities = 72/268 (26%), Positives = 107/268 (39%), Gaps = 40/268 (14%)

Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL---RHPNII 62
           +++G GNFG      L    +    VAVK   R     +  ++ +     L    HPNI+
Sbjct: 1   EKIGKGNFGDVYKGVL----KGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIV 55

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAG-------RFSEDEARFFFQQLISGVS 113
           +   V +    + IVME   GG L  F R            + S D A        +G+ 
Sbjct: 56  KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAA--------AGME 107

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTP-AYIAPE 170
           Y  S    HRDL   N L+  +    LKI DFG S+   G +++        P  + APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPE 165

Query: 171 VLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
            L    Y  + SDVWS G+ L+    +G  P+    + +  R+ I+      Y +P    
Sbjct: 166 ALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQT-RERIES----GYRMPAPQL 219

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKK 257
              +   L+ Q +  DP  R    EI  
Sbjct: 220 CPEEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 73/254 (28%), Positives = 110/254 (43%), Gaps = 25/254 (9%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFKEV 67
           +G G FG   +++ + T + VAVK I    K D   Q    E      L H N++R   V
Sbjct: 14  IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSMEICHRDL 125
           +L    L IVME  + G L   + + GR      +   F   +  G+ Y  S ++ HRDL
Sbjct: 68  ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISDV 184
              N L+  S     K+ DFG ++ G   S        P  + APE L  K++  K SDV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLARVG---SMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180

Query: 185 WSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
           WS GV L+ V   G  P+     P+   K +       Y +       AD   L++  + 
Sbjct: 181 WSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235

Query: 244 ADPSKRIPIPEIKK 257
            +P KR    ++++
Sbjct: 236 TEPKKRPSFHKLRE 249

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.1 bits (161), Expect = 2e-12
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ ++  S+     HPNI
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNI 67

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           I  + V+     + IV EY   G L  F R    G+F+  +     + + SG+ Y   M 
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMG 126

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE +A
Sbjct: 127 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SDVWS G+ ++ VM  G  P+ +
Sbjct: 183 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 10  ELGSGNFG-VARLVRDKRTKEL-VAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
           ELGSGNFG V + V   R K++ VA+K ++    K + + + RE      L +P I+R  
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHR 123
            V      L +VME A+GG L  +  S  +   +         Q+  G+ Y       HR
Sbjct: 62  GVC-EAEALMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTP---AYIAPEVLARKEYDG 179
           DL   N LL    Q   KI DFG SK+ G   S  K+         + APE +  +++  
Sbjct: 120 DLAARNVLLVN--QHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDP 207
           + SDVWS G+T++     G  P++  + P
Sbjct: 178 R-SDVWSYGITMWEAFSYGQKPYKKMKGP 205

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 59/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREI-------INHRSLRH 58
           K LG G FG     +L +D  ++  VAVK +    K+D +   EI          +   H
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 59  PNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLI--- 109
           PN+++   V    + L       +++ +   G+L + +  + R      +   Q L+   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFM 119

Query: 110 ----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKST 160
                G+ Y  +    HRDL   N +L       + +C  DFG SK   SG  + Q +  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                +IA E LA + Y  K SDVW+ GVT++ +   G  P+
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 65.0 bits (158), Expect = 4e-12
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 15/194 (7%)

Query: 9   KELGSGNFGVAR--LVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNII 62
            ELGSGNFG  +  + + K++++ VAVK I +    D  ++ E++      + L +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           R   +        +VME A  G L   +      +E        Q+  G+ Y       H
Sbjct: 60  RMIGI-CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPA-YIAPEVLARKEYD 178
           RDL   N LL    Q   KI DFG SK   +   + + K+    P  + APE +   ++ 
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 177 SK-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.5 bits (157), Expect = 5e-12
 Identities = 58/246 (23%), Positives = 107/246 (43%), Gaps = 24/246 (9%)

Query: 21  LVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY 80
           LV D RT++   +K + +  +     +  II H     PN++   + +++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 81  AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL 140
           A GG+L++ I       E+  + +  +++  +   H   I  RDL   N LLD     +L
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126

Query: 141 KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYP 200
                 +S+   +            Y APEV    E + +  D WS G  L+ +L G   
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181

Query: 201 FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI-----PIPEI 255
            E      N         +    +P++  VS + R LL Q+   +P++R+      + +I
Sbjct: 182 VECHPSGIN--------THTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 256 KKHPWF 261
           K HP+F
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.8 bits (158), Expect = 5e-12
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)

Query: 3   ERYEPVKELGSGNFG---VARLVRDKRTKELVAVKY--IERGKKIDENVQREIINHRSLR 57
           E     + +G G FG       +  +  K  VAVK         + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYC 115
           HP+I++   V+ T   + IVME A  GEL + +    ++S D A    +  QL + ++Y 
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-P-AYIAPEVLA 173
            S    HRD+   N L+  SP   +K+ DFG S+     S  K++ G  P  ++APE + 
Sbjct: 124 ESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            + +    SDVW  GV ++ ++++G  PF+  ++       I RI N +  LP       
Sbjct: 182 FRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIENGER-LPMPPNCPP 235

Query: 233 DCRHLLSQIFVADPSKRIPIPEIK 256
               L+++ +  DPSKR    E+K
Sbjct: 236 TLYSLMTKCWAYDPSKRPRFTELK 259

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.7 bits (157), Expect = 5e-12
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 57/293 (19%)

Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           VK+LG+G FG V     +  TK  VAVK ++ G    +    E    ++L+H  ++R   
Sbjct: 11  VKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 68

Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+     + I+ EY A G L  F +    G+    +   F  Q+  G++Y       HRD
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKI 181
           L+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K 
Sbjct: 129 LRAANVLV--SESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK- 184

Query: 182 SDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           SDVWS G+ LY ++  G  P+                             ++D    L +
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPG-------------------------MSNSDVMSALQR 219

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT----QSV 289
            +      R+P  E         N P E+ +I KT +KE   ++PT    QSV
Sbjct: 220 GY------RMPRME---------NCPDELYDIMKTCWKEKAEERPTFDYLQSV 257

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 66/257 (25%), Positives = 105/257 (40%), Gaps = 34/257 (13%)

Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
            ++LG+G FG V     +  TK  VAVK ++ G    E   +E    + LRH  +++   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFF-FQQLI-------SGVSYCHSM 118
           V      + IV EY + G L   +         E +     QL+        G++Y  S 
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTP-AYIAPEVLAR 174
              HRDL   N L+        KI DFG ++  L+       +     P  + APE    
Sbjct: 123 NYIHRDLAARNILV--GENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178

Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSA 232
             +  K SDVWS G+ L  ++  G  P+         R+ ++++ R   Y +P       
Sbjct: 179 GRFTIK-SDVWSFGILLTEIVTYGRVPYPG----MTNREVLEQVERG--YRMPRPPNCPE 231

Query: 233 DCRHLLSQIFVADPSKR 249
           +   L+ Q +  DP +R
Sbjct: 232 ELYDLMLQCWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 67/254 (26%), Positives = 105/254 (41%), Gaps = 27/254 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKE 66
           + +G GNFG     R +     VAVK         +     +E    +   HPNI+R   
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
           V      + IVME   GG+    + + G R    E     +   +G+ Y  S    HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 126 KLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
              N L+  + +  LKI DFG         Y+ +G +   P        + APE L    
Sbjct: 121 AARNCLV--TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK------WTAPEALNYGR 172

Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           Y  + SDVWS G+ L+    +GA P+ +  + +  R+ I+  + V+   P+         
Sbjct: 173 YSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIE--QGVRLPCPE--LCPDAVY 226

Query: 236 HLLSQIFVADPSKR 249
            L+ + +  DP +R
Sbjct: 227 RLMERCWEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 7/187 (3%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 70  TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ--QLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L   +    R   +     +   Q+ S + Y       HRDL  
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132

Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 133 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 189

Query: 186 SCGVTLY 192
           + GV L+
Sbjct: 190 AFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 26/205 (12%)

Query: 18  VARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRFKEVLLTPTHL 74
              L R K T E V V+ I      +E V   Q E+   +   HPNI+ ++   +    L
Sbjct: 15  TVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74

Query: 75  AIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL- 131
            +V  + A G     IC+      SE    +  Q ++  + Y H M   HR +K  + L 
Sbjct: 75  WVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI 134

Query: 132 -LDGSPQPRLKICDFGY----------SKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYD 178
            +DG      K+   G            +  ++H  PK +V    +++PEVL +  + YD
Sbjct: 135 SVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD 188

Query: 179 GKISDVWSCGVTLYVMLVGAYPFED 203
            K SD++S G+T   +  G  PF+D
Sbjct: 189 AK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 62.3 bits (151), Expect = 4e-11
 Identities = 78/290 (26%), Positives = 121/290 (41%), Gaps = 55/290 (18%)

Query: 9   KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNI 61
           K LG G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARIC---------------SAGRFSEDEARFF 104
           I+          L +++EYA  G L  F R                 S+   + DE    
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 105 FQQLIS-------GVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSK------S 150
              LIS       G+ Y   M++ HRDL   N L+ +G    ++KI DFG S+      S
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFGLSRDVYEEDS 182

Query: 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDP 207
            +  S+ +  V    ++A E L    Y  + SDVWS GV L+ ++ +G   YP   PE  
Sbjct: 183 YVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
            N  KT  R+       P+    S +  +L+   +  +P KR    +I K
Sbjct: 239 FNLLKTGYRMER-----PE--NCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 61.5 bits (149), Expect = 7e-11
 Identities = 62/189 (32%), Positives = 84/189 (44%), Gaps = 19/189 (10%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRHPNIIRFKEV 67
           +G G FG   ++ D R  + VAVK I    K D   Q    E      LRH N+++   V
Sbjct: 14  IGKGEFGDV-MLGDYRGNK-VAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67

Query: 68  LLTP-THLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
           ++     L IV EY A G L   + S GR     D    F   +   + Y  +    HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
           L   N L+  S     K+ DFG +K     S  + T   P  + APE L  K++  K SD
Sbjct: 128 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SD 181

Query: 184 VWSCGVTLY 192
           VWS G+ L+
Sbjct: 182 VWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 15/185 (8%)

Query: 27  TKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI-VMEYA 81
           T   VA+K +       +      +RE      L HPNI+   +    P  L   V EY 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 82  AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRL 140
            G  L   + + G     E      Q++  ++  H+  I HRDLK +N ++  +  +P  
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 141 KICDFGYSKSG--------LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
           K+ DFG                ++    +GTP Y APE L R E     SD+++ G+   
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFL 180

Query: 193 VMLVG 197
             L G
Sbjct: 181 ECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 60/219 (27%), Positives = 90/219 (41%), Gaps = 34/219 (15%)

Query: 9   KELGSGNFGVARLVRDKRTKE--------------LVAVKYI--ERGKKIDENVQREIIN 52
           ++LG G FG   L   +   E              LVAVK +  +  K    +  +EI  
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL------------FARICSAGRFSEDE 100
              L++PNIIR   V ++   L ++ EY   G+L            F    +    S   
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQP 157
             +   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S+   SG  +   
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQ 188

Query: 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
              V    ++A E +   ++    SDVW+ GVTL+ M  
Sbjct: 189 GRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 71/275 (25%), Positives = 107/275 (38%), Gaps = 56/275 (20%)

Query: 11  LGSGNFG------VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPN 60
           LGSG FG         ++        VAVK + +G    E  ++E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS-------GVS 113
           I++   V L      I+ME   GG+L + +  A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 114 YCHSMEICHRDLKLENTLL---DGSPQPRLKICDFG----------YSKSGLLHSQPKST 160
           Y   M   HRDL   N L+          +KI DFG          Y K G    +    
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG----EGLLP 176

Query: 161 VGTPAYIAPEVLARKEYDGKI---SDVWSCGVTLY-VMLVG--AYPFEDPEDPRNFRKTI 214
           V    ++APE L     DGK    SDVWS GV ++ ++ +G   YP  + ++        
Sbjct: 177 V---RWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229

Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 249
            R++  +   PD          L++  +  DPS+R
Sbjct: 230 GRLQKPEN-CPD------KIYQLMTNCWAQDPSER 257

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.0 bits (143), Expect = 5e-10
 Identities = 50/186 (26%), Positives = 73/186 (39%), Gaps = 32/186 (17%)

Query: 54  RSLRHPNIIRFKEVLLTPTHLAI--------VMEYAAGGEL--FARICSAGR------FS 97
             L H NI       L   H+ I        +  Y   G L  F + C  G        S
Sbjct: 63  YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115

Query: 98  EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLH 154
             +      Q+  G+SY H   + H+D+   N ++D   Q  +KI D   S+       H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYH 173

Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE--DPEDPRNFR 211
               +      ++A E L  KEY    SDVWS GV L+ +M +G  P+   DP +   + 
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232

Query: 212 KTIDRI 217
           K   R+
Sbjct: 233 KDGYRL 238

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 59.5 bits (144), Expect = 7e-10
 Identities = 55/204 (26%), Positives = 88/204 (43%), Gaps = 15/204 (7%)

Query: 4   RYEPVKELGSGNFGVARLV--RDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           +Y  +  L  G+ G   +        ++ V VK +  GK       REI   +++ H  I
Sbjct: 93  QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAI 148

Query: 62  IRFKEVLLTPTHLAIVM-EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I         + + +VM +Y    +LF  +  +G    ++A    ++L+  ++Y H   I
Sbjct: 149 INLIHAYRWKSTVCMVMPKYKC--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGI 206

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYS-KSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
            HRD+K EN  LD      L   DFG + K       P+     GT    +PE+LA   Y
Sbjct: 207 IHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264

Query: 178 DGKISDVWSCGVTLYVMLVGAYPF 201
             K +D+WS G+ L+ M V     
Sbjct: 265 CAK-TDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 64/258 (24%), Positives = 98/258 (37%), Gaps = 61/258 (23%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----- 57
           +RY+ ++ +G G  G   L  D      VA+K I   + + EN    ++  R LR     
Sbjct: 2   QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIR--EDLSEN---PLLKKRFLREAKIA 56

Query: 58  ----HPNIIRFKEVLLTPTHLAIVMEYAAGGEL----------------FARICSAGRFS 97
               HP I+    +      +   M Y  G  L                 A   S G F 
Sbjct: 57  ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 98  EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----------- 146
                  F ++ + + Y HS  + HRDLK +N LL    +  + I D+G           
Sbjct: 117 S-----IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEED 169

Query: 147 -----YSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA 198
                  +  + +S    P   VGTP Y+APE L         +D+++ GV LY ML  +
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLS 228

Query: 199 YPFEDPEDPRNFRKTIDR 216
           +P+      +  RK   R
Sbjct: 229 FPYRR----KKGRKISYR 242

Length = 932

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 41/235 (17%)

Query: 9   KELGSGNFG------VARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPN 60
            E+G+G FG        R +   R    V VK +      DE +   +E+  +R L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKAR----VVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQL----ISGVSY 114
           +++     +      +V+E+   G+L  + R    G  ++   +   Q++     SG+ +
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNR-GMVAQMAQKDVLQRMACEVASGLLW 115

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------Y 166
            H  +  H DL L N  L  +    +KI D+     GL   Q                 +
Sbjct: 116 LHQADFIHSDLALRNCQL--TADLSVKIGDY-----GLALEQYPEDYYITKDCHAVPLRW 168

Query: 167 IAPEVLARKEYD------GKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTI 214
           +APE++  +  D       K S++WS GVT++ +      P+ D  D +  ++ +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 9   KELGSGNFGVARLVR-----DKRTKELVAVKYIERGKKIDENVQREIINHR------SLR 57
           +ELG G FG   L        ++ K LVAVK +   K   +N +++   HR      +L+
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDF--HREAELLTNLQ 65

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-------------RFSEDEARFF 104
           H +I++F  V +    L +V EY   G+L   + + G               ++ +    
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
            QQ+ +G+ Y  S    HRDL   N L+       +KI DFG S+   ++S     VG  
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLV--GENLLVKIGDFGMSRD--VYSTDYYRVGGH 181

Query: 165 A-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                 ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 182 TMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 35/277 (12%)

Query: 9   KELGSGNFG-VAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
           +ELG G FG V +       ++ +   VA+K ++     K+ +  ++E      L+HPNI
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELF------ARICSAGRFSED-------EARFFFQ-- 106
           +    V        ++ EY A G+L       +     G  S D       +   F    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 107 -QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVG 162
            Q+ +G+ Y  S    HRDL   N L+       +KI DFG S+   S   +     ++ 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 221
              ++ PE +   ++  + SD+WS GV L+ +   G  P+       + ++ I+ IR+ Q
Sbjct: 189 PVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYG----FSNQEVIEMIRSRQ 243

Query: 222 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
             LP      A    L+ + +   P++R    +I   
Sbjct: 244 -LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 63/202 (31%), Positives = 88/202 (43%), Gaps = 39/202 (19%)

Query: 11  LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKE 66
           LG GNFG      ++DK     VAVK  +     +  ++   E    +   HPNI++   
Sbjct: 3   LGKGNFGEVFKGTLKDKTP---VAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSME 119
           V      + IVME   GG+  + +    R  +DE +   +QL+       +G++Y  S  
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTPAYIAPE 170
             HRDL   N L+  +    LKI DFG         YS SGL     K T       APE
Sbjct: 114 CIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIKWT-------APE 164

Query: 171 VLARKEYDGKISDVWSCGVTLY 192
            L    Y  + SDVWS G+ L+
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 39/215 (18%)

Query: 8   VKELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
            +ELG G FG   L     +  +  KELVAVK ++     D  ++ +RE     + +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL----------FARICSA----GRFSEDEARFFFQ 106
           I++F  V        +V EY   G+L           A + S     G  +  +      
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA- 165
           Q+ SG+ Y  S    HRDL   N L+       +KI DFG S+   +++     VG    
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHTM 185

Query: 166 ----YIAPE-VLARK---EYDGKISDVWSCGVTLY 192
               ++ PE ++ RK   E     SDVWS GV L+
Sbjct: 186 LPIRWMPPESIMYRKFTTE-----SDVWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 73/264 (27%), Positives = 111/264 (42%), Gaps = 36/264 (13%)

Query: 11  LGSGNFGVAR---LVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRF 64
           LG G FG  R   L  +  + + VAVK ++       +++   RE    +   HPN+I+ 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 65  KEVLL---TPTHLAIVM---EYAAGGELFARICSAGRFSEDEARFFFQQLI-------SG 111
             V L       L I M    +   G+L   +    R  E+      Q L+       SG
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKSTVGTPAY 166
           + Y  S    HRDL   N +L+ +    + +C  DFG SK   SG  + Q  ++     +
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           +A E LA   Y    SDVW+ GVT++ +M  G  P+   E+   +   I   R  Q   P
Sbjct: 182 LALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ--PP 238

Query: 226 DYVRVSADCRHLLSQIFVADPSKR 249
           D +    D   L+ Q +  +P  R
Sbjct: 239 DCL---EDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 21/183 (11%)

Query: 30  LVAVKYI--ERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELF 87
           LVAVK +  +  K    +  +EI     L+ PNIIR   V +T   L ++ EY   G+L 
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 88  ARICSAGRFSEDEA------------RFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135
             +       E                F   Q+ SG+ Y  S+   HRDL   N L+   
Sbjct: 108 QFLSRH-EPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV--G 164

Query: 136 PQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
               +KI DFG S+   SG  +      V    +++ E +   ++    SDVW+ GVTL+
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLW 223

Query: 193 VML 195
            +L
Sbjct: 224 EIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 50/162 (30%), Positives = 77/162 (47%), Gaps = 23/162 (14%)

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242

Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+     D E  R  ++   R
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-R 300

Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           +R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 301 MRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 31/209 (14%)

Query: 10  ELGSGNFGVARLVR-----DKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
           ELG G FG   L        ++ K LVAVK + E  +   ++ QRE      L+H +I+R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FAR-------------ICSAGRFSEDEARFFFQQL 108
           F  V      L +V EY   G+L  F R               + G+ +  +      Q+
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
            SG+ Y  S+   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRTMLP 187

Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY 192
             ++ PE +  +++  + SD+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 71/235 (30%), Positives = 104/235 (44%), Gaps = 27/235 (11%)

Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+     K   AVK + R   ++E  Q  +E I  +   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 66  EVLLTPTHLA-IVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L       +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ-VAKGMEYLASKKFVH 121

Query: 123 RDLKLENTLLDGSPQPRLKICDFG-----YSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
           RDL   N +LD S    +K+ DFG     Y K   S   H+  K  V    ++A E L  
Sbjct: 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQT 176

Query: 175 KEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           +++  K SDVWS GV L+ +M  GA  YP  D  D   +     R+   +Y  PD
Sbjct: 177 QKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPD 229

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 68/239 (28%), Positives = 104/239 (43%), Gaps = 55/239 (23%)

Query: 3   ERYEPVKELGSGNFGVARLVR------DKRTKEL-VAVKYIERGKKIDENVQREIINHRS 55
           +R    K LG G FG  ++V+      D   +   VAVK ++     D+  ++++ +  S
Sbjct: 12  DRLTLGKPLGEGAFG--QVVKAEAVGLDNPNETSTVAVKMLK-----DDATEKDLSDLVS 64

Query: 56  L--------RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARF-- 103
                    +H NII    V      L +V+EYAA G L  F R   A R   + A    
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLR---ARRPPGEYASPDD 121

Query: 104 ---------------FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS 148
                          F  Q+  G+ +  S +  HRDL   N L+  +    +KI DFG +
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLA 179

Query: 149 KSGLLHSQP---KSTVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           +   +H      K+T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 180 RD--IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 55.5 bits (134), Expect = 8e-09
 Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           +++LG+G FG V   + +  T   VAVK ++ G    ++   E    + LRHP +I+   
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 67  VLLTPTHLAIVMEYAAGGELF-------ARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           V      + IV E    G L         R     +  +  A     Q+ SG++Y  +  
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEAQN 123

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKE 176
             HRDL   N L+  +     K+ DFG ++  +     ++  G    I   APE      
Sbjct: 124 YIHRDLAARNVLVGENNI--CKVADFGLARV-IKEDIYEAREGAKFPIKWTAPEAALYNR 180

Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPF 201
           +  K SDVWS G+ L  ++  G  P+
Sbjct: 181 FSIK-SDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNII 62
           +ELG G FG   L     +   + K LVAVK ++       ++ QRE     +L+H +I+
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FAR--------------ICSAGRFSEDEARFFFQ 106
           +F  V      L +V EY   G+L  F R                + G     +      
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA- 165
           Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   ++S     VG    
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRD--VYSTDYYRVGGHTM 186

Query: 166 ----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
               ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 187 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.2 bits (133), Expect = 8e-09
 Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 56/287 (19%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           VK+LG+G FG   +       + VA+K +++G    E    E    + L+HP ++R   V
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
           + T   + I+ EY   G L  F +     + + ++      Q+  G+++       HRDL
Sbjct: 70  V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGK 180
           +  N L+  S     KI DFG ++   L    + T    A     + APE +    +  K
Sbjct: 129 RAANILV--SETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 181 ISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
            SDVWS G+ L  ++  G  P+    +P       + I+N+                   
Sbjct: 184 -SDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNL------------------- 216

Query: 240 QIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 286
                +   R+P P+         N P+E+ E+ +  +KE   ++PT
Sbjct: 217 -----ERGYRMPRPD---------NCPEELYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 32/225 (14%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERGKKIDENVQ----REIINHRSL 56
           + +  LG G FG   L + K  +E     LV VK +++ K  DEN+Q    RE+   R L
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKL 65

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS---- 110
            H N++R   +        +++EY   G+L  F R   +            +Q ++    
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 111 ---GVSYCHSMEICHRDLKLENTLLDGSPQPRLKI-----CDFGYSKSGLLHSQPKSTVG 162
              G+ +  +    HRDL   N L+  S Q  +K+         Y+            + 
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLV--SSQREVKVSLLSLSKDVYNSEYYKLRNALIPL- 182

Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
              ++APE +   ++  K SDVWS GV ++ V   G  PF    D
Sbjct: 183 --RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNII 62
           K LG G FG     +L +D    + VAVK ++     +   E+   E +  +   HPN++
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILK-VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 63  RFKEVLLTPTHL------AIVMEYAAGGEL-----FARICSAGRFSEDEARF-FFQQLIS 110
           R   V L            +++ +   G+L     ++R+    ++   +    F   + S
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYI 167
           G+ Y  S    HRDL   N +L+ +    + + DFG SK   +G  + Q +       +I
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
           A E LA + Y  K SDVWS GVT++ +   G  P+   E+
Sbjct: 182 AIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 32/165 (19%)

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236

Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
            P  ++APE +  K Y  + SDVWS GV L+ +  +GA P+     D E  R  ++   R
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-R 294

Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +R  +Y  P+   +  DC H        +P  R         P F
Sbjct: 295 MRAPEYATPEIYSIMLDCWH-------NNPEDR---------PTF 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 21/158 (13%)

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P    K +  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237

Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTID---RI 217
            P  ++APE +  K Y  + SDVWS GV L+ +  +GA P+   +    F + +    R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
           R  +   P+  R+   C          DP +R     +
Sbjct: 297 RAPENATPEIYRIMLACWQ-------GDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 53/209 (25%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 10  ELGSG--NFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHPNIIRF 64
           E+G G  N     L R   T  LV V+  +     +E++   Q E++     RHPNI+  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 65  KEVLLTPTHLAIV---MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
             V  T + L ++   M Y +   L       G  SE          + G++Y H     
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYS------KSGLLHSQPKSTVGTPAYIAPEVLARK 175
           HR++K  + L+ G     L      YS      K+ +++  P+ +     +++PE+L + 
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183

Query: 176 EYDGKI-SDVWSCGVTLYVMLVGAYPFED 203
            Y   + SD++S G+T   +  G  PF+D
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 31/220 (14%)

Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 65

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS----- 110
           + +P++ R   + LT T   I        +L    C      E +     Q L++     
Sbjct: 66  VDNPHVCRLLGICLTSTVQLIT-------QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 111 --GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
             G++Y     + HRDL   N L+   PQ  +KI DFG +K  LL +  K          
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKT-PQ-HVKITDFGLAK--LLGADEKEYHAEGGKVP 174

Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
             ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 175 IKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 52/195 (26%), Positives = 86/195 (44%), Gaps = 17/195 (8%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++    G  G A    D +T E V +K  +RG    E     I+  R++ HP+II+ K  
Sbjct: 97  LETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGT 151

Query: 68  LLTPTHLAIVM-EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                   +++  Y    +L+  + +    +  +     + ++  + Y H   I HRD+K
Sbjct: 152 FTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIK 209

Query: 127 LENTLLDGSPQPRLKIC--DFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYDGKIS 182
            EN  ++    P   +C  DFG +   +  +  K     GT A  APE+LAR  Y G   
Sbjct: 210 AENIFIN---HPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAV 264

Query: 183 DVWSCGVTLYVMLVG 197
           D+WS G+ L+ M   
Sbjct: 265 DIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 6   EPVKELGSGNFGV---AR---LVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLR 57
           E V+++G G FG    AR   L+       +VAVK ++     D   + QRE        
Sbjct: 8   EYVRDIGQGAFGRVFQARAPGLLPY-EPFTMVAVKMLKEEASADMQADFQREAALMAEFD 66

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGR-------------------- 95
           HPNI++   V      + ++ EY A G+L  F R  S                       
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 96  FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGL 152
            S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+   S  
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSAD 184

Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
            +   ++      ++ PE +    Y  + SDVW+ GV L+
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.6 bits (126), Expect = 6e-08
 Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 38/243 (15%)

Query: 9   KELGSGNFGVARL--VRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRF 64
           KE+G+G FG   L  V    T   V VK +     + E ++   E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 65  KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQ---QLISGVSYCHSME 119
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEV 171
             H DL L N LL  +    +KI D+G S     H++ K               +IAPE+
Sbjct: 121 FIHSDLALRNCLL--TADLTVKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 172 LARKEYDG--------KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQY 222
           +   E  G        K S+VWS GVT++ +  +G+ P+    D +    T   +R  Q 
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQL 228

Query: 223 FLP 225
            LP
Sbjct: 229 KLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)

Query: 11  LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
           +G GNFG  +  +++    K   A+K ++  +   EN  R+      +      HPNII 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 64  FKEVLLTPTHLAIVMEYAAGGEL---------------FARI-CSAGRFSEDEARFFFQQ 107
                    +L I +EYA  G L               FA+   +A   +  +   F   
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA- 165
           + +G+ Y    +  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           ++A E L    Y  K SDVWS GV L+ ++ +G  P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 6/102 (5%)

Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220
           +GTP Y+APE+L  K +   + D W+ GV L+  L G  PF D E P   ++    I N 
Sbjct: 541 LGTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFND-ETP---QQVFQNILNR 595

Query: 221 QYFLPD-YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
               P+   ++S + ++ +  +   DP+KR  + E+K+HP F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 19/214 (8%)

Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIER--GKKIDENVQREIINHRS 55
           E   + VK LGSG FG       +   +  K  VA+K +    G K +     E +   S
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSY 114
           + HP+++R   V L+PT + +V +    G L   +              +  Q+  G+ Y
Sbjct: 66  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMY 124

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
                + HRDL   N L+  SP   +KI DFG ++  LL    K            ++A 
Sbjct: 125 LEERRLVHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMAL 180

Query: 170 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           E +  +++  + SDVWS GVT++ +M  G  P++
Sbjct: 181 ECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 56/217 (25%), Positives = 90/217 (41%), Gaps = 33/217 (15%)

Query: 11  LGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIR 63
           +G GNFG  +   ++    +   A+K ++  +   ++  R+      +      HPNII 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 64  FKEVLLTPTHLAIVMEYAAGGEL---------------FARI-CSAGRFSEDEARFFFQQ 107
                    +L + +EYA  G L               FA    +A   S  +   F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT-PA- 165
           +  G+ Y    +  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           ++A E L    Y    SDVWS GV L+ ++ +G  P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 21/214 (9%)

Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRS 55
           E     +K LGSG FG       +      K  VA+K I+   G++  + +   ++   S
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVS 113
           L H  I+R   +    + L +V + +  G L   +    R S D  R   +  Q+  G+ 
Sbjct: 66  LDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTP-AYIA 168
           Y     + HR+L   N LL       ++I DFG +   LL+   K    S   TP  ++A
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSI--VQIADFGVAD--LLYPDDKKYFYSEHKTPIKWMA 179

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPF 201
            E +    Y  + SDVWS GVT++ M+  GA P+
Sbjct: 180 LESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)

Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           K+LG+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +++   V
Sbjct: 12  KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
           + T   + I+ E+ A G L  F +     +    +   F  Q+  G+++       HRDL
Sbjct: 70  V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K S
Sbjct: 129 RAANILV--SASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 184

Query: 183 DVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
           DVWS G+ L  ++  G  P+    +P   R
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 33/223 (14%)

Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 21  KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEAR-----FFFQQLI 109
            NII           L +++EYA+ G L     AR      +S D AR       F+ L+
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 162 G--TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G     ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 44/123 (35%), Positives = 57/123 (46%), Gaps = 19/123 (15%)

Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGY------SKSGLLHSQP 157
           +QL+S + Y H   I HRD+K EN L++G P+    IC  DFG       S S   H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNG-PE---DICLGDFGAACFARGSWSTPFHYGI 322

Query: 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP--RNFRKTI 214
             TV T    APEVLA   Y   + D+WS G+ ++   V  A  F        R +   I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378

Query: 215 DRI 217
            RI
Sbjct: 379 LRI 381

Length = 461

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 63/242 (26%), Positives = 97/242 (40%), Gaps = 49/242 (20%)

Query: 9   KELGSGNFGVARL-----------------VRDKRTKELVAVKYI--ERGKKIDENVQRE 49
           ++LG G FG   L                 VR  R   LVAVK +  +  K    +  +E
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPL-LVAVKILRPDANKNARNDFLKE 69

Query: 50  IINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEAR------- 102
           +     L+ PNIIR   V +    L ++ EY   G+L  +  S+    + E         
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPP 128

Query: 103 -------------FFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
                            Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S+
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSR 186

Query: 150 ---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY--VMLVGAYPFEDP 204
              +G  +      V    ++A E +   ++    SDVW+ GVTL+  +ML    P+ + 
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 205 ED 206
            D
Sbjct: 246 TD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 37/225 (16%)

Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIE---RGKKIDENVQREIINHRSLRH 58
           K LG G FG   +       +DK  K + VAVK ++     K + + V    +     +H
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G L     AR      +S D     E +  F+ L+
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H+     K+
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLV--TEDNVMKIADFGLARD--VHNIDYYKKT 193

Query: 160 TVG--TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G     ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-- 60
           +R++ +  LG G FG      D++ KE  AVK +    K   + + EI     +R  +  
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 61  ----IIRFKEVLLTPT-HLAIVM-EYAAGGELFARICSAGRFSEDE-ARFFFQQLISGVS 113
               +++ +      T H+ IVM +Y  G  L   I   G FS    A+  FQ  ++ + 
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-LD 245

Query: 114 YCHS-MEICHRDLKLENTLLDGS-------------PQP-RLKICDFGYSKSGLLHSQPK 158
           Y H+ + + H DLK EN L++ S             P P R++ICD G       HS+  
Sbjct: 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-T 303

Query: 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
           + V T  Y +PEV+    +    +D+WS G  +Y +  G
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 62/221 (28%), Positives = 92/221 (41%), Gaps = 41/221 (18%)

Query: 11  LGSGNFGV---ARLVRD--------KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           +G GNFG    AR+ +D        KR KE     Y  +    D   + E++  +   HP
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----YASKDDHRDFAGELEVLC-KLGHHP 68

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-----ARIC-----------SAGRFSEDEARF 103
           NII          +L + +EYA  G L      +R+            +A   S  +   
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
           F   +  G+ Y    +  HRDL   N L+        KI DFG S+   ++   K T+G 
Sbjct: 129 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVYV--KKTMGR 184

Query: 164 -PA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            P  ++A E L    Y    SDVWS GV L+ ++ +G  P+
Sbjct: 185 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 58/215 (26%), Positives = 86/215 (40%), Gaps = 24/215 (11%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYI-ERGKKIDE-NVQREIINHRSLRHPN 60
           ++ LG G FG     + R       +  VAVK + E   + DE +   E +      H N
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN 70

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC--SAGRFSE---DEARFFFQQLISGVS 113
           I+R   V        I++E  AGG+L  F R       R S     +  F  + +  G  
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 114 YCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YI 167
           Y       HRD+   N LL    P    KI DFG ++   ++       G  A     ++
Sbjct: 131 YLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD--IYRASYYRKGGRAMLPIKWM 188

Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            PE      +  K +DVWS GV L+ +  +G  P+
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 14/203 (6%)

Query: 11  LGSGNFG-VAR--LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
           LG+G FG + R  L    + +  VA+  +  G   K       E +      H NI+R +
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 66  EVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
            V+     + IV EY + G L  F R    G+    +       L SG+ Y   M   H+
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG-TPA-YIAPEVLARKEYDGKI 181
            L     L++       KI  F   +     +   +  G +P  + APE +    +    
Sbjct: 132 GLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA- 188

Query: 182 SDVWSCGVTLY-VMLVGAYPFED 203
           SDVWS G+ ++ VM  G  P+ D
Sbjct: 189 SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQ 107
           +H NII    V      L +++EYAA G     L AR      ++ D     E +  F+ 
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK 158
           L+S       G+ Y  S    HRDL   N L+  +    +KI DFG ++ G+       K
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLV--TEDNVMKIADFGLAR-GVHDIDYYKK 192

Query: 159 STVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           ++ G  P  ++APE L  + Y  + SDVWS G+ ++ +  +G  P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 41/245 (16%)

Query: 9   KELGSGNFG------------VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL 56
           +E+G+G FG            VAR+V     KEL A        K      ++   +R L
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVV----VKELKA----NASSKEQNEFLQQGDPYRIL 52

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ----QLISGV 112
           +HPNI++     +      +V EY   G+L + +        +      Q    ++ +GV
Sbjct: 53  QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIA 168
           ++ H     H DL L N  L       +K+ D+G      K   + ++    V    ++A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWLA 169

Query: 169 PEVLARKEYDG-------KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNV 220
           PE++      G       K S+VW+ GVTL+ +    A P+    D R     + + + V
Sbjct: 170 PELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-REVLNHVIKDQQV 227

Query: 221 QYFLP 225
           + F P
Sbjct: 228 KLFKP 232

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 13/120 (10%)

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQ---PKS 159
           F  Q+ +G+ +  S    HRDL   N L+ +G     +KICDFG ++  +  S      S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGK---LVKICDFGLARDIMRDSNYISKGS 300

Query: 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRN--FRKTIDR 216
           T     ++APE +    Y   +SDVWS G+ L+ +  +G  P+  PE P N  F   I R
Sbjct: 301 TFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR 357

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.3 bits (110), Expect = 7e-06
 Identities = 44/203 (21%), Positives = 79/203 (38%), Gaps = 29/203 (14%)

Query: 11  LGSGNF-----GVARLVRDK----RTKEL-VAVKYIERGKKIDENVQREIINHRSLRHPN 60
           LG G F     GV R+  D       +E+ V +K +    +              L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL-----FARICSAGRFSEDEARFFFQQLISGVSYC 115
           +++   V +   ++ +V EY   G L       +   +  +  D A    +QL S + Y 
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYL 117

Query: 116 HSMEICHRDLKLENTLL-----DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
              ++ H ++  +N L+     +    P +K+ D G   + L   +    +    +IAPE
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPE 174

Query: 171 VLARKEYDGKI-SDVWSCGVTLY 192
            +   +    I +D WS G TL 
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 56/212 (26%), Positives = 94/212 (44%), Gaps = 15/212 (7%)

Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E   + VK LGSG FG       +   +  K  VA+K +      K ++ +  E      
Sbjct: 6   ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 65

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSY 114
           +  P + R   + LT T + +V +    G L   +  +  R    +   +  Q+  G+SY
Sbjct: 66  VGSPYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEV 171
              + + HRDL   N L+  SP   +KI DFG ++   +        G      ++A E 
Sbjct: 125 LEEVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           +  + +  + SDVWS GVT++ +M  GA P++
Sbjct: 183 ILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 69/265 (26%), Positives = 111/265 (41%), Gaps = 29/265 (10%)

Query: 9   KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP 59
           K LG+G FG      A  +        VAVK ++      E      + +I++H    H 
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-NHE 99

Query: 60  NIIRFKEVLLTPTH---LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSY 114
           NI+    +L   T    + ++ EY   G+L  F R       + ++   F  Q+  G+++
Sbjct: 100 NIV---NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPA-YIAPEV 171
             S    HRDL   N LL  +    +KICDFG ++  +  S    K     P  ++APE 
Sbjct: 157 LASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
           +    Y  + SDVWS G+ L+ +  +G+ P+        F K I       Y +      
Sbjct: 215 IFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHA 269

Query: 231 SADCRHLLSQIFVADPSKRIPIPEI 255
            A+   ++   + ADP KR    +I
Sbjct: 270 PAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 73/261 (27%), Positives = 115/261 (44%), Gaps = 33/261 (12%)

Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + +K+LG+G FG V     +  TK  VAVK ++ G    E+   E    + LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSE-----DEARFFFQQLISGVSYC 115
           ++   V+ +   + IV EY + G L   +    GR  +     D A     Q+ +G++Y 
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118

Query: 116 HSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
             M   HRDL+  N L+ DG      KI DFG ++   L    + T    A     + AP
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV---CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAP 172

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           E      +  K SDVWS G+ L  ++  G  P+       N R+ ++++    Y +P   
Sbjct: 173 EAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPG----MNNREVLEQVER-GYRMPCPQ 226

Query: 229 RVSADCRHLLSQIFVADPSKR 249
                   L+ Q +  DP +R
Sbjct: 227 DCPISLHELMLQCWKKDPEER 247

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 23/249 (9%)

Query: 10  ELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           +LG G FG V     +  T+  VA+K ++ G    E   +E    + LRH  +++   V+
Sbjct: 13  KLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70

Query: 69  LTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+
Sbjct: 71  -SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 129

Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKI 181
             N L+        K+ DFG ++   L    + T    A     + APE      +  K 
Sbjct: 130 AANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK- 183

Query: 182 SDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           SDVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q
Sbjct: 184 SDVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQ 238

Query: 241 IFVADPSKR 249
            +  +P +R
Sbjct: 239 CWRKEPEER 247

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 41/249 (16%)

Query: 29  ELVAVKYIERGKKIDE--NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL 86
           +LVA+K ++      +    Q+E      L HPNI+    V+     + ++ EY   G+L
Sbjct: 35  QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 87  FARI----------CSAG-----RFSEDEARFFFQ--QLISGVSYCHSMEICHRDLKLEN 129
              +          CS+      + S D   F     Q+ +G+ Y  S    H+DL   N
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154

Query: 130 TLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            L+    Q  +KI D G S+    +     QPKS +    ++ PE +   ++    SD+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210

Query: 186 SCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----RHLLSQ 240
           S GV L+ +   G  P+    +    ++ I+ +R  Q  LP     S DC      L+++
Sbjct: 211 SFGVVLWEIFSFGLQPYYGFSN----QEVIEMVRKRQ-LLP----CSEDCPPRMYSLMTE 261

Query: 241 IFVADPSKR 249
            +   PS+R
Sbjct: 262 CWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 43/173 (24%), Positives = 78/173 (45%), Gaps = 22/173 (12%)

Query: 40  KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED 99
             ++     EI +   L+HPNI++   +  +     ++ EY  G  L + +     +   
Sbjct: 724 NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-SEVLRNLSW--- 779

Query: 100 EARFFFQQLISGVS------YCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL 152
           E R   +++  G++      +C  S  +   +L  E  ++DG  +P L++     S  GL
Sbjct: 780 ERR---RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL-----SLPGL 831

Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           L +  K  + + AY+APE    K+   K SD++  G+ L  +L G  P  D E
Sbjct: 832 LCTDTKCFISS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP-ADAE 881

Length = 968

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
           F  Q+  G+ +  S    HRDL   N LL  +    +KICDFG ++  ++H     + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLARD-IMHDSNYVSKGS 298

Query: 164 P----AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                 ++APE +    Y   +SDVWS G+ L+ +  +G  P+
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPY 340

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 27/167 (16%)

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSED-----EARFFFQQ 107
           +H NII           L +++EYA+ G L     AR      +  +     E +  F+ 
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QP 157
           L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYK 197

Query: 158 KSTVG--TPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           K+T G     ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 21/161 (13%)

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQ--PKST 160
           F  Q+  G+S+  S    HRDL   N LL      R+ KICDFG ++     S    K  
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVKGN 275

Query: 161 VGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFED-PEDPRNFRKTID-- 215
              P  ++APE +    Y  + SDVWS G+ L+ +  +G+ P+   P D + F K I   
Sbjct: 276 ARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEG 333

Query: 216 -RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
            R+ + +    +   +   C       + ADP KR    +I
Sbjct: 334 YRMLSPECAPSEMYDIMKSC-------WDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 51/224 (22%)

Query: 3   ERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR 57
           E+   ++ELG G+FG      AR +     +  VAVK +     + E +  E +N  S+ 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63

Query: 58  HP----NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED----------EARF 103
                 +++R   V+       +VME  A G+L + + S    +E+          E   
Sbjct: 64  KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------------SG 151
              ++  G++Y ++ +  HRDL   N ++  +    +KI DFG ++             G
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMV--AHDFTVKIGDFGMTRDIYETDYYRKGGKG 181

Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKI---SDVWSCGVTLY 192
           LL  +         ++APE L     DG     SD+WS GV L+
Sbjct: 182 LLPVR---------WMAPESLK----DGVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 21/248 (8%)

Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T + VA+K ++ G  + E   +E    + LRH  ++    V+ 
Sbjct: 13  KLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70

Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV E+   G L  F +          +      Q+  G++Y   M   HRDL+ 
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130

Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        KI DFG ++   L    + T    A     + APE      +  K S
Sbjct: 131 ANILV--GDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 184

Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  ++  G  P+    + R   + ++R     Y +P           L+   
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMVN-REVLEQVER----GYRMPCPQGCPESLHELMKLC 239

Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 240 WKKDPDER 247

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 40/134 (29%), Positives = 60/134 (44%), Gaps = 10/134 (7%)

Query: 98  EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ- 156
           +D  RF  Q +  G+ +  S    HRD+   N LL  +     KICDFG ++  +  S  
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLL--TDGRVAKICDFGLARDIMNDSNY 268

Query: 157 -PKSTVGTPA-YIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKT 213
             K     P  ++APE +    Y  + SDVWS G+ L+ +  +G  P+        F K 
Sbjct: 269 VVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM 327

Query: 214 IDRIRNVQYFLPDY 227
           +   R  Q   PD+
Sbjct: 328 VK--RGYQMSRPDF 339

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 28/204 (13%)

Query: 44  ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC------SAGRFS 97
           E  + E +    L+HPNI+    V+     L+++  Y +  +L   +         G   
Sbjct: 53  EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112

Query: 98  EDE--------ARFF--FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147
           +D+        A F     Q+ +G+ +  S  + H+DL   N L+    +  +KI D G 
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGL 170

Query: 148 SK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +   +   +    +++    +++PE +   ++    SD+WS GV L+ V   G  P+  
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCG 229

Query: 204 PEDPRNFRKTIDRIRNVQYFL-PD 226
             +    +  I+ IRN Q    PD
Sbjct: 230 YSN----QDVIEMIRNRQVLPCPD 249

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 5/69 (7%)

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTV 161
            +Q++  +   HS  I HRD+K +N +         KI D G +   + G ++  PK  +
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG-SFKIIDLGAAADLRVG-INYIPKEFL 318

Query: 162 GTPAYIAPE 170
             P Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	341
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK10345	210	hypothetical protein; Provisional	99.9
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
smart00090	237	RIO RIO-like kinase.	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.75
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
KOG1243	690	consensus Protein kinase [General function predict	99.66
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.57
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.36
KOG3087	229	consensus Serine/threonine protein kinase [General	99.33
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.21
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.2
COG4248	637	Uncharacterized protein with protein kinase and he	99.1
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.95
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
PRK09902	216	hypothetical protein; Provisional	98.93
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.9
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.63
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.62
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.61
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
PLN02876	822	acyl-CoA dehydrogenase	98.5
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.48
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.37
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.26
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.25
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.2
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.17
PRK10593	297	hypothetical protein; Provisional	98.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.01
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.96
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.92
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.91
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.87
KOG2270	520	consensus Serine/threonine protein kinase involved	97.78
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
PRK05231	319	homoserine kinase; Provisional	97.66
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.39
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.37
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.35
PLN02236	344	choline kinase	97.33
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.17
PRK12396	409	5-methylribose kinase; Reviewed	97.1
PLN02756	418	S-methyl-5-thioribose kinase	97.1
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.02
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.94
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.27
PRK11768	325	serine/threonine protein kinase; Provisional	96.25
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.08
PTZ00384	383	choline kinase; Provisional	96.08
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.03
PRK06148	1013	hypothetical protein; Provisional	95.71
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.66
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.5
PTZ00296	442	choline kinase; Provisional	94.91
KOG2269	531	consensus Serine/threonine protein kinase [Signal	94.26

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-64  Score=441.44  Aligned_cols=263  Identities=37%  Similarity=0.606  Sum_probs=228.8

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--------IDENVQREIINHRSLRHPNIIRFKEVLLTPT   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~   72 (341)
                      +++.|.+.+.||+|+||.|-+|..+.||+.||||++.+...        ....+.+|+.+|++|+|||||+++++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            35779999999999999999999999999999999976332        2234679999999999999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSG  151 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~  151 (341)
                      ..|+||||+.||+|++.+..++.+.+..-+.+++||+.|+.|||++||+||||||+|||+..+ ....+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999876 3345999999999976


Q ss_pred             CCCCCCCCccCCCCccccccccccc--cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .....+.+.||||.|.|||++.+..  +++.+.||||||||||-+++|.+||++......+.+.+... ...+..+.|.+
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G-~y~f~p~~w~~  408 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG-RYAFGPLQWDR  408 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-cccccChhhhh
Confidence            6667788999999999999997654  34556899999999999999999998876655444433221 22333467789


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +|.+.++||.+||..||+.|||+.|+|+||||...
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999999999999999999999999999999644

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.7e-62  Score=444.46  Aligned_cols=254  Identities=37%  Similarity=0.641  Sum_probs=235.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEccc----CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .+|...+.||+|||.+||.+++..+|+.||+|++.+    .....+.+.+||+++++|+|||||+++++|++.+++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            479999999999999999999999999999999987    5566778999999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      |+|..++|..++.+.++++|.+++.+++||+.||.|||+++|+|||||..|+|++.+.+  |||+|||+|...... ...
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence            99999999999999999999999999999999999999999999999999999998877  999999999876544 677


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .+.||||.|.|||++....+.-. +||||+||++|.|+.|++||..    ..+.++...++...+.+|.  .+|.++++|
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dL  248 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDL  248 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence            88999999999999997777655 8999999999999999999987    3466777888888888887  799999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      |.+||.+||.+|||++++|.|+||.+..
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            9999999999999999999999995544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-61  Score=415.65  Aligned_cols=259  Identities=31%  Similarity=0.479  Sum_probs=228.6

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcc--cCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE-EEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-LAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~-~~iv~e~   80 (341)
                      ..+.++.||+|..|+||+|+|+.|++.+|+|.+.  ......+++.+|+++++.++||+||++|++|..+.. ++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4567899999999999999999999999999984  345566789999999999999999999999999994 9999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |++|+|...+...++++|.....++.++++||.|||+ ++||||||||+||||++.|.  |||||||.++..... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence            9999999999998999999999999999999999995 99999999999999999888  999999999865444 6788


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCC-CChhHHHHHHHHHhc-ccccCCCCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~l  237 (341)
                      .+||..|||||.+.+..|..+ +||||||++++|+++|+.||... .......+.+..+.. ....+|.. .+|+++++|
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F  314 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF  314 (364)
T ss_pred             ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence            999999999999999999776 89999999999999999999875 323344455555544 34444542 499999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +..||++||.+|||+.|+++|||+.+...+
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999999766543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.3e-60  Score=399.38  Aligned_cols=258  Identities=27%  Similarity=0.467  Sum_probs=225.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|+.+.++|+|+||+||+|+++.||+.||||++..+.   ...+.+.+||+++++|+|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            68999999999999999999999999999999987654   345678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~~  158 (341)
                      ||+..-|..+-.....++...++.+++|++.|+.|+|++++|||||||+||||+.++.  +||||||+|+... +.....
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhh
Confidence            9988555444444557999999999999999999999999999999999999998887  9999999998755 555667


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc---------------cc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------YF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~  223 (341)
                      ..+.|.||+|||.+.|...+++..||||+||++.||++|.+.|.+.++.+++..+...+.+..               ..
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            788999999999999977777779999999999999999999999999888877665443211               01


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          224 LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       224 ~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +|.          +..++.-+.+|+++||..||.+|+|.+++|.||||.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence            222          245778899999999999999999999999999993

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-58  Score=399.58  Aligned_cols=261  Identities=36%  Similarity=0.601  Sum_probs=227.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++++.||+|+||+||+++.+.|++.||+|++++..    +..+...+|..++..++||.||+++..|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            57999999999999999999999999999999998754    23456888999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      ||+.||.|+..+++.+.|++..++.++..|+.||.|||++|||||||||+|||+|..|+  ++|+|||+++..... ...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCcc
Confidence            99999999999999999999999999999999999999999999999999999998888  999999999854443 455


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .+.|||+.|||||++.+..|+.. +|+||||+++|+|++|.+||...+....    .+.+.......+. ..+|.++++|
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k~~~~p-~~ls~~ardl  256 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGKLPLPP-GYLSEEARDL  256 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCcCCCCC-ccCCHHHHHH
Confidence            66799999999999999988755 9999999999999999999988665433    3334333322221 2489999999


Q ss_pred             HHHhcccCCCCCC----ChhHHhcCCccCCCCChhHHH
Q 019433          238 LSQIFVADPSKRI----PIPEIKKHPWFLKNLPKEIIE  271 (341)
Q Consensus       238 i~~~L~~dp~~R~----s~~e~l~hp~~~~~~~~~~~~  271 (341)
                      |+++|..||.+|.    ++.++.+||||..-..+....
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~  294 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLA  294 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHh
Confidence            9999999999995    799999999997766655543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=416.69  Aligned_cols=255  Identities=51%  Similarity=0.854  Sum_probs=231.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----c--cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----K--KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~--~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~   74 (341)
                      .++|.+.+.||+|+||+|++|.+..++..||+|++.+.    .  ...+.+.+|+.+++.+. ||||+++++++.....+
T Consensus        16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~   95 (370)
T KOG0583|consen   16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI   95 (370)
T ss_pred             cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence            46899999999999999999999999999999987764    1  23456778999999998 99999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCC-C
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSG-L  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~-~  152 (341)
                      |+|||||.||+|++++.+.+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ ++  +||+|||++... .
T Consensus        96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPG  173 (370)
T ss_pred             EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCC
Confidence            9999999999999999998999999999999999999999999999999999999999988 55  999999999876 4


Q ss_pred             CCCCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ......+.+||+.|+|||++.+.. |.++++||||+|++||.|++|..||...+...    +...+....+.+|.+.. |
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~ki~~~~~~~p~~~~-S  248 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYRKIRKGEFKIPSYLL-S  248 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHHHHhcCCccCCCCcC-C
Confidence            556778899999999999999988 99899999999999999999999999855443    34446677788887544 9


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +++.+||++||.+||.+|+|+.+++.||||+.
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=399.46  Aligned_cols=258  Identities=36%  Similarity=0.591  Sum_probs=227.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+|.+.+.||+|+||+||+|+++.++..||||.+.+..   +..+.+..||.+++.++|||||++++++..++.+|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            57999999999999999999999999999999998753   344567899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CC---CCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQ---PRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~---~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||.||+|..++.+.+.+++..++.++.||+.||++||+++||||||||+|||++.. ..   ..+||+|||+|+......
T Consensus        90 yC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~  169 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS  169 (429)
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh
Confidence            99999999999999999999999999999999999999999999999999999864 22   569999999999877777


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC-CCCCCHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVRVSADC  234 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~  234 (341)
                      ...+.+|+|.|||||++....|+.+ +|+||+|+|+|++++|+.||...+..+.+.    .++......|. ...+++.+
T Consensus       170 ~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~~~  244 (429)
T KOG0595|consen  170 MAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSNPL  244 (429)
T ss_pred             HHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccCch
Confidence            7888999999999999999999887 799999999999999999998765543332    33332222222 12577788


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .+|+...|+.+|.+|.+..+.+.|+++..+.
T Consensus       245 ~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  245 RELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            8999999999999999999999999986655

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-58  Score=408.68  Aligned_cols=261  Identities=30%  Similarity=0.463  Sum_probs=230.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH--HHHHHHHHHhcCC-CCCeeeEEEEEEcCC-EEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLR-HPNIIRFKEVLLTPT-HLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~ei~~~~~l~-hp~iv~l~~~~~~~~-~~~iv   77 (341)
                      .+||.++++||.|.||.||+|+.+.+|+.||||.+.+.-...+  .-+||++.+++|+ |||||++.+++.++. .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4799999999999999999999999999999999987543333  3568999999998 999999999999888 99999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||+. .|.++|... ..|++..++.|++||++||+|+|.+|+.|||+||+||||.+...  |||+|||+|+.......
T Consensus        89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCC
Confidence            999977 899998765 46999999999999999999999999999999999999986555  99999999999888888


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------c
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------Q  221 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  221 (341)
                      ....+.|.||+|||++....+++.+.||||+|||++|+.+-++.|.+.++.+++.++..-+...               .
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            8999999999999999888777777999999999999999999999998888888776554322               2


Q ss_pred             ccCCCC---------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          222 YFLPDY---------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       222 ~~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.+|..         ...++++.+||.+||..||.+||||.|+|+||||+...
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            333432         24788999999999999999999999999999996544

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-57  Score=406.70  Aligned_cols=265  Identities=32%  Similarity=0.540  Sum_probs=232.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|+++++||+|+||.||+|+.+.||..||+|+++++..    .-+.++.|-.+|...++|+||+|+..|.+..++|+||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            679999999999999999999999999999999988643    3445777888888889999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-----
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-----  153 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-----  153 (341)
                      ||.+||++..++.+.+.|++..++.++.+++.|+..||+.|+|||||||+|+|||..|+  +||+|||++.....     
T Consensus       221 EylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~  298 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIE  298 (550)
T ss_pred             EecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999888  99999999841100     


Q ss_pred             ------------------CCC-------------------------CCCccCCCCccccccccccccCCCccchhhHHHH
Q 019433          154 ------------------HSQ-------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT  190 (341)
Q Consensus       154 ------------------~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~v  190 (341)
                                        ...                         ..+.+|||.|||||++.+..|+-. +|+||||||
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~I  377 (550)
T KOG0605|consen  299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGCI  377 (550)
T ss_pred             hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHHH
Confidence                              000                         013479999999999999998665 999999999


Q ss_pred             HHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCC---ChhHHhcCCccCCCCCh
Q 019433          191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~~  267 (341)
                      +|||+.|.+||...+....+++++.+-.  .+.+|....+++++.|||.+||+ ||.+|.   +++|+.+||||......
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~--~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRE--TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhh--hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            9999999999999888888877776643  34457777899999999999999 999998   59999999999887766


Q ss_pred             hHHHHH
Q 019433          268 EIIEIE  273 (341)
Q Consensus       268 ~~~~~~  273 (341)
                      .+....
T Consensus       455 ~l~~~~  460 (550)
T KOG0605|consen  455 HLREMP  460 (550)
T ss_pred             hhhcCC
Confidence            655543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-57  Score=407.08  Aligned_cols=258  Identities=34%  Similarity=0.550  Sum_probs=225.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|...+.||+|+|++|++|+.+.+++.||||++.+....    .+-+.+|-..|..| .||.|++|+-.|.+...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4789999999999999999999999999999998764322    22355677777778 899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--  155 (341)
                      +||+++|+|..+|++.+.|++...+.++.+|+.||+|||++|||||||||+|||+|++++  ++|+|||.|+......  
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhcc
Confidence            999999999999999999999999999999999999999999999999999999999887  9999999987432111  


Q ss_pred             ------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          156 ------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       156 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                                  ...+.+||..|.+||++.....+. .+|||+|||+||+|+.|.+||...+....+++    +....+.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~-~sDiWAlGCilyQmlaG~PPFra~NeyliFqk----I~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGP-SSDLWALGCILYQMLAGQPPFRAANEYLIFQK----IQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCc-ccchHHHHHHHHHHhcCCCCCccccHHHHHHH----HHHhccc
Confidence                        124578999999999998776654 59999999999999999999999887666555    4556777


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      +|.  .+++.+.+||+++|..||.+|+|+.++.+||||.......+
T Consensus       306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence            776  79999999999999999999999999999999977665553

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-56  Score=371.45  Aligned_cols=260  Identities=32%  Similarity=0.481  Sum_probs=227.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .||..++.||+|.||+||+|++..||+.||||++....   .....+.+||+.++.++||||+.++++|.+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            68999999999999999999999999999999997653   335689999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC-
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~-  157 (341)
                      |++. +|...+.... .++..+++.++.++++||+|||++.|+||||||+|+||+++|.  +||+|||+|+........ 
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence            9976 8988887654 6999999999999999999999999999999999999998887  999999999865444333 


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cCCC----------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD----------  226 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~----------  226 (341)
                      ...+.|.||+|||.+.|...++...||||.|||+.||+.|.+-|.+.++.+++..++..+..... .+|+          
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence            33478999999999999887777799999999999999999999999998888888776643321 1111          


Q ss_pred             -----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          227 -----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       227 -----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                 +...+.++.||+.+||.+||.+|+|+.|+|+|+||....
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                       234678889999999999999999999999999997643

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-56  Score=413.19  Aligned_cols=254  Identities=39%  Similarity=0.736  Sum_probs=238.0

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      =|++.+.||.|+-|.|.+|++..||+.+|||++.+..    .....+.+||.+|+.+.||||++++++++.+.++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            4788999999999999999999999999999997752    344578999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |++||.|++++.+++++++.++..+++||+.|+.|||..+|+|||+||+|+|++..++  |||+|||+|..-.......+
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccc
Confidence            9999999999999999999999999999999999999999999999999999998877  99999999998788888889


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .||+|.|.|||++.|..|++.++||||.|||||.|++|++||.+    .+++.++..++...+.+|.  .+|+++++||+
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr  244 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLR  244 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHH
Confidence            99999999999999999999999999999999999999999985    4566777888888998986  79999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +||..||.+|+|.+++++|||+....
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcCC
Confidence            99999999999999999999996644

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-56  Score=388.60  Aligned_cols=293  Identities=29%  Similarity=0.417  Sum_probs=238.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEccc---CccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----CC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----PT   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----~~   72 (341)
                      +..+|..++.||+|+||.|+.|.++.+|+.||||++.+   .....+...+|+++++.++|+||+.+.+++..     -+
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            35788889999999999999999999999999999874   34556788999999999999999999999976     35


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+|+|+|+ .+|...+..++.+++..++.+++||++||+|+|+.||+|||+||+|++++.+..  +||||||+|+...
T Consensus       100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLD  176 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeecc
Confidence            6999999994 489999988888999999999999999999999999999999999999998888  9999999998654


Q ss_pred             C---CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--------
Q 019433          153 L---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------  221 (341)
Q Consensus       153 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  221 (341)
                      .   ....+..+.|.||+|||++.....++++.||||+|||+.||++|++.|.+.+...++..++..+....        
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            2   33345678899999999987666666779999999999999999999998776666554443221110        


Q ss_pred             --------ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCC
Q 019433          222 --------YFLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQ  284 (341)
Q Consensus       222 --------~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~  284 (341)
                              ..+|         .+.+.++.+.+|+.+||.+||.+|+|++|+|.||||.....++........+..   ..
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~~  333 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---FE  333 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---cc
Confidence                    0011         134688999999999999999999999999999999776655443322222221   22


Q ss_pred             CCCCHHHHHHHHHHh
Q 019433          285 PTQSVEEIMRIIQEA  299 (341)
Q Consensus       285 ~~~~~~~~~~~~~~~  299 (341)
                      ...+.+++++++.+.
T Consensus       334 ~~~~~~~~r~~i~~e  348 (359)
T KOG0660|consen  334 HELTEEELRELIYKE  348 (359)
T ss_pred             ccccHHHHHHHHHHH
Confidence            226678888877655

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-58  Score=377.84  Aligned_cols=261  Identities=34%  Similarity=0.603  Sum_probs=228.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.+.|++.+.||+|.|++|+.|.+..||+.+|+|++...   ....+++.+|+.+-+.|+||||+++++.+......|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            467899999999999999999999999999999998642   23567899999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +|++.|++|..-+...--++|..+..++.||+.||.|+|.+||||||+||+|+++-+.. ...+||+|||+|........
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            99999999988777767789999999999999999999999999999999999996433 23599999999987666666


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....|||.|||||++...+|... +|||+-|+|||-|+.|++||.+.+..+.+..++..  ...+..|+|..+++++++
T Consensus       169 ~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--AYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--ccCCCCcccCcCCHHHHH
Confidence            677899999999999998888655 89999999999999999999986554444443322  234445678899999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |+++||..||.+|+|+.|+|+|||+.+.
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999764

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-56  Score=373.22  Aligned_cols=256  Identities=36%  Similarity=0.656  Sum_probs=228.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++++.||.|+||+|.+++.+.+|..+|+|++.+..    ++.+...+|..+++.+.||.++++++.|.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46899999999999999999999999999999998754    34456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||.+||.|+.++.+.++|++..++.++.||+.||+|||+++|++||+||+|||+|++|.  +||+|||+|+.  .....-
T Consensus       124 eyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~--v~~rT~  199 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKR--VSGRTW  199 (355)
T ss_pred             eccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEE--ecCcEE
Confidence            99999999999999999999999999999999999999999999999999999999988  99999999984  344467


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      +.||||.|+|||++....++ +++|.||||+++|||+.|.+||...+....+    ..+......+|.  .+++++++||
T Consensus       200 TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY----~KI~~~~v~fP~--~fs~~~kdLl  272 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIY----EKILEGKVKFPS--YFSSDAKDLL  272 (355)
T ss_pred             EecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHH----HHHHhCcccCCc--ccCHHHHHHH
Confidence            88999999999999998886 5599999999999999999999987764444    445556666776  6899999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCCChhH
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~~  269 (341)
                      +++|+.|-.+|.     ...++..||||.......+
T Consensus       273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i  308 (355)
T KOG0616|consen  273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAI  308 (355)
T ss_pred             HHHHhhhhHhhhcCcCCCccccccCcccccccHHHH
Confidence            999999999994     6789999999976554443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-55  Score=391.51  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=223.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv   77 (341)
                      +.|+.+++||+|.||.||+|++..||+.||+|+++...   ..-....+||.+|++|+||||++|.++..+.  ..+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            46899999999999999999999999999999987643   3445788999999999999999999998876  789999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      +|||+. +|..++.+. -.|++.+++.+++||+.||.|||++||+|||||.+|||||++|.  +||+|||+|+...... 
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence            999987 787777663 37999999999999999999999999999999999999998888  9999999998443333 


Q ss_pred             -CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc------cCCC--
Q 019433          156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------FLPD--  226 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~--  226 (341)
                       .....+.|.||+|||.+.|...++.++|+||.||||.||++|++.|.+.++..++..++........      .+|.  
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence             4667789999999999999887788899999999999999999999999998888887765432211      1111  


Q ss_pred             ---------------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          227 ---------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       227 ---------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                                     +..++..+.+|+..||+.||.+|.||.++|.|+||.
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~  404 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT  404 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence                           245788899999999999999999999999999993

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-55  Score=389.11  Aligned_cols=257  Identities=37%  Similarity=0.618  Sum_probs=222.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---------------cccHHHHHHHHHHhcCCCCCeeeEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------------KIDENVQREIINHRSLRHPNIIRFKEV   67 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~ei~~~~~l~hp~iv~l~~~   67 (341)
                      +.|++++.||+|.||+|.+|++..+++.||||++.+..               ...+...+||.++++|.|||||+|+++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            67999999999999999999999999999999987532               122578899999999999999999999


Q ss_pred             EEcC--CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           68 LLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        68 ~~~~--~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                      ..+.  +.+|+|+|||..|.+...-.....+++.+++.++++++.||+|||.+|||||||||+|+|+++++.  +||+||
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDF  254 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDF  254 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeecc
Confidence            8765  679999999999988554333333999999999999999999999999999999999999998876  999999


Q ss_pred             CCccCCCC------CCCCCCccCCCCccccccccc---cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHH
Q 019433          146 GYSKSGLL------HSQPKSTVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       146 g~a~~~~~------~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~  216 (341)
                      |.+.....      .......+|||.|+|||.+.+   ..+.+++.||||+||+||.|+.|..||.+..    ..++...
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----~~~l~~K  330 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----ELELFDK  330 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----HHHHHHH
Confidence            99864311      112234789999999999987   5677888999999999999999999998744    3456667


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.+....+|....+...+++||.+||++||.+|+++.++..|||.....
T Consensus       331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            7788888898888999999999999999999999999999999997664

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-54  Score=381.26  Aligned_cols=256  Identities=35%  Similarity=0.528  Sum_probs=213.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--EEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--~~~iv~e~   80 (341)
                      +|...+.||+|+||+||++.++.+|+.+|||.+..... ..+.+.+|+.+++.++|||||++++......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            57888999999999999999999999999999876421 1456899999999999999999999754444  79999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-CCCCCEEEeecCCccCCCC----C
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLL----H  154 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~~~~----~  154 (341)
                      +++|+|.+++.+.+ +|++..++.+.+||++||+|||++||+||||||+|||++. ++.  +||+|||+++....    .
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccc
Confidence            99999999999877 7999999999999999999999999999999999999998 566  99999999875442    2


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCC-CChhHHHHHHHHHhcc-cccCCCCCCCCH
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKTIDRIRNV-QYFLPDYVRVSA  232 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~s~  232 (341)
                      .......||+.|||||++.......+++|||||||++.||+||..||... .....   ........ ...+|.  .+|+
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~---~~~ig~~~~~P~ip~--~ls~  250 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA---LLLIGREDSLPEIPD--SLSD  250 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH---HHHHhccCCCCCCCc--ccCH
Confidence            33456789999999999986434444699999999999999999999873 22111   11111111 123343  5999


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++++||++||..||++||||.++|+|||..+..+
T Consensus       251 ~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  251 EAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999977655

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.7e-55  Score=394.42  Aligned_cols=251  Identities=34%  Similarity=0.608  Sum_probs=223.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|.+.+.||+|+||+||+++.+.|.+.||||.+.+.....   +.+.+|+.+++.|+|||||.++++|+...++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            68999999999999999999999999999999998755433   468899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      ||.| +|+.++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+...+.  +||||||+|+...... ...
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence            9988 99999999999999999999999999999999999999999999999998877  9999999998543333 234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..-|||.|||||++.+..|+.. +|+|||||++||++.|++||...    .+....+.+.......|.  ..|.++..||
T Consensus       159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~p~--~~S~~f~nfl  231 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKPPS--TASSSFVNFL  231 (808)
T ss_pred             eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence            5679999999999999988876 89999999999999999999763    344455555555554554  7899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..+|.+||.+|+|..+++.|||...
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhh
Confidence            9999999999999999999999854

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3e-53  Score=362.72  Aligned_cols=259  Identities=30%  Similarity=0.416  Sum_probs=222.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv   77 (341)
                      +.|+.+..|++|+||.||.|+++.|++.||+|+++....   ..-..++||.++.+++|||||.+.++....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            458999999999999999999999999999999876542   223688999999999999999999987643  679999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-C
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~  155 (341)
                      ||||+. +|...+.+.+ +|...+++.++.|+++||+|||.+.|+|||+||+|+|++..|.  +||+|||+|+..... .
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLK  232 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcc
Confidence            999977 8988887755 8999999999999999999999999999999999999998888  999999999854333 3


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc-CCC--------
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPD--------  226 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~--------  226 (341)
                      .....+.|.||+|||.+.|...++++.|+||+|||+.||+++.+.|.+.....++.+++..+...... +|.        
T Consensus       233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k  312 (419)
T KOG0663|consen  233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK  312 (419)
T ss_pred             cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence            45667889999999999998877788999999999999999999999999988888887665432211 111        


Q ss_pred             ---------------C--CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          227 ---------------Y--VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       227 ---------------~--~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                     +  ..++....+|+..+|.+||.+|.||.++|+|+||.+.
T Consensus       313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                           0  1256888999999999999999999999999999764

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-55  Score=366.46  Aligned_cols=241  Identities=33%  Similarity=0.502  Sum_probs=205.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEE-EEEcCCE-EEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKE-VLLTPTH-LAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~-~~~~~~~-~~iv~   78 (341)
                      .|+|+++||+|+||.||++++..+|..+|.|.+.-.   .+..+.+..|+.++++|+|||||++++ .|..++. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            499999999999999999999999999999998743   234457889999999999999999999 5555554 99999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHS--ME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~--~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      |||.+|+|...++.    .+.++|..+|+++.|+++||.++|+  ..  |+||||||.|||++.+|.  +||+|||+++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~  177 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRF  177 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHhH
Confidence            99999999988865    3469999999999999999999999  45  999999999999998887  99999999985


Q ss_pred             CCCCC-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc-CCCCC
Q 019433          151 GLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYV  228 (341)
Q Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  228 (341)
                      ..... ...+.+|||+||+||.+.+..|+.+ ||||||||++|||+.-++||.+.    .+..+...+.+..+. +|. .
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-~  251 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-E  251 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-H
Confidence            44333 3456799999999999999999876 99999999999999999999885    334444555555443 331 4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCh
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPI  252 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~  252 (341)
                      .+|.++..+|..|+..||..||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            689999999999999999999984

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-53  Score=384.50  Aligned_cols=259  Identities=37%  Similarity=0.631  Sum_probs=231.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~i   76 (341)
                      ..+|++.+.||+|.||+||.|+.+.||+.+|+|++.+...    ..+.+.+|+.+|+.++ |||||.++++|++...+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            4689999999999999999999999999999999976543    3358999999999998 9999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC--CCEEEeecCCccCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLH  154 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~--~~ikL~Dfg~a~~~~~~  154 (341)
                      |||+|.||.|++.+... .+++..+..++.|++.|++|||+.||+|||+||+|+|+.....  ..+|++|||++......
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~  192 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG  192 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence            99999999999999877 5999999999999999999999999999999999999976533  46999999999876665


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ......+||+.|+|||++....|... +||||+|+++|.|++|.+||...+....+..+...  ...+..+.|..+|..+
T Consensus       193 ~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~a  269 (382)
T KOG0032|consen  193 ERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESA  269 (382)
T ss_pred             ceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHH
Confidence            66778899999999999988888766 89999999999999999999987766555533322  3355667788999999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+||++||..||.+|+|+.++|+|||+...
T Consensus       270 kd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  270 KDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999999999764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-52  Score=363.48  Aligned_cols=259  Identities=30%  Similarity=0.433  Sum_probs=223.0

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCC------E
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPN-IIRFKEVLLTPT------H   73 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~------~   73 (341)
                      .|..+++||+|+||+||+|+.+.+|+.||+|+++-...   ......+|+.+++.|+|+| ||++++++...+      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            48889999999999999999999999999999876544   4567899999999999999 999999998877      8


Q ss_pred             EEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           74 LAIVMEYAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      +++||||+.. +|..++....    .++...++.+++||+.||+|||++||+||||||+||+|++++.  +||+|||+|+
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAr  168 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLAR  168 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHH
Confidence            9999999976 8988887754    5888899999999999999999999999999999999998777  9999999998


Q ss_pred             CCC-CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc------
Q 019433          150 SGL-LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------  222 (341)
Q Consensus       150 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------  222 (341)
                      ... ........++|.+|+|||++.|...++...||||+|||++||+++++.|.+..+.+++..+...+.....      
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            654 3444677889999999999999866566699999999999999999999998888888777765543311      


Q ss_pred             --------cCCCC----------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          223 --------FLPDY----------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       223 --------~~~~~----------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                              .++.+          ...+++..+++.+||+.+|.+|.|+..+|.||||....
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                    11111          22346899999999999999999999999999997653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-53  Score=383.79  Aligned_cols=257  Identities=31%  Similarity=0.515  Sum_probs=222.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc-cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+|....+||+|+.|.||.|+...+++.||||.+...... .+-+..|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4789999999999999999999999999999998765443 456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  160 (341)
                      +||+|.+.+.. ..++|.++..+++.++.||+|||.+||+|||||.+|||++.++.  +||+|||++....... ...+.
T Consensus       353 ~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence            99998887754 45999999999999999999999999999999999999998888  9999999987644433 45567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      +|||+|||||++....|..+ .||||||+++.||+-|.+||-..+..+.+.. +..  +....+.....+|+.+++||.+
T Consensus       430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAlyL-Ia~--ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT--NGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHHHH-Hhh--cCCCCcCCccccCHHHHHHHHH
Confidence            89999999999999998776 8999999999999999999986444333322 222  3344445556899999999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCC
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ||+.|+.+|+||.|||+||||....+
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcCC
Confidence            99999999999999999999955544

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.6e-54  Score=356.84  Aligned_cols=256  Identities=35%  Similarity=0.571  Sum_probs=223.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---------cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|...+.||+|..++|..|.++.+|..+|+|++.-..         ...+...+|+.+++++ .||+|+++.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            47889999999999999999999999999999985421         1123566799999988 6999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+++|+|.|+.|.|++++...-.+++...+.+++|++.|+.|||.++|||||+||+|||++++.+  |||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999999999999999999999999999999999999999999999998877  9999999999888


Q ss_pred             CCCCCCCccCCCCcccccccccc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY  227 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (341)
                      ........||||+|+|||.+...     .-+++..|+|++|+++|.|+.|.+||-.......++.++.  .+.++..|+|
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime--GkyqF~speW  252 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME--GKYQFRSPEW  252 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh--cccccCCcch
Confidence            88888899999999999998632     2223448999999999999999999976433222222221  2456667899


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      .++|...++||.+||+.||.+|+|++|+|.||||.
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            99999999999999999999999999999999993

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-52  Score=368.77  Aligned_cols=263  Identities=30%  Similarity=0.449  Sum_probs=220.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.|++...||.|..++||+|+...+++.||||++.-.+  ...+.+.+|++.++.++||||++++.+|..++.+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            57999999999999999999999999999999986543  3456899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      |.+|++.+++...  ..|+|..|..+++++++||.|||.+|.||||||+.||||+++|.  |||+|||.+........  
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCcee
Confidence            9999999999763  46999999999999999999999999999999999999999988  99999998753222221  


Q ss_pred             --C-CCccCCCCcccccccc--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc----cccCCCC
Q 019433          157 --P-KSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----QYFLPDY  227 (341)
Q Consensus       157 --~-~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~  227 (341)
                        . .+.+||++|||||++.  ...|+.+ +||||||++..||.+|+.||......+.+...+.+-...    .......
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~  262 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED  262 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence              1 4568999999999953  2355544 899999999999999999999877655554433221110    0111233


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      ..++..++.++..||++||.+|||+.++|+|+||.+...++
T Consensus       263 k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~  303 (516)
T KOG0582|consen  263 KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE  303 (516)
T ss_pred             hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence            46788899999999999999999999999999998766544

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-53  Score=346.49  Aligned_cols=251  Identities=35%  Similarity=0.652  Sum_probs=228.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|.||.||+|+.+.++..||+|++.++.    .....+.+|+.+...|+||||++++++|.+...+|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            57999999999999999999999999999999998754    34457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           79 EYAAGGELFARIC--SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~--~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||...|+|+..+.  ...++++.....++.|++.||.|+|.++++||||||+|+|++..+.  +||+|||-+.... ...
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNK  178 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCC
Confidence            9999999999998  6668999999999999999999999999999999999999998887  9999999987644 566


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ..+.|||..|.+||+..+..++.. .|+|++|++.|+++.|.+||.....    .++...+......+|.  .+|.++.|
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p~--~is~~a~d  251 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFPS--TISGGAAD  251 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCCc--ccChhHHH
Confidence            778899999999999999998876 8999999999999999999987553    4555666777777774  79999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ||.+||.++|.+|++..|++.|||+..
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999854

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.1e-52  Score=364.43  Aligned_cols=256  Identities=32%  Similarity=0.498  Sum_probs=220.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----EEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----~~~iv~   78 (341)
                      +|.-.+.+|+|+||+||.|....+++.||||++-..+..   .-+|+++|+.++|||||++..+|....     ...+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            478889999999999999999999999999998765543   338999999999999999999997542     357999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||++. +|...+..    +.+++.-.++-+++||++||.|||+.||+||||||.|+|||.+. +.+||||||.|+.....
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccC
Confidence            99976 88887764    57899999999999999999999999999999999999998653 35999999999988888


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc------------
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY------------  222 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  222 (341)
                      ....+...|..|+|||.+.|...++.+.||||.|||+.||+.|++-|.+.+...++..+++-+.....            
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            88888999999999999999877777799999999999999999999998888888777654432111            


Q ss_pred             -cCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          223 -FLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       223 -~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                       .+|+          ....++++.+|+.++|+++|.+|.++.|++.||||...
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence             1111          23578999999999999999999999999999999543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.5e-52  Score=362.70  Aligned_cols=258  Identities=31%  Similarity=0.490  Sum_probs=224.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||.|.-|+||+|+...++..+|+|++.+..    +....+..|-.||..++||.++.||..|+.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            36889999999999999999999999999999998743    33446778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---
Q 019433           79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---  153 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---  153 (341)
                      |||+||+|..+.+++.  .|++..++.++..++.||+|||..|||.|||||+||||..+|+  |.|+||.++.....   
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCCe
Confidence            9999999999887644  6999999999999999999999999999999999999999988  99999998742100   


Q ss_pred             ------------------------------C-C-----------------------CCCCccCCCCccccccccccccCC
Q 019433          154 ------------------------------H-S-----------------------QPKSTVGTPAYIAPEVLARKEYDG  179 (341)
Q Consensus       154 ------------------------------~-~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~  179 (341)
                                                    . .                       ...+.+||-.|.|||++.|.....
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                          0 0                       012346899999999999988865


Q ss_pred             CccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----hhHH
Q 019433          180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP----IPEI  255 (341)
Q Consensus       180 ~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~e~  255 (341)
                       ++|+|+||+++|||+.|..||.+.++...+.++    ......+|....+|..++|||+++|.+||++|..    |.|+
T Consensus       315 -AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI----v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  315 -AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI----VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             -hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH----hcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence             489999999999999999999998886665554    4456667777789999999999999999999998    9999


Q ss_pred             hcCCccCCCCCh
Q 019433          256 KKHPWFLKNLPK  267 (341)
Q Consensus       256 l~hp~~~~~~~~  267 (341)
                      .+||||......
T Consensus       390 K~HpFF~gVnWa  401 (459)
T KOG0610|consen  390 KRHPFFEGVNWA  401 (459)
T ss_pred             hcCccccCCChh
Confidence            999999765543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-52  Score=371.45  Aligned_cols=251  Identities=33%  Similarity=0.581  Sum_probs=215.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            57999999999999999999999999999999986532    23346788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++....  ....
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~--~~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLR--DRTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhcc--CCcc
Confidence            99999999999998889999999999999999999999999999999999999988776  9999999987432  2234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..++. ++|||||||++|+|++|..||..........    .+......++.  .+++.+.+||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYE----KILAGKLEFPR--HLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCcCCCc--cCCHHHHHHH
Confidence            467999999999998877754 4899999999999999999998765433332    22223333333  5789999999


Q ss_pred             HHhcccCCCCCCC-----hhHHhcCCccCCC
Q 019433          239 SQIFVADPSKRIP-----IPEIKKHPWFLKN  264 (341)
Q Consensus       239 ~~~L~~dp~~R~s-----~~e~l~hp~~~~~  264 (341)
                      ++||+.||.+|++     +.++++||||...
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            9999999999995     9999999999653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-51  Score=375.28  Aligned_cols=252  Identities=33%  Similarity=0.565  Sum_probs=217.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++.+.||+|+||+||+|.++.+++.||+|++....    ...+.+.+|+.+++.++||||+++++++..++.+++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    23356789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+.+++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....  ....
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~--~~~~  173 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVP--DRTF  173 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcC--CCcc
Confidence            99999999999998889999999999999999999999999999999999999998776  9999999987432  2234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|++|..||........    ...+......+|.  .++..+.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li  246 (329)
T PTZ00263        174 TLCGTPEYLAPEVIQSKGHGK-AVDWWTMGVLLYEFIAGYPPFFDDTPFRI----YEKILAGRLKFPN--WFDGRARDLV  246 (329)
T ss_pred             eecCChhhcCHHHHcCCCCCC-cceeechHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCcCCCC--CCCHHHHHHH
Confidence            567999999999998877754 48999999999999999999987544322    2333333333443  5889999999


Q ss_pred             HHhcccCCCCCCC-----hhHHhcCCccCCCC
Q 019433          239 SQIFVADPSKRIP-----IPEIKKHPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~s-----~~e~l~hp~~~~~~  265 (341)
                      ++||+.||.+|++     ++++++||||....
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            9999999999997     79999999997643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-52  Score=365.56  Aligned_cols=252  Identities=38%  Similarity=0.685  Sum_probs=229.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH----HHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE----NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ..||++.+.||+|.||+|-+|+....|+.||||.++++....+    .+.+||.++..|+||||+.++++|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3589999999999999999999988999999999988654333    578999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||..+|.|.+++...+.|++.+++.+++||.+|+.|+|.++++|||+|.+|||+|.+++  +||+|||++.........
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfL  209 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFL  209 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHH
Confidence            999999999999999999999999999999999999999999999999999999999888  999999999876666667


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .+.||+|-|.+||++.|..|.+...|.||||++||.|+.|..||.+.+    ...+++.+....+.-|.   -+.++.-|
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D----hk~lvrQIs~GaYrEP~---~PSdA~gL  282 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD----HKRLVRQISRGAYREPE---TPSDASGL  282 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch----HHHHHHHhhcccccCCC---CCchHHHH
Confidence            889999999999999999998888999999999999999999998854    34555666666666554   56778999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      |++||..||.+|.|++++-.|=|++
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhheee
Confidence            9999999999999999999998874

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.6e-51  Score=365.31  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=215.6

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      |++++.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            889999999999999999999999999999986532    2223567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      +.+|+|...+...  ..+++..+..++.|++.||.|||++||+||||||+|||+++++.  ++|+|||++..........
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCeec
Confidence            9999998877543  36899999999999999999999999999999999999987776  9999999987543333334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+.......+  ..+++++.+||
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li  236 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSIC  236 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHH
Confidence            5679999999999988877655 89999999999999999999876543333333333332222222  36899999999


Q ss_pred             HHhcccCCCCCCC-----hhHHhcCCccCCCCCh
Q 019433          239 SQIFVADPSKRIP-----IPEIKKHPWFLKNLPK  267 (341)
Q Consensus       239 ~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~  267 (341)
                      ++||+.||.+||+     ++++++||||.....+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence            9999999999997     8999999999765433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-52  Score=383.28  Aligned_cols=259  Identities=34%  Similarity=0.573  Sum_probs=226.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.|+++++||+|+||+|+++..+.+++.||||++++..    ..-+....|-.++... +||.+++++.+|.+..++|+|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            57899999999999999999999999999999998854    3345677788888776 599999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      |||+.||++ ..+.....|++..++.++..|+.||.|||++|||+||||.+|||+|..|.  +||+|||+++.+. ....
T Consensus       448 mey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~  524 (694)
T KOG0694|consen  448 MEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDR  524 (694)
T ss_pred             EEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCc
Confidence            999999994 34445578999999999999999999999999999999999999999888  9999999999766 5556


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      +.+.||||.|||||++.+..|+.. +|+|||||++|+|+.|.+||.+.+..+    ..+.+......+|.  .+|.++.+
T Consensus       525 TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee----~FdsI~~d~~~yP~--~ls~ea~~  597 (694)
T KOG0694|consen  525 TSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPR--FLSKEAIA  597 (694)
T ss_pred             cccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCC--cccHHHHH
Confidence            778999999999999999999655 899999999999999999999866543    44555666666666  68999999


Q ss_pred             HHHHhcccCCCCCCC-----hhHHhcCCccCCCCChhHHH
Q 019433          237 LLSQIFVADPSKRIP-----IPEIKKHPWFLKNLPKEIIE  271 (341)
Q Consensus       237 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~~~~  271 (341)
                      +++++|.++|++|..     +.++..||||+......+..
T Consensus       598 il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~  637 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN  637 (694)
T ss_pred             HHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence            999999999999984     58999999998776555443

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.8e-51  Score=376.44  Aligned_cols=260  Identities=27%  Similarity=0.467  Sum_probs=215.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+..    .....+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            57999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      |||+||+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999988776  9999999986422110   


Q ss_pred             ---------------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCC
Q 019433          156 ---------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE  202 (341)
Q Consensus       156 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~  202 (341)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence                                             0123579999999999988877654 899999999999999999998


Q ss_pred             CCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCC---CCCChhHHhcCCccCCCCChh
Q 019433          203 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS---KRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~---~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      .......+..+...  .....+|....+++++.+||.+|+. +|.   .||+++++++||||.......
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~  303 (363)
T cd05628         238 SETPQETYKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH  303 (363)
T ss_pred             CCCHHHHHHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence            76544333332211  1223345545689999999999876 455   458999999999997765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=5.6e-51  Score=371.19  Aligned_cols=250  Identities=36%  Similarity=0.584  Sum_probs=212.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||.||+|.++.+|+.||||++.+..    .....+.+|+.+++.++||||+++++++...+.+++||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999987532    22345678999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccCC
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGT  163 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt  163 (341)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            99999988889999999999999999999999999999999999999988776  99999999874322 2223456799


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV  243 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  243 (341)
                      +.|+|||++.+..++.. +|||||||++|+|++|..||...+....    ...+......+|.  .+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            99999999988777654 8999999999999999999977543322    2222223333343  689999999999999


Q ss_pred             cCCCCCC-----ChhHHhcCCccCCCCCh
Q 019433          244 ADPSKRI-----PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       244 ~dp~~R~-----s~~e~l~hp~~~~~~~~  267 (341)
                      .||++||     ++.++++||||......
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~  260 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASINWQ  260 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999999     89999999999775443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.1e-50  Score=363.46  Aligned_cols=256  Identities=29%  Similarity=0.468  Sum_probs=210.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||.|+||+||+|.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57999999999999999999999999999999986532  2344678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      +.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcccc
Confidence            986 8888886544 5899999999999999999999999999999999999988776  999999998643222 2233


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|.+||........+..........               ...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            45789999999998765444556999999999999999999998765544443332221100               001


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+.         ...+++++.+||++||++||.+|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            111         13578899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-50  Score=365.28  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=209.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++++.||+|+||+||+|.++.+++.||||++....  .....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999999999999999987543  223467789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      |+.+ +|..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++..... ....
T Consensus        84 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          84 YVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             CCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccC
Confidence            9965 77776655 357999999999999999999999999999999999999988776  99999999864322 2223


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHH-HHHHHHHhccc---------------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF-RKTIDRIRNVQ---------------  221 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~---------------  221 (341)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|..||....+.... ...........               
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            44678999999999876554455689999999999999999999875543222 11111110000               


Q ss_pred             --cc--CC-------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          222 --YF--LP-------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       222 --~~--~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                        +.  .+       .....++++.+|+.+||++||++|||+.++++||||.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence              00  00       0012457899999999999999999999999999997653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-51  Score=378.33  Aligned_cols=257  Identities=32%  Similarity=0.562  Sum_probs=216.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|++..+++.||||++....    .....+.+|+.+++.++||||+++++++..+..+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987532    22345678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      |||.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++.......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999988888999999999999999999999999999999999999998776  9999999986321110   


Q ss_pred             ------------------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCC
Q 019433          156 ------------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY  199 (341)
Q Consensus       156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~  199 (341)
                                                          .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence                                                0113469999999999988777654 899999999999999999


Q ss_pred             CCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhHHhcCCccCCCC
Q 019433          200 PFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKNL  265 (341)
Q Consensus       200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~  265 (341)
                      ||...............  ......|....+++++.+||.+||. +|.+|++   +.++++||||....
T Consensus       238 Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~  303 (364)
T cd05599         238 PFCSDNPQETYRKIINW--KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVD  303 (364)
T ss_pred             CCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence            99876544333332221  1223344545689999999999997 9999998   99999999997654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.8e-50  Score=361.55  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=210.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||+||+|+++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            58999999999999999999999999999999987542   234567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      |++++++..+......+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence            9999877666555567999999999999999999999999999999999999988776  9999999987532211  22


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------cc
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QY  222 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  222 (341)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|++||...................               ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGK-AVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCCC-chhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            3457899999999998877754 5999999999999999999998765443332221111000               00


Q ss_pred             cCCC-----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          223 FLPD-----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       223 ~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..+.           ...+|+++.+||++||++||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            0111           11368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-50  Score=369.20  Aligned_cols=257  Identities=29%  Similarity=0.473  Sum_probs=218.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||.||+|.+..+++.||||++....    .....+..|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987532    22346778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            99999999999988889999999999999999999999999999999999999988776  99999999874322  345


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC----CCCCHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY----VRVSADC  234 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~  234 (341)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+........  ....|..    ..+++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--TLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--cccCCCCCccccccCHHH
Confidence            6689999999999988877654 8999999999999999999987554333332221111  1111221    2568999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      .+||.+||..+|.+|||+.++++||||.....
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~  265 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEVDW  265 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence            99999999999999999999999999976533

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-51  Score=377.98  Aligned_cols=257  Identities=29%  Similarity=0.409  Sum_probs=220.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-C-----CCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-H-----PNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-h-----p~iv~l~~~~~~~~~~~i   76 (341)
                      -||.|++.||+|+||+|.+|.+..|++.||||++++..........|+.+|..|+ |     -|+|+++++|...+++||
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            4899999999999999999999999999999999999888899999999999986 3     489999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           77 VMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      |+|.+.. +|.++++.++  +|+...++.++.||+.||.+||+.||||+||||+|||+...+...||++|||+|...  .
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~--~  342 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE--S  342 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc--C
Confidence            9999955 9999998765  689999999999999999999999999999999999998877778999999999742  2


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc------------c
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------Y  222 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~  222 (341)
                      ....+.+-+..|+|||++.|..|+.. .||||||||++||++|.+.|.+.+..+++..++..+....            +
T Consensus       343 q~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kf  421 (586)
T KOG0667|consen  343 QRVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKF  421 (586)
T ss_pred             CcceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccccee
Confidence            23337788999999999999999876 8999999999999999999998888777776654331100            0


Q ss_pred             ------------------------------------cCC-CC-------C-CCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          223 ------------------------------------FLP-DY-------V-RVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       223 ------------------------------------~~~-~~-------~-~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                                                          ..| ..       . .-...+.+||++||..||.+|+|+.++|+
T Consensus       422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~  501 (586)
T KOG0667|consen  422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN  501 (586)
T ss_pred             hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                                001 00       0 11244789999999999999999999999


Q ss_pred             CCccCC
Q 019433          258 HPWFLK  263 (341)
Q Consensus       258 hp~~~~  263 (341)
                      ||||..
T Consensus       502 Hpfl~~  507 (586)
T KOG0667|consen  502 HPFLTG  507 (586)
T ss_pred             Cccccc
Confidence            999974

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-50  Score=376.02  Aligned_cols=258  Identities=29%  Similarity=0.511  Sum_probs=214.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+..    .....+.+|+.+++.++||||++++++|.....+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            57999999999999999999999999999999986532    22345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      ||+++|+|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999987776  9999999985211000   


Q ss_pred             ---------------------------------------------CCCCccCCCCccccccccccccCCCccchhhHHHH
Q 019433          156 ---------------------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT  190 (341)
Q Consensus       156 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~v  190 (341)
                                                                   .....+||+.|+|||++.+..++.+ +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence                                                         0012469999999999988777654 899999999


Q ss_pred             HHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCC---CChhHHhcCCccCCCCC
Q 019433          191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR---IPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~~~~~~  266 (341)
                      +|+|++|.+||........+..+...  .....+|....++.++.+||.+||. +|.+|   +|+.+++.||||.....
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999876544333332221  1223345555789999999999998 77765   59999999999976443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-50  Score=370.35  Aligned_cols=252  Identities=32%  Similarity=0.533  Sum_probs=215.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC-cEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||.||+|.+..++ ..||+|++....    ...+.+.+|+.+++.++||||+++++++.....+++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            57999999999999999999977654 689999986532    2344677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....  ...
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~--~~~  185 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVD--TRT  185 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecC--CCc
Confidence            999999999999998889999999999999999999999999999999999999987776  9999999987432  233


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|..||...+.......    +......+|.  .+++.+.++
T Consensus       186 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~----i~~~~~~~p~--~~~~~~~~l  258 (340)
T PTZ00426        186 YTLCGTPEYIAPEILLNVGHGK-AADWWTLGIFIYEILVGCPPFYANEPLLIYQK----ILEGIIYFPK--FLDNNCKHL  258 (340)
T ss_pred             ceecCChhhcCHHHHhCCCCCc-cccccchhhHHHHHhcCCCCCCCCCHHHHHHH----HhcCCCCCCC--CCCHHHHHH
Confidence            4567999999999998777654 48999999999999999999987654333322    3333333443  588999999


Q ss_pred             HHHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          238 LSQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       238 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      |++||+.||.+|+     |++++++||||.+..
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999995     899999999997643

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-50  Score=373.74  Aligned_cols=258  Identities=30%  Similarity=0.467  Sum_probs=214.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .|++++.||+|+||+||+|.++.+++.||||++....    .....+.+|+.+++.++||||+++++++.....+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            6999999999999999999999999999999987642    223457889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-----
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-----  154 (341)
                      |+++|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccccccc
Confidence            9999999999988888999999999999999999999999999999999999987776  999999987521100     


Q ss_pred             -------------------------------------------CCCCCccCCCCccccccccccccCCCccchhhHHHHH
Q 019433          155 -------------------------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL  191 (341)
Q Consensus       155 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl  191 (341)
                                                                 ......+||+.|+|||++.+..++.. +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence                                                       00123579999999999988777654 8999999999


Q ss_pred             HHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhccc--CCCCCCChhHHhcCCccCCCCC
Q 019433          192 YVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA--DPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       192 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |+|++|..||...............  ......|....+++++.+||.+||..  +|..|+++.++++||||.+...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINW--ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHcc--ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            9999999999876543333222211  12233455557899999999997654  4455999999999999976543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.3e-50  Score=375.45  Aligned_cols=256  Identities=33%  Similarity=0.522  Sum_probs=214.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .+|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||++++++|..+..+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999987642    22346778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC----
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~----  154 (341)
                      |||++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCcccccccccc
Confidence            99999999999988888999999999999999999999999999999999999988776  999999987421100    


Q ss_pred             --------------------------------------------CCCCCccCCCCccccccccccccCCCccchhhHHHH
Q 019433          155 --------------------------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT  190 (341)
Q Consensus       155 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~v  190 (341)
                                                                  ......+||+.|+|||++.+..++.. +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHH
Confidence                                                        00123479999999999988887655 899999999


Q ss_pred             HHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC---hhHHhcCCccCCC
Q 019433          191 LYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKN  264 (341)
Q Consensus       191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~  264 (341)
                      +|+|++|.+||...+...........  ......|....+++++.+||.+|+ .+|.+|++   +.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVINW--QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcc--CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999999876543333322211  122334555678999999999986 59999997   9999999999664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-50  Score=373.08  Aligned_cols=256  Identities=34%  Similarity=0.555  Sum_probs=219.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.+..+++.||||++....    .....+..|+.+++.++||||+++++++.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999987532    33456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      ||+++++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999988888999999999999999999999999999999999999998877  9999999987433222   


Q ss_pred             ---------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh
Q 019433          156 ---------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR  208 (341)
Q Consensus       156 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~  208 (341)
                                                 ......||+.|+|||++.+..++.. +|||||||++|+|++|..||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       2234579999999999988877655 899999999999999999998766443


Q ss_pred             HHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC-hhHHhcCCccCCC
Q 019433          209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-IPEIKKHPWFLKN  264 (341)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s-~~e~l~hp~~~~~  264 (341)
                      ....+....  .....|....+++++.+||.+||. ||.+|++ +.++++||||...
T Consensus       238 ~~~~i~~~~--~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         238 TYNKIINWK--ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHHhccC--CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            333322211  223345545589999999999997 9999999 9999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-51  Score=347.98  Aligned_cols=258  Identities=36%  Similarity=0.572  Sum_probs=222.2

Q ss_pred             CCCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEc----CCEEE
Q 019433            2 EERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT----PTHLA   75 (341)
Q Consensus         2 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~----~~~~~   75 (341)
                      .+.|++. ++||-|-.|.|..|.++.|++.+|+|++..+    ..+.+|+.++-.. .|||||.++++|..    ...+.
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL  135 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL  135 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence            4567665 4599999999999999999999999998764    4577888887655 69999999999864    35688


Q ss_pred             EEEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCC
Q 019433           76 IVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL  152 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~  152 (341)
                      +|||.++||.|+..++..+.  |+|.++..|++||..|+.|||+.+|.||||||+|+|..+.+ +..+||+|||+|+...
T Consensus       136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence            99999999999999988764  99999999999999999999999999999999999997543 3569999999999766


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (341)
                      ......+.+-||+|.|||++....|+ +.+|+||+||++|-|++|.+||..............+++..++.+  |+|..+
T Consensus       216 ~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence            66777889999999999999887876 459999999999999999999987655444444556666666655  467889


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |...+++|+++|..+|.+|+|+.++++|||+.+.
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            9999999999999999999999999999999764

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.3e-50  Score=365.24  Aligned_cols=258  Identities=32%  Similarity=0.539  Sum_probs=213.4

Q ss_pred             CccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      .|++++.||+|+||+||+|++.   .+++.||+|++.+..     ...+.+..|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999874   578999999986532     2234577899999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++||||+.+|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence            999999999999999988888999999999999999999999999999999999999998776  999999998743222


Q ss_pred             C--CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          155 S--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      .  ......||+.|+|||++.+....+.++|||||||++|+|++|..||...............+......++  ..+++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCH
Confidence            1  2234579999999999987654455699999999999999999999754332222233333333333333  36899


Q ss_pred             HHHHHHHHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          233 DCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      .+.+||.+||+.||++||     +++++++||||....
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999999999999     788999999997653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-50  Score=362.94  Aligned_cols=245  Identities=33%  Similarity=0.579  Sum_probs=209.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999986532    2334577899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccCCCC
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPA  165 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt~~  165 (341)
                      ..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||+++.... .......+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999988888999999999999999999999999999999999999988776  99999999874322 222334579999


Q ss_pred             ccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 019433          166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD  245 (341)
Q Consensus       166 y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  245 (341)
                      |+|||++.+..++.+ +|||||||++|+|++|..||........+    ..+......++.  .+++++.+||.+||+.|
T Consensus       159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMY----RKILQEPLRFPD--GFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCCCCC--cCCHHHHHHHHHHcCCC
Confidence            999999988777654 89999999999999999999875543322    223333333343  68999999999999999


Q ss_pred             CCCCC---ChhHHhcCCccCCC
Q 019433          246 PSKRI---PIPEIKKHPWFLKN  264 (341)
Q Consensus       246 p~~R~---s~~e~l~hp~~~~~  264 (341)
                      |.+||   ++.++++||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   57999999999765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.6e-50  Score=374.29  Aligned_cols=257  Identities=31%  Similarity=0.509  Sum_probs=215.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .+|++++.||+|+||.||+|.++.+++.||||++.+..    .....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986532    23456778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC----
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH----  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~----  154 (341)
                      |||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999988888999999999999999999999999999999999999988776  999999987421100    


Q ss_pred             ----------------------------------------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHH
Q 019433          155 ----------------------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM  194 (341)
Q Consensus       155 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l  194 (341)
                                                              ......+||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence                                                    00123479999999999988777654 8999999999999


Q ss_pred             HhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCC---ChhHHhcCCccCCCC
Q 019433          195 LVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKNL  265 (341)
Q Consensus       195 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~  265 (341)
                      ++|..||...............  ......+....+++++.+||.+|+ .+|.+|+   |+.++++||||....
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVINW--ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhcc--CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            9999999876544333222211  112234444578999999999976 5999999   999999999997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-51  Score=364.88  Aligned_cols=257  Identities=35%  Similarity=0.643  Sum_probs=232.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      |.+=|.+-+.||+|.|.+|.+|++.-||+.||||++.+.+.   ....+..|++.|+.++|||||+||++...+..+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            45668999999999999999999999999999999988643   233688999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +|+-++|+|+++|.+. ..+.+..+++++.||+.|+.|+|+..+||||+||+||.+... .+.+||.|||++....+...
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcch
Confidence            9999999999999774 479999999999999999999999999999999999987643 23499999999998888888


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ..+.||+..|.|||++.|..|+..+.||||||||||-|++|++||...++.+.+..    +....+..|.  .+|.+|++
T Consensus       175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm----ImDCKYtvPs--hvS~eCrd  248 (864)
T KOG4717|consen  175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM----IMDCKYTVPS--HVSKECRD  248 (864)
T ss_pred             hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh----hhcccccCch--hhhHHHHH
Confidence            89999999999999999999999999999999999999999999998888655544    4556777776  79999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ||..||+.||++|.|.+++..|+|++..
T Consensus       249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  249 LIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHHHHHhcCchhhccHHHHhccccccCC
Confidence            9999999999999999999999999653

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=9.3e-50  Score=363.84  Aligned_cols=250  Identities=36%  Similarity=0.596  Sum_probs=211.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||.||+|.++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999987532    22345778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccCC
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGT  163 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~gt  163 (341)
                      +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            99999988888999999999999999999999999999999999999998776  99999999875322 2223446799


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV  243 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  243 (341)
                      +.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+......+|.  .+++++.+||++||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEDIKFPR--TLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHH----HHHhccCCccCCC--CCCHHHHHHHHHHcC
Confidence            99999999988777554 8999999999999999999976543322    2222223333343  689999999999999


Q ss_pred             cCCCCCC-----ChhHHhcCCccCCCCCh
Q 019433          244 ADPSKRI-----PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       244 ~dp~~R~-----s~~e~l~hp~~~~~~~~  267 (341)
                      .||.+|+     ++.++++||||......
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~  260 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ  260 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999997     89999999999765433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1e-49  Score=362.89  Aligned_cols=250  Identities=35%  Similarity=0.592  Sum_probs=211.7

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||.||++.++.+|..||+|++....    .....+.+|+.+++.++||||++++++|.....+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999987532    22345668999999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCccCC
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGT  163 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~gt  163 (341)
                      +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... .......||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            99999988888999999999999999999999999999999999999988776  999999998743222 223346799


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV  243 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  243 (341)
                      +.|+|||++.+..++.+ +|||||||++|+|++|..||...+......    .+......+|.  .+++++.+||.+||.
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~p~--~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFPR--TLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence            99999999988777654 899999999999999999998755433222    22222333343  689999999999999


Q ss_pred             cCCCCCC-----ChhHHhcCCccCCCCCh
Q 019433          244 ADPSKRI-----PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       244 ~dp~~R~-----s~~e~l~hp~~~~~~~~  267 (341)
                      .||.+|+     ++.++++||||.+....
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~  260 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ  260 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence            9999998     99999999999775543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-49  Score=362.11  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=215.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++++.||+|+||.||++.+..++..+|+|++....  .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            579999999999999999999999999999999987542  234568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+++++|..++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.  ++|+|||++.... .....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~  160 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN  160 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCccccccc-ccccc
Confidence            999999999998888899999999999999999999986 6999999999999988776  9999999987432 22334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH------------------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI------------------------  214 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~------------------------  214 (341)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .+...+                        
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccccccc
Confidence            5679999999999988777654 89999999999999999999754321 111111                        


Q ss_pred             -------------------HHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          215 -------------------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       215 -------------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                                         ..+............+++++.+||.+||+.||++|||+.++++||||......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~  310 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE  310 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccc
Confidence                               00100000000112478899999999999999999999999999999765543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=363.97  Aligned_cols=254  Identities=29%  Similarity=0.436  Sum_probs=219.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ..|+.++.||+|+||.||+|.+..+++.||||++.-..  ...+.+.+|+.++.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            46889999999999999999999999999999987643  3446788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      |.||++.+.+.....+.+..+..++++++.||.|||..+.+|||||+.|||+..++.  +||+|||++....... ...+
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcccc
Confidence            999999999988888899999999999999999999999999999999999998876  9999999987543332 3367


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .+|||.|||||++.+..|+.+ +||||||++.+||++|.+||......+.+..+-+   .....+.  ..+|+.+++|+.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---~~PP~L~--~~~S~~~kEFV~  244 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---SAPPRLD--GDFSPPFKEFVE  244 (467)
T ss_pred             ccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC---CCCCccc--cccCHHHHHHHH
Confidence            899999999999998888877 7999999999999999999988665322211110   1111111  268999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .||.+||+.||||.++|+|+|+...
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhc
Confidence            9999999999999999999999663

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-49  Score=368.68  Aligned_cols=257  Identities=32%  Similarity=0.513  Sum_probs=214.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999986532    22344678999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--C
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~  156 (341)
                      ||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCccc
Confidence            99999999998865 46899999999999999999999999999999999999988776  9999999987432221  2


Q ss_pred             CCCccCCCCccccccccccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|..||........+..+...  .....+|....+|.+
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQ  277 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHH
Confidence            23467999999999987543   2345599999999999999999999876554333333221  122345555578999


Q ss_pred             HHHHHHHhcccCCCC--CCChhHHhcCCccCCC
Q 019433          234 CRHLLSQIFVADPSK--RIPIPEIKKHPWFLKN  264 (341)
Q Consensus       234 ~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~  264 (341)
                      +.+||.+||+.+|.+  |+|+.++++||||.+.
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999998  9999999999999763

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.6e-50  Score=376.77  Aligned_cols=257  Identities=28%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--------CE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP--------TH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--------~~   73 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++....   ....+|+.+++.++||||+++++++...        ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  141 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF  141 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence            358999999999999999999999999999999886542   3345799999999999999999987532        24


Q ss_pred             EEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           74 LAIVMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      +++||||+++ +|..++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+
T Consensus       142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~  219 (440)
T PTZ00036        142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAK  219 (440)
T ss_pred             EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC-ceeeeccccch
Confidence            7799999986 6666554    3457999999999999999999999999999999999999985542 39999999998


Q ss_pred             CCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------  220 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------  220 (341)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+..++......         
T Consensus       220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~  299 (440)
T PTZ00036        220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN  299 (440)
T ss_pred             hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence            65444444567889999999998775444456999999999999999999998876655555544322110         


Q ss_pred             ----cccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          221 ----QYFLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       221 ----~~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                          ...+|.          ....++++.+||.+||++||.+|||+.++|+||||..
T Consensus       300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence                001111          1146789999999999999999999999999999954

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.5e-50  Score=367.03  Aligned_cols=257  Identities=29%  Similarity=0.498  Sum_probs=215.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||+||+|.++.+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            579999999999999999999999999999999876422    3345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      ||+++++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence            999999999999876 67999999999999999999999999999999999999998776  99999999874332221 


Q ss_pred             -CCCccCCCCccccccccc------cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          157 -PKSTVGTPAYIAPEVLAR------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                       .....||+.|+|||++..      ..+ +.++|||||||++|+|++|..||........+..+...  .....+|....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  235 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTY-GVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK  235 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCC-CCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence             223478999999999863      333 34589999999999999999999876654444333221  11223455556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +++++.+||.+||+ +|.+|||+.++++||||....
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            89999999999998 999999999999999997643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.1e-49  Score=368.03  Aligned_cols=260  Identities=29%  Similarity=0.504  Sum_probs=216.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++++.||+|+||+||+|.++.+++.||+|++...    ......+..|+.++..++||||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999998653    223446778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      ||++||+|..++.+...+++..++.++.|++.||.|||++||+||||||+|||++.++.  ++|+|||++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCcccccccccc
Confidence            99999999999988889999999999999999999999999999999999999988776  9999999986321110   


Q ss_pred             ---------------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCC
Q 019433          156 ---------------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE  202 (341)
Q Consensus       156 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~  202 (341)
                                                       .....+||+.|+|||++.+..++.. +|||||||++|+|++|..||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence                                             0123579999999999988887655 899999999999999999998


Q ss_pred             CCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCC---ChhHHhcCCccCCCCChh
Q 019433          203 DPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~~~  268 (341)
                      .......+..+...  .....+|....+++++.+||.+|+ .||.+|+   ++.++++||||.......
T Consensus       238 ~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~  303 (360)
T cd05627         238 SETPQETYRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH  303 (360)
T ss_pred             CCCHHHHHHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence            76554333332211  122234444458999999999987 4999998   479999999997754433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-49  Score=364.26  Aligned_cols=258  Identities=29%  Similarity=0.469  Sum_probs=206.8

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----THLA   75 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~~~   75 (341)
                      ||++.+.||+|+||.||+|.++.+++.||||++....   .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            7999999999999999999999999999999986432   2234578899999999999999999988643     3589


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      +|||||. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            9999995 589999988888999999999999999999999999999999999999988776  9999999987432211


Q ss_pred             ----CCCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHH--------------
Q 019433          156 ----QPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID--------------  215 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~--------------  215 (341)
                          ......||+.|+|||++.+  ..++ .++|||||||++|+|++|++||........+.....              
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                1234579999999999865  3444 458999999999999999999976554322211111              


Q ss_pred             ---------HHhccc-c-cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          216 ---------RIRNVQ-Y-FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       216 ---------~~~~~~-~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                               .+.... . .......+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                     000000 0 0011235678899999999999999999999999999996543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-49  Score=368.69  Aligned_cols=253  Identities=21%  Similarity=0.302  Sum_probs=206.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.+++.++||||++++++|..+...++|+|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            589999999999999999999999999999997543     346789999999999999999999999999999999995


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC--CCCCCCc
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--HSQPKST  160 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~--~~~~~~~  160 (341)
                       ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....  .......
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccc
Confidence             588888888888999999999999999999999999999999999999988776  99999999864221  1223346


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-------hhHHHHHHHHHhc--------------
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRN--------------  219 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~--------------  219 (341)
                      .||+.|+|||++.+..++. ++|||||||++|+|++|..||.....       ...+..++.....              
T Consensus       244 ~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        244 AGTIATNAPELLARDPYGP-AVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             cCccCCCChhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            7999999999998877755 48999999999999999988754321       1111111111100              


Q ss_pred             --------ccc----cCCC---CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          220 --------VQY----FLPD---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       220 --------~~~----~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                              ...    ..+.   ...++.++.+||.+||++||.+|||+.|+|+||||...
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                    000    0011   12356789999999999999999999999999999653

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-49  Score=367.45  Aligned_cols=258  Identities=31%  Similarity=0.502  Sum_probs=213.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            368999999999999999999999999999999986522    2234577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--  155 (341)
                      |||+++|+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......  
T Consensus       122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMV  198 (370)
T ss_pred             EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCce
Confidence            9999999999988654 6899999999999999999999999999999999999998776  9999999987532221  


Q ss_pred             CCCCccCCCCccccccccccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          156 QPKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      .....+||+.|+|||++.+..   +.+.++|||||||++|+|++|..||........+..+...  .....+|....++.
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~  276 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISK  276 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCH
Confidence            123567999999999987543   2345699999999999999999999876554443333221  12234555557899


Q ss_pred             HHHHHHHHhcccCCCC--CCChhHHhcCCccCCC
Q 019433          233 DCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKN  264 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~  264 (341)
                      .+.+++.+||+.++.+  |+|+.++++||||...
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            9999999999865544  8999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.2e-49  Score=364.83  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=208.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------   72 (341)
                      .++|++++.||+|+||.||+|.+..+|..||+|++....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            479999999999999999999999999999999986532   23456778999999999999999999986543      


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+||||+.+ +|...+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            57999999976 5655553  35899999999999999999999999999999999999998776  9999999997544


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-------------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-------------  219 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------  219 (341)
                      .........||+.|+|||++.+..+..+ +|||||||++|+|++|..||...+....+.........             
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            4444455688999999999988887665 89999999999999999999876544333222211100             


Q ss_pred             -----cccc---------CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          220 -----VQYF---------LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       220 -----~~~~---------~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                           ....         .+.         ....++.+.+||.+||+.||++|||+.|+|+||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  322 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY  322 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence                 0000         000         012467799999999999999999999999999997544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3e-49  Score=359.31  Aligned_cols=249  Identities=34%  Similarity=0.541  Sum_probs=209.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+++.||||++.+..    ...+.+..|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    2234566777777765 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++..... ........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999999988889999999999999999999999999999999999999988776  99999999874322 222344679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.. +|||||||++|+|++|..||...+.....    ..+.......|.  .+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPT--WLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999987777654 89999999999999999999876543332    233333333333  58999999999999


Q ss_pred             ccCCCCCCCh------hHHhcCCccCCCCC
Q 019433          243 VADPSKRIPI------PEIKKHPWFLKNLP  266 (341)
Q Consensus       243 ~~dp~~R~s~------~e~l~hp~~~~~~~  266 (341)
                      +.||.+|+++      +++++||||.....
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~  261 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKELDW  261 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999998      99999999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-49  Score=365.88  Aligned_cols=258  Identities=28%  Similarity=0.416  Sum_probs=209.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            479999999999999999999999999999999987532   2345677899999999999999999988643      3


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+||||+.+ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccC
Confidence            57999999976 66666643  4889999999999999999999999999999999999988776  9999999997544


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----------  221 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (341)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+...+.......           
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            4444455679999999999988877655 8999999999999999999987665544444332111000           


Q ss_pred             ----ccCC---------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          222 ----YFLP---------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       222 ----~~~~---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                          ...|                     .....+..+++||.+||+.||.+|||+.++|+||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~  325 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  325 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence                0000                     0012356789999999999999999999999999996543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=3.3e-49  Score=360.40  Aligned_cols=251  Identities=29%  Similarity=0.509  Sum_probs=208.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||.||+|.++.+++.||+|++.+..    .....+.+|+.++..+ +||||++++++|...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            47999999999999999999999999987632    2233567888888888 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++...+++++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            999999988889999999999999999999999999999999999999988776  99999999874222 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----hHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      |+.|+|||++.+..++.+ +|+|||||++|+|++|..||......     .........+.......|.  .++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            999999999988777654 89999999999999999999632111     1111122223333333443  588999999


Q ss_pred             HHHhcccCCCCCCC------hhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIP------IPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s------~~e~l~hp~~~~~  264 (341)
                      |++||+.||.+|+|      ++++++||||...
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999997      7899999999654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-49  Score=361.36  Aligned_cols=250  Identities=36%  Similarity=0.582  Sum_probs=211.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||+||+|.+..++..||+|++....    .....+..|+.+++.++||||+++++++..+..+++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999987532    22345678899999999999999999999999999999999999


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      +|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 89999999999999998776  99999999864322 222334579


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||........    ...+......+|.  .+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFPR--TLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777654 8999999999999999999977554322    2222233333343  68999999999999


Q ss_pred             ccCCCCCC-----ChhHHhcCCccCCCCCh
Q 019433          243 VADPSKRI-----PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       243 ~~dp~~R~-----s~~e~l~hp~~~~~~~~  267 (341)
                      +.||++|+     ++.++++||||.+....
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~  261 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ  261 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence            99999997     99999999999775543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.2e-49  Score=352.20  Aligned_cols=255  Identities=29%  Similarity=0.422  Sum_probs=206.0

Q ss_pred             CCccccceecccCCeEEEEEEEcC-CCcEEEEEEcccCc---cccHHHHHHHHHHhcC---CCCCeeeEEEEEE-----c
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGK---KIDENVQREIINHRSL---RHPNIIRFKEVLL-----T   70 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~-----~   70 (341)
                      ++|++++.||+|+||+||+|.+.. ++..||+|.+....   .......+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 57889999886532   2233566777776655   6999999999985     3


Q ss_pred             CCEEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           71 PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        71 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      ...+++||||+. ++|..++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            456899999997 4888888653  35899999999999999999999999999999999999988776  999999998


Q ss_pred             cCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCC--
Q 019433          149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP--  225 (341)
Q Consensus       149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--  225 (341)
                      .............||+.|+|||++.+..++.+ +|||||||++|+|++|.+||....+...+..+........ ..++  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            75444444455678999999999987777654 8999999999999999999998776666555543321100 0000  


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          226 ------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       226 ------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                        ....+++.+.+||.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-50  Score=363.89  Aligned_cols=255  Identities=32%  Similarity=0.504  Sum_probs=225.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE-EEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-LAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~-~~iv~   78 (341)
                      ++|..++++|+|+||.+++++++..+..|++|.+.-..   ...+.+..|+.+++++.|||||.+.+.|..++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            68999999999999999999999999999999987543   334478899999999999999999999998888 99999


Q ss_pred             eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      +||+||+|.+.+...+  .|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.++.  |+|+|||+|+...... 
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDS  161 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchh
Confidence            9999999999997755  6999999999999999999999999999999999999999888  9999999999876666 


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...+.+|||.||+||++.+..|+.+ +|||||||++|||++-+++|...+-.....++....     ..|-....|.+++
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~Plp~~ys~el~  235 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YSPLPSMYSSELR  235 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CCCCCccccHHHH
Confidence            6778899999999999999999877 999999999999999999999876554444443332     2344457999999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .|++.||..+|..||++.++|.+|.++...
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            999999999999999999999998876444

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.1e-49  Score=357.53  Aligned_cols=254  Identities=31%  Similarity=0.522  Sum_probs=213.8

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~   78 (341)
                      .|++++.||+|+||.||+|.++.+++.||||++.+..    ...+.+..|+.++..++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4899999999999999999999999999999987532    233456788888888876 56889999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      ||+++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence            99999999999988888999999999999999999999999999999999999988776  99999999864322 2233


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+.    .+......+|.  .+++++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYPK--SLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHH
Confidence            44579999999999988777654 899999999999999999998765433332    23333333333  689999999


Q ss_pred             HHHhcccCCCCCCCh-----hHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIPI-----PEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~  266 (341)
                      +++||.+||.+|+++     +++++||||.....
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~  265 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW  265 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999987     89999999976543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-49  Score=351.03  Aligned_cols=259  Identities=26%  Similarity=0.404  Sum_probs=215.8

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4899999999999999999999999999999986532    122346789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.  ++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCcc
Confidence            99999998887653  36999999999999999999999999999999999999987766  999999998754333333


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||++.+..++.+ +||||+||++|+|++|..||...............+.......+  ..++..+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHH
Confidence            45678999999999987776655 89999999999999999999875543333333333333222222  3588999999


Q ss_pred             HHHhcccCCCCCC-----ChhHHhcCCccCCCCCh
Q 019433          238 LSQIFVADPSKRI-----PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       238 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~  267 (341)
                      |.+||..||.+||     +++++++||||.....+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~  270 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK  270 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence            9999999999999     89999999999764433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=367.38  Aligned_cols=266  Identities=29%  Similarity=0.435  Sum_probs=222.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|.-++.||+|+||.||.|++..+.+.||||++..+-+..    ..+.+|+..++.|.|||++.+.++|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            46888999999999999999999999999999997654333    36889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||-| +-.+++.. .+++.+.+|..|..+.+.||+|||+++.||||||..|||++..+.  |||+|||.|..   ..+.
T Consensus       106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~PA  179 (948)
T KOG0577|consen  106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAPA  179 (948)
T ss_pred             HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCch
Confidence            99976 55555543 568999999999999999999999999999999999999998887  99999999864   3456


Q ss_pred             CCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          158 KSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      .+.+|||+|||||++.   .+.|+++ +||||||++..+|.-.++|+..-+....+.-+   ..+....++ ...+|..|
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHI---AQNesPtLq-s~eWS~~F  254 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQNESPTLQ-SNEWSDYF  254 (948)
T ss_pred             hcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHH---HhcCCCCCC-CchhHHHH
Confidence            7899999999999986   4577777 89999999999999999997664433222221   223333333 24689999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhh
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE  279 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~  279 (341)
                      ..|+..||++-|.+|||.+++|+|+|....-|.+.+..-.+.-+.
T Consensus       255 ~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKd  299 (948)
T KOG0577|consen  255 RNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKD  299 (948)
T ss_pred             HHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHH
Confidence            999999999999999999999999999988887765544443333

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-48  Score=356.10  Aligned_cols=250  Identities=32%  Similarity=0.524  Sum_probs=210.6

Q ss_pred             cceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++.||+|+||.||+|.+.   .+++.||+|++.+..     .....+..|+.+++.++||||++++++|..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            478999999999999874   578999999987532     223456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~  158 (341)
                      |+.+++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccc
Confidence            9999999999988888999999999999999999999999999999999999988776  99999999864322 22233


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|++|..||.........    ..+......+|.  .+++.+.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGK-AVDWWSLGALMYDMLTGAPPFTAENRKKTI----DKILKGKLNLPP--YLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCCC-cceecccHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHH
Confidence            457999999999998777654 489999999999999999999876543332    223333333343  5789999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      ++||+.||.+||     ++.++++||||.....
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~  264 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW  264 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999     8999999999976543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.7e-49  Score=357.94  Aligned_cols=251  Identities=29%  Similarity=0.520  Sum_probs=207.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+++.||+|++.+..    .....+..|+.++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999987642    2223466788887766 899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            999999988889999999999999999999999999999999999999988776  99999999874322 222345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----hhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----PRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.....     ..........+......+|.  .++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHH
Confidence            999999999988877654 8999999999999999999953111     11111122223333333443  688999999


Q ss_pred             HHHhcccCCCCCCC------hhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIP------IPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s------~~e~l~hp~~~~~  264 (341)
                      |.+||+.||.+||+      +.++++||||...
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999998      4799999999664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-48  Score=356.37  Aligned_cols=252  Identities=35%  Similarity=0.573  Sum_probs=209.6

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHH---hcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINH---RSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~---~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      |++++.||+|+||.||+|.+..+++.||||++.+..    ...+.+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999987532    2234556666554   566899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      |||+.+++|...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... ...
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999888754 57999999999999999999999999999999999999998876  99999999874322 222


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+|++.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+.    .+.......|.  .+++++.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYPR--FLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--CCCHHHHH
Confidence            345679999999999988777554 899999999999999999998765433322    23333333333  58999999


Q ss_pred             HHHHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      ||.+||+.||.+||     ++.++++||||.....
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~  265 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW  265 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence            99999999999999     7999999999976543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-48  Score=355.65  Aligned_cols=250  Identities=32%  Similarity=0.520  Sum_probs=209.8

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||.||+|.++.+++.||||++.+..    .....+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987532    2233466788887755 899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..... ........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence            999999988889999999999999999999999999999999999999998776  99999999874322 222344579


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||........+.    .+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFE----SILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777655 899999999999999999998765433332    23333333333  57899999999999


Q ss_pred             ccCCCCCC-------ChhHHhcCCccCCCCCh
Q 019433          243 VADPSKRI-------PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       243 ~~dp~~R~-------s~~e~l~hp~~~~~~~~  267 (341)
                      +.||.+|+       ++.++++||||......
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~  263 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV  263 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence            99999999       89999999999665433

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.6e-49  Score=375.63  Aligned_cols=261  Identities=25%  Similarity=0.396  Sum_probs=205.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC------CCCeeeEEEEEEcC-CEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR------HPNIIRFKEVLLTP-THL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~------hp~iv~l~~~~~~~-~~~   74 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++............|+.+++.+.      |+++++++++|... .++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            36899999999999999999999999999999999765444555667777776664      45689999988765 578


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCC--------------CC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQ--------------PR  139 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~--------------~~  139 (341)
                      ++||+++ |++|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.              ..
T Consensus       208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            9999988 66888888888889999999999999999999998 69999999999999986542              24


Q ss_pred             EEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc
Q 019433          140 LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN  219 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~  219 (341)
                      +||+|||.+...  .......+||+.|+|||++.+..+... +|||||||++|+|++|++||........+..+......
T Consensus       287 vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        287 VRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             EEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            999999987632  223445789999999999998887655 89999999999999999999876654333322111100


Q ss_pred             cc--------------------ccCCC----------------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          220 VQ--------------------YFLPD----------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       220 ~~--------------------~~~~~----------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..                    ...+.                ....++.+.+||.+||++||.+|||+.|+|+||||.+
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            00                    00000                0012456789999999999999999999999999976


Q ss_pred             CCC
Q 019433          264 NLP  266 (341)
Q Consensus       264 ~~~  266 (341)
                      ..+
T Consensus       444 ~~~  446 (467)
T PTZ00284        444 YYP  446 (467)
T ss_pred             cCC
Confidence            543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-48  Score=354.31  Aligned_cols=249  Identities=33%  Similarity=0.545  Sum_probs=207.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~-l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||.||+|.++.+|+.||+|++....    ........|..++.. ++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987532    223455667777764 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..+..++.||+.||+|||++||+||||||+||+++.++.  ++|+|||++..... .......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence            999999988888999999999999999999999999999999999999998776  99999999864222 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||........    ...+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988877655 8999999999999999999986554322    2223333333333  57899999999999


Q ss_pred             ccCCCCCCCh-hHHhcCCccCCCCC
Q 019433          243 VADPSKRIPI-PEIKKHPWFLKNLP  266 (341)
Q Consensus       243 ~~dp~~R~s~-~e~l~hp~~~~~~~  266 (341)
                      +.||.+|+++ +++++||||.....
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~~  256 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTINW  256 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCCH
Confidence            9999999998 58899999976543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.6e-48  Score=349.05  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=205.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcC---CCCCeeeEEEEEEc-----CC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSL---RHPNIIRFKEVLLT-----PT   72 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~-----~~   72 (341)
                      +|++++.||+|+||+||+|.++.+++.||+|.+....   .......+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            6999999999999999999999999999999987532   2233566777776655   79999999999864     34


Q ss_pred             EEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           73 HLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      .++++|||+.+ +|..++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            58999999985 888888664  35899999999999999999999999999999999999988776  99999999875


Q ss_pred             CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCC----
Q 019433          151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP----  225 (341)
Q Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----  225 (341)
                      ...........||+.|+|||++.+..++.+ +|||||||++|+|++|.+||........+.+......... ..++    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            443333445678999999999987776654 8999999999999999999987666555544443221100 0000    


Q ss_pred             ----------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          226 ----------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       226 ----------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                      ....++..+.+||.+||++||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-48  Score=347.45  Aligned_cols=250  Identities=30%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||+|+||+||++.+..+++.||+|.+.....    ..+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999865321    224567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCcc
Q 019433           87 FARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTV  161 (341)
Q Consensus        87 ~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  161 (341)
                      ...+..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++...... .......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence            877743    346999999999999999999999999999999999999987766  999999998643222 1223457


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+.......+  ..+++.+.+++.+|
T Consensus       159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHH
Confidence            8999999999988877654 89999999999999999999865433222222222222222222  36899999999999


Q ss_pred             cccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          242 FVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       242 L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      |+.||++||     +++++++||||....
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~~  264 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDLN  264 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence            999999999     889999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-48  Score=360.10  Aligned_cols=258  Identities=28%  Similarity=0.420  Sum_probs=208.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .++|++++.||+|+||.||+|.+..+++.||||.+....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            479999999999999999999999999999999987532   2234677899999999999999999998654      3


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..++||||+.+ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCC
Confidence            57999999976 56666643  5899999999999999999999999999999999999988776  9999999998654


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc------------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------  220 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  220 (341)
                      .........||+.|+|||++.+..+..+ +|||||||++|+|++|..||........+...+......            
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            4444456689999999999988877655 899999999999999999998765443333322211100            


Q ss_pred             --------c---ccCC-------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          221 --------Q---YFLP-------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       221 --------~---~~~~-------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                              .   ..++             .....+..+.+||.+||+.||.+|||+.|+|+||||....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                    0   0000             0112456789999999999999999999999999997554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.6e-48  Score=353.68  Aligned_cols=254  Identities=33%  Similarity=0.516  Sum_probs=213.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .|++++.||+|+||.||+|.++.+++.||+|++.+...    .......|..++..+ .||+|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48999999999999999999999999999999876421    223455677777666 5899999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      ||+++|+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            99999999999988888999999999999999999999999999999999999998876  99999999874322 2233


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........    .+......+|.  .++.++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAYPK--SMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--cCCHHHHHH
Confidence            45679999999999988877655 899999999999999999998765433332    23333333343  689999999


Q ss_pred             HHHhcccCCCCCCCh-----hHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIPI-----PEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~  266 (341)
                      +.+||+.||.+|+++     .++++||||.....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~  265 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  265 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCH
Confidence            999999999999985     89999999976543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=353.51  Aligned_cols=245  Identities=32%  Similarity=0.466  Sum_probs=204.9

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcE-EEEEEcccCccc---cHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-EEEEEEe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKEL-VAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVME   79 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~---~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-~~~iv~e   79 (341)
                      ..+.+.||+|+||+||.+.+.  |+. ||+|++......   .+.+.+|+.++++++|||||++++++..+. .++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            345667999999999999996  555 999998765432   448999999999999999999999999988 7999999


Q ss_pred             ecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-C
Q 019433           80 YAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSME-ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~-iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~  155 (341)
                      |+++|+|..++..  ...++...+..++.||++|+.|||+++ ||||||||+|||++.+. .++||+|||+++..... .
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKT  199 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccc
Confidence            9999999999988  578999999999999999999999999 99999999999999876 24999999999864443 3


Q ss_pred             CCCCccCCCCcccccccc--ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 QPKSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ......||+.|||||++.  ...++.+ +||||||+++|||+||..||...............  .....+|.  ..++.
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~--~~Rp~~p~--~~~~~  274 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG--GLRPPIPK--ECPPH  274 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--CCCCCCCc--cCCHH
Confidence            344478999999999999  4466655 99999999999999999999987763333222211  22222232  48899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +..|+.+||..||.+||+..+++.
T Consensus       275 l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  275 LSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999998876

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-48  Score=354.70  Aligned_cols=258  Identities=29%  Similarity=0.485  Sum_probs=212.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++.+.||+|+||.||++.+..++..+|+|++....  .....+.+|+.+++.++||||++++++|..++.+++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            579999999999999999999999999999999887542  223568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+.+++|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.  +||+|||++.... .....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~-~~~~~  160 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN  160 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhh-hhccc
Confidence            999999999998888899999999999999999999985 7999999999999988776  9999999986432 22234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH------------------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI------------------------  214 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~------------------------  214 (341)
                      ...|++.|+|||++.+..++.+ +|+|||||++|+|++|..||...... .+....                        
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCccchh
Confidence            4578999999999987776554 89999999999999999999754321 111110                        


Q ss_pred             -----------------HHHhccc-ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          215 -----------------DRIRNVQ-YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       215 -----------------~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                       ..+.... ...+ ...++.++.+||.+||++||++|||+.+++.||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLP-SGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCC-CCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                             0000000 0001 113678899999999999999999999999999996553

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.6e-48  Score=361.23  Aligned_cols=258  Identities=32%  Similarity=0.498  Sum_probs=212.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999999999999999999986522    2233467899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--  155 (341)
                      |||+++|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......  
T Consensus       122 ~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         122 MEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCcc
Confidence            999999999998865 46899999999999999999999999999999999999988776  9999999987432221  


Q ss_pred             CCCCccCCCCccccccccccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          156 QPKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      .....+||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...+....+..+...  .....+|....++.
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~  276 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISK  276 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCH
Confidence            223567999999999987543   2345599999999999999999999876544333333221  12233455567999


Q ss_pred             HHHHHHHHhcccCCCC--CCChhHHhcCCccCCC
Q 019433          233 DCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKN  264 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~  264 (341)
                      .+.+||.+||..++.+  |+++.++++||||.+.
T Consensus       277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999999999844443  7899999999999664

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-48  Score=353.99  Aligned_cols=248  Identities=36%  Similarity=0.597  Sum_probs=209.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+++.||||++.+..    ........|+.+++.+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987642    2234566788888777 799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|...+.+...+++..+..++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            999999988889999999999999999999999999999999999999998776  99999999864322 222334579


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.........    ..+.......|.  .++..+.+||++||
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYPR--WLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence            999999999988877655 89999999999999999999765543222    223333333333  58899999999999


Q ss_pred             ccCCCCCCCh-----hHHhcCCccCCCC
Q 019433          243 VADPSKRIPI-----PEIKKHPWFLKNL  265 (341)
Q Consensus       243 ~~dp~~R~s~-----~e~l~hp~~~~~~  265 (341)
                      +.||.+|||+     .++++||||....
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999     9999999997653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-48  Score=352.21  Aligned_cols=250  Identities=34%  Similarity=0.564  Sum_probs=208.0

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~-l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|++..+++.||||++....    ........|..++.. ++||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999987642    223445667777765 5899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      |+|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||++..... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999999988888999999999999999999999999999999999999998776  99999999864222 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYPR--WLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence            999999999988777655 8999999999999999999987554322    2222222223333  47899999999999


Q ss_pred             ccCCCCCCChh-HHhcCCccCCCCCh
Q 019433          243 VADPSKRIPIP-EIKKHPWFLKNLPK  267 (341)
Q Consensus       243 ~~dp~~R~s~~-e~l~hp~~~~~~~~  267 (341)
                      +.||.+||++. +++.||||......
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~~~  257 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREIDWS  257 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCCHH
Confidence            99999999996 89999999775443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.9e-48  Score=351.21  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=210.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||.||+|.++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            68999999999999999999999999999999986532  2334677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      +.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... ....
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccccc
Confidence            986 777777654 35899999999999999999999999999999999999988776  999999998643222 2223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...+|+.|+|||++.+....+.++|||||||++|+|++|.+||...+....+..........               ...
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            45689999999998765544556999999999999999999998765443333332211100               000


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+         ....+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            11         123578899999999999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.3e-48  Score=353.95  Aligned_cols=249  Identities=34%  Similarity=0.557  Sum_probs=206.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~-~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+|+.||||++.+..    .....+..|.. +++.++||||+++++++......++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    11233444444 45778999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence            999999988889999999999999999999999999999999999999988776  99999999874322 222334579


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......+  ..+++.+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRLK--PNISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence            999999999988777654 8999999999999999999987544322    222323233233  357999999999999


Q ss_pred             ccCCCCCCCh----hHHhcCCccCCCCC
Q 019433          243 VADPSKRIPI----PEIKKHPWFLKNLP  266 (341)
Q Consensus       243 ~~dp~~R~s~----~e~l~hp~~~~~~~  266 (341)
                      +.||.+||++    .++++||||.....
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~  259 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSINW  259 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence            9999999998    59999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-48  Score=354.30  Aligned_cols=259  Identities=28%  Similarity=0.493  Sum_probs=209.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||++.++.+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            58999999999999999999999999999999987522    22345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      ||+.+++|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence            99999999999976 457999999999999999999999999999999999999987776  99999999864332222 


Q ss_pred             -CCCccCCCCccccccccc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC-CCCCCC
Q 019433          157 -PKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-PDYVRV  230 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  230 (341)
                       .....||+.|+|||++.+    ....+.++|||||||++|+|++|..||........+..+....  ....+ +....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CcccCCCccCCC
Confidence             123469999999999863    2223445899999999999999999998755433333322111  11112 223358


Q ss_pred             CHHHHHHHHHhcccCCCC--CCChhHHhcCCccCCCC
Q 019433          231 SADCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~  265 (341)
                      +..+++||++||+.++++  |+++.++++||||....
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            999999999999765554  78999999999996643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.7e-48  Score=350.85  Aligned_cols=248  Identities=37%  Similarity=0.612  Sum_probs=205.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhc-CCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~-l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.+..+++.||||++....    ...+....|..++.. .+||||+++++++.....+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    222344556666654 4899999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      |+|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... .......+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            999999988889999999999999999999999999999999999999988776  99999999874322 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+.    .+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILNDRPHFPR--WISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 899999999999999999998765433322    22222223333  58899999999999


Q ss_pred             ccCCCCCCChh-HHhcCCccCCCC
Q 019433          243 VADPSKRIPIP-EIKKHPWFLKNL  265 (341)
Q Consensus       243 ~~dp~~R~s~~-e~l~hp~~~~~~  265 (341)
                      +.||.+||++. ++++||||....
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999874 888999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-48  Score=361.55  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=210.5

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----EEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLA   75 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----~~~   75 (341)
                      .|++.+.||+|+||+||+|.+..+++.||||.+....   .....+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4889999999999999999999999999999986532   22346789999999999999999999998776     799


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-  154 (341)
                      +||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999997 488888887888999999999999999999999999999999999999998776  999999998743222 


Q ss_pred             -CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh---------------
Q 019433          155 -SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR---------------  218 (341)
Q Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~---------------  218 (341)
                       .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.....               
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence             1223456899999999998765445568999999999999999999987655444333221110               


Q ss_pred             ----cccccCC-------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          219 ----NVQYFLP-------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       219 ----~~~~~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                          ......+       .....++++.+||.+||+.||.+|||+.++++||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                0000001       112467889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-48  Score=357.36  Aligned_cols=256  Identities=29%  Similarity=0.472  Sum_probs=206.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.|+.++.||+|+||.||+|.+..+++.||||++....  .....+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            35888999999999999999999999999999986532  2345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      +.+++|...    ....+..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... .....
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccc
Confidence            999998543    34678888999999999999999999999999999999988776  999999998743222 12245


Q ss_pred             ccCCCCccccccccc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          160 TVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ..||..|+|||++..    ..+.+.++|||||||++|+|++|+.||...... .+......+.. .........++.++.
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~l~  305 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICM-SQPPEAPATASREFR  305 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhc-cCCCCCCCccCHHHH
Confidence            679999999999753    233345689999999999999999999743321 22222222211 111112236789999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +||.+||..||++|||+.|+++||||.....
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999999999977643

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=336.55  Aligned_cols=259  Identities=29%  Similarity=0.506  Sum_probs=220.7

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc-HHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      +.||+|+|+.|--|.+..+|..||||++.+..... ..+.+|+.++..+ .|+||++|+++|+++..+|+|||.+.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            57999999999999999999999999999876543 4789999999988 599999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCC--------CCCCC
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL--------LHSQP  157 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~--------~~~~~  157 (341)
                      ...|++.+.|++.++..++++|+.||.|||.+||.|||+||+|||-...+ ...||||||.+.....        .....
T Consensus       164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L  243 (463)
T KOG0607|consen  164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL  243 (463)
T ss_pred             HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence            99999999999999999999999999999999999999999999986433 3569999999874211        11123


Q ss_pred             CCccCCCCcccccccc----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------hhHHHHHHHHHhcccc
Q 019433          158 KSTVGTPAYIAPEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRNVQY  222 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~  222 (341)
                      .+.+|+..|||||+..    ...++.+.+|.||||||+|.|++|.+||.+.-.           ..-.++++..++...+
T Consensus       244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY  323 (463)
T KOG0607|consen  244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY  323 (463)
T ss_pred             cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence            4567888999999853    344556779999999999999999999975321           1223456677887777


Q ss_pred             cCC--CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          223 FLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       223 ~~~--~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      .+|  +|..+|.+.++|++.+|..|+.+|.++.++++|||++...+.
T Consensus       324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            777  478899999999999999999999999999999999776543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-48  Score=354.47  Aligned_cols=249  Identities=32%  Similarity=0.566  Sum_probs=209.6

Q ss_pred             cceecccCCeEEEEEEE---cCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            8 VKELGSGNFGVARLVRD---KRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++.||+|+||.||++.+   +.+|+.||+|++....   ........|+.+++.++||||+++++++..++.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            46899999999999987   3678999999987532   12345678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  160 (341)
                      .+++|..++.+...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988888999999999999999999999999999999999999988776  999999998753332 223456


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      .||+.|+|||++.+..+.. ++|||||||++|+|++|+.||.........    ..+.......|.  .+++++.+||++
T Consensus       159 ~g~~~y~aPE~~~~~~~~~-~~DiwslG~il~el~tg~~p~~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLPFQGKDRKETM----TMILKAKLGMPQ--FLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCCC-ccceeccceEeeeeccCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHH
Confidence            7999999999998777654 489999999999999999999875543322    223333333343  588999999999


Q ss_pred             hcccCCCCCCC-----hhHHhcCCccCCCC
Q 019433          241 IFVADPSKRIP-----IPEIKKHPWFLKNL  265 (341)
Q Consensus       241 ~L~~dp~~R~s-----~~e~l~hp~~~~~~  265 (341)
                      ||+.||.+|||     +.++++||||....
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999     67799999997654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-48  Score=352.01  Aligned_cols=252  Identities=29%  Similarity=0.501  Sum_probs=208.3

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.+..+++.||+|++.+..    ...+.+.+|+.++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            47999999999999999999999999997642    2233567888888777 699999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  162 (341)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999999988888999999999999999999999999999999999999988776  9999999987422 2223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||......   .........+.......|.  .++..+.++|.
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence            999999999988777654 89999999999999999999642211   1111122222333333443  58899999999


Q ss_pred             HhcccCCCCCCCh------hHHhcCCccCCCC
Q 019433          240 QIFVADPSKRIPI------PEIKKHPWFLKNL  265 (341)
Q Consensus       240 ~~L~~dp~~R~s~------~e~l~hp~~~~~~  265 (341)
                      +||+.||.+|+++      .++++||||....
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            9999999999984      6999999997654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.8e-48  Score=344.45  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=211.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+..|+.+++.++|++|+++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999865422    12346789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            99999998888553  35999999999999999999999999999999999999988776  999999998754333333


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||++.+..++.+ +||||+||++|+|++|..||.......................+  ..+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYS--EKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcC--ccCCHHHHHH
Confidence            45679999999999988777654 89999999999999999999865432111111111111111122  3588999999


Q ss_pred             HHHhcccCCCCCCC-----hhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIP-----IPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~  264 (341)
                      +.+||+.||.+|||     +.++++||||.+.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            99999999999999     8999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-48  Score=343.78  Aligned_cols=254  Identities=37%  Similarity=0.599  Sum_probs=210.4

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHH---HHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      |++++.||+|+||+||++.++.+++.||+|++.........   ..+|+.+++.++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            88999999999999999999999999999999876533332   345999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC-CCCCCCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~-~~~~~~~~~~  160 (341)
                      .+++|..++.....+++..+..++.||+.||.+||++|++|+||||+||+++.++.  ++|+|||.+.. ..........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            99999999988888999999999999999999999999999999999999997776  99999999864 2233344566


Q ss_pred             cCCCCcccccccc-ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-ccccCCCCCCCCHHHHHHH
Q 019433          161 VGTPAYIAPEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       161 ~gt~~y~aPE~~~-~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li  238 (341)
                      .+++.|+|||++. +... +.++|+||||+++|+|++|..||.................. ...........++.+.++|
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             cccccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            7899999999988 4454 45599999999999999999999876322222222222111 1111111112348899999


Q ss_pred             HHhcccCCCCCCChhHHhcCCcc
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-51  Score=345.09  Aligned_cols=263  Identities=23%  Similarity=0.395  Sum_probs=225.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +-|.++++||+|+||.||+|.++.+|+.+|||.+.-.. ..+++.+||.++.+++.|+||++|+.+..+..++||||||.
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            45889999999999999999999999999999987654 46789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCCc
Q 019433           83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST  160 (341)
Q Consensus        83 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  160 (341)
                      .|++.+.+.- +++|++.++..+++..++||.|||...-||||||..|||++.+|.  .||+|||.|....... ...+.
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCcc
Confidence            9999998854 668999999999999999999999999999999999999998887  9999999987533222 34567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      +|||.|||||++..-.|++. +||||||++..+|..|++||.+--..+.+.- +..  +....+.....+|.++.||+++
T Consensus       190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT--~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPT--KPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccceeEe-ccC--CCCCCCCChHhhhhHHHHHHHH
Confidence            89999999999998889877 7999999999999999999987443222110 111  1122223334689999999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCChhHHHH
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI  272 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~  272 (341)
                      ||.++|++|.|+.++++|||+.+.....+...
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA~g~~I~~~  297 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNAPGCDIMQL  297 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCCCcccHHHH
Confidence            99999999999999999999998887776654

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.6e-48  Score=349.88  Aligned_cols=254  Identities=31%  Similarity=0.518  Sum_probs=212.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .|+..+.||+|+||+||+|.++.+++.||+|++.+..    ...+....|+.+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4889999999999999999999999999999987532    22234667888887775 678889999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      ||+++|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... ...
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            99999999999988889999999999999999999999999999999999999998776  999999998743222 223


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.......|.  .++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~~----i~~~~~~~p~--~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCc--cCCHHHHHH
Confidence            44569999999999988777654 8999999999999999999987654333322    2333333333  688999999


Q ss_pred             HHHhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      +.+||+.+|.+|++     ..++++||||.....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            99999999999997     478999999976543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.7e-48  Score=352.25  Aligned_cols=250  Identities=31%  Similarity=0.523  Sum_probs=207.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~-~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+|+.||+|++.+..    .....+..|.. +++.++||||+++++++...+.+++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            47999999999999999999999999987532    12233445544 46778999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            999999988889999999999999999999999999999999999999998776  99999999874322 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+..    +.......+  ...+..+.++|++||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPLVLR--PGASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCccCC--CCCCHHHHHHHHHHh
Confidence            999999999988877654 8999999999999999999987554333322    222222222  258899999999999


Q ss_pred             ccCCCCCCCh----hHHhcCCccCCCCCh
Q 019433          243 VADPSKRIPI----PEIKKHPWFLKNLPK  267 (341)
Q Consensus       243 ~~dp~~R~s~----~e~l~hp~~~~~~~~  267 (341)
                      +.+|.+||++    .++++||||......
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~~  260 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSWT  260 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCHH
Confidence            9999999987    489999999765443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-48  Score=356.34  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=207.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            479999999999999999999999999999999987532   2234577899999999999999999988543      4


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|++++++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~  169 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD  169 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence            579999988 668877764 457999999999999999999999999999999999999998777  9999999987532


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----------  221 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (341)
                        .......||+.|+|||++.+....+.++|||||||++|+|++|..||........+...........           
T Consensus       170 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         170 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             --CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence              2334567899999999997754445569999999999999999999987554433333221110000           


Q ss_pred             -----ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          222 -----YFLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       222 -----~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                           ..++         .....++.+.+||.+||+.||.+|||+.+++.||||.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                 0000         0124567789999999999999999999999999997643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-49  Score=361.83  Aligned_cols=258  Identities=30%  Similarity=0.439  Sum_probs=220.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEccc-CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +-|.|+..||.|+||+||+|.++.++-..|.|++.. +....+.+.-||.++..++||+||+|++.|+..+.++|..|+|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            457899999999999999999999999999998865 3445677889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC-CCCCCCCCC
Q 019433           82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~-~~~~~~~~~  159 (341)
                      .||-....+..-+ .|++.+++-+++|++.||.|||+++|||||||..|||++.+|.  |+|+|||.+.. ........+
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcc
Confidence            9999998887744 6999999999999999999999999999999999999999998  99999998753 222233457


Q ss_pred             ccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          160 TVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       160 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      .+|||+|||||+..     ...|+.+ +||||||++|.+|..+.+|....+..+.+.++..   .....+-....++..+
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccCcchhhhHH
Confidence            89999999999865     3456555 8999999999999999999988776655544322   2222333445899999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      .|||.+||.+||..||++.++|+||||.+...
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence            99999999999999999999999999986544

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1e-47  Score=350.99  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=210.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||++.++.+++.||+|++.+..    .....+..|+.++..++||||+++++++.....+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999986421    22334678888999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      ||+.+|+|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence            99999999999977 457999999999999999999999999999999999999987776  99999999864322211 


Q ss_pred             -CCCccCCCCccccccccc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC-CCCCC
Q 019433          157 -PKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-DYVRV  230 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  230 (341)
                       ....+||+.|+|||++.+    ....+.++|||||||++|+|++|..||...+....+..+....  .....| ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~  236 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTDV  236 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCccccC
Confidence             223579999999999863    2223445999999999999999999998765444433332211  111222 23468


Q ss_pred             CHHHHHHHHHhcccCCCC--CCChhHHhcCCccCCCCC
Q 019433          231 SADCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~  266 (341)
                      ++++.+||++||+.++.+  |+++.++++||||.....
T Consensus       237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            999999999999776555  689999999999976543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.2e-48  Score=350.36  Aligned_cols=251  Identities=33%  Similarity=0.560  Sum_probs=206.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHH-HHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREI-INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei-~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.++.+++.||+|++.+..    .....+..|. .+++.++||||+++++++...+.+++||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999987532    1122334444 346778999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccC
Confidence            999999988888999999999999999999999999999999999999988776  99999999874322 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||........+..    +.......+  ..+++.+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~~--~~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLK--PNITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcCCC--CCCCHHHHHHHHHHc
Confidence            999999999988777654 8999999999999999999987554333322    222222222  368999999999999


Q ss_pred             ccCCCCCCChh----HHhcCCccCCCCChh
Q 019433          243 VADPSKRIPIP----EIKKHPWFLKNLPKE  268 (341)
Q Consensus       243 ~~dp~~R~s~~----e~l~hp~~~~~~~~~  268 (341)
                      +.||.+|+++.    ++++|+||.......
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~  261 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDD  261 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence            99999999876    899999996544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-47  Score=353.76  Aligned_cols=252  Identities=27%  Similarity=0.438  Sum_probs=201.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .+|++++.||+|+||+||+|.+..+++.||+|+....     ....|+.+++.++||||+++++++......++|||++.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            4799999999999999999999999999999985443     24579999999999999999999999999999999996


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCcc
Q 019433           83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV  161 (341)
Q Consensus        83 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  161 (341)
                      + +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.............
T Consensus       141 ~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 S-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             C-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccc
Confidence            5 77777754 457999999999999999999999999999999999999988776  9999999987433333344567


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCC-CCCCCCCh---------hHHHHHHHHHhcccccCC------
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY-PFEDPEDP---------RNFRKTIDRIRNVQYFLP------  225 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~-pf~~~~~~---------~~~~~~~~~~~~~~~~~~------  225 (341)
                      ||+.|+|||++.+..++.+ +|||||||++|+|+++.. +|......         ..+...+.........++      
T Consensus       218 gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             ccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            9999999999988877655 899999999999998544 44432211         111111111110000011      


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          226 ----------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       226 ----------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                            ....++.++.+||.+||+.||.+|||+.|+|+||||.+
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                  11245777889999999999999999999999999964

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-47  Score=338.97  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=204.0

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||+|+||.||++.++.+|+.||+|.+.....    ....+..|+.+++.++||||+++++++..+..+++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999865321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCC
Q 019433           87 FARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP  164 (341)
Q Consensus        87 ~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~  164 (341)
                      ..++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.............|++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            88876543  5889999999999999999999999999999999999988776  9999999987543333334457899


Q ss_pred             CccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhccc
Q 019433          165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA  244 (341)
Q Consensus       165 ~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (341)
                      .|+|||++.+..++.. +|+|||||++|+|++|..||....................... ....+++++.+|+.+||++
T Consensus       159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc-ccccCCHHHHHHHHHHhcc
Confidence            9999999988776554 8999999999999999999976443222222222222212111 1235899999999999999


Q ss_pred             CCCCCCCh----hHHhcCCccCCC
Q 019433          245 DPSKRIPI----PEIKKHPWFLKN  264 (341)
Q Consensus       245 dp~~R~s~----~e~l~hp~~~~~  264 (341)
                      ||.+||++    +++++||||...
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    678899999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.8e-47  Score=339.99  Aligned_cols=257  Identities=25%  Similarity=0.421  Sum_probs=214.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .|+..+.||.|+||+||++.+..+++.||+|.+....    .....+.+|+.+++.++|+||+++++.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            4889999999999999999999999999999986542    122346789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |+.+++|...+...  .++++..+..++.|++.||.|||++||+||||||+||++++++.  ++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcc
Confidence            99999998887653  36999999999999999999999999999999999999987766  999999998653333333


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...............+.......+  ..+++++.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHH
Confidence            45678999999999988777655 89999999999999999999876543333333333332222222  3688999999


Q ss_pred             HHHhcccCCCCCCC-----hhHHhcCCccCCCC
Q 019433          238 LSQIFVADPSKRIP-----IPEIKKHPWFLKNL  265 (341)
Q Consensus       238 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~~  265 (341)
                      +.+||+.||++||+     +.+++.|+||....
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            99999999999999     88999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-47  Score=347.79  Aligned_cols=248  Identities=33%  Similarity=0.548  Sum_probs=205.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHH-HHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREI-INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei-~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.+..+++.||+|++.+..    .....+..|+ .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999986532    1223344454 357889999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~~~~~g  162 (341)
                      ++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.... ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999998776  9999999987432 2223344679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......|.  ..+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQM----YDNILHKPLQLPG--GKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988777655 8999999999999999999987543222    2233333333333  57889999999999


Q ss_pred             ccCCCCCCChh----HHhcCCccCCCC
Q 019433          243 VADPSKRIPIP----EIKKHPWFLKNL  265 (341)
Q Consensus       243 ~~dp~~R~s~~----e~l~hp~~~~~~  265 (341)
                      +.||.+|+++.    ++++|+||....
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            99999999764    999999997544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-48  Score=352.48  Aligned_cols=249  Identities=32%  Similarity=0.507  Sum_probs=203.7

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL---RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      ||+|+||+||+|.++.+++.||+|++.+...    .......|..++..+   .||||+++++++.....+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            7999999999999999999999999865321    112233455555444   799999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~g  162 (341)
                      ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++..... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence            999999988889999999999999999999999999999999999999988776  99999999874322 223345679


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |+.|+|||++.+....+.++|||||||++|+|++|..||.......    ....+......++. ..+++++.+||++||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~-~~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPK-NVLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCC-ccCCHHHHHHHHHHc
Confidence            9999999998765544556999999999999999999998754432    22333333333333 247899999999999


Q ss_pred             ccCCCCCC----ChhHHhcCCccCCCCC
Q 019433          243 VADPSKRI----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       243 ~~dp~~R~----s~~e~l~hp~~~~~~~  266 (341)
                      +.||.+||    ++.++++||||.....
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~~  261 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADIDW  261 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence            99999998    7999999999976543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-47  Score=349.26  Aligned_cols=258  Identities=27%  Similarity=0.482  Sum_probs=209.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||++.++.+++.||+|++.+..    .....+..|+.+++.++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999986532    22334677889999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      ||+.||+|..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence            99999999999977 467999999999999999999999999999999999999987776  99999999864322221 


Q ss_pred             -CCCccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC-CCC
Q 019433          157 -PKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVR  229 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  229 (341)
                       .....||+.|+|||++.+     ..+ +.++|||||||++|+|++|+.||........+..+...  .....+|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~  235 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD  235 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence             123569999999999865     233 34589999999999999999999875543333322211  11122222 245


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCChhHHhcCCccCCCC
Q 019433          230 VSADCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~  265 (341)
                      ++.++.+||.+||+.++.+  |++++++++||||....
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            7899999999999976655  57999999999997644

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.2e-47  Score=343.07  Aligned_cols=259  Identities=27%  Similarity=0.447  Sum_probs=210.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||.|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57999999999999999999999999999999986532  2334677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      +.+ +|..++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....... ...
T Consensus        86 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          86 LDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCccc
Confidence            975 88887765 346899999999999999999999999999999999999998776  9999999986432221 223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|.+||...+...............               ...
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            45678999999998765544556999999999999999999998765433332222211100               001


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+.         ...+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            111         12478899999999999999999999999999999544

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=332.37  Aligned_cols=252  Identities=32%  Similarity=0.443  Sum_probs=211.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++..+...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999999865321      22457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |+||+++++|.+.+...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence            9999999999999988888999999999999999999999999999999999999987776  99999999864322111


Q ss_pred             ----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                          .....|+..|+|||++.+..++. ++||||||+++|+|++|+.||...+.......    .............++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGR-KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCc-hhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence                12356788999999998877654 48999999999999999999987554333222    1111111222236889


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+.++|.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.9e-47  Score=336.91  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=211.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||.||+|.++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            58999999999999999999999999999999886532   233567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |+++++|..++.....+++..++.++.||+.||.|||++|++||||||+||++++++.  ++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCccccc
Confidence            9999988888777778999999999999999999999999999999999999988776  9999999987533222 223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...++..|+|||++.+....+.++|+|||||++|+|++|.+||...................               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            44678899999998765444455999999999999999999998766544433322211100               000


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+.          ...++..+.+||.+||+++|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            010          13568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-49  Score=378.64  Aligned_cols=265  Identities=32%  Similarity=0.495  Sum_probs=224.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|.|++.||+|+||.|.+++++.|++.||+|++.+.    +....-+..|-.+|.--+.+.|+.++..|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            5799999999999999999999999999999998872    223344666777887778999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      ||++||+|..++.+..++++..++.++..|+.||..||+.|+|||||||+|||+|..|+  |||+|||.+-.....+.  
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEE
Confidence            99999999999999889999999999999999999999999999999999999998888  99999998754332222  


Q ss_pred             CCCccCCCCcccccccc----c-cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 PKSTVGTPAYIAPEVLA----R-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~----~-~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ....+|||.|.+||++.    + +.| ++-+|+||+||++|||+.|..||....-...+.+++..  ...+.+|....+|
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~y-G~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~VS  309 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEY-GRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDVS  309 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCcccc-CCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCcccccC
Confidence            34568999999999986    2 344 44499999999999999999999875555555555444  2355667667899


Q ss_pred             HHHHHHHHHhcccCCCCCCC---hhHHhcCCccCCCCChhHHHHH
Q 019433          232 ADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKNLPKEIIEIE  273 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~~~~~~~  273 (341)
                      .++++||.++|+ +|..|..   ++++..||||.+..+..+....
T Consensus       310 eeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~  353 (1317)
T KOG0612|consen  310 EEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESV  353 (1317)
T ss_pred             HHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcC
Confidence            999999999985 7888998   9999999999887776555443

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-48  Score=303.16  Aligned_cols=260  Identities=27%  Similarity=0.482  Sum_probs=220.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+|..+++||+|.||+||+|++..+++.||+|.++-..   ......++||.+++.++|.|||+++++..+++.+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            47889999999999999999999999999999987543   345689999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~  157 (341)
                      ||.. +|..+... ++.++.+.++.++.|+++||.++|++++.|||+||.|++|+.+|.  +||+|||+++... +....
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy  158 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence            9976 78777765 557999999999999999999999999999999999999999888  9999999998533 33344


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc-cC------CCC--
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY-FL------PDY--  227 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------~~~--  227 (341)
                      ...+.|.+|++|.++.|...++...|+||.||++.|+.. |++.|.+.+-..++.++...+..... .+      |++  
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            556789999999999998877777999999999999986 88888887777777777665543221 11      111  


Q ss_pred             --------------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          228 --------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       228 --------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                    .+++...++|++++|.-+|.+|+|++.+++||||....
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                          22345568999999999999999999999999996543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-47  Score=353.42  Aligned_cols=256  Identities=25%  Similarity=0.342  Sum_probs=207.3

Q ss_pred             CCCccccceecccCCeEEEEEEEc--CCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ..+|++++.||+|+||.||+|...  .++..||+|.+...    ....+|+.+++.++||||+++++++......++|||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            457999999999999999999764  45788999987653    345689999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---C
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~  156 (341)
                      ++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++.......   .
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence            996 588888877778999999999999999999999999999999999999988776  9999999986433221   1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHHHHHhcccc-----------
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---PRNFRKTIDRIRNVQY-----------  222 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-----------  222 (341)
                      .....||+.|+|||++.+..+..+ +|||||||++|+|++|..||.....   ...+..++..+.....           
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            234579999999999988777655 8999999999999999999976432   2222222222111110           


Q ss_pred             --------------cCCC---CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          223 --------------FLPD---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       223 --------------~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                    ..+.   ...++.++.+||.+||..||++|||+.++|.||||.+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                          0111   023567889999999999999999999999999996643

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.1e-46  Score=336.64  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=206.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .|++++.||+|++|.||+|.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++..+..+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5899999999999999999999999999999986532   2335678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CC
Q 019433           81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~  156 (341)
                      +. ++|..++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++...... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 4888877543   46899999999999999999999999999999999999998776  999999998643222 12


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc--------------ccc
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------------VQY  222 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~  222 (341)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|++||..................              ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            234467899999999876554445699999999999999999999875543332222211100              000


Q ss_pred             cC---------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          223 FL---------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       223 ~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..         .....+++++.+||++||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00         0123478999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-46  Score=342.19  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=193.2

Q ss_pred             cceecccCCeEEEEEEEc--CCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEEEEeecCC
Q 019433            8 VKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAG   83 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~iv~e~~~~   83 (341)
                      .++||+|+||+||+|.++  .+++.||+|.+.... ....+.+|+.+++.++||||+++++++..  +..++++|||+.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            468999999999999976  467899999987543 34567899999999999999999999864  4678999999965


Q ss_pred             CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC--CCCCEEEeecCCccCCC
Q 019433           84 GELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGL  152 (341)
Q Consensus        84 ~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~--~~~~ikL~Dfg~a~~~~  152 (341)
                       +|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||++..  ....+||+|||+++...
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence             777776432         258999999999999999999999999999999999999532  22359999999997432


Q ss_pred             CC----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh---------hHHHHHHHHHh-
Q 019433          153 LH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIR-  218 (341)
Q Consensus       153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~---------~~~~~~~~~~~-  218 (341)
                      ..    .......||+.|+|||++.+....+.++|||||||++|+|++|.+||......         ..+..+..... 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            21    12234678999999999987654456699999999999999999999754321         11111111000 


Q ss_pred             ----------ccc-------------cc--------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          219 ----------NVQ-------------YF--------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       219 ----------~~~-------------~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                ...             ..        .......+..+.+||.+||++||.+|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                      000             00        00011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-46  Score=359.75  Aligned_cols=253  Identities=27%  Similarity=0.404  Sum_probs=210.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCC-CcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ..|.+.+.||+|+||.||+|....+ ++.||+|.+.... .....+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3599999999999999999999877 7889999875433 2234567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           81 AAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        81 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      +++|+|..++..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccc
Confidence            999999887753    346899999999999999999999999999999999999998776  9999999987532221 


Q ss_pred             --CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                        .....+||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..    +..... .+....++++
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~----~~~~~~-~~~~~~~s~~  298 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSK-KADMWSLGVILYELLTLHRPFKGPSQREIMQQ----VLYGKY-DPFPCPVSSG  298 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCC-CCCCccCCHH
Confidence              234557999999999998877755 48999999999999999999987554332222    222111 1222368899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +.+||.+||..||++|||+.+++.|||+..
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999999843

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.8e-47  Score=337.86  Aligned_cols=255  Identities=27%  Similarity=0.491  Sum_probs=205.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ||++++.||+|+||.||+|.++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.+...+++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            7999999999999999999999999999999986532   2234677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      +.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++...... ....
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence            975 77777654 567999999999999999999999999999999999999998776  999999998743222 2223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHHhcc------------cc-cC
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV------------QY-FL  224 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~------------~~-~~  224 (341)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|..||....+. ..+..+.......            .. ..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            4567899999999877654455699999999999999998886544332 2222221111000            00 00


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 ----------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 ----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                .....+++++.+||.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                      0112478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.2e-48  Score=353.18  Aligned_cols=257  Identities=40%  Similarity=0.654  Sum_probs=230.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .-|.+.+.||+|.|++|.++++..|+..||||++.++..   ....+.+|++++..|+|||||+++.+......+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            468999999999999999999999999999999988643   23457899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+.+|.+++++.+.+++.+..++.++.|+++|++|||+++|+|||||++|||++.+.+  +||+|||++..........+
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999998877  99999999998888888899


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .+|++.|.|||++.+..|++..+|+||||+++|.|+.|.+||.+..-    ...........+.+|.  -++.++.++|+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----k~Lr~rvl~gk~rIp~--~ms~dce~lLr  287 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----KELRPRVLRGKYRIPF--YMSCDCEDLLR  287 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc----ccccchheeeeecccc--eeechhHHHHH
Confidence            99999999999999999999889999999999999999999987442    2333333344455554  58899999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +||.++|.+|++.+++.+|.|.......
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999998654443

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-46  Score=332.91  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=208.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC------CEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTP------THL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~------~~~   74 (341)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++.+ +||||+++++++...      ..+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            4789999999999999999999999999999999987665566788999999888 699999999998753      468


Q ss_pred             EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      +++|||+.+++|..++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~  162 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecc
Confidence            9999999999999998764  36899999999999999999999999999999999999998776  9999999987432


Q ss_pred             CC-CCCCCccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          153 LH-SQPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       153 ~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      .. .......|++.|+|||++.+     ..++ .++|+|||||++|+|++|..||...........    ..........
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~  237 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLK  237 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCC-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCC
Confidence            21 22344578999999999863     2343 448999999999999999999976443222211    1111111122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ...++..+.+||.+||..||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         238 SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            23578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.7e-46  Score=334.37  Aligned_cols=252  Identities=37%  Similarity=0.631  Sum_probs=215.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            57999999999999999999999999999999987532    23456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.  +||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence            99999999999988889999999999999999999999999999999999999988776  999999998753322  44


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...|++.|+|||.+.+...+ .++||||||+++|+|++|..||...........    +......+|.  .++..+.++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~--~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK----ILEGKVRFPS--FFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCccCCc--cCCHHHHHHH
Confidence            55789999999998777655 448999999999999999999977553222222    2222333333  5789999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      .+||+.||.+|+     +++++++||||....
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            999999999999     999999999996544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.8e-46  Score=332.47  Aligned_cols=255  Identities=25%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            57999999999999999999999999999999986542  2234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      +++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||++.... .......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~-~~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLV-NSIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecc-cccccCC
Confidence            999998654    35889999999999999999999999999999999999998776  9999999987432 2233456


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH---HHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN---FRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .||..|+|||++.+..++.+ +|+|||||++|+|++|..||........   .....................++++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            78999999999988777554 8999999999999999999965332111   1111111111111111123478899999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.+||+.+|.+||+++++++||||....
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCccccccc
Confidence            9999999999999999999999996653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.2e-47  Score=361.52  Aligned_cols=255  Identities=28%  Similarity=0.406  Sum_probs=210.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT------   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------   72 (341)
                      .+||++.+.||+|+||+||+|.+..+++.||||++.....   ....+.+|+..+..++|+||+++++.+....      
T Consensus        31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~  110 (496)
T PTZ00283         31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN  110 (496)
T ss_pred             CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence            4799999999999999999999999999999999865432   2345778999999999999999998875432      


Q ss_pred             --EEEEEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           73 --HLAIVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        73 --~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                        .+++||||+.+|+|.+++...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||
T Consensus       111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFG  188 (496)
T PTZ00283        111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFG  188 (496)
T ss_pred             ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecc
Confidence              378999999999999988652    46899999999999999999999999999999999999998776  9999999


Q ss_pred             CccCCCC---CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          147 YSKSGLL---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       147 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      +++....   .......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+.    ....... 
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~~----~~~~~~~-  262 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVMH----KTLAGRY-  262 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHhcCCC-
Confidence            9864321   122345679999999999988777654 899999999999999999998654332222    2222111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+....+++++.+|+.+||+.||.+|||+.++++|||+...
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            12234689999999999999999999999999999998543

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-46  Score=353.77  Aligned_cols=253  Identities=22%  Similarity=0.290  Sum_probs=201.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||...     .....+|+.+++.|+|||||++++++...+..++||+++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            357999999999999999999999999999999633     234678999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---CC
Q 019433           82 AGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~  157 (341)
                      . ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||+++......   ..
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~  319 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFH  319 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccc
Confidence            6 5888877654 46999999999999999999999999999999999999987776  9999999987432211   12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCC-C------hhHHHHHHHHHhccc---------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-D------PRNFRKTIDRIRNVQ---------  221 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~-~------~~~~~~~~~~~~~~~---------  221 (341)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..|+.... .      ...+.+++.......         
T Consensus       320 ~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        320 YGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             cccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            23569999999999988877654 899999999999999876543221 1      122222222211000         


Q ss_pred             -----------------cc---CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          222 -----------------YF---LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       222 -----------------~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                       ..   +..+..++.++.+||.+||++||.+|||+.|+|+||||..
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                             00   1111245678999999999999999999999999999953

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.3e-46  Score=336.87  Aligned_cols=256  Identities=30%  Similarity=0.509  Sum_probs=211.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||.||++.+..++..+|+|.+....  .....+.+|+.+++.++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            47999999999999999999999999999999986542  2234578899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      +++++|..++.+.+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.  ++|+|||++.... ......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCccccc-cccccc
Confidence            9999999999888889999999999999999999998 69999999999999988776  9999999986432 223345


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHH-----------------------
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR-----------------------  216 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~-----------------------  216 (341)
                      ..|++.|+|||.+.+..+..+ +|+|||||++|+|++|..||...+. ......+..                       
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            678999999999877766544 8999999999999999999965432 111111110                       


Q ss_pred             ----------Hhc-ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          217 ----------IRN-VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       217 ----------~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                ... .....|. ..++.++.+|+.+||..+|++|||+.++++||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                      000 0000111 1367889999999999999999999999999999664

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-46  Score=372.98  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=211.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~i   76 (341)
                      -++|++++.||+|+||+||+|.+..++..||+|++....   .....+..|+.+++.|+|||||+++++|..  ...+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            368999999999999999999999999999999987532   233467889999999999999999998854  467999


Q ss_pred             EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeeCCCCCCCEEecCC----------
Q 019433           77 VMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSM-------EICHRDLKLENTLLDGS----------  135 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-------~iiHrDikp~Nili~~~----------  135 (341)
                      ||||+.+++|..++..    ...+++..++.|+.||+.||.|||+.       +|+||||||+||||+..          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999998865    25799999999999999999999985       49999999999999642          


Q ss_pred             -----CCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhH
Q 019433          136 -----PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN  209 (341)
Q Consensus       136 -----~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~  209 (341)
                           +...+||+|||++.............||+.|+|||++.+.. ..+.++||||||||||+|++|..||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                 23348999999997544333445567999999999986432 223458999999999999999999987655443


Q ss_pred             HHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          210 FRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +...+   .... .++ ....+.++.+||..||+++|.+|||+.++|.|||+....
T Consensus       252 li~~l---k~~p-~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        252 LISEL---KRGP-DLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHH---hcCC-CCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            33222   2111 111 235789999999999999999999999999999996543

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.5e-46  Score=328.56  Aligned_cols=254  Identities=30%  Similarity=0.451  Sum_probs=212.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++.+.||.|+||+||+|....++..+|+|++....  .....+.+|+..++.++||||+++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            57999999999999999999999899999999986533  2345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      +++++|..++...   ..+++..++.++.|++.||.|||++|++||||+|+||++++++.  ++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence            9999999999764   45899999999999999999999999999999999999998766  99999998864332221 


Q ss_pred             ----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC---CCC
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD---YVR  229 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  229 (341)
                          .....|+..|+|||++......+.++|+|||||++|+|++|..||........+.+....   .....+.   +..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence                233468899999999877634445599999999999999999999876554433333222   1111111   236


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +++.+.+++.+||..||.+|||+.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.5e-46  Score=346.26  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=209.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------   71 (341)
                      +.++|++++.||+|+||+||+|.+..+++.||||.+.+..   .....+.+|+.+++.++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3578999999999999999999999999999999986532   2234677899999999999999999998654      


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ...|+||||+.+ +|...+...  +++..+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||++...
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~  168 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA  168 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeC
Confidence            357999999965 787777544  899999999999999999999999999999999999998776  999999999754


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------  220 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (341)
                      ..........+++.|+|||.+.+..+..+ +|||||||++|+|++|..||...+....+.++.......           
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            43333445678999999999988777655 899999999999999999998765444333332211100           


Q ss_pred             --------c-c-------cCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          221 --------Q-Y-------FLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       221 --------~-~-------~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                              . .       ..+.          ....+..+.+||.+||+.||++|||+.++|.||||..+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                    0 0       0000          1124567899999999999999999999999999976554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.4e-46  Score=332.72  Aligned_cols=256  Identities=28%  Similarity=0.444  Sum_probs=212.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++.+.||.|+||.||+|.+..+|+.||+|++....   .....+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            6999999999999999999999999999999987543   2345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      + +++|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++.......  ..
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence            9 9999998865 456999999999999999999999999999999999999998766  9999999987543322  13


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc---------------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------------  222 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  222 (341)
                      ....|+..|+|||++.+....+.++|||||||++|+|++|.+||....+...+............               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            34578999999999876655556699999999999999999888776655444443332211100               


Q ss_pred             cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          223 FLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       223 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ..+         .....+..+.+||++||..+|.+|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000         0124678899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=341.01  Aligned_cols=243  Identities=28%  Similarity=0.442  Sum_probs=208.9

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      ++.++.||+|.||.||++..+. ...||+|.+.......+.+.+|+++|++|+|+|||++++++..+..+||||||++.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            4678999999999999999973 447999999887777788999999999999999999999999999999999999999


Q ss_pred             chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           85 ELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        85 ~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      +|.+++..  ...+...+...++.||++|++||+++++|||||-..||||+.+..  +||+|||+|+. ..........|
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~-~~d~~Y~~~~~  363 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARL-IGDDEYTASEG  363 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccc-cCCCceeecCC
Confidence            99999987  457999999999999999999999999999999999999998876  99999999993 22222222222


Q ss_pred             ---CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          163 ---TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       163 ---t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                         ...|.|||.+....++.+ |||||||++||||+| |+.||....+.+.+..+     ...+.+|.+...|+++.+++
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-----e~GyRlp~P~~CP~~vY~lM  437 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-----ERGYRLPRPEGCPDEVYELM  437 (468)
T ss_pred             CCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-----hccCcCCCCCCCCHHHHHHH
Confidence               345999999999998876 999999999999998 99999887765444332     23455677778999999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..|+..+|++|||++.+..
T Consensus       438 ~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHhhCCcccCCCHHHHHH
Confidence            9999999999999986543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.1e-46  Score=329.88  Aligned_cols=254  Identities=30%  Similarity=0.447  Sum_probs=208.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            689999999999999999999999999999999875432 2345778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  160 (341)
                      ++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++...... ......
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccc
Confidence            99999999988889999999999999999999999999999999999999987776  999999998643221 122345


Q ss_pred             cCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          161 VGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       161 ~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .|++.|+|||++.   ...++ .++|+|||||++|+|++|..||............... ............++..+.++
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS-NFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cCcccccChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-CCCCCcccccCCCCHHHHHH
Confidence            7899999999974   23343 4589999999999999999999764432222111110 00011111223578899999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~  260 (341)
                      |.+||+.+|++|||+.++++|||
T Consensus       245 i~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-46  Score=342.10  Aligned_cols=248  Identities=23%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC-CE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP-TH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~-~~   73 (341)
                      +||++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+|+.+++.+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            6899999999999999999975     24567899999875432  234688899999999 899999999988764 46


Q ss_pred             EEEEEeecCCCchHHHHHhc------------------------------------------------------------
Q 019433           74 LAIVMEYAAGGELFARICSA------------------------------------------------------------   93 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~------------------------------------------------------------   93 (341)
                      ++++|||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999888642                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---CCCCccCCCCccc
Q 019433           94 --GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIA  168 (341)
Q Consensus        94 --~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~a  168 (341)
                        .++++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......   ......+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccccC
Confidence              24778889999999999999999999999999999999987776  9999999987432211   1123345678999


Q ss_pred             cccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019433          169 PEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS  247 (341)
Q Consensus       169 PE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  247 (341)
                      ||++.+..++.+ +|||||||++|+|++ |..||........+...+   .... ..+.....++.+.+|+.+||+.||.
T Consensus       245 PE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL---KDGT-RMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---hcCC-CCCCCCCCCHHHHHHHHHHccCChh
Confidence            999988777655 899999999999997 999998755433322222   1111 1122236789999999999999999


Q ss_pred             CCCChhHHhc
Q 019433          248 KRIPIPEIKK  257 (341)
Q Consensus       248 ~R~s~~e~l~  257 (341)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-47  Score=338.93  Aligned_cols=257  Identities=29%  Similarity=0.446  Sum_probs=225.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|+.-+.||+|+||.||-|+...||+-||+|.+.+.+    ....-.+.|-+++..++.|.||.+-..|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56888999999999999999999999999999987643    33445788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ..|.||+|.-.|.+.+  .|++..++.++.+|+.||.+||..+||.||+||+|||+|+.|+  ++|+|+|+|........
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence            9999999988887765  7999999999999999999999999999999999999998888  99999999987666666


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||.+|||||++.+..|+.. .|+|||||+||+|+.|+.||.....-....++-..+......+++  .+|+++++
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eaks  419 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKS  419 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHH
Confidence            777899999999999999998765 799999999999999999998755433333444444555555554  79999999


Q ss_pred             HHHHhcccCCCCCC-----ChhHHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRI-----PIPEIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~  264 (341)
                      +++.+|++||++|.     .++++.+||||...
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence            99999999999998     67899999999663

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-46  Score=336.46  Aligned_cols=255  Identities=35%  Similarity=0.548  Sum_probs=214.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+.....    ....+..|+.+++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            589999999999999999999999999999999876432    2345788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           79 EYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||+.+++|..++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence            999999999998764  46999999999999999999999999999999999999998776  9999999876422111 


Q ss_pred             -----------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 019433          156 -----------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED  206 (341)
Q Consensus       156 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~  206 (341)
                                                   ......||..|+|||++.+..++. ++||||||+++|+|++|..||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         111346888999999998777654 58999999999999999999987665


Q ss_pred             hhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----hhHHhcCCccCCC
Q 019433          207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP----IPEIKKHPWFLKN  264 (341)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s----~~e~l~hp~~~~~  264 (341)
                      ...+....    ......+....++..+.++|.+||+.||++|||    +++++.||||.+.
T Consensus       238 ~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSNIL----KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHHh----cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            44443322    223334444447999999999999999999999    9999999999654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-45  Score=326.89  Aligned_cols=250  Identities=33%  Similarity=0.505  Sum_probs=209.5

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----------cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----------DENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      ||.+.+.||.|+||.||+|.+..+++.+|+|.+......          .+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            689999999999999999999999999999988653221          2357789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .+++|||+++++|..++...+.+++..++.++.|++.||.|||++|++||||+|+||++++++.  ++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988888999999999999999999999999999999999999987776  99999999874331


Q ss_pred             CC-------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          154 HS-------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       154 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      ..       ......|+..|+|||.+.+..++.. +|+|||||++|+|++|..||..............   ......  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~--  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASPEI--  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCCcC--
Confidence            11       1123457889999999987776554 8999999999999999999987654333222111   111112  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ...++..+.++|++||+.||.+||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            23578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-45  Score=329.87  Aligned_cols=261  Identities=30%  Similarity=0.427  Sum_probs=213.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +-|++++.||.|+||.||++.+..++..+++|.+.... ...+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            45799999999999999999999999999999986543 33456778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      ++++|...+.+ ..++++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... .....
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence            99999888765 457999999999999999999999999999999999999988776  999999998643221 12234


Q ss_pred             ccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          160 TVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ..+++.|+|||++..     ..++ .++|+|||||++|+|++|.+||..............   ......+....++.++
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  238 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHH
Confidence            568999999999842     2333 459999999999999999999987554333222211   1111222334688999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      .+||.+||+.||.+|||+.++++||||.......+
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  273 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI  273 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEeccCCCCH
Confidence            99999999999999999999999999976655443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=328.14  Aligned_cols=257  Identities=30%  Similarity=0.457  Sum_probs=215.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++.+.||.|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            58999999999999999999999999999999987543  2234678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      +++++|..++... ++++..++.++.|++.||.|||+++++||||+|+||++++++.  ++|+|||++...... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998765 8999999999999999999999999999999999999998776  999999998754332 22344


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..+++.|+|||.+.+..++. ++|||||||++|+|++|..||.............   .......+. ..++.++.+++.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~-~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~l~  232 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDE-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---KNNPPSLEG-NKFSKPFKDFVS  232 (274)
T ss_pred             ccCCccccChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh---hcCCCCCcc-cccCHHHHHHHH
Confidence            57888999999998877654 4999999999999999999997654322221111   111111222 127889999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +||..+|.+|||++++++||||.+....
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            9999999999999999999999776554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=342.06  Aligned_cols=263  Identities=28%  Similarity=0.444  Sum_probs=207.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~   73 (341)
                      +.++|++.+.||+|+||.||+|.+..+|+.||+|.+...  ......+.+|+.+++.++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            468999999999999999999999999999999998642  23345677899999999999999999987644     35


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .++++||+.+ +|...+. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.....
T Consensus        83 ~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~  158 (336)
T cd07849          83 VYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADP  158 (336)
T ss_pred             EEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccc
Confidence            8999999975 7777664 457999999999999999999999999999999999999988776  99999999864322


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc----------
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------  219 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------  219 (341)
                      ..    ......||+.|+|||++.+....+.++|||||||++|+|++|+.||..................          
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            11    1123568999999998765443445699999999999999999999765432222211111000          


Q ss_pred             ----------ccc--cCC---CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          220 ----------VQY--FLP---DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       220 ----------~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                                ...  ..+   ....+++++.+|+.+||+.+|.+|||+.++++||||......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                      000  000   012467889999999999999999999999999999776543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=318.31  Aligned_cols=253  Identities=29%  Similarity=0.431  Sum_probs=207.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----THLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~~~   75 (341)
                      ++||++.++||+|||+.||++.+..++..||+|++.... ...+...+|+...+.++||||++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            689999999999999999999999999999999988765 5566899999999999999999999876543     4599


Q ss_pred             EEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           76 IVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ++++|...|+|.+.+...    ..+++.++..|+.+|++||++||+..  ++||||||.||++.+++.  ++|.|||.++
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~  177 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSAT  177 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCcc
Confidence            999999999999888653    26999999999999999999999999  999999999999988676  9999999987


Q ss_pred             CCCCCCCCC----------CccCCCCcccccccccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHH
Q 019433          150 SGLLHSQPK----------STVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       150 ~~~~~~~~~----------~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      .....-...          ....|..|+|||.+.-...  -+.++|||||||+||.|+.|..||........  ...-.+
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv  255 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAV  255 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEee
Confidence            433222111          1236888999999864332  24558999999999999999999964211000  001112


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.++.+|....+|..+.+||++||+.||.+||++.+++.+
T Consensus       256 ~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  256 QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            34566678878899999999999999999999999999875

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.2e-46  Score=334.51  Aligned_cols=260  Identities=30%  Similarity=0.428  Sum_probs=212.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ||++.+.||.|+||.||+|.+..+++.||||.+.....      ....+..|+.+++.++||||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            69999999999999999999999999999999876432      234567899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-C
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~  155 (341)
                      |||+ +++|..++.... .+++..++.++.||++||.|||++|++||||+|+||+++.++.  ++|+|||++...... .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence            9999 889999997766 7999999999999999999999999999999999999998776  999999998753322 2


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-------cC----
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------FL----  224 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~----  224 (341)
                      ......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||....+...+............       ..    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2233457888999999866554455699999999999999998888776655444443322111000       00    


Q ss_pred             -----------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          225 -----------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       225 -----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                                 ......+..+.+||.+||.+||++|||+.+++.||||.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                       001245788999999999999999999999999999977643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.7e-46  Score=340.06  Aligned_cols=255  Identities=24%  Similarity=0.397  Sum_probs=201.0

Q ss_pred             cccceeccc--CCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            6 EPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         6 ~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +++++||+|  +||+||++.++.+|+.||+|.+....   ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            467899999  78899999999999999999987543   2234677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      +++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++++||+.+.......   
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccc
Confidence            9999999998653  45899999999999999999999999999999999999988776  9999998653211111   


Q ss_pred             -----CCCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--------
Q 019433          156 -----QPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------  220 (341)
Q Consensus       156 -----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  220 (341)
                           ......++..|+|||++.+.  .++ .++|||||||++|+|++|..||...................        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                 11223567789999998763  344 45899999999999999999997654332222211100000        


Q ss_pred             --c------------------------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          221 --Q------------------------------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       221 --~------------------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                        .                              ...+....+++.+.+||.+||+.||++|||+.++++||||.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence              0                              000011235778999999999999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.9e-46  Score=342.16  Aligned_cols=261  Identities=30%  Similarity=0.477  Sum_probs=209.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----C
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTP-----T   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~   72 (341)
                      +.++|++.+.||+|+||+||+|.+..+++.||||.+...   ......+.+|+.+++.++||||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            578999999999999999999999999999999998653   22334677899999999999999999988654     3


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..++|+||+. ++|..++....++++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++....
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~  159 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTS  159 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccC
Confidence            5899999996 589899888888999999999999999999999999999999999999988776  9999999987543


Q ss_pred             CC-CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh-------------
Q 019433          153 LH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------  218 (341)
Q Consensus       153 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------  218 (341)
                      .. .......++..|+|||.+.+....+.++|||||||++|+|++|.+||...+....+........             
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence            22 2223456888999999987543344569999999999999999999976543222221111000             


Q ss_pred             -------ccccc-----CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          219 -------NVQYF-----LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       219 -------~~~~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                             .....     ......+++++.+||++||+.+|++|||+.++++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                   00000     00123578999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5e-46  Score=329.31  Aligned_cols=252  Identities=29%  Similarity=0.432  Sum_probs=207.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999999999999999999987543 2334577899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      +++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....... ....
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence            999999999988888999999999999999999999999999999999999987776  9999999987432221 2234


Q ss_pred             ccCCCCccccccccc---cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc---CCCCCCCCHH
Q 019433          160 TVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF---LPDYVRVSAD  233 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~  233 (341)
                      ..|++.|+|||.+.+   ..+ +.++|+|||||++|+|++|..||...........    .......   .+....++..
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhhee----eecCCCCCCCCccccccCHH
Confidence            568899999999853   223 3458999999999999999999965432211111    1111111   1122357889


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~  260 (341)
                      +.+||++||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=326.13  Aligned_cols=260  Identities=36%  Similarity=0.586  Sum_probs=227.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH----HHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE----NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|..++.||+|.||+|-+|+.+.+++.||||++++.....+    ..+.|-++++..+||.+..+...|..++.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            568899999999999999999999999999999988543332    3556888999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      ||..||.|+-.+.+...|++...+.+-..|+.||.|||+++||.||+|.+|+|+|.+|+  |||.|||+++.... ....
T Consensus       248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~  325 (516)
T KOG0690|consen  248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTT  325 (516)
T ss_pred             EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhccccccee
Confidence            99999999999999999999999999999999999999999999999999999999988  99999999986543 3445


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      .+.||||.|+|||++....|.. +.|+|.+|||+|+|++|+.||...+....+.-    +......+|.  .+|++++.|
T Consensus       326 kTFCGTPEYLAPEVleDnDYgr-aVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL----Il~ed~kFPr--~ls~eAktL  398 (516)
T KOG0690|consen  326 KTFCGTPEYLAPEVLEDNDYGR-AVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL----ILMEDLKFPR--TLSPEAKTL  398 (516)
T ss_pred             ccccCChhhcCchhhccccccc-eeehhhhhHHHHHHHhccCcccccchhHHHHH----HHhhhccCCc--cCCHHHHHH
Confidence            6789999999999999888864 58999999999999999999988766544433    3333444565  799999999


Q ss_pred             HHHhcccCCCCCC-----ChhHHhcCCccCCCCChhHHH
Q 019433          238 LSQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE  271 (341)
Q Consensus       238 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~~~~  271 (341)
                      +..+|.+||.+|.     .+.|+.+|+||..........
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~  437 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYR  437 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHH
Confidence            9999999999998     689999999998776655443

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.1e-46  Score=332.14  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=210.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||+||+|.+..++..||+|.+....  .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            57999999999999999999999999999999886532  2235688899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           81 AAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +++++|..++...   ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.  ++|+|||++.... ...
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~-~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLV-ASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC--EEEeecCCccccc-CCc
Confidence            9999998888763   379999999999999999999997 69999999999999988666  9999999986432 223


Q ss_pred             CCCccCCCCcccccccccccc-----CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-ccccCCCCCCC
Q 019433          157 PKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRV  230 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  230 (341)
                      .....+++.|+|||.+.+...     .+.++|+|||||++|+|++|..||.......... .+..+.. .....+  ..+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~--~~~  234 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-QLSAIVDGDPPTLP--SGY  234 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-HHHHHhhcCCCCCC--ccc
Confidence            344568889999999865432     2445899999999999999999997644332222 2222221 112222  258


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.++.+||.+||+.+|.+||++.+++.||||....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            89999999999999999999999999999995543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-45  Score=331.16  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=213.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ..+|++++.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++.+......++||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            478999999999999999999999999999999987543 2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      +++++|..++.+ ..+++.++..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....... ....
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCc
Confidence            999999998854 46899999999999999999999999999999999999987776  9999999886432221 1233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..|++.|+|||.+.+..++. ++|||||||++|+|++|..||........+..   .........+....++..+.+|+.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             ccCCccccCHHHHcCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---HhcCCCCCCCCccccCHHHHHHHH
Confidence            57889999999998776654 49999999999999999999976554322221   111122222233468899999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +||.++|++|||+.++++||||...
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.6e-46  Score=328.55  Aligned_cols=252  Identities=29%  Similarity=0.523  Sum_probs=214.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +|++.+.||.|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5899999999999999999999999999999987543    234578889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+.+++|..++....++++..+..++.||+.||.|||++|++|+||+|+||++++++.  ++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999999988778999999999999999999999999999999999999998776  99999999875444434445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..|+..|+|||.+.+..+..+ +|+||||+++|+|++|..||...... ................+  ..++..+.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADVLYP--ATWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccccCc--ccCcHHHHHHHH
Confidence            678889999999987776544 99999999999999999999876541 11122222221222222  367899999999


Q ss_pred             HhcccCCCCCCCh--hHHhcCCcc
Q 019433          240 QIFVADPSKRIPI--PEIKKHPWF  261 (341)
Q Consensus       240 ~~L~~dp~~R~s~--~e~l~hp~~  261 (341)
                      +||..||.+||++  .++++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.2e-45  Score=329.63  Aligned_cols=259  Identities=28%  Similarity=0.408  Sum_probs=210.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +++|++++.||.|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++..++.+++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            568999999999999999999999999999999987543 2345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      +++++|..++.+ ...+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... ....
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccc
Confidence            999999887755 456899999999999999999999999999999999999987776  999999987642221 1223


Q ss_pred             CccCCCCccccccccccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          159 STVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ...+++.|+|||++.+..    ..+.++|+|||||++|+|++|..||............   ........+....++.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI---AKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH---hcCCCccCCCCcccCHHH
Confidence            456889999999985322    1234589999999999999999999765432222111   111111222334678899


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .++|.+||..+|.+||++.++++||||....
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            9999999999999999999999999996543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-45  Score=329.63  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=212.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||.|+||.||++.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            368999999999999999999999899999999986543 2334677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      +++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....... ...
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccc
Confidence            9999999988764 47999999999999999999999999999999999999988776  9999999876432221 223


Q ss_pred             CccCCCCccccccccccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-cccCCCCCCCCHH
Q 019433          159 STVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSAD  233 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~  233 (341)
                      ...+++.|+|||++....    ..+.++|+|||||++|+|++|.+||...........    +... ...+.....++.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  237 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWSSS  237 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCCHH
Confidence            456899999999975322    223458999999999999999999987544332222    2211 1112222367899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.++|.+||+.+|.+|||+.++++||||.+..
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence            99999999999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.2e-45  Score=324.42  Aligned_cols=253  Identities=28%  Similarity=0.449  Sum_probs=212.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +++|++.+.||.|+||.||++.+..+++.+|+|.+..... .+.+.+|+.+++.++||||+++++++......|+++||+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            4789999999999999999999998899999999876543 667889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      .+++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||++++++.  ++|+|||++....... ....
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence            99999999875 447899999999999999999999999999999999999998776  9999999987533222 2234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..++..|+|||++.+..++.+ +||||||+++|+|++|..||............   .............++.++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---ccCCCCCCCchhhcCHHHHHHHH
Confidence            458889999999988776554 89999999999999999999765432221111   01111112222357789999999


Q ss_pred             HhcccCCCCCCChhHHhcCCcc
Q 019433          240 QIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +||+.||.+|||+.+++.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.2e-45  Score=329.25  Aligned_cols=253  Identities=29%  Similarity=0.464  Sum_probs=203.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCC-CCCeeeEEEEEEcC--CEEEEEEe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTP--THLAIVME   79 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~--~~~~iv~e   79 (341)
                      |++++.||+|+||.||+|.+..+++.||+|.+.....  ......+|+.+++.+. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7899999999999999999999999999999876422  2224457888888885 99999999999987  88999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+.+ +|...+.. ...+++..++.++.|++.||.|||++|++||||+|+||+++. +.  +||+|||++..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI--LKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC--eEEEecccccccccCCCcC
Confidence            9975 77777765 357899999999999999999999999999999999999997 54  9999999987544333334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc--------------ccccC
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------------VQYFL  224 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~  224 (341)
                      ...+++.|+|||.+......+.++|||||||++|+|++|.+||...+....+.........              ..+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            4568899999998765554455699999999999999999999876544333322221100              01111


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 PD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 ~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.         ...++..+.+||.+||.++|++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11         12468899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.4e-45  Score=329.53  Aligned_cols=258  Identities=27%  Similarity=0.454  Sum_probs=213.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||+||++.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            68999999999999999999999999999999876542  3345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      +++++|..++...+.+++..++.++.+++.||.|||+ ++++||||||+||+++.++.  ++|+|||++.... ......
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~-~~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELI-NSIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchh-hhccCc
Confidence            9999999999888889999999999999999999997 69999999999999987776  9999999886432 222334


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-------hHHHHHHHHHhccc-ccCCCCCCCC
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-------RNFRKTIDRIRNVQ-YFLPDYVRVS  231 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~s  231 (341)
                      ..|+..|+|||++.+..++.+ +|+|||||++|++++|..||......       ..+......+.... ..++ ...++
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  239 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-SSDFP  239 (284)
T ss_pred             cccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC-chhcC
Confidence            578999999999887766555 89999999999999999999864432       11112222222111 1111 12377


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .++.+|+.+||++||.+|||+.++++|+||.+..
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            8899999999999999999999999999996654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.9e-45  Score=329.62  Aligned_cols=255  Identities=29%  Similarity=0.451  Sum_probs=213.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+|++++.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            57999999999999999999999999999999886543 23456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-CCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-~~~~  160 (341)
                      .+++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCc
Confidence            99999988854 46999999999999999999999999999999999999987776  99999998864322221 2334


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      .+++.|+|||.+.+..+..+ +|+|||||++|+|++|..||...+.........   ......+.....+++.+.+||.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHH
Confidence            68899999999987776554 899999999999999999998765433322211   11112223334688999999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCC
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ||..||.+|||+.+++.||||...
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.9e-45  Score=328.20  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=206.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEc------CCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT------PTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~------~~~~~   75 (341)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.........+..|+.+++.+ +||||+++++++..      ...++
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            689999999999999999999999999999999877655556788899988888 79999999999853      46789


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++|||+.+++|..++...  ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.  ++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence            999999999999988763  35889999999999999999999999999999999999998776  99999999864322


Q ss_pred             -CCCCCCccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC
Q 019433          154 -HSQPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY  227 (341)
Q Consensus       154 -~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (341)
                       ........|++.|+|||++..     ..++ .++|+|||||++|+|++|..||...........    ...........
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  248 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKS  248 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcc
Confidence             122344678999999999863     2343 448999999999999999999976543322221    11111111122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..++.++.+||.+||+.||.+|||+.++++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            3578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-46  Score=331.38  Aligned_cols=257  Identities=28%  Similarity=0.471  Sum_probs=210.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||.||+|.++.+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            589999999999999999999999999999999765332   23467789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |+++++|..+......+++..++.++.|++.||.|||+.|++||||+|+||++++++.  ++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9999999888776667999999999999999999999999999999999999988776  9999999987432222 223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...++..|+|||++.+....+.++|||||||++|+|++|.+||...................               ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            35678899999998765544556999999999999999999997655433333322211100               000


Q ss_pred             CC----------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 LP----------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+          ....++..+.+|+.+||..+|.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11          123578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-45  Score=325.65  Aligned_cols=256  Identities=30%  Similarity=0.457  Sum_probs=210.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....       ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58999999999999999999999999999999865331       23568889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      |+||+.+++|.+++.+.+++++..++.++.|++.||.|||++|++||||+|+||+++.++. .++|+|||++....... 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999976543 39999999986432211 


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                          ......|+..|+|||.+.+..++. ++|+|||||++|+|++|..||........... +...............++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~-~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGR-SCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-IFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-HHHHhccCCCCCCchhhC
Confidence                112346788999999998776654 48999999999999999999975443222222 212111111111223578


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +++.+++.+||..+|.+|||+.++++||||.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.3e-45  Score=327.54  Aligned_cols=256  Identities=27%  Similarity=0.430  Sum_probs=208.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC-----CEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTP-----THLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~-----~~~~   75 (341)
                      .++|++.+.||.|+||.||++.++.+++.+|+|.+.........+.+|+.+++.+ +|||++++++++...     ...+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            5789999999999999999999999999999999876555556778899999888 899999999998753     4689


Q ss_pred             EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           76 IVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      +||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhc
Confidence            99999999999988753    457899999999999999999999999999999999999988776  999999998743


Q ss_pred             CCCC-CCCCccCCCCcccccccccccc----CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          152 LLHS-QPKSTVGTPAYIAPEVLARKEY----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      .... ......|+..|+|||++.....    .+.++|||||||++|+|++|.+||........+....   .........
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~  255 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP---RNPPPTLLH  255 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh---cCCCCCCCc
Confidence            2221 2234568899999999864331    2345999999999999999999998755433332211   111112222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ...++..+.+||.+||+.+|++|||+.+++.||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            235778899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.4e-45  Score=322.42  Aligned_cols=254  Identities=29%  Similarity=0.490  Sum_probs=213.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ||++.+.||+|+||.||++.+..+++.||+|.+.....   ..+.+..|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            79999999999999999999999999999999876543   455788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----  156 (341)
                      +++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  +||+|||++........    
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence            999999999988778999999999999999999999999999999999999998776  99999999875332222    


Q ss_pred             -CCCccCCCCccccccccccc--cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 -PKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                       .....+++.|+|||++.+..  ....++||||||+++|++++|..||.............  .......+|....+++.
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHV--GAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHH--hcCCCCCCCcccccCHH
Confidence             11346788999999987665  12345899999999999999999997654322221111  11223344555567899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.+||.+||+.+|.+|||+.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=342.43  Aligned_cols=249  Identities=35%  Similarity=0.626  Sum_probs=217.8

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCc
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~   85 (341)
                      +.||.|.||+||-+.+..+|+.||||++.+-   .+....+.+|+.++..+.||+||.+.-.|+..+.+++|||.+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            6799999999999999999999999998763   3455678999999999999999999999999999999999997754


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCCCCCCCCccCC
Q 019433           86 LFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGT  163 (341)
Q Consensus        86 L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~~~~~~~~~gt  163 (341)
                      |.-.+.. .++|++...+.++.||+.||.|||.+||+|+|+||+|||+.+... +++||||||+|+......-..+.+||
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT  729 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT  729 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence            5444433 558999999999999999999999999999999999999976433 67999999999976555566788999


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCCCHHHHHHHHHh
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQI  241 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~  241 (341)
                      |.|+|||++..+.|+.. .|+||+|+|+|--+.|..||...++      +.+.+++..+.+|  .|..+|+++.|||..+
T Consensus       730 PAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  730 PAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDED------INDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             ccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccc------hhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            99999999999999766 8999999999999999999987654      3444566666555  4778999999999999


Q ss_pred             cccCCCCCCChhHHhcCCccCCC
Q 019433          242 FVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |+..=.+|.|+++.|.|||+++-
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999653

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-45  Score=329.28  Aligned_cols=255  Identities=29%  Similarity=0.461  Sum_probs=208.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .|++++.||.|++|.||+|.++.+++.||||.+....   .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4899999999999999999999999999999886532   2234688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCC
Q 019433           81 AAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      +. ++|..++..  ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++...... ...
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            96 588888765  346899999999999999999999999999999999999998876  999999998643221 122


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--------------cc
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------YF  223 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~  223 (341)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|..||...+................              ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            3345788999999987766545669999999999999999999987665444433332211100              00


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.         ...+++++.++|.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            111         12478889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-45  Score=321.17  Aligned_cols=250  Identities=26%  Similarity=0.455  Sum_probs=206.8

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~iv~e   79 (341)
                      +|++++.||+|++|.||++.++.+++.||+|.+....   ...+.+..|+.+++.++|||++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5999999999999999999999999999999986532   233467889999999999999999998864 456899999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CC
Q 019433           80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~  156 (341)
                      |+++++|.+++...  ..+++.+++.++.|++.||.+||++|++||||||+||+++.++.  ++|+|||++...... ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence            99999999988763  45899999999999999999999999999999999999987776  999999998643222 22


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....+++.|+|||++.+..++.+ +|+|||||++|+|++|..||...+.......    +..... .+....+++.+.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~  232 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPELGE  232 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHHHH
Confidence            234568899999999988777655 8999999999999999999976543222222    111111 1112368899999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCcc
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.+||+.||.+|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.1e-47  Score=322.26  Aligned_cols=261  Identities=28%  Similarity=0.405  Sum_probs=209.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCc----EEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLA   75 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~   75 (341)
                      .|++++.||+|.||.||+|..+.++.    .+|||.+..+.   ....++-+|+.++|.|+||||+.|..+|.. +..++
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            58999999999999999997665543    78999987653   456789999999999999999999999988 78899


Q ss_pred             EEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC--CCCEEEeecCCc
Q 019433           76 IVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYS  148 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a  148 (341)
                      +++||.+. +|+..|.-     .+.++...++.+++||+.|+.|||++-|+|||+||.||||..++  .++|||+|||++
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla  183 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA  183 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence            99999977 88887743     34699999999999999999999999999999999999998763  256999999999


Q ss_pred             cCCCCCC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---------hhHHHHHHH
Q 019433          149 KSGLLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------PRNFRKTID  215 (341)
Q Consensus       149 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~---------~~~~~~~~~  215 (341)
                      +.....-    .....+.|.+|+|||.+.|...++++.||||.|||+.||++-.+.|.+.+.         ..++.+++.
T Consensus       184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~  263 (438)
T KOG0666|consen  184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE  263 (438)
T ss_pred             HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence            8533221    233567899999999999999989999999999999999999988876432         122223322


Q ss_pred             HHhccc-cc------CCC------------------------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          216 RIRNVQ-YF------LPD------------------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       216 ~~~~~~-~~------~~~------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      -+.... ..      .|+                        ...-++...+|+.+||++||.+|+|++++++|+||...
T Consensus       264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence            221110 00      111                        11234558899999999999999999999999999876


Q ss_pred             C
Q 019433          265 L  265 (341)
Q Consensus       265 ~  265 (341)
                      .
T Consensus       344 ~  344 (438)
T KOG0666|consen  344 P  344 (438)
T ss_pred             C
Confidence            3

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.2e-45  Score=326.99  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=202.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+....  .....+.+|+.+++.++|+||+++++++......++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            68999999999999999999999999999999986543  2234677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      +. ++|...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||+++..... ....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCC
Confidence            96 566666544 456889999999999999999999999999999999999987776  999999998743221 1223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh-HHHHHHHHHh-----------ccc----c
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-NFRKTIDRIR-----------NVQ----Y  222 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~-~~~~~~~~~~-----------~~~----~  222 (341)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||....+.. .+.+......           ...    .
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            44678999999998765433445899999999999999999997654321 1111111000           000    0


Q ss_pred             cC----C-------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          223 FL----P-------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       223 ~~----~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..    +       .....++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            00    0       001235788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=5.1e-45  Score=329.37  Aligned_cols=257  Identities=32%  Similarity=0.522  Sum_probs=212.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++++.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987543    22345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      ||++|++|..++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence            99999999999988888999999999999999999999999999999999999988776  9999999886321110   


Q ss_pred             -------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          156 -------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       156 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                                   ......++..|+|||.+.+..+..+ +|+|||||++|+|++|..||..........    .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~----~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccc
Confidence                         0112357888999999887776554 899999999999999999997654332222    2222222


Q ss_pred             cCCC-CCCCCHHHHHHHHHhcccCCCCCCC---hhHHhcCCccCCCCC
Q 019433          223 FLPD-YVRVSADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKNLP  266 (341)
Q Consensus       223 ~~~~-~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~  266 (341)
                      ..+. ...++.++.++|.+||+.||.+||+   +.++++||||.....
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            2222 1257899999999999999999998   799999999976543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-45  Score=328.02  Aligned_cols=257  Identities=29%  Similarity=0.473  Sum_probs=204.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      -++|++.+.||.|++|.||+|.++.+++.||||.+.....  ....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            3689999999999999999999999999999999865432  23456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CC
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~  157 (341)
                      |+.+ +|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||+++...... ..
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence            9985 898888654 46899999999999999999999999999999999999988776  9999999986432211 12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH-HHHHHHHHhcc---------------c
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNV---------------Q  221 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~---------------~  221 (341)
                      ....++..|+|||++.+....+.++||||+||++|+|++|..||........ +..........               .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            2345688899999987654444558999999999999999999976553222 11111110000               0


Q ss_pred             ccC---------CCCCCCC--HHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          222 YFL---------PDYVRVS--ADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       222 ~~~---------~~~~~~s--~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ...         .....++  .++.+++.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000         0011344  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-45  Score=328.36  Aligned_cols=257  Identities=32%  Similarity=0.515  Sum_probs=210.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+...   ......+.+|+.+++.++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            5899999999999999999999999999999988653   2334678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      |++++.+..+..+...+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence            9998777776666677999999999999999999999999999999999999998776  9999999987543332  23


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc------------c---
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ------------Y---  222 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~---  222 (341)
                      ....++..|+|||++.+....+.++|+||||+++|+|++|.+||........+...........            .   
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            3456789999999998773444559999999999999999999987554433322221110000            0   


Q ss_pred             cCCC-----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          223 FLPD-----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       223 ~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..+.           ...++.++.+||++||..+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0000           11248889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4e-45  Score=328.21  Aligned_cols=257  Identities=28%  Similarity=0.391  Sum_probs=206.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCE-----
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTH-----   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~-----   73 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+....   .....+.+|+.+++.+. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            57999999999999999999999999999999876542   23356788999999995 6999999999987665     


Q ss_pred             EEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-CCCCCEEEeecCC
Q 019433           74 LAIVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGY  147 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~  147 (341)
                      .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.  ++|+|||+
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~  157 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGL  157 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe--EEEeeccc
Confidence            8999999986 787777542     35899999999999999999999999999999999999987 544  99999999


Q ss_pred             ccCCCCC-CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-c--
Q 019433          148 SKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F--  223 (341)
Q Consensus       148 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~--  223 (341)
                      +...... .......+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......+.......... .  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T cd07837         158 GRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP  237 (295)
T ss_pred             ceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            8743222 22233467889999999876544455699999999999999999999876665554444332211000 0  


Q ss_pred             ----------CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          224 ----------LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       224 ----------~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                                .+.         ...+++.+.+||.+||.+||.+|||+.+++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                      000         134788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-45  Score=330.92  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=212.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||.|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            578999999999999999999999999999999987543 2335677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      +++++|..++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.  ++|+|||++....... ....
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCc
Confidence            999999998854 46899999999999999999999999999999999999987776  9999999886432221 1234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..+++.|+|||.+.+..+.. ++|+|||||++|++++|..||...+.........   ............++..+.+|+.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~-~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             ccCCccccCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---cCCCCCCCCccccCHHHHHHHH
Confidence            56889999999998776654 4899999999999999999997654322211111   1111111223467888999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +||..+|.+|||+.++++||||....
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhcccc
Confidence            99999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.4e-45  Score=326.98  Aligned_cols=248  Identities=30%  Similarity=0.459  Sum_probs=205.3

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||+|+||+||+|.+..+|+.||+|.+....    .....+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999986532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCC
Q 019433           87 FARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP  164 (341)
Q Consensus        87 ~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~  164 (341)
                      ..++.+..  .+++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            99987766  7999999999999999999999999999999999999988776  9999999887533333334456788


Q ss_pred             CccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhccc
Q 019433          165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA  244 (341)
Q Consensus       165 ~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  244 (341)
                      .|+|||++.+..+.. ++|+|||||++|+|++|..||.......................+  ..+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVYDF-SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCCCc-hhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccC
Confidence            999999988777654 489999999999999999999765542222222222222222222  35799999999999999


Q ss_pred             CCCCCC-----ChhHHhcCCccCC
Q 019433          245 DPSKRI-----PIPEIKKHPWFLK  263 (341)
Q Consensus       245 dp~~R~-----s~~e~l~hp~~~~  263 (341)
                      ||.+||     ++.++++||||..
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhc
Confidence            999999     8888999999954

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-45  Score=325.20  Aligned_cols=256  Identities=30%  Similarity=0.441  Sum_probs=207.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-----------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------IDENVQREIINHRSLRHPNIIRFKEVLLTPT   72 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~   72 (341)
                      +|.+.+.||.|+||.||+|.+..+++.+|+|.+.....           ..+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999999999999998753211           1235678999999999999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..++||||+.+++|..++.....+++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999987776  9999999987432


Q ss_pred             CC---CCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          153 LH---SQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       153 ~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ..   .......|+..|+|||.+.+.. ..+.++|+||||+++|++++|..||..........+................
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSM  239 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccc
Confidence            11   1123346788999999987654 2345599999999999999999999754433222221111111111111123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .++.++.++|.+||.++|.+|||+.++++||||
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         240 NLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.7e-45  Score=333.13  Aligned_cols=259  Identities=29%  Similarity=0.450  Sum_probs=208.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+.....   ......+|+.+++.++|+||+++++++...  +.+++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            679999999999999999999999999999999865322   223466899999999999999999998765  568999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-C
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~  155 (341)
                      |||+.+ +|..++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... .
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK  163 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC
Confidence            999975 78777765 357999999999999999999999999999999999999988776  999999998754322 1


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------  220 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------  220 (341)
                      ......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+....+..........               
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence            22334567889999998765544556999999999999999999998776655544443321110               


Q ss_pred             cccCCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          221 QYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       221 ~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ....+.         ...+++++.+||.+||+.||++|||+.+++.||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            000010         12358889999999999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.1e-45  Score=320.77  Aligned_cols=252  Identities=29%  Similarity=0.450  Sum_probs=211.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ||+..+.||+|+||+||+|.+..+++.|++|.+....      ...+.+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            7899999999999999999999899999999886532      1335688899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      +||+++++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.  +||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence            999999999999988888999999999999999999999999999999999999987776  999999998754333334


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||.+......+.++|+|||||++|+|++|..||............    ............+++++.++
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI----GRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH----HhcccCCCcCCCcCHHHHHH
Confidence            45678999999999876652344599999999999999999999775532222211    11011111123578999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.+||+.+|.+||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-45  Score=322.71  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=207.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +|++.+.||.|+||.||+|.+. +++.+|+|.+.....       ....+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5899999999999999999874 788999998764321       12457789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---  153 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---  153 (341)
                      ++||+++++|..++.+..++++..++.++.|++.||.|||+.||+|+||+|+||++++++.  ++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            9999999999999988888999999999999999999999999999999999999987776  99999998864211   


Q ss_pred             ----CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          154 ----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       154 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                          ........|+..|+|||++.+..++.. +|+|||||++|+|++|..||...+.........   .......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~  233 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG---AHRGLMPRLPDS  233 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhh---hccCCCCCCCCC
Confidence                112234568899999999987776554 899999999999999999997654432221111   111111112235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.++.++|++||..+|.+||++.++++||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            88999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-45  Score=325.60  Aligned_cols=255  Identities=29%  Similarity=0.443  Sum_probs=208.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC------EE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPT------HL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~------~~   74 (341)
                      .++|++.+.||.|+||.||+|.++.+++.+++|++.......+.+.+|+.+++.+ +||||+++++++....      .+
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            4799999999999999999999999999999999887665567788999999998 7999999999997644      48


Q ss_pred             EEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           75 AIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~  162 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCcccee
Confidence            999999999999888865    347999999999999999999999999999999999999988776  99999998864


Q ss_pred             CCC-CCCCCCccCCCCccccccccccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          151 GLL-HSQPKSTVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       151 ~~~-~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                      ... ........|+..|+|||++....    ..+.++|||||||++|+|++|..||.............   ........
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~  239 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP---RNPPPTLK  239 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh---ccCCCCCC
Confidence            222 12223456889999999975432    12344899999999999999999997654433332221   11111222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ....++..+.+||.+||..||++|||+.++++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            223477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-45  Score=332.62  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=191.0

Q ss_pred             ceecccCCeEEEEEEEcC--CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKR--TKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~iv~e~~~~~   84 (341)
                      .+||+|+||+||+|..+.  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  +..+++||||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            579999999999999754  66889999987643 34567899999999999999999999854  5678999999975 


Q ss_pred             chHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC--CCCCEEEeecCCccCCCC
Q 019433           85 ELFARICS---------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        85 ~L~~~l~~---------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~--~~~~ikL~Dfg~a~~~~~  153 (341)
                      +|...+..         ...+++..++.++.||+.||.|||++||+||||||+||++..+  ..+++||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            77676642         1248899999999999999999999999999999999999532  223599999999874322


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh---------hHHHHHHHHHh--
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIR--  218 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~---------~~~~~~~~~~~--  218 (341)
                      ..    ......||+.|+|||++.+....+.++|||||||++|+|++|.+||......         ..+........  
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            21    1234578999999999977554455699999999999999999999754321         11111110000  


Q ss_pred             ---------cc-------------ccc--------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          219 ---------NV-------------QYF--------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       219 ---------~~-------------~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                               ..             ...        .......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                     00             000        00011245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.5e-45  Score=327.10  Aligned_cols=254  Identities=27%  Similarity=0.423  Sum_probs=205.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEE-----cCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLL-----TPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~-----~~~~~~   75 (341)
                      .++|++++.||+|+||+||+|.++.+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     .....+
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            5799999999999999999999999999999999876544456788899999998 6999999999874     346789


Q ss_pred             EEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           76 IVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      +||||+++++|..++..    ...+++..++.++.|++.||.|||+++++||||||+||+++.++.  ++|+|||++...
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~  174 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQL  174 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeec
Confidence            99999999999887643    346899999999999999999999999999999999999998776  999999998643


Q ss_pred             CCCC-CCCCccCCCCcccccccccc-----ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          152 LLHS-QPKSTVGTPAYIAPEVLARK-----EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                      .... ......|++.|+|||++...     .+ +.++|||||||++|+|++|..||........+....   ........
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~  250 (286)
T cd06638         175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLH  250 (286)
T ss_pred             ccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCccc
Confidence            2221 22345689999999998532     23 345899999999999999999997654433222111   11111111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ....++..+.+||.+||+.||.+|||+.++++|+||
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            223467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7e-45  Score=322.34  Aligned_cols=248  Identities=30%  Similarity=0.495  Sum_probs=201.0

Q ss_pred             CCcccccee--cccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKEL--GSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|.+.+.+  |.|+||.||++.++.++..+|+|.+.......    .|+.....+ +||||+++++.|...+..++|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            467777777  99999999999999999999999987643211    122222222 79999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+++++|..++.....+++..++.++.|+++||.|||+.|++||||||+||+++.++. .++|+|||++....   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~-~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD-RIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC-eEEEecCccceecC---CCcc
Confidence            9999999999988889999999999999999999999999999999999999987761 39999999886432   2233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH-HHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||++.+..++.+ +|+|||||++|+|++|..||........ ........   ....+....+++.+.+||
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li  241 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFV  241 (267)
T ss_pred             CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHH
Confidence            468899999999988777654 8999999999999999999985443221 11111111   222233346899999999


Q ss_pred             HHhcccCCCCCCC-hhHHhcCCccC
Q 019433          239 SQIFVADPSKRIP-IPEIKKHPWFL  262 (341)
Q Consensus       239 ~~~L~~dp~~R~s-~~e~l~hp~~~  262 (341)
                      .+||+.+|.+||+ ++++|+||||.
T Consensus       242 ~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        242 QSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHHhccChhhCCchHHHHhcCCccc
Confidence            9999999999996 69999999995

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.1e-45  Score=321.94  Aligned_cols=246  Identities=32%  Similarity=0.559  Sum_probs=207.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||.|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999999999999987643    2335688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCc
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY  166 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y  166 (341)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||++++++.  ++|+|||++.............+++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988888999999999999999999999999999999999999988776  999999998754333233445789999


Q ss_pred             cccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh--cccccCCCCCCCCHHHHHHHHHhccc
Q 019433          167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR--NVQYFLPDYVRVSADCRHLLSQIFVA  244 (341)
Q Consensus       167 ~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~  244 (341)
                      +|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+.  ......|.  ..++++.++|.+||+.
T Consensus       159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~  233 (262)
T cd05572         159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRR  233 (262)
T ss_pred             cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccC
Confidence            99999887776655 89999999999999999999876521  112222222  12222232  4588999999999999


Q ss_pred             CCCCCCC-----hhHHhcCCccCC
Q 019433          245 DPSKRIP-----IPEIKKHPWFLK  263 (341)
Q Consensus       245 dp~~R~s-----~~e~l~hp~~~~  263 (341)
                      +|.+||+     +.|+++||||..
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhC
Confidence            9999999     999999999964

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-45  Score=321.51  Aligned_cols=255  Identities=32%  Similarity=0.448  Sum_probs=211.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++.+.||.|+||.||+|.+..+++.+|+|++..... ....+.+|+.+++.++||||+++++++.....++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            3689999999999999999999999999999999876432 346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      +.+++|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++....... ...
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence            9999999998776 68999999999999999999999999999999999999998776  9999999986433221 223


Q ss_pred             CccCCCCcccccccccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          159 STVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...++..|+|||.+.+.   .++. ++|+|||||++|+|++|.+||................. ..........++.++.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccCCccccCchhhcccccCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHH
Confidence            45688899999998766   5554 58999999999999999999987554333222111100 0111112234678899


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCc
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~  260 (341)
                      +|+.+||..+|..|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.4e-45  Score=325.81  Aligned_cols=257  Identities=31%  Similarity=0.512  Sum_probs=212.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++.+.||.|+||.||+|.++.+++.+|+|.+....  .....+.+|+.+++.++||||+++++++......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            47899999999999999999999999999999987653  2334678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.  ++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~-~~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSL-AK  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHH-hh
Confidence            9999999999876 789999999999999999999999 99999999999999998766  9999999886432221 12


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHHHHHhcc-cccCCCCCCCCHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRNV-QYFLPDYVRVSADCRH  236 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~  236 (341)
                      ...++..|+|||.+.+..+..+ +|+|||||++|+|++|..||..... .............. ....+. ..++.++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHH
Confidence            2678899999999988776554 8999999999999999999975421 11112222222221 111222 127889999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +|.+||..||.+|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.1e-45  Score=320.05  Aligned_cols=251  Identities=36%  Similarity=0.519  Sum_probs=210.6

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++++.||+|+||.||+|.+..+++.+|+|.+....   .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            6999999999999999999999999999999987542   2345688899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++|++||||+|+||+++.++. .++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence            9999999999764  35899999999999999999999999999999999999975443 48999999987544333334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...|++.|+|||.+.+..++. ++|+||||+++|+|++|..||...+..........   ......+  ..+++++.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQ-KSDIWALGCVLYELASLKRAFEAANLPALVLKIMS---GTFAPIS--DRYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCCCc-ccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh---cCCCCCC--CCcCHHHHHHH
Confidence            467889999999998776654 48999999999999999999977554333222211   1111122  35889999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCcc
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+||..+|.+|||+.+++.||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-44  Score=318.15  Aligned_cols=250  Identities=33%  Similarity=0.512  Sum_probs=211.6

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ||++++.||.|+||.||.+++..+++.+++|.+...   ......+.+|+.+++.++|+||+++++++......+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            799999999999999999999999999999987653   23345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CC
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~  157 (341)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999999765  46899999999999999999999999999999999999998776  9999999987433222 23


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||.+.+..++.. +|+||||+++|+|++|..||...........    +...... +....++.++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHH
Confidence            44678999999999987766544 8999999999999999999977544333322    2222221 2224678999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      |.+||..+|.+|||+.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=5.6e-45  Score=333.38  Aligned_cols=262  Identities=25%  Similarity=0.364  Sum_probs=212.6

Q ss_pred             CCCCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc---------------HHHHHHHHHHhcCCCCCeeeE
Q 019433            1 MEERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---------------ENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus         1 i~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      +.+||..+ +.||.|+||+||+|.++.+++.||||++.......               ..+.+|+.+++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            45789865 66999999999999999999999999986532211               246789999999999999999


Q ss_pred             EEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      ++++......++||||+. ++|..++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d  162 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD  162 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence            999999999999999997 589999988888999999999999999999999999999999999999988776  99999


Q ss_pred             cCCccCCCC---------------CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH
Q 019433          145 FGYSKSGLL---------------HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN  209 (341)
Q Consensus       145 fg~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~  209 (341)
                      ||++.....               ........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||...++...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998864320               11122345688899999987765445569999999999999999999988776555


Q ss_pred             HHHHHHHHhccccc-CC---------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          210 FRKTIDRIRNVQYF-LP---------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       210 ~~~~~~~~~~~~~~-~~---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +..+.......... ++                     .....+..+.++|.+||+.+|.+|||+++++.||||....
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            44443322111100 00                     0123578899999999999999999999999999997653

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.8e-45  Score=318.74  Aligned_cols=250  Identities=32%  Similarity=0.458  Sum_probs=209.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .|.+.+.||+|++|.||+|.++.+++.|++|.+...   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            488999999999999999999999999999998643   23345688899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CC
Q 019433           81 AAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~  157 (341)
                      +++++|..++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++....... ..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence            9999999998764  57899999999999999999999999999999999999998776  9999999887433222 12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||++.+..++.+ +|+|||||++|+|++|..||..........    .+..... .+....++.++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCC-CCCccccCHHHHHH
Confidence            33468899999999988776654 899999999999999999997765322222    2221111 11112678899999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-45  Score=326.63  Aligned_cols=256  Identities=31%  Similarity=0.468  Sum_probs=208.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv   77 (341)
                      +.|++.+.||.|+||.||+|.++.+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            579999999999999999999999999999999875432   223567899999999999999999998877  889999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-C
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-S  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~  155 (341)
                      |||+.+ +|..++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... .
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLK  161 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCcc
Confidence            999975 8888886644 5999999999999999999999999999999999999998776  999999998753332 2


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------c---
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------Q---  221 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~---  221 (341)
                      ......+++.|+|||.+.+....+.++|+||||+++|+|++|.+||..........+........           .   
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence            23345678899999998766544556999999999999999999998766554444333221100           0   


Q ss_pred             ---c-------cCCCCCC--CCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          222 ---Y-------FLPDYVR--VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       222 ---~-------~~~~~~~--~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                         .       .......  +++.+.++|++||+.+|++|||+.|++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence               0       0001111  58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.5e-45  Score=324.18  Aligned_cols=249  Identities=29%  Similarity=0.434  Sum_probs=198.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHh---cCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHR---SLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~---~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .||+|+||.||++.+..+++.+|+|.+.+....    ......|..+++   ..+||||+.+++.+...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998654321    122344444333   3479999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      +++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++..... .......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~-~~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceeccc-cCccCcCC
Confidence            9999999988888999999999999999999999999999999999999987776  99999999864322 22234578


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      ++.|+|||.+.+....+.++|+||+||++|+|++|..||........ .............++  ..+++++.++|.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l  234 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVELP--DSFSPELKSLLEGLL  234 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcCCc--cccCHHHHHHHHHHh
Confidence            99999999986443334458999999999999999999975433211 111111111222222  358899999999999


Q ss_pred             ccCCCCCC-----ChhHHhcCCccCCC
Q 019433          243 VADPSKRI-----PIPEIKKHPWFLKN  264 (341)
Q Consensus       243 ~~dp~~R~-----s~~e~l~hp~~~~~  264 (341)
                      ..||.+|+     |+.++++||||...
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            99999999     69999999999664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-46  Score=354.76  Aligned_cols=249  Identities=28%  Similarity=0.458  Sum_probs=208.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEccc-CccccHHHHHHHHHHhcCC-CCCeeeEEEE-EEc---C---CE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLR-HPNIIRFKEV-LLT---P---TH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~-~~~---~---~~   73 (341)
                      .+++|.+.|-+|||+.||+|++...+..||+|++.. .....+.+.+||.+|+.|+ |+|||.+++. ...   +   -.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            367899999999999999999998889999998754 3445667899999999996 9999999993 321   1   35


Q ss_pred             EEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           74 LAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ++|.||||.||.|.++|+.  ..+|++.++++|++|+++|+.+||.+.  |||||||-+||||..++.  +||||||.+.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSat  194 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSAT  194 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccc
Confidence            7899999999999999975  346999999999999999999999998  999999999999998887  9999999987


Q ss_pred             CCCCCCCCC----------CccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHH
Q 019433          150 SGLLHSQPK----------STVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       150 ~~~~~~~~~----------~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~  216 (341)
                      .........          ....|+.|+|||++.   +...+ +++|||+|||+||.|+....||......        .
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~-eKsDIWALGclLYkLCy~t~PFe~sg~l--------a  265 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG-EKSDIWALGCLLYKLCYFTTPFEESGKL--------A  265 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc-chhHHHHHHHHHHHHHHhCCCcCcCcce--------e
Confidence            433222111          234799999999974   44444 4599999999999999999999886432        2


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +.+..+.+|....+|..+.+||+.||+.||.+||++-|++.+-+-.
T Consensus       266 Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  266 ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence            4467788898889999999999999999999999999998875443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-45  Score=336.49  Aligned_cols=259  Identities=32%  Similarity=0.453  Sum_probs=213.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----EEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----HLA   75 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----~~~   75 (341)
                      ||++.+.||.|+||.||+|.+..+++.||||++....   ...+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            7999999999999999999999999999999987632   33457889999999999999999999998775     789


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ++|+|+.+ +|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++.......
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccc
Confidence            99999975 89888888778999999999999999999999999999999999999998766  9999999987543332


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc--------
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------  223 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------  223 (341)
                          ......+++.|+|||++.+....+.++|+|||||++|+|++|.+||........+..+..........        
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                23345688999999999887444555999999999999999999998766544443333221110000        


Q ss_pred             ----------------C-CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          224 ----------------L-PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       224 ----------------~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                      + .....+++++.+||.+||+.+|.+|||+.+++.||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                            0 00123688899999999999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=8.8e-45  Score=321.34  Aligned_cols=252  Identities=30%  Similarity=0.448  Sum_probs=205.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~   74 (341)
                      ..|++.+.||+|+||.||+|.+..++..||+|.+....      .....+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46999999999999999999999999999999876432      122357789999999999999999999875  3678


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-  153 (341)
                      ++++||+++++|..++.....+++..++.++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++..... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccc
Confidence            999999999999999988888999999999999999999999999999999999999987776  99999999864321 


Q ss_pred             ---CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          154 ---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                         ........++..|+|||.+.+..++. ++|+|||||++|+|++|..||...............  .....++  ..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~--~~~  234 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYGR-KADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTNPQLP--SHI  234 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCCCCCc--hhc
Confidence               11122345888999999998776654 489999999999999999999875443332221110  0111112  246


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ++.+.++| +||..+|++||+++++++||||.
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78899999 56678999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-45  Score=352.46  Aligned_cols=262  Identities=25%  Similarity=0.381  Sum_probs=195.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCC-cEEEEE------------------EcccCccccHHHHHHHHHHhcCCCCCee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTK-ELVAVK------------------YIERGKKIDENVQREIINHRSLRHPNII   62 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~ei~~~~~l~hp~iv   62 (341)
                      .++|++++.||+|+||+||+|..+... ...++|                  .+.........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            368999999999999999999765332 222222                  1222222334577899999999999999


Q ss_pred             eEEEEEEcCCEEEEEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC
Q 019433           63 RFKEVLLTPTHLAIVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ  137 (341)
Q Consensus        63 ~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~  137 (341)
                      ++++++...+..|+|++++.+ +|..++...     .......++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            999999999999999999965 676666432     22446678899999999999999999999999999999988776


Q ss_pred             CCEEEeecCCccCCCCCC--CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCC-CCCCCC--ChhHHHH
Q 019433          138 PRLKICDFGYSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAY-PFEDPE--DPRNFRK  212 (341)
Q Consensus       138 ~~ikL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~-pf~~~~--~~~~~~~  212 (341)
                        +||+|||++.......  ......||+.|+|||++.+..++.. +|||||||++|+|++|.. ||....  ....+.+
T Consensus       306 --vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        306 --IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             --EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence              9999999997533222  2234679999999999988877655 899999999999999875 443322  1222322


Q ss_pred             HHHHHhcccccCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          213 TIDRIRNVQYFLP--------------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       213 ~~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      .+..+......+|                          ....++.++.++|.+||++||++|||+.|+|.||||.....
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            2222111000000                          01236677889999999999999999999999999976654


Q ss_pred             h
Q 019433          267 K  267 (341)
Q Consensus       267 ~  267 (341)
                      .
T Consensus       463 ~  463 (501)
T PHA03210        463 E  463 (501)
T ss_pred             h
Confidence            3

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-44  Score=323.67  Aligned_cols=255  Identities=27%  Similarity=0.468  Sum_probs=208.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +|++++.||.|++|.||+|.++.+|..||||.+....  .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5899999999999999999999999999999987543  23456778999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCC
Q 019433           82 AGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      .+ +|..++...   ..+++..+..++.|++.||.|||++|++||||||+||++++++.  ++|+|||++...... ...
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            86 888877653   36899999999999999999999999999999999999988776  999999998643221 122


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------c---cc
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------Q---YF  223 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~---~~  223 (341)
                      ....+++.|++||++.+....+.++|+|||||++|+|++|..||...+...............           .   ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            345678899999998765544556999999999999999999998876655444433221100           0   00


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+.         ...+++.+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            000         12457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-44  Score=326.90  Aligned_cols=253  Identities=26%  Similarity=0.360  Sum_probs=199.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcC----------------CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR----------------TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIR   63 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~   63 (341)
                      .++|++.++||+|+||.||+|.+..                ++..||+|++.....  ....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998642                345799999876432  2346889999999999999999


Q ss_pred             EEEEEEcCCEEEEEEeecCCCchHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCC
Q 019433           64 FKEVLLTPTHLAIVMEYAAGGELFARICSAG-------------------RFSEDEARFFFQQLISGVSYCHSMEICHRD  124 (341)
Q Consensus        64 l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrD  124 (341)
                      +++++...+..++||||+.+++|..++....                   .+++..+..++.||+.||.|||++||+|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999999999999886532                   367788999999999999999999999999


Q ss_pred             CCCCCEEecCCCCCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh--CCC
Q 019433          125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAY  199 (341)
Q Consensus       125 ikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--g~~  199 (341)
                      |||+|||++.++.  +||+|||+++......   ......++..|+|||++.+..++.+ +|||||||++|+|++  +..
T Consensus       164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence            9999999998776  9999999987432221   1223345778999999887776654 899999999999986  567


Q ss_pred             CCCCCCChhHHHHHHHHHhcc--cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          200 PFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       200 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ||........+..........  ..........+..+.+|+.+||+.||.+|||+.++.+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            887655443333222221111  1111122357889999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-44  Score=318.47  Aligned_cols=252  Identities=32%  Similarity=0.452  Sum_probs=206.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTP--THL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~   74 (341)
                      +.|++.+.||+|+||.||.+.+..++..||||.+.....      ..+.+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            579999999999999999999999999999998754221      224677899999999999999999998764  568


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-  153 (341)
                      +++|||+++++|.+++.+...+++..+..++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++..... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence            899999999999999988788999999999999999999999999999999999999987776  99999998864321 


Q ss_pred             ---CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          154 ---HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                         ........|+..|+|||++.+..++. ++|+|||||++|+|++|..||...........    .............+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~  234 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGR-KADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPVLPPHV  234 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCc-chhHHHHHHHHHHHhhCCCCCCccchHHHHHH----HhcCCCCCCCchhh
Confidence               11223456888999999998776654 48999999999999999999986544333222    11111111112357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +..+.++|.+||. +|++||+++++++|||+.
T Consensus       235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            7889999999995 999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-45  Score=335.67  Aligned_cols=289  Identities=27%  Similarity=0.375  Sum_probs=220.5

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----   72 (341)
                      +.+||++++.||+|+||.||++.+..++..||||.+....   .....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4579999999999999999999999999999999986532   22346778999999999999999999987653     


Q ss_pred             -EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        73 -~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                       .+++||+|+ +++|..++. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~  168 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQT  168 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccc
Confidence             468999999 668887775 457999999999999999999999999999999999999987776  999999998743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------  220 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (341)
                      .  .......+++.|+|||.+.+....+.++|+|||||++|+|++|..||........+.+........           
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 D--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             c--cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            2  223345678999999998764434556999999999999999999998765443333322111000           


Q ss_pred             -----cccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCC
Q 019433          221 -----QYFLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT  286 (341)
Q Consensus       221 -----~~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (341)
                           ...++         -...+++.+.++|.+||+.||.+|||+.+++.||||............  ..-....+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  324 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEA--PPYDDSFDEVD  324 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCC--CCccccHHhhc
Confidence                 00000         013578889999999999999999999999999999765433221111  11112234455


Q ss_pred             CCHHHHHHHHH
Q 019433          287 QSVEEIMRIIQ  297 (341)
Q Consensus       287 ~~~~~~~~~~~  297 (341)
                      ++.+|+.++..
T Consensus       325 ~~~~~~~~~~~  335 (343)
T cd07880         325 QSLEEWKRLTF  335 (343)
T ss_pred             cchHHHHHHHH
Confidence            66667666644

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.9e-45  Score=336.35  Aligned_cols=266  Identities=28%  Similarity=0.448  Sum_probs=212.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~----~~~   73 (341)
                      +.++|++.+.||.|+||.||+|.++.+++.||+|++....   .....+.+|+.+++.++||||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            3578999999999999999999999999999999987542   234567789999999999999999998763    357


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +++||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  159 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecc
Confidence            899999996 589999887788999999999999999999999999999999999999998777  99999999864322


Q ss_pred             CCC-----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh----------
Q 019433          154 HSQ-----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR----------  218 (341)
Q Consensus       154 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  218 (341)
                      ...     .....|+..|+|||++.+....+.++|||||||++|+|++|+.||...+....+........          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            111     12457889999999986644345569999999999999999999976554333222111100          


Q ss_pred             ----------cccccCC-----CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          219 ----------NVQYFLP-----DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       219 ----------~~~~~~~-----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                                ......+     ....++.++.++|.+||+.+|.+|||+.+++.||||.+...+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~  305 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD  305 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence                      0000000     01346899999999999999999999999999999976554443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.1e-44  Score=322.49  Aligned_cols=262  Identities=30%  Similarity=0.486  Sum_probs=209.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv~   78 (341)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ....+.+|+.+++.++||||+++++++...  ..+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999999999999999875432  345688999999999999999999988653  4789999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887643    345899999999999999999999999999999999999988776  999999998643222


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHHhcc-cccCCC----CC
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV-QYFLPD----YV  228 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-~~~~~~----~~  228 (341)
                       ......++..|+|||.+.+..++.+ +|||||||++|+|++|..||...... ....+....+... ...++.    ..
T Consensus       159 -~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 -LAGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             -ccccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence             2234467889999999987777655 89999999999999999999765220 0111122222221 111111    12


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      .+++.+.+||.+||..+|.+|||+.|+++||||.+...+.
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~  276 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKK  276 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccch
Confidence            3567899999999999999999999999999996665543

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-45  Score=329.28  Aligned_cols=255  Identities=27%  Similarity=0.393  Sum_probs=202.1

Q ss_pred             CccccceecccCCeEEEEEEEcC--CCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKR--TKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLA   75 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~   75 (341)
                      +|++.+.||+|+||.||+|.++.  +++.||+|.+....    ...+...+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            69999999999999999999998  89999999987632    3446778899999999999999999999988  8899


Q ss_pred             EEEeecCCCchHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC----CCCCCEEEeecC
Q 019433           76 IVMEYAAGGELFARICSA-----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG----SPQPRLKICDFG  146 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~----~~~~~ikL~Dfg  146 (341)
                      +||||+.+ +|...+...     ..+++..++.++.|++.||.|||++||+||||||+||+++.    ++.  +||+|||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg  157 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGV--VKIGDLG  157 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccce--EEECCCc
Confidence            99999976 666665432     26899999999999999999999999999999999999987    555  9999999


Q ss_pred             CccCCCCCC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh---------HHHHH
Q 019433          147 YSKSGLLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR---------NFRKT  213 (341)
Q Consensus       147 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~---------~~~~~  213 (341)
                      ++.......    ......+++.|+|||++.+....+.++|||||||++|+|++|.+||.......         .+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd07842         158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI  237 (316)
T ss_pred             cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence            987432221    12345678899999998775544556999999999999999999997644321         11111


Q ss_pred             HHHHhc-----------c--------cc---cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          214 IDRIRN-----------V--------QY---FLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       214 ~~~~~~-----------~--------~~---~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ...+..           .        ..   ..+         .....+.++.++|.+||+.||++|||+.+++.||||
T Consensus       238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            110000           0        00   000         011467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.4e-44  Score=322.99  Aligned_cols=256  Identities=30%  Similarity=0.426  Sum_probs=208.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            5789999999999999999999999999999999864322    224577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +||+.+ ++...+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++....   .
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~---~  167 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS---P  167 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---C
Confidence            999975 66666543 457999999999999999999999999999999999999988776  9999999886432   2


Q ss_pred             CCCccCCCCccccccccc---cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PKSTVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .....+++.|+|||++.+   ..+. .++||||||+++|+|++|..||...+.........   .......+ ...++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~  242 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNDSPTLS-SNDWSDY  242 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cCCCCCCC-chhhCHH
Confidence            234578889999999742   3343 45999999999999999999997654432222111   11111111 1246789


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      +.++|.+||+.+|.+||++.+++.||||....+.+
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  277 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPT  277 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhcccCCcH
Confidence            99999999999999999999999999998776544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-44  Score=323.06  Aligned_cols=257  Identities=25%  Similarity=0.406  Sum_probs=203.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHH-HhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~-~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.|++++.||+|+||.||++.++.+|+.||||.+.....  ....+..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            479999999999999999999999999999999876432  22345556554 566799999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           80 YAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      |++ ++|..++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.  +||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            997 477666644    34689999999999999999999997 9999999999999988776  999999998753322


Q ss_pred             CCCCCccCCCCccccccccccc---cCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQPKSTVGTPAYIAPEVLARKE---YDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .......|+..|+|||.+.+..   ..+.++|+|||||++|+|++|..||...... ..+...   ........+. ..+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~  233 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKF  233 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-ccc
Confidence            2233356889999999886522   1234589999999999999999999754322 222211   1111222222 257


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |.++.+||.+||..+|.+|||+.++++||||.+...
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            899999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-44  Score=322.39  Aligned_cols=238  Identities=20%  Similarity=0.232  Sum_probs=197.4

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc----HHHHHHHHHHhcCCCCCeeeEEEEEEc----CCEEEEEEee
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLT----PTHLAIVMEY   80 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~~~~l~hp~iv~l~~~~~~----~~~~~iv~e~   80 (341)
                      ..||+|++|.||+|..  +|+.||||.+.......    +.+.+|+.+++.++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5799999999999998  68999999997754433    456699999999999999999999876    4578999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      +++|+|..++.+.+.+++.....++.|++.||.|||+ .+++||||||+||+++.++.  +||+|||+++...  .....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~--~~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILS--SPPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhc--ccccc
Confidence            9999999999888889999999999999999999998 49999999999999998776  9999999987432  22334


Q ss_pred             ccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ..|++.|+|||++.+  ..++ .++|||||||++|+|++|..||...+...........  ......|  ...++.+.+|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~-~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~--~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYT-IKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK--NNSLKLP--LDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhcccccc-chhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc--CCCCCCC--CcCcHHHHHH
Confidence            678999999999876  4454 4599999999999999999999876543332222111  1122222  3578999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+||+.||.+|||+.++++
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999986

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5e-45  Score=334.01  Aligned_cols=293  Identities=29%  Similarity=0.387  Sum_probs=220.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC--CEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSL-RHPNIIRFKEVLLTP--THL   74 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~--~~~   74 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.+|+|.+...   ......+.+|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            357899999999999999999999999999999987542   22334577899999999 999999999998654  468


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++||||+.+ +|..++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus        85 ~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~  160 (337)
T cd07852          85 YLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSEL  160 (337)
T ss_pred             EEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccc
Confidence            999999975 898888665 7899999999999999999999999999999999999998877  999999998743222


Q ss_pred             C------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc---------
Q 019433          155 S------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------  219 (341)
Q Consensus       155 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------  219 (341)
                      .      ......|++.|+|||++.+....+.++|+|||||++|+|++|+.||..........+.......         
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            1      1223468899999999876554456699999999999999999999765544333332221100         


Q ss_pred             --------------ccc--cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCC
Q 019433          220 --------------VQY--FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRD  283 (341)
Q Consensus       220 --------------~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  283 (341)
                                    ...  .......++.++.+||.+||+.||.+|||+.++++||||.+...................+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLDD  320 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCccc
Confidence                          000  0001123688999999999999999999999999999996653222111112222223334


Q ss_pred             CCCCCHHHHHHHHH
Q 019433          284 QPTQSVEEIMRIIQ  297 (341)
Q Consensus       284 ~~~~~~~~~~~~~~  297 (341)
                      ....++.|....+.
T Consensus       321 ~~~~~~~~~~~~~~  334 (337)
T cd07852         321 NVKLSVAEYRNKLY  334 (337)
T ss_pred             cceeeHHHHHhhhh
Confidence            44455555554443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-44  Score=323.17  Aligned_cols=254  Identities=30%  Similarity=0.457  Sum_probs=207.9

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      |++++.||.|++|.||+|.++.+|..||+|++....   .....+.+|+.+++.++|||++++++++......+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            789999999999999999999999999999987543   22356788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPK  158 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~  158 (341)
                      . ++|..++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.  ++|+|||++...... ....
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc--EEEeecccccccCCCccccC
Confidence            5 58999887765  7999999999999999999999999999999999999998666  999999998643221 1223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--------------cccC
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------QYFL  224 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~  224 (341)
                      ...+++.|+|||++.+....+.++|+||||+++|+|++|.+||...+......+........              ....
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            34568899999998765444455999999999999999999998766544443332221100              0000


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 ---------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 ---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                               .....++..+.++|.+||++||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     0123577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-44  Score=318.12  Aligned_cols=256  Identities=30%  Similarity=0.500  Sum_probs=214.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.|++.+.||.|++|.||+|.+..+++.||+|++....  .....+.+|+..+..++||||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46899999999999999999999999999999987654  2356788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC-C
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-K  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~-~  158 (341)
                      +++++|..++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.  ++|+|||++......... .
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence            9999999999888889999999999999999999999 99999999999999988776  999999998754322222 2


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC-CCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~l  237 (341)
                      ...++..|+|||.+.+..++. ++|+||||+++|+|++|..||...... ........+..... .+.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~-~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSY-AADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPP-PSLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCC-CCCCcccCCHHHHHH
Confidence            456888999999988776554 489999999999999999999776521 11222222222111 111123 78899999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      |.+||..+|.+|||+.++++||||..
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999953

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.1e-44  Score=323.50  Aligned_cols=259  Identities=28%  Similarity=0.434  Sum_probs=207.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57999999999999999999999999999999986542   223567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CC
Q 019433           80 YAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~  156 (341)
                      |+++ +|...+....  .+++..++.++.||+.||.|||++|++||||+|+||+++..+. .+||+|||++...... ..
T Consensus        82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccc
Confidence            9965 7877776544  3578889999999999999999999999999999999985432 3899999998643222 22


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--------------c
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------------Y  222 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~  222 (341)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|.+||..........+.........              .
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            23456788999999987655444569999999999999999999987655444433322111100              0


Q ss_pred             cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          223 FLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       223 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..+         ....+++.+.+++.+||+.+|.+||++.++++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            000         01347888999999999999999999999999999954

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-44  Score=318.03  Aligned_cols=250  Identities=31%  Similarity=0.521  Sum_probs=209.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ||++++.||+|+||.||++.+..+++.||+|.+...   ......+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            799999999999999999999999999999998643   22345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CC
Q 019433           81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~  157 (341)
                      +.+++|...+....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++....... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999999887643  5899999999999999999999999999999999999987776  9999999886432211 12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||++.+..+..+ +|+|||||++|+|++|..||............    ..... .+....++.++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI----IRGSY-PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHHH----hcCCC-CCCcccCCHHHHHH
Confidence            23468889999999987776554 89999999999999999999765443322222    11111 12223678999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=325.94  Aligned_cols=260  Identities=30%  Similarity=0.447  Sum_probs=213.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC--CC----CeeeEEEEEEcCCEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--HP----NIIRFKEVLLTPTHL   74 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~--hp----~iv~l~~~~~~~~~~   74 (341)
                      +.+||.++..+|+|.||+|..|.+..++..||||+++.-.+..+...-|+.++..+.  -|    -+|.+.++|...+++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            468999999999999999999999999999999999988888889999999999983  23    378888899999999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC----------------
Q 019433           75 AIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP----------------  136 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~----------------  136 (341)
                      |||+|.+ |.++++++.+++  +|+...++.+.+||++++++||+.+++|.|+||+||++.++.                
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~  245 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP  245 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence            9999998 569999998765  699999999999999999999999999999999999984211                


Q ss_pred             --CCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH
Q 019433          137 --QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       137 --~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~  214 (341)
                        ...|+|+|||.|+..  .....+.+.|..|+|||++.+-.++.+ +||||+||||+||++|...|...++.+.+ ..+
T Consensus       246 ~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMM  321 (415)
T KOG0671|consen  246 LKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMM  321 (415)
T ss_pred             CCCcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHH
Confidence              224899999999732  233366788999999999999999877 99999999999999999999887766544 222


Q ss_pred             HHHhc------------------ccccCCCC-----------------------CCCCHHHHHHHHHhcccCCCCCCChh
Q 019433          215 DRIRN------------------VQYFLPDY-----------------------VRVSADCRHLLSQIFVADPSKRIPIP  253 (341)
Q Consensus       215 ~~~~~------------------~~~~~~~~-----------------------~~~s~~~~~li~~~L~~dp~~R~s~~  253 (341)
                      ..+..                  ....+++.                       ..--..+.|||++||.+||.+|+|+.
T Consensus       322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~  401 (415)
T KOG0671|consen  322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR  401 (415)
T ss_pred             HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence            22210                  01111110                       00113378999999999999999999


Q ss_pred             HHhcCCccCCCC
Q 019433          254 EIKKHPWFLKNL  265 (341)
Q Consensus       254 e~l~hp~~~~~~  265 (341)
                      |+|.||||....
T Consensus       402 EAL~HpFF~~~~  413 (415)
T KOG0671|consen  402 EALSHPFFARLT  413 (415)
T ss_pred             HHhcCHHhhcCC
Confidence            999999996543

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-44  Score=318.40  Aligned_cols=247  Identities=32%  Similarity=0.512  Sum_probs=200.8

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHH-HhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~-~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++.||.|+||.||+|.+..+++.||+|.+.+....    ......|..+ ....+||||+++++++...+..++|+||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999998754321    1223344433 345589999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      +++|..++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++.....   .....+
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCC
Confidence            9999999988888999999999999999999999999999999999999988776  99999998874322   334568


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCCCHHHHHHHHH
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHLLSQ  240 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~  240 (341)
                      ++.|+|||.+.+..+. .++||||||+++|+|++|..||...+....+..    ........+  ....+++.+.+++.+
T Consensus       156 ~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         156 TPDYLAPETILGVGDD-KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             CcCccChhhhcCCCCc-chhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccccCCHHHHHHHHH
Confidence            8999999999877754 459999999999999999999977554333222    221111111  222578999999999


Q ss_pred             hcccCCCCCCCh---hHHhcCCccCCC
Q 019433          241 IFVADPSKRIPI---PEIKKHPWFLKN  264 (341)
Q Consensus       241 ~L~~dp~~R~s~---~e~l~hp~~~~~  264 (341)
                      ||+.+|.+||++   +|++.||||.+.
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhcC
Confidence            999999999955   799999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-45  Score=329.03  Aligned_cols=253  Identities=28%  Similarity=0.408  Sum_probs=198.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEccc---CccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.-|+++++||+||.+.||++.....+ .||+|++.-   .......+..||..|..| .|.+||+|+++-..++.+|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            356999999999999999999997554 456555432   334455788999999999 599999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||-+. +|..++.+.+.. +.-.++.+..|+|.|+.++|+.||||.||||.|+|+-. |  ++||+|||+|........
T Consensus       439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G--~LKLIDFGIA~aI~~DTT  514 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G--RLKLIDFGIANAIQPDTT  514 (677)
T ss_pred             eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e--eEEeeeechhcccCcccc
Confidence            998754 999999887754 33688999999999999999999999999999999853 3  399999999985443332


Q ss_pred             ---CCCccCCCCccccccccccccC----------CCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--c
Q 019433          157 ---PKSTVGTPAYIAPEVLARKEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--Q  221 (341)
Q Consensus       157 ---~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~  221 (341)
                         ..+.+||+.||+||.+....+.          +.++||||||||||+|+.|++||..-.+   ....+..+.+.  .
T Consensus       515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~~  591 (677)
T KOG0596|consen  515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNHE  591 (677)
T ss_pred             ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCcc
Confidence               3467899999999998654332          3458999999999999999999975321   12222222222  2


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          222 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..+|.... ..++.++++.||+.||++|||+.++|+|||++-
T Consensus       592 Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  592 IEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             ccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            23333211 123899999999999999999999999999965

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-44  Score=321.38  Aligned_cols=256  Identities=30%  Similarity=0.455  Sum_probs=211.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+.|+.++.||.|+||.||+|.+..++..||+|++....  .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            467999999999999999999999999999999987542  233567889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |+++++|.+++.. .++++..+..++.|++.||.|||+++++|+||+|+||+++.++.  ++|+|||++....... ...
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccc
Confidence            9999999998864 57999999999999999999999999999999999999987776  9999999986432222 123


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...++..|+|||++.+..++.+ +|+|||||++|+|++|..||..........    .+.... .......++..+.+++
T Consensus       160 ~~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li  233 (277)
T cd06640         160 TFVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKNN-PPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcCC-CCCCchhhhHHHHHHH
Confidence            3467889999999987766554 899999999999999999997654322221    111110 1111224678899999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      .+||..+|++||++.++++||||.+...
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcch
Confidence            9999999999999999999999966544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-44  Score=334.56  Aligned_cols=249  Identities=25%  Similarity=0.343  Sum_probs=200.2

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||+||+|.+     ..++..||+|++....  ...+.+.+|+.+++.+ +||||+++++++......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     3567789999987543  2234678899999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC------------------------------------------------------------
Q 019433           75 AIVMEYAAGGELFARICSAG------------------------------------------------------------   94 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~------------------------------------------------------------   94 (341)
                      ++|||||++|+|..++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999998886422                                                            


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC---
Q 019433           95 ---------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---  156 (341)
Q Consensus        95 ---------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~---  156 (341)
                                     .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......   
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccc
Confidence                           4778889999999999999999999999999999999987665  99999999874322211   


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||........+...+..   . .........+.++.
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~l~  347 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE---G-YRMLSPECAPSEMY  347 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh---C-ccCCCCCCCCHHHH
Confidence            112234567999999988777654 999999999999998 89999775544333333221   1 11112235688999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +||.+||+.||++|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-45  Score=335.22  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=211.8

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE----
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH----   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~----   73 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.+++.++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999999999999998653   2233457789999999999999999998876554    


Q ss_pred             --EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           74 --LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        74 --~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                        .++|+||+ +++|.+++.. .++++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++...
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~  168 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHT  168 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEccccccccc
Confidence              89999999 5689888765 57999999999999999999999999999999999999998776  999999998743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------  221 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (341)
                      .  .......++..|+|||.+.+....+.++|||||||++|+|++|..||........+...........          
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             c--ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            2  2234557888999999987644445569999999999999999999987665444433322111000          


Q ss_pred             ----------cc-----CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          222 ----------YF-----LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       222 ----------~~-----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                                ..     ......+++.+.+||.+||+.||.+|||+.++++||||.+...++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                      00     000124688999999999999999999999999999998776554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.8e-44  Score=318.31  Aligned_cols=250  Identities=28%  Similarity=0.434  Sum_probs=200.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHH---HHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREI---INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei---~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .||+|+||.||+|.+..+++.||+|.+......    ......|.   ..++...||+|+++++++......++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764211    11223333   34445689999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      |++|..++...+.+++..++.++.|++.||.|||+++++||||||+||+++.++.  ++|+|||++..... .......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~-~~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCc-cCCcCcCC
Confidence            9999999988888999999999999999999999999999999999999988776  99999999864322 22344578


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      +..|+|||++.+....+.++||||+||++|+|++|..||......... ............++.  .+|+++.+++.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPD--SFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-HHHHHhhccCCCCCC--cCCHHHHHHHHHHh
Confidence            999999999875533334589999999999999999999765322111 111111222222332  57899999999999


Q ss_pred             ccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          243 VADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       243 ~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      ..+|.+||     ++.++++||||....
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999     999999999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-44  Score=324.69  Aligned_cols=255  Identities=26%  Similarity=0.423  Sum_probs=200.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-------
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-------   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-------   72 (341)
                      ++|++++.||+|+||.||+|.+..+++.||||.+....   .......+|+.+++.++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999999999999999886432   22335678999999999999999999987543       


Q ss_pred             -EEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           73 -HLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        73 -~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                       ..++||||+.+ +|...+.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.  +||+|||++..
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~  168 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARA  168 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCccc
Confidence             46999999975 7777765543 7899999999999999999999999999999999999988776  99999999864


Q ss_pred             CCCCCC-----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-cc---
Q 019433          151 GLLHSQ-----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQ---  221 (341)
Q Consensus       151 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~---  221 (341)
                      ......     .....++..|+|||.+.+....+.++||||||+++|+|++|.+||.......... .+..+.. ..   
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  247 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQLCGSITPEV  247 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhh
Confidence            322211     1234578889999998765544456999999999999999999997755432222 1111110 00   


Q ss_pred             ------------ccCCC-----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          222 ------------YFLPD-----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       222 ------------~~~~~-----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                  ...+.           ....++.+.+||.+||..||.+|||++++++||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        00000           01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-44  Score=318.89  Aligned_cols=255  Identities=28%  Similarity=0.485  Sum_probs=209.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.|++++.||+|+||.||+|.+..+++.||+|.+...  ......+.+|+.+++.+.   |||++++++++......++|
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv   80 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII   80 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence            3589999999999999999999999999999998653  223456778999988886   99999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-C
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~  156 (341)
                      |||+++++|..++.. ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++....... .
T Consensus        81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccc
Confidence            999999999998865 47999999999999999999999999999999999999998766  9999999886433222 2


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~  235 (341)
                      .....|+..|+|||.+.+....+.++|+|||||++|+|++|..||.........    ....... ..++. ..++.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~  232 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLED-NGYSKLLR  232 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCCc-ccCCHHHH
Confidence            234468899999999876554455699999999999999999999765432221    1111111 11111 13788999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +++.+||..||.+||++.++++||||.+..
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999999996654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-44  Score=335.56  Aligned_cols=248  Identities=23%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||.||+|.+..+     +..||+|++.....  ....+.+|+.+++.+ +||||+++++++......
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986543     35799999875432  234678899999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc-------------------------------------------------------------
Q 019433           75 AIVMEYAAGGELFARICSA-------------------------------------------------------------   93 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~-------------------------------------------------------------   93 (341)
                      ++|||||++|+|.+++...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999888542                                                             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC---CCCcc
Q 019433           94 ---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTV  161 (341)
Q Consensus        94 ---------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~  161 (341)
                               .++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......   .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCC
Confidence                     24788899999999999999999999999999999999987766  99999999874322211   11223


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      ++..|+|||++.+..++.+ +|||||||++|+|++ |..||........+......    ....+....+++++.+++.+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR----GYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc----ccCccCCCCCCHHHHHHHHH
Confidence            4567999999987777654 899999999999997 99999765443333222211    11112223578999999999


Q ss_pred             hcccCCCCCCChhHHhc
Q 019433          241 IFVADPSKRIPIPEIKK  257 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~  257 (341)
                      ||+.||.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.9e-44  Score=327.46  Aligned_cols=290  Identities=27%  Similarity=0.378  Sum_probs=219.3

Q ss_pred             CccccceecccCCeEEEEEEEcCC--CcEEEEEEcccCc---cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC----CE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRT--KELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTP----TH   73 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~----~~   73 (341)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+....   ...+.+.+|+.+++.+ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            689999999999999999999988  9999999986532   2234677899999988 599999999975432    45


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++++++|+. ++|..++.....+++..++.++.||+.||.|||++|++||||||+|||++.++.  ++|+|||++.....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            789999986 589999988888999999999999999999999999999999999999988776  99999999874322


Q ss_pred             CC-----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh----------
Q 019433          154 HS-----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR----------  218 (341)
Q Consensus       154 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  218 (341)
                      ..     ......||+.|+|||.+.+....+.++|||||||++|+|++|.+||........+...+....          
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            11     123347899999999886644334559999999999999999999987554333322221110          


Q ss_pred             ----------cc---c-ccC-CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCC
Q 019433          219 ----------NV---Q-YFL-PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRD  283 (341)
Q Consensus       219 ----------~~---~-~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~  283 (341)
                                ..   . ..+ ......+..+.+|+.+||+.||.+|||+.+++.||||.+...+.........+.  ..-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~--~~~  315 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFD--FSF  315 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCcccccccccccc--CCc
Confidence                      00   0 000 011246788999999999999999999999999999976643322222222111  223


Q ss_pred             CCCCCHHHHHHHHHH
Q 019433          284 QPTQSVEEIMRIIQE  298 (341)
Q Consensus       284 ~~~~~~~~~~~~~~~  298 (341)
                      ..+.++++++.++++
T Consensus       316 ~~~~~~~~~~~~~~~  330 (332)
T cd07857         316 ESEDSMEELRDMIIE  330 (332)
T ss_pred             cccccHHHHHHHHhh
Confidence            445677777777664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.8e-44  Score=318.21  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             CCCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +++|++.+.||+|+||.||+|.++   ..+..||+|.+....  .....+.+|+.+++.++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357999999999999999999875   456789999987643  223467889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+++++|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||.+.......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~  161 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccc
Confidence            99999999999998764 47899999999999999999999999999999999999988776  9999999876432221


Q ss_pred             CC--CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          156 QP--KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       156 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      ..  ....++..|+|||++.+..++.+ +|||||||++|++++ |..||..........    .+... ...+....++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~  235 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK----AVEDG-FRLPAPRNCPN  235 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHHCC-CCCCCCCCCCH
Confidence            11  12234578999999988777654 899999999999775 999998755433222    22221 22333446889


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhc
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         236 LLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.5e-44  Score=313.18  Aligned_cols=252  Identities=33%  Similarity=0.498  Sum_probs=213.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv~   78 (341)
                      +|++.+.||+|++|.||+|.+..++..|++|++....   ...+.+.+|+.+++.++||||+++++++...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5899999999999999999999999999999987654   3456788999999999999999999999988  8999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      ||+.+++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccc
Confidence            99999999999988889999999999999999999999999999999999999998666  99999999875444332  


Q ss_pred             -CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          157 -PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                       .....++..|+|||.+.+.....+ +|+||||+++|+|++|..||....+....   ................++..+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHhccccCCCcCCCcccCHHHH
Confidence             345678899999999887765544 89999999999999999999876532221   1111111111122235689999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++|.+||+.+|.+||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-46  Score=342.74  Aligned_cols=251  Identities=30%  Similarity=0.474  Sum_probs=210.7

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEccc-CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHH
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFA   88 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~   88 (341)
                      .||+|.||+||.|++..|...+|||-+.. .....+-+..||.+++.|+|.|||++++++..++.+-|.||-.+||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999999999999998864 33455678899999999999999999999999999999999999999999


Q ss_pred             HHHhcC-CC--CHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC-CCCCCCCCccCCC
Q 019433           89 RICSAG-RF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKSTVGTP  164 (341)
Q Consensus        89 ~l~~~~-~l--~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~-~~~~~~~~~~gt~  164 (341)
                      ++.... ++  .+..+-.+.+||++||+|||++.|||||||-+||||+.. .+.+||+|||.++.. .....+.+..||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccch
Confidence            997654 67  789999999999999999999999999999999999753 345999999998753 3344456778999


Q ss_pred             Ccccccccc-ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcc
Q 019433          165 AYIAPEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV  243 (341)
Q Consensus       165 ~y~aPE~~~-~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  243 (341)
                      .|||||++- |.+-+++++|||||||++.||.||++||.....+....-.   +.-.+.-.|-...+|.+++.||.+|+.
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            999999985 4444577899999999999999999999876665432211   111111122334688999999999999


Q ss_pred             cCCCCCCChhHHhcCCccCCC
Q 019433          244 ADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       244 ~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +||.+||||.++|..||++..
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999655

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.7e-45  Score=325.87  Aligned_cols=257  Identities=29%  Similarity=0.489  Sum_probs=211.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +.|.....||.|+||.||++.+..++..||||.+.... ...+.+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            45667788999999999999999999999999986532 23446788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  160 (341)
                      ++++|..++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++...... ......
T Consensus       102 ~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         102 EGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCcee
Confidence            99999888744 56999999999999999999999999999999999999988776  999999988642211 122345


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      .|+..|+|||.+.+..++. ++|+||||+++|+|++|..||........+.....   ......+....++..+.+++.+
T Consensus       179 ~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ecCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCCccccccccCHHHHHHHHH
Confidence            6889999999997777655 48999999999999999999987554333322111   1122223333578899999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCC
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ||..||.+|||+.++++||||....+
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~  280 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGP  280 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCC
Confidence            99999999999999999999975443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-44  Score=322.92  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=203.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.|...+.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.++..+. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35788899999999999999999999999999987543  22346778998888885 9999999999999999999999


Q ss_pred             ecCCCchHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           80 YAAGGELFAR---IC--SAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        80 ~~~~~~L~~~---l~--~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      |+.. ++..+   +.  ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.  ++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence            9865 44332   22  23579999999999999999999997 59999999999999987776  99999999864333


Q ss_pred             CCCCCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCC
Q 019433          154 HSQPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVR  229 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  229 (341)
                      ........|++.|+|||++.+.  ...+.++|||||||++|+|++|..||.....  ...............++  ....
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCcCCCc
Confidence            3333445788999999998766  2334458999999999999999999976442  11111111111111111  1235


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ++.++.+||.+||+.+|.+|||++++++||||....
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            889999999999999999999999999999997644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-44  Score=318.90  Aligned_cols=254  Identities=30%  Similarity=0.498  Sum_probs=207.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEEEe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIVME   79 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv~e   79 (341)
                      |++++.||.|+||.||+|.+..+++.+|+|.+....   .....+.+|+.+++.++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999999999999999998652   3345678899999999999999999999988  89999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--C
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~  156 (341)
                      |+++ +|..++... ..+++..++.++.||+.||+|||++|++|+||+|+||++++++.  ++|+|||++.......  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9975 888888665 57999999999999999999999999999999999999998776  9999999987543332  1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCCC---------
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPD---------  226 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~---------  226 (341)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|..||.................... ..++.         
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23446788899999887654445569999999999999999999987665444443332211100 00000         


Q ss_pred             --------------CCC-CCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          227 --------------YVR-VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       227 --------------~~~-~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                    ... .++.+.+++++||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          112 38889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8e-44  Score=314.06  Aligned_cols=250  Identities=32%  Similarity=0.520  Sum_probs=207.5

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~iv~   78 (341)
                      +|++++.||.|+||.||+|.+..+++.||+|.+....   ...+.+..|+.+++.++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5899999999999999999999999999999986533   223457789999999999999999998764  45689999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH-----~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ||+++++|..++..    ..++++..++.++.||+.||.|||     +.+++|+||+|+||++++++.  ++|+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccc
Confidence            99999999998865    357999999999999999999999     999999999999999998776  9999999987


Q ss_pred             CCCCCCC-CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          150 SGLLHSQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       150 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ....... .....+++.|+|||++.+..++. ++|+||||+++|+|++|..||...... ..   ...+...... +-..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~~-~~~~  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSPPFTARNQL-QL---ASKIKEGKFR-RIPY  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCc-hhHHHHHHHHHHHHHHCCCcccCcCHH-HH---HHHHhcCCCC-CCcc
Confidence            5433322 33457899999999998777654 489999999999999999999876532 22   2222222211 1123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .++..+.+++.+||+.+|.+|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.1e-43  Score=317.70  Aligned_cols=255  Identities=29%  Similarity=0.517  Sum_probs=211.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +|...+.||.|++|.||++.+..+++.+++|.+..... ..+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            56777899999999999999999999999998864332 23457889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCcc
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTV  161 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  161 (341)
                      +++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++...... .......
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccccccc
Confidence            9999998877 67999999999999999999999999999999999999988776  999999987632221 1223356


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-cccCCCCCCCCHHHHHHHHH
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~  240 (341)
                      |++.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+.......    +... .........++..+.+|+.+
T Consensus       177 ~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             CCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHHH
Confidence            8999999999987776554 8999999999999999999976543322222    2221 11122223478899999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCC
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ||+.+|++|||+.++++||||.+..+
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999977654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-44  Score=322.33  Aligned_cols=257  Identities=30%  Similarity=0.479  Sum_probs=206.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------   72 (341)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+....   .....+.+|+.+++.++||||+++++++....      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999999999999986532   23346778999999999999999999987655      


Q ss_pred             ----EEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           73 ----HLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        73 ----~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                          .+++|+||+++ ++...+... ..+++..++.++.|++.||.|||++||+||||||+||++++++.  +||+|||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence                79999999987 666666543 46999999999999999999999999999999999999998776  99999999


Q ss_pred             ccCCCCCC--CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cC
Q 019433          148 SKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL  224 (341)
Q Consensus       148 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  224 (341)
                      +.......  ......++..|+|||.+.+....+.++|||||||++|+|++|++||...+....+............ .+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            87533222  1122356788999998876544445699999999999999999999876654444333332111000 00


Q ss_pred             -----------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 -----------------------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 -----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                                             ..+..++..+.+++.+||..||.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                   1123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=306.07  Aligned_cols=254  Identities=26%  Similarity=0.399  Sum_probs=209.1

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+.+..||.|+.|+||+++...+|..+|||.+++...  ..+.++..+.++... ++|.||+++++|..+..++|.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            3578899999999999999999999999999987543  334566666665444 4899999999999999999999988


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      .. -+..++.+ .++++|.-+-++...+++||.||-+ +||+|||+||+|||+|..|+  |||||||++...........
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtr  250 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTR  250 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccccccc
Confidence            43 33444433 5579999999999999999999976 68999999999999999888  99999999987766666677


Q ss_pred             ccCCCCcccccccccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCC-ChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          160 TVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPE-DPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~vl~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ..|.+.|||||.+...   .|+-. +||||||++++||.||..||.... +...+.+++.   .....++.-..+|++++
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSPDFQ  326 (391)
T ss_pred             ccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCHHHH
Confidence            7899999999998633   45555 899999999999999999998754 3334433332   34455666667999999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +|+..||.+|+.+||...++|+|||+..-.
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            999999999999999999999999996543

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.6e-44  Score=323.58  Aligned_cols=254  Identities=27%  Similarity=0.487  Sum_probs=209.9

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      |.....||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            556678999999999999999999999999986532 3345678899999999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~g  162 (341)
                      ++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++....... ......|
T Consensus       103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceec
Confidence            999887644 56999999999999999999999999999999999999988776  9999999886322211 2234578


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-cccCCCCCCCCHHHHHHHHHh
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~  241 (341)
                      +..|+|||++.+..+.. ++|+|||||++|+|++|..||...........    +... .........++..+.++|.+|
T Consensus       180 ~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         180 TPYWMAPEVISRTPYGT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             CccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCCCccccCCCCHHHHHHHHHH
Confidence            99999999998777654 48999999999999999999986554333221    1111 111222346788999999999


Q ss_pred             cccCCCCCCChhHHhcCCccCCCCC
Q 019433          242 FVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |+.+|.+||++.++++||||.+...
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhccCCC
Confidence            9999999999999999999977643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-44  Score=320.75  Aligned_cols=250  Identities=34%  Similarity=0.573  Sum_probs=212.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999987632    22356788999999998 99999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--  155 (341)
                      ||++.+++|.+++.+...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.  ++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence            999999999999988888999999999999999999999999999999999999987776  9999999886432211  


Q ss_pred             -------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHH
Q 019433          156 -------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       156 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~  216 (341)
                                         ......++..|+|||++.+..+.. ++|+||||++++++++|..||........+...   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---  234 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI---  234 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---
Confidence                               112345788999999987766544 489999999999999999999876644333322   


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCCh----hHHhcCCcc
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI----PEIKKHPWF  261 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~----~e~l~hp~~  261 (341)
                       .......+.  .+++.+.+||.+||+.+|.+|||+    .++++||||
T Consensus       235 -~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         235 -LKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             -HhcCCCCCC--ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             223333333  678999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3e-44  Score=329.51  Aligned_cols=260  Identities=29%  Similarity=0.399  Sum_probs=205.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--------
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP--------   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--------   71 (341)
                      +..||++.+.||.|+||.||+|.++.+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++...        
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            4689999999999999999999999999999999986543 3345688899999999999999999876544        


Q ss_pred             ------CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           72 ------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        72 ------~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                            ...++||||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+||+++..+. .++|+||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~df  159 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDF  159 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCc
Confidence                  358999999974 88887754 46999999999999999999999999999999999999975432 3899999


Q ss_pred             CCccCCCCCC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc--
Q 019433          146 GYSKSGLLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--  219 (341)
Q Consensus       146 g~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~--  219 (341)
                      |++.......    ......++..|+|||++.+....+.++|||||||++|+|++|..||..................  
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            9986432111    1123467889999998765444455699999999999999999999876544333332221100  


Q ss_pred             -------------------ccccCC---CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          220 -------------------VQYFLP---DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       220 -------------------~~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                         .....+   ....++.++.+||.+||+.||.+|||+.+++.||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                               000000   01247888999999999999999999999999999954

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-43  Score=308.73  Aligned_cols=251  Identities=31%  Similarity=0.500  Sum_probs=211.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .|.+.+.||.|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++||||+++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999999999999999877543 45678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCcc
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV  161 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  161 (341)
                      +++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.  ++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence            99999998776 57999999999999999999999999999999999999998766  9999999987543332234567


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      ++..|+|||.+.+...+. ++|+||||+++|+|++|..||...+.........   .......+....++..+.++|.+|
T Consensus       159 ~~~~~~~PE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence            889999999988776544 4999999999999999999998754332222111   111112233233588999999999


Q ss_pred             cccCCCCCCChhHHhcCCc
Q 019433          242 FVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~hp~  260 (341)
                      |+.||++|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-44  Score=321.73  Aligned_cols=254  Identities=30%  Similarity=0.435  Sum_probs=209.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+.|++++.||.|+||.||+|.+..++..||+|.+....  ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            467999999999999999999999999999999986432  233468899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |+++++|..++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++....... ...
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhh
Confidence            9999999988754 57899999999999999999999999999999999999988776  9999999986433221 122


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    .+.... .......++.++.++|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li  233 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNS-PPTLEGQYSKPFKEFV  233 (277)
T ss_pred             cccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCC-CCCCCcccCHHHHHHH
Confidence            3467889999999987776554 999999999999999999997644322221    111111 1111125788899999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+||+.+|.+|||+.++++||||...
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999999999543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-44  Score=329.00  Aligned_cols=258  Identities=28%  Similarity=0.447  Sum_probs=205.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------   71 (341)
                      +.++|.+.+.||+|+||.||+|.+..+|+.||+|++.+..   .....+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3579999999999999999999999999999999986532   2334678899999999999999999998754      


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..+++|++|+.. +|...+  ...+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++..
T Consensus        93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~  167 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHA  167 (342)
T ss_pred             ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCC
Confidence            357999999964 676654  346999999999999999999999999999999999999998776  999999998743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh-------------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------  218 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------  218 (341)
                        ........+++.|+|||++.+....+.++|+|||||++|+|++|+.||...+....+...+....             
T Consensus       168 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 --DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             --CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence              22233456788999999987644344559999999999999999999987654333332222100             


Q ss_pred             -------cccccC-----CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          219 -------NVQYFL-----PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       219 -------~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                             ......     ......++.+.+||.+||+.||.+||++.+++.||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                   000000     00124678899999999999999999999999999996654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-43  Score=318.05  Aligned_cols=258  Identities=31%  Similarity=0.523  Sum_probs=211.4

Q ss_pred             CccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++....     ...+.+.+|+.+++.+ +||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999985   478999999986532     2335677899999999 699999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccc
Confidence            999999999999999988888999999999999999999999999999999999999988766  999999998753222


Q ss_pred             C--CCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          155 S--QPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      .  ......|+..|+|||.+.+.. ....++||||||+++|+|++|..||.......................+  ..++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCC
Confidence            1  122456889999999986532 2344589999999999999999999754433333333333332222222  3578


Q ss_pred             HHHHHHHHHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          232 ADCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      +.+.+++++||+.||.+||     ++.+++.||||....
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999999999997     899999999997654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-44  Score=323.92  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP-------   71 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-------   71 (341)
                      .++|++.+.||.|+||.||+|.++.+++.+|+|.+.....   ......+|+.+++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            3689999999999999999999999999999999865321   234577899999999999999999987543       


Q ss_pred             -CEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           72 -THLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        72 -~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                       ..+++|++|+.+ +|...+.. ...+++..++.++.|+++||.|||++||+||||||+||++++++.  ++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence             357999999976 56666554 457999999999999999999999999999999999999998776  9999999986


Q ss_pred             CCCCCCC------------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHH
Q 019433          150 SGLLHSQ------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       150 ~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      .......            .....+++.|+|||.+.+....+.++|||||||++|+|++|.+||................
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            4221111            1223568889999998765444455999999999999999999998766554444333221


Q ss_pred             hcccc-------------------cC-----CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          218 RNVQY-------------------FL-----PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       218 ~~~~~-------------------~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .....                   ..     .....+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            11000                   00     0012355788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.1e-44  Score=318.18  Aligned_cols=248  Identities=24%  Similarity=0.381  Sum_probs=204.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC-----cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK-----ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||.||+|.....+     ..||+|.+....  .....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47999999999999999999986555     789999986543  22346788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      ++|||+++++|.+++...                ..+++..++.++.|++.||.|||++|++||||||+||++++++.  
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence            999999999999998764                45788999999999999999999999999999999999988776  


Q ss_pred             EEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHH
Q 019433          140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID  215 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~  215 (341)
                      ++|+|||++.......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||......+.    ..
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~----~~  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEV----IE  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence            9999999987432221   2233456788999999887777654 899999999999998 9999987554322    22


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.... ..+....+++++.+|+.+||+.||.+||++.+++++
T Consensus       238 ~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222211 112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-44  Score=327.15  Aligned_cols=260  Identities=25%  Similarity=0.424  Sum_probs=207.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .++|.+++.||+|+||.||++.+..+++.||+|++.+..   ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            579999999999999999999999999999999987532   2235677899999999999999999988643      3


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..+++++++ +++|..++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++... 
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~-  170 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT-  170 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc-
Confidence            478888887 6788777654 46999999999999999999999999999999999999998776  999999998743 


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc------------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------  220 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  220 (341)
                       ........+++.|+|||.+.+....+.++|||||||++|+|++|..||........+..........            
T Consensus       171 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         171 -DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             -cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence             2233445788999999998764333455999999999999999999997655443333222111000            


Q ss_pred             -------cccCCC------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          221 -------QYFLPD------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       221 -------~~~~~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                             ....+.      ....++++.+||.+||++||.+|||+.+++.||||.+...+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                   000000      12357889999999999999999999999999999765543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-43  Score=311.69  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=202.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +.|++.+.||+|+||.||++..+ .+..+|+|.+.........+.+|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            46899999999999999999886 45679999987665556678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC--CC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~--~~  159 (341)
                      +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||.++........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCC
Confidence            99999988753 46899999999999999999999999999999999999987776  999999988743221111  12


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||++.+..+..+ +|+||||+++|+|++ |+.||........+...    ..... .......+..+.+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~~~-~~~~~~~~~~~~~li  234 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRGFR-LYRPKLASMTVYEVM  234 (256)
T ss_pred             CCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCC-CCCCCCCCHHHHHHH
Confidence            234567999999987776554 999999999999999 99999876544333332    22111 111234678899999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||+.+|.+|||+.++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-44  Score=320.98  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=210.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|.+++.||+|+||+||++.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            68999999999999999999999899999999986432 23456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~  160 (341)
                      ++++|..++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++....... .....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccccc
Confidence            99999998865 35889999999999999999999999999999999999987776  9999999876432222 22334


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      .|++.|+|||.+.+..++. ++|+|||||++|++++|..||............   ........+....++..+.++|++
T Consensus       176 ~~~~~y~~PE~~~~~~~~~-~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cCChhhcCchhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHHH
Confidence            6888999999988776655 489999999999999999999765432221111   111111222334578899999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCC
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||..+|.+||++.+++.||||....
T Consensus       252 ~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         252 CLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.4e-44  Score=314.69  Aligned_cols=246  Identities=36%  Similarity=0.589  Sum_probs=208.1

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||.|+||.||++.+..+++.+|+|.+....    .....+.+|+.+++.++||||+++++.+......|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999999999999999986543    2345688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---------CC
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---------QP  157 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---------~~  157 (341)
                      ..++.+...+++..+..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999988778999999999999999999999999999999999999998776  9999999987533321         12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....++..|+|||.+.+.... .++|+||||+++|+|++|..||........+    ..........+....++..+.++
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHS-KTVDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHH
Confidence            334678899999998777654 4589999999999999999999765543322    22233333444444468999999


Q ss_pred             HHHhcccCCCCCCCh---hHHhcCCccCC
Q 019433          238 LSQIFVADPSKRIPI---PEIKKHPWFLK  263 (341)
Q Consensus       238 i~~~L~~dp~~R~s~---~e~l~hp~~~~  263 (341)
                      +.+||+.+|.+|||+   .++++||||..
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            999999999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.8e-44  Score=316.70  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=203.7

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|.+.+.||+|+||.||+|.+.     .++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            57999999999999999999875     3468899999876433  2457889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           76 IVMEYAAGGELFARICSAG--------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      +||||+++++|..++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EE
Confidence            9999999999999987542              4788999999999999999999999999999999999988776  99


Q ss_pred             EeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHH
Q 019433          142 ICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       142 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      |+|||++.......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.........    ..+
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~----~~~  237 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVI----ECI  237 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHH
Confidence            99999986432211   1223446788999999988877655 899999999999998 99999776543332    222


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ...... +....++..+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            222221 122368899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-43  Score=311.69  Aligned_cols=247  Identities=32%  Similarity=0.492  Sum_probs=205.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +|++.+.||.|+||.||++.++.+++.+|+|.+...  ....+.+.+|+.+++.++||||+++++.+.....++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            689999999999999999999999999999987643  233456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      ++++|..++...  ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            999999988653  35899999999999999999999999999999999999988776  9999999986433222 223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+....    ...+..... .+....++..+.+||
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li  232 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYELRSLI  232 (255)
T ss_pred             cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHHHHHH
Confidence            4568899999999987776554 8999999999999999999976443222    222222211 112235788999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.||.+|||+.+++.-
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.6e-43  Score=312.19  Aligned_cols=251  Identities=29%  Similarity=0.476  Sum_probs=200.9

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCc
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~   85 (341)
                      ....||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++++||+++++
T Consensus        12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            4468999999999999999999999999886543 234568899999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCCCcc
Q 019433           86 LFARICSA-GRF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTV  161 (341)
Q Consensus        86 L~~~l~~~-~~l--~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~~~~  161 (341)
                      |..++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++.+. ..++|+|||++..... ........
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~  170 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETFT  170 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccCC
Confidence            99998764 455  8889999999999999999999999999999999997532 2499999998864321 11223346


Q ss_pred             CCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          162 GTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       162 gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      |++.|+|||++.+.. ..+.++|+||||+++|+|++|..||.............. ........+  ..+++++.+|+.+
T Consensus       171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~li~~  247 (268)
T cd06624         171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG-MFKIHPEIP--ESLSAEAKNFILR  247 (268)
T ss_pred             CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh-hhccCCCCC--cccCHHHHHHHHH
Confidence            889999999986543 234558999999999999999999976443221111110 111111122  2578899999999


Q ss_pred             hcccCCCCCCChhHHhcCCcc
Q 019433          241 IFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ||+.+|.+|||+.+++.||||
T Consensus       248 ~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         248 CFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.8e-44  Score=350.95  Aligned_cols=250  Identities=26%  Similarity=0.364  Sum_probs=201.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +||+++++||+|+||.||+|.+..+++.||||++.....    ..+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            689999999999999999999999999999999875422    2346788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           79 EYAAGGELFARICSA-----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        79 e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      ||++|++|..++.+.           ..++...+..++.||+.||.|||++||+||||||+||+++.++.  ++|+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence            999999999988642           23556778899999999999999999999999999999988777  99999999


Q ss_pred             ccCCCCC-------------------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh
Q 019433          148 SKSGLLH-------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR  208 (341)
Q Consensus       148 a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~  208 (341)
                      ++.....                   ......+||+.|+|||++.+..++. ++|||||||++|+|++|..||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~-kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE-STDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            8743110                   0112346999999999998877755 4899999999999999999997644321


Q ss_pred             HHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....  ... ...........+++.+.+++.+||+.||++|++..+.+.+
T Consensus       239 i~~~--~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 ISYR--DVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhh--hhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1111  111 1111122234688999999999999999999877665543

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-43  Score=315.35  Aligned_cols=258  Identities=30%  Similarity=0.496  Sum_probs=216.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+.|++.+.||.|+||.||++.+..++..||+|++.......+.+.+|+.+++.++|+||+++++++......++++||+
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   97 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM   97 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence            46799999999999999999999989999999998865544567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      ++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.  ++|+|||++....... ....
T Consensus        98 ~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~  175 (286)
T cd06614          98 DGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNS  175 (286)
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhcc
Confidence            9999999998876 8999999999999999999999999999999999999998776  9999999876432211 1233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.............   .......+....++..+.++|.
T Consensus       176 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~  251 (286)
T cd06614         176 VVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLN  251 (286)
T ss_pred             ccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHH
Confidence            457889999999887776554 999999999999999999997654432222111   1111122233347899999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +||+.+|.+|||+.++++||||.+..
T Consensus       252 ~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         252 KCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHhccChhhCcCHHHHhhChHhhccC
Confidence            99999999999999999999997743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.5e-43  Score=322.98  Aligned_cols=261  Identities=28%  Similarity=0.479  Sum_probs=207.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~i   76 (341)
                      ++++|++++.||.|+||.||+|.++.+++.||+|++...   ....+.+.+|+.+++.++||||+++.++|.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            478999999999999999999999999999999987542   2234567889999999999999999999876 567899


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ++||+ +++|..++. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++...  ...
T Consensus        88 v~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~--~~~  161 (328)
T cd07856          88 VTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQ--DPQ  161 (328)
T ss_pred             Eeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCcccccccc--CCC
Confidence            99999 458877765 456899999999999999999999999999999999999987766  999999998742  222


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh------------------
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR------------------  218 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------  218 (341)
                      .....+++.|+|||.+.+....+.++|+|||||++|+|++|..||........+........                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            34456788999999987644445569999999999999999999976543222211111100                  


Q ss_pred             --cccc--cCC---CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          219 --NVQY--FLP---DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       219 --~~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                        ....  ..+   ....++..+.++|++||+.+|++|||+++++.||||.....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence              0000  001   112467899999999999999999999999999999665443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-43  Score=314.88  Aligned_cols=251  Identities=28%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             CCCCc-cccceecccCCeEEEEEE----EcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--
Q 019433            1 MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTP--   71 (341)
Q Consensus         1 i~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--   71 (341)
                      +.+|| ++++.||+|+||+||++.    ...++..||+|.+.....  ....+.+|+.+++.++||||+++++++...  
T Consensus         1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             CChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            46788 999999999999998865    345788999999876432  345678899999999999999999987653  


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..++++|||+.+++|..++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++...
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~  157 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAV  157 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeeccccccc
Confidence            4689999999999999998654 5999999999999999999999999999999999999987766  999999998743


Q ss_pred             CCCCC----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH------------H
Q 019433          152 LLHSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI------------D  215 (341)
Q Consensus       152 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~------------~  215 (341)
                      .....    .....++..|+|||.+.+..++.+ +|||||||++|+|++|..||......  +....            .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~  234 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLI  234 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhh
Confidence            22111    122345667999999887776554 89999999999999999998654321  11100            0


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .........+.....+..+.+++.+||+.+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            000111112223457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.1e-45  Score=335.87  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=212.1

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcc-----cCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE--EEEEE
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTH--LAIVM   78 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~--~~iv~   78 (341)
                      +.-..||+|+|-+||+|.+..+|..||.-.+.     ++....+.+..|+.+|+.|+||||++++.+|.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            44567999999999999999999999966543     344455789999999999999999999999987654  89999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |.+.+|+|+.++.+.+.++...++.|++||++||.|||++.  |||||||-+||||+++- +.|||+|+|+|..... ..
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~-s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRK-SH  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhc-cc
Confidence            99999999999999999999999999999999999999986  99999999999998643 4599999999986443 34


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-ccccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~  235 (341)
                      ..+.+|||.|||||++. ..|+.. +||||||+++.||+|+..||....++.++.+.+....+ ..+.  .  --.++++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~--k--V~dPevr  274 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS--K--VKDPEVR  274 (632)
T ss_pred             cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh--c--cCCHHHH
Confidence            45589999999999986 566554 89999999999999999999988887666554433222 2221  1  1258899


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +||.+||.. .+.|+|+.|||+||||...
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999999 9999999999999999875

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-43  Score=312.05  Aligned_cols=251  Identities=35%  Similarity=0.536  Sum_probs=208.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++.+.||+|+||.||++.++.+|..+|+|.+....   ...+.+.+|+.+++.++||||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6999999999999999999999999999999986532   3345678999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CC
Q 019433           81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~  157 (341)
                      +++++|..++....  .+++..+..++.|++.||.|||+++++|+||||+||++++++. .++|+|||.+....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987644  4799999999999999999999999999999999999987643 37999999886433222 12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....|++.|+|||++.+..++. ++|+||||+++|+|++|..||...........    ..... ..+....++.++.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHHHHH
Confidence            2346888999999987776654 49999999999999999999976543322222    11111 112223578899999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      |.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-43  Score=312.43  Aligned_cols=248  Identities=22%  Similarity=0.326  Sum_probs=204.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ..|.+.+.||+|+||.||+|.++.+++.||+|.+.........+.+|+.+++.++||||+++++++.....++++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35889999999999999999999999999999987665445678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC--C
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--K  158 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~--~  158 (341)
                      +++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||++++++.  +||+|||++.........  .
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccC
Confidence            999999987643  5899999999999999999999999999999999999987776  999999998753322111  1


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||.+.+..++.. +|||||||++|+|++ |..||..........    .+.. ....+....+++.+.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEK-GYRMERPEGCPPKVYEL  237 (263)
T ss_pred             CCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHC-CCCCCCCCCCCHHHHHH
Confidence            1233567999999987777655 899999999999998 999997654332222    2221 11122234688999999


Q ss_pred             HHHhcccCCCCCCChhHHhcC
Q 019433          238 LSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~h  258 (341)
                      |.+||+.||++|||+.++++.
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-43  Score=312.02  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=203.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.++.+++.||||.+....    .....+.+|+.+++.++||||+++++++...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            58999999999999999999999999999999876422    22335778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||+++++|..++..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence            99999999888753    335899999999999999999999999999999999999988776  999999988643221


Q ss_pred             C-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 S-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      . ......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+............++..
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHH
Confidence            1 1223468889999999987776554 89999999999999999999654321  112222222222111112257788


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+++.+||..+|.+|||+.++++.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHH
Confidence            9999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=307.48  Aligned_cols=250  Identities=31%  Similarity=0.485  Sum_probs=211.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++.+.||+|++|.||++.+..+++.||+|.+.....   ....+.+|+.+++.++|||++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            69999999999999999999999999999999876542   445688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-CCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-~~~  159 (341)
                      +++++|.+++.....+++..++.++.|++.||.+||++||+||||+|+||+++.++.  ++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC--EEEeccccceecCCCcccccc
Confidence            999999999988888999999999999999999999999999999999999988665  99999999874332222 234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..++..|+|||.+.+..+. .++|+||||+++|+|++|..||............   ......  +....++..+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI---VQDDHP--PLPEGISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---hccCCC--CCCCCCCHHHHHHHH
Confidence            5688899999998776654 4589999999999999999999865533222221   111111  122367899999999


Q ss_pred             HhcccCCCCCCChhHHhcCCcc
Q 019433          240 QIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.9e-43  Score=310.25  Aligned_cols=250  Identities=36%  Similarity=0.553  Sum_probs=210.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++.+.||+|+||.||++.+..++..||+|++....   .....+.+|+.+++.++|||++++.+.+......++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            6999999999999999999999999999999987643   3345688899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           81 AAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      +++++|...+.+.    ..+++..+..++.+++.||.+||++|++|+||+|+||+++.++.  ++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999998764    67999999999999999999999999999999999999987766  9999999987433222 


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ......|++.|+|||.+.+..+..+ +|+||+|+++|+|++|..||...+.......    ..... ..+....++..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALK----ILKGQ-YPPIPSQYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH----HhcCC-CCCCCCCCCHHHH
Confidence            2334578899999999887776554 8999999999999999999976553322222    21111 1111226789999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +++.+||..+|.+|||+.++++||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.8e-44  Score=325.54  Aligned_cols=249  Identities=23%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEc-CCE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLT-PTH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~-~~~   73 (341)
                      +||++.+.||+|+||.||+|...     .+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++.. ...
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            68999999999999999999754     3457899999875432  234577899999999 89999999998765 467


Q ss_pred             EEEEEeecCCCchHHHHHhc------------------------------------------------------------
Q 019433           74 LAIVMEYAAGGELFARICSA------------------------------------------------------------   93 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~------------------------------------------------------------   93 (341)
                      ++++|||+++++|..++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            89999999999999888542                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---CCCCccCCCCcccc
Q 019433           94 -GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAP  169 (341)
Q Consensus        94 -~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aP  169 (341)
                       .++++..+..++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++.......   ......++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             25789999999999999999999999999999999999997766  9999999987532211   12233456789999


Q ss_pred             ccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019433          170 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSK  248 (341)
Q Consensus       170 E~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~  248 (341)
                      |++.+..++.+ +|||||||++|+|++ |..||........+...+...  .....  ....++++.+++.+||+.+|++
T Consensus       245 E~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         245 ESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG--TRMRA--PEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             HHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc--CCCCC--CccCCHHHHHHHHHHccCChhh
Confidence            99988887665 899999999999997 999997654433333222211  11112  2357889999999999999999


Q ss_pred             CCChhHHhcC
Q 019433          249 RIPIPEIKKH  258 (341)
Q Consensus       249 R~s~~e~l~h  258 (341)
                      ||++.++++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=316.96  Aligned_cols=254  Identities=30%  Similarity=0.474  Sum_probs=207.2

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc--cHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      |++.+.||+|++|+||+|....+++.||||.+......  .....+|+..++.++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            78999999999999999999999999999998664322  224557889999998 999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                       +++|...+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             779988887765  7899999999999999999999999999999999999998776  99999999875443333445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc---------------ccccC
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN---------------VQYFL  224 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~  224 (341)
                      ..++..|+|||++.+....+.++|+||||+++++|++|.+||..........+.......               .....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678899999999865544455699999999999999999999876654444333221110               00000


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 PD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 ~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.         ....+.++.+||++||+.+|.+|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00         11246889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-43  Score=310.71  Aligned_cols=251  Identities=33%  Similarity=0.501  Sum_probs=206.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~   74 (341)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....      .....+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875321      1224677899999999999999999998764  568


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence            999999999999999988778999999999999999999999999999999999999987776  999999998743221


Q ss_pred             ----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                          .......|+..|+|||.+.+..++. ++|+|||||++|+|++|..||..............  .......|  ..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~p--~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGR-KADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT--QPTKPMLP--DGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc--CCCCCCCC--ccc
Confidence                1122356889999999998776654 48999999999999999999987544333222110  11112223  368


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.+.++|.+||+ +|..||++.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-44  Score=317.14  Aligned_cols=254  Identities=31%  Similarity=0.476  Sum_probs=208.4

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      |++++.||.|++|.||+|.+..+++.+++|.+.....   ....+.+|+.+++.++||||+++++++......++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            7889999999999999999999999999999865432   3457888999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      .+ +|...+.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccC
Confidence            76 77777766 357999999999999999999999999999999999999997776  9999999886543322 2233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc---------------ccC
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ---------------YFL  224 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~  224 (341)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+....+...........               ...
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            56788999999987763445569999999999999999999987665544444332221100               000


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          225 P---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       225 ~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +         ....++.++.+||.+||.+||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0         012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.8e-43  Score=313.64  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=209.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +=|++++.||+|+||.||+|.+..++..||||.+....  .....+.+|+.+++.++||||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            45889999999999999999999999999999876432  2234677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      +++++|..++.. ..+++..+..++.|++.||.+||++|++|+||+|+||++++++.  ++|+|||++....... ....
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence            999999988854 46899999999999999999999999999999999999988776  9999999886432221 1223


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..++..|+|||.+.+...+.. +|+|||||++|+|++|..||...........    +..... ......++.++.+++.
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~i~  234 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFL----IPKNNP-PTLEGNYSKPLKEFVE  234 (277)
T ss_pred             ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHHH----HhcCCC-CCCCcccCHHHHHHHH
Confidence            468889999999877666544 8999999999999999999976543222211    111111 0111257889999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +||+.+|.+||++.++++||||.+...
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhhhh
Confidence            999999999999999999999976543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-43  Score=311.51  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=203.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|+++++||+|+||.||+|... ++..||+|.+.......+.+.+|+.+++.++||||+++++++......+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            57999999999999999999976 56779999987655556678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +++|.+++...  ..++...++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.......  ...
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccC
Confidence            99999998653  46889999999999999999999999999999999999988776  9999999987432211  112


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +.. ....+....++.++.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----LQR-GYRMPRMENCPDELYDI  236 (261)
T ss_pred             CCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            2335667999999987776554 899999999999998 9999976544322222    221 12234445688999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+||..+|++|||++++.+
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-43  Score=319.98  Aligned_cols=248  Identities=24%  Similarity=0.331  Sum_probs=198.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcE--EEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.|++.+.||+|+||+||+|.+..++..  +|+|.+....  .....+.+|+.++..+ +||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            4789999999999999999999877754  5777665422  2334677899999999 899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      |||+++++|..++....                .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +|
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~k  164 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK  164 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EE
Confidence            99999999999986542                4789999999999999999999999999999999999987776  99


Q ss_pred             EeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      |+|||++.............++..|+|||.+.+..++. ++|||||||++|+|++ |..||..........    .+.. 
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~-  238 (303)
T cd05088         165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLPQ-  238 (303)
T ss_pred             eCccccCcccchhhhcccCCCcccccCHHHHhccCCcc-cccchhhhhHHHHHHhcCCCCcccCChHHHHH----HHhc-
Confidence            99999986322111112223456799999987766654 5999999999999998 999997654432222    2221 


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....+....+++++.+|+.+||+.+|.+|||+.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11222233578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.7e-43  Score=317.17  Aligned_cols=257  Identities=27%  Similarity=0.410  Sum_probs=208.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++.|...+.||+|+||+||+|.+..+++.|++|++.....    ....+.+|+.+++.++|||++++++++.+....++|
T Consensus        20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   99 (313)
T cd06633          20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLV   99 (313)
T ss_pred             HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3567888999999999999999999999999999865322    223577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+.+ ++...+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++...   ..
T Consensus       100 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~  173 (313)
T cd06633         100 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SP  173 (313)
T ss_pred             EecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CC
Confidence            999965 66666654 457999999999999999999999999999999999999987776  999999988642   22


Q ss_pred             CCCccCCCCccccccccc---cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PKSTVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .....|+..|+|||++..   ..++ .++|||||||++|+|++|..||...+..........    ..........++..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  248 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEWTDS  248 (313)
T ss_pred             CCCccccccccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccccCHH
Confidence            345678999999999842   3343 458999999999999999999977654333322211    11111112357788


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      +.+|+.+||+.+|.+||++.+++.||||....+.+.
T Consensus       249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            999999999999999999999999999987665443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-43  Score=309.30  Aligned_cols=242  Identities=28%  Similarity=0.429  Sum_probs=203.9

Q ss_pred             ceecccCCeEEEEEEEcCC---CcEEEEEEcccCccc--cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRT---KELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||.||+|.+...   +..||+|.+......  ...+.+|+..++.++|+||+++++++.....++++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   899999998775443  46788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           84 GELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        84 ~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++|..++...         ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence            9999999875         67999999999999999999999999999999999999998776  999999998754332


Q ss_pred             ---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 ---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                         .......+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...........    +.. ....+....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccC
Confidence               12334567889999999887766544 899999999999999 6999988654333222    221 1222333467


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++++.+++.+||..+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999975

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1e-43  Score=324.07  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=197.0

Q ss_pred             cceeccc--CCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            8 VKELGSG--NFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         8 ~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ...||+|  +||+||+|.+..+|+.||+|++.....   ..+.+.+|+.+++.++||||++++++|......++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            4567777  999999999999999999999875432   23567889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----  156 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----  156 (341)
                      +++|..++.+.  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++++||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccc
Confidence            99999988764  35899999999999999999999999999999999999987776  99999985432111110    


Q ss_pred             ----CCCccCCCCcccccccccccc-CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh-------------
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-------------  218 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------  218 (341)
                          .....++..|+|||++.+... .+.++|||||||++|+|++|..||............+....             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111234567999999876422 24458999999999999999999976544322221111000             


Q ss_pred             ----------------------------cccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          219 ----------------------------NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       219 ----------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                                  ......+....+++.+.+||++||+.||++|||+.++++||||.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                        000001112235678999999999999999999999999999943

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.4e-43  Score=310.50  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=202.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||+||++.+.. +..+|+|.+.........+.+|+.+++.++||||+++++++......+++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            469999999999999999998764 4569999987655555678999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--CCC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  159 (341)
                      +++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.  +||+|||+++.......  ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecCC
Confidence            99999998764 36899999999999999999999999999999999999987766  99999998864322211  112


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |..||............    ..... .+.....+..+.+++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLR-LYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCC-CCCCCCCCHHHHHHH
Confidence            234567999999987776654 899999999999998 99999765543332222    22111 112234688999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.+|.+|||+.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5e-43  Score=313.00  Aligned_cols=253  Identities=30%  Similarity=0.466  Sum_probs=204.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCE-----
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSL---RHPNIIRFKEVLLTPTH-----   73 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~~~~-----   73 (341)
                      |++++.||.|+||.||+|.++.+++.||+|.+.....   ....+.+|+.+++.+   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7899999999999999999998999999999875322   123455677766555   69999999999988776     


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ++++|||+.+ +|..++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence            9999999975 7888876643  5899999999999999999999999999999999999998866  999999998754


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-cc-------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YF-------  223 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~-------  223 (341)
                      ..........++..|+|||++.+..+..+ +|+|||||++|+|++|.+||........+.+......... ..       
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            33333344567889999999988776655 8999999999999999999988766555555443321100 00       


Q ss_pred             ----CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          224 ----LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       224 ----~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                          .+.         ...+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                000         12356788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-43  Score=315.66  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=204.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC----------------cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK----------------ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      ++|++++.||+|+||.||+|.+..++                ..||+|.+....  ...+.+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            68999999999999999999887644                568999987643  234567889999999999999999


Q ss_pred             EEEEEcCCEEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec
Q 019433           65 KEVLLTPTHLAIVMEYAAGGELFARICSAG-----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD  133 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~  133 (341)
                      ++++..+...+++||++.+++|..++....           .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999999999999997765           689999999999999999999999999999999999998


Q ss_pred             CCCCCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh--CCCCCCCCCChh
Q 019433          134 GSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPR  208 (341)
Q Consensus       134 ~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--g~~pf~~~~~~~  208 (341)
                      .++.  ++|+|||++.......   ......+++.|+|||.+.+..+.. ++|||||||++|+|++  +..||.......
T Consensus       165 ~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         165 KNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT-KSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             CCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCc-cchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            8766  9999999987432221   122345677899999988766654 4999999999999998  778887665544


Q ss_pred             HHHHHHHHHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          209 NFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       209 ~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+.........  .....+....++.++.+++.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            43333221111  11112223356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.6e-43  Score=316.26  Aligned_cols=256  Identities=27%  Similarity=0.473  Sum_probs=209.8

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      |.....||+|+||.||++.++.+++.||||.+.... .....+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            445678999999999999999999999999876432 2334678899999999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCCccC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~g  162 (341)
                      ++|..++. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++....... ......|
T Consensus       102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceeccccccccccccc
Confidence            99988764 456899999999999999999999999999999999999998776  9999999876432221 2233568


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      ++.|+|||.+.+..++. ++|+||+|+++|+|++|..||............ ..  .....++....+++.+.+++.+||
T Consensus       179 ~~~y~~pE~~~~~~~~~-~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         179 TPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-RD--NLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             CccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-Hh--hCCcccCCcccCCHHHHHHHHHHH
Confidence            89999999987766654 489999999999999999999865443332221 11  112222233467899999999999


Q ss_pred             ccCCCCCCChhHHhcCCccCCCCCh
Q 019433          243 VADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       243 ~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +.+|.+||++.+++.||||....++
T Consensus       255 ~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         255 VRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             hCCcccCcCHHHHhcChHHhccCCC
Confidence            9999999999999999999776653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-43  Score=308.45  Aligned_cols=241  Identities=27%  Similarity=0.401  Sum_probs=195.4

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      +.||+|+||+||+|.++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999999999999999876432  2345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC---CCccC
Q 019433           87 FARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVG  162 (341)
Q Consensus        87 ~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~---~~~~g  162 (341)
                      .+++.... .+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.........   ....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCC
Confidence            99987644 6899999999999999999999999999999999999987776  999999998743211110   11122


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      +..|+|||.+.+..+..+ +|||||||++|+|++ |..||....... ....+   .. ....+.....+..+.+|+.+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~---~~-~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAI---EQ-GVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHH---Hc-CCCCCCcccCCHHHHHHHHHH
Confidence            456999999987777655 899999999999997 899997644322 11111   11 111222336789999999999


Q ss_pred             cccCCCCCCChhHHhc
Q 019433          242 FVADPSKRIPIPEIKK  257 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~  257 (341)
                      |+.+|++|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-45  Score=330.23  Aligned_cols=237  Identities=32%  Similarity=0.457  Sum_probs=207.0

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchH
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELF   87 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~   87 (341)
                      ++=||.|+.|.||+++..  ++.||||+++.      ....+|+-|+.|+||||+.|.++|.....+|||||||..|.|.
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            456899999999999985  78899997654      3447899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCcc
Q 019433           88 ARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI  167 (341)
Q Consensus        88 ~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~  167 (341)
                      ..+.....++......|..+|+.|+.|||.+.|||||||.-||||.-+..  |||+|||.++.........+.+||..||
T Consensus       201 ~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaWM  278 (904)
T KOG4721|consen  201 EVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAWM  278 (904)
T ss_pred             HHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhhh
Confidence            99999999999999999999999999999999999999999999987776  9999999998665566778899999999


Q ss_pred             ccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019433          168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS  247 (341)
Q Consensus       168 aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  247 (341)
                      |||++.+.....+ +||||||||||||+||..||.+.+....+    =.+....+.+|-....+..++-|++.||.-.|.
T Consensus       279 APEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  279 APEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             CHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchheeE----EeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            9999998887665 89999999999999999999876543222    122333344444457888899999999999999


Q ss_pred             CCCChhHHhcCC
Q 019433          248 KRIPIPEIKKHP  259 (341)
Q Consensus       248 ~R~s~~e~l~hp  259 (341)
                      .|||+.++|.|-
T Consensus       354 NRPSFrqil~Hl  365 (904)
T KOG4721|consen  354 NRPSFRQILLHL  365 (904)
T ss_pred             CCccHHHHHHHH
Confidence            999999999993

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-43  Score=308.61  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+.......+.+.+|+.+++.++||||+++++++...+..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            67999999999999999999976 45779999987765556678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      +++|.+++....  .+++..+..++.|++.||.+||++|++||||||+||+++.++.  ++|+|||++...... .....
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~  161 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKED-IYEAR  161 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCC-ccccc
Confidence            999999987654  6999999999999999999999999999999999999998776  999999998743311 11112


Q ss_pred             cC---CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          161 VG---TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       161 ~g---t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .|   +..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..........    .+.. ....+.....+..+.+
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~  235 (261)
T cd05068         162 EGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QVDQ-GYRMPCPPGCPKELYD  235 (261)
T ss_pred             CCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHHH
Confidence            22   357999999987776655 899999999999999 999997755433222    2211 1122333467899999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ++.+||+.+|.+||++.++++
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-42  Score=315.28  Aligned_cols=256  Identities=27%  Similarity=0.413  Sum_probs=208.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|...+.||+|+||.||++.+..++..+|+|.+.....    ....+.+|+.+++.++|||++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            458899999999999999999999999999999875422    2235778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      ||+.| +|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++....   ..
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PA  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---Cc
Confidence            99976 66666644 557999999999999999999999999999999999999987776  9999999876422   23


Q ss_pred             CCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          158 KSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ....|++.|+|||.+.   +..+ +.++|+|||||++|+|++|..||.............    ...........+++.+
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l  253 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPTLQSNEWSDYF  253 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hccCCCCCCccccHHH
Confidence            3457889999999974   2334 345899999999999999999997654333322221    1111122233578899


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      .+++.+||+.+|.+||++.++++|+|+....+...
T Consensus       254 ~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         254 RNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            99999999999999999999999999977666443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.4e-43  Score=313.03  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             CCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++.+.||+|+||.||+|.+..     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            679999999999999999999987     788999998865332  2345788999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCC
Q 019433           76 IVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGY  147 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~  147 (341)
                      +||||+.+++|..++....       .+++..+..++.||+.||.|||++|++||||||+||+++.++. ..+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999987653       4899999999999999999999999999999999999986542 3489999999


Q ss_pred             ccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          148 SKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      ++.......   ......+..|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+..  .... 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~-~~~~~--~~~~-  240 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVM-EFVTG--GGRL-  240 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHc--CCcC-
Confidence            875321111   112233567999999987777654 999999999999997 99999875543322 22211  1111 


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       .....++..+.+++.+||+.+|++|||+.++++|
T Consensus       241 -~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 -DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             2223678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-43  Score=318.38  Aligned_cols=258  Identities=26%  Similarity=0.395  Sum_probs=207.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|...+.||+|+||.||+++++.+++.+|+|.+....    .....+.+|+.+++.++|||++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            357899999999999999999999999999999986432    1223567899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+.+ ++...+.. ..++++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++....   .
T Consensus        94 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~---~  167 (308)
T cd06634          94 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---P  167 (308)
T ss_pred             EEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeec---C
Confidence            999975 77666543 456899999999999999999999999999999999999987766  9999999886432   2


Q ss_pred             CCCccCCCCccccccccc---cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PKSTVGTPAYIAPEVLAR---KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .....+++.|+|||.+.+   ..+ +.++|||||||++|+|++|..||............    ............++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  242 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPALQSGHWSEY  242 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH----hhcCCCCcCcccccHH
Confidence            234568899999999753   233 34589999999999999999999765432222211    1111111122357889


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHH
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII  270 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~  270 (341)
                      +.+||.+||+.+|.+||++.++++|||+....+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~~  279 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI  279 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccCChhHH
Confidence            9999999999999999999999999999887665433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.6e-43  Score=319.86  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcE----EEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKEL----VAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      +.+|++++.||+|+||+||+|.+..+++.    ||+|++....  ...+.+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            46899999999999999999998766654    8999986432  3345688899999999999999999998765 567


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++++|+.+|+|.+++.... .++...+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++.....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~  162 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAD  162 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCC
Confidence            9999999999999987744 6889999999999999999999999999999999999987776  999999999754322


Q ss_pred             CCC---CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQP---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ...   ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...... .+....    ......+.....
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~~  236 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS-EISSIL----EKGERLPQPPIC  236 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----hCCCCCCCCCCC
Confidence            221   12234567999999988777655 899999999999997 99999764432 222222    222233334467


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.++.+++.+||..+|.+|||+.+++.+
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.4e-43  Score=312.32  Aligned_cols=254  Identities=22%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCccc--cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .+||++.+.||+|+||.||+|.++.     .+..||+|.+......  ...+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            3689999999999999999997652     3558999988654322  23567899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           75 AIVMEYAAGGELFARICSAG----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      ++||||+++|+|..++...+          .++...+..++.|++.||.|||++||+||||||+||++++++.  ++|+|
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~D  162 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGD  162 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECc
Confidence            99999999999999997532          3456788999999999999999999999999999999988766  99999


Q ss_pred             cCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||+++.......   .....++..|+|||.+.+..++.+ +|+|||||++|+|++ |..||.........    ..+...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~  237 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDG  237 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC
Confidence            999874322111   122345677999999987776654 899999999999998 78999765443222    222211


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc------CCccCC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK------HPWFLK  263 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~------hp~~~~  263 (341)
                      . ..+.....++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       238 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         238 G-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            1 11222356889999999999999999999999987      888854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=5.1e-43  Score=311.86  Aligned_cols=249  Identities=20%  Similarity=0.277  Sum_probs=199.7

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||+||+|.++     .++..||+|.+....  .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~   84 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   84 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence            578999999999999999999865     245789999986532  2234577899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           75 AIVMEYAAGGELFARICSAG----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      ++||||+++++|.+++.+..          .++...+..++.|++.||.|||++|++||||||+||++++++.  ++|+|
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~d  162 (277)
T cd05062          85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECC
Confidence            99999999999999986532          3567889999999999999999999999999999999998776  99999


Q ss_pred             cCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||++........   .....+++.|+|||++.+..++.. +|||||||++|+|++ |..||.........    ......
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~  237 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVL----RFVMEG  237 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcC
Confidence            999864222111   122345778999999987776554 899999999999998 78999765443222    222221


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .. .+.....+..+.+++.+||+.||++|||+.+++++
T Consensus       238 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         238 GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11 11223578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-43  Score=308.13  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=202.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .+|++.+.||+|+||.||++.++ ++..+|+|++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46899999999999999999986 56789999987665555678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC--CC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~--~~  159 (341)
                      +++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999998763 46899999999999999999999999999999999999998776  999999998643221111  11


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||.+.+..++.+ +|+||||+++|+|++ |..||..........    .+.. ....+.....+..+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVSA-GYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHHc-CCcCCCCCCCCHHHHHHH
Confidence            123457999999988777655 899999999999998 899997655433222    2221 111222335789999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||..+|++|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=331.29  Aligned_cols=244  Identities=36%  Similarity=0.532  Sum_probs=207.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHH-hcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .+.|.+...+|.|+||.|..|.+..+++.+++|++.+.   .....+|+.++ ..-+||||+++.+++.+..+.|+|||+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            35788889999999999999999999999999999876   22334566444 344899999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec-CCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~-~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      +.|+.+...+.....+. .++..|+.+|+.|+.|||++|++|||+||+|||++ +.+.  ++|+|||.++.....  ..+
T Consensus       398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~--~~t  472 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERS--CDT  472 (612)
T ss_pred             ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchh--hcc
Confidence            99999999887766555 88889999999999999999999999999999995 5555  999999999854333  445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .+-|..|.|||++....|+. ++||||||++||+|++|+.||....+.   .++...+...++.    ..+|..+++||+
T Consensus       473 p~~t~~y~APEvl~~~~yt~-acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~  544 (612)
T KOG0603|consen  473 PALTLQYVAPEVLAIQEYTE-ACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQ  544 (612)
T ss_pred             cchhhcccChhhhccCCCCc-chhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHH
Confidence            67788999999999777765 599999999999999999999876664   2344444444333    479999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCcc
Q 019433          240 QIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +||++||.+|+++.+++.||||
T Consensus       545 ~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  545 QLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HhccCChhhCcChhhhccCcch
Confidence            9999999999999999999999

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-43  Score=310.68  Aligned_cols=250  Identities=27%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||.|+||.||++.++.++..+|||.+....    .....+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            57999999999999999999999999999999876532    22346778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||+++++|..++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccC
Confidence            99999999988863    346899999999999999999999999999999999999987776  999999988643222


Q ss_pred             C-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 S-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      . ......|+..|+|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+............++..
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence            2 1234568899999999987776554 89999999999999999999654321  122222222222211122357889


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+++.+||..||++|||+.++++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.1e-43  Score=313.61  Aligned_cols=262  Identities=31%  Similarity=0.519  Sum_probs=210.1

Q ss_pred             CccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      .|++.+.||+|+||.||++.+.   .+++.||||.+.+..     .....+..|+.++..+ +||||+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4889999999999999999864   467899999986532     2334577899999999 599999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++||||+.+++|..++.....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccc
Confidence            999999999999999988788999999999999999999999999999999999999987766  999999998653322


Q ss_pred             CC--CCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          155 SQ--PKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ..  .....|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.......................+  ..++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFP--KTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCC--cccC
Confidence            21  22346889999999987654 2334589999999999999999999654332222232232222222222  3578


Q ss_pred             HHHHHHHHHhcccCCCCCCC---hhHHhcCCccCCCCChhH
Q 019433          232 ADCRHLLSQIFVADPSKRIP---IPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~~~  269 (341)
                      ..+.++|.+||+.||++|||   +.++|+||||.......+
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~  277 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDL  277 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHH
Confidence            99999999999999999998   567799999977654433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.6e-43  Score=308.75  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=200.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.++||+|+||.||+|.+..+ ..||+|++.......+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence            6899999999999999999998765 459999998755555678899999999999999999998754 55799999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--CC
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK  158 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~~  158 (341)
                      +++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||.+........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccccc
Confidence            99999999763  35889999999999999999999999999999999999988776  99999999864322211  12


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||++.+..++.. +|+|||||++|+|++ |..||...........    +.. ....+....++..+.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  235 (262)
T ss_pred             CCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hhc-CCCCCCccccCHHHHHH
Confidence            2345678999999887777554 899999999999999 8899976554332222    111 11122234688999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+||+.||.+|||+.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=6.7e-43  Score=312.08  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             CCccccceecccCCeEEEEEEEc----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ..|++.+.||+|+||+||+|.+.    .++..||+|.+.....  ....+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            35899999999999999999853    4568899999875322  22467789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      ||||+.+++|..++...                 ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence            99999999999988532                 24788999999999999999999999999999999999998776  


Q ss_pred             EEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHH
Q 019433          140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID  215 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~  215 (341)
                      +||+|||+++......   ......++..|+|||.+.+..++. ++|+|||||++|+|++ |..||...... .+   ..
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~g~~p~~~~~~~-~~---~~  237 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS-DSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EV---IE  237 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH---HH
Confidence            9999999987432221   123344567899999998777655 4999999999999998 99999765432 22   22


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.. ....+....+++.+.+++.+||+.||.+||++.+++++
T Consensus       238 ~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 MVRK-RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2221 11223344688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-42  Score=307.23  Aligned_cols=250  Identities=29%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+....    .....+.+|+.+++.++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999876422    23456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||+++++|..++..    ...+++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence            99999999988854    345899999999999999999999999999999999999988776  999999988643222


Q ss_pred             C-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 S-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      . ......+++.|+|||.+.+..+... +|+|||||++|+|++|..||.....  ........+............++..
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCHH
Confidence            1 2234568899999999987777554 8999999999999999999965432  1222222222211111111257889


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.++|.+||..+|++|||+.++++
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.8e-43  Score=315.32  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=199.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc--EEEEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|..+.++.  .+++|.+...  ....+.+.+|+.+++++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            579999999999999999999987765  4688887642  22335678899999888 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      +||+++++|.+++....                .+++..++.++.|++.||+|||++||+||||||+||+++.++.  +|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence            99999999999986532                4888999999999999999999999999999999999987766  99


Q ss_pred             EeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      |+|||++..............+..|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +.. 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~~-  233 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-  233 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hhc-
Confidence            999999864222111122223457999999987776554 999999999999997 9999977554333222    211 


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....+....++..+.+|+.+||+.+|.+|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            11122223588999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-44  Score=328.90  Aligned_cols=256  Identities=31%  Similarity=0.498  Sum_probs=215.5

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      |..++.||-|+||.|++++...|...||+|.+++....    ...++.|-.||..-+++.||+|+..|.+++.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            67789999999999999999999999999999875432    23466788888888999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----  156 (341)
                      ++||++..++-+.+-|+|..++.++..+..|++++|..|+|||||||+|||||.+|+  |||.|||++.-......    
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccc
Confidence            999999999999999999999999999999999999999999999999999999888  99999999862211100    


Q ss_pred             ---------------------------------------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhC
Q 019433          157 ---------------------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG  197 (341)
Q Consensus       157 ---------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g  197 (341)
                                                             ....+||+.|+|||++....|+.- +|+||.|||||+|+.|
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVG  867 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhC
Confidence                                                   012369999999999998888765 9999999999999999


Q ss_pred             CCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCC---ChhHHhcCCccCCCCC
Q 019433          198 AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~  266 (341)
                      ++||..........+++.+-.  .+.++....+|+++.+||.++. .+++.|+   -++++..||||....-
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~--~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRN--FLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhh--ccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            999987766555444443322  2234566789999999999875 5788887   4678999999966443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-43  Score=313.37  Aligned_cols=254  Identities=33%  Similarity=0.519  Sum_probs=208.4

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      |++.+.||+|+||.||+|.+..+++.||+|++...   ......+..|+.+++.++||||+++++++......++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            78889999999999999999999999999998764   334456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCCC
Q 019433           82 AGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~~  159 (341)
                      .+ +|..++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence            85 899999876 57999999999999999999999999999999999999998776  9999999987533222 2233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-----------c---cccCC
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-----------V---QYFLP  225 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------~---~~~~~  225 (341)
                      ..++..|+|||.+.+....+.++|+|||||++|++++|.+||........+.+.......           .   ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            456788999999877634445599999999999999999999876654444333221110           0   00011


Q ss_pred             C---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          226 D---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       226 ~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .         ...++..+.++|++||..||.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1         12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.5e-43  Score=307.23  Aligned_cols=246  Identities=23%  Similarity=0.365  Sum_probs=202.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|+++++||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++.++||||+++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            578999999999999999999976 5788999998876665678899999999999999999999874 45689999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      .+++|.+++...  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++.......  ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccc
Confidence            999999988653  36899999999999999999999999999999999999998776  9999999986433111  11


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....++..|+|||++.+..+..+ +||||||+++|++++ |.+||............    .. ....+.....+.++.+
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~  234 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----ER-GYRMPRPDNCPEELYE  234 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----Hc-CCCCCCCCCCCHHHHH
Confidence            22345678999999987776544 899999999999998 99999876543332221    11 1222333467889999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ++.+||..+|++|||++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHH
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=6e-43  Score=307.22  Aligned_cols=249  Identities=35%  Similarity=0.489  Sum_probs=209.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+....   .....+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            6999999999999999999999999999999987543   2334677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           81 AAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        81 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +++++|..++..    ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.  +||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-C
Confidence            999999998866    356899999999999999999999999999999999999998665  999999998754333 3


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.... ..   ....... .+....++.++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~---~~~~~~~-~~~~~~~~~~~~~  231 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDL-RY---KVQRGKY-PPIPPIYSQDLQN  231 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH---HHhcCCC-CCCchhhCHHHHH
Confidence            344668899999999987776554 8999999999999999999987654222 11   1121111 1122367889999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCcc
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.+||+.+|.+|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.9e-43  Score=325.24  Aligned_cols=248  Identities=24%  Similarity=0.357  Sum_probs=199.1

Q ss_pred             CCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||.||+|.+..     ++..||||++.....  ..+.+.+|+.+++.+. ||||+++++++.....+
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            578899999999999999998743     245799999865332  2356889999999996 99999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc-------------------------------------------------------------
Q 019433           75 AIVMEYAAGGELFARICSA-------------------------------------------------------------   93 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~-------------------------------------------------------------   93 (341)
                      |+|||||++|+|.+++...                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999887542                                                             


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC
Q 019433           94 -----------------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        94 -----------------------------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~  138 (341)
                                                         ..+++..+..++.|++.||.|||++||+||||||+|||++.++. 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~-  275 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI-  275 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE-
Confidence                                               23778888999999999999999999999999999999987766 


Q ss_pred             CEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHH
Q 019433          139 RLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       139 ~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~  214 (341)
                       +||+|||+++......   ......+++.|+|||++.+..++. ++|||||||++|+|++ |..||........+...+
T Consensus       276 -~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~  353 (400)
T cd05105         276 -VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT-LSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI  353 (400)
T ss_pred             -EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHH
Confidence             9999999987432211   122345678899999998777755 4899999999999997 999997644322222221


Q ss_pred             HHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       215 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                         .. ....+....++.++.+++.+||+.||++|||+.++.+
T Consensus       354 ---~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         354 ---KS-GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ---hc-CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence               11 1222333468899999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=360.92  Aligned_cols=252  Identities=29%  Similarity=0.459  Sum_probs=214.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      -|++-...||.|.||.||.|.+..+|+..|+|-+.-..   +..+.+.+|..++..++|||+|+++++=.+....+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            36778889999999999999999999999999876433   445578899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC----
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~----  155 (341)
                      ||.+|+|.+.+....-.++...+.+..|++.|+.|||+.|||||||||+||+++.+|.  ||++|||.|.......    
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence            9999999999988888899999999999999999999999999999999999998886  9999999987432221    


Q ss_pred             -CCCCccCCCCcccccccccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHh-cccccCCCCCCCC
Q 019433          156 -QPKSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVS  231 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s  231 (341)
                       ......||+.|||||++.+...  ...+.||||||||+.||+||+.||...++.-.+   +..+. .....+|+  ++|
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI---My~V~~gh~Pq~P~--~ls 1467 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI---MYHVAAGHKPQIPE--RLS 1467 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH---HhHHhccCCCCCch--hhh
Confidence             2235689999999999987542  234589999999999999999999876653222   22221 22334455  599


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.++||.+||+.||++|+++.|+++|.|-
T Consensus      1468 ~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1468 SEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             HhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence            999999999999999999999999999875

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1e-42  Score=311.84  Aligned_cols=247  Identities=26%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +.|.+.+.||+|+||+||++..     ..++..+|+|.+.... .....+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            4689999999999999999985     3356779999987643 234468899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEe
Q 019433           77 VMEYAAGGELFARICSAG-------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC  143 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~  143 (341)
                      ||||+++++|..++...+             .+++..++.++.|++.||+|||++|++||||||+||++++++.  ++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEec
Confidence            999999999999987543             4899999999999999999999999999999999999988776  9999


Q ss_pred             ecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhc
Q 019433          144 DFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRN  219 (341)
Q Consensus       144 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  219 (341)
                      |||++.......   ......++..|+|||++.+..++.+ +|||||||++|+|++ |.+||.........    ..+..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~----~~i~~  237 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVI----ECITQ  237 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHc
Confidence            999987432211   1223345778999999987776654 999999999999998 99999776543322    22222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ... .+....+++++.+|+.+||+.||.+|||+.+++.
T Consensus       238 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            221 1222357899999999999999999999999966

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.8e-43  Score=308.56  Aligned_cols=246  Identities=23%  Similarity=0.356  Sum_probs=205.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +.|++++.||.|+||.||+|.++. +..+|+|.+..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            469999999999999999999987 88999999876543 4567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      ++++|.+++.+.  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++....... ...
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999763  36899999999999999999999999999999999999988776  9999999986432211 112


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||.+.+..+..+ +||||||+++|+|++ |..||........+....    . ....+.....++.+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----A-GYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH----h-CCcCCCCCCCCHHHHHH
Confidence            2345667999999987766554 899999999999998 899997755433333222    1 12223334788999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+||+.||.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-43  Score=305.07  Aligned_cols=242  Identities=40%  Similarity=0.643  Sum_probs=205.7

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ||.|+||.||++.+..+++.+|+|.+.....    ....+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999998999999999876432    234688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCccCCCC
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPA  165 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~gt~~  165 (341)
                      .+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence            999988888999999999999999999999999999999999999988776  999999998753322 12344568889


Q ss_pred             ccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 019433          166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD  245 (341)
Q Consensus       166 y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  245 (341)
                      |+|||.+.+...... +|+||||+++|++++|..||...+....    ...+.......+.  .++..+.++|++||..|
T Consensus       159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEI----YEKILKDPLRFPE--FLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCCCCCCC--CCCHHHHHHHHHHhcCC
Confidence            999999887666544 8999999999999999999976554222    2222222333333  56899999999999999


Q ss_pred             CCCCCCh---hHHhcCCcc
Q 019433          246 PSKRIPI---PEIKKHPWF  261 (341)
Q Consensus       246 p~~R~s~---~e~l~hp~~  261 (341)
                      |.+||++   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-43  Score=312.93  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=199.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC--------------cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK--------------ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKE   66 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~   66 (341)
                      +||++.+.||+|+||.||+|.+..++              ..||+|.+....  .....+.+|+.+++.++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            68999999999999999999876432              359999987542  22346788999999999999999999


Q ss_pred             EEEcCCEEEEEEeecCCCchHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC
Q 019433           67 VLLTPTHLAIVMEYAAGGELFARICSAG------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG  134 (341)
Q Consensus        67 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~  134 (341)
                      ++...+..++||||+.+++|..++....            .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999886532            3688899999999999999999999999999999999987


Q ss_pred             CCCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh--CCCCCCCCCChhH
Q 019433          135 SPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRN  209 (341)
Q Consensus       135 ~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--g~~pf~~~~~~~~  209 (341)
                      ++.  +||+|||++........   .....++..|+|||++.+..++. ++|+|||||++|+|++  +..||........
T Consensus       165 ~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         165 HYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT-ASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCc-hhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            766  99999999864322211   12234567899999988777655 4999999999999988  6788887655443


Q ss_pred             HHHHHHHHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          210 FRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       210 ~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..........  ...........++.+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3332221111  11112223357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.7e-42  Score=305.68  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=200.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++++.||+|+||.||+|.+. .+..+|+|.+.......+.+.+|+.+++.++||||+++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            478999999999999999999876 5667999998876555667899999999999999999999875 45678999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      .+++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||++++++.  ++|+|||++.......  ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccc
Confidence            999999998753  35899999999999999999999999999999999999987766  9999999986432211  11


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....++..|+|||.+.+..++. ++|+||||+++|+|++ |.+||..........    .+.. ....+.....+..+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~  234 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVER-GYRMPCPQDCPISLHE  234 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcc-hhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHHH
Confidence            1223456799999987776654 4899999999999999 899997654433222    2221 1122333467899999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      |+.+||.++|.+|||+.++.+
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=309.18  Aligned_cols=248  Identities=23%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||.||++.++..     +..||+|.+.....  ....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            36899999999999999999998744     48899999865432  234577899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           75 AIVMEYAAGGELFARICSAG----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      ++||||+++++|..++....          .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~d  162 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGD  162 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECC
Confidence            99999999999999986532          3678899999999999999999999999999999999998876  99999


Q ss_pred             cCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||+++......   ......++..|+|||.+.+..++.+ +|||||||++|++++ |..||......... +.   +...
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~---~~~~  237 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KF---VIDG  237 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHH-HH---HhcC
Confidence            99986432221   1223456788999999887776554 899999999999998 99999765443222 22   2211


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      . ..+.....+..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 G-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1 11222356899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=306.61  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|.++.+   ...||+|.+.....  ....+.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            6799999999999999999998744   46799999865432  234677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence            9999999999998764 46899999999999999999999999999999999999988776  99999999875431111


Q ss_pred             ---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          157 ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       157 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                         .....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.........    ..+.. ....+.....+.
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~~  235 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI----KAVED-GYRLPPPMDCPS  235 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCCH
Confidence               112234567999999987776654 899999999999997 99999765543222    22222 122233346789


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.+|+.+||+.+|.+||++.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=303.67  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=202.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +.|++.+.||.|+||.||+|...  |+.||+|.+.......+.+.+|+.+++.++|+||+++++++......++||||++
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57999999999999999999875  7889999998765555678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      +++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||.+.....  .....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~--~~~~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQ--GQDSG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccc--ccccC
Confidence            999999997765  6999999999999999999999999999999999999987776  99999999875422  12233


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .++..|+|||.+.+..+.. ++|+||||+++|++++ |..||...... .+.   ..+.. .........+++.+.++|.
T Consensus       160 ~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~---~~~~~-~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         160 KLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLK-DVV---PHVEK-GYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             CCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH---HHHhc-CCCCCCccCCCHHHHHHHH
Confidence            4456799999987776655 4899999999999997 99999765432 221   12111 1111222367899999999


Q ss_pred             HhcccCCCCCCChhHHhc
Q 019433          240 QIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~  257 (341)
                      +||..+|++|||+.++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-42  Score=312.30  Aligned_cols=248  Identities=25%  Similarity=0.363  Sum_probs=201.9

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|.+.+.||+|+||.||++.+     ..++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            5789999999999999999975     34566899999876432  234678899999999 799999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      +++|||+.+++|..++....  .+++..+..++.|++.||.|||++||+|+||||+||+++.++.  ++|+|||+++...
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe--EEECCCccccccc
Confidence            99999999999999987643  3899999999999999999999999999999999999987665  9999999987432


Q ss_pred             CCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          153 LHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       153 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ....   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||........+.+....    ....+...
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~  267 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPE  267 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc----CCcCCCCC
Confidence            2211   122345778999999987776554 899999999999998 99999876544333332221    11222233


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..++.+.+++.+||.++|++|||+.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.7e-42  Score=311.55  Aligned_cols=259  Identities=25%  Similarity=0.390  Sum_probs=203.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.|++.+.||.|+||.||+|.+..+++.||||.+.....  ....+..|+.++..+ .||||+++++++......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            568999999999999999999999999999999876432  233456677655555 59999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |+.+ ++...+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||++++++.  ++|+|||++.........
T Consensus        95 ~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~  171 (296)
T cd06618          95 LMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKAK  171 (296)
T ss_pred             ccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCcc
Confidence            9865 66666654 4579999999999999999999997 69999999999999987766  999999998643322233


Q ss_pred             CCccCCCCccccccccccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          158 KSTVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ....++..|+|||.+.+..    ++ .++||||||+++|+|++|..||......  ...............+....++.+
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  248 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPSLPPNEGFSPD  248 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccc-cchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCCCCCCCCCCHH
Confidence            3446788999999987553    33 4489999999999999999999753321  111111111112223333357889


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +.+|+.+||..||.+||++.+++.||||.....+
T Consensus       249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  282 (296)
T cd06618         249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA  282 (296)
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence            9999999999999999999999999999765544

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.6e-42  Score=309.61  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=200.7

Q ss_pred             CCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .+|++++.||+|+||+||+|.+..     .+..||+|++.....  ..+.+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            368999999999999999998764     357899999875432  2345778999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      +++||+.+++|..++...                ..++...+..++.|++.||.|||++||+||||||+||++++++.  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999988532                24788899999999999999999999999999999999987766  


Q ss_pred             EEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHH
Q 019433          140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID  215 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~  215 (341)
                      +||+|||+++......   ......+++.|+|||.+.+..++.. +|||||||++|+|++ |..||........    ..
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV----IE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHH----HH
Confidence            9999999987432221   1223445778999999987776554 899999999999998 8889976544322    22


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+..... .+.....+..+.+|+.+||+.+|.+||++.+++..
T Consensus       238 ~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            2222221 12223688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=311.84  Aligned_cols=285  Identities=29%  Similarity=0.492  Sum_probs=233.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc----HHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ..|..+..||+|+||+|.+|..+.|.+.||||++++.....    +-...|-++|... +-|.+++++.+|..-+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            36889999999999999999999999999999998753222    2233455555544 578999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-C
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~  156 (341)
                      |||+.||+|.-.|++-++|.+..+..++..|+-||-+||++|||.||||.+|||++..|+  |||.|||+++...... .
T Consensus       429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVT  506 (683)
T ss_pred             EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcc
Confidence            999999999999999999999999999999999999999999999999999999998887  9999999998655444 4


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ..+.+|||.|+|||++....|. +.+|+||+|++||||+.|++||.+.+..+.++.+...    ...+|.  .+|.++.+
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----nvsyPK--slSkEAv~  579 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----NVSYPK--SLSKEAVA  579 (683)
T ss_pred             eeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----cCcCcc--cccHHHHH
Confidence            5678999999999999988885 4589999999999999999999998776666655443    334444  79999999


Q ss_pred             HHHHhcccCCCCCCC-----hhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCCHHHHHHHHH
Q 019433          237 LLSQIFVADPSKRIP-----IPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQ  297 (341)
Q Consensus       237 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (341)
                      +++.+|.+.|.+|..     -.++..||||+......+...+.+.. ..++.....+.+...+.+.
T Consensus       580 ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPP-fkPk~k~~r~~eNFD~~Ft  644 (683)
T KOG0696|consen  580 ICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPP-FKPKIKCGRDAENFDKFFT  644 (683)
T ss_pred             HHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCC-CCCccccCCchhhhhHHHh
Confidence            999999999999984     36899999998877666655443221 1123333445555555554

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-42  Score=309.17  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=198.0

Q ss_pred             ccccceecccCCeEEEEEEE----cCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRD----KRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAI   76 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~i   76 (341)
                      |++++.||+|+||.||+|..    ..++..||+|.+....  .....+.+|+.+++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            59999999999999999984    4678999999986542  2335688999999999999999999998775  56899


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+++++|..++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.......
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~  163 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccCc
Confidence            999999999999987654 5899999999999999999999999999999999999987766  9999999987433221


Q ss_pred             C----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC-----------hhHHHHHHHHHhcc
Q 019433          156 Q----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED-----------PRNFRKTIDRIRNV  220 (341)
Q Consensus       156 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~  220 (341)
                      .    .....++..|+|||++.+..++.+ +|||||||++|+|+++..|+.....           ............. 
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  241 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE-  241 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc-
Confidence            1    123456678999999887776554 8999999999999998766533211           0011111111111 


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....+....++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            12233344688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-42  Score=308.04  Aligned_cols=247  Identities=23%  Similarity=0.363  Sum_probs=199.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc----EEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++++.||.|+||+||+|.+..++.    .||+|++....  .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            3679999999999999999999877766    48999886532  2345677899999999999999999998754 468


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++++|+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||++++++.  +||+|||+++.....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~  162 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID  162 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccc
Confidence            999999999999998764 46999999999999999999999999999999999999987776  999999998753322


Q ss_pred             CC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ..   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...... .....+.   . ....+.....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~---~-~~~~~~~~~~  236 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE---K-GERLPQPPIC  236 (279)
T ss_pred             cceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH---C-CCcCCCCccC
Confidence            21   112234678999999987777654 899999999999998 89999765432 2222221   1 1222333467


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.++.+++.+||..||++||++.+++.
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-42  Score=342.15  Aligned_cols=145  Identities=32%  Similarity=0.474  Sum_probs=133.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.+..+++.||||++......    ...+..|+.+++.++||||++++.++.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998764322    246778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence            99999999999988888999999999999999999999999999999999999987776  9999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-42  Score=309.93  Aligned_cols=253  Identities=27%  Similarity=0.408  Sum_probs=200.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcC----------------CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR----------------TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIR   63 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~   63 (341)
                      .+||++.+.||+|+||.||++.+..                ++..+|+|.+.....  ....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            3689999999999999999986542                345799999875432  2356889999999999999999


Q ss_pred             EEEEEEcCCEEEEEEeecCCCchHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe
Q 019433           64 FKEVLLTPTHLAIVMEYAAGGELFARICSAG-----------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL  132 (341)
Q Consensus        64 l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili  132 (341)
                      +++++......+++|||+.+++|..++....           .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999999999999987643           36678899999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh--CCCCCCCCCCh
Q 019433          133 DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDP  207 (341)
Q Consensus       133 ~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--g~~pf~~~~~~  207 (341)
                      +.++.  ++|+|||++........   .....+++.|+|||+..+..++. ++|+|||||++|+|++  |..||......
T Consensus       164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         164 GKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT-ASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             cCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc-hhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            87766  99999999874322211   12233467899999887777654 4899999999999998  77899765544


Q ss_pred             hHHHHHHHHHhc--ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          208 RNFRKTIDRIRN--VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       208 ~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ............  .....+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            333322211111  11223334467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-42  Score=303.72  Aligned_cols=245  Identities=23%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||+|.+..+ ..+|+|.+.......+.+.+|+.+++.++|||++++++++. ....+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            6899999999999999999998755 45999998766555667889999999999999999999875 456789999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||++++++.  ++|+|||++.......  ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            999999987643  4889999999999999999999999999999999999988776  9999999986432211  112


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||.+.+..++. ++||||||+++|+|++ |..||...........    +.. ....+....++..+.++
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----VER-GYRMPCPQGCPESLHEL  235 (260)
T ss_pred             CCccchhhCCHHHhccCCcCh-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCcccCHHHHHH
Confidence            234567799999987777654 4899999999999999 9999987554333222    211 11222234688999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      +++||.+||.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999876

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.3e-42  Score=310.07  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=200.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||.||++.+...     ...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++..+..+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            6899999999999999999998644     37899999875422  224577899999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC
Q 019433           75 AIVMEYAAGGELFARICS----------------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~----------------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~  138 (341)
                      +++|||+.+++|..++..                ...+++..+..++.|++.||.|||++||+||||||+||+++.++. 
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~-  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe-
Confidence            999999999999999854                235889999999999999999999999999999999999987776 


Q ss_pred             CEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHH
Q 019433          139 RLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       139 ~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~  214 (341)
                       +||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||...........  
T Consensus       171 -~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--  246 (293)
T cd05053         171 -MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--  246 (293)
T ss_pred             -EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHH--
Confidence             99999999874322111   112234567999999877776655 899999999999997 9999976554333222  


Q ss_pred             HHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       215 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                        +.. ....+.....+.++.+|+.+||..||++|||+.+++++
T Consensus       247 --~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 --LKE-GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             --HHc-CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence              111 11122233678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1e-42  Score=315.45  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             ceeccc--CCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSG--NFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      .+||+|  ++|.||++++..+++.||+|++...   ......+.+|+.+++.++||||+++++++......+++|||+++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344544  5567788888889999999998754   23345788999999999999999999999999999999999999


Q ss_pred             CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC------
Q 019433           84 GELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS------  155 (341)
Q Consensus        84 ~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~------  155 (341)
                      ++|..++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||.+.......      
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccc
Confidence            9999998763  46899999999999999999999999999999999999987776  9999999875322111      


Q ss_pred             --CCCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------
Q 019433          156 --QPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------  220 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (341)
                        ......++..|+|||++.+.  .++ .++|+||+||++|+|++|..||..........+........           
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence              12234567789999998653  343 45999999999999999999998755433222211100000           


Q ss_pred             -----------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          221 -----------------QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       221 -----------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                       ....+....++.++.+|+.+||+.||++|||+.++++||||.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                             00000011245678999999999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-44  Score=315.95  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=215.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc--------HHHHHHHHHHhcCCCCCeeeEEEEEE-cC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--------ENVQREIINHRSLRHPNIIRFKEVLL-TP   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~ei~~~~~l~hp~iv~l~~~~~-~~   71 (341)
                      |++||-++.+||+|||+.||+|.+...+++||+|+-.-...+.        +..-+|..+++.|+||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            5789999999999999999999999999999999854433222        24568999999999999999999996 55


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecC-CCCCCEEEeecCCc
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDG-SPQPRLKICDFGYS  148 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~-~~~~~ikL~Dfg~a  148 (341)
                      +.+|.|+|||+|.+|.-++...+-+++.+++.|+.||+.||.||.+..  |||=||||.|||+-+ .-.+-|||.|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            779999999999999999999999999999999999999999999865  999999999999853 22345999999999


Q ss_pred             cCCCCCCC--------CCCccCCCCcccccccccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHH
Q 019433          149 KSGLLHSQ--------PKSTVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       149 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      +.......        .....||.||++||.+.-.   .-.+.++||||+|||+|+++.|+.||........+...-..+
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            86433222        2344699999999987522   223445899999999999999999998765443333222223


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ......+|.-..+|+++++||++||++.-++|.++.++-.||||.
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll  745 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL  745 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence            333445676678999999999999999999999999999999994

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-42  Score=302.12  Aligned_cols=240  Identities=28%  Similarity=0.354  Sum_probs=195.2

Q ss_pred             ceecccCCeEEEEEEEcCCC---cEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTK---ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      ++||+|+||.||+|....++   ..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876555   7899999876543  3456888999999999999999999876 4467999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC----CC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KS  159 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~----~~  159 (341)
                      ++|.+++.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++........    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            999999988888999999999999999999999999999999999999988776  999999998743222211    11


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||.+.+..++.+ +|||||||++|++++ |.+||....... +...+   ... ...+....++..+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~---~~~-~~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAML---ESG-ERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH---HcC-CcCCCCCCCCHHHHHHH
Confidence            123457999999987777654 999999999999997 999997755432 22222   111 12233346789999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||..+|.+|||+.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-42  Score=305.01  Aligned_cols=246  Identities=22%  Similarity=0.333  Sum_probs=196.8

Q ss_pred             ccccceecccCCeEEEEEEEcC---CCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE-----
Q 019433            5 YEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTH-----   73 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~-----   73 (341)
                      |++.+.||+|+||.||.|....   ++..||+|.+.....   ....+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6889999999999999998764   347899999875432   23467889999999999999999998866544     


Q ss_pred             -EEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           74 -LAIVMEYAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        74 -~~iv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                       .++++||+++++|..++...      ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCcc
Confidence             79999999999998887442      35899999999999999999999999999999999999987766  9999999


Q ss_pred             CccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      +++.......   .....++..|+|||.+.+..++. ++|||||||++|+|++ |.+||........+.    .+... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~----~~~~~-~  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEIYD----YLRHG-N  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcC-C
Confidence            9875332221   11223466799999987776655 4999999999999999 899997755433322    22211 1


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..+....++..+.+++.+||+.||++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            122234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.8e-42  Score=302.31  Aligned_cols=240  Identities=25%  Similarity=0.340  Sum_probs=193.1

Q ss_pred             ceecccCCeEEEEEEE--cCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRD--KRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      ++||+|+||.||+|..  +.++..+|+|++.....   ..+.+..|+.+++.++||||+++++++. ....++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            3699999999999964  56789999999865432   2346788999999999999999999875 4567899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----CCC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKS  159 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----~~~  159 (341)
                      ++|..++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++........    ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCC
Confidence            999999988888999999999999999999999999999999999999987765  99999999874322211    122


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||.+.+..++. ++|+|||||++|+|++ |..||........    ...+.... ..+....+++++.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~i~~~~-~~~~~~~~~~~l~~li  231 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSS-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----TQMIESGE-RMECPQRCPPEMYDLM  231 (257)
T ss_pred             CCCCccccCHhHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHCCC-CCCCCCCCCHHHHHHH
Confidence            23457899999987666654 4899999999999998 9999986544322    22222221 1222236899999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||+.||++|||+.++..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999998865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-42  Score=303.02  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++.+.||+|+||.||+|.+. .+..+|||.+.........+.+|+.+++.++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            468999999999999999999986 5578999998876655678999999999999999999999999989999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      ++++|.+++....  .++...+..++.|++.||.|||++|++|+||||+||++++++.  ++|+|||++.......  ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhh
Confidence            9999999987643  6899999999999999999999999999999999999988776  9999999986432111  11


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....++..|+|||.+.+..+.. ++|+|||||++|++++ |+.||........+...    .. ....+.....+.++.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~  235 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTI-KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV----ER-GYRMPRPPNCPEELYD  235 (261)
T ss_pred             hccCCCccccCHHHhccCCcCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHH
Confidence            1223456799999998776654 4899999999999998 99999775543333322    11 1222333456889999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ++.+||+.+|.+||++.+++.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.3e-42  Score=308.92  Aligned_cols=247  Identities=27%  Similarity=0.384  Sum_probs=201.2

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ++|.+.+.||+|+||.||+|.+.     .++..+++|.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46899999999999999999854     3556799998865432 23468899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCE
Q 019433           77 VMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL  140 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~i  140 (341)
                      ||||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--V  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--E
Confidence            999999999999997543                3889999999999999999999999999999999999998776  9


Q ss_pred             EEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHH
Q 019433          141 KICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       141 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~  216 (341)
                      +|+|||++.......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.........    ..
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~----~~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVI----EC  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH
Confidence            999999986432221   1233456788999999988776654 899999999999998 99999775543322    22


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +..... .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            222211 1122357889999999999999999999999977

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-42  Score=305.82  Aligned_cols=249  Identities=22%  Similarity=0.390  Sum_probs=204.8

Q ss_pred             CCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||.||+|+.+.     +.+.+++|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            689999999999999999999764     356799998866433  2457889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           76 IVMEYAAGGELFARICSAG---------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      +||||+++++|.+++....         .+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999997765         6999999999999999999999999999999999999988776  9999999


Q ss_pred             CccCCCCCC--CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          147 YSKSGLLHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       147 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      ++.......  ......++..|+|||.+.+..+.. ++||||||+++|+|++ |..||........    ..........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~~l~~~~~~p~~~~~~~~~----~~~~~~~~~~  237 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFST-KSDVWSFGVLMWEVFTQGELPFYGLSDEEV----LNRLQAGKLE  237 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccchHHH----HHHHHcCCcC
Confidence            886432111  123345677899999987776654 4899999999999998 8899976544322    2223322222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33334688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.3e-42  Score=302.31  Aligned_cols=229  Identities=25%  Similarity=0.390  Sum_probs=189.6

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhc
Q 019433           14 GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA   93 (341)
Q Consensus        14 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~   93 (341)
                      |.||.||+|.++.+++.||+|.+.....    ...|...+....||||+++++++......+++|||+++++|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8999999999999999999999876532    234444445567999999999999999999999999999999999888


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCcccccccc
Q 019433           94 GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA  173 (341)
Q Consensus        94 ~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  173 (341)
                      .++++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||.+....  .......++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~--~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVE--DSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccc--cccccCCcCccccCCcccC
Confidence            88999999999999999999999999999999999999998776  9999999875322  2223445677899999987


Q ss_pred             ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCCh-
Q 019433          174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI-  252 (341)
Q Consensus       174 ~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~-  252 (341)
                      +..++.+ +|+||+||++|+|++|..||......      ..  .......|.  .+++.+.+||.+||+.||++||++ 
T Consensus       156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~------~~--~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSG------IN--THTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh------cc--cccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCC
Confidence            7766554 89999999999999999887643211      00  011112332  578999999999999999999986 


Q ss_pred             ----hHHhcCCcc
Q 019433          253 ----PEIKKHPWF  261 (341)
Q Consensus       253 ----~e~l~hp~~  261 (341)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.6e-42  Score=311.98  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=199.0

Q ss_pred             CCccccceecccCCeEEEEEEEcC-------CCcEEEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.+....  .....+..|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            679999999999999999998743       33579999987642  2234677899999999 7999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      ..++||||+++++|.+++....                .++...++.++.|++.||+|||++|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999997642                478899999999999999999999999999999999998777


Q ss_pred             CCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  ++|+|||++........   .....+++.|+|||++.+..++. ++|+|||||++|+|++ |..||..... ..+..
T Consensus       178 ~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~  253 (307)
T cd05098         178 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFK  253 (307)
T ss_pred             c--EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCc-HHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHH
Confidence            6  99999999864322111   11123456899999998777655 4899999999999998 8899976432 22222


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+   ... ...+.....+.++.+|+.+||..+|.+|||+.+++++
T Consensus       254 ~~---~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LL---KEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HH---HcC-CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            22   211 1122234678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-45  Score=300.66  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=212.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEccc---CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--------
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLTP--------   71 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--------   71 (341)
                      .+|.-+.+||+|.||.||+|+.+.+|+.||+|++.-   .........+|+.++..|+|+|++.++++|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            578889999999999999999999999999997643   234556889999999999999999999988532        


Q ss_pred             CEEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           72 THLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      ..+|+||++|+. +|..++.+. .+|+..+++.++.+++.||.|+|++.|+|||+||+|+||+.++.  +||+|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccc
Confidence            458999999976 888888765 58999999999999999999999999999999999999998887  99999999964


Q ss_pred             CCCC-----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccC
Q 019433          151 GLLH-----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFL  224 (341)
Q Consensus       151 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  224 (341)
                      ....     ......+.|.+|++||.+.|..-+++..|||..|||+.+|+++.+-|.+.++..++.-+..-..... ..+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            3222     1233456799999999999988777779999999999999999999988777665544332221111 011


Q ss_pred             CCC----------------------------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          225 PDY----------------------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       225 ~~~----------------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |..                            -.-.+++.+|+.+||..||.+|+++.++++|.||.....
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~  323 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM  323 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence            110                            012357889999999999999999999999999976544

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-42  Score=305.91  Aligned_cols=252  Identities=29%  Similarity=0.420  Sum_probs=197.5

Q ss_pred             CCCccccceecccCCeEEEEEE----EcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLT--PTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~   74 (341)
                      +++|++++.||+|+||+||+|.    +..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..  ...+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4689999999999999999997    446788999999875432 23467899999999999999999998754  3568


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++||||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.....
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~  160 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccC
Confidence            9999999999999998764 46899999999999999999999999999999999999987776  99999999875322


Q ss_pred             CCCC----CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh------------hHHHHHHHHH
Q 019433          154 HSQP----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------------RNFRKTIDRI  217 (341)
Q Consensus       154 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~------------~~~~~~~~~~  217 (341)
                      ....    ....++..|+|||++.+..++. ++|||||||++|+|++|..|+......            ........ .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  238 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE-L  238 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcCh-HHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH-H
Confidence            2111    1122344599999998777654 489999999999999987776433211            00001111 1


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .......+....++.++.+|+.+||..+|++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1112223334568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.5e-42  Score=307.11  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ..+|+..++||+|+||.||++...     .++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            357899999999999999999743     356789999876543 23456889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCE
Q 019433           76 IVMEYAAGGELFARICSAG---------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL  140 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~i  140 (341)
                      ++|||+++++|..++....               .+++..++.++.|++.||+|||++|++||||||+|||+++++.  +
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--V  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--E
Confidence            9999999999999987643               4889999999999999999999999999999999999987666  9


Q ss_pred             EEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHH
Q 019433          141 KICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       141 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~  216 (341)
                      +|+|||++.......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||.............. 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ-  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc-
Confidence            999999986432211   1122345678999999988777655 899999999999998 9999976554333322211 


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                        ...  ......+++.+.+|+.+||+.||.+||++.++++
T Consensus       240 --~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 --GRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             --Ccc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence              111  1222367899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.7e-42  Score=305.47  Aligned_cols=249  Identities=32%  Similarity=0.492  Sum_probs=202.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ||.+.+.||+|+||.||++.+..++..+++|++....      .....+..|+.+++.++||||+++++.+......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            7999999999999999999998888778777765421      1223466789999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           78 MEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +||+++++|..++..    ...+++..++.++.|++.||.|||++|++|+||+|+||++++ +.  ++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC--EeecccCceeecCC
Confidence            999999999888754    346999999999999999999999999999999999999974 33  99999998864322


Q ss_pred             C-CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          154 H-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      . .......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||............   ........+  ..++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~  231 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI---VEGPTPSLP--ETYSR  231 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH---HcCCCCCCc--chhcH
Confidence            2 12234568889999999877766655 89999999999999999999764432222211   111111122  36788


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ++.++|.+||..+|.+||++.++++||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.4e-42  Score=304.21  Aligned_cols=246  Identities=25%  Similarity=0.359  Sum_probs=195.0

Q ss_pred             ccccceecccCCeEEEEEEEcCCCc--EEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------CE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKE--LVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------TH   73 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~~   73 (341)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+....   ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4678999999999999999987765  69999886542   2345677899999999999999999977432      34


Q ss_pred             EEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           74 LAIVMEYAAGGELFARICS------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      .+++|||+.+++|..++..      ...+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            7899999999999888742      234889999999999999999999999999999999999987776  99999999


Q ss_pred             ccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          148 SKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       148 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      ++.......   .....+++.|+|||.+.+..++.. +|||||||++|+|++ |..||........    ...+.... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~-~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEI----YDYLRQGN-R  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcCC-C
Confidence            875322211   122345678999999987776554 899999999999999 8999976544222    22222221 1


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+....++..+.++|.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22234678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.1e-42  Score=316.20  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=197.1

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC-CE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP-TH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~-~~   73 (341)
                      +||++.+.||+|+||+||+|.+     ..+++.||||++.....  ....+.+|+.++..+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            6899999999999999999984     35678999999876432  234677899999999 689999999987654 56


Q ss_pred             EEEEEeecCCCchHHHHHhc------------------------------------------------------------
Q 019433           74 LAIVMEYAAGGELFARICSA------------------------------------------------------------   93 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~------------------------------------------------------------   93 (341)
                      ++++||||++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            89999999999999988642                                                            


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---CCCCccCC
Q 019433           94 -------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGT  163 (341)
Q Consensus        94 -------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt  163 (341)
                             ..++...+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......   ......++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCC
Confidence                   13677888999999999999999999999999999999987776  9999999987432111   11123356


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      ..|+|||++.+..++.+ +|||||||++|+|++ |..||........+...+..  ......|  ...++++.+++.+||
T Consensus       245 ~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~cl  319 (343)
T cd05103         245 LKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE--GTRMRAP--DYTTPEMYQTMLDCW  319 (343)
T ss_pred             cceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc--cCCCCCC--CCCCHHHHHHHHHHc
Confidence            67999999987777655 899999999999997 99999765433332222211  1111222  246789999999999


Q ss_pred             ccCCCCCCChhHHhcC
Q 019433          243 VADPSKRIPIPEIKKH  258 (341)
Q Consensus       243 ~~dp~~R~s~~e~l~h  258 (341)
                      +.||++|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=314.82  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc-cHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-EEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-~~~iv~e~   80 (341)
                      +.|..-..||+|+||.||+|.... +..||||.+...... ..++.+|+.++.+++|||+|+|+|+|.+.+ ..++|+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            567778899999999999999974 488999988775554 667999999999999999999999999998 59999999


Q ss_pred             cCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-C
Q 019433           81 AAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSME---ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-H  154 (341)
Q Consensus        81 ~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~---iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~  154 (341)
                      +++|+|.+++....  .++|....+|+.++++||+|||...   ||||||||+|||+|.+..  .||+|||+|+.... .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence            99999999997755  8999999999999999999999854   999999999999998887  99999999976544 3


Q ss_pred             CCCCCc-cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCC--ChhHHHHH-HHHHhcc---cccCCCC
Q 019433          155 SQPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE--DPRNFRKT-IDRIRNV---QYFLPDY  227 (341)
Q Consensus       155 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~--~~~~~~~~-~~~~~~~---~~~~~~~  227 (341)
                      ...... .||.+|+|||.+..+..+.+ +||||||+++.||++|+.|.....  ....+... ...+...   ...-|..
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            333333 89999999999987666555 999999999999999998887542  11112221 1111111   1111111


Q ss_pred             --CCCC-----HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          228 --VRVS-----ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       228 --~~~s-----~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                        ...+     ..+..+..+|++.+|..||++.++.+
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              1222     12567888999999999999998754

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.5e-42  Score=306.05  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=198.1

Q ss_pred             CccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +|++.+.||+|+||+||+|.+..     ....+|+|.+.....  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58999999999999999998753     235799998865432  23467889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe
Q 019433           77 VMEYAAGGELFARICSA------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL  132 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili  132 (341)
                      ++||+.+++|..++...                        ..+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999988642                        247889999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChh
Q 019433          133 DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPR  208 (341)
Q Consensus       133 ~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~  208 (341)
                      ++++.  ++|+|||++........   .....++..|+|||.+.+..++. ++||||||+++|+|++ |..||.......
T Consensus       161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch-HhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            87766  99999999864322111   12234567899999987776654 4899999999999998 999997654322


Q ss_pred             HHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                       +...   ... ....+.....+.++.+++.+||+.+|.+||++.++++
T Consensus       238 -~~~~---~~~-~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 -LFNL---LKT-GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -HHHH---HhC-CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence             2222   111 1222333468899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-42  Score=303.77  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=192.7

Q ss_pred             ceecccCCeEEEEEEEcCCCc--EEEEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||.||+|.++.++.  .+|+|.+...  ....+.+.+|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999988775  4688887643  22345678899999999 799999999999999999999999999


Q ss_pred             CchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           84 GELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        84 ~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      ++|.+++....                .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence            99999987543                4789999999999999999999999999999999999988776  99999999


Q ss_pred             ccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      +..............+..|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.. ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~~~-~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLPQ-GYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HHhC-CCCCCC
Confidence            86322211112223356799999987766654 4899999999999997 999997654332222    2221 112222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ....+.++.+|+.+||..||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            2357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.4e-42  Score=300.85  Aligned_cols=242  Identities=25%  Similarity=0.375  Sum_probs=197.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEE-cCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~-~~~~~~iv~e~~   81 (341)
                      ++|++.+.||+|+||.||++...  |..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++. .....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            47899999999999999999875  7789999986543 3456889999999999999999999764 556789999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      ++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.....  ....
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~--~~~~  158 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDT  158 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceeccc--cCCC
Confidence            9999999987644  4889999999999999999999999999999999999988776  99999999874322  2233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..++..|+|||++.+..++.. +|||||||++|+|++ |..||.......    ....+... ........+++.+.+++
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~li  232 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVEKG-YKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             CccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHhcC-CCCCCCCCCCHHHHHHH
Confidence            345668999999987776554 899999999999997 999997643322    22222211 11112236789999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||..+|.+|||+.++++
T Consensus       233 ~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         233 KQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-41  Score=299.25  Aligned_cols=245  Identities=29%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             ccccceecccCCeEEEEEEEcCCC----cEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +++.+.||.|+||.||+|.+..++    ..||+|.+.....  ....+..|+.+++.++||||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            468899999999999999998766    9999999876543  3557889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           79 EYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||+++++|.+++.....  +++..+..++.|++.||.+||++|++||||||+||++++++.  ++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceecccccc
Confidence            99999999999976554  999999999999999999999999999999999999998776  99999999874332211


Q ss_pred             CC--CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PK--STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ..  ...+++.|+|||.+.+..++. ++|+|||||++|+|++ |.+||...........    +.... ..+.....+.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKGY-RLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCC-CCCCCCcCCHH
Confidence            11  123678899999987666654 4999999999999998 8899976444322222    22211 12222358899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+++.+||..||.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.3e-41  Score=303.33  Aligned_cols=246  Identities=22%  Similarity=0.315  Sum_probs=195.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc----EEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ++|++++.||+|+||+||+|.+..+++    .+++|.+....  .....+..|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            579999999999999999999987776    47777765322  223456778888899999999999998754 45788


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ++||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.  +||+|||+++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCC
Confidence            99999999999999764 47899999999999999999999999999999999999987766  9999999987432221


Q ss_pred             C---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          156 Q---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       156 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      .   .....++..|+|||.+.+..++.+ +|||||||++|++++ |..||...... ...+.+.   .. ...+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~~~---~~-~~~~~~~~~~  237 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLLE---KG-ERLAQPQICT  237 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH---CC-CcCCCCCCCC
Confidence            1   123346678999999987777654 899999999999998 99999765432 2222221   11 1122223467


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .++.+++.+||..||.+|||+.++++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            78999999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-41  Score=299.91  Aligned_cols=246  Identities=24%  Similarity=0.367  Sum_probs=200.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            579999999999999999999865 45679999887655445678899999999999999999999887 7789999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--C
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--P  157 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~  157 (341)
                      ++++|.+++...  ..++...+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcccc
Confidence            999999999763  35788899999999999999999999999999999999987766  99999998864322111  1


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....++..|+|||++.+..++.+ +|+|||||++|++++ |..||...........    +. .....+.....+.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA----LE-RGYRMPRPENCPEELYN  234 (260)
T ss_pred             cCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH----Hh-CCCCCCCcccCCHHHHH
Confidence            12234567999999987766554 899999999999998 9999987554322221    11 12223333468899999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ++.+||+.+|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.1e-41  Score=301.71  Aligned_cols=247  Identities=26%  Similarity=0.383  Sum_probs=201.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC---cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|.++.++   ..+|+|.+....  ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            68999999999999999999987544   379999986543  2234678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|..++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccccc
Confidence            9999999999999764 46899999999999999999999999999999999999987766  99999999874322111


Q ss_pred             ----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                          .....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..........    .+... ...+....++
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~  235 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIK----AIEEG-YRLPAPMDCP  235 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHH----HHhCC-CcCCCCCCCC
Confidence                111223467999999987776655 899999999999886 999997655432222    22221 2234444678


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+.+++.+||+.+|.+|||+.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-41  Score=308.60  Aligned_cols=247  Identities=24%  Similarity=0.335  Sum_probs=197.2

Q ss_pred             CCccccceecccCCeEEEEEEEc-------CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|.+.+.||+|+||.||+|.+.       .....+|+|.+.....  ....+..|+.+++.+ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57999999999999999999863       2355799999875332  234577899999988 6999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      .++++|||+.+++|..++...                ..++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999999999999653                2488899999999999999999999999999999999998777


Q ss_pred             CCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||........+ .
T Consensus       172 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~-~  247 (314)
T cd05099         172 V--MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELF-K  247 (314)
T ss_pred             c--EEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHH-H
Confidence            6  99999999874322111   112234467999999987776554 899999999999998 89999764432222 2


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .   +.... .......++.++.+++.+||..+|++|||+.++++
T Consensus       248 ~---~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 L---LREGH-RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             H---HHcCC-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2   22211 11122357889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.5e-42  Score=302.63  Aligned_cols=247  Identities=24%  Similarity=0.394  Sum_probs=200.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc---EEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.|++.+.||+|+||.||+|..+.++.   .||||++...  ......+..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            468999999999999999999987664   6999998753  22345788899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|..++... +.++...++.++.|++.||.|||++|++||||||+||++++++.  ++|+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc--EEECCCccccccccCcc
Confidence            9999999999988764 46899999999999999999999999999999999999987665  99999998864322111


Q ss_pred             C---CCcc---CCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          157 P---KSTV---GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       157 ~---~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .   ....   .+..|+|||.+.+..++.+ +|||||||++|++++ |..||.........    ..+.. ....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI----NAIEQ-DYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHH----HHHHc-CCcCCCccc
Confidence            1   1111   1346999999987777654 899999999999886 99999765543222    22221 223344446


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+..+.+++.+||+.+|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-41  Score=298.84  Aligned_cols=241  Identities=29%  Similarity=0.401  Sum_probs=197.0

Q ss_pred             ceecccCCeEEEEEEEcC-CC--cEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRDKR-TK--ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|++|.||+|.+.. .+  ..||||.+.....  ..+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999999865 33  3699999877543  34578899999999999999999999988 889999999999


Q ss_pred             CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC----CC
Q 019433           84 GELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QP  157 (341)
Q Consensus        84 ~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~----~~  157 (341)
                      ++|..++.+..  .+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.......    ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence            99999997754  6899999999999999999999999999999999999998766  9999999987532211    11


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....++..|+|||.+.+..++.. +|||||||++|+|++ |..||............    .......+.....+..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence            23456778999999987777655 899999999999998 99999765543332222    1112222333467899999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ++.+||+.+|++|||+.++++
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-41  Score=298.31  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=202.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++||||+++++++......++||||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46899999999999999999886 46789999988765556678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--CCC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~~~  159 (341)
                      +++|..++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccCC
Confidence            99999988764 46899999999999999999999999999999999999987766  99999998864321111  112


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc-cccCCCCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~l  237 (341)
                      ..++..|+|||.+.+..+.. ++||||||+++|+|++ |..||..........    .+... ....+  ...+..+.+|
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~-~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l  233 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSS-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----TINAGFRLYKP--RLASQSVYEL  233 (256)
T ss_pred             CccchhhcCHhHhccCCcCh-HHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----HHhCCCCCCCC--CCCCHHHHHH
Confidence            23456899999998777654 4899999999999998 999997654432222    22211 11122  2468899999


Q ss_pred             HHHhcccCCCCCCChhHHhcC
Q 019433          238 LSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+||+.+|++|||+.+++++
T Consensus       234 ~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         234 MQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHcccChhhCCCHHHHHHh
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.8e-42  Score=318.14  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=199.8

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~   74 (341)
                      ++|.+.+.||+|+||.||+|++.     .++..||+|++.....  ..+.+.+|+.++..+. ||||+++++++......
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999963     4567899999976432  2346788999999997 99999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC------------------------------------------------------------
Q 019433           75 AIVMEYAAGGELFARICSAG------------------------------------------------------------   94 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~------------------------------------------------------------   94 (341)
                      ++|||||.+|+|.+++...+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999886432                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           95 --------------------------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        95 --------------------------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                                                            .++...++.++.||+.||.|||++|++||||||+|||++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  256677889999999999999999999999999999998766


Q ss_pred             CCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  ++|+|||+++......   ......+++.|+|||.+.+..+.. ++|||||||++|+|++ |..||...........
T Consensus       277 ~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         277 L--VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT-LSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             E--EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCc-HhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence            5  9999999987432111   122345778899999998776654 4899999999999998 8899976544333322


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+..    ....+....++.++.+|+.+||..+|.+||++.++++.
T Consensus       354 ~~~~----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 AIKR----GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHc----CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2211    11222334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-42  Score=305.97  Aligned_cols=244  Identities=34%  Similarity=0.481  Sum_probs=194.2

Q ss_pred             cccceecccCCeEEEEEEEc----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            6 EPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+.+.||.|+||.||.|...    ..+..|+||.+.....  ..+.+.+|+..++.++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999988    5678899999965322  34678899999999999999999999998888999999


Q ss_pred             ecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---
Q 019433           80 YAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---  154 (341)
                      ||++|+|.+++...  ..++...+..++.||+.||.|||+++++|++|+++||++++++.  +||+|||++......   
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence            99999999999886  67999999999999999999999999999999999999998776  999999998754111   


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .......+...|+|||.+.+..++. ++||||||+++|++++ |..||.........    ..+.... ..+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~-ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTK-KSDVYSFGMLLYEILTLGKFPFSDYDNEEII----EKLKQGQ-RLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESH-HHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH----HHHHTTE-ETTSBTTSBHH
T ss_pred             ccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc----ccccccc-cceeccchhHH
Confidence            1123345677899999998877654 4999999999999999 78999876443222    2222221 22333468999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+++.+||..||.+|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-41  Score=300.66  Aligned_cols=245  Identities=24%  Similarity=0.334  Sum_probs=189.2

Q ss_pred             ceecccCCeEEEEEEEc--CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDK--RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999864  4567899998876432  2236778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---C
Q 019433           85 ELFARICSAG-----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q  156 (341)
Q Consensus        85 ~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~  156 (341)
                      +|.+++....     ..++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeec
Confidence            9999986532     3567788899999999999999999999999999999987766  9999999986432221   1


Q ss_pred             CCCccCCCCccccccccccc------cCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC-CC
Q 019433          157 PKSTVGTPAYIAPEVLARKE------YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YV  228 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~  228 (341)
                      .....++..|+|||++.+..      ..+.++|||||||++|+|++ |..||............... .......+. ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  237 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKL  237 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCC
Confidence            12345678899999986432      12445899999999999996 99999776544332222111 111111111 12


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..+..+.+++.+|+ .+|.+|||+++++.
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            46788999999998 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=301.15  Aligned_cols=297  Identities=26%  Similarity=0.386  Sum_probs=230.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      ..||.-++.+|.|+- .|..|.+.-++++||+|++...   ....+...+|..++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            468999999999999 8899999999999999987543   34456788999999999999999999999755      4


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..|+|||++.. +|...+.  -.++...+..++.|++.|++|||+.||+||||||+||++..+..  +|++|||+|+...
T Consensus        95 e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTED  169 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccC
Confidence            58999999965 8877776  45889999999999999999999999999999999999988777  9999999998766


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY----------  222 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  222 (341)
                      ........+.|..|+|||++.+..+..+ +||||+||++.+|++|+..|.+.+...++.++.....+...          
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             cccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            6666778899999999999999887666 89999999999999999999887665555555443322110          


Q ss_pred             -----------------cCCCC---------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhh
Q 019433          223 -----------------FLPDY---------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN  276 (341)
Q Consensus       223 -----------------~~~~~---------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~  276 (341)
                                       .+|+.         ..-+..+++|+.+||..||++|.|++++|+||||.=+......+.....
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe  328 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE  328 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence                             01110         0123447899999999999999999999999999733322222211111


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHhcCCCcc
Q 019433          277 YKEAGRDQPTQSVEEIMRIIQEAKMPGEA  305 (341)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (341)
                      ......+-...+.+|+++.+.+.-+.-+.
T Consensus       329 ~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  329 IYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             hhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            11112233344588888888766554433

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-41  Score=307.39  Aligned_cols=248  Identities=22%  Similarity=0.332  Sum_probs=199.7

Q ss_pred             CCccccceecccCCeEEEEEEEc-------CCCcEEEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|.+.+.||+|+||.||+|+..       .++..||+|.+....  .....+.+|+.+++.+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            57899999999999999999752       235579999986532  2335688999999999 8999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      ..+++|||+.+++|..++.+.                ..++...+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999998763                2477888999999999999999999999999999999998777


Q ss_pred             CCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++......   ......+++.|+|||++.+..++.+ +||||||+++|+|++ |..||........   
T Consensus       175 ~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~---  248 (304)
T cd05101         175 V--MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  248 (304)
T ss_pred             c--EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH---
Confidence            6  9999999987432211   1222345678999999987777655 899999999999998 7888876543222   


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       ...+.... ........+..+.+|+.+||..+|.+|||+.++++.
T Consensus       249 -~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 -FKLLKEGH-RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             -HHHHHcCC-cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence             22222211 112234678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.4e-41  Score=301.00  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=201.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc---EEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|+..+.||+|+||.||+|.++.++.   .+|+|.+....  ...+.+..|+.+++.++||||+++.+++......++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            578999999999999999999986654   79999986542  2345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccc
Confidence            9999999999998764 57899999999999999999999999999999999999987766  99999999864322111


Q ss_pred             C----CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 P----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      .    .....+..|+|||++.+..++.+ +|||||||++|++++ |..||.........    ..+.. ....+.....+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~~  236 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIND-GFRLPAPMDCP  236 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhc-CCCCCCCCCCC
Confidence            1    11122456999999987776554 899999999999997 99999765543222    22222 12334444678


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=9e-43  Score=339.63  Aligned_cols=251  Identities=31%  Similarity=0.460  Sum_probs=200.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEc----------
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLT----------   70 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~----------   70 (341)
                      +.|+.++.||+||||.||+|+++-+|+.||||++.-.  .+....+.+|+..+.+|+|||||+++..|..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4678999999999999999999999999999998765  5556689999999999999999999766520          


Q ss_pred             --------------------------------------------------------------------------------
Q 019433           71 --------------------------------------------------------------------------------   70 (341)
Q Consensus        71 --------------------------------------------------------------------------------   70 (341)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CEEEEEEeecCCCchHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCC
Q 019433           71 ---------------------P--------THLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSMEI  120 (341)
Q Consensus        71 ---------------------~--------~~~~iv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~qil~aL~~LH~~~i  120 (341)
                                           +        ..+||-||||+..++.+++.++... ....++.++++|+.||.|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        1268999999997787777766554 478899999999999999999999


Q ss_pred             eeCCCCCCCEEecCCCCCCEEEeecCCccCCC-------------------CCCCCCCccCCCCccccccccccc---cC
Q 019433          121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-------------------LHSQPKSTVGTPAYIAPEVLARKE---YD  178 (341)
Q Consensus       121 iHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~  178 (341)
                      |||||||.|||+++++.  |||+|||+|+...                   ........+||.-|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999998877  9999999997411                   111234568999999999998765   55


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC--CCCCCHHHHHHHHHhcccCCCCCCChhHHh
Q 019433          179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIK  256 (341)
Q Consensus       179 ~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~e~l  256 (341)
                      .+ +||||||+||+||+   .||...-+   -..++..+++.....+.  +..--+.-..+|++||+.||.+||||.|+|
T Consensus       797 ~K-iDmYSLGIVlFEM~---yPF~TsME---Ra~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  797 SK-IDMYSLGIVLFEML---YPFGTSME---RASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             ch-hhhHHHHHHHHHHh---ccCCchHH---HHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            54 99999999999998   46765322   22344555555444441  011224457899999999999999999999


Q ss_pred             cCCccC
Q 019433          257 KHPWFL  262 (341)
Q Consensus       257 ~hp~~~  262 (341)
                      ++.||.
T Consensus       870 ~s~llp  875 (1351)
T KOG1035|consen  870 NSELLP  875 (1351)
T ss_pred             hccCCC
Confidence            999996

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-41  Score=304.43  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.5

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||.||+|.++     .++..||+|++.....  ....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            368999999999999999999975     3678999999875432  234678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe
Q 019433           75 AIVMEYAAGGELFARICSAG----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL  132 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili  132 (341)
                      +++|||+++++|..++....                      .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            99999999999999986432                      37788899999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChh
Q 019433          133 DGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPR  208 (341)
Q Consensus       133 ~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~  208 (341)
                      +.++.  ++|+|||++.......   .......+..|+|||.+.+..++.+ +|||||||++|+|++ |..||.......
T Consensus       164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            88776  9999999986432221   1122344667999999887777654 899999999999997 888987654332


Q ss_pred             HHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                          ....+..... .+....++.++.+||.+||+.+|.+|||+.|+++
T Consensus       241 ----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 ----VIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ----HHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                2222222221 1222367899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-41  Score=300.69  Aligned_cols=245  Identities=22%  Similarity=0.371  Sum_probs=188.3

Q ss_pred             ceecccCCeEEEEEEEcC--CCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKR--TKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +.||+|+||+||+|....  ....+|+|.+.....  ....+.+|+..++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999996542  456788998764322  2345778999999999999999999999999999999999999


Q ss_pred             chHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---C
Q 019433           85 ELFARICSAG-----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q  156 (341)
Q Consensus        85 ~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~  156 (341)
                      +|.+++....     .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......   .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999987643     2467788999999999999999999999999999999998776  9999999986432211   1


Q ss_pred             CCCccCCCCcccccccccc------ccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC-CC
Q 019433          157 PKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YV  228 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~  228 (341)
                      .....++..|+|||++...      ...+.++|||||||++|+|++ |..||....+...+....... ......+. ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ-DIKLPKPQLDL  237 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc-CccCCCCcccc
Confidence            1233456779999997532      223456999999999999998 788998765544333322211 11111111 23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+++.+.+++..|+ .||.+|||++++++
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            57888999999998 59999999999986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-42  Score=303.37  Aligned_cols=240  Identities=18%  Similarity=0.231  Sum_probs=191.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcE-------EEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            9 KELGSGNFGVARLVRDKRTKEL-------VAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~-------vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.||+|+||.||+|.+..++..       +|+|.+.... ...+.+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            4799999999999998765544       8888876543 2335678899999999999999999999998999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC------CEEEeecCCccCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP------RLKICDFGYSKSGLL  153 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~------~ikL~Dfg~a~~~~~  153 (341)
                      +.+|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++..      .++|+|||++.... 
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~-  159 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL-  159 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC-
Confidence            99999999997654 58999999999999999999999999999999999999866542      37999999886432 


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-CCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                        ......++..|+|||++.+....+.++|||||||++|+|++|. +||......... ...    ......|.  ..+.
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~----~~~~~~~~--~~~~  230 (258)
T cd05078         160 --PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFY----EDRHQLPA--PKWT  230 (258)
T ss_pred             --CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHH----HccccCCC--CCcH
Confidence              2234567889999999987544445599999999999999984 666554332211 111    11222232  4668


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++.+|+.+||+.||++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-42  Score=307.07  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=201.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----C---CCeeeEEEEEEc----
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----H---PNIIRFKEVLLT----   70 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----h---p~iv~l~~~~~~----   70 (341)
                      +||-+.++||+|.|++||+|.+..+.+.||+|+.+......+....||++++++.     |   .+||+|++.|..    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            8999999999999999999999999999999999998888899999999999872     3   369999999975    


Q ss_pred             CCEEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCC------------
Q 019433           71 PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGS------------  135 (341)
Q Consensus        71 ~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~------------  135 (341)
                      ..++|+|+|+. |..|..+|...  +.++...++.|++|||.||.|||. +||||.||||+|||+..+            
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence            46899999999 66888888664  469999999999999999999996 799999999999998410            


Q ss_pred             --------------------------------------------------------------------------------
Q 019433          136 --------------------------------------------------------------------------------  135 (341)
Q Consensus       136 --------------------------------------------------------------------------------  135 (341)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             -------------------------------------------------C-----------------------CCCEEEe
Q 019433          136 -------------------------------------------------P-----------------------QPRLKIC  143 (341)
Q Consensus       136 -------------------------------------------------~-----------------------~~~ikL~  143 (341)
                                                                       .                       ..++||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                                             0                       0024445


Q ss_pred             ecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCC------ChhHHHHHHHHH
Q 019433          144 DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE------DPRNFRKTIDRI  217 (341)
Q Consensus       144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~------~~~~~~~~~~~~  217 (341)
                      |||-|.  .........+.|..|+|||++.|..|.+. +||||++|+++||+||...|....      +...+..++..+
T Consensus       397 DlGNAC--W~~khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL  473 (590)
T KOG1290|consen  397 DLGNAC--WVHKHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL  473 (590)
T ss_pred             eccchh--hhhhhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence            554443  22233334456888999999999999877 799999999999999999996532      222333332222


Q ss_pred             hcccc--------------------------cCC------CCCCC----CHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          218 RNVQY--------------------------FLP------DYVRV----SADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       218 ~~~~~--------------------------~~~------~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ...+.                          .+|      +.-.+    ..++.+||.-||+++|++||||.++|+|||+
T Consensus       474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence            11100                          000      00112    2458899999999999999999999999999


Q ss_pred             CCCC
Q 019433          262 LKNL  265 (341)
Q Consensus       262 ~~~~  265 (341)
                      +...
T Consensus       554 n~~~  557 (590)
T KOG1290|consen  554 NPVA  557 (590)
T ss_pred             cCCC
Confidence            6543

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=319.96  Aligned_cols=256  Identities=30%  Similarity=0.510  Sum_probs=229.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ..+++..||-|+||+|=++..+.....+|+|++++.    .++.+.+..|-.+|..++.|.||++|..|.++.++|+.||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            356788899999999999998866667999998774    3445568889999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      .|-||.|+..+...+.|++...+.++..+++|+.|||++|||.||+||+|++++.+|-  +||.|||+|+.......+-+
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCceee
Confidence            9999999999999999999999999999999999999999999999999999998887  99999999997777777778


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .||||.|.|||++.+...+.. +|.||||+++|||++|.+||+..+....+..++..+....  +|.  .++....+||+
T Consensus       579 FcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~Pr--~I~k~a~~Lik  653 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FPR--RITKTATDLIK  653 (732)
T ss_pred             ecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--ccc--ccchhHHHHHH
Confidence            999999999999999888765 8999999999999999999999998888877777765444  343  78999999999


Q ss_pred             HhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          240 QIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       240 ~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      ++..-+|.+|..     +.++.+|.||.....
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw  685 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEGFDW  685 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence            999999999985     899999999966544

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-41  Score=310.20  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             CCccccceecccCCeEEEEEEEcC-------CCcEEEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      .+|++.+.||+|+||.||+|.+..       .+..||+|.+....  .....+.+|+.+++.+ +||||+++++++....
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            579999999999999999998643       23469999887532  2235688899999999 7999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      ..++++||+++++|..++....                .++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            9999999999999999987532                377888999999999999999999999999999999998777


Q ss_pred             CCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||.........  
T Consensus       172 ~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~--  246 (334)
T cd05100         172 V--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  246 (334)
T ss_pred             c--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence            6  99999999874322111   112234567999999988777655 899999999999998 88999765432222  


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                        ..+.. ....+.....+..+.+|+.+||+.+|.+|||+.+++++
T Consensus       247 --~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 --KLLKE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             --HHHHc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence              22221 11122233678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-41  Score=299.77  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=199.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc----EEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ..+|++.+.||+|+||+||+|.++.+|.    .+|+|.+.....  ....+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            3689999999999999999999877665    589998766532  33567889999999999999999999887 7889


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +||||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++.....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~  162 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVD  162 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCc
Confidence            999999999999998774 46999999999999999999999999999999999999987776  999999998753322


Q ss_pred             CCC---CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQP---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ...   ....++..|+|||.+....++.. +|+|||||++|++++ |..||....... +..   .+.. ....+.....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~~~~-~~~~~~~~~~  236 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVE-IPD---LLEK-GERLPQPPIC  236 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---HHhC-CCCCCCCCCC
Confidence            111   11223567999999877666554 899999999999998 999997754322 222   2221 1122333357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.++.+++.+||..+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         237 TIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.6e-41  Score=295.64  Aligned_cols=240  Identities=25%  Similarity=0.381  Sum_probs=190.0

Q ss_pred             eecccCCeEEEEEEEc--CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCc
Q 019433           10 ELGSGNFGVARLVRDK--RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~   85 (341)
                      .||+|+||.||+|.+.  .++..||+|++.....  ..+.+.+|+.+++.++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999765  4566799999875432  23468899999999999999999998754 56899999999999


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----CCCc
Q 019433           86 LFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKST  160 (341)
Q Consensus        86 L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----~~~~  160 (341)
                      |.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence            9998875 457999999999999999999999999999999999999987766  99999999864322211    1112


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .++..|+|||.+.+..++. ++|||||||++|++++ |..||......... .   .+.... ..+.....++++.++|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---~~~~~~-~~~~~~~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFSS-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-S---FIEQGK-RLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCCc-hhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-H---HHHCCC-CCCCCCCCCHHHHHHHH
Confidence            2356899999988777654 4899999999999996 99999876543322 1   111111 11222357899999999


Q ss_pred             HhcccCCCCCCChhHHhcC
Q 019433          240 QIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~h  258 (341)
                      +||+.+|++||++.++.+.
T Consensus       233 ~c~~~~~~~Rp~~~~i~~~  251 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEER  251 (257)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=9.4e-43  Score=284.32  Aligned_cols=255  Identities=24%  Similarity=0.429  Sum_probs=210.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcC--CEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTP--THLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~--~~~~iv~   78 (341)
                      .+.|++++++|+|.|+.||-|.+..+++.++||+++.-+  .+.+.+|++++..|. ||||++++++..++  ....+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            368999999999999999999999999999999987643  567999999999996 99999999998765  4578999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+.+.+...+.   ..|+.-.++.++.+++.||.|||++||+|||+||.|++|+... ..++|+|+|+|...-+.....
T Consensus       115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCceee
Confidence            999887765554   4588899999999999999999999999999999999998654 369999999998666666666


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCC-CCCChhHHHHHHHHHhc---------ccccC----
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFRKTIDRIRN---------VQYFL----  224 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~-~~~~~~~~~~~~~~~~~---------~~~~~----  224 (341)
                      ..+.+..|--||.+..-.......|+|||||++..|+..+-||. +.++..++.++..-+..         ....+    
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            77888999999999877666666899999999999999988874 45555565554332211         00000    


Q ss_pred             -----------------CCC-CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          225 -----------------PDY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       225 -----------------~~~-~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                                       ++. .-+++++.|||.++|..|-++|+||.|++.||||.
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence                             111 12569999999999999999999999999999993

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=316.99  Aligned_cols=246  Identities=30%  Similarity=0.401  Sum_probs=204.0

Q ss_pred             ccccceecccCCeEEEEEEEcCCCc---E-EEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKE---L-VAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      -.+.++||+|+||.||+|..+..+.   . ||+|....+    .....++.+|.++++.++|||||+++|+......+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3456899999999999999875432   3 899988742    3344578899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      |||+|.||+|.+++.+.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.  +||+|||+++.+....
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCccee
Confidence            999999999999999887 4999999999999999999999999999999999999987776  8999999998654222


Q ss_pred             CCC-CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 QPK-STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 ~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ... ...-...|+|||.+....++.+ +||||+||++||+++ |..||.+......    ...+....+..+.....+.+
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~v----~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYEV----KAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             eccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHHH----HHHHHhcCccCCCCCCCHHH
Confidence            222 2224567999999998877655 999999999999998 7889988765433    33332333444444478888


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +..++.+|+..+|++|||+.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999998876

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-41  Score=300.79  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=200.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcC----CCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR----TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~   74 (341)
                      .++|++.+.||+|+||.||+|.+..    ++..|++|.+....  .....+.+|+.+++.++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3689999999999999999999876    36889999886542  223457889999999999999999998765 5778


Q ss_pred             EEEEeecCCCchHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           75 AIVMEYAAGGELFARICSA--------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      +++++|+.+++|..++...        ..+++..++.++.|++.||.|||++|++||||||+||++++++.  +||+|||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g  162 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNA  162 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCC
Confidence            9999999999999998663        45899999999999999999999999999999999999987766  9999999


Q ss_pred             CccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      +++......   ......++..|+|||++.+..++.+ +|||||||++|++++ |..||...... .+..   .+.. ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~---~~~~-~~  236 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPF-EMAA---YLKD-GY  236 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHH-HHHH---HHHc-CC
Confidence            987432211   1122345667999999987776555 899999999999998 99999765432 2222   2221 22


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..+....+++++.+++.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            22333457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-41  Score=301.17  Aligned_cols=251  Identities=27%  Similarity=0.417  Sum_probs=201.2

Q ss_pred             CCccccceecccCCeEEEEEEEc----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLT--PTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~   74 (341)
                      +.|++.+.||+|+||.||++...    .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            57899999999999999999864    3588999999886554  35678899999999999999999999887  5679


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +++|||+++++|..++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEccccccccccc
Confidence            99999999999999997655 5999999999999999999999999999999999999988766  99999999875331


Q ss_pred             CCC----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh-----------HHHHHHHHHh
Q 019433          154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRKTIDRIR  218 (341)
Q Consensus       154 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~  218 (341)
                      ...    .....++..|+|||.+.+..+... +|||||||++|+|++|..||.......           ........+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            111    112234566999999877766544 899999999999999999986543211           1111122221


Q ss_pred             cccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                       .....+.....+..+.+|+.+||..+|.+|||+.++++
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 -EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             12222333456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-41  Score=297.05  Aligned_cols=238  Identities=21%  Similarity=0.226  Sum_probs=191.7

Q ss_pred             ceecccCCeEEEEEEEcCCC----------cEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            9 KELGSGNFGVARLVRDKRTK----------ELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            47999999999999998776          458888876654446778899999999999999999999888 7789999


Q ss_pred             eecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC-----CEEEeecCCccCCC
Q 019433           79 EYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-----RLKICDFGYSKSGL  152 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~-----~ikL~Dfg~a~~~~  152 (341)
                      ||+++++|..++.... .++...+..++.||+.||.|||++||+||||||+||+++.++..     .++|+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998766 79999999999999999999999999999999999999876621     49999999987532


Q ss_pred             CCCCCCCccCCCCcccccccccc-ccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .   .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||........ .....   . ....+.  ..
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~---~-~~~~~~--~~  229 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQ---D-QHRLPM--PD  229 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHh---c-CCCCCC--CC
Confidence            2   3345577789999998776 233455899999999999999 6888876542211 11111   1 111111  22


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +..+.+++.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-41  Score=297.99  Aligned_cols=240  Identities=20%  Similarity=0.221  Sum_probs=188.4

Q ss_pred             ceecccCCeEEEEEEEcC------------CCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            9 KELGSGNFGVARLVRDKR------------TKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      +.||+|+||.||++....            ....+|+|.+..... ....+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            469999999999998532            234689998765432 3346778889999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-----CCEEEeecCCcc
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-----PRLKICDFGYSK  149 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-----~~ikL~Dfg~a~  149 (341)
                      ++|||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.     ..++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            999999999998888653 46999999999999999999999999999999999999975442     238999999886


Q ss_pred             CCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHH-hCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ...   ......++..|+|||.+.+....+.++|||||||++|+|+ +|..||....... ...    ......  +...
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~--~~~~  230 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KER----FYEGQC--MLVT  230 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHH----HHhcCc--cCCC
Confidence            432   2234567888999999875444445599999999999997 5888887543211 111    111111  1112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..+.++.+||.+||+.||.+||++.+++++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.3e-41  Score=301.15  Aligned_cols=249  Identities=15%  Similarity=0.134  Sum_probs=188.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCcccc--H----------HHHHHHHHHhcCCCCCeeeEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKKID--E----------NVQREIINHRSLRHPNIIRFKE   66 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~--~----------~~~~ei~~~~~l~hp~iv~l~~   66 (341)
                      +++|++.+.||+|+||+||+|.+..+   +..+|+|+........  +          ....++..+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            57999999999999999999999877   6778888643322111  1          1122334455678999999999


Q ss_pred             EEEcCC----EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEE
Q 019433           67 VLLTPT----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI  142 (341)
Q Consensus        67 ~~~~~~----~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL  142 (341)
                      ++....    ..+++++++.. ++...+.....+++..++.++.|++.||.|||+++|+||||||+|||++.++.  ++|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l  167 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYI  167 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEE
Confidence            765443    45788887744 66666666556789999999999999999999999999999999999987766  999


Q ss_pred             eecCCccCCCCCC--------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHH--
Q 019433          143 CDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK--  212 (341)
Q Consensus       143 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~--  212 (341)
                      +|||+|+......        ......||+.|+|||++.+..++. ++|||||||++|+|++|..||...........  
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~-~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTR-RGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999987432211        122346999999999998877755 48999999999999999999987643222111  


Q ss_pred             ---HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          213 ---TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       213 ---~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                         .+..+......   ....++.+.+++..|+..+|.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence               11222222222   2346788999999999999999999999876

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-41  Score=293.25  Aligned_cols=240  Identities=27%  Similarity=0.368  Sum_probs=195.6

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ++||.|+||.||+|.+.. ++.||+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999987 99999998876432  345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC---CCCccC
Q 019433           87 FARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVG  162 (341)
Q Consensus        87 ~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~g  162 (341)
                      ..++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.  ++|+|||++........   .....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence            9998653 46899999999999999999999999999999999999988776  99999999874321111   112233


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      +..|+|||.+.+..++. ++|+|||||++|+|++ |..||......... ..   +.. ....+.....+..+.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~~~-~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRYTS-ESDVWSYGILLWETFSLGDTPYPGMSNQQTR-ER---IES-GYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCCCc-chhHHHHHHHHHHHHhccCCCCccCCHHHHH-HH---Hhc-CCCCCCCccCCHHHHHHHHHH
Confidence            56799999988777654 4899999999999998 88999765542222 11   111 112222346789999999999


Q ss_pred             cccCCCCCCChhHHhc
Q 019433          242 FVADPSKRIPIPEIKK  257 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~  257 (341)
                      |..+|.+|||+.++++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-41  Score=297.87  Aligned_cols=247  Identities=26%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|.+.+.||+|+||.||+|.+...   ...||||......  ...+.+.+|+.+++.++||||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            5799999999999999999987644   4569999876543  234568889999999999999999998875 456899


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccc
Confidence            99999999999997644 5899999999999999999999999999999999999988776  99999999864322211


Q ss_pred             --CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 --PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                        .....++..|+|||.+.+..+..+ +|||||||++|++++ |..||...........    +... ...+....++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~~~-~~~~~~~~~~~~  236 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IENG-ERLPMPPNCPPT  236 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcC-CcCCCCCCCCHH
Confidence              112234567999999877766544 899999999999986 9999987654333222    2221 122333468899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+++.+||..+|.+|||+.+++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1e-40  Score=292.36  Aligned_cols=241  Identities=25%  Similarity=0.366  Sum_probs=194.0

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      +.||+|+||.||++... ++..+|+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            47999999999999865 688999999875432  233577899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--CCCccCC
Q 019433           87 FARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGT  163 (341)
Q Consensus        87 ~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~~~~~gt  163 (341)
                      ..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........  .....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence            9988654 46899999999999999999999999999999999999987776  99999999864221111  1122345


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      ..|+|||++.+..+..+ +||||||+++|++++ |..||..........    .+.. .........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVEK-GYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence            67999999987766554 899999999999998 999997654432222    1211 1111222357899999999999


Q ss_pred             ccCCCCCCChhHHhcC
Q 019433          243 VADPSKRIPIPEIKKH  258 (341)
Q Consensus       243 ~~dp~~R~s~~e~l~h  258 (341)
                      +.+|++|||+.++++.
T Consensus       232 ~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         232 DYKPENRPKFSELQKE  247 (250)
T ss_pred             ccCcccCCCHHHHHHH
Confidence            9999999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.8e-41  Score=295.31  Aligned_cols=241  Identities=27%  Similarity=0.404  Sum_probs=196.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||++..  +++.||+|.+.... ....+.+|+.+++.++||||+++++++..+. .+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence            4799999999999999999864  68889999986543 3467889999999999999999999987654 799999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      +++|..++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.....  .....
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~--~~~~~  157 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSM--GVDNS  157 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceeccc--cCCCC
Confidence            999999987644  5899999999999999999999999999999999999988776  99999999874321  22233


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..+..|+|||.+.+..+..+ +|+|||||++|+|++ |..||....... ..   ..+.. ....+....++..+.+++.
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~---~~~~~-~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKE-VK---ECVEK-GYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHH-HH---HHHhC-CCCCCCCCcCCHHHHHHHH
Confidence            44567999999887776554 899999999999997 999997654322 22   22221 1222223467899999999


Q ss_pred             HhcccCCCCCCChhHHhc
Q 019433          240 QIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~  257 (341)
                      +||+.+|.+||++.+++.
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999876

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.4e-41  Score=296.95  Aligned_cols=248  Identities=30%  Similarity=0.449  Sum_probs=200.4

Q ss_pred             CccccceecccCCeEEEEEEEcC-CCcEEEEEEcccCc-----------cccHHHHHHHHHHhc-CCCCCeeeEEEEEEc
Q 019433            4 RYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGK-----------KIDENVQREIINHRS-LRHPNIIRFKEVLLT   70 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----------~~~~~~~~ei~~~~~-l~hp~iv~l~~~~~~   70 (341)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+....           .....+..|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48999999999999999999987 78899999875321           112345677777764 799999999999999


Q ss_pred             CCEEEEEEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           71 PTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        71 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                      ++..+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||++++++.  ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999887743    3468999999999999999999996 78999999999999988776  999999


Q ss_pred             CCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          146 GYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       146 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                      |++.............|+..|+|||.+.+..+.. ++|+||||+++|+|++|..||..........    .+........
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGE-KADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCch-HHHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcC
Confidence            9987544333344567889999999998777654 4899999999999999999997654432222    2222222111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....+++.+.++|.+||+.||.+||++.++..+
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            223578999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.1e-41  Score=299.31  Aligned_cols=239  Identities=22%  Similarity=0.270  Sum_probs=188.5

Q ss_pred             eecccCCeEEEEEEEcC------------------------CCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeE
Q 019433           10 ELGSGNFGVARLVRDKR------------------------TKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      .||+|+||.||++....                        ....||+|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                        224588998865432 23467788899999999999999


Q ss_pred             EEEEEcCCEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-----CC
Q 019433           65 KEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-----QP  138 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-----~~  138 (341)
                      ++++..+...++||||+++++|..++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++..+     ..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999988865 45789999999999999999999999999999999999997543     22


Q ss_pred             CEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHH-hCCCCCCCCCChhHHHHHHHHH
Q 019433          139 RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       139 ~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~-~g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      .++|+|||++....   ......++..|+|||.+.+....+.++|||||||++|+++ +|..||........ .....  
T Consensus       162 ~~kl~d~g~~~~~~---~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~--  235 (274)
T cd05076         162 FIKLSDPGVSFTAL---SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYE--  235 (274)
T ss_pred             eeeecCCccccccc---cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHH--
Confidence            48999999875322   1233467888999999876443345599999999999985 69999976543222 11111  


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                        .....+.  ..++.+.++|.+||+.+|.+|||+.+++++
T Consensus       236 --~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         236 --KKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             --hccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence              1112222  356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.3e-41  Score=297.96  Aligned_cols=243  Identities=25%  Similarity=0.373  Sum_probs=194.9

Q ss_pred             ceecccCCeEEEEEEEcCCC------cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            9 KELGSGNFGVARLVRDKRTK------ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.||+|+||.||+|..+...      ..+|||.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999987544      789999886543  3345688899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC---CCCEEEeecCCccC
Q 019433           81 AAGGELFARICSA-------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---QPRLKICDFGYSKS  150 (341)
Q Consensus        81 ~~~~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~---~~~ikL~Dfg~a~~  150 (341)
                      +++++|..++...       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       2478899999999999999999999999999999999998765   12499999999864


Q ss_pred             CCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          151 GLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       151 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      .....   ......++..|+|||.+.+..+.. ++|||||||++|+|++ |..||..........    .+.. ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTT-QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVTA-GGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCccc-chhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHhc-CCccCC
Confidence            32211   112334567899999998777654 4899999999999998 999997655433222    1111 111222


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ...++..+.++|.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            3467899999999999999999999999876

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=319.19  Aligned_cols=257  Identities=28%  Similarity=0.455  Sum_probs=221.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEc-----CCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT-----PTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~-----~~~~~i   76 (341)
                      ..|.+.+.||.|.+|.||+++++.+++..|+|+........+++..|+.+++.+ .|||++.++++|..     ++.+|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            568999999999999999999999999999999999888889999999999887 69999999999864     467999


Q ss_pred             EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      |||||.||+..+++++.  .++.|..+..|++.++.||.+||.+.++|||||-.|||++.++.  |||+|||++......
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence            99999999999998764  47999999999999999999999999999999999999998888  999999998754433


Q ss_pred             -CCCCCccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          155 -SQPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       155 -~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                       ....+.+|||.|||||++..     ..|+.. +|+||||++..||.-|.+|+.+.-....+   +...++....+..+.
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPK  252 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchh
Confidence             33456789999999999864     344444 89999999999999999999875543332   333344444555566


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .++.++.+||..||.+|..+||+..++|+|||+.+..
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            8999999999999999999999999999999997544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-42  Score=326.35  Aligned_cols=244  Identities=27%  Similarity=0.413  Sum_probs=207.4

Q ss_pred             cccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            6 EPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.++.||+|+||+||+|+..     .....||||.++....  ...++.+|+.++..++|||||+|+|+|..++.+++|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            56789999999999999864     3457799999987543  4568999999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           79 EYAAGGELFARICSAG--------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      |||..|+|..++....              +|+..+...|+.||+.|+.||-++.+|||||-..|+||..+-.  |||+|
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsD  646 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISD  646 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEecc
Confidence            9999999999985422              2889999999999999999999999999999999999987766  99999


Q ss_pred             cCCccCCCCCCCCC---CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||+++........+   ...-...||+||.|..+.++++ |||||+||||||+++ |..||.+..+.+.+    ..++..
T Consensus       647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVI----e~i~~g  721 (774)
T KOG1026|consen  647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----ECIRAG  721 (774)
T ss_pred             cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHH----HHHHcC
Confidence            99998654433322   2233567999999999999877 999999999999998 99999998875544    444444


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .. ++.....|.++.+|+..||+.+|++|||+.|+-.
T Consensus       722 ~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  722 QL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             Cc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            44 5555689999999999999999999999988744

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.1e-43  Score=314.88  Aligned_cols=259  Identities=26%  Similarity=0.408  Sum_probs=213.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC------CCCeeeEEEEEEcCCEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR------HPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~------hp~iv~l~~~~~~~~~~   74 (341)
                      |..||.+..-.|+|-||+|..|.+...|+.||||+++....-.+.=++|+.+|+.|+      --|+++|+..|.+.+++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            578999999999999999999999999999999999998877778889999999984      35899999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           75 AIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      |+|||... ..|...+.+.+   .|....++.++.|++.||..|-.+||+|.||||+||||+.+.. .+||||||.|...
T Consensus       510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFA  587 (752)
T ss_pred             EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCcccccc
Confidence            99999884 48888887755   5888999999999999999999999999999999999986544 5999999998642


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHH--------hccccc
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------RNVQYF  223 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~  223 (341)
                       ..........+..|+|||++.|..|+.. .|+||+||+||||+||+..|.+.++...+.-.+.--        +...+.
T Consensus       588 -~eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  588 -SENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             -ccccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence             2233445566778999999999999876 899999999999999999999887765554332110        000100


Q ss_pred             ------------------------------CC---------CCCCCC-------HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          224 ------------------------------LP---------DYVRVS-------ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       224 ------------------------------~~---------~~~~~s-------~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                                                    -|         ....++       ..+.+||.+||..||++|.|+.++|.
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                                          00         000122       34789999999999999999999999


Q ss_pred             CCccCC
Q 019433          258 HPWFLK  263 (341)
Q Consensus       258 hp~~~~  263 (341)
                      ||||..
T Consensus       746 HpFi~~  751 (752)
T KOG0670|consen  746 HPFITE  751 (752)
T ss_pred             CCcccC
Confidence            999964

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=320.47  Aligned_cols=245  Identities=33%  Similarity=0.428  Sum_probs=198.4

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------EEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPT------HLAI   76 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------~~~i   76 (341)
                      +..-+.||+|+||.||.++++.+|+.||||.++..  ....+..-+|++++++|+|||||+++++=....      .-.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            45567899999999999999999999999998763  344567789999999999999999999865443      4689


Q ss_pred             EEeecCCCchHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC--CCCCEEEeecCCccCC
Q 019433           77 VMEYAAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS--PQPRLKICDFGYSKSG  151 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~--~~~~ikL~Dfg~a~~~  151 (341)
                      |||||.||+|+..+.+.   ..|++.+++.++..+..||.|||++||+||||||.||++-..  |....||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999999763   369999999999999999999999999999999999998533  3344799999999988


Q ss_pred             CCCCCCCCccCCCCccccccccc-cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-----------  219 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------  219 (341)
                      .......+.+||+.|.+||++.. +.|+.. +|.|||||++|+++||..||.....+....+++-.+..           
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~t-VDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTAT-VDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCce-eehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            87888889999999999999985 555444 89999999999999999999776655433332222211           


Q ss_pred             --------ccccCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 019433          220 --------VQYFLPDYVRVSAD----CRHLLSQIFVADPSKRI  250 (341)
Q Consensus       220 --------~~~~~~~~~~~s~~----~~~li~~~L~~dp~~R~  250 (341)
                              ....+|....+++.    +...+..||..+|.+|.
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                    11224444445544    35678888999999998

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=9.8e-41  Score=301.15  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=197.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc----EEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++++.||+|+||.||++.+..++.    .+|+|.+.....  ....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            3678999999999999999999987776    468888765432  223577899999999999999999988754 467


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++++|+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.  +||+|||+++.....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~  162 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGD  162 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCc
Confidence            9999999999999987654 6899999999999999999999999999999999999987766  999999998743222


Q ss_pred             CC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ..   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||..... ......+.    .....+.....
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~----~~~~~~~~~~~  236 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLE----KGERLPQPPIC  236 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHH----CCCCCCCCCCC
Confidence            11   122345678999999987776554 899999999999997 8999976432 22222221    11222333457


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +..+.+++.+||..+|.+||++.++++.
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=292.41  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=214.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.|++++.||+|+|.+|.+++.+.|.+.||+|++++.-    ........|-.+..+- +||.+|.++.+|.....+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            57999999999999999999999999999999987642    2333455666655544 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      .||.+||+|.-.+++...++++.++.+...|+.||.|||++|||.||+|.+|||++..+.  +||.|+|+++.+.. ...
T Consensus       330 ieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcc
Confidence            999999999999999999999999999999999999999999999999999999998887  99999999986544 345


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCC--CChhH--HHHHHHHHhcccccCCCCCCCCH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP--EDPRN--FRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      +.+.+|||.|.|||++.|..|.-. .|+|+||+++++|+.|+.||.-.  +++..  -.-+..-+...+...|.  .+|-
T Consensus       408 tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsv  484 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSV  484 (593)
T ss_pred             cccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeeh
Confidence            567899999999999999998654 89999999999999999999632  11111  11122223333444444  5677


Q ss_pred             HHHHHHHHhcccCCCCCC------ChhHHhcCCccCCCC
Q 019433          233 DCRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNL  265 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~------s~~e~l~hp~~~~~~  265 (341)
                      .+..+++..|.+||.+|.      ...++..|+||+...
T Consensus       485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id  523 (593)
T KOG0695|consen  485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID  523 (593)
T ss_pred             hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence            788999999999999997      468999999997443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=316.06  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=196.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEccc---CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ...+...||+|.||+||+|.+-.+   ||||++.-   .+...+.++.|+.+++.-+|.||+-+.|++..+.. .||+.+
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw  468 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW  468 (678)
T ss_pred             Hhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence            456788999999999999999644   99999865   34466789999999999999999999999988888 999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---CC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQ  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~~  156 (341)
                      |+|-+|..++.... .|.....+.|+.|+++|+.|||.++|||||||..|||+.+++.  |||+|||++......   ..
T Consensus       469 CeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~q  546 (678)
T KOG0193|consen  469 CEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQQ  546 (678)
T ss_pred             ccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccccc
Confidence            99999999986644 6999999999999999999999999999999999999998766  999999998643222   22


Q ss_pred             CCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC----CCCC
Q 019433          157 PKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD----YVRV  230 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  230 (341)
                      .....|...|||||++...  ...++.+||||||||+|||++|..||.. ++.+++--    .....+..|+    ....
T Consensus       547 ~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIif----mVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  547 LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQIIF----MVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheEE----EecccccCccchhhhccC
Confidence            3344577789999998743  2335569999999999999999999994 33222211    1111111121    2345


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.++++|+..||.+++++||.+.++|.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            678999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.8e-40  Score=292.94  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=187.8

Q ss_pred             ceecccCCeEEEEEEEcCC--CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            9 KELGSGNFGVARLVRDKRT--KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      ++||+|+||+||++.....  ...+++|.+....  ...+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999975432  3456777765432  23457888999999999999999999999999999999999999


Q ss_pred             chHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---CCC
Q 019433           85 ELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQP  157 (341)
Q Consensus        85 ~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~~~  157 (341)
                      +|..++.+.    ..++...++.++.||+.||.|||+++++||||||+|||++.++.  ++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence            999998764    24667788999999999999999999999999999999987776  999999987532211   122


Q ss_pred             CCccCCCCccccccccccc------cCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC-CCC
Q 019433          158 KSTVGTPAYIAPEVLARKE------YDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-YVR  229 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  229 (341)
                      ....++..|+|||++....      ..+.++|||||||++|+|++ |..||........+...+.... .....|. ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  237 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ-VKLFKPQLELP  237 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcc-cccCCCccCCC
Confidence            3456788999999975321      11345899999999999997 5778876655444443332211 1111121 224


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +++.+.+++..|+ .+|.+|||+.++++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7888999999999 68999999999976

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-40  Score=292.35  Aligned_cols=242  Identities=24%  Similarity=0.316  Sum_probs=188.2

Q ss_pred             ceecccCCeEEEEEEEcC---CCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEE-cCCEEEEEEeecC
Q 019433            9 KELGSGNFGVARLVRDKR---TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAIVMEYAA   82 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~-~~~~~~iv~e~~~   82 (341)
                      +.||+|+||+||+|.+..   .+..+|+|.+....  .....+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   34679999885432  22356778999999999999999999765 4566899999999


Q ss_pred             CCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-----C
Q 019433           83 GGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----Q  156 (341)
Q Consensus        83 ~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-----~  156 (341)
                      +++|..++.+.. .++...+..++.|++.||.|||+++++||||||+||++++++.  +||+|||+++......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            999999987643 4677888999999999999999999999999999999988776  9999999986432111     1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||....... .   ...+... ...+....+++.+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~-~---~~~~~~~-~~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFD-I---TVYLLQG-RRLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH-H---HHHHhcC-CCCCCCCcCCHHHH
Confidence            123345678999999887776554 899999999999999 566776543322 1   1222111 11222235788999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +++.+||..+|++||++.++++.
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.2e-40  Score=292.23  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=193.4

Q ss_pred             ccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 019433            5 YEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------   72 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------   72 (341)
                      |++.+.||+|+||.||+|...   .+++.||||++....   ...+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            788999999999999999864   467899999987643   22346778999999999999999999886532      


Q ss_pred             EEEEEEeecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           73 HLAIVMEYAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      ..+++++|+.+++|..++...      ..++...++.++.|++.||+|||++||+||||||+||++++++.  +||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECccc
Confidence            247899999999998876432      14788999999999999999999999999999999999987766  9999999


Q ss_pred             CccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      +++......   ......+++.|++||.+.+..++.+ +|||||||++|+|++ |.+||.........    ..+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~----~~~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIY----NYLIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHH----HHHHcCC-
Confidence            987532221   1122345678999999887776554 899999999999999 88999765432221    1121111 


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..+.....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            112223577899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=293.72  Aligned_cols=256  Identities=28%  Similarity=0.421  Sum_probs=209.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----THLAI   76 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~~~i   76 (341)
                      -+.-+.||-|+||+||.+.+.++|+.||+|++..-.   ...+.+.+|++++...+|.|++..+++..-.     ..+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            356688999999999999999999999999986522   2345788999999999999999999987654     34788


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ++|++.. +|...+...+.++...++-+++||++||+|||+.||.||||||.|+|++++..  +||||||+++...... 
T Consensus       135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhh
Confidence            9999965 88888888889999999999999999999999999999999999999988877  9999999998543322 


Q ss_pred             -CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--------------
Q 019433          156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------------  220 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------  220 (341)
                       .....+.|.+|+|||++.|.+.++.+.||||+|||+.||+..+..|......+++.-+.+-+...              
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             23445678999999999999888888999999999999999999998877666665444322111              


Q ss_pred             -----cccCCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          221 -----QYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       221 -----~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                           ...-|+         ...-..+..+++.+||.+||.+|.+..+++.|+++-+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence                 111111         1123345789999999999999999999999999843

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=290.00  Aligned_cols=251  Identities=27%  Similarity=0.422  Sum_probs=202.1

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHH-hcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINH-RSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +-+..||.|+||+|++..++.+|+.+|||.++....  ....++.|.... ++-+.||||++++....++..||.||+|+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            456789999999999999999999999999986543  344566676654 44579999999999999999999999995


Q ss_pred             CCchHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           83 GGELFARI-----CSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        83 ~~~L~~~l-----~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      - +|..+.     .++..++|+-+-.|....+.||.||-. ..||||||||+|||++..|.  +||||||++......-.
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIA  223 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHH
Confidence            4 553332     235579999999999999999999975 68999999999999998888  99999999986555555


Q ss_pred             CCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--ccC--CCCCCC
Q 019433          157 PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFL--PDYVRV  230 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~  230 (341)
                      .....|...|||||.+..  ..|+-+ ||+||||++|||+.||..||...++   ..+.+..+....  ...  .....+
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~  299 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHY  299 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCccccccc
Confidence            666789999999999864  345555 8999999999999999999987554   222232222221  111  123458


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      |..+..+|..||.+|-..||...+++++||++.
T Consensus       300 s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~  332 (361)
T KOG1006|consen  300 SFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM  332 (361)
T ss_pred             CHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence            999999999999999999999999999999853

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1e-39  Score=315.26  Aligned_cols=258  Identities=20%  Similarity=0.193  Sum_probs=175.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCC----CcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEE------EEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT----KELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV------LLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~------~~~~~   72 (341)
                      ++|++.+.||+|+||.||+|.+..+    +..||+|.+..... .+....+ . ++...+.++..+...      .....
T Consensus       132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE-R-VRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH-H-HHhhchhhHHHHHHhhhcccccccCC
Confidence            6899999999999999999999988    99999998764321 1111111 1 111222222222222      23456


Q ss_pred             EEEEEEeecCCCchHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe
Q 019433           73 HLAIVMEYAAGGELFARICSAGR--------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL  132 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili  132 (341)
                      .+++|+||+.+++|.+++.....                    .....+..++.||+.||.|||++||+||||||+|||+
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl  288 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF  288 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence            79999999999999988865321                    1234567899999999999999999999999999999


Q ss_pred             cCCCCCCEEEeecCCccCCCC--CCCCCCccCCCCccccccccccccC---------------------CCccchhhHHH
Q 019433          133 DGSPQPRLKICDFGYSKSGLL--HSQPKSTVGTPAYIAPEVLARKEYD---------------------GKISDVWSCGV  189 (341)
Q Consensus       133 ~~~~~~~ikL~Dfg~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG~  189 (341)
                      +.+. ..+||+|||+|+....  .......++|+.|+|||.+......                     +.++|||||||
T Consensus       289 ~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        289 SEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             eCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            8532 2399999999974322  1223456789999999976432211                     12359999999


Q ss_pred             HHHHHHhCCCCCCCCCChhHHHHHHHHHhc--------ccc-cCC-------CCCCCCHHHHHHHHHhcccCCCCCCChh
Q 019433          190 TLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--------VQY-FLP-------DYVRVSADCRHLLSQIFVADPSKRIPIP  253 (341)
Q Consensus       190 vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------~~~-~~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~  253 (341)
                      ++|+|+++..|+..  ....+...+.....        ... ..+       .....+....+||.+||++||.+|||+.
T Consensus       368 iL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~  445 (566)
T PLN03225        368 IFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK  445 (566)
T ss_pred             HHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence            99999997666532  22222222211000        000 000       0011233456899999999999999999


Q ss_pred             HHhcCCccCCCCC
Q 019433          254 EIKKHPWFLKNLP  266 (341)
Q Consensus       254 e~l~hp~~~~~~~  266 (341)
                      ++|+||||.....
T Consensus       446 e~L~Hpff~~~~~  458 (566)
T PLN03225        446 AALAHPYFDREGL  458 (566)
T ss_pred             HHhCCcCcCCCCc
Confidence            9999999976544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=305.24  Aligned_cols=260  Identities=19%  Similarity=0.239  Sum_probs=188.0

Q ss_pred             CCCccccceecccCCeEEEEEEEc----------------CCCcEEEEEEcccCcc---------------ccHHHHHHH
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK----------------RTKELVAVKYIERGKK---------------IDENVQREI   50 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~---------------~~~~~~~ei   50 (341)
                      .++|++.++||+|+||+||+|...                ..++.||||.+.....               ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            368999999999999999999752                3456799999864321               112233466


Q ss_pred             HHHhcCCCCC-----eeeEEEEEEc--------CCEEEEEEeecCCCchHHHHHhc------------------------
Q 019433           51 INHRSLRHPN-----IIRFKEVLLT--------PTHLAIVMEYAAGGELFARICSA------------------------   93 (341)
Q Consensus        51 ~~~~~l~hp~-----iv~l~~~~~~--------~~~~~iv~e~~~~~~L~~~l~~~------------------------   93 (341)
                      .++..++|.+     +++++++|..        ....++|+||+++++|.+++...                        
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            6666666554     4667776643        35689999999999998887532                        


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC--ccCCCCcccccc
Q 019433           94 GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS--TVGTPAYIAPEV  171 (341)
Q Consensus        94 ~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~--~~gt~~y~aPE~  171 (341)
                      ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.  +||+|||++...........  ..+|+.|+|||+
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence            12456778899999999999999999999999999999988776  99999999864332222222  234789999999


Q ss_pred             cccccc--------------------C-CCccchhhHHHHHHHHHhCCC-CCCCCCChhHH-------HHHHHHHhcccc
Q 019433          172 LARKEY--------------------D-GKISDVWSCGVTLYVMLVGAY-PFEDPEDPRNF-------RKTIDRIRNVQY  222 (341)
Q Consensus       172 ~~~~~~--------------------~-~~~~DiwslG~vl~~l~~g~~-pf~~~~~~~~~-------~~~~~~~~~~~~  222 (341)
                      +.....                    . ....||||+||++|+|++|.. ||.........       ...+........
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            754321                    1 123699999999999999875 77542211110       011122223334


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCC---CCCCChhHHhcCCccCC
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADP---SKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp---~~R~s~~e~l~hp~~~~  263 (341)
                      .++.+...++.+.+|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            445556789999999999999876   68999999999999964

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=321.59  Aligned_cols=245  Identities=26%  Similarity=0.373  Sum_probs=203.9

Q ss_pred             ccccceecccCCeEEEEEEEcCCC-----cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTK-----ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      -...+.||+|+||.||.|......     ..||||.+.+..  .....+.+|..+++.++|||||++++++.+....+|+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            356788999999999999886433     349999998754  3445799999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           78 MEYAAGGELFARICSA-------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      +|||.||+|..++.+.       ..++..+...++.||++|..||+++++|||||...|+|++....  +||+|||+|+.
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlArD  851 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLARD  851 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhHh
Confidence            9999999999999876       25889999999999999999999999999999999999987754  99999999983


Q ss_pred             CCCCCCCC---CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          151 GLLHSQPK---STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       151 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      ........   ...-...|||||.+....++++ +|||||||++||+++ |..||....+.+.+.....   ..  .++.
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---gg--RL~~  925 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---GG--RLDP  925 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---CC--ccCC
Confidence            22211111   1122357999999998888776 999999999999998 9999998777555433222   22  4555


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ....+..+.+++..||..+|++||++..+++
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            5578899999999999999999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.1e-38  Score=276.84  Aligned_cols=241  Identities=41%  Similarity=0.677  Sum_probs=203.5

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEcccCccc--cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHh
Q 019433           15 NFGVARLVRDKRTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS   92 (341)
Q Consensus        15 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~   92 (341)
                      +||.||+|.+..+++.+|+|++......  .+.+.+|+..++.++|+||+++++++......++++||+.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999999999999998765433  46888999999999999999999999999999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccc
Q 019433           93 AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL  172 (341)
Q Consensus        93 ~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  172 (341)
                      ...++...+..++.+++.++.+||+.|++|+||+|+||++++++.  ++|+|||.+.............++..|++||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH--VKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc--EEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            777999999999999999999999999999999999999998765  999999998764444345566788999999999


Q ss_pred             cccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC-CCCCHHHHHHHHHhcccCCCCCCC
Q 019433          173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-VRVSADCRHLLSQIFVADPSKRIP  251 (341)
Q Consensus       173 ~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dp~~R~s  251 (341)
                      .+..++. ++|+||||++++++++|..||....+......   ............ ..++.++.+++.+||..+|++||+
T Consensus       159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFK---KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            8777765 59999999999999999999977444333222   222222222111 127889999999999999999999


Q ss_pred             hhHHhcCCcc
Q 019433          252 IPEIKKHPWF  261 (341)
Q Consensus       252 ~~e~l~hp~~  261 (341)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=289.22  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +-.++++||+|.||.|.+|.-. .+..||+|+++....  ...++.+||++|.+|+||||++++++|..++.+++++||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4568899999999999999986 368999999987543  3368999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC-
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-  158 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~-  158 (341)
                      +.|+|.+++....  .+.......++.||+.|++||.+.++|||||-+.|+|++++..  +||+|||+++......... 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceee
Confidence            9999999998763  3345566779999999999999999999999999999987776  9999999998644433222 


Q ss_pred             --CccCCCCccccccccccccCCCccchhhHHHHHHHHHh--CCCCCCCCCChhHHHHHHHHHhcc--cccCCCCCCCCH
Q 019433          159 --STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--GAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSA  232 (341)
Q Consensus       159 --~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~  232 (341)
                        ..+-...|||||.+..+.+++. +|+|++|+++||+++  ...||....+.+...+.-......  ...++...-.+.
T Consensus       696 qgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~  774 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQ  774 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcH
Confidence              2244578999999988888665 999999999998764  778998877765554433332221  122333446788


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.+|+.+|+..+-++|||++++-.|
T Consensus       775 ~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  775 GLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             HHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            89999999999999999999998654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=301.32  Aligned_cols=246  Identities=29%  Similarity=0.365  Sum_probs=191.4

Q ss_pred             ccccceecccCCeE-EEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            5 YEPVKELGSGNFGV-ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         5 y~~~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      |..-+.+|.|+-|+ ||.+..  .|+.||||.+-..  ....+.+||..++.- +|||||++++.-.+....||+.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            34457789998885 588887  5889999987654  345788999999877 69999999999999999999999997


Q ss_pred             CCchHHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC---CCCCCEEEeecCCccCCCCCC
Q 019433           83 GGELFARICSA-GR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        83 ~~~L~~~l~~~-~~---l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~---~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      . +|.+++... ..   ......+.++.|++.||++||+.+||||||||.||||+.   ++..+++|+|||+++......
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            7 999998763 11   112456889999999999999999999999999999986   455679999999998543322


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                          ......||-+|+|||++....... ++||+|||||+|..++ |..||.+.-.  ...+++.........-+.   .
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~~~~L~~L~~~---~  739 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTGNYTLVHLEPL---P  739 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHH--hhhhhhcCccceeeeccC---c
Confidence                234457999999999998777654 5899999999998887 5999987432  111122111111111111   1


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..++.+||.+||.++|..||+|.++|.||+|
T Consensus       740 d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlF  770 (903)
T KOG1027|consen  740 DCEAKDLISRMLNPDPQLRPSATDVLNHPLF  770 (903)
T ss_pred             hHHHHHHHHHhcCCCcccCCCHHHHhCCCcc
Confidence            1289999999999999999999999999999

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=287.87  Aligned_cols=243  Identities=26%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             cccceecccCCeEEEEEEEcC----CCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            6 EPVKELGSGNFGVARLVRDKR----TKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+.+.||.|.||.||.|....    ..--||||..+..  ....+.+..|..+++.++||||++++|++.. ...+||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            456789999999999998642    2345889987663  3456789999999999999999999999865 45799999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      +++-|.|..+++.++ .++......+++||+.||+|||++++|||||-..||||.+...  +||+|||+++-........
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhh
Confidence            999999999998766 6999999999999999999999999999999999999987766  9999999998655444433


Q ss_pred             CccC--CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          159 STVG--TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       159 ~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...|  ..-|||||.+.-.++.+ ++|||-|||++||++. |..||.+..+.+.+..    +. ....+|-....++.+.
T Consensus       549 aS~~kLPIKWmaPESINfRrFTt-ASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~----iE-nGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFTT-ASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH----IE-NGERLPCPPNCPPALY  622 (974)
T ss_pred             ccccccceeecCccccchhcccc-hhhHHHHHHHHHHHHHhcCCccccccccceEEE----ec-CCCCCCCCCCCChHHH
Confidence            3333  34599999998888865 5999999999999875 9999998776544322    11 2234555568899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhc
Q 019433          236 HLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .|+.+||+++|.+||.+.++..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999888754

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=289.44  Aligned_cols=252  Identities=27%  Similarity=0.386  Sum_probs=208.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++-+..++||+|+||+|+.+.++..   --.||||+++....  ....+++|+.+|.+|+|||+++||++..+ ..+.+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            4557789999999999999998743   34599999987543  45689999999999999999999999988 778999


Q ss_pred             EeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           78 MEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||++++|+|.+.+...  ..|.......++.||+.|+.||.++++||||+-..|+++-+...  |||||||+.+......
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCC
Confidence            9999999999999873  35888999999999999999999999999999999999986544  9999999998543333


Q ss_pred             CCCC----ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          156 QPKS----TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       156 ~~~~----~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ....    .--...|+|||.+....+... +|+|++||+||||++ |.-||.+......+.+    +. ....++..+..
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~----iD-~~erLpRPk~c  340 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN----ID-AGERLPRPKYC  340 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHHHh----cc-ccccCCCCCCC
Confidence            2221    122446999999998888765 999999999999998 8999998776544433    22 34456666678


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      |.++.+++..||..+|++|||+..+.+.-+...
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            999999999999999999999998876544433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=287.45  Aligned_cols=196  Identities=31%  Similarity=0.495  Sum_probs=177.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH---------HHHHHHHHHhcCC---CCCeeeEEEEEEcC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE---------NVQREIINHRSLR---HPNIIRFKEVLLTP   71 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~ei~~~~~l~---hp~iv~l~~~~~~~   71 (341)
                      .|..++.+|.|+||.|++|.++.+...|+||.+.+.+-...         .+-.||++|..|+   |+||++++++|+++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd  641 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD  641 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence            48999999999999999999999999999999988653222         3457999999996   99999999999999


Q ss_pred             CEEEEEEeec-CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           72 THLAIVMEYA-AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        72 ~~~~iv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      +++|++||.- +|-+|+++|..+..++|.++..|++|++.|+++||+.||||||||-+||.++++|-  +||+|||.|.-
T Consensus       642 d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~  719 (772)
T KOG1152|consen  642 DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAY  719 (772)
T ss_pred             CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhh
Confidence            9999999975 67899999999999999999999999999999999999999999999999998887  99999998863


Q ss_pred             CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCC
Q 019433          151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE  202 (341)
Q Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~  202 (341)
                       ....+....+||..|.|||++.|..|-++..|||+||++||.++....||.
T Consensus       720 -~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  720 -TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             -hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence             334556778999999999999999999998999999999999999888885

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=312.89  Aligned_cols=242  Identities=18%  Similarity=0.222  Sum_probs=185.7

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      .|...+.||+|+||.||+|.++.++..||+|.+.....   ....|+..++.++|||||++++++......++||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            45667789999999999999999999999999875432   223568889999999999999999999999999999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCH---SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH---~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      |+|.+++.   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.+..  .++. ||......   .....
T Consensus       768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            99999985   3889999999999999999999   679999999999999987776  4444 55443211   12234


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHHh-c--c----cccCCCC----C
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIR-N--V----QYFLPDY----V  228 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~~-~--~----~~~~~~~----~  228 (341)
                      .||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ....+...... .  .    ....+..    .
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            78899999999988777655 99999999999999999999543211 11111111000 0  0    0000000    0


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....++.+++.+||+.||++|||+.++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112346789999999999999999999874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=292.81  Aligned_cols=260  Identities=30%  Similarity=0.431  Sum_probs=217.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|..+..+|.|.||.||+|+++.+++..|+|+++-... ....+..||.+++.++|||||.+++.+.....++|+||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            689999999999999999999999999999999886543 3456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC-CCCCCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~-~~~~~~~~~  160 (341)
                      .||+|++.-.-.+++++.++..+.+..+.||+|||+.|=+|||||-.||++++.+.  +||.|||.+... .......+.
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence            99999998888889999999999999999999999999999999999999999988  999999987632 222345678


Q ss_pred             cCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          161 VGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       161 ~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      +|||+|||||+-.   ...|... +|||++|++..++---++|-.+.-..+.+.-.... ......+.+...+++.+.+|
T Consensus       173 iGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-GFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHHHHhhcc-CCCCCcccCCccchHHHHHH
Confidence            9999999999853   3445444 99999999999998888886554333322211111 11111233345789999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++.+|.++|++|||++.+|.|||..+...
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~l~  279 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQTLS  279 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccchh
Confidence            99999999999999999999999977644

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=2.9e-37  Score=272.34  Aligned_cols=257  Identities=27%  Similarity=0.414  Sum_probs=201.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcC---CCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~i   76 (341)
                      |.+-|.++.+||.|.|++||++.+..   .++.||+|.+..... ...+..|+.++..+ .+.||+++.+++..++...+
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i  112 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI  112 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence            35679999999999999999999987   789999999887543 45689999999888 59999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC------
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS------  150 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~------  150 (341)
                      |+||++..+..++...   ++..+++.+++.++.||.++|.+|||||||||+|++.+.... +-.|+|||+|-.      
T Consensus       113 vlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  113 VLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             EecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC-CceEEechhHHHHHhhhh
Confidence            9999998877776643   778999999999999999999999999999999999975433 578999999851      


Q ss_pred             -----------CCC-CCC---------------------------CCCccCCCCccccccccccccCCCccchhhHHHHH
Q 019433          151 -----------GLL-HSQ---------------------------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL  191 (341)
Q Consensus       151 -----------~~~-~~~---------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl  191 (341)
                                 ... ...                           .....||++|+|||++..-...+.++||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                       000 000                           00225999999999998766666779999999999


Q ss_pred             HHHHhCCCCCCCCCC-hhHHHHHHHHH---------------------------------hccc----ccCC--------
Q 019433          192 YVMLVGAYPFEDPED-PRNFRKTIDRI---------------------------------RNVQ----YFLP--------  225 (341)
Q Consensus       192 ~~l~~g~~pf~~~~~-~~~~~~~~~~~---------------------------------~~~~----~~~~--------  225 (341)
                      ..+++++.||....+ ...+.++....                                 ....    ....        
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            999999999865332 22221111000                                 0000    0000        


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ....++..+.+|+.+||..||.+|+|++++|+||||.
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            0112455789999999999999999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=291.33  Aligned_cols=245  Identities=27%  Similarity=0.416  Sum_probs=209.1

Q ss_pred             cccceecccCCeEEEEEEEcCCC---cEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            6 EPVKELGSGNFGVARLVRDKRTK---ELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .|-+.||.|.||.||.++.+..|   ..||||.++..  .+....++.|..+|-+.+||||++|.++....+.+.||+||
T Consensus       632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy  711 (996)
T KOG0196|consen  632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY  711 (996)
T ss_pred             EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence            57788999999999999998665   56999999864  34566899999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           81 AAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |++|+|..++..+ ++|+..++..+++.|+.|++||.++|+|||||-..||||+++-.  +|++|||+++...... ...
T Consensus       712 MENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~y  789 (996)
T KOG0196|consen  712 MENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAY  789 (996)
T ss_pred             hhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCccc
Confidence            9999999999764 47999999999999999999999999999999999999987766  9999999998543332 222


Q ss_pred             CccC---CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          159 STVG---TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       159 ~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      +..|   ...|.|||.+....+.+. +||||+|+|+||.+. |..||-+-.+.+.+..+     ...+.+|...+.+..+
T Consensus       790 tt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI-----e~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  790 TTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI-----EQGYRLPPPMDCPAAL  863 (996)
T ss_pred             cccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHHH-----HhccCCCCCCCCcHHH
Confidence            2222   356999999998888665 999999999998775 99999887775544432     3456678878899999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..|+..||++|-.+||.+.|+..+
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999998775

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=278.37  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=206.1

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ...+||-|.||.||.+.+++-.-.||||.++......+++++|..+|+.++|||+|+|+++|.....+|||+|||..|.|
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL  350 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL  350 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence            45689999999999999999889999999998888888999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC--
Q 019433           87 FARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG--  162 (341)
Q Consensus        87 ~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g--  162 (341)
                      .+++.+..  .++.-....++.||..|+.||..+++|||||-..|+||..+..  +|++|||+++.... .......|  
T Consensus       351 LdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtg-DTYTAHAGAK  427 (1157)
T KOG4278|consen  351 LDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTG-DTYTAHAGAK  427 (1157)
T ss_pred             HHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcC-CceecccCcc
Confidence            99997644  4777888899999999999999999999999999999987776  99999999985322 22222222  


Q ss_pred             -CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          163 -TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       163 -t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                       ..-|.|||-+....+..+ +|||+|||+|||+.| |-.||.+-+-.+. ..+    ....+.+......++.+.+|++.
T Consensus       428 FPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~L----LEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  428 FPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGL----LEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             CcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHH----HhccccccCCCCCCHHHHHHHHH
Confidence             456999999998888777 899999999999998 8899987554322 222    23344555556899999999999


Q ss_pred             hcccCCCCCCChhHHhc
Q 019433          241 IFVADPSKRIPIPEIKK  257 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~  257 (341)
                      ||+.+|.+||++.|+-+
T Consensus       502 CW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HhcCCcccCccHHHHHH
Confidence            99999999999988743

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=257.43  Aligned_cols=258  Identities=25%  Similarity=0.429  Sum_probs=202.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEE-EEcCCEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEV-LLTPTHLAIVM   78 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~-~~~~~~~~iv~   78 (341)
                      +++.|.|.+.||+|.||.+-+|.++.+++.+++|.+.+......++.+|...--.| .|.||+.-+++ |...+.+++++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            46789999999999999999999999999999999999888888999998765555 48999988874 67788999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||++.|+|..-+.. ..+.|...+.++.|+++|+.|+|++++||||||.+||||-.....+|||||||+++..  ...-.
T Consensus       102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g~tV~  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--GTTVK  178 (378)
T ss_pred             ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--Cceeh
Confidence            99999999887754 4689999999999999999999999999999999999997666668999999988632  11112


Q ss_pred             CccCCCCcccccccccc---c-cCCCccchhhHHHHHHHHHhCCCCCCCCC-ChhHHHHHHHHHhcccccCC-CCCCCCH
Q 019433          159 STVGTPAYIAPEVLARK---E-YDGKISDVWSCGVTLYVMLVGAYPFEDPE-DPRNFRKTIDRIRNVQYFLP-DYVRVSA  232 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~---~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~s~  232 (341)
                      ..--+..|.+||++...   . ...+.+|+|.||+++|.+++|++||.... ....+.+............| .+..+|+
T Consensus       179 ~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~  258 (378)
T KOG1345|consen  179 YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSE  258 (378)
T ss_pred             hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCH
Confidence            22335568999876422   2 22344899999999999999999997422 11223333333333333334 3457899


Q ss_pred             HHHHHHHHhcccCCCCC---CChhHHhcCCcc
Q 019433          233 DCRHLLSQIFVADPSKR---IPIPEIKKHPWF  261 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R---~s~~e~l~hp~~  261 (341)
                      .+..++++-|.++|++|   .++....+.-|.
T Consensus       259 ~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  259 KALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            99999999999999999   555555555554

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=241.89  Aligned_cols=199  Identities=29%  Similarity=0.438  Sum_probs=164.3

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHH-hcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINH-RSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ...+..||+|+||+|=+.++..+|+..|+|.+...-  +..+..++|+.+. +...+|.+|.+++.......++|.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            345678999999999999999999999999987543  2334566777665 4457999999999999999999999999


Q ss_pred             CCCchHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           82 AGGELFAR----ICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        82 ~~~~L~~~----l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      .. +|..+    +..++.++|..+-+++..++.||.|||++ .++|||+||+||||+..|.  +|+||||++......-.
T Consensus       128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIA  204 (282)
T ss_pred             hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhhH
Confidence            65 66444    34567899999999999999999999985 8999999999999998887  99999999875444433


Q ss_pred             CCCccCCCCccccccccc----cccCCCccchhhHHHHHHHHHhCCCCCCCCCCh
Q 019433          157 PKSTVGTPAYIAPEVLAR----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP  207 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~  207 (341)
                      .....|...|||||.+..    ..|+-+ +||||||+++.||.+++.||.....+
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence            344678889999999853    355555 89999999999999999999776543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=257.74  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=186.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC----CEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP----THLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~----~~~~iv   77 (341)
                      .+.-++.+.||+|.||.||.+.+.  |+.||||++.........-+.||..-..|+|+||+.+++.-..+    ..+++|
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            455678899999999999999995  88999999987544333333445444567999999999986544    358999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----c---CCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-----M---EICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-----~---~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ++|.+.|||++++++ ..++.+...+++..++.||+|||.     +   .|.|||||..||||.+++.  .-|+|+|+|.
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence            999999999999987 679999999999999999999994     2   4999999999999998887  9999999996


Q ss_pred             CCCCC-----CCCCCccCCCCccccccccccc----c-CCCccchhhHHHHHHHHHhC----------CCCCCCCCChh-
Q 019433          150 SGLLH-----SQPKSTVGTPAYIAPEVLARKE----Y-DGKISDVWSCGVTLYVMLVG----------AYPFEDPEDPR-  208 (341)
Q Consensus       150 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~-~~~~~DiwslG~vl~~l~~g----------~~pf~~~~~~~-  208 (341)
                      .....     -.....+||..|||||++...-    + ..+.+||||||.|+||++..          .+||.+.-..+ 
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            43332     2345779999999999985321    1 12348999999999999763          47886533221 


Q ss_pred             HHHHHHHHH--hcccccCCCCCCCC---HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          209 NFRKTIDRI--RNVQYFLPDYVRVS---ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       209 ~~~~~~~~~--~~~~~~~~~~~~~s---~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+.+..+-+  ++.....|..-.-.   ..+..+++.||..||..|.|+--+.+
T Consensus       445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            222221111  12222222211112   23567899999999999999866554

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=261.84  Aligned_cols=244  Identities=23%  Similarity=0.289  Sum_probs=181.9

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----EEEEEEeec
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAIVMEYA   81 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----~~~iv~e~~   81 (341)
                      +.+++||+|.||.||+|...  ++.||||++.......-...++|.-+-.++|+||+++++.-....    .+++|++|.
T Consensus       213 ~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh  290 (534)
T KOG3653|consen  213 QLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH  290 (534)
T ss_pred             hhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence            56789999999999999985  689999999876544444444555455668999999999876544    799999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS---------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~---------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      +.|+|.+++..+ .+++....+++..+++||+|||+         ..|+|||||..||||.++..  ..|+|||+|....
T Consensus       291 ~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~  367 (534)
T KOG3653|consen  291 PKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLE  367 (534)
T ss_pred             cCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEec
Confidence            999999999654 69999999999999999999995         35999999999999998887  9999999997544


Q ss_pred             CC---CCCCCccCCCCccccccccccccCC-----CccchhhHHHHHHHHHhCCCCCCC--C--------------CChh
Q 019433          153 LH---SQPKSTVGTPAYIAPEVLARKEYDG-----KISDVWSCGVTLYVMLVGAYPFED--P--------------EDPR  208 (341)
Q Consensus       153 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~vl~~l~~g~~pf~~--~--------------~~~~  208 (341)
                      ..   ......+||..|||||++.|.-.-.     +..||||+|.|+||+++...-+..  .              ...+
T Consensus       368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e  447 (534)
T KOG3653|consen  368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE  447 (534)
T ss_pred             CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence            32   2334578999999999997653322     458999999999999987533321  0              0112


Q ss_pred             HHHHHHHHHhcccccCCC-CC--CCCHHHHHHHHHhcccCCCCCCChhHH
Q 019433          209 NFRKTIDRIRNVQYFLPD-YV--RVSADCRHLLSQIFVADPSKRIPIPEI  255 (341)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~-~~--~~s~~~~~li~~~L~~dp~~R~s~~e~  255 (341)
                      ..+...-.-+ ....+|+ |.  .-..-+.+.+..|+..||+.|.|+.=+
T Consensus       448 ~mq~~VV~kK-~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  448 EMQELVVRKK-QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHHHHHHhhc-cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            2222221111 1111221 11  122447899999999999999997533

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=275.84  Aligned_cols=245  Identities=25%  Similarity=0.401  Sum_probs=198.4

Q ss_pred             cccceecccCCeEEEEEEEcC-------CCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEE
Q 019433            6 EPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~   75 (341)
                      .+.+.||+|+||.|++|..+.       ....||||.+.....  ..+.+..|+.+++.+ .||||+.+++++...+.++
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            566799999999999997541       256799999876443  356788999999988 6999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           76 IVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      +|+||+..|+|..++...+                .++..+...+++||+.|++||+++.++|||+-..|||+..+..  
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--  456 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--  456 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--
Confidence            9999999999999997765                3889999999999999999999999999999999999998766  


Q ss_pred             EEEeecCCccCCCCCCCCC--CccC--CCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHH
Q 019433          140 LKICDFGYSKSGLLHSQPK--STVG--TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~  214 (341)
                      +||+|||+|+.........  ...|  ...|||||.+....++.+ +||||+|+++||+++ |..||.+......+   .
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l---~  532 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEEL---L  532 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHH---H
Confidence            9999999998533332222  1122  234999999998777665 899999999999998 88999874322222   2


Q ss_pred             HHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       215 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..++.. ..+......++++.++++.|+..+|++||++.++.+
T Consensus       533 ~~l~~G-~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  533 EFLKEG-NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHhcC-CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            333332 223334467999999999999999999999999887

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=4e-33  Score=236.20  Aligned_cols=210  Identities=43%  Similarity=0.665  Sum_probs=183.5

Q ss_pred             ecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHH
Q 019433           11 LGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFA   88 (341)
Q Consensus        11 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~   88 (341)
                      ||.|++|.||++....+++.+++|++.....  ..+.+.+|+..++.++|++|+++++++......++++|++.+++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999998899999999887644  24678999999999999999999999999999999999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-CCCCCEEEeecCCccCCCCCC-CCCCccCCCC
Q 019433           89 RICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHS-QPKSTVGTPA  165 (341)
Q Consensus        89 ~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~~~~~~-~~~~~~gt~~  165 (341)
                      ++... ..++...++.++.+++++|.+||++|++|+||+|.||+++. ++.  ++|+|||.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCc--EEEecCCceEEccCCcchhhcccCCCC
Confidence            98776 47999999999999999999999999999999999999987 555  9999999987432221 1334567888


Q ss_pred             ccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccC
Q 019433          166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD  245 (341)
Q Consensus       166 y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  245 (341)
                      |++||.+......+..+|+|++|++++++                                     ..+.+++.+||+.+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence            99999987762334458999999999998                                     56899999999999


Q ss_pred             CCCCCChhHHhcCC
Q 019433          246 PSKRIPIPEIKKHP  259 (341)
Q Consensus       246 p~~R~s~~e~l~hp  259 (341)
                      |.+||++.++++|+
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=270.54  Aligned_cols=243  Identities=24%  Similarity=0.338  Sum_probs=200.2

Q ss_pred             cccceecccCCeEEEEEEEcCCC----cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            6 EPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +..++||.|+||+||++.+...|    -+||||++....  +...++++|+.++.+|+|||+++|++++.... +-||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            45789999999999999987554    468889886643  44678999999999999999999999998776 789999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+++|.|.++++..+ ++.-.....|..||++|+.|||+++++||||-..||||.+.+.  +|+.|||+++.........
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccc
Confidence            999999999998754 7889999999999999999999999999999999999998777  9999999998644333222


Q ss_pred             Ccc---CCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          159 STV---GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       159 ~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ..-   -.+.|||-|.+....+... +||||+||++||++| |..|+.+... +.+.+   .++ ....+++....+-++
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~-~eI~d---lle-~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA-EEIPD---LLE-KGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH-HHhhH---HHh-ccccCCCCCCccHHH
Confidence            221   2456999999988888766 999999999999998 8999977543 22222   222 233366666788999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhc
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .-++.+||..|+..||+++++..
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999988754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=5.4e-32  Score=232.56  Aligned_cols=196  Identities=45%  Similarity=0.715  Sum_probs=172.2

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+.....  ..+.+.+|+..++.++|+|++++++.+......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999998899999999886543  35678889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCCC
Q 019433           83 GGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~~  159 (341)
                      +++|..++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.  ++|+|||++.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL--VKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeCceeeEecCcccccccc
Confidence            9999999988776 899999999999999999999999999999999999987755  9999999887543322  2345


Q ss_pred             ccCCCCccccccc-cccccCCCccchhhHHHHHHHHHhCCCCCCC
Q 019433          160 TVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFED  203 (341)
Q Consensus       160 ~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~  203 (341)
                      ..++..|++||.+ ....+.. ++|+|+||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence            5788899999998 4444444 58999999999999999999966

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=5.3e-33  Score=280.62  Aligned_cols=201  Identities=16%  Similarity=0.184  Sum_probs=147.1

Q ss_pred             cCCC-CCeeeEEEEE-------EcCCEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCC
Q 019433           55 SLRH-PNIIRFKEVL-------LTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDL  125 (341)
Q Consensus        55 ~l~h-p~iv~l~~~~-------~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDi  125 (341)
                      .++| +||+++++.|       .....+++++|++ +++|..++.. ...+++.+++.+++||++||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3455 5788888877       2334678888987 5599999965 346999999999999999999999999999999


Q ss_pred             CCCCEEecCCC-----------------CCCEEEeecCCccCCCCCC-----------------CCCCccCCCCcccccc
Q 019433          126 KLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHS-----------------QPKSTVGTPAYIAPEV  171 (341)
Q Consensus       126 kp~Nili~~~~-----------------~~~ikL~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~aPE~  171 (341)
                      ||+||||+..+                 ...+|++|||+++......                 .....+||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996422                 2336777777765311000                 0012458999999999


Q ss_pred             ccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019433          172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIP  251 (341)
Q Consensus       172 ~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s  251 (341)
                      +.+..+.. ++|||||||++|||++|.+|+.....  .+.......     ..+......+...+++.+||+++|.+|||
T Consensus       187 ~~~~~~~~-~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        187 DNGSSSNC-ASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-----LPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hccCCCCc-hhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-----cChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            98888865 49999999999999999888754211  111111111     11111123456789999999999999999


Q ss_pred             hhHHhcCCccCCC
Q 019433          252 IPEIKKHPWFLKN  264 (341)
Q Consensus       252 ~~e~l~hp~~~~~  264 (341)
                      +.++++||||...
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.4e-32  Score=262.42  Aligned_cols=259  Identities=33%  Similarity=0.511  Sum_probs=203.7

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcc----cCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIE----RGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .....+|.|++|.|+.+........++.|.+.    ...   .....+..|+.+-..+.|||++..+..+......+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56778999999999999888777777777654    111   11122556777788899999988888777766666669


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      |||++ +|+.++.....+...++..++.|++.|++|+|++||.|||+|++|++++.++.  +||+|||.+........  
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence            99999 99999988888999999999999999999999999999999999999998886  99999999875433332  


Q ss_pred             ---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHH---hcccccCCCCCCC
Q 019433          157 ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---RNVQYFLPDYVRV  230 (341)
Q Consensus       157 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  230 (341)
                         ....+|+..|+|||++.+..|++...||||.|++++.|.+|+.||................   ....-..+-+..+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence               3456799999999999999999999999999999999999999997654432221000000   0000001112347


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +...+.+|.+||++||.+|.|++++++.+||+.....
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c  594 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC  594 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence            7888999999999999999999999999999765443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.3e-30  Score=213.86  Aligned_cols=164  Identities=21%  Similarity=0.222  Sum_probs=126.2

Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           84 GELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        84 ~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      |+|.+++.. ..++++..++.++.|++.||.|||+++      ||+|||++.++.  +++  ||++.....    ....|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCC
Confidence            688899876 446999999999999999999999998      999999988776  888  999874322    22368


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH-HHHHHHHHhccccc-CCCCCCCCH--HHHHHH
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYF-LPDYVRVSA--DCRHLL  238 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~s~--~~~~li  238 (341)
                      |+.|||||++.+..++.+ +|||||||++|+|++|..||........ +............. .+....++.  .+.+++
T Consensus        67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            999999999988887655 9999999999999999999976543222 22222221111000 011122333  699999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      .+||..+|.+|||+.++++|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999873

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=9e-29  Score=216.55  Aligned_cols=247  Identities=18%  Similarity=0.210  Sum_probs=193.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-CEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP-THL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-~~~   74 (341)
                      .|++....+-+|.||.||.|.+.+.     .+.|.+|.+....  .+-..++.|-.++..+.|||+..+.++...+ ..-
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            5788888999999999999976543     2345566655432  2334577888888889999999999987654 556


Q ss_pred             EEEEeecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           75 AIVMEYAAGGELFARICS--------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      ++++.+..-|+|..++..        .+.++..+...++.|++.|++|||++|+||.||-..|++|++.-.  +||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq--VkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ--VKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee--EEeccch
Confidence            788888888999999872        224778889999999999999999999999999999999987655  9999999


Q ss_pred             CccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      +++...+..   ..........||+||.+.+..|++. +|+||||+++|||+| |+.||..-+..+..     ......+
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm~-----~ylkdGy  515 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEME-----HYLKDGY  515 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHHH-----HHHhccc
Confidence            988533222   1122233557999999998888755 999999999999998 99999876654332     2223344


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+.+..+.|+++-.++..||..+|++||+.+|+..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            45556688999999999999999999999998854

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2e-27  Score=215.82  Aligned_cols=252  Identities=24%  Similarity=0.191  Sum_probs=193.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCC-cEEEEEEcccCccc-cHHHHHHHHHHhcCC----CCCeeeEEEEE-EcCCEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKI-DENVQREIINHRSLR----HPNIIRFKEVL-LTPTHLAI   76 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~-~~~~~~ei~~~~~l~----hp~iv~l~~~~-~~~~~~~i   76 (341)
                      +|.+.++||+|+||.||+|.+..++ ..+|+|........ ...+..|+.++..+.    .+++..+++.+ ......|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999998774 67999987664322 226888888888886    36999999999 57888999


Q ss_pred             EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-C--CCEEEeecCCcc--
Q 019433           77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-Q--PRLKICDFGYSK--  149 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~--~~ikL~Dfg~a~--  149 (341)
                      ||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99988 66998877443  5799999999999999999999999999999999999997653 1  359999999998  


Q ss_pred             CCCCCC--------C-CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc
Q 019433          150 SGLLHS--------Q-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       150 ~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ......        . .....||..|+++.+..+...... .|+||++.++.+++.|..||..........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            311111        1 123459999999999888877655 899999999999999999997765433333322222111


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ... ......+..+..+...+-..+...+|....+...
T Consensus       257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  257 LTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             ccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            111 0122355678888888877899999988777664

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=4.1e-27  Score=212.47  Aligned_cols=255  Identities=36%  Similarity=0.553  Sum_probs=201.5

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCC-CeeeEEEEEEcCCEEEEEEe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHP-NIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp-~iv~l~~~~~~~~~~~iv~e   79 (341)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....    ....+.+|+.+++.+.|+ +|+++.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999998   7799999876543    355788999999999988 79999999988888999999


Q ss_pred             ecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           80 YAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ++.++++...+....   .++......++.|++.++.|+|+.|++|||+||+||+++..+. .++++|||++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997776664   7999999999999999999999999999999999999987662 39999999986332222 


Q ss_pred             ------CCCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHHHHHhcccccC
Q 019433          156 ------QPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLVGAYPFEDPED---PRNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       156 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  224 (341)
                            ......||..|+|||.+.+.  .......|+||+|++++++++|..||.....   .......+..........
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  24667899999999999874  3444558999999999999999999877654   222222222211110111


Q ss_pred             CCCCCC----CHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          225 PDYVRV----SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       225 ~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +.....    ...+.+++.+++..+|..|.+..+...+++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            111111    257899999999999999999999999866643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.8e-28  Score=222.83  Aligned_cols=162  Identities=16%  Similarity=0.151  Sum_probs=127.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcC-CCcEEEEEEcccC------ccccHHHHHHHHHHhcCCCCCeee-EEEEEEcCC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERG------KKIDENVQREIINHRSLRHPNIIR-FKEVLLTPT   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~ei~~~~~l~hp~iv~-l~~~~~~~~   72 (341)
                      +.++|++.+.||+|+||+||+|+++. +++.+|||++...      ......+.+|+.+++.++|+|++. +++    ..
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence            35789999999999999999999886 6788899986532      112346889999999999999985 443    24


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCC-CCCCEEecCCCCCCEEEeecCCccCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDi-kp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..|+||||++|++|.. +.   ...   ...++.|+++||.|||++||+|||| ||+|||++.++.  ++|+|||+|+..
T Consensus        92 ~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~  162 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVF  162 (365)
T ss_pred             CcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceec
Confidence            5799999999999963 21   111   2568899999999999999999999 999999987665  999999999743


Q ss_pred             CCCCC---------CCCccCCCCcccccccccc
Q 019433          152 LLHSQ---------PKSTVGTPAYIAPEVLARK  175 (341)
Q Consensus       152 ~~~~~---------~~~~~gt~~y~aPE~~~~~  175 (341)
                      .....         .....+++.|+|||.+...
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            22211         1245678889999998644

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.5e-27  Score=193.96  Aligned_cols=247  Identities=21%  Similarity=0.236  Sum_probs=191.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|+++++||.|+||.+|++.+..+|+.||||+-.... -...+..|.++.+.|++ ..|+.+..++....+-.+||+.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            478999999999999999999999999999999866543 35567889999888864 6788888888888889999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCCC----
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLH----  154 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~~----  154 (341)
                      . |.+|.++.+- ...|+...+.-++-|++.-++|+|.++++||||||+|.|..-+-. .++.|+|||+|+.....    
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            8 6688887765 346999999999999999999999999999999999999853322 35899999999753322    


Q ss_pred             ----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC---CC
Q 019433          155 ----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---DY  227 (341)
Q Consensus       155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~  227 (341)
                          .......||..|.+-....+...+.. .|+-|+|.++..+..|..||.+.......++. +.+.......|   -+
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-EkI~EkK~s~~ie~LC  249 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-EKISEKKMSTPIEVLC  249 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHHHHH-HHHHHhhcCCCHHHHh
Confidence                22344578999998877766665544 89999999999999999999886554333322 22222222222   24


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCh
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPI  252 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~  252 (341)
                      +.+|.++.-.+..|-..--++-|+.
T Consensus       250 ~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  250 KGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CCCcHHHHHHHHHHhhcCCCCCCcH
Confidence            6788999888888876666666654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.4e-29  Score=230.07  Aligned_cols=242  Identities=30%  Similarity=0.515  Sum_probs=201.0

Q ss_pred             eecccCCeEEEEEEE---cCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEeecC
Q 019433           10 ELGSGNFGVARLVRD---KRTKELVAVKYIERGKK---IDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .+|.|+||.|++++.   ...+..+|+|+..+...   .......|-.++..++ ||.+|+++..|..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998764   35688899998766321   1113445666667675 9999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccC
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG  162 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~g  162 (341)
                      ||+|...+.....+.+...+.+...++.++.++|+.+|+|||+|++||+++.+|+  +++.|||+++........   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence            9999999988888999999999999999999999999999999999999998887  999999999864443322   99


Q ss_pred             CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       163 t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      |..|||||++.+  . ..++|.||+|++.++|++|..||..        ++...+.......|.  .++..+++++..|+
T Consensus       156 t~eymApEI~~g--h-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIING--H-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhhc--c-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence            999999999972  2 2348999999999999999999987        344555555555555  68999999999999


Q ss_pred             ccCCCCCCC-----hhHHhcCCccCCCCChhH
Q 019433          243 VADPSKRIP-----IPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       243 ~~dp~~R~s-----~~e~l~hp~~~~~~~~~~  269 (341)
                      ..+|..|.-     +.++++|+||......+.
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l  254 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWNEL  254 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeeeHhhH
Confidence            999999984     579999999976554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-25  Score=193.46  Aligned_cols=200  Identities=24%  Similarity=0.314  Sum_probs=171.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .|++.++||+|+||+.+.+.+.-++++||||.-.+.. ....+..|.+..+.| ..++|...+.+.....+-.+|+|+. 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            5999999999999999999999999999999866543 366788899888888 5799999999999999999999998 


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC---CCEEEeecCCccCCCCCCC--
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~---~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      |.+|.++..-. .+|+...+..++.|++.-++|+|++.+|.|||||+|+||...+.   ..|-++|||+|+.......  
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            66888877654 46999999999999999999999999999999999999964332   3489999999985443332  


Q ss_pred             ------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 019433          157 ------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED  206 (341)
Q Consensus       157 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~  206 (341)
                            ..+..||..||+-....|...+.. -|+=|||-+++..+-|.+||.+...
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence                  335579999999999888887655 8999999999999999999987543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=2.2e-26  Score=223.20  Aligned_cols=223  Identities=32%  Similarity=0.530  Sum_probs=170.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +..|..++.|..|+||.||+++++.+.+.+|+|+ .++..    +.+-  ++....+|.+|                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc--cccccCCccee-------------------
Confidence            5689999999999999999999999999999954 33221    1111  33334555555                   


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-----
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----  156 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-----  156 (341)
                        |+-...+..-++++...        +.+++|||+.||+|||+||+|.+|+.-|.  +||.|||+++.+.....     
T Consensus       136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhh
Confidence              45555566656666654        78999999999999999999999998777  99999999875432221     


Q ss_pred             -----------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          157 -----------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       157 -----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                                 ....+|||.|.|||++....|. +.+|+|++|+|+|+.+-|+.||.+.+..+.+...+..    ...+|
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd----~i~wp  278 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD----DIEWP  278 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----hcccc
Confidence                       2345899999999999988885 4599999999999999999999886665444443322    22222


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCC---ChhHHhcCCccCCCCCh
Q 019433          226 -DYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       226 -~~~~~s~~~~~li~~~L~~dp~~R~---s~~e~l~hp~~~~~~~~  267 (341)
                       ....++++++++|.++|..+|..|.   .+-++.+|+||+.....
T Consensus       279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence             2346889999999999999999996   67888999999765444

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=6e-26  Score=192.54  Aligned_cols=170  Identities=14%  Similarity=0.164  Sum_probs=130.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHH----------HHHHHHHHhcCCCCCeeeEEEEEEc
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----------VQREIINHRSLRHPNIIRFKEVLLT   70 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~ei~~~~~l~hp~iv~l~~~~~~   70 (341)
                      |++||+++++||.|+||.||++..  ++..+|||++.......+.          +.+|+..+.++.||+|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            578999999999999999999755  4678999998754322222          5789999999999999999988664


Q ss_pred             C--------CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEE
Q 019433           71 P--------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI  142 (341)
Q Consensus        71 ~--------~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL  142 (341)
                      .        ...+++|||++|.+|.+..    .+++    ....+++.+|..||+.|++|||++|+||+++.++   ++|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~l  175 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRI  175 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEE
Confidence            3        3578999999999997763    2333    2466999999999999999999999999998655   999


Q ss_pred             eecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHH
Q 019433          143 CDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML  195 (341)
Q Consensus       143 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~  195 (341)
                      +|||.+.........           .-.+....++. ++|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~-----------d~~vler~y~~-~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAK-----------DRIDLERHYGI-KNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhH-----------HHHHHHhHhcc-cccccceeEeehHHH
Confidence            999987643211100           11333445553 489999999886653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=2.3e-25  Score=186.51  Aligned_cols=138  Identities=22%  Similarity=0.207  Sum_probs=109.5

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc--c-------------------------HHHHHHHHHHhcCCCC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--D-------------------------ENVQREIINHRSLRHP   59 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-------------------------~~~~~ei~~~~~l~hp   59 (341)
                      +...||+|+||.||+|.+. +|+.||||+++.....  .                         .....|+..+..+.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            3578999999999999997 8999999998754211  0                         1223588999988877


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeCCCCCCCEEecCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHrDikp~Nili~~~~~~  138 (341)
                      ++.....+... . .+|||||++|+++...+....+++...+..++.|++.+|.+| |+.||+||||||+||++++ +. 
T Consensus        80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~-  155 (190)
T cd05147          80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK-  155 (190)
T ss_pred             CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc-
Confidence            76443332222 2 389999999987766655567899999999999999999999 7999999999999999983 44 


Q ss_pred             CEEEeecCCccC
Q 019433          139 RLKICDFGYSKS  150 (341)
Q Consensus       139 ~ikL~Dfg~a~~  150 (341)
                       ++|+|||+|..
T Consensus       156 -v~LiDFG~a~~  166 (190)
T cd05147         156 -LYIIDVSQSVE  166 (190)
T ss_pred             -EEEEEcccccc
Confidence             99999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=2.6e-24  Score=180.60  Aligned_cols=138  Identities=19%  Similarity=0.150  Sum_probs=110.9

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---------------------------cHHHHHHHHHHhcCCCC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------------------------DENVQREIINHRSLRHP   59 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~ei~~~~~l~hp   59 (341)
                      +.+.||+|++|+||+|.+. +|+.||||+++.....                           ......|+..+..+.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999988 8999999998764210                           11235788888889898


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~  138 (341)
                      +|.....+....  .++||||++|+++........+++...+..++.|++.+|.+||+ +||+||||||+||+++ ++. 
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~-  155 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK-  155 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC-
Confidence            875544443332  48999999988665443345678899999999999999999999 9999999999999998 454 


Q ss_pred             CEEEeecCCccC
Q 019433          139 RLKICDFGYSKS  150 (341)
Q Consensus       139 ~ikL~Dfg~a~~  150 (341)
                       ++|+|||++..
T Consensus       156 -~~liDFG~a~~  166 (190)
T cd05145         156 -PYIIDVSQAVE  166 (190)
T ss_pred             -EEEEEccccee
Confidence             99999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=5.6e-25  Score=192.04  Aligned_cols=230  Identities=20%  Similarity=0.243  Sum_probs=144.1

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCC----------CCeeeEEEEEE-
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH----------PNIIRFKEVLL-   69 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~h----------p~iv~l~~~~~-   69 (341)
                      ....+.||.|++|.||.+.+..||+.+|+|++....    ...+.+++|......+.+          -.++..++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999999999999999975432    122345555544433221          12222233222 


Q ss_pred             -----------cCC-----EEEEEEeecCCCchHHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCC
Q 019433           70 -----------TPT-----HLAIVMEYAAGGELFARICS---AGR----FSEDEARFFFQQLISGVSYCHSMEICHRDLK  126 (341)
Q Consensus        70 -----------~~~-----~~~iv~e~~~~~~L~~~l~~---~~~----l~~~~~~~i~~qil~aL~~LH~~~iiHrDik  126 (341)
                                 +..     +.+++|+.+.+ +|...+..   ...    +.......+..|+++.+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                       111     23677887744 77666532   222    2233445566999999999999999999999


Q ss_pred             CCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCcccccccccc-------ccCCCccchhhHHHHHHHHHhCCC
Q 019433          127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-------EYDGKISDVWSCGVTLYVMLVGAY  199 (341)
Q Consensus       127 p~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~vl~~l~~g~~  199 (341)
                      |+|+|++.+|.  +.|+||+.......  .......+..|.+||.....       ...+.+.|.|+||+++|.|+|+..
T Consensus       173 ~~nfll~~~G~--v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGG--VFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCC--EEEcChHHHeecCc--eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999887  99999987653221  11113445778999976432       122445799999999999999999


Q ss_pred             CCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019433          200 PFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKR  249 (341)
Q Consensus       200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R  249 (341)
                      ||........          ....+..+.+++..++.||+.||++||.+|
T Consensus       249 Pf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9986533111          111334555799999999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.8e-23  Score=173.89  Aligned_cols=184  Identities=18%  Similarity=0.159  Sum_probs=138.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH-----HHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE-----NVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.+...|++|+||+|+++..  .+.+++.+.+....-..+     .+.+|+.+++.|. |++|++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999997776  577888887776554333     5789999999995 5889999885    3469999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCC-CCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL-KLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDi-kp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      +|+.|.+|......      . ...++.|++.+|.++|++||+|||| ||+|||++.++.  ++|+|||+|.........
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchH
Confidence            99999988654321      1 2357889999999999999999999 799999987766  999999999743322210


Q ss_pred             --------------CCccCCCCcccccccccc-ccCCCccchhhHHHHHHHHHhCCCCCCC
Q 019433          158 --------------KSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFED  203 (341)
Q Consensus       158 --------------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~vl~~l~~g~~pf~~  203 (341)
                                    .....++.|++|+...-- ..+-...+.++.|+-+|.++|+..|+-.
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                          011257888888764322 1111235889999999999999877643

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-25  Score=215.46  Aligned_cols=243  Identities=23%  Similarity=0.330  Sum_probs=177.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccH---HHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDE---NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~---~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .|...+.||++.|=+|.+|++. .|. |+||++-+..  -..+   +...|++ ....++||++.+.-+...++..|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            3567889999999999999986 454 9999986643  1222   3444555 45669999999998888888899999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      +|... +|.+.+....-+...+.+.|+.||+.||.-+|..||+|||||.+||||++=+  ++.|+||..-+.........
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCc
Confidence            99966 9999998777788899999999999999999999999999999999998533  58999998765322111111


Q ss_pred             --------CccCCCCccccccccccc---------c-CCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHh-
Q 019433          159 --------STVGTPAYIAPEVLARKE---------Y-DGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIR-  218 (341)
Q Consensus       159 --------~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~-  218 (341)
                              +.....+|.|||.+....         . -.++.||||+||++.||++ |++||.-.    ++........ 
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~~  253 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNAD  253 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCcc
Confidence                    112234699999876421         1 2355899999999999998 89999531    1111100000 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .....+..  --+..++.||..|++.||.+|.||++.|+-
T Consensus       254 ~~e~~Le~--Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEK--IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHh--CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00000011  113468999999999999999999999986

>PRK10345 hypothetical protein; Provisional

Probab=99.90  E-value=1.2e-22  Score=171.77  Aligned_cols=137  Identities=18%  Similarity=0.214  Sum_probs=109.8

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccC-ccccHHHHHHHHHHhcC-----CCCCeeeEEEEEEcCC---E-EE
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSL-----RHPNIIRFKEVLLTPT---H-LA   75 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~ei~~~~~l-----~hp~iv~l~~~~~~~~---~-~~   75 (341)
                      .-.+.||+|+||.||.  ++.++.. +||++... ....+.+.+|+.+++.+     +||||+++++++.++.   . +.
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999995  7777766 69988654 23456789999999999     6799999999998873   4 34


Q ss_pred             EEEee--cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeeCCCCCCCEEecCC--CCCCEEEeecCCc
Q 019433           76 IVMEY--AAGGELFARICSAGRFSEDEARFFFQQLISGV-SYCHSMEICHRDLKLENTLLDGS--PQPRLKICDFGYS  148 (341)
Q Consensus        76 iv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL-~~LH~~~iiHrDikp~Nili~~~--~~~~ikL~Dfg~a  148 (341)
                      +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..  +..+++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  5589999999664 56666  46688888888 89999999999999999999743  3346999995533

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=8.7e-23  Score=179.74  Aligned_cols=191  Identities=28%  Similarity=0.414  Sum_probs=141.7

Q ss_pred             CCCCeeeEEEEEEc---------------------------CCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHH
Q 019433           57 RHPNIIRFKEVLLT---------------------------PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI  109 (341)
Q Consensus        57 ~hp~iv~l~~~~~~---------------------------~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil  109 (341)
                      .|||||++..+|.+                           +..+|+||..+.. +|..++.... .+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999998864                           2568999998866 8999886654 55666777899999


Q ss_pred             HHHHHHHHcCCeeCCCCCCCEEe--cCCCCCCEEEeecCCccCCCC-------CCCCCCccCCCCccccccccccc----
Q 019433          110 SGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL-------HSQPKSTVGTPAYIAPEVLARKE----  176 (341)
Q Consensus       110 ~aL~~LH~~~iiHrDikp~Nili--~~~~~~~ikL~Dfg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~----  176 (341)
                      +|+.|||.+||.|||+|.+|||+  +++..+.+.|+|||++-....       ....-..-|....||||+...-.    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998  556668899999998742221       11122334777899999975321    


Q ss_pred             -cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhH
Q 019433          177 -YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE  254 (341)
Q Consensus       177 -~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e  254 (341)
                       .+..++|.|+.|.+.||+++...||......-.-...   .+.. ...+|  ..+++.+++|+..+|+.||++|+|+.=
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp--~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALP--SRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCc--ccCChHHHHHHHHHhcCCccccCCccH
Confidence             2233489999999999999999999773321110011   1111 11223  378999999999999999999998643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=7.7e-23  Score=201.96  Aligned_cols=193  Identities=25%  Similarity=0.288  Sum_probs=157.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +++|.|-+.||+|+||+||.|.... |+.||+|+-....  ..++.--.+++.+|+   -+.|..+..++...+..++|+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            4689999999999999999999987 9999999865532  233333344444554   245666666666778889999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-----CCCCCEEEeecCCccCC--
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----SPQPRLKICDFGYSKSG--  151 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-----~~~~~ikL~Dfg~a~~~--  151 (341)
                      ||.+.|+|.++++..+.+++..+..++.|++..+++||.++|||+||||+|.||..     .+..-++|+|||.+...  
T Consensus       774 ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  774 EYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             eccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            99999999999998889999999999999999999999999999999999999942     22334999999988532  


Q ss_pred             -CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC
Q 019433          152 -LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA  198 (341)
Q Consensus       152 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~  198 (341)
                       .........++|-.+-.+|+..|..++.. +|.|.|+.+++.|+.|+
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence             22233455678899999999999999766 89999999999999996

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.1e-22  Score=171.04  Aligned_cols=239  Identities=22%  Similarity=0.345  Sum_probs=187.6

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEccc---CccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .++-+|.+...|..|++++.  |..++.|++.-   .....+.+..|.-.++...||||+.+++.+..+.++.++..|++
T Consensus       193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            45667888999999999996  55677787653   33455678889989999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC-Ce-eCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           83 GGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSME-IC-HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~-ii-HrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      .|+|+..+.....  .+..++.+++.++++|++|||+.. ++ ---+....|+||.+-..++-.+|--++..      ..
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e~  344 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EV  344 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------cc
Confidence            9999999987664  678899999999999999999975 33 33688889999988776677777544331      12


Q ss_pred             CccCCCCccccccccccccC--CCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ...-.|.||+||.+....-+  -.++|+|||++++|||.|...||.+....+.-.++.  +.......|  ..+|+....
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--leglrv~ip--pgis~hm~k  420 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--LEGLRVHIP--PGISRHMNK  420 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--hccccccCC--CCccHHHHH
Confidence            33457889999999765443  356899999999999999999999877654433322  112222233  489999999


Q ss_pred             HHHHhcccCCCCCCChhHHh
Q 019433          237 LLSQIFVADPSKRIPIPEIK  256 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l  256 (341)
                      |+.-|+..||.+||.+..+.
T Consensus       421 lm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHhcCCCCcCCCcceeh
Confidence            99999999999999877654

>smart00090 RIO RIO-like kinase

Probab=99.88  E-value=3.2e-22  Score=173.11  Aligned_cols=138  Identities=17%  Similarity=0.102  Sum_probs=111.3

Q ss_pred             ccccceecccCCeEEEEEE-EcCCCcEEEEEEcccCccc-------------------------cHHHHHHHHHHhcCCC
Q 019433            5 YEPVKELGSGNFGVARLVR-DKRTKELVAVKYIERGKKI-------------------------DENVQREIINHRSLRH   58 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~ei~~~~~l~h   58 (341)
                      |++.+.||.|+||.||+|. +..+|+.||||++......                         ...+.+|+.++..+.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            8899999999999999999 7779999999998753210                         0124679999988865


Q ss_pred             C--CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeeCCCCCCCEEecCC
Q 019433           59 P--NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-ICHRDLKLENTLLDGS  135 (341)
Q Consensus        59 p--~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~-iiHrDikp~Nili~~~  135 (341)
                      .  .++++++.    ...++||||+.|++|.........+....+..++.|++.+|.+||++| |+||||||+||+++ +
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            3  34444442    234899999999888766545556777778899999999999999999 99999999999998 4


Q ss_pred             CCCCEEEeecCCcc
Q 019433          136 PQPRLKICDFGYSK  149 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~  149 (341)
                      +.  ++|+|||.+.
T Consensus       185 ~~--i~LiDFg~a~  196 (237)
T smart00090      185 GK--VVIIDVSQSV  196 (237)
T ss_pred             CC--EEEEEChhhh
Confidence            44  9999999876

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.6e-23  Score=202.44  Aligned_cols=259  Identities=31%  Similarity=0.506  Sum_probs=208.0

Q ss_pred             CCccccceecccCCeEEEEEEEcC-CCcEEEEEEcccCc---cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGK---KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ..|.+.+.||+|+|+.|-++.... +...+|.|.+....   .....+..|..+.+.+. |+|++++++........++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            468999999999999999888853 44556777665443   33344556888888886 99999999999999999999


Q ss_pred             EeecCCCchHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-
Q 019433           78 MEYAAGGELFARI-CSAG-RFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-  153 (341)
Q Consensus        78 ~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~qil~aL~~LH-~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-  153 (341)
                      ++|..|++++..+ .... ..+......++.|+..++.|+| ..++.||||||+|.+++.++. .+++.|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9999999999988 5554 6888889999999999999999 999999999999999998883 399999999975443 


Q ss_pred             CC---CCCCccC-CCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          154 HS---QPKSTVG-TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       154 ~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .+   .....+| ++.|+|||...+..+..+..|+||.|+++..+++|..||............+.... .......+..
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  257 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNS  257 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc-cccccCcccc
Confidence            22   2234578 99999999999877777779999999999999999999977554322111111111 1112344567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ++....+++.++|..+|..|.+.+++..+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8999999999999999999999999999999976

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=3.2e-22  Score=182.47  Aligned_cols=176  Identities=27%  Similarity=0.379  Sum_probs=134.6

Q ss_pred             CEEEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           72 THLAIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      .++||.|++|.-.+|.+++....   ..+......++.|+..|+.|   +|.+|||+||.||+...+..  +||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhe
Confidence            35899999999999999997543   46778899999999999999   99999999999999987776  999999997


Q ss_pred             cCCCCCC-------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          149 KSGLLHS-------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       149 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      .......       ......||.+||+||.+.+..|..+ +||||||++|+||+. -..+|..       ......++..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDG  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcC
Confidence            6433333       3345689999999999999999766 899999999999987 3333322       1122223332


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+. |....-.+.-.+|+.+||.+.|.+||++.+.--|+|.
T Consensus       476 ~ip-~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIP-PEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCC-hHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            221 1111222445699999999999999988877777764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=3.5e-20  Score=158.26  Aligned_cols=134  Identities=24%  Similarity=0.224  Sum_probs=112.1

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---------cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++.||+|++|.||+|.+  .|..+++|+.......         ...+.+|+.++..+.|++|+....++......+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            46899999999999987  6778999986542211         134668899999999999887777777778889999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      ||++|++|.+.+.....    ....++.+++.+|.+||+.|++|||++|.||+++ ++.  ++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~--~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGK--IYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence            99999999998865432    7889999999999999999999999999999998 444  99999998763

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3e-20  Score=172.37  Aligned_cols=204  Identities=23%  Similarity=0.327  Sum_probs=156.5

Q ss_pred             HhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eeCCCCCCCE
Q 019433           53 HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEI-CHRDLKLENT  130 (341)
Q Consensus        53 ~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~i-iHrDikp~Ni  130 (341)
                      ++.+.|.|+.++++.+.+....++|.+||..|+|.+.+.. ...++......++++|+.||.|||.-.| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3678999999999999999999999999999999999977 4478889999999999999999998765 9999999999


Q ss_pred             EecCCCCCCEEEeecCCccCCCCC---CCCCCccCCCCcccccccccccc------CCCccchhhHHHHHHHHHhCCCCC
Q 019433          131 LLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEY------DGKISDVWSCGVTLYVMLVGAYPF  201 (341)
Q Consensus       131 li~~~~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~vl~~l~~g~~pf  201 (341)
                      +++....  +||+|||+.......   .......-..-|.|||.+.+...      .+.+.||||+|++++++++...||
T Consensus        81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9998777  999999997644220   00111112345899999876422      244589999999999999999999


Q ss_pred             CCCCChhHHHHHHHHHhc-cc-ccCCC---CCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          202 EDPEDPRNFRKTIDRIRN-VQ-YFLPD---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~-~~-~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ........-.+++..+.. .. ...|.   ...+.+++..+++.|+..+|..||+++++-..
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            774432222333433333 11 12222   12456679999999999999999999988653

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=8e-20  Score=154.52  Aligned_cols=133  Identities=22%  Similarity=0.255  Sum_probs=105.6

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-----------------------ccHHHHHHHHHHhcCCCC--
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------------------IDENVQREIINHRSLRHP--   59 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~ei~~~~~l~hp--   59 (341)
                      |.+.+.||.|+||.||++... +|+.||||+++....                       .......|+.++..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999886 799999998654320                       011356788888888776  


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      .++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||+++.++.  
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--  163 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--  163 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--
Confidence            4444443    244589999999998865432      1345678999999999999999999999999999987665  


Q ss_pred             EEEeecCCccC
Q 019433          140 LKICDFGYSKS  150 (341)
Q Consensus       140 ikL~Dfg~a~~  150 (341)
                      ++|+|||++..
T Consensus       164 ~~liDfg~~~~  174 (198)
T cd05144         164 IYIIDWPQMVS  174 (198)
T ss_pred             EEEEECCcccc
Confidence            99999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.8e-19  Score=152.45  Aligned_cols=129  Identities=21%  Similarity=0.185  Sum_probs=103.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCc-c--------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGK-K--------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~--------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .||+|+||.||++..  ++..+++|...... .        ....+.+|+.+++.+.|+++....-++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999995  57889999854321 1        113466899999999888765555555566777999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      ++|++|...+.....       .++.+++.+|.+||+.|++|||++|.||+++ ++.  ++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~--~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDK--LYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCc--EEEEECCCCcC
Confidence            999999887754321       7899999999999999999999999999998 444  99999998864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=5.4e-19  Score=171.15  Aligned_cols=135  Identities=21%  Similarity=0.190  Sum_probs=109.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcc-cCc--------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGK--------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~--------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      .+|...+.||+|+||+||++.....  .+++|+.. +..        ...+.+.+|+.+++.++|++++....++.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            3456789999999999999987533  34444322 111        112357789999999999999988777777777


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      .++||||++|++|.+++.        ....++.+++.+|.+||++|++||||||+||+++ ++.  ++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~--~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc--EEEEeCccccc
Confidence            899999999999988874        4577999999999999999999999999999994 444  99999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=7.4e-19  Score=147.14  Aligned_cols=135  Identities=21%  Similarity=0.247  Sum_probs=96.2

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHH-------------------------HHHHHHHHhcCCCC--
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------------------------VQREIINHRSLRHP--   59 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~ei~~~~~l~hp--   59 (341)
                      +.+.||+|+||+||+|.+. +++.||||++.........                         ...|...+..+.+.  
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999987 8999999998753221111                         12445555444333  


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~  138 (341)
                      .+.+++.+    ...++||||++++++........... ..++.++.+++.++.++|. +||+||||||+||+++ ++. 
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~-  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK-  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc-
Confidence            34555443    23589999999954322111111111 6788999999999999999 9999999999999998 554 


Q ss_pred             CEEEeecCCccC
Q 019433          139 RLKICDFGYSKS  150 (341)
Q Consensus       139 ~ikL~Dfg~a~~  150 (341)
                       ++|+|||.+..
T Consensus       153 -~~liDfg~a~~  163 (187)
T cd05119         153 -VYIIDVPQAVE  163 (187)
T ss_pred             -EEEEECccccc
Confidence             99999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.75  E-value=2.6e-17  Score=142.70  Aligned_cols=134  Identities=19%  Similarity=0.231  Sum_probs=103.1

Q ss_pred             cceec-ccCCeEEEEEEEcCCCcEEEEEEcccCc--------------cccHHHHHHHHHHhcCCCCCe--eeEEEEEEc
Q 019433            8 VKELG-SGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQREIINHRSLRHPNI--IRFKEVLLT   70 (341)
Q Consensus         8 ~~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~ei~~~~~l~hp~i--v~l~~~~~~   70 (341)
                      ...|| .|+.|+||.+...  +..++||.+.+..              .....+.+|+.++..|.|++|  ++.+++...
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34687 8899999998875  7789999875421              122457789999999988774  677766433


Q ss_pred             C-C---EEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           71 P-T---HLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        71 ~-~---~~~iv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                      . .   ..++|||+++| .+|..++.. .++++..    +.+++.+|.+||++||+||||||+|||++.++.  ++|+||
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDf  186 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDF  186 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEEC
Confidence            2 2   23599999997 688877754 4566543    578999999999999999999999999987665  999999


Q ss_pred             CCccC
Q 019433          146 GYSKS  150 (341)
Q Consensus       146 g~a~~  150 (341)
                      |.+..
T Consensus       187 g~~~~  191 (239)
T PRK01723        187 DRGEL  191 (239)
T ss_pred             CCccc
Confidence            98763

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=2.9e-17  Score=131.93  Aligned_cols=131  Identities=24%  Similarity=0.269  Sum_probs=111.7

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCC--CCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h--p~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      +++.||.|.++.||++....  ..+++|....... ...+.+|+..++.+.+  +++++++..+...+..+++|||+.++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            57889999999999999864  6799999866543 4578899999999876  58999999888888899999999987


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---EICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ++...       +......++.+++.+|++||..   +++|+|++|+||++++.+.  ++++|||.+.
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~--~~l~Df~~~~  137 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI--LGIIDWEYAG  137 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE--EEEEeccccc
Confidence            77543       5567778899999999999984   7999999999999987555  9999999876

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.3e-17  Score=155.15  Aligned_cols=251  Identities=21%  Similarity=0.175  Sum_probs=194.2

Q ss_pred             CCCccccceecc--cCCeEEEEEEE--cCCCcEEEEEEccc---CccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGS--GNFGVARLVRD--KRTKELVAVKYIER---GKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~---~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~   73 (341)
                      ..++.+.+.+|.  |.+|.||.+..  ..++..+|+|.-..   .......-.+|+...+.+ .|+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            467889999999  99999999999  89999999997332   223344556777777777 59999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           74 LAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLIS----GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~----aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      .++-+|+|. .+|..+...... ++...++..+.+...    ||.++|+.+++|-|+||.||+..++.. ..+++|||+.
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~-s~~~~df~~v  270 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWT-SCKLTDFGLV  270 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccc-eeecCCccee
Confidence            999999996 577777665544 899999999999999    999999999999999999999988732 3899999987


Q ss_pred             cCCCCCCC------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCC--CChhHHHHHHHHHhcc
Q 019433          149 KSGLLHSQ------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP--EDPRNFRKTIDRIRNV  220 (341)
Q Consensus       149 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~  220 (341)
                      ........      .....|...|++||.+.+..  +.+.|+++||.++.+..++..++...  ..+..+       +..
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-------r~~  341 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-------RQG  341 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccc-------ccc
Confidence            64322221      11225677899999986544  34589999999999998887776554  222222       111


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ......+...+..+...+..|+..+|-.|++++.+++|+++..
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            1111223356677778999999999999999999999998853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=2.5e-17  Score=160.92  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=197.3

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccH----HHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE----NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .+.+.+.+-+|++|.++.+.-..+|...++|+.........    ....+-.++....+|-+++....+.-....+++++
T Consensus       805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~  884 (1205)
T KOG0606|consen  805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH  884 (1205)
T ss_pred             cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence            45677788999999999999888887788877655433222    22222222222345666665555555678899999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCc-cCCCCC----
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS-KSGLLH----  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a-~~~~~~----  154 (341)
                      |..+++|...+.+.+..+.+..+..+..+..++.+||...+.|||++|.|+++..++.  .++.|||.. ..+...    
T Consensus       885 ~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  885 YLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             HhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcCC
Confidence            9999999999999888999999999999999999999999999999999999988777  899999833 211110    


Q ss_pred             ---------------------------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh
Q 019433          155 ---------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP  207 (341)
Q Consensus       155 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~  207 (341)
                                                 .......||+.|.+||.+.+...... +|+|++|+++++.++|.+||......
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcchh
Confidence                                       00122368999999999998887655 89999999999999999999987765


Q ss_pred             hHHHHHHHHHhcccccCCC-CCCCCHHHHHHHHHhcccCCCCCCChh---HHhcCCccCCCCCh
Q 019433          208 RNFRKTIDRIRNVQYFLPD-YVRVSADCRHLLSQIFVADPSKRIPIP---EIKKHPWFLKNLPK  267 (341)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dp~~R~s~~---e~l~hp~~~~~~~~  267 (341)
                      +.+.    ++.+....+|. ....+.+.++++..+|..+|.+|..+.   ++..|+||......
T Consensus      1042 ~~f~----ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1042 QIFE----NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             hhhh----ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            5543    34444444443 235788999999999999999999888   99999999765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.66  E-value=3.5e-15  Score=140.45  Aligned_cols=236  Identities=17%  Similarity=0.214  Sum_probs=162.1

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHH
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFA   88 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~   88 (341)
                      ...-++.+....+..+.++.+|.|.....+.. ....+.+.++.++.++||||+++++.+.....+|+|+|.+.  .|..
T Consensus        19 ~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~   96 (690)
T KOG1243|consen   19 ETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLET   96 (690)
T ss_pred             cccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHH
Confidence            33334444322566778899999998876543 33457888999999999999999999999999999999985  4555


Q ss_pred             HHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-CCCccCCCCc
Q 019433           89 RICSAGRFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAY  166 (341)
Q Consensus        89 ~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-~~~~~gt~~y  166 (341)
                      .+.+   +....+...++||+.||.||| +++++|++|.-+.|+|+..|.  .||++|.++........ .....--..|
T Consensus        97 ~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~  171 (690)
T KOG1243|consen   97 VLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESF  171 (690)
T ss_pred             HHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcc
Confidence            5544   347788889999999999997 688999999999999999888  99999988753222221 1222223346


Q ss_pred             cccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCC
Q 019433          167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP  246 (341)
Q Consensus       167 ~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp  246 (341)
                      ..|+.+....+   ..|.|-|||++++++.|  ++....+..                 ....++.....+..+-+.-.+
T Consensus       172 ~~P~~~~~s~~---s~D~~~Lg~li~el~ng--~~~~~~~~~-----------------~~~~ipk~~~~~~~k~~~~~~  229 (690)
T KOG1243|consen  172 DDPEEIDPSEW---SIDSWGLGCLIEELFNG--SLLTKTDLS-----------------NTGKIPKALIELYCKKLGATE  229 (690)
T ss_pred             cChhhcCcccc---chhhhhHHHHHHHHhCc--ccCcchhhh-----------------ccCccchhHHHHHHHHhcccc
Confidence            77776543332   26999999999999998  333322210                 111234344444444445556


Q ss_pred             CCCCChh----HH-hcCCccCCCCChhHHHHHh
Q 019433          247 SKRIPIP----EI-KKHPWFLKNLPKEIIEIEK  274 (341)
Q Consensus       247 ~~R~s~~----e~-l~hp~~~~~~~~~~~~~~~  274 (341)
                      ..||...    ++ +-|+||.+.+-.....++.
T Consensus       230 ~~r~n~~~~~~~~~~~~gff~n~fvd~~~fLee  262 (690)
T KOG1243|consen  230 LKRPNKLRFILECRLLGGFFRNDFVDTLLFLEE  262 (690)
T ss_pred             ccccchhhHHHHHHhccccccchHHHHHHHHHh
Confidence            6666532    22 3389998777665555443

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.62  E-value=8.2e-17  Score=139.16  Aligned_cols=238  Identities=18%  Similarity=0.236  Sum_probs=156.1

Q ss_pred             EEEEEEEcCCCcEEEEEEccc----CccccHHHH-HHHHHHhcCCCCCeeeEEEEEEcCC-----EEEEEEeecCCCchH
Q 019433           18 VARLVRDKRTKELVAVKYIER----GKKIDENVQ-REIINHRSLRHPNIIRFKEVLLTPT-----HLAIVMEYAAGGELF   87 (341)
Q Consensus        18 ~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~-~ei~~~~~l~hp~iv~l~~~~~~~~-----~~~iv~e~~~~~~L~   87 (341)
                      .||++.+...|.+|+...+..    ..+..++.. .-...+-.+-|.|||+++.++.+.+     ...+++||+..|++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            456666766776666554432    222122211 1222334457999999999987653     478999999999999


Q ss_pred             HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-----CCC
Q 019433           88 ARICSA----GRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-----HSQ  156 (341)
Q Consensus        88 ~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-----~~~  156 (341)
                      .++++.    +.+.....++|+-||+.||.|||+..  |+|+++.-+.|++..++-  ||++--.-......     ...
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~E  238 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAE  238 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhh
Confidence            998764    35889999999999999999999986  999999999999986664  66543221111000     011


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....+-++|.|||.=....... ++|||++|++..+|..+..--...+..-.....+.+   ....+.     .+.-++
T Consensus       239 k~~~~~~~g~~a~~sg~~tn~~~-a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~---~i~~le-----n~lqr~  309 (458)
T KOG1266|consen  239 KSVNTSLPGFSAPESGTTTNTTG-ASDIYKFGMCALEMAILEIQSTNSESKVEVEENIAN---VIIGLE-----NGLQRG  309 (458)
T ss_pred             hhccccCCccccCCcCccccccc-chhhhhhhHHHHHHHHheeccCCCcceeehhhhhhh---heeecc-----CccccC
Confidence            12234678899999754444444 489999999999998775432221111111111111   111111     112367


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++.+||+..|..||++..++.||-+.+...
T Consensus       310 ~i~kcl~~eP~~rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  310 SITKCLEGEPNGRPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             cCcccccCCCCCCcchhhhhcCceeeecch
Confidence            899999999999999999999998866543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1e-15  Score=142.46  Aligned_cols=249  Identities=20%  Similarity=0.187  Sum_probs=182.8

Q ss_pred             CCccccceecccCCeEEEEEEEc-CCCcEEEEEEcccCcc---ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGKK---IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .+|..+..||.|.|+.|+.+... .++..|++|...+.-.   ....-..|+.+...+ .|.+++++...|......|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            46889999999999999988755 6788899998765422   222344677666665 599999999999888888999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      -|||.++++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..++ ...++.|||+....  ....
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--ceec
Confidence            99999999877776666789999999999999999999999999999999999998754 34899999987631  1111


Q ss_pred             CCccCCCCcc-ccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYI-APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+.-++. .+|++........+.|++|||..+.+.+++.+.-......       ..++..  ..+.....+..++.
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~~--~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------LTIRSG--DTPNLPGLKLQLQV  492 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------eeeecc--cccCCCchHHhhhh
Confidence            1222333444 3555544444444589999999999999886322111111       111111  12333345578899


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +.+.|+.+++..|+++.++..|+-|..
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhh
Confidence            999999999999999999999876643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=1.5e-15  Score=144.57  Aligned_cols=139  Identities=24%  Similarity=0.349  Sum_probs=94.8

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-----------------------------------ccHHHH-
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------------------------------IDENVQ-   47 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~~~-   47 (341)
                      .|.. +.||+|++|+||.|+.+.+|+.||||+.+..-.                                   ..+.+. 
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            3555 789999999999999998899999999875310                                   011122 


Q ss_pred             -----HHHHHHhcC----CCCCeeeEEEEEEc-CCEEEEEEeecCCCchHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 019433           48 -----REIINHRSL----RHPNIIRFKEVLLT-PTHLAIVMEYAAGGELFAR--ICSAG----RFSEDEARFFFQQLISG  111 (341)
Q Consensus        48 -----~ei~~~~~l----~hp~iv~l~~~~~~-~~~~~iv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~qil~a  111 (341)
                           +|.....++    .+.+.+.+-.++.+ ....++||||+.|+.+.+.  +...+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence                 233222222    34444444454432 4567899999999999764  22222    244555555666665  


Q ss_pred             HHHHHHcCCeeCCCCCCCEEecCCC--CCCEEEeecCCccC
Q 019433          112 VSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKS  150 (341)
Q Consensus       112 L~~LH~~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a~~  150 (341)
                           ..|++|+|++|.||+++.++  .++++++|||++..
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence                 59999999999999998765  23499999998864

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.57  E-value=2e-14  Score=118.20  Aligned_cols=127  Identities=20%  Similarity=0.218  Sum_probs=96.7

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ++.|+.|.++.||.+...  +..|++|+............+|+.+++.+.+.+ +++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            578999999999999975  778999997665433345678888888875544 445555443  334799999999887


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           87 FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI-----CHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        87 ~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~i-----iHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ...        ......++.+++++|+.||+.++     +|+|++|.||+++ ++.  ++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~--~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGR--LWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCe--EEEEeccccc
Confidence            543        11123467899999999999985     9999999999998 444  9999999775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.57  E-value=2.3e-14  Score=134.84  Aligned_cols=136  Identities=19%  Similarity=0.196  Sum_probs=92.7

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---------------------------cH--------------HHH
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------------------------DE--------------NVQ   47 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~--------------~~~   47 (341)
                      +.||.|++|+||+|+.+ +|+.||||+.+..-..                           ..              .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999986 7899999997553100                           00              122


Q ss_pred             HHHHHHhcC----CCCCeeeEEEEE-EcCCEEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 019433           48 REIINHRSL----RHPNIIRFKEVL-LTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLIS-GVSYCHSMEI  120 (341)
Q Consensus        48 ~ei~~~~~l----~hp~iv~l~~~~-~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~-aL~~LH~~~i  120 (341)
                      +|...+..+    ++.+-+.+-.++ ......++||||++|++|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            333333333    233323333333 2234568999999999997765432 122   23445666665 4678999999


Q ss_pred             eeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433          121 CHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       121 iHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      +|+|++|.||+++.++.  ++|+|||++..
T Consensus       279 ~H~D~hPgNilv~~~g~--i~liDfG~~~~  306 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGK--IIALDFGIVGR  306 (437)
T ss_pred             eeCCCCcccEEECCCCc--EEEEeCCCeeE
Confidence            99999999999987766  99999999864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=7.4e-14  Score=116.19  Aligned_cols=136  Identities=14%  Similarity=0.152  Sum_probs=100.2

Q ss_pred             cceecccCCeEEEEEEEcC------CCcEEEEEEcccCc--------------c---------ccH----HHHHHHHHHh
Q 019433            8 VKELGSGNFGVARLVRDKR------TKELVAVKYIERGK--------------K---------IDE----NVQREIINHR   54 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~--------------~---------~~~----~~~~ei~~~~   54 (341)
                      ...||.|--+.||.|....      .+..+|||+.+.+.              .         ...    ...+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999998753      35789999864210              0         011    2347888888


Q ss_pred             cCC--CCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeCCCCCCCEE
Q 019433           55 SLR--HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTL  131 (341)
Q Consensus        55 ~l~--hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHrDikp~Nil  131 (341)
                      ++.  .-++++.+.+    ..-++||||+.++.+.....+...++......++.+++.+|..| |+.||+|||+++.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            874  3456666654    45689999998754433222333466677788899999999998 8999999999999999


Q ss_pred             ecCCCCCCEEEeecCCccC
Q 019433          132 LDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       132 i~~~~~~~ikL~Dfg~a~~  150 (341)
                      ++. +.  +.|+|||.+..
T Consensus       158 ~~~-~~--v~iIDF~qav~  173 (197)
T cd05146         158 WHD-GK--VWFIDVSQSVE  173 (197)
T ss_pred             EEC-Cc--EEEEECCCcee
Confidence            974 34  99999998763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.41  E-value=1e-11  Score=113.99  Aligned_cols=212  Identities=17%  Similarity=0.234  Sum_probs=153.4

Q ss_pred             CeEEEEEEEcCCCcEEEEEEcccCccccH-HHHHHHHHHhcCCCCCeeeEEEEEE----cCCEEEEEEeecCC-CchHHH
Q 019433           16 FGVARLVRDKRTKELVAVKYIERGKKIDE-NVQREIINHRSLRHPNIIRFKEVLL----TPTHLAIVMEYAAG-GELFAR   89 (341)
Q Consensus        16 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~ei~~~~~l~hp~iv~l~~~~~----~~~~~~iv~e~~~~-~~L~~~   89 (341)
                      -.+.|+|..+.+|..|++|++...+.... ..-.-+++++++.|+|||++.++|.    .+..+++|++|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35779999999999999999954333222 3445677889999999999999997    35679999999876 566555


Q ss_pred             HHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           90 ICS---------------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        90 l~~---------------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      .-.               +...++..+|.++.||..||.++|+.|+.-+-+.|.+|+++++.  +|+|...|........
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQED  446 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCC
Confidence            422               22478899999999999999999999999999999999998665  4888887765432221


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      .      +       +.+.+.    ..-|.=.||.++..|.||..--...+.....  .+..+.         ..+|.++
T Consensus       447 ~------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I~---------~~yS~D~  498 (655)
T KOG3741|consen  447 P------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRIT---------TTYSTDL  498 (655)
T ss_pred             C------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHhh---------hhhhHHH
Confidence            1      0       112111    2268999999999999996321111111111  011111         1478899


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++++..+...++.+ -++.+++.|
T Consensus       499 rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  499 RNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999999999887 688888876

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=7.4e-12  Score=101.05  Aligned_cols=129  Identities=22%  Similarity=0.210  Sum_probs=97.1

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEc-ccC---ccc-----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYI-ERG---KKI-----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~---~~~-----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ..+++|+-+.+|.+...  |..+++|.- ++.   +..     .....+|..+++.+.--.|..-.=++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46889999999999764  555777753 221   111     1245678888887755454444444566777889999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      |++|..|.+.+...       ...++..+-.-+.-||..||+|+|+.++||++.+.+   +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence            99998888887655       255777788888999999999999999999997554   8999999986

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.36  E-value=7.9e-12  Score=107.18  Aligned_cols=141  Identities=21%  Similarity=0.247  Sum_probs=106.5

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCC--CCeeeEEEEEEcC---CEEEEEEee
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRH--PNIIRFKEVLLTP---THLAIVMEY   80 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~h--p~iv~l~~~~~~~---~~~~iv~e~   80 (341)
                      ++.|+.|..+.||++.... |..+++|+......  ....+..|+.+++.+.+  ..+++++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            4678999999999998753 67899999776543  35578899999998865  3467777776553   256899999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  117 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------------  117 (341)
                      ++|.++...+.. ..+++.....++.+++++|..||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888665432 346777777788888888888873                                           


Q ss_pred             -------------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433          118 -------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       118 -------------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                                   ..++|+|+.|.||+++.+....+.|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         236999999999999873222378999997763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.33  E-value=2e-11  Score=98.23  Aligned_cols=142  Identities=18%  Similarity=0.119  Sum_probs=105.2

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEccc-C--------ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER-G--------KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~--------~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .+..|-+|+-+.|+.+..  .|+.++||.-.. .        +......++|++.+.++.--+|.--.=+|.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            677889999999999988  488889986322 1        12334577888888877544444444445666677899


Q ss_pred             EeecCC-CchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC-CEEEeecCCccC
Q 019433           78 MEYAAG-GELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-RLKICDFGYSKS  150 (341)
Q Consensus        78 ~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~-~ikL~Dfg~a~~  150 (341)
                      |||++| .++.+++....  .........++..|-+.+.-||..+|+|+|+..+||++.+++.. .+.|+|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999988 46677765532  23333447899999999999999999999999999999876653 358999999863

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=7.2e-12  Score=118.77  Aligned_cols=162  Identities=16%  Similarity=0.247  Sum_probs=113.2

Q ss_pred             HHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-----C---CC--ccCCCCcccccccc
Q 019433          105 FQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-----P---KS--TVGTPAYIAPEVLA  173 (341)
Q Consensus       105 ~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-----~---~~--~~gt~~y~aPE~~~  173 (341)
                      +.++..||.|+|. .++||++|.|++|+++..+.  .||+.|+.+........     .   ..  ..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            3455599999996 58999999999999998888  99999998764332111     0   01  12355699999998


Q ss_pred             ccccCCCccchhhHHHHHHHHH-hCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCCh
Q 019433          174 RKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPI  252 (341)
Q Consensus       174 ~~~~~~~~~DiwslG~vl~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~  252 (341)
                      +... +.++|++||||++|.+. .|+.-+.......... ......+... .-....+++++++=+.++|..++.-||++
T Consensus       183 ~~~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~-~~~s~~~p~el~~~l~k~l~~~~~~rp~~  259 (700)
T KOG2137|consen  183 GTTN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGA-FGYSNNLPSELRESLKKLLNGDSAVRPTL  259 (700)
T ss_pred             cccc-cccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhccccccc-ccccccCcHHHHHHHHHHhcCCcccCcch
Confidence            8444 45599999999999999 5666555443221111 1111111110 11114789999999999999999999999


Q ss_pred             hHHhcCCccCCCCChhHHH
Q 019433          253 PEIKKHPWFLKNLPKEIIE  271 (341)
Q Consensus       253 ~e~l~hp~~~~~~~~~~~~  271 (341)
                      ..++..|||....-+.+..
T Consensus       260 ~~l~~~~ff~D~~~~aLrf  278 (700)
T KOG2137|consen  260 DLLLSIPFFSDPGLKALRF  278 (700)
T ss_pred             hhhhcccccCCchhhhhhh
Confidence            9999999997665554443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.21  E-value=6.4e-10  Score=97.73  Aligned_cols=132  Identities=14%  Similarity=0.020  Sum_probs=92.3

Q ss_pred             CeEEEEEEEcCCCcEEEEEEcccCc------------cccHHHHHHHHHHhcCCCCC--eeeEEEEEEc-----CCEEEE
Q 019433           16 FGVARLVRDKRTKELVAVKYIERGK------------KIDENVQREIINHRSLRHPN--IIRFKEVLLT-----PTHLAI   76 (341)
Q Consensus        16 ~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~ei~~~~~l~hp~--iv~l~~~~~~-----~~~~~i   76 (341)
                      ...|+.+..  .|+.|.||......            .....+.+|...+..|..-+  ++..+.++..     ....++
T Consensus        35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L  112 (268)
T PRK15123         35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI  112 (268)
T ss_pred             CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence            334555544  57789999663321            00113678888776663222  2233333332     235789


Q ss_pred             EEeecCCC-chHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-----CCCCCEEEeecCCc
Q 019433           77 VMEYAAGG-ELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----SPQPRLKICDFGYS  148 (341)
Q Consensus        77 v~e~~~~~-~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-----~~~~~ikL~Dfg~a  148 (341)
                      |||++++. +|.+++..  ..+.+......++.+++..+.-||+.||+|+|+++.|||++.     .+...+.|+||+.+
T Consensus       113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99999885 78888754  345667788899999999999999999999999999999975     23456999999977


Q ss_pred             c
Q 019433          149 K  149 (341)
Q Consensus       149 ~  149 (341)
                      .
T Consensus       193 ~  193 (268)
T PRK15123        193 Q  193 (268)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.20  E-value=1.6e-10  Score=95.84  Aligned_cols=123  Identities=27%  Similarity=0.315  Sum_probs=81.5

Q ss_pred             EEEEEEEcCCCcEEEEEEcccCc--------------c-------------ccHHHHHHHHHHhcCCCC--CeeeEEEEE
Q 019433           18 VARLVRDKRTKELVAVKYIERGK--------------K-------------IDENVQREIINHRSLRHP--NIIRFKEVL   68 (341)
Q Consensus        18 ~V~~~~~~~~~~~vaiK~~~~~~--------------~-------------~~~~~~~ei~~~~~l~hp--~iv~l~~~~   68 (341)
                      .||.|... .|..+|+|+.+.+.              .             ......+|...|..+..-  ++++.+.+-
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999986 67899999864311              0             012466899999998655  567776542


Q ss_pred             EcCCEEEEEEeecC--CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           69 LTPTHLAIVMEYAA--GGELFARICSAGRFSEDEARFFFQQLISGVSY-CHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        69 ~~~~~~~iv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~-LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                          .-+|||||++  |..+..+....  ++......++.+++..+.. +|..||+|+|+.+.||+++.+ .  +.++||
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf  150 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDF  150 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--G
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEec
Confidence                2369999998  65554433222  2245667788888886555 589999999999999999866 4  999999


Q ss_pred             CCccC
Q 019433          146 GYSKS  150 (341)
Q Consensus       146 g~a~~  150 (341)
                      |.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            98763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.10  E-value=6.2e-09  Score=93.95  Aligned_cols=242  Identities=14%  Similarity=0.101  Sum_probs=149.6

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEE------E-cCCEEEEEE
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL------L-TPTHLAIVM   78 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~------~-~~~~~~iv~   78 (341)
                      ...+.||+|+-+.+|-.-...+   .+.|+...-.-..+..+.+ .+...-.||-+-.=+.+=      - ....+.+.|
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a-~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVA-ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHHHHHHH-HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            3567899999999987655422   4557665533222221111 112223565433211110      1 123378888


Q ss_pred             eecCCCch-HHHH---Hhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           79 EYAAGGEL-FARI---CSA---GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        79 e~~~~~~L-~~~l---~~~---~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..+.|..- ..+.   .+.   ....+....++++.|+.+.+.||..|.+-+|++++|+|+.+++.  +.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            88877432 1221   111   23677889999999999999999999999999999999988877  889886543322


Q ss_pred             CCCCCCCCccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhC-CCCCCCCCC----hhHHHHHHHHH----
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPED----PRNFRKTIDRI----  217 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g-~~pf~~~~~----~~~~~~~~~~~----  217 (341)
                      .......-.+|.+.|.+||.-.     +..-+.+ +|.|.||+++++++.| +.||++-..    +.-....+...    
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            3333444567899999999754     3333444 7999999999999886 999976321    11111111110    


Q ss_pred             ---hcc----cccCCCCCCCCHHHHHHHHHhccc--CCCCCCChhH
Q 019433          218 ---RNV----QYFLPDYVRVSADCRHLLSQIFVA--DPSKRIPIPE  254 (341)
Q Consensus       218 ---~~~----~~~~~~~~~~s~~~~~li~~~L~~--dp~~R~s~~e  254 (341)
                         ...    ....+.+.-++++++.|+.+|+..  ++.-|||++-
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence               000    001123445788889999888865  3557888754

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.09  E-value=7.8e-10  Score=94.67  Aligned_cols=133  Identities=21%  Similarity=0.236  Sum_probs=102.8

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-----------------------cccHHHHHHHHHHhcCCCC--
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------------------KIDENVQREIINHRSLRHP--   59 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~ei~~~~~l~hp--   59 (341)
                      +.+..+||-|--|.||.|.+. .|.++|||.-+-..                       .....+.+|...|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356789999999999999998 78899999743211                       0112567899999988654  


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      .|++.++    .+...+|||+++|-.|...     +++......++..|+.-+..+-..||||+|+++-||+++.+|.  
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--  240 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--  240 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence            6776654    4566899999999666432     2345667778888888888888999999999999999999887  


Q ss_pred             EEEeecCCcc
Q 019433          140 LKICDFGYSK  149 (341)
Q Consensus       140 ikL~Dfg~a~  149 (341)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999996543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.95  E-value=6.4e-11  Score=111.41  Aligned_cols=243  Identities=20%  Similarity=0.178  Sum_probs=171.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ..|.....+++|+++++++.+...+...+ .+++...    ....-++.+|.+++||| .+..++-+.-+...+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            45667778899999999999988776555 6665543    45667888999999999 777777777788899999999


Q ss_pred             CCC-chHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGG-ELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~-~L~~~l-~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      .++ +....+ ...-.+.+-+...+.+.-+++|++||+.-=+|||    ||+..+. .  .++.||+............+
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~-~--~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE-E--VKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc-c--cccccccCCcccCccccccc
Confidence            887 221111 1122355556667778888999999998778998    8877653 3  79999998875544445677


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--cccCCCCCCCCHHHH-H
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSADCR-H  236 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~-~  236 (341)
                      ..+++.++|||+.....+... .|.|++|.--.++.-|.+|-..+..  ..    ..+...  ...+......++... +
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~--~~----~~~g~~p~s~~L~~~~aw~~~~~~~  462 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPA--VL----PMIGNGPNSPMLTDKSAWSPVFHRD  462 (829)
T ss_pred             CCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCcc--cc----CCCCCCCCccccchhhhcCcccccC
Confidence            889999999999998888877 7999999877777777666443111  00    000000  000000011122222 4


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +-..|+..-|..|+....++.|.+|...
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhccC
Confidence            7788999999999999999999988654

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=9.7e-09  Score=87.16  Aligned_cols=107  Identities=20%  Similarity=0.175  Sum_probs=82.1

Q ss_pred             cHHHHHHHHHHhcCCC--CCeeeEEEEEEcC----CEEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 019433           43 DENVQREIINHRSLRH--PNIIRFKEVLLTP----THLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYC  115 (341)
Q Consensus        43 ~~~~~~ei~~~~~l~h--p~iv~l~~~~~~~----~~~~iv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L  115 (341)
                      .....+|...+..|..  =.+++.+.+....    ...++|+|++++ .+|.+++.....++......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            3457778777666632  1234444444332    346899999987 47888887755678888899999999999999


Q ss_pred             HHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCcc
Q 019433          116 HSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSK  149 (341)
Q Consensus       116 H~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~  149 (341)
                      |++||+|+|+++.|||++.++ ...+.|+||+.++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999998775 3459999999765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.93  E-value=3.4e-08  Score=82.69  Aligned_cols=136  Identities=12%  Similarity=0.077  Sum_probs=99.6

Q ss_pred             cccCCeEEEEEEEcCCCcEEEEEEccc----C---ccccHHHHHHHHHHhcCCCC--CeeeEEEEE--Ec--CCEEEEEE
Q 019433           12 GSGNFGVARLVRDKRTKELVAVKYIER----G---KKIDENVQREIINHRSLRHP--NIIRFKEVL--LT--PTHLAIVM   78 (341)
Q Consensus        12 g~G~~g~V~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~ei~~~~~l~hp--~iv~l~~~~--~~--~~~~~iv~   78 (341)
                      |+||-|-|+.....  |..+-+|.-..    +   +.....+.+|+..+..|..-  .+++.....  ..  .-..+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            56888889887764  44688887541    1   33557899999998877422  244444211  11  12368999


Q ss_pred             eecCC-CchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           79 EYAAG-GELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        79 e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      |-+.| -+|.+++.+.  .+.+......++.+++.++.-||+.|+.|+|+.+.||+++..+...++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5787777553  35678888999999999999999999999999999999986665569999998665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.90  E-value=3.4e-08  Score=82.96  Aligned_cols=136  Identities=16%  Similarity=0.186  Sum_probs=88.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc----------HHHHHHHHHHhcCCC---CCeeeEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----------ENVQREIINHRSLRH---PNIIRFKEV   67 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~ei~~~~~l~h---p~iv~l~~~   67 (341)
                      +++.|.+++.+-......|.+..-  .|..+++|..+....-.          ....+.+.....+..   -....++-+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            457788888888888777766665  57889999875432111          112233333333322   222222222


Q ss_pred             -----EEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEE
Q 019433           68 -----LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI  142 (341)
Q Consensus        68 -----~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL  142 (341)
                           +......+++|||++|..|.+..    .+++    .+...+..++.-||+.|++|+|..|.|+++++++   +++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~i  175 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRI  175 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEE
Confidence                 22234567999999998775542    1333    2446677889999999999999999999998544   999


Q ss_pred             eecCCcc
Q 019433          143 CDFGYSK  149 (341)
Q Consensus       143 ~Dfg~a~  149 (341)
                      +||+..+
T Consensus       176 ID~~~k~  182 (229)
T PF06176_consen  176 IDTQGKR  182 (229)
T ss_pred             EECcccc
Confidence            9998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.74  E-value=9.4e-08  Score=96.07  Aligned_cols=201  Identities=21%  Similarity=0.256  Sum_probs=143.0

Q ss_pred             HHHHHHHHhcCCCCCeeeEEEEEEcCCEE----EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 019433           46 VQREIINHRSLRHPNIIRFKEVLLTPTHL----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC  121 (341)
Q Consensus        46 ~~~ei~~~~~l~hp~iv~l~~~~~~~~~~----~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~ii  121 (341)
                      ...|+..+..+.|+|++.++.+-......    .+..++|...++...+..-...+....+.+..++++||.++|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            44566667778999999999987655433    34557899999999999999999999999999999999999999666


Q ss_pred             eCCCCCC---CEEecCCCCCCEEEe--ecCCccCCCCCCCCCCccCCCCccccccccccccCC-CccchhhHHHHHHHHH
Q 019433          122 HRDLKLE---NTLLDGSPQPRLKIC--DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG-KISDVWSCGVTLYVML  195 (341)
Q Consensus       122 HrDikp~---Nili~~~~~~~ikL~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~vl~~l~  195 (341)
                      |.-+..+   +--++..+.  +..+  ||+.+.............-+..+.+||......... ...|+|.+|..+..+.
T Consensus       309 ~v~L~~s~~~~~~~~~e~~--~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVDGEGV--VAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccCccce--eecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            6655444   333333333  5555  888887655555555556667788888876554432 2269999999999988


Q ss_pred             hCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          196 VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      .|..+-.....       ...      .++.  .......+++.+|+.-++++|+++.+++.|+|...
T Consensus       387 ~~~~i~~~~~~-------~~~------~l~~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  387 QGEDISEKSAV-------PVS------LLDV--LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hcCcccccccc-------hhh------hhcc--ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            87543221110       000      1111  11116788999999999999999999999999743

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.63  E-value=7.6e-07  Score=76.62  Aligned_cols=72  Identities=17%  Similarity=0.162  Sum_probs=55.2

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC--CeeeEEEEEEcCCEEEEEEeecCCCc
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEVLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp--~iv~l~~~~~~~~~~~iv~e~~~~~~   85 (341)
                      .+||.|..+.||+.    .+..+++|...... ....+.+|.++++.+..-  .+++.+.+....+...+||++++|.+
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            67899999999984    25568899877543 345678999999887532  25777777777888899999999963

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.62  E-value=3.5e-07  Score=77.79  Aligned_cols=133  Identities=17%  Similarity=0.134  Sum_probs=90.4

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCccc-------------------c------HHHHHHHHHHhcCC--CCCee
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-------------------D------ENVQREIINHRSLR--HPNII   62 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~------~~~~~ei~~~~~l~--hp~iv   62 (341)
                      .|+.|--+.||+|... ++..+|+|++..+...                   .      ....+|+..|+++.  +=.++
T Consensus        55 ~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            4566777799999874 6889999997542110                   1      12446777777663  33444


Q ss_pred             eEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEE
Q 019433           63 RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        63 ~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      +-+.+.    .-.+|||++.....-.-..+.-++...+...+..++++.+.-|-. .++||+||+.=|||+. ++.  +.
T Consensus       134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~  206 (268)
T COG1718         134 EPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PY  206 (268)
T ss_pred             Cceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EE
Confidence            554443    347999998653211111112234444788889999999999876 9999999999999998 444  89


Q ss_pred             EeecCCccC
Q 019433          142 ICDFGYSKS  150 (341)
Q Consensus       142 L~Dfg~a~~  150 (341)
                      ++|||-|..
T Consensus       207 iID~~QaV~  215 (268)
T COG1718         207 IIDVSQAVT  215 (268)
T ss_pred             EEECccccc
Confidence            999998763

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=3.2e-07  Score=87.40  Aligned_cols=136  Identities=18%  Similarity=0.224  Sum_probs=87.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-----------------------------------ccHH------HH
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK-----------------------------------IDEN------VQ   47 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~------~~   47 (341)
                      ..|+.++-|+||.|..+ +|+.||||+.+.+-.                                   ..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            56889999999999998 599999999754210                                   0011      22


Q ss_pred             HHHHHHhcC----C-CCCeeeEEEEE-EcCCEEEEEEeecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 019433           48 REIINHRSL----R-HPNIIRFKEVL-LTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEI  120 (341)
Q Consensus        48 ~ei~~~~~l----~-hp~iv~l~~~~-~~~~~~~iv~e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~i  120 (341)
                      +|...+..+    . .|+| ++-.++ ...+.-.++|||++|..+.+... +...++...+.....++  -+.-+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence            333333322    2 3433 333443 34566789999999988866631 22445543333322222  1223334899


Q ss_pred             eeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433          121 CHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       121 iHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      .|.|..|.||+++.++.  +.+.|||+...
T Consensus       287 fHaDpHpGNi~v~~~g~--i~~lDfGi~g~  314 (517)
T COG0661         287 FHADPHPGNILVRSDGR--IVLLDFGIVGR  314 (517)
T ss_pred             cccCCCccceEEecCCc--EEEEcCcceec
Confidence            99999999999998876  99999998763

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=9.3e-07  Score=76.12  Aligned_cols=78  Identities=19%  Similarity=0.178  Sum_probs=56.5

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC--CeeeEEEEEE---cCCEEEEEEeecC
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEVLL---TPTHLAIVMEYAA   82 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp--~iv~l~~~~~---~~~~~~iv~e~~~   82 (341)
                      ++.|+.|..+.||.+....  ..+++|..... .....+..|..+++.+...  .+++++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999999875  48999997665 3456777888887776422  3566666443   3345799999999


Q ss_pred             CCchHH
Q 019433           83 GGELFA   88 (341)
Q Consensus        83 ~~~L~~   88 (341)
                      |.++..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=98.50  E-value=2e-06  Score=87.87  Aligned_cols=144  Identities=19%  Similarity=0.278  Sum_probs=91.6

Q ss_pred             cceecccCCeEEEEEEEcCCC--cEEEEEEcccCcc--ccHHHHHHHHHHhcCC-CCCe--eeEEEEEEcC---CEEEEE
Q 019433            8 VKELGSGNFGVARLVRDKRTK--ELVAVKYIERGKK--IDENVQREIINHRSLR-HPNI--IRFKEVLLTP---THLAIV   77 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~-hp~i--v~l~~~~~~~---~~~~iv   77 (341)
                      +++|+.|.+..+|+......+  ..+++|+......  ....+.+|+.+++.+. |++|  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            678899999999998775432  4688887655332  2346889999999885 6654  7777777654   457899


Q ss_pred             EeecCCCchHH--------------------H---HHhcC----CC---------CHHHHHHHHHH--------------
Q 019433           78 MEYAAGGELFA--------------------R---ICSAG----RF---------SEDEARFFFQQ--------------  107 (341)
Q Consensus        78 ~e~~~~~~L~~--------------------~---l~~~~----~l---------~~~~~~~i~~q--------------  107 (341)
                      |||++|..+.+                    .   +..-.    .+         ...++..|..+              
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99998854311                    0   11100    01         11233322222              


Q ss_pred             -HHHHHHHHHH-----------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433          108 -LISGVSYCHS-----------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus       108 -il~aL~~LH~-----------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                       +...+.+|..           ..++|+|+++.||+++.+....+-|.||.++..+
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence             2223455532           3599999999999998543323579999988654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.48  E-value=2.5e-06  Score=74.33  Aligned_cols=76  Identities=13%  Similarity=0.055  Sum_probs=54.8

Q ss_pred             ceecccCC-eEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            9 KELGSGNF-GVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         9 ~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ..|-.|.+ ..||++...  +..+++|+.....  ...+.+|+.+++.+. +--+++++.+....+..++||++++|.++
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555666 688998764  4679999876543  345778888887773 34467778877766778999999999776


Q ss_pred             HH
Q 019433           87 FA   88 (341)
Q Consensus        87 ~~   88 (341)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.42  E-value=8.6e-06  Score=68.26  Aligned_cols=129  Identities=22%  Similarity=0.212  Sum_probs=93.0

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCc-----------------cccHHHHHHHHHHhcCC------CCCeeeE
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------------KIDENVQREIINHRSLR------HPNIIRF   64 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~ei~~~~~l~------hp~iv~l   64 (341)
                      ...||.|+.=.||.--+.   ...+||+.....                 .......+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~d---p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDD---PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCCC---CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            457899999888875443   348899886654                 22456667776655554      8899999


Q ss_pred             EEEEEcCCEEEEEEeecCC------CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC
Q 019433           65 KEVLLTPTHLAIVMEYAAG------GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP  138 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~------~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~  138 (341)
                      +|+..++.-..+|+|.+..      -+|.+++. .+.++. .   +...+-.-..+|-+.+|+.+|++|+||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK-EGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHH-cCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997633      35777773 344665 3   33344455568899999999999999999755432


Q ss_pred             --CEEEee
Q 019433          139 --RLKICD  144 (341)
Q Consensus       139 --~ikL~D  144 (341)
                        ++.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              478888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=4.5e-06  Score=67.39  Aligned_cols=127  Identities=22%  Similarity=0.167  Sum_probs=89.8

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCee-eEEEEEEcCCEEEEEEeecCCC
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII-RFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv-~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      ++.+.|++|.+|+||++.+.  |..+|+|+-+.. .....+..|.+++..+.--++- +++.+.    ..++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            46788999999999999985  668999976554 3467899999999888755543 333322    234669999997


Q ss_pred             chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCC-C-CEEecCCCCCCEEEeecCCcc
Q 019433           85 ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL-E-NTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        85 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp-~-Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      .|.......   +    ++-+..++++---|-..||-|+.|.- . ||++. ++.  +.|+||..|+
T Consensus        98 ~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~--~~iIDFd~At  154 (201)
T COG2112          98 PLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRD--VYIIDFDSAT  154 (201)
T ss_pred             chhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CCc--EEEEEccchh
Confidence            876654221   2    33445566665667889999999863 3 56664 334  9999999876

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.26  E-value=2.2e-05  Score=65.37  Aligned_cols=124  Identities=21%  Similarity=0.236  Sum_probs=88.0

Q ss_pred             CCccccceecccCC-eEEEEEEEcCCCcEEEEEEccc----Cc------------------cccHHHHHHHHHHhcC---
Q 019433            3 ERYEPVKELGSGNF-GVARLVRDKRTKELVAVKYIER----GK------------------KIDENVQREIINHRSL---   56 (341)
Q Consensus         3 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~----~~------------------~~~~~~~~ei~~~~~l---   56 (341)
                      ..++.++.||.|.- |.||++.-.  |+.||+|++..    ..                  ....-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            46788999999999 999999984  77999999321    00                  0112345566555544   


Q ss_pred             CCCCe--eeEEEEEEcC------------------CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019433           57 RHPNI--IRFKEVLLTP------------------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH  116 (341)
Q Consensus        57 ~hp~i--v~l~~~~~~~------------------~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH  116 (341)
                      .+.++  |+++++..-.                  ....||.||.+...         .+...    -+.+|++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence            45566  9999987422                  12578888886643         22333    3456777789999


Q ss_pred             HcCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433          117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus       117 ~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      ..||+-+|+++.|..=       -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~~-------G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYRG-------GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCccccccC-------CEEEecccC
Confidence            9999999999999651       489999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.25  E-value=7e-06  Score=71.17  Aligned_cols=73  Identities=11%  Similarity=-0.003  Sum_probs=47.1

Q ss_pred             cceecccCCe-EEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC---CeeeEEEEEEcC---CEEEEEEee
Q 019433            8 VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---NIIRFKEVLLTP---THLAIVMEY   80 (341)
Q Consensus         8 ~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp---~iv~l~~~~~~~---~~~~iv~e~   80 (341)
                      ++.|+.|+.. .||...     ..+++|+.... .....+.+|..+++.|...   -+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            5678877777 488762     34788876543 2345788899888777421   344444443322   234889999


Q ss_pred             cCCCch
Q 019433           81 AAGGEL   86 (341)
Q Consensus        81 ~~~~~L   86 (341)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.20  E-value=1.3e-05  Score=76.36  Aligned_cols=135  Identities=19%  Similarity=0.194  Sum_probs=84.5

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--------------------------------ccHH------HHHHH
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKK--------------------------------IDEN------VQREI   50 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------~~~~------~~~ei   50 (341)
                      +.||.-+.|+||.|+.+. |+.||||+-+.+-+                                ..+.      +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468899999999999985 99999998654210                                0011      12232


Q ss_pred             HH----HhcCCCCC------eeeEEEEEEcCCEEEEEEeecCCCchHH--HHHhcCCCCHHHHHHHHHHHHHHHHH-HHH
Q 019433           51 IN----HRSLRHPN------IIRFKEVLLTPTHLAIVMEYAAGGELFA--RICSAGRFSEDEARFFFQQLISGVSY-CHS  117 (341)
Q Consensus        51 ~~----~~~l~hp~------iv~l~~~~~~~~~~~iv~e~~~~~~L~~--~l~~~~~l~~~~~~~i~~qil~aL~~-LH~  117 (341)
                      +.    .+.+.|-+      |++++-.  ......++||||+|..+.+  .|.+. .++...+..   .+.++... +=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~---~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILN---KLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHH---HHHHHHHHHHHh
Confidence            22    22233444      3333322  2346789999999976633  33333 355554333   33333222 235


Q ss_pred             cCCeeCCCCCCCEEecCC--CCCCEEEeecCCccC
Q 019433          118 MEICHRDLKLENTLLDGS--PQPRLKICDFGYSKS  150 (341)
Q Consensus       118 ~~iiHrDikp~Nili~~~--~~~~ikL~Dfg~a~~  150 (341)
                      .|++|+|=.|.||+++.+  +...+.+.|||+...
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            689999999999999853  355699999998763

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.17  E-value=4.2e-05  Score=66.17  Aligned_cols=75  Identities=17%  Similarity=0.238  Sum_probs=49.6

Q ss_pred             cceecccCCeEEEEEEEcC-CCcEEEEEEcccCccccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEeecCCCc
Q 019433            8 VKELGSGNFGVARLVRDKR-TKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e~~~~~~   85 (341)
                      ++.|..|-...+|++.... .+..|++|+........-...+|+.+++.+.. .-.++++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4677888888999997653 35679999876543322344578888887743 23445544332  2  48999999866


Q ss_pred             h
Q 019433           86 L   86 (341)
Q Consensus        86 L   86 (341)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=0.00011  Score=66.12  Aligned_cols=77  Identities=12%  Similarity=0.055  Sum_probs=56.3

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCC---CCeeeEEEEEEc---CCEEEEEEee
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---PNIIRFKEVLLT---PTHLAIVMEY   80 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h---p~iv~l~~~~~~---~~~~~iv~e~   80 (341)
                      -.+.||.|..+.||...... + .+++|..+. ......+..|...++.|..   -.++++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            35679999999999997642 3 477787433 2234678899999888742   468888887754   3668999999


Q ss_pred             cCCCch
Q 019433           81 AAGGEL   86 (341)
Q Consensus        81 ~~~~~L   86 (341)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.01  E-value=0.00027  Score=65.64  Aligned_cols=76  Identities=17%  Similarity=0.108  Sum_probs=53.7

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEccc-------C-ccccHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCEEEE
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIER-------G-KKIDENVQREIINHRSL---RHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~-~~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .+.||.|.+..||.+.....++.++||.-..       + +...+....|...|+.+   ...++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999999975446899998431       1 12334566777777765   23467777776  4456789


Q ss_pred             EEeecCCCc
Q 019433           77 VMEYAAGGE   85 (341)
Q Consensus        77 v~e~~~~~~   85 (341)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.96  E-value=8.1e-06  Score=72.14  Aligned_cols=131  Identities=15%  Similarity=0.160  Sum_probs=94.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------------------cc----HHHHHHHHHHhcCCC--C
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------------------ID----ENVQREIINHRSLRH--P   59 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~----~~~~~ei~~~~~l~h--p   59 (341)
                      |.+..+||-|.-+-||.+.+. .|++.++|+-+-.+.                   +.    -.+.+|...++.|..  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            567889999999999999987 688999996432110                   00    135578888877743  2


Q ss_pred             CeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           60 NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        60 ~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      -|++.++    .+..++|||++.|..|...-.      ...+..+...+..-+.-|..+|+||+|..--||+|+.++.  
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~--  240 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK--  240 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC--
Confidence            2455443    456789999999977754321      1223456666777778899999999999999999997766  


Q ss_pred             EEEeecCCc
Q 019433          140 LKICDFGYS  148 (341)
Q Consensus       140 ikL~Dfg~a  148 (341)
                      ++++||--.
T Consensus       241 i~vIDFPQm  249 (465)
T KOG2268|consen  241 IVVIDFPQM  249 (465)
T ss_pred             EEEeechHh
Confidence            999999643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.92  E-value=8.4e-05  Score=65.26  Aligned_cols=131  Identities=16%  Similarity=0.090  Sum_probs=76.3

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCcccc-HHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEeecCCCchH
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYAAGGELF   87 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~~~~~~L~   87 (341)
                      .+..|-.+.+|++..  ++..+++|......... -...+|..+++.+...+ .++++....    -++|++|++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            456688889998873  56789999865433221 23577888888775332 244444332    26899999986542


Q ss_pred             HH----------H-------Hhc----CCCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeeCCCCCC
Q 019433           88 AR----------I-------CSA----GRFSE-DEARFFFQQL---------ISGVSYCHS--------MEICHRDLKLE  128 (341)
Q Consensus        88 ~~----------l-------~~~----~~l~~-~~~~~i~~qi---------l~aL~~LH~--------~~iiHrDikp~  128 (341)
                      ..          +       ...    .+++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            11          1       111    11221 1122222111         111222221        24899999999


Q ss_pred             CEEecCCCCCCEEEeecCCcc
Q 019433          129 NTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       129 Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      ||++++++   +.|+||..+.
T Consensus       157 Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC---CEEEeccccC
Confidence            99998654   7899998775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.91  E-value=1e-06  Score=90.89  Aligned_cols=205  Identities=15%  Similarity=0.070  Sum_probs=139.3

Q ss_pred             HHHHHhcCCCCCeeeEEEEEEc--CCEEEEEEeecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC---
Q 019433           49 EIINHRSLRHPNIIRFKEVLLT--PTHLAIVMEYAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSME---  119 (341)
Q Consensus        49 ei~~~~~l~hp~iv~l~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~---  119 (341)
                      |....+...|++++....-...  +...+.+++|+.+|.++..+.++.    .+.+..+.....+.+.+..-+|+..   
T Consensus      1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred             hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence            3334455689988876665432  345789999999999999987643    3555555555556577777777532   


Q ss_pred             --CeeCCCCCCCEEecCCCCCCEEEeecCCccC-CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh
Q 019433          120 --ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV  196 (341)
Q Consensus       120 --iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~  196 (341)
                        .+|+++|+-|.+|..+..  ++++++|+.+. ...........+++.|++|++...-.+..+ +|+|++|+-+|.+..
T Consensus      1359 ~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRSD 1435 (2724)
T ss_pred             ccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHhc
Confidence              789999999999987666  99999999983 222233445678889999999876666554 899999999999998


Q ss_pred             CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          197 GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       197 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      |..+|..     ..+..++.+.............|.+.......+|-..-..||.-...+.-+.|
T Consensus      1436 ~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1436 GNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             ccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            8877632     22222222211111111112334555566666666777788988888887766

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.87  E-value=6.3e-05  Score=62.70  Aligned_cols=97  Identities=14%  Similarity=0.081  Sum_probs=77.4

Q ss_pred             HHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEeecCCCchHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 019433           47 QREIINHRSLRH-PNIIRFKEVLLTPTHLAIVMEYAAGGELFA---RICSAGRFSEDEARFFFQQLISGVSYCHS---ME  119 (341)
Q Consensus        47 ~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e~~~~~~L~~---~l~~~~~l~~~~~~~i~~qil~aL~~LH~---~~  119 (341)
                      ..|..+++.+.+ +++++++|+|-.    ++|.||...+++..   .+...-..++..+.+++.++++.+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357888888865 699999999832    67899998766542   12222346899999999999999999987   45


Q ss_pred             CeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       120 iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      +.-.|++|+|+-|++++.  +|++|.+.+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence            888999999999997776  9999998664

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.78  E-value=0.00014  Score=65.64  Aligned_cols=136  Identities=21%  Similarity=0.206  Sum_probs=94.1

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccC----------------------ccc-----cHHHHHHHHHHhcCCCCC
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERG----------------------KKI-----DENVQREIINHRSLRHPN   60 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~-----~~~~~~ei~~~~~l~hp~   60 (341)
                      -..|..|--+.||-|... +|..+|||++..+                      ...     .-.+..|++.|.+|....
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345777888899998876 6788999986431                      001     113567888888776555


Q ss_pred             eeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeCCCCCCCEEecCCCCCC
Q 019433           61 IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        61 iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      |+----+.. . ...+||+++....--.-..+.-.++...+..+-.|++.-+.-| |.+++||.||+--|+|+.. |.  
T Consensus       228 IP~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~--  302 (520)
T KOG2270|consen  228 IPCPEPILL-K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK--  302 (520)
T ss_pred             CCCCCceee-e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE--
Confidence            332211111 2 2369999996433222222334688888999999999988887 5789999999999999974 44  


Q ss_pred             EEEeecCCcc
Q 019433          140 LKICDFGYSK  149 (341)
Q Consensus       140 ikL~Dfg~a~  149 (341)
                      +.++|.+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999998765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.77  E-value=0.0003  Score=63.38  Aligned_cols=75  Identities=13%  Similarity=0.147  Sum_probs=49.5

Q ss_pred             cceecccCCeEEEEEEEcC------CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEee
Q 019433            8 VKELGSGNFGVARLVRDKR------TKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++.|..|--..+|++....      +++.+++|+............+|..+++.+...+ .++++.++..    .+|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            4566667777999998653      2678999997665444445678888877774322 3455555532    358899


Q ss_pred             cCCCch
Q 019433           81 AAGGEL   86 (341)
Q Consensus        81 ~~~~~L   86 (341)
                      ++|.++
T Consensus        79 i~G~~l   84 (302)
T cd05156          79 IPSRTL   84 (302)
T ss_pred             eCCCcC
Confidence            888665

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.0004  Score=62.29  Aligned_cols=136  Identities=18%  Similarity=0.127  Sum_probs=81.0

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC--CeeeEEEE------EEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEV------LLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp--~iv~l~~~------~~~~~~~~iv~e   79 (341)
                      ++.|..|....+|++...  +..+++|+...  .....+..|+.++..|.+.  .+++++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567777888899998753  44699998765  2345667777777766322  24444432      233456789999


Q ss_pred             ecCCCchHH----HH----------Hh-cCCCCH--------HHHH------------HHHHHHHHHHHHHHH-------
Q 019433           80 YAAGGELFA----RI----------CS-AGRFSE--------DEAR------------FFFQQLISGVSYCHS-------  117 (341)
Q Consensus        80 ~~~~~~L~~----~l----------~~-~~~l~~--------~~~~------------~i~~qil~aL~~LH~-------  117 (341)
                      +++|..+..    ..          .. ...+..        ....            .....+..++.++..       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998865421    00          10 000100        0000            011112334444443       


Q ss_pred             cCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       118 ~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      .+++|+|+.|.||++++++.  +.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence            47999999999999987543  6899998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.00048  Score=62.22  Aligned_cols=137  Identities=15%  Similarity=0.159  Sum_probs=78.6

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC--eeeEEEE------EEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEV------LLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~--iv~l~~~------~~~~~~~~iv~e   79 (341)
                      ++.++.|....+|++...  +..+++|+..... ....+..|+.++..|...+  +++++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            566777877899998753  3368889875532 2344556666666663222  3444332      122456789999


Q ss_pred             ecCCCchH----H----------HHHh-cCCCC--------HHH-----HH----------HHHHHHHHHHHHHH-----
Q 019433           80 YAAGGELF----A----------RICS-AGRFS--------EDE-----AR----------FFFQQLISGVSYCH-----  116 (341)
Q Consensus        80 ~~~~~~L~----~----------~l~~-~~~l~--------~~~-----~~----------~i~~qil~aL~~LH-----  116 (341)
                      |++|..+.    .          .+.. ...++        ...     ..          .....+...+.++.     
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99885431    0          0111 01110        000     00          00112233455553     


Q ss_pred             --HcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          117 --SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       117 --~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                        ..+++|+|+.+.||++++++.  +.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSV--KGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence              268999999999999987653  6899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.66  E-value=0.0016  Score=59.15  Aligned_cols=74  Identities=11%  Similarity=0.026  Sum_probs=43.9

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC--CeeeEEE------EEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKE------VLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp--~iv~l~~------~~~~~~~~~iv~e   79 (341)
                      ++.|+.|....+|.+...  +..+++|++..  ...+.+..++.+++.|...  .+++.+.      +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            455667777889998764  33699998762  2234444555555544211  1333332      1223566789999


Q ss_pred             ecCCCc
Q 019433           80 YAAGGE   85 (341)
Q Consensus        80 ~~~~~~   85 (341)
                      |++|..
T Consensus       103 ~l~G~~  108 (319)
T PRK05231        103 FLEGKW  108 (319)
T ss_pred             ecCCCC
Confidence            998864

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.39  E-value=0.0039  Score=56.92  Aligned_cols=73  Identities=19%  Similarity=0.148  Sum_probs=48.7

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEc----cc---C-ccccHHHHHHHHHHhcCC--CC-CeeeEEEEEEcCCEEEEE
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYI----ER---G-KKIDENVQREIINHRSLR--HP-NIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~----~~---~-~~~~~~~~~ei~~~~~l~--hp-~iv~l~~~~~~~~~~~iv   77 (341)
                      +.||.|....||++.+...++.++||.-    +.   + +...+...-|...|+...  -| .+++++.  .+.....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            3689999999999998644468999963    21   1 233445666777776552  34 4555554  445566799


Q ss_pred             EeecCC
Q 019433           78 MEYAAG   83 (341)
Q Consensus        78 ~e~~~~   83 (341)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.37  E-value=0.00048  Score=64.67  Aligned_cols=168  Identities=18%  Similarity=0.194  Sum_probs=101.0

Q ss_pred             cHHHHHHHHHHhcCCCCCeeeEEEEEEcC-CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 019433           43 DENVQREIINHRSLRHPNIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC  121 (341)
Q Consensus        43 ~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~ii  121 (341)
                      ...++.-.++++.+.|+|...++.+.... ....+|||++ +.+|.+.+.... +-.....                  .
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~   85 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A   85 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence            44577778889999999999999987543 4578999999 458888776543 2111111                  2


Q ss_pred             eCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCC
Q 019433          122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF  201 (341)
Q Consensus       122 HrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf  201 (341)
                      ||-+ +-|+         ++.+| -++..    .  ....|                 .++||||+|.++.++..|..-|
T Consensus        86 ~~~~-~~~~---------~~~td-~~~t~----~--~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   86 HGVL-HLNI---------IYITD-HFLTK----Y--PSPIG-----------------PKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             cccc-eehh---------hhccc-ccccc----C--CCCCC-----------------cchhhhhHHHHHHHHHHhhHHH
Confidence            2211 1111         33333 11100    0  11111                 2599999999999999998777


Q ss_pred             CCCCChhHHHHHHHHHhcccccC------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          202 EDPEDPRNFRKTIDRIRNVQYFL------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ......+....+..-........      --....+..+..++.+|+-..|..||...++.+++-|.+.
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            65444333322211100000000      0001245567889999999999999999999999988654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.35  E-value=0.0018  Score=58.22  Aligned_cols=142  Identities=13%  Similarity=0.118  Sum_probs=80.1

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEccc-C--ccccHHHHHHHHHHhcCCC--CCeeeEEEEEEcCC--EEEEEEe
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER-G--KKIDENVQREIINHRSLRH--PNIIRFKEVLLTPT--HLAIVME   79 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~--~~~~~~~~~ei~~~~~l~h--p~iv~l~~~~~~~~--~~~iv~e   79 (341)
                      +++.+..|..-.+|.....  ++.+++. ... .  ........+|+.+++.+.-  --+...++++....  ..|.||+
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~  105 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME  105 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence            4455544444455665554  7888888 332 1  2234456678888776632  22444555555544  6799999


Q ss_pred             ecCCCchHHHHHhcC--------------------------------CCCHHHHHHHHHHH--------------HHHHH
Q 019433           80 YAAGGELFARICSAG--------------------------------RFSEDEARFFFQQL--------------ISGVS  113 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~--------------------------------~l~~~~~~~i~~qi--------------l~aL~  113 (341)
                      |++|..+...+....                                .+...++..+..+.              ..-..
T Consensus       106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            999843321110000                                00111111111111              12233


Q ss_pred             HHHH--------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433          114 YCHS--------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus       114 ~LH~--------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +|+.        -.++|+|+.+.|+++++...  +-+.||+++..+.+
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP  231 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP  231 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence            3332        24899999999999997766  89999999875543

>PLN02236 choline kinase

Probab=97.33  E-value=0.0039  Score=57.23  Aligned_cols=138  Identities=18%  Similarity=0.205  Sum_probs=78.7

Q ss_pred             ccceecccCCeEEEEEEEcC----CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEeec
Q 019433            7 PVKELGSGNFGVARLVRDKR----TKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      -++.|..|-.-.+|++....    +++.|++|+........-.-..|..+++.+..-+ -+++++.+.. .   .|.+|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            34556557778899987532    3478999987664332223467888877774322 3345565533 2   578888


Q ss_pred             CCCchHHH----------H-------HhcC------CCCHHHHHHHHHHHH-----------------HHHHHH----H-
Q 019433           82 AGGELFAR----------I-------CSAG------RFSEDEARFFFQQLI-----------------SGVSYC----H-  116 (341)
Q Consensus        82 ~~~~L~~~----------l-------~~~~------~l~~~~~~~i~~qil-----------------~aL~~L----H-  116 (341)
                      ++.++...          +       ....      ......+..++.++.                 ..+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665211          0       0100      111233333332221                 111112    1 


Q ss_pred             ---HcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          117 ---SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       117 ---~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                         ...++|+|+++.||++++.. ..+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence               23589999999999997532 249999998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.17  E-value=0.0027  Score=56.34  Aligned_cols=31  Identities=23%  Similarity=0.333  Sum_probs=24.5

Q ss_pred             CCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433          119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       119 ~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      .++|+|+.|.||++++++. ..-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence            4899999999999986432 246999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.10  E-value=0.0066  Score=56.18  Aligned_cols=74  Identities=22%  Similarity=0.161  Sum_probs=50.6

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEc----ccC---ccccHHHHHHHHHHhcCC--CC-CeeeEEEEEEcCCEEEEE
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYI----ERG---KKIDENVQREIINHRSLR--HP-NIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~----~~~---~~~~~~~~~ei~~~~~l~--hp-~iv~l~~~~~~~~~~~iv   77 (341)
                      ++.||.|.-..||++.+...+..|+||.-    +..   +...+...-|...|+.+.  .| .+++++.  .+.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            67899999999999998544567999963    221   233456667777777552  34 5666655  455666899


Q ss_pred             EeecCC
Q 019433           78 MEYAAG   83 (341)
Q Consensus        78 ~e~~~~   83 (341)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.10  E-value=0.0099  Score=55.30  Aligned_cols=73  Identities=21%  Similarity=0.189  Sum_probs=49.5

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEccc-----Cc---cccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GK---KIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~~~   75 (341)
                      ..+.||.|....||++.+.  +..++||.-..     +.   ........|...|+.+.   ...+++++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4668899999999999874  45699997541     11   12334445565555442   247888888776  4457


Q ss_pred             EEEeecCC
Q 019433           76 IVMEYAAG   83 (341)
Q Consensus        76 iv~e~~~~   83 (341)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.02  E-value=0.0082  Score=54.82  Aligned_cols=75  Identities=15%  Similarity=0.172  Sum_probs=44.8

Q ss_pred             cceecccCCeEEEEEEEcCC---CcEEEEEEcccCccccHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCEEEEEEeecCC
Q 019433            8 VKELGSGNFGVARLVRDKRT---KELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~i-v~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      ++.|..|=-..+|++.....   +..|++|+........-.-.+|..+++.+..-++ +++++++. ++   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            34454466668888875432   3479999876543322234577777777754333 45555552 22   58888877


Q ss_pred             Cch
Q 019433           84 GEL   86 (341)
Q Consensus        84 ~~L   86 (341)
                      .++
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            554

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.94  E-value=0.038  Score=49.82  Aligned_cols=29  Identities=31%  Similarity=0.647  Sum_probs=24.6

Q ss_pred             cCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       118 ~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      .+++|+|+.+.||+++. +.  +.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~--i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NE--VYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-Cc--EEEEECcccc
Confidence            57899999999999986 44  8999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.66  E-value=0.043  Score=49.57  Aligned_cols=29  Identities=21%  Similarity=0.256  Sum_probs=25.8

Q ss_pred             CCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       119 ~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      +++|+|+.++||++++++.  +.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence            6999999999999987766  8999998765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.27  E-value=0.014  Score=49.45  Aligned_cols=55  Identities=16%  Similarity=0.048  Sum_probs=32.7

Q ss_pred             CcEEEEEEcccCccccHHHHHHHHHHhcCCCC-CeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           28 KELVAVKYIERGKKIDENVQREIINHRSLRHP-NIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        28 ~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp-~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ++.|++++........-.-..|..+++.+..- .-+++++.+..    ..|.+|+.|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEeccccc
Confidence            46789998877655555667788888877533 33556665432    256688876543

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.25  E-value=0.18  Score=45.98  Aligned_cols=70  Identities=10%  Similarity=0.011  Sum_probs=42.9

Q ss_pred             CCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC--eeeEE---E--EEEcCCEEEEEEeecCCCc
Q 019433           15 NFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFK---E--VLLTPTHLAIVMEYAAGGE   85 (341)
Q Consensus        15 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~--iv~l~---~--~~~~~~~~~iv~e~~~~~~   85 (341)
                      .-..||.+... ++..+++|+.+........+..|+..+..|....  ++...   +  +...++..+.++++.+|..
T Consensus        37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            44568888764 4667999988755445566777877776552111  22211   1  1233567788999988753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.08  E-value=0.047  Score=48.70  Aligned_cols=74  Identities=11%  Similarity=0.067  Sum_probs=48.1

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC---CCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL---RHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      -.+.++-|....+|...  .+++.+.+|+-..  .....+..|..-|+.|   .--.+++.+.+....+.-+++|||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~--~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSE--SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG--GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecCh--hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            35678889999999988  5688899998763  2345677787777776   345688888888877777999999877


Q ss_pred             C
Q 019433           84 G   84 (341)
Q Consensus        84 ~   84 (341)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.08  E-value=0.11  Score=48.33  Aligned_cols=76  Identities=11%  Similarity=0.022  Sum_probs=45.0

Q ss_pred             ccceecccCCeEEEEEEEcCC-CcE-----EEEEEcccCccccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEe
Q 019433            7 PVKELGSGNFGVARLVRDKRT-KEL-----VAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++.|..|--..+|++..... +..     |.++.........-.-.+|+.+++.+.. -.-.++++.+..    +++.|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            345665688889999975432 122     4444322222112234568888888854 445566666632    69999


Q ss_pred             ecCCCch
Q 019433           80 YAAGGEL   86 (341)
Q Consensus        80 ~~~~~~L   86 (341)
                      |++|-+|
T Consensus       130 fIeGr~l  136 (383)
T PTZ00384        130 WVEGNTM  136 (383)
T ss_pred             EeccccC
Confidence            9988665

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.03  E-value=0.035  Score=50.45  Aligned_cols=71  Identities=24%  Similarity=0.275  Sum_probs=55.4

Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      .+.|++|++- |+++...    +.-..+++..++++.+..+.-+..+ .+-|||+...||+|+ .|+  |.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence            4567888876 4454221    2245688899999999988888865 588999999999999 666  99999999984

>PRK06148 hypothetical protein; Provisional

Probab=95.71  E-value=0.33  Score=51.14  Aligned_cols=138  Identities=14%  Similarity=0.165  Sum_probs=75.8

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-------CCCCeeeEE-----EEEEc-CC--E
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-------RHPNIIRFK-----EVLLT-PT--H   73 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-------~hp~iv~l~-----~~~~~-~~--~   73 (341)
                      +.|+ |..-.+|++... +|..+++|+.+... .......|...+..|       .-|.+++-.     ..... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTD-DGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 456778888754 57789999988653 233344444444333       233333321     11111 22  5


Q ss_pred             EEEEEeecCCCchHHH-----------------HHh----c------CCCCH-----------------HHHHHHHHHHH
Q 019433           74 LAIVMEYAAGGELFAR-----------------ICS----A------GRFSE-----------------DEARFFFQQLI  109 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~-----------------l~~----~------~~l~~-----------------~~~~~i~~qil  109 (341)
                      .+-+++|.+|..+...                 +..    .      ..+.+                 ...+.++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            6778999999766431                 000    0      00111                 11223333333


Q ss_pred             HHHHH-----HH--HcCCeeCCCCCCCEEecCCCCCCEE-EeecCCcc
Q 019433          110 SGVSY-----CH--SMEICHRDLKLENTLLDGSPQPRLK-ICDFGYSK  149 (341)
Q Consensus       110 ~aL~~-----LH--~~~iiHrDikp~Nili~~~~~~~ik-L~Dfg~a~  149 (341)
                      ..+.-     |.  ..++||+|+.+.||+++.++..++. |+|||-+.
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            33321     22  2579999999999999876532355 99999765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.66  E-value=0.064  Score=45.47  Aligned_cols=101  Identities=18%  Similarity=0.108  Sum_probs=66.1

Q ss_pred             cEEEEEEcccCccc--cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHH
Q 019433           29 ELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQ  106 (341)
Q Consensus        29 ~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~  106 (341)
                      -+..+|+++..+..  ...+..+..++.++  -+|+++..-  ....+.++.|+|-....             ....++.
T Consensus        86 G~L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~~N~i~  148 (308)
T PF07387_consen   86 GPLFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI-------------NFSNFIT  148 (308)
T ss_pred             chhhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc-------------chhHHHH
Confidence            34666766655433  33455666666543  367777642  34457899999953211             1112333


Q ss_pred             HHHHHHHHHHH--cCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433          107 QLISGVSYCHS--MEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus       107 qil~aL~~LH~--~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      .=+.+|.-.|+  .+.+|+|..|+|||-|+.|.  +||.|-+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhhh
Confidence            33567778884  46999999999999999888  999998753

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.50  E-value=0.087  Score=48.73  Aligned_cols=61  Identities=16%  Similarity=0.104  Sum_probs=44.8

Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeCCCCCCCEEecC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDG  134 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHrDikp~Nili~~  134 (341)
                      ...++-+|..|.++..++.. +..++...+.++.-...||--+ ---+++|.|+.|.||++.-
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            34677788888888877754 3466666777776666665543 4568999999999999954

>PTZ00296 choline kinase; Provisional

Probab=94.91  E-value=0.46  Score=45.19  Aligned_cols=76  Identities=16%  Similarity=0.054  Sum_probs=44.4

Q ss_pred             ccceecccCCeEEEEEEEcC--------CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCEEEEE
Q 019433            7 PVKELGSGNFGVARLVRDKR--------TKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIV   77 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~i-v~l~~~~~~~~~~~iv   77 (341)
                      -++.|..|=--.+|++....        .++.|.+++.-......-.-..|..+++.+..-+| .++++.+.    -+.+
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            34556666666788887542        25679999876544322234567777666643232 24455442    2457


Q ss_pred             EeecCCCch
Q 019433           78 MEYAAGGEL   86 (341)
Q Consensus        78 ~e~~~~~~L   86 (341)
                      .+|++|-+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            888887543

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=94.26  E-value=0.12  Score=46.32  Aligned_cols=133  Identities=19%  Similarity=0.207  Sum_probs=89.5

Q ss_pred             ccceecccCCeEEEEEEE-------cC---CCcEEEEEEcccC----------------------ccccH-----HHHHH
Q 019433            7 PVKELGSGNFGVARLVRD-------KR---TKELVAVKYIERG----------------------KKIDE-----NVQRE   49 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~-------~~---~~~~vaiK~~~~~----------------------~~~~~-----~~~~e   49 (341)
                      |-..|..|.-++|+-|..       ..   ....+|||+++..                      ....+     ...+|
T Consensus       256 i~GiIsTGKEsvvlHAY~GS~E~~~qd~ql~ptecAIKvfKTTLnEFKnRd~YiKDDfRFKDRFSK~NpR~i~~mWAEkE  335 (531)
T KOG2269|consen  256 IDGIISTGKESVVLHAYAGSNEHGHQDPQLSPTECAIKVFKTTLNEFKNRDEYIKDDFRFKDRFSKQNPRGILKMWAEKE  335 (531)
T ss_pred             hhhhhhcCcceEEEEeccCcccccccCcccCchHHHHHHHHHHHHHHhhhhhhhccchhhhhhhcccCcHHHHHHHHHHH
Confidence            445677888888887743       11   3456899987421                      00111     13345


Q ss_pred             HHHHhcC-----CCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeC
Q 019433           50 IINHRSL-----RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-HSMEICHR  123 (341)
Q Consensus        50 i~~~~~l-----~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHr  123 (341)
                      +..+.++     .+|-+|.+..       ..+||-++...-+-.--.+.-.|+..+.+..-.|++.++.-| |++-+||.
T Consensus       336 mhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHA  408 (531)
T KOG2269|consen  336 MHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHA  408 (531)
T ss_pred             HHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeec
Confidence            5444443     5788887743       368999885433322222333589999999999999999887 78899999


Q ss_pred             CCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          124 DLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       124 Dikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      |++--|+|...+ .  +.++|..-+.
T Consensus       409 DlSEyN~Lw~~g-K--vw~IDVsQsv  431 (531)
T KOG2269|consen  409 DLSEYNLLWTPG-K--VWVIDVSQSV  431 (531)
T ss_pred             chhhhhheecCC-c--eEEEechhcc
Confidence            999999999854 4  8999987554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	341
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-149
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-146
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-146
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-146
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-141
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-140
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-55
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-51
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-51
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-50
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-49
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-49
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-48
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-48
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-48
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-48
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-47
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-47
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-47
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-47
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-46
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-46
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-46
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-45
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-42
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-41
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-41
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-41
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-41
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-41
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-41
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-41
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-41
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-41
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-41
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-41
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-41
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-41
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-41
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-41
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-41
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-41
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-41
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-41
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-41
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-41
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-40
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-40
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-40
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-40
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-40
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-40
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-40
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-40
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-40
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-40
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-40
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-40
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-40
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-40
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-40
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-40
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-39
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-39
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-39
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-39
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-39
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-39
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-39
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-39
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-39
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-38
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-38
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-38
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-38
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		9e-38
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-37
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-37
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-37
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-37
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-37
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-37
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-37
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-37
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-37
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-37
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-37
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-37
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-37
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-37
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		8e-37
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		8e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-37
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-36
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-36
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-36
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-35
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-35
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-35
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-35
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-35
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-35
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-35
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-35
3soa_A	444	Full-Length Human Camkii Length = 444		6e-35
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-34
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-34
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-34
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-34
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-34
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-34
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-34
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-34
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-34
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-34
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-34
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		7e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-34
3kk8_A	284	Camkii Substrate Complex A Length = 284		9e-34
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		9e-34
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-34
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-34
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-33
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-33
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-33
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-33
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-33
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-33
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-33
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-33
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-33
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-33
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-33
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-33
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-33
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-33
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-33
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-33
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-33
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-33
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-33
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-33
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-33
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-33
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-33
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-33
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-33
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-33
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-33
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-33
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-33
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-33
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-33
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-33
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-33
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-33
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-33
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-33
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-33
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-33
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-33
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-33
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-33
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-33
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-33
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-33
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-33
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-33
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-33
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-33
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-33
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-33
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-33
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-33
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-33
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-33
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-33
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-33
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-33
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-32
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-32
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-32
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-32
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-32
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-32
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-32
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-32
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-32
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-32
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-32
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-32
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-32
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-32
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-32
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-32
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-32
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-31
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-31
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-31
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-31
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-30
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-30
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-30
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-30
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-30
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-30
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-30
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-30
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-30
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		9e-30
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-30
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-29
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-29
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-28
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-28
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-28
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-28
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-28
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-28
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-27
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-27
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-27
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-27
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-27
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-27
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-27
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-27
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-27
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-26
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-26
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-26
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-26
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-26
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-26
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-26
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-26
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-26
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-25
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-25
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-25
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-25
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-25
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-25
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-25
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-25
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-25
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-25
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-25
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-25
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-25
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-25
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-25
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-25
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-25
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-25
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-25
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-25
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-25
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-25
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-25
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-25
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-25
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-25
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-25
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-25
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-25
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-25
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-25
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-25
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-25
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-25
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-25
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-25
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-25
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-25
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-25
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-25
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-25
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		7e-25
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-25
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-25
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-25
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-25
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-24
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-24
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-24
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-24
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-23
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-23
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-23
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-23
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-23
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-23
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-23
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-23
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-22
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		9e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-22
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		9e-22
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-21
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-21
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-21
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-21
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-21
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-21
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-21
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-21
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-21
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-21
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-20
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-20
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-20
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-20
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-20
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-20
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-19
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-19
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-19
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-19
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-19
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-19
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-19
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-19
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-19
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-19
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-19
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-19
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-19
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-19
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-19
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-19
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-19
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-19
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-19
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		9e-19
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-18
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-18
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-17
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-17
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-17
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-17
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-17
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-17
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-17
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-17
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-17
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-17
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-17
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-17
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-17
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-17
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-17
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-17
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-17
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-17
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-17
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-17
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-17
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-17
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-17
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-17
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-17
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-17
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-17
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-17
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-17
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-17
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-17
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-17
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-17
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-17
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-17
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-17
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-17
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-17
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-17
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-17
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-17
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		6e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-17
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-17
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		9e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-17
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-16
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-16
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-16
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-16
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-16
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-16
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-16
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-16
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-16
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-16
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-16
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-16
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-16
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-16
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-16
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-16
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-16
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		7e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-16
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-15
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-15
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-15
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		8e-15
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-15
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-15
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-14
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-14
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-14
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-13
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-13
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-13
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		7e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-12
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-12
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-12
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-12
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		6e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-10
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		2e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		6e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		7e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-09
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		8e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		5e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		5e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		6e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		7e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		7e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		7e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-08
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		9e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-08
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-07
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		3e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-06
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-06
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-06

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  523 bits (1346), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 242/319 (75%), Positives = 279/319 (87%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 197
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 257
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+KRI IPEI+ H WFLKNLP +++       + A  DQP QS+EEIM+II EA +P
Sbjct: 258 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPGQSIEEIMQIIAEATVP 317
Query: 303 GEATKVAGQGAAGASDPDD 321
              T+       G+ D DD
Sbjct: 318 PAGTQNLNHYLTGSLDIDD 336

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  515 bits (1327), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 240/319 (75%), Positives = 277/319 (86%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKIC FGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+KRI IPEI+ H WFLKNLP +++       +    DQP QS+EEIM+II EA +P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 303 GEATKVAGQGAAGASDPDD 321
              T+       G+ D DD
Sbjct: 319 PAGTQNLNHYLTGSLDIDD 337

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  513 bits (1322), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 239/319 (74%), Positives = 276/319 (86%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKIC FGYSKS +LHSQPK TVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+KRI IPEI+ H WFLKNLP +++       +    DQP QS+EEIM+II EA +P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 303 GEATKVAGQGAAGASDPDD 321
              T+       G+ D DD
Sbjct: 319 PAGTQNLNHYLTGSLDIDD 337

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  513 bits (1322), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 239/319 (74%), Positives = 276/319 (86%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++GSGNFGVARL+RDK++ ELVAVKYIERG+KI  NV+REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSYCH+M++CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+KRI IPEI+ H WFLKNLP +++       +    DQP QS+EEIM+II EA +P
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATVP 318
Query: 303 GEATKVAGQGAAGASDPDD 321
              T+       G+ D DD
Sbjct: 319 PAGTQNLNHYLTGSLDIDD 337

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  496 bits (1277), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 230/301 (76%), Positives = 267/301 (88%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG  IDENVQREIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+ RI IPEIK H WFLKNLP +++    T  +    +QP QS++ IM+II EA +P
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
Query: 303 G 303
Sbjct: 320 A 320

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  495 bits (1274), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 229/299 (76%), Positives = 265/299 (88%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RYE VK++G+GNFGVARL+RDK+  ELVAVKYIERG+KIDENV+REIINHRSLRHPNI+
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAIVMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGVSY H+M++ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKI DFGYSK+ +LHSQPKS VGTPAYIAPEVL +KEYDGK++
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVA 198
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+P+NFRKTI RI NVQY +PDYV +S +CRHL+S+IF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKM 301
           VADP+KRI IPEI+ H WFLKNLP +++       +    DQP QS+EEIM+II EA +
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQSIEEIMQIIAEATV 317

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 119/260 (45%), Positives = 162/260 (62%), Gaps = 13/260 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDEN--VQREIINHRSLRHPNIIRFKE 66
           LG G+FG  +L    +T++ VA+K+I R   KK D +  V+REI   + LRHP+II+  +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V+ TPT + +V+EYA GGELF  I    R +EDE R FFQQ+I  + YCH  +I HRDLK
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            EN LLD +    +KI DFG S      +  K++ G+P Y APEV+  K Y G   DVWS
Sbjct: 136 PENLLLDDNLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246
           CG+ LYVMLVG  PF+D   P  F+K    + +  Y +PD+  +S   + L+ ++ VADP
Sbjct: 194 CGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRRMIVADP 247
Query: 247 SKRIPIPEIKKHPWFLKNLP 266
            +RI I EI++ PWF  NLP
Sbjct: 248 MQRITIQEIRRDPWFNVNLP 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  198 bits (503), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 109/260 (41%), Positives = 148/260 (56%), Gaps = 12/260 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKE 66
           LG G FG  ++   + T   VAVK + R K     +   ++REI N +  RHP+II+  +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V+ TPT   +VMEY +GGELF  IC  GR  E EAR  FQQ++S V YCH   + HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            EN LLD       KI DFG S         +++ G+P Y APEV++ + Y G   D+WS
Sbjct: 139 PENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246
           CGV LY +L G  PF+D   P  F+K    IR   +++P+Y+  S     LL  +   DP
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEYLNRSVAT--LLMHMLQVDP 250
Query: 247 SKRIPIPEIKKHPWFLKNLP 266
            KR  I +I++H WF ++LP
Sbjct: 251 LKRATIKDIREHEWFKQDLP 270

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  197 bits (501), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 109/260 (41%), Positives = 147/260 (56%), Gaps = 12/260 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKE 66
           LG G FG  ++   + T   VAVK + R K     +   ++REI N +  RHP+II+  +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V+ TPT   +VMEY +GGELF  IC  GR  E EAR  FQQ++S V YCH   + HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            EN LLD       KI DFG S         + + G+P Y APEV++ + Y G   D+WS
Sbjct: 139 PENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246
           CGV LY +L G  PF+D   P  F+K    IR   +++P+Y+  S     LL  +   DP
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEYLNRSVAT--LLMHMLQVDP 250
Query: 247 SKRIPIPEIKKHPWFLKNLP 266
            KR  I +I++H WF ++LP
Sbjct: 251 LKRATIKDIREHEWFKQDLP 270

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  195 bits (496), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 108/264 (40%), Positives = 149/264 (56%), Gaps = 12/264 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKE 66
           LG G FG  ++ + + T   VAVK + R K     +   ++REI N +  RHP+II+  +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V+ TP+ + +VMEY +GGELF  IC  GR  E E+R  FQQ++SGV YCH   + HRDLK
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWS 186
            EN LLD       KI DFG S         + + G+P Y APEV++ + Y G   D+WS
Sbjct: 144 PENVLLDAHMNA--KIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 187 CGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADP 246
            GV LY +L G  PF+D   P  F+K  D I    ++ P Y+  S     LL  +   DP
Sbjct: 202 SGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQYLNPSVIS--LLKHMLQVDP 255
Query: 247 SKRIPIPEIKKHPWFLKNLPKEII 270
            KR  I +I++H WF ++LPK + 
Sbjct: 256 MKRATIKDIREHEWFKQDLPKYLF 279

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPW 260
            + +PSKR  + +I K  W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPW 260
            + +PSKR  + +I K  W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 104/260 (40%), Positives = 150/260 (57%), Gaps = 11/260 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPWF 261
            + +PSKR  + +I K  W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 151/260 (58%), Gaps = 11/260 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAV+ I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPWF 261
            + +PSKR  + +I K  W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 150/260 (57%), Gaps = 11/260 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAV+ I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++     G+P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPWF 261
            + +PSKR  + +I K  W 
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  187 bits (475), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + G   E EAR  F+Q++S V YCH   I 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   K+YDG  
Sbjct: 129 HRDLKAENLLLDADMN--IKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 242 FVADPSKRIPIPEIKKHPW 260
            + +PSKR  + +I K  W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T   VA+K I++ +    ++Q   RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L ++MEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+   K+YDG  
Sbjct: 134 HRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 192 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 242 FVADPSKRIPIPEIKKHPW 260
            V +P KR  + +I K  W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 148/259 (57%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T + VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +V EYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   K+YDG  
Sbjct: 136 HRDLKAENLLLDADXN--IKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y   S DC +LL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--XSTDCENLLKKF 247
Query: 242 FVADPSKRIPIPEIKKHPW 260
            + +PSKR  + +I K  W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  186 bits (472), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 148/259 (57%), Gaps = 11/259 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y  +K +G GNF   +L R   T   VA+K I++ +    ++Q   RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L ++MEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL + 
Sbjct: 195 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 242 FVADPSKRIPIPEIKKHPW 260
            V +P KR  + +I K  W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  185 bits (469), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 112/271 (41%), Positives = 153/271 (56%), Gaps = 13/271 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPN 60
           Y+ VK LG G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           II+  +V+ +   + +V+EYA G ELF  I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 135 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DVWSCGV LYVML    PF+D   P  F+     I N  Y LP +  +S     L+ +
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKN----ISNGVYTLPKF--LSPGAAGLIKR 246
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
           + + +P  RI I EI +  WF  +LP+ ++E
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  183 bits (464), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 152/270 (56%), Gaps = 13/270 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPN 60
           Y+ VK LG G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           II+  +V+ +   + +V+EYA G ELF  I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 134 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DVWSCGV LYVML    PF+D   P  F+     I N  Y LP +  +S     L+ +
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKN----ISNGVYTLPKF--LSPGAAGLIKR 245
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           + + +P  RI I EI +  WF  +LP+ ++
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 152/270 (56%), Gaps = 13/270 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPN 60
           Y+ VK LG G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           II+  +V+ +   + +V+EYA G ELF  I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 129 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DVWSCGV LYVML    PF+D   P  F+     I N  Y LP +  +S     L+ +
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKN----ISNGVYTLPKF--LSPGAAGLIKR 240
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           + + +P  RI I EI +  WF  +LP+ ++
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 111/270 (41%), Positives = 152/270 (56%), Gaps = 13/270 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPN 60
           Y+ VK LG G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           II+  +V+ +   + +V+EYA G ELF  I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV++ K Y G 
Sbjct: 125 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DVWSCGV LYVML    PF+D   P  F+     I N  Y LP +  +S     L+ +
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKN----ISNGVYTLPKF--LSPGAAGLIKR 236
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           + + +P  RI I EI +  WF  +LP+ ++
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  179 bits (453), Expect = 3e-45,   Method: Compositional matrix adjust.
 Identities = 105/260 (40%), Positives = 151/260 (58%), Gaps = 11/260 (4%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
           Y   K +G GNF   +L R   T   VAVK I++ +    ++Q   RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           ++  EV+ T   L +VMEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   K+YDG  
Sbjct: 137 HRDLKAENLLLDGDMN--IKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            DVWS GV LY ++ G+ PF    D +N ++  +R+   +Y +P Y  +S DC +LL ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPF----DGQNLKELRERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 242 FVADPSKRIPIPEIKKHPWF 261
            V +P KR  + +I K  W 
Sbjct: 249 LVLNPIKRGSLEQIMKDRWM 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 102/270 (37%), Positives = 148/270 (54%), Gaps = 13/270 (4%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSL 56
           + +RY+ VK+LGSG +G   L +DK T    A+K I++      +    +++     + L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            HPNI++  E      +  +VME   GGELF  I    +FSE +A    +Q++SG +Y H
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH 121
Query: 117 SMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
              I HRDLK EN LL+   +  L KI DFG S    +  + K  +GT  YIAPEVL RK
Sbjct: 122 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RK 180
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSAD 233
           +YD K  DVWSCGV LY++L G  PF    D    ++ + R+   ++    PD+ +VS +
Sbjct: 181 KYDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDE 235
Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            + L+  +   +PSKRI   E   HPW +K
Sbjct: 236 AKQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 148/270 (54%), Gaps = 13/270 (4%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSL 56
           + +RY+ VK+LGSG +G   L +DK T    A+K I++      +    +  E+   + L
Sbjct: 19  LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            HPNI++  E      +  +VME   GGELF  I    +FSE +A    +Q++SG +Y H
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLH 138
Query: 117 SMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
              I HRDLK EN LL+   +  L KI DFG S    +  + K  +GT  YIAPEVL RK
Sbjct: 139 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RK 197
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSAD 233
           +YD K  DVWSCGV LY++L G  PF    D    ++ + R+   ++    PD+ +VS +
Sbjct: 198 KYDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDE 252
Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            + L+  +   +PSKRI   E   HPW +K
Sbjct: 253 AKQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 152/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTPA++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 97/270 (35%), Positives = 152/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D     +     +  + +L  + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDS---XQEYSDWKEKKTYLNPWKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 153/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 125 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 239
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLKK 269

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  164 bits (414), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 151/271 (55%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 242
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 242
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 10/268 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNL 265
           L +I V +PS RI IP+IKK  W+ K L
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 151/271 (55%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 10/268 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNL 265
           L +I V +PS RI IP+IKK  W+ K L
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 10/268 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNL 265
           L +I V +PS RI IP+IKK  W+ K L
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 152/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  +  L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 241
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 152/268 (56%), Gaps = 10/268 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNL 265
           L +I V +PS RI IP+IKK  W+ K L
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 153/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/270 (36%), Positives = 152/270 (56%), Gaps = 10/270 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G  G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 126 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D  + ++  D      Y  P + ++ +    L
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNP-WKKIDSAPLAL 240
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 241 LHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 102/267 (38%), Positives = 141/267 (52%), Gaps = 12/267 (4%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHP 59
           ERY  V  LG G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI++  E+L   +   IV E   GGELF  I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 120 ICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           I HRDLK EN LL+   +   +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRH 236
            K  DVWS GV LY++L G  PF      +N    + R+   +Y   LP +  +S D + 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLK 263
           L+ ++    PS RI   +  +HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 93/271 (34%), Positives = 152/271 (56%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   
Sbjct: 9   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           + ++HPN+I   EV    T + ++ E  AGGELF  +      +E+EA  F +Q+++GV 
Sbjct: 69  KEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 128
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  +  V Y   D  +  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSN 243
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            SA  +  + ++ V DP KR+ I +  +HPW
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 103/308 (33%), Positives = 156/308 (50%), Gaps = 22/308 (7%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKE 66
           LG+G F    L  DKRT++LVA+K I +    GK  + +++ EI     ++HPNI+   +
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           +  +  HL ++M+  +GGELF RI   G ++E +A     Q++  V Y H + I HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 127 LENTL---LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
            EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVLA+K Y  K  D
Sbjct: 144 PENLLYYSLD--EDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVD 200
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
            WS GV  Y++L G  PF D  D + F + +      ++  P +  +S   +  +  +  
Sbjct: 201 CWSIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISDSAKDFIRHLME 258
Query: 244 ADPSKRIPIPEIKKHPWFL------KNLPKEIIEIEKTNYKEAGRDQPTQSVEEI--MRI 295
            DP KR    +  +HPW        KN+ + + E  K N+ ++   Q   +   +  MR 
Sbjct: 259 KDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRHMRK 318
Query: 296 IQEAKMPG 303
           +Q    PG
Sbjct: 319 LQLGHQPG 326

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/267 (38%), Positives = 141/267 (52%), Gaps = 12/267 (4%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHP 59
           ERY  V  LG G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI++  E+L   +   IV E   GGELF  I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 120 ICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           I HRDLK EN LL+   +   +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRH 236
            K  DVWS GV LY++L G  PF      +N    + R+   +Y   LP +  +S D + 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLK 263
           L+ ++    PS RI   +  +HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 102/267 (38%), Positives = 141/267 (52%), Gaps = 12/267 (4%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHP 59
           ERY  V  LG G+FG     +D+ T++  AVK I +     K    + RE+   + L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI++  E+L   +   IV E   GGELF  I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 120 ICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           I HRDLK EN LL+   +   +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRH 236
            K  DVWS GV LY++L G  PF      +N    + R+   +Y   LP +  +S D + 
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLK 263
           L+ ++    PS RI   +  +HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 115/342 (33%), Positives = 167/342 (48%), Gaps = 23/342 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLR 57
           + E Y+ VK+LGSG +G   L RDK T    A+K I +       +  +  E+   + L 
Sbjct: 35  LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI++  +      +  +VME   GGELF  I    +F+E +A    +Q++SGV+Y H 
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 118 MEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HRDLK EN LL+   +  L KI DFG S       + K  +GT  YIAPEVL RK+
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKK 213
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234
           YD K  DVWS GV L+++L G  PF    D    RK    +   +Y    P++  VS   
Sbjct: 214 YDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGA 268
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT-QSVEEIM 293
           + L+ Q+   D  +RI   +  +HPW  +   K          KE+G + P+  +  E M
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK----------KESGIELPSLANAIENM 318
Query: 294 RIIQEAKMPGEATKVAGQGAAGASDPDDMEGDIESEIDASGD 335
           R  Q ++   +A  +       + +      DI   ID +GD
Sbjct: 319 RKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGD 360

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/266 (37%), Positives = 146/266 (54%), Gaps = 14/266 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR-EIINHRSLRHP 59
           + + +E   ELG G   +    + K T++  A+K ++  K +D+ + R EI     L HP
Sbjct: 51  LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHP 108
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NII+ KE+  TPT +++V+E   GGELF RI   G +SE +A    +Q++  V+Y H   
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 120 ICHRDLKLENTLLDGSPQPR--LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           I HRDLK EN LL  +P P   LKI DFG SK        K+  GTP Y APE+L    Y
Sbjct: 169 IVHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPE-DPRNFRKTIDRIRNVQYFL--PDYVRVSADC 234
             ++ D+WS G+  Y++L G  PF D   D   FR    RI N +Y+   P +  VS + 
Sbjct: 228 GPEV-DMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEYYFISPWWDEVSLNA 282
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPW 260
           + L+ ++ V DP KR+   +  +HPW
Sbjct: 283 KDLVRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 147/271 (54%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +E+ YE  +ELGSG F + R  R K T +  A K+I++ +          E ++RE+   
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R +RHPNII   ++    T + +++E  +GGELF  +      +EDEA  F +Q++ GV 
Sbjct: 84  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 143
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS  I H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+
Sbjct: 144 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 203
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRV 230
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y F  +Y   
Sbjct: 204 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSN 258
Query: 231 SAD-CRHLLSQIFVADPSKRIPIPEIKKHPW 260
           +++  +  + ++ V DP +R+ I +  +H W
Sbjct: 259 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 147/271 (54%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +E+ YE  +ELGSG F + R  R K T +  A K+I++ +          E ++RE+   
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R +RHPNII   ++    T + +++E  +GGELF  +      +EDEA  F +Q++ GV 
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS  I H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRV 230
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y F  +Y   
Sbjct: 183 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSN 237
Query: 231 SAD-CRHLLSQIFVADPSKRIPIPEIKKHPW 260
           +++  +  + ++ V DP +R+ I +  +H W
Sbjct: 238 TSELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 137/259 (52%), Gaps = 6/259 (2%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
           +E  + LG+G F    L  +K T +L AVK I +   K  + +++ EI   R ++H NI+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             +++  +P HL +VM+  +GGELF RI   G ++E +A    +Q++  V Y H M I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 123 RDLKLENTL-LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           RDLK EN L      + ++ I DFG SK         +  GTP Y+APEVLA+K Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            D WS GV  Y++L G  PF D  D + F + +      ++  P +  +S   +  +  +
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLFEQILK--AEYEFDSPYWDDISDSAKDFIRNL 260
Query: 242 FVADPSKRIPIPEIKKHPW 260
              DP+KR    +  +HPW
Sbjct: 261 MEKDPNKRYTCEQAARHPW 279

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 92/271 (33%), Positives = 147/271 (54%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINH 53
           +E+ YE  +ELGSG F + R  R K T +  A K+I++ +          E ++RE+   
Sbjct: 10  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R +RHPNII   ++    T + +++E  +GGELF  +      +EDEA  F +Q++ GV 
Sbjct: 70  REIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y HS  I H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+
Sbjct: 130 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRV 230
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y F  +Y   
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSN 244
Query: 231 SAD-CRHLLSQIFVADPSKRIPIPEIKKHPW 260
           +++  +  + ++ V DP +R+ I +  +H W
Sbjct: 245 TSELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  157 bits (397), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 99/300 (33%), Positives = 153/300 (51%), Gaps = 18/300 (6%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKE 66
           LG+G F    L  DKRT++LVA+K I +    GK  + +++ EI     ++HPNI+   +
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           +  +  HL ++M+  +GGELF RI   G ++E +A     Q++  V Y H + I HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 127 LENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            EN L     +  ++ I DFG SK     S   +  GTP Y+APEVLA+K Y  K  D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCW 202
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S GV  Y++L G  PF D  D + F + +      ++  P +  +S   +  +  +   D
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISDSAKDFIRHLMEKD 260
Query: 246 PSKRIPIPEIKKHPWFL------KNLPKEIIEIEKTNYKEAGRDQPTQSVEEI--MRIIQ 297
           P KR    +  +HPW        KN+ + + E  K N+ ++   Q   +   +  MR +Q
Sbjct: 261 PEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVVRHMRKLQ 320

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 147/285 (51%), Gaps = 16/285 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKE 66
           LG+G F    L  DKRT++LVA+K I +    GK  + +++ EI     ++HPNI+   +
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           +  +  HL ++M+  +GGELF RI   G ++E +A     Q++  V Y H + I HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 127 LENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            EN L     +  ++ I DFG SK     S   +  GTP Y+APEVLA+K Y  K  D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCW 202
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S GV  Y++L G  PF D  D + F + +      ++  P +  +S   +  +  +   D
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISDSAKDFIRHLMEKD 260
Query: 246 PSKRIPIPEIKKHPWFL------KNLPKEIIEIEKTNYKEAGRDQ 284
           P KR    +  +HPW        KN+ + + E  K N+ ++   Q
Sbjct: 261 PEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQ 305

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  GE++  +    +F E     +  +L + +SYCHS 
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 133 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 190 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 242
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSK 271

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 90/255 (35%), Positives = 135/255 (52%), Gaps = 10/255 (3%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER----GKKIDENVQREIINHRSLRHPNIIRFKE 66
           LG+G F    L  DKRT++LVA+K I +    GK  + +++ EI     ++HPNI+   +
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           +  +  HL ++M+  +GGELF RI   G ++E +A     Q++  V Y H + I HRDLK
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 127 LENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            EN L     +  ++ I DFG SK     S   +  GTP Y+APEVLA+K Y  K  D W
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCW 202
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S GV  Y++L G  PF D  D + F + +      ++  P +  +S   +  +  +   D
Sbjct: 203 SIGVIAYILLCGYPPFYDENDAKLFEQILK--AEYEFDSPYWDDISDSAKDFIRHLMEKD 260
Query: 246 PSKRIPIPEIKKHPW 260
           P KR    +  +HPW
Sbjct: 261 PEKRFTCEQALQHPW 275

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  154 bits (389), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  GE++  +    +F E     +  +L + +SYCHS 
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 133 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 190 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 242
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSK 271

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 150/276 (54%), Gaps = 10/276 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKID-ENVQREIINHRSLRH 58
           +RY+  + LG G+FG   L +DK T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H  
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 227
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K  DVWS GV LY++L G  PF +  +  +  K +++ +   + LP + +VS   + L
Sbjct: 228 DEK-CDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYT-FELPQWKKVSESAKDL 284
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 273
           + ++    PS RI   +   H W ++   KE I ++
Sbjct: 285 IRKMLTYVPSMRISARDALDHEW-IQTYTKEQISVD 319

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 150/276 (54%), Gaps = 10/276 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKID-ENVQREIINHRSLRH 58
           +RY+  + LG G+FG   L +DK T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H  
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 228
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K  DVWS GV LY++L G  PF +  +  +  K +++ +   + LP + +VS   + L
Sbjct: 229 DEK-CDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYT-FELPQWKKVSESAKDL 285
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 273
           + ++    PS RI   +   H W ++   KE I ++
Sbjct: 286 IRKMLTYVPSMRISARDALDHEW-IQTYTKEQISVD 320

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 101/276 (36%), Positives = 150/276 (54%), Gaps = 10/276 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKID-ENVQREIINHRSLRH 58
           +RY+  + LG G+FG   L +DK T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K  DVWS GV LY++L G  PF +  +  +  K +++ +   + LP + +VS   + L
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYT-FELPQWKKVSESAKDL 261
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 273
           + ++    PS RI   +   H W ++   KE I ++
Sbjct: 262 IRKMLTYVPSMRISARDALDHEW-IQTYTKEQISVD 296

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 25  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 84
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 85  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 144
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 145 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 202 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 254
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWITANSSK 283

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 154 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 211 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 263
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSK 292

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 133 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 190 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 242
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSK 271

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE +  + +D
Sbjct: 133 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 190 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 242
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWITANSSK 271

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 71
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 131
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 132 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 189 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 241
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 242 SRLLKHNPSQRPMLREVLEHPWITANSSK 270

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 34  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 94  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 153
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 154 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 211 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 263
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSK 292

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 129 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 186 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 238
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 129 RVIHRDIKPENLLLGSAGE--LKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 186 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 238
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 66
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 67  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 126
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 127 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 184 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 236
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 237 SRLLKHNPSQRPMLREVLEHPWITANSSK 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 101/278 (36%), Positives = 148/278 (53%), Gaps = 10/278 (3%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKID-ENVQREIINHRSL 56
             +RY+  + LG G+FG   L +DK T +  AVK I +    +K D E++ RE+   + L
Sbjct: 24  FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            HPNI +  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXH 143
Query: 117 SMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
             +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL   
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HG 202
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            YD K  DVWS GV LY++L G  PF +  +  +  K +++ +   + LP + +VS   +
Sbjct: 203 TYDEK-CDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYT-FELPQWKKVSESAK 259
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 273
            L+ +     PS RI   +   H W ++   KE I ++
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEW-IQTYTKEQISVD 296

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 130 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 187 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 239
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSK 268

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  151 bits (382), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 13  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 72
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 73  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 133 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 190 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 242
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSK 271

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 129 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 186 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 238
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSK 267

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K +K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 128 KVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       ++ T  RI  V++  PD+  V+   R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQDTYKRISRVEFTFPDF--VTEGARDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 67
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 68  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 127
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+     GT  Y+ PE++  + +D
Sbjct: 128 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 237
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 238 SRLLKHNPSQRPMLREVLEHPWITANSSK 266

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 10  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 69
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 70  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 129
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI +FG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 130 RVIHRDIKPENLLLGSAGE--LKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V   A  R L+
Sbjct: 187 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFVTEGA--RDLI 239
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSK 268

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 98/263 (37%), Positives = 143/263 (54%), Gaps = 9/263 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKID-ENVQREIINHRSLRH 58
           +RY+  + LG G+FG   L +DK T +  AVK I +    +K D E++ RE+   + L H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H  
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 210
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K  DVWS GV LY++L G  PF +  +  +  K +++ +   + LP + +VS   + L
Sbjct: 211 DEK-CDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYT-FELPQWKKVSESAKDL 267
Query: 238 LSQIFVADPSKRIPIPEIKKHPW 260
           + ++    PS RI   +   H W
Sbjct: 268 IRKMLTYVPSMRISARDALDHEW 290

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K+ K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 64
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 65  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 125 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 182 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 234
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKN 264
           S++   +PS+R  + E+ +HPW   N
Sbjct: 235 SRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 70
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 71  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI +FG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 131 RVIHRDIKPENLLLGSAGE--LKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDF--VTEGARDLI 240
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   +PS+R  + E+ +HPW   N  K
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSK 269

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 136/255 (53%), Gaps = 12/255 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSLRHPNIIRFKEVLL 69
           LGSG F    LV+ + T +L A+K I++     D +++ EI   + ++H NI+  +++  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 70  TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLEN 129
           + TH  +VM+  +GGELF RI   G ++E +A    QQ++S V Y H   I HRDLK EN
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPEN 136
Query: 130 TL-LDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            L L      ++ I DFG SK   +G++     +  GTP Y+APEVLA+K Y  K  D W
Sbjct: 137 LLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVAPEVLAQKPY-SKAVDCW 191
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S GV  Y++L G  PF +  + + F K  +     +   P +  +S   +  +  +   D
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--PFWDDISESAKDFICHLLEKD 249
Query: 246 PSKRIPIPEIKKHPW 260
           P++R    +   HPW
Sbjct: 250 PNERYTCEKALSHPW 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E ++  + LG G FG   L R++++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 132 RVIHRDIKPENLLLGSNGE--LKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 189 EKV-DLWSLGVLCYEFLVGMPPFE----AHTYQETYRRISRVEFTFPDF--VTEGARDLI 241
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   + S+R+ + E+ +HPW   N  K
Sbjct: 242 SRLLKHNASQRLTLAEVLEHPWIKANSSK 270

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 147/269 (54%), Gaps = 14/269 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E ++  + LG G FG   L R++++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSK 131
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL  + +  LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 132 RVIHRDIKPENLLLGSNGE--LKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMHD 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 189 EKV-DLWSLGVLCYEFLVGMPPFE----AHTYQETYRRISRVEFTFPDF--VTEGARDLI 241
Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S++   + S+R+ + E+ +HPW   N  K
Sbjct: 242 SRLLKHNASQRLTLAEVLEHPWIKANSSK 270

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 139/266 (52%), Gaps = 8/266 (3%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
            +  Y+  +ELG G F V R        +  A K I   K   +  + ++RE    R L+
Sbjct: 20  FQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK 79
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +    H  ++ +   GGELF  I +   +SE +A    QQ++  V +CH 
Sbjct: 80  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 139
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
           M + HRDLK EN LL    +   +K+ DFG +       Q      GTP Y++PEVL RK
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RK 198
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +  GK  D+W+CGV LY++LVG  PF D +  R +++   +     +  P++  V+ + +
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAK 256
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWF 261
            L++++   +PSKRI   E  KHPW 
Sbjct: 257 DLINKMLTINPSKRITAAEALKHPWI 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 88/261 (33%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEV 67
           K LG G+F + R    K++ +  AVK I   K+++ N Q+EI   +    HPNI++  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKII--SKRMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                H  +VME   GGELF RI     FSE EA +  ++L+S VS+ H + + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 128 ENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYDGKISDVW 185
           EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L +  YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----YFLPDYVRVSADCRHLLSQ 240
           S GV LY ML G  PF+  +        ++ ++ ++     +    +  VS + + L+  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 241 IFVADPSKRIPIPEIKKHPWF 261
           +   DP+KR+ +  ++ + W 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 141/268 (52%), Gaps = 8/268 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
           M + Y+  +ELG G F V R      T +  A K I   K   +  + ++RE    R L+
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +       +V +   GGELF  I +   +SE +A    QQ++  V++CH 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 118 MEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
             I HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL RK
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RK 180
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +  GK  D+W+CGV LY++LVG  PF D +  R +++   +     +  P++  V+ + +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAK 238
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            L++++   +P+KRI   E  KHPW  +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 141/268 (52%), Gaps = 8/268 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
           M + Y+  +ELG G F V R      T +  A K I   K   +  + ++RE    R L+
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +       +V +   GGELF  I +   +SE +A    QQ++  V++CH 
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHL 121
Query: 118 MEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
             I HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL RK
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RK 180
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +  GK  D+W+CGV LY++LVG  PF D +  R +++   +     +  P++  V+ + +
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAK 238
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLK 263
            L++++   +P+KRI   E  KHPW  +
Sbjct: 239 DLINKMLTINPAKRITASEALKHPWICQ 266

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 145/294 (49%), Gaps = 49/294 (16%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------------------- 43
           +Y    E+G G++GV +L  ++      A+K + + K I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 44  -------ENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAG 94
                  E V +EI   + L HPN+++  EVL  P   HL +V E    G +   + +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPTLK 132
Query: 95  RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSK--- 149
             SED+ARF+FQ LI G+ Y H  +I HRD+K  N L+  DG     +KI DFG S    
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEFK 188
Query: 150 -SGLLHSQPKSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
            S  L S   +TVGTPA++APE L+  RK + GK  DVW+ GVTLY  + G  PF D   
Sbjct: 189 GSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD--- 242
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                    +I++     PD   ++ D + L++++   +P  RI +PEIK HPW
Sbjct: 243 -ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLR 57
           + + Y     +G G++G  ++   K T+   A K I   K   E+V R   EI   +SL 
Sbjct: 24  INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--KYFVEDVDRFKQEIEIMKSLD 81
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNIIR  E     T + +VME   GGELF R+     F E +A    + ++S V+YCH 
Sbjct: 82  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 141
Query: 118 MEICHRDLKLENTL-LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           + + HRDLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL  + 
Sbjct: 142 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 199
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADC 234
             G   D WS GV +YV+L G  PF  P D     + + +IR   +  P  D++ VS   
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQA 255
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 265
             L+ ++    P +RI   +  +H WF K L
Sbjct: 256 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL 286

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 95/271 (35%), Positives = 137/271 (50%), Gaps = 14/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLR 57
           + + Y     +G G++G  ++   K T+   A K I   K   E+V R   EI   +SL 
Sbjct: 7   INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP--KYFVEDVDRFKQEIEIMKSLD 64
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNIIR  E     T + +VME   GGELF R+     F E +A    + ++S V+YCH 
Sbjct: 65  HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 118 MEICHRDLKLENTL-LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           + + HRDLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL  + 
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADC 234
             G   D WS GV +YV+L G  PF  P D     + + +IR   +  P  D++ VS   
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQA 238
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 265
             L+ ++    P +RI   +  +H WF K L
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 141/278 (50%), Gaps = 23/278 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQR 48
           E Y  V++LGSG +G   L ++K      A+K I++ +              K  E +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 49  EIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
           EI   +SL HPNII+  +V     +  +V E+  GGELF +I +  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
           +SG+ Y H   I HRD+K EN LL+  +    +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-- 225
           APEVL +K+Y+ K  DVWSCGV +Y++L G  PF    D    +  I ++   +Y+    
Sbjct: 216 APEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDFN 269
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           D+  +S + + L+  +   D +KR    E     W  K
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  144 bits (364), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 143/265 (53%), Gaps = 12/265 (4%)
Query: 3   ERYEPVKELGSGNFGVAR-LVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR 57
           E Y+  +ELG G F V R  V+    +E  A+  I   KK+     + ++RE    R L+
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAM--IINTKKLSARDHQKLEREARICRLLK 68
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +    H  ++ +   GGELF  I +   +SE +A    QQ++  V +CH 
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
           M + HR+LK EN LL    +   +K+ DFG +       Q      GTP Y++PEVL RK
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RK 187
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +  GK  D+W+CGV LY++LVG  PF D +  R +++   +     +  P++  V+ + +
Sbjct: 188 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAK 245
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPW 260
            L++++   +PSKRI   E  KHPW
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPW 270

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 144/271 (53%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + HPNII   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y   +  + +
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQ 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 141/267 (52%), Gaps = 20/267 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPN 60
           ++ V+ LG G FG   L R+K+ K ++A+K + + +     ++  ++REI     LRHPN
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+R          + +++E+A  GEL+  +   GRF E  +  F ++L   + YCH  ++
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 177
            HRD+K EN L+    +  LKI DFG+S    +H+   + +   GT  Y+ PE++  K +
Sbjct: 136 IHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTH 189
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K+ D+W  GV  Y  LVG  PF+ P      R    RI NV    P +  +S   + L
Sbjct: 190 DEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGSKDL 242
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKN 264
           +S++    P +R+P+  + +HPW   N
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 138/265 (52%), Gaps = 8/265 (3%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
           M + Y+  +++G G F V R      T    A K I   K   +  + ++RE    R L+
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           H NI+R  + +       +V +   GGELF  I +   +SE +A    QQ++  V +CH 
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 121
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
           M + HRDLK EN LL    +   +K+ DFG +       Q      GTP Y++PEVL RK
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-RK 180
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           E  GK  D+W+CGV LY++LVG  PF D ED     + I +     +  P++  V+ + +
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQI-KAGAYDFPSPEWDTVTPEAK 238
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPW 260
           +L++Q+   +P+KRI   E  KHPW
Sbjct: 239 NLINQMLTINPAKRITAHEALKHPW 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 20/263 (7%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRF 64
           + LG G FG   L R+K+ K ++A+K + + +     ++  ++REI     LRHPNI+R 
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    + +++E+A  GEL+  +   GRF E  +  F ++L   + YCH  ++ HRD
Sbjct: 81  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 140
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKI 181
           +K EN L+    +  LKI DFG+S    +H+   + +   GT  Y+ PE++  K +D K+
Sbjct: 141 IKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 194
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            D+W  GV  Y  LVG  PF+ P      R    RI NV    P +  +S   + L+S++
Sbjct: 195 -DLWCAGVLCYEFLVGMPPFDSPSHTETHR----RIVNVDLKFPPF--LSDGSKDLISKL 247
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
               P +R+P+  + +HPW   N
Sbjct: 248 LRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 131/265 (49%), Gaps = 7/265 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLR 57
             + Y+  +ELG G F V R    K T    A K I   K    + Q   RE    R L+
Sbjct: 27  FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HR+LK EN LL    +   +K+ DFG +             GTP Y++PEVL +  
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y   + D+W+CGV LY++LVG  PF D +  R + +   +     Y  P++  V+ + + 
Sbjct: 207 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKS 263
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           L+  +   +P KRI   +  K PW 
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWI 288

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 145/271 (53%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF    D +  ++T+  I +V Y   +  +  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSH 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 93/266 (34%), Positives = 141/266 (53%), Gaps = 16/266 (6%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----R 57
           E +E  K LG G+FG   L   K+T +  A+K +++   + D++V+  ++  R L     
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP +        T  +L  VMEY  GG+L   I S  +F    A F+  ++I G+ + HS
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 137
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKE 176
             I +RDLKL+N LLD      +KI DFG  K  +L  ++     GTP YIAPE+L  ++
Sbjct: 138 KGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y+  + D WS GV LY ML+G  PF   ++   F      IR    F P ++   A  + 
Sbjct: 196 YNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRWLEKEA--KD 248
Query: 237 LLSQIFVADPSKRIPI-PEIKKHPWF 261
           LL ++FV +P KR+ +  +I++HP F
Sbjct: 249 LLVKLFVREPEKRLGVRGDIRQHPLF 274

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   E  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
           +++E ++ LG+G+FG   LV+ K T    A+K +++ K +        +N + ++     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +V+EYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 133/264 (50%), Gaps = 7/264 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
             + Y+  +ELG G F V R    K T    A K I   K   +  + ++RE    R L+
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HR+LK EN LL    +   +K+ DFG +             GTP Y++PEVL +  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y  K  D+W+CGV LY++LVG  PF D +  R + +   +     Y  P++  V+ + + 
Sbjct: 184 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKS 240
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           L+  +   +P KRI   +  K PW
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 133/264 (50%), Gaps = 7/264 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
             + Y+  +ELG G F V R    K T    A K I   K   +  + ++RE    R L+
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 122
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HR+LK EN LL    +   +K+ DFG +             GTP Y++PEVL +  
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y  K  D+W+CGV LY++LVG  PF D +  R + +   +     Y  P++  V+ + + 
Sbjct: 183 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKS 239
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           L+  +   +P KRI   +  K PW
Sbjct: 240 LIDSMLTVNPKKRITADQALKVPW 263

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 133/264 (50%), Gaps = 7/264 (2%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR 57
             + Y+  +ELG G F V R    K T    A K I   K   +  + ++RE    R L+
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 118 MEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             I HR+LK EN LL    +   +K+ DFG +             GTP Y++PEVL +  
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y  K  D+W+CGV LY++LVG  PF D +  R + +   +     Y  P++  V+ + + 
Sbjct: 184 Y-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKS 240
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           L+  +   +P KRI   +  K PW
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPW 264

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I +V Y   +  +  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSH 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +     +  GTP Y+APE++  K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGYN 237
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 289
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 145/278 (52%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 236
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 145/278 (52%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 236
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 145/278 (52%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 129
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y G
Sbjct: 130 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 186
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 239
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 240 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 289
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I +V Y   +  +  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSH 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y   +  + +
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQ 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 144/278 (51%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 236
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 144/278 (51%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 72  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 131
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y G
Sbjct: 132 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 188
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 241
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 242 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 279

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 16/271 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINH 53
           +E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   
Sbjct: 10  VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           R + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+
Sbjct: 70  RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 114 YCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           Y H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVR 229
           +   E  G  +D+WS GV  Y++L GA PF         ++T+  I  V Y   +  + +
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQ 244
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            S   +  + ++ V +  KR+ I E  +HPW
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 153
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 154 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 210 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 261
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 90/261 (34%), Positives = 137/261 (52%), Gaps = 8/261 (3%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNI 61
           Y+  +ELG G F V R    K   +  A K I   K   +  + ++RE    R L+HPNI
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 92
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +R  + +       +V +   GGELF  I +   +SE +A     Q++  V++ H  +I 
Sbjct: 93  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDIV 152
Query: 122 HRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARKEYDG 179
           HRDLK EN LL    +   +K+ DFG +       Q      GTP Y++PEVL RK+  G
Sbjct: 153 HRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVL-RKDPYG 211
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K  D+W+CGV LY++LVG  PF D ED     + I +     +  P++  V+ + ++L++
Sbjct: 212 KPVDIWACGVILYILLVGYPPFWD-EDQHKLYQQI-KAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 240 QIFVADPSKRIPIPEIKKHPW 260
           Q+   +P+KRI   +  KHPW
Sbjct: 270 QMLTINPAKRITADQALKHPW 290

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 144/278 (51%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 236
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 92/278 (33%), Positives = 144/278 (51%), Gaps = 21/278 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           ++ +K LG G FG   LVR+K T    A+K + +   I ++ V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHLL 238
           +  D W  GV +Y M+ G  PF + +  R F   + + IR  +        +S + + LL
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR-------TLSPEAKSLL 236
Query: 239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKEIIE 271
           + +   DP +R+        E+ +H +FL    +++++
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 148 DLIYRDLKPENLLID--EQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 204 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 255
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 141/267 (52%), Gaps = 22/267 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHP 59
           ++ ++ LG+G+FG   L+R +      A+K ++     R K++ E+   E +    + HP
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQV-EHTNDERLMLSIVTHP 66
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR          + ++M+Y  GGELF+ +  + RF    A+F+  ++   + Y HS +
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I +RDLK EN LLD +    +KI DFG++K   +        GTP YIAPEV++ K Y+ 
Sbjct: 127 IIYRDLKPENILLDKNGH--IKITDFGFAK--YVPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
            I D WS G+ +Y ML G  PF D     N  KT ++I N +   P +   + D + LLS
Sbjct: 183 SI-DWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKDLLS 235
Query: 240 QIFVADPSKRI-----PIPEIKKHPWF 261
           ++   D S+R+        ++K HPWF
Sbjct: 236 RLITRDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +  +  GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P + + +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF+E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P + + +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 145/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLIID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 91/260 (35%), Positives = 138/260 (53%), Gaps = 16/260 (6%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIR 63
           K LG G+FG   L   K+T +  A+K +++   + D++V+  ++  R L     HP +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 T  +L  VMEY  GG+L   I S  +F    A F+  ++I G+ + HS  I +R
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           DLKL+N LLD      +KI DFG  K  +L  ++     GTP YIAPE+L  ++Y+  + 
Sbjct: 143 DLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSV- 199
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D WS GV LY ML+G  PF   ++   F      IR    F P ++   A  + LL ++F
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRWLEKEA--KDLLVKLF 253
Query: 243 VADPSKRIPI-PEIKKHPWF 261
           V +P KR+ +  +I++HP F
Sbjct: 254 VREPEKRLGVRGDIRQHPLF 273

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA+K I +        ++ D   NV+ EI 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 243
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 181
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 238 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 289
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA+K I +        ++ D   NV+ EI 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 243
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K +G+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 146
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +  +  GTP Y+APE++  K Y+
Sbjct: 147 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 202
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 203 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 254
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA+K I +        ++ D   NV+ EI 
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 68  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 243
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA+K I +        ++ D   NV+ EI 
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 74  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 132
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 133 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 192
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 249
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 250 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/275 (34%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA+K I +        ++ D   NV+ EI 
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 67  ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 125
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 126 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 185
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 242
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 243 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 84/269 (31%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG +K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +I  H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+ K T    A+K +++ K +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 153
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 154 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 210 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 261
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 155
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 156 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 212 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 263
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 96
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 97  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 156
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 157 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 215
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 216 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 275
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 276 LKTEPTQRMTITEFMNHPWIMQS 298

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 132
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 133 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 192
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 193 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 251
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 252 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 311
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 312 LKTEPTQRMTITEFMNHPWIMQS 334

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+AP ++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 245
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQS 328

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 199
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 259
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 260 LKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 81
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 82  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 141
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 142 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 200
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 201 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 260
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 261 LKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 87
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 88  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 147
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 148 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 206
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 207 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 266
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 267 LKTEPTQRMTITEFMNHPWIMQS 289

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 201
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 261
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 262 LKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 201
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 261
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 262 LKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 88
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 89  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 148
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 149 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 207
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 208 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 267
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 268 LKTEPTQRMTITEFMNHPWIMQS 290

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  137 bits (345), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 86
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 87  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 146
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 147 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 205
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 206 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 265
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 266 LKTEPTQRMTITEFMNHPWIMQS 288

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +K        + +IK H WF
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  137 bits (345), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 139/269 (51%), Gaps = 22/269 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           +E +K LG G FG   LV++K T    A+K +++   + ++ V   +  +R L   RHP 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-ME 119
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           + +RDLKLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y 
Sbjct: 270 VVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY- 326
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHL 237
           G+  D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + L
Sbjct: 327 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP-------EAKSL 379
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           LS +   DP +R+        EI +H +F
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 139/269 (51%), Gaps = 22/269 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           +E +K LG G FG   LV++K T    A+K +++   + ++ V   +  +R L   RHP 
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-ME 119
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   
Sbjct: 213 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 272
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           + +RDLKLEN +LD      +KI DFG  K G+   +  K+  GTP Y+APEVL   +Y 
Sbjct: 273 VVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY- 329
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHL 237
           G+  D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + L
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP-------EAKSL 382
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           LS +   DP +R+        EI +H +F
Sbjct: 383 LSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 142/269 (52%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P + + +      ++L +VMEYA GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEYA GGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN ++D   Q  +++ DFG +K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K +G+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GG++F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 143/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K +G+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GG++F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +K+ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 136/263 (51%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+       TP Y+APEVL  ++YD K  D
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KSCD 199
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 259
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 260 LKTEPTQRMTITEFMNHPWIMQS 282

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 144/269 (53%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP  +APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 10/280 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
           + Y+  +ELG+G FGV   V ++ T    A K++    + D E V++EI     LRHP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   +       + ++ E+ +GGELF ++     + SEDEA  + +Q+  G+ + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            H DLK EN +        LK+ DFG +         K T GT  + APEV   K   G 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GY 335
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLL 238
            +D+WS GV  Y++L G  PF    D    R     +++  + + D  +  +S D +  +
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFI 391
Query: 239 SQIFVADPSKRIPIPEIKKHPWFL-KNLPKEIIEIEKTNY 277
            ++ +ADP+ R+ I +  +HPW    N P    +I  + Y
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 431

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 136/280 (48%), Gaps = 10/280 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
           + Y+  +ELG+G FGV   V ++ T    A K++    + D E V++EI     LRHP +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   +       + ++ E+ +GGELF ++     + SEDEA  + +Q+  G+ + H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 170
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            H DLK EN +        LK+ DFG +         K T GT  + APEV   K   G 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GY 229
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLL 238
            +D+WS GV  Y++L G  PF    D    R     +++  + + D  +  +S D +  +
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFI 285
Query: 239 SQIFVADPSKRIPIPEIKKHPWFL-KNLPKEIIEIEKTNY 277
            ++ +ADP+ R+ I +  +HPW    N P    +I  + Y
Sbjct: 286 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 325

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 138/269 (51%), Gaps = 22/269 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           +E +K LG G FG   LV++K T    A+K +++   + ++ V   +  +R L   RHP 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-ME 119
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   
Sbjct: 71  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 130
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           + +RDLKLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y 
Sbjct: 131 VVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY- 187
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHL 237
           G+  D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + L
Sbjct: 188 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP-------EAKSL 240
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           LS +   DP +R+        EI +H +F
Sbjct: 241 LSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 142/269 (52%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 218 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 269
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 138/269 (51%), Gaps = 22/269 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           +E +K LG G FG   LV++K T    A+K +++   + ++ V   +  +R L   RHP 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-ME 119
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   
Sbjct: 72  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 131
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           + +RDLKLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y 
Sbjct: 132 VVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY- 188
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHL 237
           G+  D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + L
Sbjct: 189 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP-------EAKSL 241
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           LS +   DP +R+        EI +H +F
Sbjct: 242 LSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 94/269 (34%), Positives = 138/269 (51%), Gaps = 22/269 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSL---RHPN 60
           +E +K LG G FG   LV++K T    A+K +++   + ++ V   +  +R L   RHP 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-ME 119
           +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y HS   
Sbjct: 70  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 129
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTVGTPAYIAPEVLARKEYD 178
           + +RDLKLEN +LD      +KI DFG  K G+   +  K   GTP Y+APEVL   +Y 
Sbjct: 130 VVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY- 186
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-DRIRNVQYFLPDYVRVSADCRHL 237
           G+  D W  GV +Y M+ G  PF + +  + F   + + IR  +   P       + + L
Sbjct: 187 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP-------EAKSL 239
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           LS +   DP +R+        EI +H +F
Sbjct: 240 LSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 142/269 (52%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 142/269 (52%), Gaps = 22/269 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           +++E +K LG+G+FG   LV+   T    A+K +++ K +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY  GGE+F+ +   GRF E  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K   +  +     GTP Y+APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID-RIRNVQYFLPDYVRVSADCRHL 237
            K  D W+ GV +Y M  G  PF   +  + + K +  ++R   +F       S+D + L
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF-------SSDLKDL 268
Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +   D +KR       + +IK H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA++ I +        ++ D   NV+ EI 
Sbjct: 147 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 207 ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 265
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 266 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 325
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 382
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 383 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 142/264 (53%), Gaps = 20/264 (7%)
Query: 8   VKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           VKE +G G++   +    K T    AVK I++ K+ D + + EI+  R  +HPNII  K+
Sbjct: 31  VKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITLKD 88
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V     H+ +V E   GGEL  +I     FSE EA F    +   V Y HS  + HRDLK
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLK 148
Query: 127 LENTL-LDGSPQPR-LKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
             N L +D S  P  L+ICDFG++K     +GLL     +   T  ++APEVL R+ YD 
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQLRAENGLL----MTPCYTANFVAPEVLKRQGYD- 203
Query: 180 KISDVWSCGVTLYVMLVGAYPFED-PEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRH 236
           +  D+WS G+ LY ML G  PF + P D     + + RI + ++ L   ++  VS   + 
Sbjct: 204 EGCDIWSLGILLYTMLAGYTPFANGPSDTP--EEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           L+S++   DP +R+   ++ +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 137/275 (49%), Gaps = 18/275 (6%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-------GKKIDE--NVQREII 51
           + + Y   K LGSG  G  +L  +++T + VA++ I +        ++ D   NV+ EI 
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           V Y H   I HRDLK EN LL    +  L KI DFG+SK     S  ++  GTP Y+APE
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311
Query: 171 VLARKEYDG--KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD- 226
           VL      G  +  D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 368
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +  VS     L+ ++ V DP  R    E  +HPW 
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 133/264 (50%), Gaps = 19/264 (7%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNII 62
           +K +G G+FG   L R K  +   AVK +++   + +  ++ I++ R++     +HP ++
Sbjct: 43  LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
                  T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ I +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 162
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGKI 181
           RDLK EN LLD   Q  + + DFG  K  + H+   ST  GTP Y+APEVL ++ YD  +
Sbjct: 163 RDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            D W  G  LY ML G  PF      RN  +  D I N    L   +  SA  RHLL  +
Sbjct: 221 -DWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPNITNSA--RHLLEGL 273
Query: 242 FVADPSKRI----PIPEIKKHPWF 261
              D +KR+       EIK H +F
Sbjct: 274 LQKDRTKRLGAKDDFMEIKSHVFF 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 142/264 (53%), Gaps = 20/264 (7%)
Query: 8   VKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           VKE +G G++   +    K T    AVK I++ K+ D + + EI+  R  +HPNII  K+
Sbjct: 31  VKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKR-DPSEEIEIL-LRYGQHPNIITLKD 88
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           V     H+ +V E   GGEL  +I     FSE EA F    +   V Y HS  + HRDLK
Sbjct: 89  VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLK 148
Query: 127 LENTL-LDGSPQPR-LKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
             N L +D S  P  L+ICDFG++K     +GLL     +   T  ++APEVL R+ YD 
Sbjct: 149 PSNILYVDESGNPECLRICDFGFAKQLRAENGLL----MTPCYTANFVAPEVLKRQGYD- 203
Query: 180 KISDVWSCGVTLYVMLVGAYPFED-PEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRH 236
           +  D+WS G+ LY ML G  PF + P D     + + RI + ++ L   ++  VS   + 
Sbjct: 204 EGCDIWSLGILLYTMLAGYTPFANGPSDTP--EEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           L+S++   DP +R+   ++ +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 127/255 (49%), Gaps = 9/255 (3%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           LG G FG      +  T   +A K I+ RG K  E V+ EI     L H N+I+  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 70  TPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           +   + +VMEY  GGELF RI       +E +   F +Q+  G+ + H M I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 129 NTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCG 188
           N L       ++KI DFG ++      + K   GTP ++APEV+   ++    +D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMWSVG 275
Query: 189 VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADP 246
           V  Y++L G  PF    D     +T++ I   ++ L D  +  +S + +  +S++ + + 
Sbjct: 276 VIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 247 SKRIPIPEIKKHPWF 261
           S RI   E  KHPW 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 134/271 (49%), Gaps = 21/271 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----R 57
           + +E ++ LG G+FG   L R K T +L AVK +++   + D++V+  +   R L     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP + +      TP  L  VME+  GG+L   I  + RF E  ARF+  ++IS + + H 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
             I +RDLKL+N LLD   +   K+ DFG  K G+ +    +T  GTP YIAPE+L    
Sbjct: 143 KGIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y G   D W+ GV LY ML G  PFE      N     + I N +   P ++    D   
Sbjct: 201 Y-GPAVDWWAMGVLLYEMLCGHAPFE----AENEDDLFEAILNDEVVYPTWLH--EDATG 253
Query: 237 LLSQIFVADPSKRIPI------PEIKKHPWF 261
           +L      +P+ R+          I +HP+F
Sbjct: 254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 93/268 (34%), Positives = 141/268 (52%), Gaps = 19/268 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           YE  +++G G++ V +    K T    AVK I++ K+ D   + EI+  R  +HPNII  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNIITL 81
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           K+V     ++ +V E   GGEL  +I     FSE EA      +   V Y H+  + HRD
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 125 LKLENTL-LDGSPQPR-LKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           LK  N L +D S  P  ++ICDFG++K     +GLL     +   T  ++APEVL R+ Y
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL----MTPCYTANFVAPEVLERQGY 197
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED-PEDPRNFRKTIDRIRNVQYFLPD--YVRVSADC 234
           D    D+WS GV LY ML G  PF + P+D     + + RI + ++ L    +  VS   
Sbjct: 198 DAA-CDIWSLGVLLYTMLTGYTPFANGPDDTP--EEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFL 262
           + L+S++   DP +R+    + +HPW +
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  131 bits (329), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 134/260 (51%), Gaps = 15/260 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKE 66
           LG G+F          T   VA+K I++       + + VQ E+  H  L+HP+I+    
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                 ++ +V+E    GE+   + +  + FSE+EAR F  Q+I+G+ Y HS  I HRDL
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDL 138
Query: 126 KLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
            L N LL  +    +KI DFG  ++  + H +  +  GTP YI+PE+  R  + G  SDV
Sbjct: 139 TLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDV 195
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           WS G   Y +L+G  PF    D    + T++++    Y +P ++ + A  + L+ Q+   
Sbjct: 196 WSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFLSIEA--KDLIHQLLRR 249
Query: 245 DPSKRIPIPEIKKHPWFLKN 264
           +P+ R+ +  +  HP+  +N
Sbjct: 250 NPADRLSLSSVLDHPFMSRN 269

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 132/263 (50%), Gaps = 13/263 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IV E   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 127 LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRD 186
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL  ++YD K  D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 245
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
            WS GV  Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 246 XWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNL 305
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R  I E   HPW  ++
Sbjct: 306 LKTEPTQRXTITEFXNHPWIXQS 328

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 149/272 (54%), Gaps = 25/272 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGK-----KIDENVQREIINHRS 55
           ++E +K LG G+FG   LV+       ++L A+K +++       ++   ++R+I+    
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + HP I++      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLAR 174
           HS+ I +RDLK EN LLD   +  +K+ DFG SK  + H +   S  GT  Y+APEV+ R
Sbjct: 144 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +  + +D WS GV ++ ML G  PF+     ++ ++T+  I   +  +P +  +S + 
Sbjct: 202 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 254
Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           + LL  +F  +P+ R+      + EIK+H +F
Sbjct: 255 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 149/272 (54%), Gaps = 25/272 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGK-----KIDENVQREIINHRS 55
           ++E +K LG G+FG   LV+       ++L A+K +++       ++   ++R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + HP I++      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLAR 174
           HS+ I +RDLK EN LLD   +  +K+ DFG SK  + H +   S  GT  Y+APEV+ R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +  + +D WS GV ++ ML G  PF+     ++ ++T+  I   +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           + LL  +F  +P+ R+      + EIK+H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 149/272 (54%), Gaps = 25/272 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGK-----KIDENVQREIINHRS 55
           ++E +K LG G+FG   LV+       ++L A+K +++       ++   ++R+I+    
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + HP I++      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLAR 174
           HS+ I +RDLK EN LLD   +  +K+ DFG SK  + H +   S  GT  Y+APEV+ R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +  + +D WS GV ++ ML G  PF+     ++ ++T+  I   +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           + LL  +F  +P+ R+      + EIK+H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/268 (34%), Positives = 139/268 (51%), Gaps = 19/268 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           YE  +++G G++ V +    K T    AVK I++ K+ D   + EI+  R  +HPNII  
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKR-DPTEEIEIL-LRYGQHPNIITL 81
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           K+V     ++ +V E   GGEL  +I     FSE EA      +   V Y H+  + HRD
Sbjct: 82  KDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 125 LKLENTL-LDGSPQPR-LKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           LK  N L +D S  P  ++ICDFG++K     +GLL     +   T  ++APEVL R+ Y
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL----XTPCYTANFVAPEVLERQGY 197
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED-PEDPRNFRKTIDRIRNVQYFLPD--YVRVSADC 234
           D    D+WS GV LY  L G  PF + P+D     + + RI + ++ L    +  VS   
Sbjct: 198 DAA-CDIWSLGVLLYTXLTGYTPFANGPDDTP--EEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFL 262
           + L+S+    DP +R+    + +HPW +
Sbjct: 255 KDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 136/271 (50%), Gaps = 34/271 (12%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           ++LGSG FG   LV ++ +     +K I  +R +   E ++ EI   +SL HPNII+  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSA---GR-FSEDEARFFFQQLISGVSYCHSMEICH 122
           V     ++ IVME   GGEL  RI SA   G+  SE       +Q+++ ++Y HS  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 123 RDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 179
           +DLK EN L  D SP   +KI DFG ++  L  S   ST   GT  Y+APEV  R   D 
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAE--LFKSDEHSTNAAGTALYMAPEVFKR---DV 202
Query: 180 KIS-DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCR-- 235
               D+WS GV +Y +L G  PF           +++ ++    Y  P+Y   + +CR  
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTG--------TSLEEVQQKATYKEPNY---AVECRPL 251
Query: 236 -----HLLSQIFVADPSKRIPIPEIKKHPWF 261
                 LL Q+   DP +R    ++  H WF
Sbjct: 252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 133/262 (50%), Gaps = 20/262 (7%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L   K T EL AVK +++   I D++V+  ++  R L    + P + +  
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ +  S  I +RDL
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           KL+N +LD   +  +KI DFG  K  +      K   GTP YIAPE++A + Y GK  D 
Sbjct: 148 KLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 204
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PFE  ++   F+  ++   NV Y         A C+ L+++    
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK---- 258
Query: 245 DPSKRIPI-PE----IKKHPWF 261
            P KR+   PE    IK+H +F
Sbjct: 259 HPGKRLGCGPEGERDIKEHAFF 280

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 139/280 (49%), Gaps = 26/280 (9%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L   K T EL AVK +++   I D++V+  ++  R L    + P + +  
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ +  S  I +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           KL+N +LD   +  +KI DFG  K  +      K   GTP YIAPE++A + Y GK  D 
Sbjct: 469 KLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDW 525
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PFE  ++   F+  ++   NV Y         A C+ L+++    
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKSMSKEAVAICKGLMTK---- 579
Query: 245 DPSKRIPI-PE----IKKHPWFLKNLPKEIIEIEKTNYKE 279
            P KR+   PE    IK+H +F        I+ EK   KE
Sbjct: 580 HPGKRLGCGPEGERDIKEHAFF------RYIDWEKLERKE 613

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 149/272 (54%), Gaps = 27/272 (9%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGK-----KIDENVQREIINHRS 55
           +E +K LG G+FG   LVR K T+     L A+K +++       ++   ++R+I+    
Sbjct: 30  FELLKVLGQGSFGKVFLVR-KVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILA--D 86
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + HP +++      T   L +++++  GG+LF R+     F+E++ +F+  +L  G+ + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLAR 174
           HS+ I +RDLK EN LLD   +  +K+ DFG SK  + H +   S  GT  Y+APEV+ R
Sbjct: 147 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    +D WS GV ++ ML G+ PF+     ++ ++T+  I   +  +P +  +S + 
Sbjct: 205 QGHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--LSTEA 257
Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           + LL  +F  +P+ R+        EIK+H ++
Sbjct: 258 QSLLRALFKRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 138/267 (51%), Gaps = 20/267 (7%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPN 60
           +E  + LG G FG   L R+K++  +VA+K + + +     ++  ++REI     L HPN
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+R          + +++EYA  GEL+  +  +  F E       ++L   + YCH  ++
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEY 177
            HRD+K EN LL    +  LKI DFG+S    +H+   + K+  GT  Y+ PE++  + +
Sbjct: 145 IHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEGRMH 198
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           + K+ D+W  GV  Y +LVG  PFE       +R    RI  V    P  V   A  + L
Sbjct: 199 NEKV-DLWCIGVLCYELLVGNPPFESASHNETYR----RIVKVDLKFPASVPTGA--QDL 251
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKN 264
           +S++   +PS+R+P+ ++  HPW   N
Sbjct: 252 ISKLLRHNPSERLPLAQVSAHPWVRAN 278

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 91/301 (30%), Positives = 150/301 (49%), Gaps = 34/301 (11%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHR 54
            E+ YE  + +G G F V R   ++ T +  AVK ++  K         E+++RE     
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAG-RFSEDEARFFFQQLIS 110
            L+HP+I+   E   +   L +V E+  G +L   I     AG  +SE  A  + +Q++ 
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPR-LKICDFGYS----KSGLLHSQPKSTVGTPA 165
            + YCH   I HRD+K EN LL        +K+ DFG +    +SGL+       VGTP 
Sbjct: 142 ALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG---GRVGTPH 198
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           ++APEV+ R+ Y GK  DVW CGV L+++L G  PF   ++     +  + I   +Y + 
Sbjct: 199 FMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMN 252
Query: 226 --DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK--------NLPKEIIEIEKT 275
              +  +S   + L+ ++ + DP++RI + E   HPW  +        +LP+ + ++ K 
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF 312
Query: 276 N 276
           N
Sbjct: 313 N 313

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 134/283 (47%), Gaps = 20/283 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----------ERGKKIDENVQREI-I 51
           E YEP + LG G   V R    K T +  AVK I          E  +++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             +   HPNII+ K+   T T   +V +    GELF  +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           +     D     GK  D+WS GV +Y +L G+ PF   +     R  +    N Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSPE 252
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           +   S   + L+S+  V  P KR    E   HP+F + + +E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 86/262 (32%), Positives = 137/262 (52%), Gaps = 20/262 (7%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-DENVQREIINHRSL----RHPNIIRFK 65
           LG G+FG   L   K T+EL A+K +++   I D++V+  ++  R L    + P + +  
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
               T   L  VMEY  GG+L   I   G+F E +A F+  ++  G+ + H   I +RDL
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDL 146
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           KL+N +LD   +  +KI DFG  K  ++     +   GTP YIAPE++A + Y GK  D 
Sbjct: 147 KLDNVMLDS--EGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GKSVDW 203
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ GV LY ML G  PF+  ++   F+  ++   NV Y         + C+ L+++    
Sbjct: 204 WAYGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICKGLMTK---- 257
Query: 245 DPSKRIPI-PE----IKKHPWF 261
            P+KR+   PE    +++H +F
Sbjct: 258 HPAKRLGCGPEGERDVREHAFF 279

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 133/283 (46%), Gaps = 20/283 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----------ERGKKIDENVQREI-I 51
           E YEP + LG G   V R    K T +  AVK I          E  +++ E   +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             +   HPNII+ K+   T T   +V +    GELF  +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           +     D     GK  D+WS GV +Y +L G+ PF   +     R  +    N Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSPE 252
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           +   S   + L+S+  V  P KR    E   HP+F + + +E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 128/275 (46%), Gaps = 20/275 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----------ERGKKIDENVQREI-I 51
           E YEP + LG G   V R    K T +  AVK I          E  +++ E   +E+ I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             +   HPNII+ K+   T T   +V +    GELF  +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           +     D     GK  D+WS GV +Y +L G+ PF   +     R  +    N Q+  P+
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSPE 239
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +   S   + L+S+  V  P KR    E   HP+F
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 127/261 (48%), Gaps = 9/261 (3%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE-NVQREIINHRSLRHPNIIR 63
           Y+ ++ELGSG FGV     +K T  +   K+I     +D+  V+ EI     L HP +I 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICH 122
             +       + +++E+ +GGELF RI +   + SE E   + +Q   G+ + H   I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
            D+K EN + +      +KI DFG +         K T  T  + APE++ R E  G  +
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYT 231
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQ 240
           D+W+ GV  YV+L G  PF   +D     +T+  ++   +   +  +  VS + +  +  
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 241 IFVADPSKRIPIPEIKKHPWF 261
           +   +P KR+ + +  +HPW 
Sbjct: 288 LLQKEPRKRLTVHDALEHPWL 308

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 131/264 (49%), Gaps = 14/264 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           +RY   + LG G F     + D  TKE+ A K + +   +     E +  EI  H+SL +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P+++ F         + +V+E      L          +E EAR+F +Q I GV Y H+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG +       + K T+ GTP YIAPEVL +K +
Sbjct: 162 RVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGH 219
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             ++ D+WS G  LY +LVG  PFE        ++T  RI+  +Y +P ++   A    L
Sbjct: 220 SFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA--L 272
Query: 238 LSQIFVADPSKRIPIPEIKKHPWF 261
           + ++  ADP+ R  + E+    +F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  121 bits (303), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E YE VK +G G FG  +LVR K T+++ A+K + + + I  +        R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
              HRD+K +N LLD S    LK+ DFG     +K G++     + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKS 248
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   +S
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 306
Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
            + ++L+   F+ D   R+    + EIK+H +F
Sbjct: 307 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 338

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E YE VK +G G FG  +LVR K T+++ A+K + + + I  +        R +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
              HRD+K +N LLD S    LK+ DFG     +K G++     + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKS 248
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   +S
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 306
Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
            + ++L+   F+ D   R+    + EIK+H +F
Sbjct: 307 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 338

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/273 (32%), Positives = 138/273 (50%), Gaps = 22/273 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E YE VK +G G FG  +LVR K T+++ A+K + + + I  +        R +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   HSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
              HRD+K +N LLD S    LK+ DFG     +K G++     + VGTP YI+PEVL  
Sbjct: 188 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKS 243
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   +S
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 301
Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
            + ++L+   F+ D   R+    + EIK+H +F
Sbjct: 302 KEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 14/264 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           +RY   + LG G F     + D  TKE+ A K + +   +     E +  EI  H+SL +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P+++ F         + +V+E      L          +E EAR+F +Q I GV Y H+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +K +
Sbjct: 162 RVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 219
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             ++ D+WS G  LY +LVG  PFE        ++T  RI+  +Y +P ++   A    L
Sbjct: 220 SFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA--L 272
Query: 238 LSQIFVADPSKRIPIPEIKKHPWF 261
           + ++  ADP+ R  + E+    +F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 14/264 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           +RY   + LG G F     + D  TKE+ A K + +   +     E +  EI  H+SL +
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 85
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P+++ F         + +V+E      L          +E EAR+F +Q I GV Y H+ 
Sbjct: 86  PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +K +
Sbjct: 146 RVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGH 203
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             ++ D+WS G  LY +LVG  PFE        ++T  RI+  +Y +P ++   A    L
Sbjct: 204 SFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA--L 256
Query: 238 LSQIFVADPSKRIPIPEIKKHPWF 261
           + ++  ADP+ R  + E+    +F
Sbjct: 257 IRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 130/264 (49%), Gaps = 14/264 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           +RY   + LG G F     + D  TKE+ A K + +   +     E +  EI  H+SL +
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDN 101
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P+++ F         + +V+E      L          +E EAR+F +Q I GV Y H+ 
Sbjct: 102 PHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNN 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +K +
Sbjct: 162 RVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGH 219
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             ++ D+WS G  LY +LVG  PFE        ++T  RI+  +Y +P ++   A    L
Sbjct: 220 SFEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA--L 272
Query: 238 LSQIFVADPSKRIPIPEIKKHPWF 261
           + ++  ADP+ R  + E+    +F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 146/295 (49%), Gaps = 20/295 (6%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-----PNIIR 63
           KELG G F V R    K T +  A K++++ ++  ++ + EI++  ++       P +I 
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVIN 93
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARIC---SAGRFSEDEARFFFQQLISGVSYCHSMEI 120
             EV    + + +++EYAAGGE+F+ +C    A   SE++     +Q++ GV Y H   I
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFS-LCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 121 CHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD- 178
            H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L    YD 
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL---NYDP 209
Query: 179 -GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
               +D+W+ G+  Y++L    PF   ED +     I ++ NV Y    +  VS      
Sbjct: 210 ITTATDMWNIGIIAYMLLTHTSPFVG-EDNQETYLNISQV-NVDYSEETFSSVSQLATDF 267
Query: 238 LSQIFVADPSKRIPIPEI-KKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEE 291
           +  + V +P KR P  EI   H W  +   + +   E+T+     +D   +S E+
Sbjct: 268 IQSLLVKNPEKR-PTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSED 321

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 139/275 (50%), Gaps = 22/275 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVR---DKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           E+Y  ++++G G+FG A LV+   D R   +  +       K  E  +RE+    +++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHS 117
           NI++++E       L IVM+Y  GG+LF RI +     F ED+   +F Q+   + + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 118 MEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVL 172
            +I HRD+K +N  L  DG+ Q    + DFG ++  +L+S     ++ +GTP Y++PE+ 
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQ----LGDFGIAR--VLNSTVELARACIGTPYYLSPEIC 197
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
             K Y+ K SD+W+ G  LY +    + FE         K I        F P  +  S 
Sbjct: 198 ENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-----GSFPPVSLHYSY 251
Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           D R L+SQ+F  +P  R  +  I +  +  K + K
Sbjct: 252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  119 bits (298), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 88/303 (29%), Positives = 148/303 (48%), Gaps = 34/303 (11%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHR 54
            E+ YE  + +G G F V R   ++ T +  AVK ++  K         E+++RE     
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 83
Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAG-RFSEDEARFFFQQLIS 110
            L+HP+I+   E   +   L +V E+  G +L   I     AG  +SE  A  + +Q++ 
Sbjct: 84  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 143
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPR-LKICDFGYS----KSGLLHSQPKSTVGTPA 165
            + YCH   I HRD+K    LL        +K+  FG +    +SGL+       VGTP 
Sbjct: 144 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPH 200
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           ++APEV+ R+ Y GK  DVW CGV L+++L G  PF   ++     +  + I   +Y + 
Sbjct: 201 FMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMN 254
Query: 226 --DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK--------NLPKEIIEIEKT 275
              +  +S   + L+ ++ + DP++RI + E   HPW  +        +LP+ + ++ K 
Sbjct: 255 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF 314
Query: 276 NYK 278
           N +
Sbjct: 315 NAR 317

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 139/273 (50%), Gaps = 22/273 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RH 58
           E Y+ VK +G G FG  +LVR K ++++ A+K + + + I  +        R +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++         +L +VMEY  GG+L   + S     E  A+F+  +++  +   HSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPEKWAKFYTAEVVLALDAIHSM 193
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            + HRD+K +N LLD      LK+ DFG      ++G++H    + VGTP YI+PEVL  
Sbjct: 194 GLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVHCD--TAVGTPDYISPEVLKS 249
Query: 175 K---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+  D WS GV L+ MLVG  PF        + K +D   ++ +  P+   +S
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCF--PEDAEIS 307
Query: 232 ADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
              ++L+   F+ D   R+    + EIK+HP+F
Sbjct: 308 KHAKNLICA-FLTDREVRLGRNGVEEIKQHPFF 339

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 146/301 (48%), Gaps = 34/301 (11%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHR 54
            E+ YE  + +G G F V R   ++ T +  AVK ++  K         E+++RE     
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH 81
Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC----SAGRFSEDEARFFFQQLIS 110
            L+HP+I+   E   +   L +V E+  G +L   I     +   +SE  A  + +Q++ 
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPR-LKICDFGYS----KSGLLHSQPKSTVGTPA 165
            + YCH   I HRD+K    LL        +K+  FG +    +SGL+       VGTP 
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG---GRVGTPH 198
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           ++APEV+ R+ Y GK  DVW CGV L+++L G  PF   ++     +  + I   +Y + 
Sbjct: 199 FMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMN 252
Query: 226 --DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK--------NLPKEIIEIEKT 275
              +  +S   + L+ ++ + DP++RI + E   HPW  +        +LP+ + ++ K 
Sbjct: 253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKF 312
Query: 276 N 276
           N
Sbjct: 313 N 313

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 27/275 (9%)
Query: 3   ERYEPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKI-------DENVQREIIN 52
           E +E ++ LG G +G     R V    T ++ A+K +++   +           +R I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL- 75
Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
              ++HP I+       T   L +++EY +GGELF ++   G F ED A F+  ++   +
Sbjct: 76  -EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 171
            + H   I +RDLK EN +L+   Q  +K+ DFG  K  +       T  GT  Y+APE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           L R  ++  + D WS G  +Y ML GA PF       N +KTID+I   +  LP Y  ++
Sbjct: 193 LMRSGHNRAV-DWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245
Query: 232 ADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
            + R LL ++   + + R+        E++ HP+F
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 137/283 (48%), Gaps = 37/283 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---------RGKKIDENVQREI-IN 52
           ++Y+P   +G G   V R    + T    AVK +E         + +++ E  +RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            +   HP+II   +   + + + +V +    GELF  +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVGTPAYIA 168
           S+ H+  I HRDLK EN LLD + Q RL   DFG+S     H +P    +   GTP Y+A
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLS--DFGFS----CHLEPGEKLRELCGTPGYLA 267
Query: 169 PEVLARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--- 220
           PE+L     +     GK  D+W+CGV L+ +L G+ PF         R+ I  +R +   
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-------RRQILMLRMIMEG 320
Query: 221 --QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             Q+  P++   S+  + L+S++   DP  R+   +  +HP+F
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 134/265 (50%), Gaps = 16/265 (6%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLL 69
           LG G  G       +RT +  A+K +    K     ++E+ +H ++   P+I+   +V  
Sbjct: 18  LGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYE 73
Query: 70  TPTH----LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHR 123
              H    L I+ME   GGELF+RI   G   F+E EA    + + + + + HS  I HR
Sbjct: 74  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 133
Query: 124 DLKLENTLLDGSPQPR-LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           D+K EN L     +   LK+ DFG++K    ++  ++   TP Y+APEVL  ++YD K  
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVLGPEKYD-KSC 191
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQ 240
           D+WS GV +Y++L G  PF              RIR  QY  P+  +  VS D + L+  
Sbjct: 192 DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL 251
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNL 265
           +   DP++R+ I +   HPW  +++
Sbjct: 252 LLKTDPTERLTITQFMNHPWINQSM 276

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 16/265 (6%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLL 69
           LG G  G       +RT +  A+K +    K     ++E+ +H ++   P+I+   +V  
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYE 92
Query: 70  TPTH----LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHR 123
              H    L I+ME   GGELF+RI   G   F+E EA    + + + + + HS  I HR
Sbjct: 93  NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152
Query: 124 DLKLENTLLDGSPQPR-LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           D+K EN L     +   LK+ DFG++K     +  ++   TP Y+APEVL  ++YD K  
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKE-TTQNALQTPCYTPYYVAPEVLGPEKYD-KSC 210
Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQ 240
           D+WS GV +Y++L G  PF              RIR  QY  P+  +  VS D + L+  
Sbjct: 211 DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL 270
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNL 265
           +   DP++R+ I +   HPW  +++
Sbjct: 271 LLKTDPTERLTITQFMNHPWINQSM 295

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 86/313 (27%), Positives = 141/313 (45%), Gaps = 56/313 (17%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHR 54
           ++++Y     +G G++GV R+  + +T+ + A+K + + K      K  E ++ E+   +
Sbjct: 24  LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC-----SAGRFSED---------- 99
            L HPNI R  EV     ++ +VME   GG L  ++      S G+ + D          
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 100 ---------------EARFFFQ----------QLISGVSYCHSMEICHRDLKLENTLLDG 134
                          E+  F Q          Q+ S + Y H+  ICHRD+K EN L   
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 135 SPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPEVL-ARKEYDGKISDVWSC 187
           +    +K+ DFG SK      +G  +    +  GTP ++APEVL    E  G   D WS 
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMT-TKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262
Query: 188 GVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS 247
           GV L+++L+GA PF    D     + ++  + + +  P+Y  +S   R LLS +   +  
Sbjct: 263 GVLLHLLLMGAVPFPGVNDADTISQVLN--KKLCFENPNYNVLSPLARDLLSNLLNRNVD 320
Query: 248 KRIPIPEIKKHPW 260
           +R       +HPW
Sbjct: 321 ERFDAMRALQHPW 333

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 135/275 (49%), Gaps = 27/275 (9%)
Query: 3   ERYEPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKI-------DENVQREIIN 52
           E +E ++ LG G +G     R V    T ++ A+K +++   +           +R I+ 
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL- 75
Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
              ++HP I+       T   L +++EY +GGELF ++   G F ED A F+  ++   +
Sbjct: 76  -EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-PKSTVGTPAYIAPEV 171
            + H   I +RDLK EN +L+   Q  +K+ DFG  K  +          GT  Y+APE+
Sbjct: 135 GHLHQKGIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEI 192
Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           L R  ++  + D WS G  +Y ML GA PF       N +KTID+I   +  LP Y  ++
Sbjct: 193 LMRSGHNRAV-DWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245
Query: 232 ADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
            + R LL ++   + + R+        E++ HP+F
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG +       + K T+ GTP YIAPEVL++K +  ++ DVW
Sbjct: 149 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 206 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAAS--LIQKMLQTD 259
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 260 PTARPTINELLNDEFF 275

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG +       + K T+ GTP YIAPEVL++K +  ++ DVW
Sbjct: 145 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAAS--LIQKMLQTD 255
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 256 PTARPTINELLNDEFF 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 126/256 (49%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG +       + K T+ GTP YIAPEVL++K +  ++ DVW
Sbjct: 145 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAAS--LIQKMLQTD 255
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 256 PTARPTINELLNDEFF 271

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 127 LENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG  +K      + K   GTP YIAPEVL++K +  ++ DVW
Sbjct: 167 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 224 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAAS--LIQKMLQTD 277
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 278 PTARPTINELLNDEFF 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 80/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG +       + K  + GTP YIAPEVL++K +  ++ DVW
Sbjct: 169 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 226 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAAS--LIQKMLQTD 279
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 280 PTARPTINELLNDEFF 295

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 126/268 (47%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 158
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-----STVGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K     S VGT  Y++PE+L  K    
Sbjct: 159 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEKS-AC 213
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 267
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 268 KLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 125/256 (48%), Gaps = 14/256 (5%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKE 66
           LG G F     + D  TKE+ A K + +   +     E +  EI  HRSL H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
                  + +V+E      L          +E EAR++ +Q++ G  Y H   + HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 127 LENTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           L N  L+   +  +KI DFG  +K      + K   GTP YIAPEVL++K +  ++ DVW
Sbjct: 143 LGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G  +Y +LVG  PFE        ++T  RI+  +Y +P ++   A    L+ ++   D
Sbjct: 200 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA--SLIQKMLQTD 253
Query: 246 PSKRIPIPEIKKHPWF 261
           P+ R  I E+    +F
Sbjct: 254 PTARPTINELLNDEFF 269

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 126/268 (47%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 154
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-----STVGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K     S VGT  Y++PE+L  K    
Sbjct: 155 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEKS-AC 209
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 263
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 264 KLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 139/284 (48%), Gaps = 23/284 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHP 59
           ++ ++ +G G++    LVR K+T  + A++ +++      + ID     + +  ++  HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLKL+N LLD   +  +K+ D+G  K GL      ST  GTP YIAPE+L  ++Y 
Sbjct: 174 IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 179 GKISDVWSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           G   D W+ GV ++ M+ G  PF+     D  D          I   Q  +P  + V A 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA- 289
Query: 234 CRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
              +L      DP +R+         +I+ HP+F +N+  +++E
Sbjct: 290 -ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 331

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 158 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 266
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 155
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 156 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 264
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 155
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 156 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 264
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 142/279 (50%), Gaps = 23/279 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGKKIDE-------NVQREIIN 52
           E +E +K LG+G +G   LVR      T +L A+K +++   + +         +R+++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
           H   + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  +
Sbjct: 114 HIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPE 170
            + H + I +RD+KLEN LLD +    + + DFG SK  +     ++    GT  Y+AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 171 VLARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
           ++   +    K  D WS GV +Y +L GA PF   +  +N +  I R R ++   P    
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISR-RILKSEPPYPQE 288
Query: 230 VSADCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLK 263
           +SA  + L+ ++ + DP KR+        EIK+H +F K
Sbjct: 289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 155
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 156 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANAFVGTAQYVSPELLTEKS-AC 210
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 264
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 155
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 156 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 264
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 265 KLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
           E ++  K LG G+F    L R+  T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P  ++          L   + YA  GEL   I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLA 173
            I HRDLK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L 
Sbjct: 152 GIIHRDLKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
            K    K SD+W+ G  +Y ++ G  PF    +   F K I     ++Y  P+  +    
Sbjct: 208 EKS-AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII----KLEYDFPE--KFFPK 260
Query: 234 CRHLLSQIFVADPSKRIPIPE------IKKHPWF 261
            R L+ ++ V D +KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 158 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 266
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 154
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 155 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 209
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 263
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 264 KLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 158
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 159 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 213
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 267
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 268 KLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVME-YAAGGELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 178
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F  
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ 229
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 230 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 158 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 266
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 134 LKPENILLNEDMH--IQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 188
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 242
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
           E ++  K LG G+F    L R+  T    A+K +E+   I EN    V RE      L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P  ++          L   + YA  GEL   I   G F E   RF+  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLA 173
            I HRDLK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L 
Sbjct: 152 GIIHRDLKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 207
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
            K    K SD+W+ G  +Y ++ G  PF    +   F K I     ++Y  P+  +    
Sbjct: 208 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII----KLEYDFPE--KFFPK 260
Query: 234 CRHLLSQIFVADPSKRIPIPE------IKKHPWF 261
            R L+ ++ V D +KR+   E      +K HP+F
Sbjct: 261 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 132
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 133 LKPENILLNEDMH--IQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 187
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 241
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 242 KLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 139
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 140 LKPENILLNEDMH--IQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 194
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 248
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 249 KLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 135
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 136 LKPENILLNEDMH--IQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 190
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 244
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 245 KLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 162
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 163 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 217
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 271
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 272 KLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  GEL   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 134
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L  K    
Sbjct: 135 LKPENILLNEDMH--IQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLTEKS-AC 189
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 243
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 244 KLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 184
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ---RV 232
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 6   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 65
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 66  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 125
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 126 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 183
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ---RV 231
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 213
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 262
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 263 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 179
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F  
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ 230
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 231 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 193
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 242
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 243 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 194
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 243
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 244 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 7   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 66
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 67  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 126
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 127 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 179
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F  
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ 230
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 231 ---RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 5   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 64
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 65  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 124
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 125 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 182
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ---RV 230
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 231 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 273

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 138/284 (48%), Gaps = 23/284 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLRHP 59
           ++ ++ +G G++    LVR K+T  + A+K +++      + ID     + +  ++  HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLKL+N LLD   +  +K+ D+G  K GL      S   GTP YIAPE+L  ++Y 
Sbjct: 142 IIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 198
Query: 179 GKISDVWSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           G   D W+ GV ++ M+ G  PF+     D  D          I   Q  +P  + V A 
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKA- 257
Query: 234 CRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
              +L      DP +R+         +I+ HP+F +N+  +++E
Sbjct: 258 -ASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMME 299

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 221
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F  
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFF-- 270
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 271 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 133/288 (46%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 206
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F  
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFF-- 255
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 256 -RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 131/283 (46%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 179
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ---RV 227
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 139/286 (48%), Gaps = 23/286 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLR 57
           + ++ ++ +G G++    LVR K+T  + A+K +++      + ID     + +  ++  
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
             I +RDLKL+N LLD   +  +K+ D+G  K GL      S   GTP YIAPE+L  ++
Sbjct: 125 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 182
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           Y G   D W+ GV ++ M+ G  PF+     D  D          I   Q  +P  + V 
Sbjct: 183 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 241
Query: 232 ADCRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
           A    +L      DP +R+         +I+ HP+F +N+  +++E
Sbjct: 242 A--ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 284

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 139/286 (48%), Gaps = 23/286 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GKKIDENVQREIINHRSLR 57
           + ++ ++ +G G++    LVR K+T  + A+K +++      + ID     + +  ++  
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
             I +RDLKL+N LLD   +  +K+ D+G  K GL      S   GTP YIAPE+L  ++
Sbjct: 129 RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 186
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFE-----DPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           Y G   D W+ GV ++ M+ G  PF+     D  D          I   Q  +P  + V 
Sbjct: 187 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVK 245
Query: 232 ADCRHLLSQIFVADPSKRI------PIPEIKKHPWFLKNLPKEIIE 271
           A    +L      DP +R+         +I+ HP+F +N+  +++E
Sbjct: 246 A--ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMME 288

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 130/283 (45%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 179
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFFRQ---RV 227
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 228 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 207
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 257
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 258 Q--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 193
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 194 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 242
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 243 -RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 194
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 243
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 244 -RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 206
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 256
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 257 Q--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 207
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 257
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 258 Q--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 130/283 (45%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 179
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F     RV
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQ--RV 227
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 206
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 256
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 257 Q--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 26/268 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHPNIIRF 64
           K LG G+F    L R+  T    A+K +E+   I EN    V RE      L HP  ++ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    L   + YA  G L   I   G F E   RF+  +++S + Y H   I HRD
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-----STVGTPAYIAPEVLARKEYDG 179
           LK EN LL+      ++I DFG +K  +L  + K     S VGT  Y++PE+L  K    
Sbjct: 158 LKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPELLTEKS-AS 212
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P+  +     R L+ 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPE--KFFPKARDLVE 266
Query: 240 QIFVADPSKRIPIPE------IKKHPWF 261
           ++ V D +KR+   E      +K HP+F
Sbjct: 267 KLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 173
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 226
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 227 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 275
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 276 -RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 322

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 130/283 (45%), Gaps = 25/283 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 29  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 88
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 89  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 148
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            V +CH+  + HRD+K EN L+D + +  LK+ DFG S + L  +      GT  Y  PE
Sbjct: 149 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG-SGALLKDTVYTDFDGTRVYSPPE 206
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE  E+          IR   +F     RV
Sbjct: 207 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------IRGQVFF---RQRV 254
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           S +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 297

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 132/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 221
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 222 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 270
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 271 -RQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
           E ++  K LG G+F    L R+  T    A+K +E+   I EN    V RE      L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P  ++          L   + YA  GEL   I   G F E   RF+  +++S + Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-----VGTPAYIAPEVLA 173
            I HRDLK EN LL+      ++I DFG +K  +L  + K       VGT  Y++PE+L 
Sbjct: 155 GIIHRDLKPENILLN--EDMHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPELLT 210
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
            K    K SD+W+ G  +Y ++ G  PF    +   F+K I     ++Y  P        
Sbjct: 211 EKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFP--AAFFPK 263
Query: 234 CRHLLSQIFVADPSKRIPIPE------IKKHPWF 261
            R L+ ++ V D +KR+   E      +K HP+F
Sbjct: 264 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 207
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 257
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 258 Q--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 206
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 207 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 256
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 257 Q--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGAL---LKDTVYTDFDGTRV 207
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F  
Sbjct: 208 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFR 257
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 258 Q--RVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 127/263 (48%), Gaps = 34/263 (12%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----FKE 66
           LG G  G    + +KRT+E  A+K ++   K    V+   ++ R+ + P+I+R    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           +      L IVME   GGELF+RI   G   F+E EA    + +   + Y HS+ I HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 125 LKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
           +K EN L     P   LK+ DFG++K          T G            ++YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKE---------TTG------------EKYD-KSCD 180
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLSQI 241
           +WS GV +Y++L G  PF              RIR  QY  P+  +  VS + + L+  +
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 240
Query: 242 FVADPSKRIPIPEIKKHPWFLKN 264
              +P++R+ I E   HPW +++
Sbjct: 241 LKTEPTQRMTITEFMNHPWIMQS 263

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 131/288 (45%), Gaps = 35/288 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREII 51
           +E +Y+    LGSG FG             VA+K++E+ +  D           ++  ++
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLIS 110
              S     +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++ 
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-----GTPA 165
            V +CH+  + HRD+K EN L+D + +  LK+ DFG   SG L    K TV     GT  
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFG---SGALL---KDTVYTDFDGTRV 194
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP 225
           Y  PE +    Y G+ + VWS G+ LY M+ G  PFE  E         + IR   +F  
Sbjct: 195 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFF-- 243
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
              RVS +C+HL+       P  R    EI+ HPW     LP+E  EI
Sbjct: 244 -RQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 133/275 (48%), Gaps = 34/275 (12%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKI-----DENVQREIINHRSLRHPNIIRFK 65
           LG G++G  + V D  T    AVK +++ K       + NV++EI   R LRH N+I+  
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 66  EVLLT--PTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +VL       + +VMEY   G  E+   +    RF   +A  +F QLI G+ Y HS  I 
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-----SQPKSTVGTPAYIAPEVL-ARK 175
           H+D+K  N LL  +    LKI   G +++  LH        +++ G+PA+  PE+     
Sbjct: 132 HKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAADDTCRTSQGSPAFQPPEIANGLD 187
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC- 234
            + G   D+WS GVTLY +  G YPFE      N  K  + I    Y +P       DC 
Sbjct: 188 TFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYKLFENIGKGSYAIP------GDCG 237
Query: 235 ---RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
                LL  +   +P+KR  I +I++H WF K  P
Sbjct: 238 PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 146/282 (51%), Gaps = 24/282 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  L R+K +   VAVK ++ R ++  E +  E++  R  +H N++   +  
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L ++ME+  GG L   I S  R +E++     + ++  ++Y H+  + HRD+K +
Sbjct: 112 LVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 129 NTL--LDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAYIAPEVLARKEYDGKISDV 184
           + L  LDG    R+K+ DFG+  + +    P  K  VGTP ++APEV++R  Y  ++ D+
Sbjct: 171 SILLTLDG----RVKLSDFGFC-AQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DI 224
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTID----RIRNVQYFLPDYVRVSADCRHLLSQ 240
           WS G+ +  M+ G  P+      +  ++  D    +++N         +VS   R  L +
Sbjct: 225 WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH-------KVSPVLRDFLER 277
Query: 241 IFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEIEKTNYKEAG 281
           + V DP +R    E+  HP+ L+  LP+ ++ + +   K+  
Sbjct: 278 MLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQTS 319

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 105/208 (50%), Gaps = 11/208 (5%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRS 55
           + ERY+ V +LG G      L  D      VA+K I     E+ + + +  +RE+ N   
Sbjct: 9   INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQ 67
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           L H NI+   +V        +VMEY  G  L   I S G  S D A  F  Q++ G+ + 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHA 127
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLA 173
           H M I HRD+K +N L+D +    LKI DFG +K  S    +Q    +GT  Y +PE  A
Sbjct: 128 HDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QA 184
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           + E   + +D++S G+ LY MLVG  PF
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 218 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 277 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 331
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 332 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 388
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 389 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 420

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 141 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 200 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 254
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 255 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 311
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 312 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 343

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 128/246 (52%), Gaps = 12/246 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           LG G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 70  TPTHLAIVMEYAAGGELFARICSA-GRFSEDEAR--FFFQQLISGVSYCHSMEICHRDLK 126
               + I ME   GG L A + S  G   ++E    F+ +Q++ G+ Y H  +I HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 127 LENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISD 183
            +N L++ +    LKI DFG SK    ++   ++  GT  Y+APE++ +  + Y GK +D
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 207
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
           +WS G T+  M  G  PF +  +P+     +   + V   +P+   +SA+ +  + + F 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-VHPEIPE--SMSAEAKAFILKCFE 264
Query: 244 ADPSKR 249
            DP KR
Sbjct: 265 PDPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 128/246 (52%), Gaps = 12/246 (4%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           LG G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NI+++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 70  TPTHLAIVMEYAAGGELFARICSA-GRFSEDEAR--FFFQQLISGVSYCHSMEICHRDLK 126
               + I ME   GG L A + S  G   ++E    F+ +Q++ G+ Y H  +I HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 127 LENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISD 183
            +N L++ +    LKI DFG SK    ++   ++  GT  Y+APE++ +  + Y GK +D
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 193
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFV 243
           +WS G T+  M  G  PF +  +P+     +   + V   +P+   +SA+ +  + + F 
Sbjct: 194 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-VHPEIPE--SMSAEAKAFILKCFE 250
Query: 244 ADPSKR 249
            DP KR
Sbjct: 251 PDPDKR 256

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 96  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 154
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 155 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 209
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 210 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 266
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 267 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 298

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 128/271 (47%), Gaps = 30/271 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE---------NVQREIINH 53
           ++Y  +  LGSG FG      DK   + V VK+I++ K +++          V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVME-YAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
             + H NII+  ++        +VME + +G +LFA I    R  E  A + F+QL+S V
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG---YSKSGLLHSQPKSTVGTPAYIAP 169
            Y    +I HRD+K EN ++  +    +K+ DFG   Y + G L     +  GT  Y AP
Sbjct: 144 GYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFY---TFCGTIEYCAP 198
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
           EVL    Y G   ++WS GVTLY ++    PF + E+      T++   +  Y       
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYL------ 246
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           VS +   L+S +    P +R  + ++   PW
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 98  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 156
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 157 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 211
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 212 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 268
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 269 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 300

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 91  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 149
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 150 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 204
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 205 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 261
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 262 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 293

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 142/272 (52%), Gaps = 14/272 (5%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +   + + +LVAVK ++ R ++  E +  E++  R  +H N++      
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +S  H+  + HRD+K +
Sbjct: 87  LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 145
Query: 129 NTLL--DGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           + LL  DG    R+K+ DFG+ ++      + K  VGTP ++APE+++R  Y  ++ D+W
Sbjct: 146 SILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV-DIW 200
Query: 186 SCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVAD 245
           S G+ +  M+ G  P+ + E P    K I    N+   L +  +VS   +  L ++ V D
Sbjct: 201 SLGIMVIEMVDGEPPYFN-EPPLKAMKMIRD--NLPPRLKNLHKVSPSLKGFLDRLLVRD 257
Query: 246 PSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTN 276
           P++R    E+ KHP+  K   P  I+ + + N
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPASIVPLMRQN 289

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 137/260 (52%), Gaps = 18/260 (6%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           ++G G+ G+  +  +K T + VAVK ++ R ++  E +  E++  R   H N++      
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
           L    L +VME+  GG L   I +  R +E++       ++  +SY H+  + HRD+K +
Sbjct: 112 LVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 170
Query: 129 NTLLDGSPQPRLKICDFGY-SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSC 187
           + LL  +   R+K+ DFG+ ++      + K  VGTP ++APEV++R  Y  ++ D+WS 
Sbjct: 171 SILL--TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV-DIWSL 227
Query: 188 GVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP----DYVRVSADCRHLLSQIFV 243
           G+ +  M+ G  P+ + E P      +  +R ++  LP    D  +VS+  R  L  + V
Sbjct: 228 GIMVIEMIDGEPPYFN-EPP------LQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLV 280
Query: 244 ADPSKRIPIPEIKKHPWFLK 263
            +PS+R    E+  HP FLK
Sbjct: 281 REPSQRATAQELLGHP-FLK 299

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/258 (32%), Positives = 123/258 (47%), Gaps = 35/258 (13%)
Query: 31  VAVKYIERGKKID-------ENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAIVMEYA 81
           VA+K++E+ +  D         V  E++  + +      +IR  +    P    +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 82  AG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL 140
               +LF  I   G   E+ AR FF Q++  V +CH+  + HRD+K EN L+D + +  L
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGEL 197
Query: 141 KICDFGYSKSGLLHSQPKSTV-----GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
           K+ DFG   SG L    K TV     GT  Y  PE +    Y G+ + VWS G+ LY M+
Sbjct: 198 KLIDFG---SGAL---LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251
Query: 196 VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
            G  PFE  E+          IR   +F     RVS++C+HL+       PS R    EI
Sbjct: 252 CGDIPFEHDEEI---------IRGQVFF---RQRVSSECQHLIRWCLALRPSDRPTFEEI 299
Query: 256 KKHPWFLKN-LPKEIIEI 272
           + HPW     LP+E  EI
Sbjct: 300 QNHPWMQDVLLPQETAEI 317

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 14/270 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  ++ +G G+FG      D RT+++VA+K I+    +   E++Q+EI         
Sbjct: 22  EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSS 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  + L I+MEY  GG     +  AG F E +     ++++ G+ Y HS +
Sbjct: 82  YVTKYYGSYLKGSKLWIIMEYLGGGSAL-DLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S Q  +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 141 KIHRDIKAANVLL--SEQGDVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K +D+WS G+T   +  G  P  D   P      I +  N    + D+ +     +  
Sbjct: 198 DSK-ADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPK-NNPPTLVGDFTK---SFKEF 251
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           +      DPS R    E+ KH + +KN  K
Sbjct: 252 IDACLNKDPSFRPTAKELLKHKFIVKNSKK 281

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 142/297 (47%), Gaps = 20/297 (6%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 62
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 123 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------LPDYVR 229
           Y  + SD+WS G++L  M VG YP   P+   + R  +     + Y        LP  V 
Sbjct: 180 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV- 237
Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 286
            S + +  +++  + +P++R  + ++  H  F+K    E ++         G +QP+
Sbjct: 238 FSLEFQDFVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEVDFAGWLCSTIGLNQPS 293

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 117/274 (42%), Gaps = 28/274 (10%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIIN-------- 52
            E  Y     LG G FG          +  VA+K I R + +  +   + +         
Sbjct: 29  FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 53  ---HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGE-LFARICSAGRFSEDEARFFFQQL 108
                   HP +IR  +   T     +V+E     + LF  I   G   E  +R FF Q+
Sbjct: 89  WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYI 167
           ++ + +CHS  + HRD+K EN L+D   +   K+ DFG     LLH +P +   GT  Y 
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLR-RGCAKLIDFG--SGALLHDEPYTDFDGTRVYS 205
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
            PE ++R +Y    + VWS G+ LY M+ G  PFE  ++          I   +   P +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------ILEAELHFPAH 255
Query: 228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             VS DC  L+ +     PS R  + EI   PW 
Sbjct: 256 --VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 80/266 (30%), Positives = 133/266 (50%), Gaps = 14/266 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+ +   + F    +         + +  QL+ G+++CHS 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK EN L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 124 RVLHRDLKPENLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 134/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+ +   + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK EN L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPENLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 133/266 (50%), Gaps = 14/266 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            HR++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ RK Y
Sbjct: 139 IHRNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 194
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 195 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 250
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 20  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 79
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 80  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 138
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +S  VGTP ++APEV+ RK Y
Sbjct: 139 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 195 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 250
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +S  VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQ-FLK 274

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 130 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK EN L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 125 RVLHRDLKPENLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK EN L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 124 RVLHRDLKPENLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 8/268 (2%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           E+Y   ++LG G FG+     +  +K+    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
              E   +   L ++ E+ +G ++F RI  SA   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           H D++ EN +        +KI +FG ++        +     P Y APEV  + +     
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTA 183
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLS 239
           +D+WS G  +YV+L G  PF    +    ++ I+ I N +Y   +  +  +S +    + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 240 QIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           ++ V +   R+   E  +HPW  + + +
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIER 267

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+S+CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 132/266 (49%), Gaps = 14/266 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 121 CHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLARKEY 177
            HRD+K +N LL  DGS    +K+ DFG+          +S  VGTP ++APEV+ RK Y
Sbjct: 138 IHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             K+ D+WS G+    M+ G  P+ + E+P   R       N    L +  ++SA  R  
Sbjct: 194 GPKV-DIWSLGIMAIEMIEGEPPYLN-ENP--LRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK 263
           L++    D  KR    E+ +H  FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 20/282 (7%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
           E+ +E + ELG G FG     ++K T  L A K I+ + ++  E+   EI    S  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++  +      +L I++E+ AGG + A +    R  +E + +   +Q +  ++Y H  +
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 120 ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLA--- 173
           I HRDLK  N L  LDG     +K+ DFG S       Q + S +GTP ++APEV+    
Sbjct: 156 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCET 211
Query: 174 --RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRV 230
              + YD K +DVWS G+TL  M       E P    N  + + +I   +   L    R 
Sbjct: 212 SKDRPYDYK-ADVWSLGITLIEMA----EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           S++ +  L +    +   R    ++ +HP+   +  K I E+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+ +   + F    +         + +  QL+ G+++CHS 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 125 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 25/277 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
           E YE +  +G+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 60  NIIRFKEVLL--TPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
           NI+R+ + ++  T T L IVMEY  GG+L + I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 114 YCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAY 166
            CH        + HRDLK  N  LDG  +  +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARI-LNHDTSFAKTFVGTPYY 182
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           ++PE + R  Y+ K SD+WS G  LY +     PF         ++   +IR  ++    
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIP 237
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           Y R S +   +++++       R  + EI ++P  L+
Sbjct: 238 Y-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 136/282 (48%), Gaps = 20/282 (7%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
           E+ +E + ELG G FG     ++K T  L A K I+ + ++  E+   EI    S  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++  +      +L I++E+ AGG + A +    R  +E + +   +Q +  ++Y H  +
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 120 ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLA--- 173
           I HRDLK  N L  LDG     +K+ DFG S       Q + S +GTP ++APEV+    
Sbjct: 156 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 211
Query: 174 --RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRV 230
              + YD K +DVWS G+TL  M       E P    N  + + +I   +   L    R 
Sbjct: 212 SKDRPYDYK-ADVWSLGITLIEMA----EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           S++ +  L +    +   R    ++ +HP+   +  K I E+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK EN L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPENLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 25/277 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
           E YE +  +G+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 60  NIIRFKEVLL--TPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
           NI+R+ + ++  T T L IVMEY  GG+L + I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 114 YCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKSTVGTPAY 166
            CH        + HRDLK  N  LDG  +  +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARI-LNHDTSFAKAFVGTPYY 182
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           ++PE + R  Y+ K SD+WS G  LY +     PF         ++   +IR  ++    
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIP 237
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           Y R S +   +++++       R  + EI ++P  L+
Sbjct: 238 Y-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+ +   + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 127 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 124 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 130 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 248 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
           E YE +  +G+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 60  NIIRFKEVLL--TPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
           NI+R+ + ++  T T L IVMEY  GG+L + I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 114 YCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PKSTVGTPAY 166
            CH        + HRDLK  N  LDG  +  +K+ DFG ++  L H +   K  VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARI-LNHDEDFAKEFVGTPYY 182
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           ++PE + R  Y+ K SD+WS G  LY +     PF         ++   +IR  ++    
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIP 237
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           Y R S +   +++++       R  + EI ++P  L+
Sbjct: 238 Y-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 124 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 127 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 245 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 125 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 126 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 244 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 64
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 125 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 243 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 135/282 (47%), Gaps = 20/282 (7%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPN 60
           E+ +E + ELG G FG     ++K T  L A K I+ + ++  E+   EI    S  HPN
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++  +      +L I++E+ AGG + A +    R  +E + +   +Q +  ++Y H  +
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 120 ICHRDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA--- 173
           I HRDLK  N L  LDG     +K+ DFG S       Q +   +GTP ++APEV+    
Sbjct: 156 IIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 174 --RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRV 230
              + YD K +DVWS G+TL  M       E P    N  + + +I   +   L    R 
Sbjct: 212 SKDRPYDYK-ADVWSLGITLIEMA----EIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 266
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           S++ +  L +    +   R    ++ +HP+   +  K I E+
Sbjct: 267 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 308

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 124 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 242 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 133/287 (46%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           E+ +  ++E+G G+FG     RD R  E+VA+K +   GK+ +E  Q   +E+   + LR
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I+++   L      +VMEY  G              E E        + G++Y HS
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 118 MEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA--- 173
             + HRD+K  N LL    +P L K+ DFG   S  + +     VGTP ++APEV+    
Sbjct: 173 HNMIHRDVKAGNILLS---EPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMD 226
Query: 174 RKEYDGKISDVWSCGVT 190
             +YDGK+ DVWS G+T
Sbjct: 227 EGQYDGKV-DVWSLGIT 242

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 135/274 (49%), Gaps = 13/274 (4%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 24  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 81
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH- 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 142 KHKIMHRDVKPSNILVN--SRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 198
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-QYFLPDYVRVSADCR 235
           Y  + SD+WS G++L  M VG YP           + +D I N     LP  V  S + +
Sbjct: 199 YSVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV-FSLEFQ 256
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
             +++  + +P++R  + ++  H +  ++  +E+
Sbjct: 257 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQ---REIINHRSLR 57
           E+ +  ++E+G G+FG     RD R  E+VA+K +   GK+ +E  Q   +E+   + LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I+++   L      +VMEY  G              E E        + G++Y HS
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---R 174
             + HRD+K  N LL  S    +K+ DFG   S  + +     VGTP ++APEV+     
Sbjct: 134 HNMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDE 188
Query: 175 KEYDGKISDVWSCGVT 190
            +YDGK+ DVWS G+T
Sbjct: 189 GQYDGKV-DVWSLGIT 203

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
           E +E +K +G G FG   +V+ K T+ + A+K + + + +          +R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
           +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  +   
Sbjct: 150 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
           H +   HRD+K +N LLD +   RL   DFG     +  G +  Q    VGTP YI+PE+
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRL--ADFGSCLKMNDDGTV--QSSVAVGTPDYISPEI 263
Query: 172 L-ARKEYDGKIS---DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           L A ++  GK     D WS GV +Y ML G  PF        + K ++     Q+  P +
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF--PSH 321
Query: 228 VR-VSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
           V  VS + + L+ ++ +    +R+    I + KKH +F
Sbjct: 322 VTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF 358

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 134/278 (48%), Gaps = 28/278 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE------NVQREIINHRSL 56
           E +E +K +G G FG   +V+ K T+ + A+K + + + +          +R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
           +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  +   
Sbjct: 134 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEV 171
           H +   HRD+K +N LLD +   RL   DFG     +  G +  Q    VGTP YI+PE+
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRL--ADFGSCLKMNDDGTV--QSSVAVGTPDYISPEI 247
Query: 172 L-ARKEYDGKIS---DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           L A ++  GK     D WS GV +Y ML G  PF        + K ++     Q+  P +
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF--PSH 305
Query: 228 VR-VSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
           V  VS + + L+ ++ +    +R+    I + KKH +F
Sbjct: 306 VTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF 342

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 28/277 (10%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I+    +   E++Q+EI        P
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 85
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 86  YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S    +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 145 KIHRDIKAANVLL--SEHGEVKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRV 230
           D K +D+WS G+T   +  G  P  +          P+N   T++               
Sbjct: 202 DSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NY 248
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S   +  +      +PS R    E+ KH + L+N  K
Sbjct: 249 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 285

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 28/277 (10%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I+    +   E++Q+EI        P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S    +K+ DFG +   L  +Q K    VGTP ++APEV+ +  Y
Sbjct: 140 KIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRV 230
           D K +D+WS G+T   +  G  P  +          P+N   T++               
Sbjct: 197 DSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NY 243
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           S   +  +      +PS R    E+ KH + L+N  K
Sbjct: 244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 133/277 (48%), Gaps = 28/277 (10%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I+    +   E++Q+EI        P
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S    +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 125 KIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRV 230
           D K +D+WS G+T   +  G  P  +          P+N   T++   N    L ++V  
Sbjct: 182 DSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE--GNYSKPLKEFVEA 238
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
             +           +PS R    E+ KH + L+N  K
Sbjct: 239 CLN----------KEPSFRPTAKELLKHKFILRNAKK 265

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 138/298 (46%), Gaps = 31/298 (10%)
Query: 1   MEERYEPVKEL-GSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIIN-HRSLR 57
            E+ Y+   EL G G +   +     +  +  AVK IE+        V RE+   ++   
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           + NI+   E     T   +V E   GG + A I     F+E EA    + + + + + H+
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHT 129
Query: 118 MEICHRDLKLENTLLDGSPQPR--LKICDFGYSKSGLLHSQ--PKST------VGTPAYI 167
             I HRDLK EN L + SP+    +KICDF       L++   P +T       G+  Y+
Sbjct: 130 KGIAHRDLKPENILCE-SPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 168 APEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPF----------EDPEDPRNFR-K 212
           APEV+     +  +  K  D+WS GV LY+ML G  PF          +  E  R  + K
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 248
Query: 213 TIDRIRNVQYFLP--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
             + I+  +Y  P  D+  +S++ + L+S++ V D  +R+   ++ +HPW     P++
Sbjct: 249 LFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEK 306

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 134/289 (46%), Gaps = 34/289 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           ++YE ++++G G +G     +++ T E+VA+K + R    DE V     REI   + L+H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            NI+R  +VL +   L +V E+     + +   C+ G    +  + F  QL+ G+ +CHS
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 176
             + HRDLK +N L++ + +  LK+ DFG +++ G+      + V T  Y  P+VL   +
Sbjct: 120 RNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------QYFLPDYV 228
                 D+WS G     +   A P     D  +  K I R+              LPDY 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 229 ----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                           +++A  R LL  +   +P +RI   E  +HP+F
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 132/277 (47%), Gaps = 28/277 (10%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I+    +   E++Q+EI        P
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S    +K+ DFG +   L  +Q K    VGTP ++APEV+ +  Y
Sbjct: 125 KIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED-------PRNFRKTIDRIRNVQYFLPDYVRV 230
           D K +D+WS G+T   +  G  P  +          P+N   T++   N    L ++V  
Sbjct: 182 DSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE--GNYSKPLKEFVEA 238
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
             +           +PS R    E+ KH + L+N  K
Sbjct: 239 CLN----------KEPSFRPTAKELLKHKFILRNAKK 265

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+  I      + +     REI   + L HP
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 123 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 241 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 132/287 (45%), Gaps = 30/287 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+  I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++ G+        V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLINT--EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFE-DPEDPRNFR--KTIDRIRNVQY----FLPDYV-- 228
                D+WS G     M+     F  D E  + FR  +T+     V +     +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +  D R LLSQ+   DP+KRI       HP+F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHP 59
           EE +  +  +G G+FG      D  TKE+VA+K I+    +   E++Q+EI        P
Sbjct: 18  EELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            I R+    L  T L I+MEY  GG     +   G   E       ++++ G+ Y HS  
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSER 136
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEY 177
             HRD+K  N LL  S Q  +K+ DFG +   L  +Q K    VGTP ++APEV+ +  Y
Sbjct: 137 KIHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
           D K +D+WS G+T   +  G  P  D
Sbjct: 194 DFK-ADIWSLGITAIELAKGEPPNSD 218

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 67  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 124
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 185 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 241
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 242 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 62
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 123 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 180 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 62
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 123 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 180 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 89
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 150 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 206
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 234

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 62
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 123 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 180 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 62
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 123 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTH 179
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  M VG YP   P+
Sbjct: 180 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 28/288 (9%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREI-INHRSLRHPNIIRFKEVL 68
           LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N++   E  
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
                  +V E   GG + + I     F+E EA    Q + S + + H+  I HRDLK E
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 129 NTLLDGSPQPR-LKICDFGYSKSGLLH--SQPKST------VGTPAYIAPEVLARKEYDG 179
           N L +   Q   +KICDFG      L+    P ST       G+  Y+APEV+     + 
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 180 KI----SDVWSCGVTLYVMLVGAYPF-----------EDPEDPRNFRKTIDRIRNVQYFL 224
            I     D+WS GV LY++L G  PF                P       + I+  +Y  
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 225 P--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           P  D+  +S   + L+S++ V D  +R+   ++ +HPW     P+  +
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 18/291 (6%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    +I   ++ +II    + H   
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECN 65
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y   
Sbjct: 66  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+       VGT +Y++PE L    
Sbjct: 126 KHKIMHRDVKPSNILVNS--RGEIKLCDFGVSGQ-LIDEMANEFVGTRSYMSPERLQGTH 182
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLPDYVRVSADCR 235
           Y  + SD+WS G++L  M VG Y    P  P    + +D I N     LP  V  S + +
Sbjct: 183 YSVQ-SDIWSMGLSLVEMAVGRY----PRPPMAIFELLDYIVNEPPPKLPSAV-FSLEFQ 236
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 286
             +++  + +P++R  + ++  H  F+K    E ++         G +QP+
Sbjct: 237 DFVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEVDFAGWLCSTIGLNQPS 286

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 8/205 (3%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRH 58
           + +E ++ +G G+FG   +V+   TK++ A+KY+ + K ++ N  R +       + L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P ++           + +V++   GG+L   +     F E+  + F  +L+  + Y  + 
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            I HRD+K +N LLD      + I DF  +      +Q  +  GT  Y+APE+ + ++  
Sbjct: 135 RIIHRDMKPDNILLD--EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 179 GK--ISDVWSCGVTLYVMLVGAYPF 201
           G     D WS GVT Y +L G  P+
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 32/288 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           ++YE ++++G G +G     +++ T E+VA+K + R    DE V     REI   + L+H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            NI+R  +VL +   L +V E+             G    +  + F  QL+ G+ +CHS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEY 177
            + HRDLK +N L++ + +  LK+ +FG +++ G+      + V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------QYFLPDYV- 228
                D+WS G     +     P     D  +  K I R+              LPDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 229 ---------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                          +++A  R LL  +   +P +RI   E  +HP+F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + H+  + +R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 369
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
             +D +S G  L+ +L G  PF   +     +  IDR+   +   LPD    S + R LL
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 425
Query: 239 SQIFVADPSKRIPI-----PEIKKHPWFLKNLPKEIIEIEK 274
             +   D ++R+        E+K+ P+F ++L  +++ ++K
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 465

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + H+  + +R
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 315
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 316 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 368
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
             +D +S G  L+ +L G  PF   +     +  IDR+   +   LPD    S + R LL
Sbjct: 369 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 424
Query: 239 SQIFVADPSKRIPI-----PEIKKHPWFLKNLPKEIIEIEK 274
             +   D ++R+        E+K+ P+F ++L  +++ ++K
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 464

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 126/276 (45%), Gaps = 24/276 (8%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQRE----IINHRS 55
           E +E +K +G G FG   +V+ K   ++ A+K + +    K+ +    RE    ++N  S
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSY 114
                I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +  
Sbjct: 134 ---KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEV 171
            H +   HRD+K +N L+D +   RL   DFG S   L+     Q    VGTP YI+PE+
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLA--DFG-SCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 172 LARKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           L   E      G   D WS GV +Y ML G  PF        + K ++     Q F    
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ-FPTQV 306
Query: 228 VRVSADCRHLLSQIFVADPSK--RIPIPEIKKHPWF 261
             VS + + L+ ++  +   +  +  I + KKHP+F
Sbjct: 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 35/274 (12%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           EE ++ +++LG G++G       K T ++VA+K +     + E + +EI   +    P++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII-KEISIMQQCDSPHV 86
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEI 120
           +++       T L IVMEY   G +   I    +  +EDE     Q  + G+ Y H M  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HSQPKSTVGTPAYIAPEVLARKEY 177
            HRD+K  N LL+   +   K+ DFG   +G L    ++    +GTP ++APEV+    Y
Sbjct: 147 IHRDIKAGNILLN--TEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED----------PED-PRNFRKTIDRIRNVQYFLPD 226
           +  ++D+WS G+T   M  G  P+ D          P + P  FRK            P+
Sbjct: 203 NC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------------PE 249
Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
               S +    + Q  V  P +R    ++ +HP+
Sbjct: 250 L--WSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + H+  + +R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 369
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
             +D +S G  L+ +L G  PF   +     +  IDR+   +   LPD    S + R LL
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 425
Query: 239 SQIFVADPSKRIPI-----PEIKKHPWFLKNLPKEIIEIEK 274
             +   D ++R+        E+K+ P+F ++L  +++ ++K
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 465

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-------PNIIR 63
           +G G FG     R   T ++ A+K +++ +   +  +   +N R +         P I+ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
                 TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + H+  + +R
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYR 316
Query: 124 DLKLENTLLDGSPQPRLK----ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 317 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 369
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHLL 238
             +D +S G  L+ +L G  PF   +     +  IDR+   +   LPD    S + R LL
Sbjct: 370 SSADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLL 425
Query: 239 SQIFVADPSKRIPI-----PEIKKHPWFLKNLPKEIIEIEK 274
             +   D ++R+        E+K+ P+F ++L  +++ ++K
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 465

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 142/306 (46%), Gaps = 48/306 (15%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLR 57
           + E+Y+ ++++G G +GV    +D + + +VA+K I      + I     REI   + L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYC 115
           HPNI+   +V+ +   L +V E+        ++    +    + + + +  QL+ GV++C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 116 HSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL 172
           H   I HRDLK +N L+  DG+    LK+ DFG +++ G+        V T  Y AP+VL
Sbjct: 136 HQHRILHRDLKPQNLLINSDGA----LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------------PRNFRKT--- 213
              K+Y   + D+WS G     M+ G   F    D               PR + +    
Sbjct: 192 MGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 214 -IDRIRNVQYF--------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            + + R  Q F        +P + +   D   LLS +   DP+KRI   +   HP+F K+
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGID---LLSNMLCFDPNKRISARDAMNHPYF-KD 306
Query: 265 LPKEII 270
           L  +I+
Sbjct: 307 LDPQIM 312

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/206 (36%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKID-----ENVQREIINHRSLRHPNIIRFK 65
           +G G FG  ++ R     + VAVK        D     ENV++E      L+HPNII  +
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS---MEICH 122
            V L   +L +VME+A GG L  R+ S  R   D    +  Q+  G++Y H    + I H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 123 RDLKLENTLL-----DGSPQPR-LKICDFGYSKSGLLHSQPK-STVGTPAYIAPEVLARK 175
           RDLK  N L+     +G    + LKI DFG ++    H   K S  G  A++APEV+ R 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVI-RA 188
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
               K SDVWS GV L+ +L G  PF
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/305 (27%), Positives = 141/305 (46%), Gaps = 48/305 (15%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSLR 57
           + E+Y+ ++++G G +GV    +D + + +VA+K I      + I     REI   + L 
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELH 77
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYC 115
           HPNI+   +V+ +   L +V E+        ++    +    + + + +  QL+ GV++C
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 116 HSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL 172
           H   I HRDLK +N L+  DG+    LK+ DFG +++ G+        V T  Y AP+VL
Sbjct: 136 HQHRILHRDLKPQNLLINSDGA----LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVL 191
Query: 173 -ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------------PRNFRKT--- 213
              K+Y   + D+WS G     M+ G   F    D               PR + +    
Sbjct: 192 MGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 214 -IDRIRNVQYF--------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            + + R  Q F        +P + +   D   LLS +   DP+KRI   +   HP+F K+
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGID---LLSNMLCFDPNKRISARDAMNHPYF-KD 306
Query: 265 LPKEI 269
           L  +I
Sbjct: 307 LDPQI 311

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 89/312 (28%), Positives = 142/312 (45%), Gaps = 39/312 (12%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLR 57
           M E+YE + ++G G++GV    R++ T ++VA+K     E    I +   REI   + L+
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN++   EV      L +V EY     L           E   +    Q +  V++CH 
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK----STVGTPAYIAPEVLA 173
               HRD+K EN L+  +    +K+CDFG+++   L + P       V T  Y +PE+L 
Sbjct: 121 HNCIHRDVKPENILI--TKHSVIKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELLV 175
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGA--YPFE-DPEDPRNFRKT----IDRIRNV----QY 222
                G   DVW+ G     +L G   +P + D +     RKT    I R + V    QY
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235
Query: 223 F----LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           F    +PD          +  +S     LL      DP++R+   ++  HP+F +N+ +E
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF-ENI-RE 293
Query: 269 IIEIEKTNYKEA 280
           I ++ K + K A
Sbjct: 294 IEDLAKEHDKPA 305

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 129/286 (45%), Gaps = 37/286 (12%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + +GK       RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYA-AGGELFARICSAGR--FSEDEARFFFQQLISGV 112
           +R +    +        +L +V++Y  A     AR  S  +        + +  QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPE- 170
           +Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y APE 
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYRAPEL 193
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
           +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L    R 
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGTPTR- 244
Query: 231 SADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
                    QI   +P+      P+IK HPW   F    P E I +
Sbjct: 245 --------EQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + +GK       RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 124/288 (43%), Gaps = 28/288 (9%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREI-INHRSLRHPNIIRFKEVL 68
           LG G     +   +  T +  AVK IE+    I   V RE+ + ++   H N++   E  
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLE 128
                  +V E   GG + + I     F+E EA    Q + S + + H+  I HRDLK E
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPE 140
Query: 129 NTLLDGSPQPR-LKICDFGYSKSGLLH--SQPKST------VGTPAYIAPEVLARKEYDG 179
           N L +   Q   +KICDF       L+    P ST       G+  Y+APEV+     + 
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 180 KI----SDVWSCGVTLYVMLVGAYPF-----------EDPEDPRNFRKTIDRIRNVQYFL 224
            I     D+WS GV LY++L G  PF                P       + I+  +Y  
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260
Query: 225 P--DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           P  D+  +S   + L+S++ V D  +R+   ++ +HPW     P+  +
Sbjct: 261 PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 11/209 (5%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--- 58
           ++ +E + ELG+GN GV   V+ + +  ++A K I    +I   ++ +II    + H   
Sbjct: 15  DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECN 72
Query: 59  -PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC-H 116
            P I+ F     +   ++I ME+  GG L   +  A R  E+        ++ G++Y   
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
             +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y+APE L    
Sbjct: 133 KHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQ-LIDSMANSFVGTRSYMAPERLQGTH 189
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
           Y  + SD+WS G++L  + VG YP   P+
Sbjct: 190 YSVQ-SDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 139/292 (47%), Gaps = 36/292 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           E+Y  ++++G G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            NI++  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARK 175
             + HRDLK +N L++   +  LKI DFG +++ G+   +    V T  Y AP+VL   K
Sbjct: 119 RRVLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNFR-------KTIDRIRNVQYFL 224
           +Y   I D+WS G     M+ GA  F    E  +  R FR       K    +  +  + 
Sbjct: 177 KYSTTI-DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 225 PDYV------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           P++              +      LLS++   DP++RI   +  +H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 109
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 165
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 223
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 275
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 276 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 316

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 111/205 (54%), Gaps = 20/205 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRF 64
           +++G+G+FG     R +     VAVK +       ++++E + RE+   + LRHPNI+ F
Sbjct: 43  EKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIVLF 99
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQ--QLISGVSYCHSME-- 119
              +  P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE 176
           I HR+LK  N L+D   +  +K+CDFG S+   S  L S  KS  GTP ++APEVL R E
Sbjct: 160 IVHRNLKSPNLLVDK--KYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL-RDE 214
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
              + SDV+S GV L+ +     P+
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPW 239

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 88/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + +GK       RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/205 (35%), Positives = 110/205 (53%), Gaps = 20/205 (9%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRF 64
           +++G+G+FG     R +     VAVK +       ++++E + RE+   + LRHPNI+ F
Sbjct: 43  EKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIVLF 99
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQ--QLISGVSYCHSME-- 119
              +  P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE 176
           I HRDLK  N L+D   +  +K+CDFG S+   S  L S  K   GTP ++APEVL R E
Sbjct: 160 IVHRDLKSPNLLVDK--KYTVKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVL-RDE 214
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
              + SDV+S GV L+ +     P+
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPW 239

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 154
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 155 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 210
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 211 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 268
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 269 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 320
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 321 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 361

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 111
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 112 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 167
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 168 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 225
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 226 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 277
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 278 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 318

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 103
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 104 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 159
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 160 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 217
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 218 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 269
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 270 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 310

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 113
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 114 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 169
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 170 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 227
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 228 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 279
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 280 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 320

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNI 109
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 165
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 223
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 224 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 275
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 276 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 31/275 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVK-YIERG--KKIDENVQREIINHRSLRHP 59
           E+YE +  +G G++G+    R+K T  +VA+K ++E    K + +   REI   + LRH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG-----ELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N++   EV        +V E+         ELF      G   +   ++ FQ +I+G+ +
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN----GLDYQVVQKYLFQ-IINGIGF 139
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLA 173
           CHS  I HRD+K EN L+  S    +K+CDFG++++     +     V T  Y APE+L 
Sbjct: 140 CHSHNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
                GK  DVW+ G  +  M +G   F    D       ID++ ++   L + +     
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-------IDQLYHIMMCLGNLIP---- 246
Query: 234 CRHLLSQIFVADPS-KRIPIPEIKKHPWFLKNLPK 267
            RH   ++F  +P    + +PEIK+     +  PK
Sbjct: 247 -RH--QELFNKNPVFAGVRLPEIKEREPLERRYPK 278

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 87
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 143
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 201
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 253
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 254 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 294

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 80
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 81  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 136
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 137 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 194
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 195 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 246
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 247 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 287

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 83
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 84  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 139
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 140 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 197
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 198 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 249
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 250 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 290

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 87
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 88  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 143
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 201
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 202 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 253
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 254 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 294

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 94
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 95  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 150
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 151 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 208
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 209 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 260
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 261 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 301

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
           +E  + LG+G FG       + T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 63  RFKEV-----LLTPTHLAIV-MEYAAGGEL------FARICSAGRFSEDEARFFFQQLIS 110
             +EV      L P  L ++ MEY  GG+L      F   C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            + Y H   I HRDLK EN +L   PQ  + KI D GY+K           VGT  Y+AP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           E+L +K+Y   + D WS G   +  + G  PF
Sbjct: 193 ELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 79
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 80  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 135
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 136 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 193
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 194 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 245
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 246 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 286

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HP 59
           E +E V ELG G FG     ++K T  L A K IE   K +E ++  I+    L    HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHP 68
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSM 118
            I++          L I++E+  GG + A +    R  +E + +   +Q++  +++ HS 
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEV-----L 172
            I HRDLK  N L+  + +  +++ DFG S   L   Q + S +GTP ++APEV     +
Sbjct: 129 RIIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 173 ARKEYDGKISDVWSCGVTLYVM 194
               YD K +D+WS G+TL  M
Sbjct: 187 KDTPYDYK-ADIWSLGITLIEM 207

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
           +E  + LG+G FG       + T E VA+K    E   K  E    EI   + L HPN++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 63  RFKEV-----LLTPTHLAIV-MEYAAGGEL------FARICSAGRFSEDEARFFFQQLIS 110
             +EV      L P  L ++ MEY  GG+L      F   C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            + Y H   I HRDLK EN +L   PQ  + KI D GY+K           VGT  Y+AP
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 193
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           E+L +K+Y   + D WS G   +  + G  PF
Sbjct: 194 ELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HP 59
           E +E V ELG G FG     ++K T  L A K IE   K +E ++  I+    L    HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHP 76
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSM 118
            I++          L I++E+  GG + A +    R  +E + +   +Q++  +++ HS 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAPEV-----L 172
            I HRDLK  N L+  + +  +++ DFG S   L   Q + S +GTP ++APEV     +
Sbjct: 137 RIIHRDLKAGNVLM--TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVM 194
               YD K +D+WS G+TL  M
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEM 215

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 88
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 89  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 144
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 145 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 202
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 203 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 254
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 255 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 295

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           E+Y  ++++G G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            NI++  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARK 175
             + HRDLK +N L++   +  LKI DFG +++ G+   +    V T  Y AP+VL   K
Sbjct: 119 RRVLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNFR-------KTIDRIRNVQYFL 224
           +Y   I D+WS G     M+ G   F    E  +  R FR       K    +  +  + 
Sbjct: 177 KYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 225 PDYV------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           P++              +      LLS++   DP++RI   +  +H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 76
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 77  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 132
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 133 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSXICSRYYR 190
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 191 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 242
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 243 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 283

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           E+Y  ++++G G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
            NI++  +V+ T   L +V E+     +    +C  G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHD 118
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-ARK 175
             + HRDLK +N L++   +  LKI DFG +++ G+   +    + T  Y AP+VL   K
Sbjct: 119 RRVLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNFR-------KTIDRIRNVQYFL 224
           +Y   I D+WS G     M+ G   F    E  +  R FR       K    +  +  + 
Sbjct: 177 KYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 225 PDYV------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           P++              +      LLS++   DP++RI   +  +H +F +N
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/239 (31%), Positives = 115/239 (48%), Gaps = 35/239 (14%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRFKE 66
           LG G FG A  V  + T E++ +K + R    DE  QR  +      R L HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
           VL     L  + EY  GG L   I S   ++   +   F + + SG++Y HSM I HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPK--------------STVGTPAYIAPE 170
              N L+  +    + + DFG ++  +   +QP+              + VG P ++APE
Sbjct: 135 NSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 171 VLARKEYDGKISDVWSCGVTLYVML--VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           ++  + YD K+ DV+S G+ L  ++  V A       DP    +T+D   NV+ FL  Y
Sbjct: 193 MINGRSYDEKV-DVFSFGIVLCEIIGRVNA-------DPDYLPRTMDFGLNVRGFLDRY 243

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 45/290 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK---NRELQIMRKLDHCNI 75
Query: 62  IRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDE-------ARFFFQQL 108
           +R +    +        +L +V++Y    E   R+  A  +S  +        + +  QL
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQL 131
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYI 167
              ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y 
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYR 189
Query: 168 APE-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           APE +    +Y   I DVWS G  L  +L+G   F  P D       +D++  +   L  
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAELLLGQPIF--PGD-----SGVDQLVEIIKVLGT 241
Query: 227 YVRVSADCRHLLSQIFVADPS-KRIPIPEIKKHPW---FLKNLPKEIIEI 272
             R          QI   +P+      P+IK HPW   F    P E I +
Sbjct: 242 PTR---------EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 130/297 (43%), Gaps = 42/297 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
           YE  + +GSG   V +       KE VA+K I  E+ +   + + +EI       HPNI+
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARI--------CSAGRFSEDEARFFFQQLISGVSY 114
            +    +    L +VM+  +GG +   I          +G   E       ++++ G+ Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSK-----SGLLHSQPKST-VGTPAY 166
            H     HRD+K  N LL  DGS Q    I DFG S        +  ++ + T VGTP +
Sbjct: 137 LHKNGQIHRDVKAGNILLGEDGSVQ----IADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 167 IAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFED-----------PEDPRNFRKTI 214
           +APEV+ + + YD K +D+WS G+T   +  GA P+               DP +    +
Sbjct: 193 MAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251
Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
                ++ +   +       R ++S     DP KR    E+ +H +F K   KE ++
Sbjct: 252 QDKEMLKKYGKSF-------RKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 10/202 (4%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           +RY  + +LG G +G      D  T E VA+K I R +  +E V     RE+   + L+H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GV++CHS 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 119 EICHRDLKLENTLL---DGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLAR 174
              HRDLK +N LL   D S  P LKI DFG +++ G+   Q    + T  Y  PE+L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 175 KEYDGKISDVWSCGVTLYVMLV 196
             +     D+WS       ML+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLM 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 31/283 (10%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIR 63
           +E V+ +G+G +G     R  +T +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 64  FKEVLLTPT------HLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYC 115
           +    +          L +VME+   G +    +        E+   +  ++++ G+S+ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLAR 174
           H  ++ HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+A 
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 175 KE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----RKTIDRIRNVQYFLP 225
            E     YD K SD+WS G+T   M  GA P  D    R      R    R+++ ++   
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--- 259
Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
                S   +  +    V + S+R    ++ KHP F+++ P E
Sbjct: 260 -----SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VAVK + R    +   +   RE++  + + H 
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C       D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++   +      V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR---------------IRN-- 219
           Y   + D+WS G  +  ++ G   F+  +    + K I++               +RN  
Sbjct: 202 YAANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 260
Query: 220 ----------VQYFLPDYVRVS---------ADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                      +   PD++  S         +  R LLS++ V DP KRI + E  +HP+
Sbjct: 261 ENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 40/295 (13%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNI 61
           +++ +++LG+G +       +K T   VA+K ++   +        REI   + L+H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 62  IRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGR----FSEDEARFFFQQLISGVSYCH 116
           +R  +V+ T   L +V E+     + +    + G        +  ++F  QL+ G+++CH
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVL-AR 174
             +I HRDLK +N L++   Q  LK+ DFG +++ G+  +   S V T  Y AP+VL   
Sbjct: 126 ENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR---------------- 218
           + Y   I D+WSCG  L  M+ G   F    D    +   D +                 
Sbjct: 184 RTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKY 242
Query: 219 --NVQYFLPDYVR----------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             N+Q   P  +R          +  +    L  +   +P  R+   +   HPWF
Sbjct: 243 NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VAVK + R    +   +   RE++  + + H 
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C       D  R  +   Q++ G+ + H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++   +      V T  Y APEV+    
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR---------------IRN-- 219
           Y   + D+WS G  +  ++ G+  F+  +    + K I++               +RN  
Sbjct: 200 YKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYV 258
Query: 220 ----------VQYFLPDYVRVS---------ADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                      +   PD++  S         +  R LLS++ V DP KRI + E  +HP+
Sbjct: 259 ENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPY 318
Query: 261 F 261
Sbjct: 319 I 319

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 90/342 (26%), Positives = 140/342 (40%), Gaps = 69/342 (20%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 62  IRFKEVLLTPT----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           I   +++  PT        ++ +  G +L+ ++      S D   +F  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAP 169
             + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y AP
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAP 216
Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI------------- 214
           E++   +   K  D+WS G  L  ML     +P +   D  N    I             
Sbjct: 217 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 215 -DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF--- 261
             + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+    
Sbjct: 277 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336
Query: 262 ------------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                             L +LPKE  ++++  ++E  R QP
Sbjct: 337 YDPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 376

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 87/341 (25%), Positives = 138/341 (40%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  ++ +G G +G+     D   K  VA+K I     +   +   REI      RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I  +++L   T  A+   Y     +     ++  + + S D   +F  Q++ G+ Y HS 
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSA 163
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N L++ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 164 NVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFL----TEXVATRWYRAPE 217
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 215 DRIRNVQYFLPDYVRVS---------ADCRHLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V+         +    LL ++   +P+KRI + E   HP+     
Sbjct: 278 MKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYY 337
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE   +++  ++E  R QP
Sbjct: 338 DPTDEPVAEEPFTFAMELDDLPKE--RLKELIFQETARFQP 376

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           LG G+FG    ++DK+T    AVK +    +++     E++    L  P I+     +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 71  PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
              + I ME   GG L   I   G   ED A ++  Q + G+ Y H+  I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 131 LL--DGSPQPRLKICDFGYSKSGLLHSQP----KSTV------GTPAYIAPEVLARKEYD 178
           LL  DGS   R  +CDFG++    L  QP    KS +      GT  ++APEV+  K  D
Sbjct: 196 LLSSDGS---RAALCDFGHA----LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 179 GKISDVWSCGVTLYVMLVGAYPF 201
            K+ D+WS    +  ML G +P+
Sbjct: 249 AKV-DIWSSCCMMLHMLNGCHPW 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 42/289 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNII 62
           YE  + +GSG   V +       KE VA+K I  E+ +   + + +EI       HPNI+
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARI--------CSAGRFSEDEARFFFQQLISGVSY 114
            +    +    L +VM+  +GG +   I          +G   E       ++++ G+ Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSK-----SGLLHSQPKST-VGTPAY 166
            H     HRD+K  N LL  DGS Q    I DFG S        +  ++ + T VGTP +
Sbjct: 132 LHKNGQIHRDVKAGNILLGEDGSVQ----IADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 167 IAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFED-----------PEDPRNFRKTI 214
           +APEV+ + + YD K +D+WS G+T   +  GA P+               DP +    +
Sbjct: 188 MAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 246
Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
                ++ +   +       R ++S     DP KR    E+ +H +F K
Sbjct: 247 QDKEMLKKYGKSF-------RKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRS 55
           E+ +   + LG G FG     + K T +L A K + + +           V+++I+    
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
            R   I+       T T L +VM    GG++   I +       F E  A F+  Q++SG
Sbjct: 244 SRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
           + + H   I +RDLK EN LLD     R  I D G +   K+G   ++ K   GTP ++A
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVR--ISDLGLAVELKAG--QTKTKGYAGTPGFMA 357
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE+L  +EYD  + D ++ GVTLY M+    PF    +    ++   R+       PD  
Sbjct: 358 PELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-- 414
Query: 229 RVSADCRHLLSQIFVADPSKRIPIPE-----IKKHPWF 261
           + S   +     +   DP KR+   +     ++ HP F
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRS 55
           E+ +   + LG G FG     + K T +L A K + + +           V+++I+    
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
            R   I+       T T L +VM    GG++   I +       F E  A F+  Q++SG
Sbjct: 244 SRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
           + + H   I +RDLK EN LLD     R  I D G +   K+G   ++ K   GTP ++A
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVR--ISDLGLAVELKAG--QTKTKGYAGTPGFMA 357
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE+L  +EYD  + D ++ GVTLY M+    PF    +    ++   R+       PD  
Sbjct: 358 PELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-- 414
Query: 229 RVSADCRHLLSQIFVADPSKRIPIPE-----IKKHPWF 261
           + S   +     +   DP KR+   +     ++ HP F
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G+FG    ++DK+T    AVK +    +++     E++    L  P I+     +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 71  PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
              + I ME   GG L   I   G   ED A ++  Q + G+ Y H+  I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 131 LL--DGSPQPRLKICDFGYSKSGLLHSQP----KSTV------GTPAYIAPEVLARKEYD 178
           LL  DGS   R  +CDFG++    L  QP    KS +      GT  ++APEV+  K  D
Sbjct: 198 LLSSDGS---RAALCDFGHA----LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 179 GKISDVWSCGVTLYVMLVGAYPF 201
            K+ D+WS    +  ML G +P+
Sbjct: 251 AKV-DIWSSCCMMLHMLNGCHPW 272

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 121/257 (47%), Gaps = 26/257 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRFKE 66
           +G G FGV  + + K   + VA+K IE    R   I E  Q   +NH     PNI++   
Sbjct: 17  VGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH-----PNIVKLYG 69
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSME---I 120
             L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSM+   +
Sbjct: 70  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV     Y  K
Sbjct: 128 IHRDLKPPNLLLVAGGT-VLKICDFGTACD--IQTHMTNNKGSAAWMAPEVFEGSNYSEK 184
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DV+S G+ L+ ++    PF++   P  FR         +   P    +      L+++
Sbjct: 185 -CDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTR--PPLIKNLPKPIESLMTR 240
Query: 241 IFVADPSKRIPIPEIKK 257
            +  DPS+R  + EI K
Sbjct: 241 CWSKDPSQRPSMEEIVK 257

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 251 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRS 55
           E+ +   + LG G FG     + K T +L A K + + +           V+++I+    
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
            R   I+       T T L +VM    GG++   I +       F E  A F+  Q++SG
Sbjct: 244 SRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
           + + H   I +RDLK EN LLD     R  I D G +   K+G   ++ K   GTP ++A
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVR--ISDLGLAVELKAG--QTKTKGYAGTPGFMA 357
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE+L  +EYD  + D ++ GVTLY M+    PF    +    ++   R+       PD  
Sbjct: 358 PELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-- 414
Query: 229 RVSADCRHLLSQIFVADPSKRIPIPE-----IKKHPWF 261
           + S   +     +   DP KR+   +     ++ HP F
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 121/257 (47%), Gaps = 26/257 (10%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE----RGKKIDENVQREIINHRSLRHPNIIRFKE 66
           +G G FGV  + + K   + VA+K IE    R   I E  Q   +NH     PNI++   
Sbjct: 16  VGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH-----PNIVKLYG 68
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSA---GRFSEDEARFFFQQLISGVSYCHSME---I 120
             L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSM+   +
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV     Y  K
Sbjct: 127 IHRDLKPPNLLLVAGGT-VLKICDFGTACD--IQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DV+S G+ L+ ++    PF++   P  FR         +   P    +      L+++
Sbjct: 184 -CDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTR--PPLIKNLPKPIESLMTR 239
Query: 241 IFVADPSKRIPIPEIKK 257
            +  DPS+R  + EI K
Sbjct: 240 CWSKDPSQRPSMEEIVK 256

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN------VQREIINHRS 55
           E+ +   + LG G FG     + K T +L A K + + +           V+++I+    
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
            R   I+       T T L +VM    GG++   I +       F E  A F+  Q++SG
Sbjct: 244 SRF--IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
           + + H   I +RDLK EN LLD     R  I D G +   K+G   ++ K   GTP ++A
Sbjct: 302 LEHLHQRNIIYRDLKPENVLLDDDGNVR--ISDLGLAVELKAG--QTKTKGYAGTPGFMA 357
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE+L  +EYD  + D ++ GVTLY M+    PF    +    ++   R+       PD  
Sbjct: 358 PELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD-- 414
Query: 229 RVSADCRHLLSQIFVADPSKRIPIPE-----IKKHPWF 261
           + S   +     +   DP KR+   +     ++ HP F
Sbjct: 415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G+FG    ++DK+T    AVK +    +++     E++    L  P I+     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 71  PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
              + I ME   GG L   I   G   ED A ++  Q + G+ Y H+  I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 131 LL--DGSPQPRLKICDFGYSKSGLLHSQP----KSTV------GTPAYIAPEVLARKEYD 178
           LL  DGS   R  +CDFG++    L  QP    KS +      GT  ++APEV+  K  D
Sbjct: 182 LLSSDGS---RAALCDFGHA----LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 179 GKISDVWSCGVTLYVMLVGAYPF 201
            K+ D+WS    +  ML G +P+
Sbjct: 235 AKV-DIWSSCCMMLHMLNGCHPW 256

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDSE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSL 56
           +RYE +  LG G F      RDK T ++VA+K I+ G +      I+    REI   + L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            HPNII   +     +++++V ++           ++   +    + +    + G+ Y H
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARK 175
              I HRDLK  N LLD +    LK+ DFG +KS G  +      V T  Y APE+L   
Sbjct: 130 QHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF----EDPEDPRNFRKTIDRIRNVQY----FLPDY 227
              G   D+W+ G  L  +L+   PF     D +      +T+      Q+     LPDY
Sbjct: 188 RMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 246
Query: 228 VRVSA---------------DCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           V   +               D   L+  +F+ +P  RI   +  K  +F
Sbjct: 247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDSE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 261 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDXE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 266 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 275 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 260 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 274 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I  + + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDSE--LKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDXE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDXE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 260 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 261 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 42/292 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNI 61
           Y  ++ +GSG +G      D RT   VA+K + R    +   +   RE+   + +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 62  IRFKEVLLTP-------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           I   +V  TP       T   +VM +   G    ++    +  ED  +F   Q++ G+ Y
Sbjct: 87  IGLLDVF-TPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            H+  I HRDLK  N  ++   +  LKI DFG ++     S+    V T  Y APEV+  
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPED--------------PRNF--RKTIDRIR 218
                +  D+WS G  +  M+ G   F+  +               P  F  R   D  +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 219 NVQYFLP-----DYVRVSADCR----HLLSQIFVADPSKRIPIPEIKKHPWF 261
           N    LP     D+  +  +      +LL ++ V D  +R+   E   HP+F
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 278 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 265 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 16/199 (8%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           LG G+FG    + DK+T    AVK +    +++     E++    L  P I+     +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 71  PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
              + I ME   GG L   +   G   ED A ++  Q + G+ Y HS  I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 131 LL--DGSPQPRLKICDFGYSKSGLLHSQPKSTV------GTPAYIAPEVLARKEYDGKIS 182
           LL  DGS      +CDFG++         KS +      GT  ++APEV+  +  D K+ 
Sbjct: 217 LLSSDGS---HAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 183 DVWSCGVTLYVMLVGAYPF 201
           DVWS    +  ML G +P+
Sbjct: 273 DVWSSCCMMLHMLNGCHPW 291

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 251 ARNYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 275 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 267 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 262 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 267 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 260 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 266 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 254 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 261 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 137/341 (40%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 146 NVLHRDLKPSNLLLNTTSD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 199
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGIN 259
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 260 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYY 319
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 320 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 358

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 128/295 (43%), Gaps = 45/295 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           E Y  + +LG G +      + K T  LVA+K I  E  +       RE+   + L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSME 119
           I+   +++ T   L +V EY    +L   +   G   +    + F  QL+ G++YCH  +
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV-LAR 174
           + HRDLK +N L++   +  LK+ DFG +++    S P  T    V T  Y  P++ L  
Sbjct: 121 VLHRDLKPQNLLIN--ERGELKLADFGLARA---KSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTIDRIRNV------------ 220
            +Y  +I D+W  G   Y M  G   +P    E+  +F   I RI               
Sbjct: 176 TDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSN 231
Query: 221 ----QYFLPDYV---------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
                Y  P Y          R+ +D   LL+++   +   RI   +  KHP+FL
Sbjct: 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 262 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 262 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 260 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 274 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 262 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++   +  LKI DFG ++      +    V T  Y APE++  
Sbjct: 161 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PEDPR 208
             +  +  D+WS G  +  +L G   +P  D                         E  R
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 277 NYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGXVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 42/294 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D ++   +AVK + R  +     +   RE+   + ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V    T L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----------TIDRI---- 217
               +     D+WS G  +  +L G   F   +     ++            I R+    
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 218 -RNVQYFLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN    LP          ++  +     LL ++ V D  KRI   E   HP+F
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 252 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 252 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 253 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 261 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 251 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 203 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 262 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 260 WF 261
           + 
Sbjct: 321 YI 322

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++   +  LKI DFG ++      +    V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PEDPR 208
             +  +  D+WS G  +  +L G   +P  D                         E  R
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 NYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 137/341 (40%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 144 NVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 197
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRN-------------FRKTID 215
           ++   +   K  D+WS G  L  ML     +P +   D  N                 I+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIIN 257
Query: 216 -RIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 318 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 356

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 137/341 (40%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 146 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 199
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 259
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 260 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYY 319
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 320 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 358

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++   +  LKI DFG ++      +    V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PEDPR 208
             +  +  D+WS G  +  +L G   +P  D                         E  R
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 257 NYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 120/295 (40%), Gaps = 48/295 (16%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVL 68
           LG G +GV      K T E+VA+K IE   K        REI   +  +H NII    + 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 69  LTPTHLAIVMEYAAGGELFA----RICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
             P       E     EL      R+ S    S+D  ++F  Q +  V   H   + HRD
Sbjct: 79  -RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 125 LKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKS-------TVGTPAYIAPEVLA 173
           LK  N L++ +    LK+CDFG ++    S   +S+P          V T  Y APEV+ 
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVML 195
Query: 174 RKEYDGKISDVWSCGVTLYVMLV--GAYPFED--------------PEDPRNFRKTIDRI 217
                 +  DVWSCG  L  + +    +P  D              P    + R  I+  
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-CIESP 254
Query: 218 RNVQYF--LPDY---------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           R  +Y   LP Y          RV+     LL ++ V DP+KRI   E  +HP+ 
Sbjct: 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++   +  LKI DFG ++      +    V T  Y APE++  
Sbjct: 164 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PEDPR 208
             +  +  D+WS G  +  +L G   +P  D                         E  R
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 280 NYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + +  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 267 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----XEXVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 40/293 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++   +  LKI DFG ++      +    V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 175 KEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PEDPR 208
             +  +  D+WS G  +  +L G   +P  D                         E  R
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 253 NYIQSLAQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 149 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----XEXVATRWYRAPE 202
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 263 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 323 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 361

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 120/295 (40%), Gaps = 48/295 (16%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVL 68
           LG G +GV      K T E+VA+K IE   K        REI   +  +H NII    + 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 69  LTPTHLAIVMEYAAGGELFA----RICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
             P       E     EL      R+ S    S+D  ++F  Q +  V   H   + HRD
Sbjct: 79  -RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 125 LKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKST-------VGTPAYIAPEVLA 173
           LK  N L++ +    LK+CDFG ++    S   +S+P          V T  Y APEV+ 
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVML 195
Query: 174 RKEYDGKISDVWSCGVTLYVMLV--GAYPFED--------------PEDPRNFRKTIDRI 217
                 +  DVWSCG  L  + +    +P  D              P    + R  I+  
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-CIESP 254
Query: 218 RNVQYF--LPDY---------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           R  +Y   LP Y          RV+     LL ++ V DP+KRI   E  +HP+ 
Sbjct: 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 144 NVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 197
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 318 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 356

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 145
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 146 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMG 203
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 204 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 262
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 263 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 321
Query: 260 WF 261
           + 
Sbjct: 322 YI 323

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 120/295 (40%), Gaps = 48/295 (16%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVL 68
           LG G +GV      K T E+VA+K IE   K        REI   +  +H NII    + 
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 69  LTPTHLAIVMEYAAGGELFA----RICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
             P       E     EL      R+ S    S+D  ++F  Q +  V   H   + HRD
Sbjct: 79  -RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 125 LKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKST-------VGTPAYIAPEVLA 173
           LK  N L++ +    LK+CDFG ++    S   +S+P          V T  Y APEV+ 
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 174 RKEYDGKISDVWSCGVTLYVMLV--GAYPFED--------------PEDPRNFRKTIDRI 217
                 +  DVWSCG  L  + +    +P  D              P    + R  I+  
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR-CIESP 254
Query: 218 RNVQYF--LPDY---------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           R  +Y   LP Y          RV+     LL ++ V DP+KRI   E  +HP+ 
Sbjct: 255 RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS GV +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 142 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 195
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 255
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 256 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 316 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 354

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 89  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 148
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 149 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 202
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 262
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 263 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 323 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 361

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 90  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 149
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 150 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 203
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 263
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 264 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 323
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 324 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 362

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 81  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 140
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 141 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 194
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 254
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 255 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 314
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 315 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 353

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 104 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 163
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 164 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 217
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 278 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 338 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 376

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 82  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 141
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 142 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 195
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIIN 255
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 256 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 316 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 354

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 92  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 151
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 152 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 205
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 265
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 266 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 325
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 326 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 364

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 144 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 197
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 318 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 356

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 10/200 (5%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELGSG FGV +L + K   + VAVK I+ G   ++   +E      L HP +++F  V
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF-FFQQLISGVSYCHSMEICHRDLK 126
                 + IV EY + G L   + S G+  E          +  G+++  S +  HRDL 
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLA 131
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+D      +K+ DFG ++  +L  Q  S+VGT     + APEV    +Y  K SD
Sbjct: 132 ARNCLVD--RDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-SD 187
Query: 184 VWSCGVTLY-VMLVGAYPFE 202
           VW+ G+ ++ V  +G  P++
Sbjct: 188 VWAFGILMWEVFSLGKMPYD 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           LG G+FG    + DK+T    AVK +    +++     E++    L  P I+     +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 71  PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
              + I ME   GG L   +   G   ED A ++  Q + G+ Y HS  I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 131 LL--DGSPQPRLKICDFGYSKSGLLHSQPKSTV------GTPAYIAPEVLARKEYDGKIS 182
           LL  DGS      +CDFG++         K  +      GT  ++APEV+  +  D K+ 
Sbjct: 198 LLSSDGS---HAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 183 DVWSCGVTLYVMLVGAYPF 201
           DVWS    +  ML G +P+
Sbjct: 254 DVWSSCCMMLHMLNGCHPW 272

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 86  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 146 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 199
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 259
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 260 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 319
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 320 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 358

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 89/341 (26%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 144 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 197
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 257
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 318 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 356

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 120/265 (45%), Gaps = 18/265 (6%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
           LG G FG     + + T ++ A K +E+ +      +   +N + +      RF   L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 70  ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I   G+  F E  A F+  ++  G+   H   I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     D 
Sbjct: 312 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-RVSADCRHLLSQIFV 243
           W+ G  LY M+ G  PF+     +  R+ ++R+  V+    +Y  R S   R L SQ+  
Sbjct: 369 WALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL--VKEVPEEYSERFSPQARSLCSQLLC 425
Query: 244 ADPSKRI-----PIPEIKKHPWFLK 263
            DP++R+        E+K+HP F K
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS GV +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 120/265 (45%), Gaps = 18/265 (6%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL- 69
           LG G FG     + + T ++ A K +E+ +      +   +N + +      RF   L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 70  ---TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I   G+  F E  A F+  ++  G+   H   I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     D 
Sbjct: 312 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-RVSADCRHLLSQIFV 243
           W+ G  LY M+ G  PF+     +  R+ ++R+  V+    +Y  R S   R L SQ+  
Sbjct: 369 WALGCLLYEMIAGQSPFQQ-RKKKIKREEVERL--VKEVPEEYSERFSPQARSLCSQLLC 425
Query: 244 ADPSKRI-----PIPEIKKHPWFLK 263
            DP++R+        E+K+HP F K
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA++ I     +   +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 88  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 147
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKICDFG ++        +G L       V T  Y APE
Sbjct: 148 NVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 201
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRNFRKTI-------------- 214
           ++   +   K  D+WS G  L  ML     +P +   D  N    I              
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261
Query: 215 DRIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 322 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 360

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR-----EIINHRSLR 57
           + YE ++ +G+G +GV    R + T + VA+K I     +  N +R     +I+ H   +
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 111
Query: 58  HPNIIRFKEVLLTPT-------HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS 110
           H NII  K++L  PT        + +V++     +L   I S+   + +  R+F  QL+ 
Sbjct: 112 HDNIIAIKDIL-RPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTP 164
           G+ Y HS ++ HRDLK  N L++ + +  LKI DFG ++ GL  S  +        V T 
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMAR-GLCTSPAEHQYFMTEYVATR 226
Query: 165 AYIAPEV-LARKEYDGKISDVWSCGVTLYVML 195
            Y APE+ L+  EY   I D+WS G     ML
Sbjct: 227 WYRAPELMLSLHEYTQAI-DLWSVGCIFGEML 257

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR-----EIINHRSLR 57
           + YE ++ +G+G +GV    R + T + VA+K I     +  N +R     +I+ H   +
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--FK 112
Query: 58  HPNIIRFKEVLLTPT-------HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS 110
           H NII  K++L  PT        + +V++     +L   I S+   + +  R+F  QL+ 
Sbjct: 113 HDNIIAIKDIL-RPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------VGTP 164
           G+ Y HS ++ HRDLK  N L++ + +  LKI DFG ++ GL  S  +        V T 
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMAR-GLCTSPAEHQYFMTEYVATR 227
Query: 165 AYIAPEV-LARKEYDGKISDVWSCGVTLYVML 195
            Y APE+ L+  EY   I D+WS G     ML
Sbjct: 228 WYRAPELMLSLHEYTQAI-DLWSVGCIFGEML 258

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++       +  V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRN-------------FRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D  N              +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYV 260
Query: 222 YFLPDY-----------VRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y           V   AD  H          LLS++ V D SKRI + E  +HP+
Sbjct: 261 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 136/344 (39%), Gaps = 45/344 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 240 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358
Query: 261 FLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGE 304
                    +E       +   D+   ++EE   +I +  M  E
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE 402

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 121/277 (43%), Gaps = 41/277 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           +E +  LG G FG     R+       A+K I   ++    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 65  KEVLL-------------TPTHLAIVMEYAAGGELFARICSAGRFSE-DEARFFFQQLIS 110
               L               + L I MEY   G L+  I S     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-------LLHSQP------ 157
            +SY HS  I HRDLK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 --KSTVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
              S +GT  Y+A EVL     Y+ KI D++S G+  + M+   YPF    +  N  K  
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILK-- 239
Query: 215 DRIRNVQY-FLPDYVRVSADCRHLLSQIFV-ADPSKR 249
            ++R+V   F PD+          + ++ +  DP+KR
Sbjct: 240 -KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 23  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 142
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 143 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 201 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 259
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 260 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 319
Query: 261 F 261
Sbjct: 320 I 320

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 203 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 262 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321
Query: 261 F 261
Sbjct: 322 I 322

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 145 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 202
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 203 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 261
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 262 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321
Query: 261 F 261
Sbjct: 322 I 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 196 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 255 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314
Query: 261 F 261
Sbjct: 315 I 315

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 196 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 254
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 255 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314
Query: 261 F 261
Sbjct: 315 I 315

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 122/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 195 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 261 F 261
Sbjct: 314 I 314

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 86/344 (25%), Positives = 136/344 (39%), Gaps = 45/344 (13%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 182 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 240 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358
Query: 261 FLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGE 304
                    +E       +   D+   ++EE   +I +  M  E
Sbjct: 359 INVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSE 402

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 44/295 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 60  NIIRFKEVLLTPTHL-----AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL 172
            HS +I HRDLK  N  ++   +  LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNEDCE--LKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVG--AYPFED------------------------PED 206
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            RN+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 255 ARNYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 121/302 (40%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------------------- 217
           Y   + D+WS G  +  M+ G   F   +    + K I+++                   
Sbjct: 202 YKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYV 260
Query: 218 --------RNVQYFLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
                    + +   PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 45/298 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYI-----ERGKKIDENVQREIINH-R 54
           +++YE V E+G G +G     RD K     VA+K +     E G  +    +  ++ H  
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 55  SLRHPNIIRFKEVLLTP-----THLAIVMEYAAG--GELFARICSAGRFSEDEARFFFQQ 107
           +  HPN++R  +V         T L +V E+          ++   G  +E      FQ 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
           L+ G+ + HS  + HRDLK +N L+  S Q  +K+ DFG ++         S V T  Y 
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---------- 217
           APEVL +  Y   + D+WS G     M      F    D     K +D I          
Sbjct: 187 APEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 218 --------------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                         + ++ F+ D   +  D   LL +    +P+KRI       HP+F
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 45/298 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYI-----ERGKKIDENVQREIINH-R 54
           +++YE V E+G G +G     RD K     VA+K +     E G  +    +  ++ H  
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 55  SLRHPNIIRFKEVLLTP-----THLAIVMEYAAG--GELFARICSAGRFSEDEARFFFQQ 107
           +  HPN++R  +V         T L +V E+          ++   G  +E      FQ 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
           L+ G+ + HS  + HRDLK +N L+  S Q  +K+ DFG ++         S V T  Y 
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---------- 217
           APEVL +  Y   + D+WS G     M      F    D     K +D I          
Sbjct: 187 APEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 218 --------------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                         + ++ F+ D   +  D   LL +    +P+KRI       HP+F
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 121/298 (40%), Gaps = 45/298 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYI-----ERGKKIDENVQREIINH-R 54
           +++YE V E+G G +G     RD K     VA+K +     E G  +    +  ++ H  
Sbjct: 10  DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 55  SLRHPNIIRFKEVLLTP-----THLAIVMEYAAG--GELFARICSAGRFSEDEARFFFQQ 107
           +  HPN++R  +V         T L +V E+          ++   G  +E      FQ 
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 128
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
           L+ G+ + HS  + HRDLK +N L+  S Q  +K+ DFG ++         S V T  Y 
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVVTLWYR 186
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI---------- 217
           APEVL +  Y   + D+WS G     M      F    D     K +D I          
Sbjct: 187 APEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245
Query: 218 --------------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                         + ++ F+ D   +  D   LL +    +P+KRI       HP+F
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 88/341 (25%), Positives = 136/341 (39%), Gaps = 67/341 (19%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRSLRHPNI 61
           RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           I   +++  PT   +   Y     +     ++      S D   +F  Q++ G+ Y HS 
Sbjct: 84  IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA 143
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
            + HRDLK  N LL+ +    LKI DFG ++        +G L       V T  Y APE
Sbjct: 144 NVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFL----TEYVATRWYRAPE 197
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVG--AYPFEDPEDPRN-------------FRKTID 215
           ++   +   K  D+WS G  L  ML     +P +   D  N                 I+
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIIN 257
Query: 216 -RIRNVQYFLPDYVRV-------SADCR--HLLSQIFVADPSKRIPIPEIKKHPWF---- 261
            + RN    LP   +V       +AD +   LL ++   +P KRI + +   HP+     
Sbjct: 258 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 262 -----------------LKNLPKEIIEIEKTNYKEAGRDQP 285
                            L +LPKE  ++++  ++E  R QP
Sbjct: 318 DPSDEPIAEAPFKFDMELDDLPKE--KLKELIFEETARFQP 356

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 125/302 (41%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++       +  V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFED----------------PEDPRNFRKTI---- 214
           Y   + D+WS G  +  M+     +P  D                PE  +  + T+    
Sbjct: 202 YKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 260
Query: 215 -DRIRNVQY----FLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
            +R +   Y      PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 261 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 260 WF 261
           + 
Sbjct: 320 YI 321

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 25/271 (9%)
Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
           EP+ ELG G +GV   +R   + +++AVK I     ++   Q+ +     I+ R++  P 
Sbjct: 54  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPF 111
Query: 61  IIRFKEVLLTPTHLAIVMEY--AAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHS 117
            + F   L     + I ME    +  + + ++   G+   ED        ++  + + HS
Sbjct: 112 TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 118 -MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV--GTPAYIAPEV--- 171
            + + HRD+K  N L++   Q  +K+CDFG   SG L      T+  G   Y+APE    
Sbjct: 172 KLSVIHRDVKPSNVLINALGQ--VKMCDFGI--SGYLVDSVAKTIDAGCKPYMAPERINP 227
Query: 172 -LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            L +K Y  K SD+WS G+T+  + +  +P++    P  F++    +      LP   + 
Sbjct: 228 ELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLPAD-KF 283
Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           SA+     SQ    +  +R   PE+ +HP+F
Sbjct: 284 SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 105/252 (41%), Gaps = 18/252 (7%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIRF 64
           K++G G F              VA+K ++    +D   + + I      + L HPN+I++
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSYCHSMEI 120
               +    L IV+E A  G+L   I    +      E     +F QL S + + HS  +
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV 157
Query: 121 CHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            HRD+K  N  +  +   +   L +  F  SK+   H    S VGTP Y++PE +    Y
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHENGY 213
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           + K SD+WS G  LY M     PF    D  N      +I    Y        S + R L
Sbjct: 214 NFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270
Query: 238 LSQIFVADPSKR 249
           ++     DP KR
Sbjct: 271 VNMCINPDPEKR 282

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 149 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 206
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFED----------------PEDPRNFRKTI---- 214
           Y   + D+WS G  +  M+     +P  D                PE  +  + T+    
Sbjct: 207 YKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 265
Query: 215 -DRIRNVQY----FLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
            +R +   Y      PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 266 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 324
Query: 260 WF 261
           + 
Sbjct: 325 YI 326

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/302 (26%), Positives = 124/302 (41%), Gaps = 47/302 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +C   +   D  R  +   Q++ G+ + H
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 137
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 138 SAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFED----------------PEDPRNFRKTI---- 214
           Y   + D+WS G  +  M+     +P  D                PE  +  + T+    
Sbjct: 196 YKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 254
Query: 215 -DRIRNVQY----FLPDYVRVSADCRH----------LLSQIFVADPSKRIPIPEIKKHP 259
            +R +   Y      PD V   AD  H          LLS++ V D SKRI + E  +HP
Sbjct: 255 ENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 313
Query: 260 WF 261
           + 
Sbjct: 314 YI 315

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
           + Y  +++LG G F    LV         A+K I   ++ D E  QRE   HR   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 62  IRFKEVLL---TPTHLA-IVMEYAAGGELFA---RICSAGRF-SEDEARFFFQQLISGVS 113
           +R     L      H A +++ +   G L+    R+   G F +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQPKSTV-------GT 163
             H+    HRDLK  N LL    QP L   D G      +H   S+   T+        T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 164 PAYIAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK--TIDRIRN 219
            +Y APE+ + + +    + +DVWS G  LY M+ G  P++       F+K  ++     
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQ 261
Query: 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 253
            Q  +P   R S+    LL+ +   DP +R  IP
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIP 295

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 46/301 (15%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNII 62
           RY  +K LG G  G+     D    + VA+K I     +  ++  REI   R L H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 63  RFKEVL-------------LTPTH-LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
           +  E+L             LT  + + IV EY       A +   G   E+ AR F  QL
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHARLFMYQL 129
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG----TP 164
           + G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++    H   K  +     T 
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188
Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI------- 217
            Y +P +L       K  D+W+ G     ML G   F    +    +  ++ I       
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248
Query: 218 -RNVQYFLPDYVR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            + +   +P Y+R                +S +    L QI    P  R+   E   HP+
Sbjct: 249 RQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY 308
Query: 261 F 261
Sbjct: 309 M 309

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +   A R    +   +  Q+  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKG 129
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 130 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 186
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 187 YAPESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+   +     T       IVMEY  G  L   + + G  +   A          +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N L+  S    +K+ DFG ++    SG    Q  + +GT  Y++
Sbjct: 130 NFSHQNGIIHRDVKPANILI--SATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLS 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+   +     T       IVMEY  G  L   + + G  +   A          +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N ++  S    +K+ DFG ++    SG   +Q  + +GT  Y++
Sbjct: 130 NFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+   +     T       IVMEY  G  L   + + G  +   A          +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N ++  S    +K+ DFG ++    SG   +Q  + +GT  Y++
Sbjct: 130 NFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+   +     T       IVMEY  G  L   + + G  +   A          +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N ++  S    +K+ DFG ++    SG   +Q  + +GT  Y++
Sbjct: 130 NFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 118/275 (42%), Gaps = 22/275 (8%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVK------YIERGKKIDENVQREIINHRSLRH 58
           +E +K +G G F    +V+ K+T ++ A+K       ++RG+      +R+++ +   R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHS 117
              + F        +L +VMEY  GG+L   +   G R   + ARF+  +++  +   H 
Sbjct: 123 ITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS--TVGTPAYIAPEVLARK 175
           +   HRD+K +N LLD     RL   DFG           +S   VGTP Y++PE+L   
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRL--ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV 238
Query: 176 EYDGKI------SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
                        D W+ GV  Y M  G  PF        + K +    ++   L D   
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE-G 297
Query: 230 VSADCRHLLSQIFVADPSK--RIPIPEIKKHPWFL 262
           V  + R  + ++     ++  R    + + HP+F 
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 27  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 86
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+   +     T       IVMEY  G  L   + + G  +   A          +
Sbjct: 87  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 146
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N ++  S    +K+ DFG ++    SG   +Q  + +GT  Y++
Sbjct: 147 NFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 204
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 205 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           +E +  LG G FG     R+       A+K I   ++    +  E++   SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 65  KEVLL-------------TPTHLAIVMEYAAGGELFARICSAGRFSE-DEARFFFQQLIS 110
               L               + L I MEY     L+  I S     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-------LLHSQP------ 157
            +SY HS  I HRDLK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 --KSTVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
              S +GT  Y+A EVL     Y+ KI D++S G+  + M+   YPF    +  N  K  
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILK-- 239
Query: 215 DRIRNVQY-FLPDYVRVSADCRHLLSQIFV-ADPSKR 249
            ++R+V   F PD+          + ++ +  DP+KR
Sbjct: 240 -KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           +R + ++ +GSG +G      D R ++ VAVK + R  +         RE+   + L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 60  NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           N+I   +V    T +     + +     G     I  +   S++  +F   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           HS  I HRDLK  N  ++   +  L+I DFG ++      +    V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSE--LRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
            +  +  D+WS G  +  +L G   F
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 15/213 (7%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSL 56
           + +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L
Sbjct: 10  LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL 69
Query: 57  RHPNIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            HP I+         T       IVMEY  G  L   + + G  +   A          +
Sbjct: 70  NHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIA 168
           ++ H   I HRD+K  N ++  S    +K+ DFG ++    SG   +Q  + +GT  Y++
Sbjct: 130 NFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF 201
           PE       D + SDV+S G  LY +L G  PF
Sbjct: 188 PEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 124/269 (46%), Gaps = 21/269 (7%)
Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
           EP+ ELG G +GV   +R   + +++AVK I     ++   Q+ +     I+ R++  P 
Sbjct: 10  EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 61  IIRFKEVLLTPTHLAIVMEY--AAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHS 117
            + F   L     + I ME    +  + + ++   G+   ED        ++  + + HS
Sbjct: 68  TVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 118 -MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE----VL 172
            + + HRD+K  N L++   Q  +K+CDFG S   +         G   Y+APE     L
Sbjct: 128 KLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            +K Y  K SD+WS G+T+  + +  +P++    P  F++    +      LP   + SA
Sbjct: 186 NQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLPAD-KFSA 241
Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +     SQ    +  +R   PE+ +HP+F
Sbjct: 242 EFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 24/218 (11%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
           E+ E  + +G G FG    V   R    VA++ I+  +  ++ ++   RE++ +R  RH 
Sbjct: 33  EQLEIGELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSM 118
           N++ F    ++P HLAI+     G  L++ +  A      ++ R   Q+++ G+ Y H+ 
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG-YSKSGLLHS-----QPKSTVGTPAYIAPEVL 172
            I H+DLK +N   D     ++ I DFG +S SG+L +     + +   G   ++APE++
Sbjct: 150 GILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 173 ARKEYD--------GKISDVWSCGVTLYVMLVGAYPFE 202
            +   D         K SDV++ G   Y +    +PF+
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH 136
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 137 SAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 195 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313
Query: 261 F 261
Sbjct: 314 I 314

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +GSG +G      DKR+ E VA+K + R    +   +   RE++  + ++H N+I   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 68  LLTPTHL------AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
               + L       +VM +        +I    +FSE++ ++   Q++ G+ Y HS  + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 179
           HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 149 HRDLKPGNLAVNEDCE--LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 180 KISDVWSCGVTLYVMLVGAYPFE 202
           +  D+WS G  +  ML G   F+
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFK 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-ARICSAGRFSEDEAR--FFFQQLISGVSYCH 116
           NII    V      L    +     EL  A +    +   D  R  +   Q++ G+ + H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  I HRDLK  N ++       LKI DFG +++          V T  Y APEV+    
Sbjct: 144 SAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 177 YDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------PRNFRKTIDRIRNVQ 221
           Y   + D+WS G  +  M+     +P  D  D             P   +K    +RN  
Sbjct: 202 YKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 260
Query: 222 YFLPDYVRVS-----------ADCRH----------LLSQIFVADPSKRIPIPEIKKHPW 260
              P Y  ++           AD  H          LLS++ V DP+KRI + +  +HP+
Sbjct: 261 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320
Query: 261 F 261
Sbjct: 321 I 321

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           +R + ++ +GSG +G      D R ++ VAVK + R  +         RE+   + L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 60  NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           N+I   +V    T +     + +     G     I      S++  +F   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           HS  I HRDLK  N  ++   +  L+I DFG ++      +    V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNEDSE--LRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
            +  +  D+WS G  +  +L G   F
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALF 229

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 126/296 (42%), Gaps = 45/296 (15%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + E VA+K + + K+      RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIVKHPNV 94
Query: 62  IRFKEVLLT------PTHLAIVMEYAA-----GGELFARICSAGRFSEDEARFFFQQLIS 110
           +  K    +         L +V+EY           +A++           + +  QL+ 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT--MPMLLIKLYMYQLLR 152
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STVGTPAYIAP 169
            ++Y HS+ ICHRD+K +N LLD  P   LK+ DFG +K  L+  +P  S + +  Y AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLD-PPSGVLKLIDFGSAKI-LIAGEPNVSXICSRYYRAP 210
Query: 170 E-VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-----RNVQYF 223
           E +     Y   I D+WS G  +  ++ G   F          + I  +       ++  
Sbjct: 211 ELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269
Query: 224 LPDYV------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            P+Y+                  R   D   L+S++    PS R+   E   HP+F
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +GSG +G      DKR+ E VA+K + R    +   +   RE++  + ++H N+I   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 68  LLTPTHL------AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
               + L       +VM +        +I     FSE++ ++   Q++ G+ Y HS  + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 179
           HRDLK  N  ++   +  LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 167 HRDLKPGNLAVNEDCE--LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 220
Query: 180 KISDVWSCGVTLYVMLVGAYPFE 202
           +  D+WS G  +  ML G   F+
Sbjct: 221 QTVDIWSVGCIMAEMLTGKTLFK 243

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 158 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 214
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 215 YAPESLTESKF-SVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 125 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 181
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
            APE L   ++    SDVWS GV LY +       + P  P  F + I
Sbjct: 182 YAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 131
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 132 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 188
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 189 YAPESLTESKF-SVASDVWSFGVVLYELFT 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 129
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 130 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 186
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 187 YAPESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 11/206 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHP 59
           +R + ++ +GSG +G      D R ++ VAVK + R  +         RE+   + L+H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 60  NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           N+I   +V    T +     + +     G     I      S++  +F   QL+ G+ Y 
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           HS  I HRDLK  N  ++   +  L+I DFG ++      +    V T  Y APE++   
Sbjct: 140 HSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 195
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF 201
            +  +  D+WS G  +  +L G   F
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALF 221

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 133
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 134 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 190
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 191 YAPESLTESKF-SVASDVWSFGVVLYELFT 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 125
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 126 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 182
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 183 YAPESLTESKF-SVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 130
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 131 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 187
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 188 YAPESLTESKF-SVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 183
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 184 YAPESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 183
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 184 YAPESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +R++  +  G G FG  +L ++K T   VA+K + +  +      + + +   L HPNI+
Sbjct: 23  DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIV 82
Query: 63  RFKEVLLT-------PTHLAIVMEYAAGGELFARICSAGRFSEDEA------RFFFQQLI 109
           + +    T         +L +VMEY    +   R C    +    A      + F  QLI
Sbjct: 83  QLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAPPPILIKVFLFQLI 139
Query: 110 SGVSYCH--SMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPK-STVGT 163
             +   H  S+ +CHRD+K  N L+   DG+    LK+CDFG +K  L  S+P  + + +
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGT----LKLCDFGSAKK-LSPSEPNVAYICS 194
Query: 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG 197
             Y APE++   ++     D+WS G     M++G
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 132
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 133 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 189
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 190 YAPESLTESKF-SVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 145 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 201
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
            APE L   ++    SDVWS GV LY +       + P  P  F + I
Sbjct: 202 YAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 246

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 145 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 201
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
            APE L   ++    SDVWS GV LY +       + P  P  F + I
Sbjct: 202 YAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSP--PAEFMRMI 246

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/223 (34%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 8   VKELGSGNFGVARLV----RDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK +  + G +     ++EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 62  IRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHS 117
           I++K          L +VMEY   G L   +    R S   A+   F QQ+  G++Y H+
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 118 MEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPA-YIAPEVL 172
               HRDL   N LLD     RL KI DFG +K+   G    + +    +P  + APE L
Sbjct: 153 QHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 173 ARKEYDGKI-SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
             KEY     SDVWS GVTLY +L      + P  P  F + I
Sbjct: 210 --KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 248

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP +++   V
Sbjct: 12  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLA 130
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 131 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 186
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 187 VWSFGVLMWEVFSEGKIPYEN 207

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++ME+   G L   +     R    +   +  Q+  G
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKG 129
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 130 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEXXKVKEPGESPIFW 186
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 187 YAPESLTESKF-SVASDVWSFGVVLYELFT 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 29  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 88  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 142 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 199 SSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 8   VKELGSGNFGVARLV----RDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 62  IRFKEVL--LTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCH 116
           +++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 117 SMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPA-YIAPEV 171
           +    HR L   N LLD     RL KI DFG +K+   G  + + +    +P  + APE 
Sbjct: 130 AQHYIHRALAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 172 LARKEYDGKISDVWSCGVTLYVMLV 196
           L   ++    SDVWS GVTLY +L 
Sbjct: 187 LKECKFY-YASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 8   VKELGSGNFGVARLV----RDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 62  IRFKEVL--LTPTHLAIVMEYAAGGEL---FARICSAGRFSEDEARFFFQQLISGVSYCH 116
           +++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 117 SMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPA-YIAPEV 171
           +    HR L   N LLD     RL KI DFG +K+   G  + + +    +P  + APE 
Sbjct: 129 AQHYIHRALAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 172 LARKEYDGKISDVWSCGVTLYVMLV 196
           L   ++    SDVWS GVTLY +L 
Sbjct: 186 LKECKFY-YASDVWSFGVTLYELLT 209

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 33/262 (12%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--------VQREIINHRSLRHPN 60
           K++G G FG+    R  + K +VA+K +  G    E          QRE+    +L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS-GVSYCHSME 119
           I++   ++  P  +  VME+   G+L+ R+       +   +      I+ G+ Y  +  
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 120 --ICHRDLKLENTL---LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL-A 173
             I HRDL+  N     LD +     K+ DFG S+   +HS     +G   ++APE + A
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSV-SGLLGNFQWMAPETIGA 200
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VS 231
            +E   + +D +S  + LY +L G  PF++         +  +I+ +     + +R  + 
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDE--------YSYGKIKFINMIREEGLRPTIP 252
Query: 232 ADC----RHLLSQIFVADPSKR 249
            DC    R+++   +  DP KR
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP +++   V
Sbjct: 12  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 130
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 131 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 186
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 187 VWSFGVLMWEVFSEGKIPYEN 207

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 13  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 72  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 126 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 183 SSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 29  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 88  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 142 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 199 SSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 33/262 (12%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--------VQREIINHRSLRHPN 60
           K++G G FG+    R  + K +VA+K +  G    E          QRE+    +L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS-GVSYCHSME 119
           I++   ++  P  +  VME+   G+L+ R+       +   +      I+ G+ Y  +  
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 120 --ICHRDLKLENTL---LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL-A 173
             I HRDL+  N     LD +     K+ DFG S+   +HS     +G   ++APE + A
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSV-SGLLGNFQWMAPETIGA 200
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VS 231
            +E   + +D +S  + LY +L G  PF++         +  +I+ +     + +R  + 
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDE--------YSYGKIKFINMIREEGLRPTIP 252
Query: 232 ADC----RHLLSQIFVADPSKR 249
            DC    R+++   +  DP KR
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HRDL   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 127 MEYLGTKRYIHRDLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFW 183
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 184 YAPESLTESKF-SVASDVWSFGVVLYELFT 212

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP +++   V
Sbjct: 10  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 129 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 184
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 185 VWSFGVLMWEVFSEGKIPYEN 205

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP +++   V
Sbjct: 15  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 133
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 134 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 189
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 190 VWSFGVLMWEVFSEGKIPYEN 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 8   VKELGSGNFGVARLV----RDKRTKELVAVKYIER--GKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK ++   G +     ++EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 62  IRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           I++K          L +VMEY   G L   +         +   F QQ+  G++Y HS  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHSQH 137
Query: 120 ICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPA-YIAPEVLAR 174
             HR+L   N LLD     RL KI DFG +K+   G  + + +    +P  + APE L  
Sbjct: 138 YIHRNLAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 192
Query: 175 KEYDGKI-SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
           KEY     SDVWS GVTLY +L      + P  P  F + I
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 231

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 9   LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 68  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 122 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 20  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 79  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 133 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 190 SSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 132/285 (46%), Gaps = 25/285 (8%)
Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIIN----HRSLRHPNI 61
           E + E+GSG  G    +R ++T  ++AVK + R    +EN +R +++     +S   P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-- 119
           ++     +T T + I ME         +    G   E   R   +  ++ V   + ++  
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKEK 143
Query: 120 --ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL----- 172
             + HRD+K  N LLD   Q  +K+CDFG S   +       + G  AY+APE +     
Sbjct: 144 HGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            + +YD + +DVWS G++L  +  G +P+++ +   +F      ++     LP ++  S 
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPYKNCK--TDFEVLTKVLQEEPPLLPGHMGFSG 258
Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNY 277
           D +  +      D  KR    ++ +H  F+K    E +E++  ++
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHS-FIKRY--ETLEVDVASW 300

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 14  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 73  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+VG+     +  PEVL   ++
Sbjct: 127 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 184 SSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP +++   V
Sbjct: 13  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 132 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 187
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 188 VWSFGVLMWEVFSEGKIPYEN 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 30  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +  S  +F   +     +Q   G+ Y H+  I HRD
Sbjct: 87  GYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +   
Sbjct: 146 LKSNNIFLH--EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +       PD  +V ++C    +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 236 HLLSQIFVADPSKRIPIPEI 255
            L+++       +R   P I
Sbjct: 260 RLMAECLKKKRDERPSFPRI 279

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 122/292 (41%), Gaps = 62/292 (21%)
Query: 32  AVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEYAAGGEL--- 86
           A+K IE G  I  +  REI   R L+HPN+I  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 87  -FARICSAGR----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL--DGSPQPR 139
            F R   A +          +    Q++ G+ Y H+  + HRDLK  N L+  +G  + R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 140 LKICDFGYSKSGLLHSQPK------STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYV 193
           +KI D G+++  L +S  K        V T  Y APE+L    +  K  D+W+ G     
Sbjct: 171 VKIADMGFAR--LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228
Query: 194 MLVGAYPF----EDPEDPRNFRK-TIDRIRNVQYF-----------LPDYVRVSADCR-- 235
           +L     F    ED +    +    +DRI NV  F           +P++  +  D R  
Sbjct: 229 LLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288
Query: 236 -----------------------HLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
                                  HLL ++   DP KRI   +  + P+FL++
Sbjct: 289 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 176 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 288 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+E+GSG FG+  L      K+ VA+K I+ G   +++   E      L HP +++   V
Sbjct: 32  VQEIGSGQFGLVHLGY-WLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            L    + +V E+   G L   +    G F+ +        +  G++Y     + HRDL 
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 150
Query: 127 LENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKISD 183
             N L+ G  Q  +K+ DFG ++  +L  Q  S+ GT     + +PEV +   Y  K SD
Sbjct: 151 ARNCLV-GENQV-IKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-SD 206
Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS GV ++ V   G  P+E+
Sbjct: 207 VWSFGVLMWEVFSEGKIPYEN 227

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGKKID-ENVQREIINHR 54
            EER+ + +++LG GNFG   + R       T E+VAVK ++   +    + +REI   +
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISG 111
           SL+H NI+++K V  +    +L ++MEY   G L   +     R    +   +  Q+  G
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 127
Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----Y 166
           + Y  +    HR+L   N L++   + R+KI DFG +K  L   +    V  P      +
Sbjct: 128 MEYLGTKRYIHRNLATRNILVEN--ENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFW 184
Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
            APE L   ++    SDVWS GV LY +  
Sbjct: 185 YAPESLTESKF-SVASDVWSFGVVLYELFT 213

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 176 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 227
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 288 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 23/260 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 30  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +  S  +F   +     +Q   G+ Y H+  I HRD
Sbjct: 87  GYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +   
Sbjct: 146 LKSNNIFLH--EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +       PD  +V ++C    +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259
Query: 236 HLLSQIFVADPSKRIPIPEI 255
            L+++       +R   P I
Sbjct: 260 RLMAECLKKKRDERPSFPRI 279

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 8   VKELGSGNFGVARLV----RDKRTKELVAVKYIER--GKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK ++   G +     ++EI   R+L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 62  IRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           I++K          L +VMEY   G L   +         +   F QQ+  G++Y H+  
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQH 137
Query: 120 ICHRDLKLENTLLDGSPQPRL-KICDFGYSKS---GLLHSQPKSTVGTPA-YIAPEVLAR 174
             HR+L   N LLD     RL KI DFG +K+   G  + + +    +P  + APE L  
Sbjct: 138 YIHRNLAARNVLLDND---RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL-- 192
Query: 175 KEYDGKI-SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
           KEY     SDVWS GVTLY +L      + P  P  F + I
Sbjct: 193 KEYKFYYASDVWSFGVTLYELLTHCDSSQSP--PTKFLELI 231

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 20/249 (8%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFKEV 67
           +GSG+FG    V   +    VAVK ++      E  Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT---VYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG- 99
Query: 68  LLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
            +T  +LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD+K
Sbjct: 100 YMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159
Query: 127 LENTLLDGSPQPRLKICDFGYS--KSGLLHSQP-KSTVGTPAYIAPEVLARKEYD--GKI 181
             N  L       +KI DFG +  KS    SQ  +   G+  ++APEV+  ++ +     
Sbjct: 160 SNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           SDV+S G+ LY ++ G  P+       N R  I  +    Y  PD  ++  +C   + ++
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHI----NNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRL 273
Query: 242 FVADPSKRI 250
            VAD  K++
Sbjct: 274 -VADCVKKV 281

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 89  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 148 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 260 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 70  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 129 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 241 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 276

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 73  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 131
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 132 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 183
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 184 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 243
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 244 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 279

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 116/260 (44%), Gaps = 23/260 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 18  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +  S  +F   +     +Q   G+ Y H+  I HRD
Sbjct: 75  GYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 133
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 134 LKSNNIFLH--EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +       PD  +V ++C    +
Sbjct: 192 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 247
Query: 236 HLLSQIFVADPSKRIPIPEI 255
            L+++       +R   P I
Sbjct: 248 RLMAECLKKKRDERPSFPRI 267

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 123/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 69  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 127
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE 
Sbjct: 128 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPEA 179
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 180 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 239
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 240 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 275

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 118/262 (45%), Gaps = 33/262 (12%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--------VQREIINHRSLRHPN 60
           K++G G FG+    R  + K +VA+K +  G    E          QRE+    +L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS-GVSYCHSME 119
           I++   ++  P  +  VME+   G+L+ R+       +   +      I+ G+ Y  +  
Sbjct: 85  IVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 120 --ICHRDLKLENTL---LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL-A 173
             I HRDL+  N     LD +     K+ DF  S+   +HS     +G   ++APE + A
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSV-SGLLGNFQWMAPETIGA 200
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VS 231
            +E   + +D +S  + LY +L G  PF++         +  +I+ +     + +R  + 
Sbjct: 201 EEESYTEKADTYSFAMILYTILTGEGPFDE--------YSYGKIKFINMIREEGLRPTIP 252
Query: 232 ADC----RHLLSQIFVADPSKR 249
            DC    R+++   +  DP KR
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 9/203 (4%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PN 60
           ++ Y+ V++LG G +       +    E V VK ++  KK    ++REI    +LR  PN
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPN 93
Query: 61  IIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           II   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCHSM
Sbjct: 94  IITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSM 150
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +  
Sbjct: 151 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 209
Query: 179 GKISDVWSCGVTLYVMLVGAYPF 201
               D+WS G  L  M+    PF
Sbjct: 210 DYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 42  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 99  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +   
Sbjct: 158 LKSNNIFL--HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 271
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 272 RLMAECLKKKRDERPLFPQILASIELLARSLPK 304

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 89  KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPK-------STVGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP        S VGT  Y+ PE 
Sbjct: 148 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDXXXVVKDSQVGTVNYMPPEA 199
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 260 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G G FG     RL    + +  VA+K ++ G    +  +R+ ++  S+     HPNI
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG--YTDKQRRDFLSEASIMGQFDHPNI 92
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I  + V+     + I+ EY   G L A +  + GRF+  +     + + SG+ Y   M  
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA 152
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLAR 174
            HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE +A 
Sbjct: 153 VHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 209 RKFTSA-SDVWSYGIVMWEVMSYGERPYWD 237

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  +++   V
Sbjct: 14  LKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSMEI 120
                 + I+ EY A G      C      E   RF  QQL+         + Y  S + 
Sbjct: 73  CTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEVLARKEY 177
            HRDL   N L++   Q  +K+ DFG S+  +L  +  S+ G+     +  PEVL   ++
Sbjct: 127 LHRDLAARNCLVN--DQGVVKVSDFGLSRY-VLDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFE 202
             K SD+W+ GV ++ +  +G  P+E
Sbjct: 184 SSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSL-- 56
           RYEPV E+G G +G     RD  +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  -RHPNIIRFKEVLLTP-----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLI 109
             HPN++R  +V  T        + +V E+       +           +  +   +Q +
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVVTLWYRAP 180
Query: 170 EVLARKEYDGKISDVWSCGVTLYVML 195
           EVL +  Y   + D+WS G     M 
Sbjct: 181 EVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 41  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 98  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 156
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 157 LKSNNIFL--HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 215 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 270
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 271 RLMAECLKKKRDERPLFPQILASIELLARSLPK 303

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 42  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 99  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 157
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 158 LKSNNIFL--HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 216 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 271
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 272 RLMAECLKKKRDERPLFPQILASIELLARSLPK 304

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 122/280 (43%), Gaps = 38/280 (13%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREI--INHRSLRHP 59
           Y  +K++GSG       V +++ K++ A+KY+   E   +  ++ + EI  +N       
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H   
Sbjct: 117 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 120 ICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-------VGTPAYIAPEV 171
           I H DLK  N L+ DG     LK+ DFG +       QP +T       VG   Y+ PE 
Sbjct: 176 IVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 172 ---LARKEYDGKIS-------DVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNV 220
              ++    +GK         DVWS G  LY M  G  PF+   +        ID    +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           ++  PD      D + +L      DP +RI IPE+  HP+
Sbjct: 288 EF--PDIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 FVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G G FG     RL    + +  VA+K ++ G    +  +R+ ++  S+     HPNI
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG--YTDKQRRDFLSEASIMGQFDHPNI 77
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I  + V+     + I+ EY   G L A +  + GRF+  +     + + SG+ Y   M  
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 137
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLAR 174
            HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE +A 
Sbjct: 138 VHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 194 RKFTSA-SDVWSYGIVMWEVMSYGERPYWD 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 34  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 91  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 149
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +   
Sbjct: 150 LKSNNIFL--HEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 208 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 263
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 264 RLMAECLKKKRDERPLFPQILASIELLARSLPK 296

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 121/273 (44%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 14  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 71  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +      S   Q +   G+  ++APEV+  ++ +   
Sbjct: 130 LKSNNIFLH--EDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSL-- 56
           RYEPV E+G G +G     RD  +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  -RHPNIIRFKEVLLTP-----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLI 109
             HPN++R  +V  T        + +V E+       +           +  +   +Q +
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVVTLWYRAP 180
Query: 170 EVLARKEYDGKISDVWSCGVTLYVML 195
           EVL +  Y   + D+WS G     M 
Sbjct: 181 EVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 22/210 (10%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G G FG     RL    + +  VA+K ++ G    +  +R+ ++  S+     HPNI
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAG--YTDKQRRDFLSEASIMGQFDHPNI 71
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I  + V+     + I+ EY   G L A +  + GRF+  +     + + SG+ Y   M  
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSY 131
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLAR 174
            HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE +A 
Sbjct: 132 VHRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 188 RKFTSA-SDVWSYGIVMWEVMSYGERPYWD 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 14  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 71  GYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 130 LKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 244 RLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 19  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 76  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 135 LKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 249 RLMAECLKKKRDERPLFPQILASIELLARSLPK 281

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 106
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 107 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 165
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 166 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 222 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIR 63
           +G+G FG     RL    + +  VA+K ++ G    E  +RE ++  S+     HPNIIR
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 81
Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
            + V+     + I+ E+   G L  F R+ + G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE +A
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEENSSDPTETSSLGGKIPIRWTAPEAIA 196
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SD WS G+ ++ VM  G  P+ D
Sbjct: 197 FRKFTSA-SDAWSYGIVMWEVMSFGERPYWD 226

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 123/287 (42%), Gaps = 45/287 (15%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLR 57
           E  + + E+G G +G    +  K + +++AVK I     +DE  Q+++     +  RS  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            P I++F   L       I ME  +    + +  + S       E       L +  +  
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 116 H---SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
           H   +++I HRD+K  N LLD S    +K+CDFG S   +         G   Y+APE +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 197
Query: 173 ----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------- 220
               +R+ YD + SDVWS G+TLY +  G +P+     P+ +    D++  V        
Sbjct: 198 DPSASRQGYDVR-SDVWSLGITLYELATGRFPY-----PK-WNSVFDQLTQVVKGDPPQL 250
Query: 221 -----QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
                + F P ++     C          D SKR    E+ KHP+ L
Sbjct: 251 SNSEEREFSPSFINFVNLC-------LTKDESKRPKYKELLKHPFIL 290

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 96
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 97  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 155
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 156 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 212 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 19  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 76  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 134
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 135 LKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 193 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 248
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 249 RLMAECLKKKRDERPLFPQILASIELLARSLPK 281

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 195 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER-GKKIDENVQREIINHR 54
            EER+ + + +LG GNFG   L R       T  LVAVK ++  G     + QREI   +
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 55  SLRHPNIIRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
           +L    I++++ V   P    L +VMEY   G L  F +   A R        +  Q+  
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICK 122
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G+ Y  S    HRDL   N L++   +  +KI DFG +K  L   +    V  P      
Sbjct: 123 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKL-LPLDKDXXVVREPGQSPIF 179
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
           + APE L+   +  + SDVWS GV LY +  
Sbjct: 180 WYAPESLSDNIFS-RQSDVWSFGVVLYELFT 209

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL----RHPNIIR 63
           +G+G FG     RL    + +  VA+K ++ G    E  +RE ++  S+     HPNIIR
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 79
Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
            + V+     + I+ E+   G L  F R+ + G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE +A
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEENSSDPTYTSSLGGKIPIRWTAPEAIA 194
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SD WS G+ ++ VM  G  P+ D
Sbjct: 195 FRKFTSA-SDAWSYGIVMWEVMSFGERPYWD 224

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 117/260 (45%), Gaps = 23/260 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 14  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 71  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 129
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 130 LKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243
Query: 236 HLLSQIFVADPSKRIPIPEI 255
            L+++       +R   P+I
Sbjct: 244 RLMAECLKKKRDERPLFPQI 263

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 123/273 (45%), Gaps = 24/273 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 16  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+  I HRD
Sbjct: 73  GYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRD 131
Query: 125 LKLENTLLDGSPQPRLKICDFGYS--KSGLLHS-QPKSTVGTPAYIAPEVLARKEYD--G 179
           LK  N  L       +KI DFG +  KS    S Q +   G+  ++APEV+  ++ +   
Sbjct: 132 LKSNNIFLH--EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC----R 235
             SDV++ G+ LY ++ G  P+ +     N R  I  +    Y  PD  +V ++C    +
Sbjct: 190 FQSDVYAFGIVLYELMTGQLPYSNI----NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 245
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            L+++       +R   P+I      L ++LPK
Sbjct: 246 RLMAECLKKKRDERPLFPQILASIELLARSLPK 278

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 21/194 (10%)
Query: 106 QQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
           + +++  SY H+   ICHRD+K  N L+D     R+K+ DFG S+  ++  + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMD--KNGRVKLSDFGESEY-MVDKKIKGSRGTY 214
Query: 165 AYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY- 222
            ++ PE  + +  Y+G   D+WS G+ LYVM     PF            I R +N++Y 
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI-RTKNIEYP 273
Query: 223 -----FLPDYVRVSADCRH---------LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
                FL       + C +          L      +P++RI   +  KH W      ++
Sbjct: 274 LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIED 333
Query: 269 IIEIEKTNYKEAGR 282
           + E  K  YK+  +
Sbjct: 334 LREFSKELYKKRKK 347

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 88/206 (42%), Gaps = 19/206 (9%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI-----ERGKKIDENVQREIINHRSL-- 56
           RYEPV E+G G +G     RD  +   VA+K +     E G  I  +  RE+   R L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  -RHPNIIRFKEVLLTP-----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLI 109
             HPN++R  +V  T        + +V E+       +           +  +   +Q +
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL 122
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAP 169
            G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T  Y AP
Sbjct: 123 RGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVVTLWYRAP 180
Query: 170 EVLARKEYDGKISDVWSCGVTLYVML 195
           EVL +  Y   + D+WS G     M 
Sbjct: 181 EVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 85/324 (26%), Positives = 124/324 (38%), Gaps = 69/324 (21%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLR-HP 59
           +YE VK+LG G +G+     D+RT E+VAVK I    +   + QR   EI+    L  H 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+    VL       + + +         +  A        ++   QLI  + Y HS  
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS--------------------GLLHSQPKS 159
           + HRD+K  N LL+   +  +K+ DFG S+S                         QP  
Sbjct: 130 LLHRDMKPSNILLNA--ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 160 T--VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML------------------VGAY 199
           T  V T  Y APE+L       K  D+WS G  L  +L                  +G  
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 200 PFEDPEDPRN----FRKTID---------RIRNVQYFLPDY------VRVSADCRH---- 236
            F   ED  +    F KT+          R  N +     +      +   ADC      
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 237 LLSQIFVADPSKRIPIPEIKKHPW 260
           LL ++   +P+KRI   +  KHP+
Sbjct: 308 LLDKLLQFNPNKRISANDALKHPF 331

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER-GKKIDENVQREIINHR 54
            EER+ + + +LG GNFG   L R       T  LVAVK ++  G     + QREI   +
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
           +L    I++++ V   P    L +VMEY   G L  F +   A R        +  Q+  
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICK 125
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G+ Y  S    HRDL   N L++   +  +KI DFG +K  L   +    V  P      
Sbjct: 126 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKL-LPLDKDYYVVREPGQSPIF 182
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
           + APE L+   +  + SDVWS GV LY +  
Sbjct: 183 WYAPESLSDNIFS-RQSDVWSFGVVLYELFT 212

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 118/269 (43%), Gaps = 21/269 (7%)
Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRHPN 60
           EP+ ELG G +GV    R   + ++ AVK I     ++   Q+ +     I+ R++  P 
Sbjct: 37  EPIXELGRGAYGVVEKXRHVPSGQIXAVKRIR--ATVNSQEQKRLLXDLDISXRTVDCPF 94
Query: 61  IIRFKEVLLTPTHLAIVMEY--AAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHS 117
            + F   L     + I  E    +  + + ++   G+   ED        ++  + + HS
Sbjct: 95  TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 154
Query: 118 -MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE----VL 172
            + + HRD+K  N L++   Q  +K CDFG S   +         G   Y APE     L
Sbjct: 155 KLSVIHRDVKPSNVLINALGQ--VKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            +K Y  K SD+WS G+T   + +  +P++    P  F++    +      LP   + SA
Sbjct: 213 NQKGYSVK-SDIWSLGITXIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADKFSA 268
Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +     SQ    +  +R   PE+ +HP+F
Sbjct: 269 EFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER-GKKIDENVQREIINHR 54
            EER+ + + +LG GNFG   L R       T  LVAVK ++  G     + QREI   +
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
           +L    I++++ V   P    L +VMEY   G L  F +   A R        +  Q+  
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICK 126
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G+ Y  S    HRDL   N L++   +  +KI DFG +K  L   +    V  P      
Sbjct: 127 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKL-LPLDKDYYVVREPGQSPIF 183
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
           + APE L+   +  + SDVWS GV LY +  
Sbjct: 184 WYAPESLSDNIFS-RQSDVWSFGVVLYELFT 213

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 49/238 (20%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           ++Y   K LG+G+FG+   V D  + +  A+K + +  +      RE+   + L H NII
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNII 63
Query: 63  RF-----------------------------------KEVLLTPT---HLAIVMEYAAGG 84
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 85  --ELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK 141
             ++      +GR    +    +  QL   V + HS+ ICHRD+K +N L++ S    LK
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 142 ICDFGYSKSGLLHSQPK-STVGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG 197
           +CDFG +K  L+ S+P  + + +  Y APE+ L   EY   I D+WS G     +++G
Sbjct: 183 LCDFGSAKK-LIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIER-GKKIDENVQREIINHR 54
            EER+ + + +LG GNFG   L R       T  LVAVK ++  G     + QREI   +
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 55  SLRHPNIIRFKEVLLTP--THLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLIS 110
           +L    I++++ V   P    L +VMEY   G L  F +   A R        +  Q+  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICK 138
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G+ Y  S    HRDL   N L++   +  +KI DFG +K  L   +    V  P      
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVES--EAHVKIADFGLAKL-LPLDKDYYVVREPGQSPIF 195
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
           + APE L+   +  + SDVWS GV LY +  
Sbjct: 196 WYAPESLSDNIFS-RQSDVWSFGVVLYELFT 225

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG ++  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 13/211 (6%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---- 59
           RYE +K +G G+FG      D +  + VA+K +   K+       EI     LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 60  --NIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
             N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           H   I H DLK EN LL    +  +K+ DFG   S   H +  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 13/211 (6%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---- 59
           RYE +K +G G+FG      D +  + VA+K +   K+       EI     LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 60  --NIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
             N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           H   I H DLK EN LL    +  +K+ DFG   S   H +  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
            Y   I D+WS G  L  +L G YP    ED
Sbjct: 275 RYGMPI-DMWSLGCILAELLTG-YPLLPGED 303

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 8   VKELGSGNFGVARLVR----DKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L R       T E VAVK +  E G     ++++EI   R+L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 62  IRFKEVLLTP--THLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSM 118
           +++K +        + ++ME+   G L   +  +  + +  +   +  Q+  G+ Y  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV----GTPAY-IAPEVLA 173
           +  HRDL   N L++   Q  +KI DFG +K+ +   +   TV     +P +  APE L 
Sbjct: 146 QYVHRDLAARNVLVESEHQ--VKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 174 RKEYDGKISDVWSCGVTLYVMLV 196
           + ++    SDVWS GVTL+ +L 
Sbjct: 203 QSKF-YIASDVWSFGVTLHELLT 224

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 87/325 (26%), Positives = 125/325 (38%), Gaps = 68/325 (20%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI--INHRSLR 57
           +  RYE V  LG G FG V   +  K     VAVK ++   +  E  + EI  + H +  
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 58  HPN----IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISG 111
            PN     ++  E      H+ IV E   G   +  I   G   F  D  R    Q+   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 112 VSYCHSMEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLH 154
           V++ HS ++ H DLK EN L   S                   P +K+ DFG +     H
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL--YVMLVGAYPFEDPEDPRNF-- 210
               + V T  Y APEV+    +  +  DVWS G  L  Y +    +P  D ++      
Sbjct: 191 HS--TLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 211 -------RKTIDRIRNVQYFLPD------------YVR----------VSADCRH----- 236
                  +  I + R  +YF  D            YV           +S D  H     
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           L+ ++   DP+KRI + E  KHP+F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/277 (25%), Positives = 117/277 (42%), Gaps = 53/277 (19%)
Query: 8   VKELGSGN-FGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF-- 64
            +++GSG  + + RL+ ++  K    ++ +   KK+               HPNI++F  
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-------------HPNIVQFCS 93
Query: 65  ------KEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
                 +E         ++ E   G   E   ++ S G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 117 SME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-------SQPKSTV------ 161
             +  I HRDLK+EN LL  S Q  +K+CDFG S + + H       +Q ++ V      
Sbjct: 154 RQKPPIIHRDLKVENLLL--SNQGTIKLCDFG-SATTISHYPDYSWSAQRRALVEEEITR 210
Query: 162 -GTPAYIAPEV--LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 218
             TP Y  PE+  L      G+  D+W+ G  LY++    +PFED            RI 
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--------RIV 262
Query: 219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
           N +Y +P +         L+  +   +P +R+ I E+
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 116/277 (41%), Gaps = 41/277 (14%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           +E +  LG G FG     R+       A+K I   ++    +  E+    SL H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 65  KEVLL-------------TPTHLAIVMEYAAGGELFARICSAGRFSE-DEARFFFQQLIS 110
               L               + L I  EY     L+  I S     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-------LLHSQP------ 157
            +SY HS  I HR+LK  N  +D S    +KI DFG +K+         L SQ       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 158 --KSTVGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
              S +GT  Y+A EVL     Y+ KI D +S G+  +  +   YPF    +  N  K  
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKI-DXYSLGIIFFEXI---YPFSTGXERVNILK-- 239
Query: 215 DRIRNVQY-FLPDYVRVSADCRHLLSQIFV-ADPSKR 249
            ++R+V   F PD+          + ++ +  DP+KR
Sbjct: 240 -KLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKR 275

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV EY   G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG  +  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 1   MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYI--ERGKKIDENVQREIINH 53
            E+R+ + +++LG G+FG   L R       T E VAVK +  E G     ++++EI   
Sbjct: 6   FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 65
Query: 54  RSLRHPNIIRFKEVLLTP--THLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLIS 110
           R+L H NI+++K +        + ++ME+   G L   +  +  + +  +   +  Q+  
Sbjct: 66  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 125
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV----GTPAY 166
           G+ Y  S +  HRDL   N L++   Q  +KI DFG +K+ +   +   TV     +P +
Sbjct: 126 GMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKA-IETDKEXXTVKDDRDSPVF 182
Query: 167 -IAPEVLARKEYDGKISDVWSCGVTLYVMLV 196
             APE L + ++    SDVWS GVTL+ +L 
Sbjct: 183 WYAPECLMQSKF-YIASDVWSFGVTLHELLT 212

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE------RGKKIDENVQREIINHRSL- 56
           RYEPV E+G G +G     RD  +   VA+K +        G  +  +  RE+   R L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  --RHPNIIRFKEVLLTP-----THLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQL 108
              HPN++R  +V  T        + +V E+       +           +  +   +Q 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
           + G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T  Y A
Sbjct: 130 LRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 169 PEVLARKEYDGKISDVWSCGVTLYVML 195
           PEVL +  Y   + D+WS G     M 
Sbjct: 188 PEVLLQSTYATPV-DMWSVGCIFAEMF 213

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 114/256 (44%), Gaps = 25/256 (9%)
Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPNIIR 63
           + +G G+FGV      +   + +   A+K + R  ++   E   RE +  R L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 64  FKEVLLTPTHLA-IVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVSYCHSMEIC 121
              ++L P  L  +++ Y   G+L   I S  R  +  +   F  Q+  G+ Y    +  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGL----LHSQPKSTVGTPA-YIAPEVLARKE 176
           HRDL   N +LD S    +K+ DFG ++  L       Q       P  + A E L    
Sbjct: 147 HRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 177 YDGKISDVWSCGVTLYVMLV-GAYPFE--DPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           +  K SDVWS GV L+ +L  GA P+   DP D  +F     R+   +Y  PD       
Sbjct: 205 FTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY-CPD------S 256
Query: 234 CRHLLSQIFVADPSKR 249
              ++ Q + ADP+ R
Sbjct: 257 LYQVMQQCWEADPAVR 272

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKY---IERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           LG G        R K+T +L A+K    I   + +D  + RE    + L H NI++   +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAI 75
Query: 68  L--LTPTHLAIVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
               T  H  ++ME+   G L+  +    +A    E E     + ++ G+++     I H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 123 RDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR------ 174
           R++K  N +  +    Q   K+ DFG ++      Q  S  GT  Y+ P++  R      
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195
Query: 175 --KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
             K+Y G   D+WS GVT Y    G+ PF   E PR  ++ + +I
Sbjct: 196 HQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 5   YEPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHP 59
           YE +  +G G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHS 117
           NI+ ++   +    L +V  + A G     IC+      +E    +  Q ++  + Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 118 MEICHRDLKLENTLL--DG-----SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           M   HR +K  + L+  DG       +  L +   G  +  ++H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 171 VLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
           VL +  + YD K SD++S G+T   +  G  PF+D
Sbjct: 190 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 5   YEPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGKKIDENV---QREIINHRSLRHP 59
           YE +  +G G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHS 117
           NI+ ++   +    L +V  + A G     IC+      +E    +  Q ++  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 118 MEICHRDLKLENTLL--DG-----SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
           M   HR +K  + L+  DG       +  L +   G  +  ++H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 171 VLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
           VL +  + YD K SD++S G+T   +  G  PF+D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 87/211 (41%), Gaps = 13/211 (6%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---- 59
           RYE +K +G G FG      D +  + VA+K +   K+       EI     LR      
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 60  --NIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
             N+I   E      H+ +  E  +    EL  +    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           H   I H DLK EN LL    +  +K+ DFG   S   H +    + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILGA 274
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPED 206
            Y   I D+WS G  L  +L G YP    ED
Sbjct: 275 RYGMPI-DMWSLGCILAELLTG-YPLLPGED 303

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV E    G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 AVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 108
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV E    G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNI 79
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + IV E    G L  F R   A +F+  +     + + SG+ Y   M 
Sbjct: 80  IRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG 138
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE +A
Sbjct: 139 YVHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            +++    SDVWS G+ L+ VM  G  P+
Sbjct: 195 YRKFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 10  ELGSGNFGVAR--LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
           ELG GNFG  R  + R ++ +  VA+K +++G  K   E + RE      L +P I+R  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSE---DEARFFFQQLISGVSYCHSMEICH 122
            V      L +VME A GG L   +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHS--QPKSTVGTP-AYIAPEVLARKEYD 178
           RDL   N LL    +   KI DFG SK+ G   S    +S    P  + APE +  +++ 
Sbjct: 134 RDLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 179 GKISDVWSCGVTLYVML-VGAYPFEDPEDP 207
            + SDVWS GVT++  L  G  P++  + P
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKKMKGP 220

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 118/258 (45%), Gaps = 30/258 (11%)
Query: 9   KELGSGNFG---VARLVRDKRTKEL-VAVKYIERG----KKIDENVQREIINHRSLRHPN 60
           K +G+G FG      L      KE+ VA+K ++ G    +++D   +  I+   S  H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHN 107
Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           IIR + V+     + I+ EY   G L  F R    G FS  +     + + +G+ Y  +M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVL 172
              HRDL   N L++ +     K+ DFG S+  +L   P++T  T        + APE +
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 173 ARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           + +++    SDVWS G+ ++ VM  G  P+ +  +    +   D  R     LP  +   
Sbjct: 223 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-----LPTPMDCP 276
Query: 232 ADCRHLLSQIFVADPSKR 249
           +    L+ Q +  + ++R
Sbjct: 277 SAIYQLMMQCWQQERARR 294

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKY---IERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           LG G        R K+T +L A+K    I   + +D  + RE    + L H NI++   +
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIVKLFAI 75
Query: 68  L--LTPTHLAIVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
               T  H  ++ME+   G L+  +    +A    E E     + ++ G+++     I H
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVH 135
Query: 123 RDLKLENTL--LDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR------ 174
           R++K  N +  +    Q   K+ DFG ++      Q     GT  Y+ P++  R      
Sbjct: 136 RNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKD 195
Query: 175 --KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
             K+Y G   D+WS GVT Y    G+ PF   E PR  ++ + +I
Sbjct: 196 HQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 33/251 (13%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +GSG+ G     RL    +    VA+K ++ G    E  +R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNI 112
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+       IV EY   G L  F R    G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE +A
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTAPEAIA 227
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            + +    SDVWS GV ++ V+  G  P+ +  +    R  I  +    Y LP       
Sbjct: 228 FRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLP----APM 277
Query: 233 DCRHLLSQIFV 243
            C H L Q+ +
Sbjct: 278 GCPHALHQLML 288

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 86/325 (26%), Positives = 124/325 (38%), Gaps = 68/325 (20%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI--INHRSLR 57
           +  RYE V  LG G FG V   +  K     VAVK ++   +  E  + EI  + H +  
Sbjct: 12  LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTT 71
Query: 58  HPN----IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISG 111
            PN     ++  E      H+ IV E   G   +  I   G   F  D  R    Q+   
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 112 VSYCHSMEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLH 154
           V++ HS ++ H DLK EN L   S                   P +K+ DFG +     H
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190
Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTL--YVMLVGAYPFEDPEDPRNF-- 210
               + V    Y APEV+    +  +  DVWS G  L  Y +    +P  D ++      
Sbjct: 191 HS--TLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 211 -------RKTIDRIRNVQYFLPD------------YVR----------VSADCRH----- 236
                  +  I + R  +YF  D            YV           +S D  H     
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           L+ ++   DP+KRI + E  KHP+F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 119/286 (41%), Gaps = 53/286 (18%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           VK LG+G FG V     +  TK  VAVK ++ G    +    E    ++L+H  ++R   
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+     + I+ EY A G L  F +    G+    +   F  Q+  G++Y       HRD
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 135
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKI 181
           L+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K 
Sbjct: 136 LRAANVLV--SESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGCFTIK- 191
Query: 182 SDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
           SDVWS G+ LY ++  G  P+                           R +AD    LSQ
Sbjct: 192 SDVWSFGILLYEIVTYGKIPYPG-------------------------RTNADVMTALSQ 226
Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 286
            +      R+P  E         N P E+ +I K  +KE   ++PT
Sbjct: 227 GY------RMPRVE---------NCPDELYDIMKMCWKEKAEERPT 257

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 111/251 (44%), Gaps = 33/251 (13%)
Query: 9   KELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNI 61
           K +GSG+ G     RL    +    VA+K ++ G    E  +R+ ++  S+     HPNI
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ERQRRDFLSEASIMGQFDHPNI 112
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+       IV EY   G L  F R    G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLA 173
             HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE +A
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
            + +    SDVWS GV ++ V+  G  P+ +  +    R  I  +    Y LP       
Sbjct: 228 FRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLP----APM 277
Query: 233 DCRHLLSQIFV 243
            C H L Q+ +
Sbjct: 278 GCPHALHQLML 288

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 108/262 (41%), Gaps = 43/262 (16%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKE 66
           +++G GNFG     R +    LVAVK        D   +  +E    +   HPNI+R   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSME 119
           V      + IVME   GG+    + + G      AR   + L+       +G+ Y  S  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFG---------YSKSGLLHSQPKSTVGTPAYIAPE 170
             HRDL   N L+  + +  LKI DFG         Y+ SG L   P        + APE
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVYAASGGLRQVPVK------WTAPE 285
Query: 171 VLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
            L    Y  + SDVWS G+ L+    +GA  YP    +  R F +   R+   +   PD 
Sbjct: 286 ALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE-LCPDA 343
Query: 228 VRVSADCRHLLSQIFVADPSKR 249
           V        L+ Q +  +P +R
Sbjct: 344 V------FRLMEQCWAYEPGQR 359

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 34/216 (15%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKK--ID-ENVQREIINHRSLRHPNIIRFKEV 67
           +G G++G   L  DK T++ VA+K + R  +  ID + + REI     L+   IIR  ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 68  -----LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
                LL    L IV+E  A  +L     +    +E+  +     L+ G ++ H   I H
Sbjct: 94  IIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKS-----------------------GLLHSQPKS 159
           RDLK  N LL+      +K+CDFG +++                         L  Q  S
Sbjct: 153 RDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
            V T  Y APE++  +E   K  D+WS G     +L
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 12/222 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ-----REIIN-HRSL 56
           +RYE    +G G+FG      D+  +E VA+K I+  K      Q      E++N H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGVSYC 115
               I+  K   +   HL +V E  +       R  +    S +  R F QQ+ + + + 
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 116 HS--MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            +  + I H DLK EN LL    +  +KI DFG   S  L  +    + +  Y +PEVL 
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVLL 231
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
              YD  I D+WS G  L  M  G   F    +     K ++
Sbjct: 232 GMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 140
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++ P        + APE LA  ++  K SDVW
Sbjct: 141 RNCLV--GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVW 197
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 198 AFGVLLWEIATYGMSPY 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 141
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++ P        + APE LA  ++  K SDVW
Sbjct: 142 RNCLV--GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVW 198
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 199 AFGVLLWEIATYGMSPY 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 98/210 (46%), Gaps = 18/210 (8%)
Query: 10  ELGSGNFGVAR--LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
           ELG GNFG  R  + R ++ +  VA+K +++G  K   E + RE      L +P I+R  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGRFSE---DEARFFFQQLISGVSYCHSMEICH 122
            V      L +VME A GG L   +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHS--QPKSTVGTP-AYIAPEVLARKEYD 178
           R+L   N LL    +   KI DFG SK+ G   S    +S    P  + APE +  +++ 
Sbjct: 460 RNLAARNVLLVN--RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 179 GKISDVWSCGVTLYVML-VGAYPFEDPEDP 207
            + SDVWS GVT++  L  G  P++  + P
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKKMKGP 546

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 82  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 141 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 199 RTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 255 YNVMVQCWAHKPEDR 269

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 12/222 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ-----REIIN-HRSL 56
           +RYE    +G G+FG      D+  +E VA+K I+  K      Q      E++N H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGVSYC 115
               I+  K   +   HL +V E  +       R  +    S +  R F QQ+ + + + 
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 116 HS--MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            +  + I H DLK EN LL    +  +KI DFG   S  L  +    + +  Y +PEVL 
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVLL 231
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
              YD  I D+WS G  L  M  G   F    +     K ++
Sbjct: 232 GMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 95/222 (42%), Gaps = 12/222 (5%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ-----REIIN-HRSL 56
           +RYE    +G G+FG      D+  +E VA+K I+  K      Q      E++N H + 
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGVSYC 115
               I+  K   +   HL +V E  +       R  +    S +  R F QQ+ + + + 
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 154
Query: 116 HS--MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            +  + I H DLK EN LL    +  +KI DFG   S  L  +    + +  Y +PEVL 
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVLL 212
Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
              YD  I D+WS G  L  M  G   F    +     K ++
Sbjct: 213 GMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 253

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 108/262 (41%), Gaps = 43/262 (16%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFKE 66
           +++G GNFG     R +    LVAVK        D   +  +E    +   HPNI+R   
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI-------SGVSYCHSME 119
           V      + IVME   GG+    + + G      AR   + L+       +G+ Y  S  
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSK---------SGLLHSQPKSTVGTPAYIAPE 170
             HRDL   N L+  + +  LKI DFG S+         SG L   P        + APE
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVXAASGGLRQVPVK------WTAPE 285
Query: 171 VLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
            L    Y  + SDVWS G+ L+    +GA  YP    +  R F +   R+   +   PD 
Sbjct: 286 ALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE-LCPDA 343
Query: 228 VRVSADCRHLLSQIFVADPSKR 249
           V        L+ Q +  +P +R
Sbjct: 344 V------FRLMEQCWAYEPGQR 359

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNIIR 63
           +G+G FG      L    + +  VA+K ++ G    E  +R+ ++  S+     HPN+I 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 98
Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
            + V+   T + I+ E+   G L  F R  + G+F+  +     + + +G+ Y   M   
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
           HRDL   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 158 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 214 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 71
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 72  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 131 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 189 RTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 245 YNVMVQCWAHKPEDR 259

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLI 109
           HPN+IR+     T   L I +E          +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 110 SGVSYCHSMEICHRDLKLENTLLD-----------GSPQPRLKICDFGYSK---SG--LL 153
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K   SG    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 154 HSQPKSTVGTPAYIAPEVL--ARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNF 210
                +  GT  + APE+L  + K    +  D++S G   Y +L  G +PF D      +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-----KY 258
Query: 211 RKTIDRIRNVQYFLPDYVR------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            +  + IR +  F  D ++      + A+   L+SQ+   DP KR    ++ +HP F
Sbjct: 259 SRESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLI 109
           HPN+IR+     T   L I +E          +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 110 SGVSYCHSMEICHRDLKLENTLLD-----------GSPQPRLKICDFGYSK---SG--LL 153
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K   SG    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 154 HSQPKSTVGTPAYIAPEVL--ARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNF 210
                +  GT  + APE+L  + K    +  D++S G   Y +L  G +PF D      +
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD-----KY 258
Query: 211 RKTIDRIRNVQYFLPDYVR------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            +  + IR +  F  D ++      + A+   L+SQ+   DP KR    ++ +HP F
Sbjct: 259 SRESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNIIR 63
           +G+G FG     RL    + +  VA+K ++ G    E  +R+ +   S+     HPNII 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + V+     + IV EY   G L   +  + G+F+  +     + + +G+ Y   M   H
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVH 147
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLARKE 176
           RDL   N L++ +     K+ DFG S+  +L   P++   T        + APE +A ++
Sbjct: 148 RDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPF 201
           +    SDVWS G+ ++ V+  G  P+
Sbjct: 204 FTSA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 81
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 82  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 141 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 199 RTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 254
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 255 YNVMVQCWAHKPEDR 269

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 75
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 76  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 134
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 135 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 193 RTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 248
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 249 YNVMVQCWAHKPEDR 263

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/327 (24%), Positives = 126/327 (38%), Gaps = 68/327 (20%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHR 54
           ++ERYE V  LG G FG V + V  +R    VA+K I+  +K  E  + EI     IN +
Sbjct: 31  LQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEK 90
Query: 55  SLRHPNI-IRFKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGV 112
              + N+ ++  +      H+ I  E        F +  +   +   + R    QL   V
Sbjct: 91  DPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAV 150
Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
            + H  ++ H DLK EN L   S                     +++ DFG   +   H 
Sbjct: 151 KFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHE 208
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
              + V T  Y APEV+    +  +  DVWS G  ++   VG   F+   D R     ++
Sbjct: 209 HHSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQ-THDNREHLAMME 266
Query: 216 RI------------RNVQYF-----------------------LPDYVRVSADCRH---- 236
           RI            R  +YF                       L  Y+   A+  H    
Sbjct: 267 RILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFD 326
Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLK 263
           L+  +   +P+KR+ + E  +HP+F +
Sbjct: 327 LIESMLEYEPAKRLTLGEALQHPFFAR 353

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 71
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 72  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 131 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 189 RTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 245 YNVMVQCWAHKPEDR 259

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 53/291 (18%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + VK+LG+G FG V     +  TK  VAVK ++ G    +    E    ++L+H  +
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 69
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+     + I+ E+ A G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 129
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKE 176
             HRDL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 130 YIHRDLRAANVLV--SESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +  K S+VWS G+ LY ++  G  P+                           R +AD  
Sbjct: 187 FTIK-SNVWSFGILLYEIVTYGKIPYPG-------------------------RTNADVM 220
Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT 286
             LSQ +      R+P          ++N P E+ +I K  +KE   ++PT
Sbjct: 221 SALSQGY------RMP---------RMENCPDELYDIMKMCWKEKAEERPT 256

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 120/290 (41%), Gaps = 61/290 (21%)
Query: 5   YEPVKELGSGNFG--VARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           + P   LG G  G  V R + D R    VAVK I  E     D  VQ   +   S  HPN
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD---VAVKRILPECFSFADREVQ---LLRESDEHPN 79
Query: 61  IIRFK--------EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
           +IR+         + +      A + EY    + FA +         E     QQ  SG+
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKD-FAHLGL-------EPITLLQQTTSGL 131
Query: 113 SYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLL----HSQPKSTVGTPA 165
           ++ HS+ I HRDLK  N L+   +   + +  I DFG  K   +     S+     GT  
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 166 YIAPEVLAR--KEYDGKISDVWSCG-VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222
           +IAPE+L+   KE      D++S G V  YV+  G++PF          K++ R  N+  
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG---------KSLQRQANIL- 241
Query: 223 FLPDYVRVSADCRH-----------LLSQIFVADPSKRIPIPEIKKHPWF 261
                   S DC H           L+ ++   DP KR     + KHP+F
Sbjct: 242 ----LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 71
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 72  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 131 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 189 RTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 245 YNVMVQCWAHKPEDR 259

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 8   VKELGSGNFGVARLVR-DKRTKELVAVKY-------IERGKKIDENVQREIINHRSLRHP 59
           +++LG G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H 
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDHR 75
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM 118
           N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S 
Sbjct: 76  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 134
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKS---GLLHSQPKSTVGTP-AYIAPEVLAR 174
              HRDL   N LL  + +  +KI DFG  ++      H   +     P A+ APE L  
Sbjct: 135 RFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SD W  GVTL+ M       ++P    N  + + +I      LP       D 
Sbjct: 193 RTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 248
Query: 235 RHLLSQIFVADPSKR 249
            +++ Q +   P  R
Sbjct: 249 YNVMVQCWAHKPEDR 263

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE + ++G G FG     R ++T + VA+K +      +       REI   + L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IIRFKEVLLTPTH--------LAIVMEYA----AGGELFARICSAGRFSEDEARFFFQQL 108
           ++   E+  T           + +V ++     AG  L + +    +F+  E +   Q L
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLV--KFTLSEIKRVMQML 134
Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL--HSQPK---STV 161
           ++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +SQP    + V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
            T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE + ++G G FG     R ++T + VA+K +      +       REI   + L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IIRFKEVLLTPTH--------LAIVMEYA----AGGELFARICSAGRFSEDEARFFFQQL 108
           ++   E+  T           + +V ++     AG  L + +    +F+  E +   Q L
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAG--LLSNVLV--KFTLSEIKRVMQML 134
Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL--HSQPK---STV 161
           ++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +SQP    + V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
            T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE + ++G G FG     R ++T + VA+K +      +       REI   + L+H N
Sbjct: 19  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 78
Query: 61  IIRFKEVLLTPTH--------LAIVMEYA----AGGELFARICSAGRFSEDEARFFFQQL 108
           ++   E+  T           + +V ++     AG  L + +    +F+  E +   Q L
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLV--KFTLSEIKRVMQML 134
Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL--HSQPK---STV 161
           ++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +SQP    + V
Sbjct: 135 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRV 190
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
            T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 191 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 137
Query: 128 ENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
            N L+       +K+ DFG S+     +   H+  K  +    + APE LA  ++  K S
Sbjct: 138 RNCLV--GENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-S 191
Query: 183 DVWSCGVTLYVML---VGAYPFEDP 204
           DVW+ GV L+ +    +  YP  DP
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDP 216

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G   +   K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 IV EY   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAA 158
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA   +  K SDVW
Sbjct: 159 RNCLV--GENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK-SDVW 215
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 216 AFGVLLWEIATYGMSPY 232

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNIIR 63
           +G+G FG     RL    +    VA+K ++ G    E  +R+ +   S+     HPN++ 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT--EKQRRDFLCEASIMGQFDHPNVVH 108
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + V+     + IV+E+   G L A +    G+F+  +     + + +G+ Y   M   H
Sbjct: 109 LEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVH 168
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA------YIAPEVLARKE 176
           RDL   N L++ +     K+ DFG S+  ++   P++   T        + APE +  ++
Sbjct: 169 RDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +    SDVWS G+ ++ VM  G  P+ D
Sbjct: 225 FTSA-SDVWSYGIVMWEVMSYGERPYWD 251

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 30/213 (14%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHPN 60
           +YE + ++G G FG     R ++T + VA+K +      +       REI   + L+H N
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 61  IIRFKEVLLTPTH--------LAIVMEYA----AGGELFARICSAGRFSEDEARFFFQQL 108
           ++   E+  T           + +V ++     AG  L + +    +F+  E +   Q L
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNVLV--KFTLSEIKRVMQML 133
Query: 109 ISGVSYCHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLL--HSQPK---STV 161
           ++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +SQP    + V
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNRV 189
Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVM 194
            T  Y  PE+L  +   G   D+W  G  +  M
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I++E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I++E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 46/288 (15%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKK-----IDE-NVQREIINHRSL- 56
           +  ++++GSG FG       K  K L    Y I+R KK     +DE N  RE+  H  L 
Sbjct: 9   FHELEKIGSGEFGSVF----KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 64
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
           +H +++R+        H+ I  EY  GG L   I    R    F E E +    Q+  G+
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPR-----------------LKICDFGYSKSGLLHS 155
            Y HSM + H D+K  N  +  +  P                   KI D G+       S
Sbjct: 125 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---S 181
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
            P+   G   ++A EVL         +D+++  +T+ V   GA P      PRN  +   
Sbjct: 182 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL-----PRNGDQW-H 234
Query: 216 RIRNVQYFLPDYVRV-SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
            IR  Q  LP   +V S +   LL  +   DP +R     + KH   L
Sbjct: 235 EIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I++E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 137
Query: 128 ENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
            N L+       +K+ DFG S+     +   H+  K  +    + APE LA  ++  K S
Sbjct: 138 RNCLV--GENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-S 191
Query: 183 DVWSCGVTLYVML---VGAYPFEDP 204
           DVW+ GV L+ +    +  YP  DP
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDP 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 144
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 145 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 201
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 202 AFGVLLWEIATYGMSPY 218

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 46/288 (15%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKK-----IDE-NVQREIINHRSL- 56
           +  ++++GSG FG       K  K L    Y I+R KK     +DE N  RE+  H  L 
Sbjct: 11  FHELEKIGSGEFGSVF----KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
           +H +++R+        H+ I  EY  GG L   I    R    F E E +    Q+  G+
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPR-----------------LKICDFGYSKSGLLHS 155
            Y HSM + H D+K  N  +  +  P                   KI D G+       S
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---S 183
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
            P+   G   ++A EVL         +D+++  +T+ V   GA P      PRN  +   
Sbjct: 184 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQW-H 236
Query: 216 RIRNVQYFLPDYVRV-SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
            IR  Q  LP   +V S +   LL  +   DP +R     + KH   L
Sbjct: 237 EIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 46/288 (15%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKK-----IDE-NVQREIINHRSL- 56
           +  ++++GSG FG       K  K L    Y I+R KK     +DE N  RE+  H  L 
Sbjct: 11  FHELEKIGSGEFGSVF----KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 66
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
           +H +++R+        H+ I  EY  GG L   I    R    F E E +    Q+  G+
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPR-----------------LKICDFGYSKSGLLHS 155
            Y HSM + H D+K  N  +  +  P                   KI D G+       S
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---S 183
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
            P+   G   ++A EVL         +D+++  +T+ V   GA P      PRN  +   
Sbjct: 184 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQW-H 236
Query: 216 RIRNVQYFLPDYVRV-SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
            IR  Q  LP   +V S +   LL  +   DP +R     + KH   L
Sbjct: 237 EIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 46/288 (15%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKY-IERGKK-----IDE-NVQREIINHRSL- 56
           +  ++++GSG FG       K  K L    Y I+R KK     +DE N  RE+  H  L 
Sbjct: 13  FHELEKIGSGEFGSVF----KCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
           +H +++R+        H+ I  EY  GG L   I    R    F E E +    Q+  G+
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPR-----------------LKICDFGYSKSGLLHS 155
            Y HSM + H D+K  N  +  +  P                   KI D G+       S
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---S 185
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
            P+   G   ++A EVL         +D+++  +T+ V   GA P      PRN  +   
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQW-H 238
Query: 216 RIRNVQYFLPDYVRV-SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL 262
            IR  Q  LP   +V S +   LL  +   DP +R     + KH   L
Sbjct: 239 EIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N L+D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 93/227 (40%), Gaps = 37/227 (16%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--ID-ENVQREIINHRSLRHP 59
           + YE    +G G++G   L  DK   + VA+K + R  +  ID + + REI     L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 60  NIIRFKEV-----LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            IIR  ++     LL    L IV+E  A  +L     +    +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS------------------------ 150
            H   I HRDLK  N LL+      +KICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 151 --GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
               L  Q  S V T  Y APE++  +E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 86/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I++E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 144
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 145 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 201
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 202 AFGVLLWEIATYGMSPY 218

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLI 109
           HPN+IR+     T   L I +E          +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 110 SGVSYCHSMEICHRDLKLENTLLD-----------GSPQPRLKICDFGYSK-----SGLL 153
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 154 HSQPKSTVGTPAYIAPEV------LARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED 206
            +   +  GT  + APE+      L  K    +  D++S G   Y +L  G +PF D   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--- 242
Query: 207 PRNFRKTIDRIRNVQYFLPDYVR------VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
              + +  + IR +  F  D ++      + A+   L+SQ+   DP KR    ++ +HP 
Sbjct: 243 --KYSRESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 261 F 261
           F
Sbjct: 299 F 299

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 10/202 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL  
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAA 137
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G   +          + APE LA  ++  K SDVW
Sbjct: 138 RNCLV--GENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 194
Query: 186 SCGVTLYVML---VGAYPFEDP 204
           + GV L+ +    +  YP  DP
Sbjct: 195 AFGVLLWEIATYGMSPYPGIDP 216

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 144
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 145 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 201
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 202 AFGVLLWEIATYGMSPY 218

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--------FFQQLI 109
           HPN+IR+     T   L I +E          +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 110 SGVSYCHSMEICHRDLKLENTLLD-----------GSPQPRLKICDFGYSK---SG--LL 153
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K   SG    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 154 HSQPKSTVGTPAYIAPEV------LARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED 206
                +  GT  + APE+      L  K    +  D++S G   Y +L  G +PF D   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD--- 242
Query: 207 PRNFRKTIDRIRNVQYFLPDYVR------VSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
              + +  + IR +  F  D ++      + A+   L+SQ+   DP KR    ++ +HP 
Sbjct: 243 --KYSRESNIIRGI--FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 261 F 261
           F
Sbjct: 299 F 299

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 112/262 (42%), Gaps = 18/262 (6%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRHPNIIRFKE 66
           E+G G+F       D  T   VA   ++  K      QR   E    + L+HPNI+RF +
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 67  VLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--I 120
              +       + +V E    G L   +           R + +Q++ G+ + H+    I
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK +N  + G P   +KI D G + +    S  K+ +GTP + APE    K YD  
Sbjct: 153 IHRDLKCDNIFITG-PTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YDES 209
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           + DV++ G          YP+ + ++    +R+    ++   +   D V +  + + ++ 
Sbjct: 210 V-DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASF---DKVAI-PEVKEIIE 264
Query: 240 QIFVADPSKRIPIPEIKKHPWF 261
                +  +R  I ++  H +F
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFF 286

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 109/266 (40%), Gaps = 41/266 (15%)
Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNII 62
           +EP++ LG G FGV    ++K      A+K I    +    E V RE+     L HP I+
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 63  RFKEVLL-----------TP-THLAIVMEYAAGGELFARI---CSAGRFSEDEARFFFQQ 107
           R+    L           +P  +L I M+      L   +   C+            F Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY--------SKSGLLHSQP-- 157
           +   V + HS  + HRDLK  N     +    +K+ DFG          +  +L   P  
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFF--TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 158 ---KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
                 VGT  Y++PE +    Y  K+ D++S G+ L+ +L   YPF    +     +T+
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPFSTQMER---VRTL 237
Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQ 240
             +RN+++  P        C +++ Q
Sbjct: 238 TDVRNLKF--PPLFTQKYPCEYVMVQ 261

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I++E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 140
Query: 128 ENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
            N L+       +K+ DFG S+     +   H+  K  +    + APE LA  ++  K S
Sbjct: 141 RNCLV--GENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-S 194
Query: 183 DVWSCGVTLY-VMLVGAYPF 201
           DVW+ GV L+ +   G  P+
Sbjct: 195 DVWAFGVLLWEIATYGMSPY 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 143
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 144 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 200
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 201 AFGVLLWEIATYGMSPY 217

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 141
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 142 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 198
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 199 AFGVLLWEIATYGMSPY 215

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/331 (23%), Positives = 121/331 (36%), Gaps = 66/331 (19%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           ++ERYE V  LG G FG V   +   R K  VA+K I    K  E  + EI   + ++  
Sbjct: 49  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 108
Query: 60  NI-IRFKEVLLTPT-----HLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGV 112
           +   +F  VL++       H+ I  E        F +  +   +     R    QL   +
Sbjct: 109 DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 168
Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
            + H  ++ H DLK EN L   S                     +++ DFG   +   H 
Sbjct: 169 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 226
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----- 210
              + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+  +      
Sbjct: 227 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 211 ------RKTIDRIRNVQYFL----------PDYVRVSADCR-----------------HL 237
                    I R R  +YF            D   V  +C+                  L
Sbjct: 286 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 345
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           + ++   DP++RI + E   HP+F    P+E
Sbjct: 346 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 376

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 11  LGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR----HPNIIR 63
           +G+G FG      L    + +  VA+K ++ G    E  +R+ ++  S+     HPN+I 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIH 72
Query: 64  FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
            + V+   T + I+ E+   G L  F R  + G+F+  +     + + +G+ Y   M   
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------YIAPEVLA 173
           HR L   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 132 HRALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +++    SDVWS G+ ++ VM  G  P+ D
Sbjct: 188 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 217

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 152
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 153 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 209
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 210 AFGVLLWEIATYGMSPY 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 141
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 142 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 198
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 199 AFGVLLWEIATYGMSPY 215

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 144
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 145 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 201
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 202 AFGVLLWEIATYGMSPY 218

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 78/331 (23%), Positives = 121/331 (36%), Gaps = 66/331 (19%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           ++ERYE V  LG G FG V   +   R K  VA+K I    K  E  + EI   + ++  
Sbjct: 17  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 76
Query: 60  NI-IRFKEVLLTPT-----HLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGV 112
           +   +F  VL++       H+ I  E        F +  +   +     R    QL   +
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
            + H  ++ H DLK EN L   S                     +++ DFG   +   H 
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 194
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----- 210
              + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+  +      
Sbjct: 195 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 211 ------RKTIDRIRNVQYFL----------PDYVRVSADCR-----------------HL 237
                    I R R  +YF            D   V  +C+                  L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           + ++   DP++RI + E   HP+F    P+E
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 78/331 (23%), Positives = 121/331 (36%), Gaps = 66/331 (19%)
Query: 1   MEERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           ++ERYE V  LG G FG V   +   R K  VA+K I    K  E  + EI   + ++  
Sbjct: 26  LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEK 85
Query: 60  NI-IRFKEVLLTPT-----HLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQLISGV 112
           +   +F  VL++       H+ I  E        F +  +   +     R    QL   +
Sbjct: 86  DKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 145
Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
            + H  ++ H DLK EN L   S                     +++ DFG   +   H 
Sbjct: 146 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 203
Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----- 210
              + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+  +      
Sbjct: 204 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 262
Query: 211 ------RKTIDRIRNVQYFL----------PDYVRVSADCR-----------------HL 237
                    I R R  +YF            D   V  +C+                  L
Sbjct: 263 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 322
Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           + ++   DP++RI + E   HP+F    P+E
Sbjct: 323 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 140 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 196
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 197 AFGVLLWEIATYGMSPY 213

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 59  PNIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           PNII   +++  P     A+V E+    + F ++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           SM I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 177 YDGKISDVWSCGVTLYVMLVGAYPF 201
                 D+WS G  L  M+    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 86/200 (43%), Gaps = 14/200 (7%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HRDL  
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 144
Query: 128 ENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
            N L+       +K+ DFG S+     +   H+  K  +    + APE LA  ++  K S
Sbjct: 145 RNCLV--GENHLVKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-S 198
Query: 183 DVWSCGVTLY-VMLVGAYPF 201
           DVW+ GV L+ +   G  P+
Sbjct: 199 DVWAFGVLLWEIATYGMSPY 218

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--ID-ENVQREIINHRSLRHP 59
           +RYE    +G+G++G      DK  K +VA+K I R  +  ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 60  NIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQLISGVS 113
           ++++  ++++         L +V+E A     F ++     + +E   +     L+ GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------------------------ 149
           Y HS  I HRDLK  N L++      +K+CDFG ++                        
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 150 ----SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
               +  L  Q    V T  Y APE++  +E   +  DVWS G     +L
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    S     +   Q+ S + Y       HR+L  
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 347 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 403
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 404 AFGVLLWEIATYGMSPY 420

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF----SEDEARFFFQ- 106
               H N++        P   L +++E+   G L   + S    F     ED  + F   
Sbjct: 89  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 107 --------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK 158
                   Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   +   P 
Sbjct: 148 EHLIXYSFQVAKGMEFLASRKXIHRDLAARNILL--SEKNVVKICDFGLARD--IXKDPD 203
Query: 159 STVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRK 212
                 A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F +
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 213 TI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 82/351 (23%), Positives = 134/351 (38%), Gaps = 74/351 (21%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI----------- 50
           + RY  V++LG G+F    L +D      VA+K +   K   E  + EI           
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 51  INHRSLRHPNIIRFKEVL--LTPTHLAIVMEYAAGGE-LFARICSAGRFSEDEARFFF-- 105
               S+   +I++  +      P  + +VM +   GE L A I    ++        +  
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI---KKYEHRGIPLIYVK 134
Query: 106 ---QQLISGVSYCH-SMEICHRDLKLENTLLDGSPQP----RLKICDFGYSKSGLLHSQP 157
              +QL+ G+ Y H    I H D+K EN L++    P    ++KI D G   +       
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192
Query: 158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
            +++ T  Y +PEVL    + G  +D+WS    ++ ++ G + FE P++  ++ K  D I
Sbjct: 193 TNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSYTKDDDHI 250
Query: 218 RNV--------QYFLPD--YVRVSADCRHLLSQI-------------------------- 241
             +         Y L +  Y R   + R LL  I                          
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 242 --FVA-----DPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQP 285
             F++     DP KR     +  HPW    L  E I +       +G D P
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIP 361

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I +     +    E      LRH N+++   V
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 68  LLTPTH-LAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
           ++     L IV EY A G L   + S GR     D    F   +   + Y       HRD
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
           L   N L+  S     K+ DFG +K     S  + T   P  + APE L  K++  K SD
Sbjct: 143 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SD 196
Query: 184 VWSCGVTLY 192
           VWS G+ L+
Sbjct: 197 VWSFGILLW 205

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 81/359 (22%), Positives = 132/359 (36%), Gaps = 90/359 (25%)
Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI----------- 50
           + RY  V++LG G+F    L +D      VA+K +   K   E  + EI           
Sbjct: 18  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 51  --------------INHRSLRHPNIIRFKEV--LLTPTHLAIVMEYAAGGELFARICSAG 94
                         ++H + + PN +    V  +L    LA++ +Y   G     +    
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 95  RFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLLDGSPQP----RLKICDFGYSK 149
           +           QL+ G+ Y H    I H D+K EN L++    P    ++KI D G   
Sbjct: 138 K-----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--N 184
Query: 150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN 209
           +        +++ T  Y +PEVL    + G  +D+WS    ++ ++ G + FE P++  +
Sbjct: 185 ACWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHS 242
Query: 210 FRKTIDRIRNV--------QYFLPD--YVRVSADCRHLLSQI------------------ 241
           + K  D I  +         Y L +  Y R   + R LL  I                  
Sbjct: 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 302
Query: 242 ----------FVA-----DPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQP 285
                     F++     DP KR     +  HPW    L  E I +       +G D P
Sbjct: 303 SKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIP 361

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I +     +    E      LRH N+++   V
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 68  LLTPTH-LAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
           ++     L IV EY A G L   + S GR     D    F   +   + Y       HRD
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 127
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
           L   N L+  S     K+ DFG +K     S  + T   P  + APE L  K++  K SD
Sbjct: 128 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SD 181
Query: 184 VWSCGVTLY 192
           VWS G+ L+
Sbjct: 182 VWSFGILLW 190

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           K+LG+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +++   V
Sbjct: 188 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSMEICHRDL 125
           + T   + I+ E+ A G L   + S     +   +   F  Q+  G+++       HRDL
Sbjct: 246 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
           +  N L+  S     KI DFG ++ G      K  +    + APE +    +  K SDVW
Sbjct: 305 RAANILVSASLV--CKIADFGLARVG-----AKFPI---KWTAPEAINFGSFTIK-SDVW 353
Query: 186 SCGVTLY-VMLVGAYPFEDPEDPRNFR 211
           S G+ L  ++  G  P+    +P   R
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIR 380

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 44/287 (15%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R    K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSAGR------------FSEDE 100
               H N++        P   L +++E+   G L   + S                + + 
Sbjct: 87  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--- 157
              +  Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P   
Sbjct: 146 LICYSFQVAKGMEFLASRKXIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYV 201
Query: 158 -KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI 214
            K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F + +
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 260
Query: 215 ---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
               R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 300

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-------GRFSEDEARFFF 105
               H N++        P   L +++E+   G L   + S            ED  + F 
Sbjct: 89  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 148 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 203
Query: 157 P----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P    K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 204 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 262
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 263 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 306

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 47/290 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R    K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSAG------RFSEDEARFFFQ 106
               H N++        P   L +++E+   G L   + S        +  ED  + F  
Sbjct: 88  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 107 ---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157
                    Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   +   P
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXKDP 202
Query: 158 KSTVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
                  A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F 
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261
Query: 212 KTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 262 RRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/189 (31%), Positives = 82/189 (43%), Gaps = 13/189 (6%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I +     +    E      LRH N+++   V
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 68  LLTPTH-LAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
           ++     L IV EY A G L   + S GR     D    F   +   + Y       HRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
           L   N L+  S     K+ DFG +K     S  + T   P  + APE L  K++  K SD
Sbjct: 315 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SD 368
Query: 184 VWSCGVTLY 192
           VWS G+ L+
Sbjct: 369 VWSFGILLW 377

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 123
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L +++E+   G L   + S    F       ED  + F 
Sbjct: 124 IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 183 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 238
Query: 157 P----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P    K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 239 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 297
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 341

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L +++E+   G L   + S    F       ED  + F 
Sbjct: 87  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 201
Query: 157 PKSTVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P       A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L +++E+   G L   + S    F       ED  + F 
Sbjct: 87  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 201
Query: 157 P----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P    K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 60  NIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           NII+  + +  P     A+V EY    + F ++      ++ + RF+  +L+  + YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
             I HRD+K  N ++D   Q +L++ D+G ++      +    V +  +  PE+L   + 
Sbjct: 156 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED 206
                D+WS G  L  M+    PF   +D
Sbjct: 215 YDYSLDMWSLGCMLASMIFRREPFFHGQD 243

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 8/197 (4%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V  
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
                 I+ E+   G L  + R C+    +     +   Q+ S + Y       HR+L  
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAA 385
Query: 128 ENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVW 185
            N L+       +K+ DFG S+  +G  ++          + APE LA  ++  K SDVW
Sbjct: 386 RNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVW 442
Query: 186 SCGVTLY-VMLVGAYPF 201
           + GV L+ +   G  P+
Sbjct: 443 AFGVLLWEIATYGMSPY 459

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 30/218 (13%)
Query: 9   KELGSGNFGVARLVR-----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNII 62
           +ELG G FG   L        ++ K LVAVK ++       ++  RE     +L+H +I+
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAG-------------RFSEDEARFFFQQLI 109
           +F  V +    L +V EY   G+L   + + G               ++ +     QQ+ 
Sbjct: 79  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138
Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---- 165
           +G+ Y  S    HRDL   N L+       +KI DFG S+   ++S     VG       
Sbjct: 139 AGMVYLASQHFVHRDLATRNCLV--GENLLVKIGDFGMSRD--VYSTDYYRVGGHTMLPI 194
Query: 166 -YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 195 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 231

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 60  NIIRFKEVLLTPTHL--AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           NII+  + +  P     A+V EY    + F ++      ++ + RF+  +L+  + YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
             I HRD+K  N ++D   Q +L++ D+G ++      +    V +  +  PE+L   + 
Sbjct: 151 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPED 206
                D+WS G  L  M+    PF   +D
Sbjct: 210 YDYSLDMWSLGCMLASMIFRREPFFHGQD 238

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIR 63
            ++G G FGV  + +       VAVK +        +++ +   +EI      +H N++ 
Sbjct: 37  NKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGR--FSEDEARFFFQQLISGVSYCHSMEI 120
                     L +V  Y   G L  R+ C  G    S        Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
            HRD+K  N LLD +     KI DFG +++    +Q       VGT AY+APE L R E 
Sbjct: 155 IHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL-RGEI 211
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
             K SD++S GV L  ++ G    ++  +P+
Sbjct: 212 TPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L ++ E+   G L   + S    F       ED  + F 
Sbjct: 78  IG-HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 192
Query: 157 P----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P    K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 252 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 30/212 (14%)
Query: 5   YEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           ++ ++ +GSG FG    A+   D +T  +  VKY       +E  +RE+     L H NI
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN------NEKAEREVKALAKLDHVNI 66
Query: 62  IRF---------------KEVLLTPTH-LAIVMEYAAGGELFARICS--AGRFSEDEARF 103
           + +               K    + T  L I ME+   G L   I      +  +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
            F+Q+  GV Y HS ++ +RDLK  N  L  + Q  +KI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
             Y++PE ++ ++Y GK  D+++ G+ L  +L
Sbjct: 185 LRYMSPEQISSQDY-GKEVDLYALGLILAELL 215

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L ++ E+   G L   + S    F       ED  + F 
Sbjct: 78  IG-HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKD 192
Query: 157 P----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P    K     P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 252 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIR 63
            ++G G FGV  + +       VAVK +        +++ +   +EI      +H N++ 
Sbjct: 37  NKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGR--FSEDEARFFFQQLISGVSYCHSMEI 120
                     L +V  Y   G L  R+ C  G    S        Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
            HRD+K  N LLD +     KI DFG +++    +Q       VGT AY+APE L R E 
Sbjct: 155 IHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEI 211
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
             K SD++S GV L  ++ G    ++  +P+
Sbjct: 212 TPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L +++E+   G L   + S    F       ED  + F 
Sbjct: 78  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   +   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXKD 192
Query: 157 PKSTVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P       A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 252 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L +++E+   G L   + S    F       ED  + F 
Sbjct: 87  IG-HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   +   
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXKD 201
Query: 157 PKSTVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P       A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 17/211 (8%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIR 63
            ++G G FGV  + +       VAVK +        +++ +   +EI      +H N++ 
Sbjct: 31  NKMGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGR--FSEDEARFFFQQLISGVSYCHSMEI 120
                     L +V  Y   G L  R+ C  G    S        Q   +G+++ H    
Sbjct: 89  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEY 177
            HRD+K  N LLD +     KI DFG +++    +Q       VGT AY+APE L R E 
Sbjct: 149 IHRDIKSANILLDEAFTA--KISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEI 205
Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
             K SD++S GV L  ++ G    ++  +P+
Sbjct: 206 TPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E     VK LGSG FG       +   +  K  VA+K +      K ++ +  E      
Sbjct: 16  ETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSY 114
           +  P + R   + LT T + +V +    G L   +  + GR    +   +  Q+  G+SY
Sbjct: 76  VGSPYVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA---YIAPEV 171
              + + HRDL   N L+  SP   +KI DFG ++   +        G      ++A E 
Sbjct: 135 LEDVRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 172 LARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           + R+ +  + SDVWS GVT++ +M  GA P++
Sbjct: 193 ILRRRFTHQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P    K    
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 254
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI---DRI 217
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F + +    R+
Sbjct: 255 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 313
Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 314 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 347

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P    K    
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 263
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+     D E  R  ++   R
Sbjct: 264 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-R 321
Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           +R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 322 MRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 356

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P    K    
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 256
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI---DRI 217
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F + +    R+
Sbjct: 257 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 316 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 349

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P    K    
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYVRKGDAR 261
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE----DPEDPRNFRKTIDR 216
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+     D E  R  ++   R
Sbjct: 262 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-R 319
Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           +R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 320 MRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 354

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 185
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 186 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 120/291 (41%), Gaps = 48/291 (16%)
Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINH 53
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 54  RSLRHPNIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSA-GRF------SEDEARFFF 105
               H N++        P   L ++ E+   G L   + S    F       ED  + F 
Sbjct: 78  IG-HHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 106 Q---------QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                     Q+  G+ +  S +  HRDL   N LL  S +  +KICDFG ++   +   
Sbjct: 137 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IXKD 192
Query: 157 PKSTVGTPA-----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNF 210
           P       A     ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF 251
Query: 211 RKTI---DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            + +    R+R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 252 CRRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 295

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 2   EERYEPVKELGSGNFGVAR---LVRDKRTKEL-VAVKYIER--GKKIDENVQREIINHRS 55
           E   + VK LGSG FG       V +  T ++ VA+K +    G K +     E +   S
Sbjct: 14  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSY 114
           + HP+++R   V L+PT + +V +    G L   +              +  Q+  G+ Y
Sbjct: 74  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 132
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
                + HRDL   N L+  SP   +KI DFG ++  LL    K            ++A 
Sbjct: 133 LEERRLVHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMAL 188
Query: 170 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           E +  +++  + SDVWS GVT++ +M  G  P++
Sbjct: 189 ECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           K+LG+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +++   V
Sbjct: 21  KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSMEICHRDL 125
           + T   + I+ E+ A G L   + S     +   +   F  Q+  G+++       HRDL
Sbjct: 79  V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K S
Sbjct: 138 RAANILVSASLV--CKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 193
Query: 183 DVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
           DVWS G+ L  ++  G  P+    +P   R
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR 223

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 80/189 (42%), Gaps = 13/189 (6%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I +     +    E      LRH N+++   V
Sbjct: 17  LQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 68  LLT-PTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
           ++     L IV EY A G L   + S GR     D    F   +   + Y       HRD
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 133
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-YIAPEVLARKEYDGKISD 183
           L   N L+  S     K+ DFG +K     S  + T   P  + APE L    +  K SD
Sbjct: 134 LAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREAAFSTK-SD 187
Query: 184 VWSCGVTLY 192
           VWS G+ L+
Sbjct: 188 VWSFGILLW 196

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 21/256 (8%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSL- 56
            ++ ++ +  LG G++G    VR K    L AVK      RG K       E+ +H  + 
Sbjct: 55  FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSY 114
           +HP  +R ++       L +  E    G    + C A   S  EA+   + +  +  +++
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS  + H D+K  N  L   P+ R K+ DFG           +   G P Y+APE+L +
Sbjct: 173 LHSQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-Q 229
Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR-VSAD 233
             Y G  +DV+S G+T+   L  A   E P     +++    +R   Y  P++   +S++
Sbjct: 230 GSY-GTAADVFSLGLTI---LEVACNMELPHGGEGWQQ----LRQ-GYLPPEFTAGLSSE 280
Query: 234 CRHLLSQIFVADPSKR 249
            R +L  +   DP  R
Sbjct: 281 LRSVLVMMLEPDPKLR 296

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 2   EERYEPVKELGSGNFGVAR---LVRDKRTKEL-VAVKYIER--GKKIDENVQREIINHRS 55
           E   + VK LGSG FG       V +  T ++ VA+K +    G K +     E +   S
Sbjct: 37  ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 96
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSY 114
           + HP+++R   V L+PT + +V +    G L   +              +  Q+  G+ Y
Sbjct: 97  MDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMY 155
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAP 169
                + HRDL   N L+  SP   +KI DFG ++  LL    K            ++A 
Sbjct: 156 LEERRLVHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMAL 211
Query: 170 EVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           E +  +++  + SDVWS GVT++ +M  G  P++
Sbjct: 212 ECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 98  EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP 157
           ED   + FQ +  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P
Sbjct: 199 EDLISYSFQ-VARGMEFLSSRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKNP 253
Query: 158 ----KSTVGTP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
               K     P  ++APE +  K Y  K SDVWS GV L+ +  +G  P+   +   +F 
Sbjct: 254 DYVRKGDTRLPLKWMAPESIFDKIYSTK-SDVWSYGVLLWEIFSLGGSPYPGVQMDEDFC 312
Query: 212 KTID---RIRNVQYFLPDYVRVSADCRH 236
             +    R+R  +Y  P+  ++  DC H
Sbjct: 313 SRLREGMRMRAPEYSTPEIYQIMLDCWH 340

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 12  GSGNFGVARLVRDKRTKELVAVKYIE-----RGKKIDENVQREIINHRSLRHPNIIRFKE 66
           G G FGV  + +       VAVK +        +++ +   +EI      +H N++    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 67  VLLTPTHLAIVMEYAAGGELFARI-CSAGR--FSEDEARFFFQQLISGVSYCHSMEICHR 123
                  L +V  Y   G L  R+ C  G    S        Q   +G+++ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGK 180
           D+K  N LLD +     KI DFG +++    +Q       VGT AY APE L R E   K
Sbjct: 149 DIKSANILLDEAFTA--KISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPK 205
Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
            SD++S GV L  ++ G    ++  +P+
Sbjct: 206 -SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 14/210 (6%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           K+LG+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +++   V
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSMEICHRDL 125
           + T   + I+ E+ A G L   + S     +   +   F  Q+  G+++       HRDL
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP---AYIAPEVLARKEYDGKIS 182
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K S
Sbjct: 311 RAANILVSASLV--CKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 366
Query: 183 DVWSCGVTLY-VMLVGAYPFEDPEDPRNFR 211
           DVWS G+ L  ++  G  P+    +P   R
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIR 396

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 186
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 187
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 188 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 44/281 (15%)
Query: 9   KELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP 59
           K LG G FG      A  +    T   VAVK ++ G    E+     + +I+ H    H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG-HHL 91
Query: 60  NIIRFKEVLLTPTH-LAIVMEYAAGGELFARICSAGR------------FSEDEARFFFQ 106
           N++        P   L +++E+   G L   + S                + +    +  
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----KSTVG 162
           Q+  G+ +  S +  HRDL   N LL  S +  +KI DFG ++   ++  P    K    
Sbjct: 152 QVAKGMEFLASRKXIHRDLAARNILL--SEKNVVKIXDFGLARD--IYKDPDYVRKGDAR 207
Query: 163 TP-AYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI---DRI 217
            P  ++APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F + +    R+
Sbjct: 208 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRM 266
Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           R   Y  P+  +   DC H        +PS+R    E+ +H
Sbjct: 267 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 300

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 188
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 189 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 185
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 186 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 118/289 (40%), Gaps = 53/289 (18%)
Query: 9   KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNI 61
           K LG G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELF-----ARICSAGRFSE------------DEARFF 104
           I+          L +++EYA  G L      +R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 105 FQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SG 151
              LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSX 206
Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPR 208
           +  SQ +  V    ++A E L    Y  + SDVWS GV L+ ++ +G   YP   PE   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           N  KT  R+       PD    S +   L+ Q +  +P KR    +I K
Sbjct: 263 NLLKTGHRMER-----PD--NCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 157
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++  L      +H++  + +    ++A E L  ++
Sbjct: 158 RDLAARNCMLD--EKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQK 214
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 215 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 270
Query: 231 SADCRH 236
              C H
Sbjct: 271 MLKCWH 276

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRS 55
           E     +K LGSG FG       +   +  K  V +K IE   G++  + V   ++   S
Sbjct: 30  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 89
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSY 114
           L H +I+R    L   + L +V +Y   G L   +    G         +  Q+  G+ Y
Sbjct: 90  LDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIA 168
                + HR+L   N LL    Q  +++ DFG +         LL+S+ K+ +    ++A
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPI---KWMA 203
Query: 169 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            E +   +Y  + SDVWS GVT++ +M  GA P+
Sbjct: 204 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 118/289 (40%), Gaps = 53/289 (18%)
Query: 9   KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNI 61
           K LG G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELF-----ARICSAGRFSE------------DEARFF 104
           I+          L +++EYA  G L      +R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 105 FQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SG 151
              LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSY 206
Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPR 208
           +  SQ +  V    ++A E L    Y  + SDVWS GV L+ ++ +G   YP   PE   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           N  KT  R+       PD    S +   L+ Q +  +P KR    +I K
Sbjct: 263 NLLKTGHRMER-----PD--NCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 117/289 (40%), Gaps = 53/289 (18%)
Query: 9   KELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNI 61
           K LG G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELF-----ARICSAGRFSE------------DEARFF 104
           I+          L +++EYA  G L      +R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 105 FQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SG 151
              LIS       G+ Y   M + HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSX 206
Query: 152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGA--YPFEDPEDPR 208
           +  SQ +  V    ++A E L    Y  + SDVWS GV L+ ++ +G   YP   PE   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           N  KT  R+       PD    S +   L+ Q +  +P KR    +I K
Sbjct: 263 NLLKTGHRMER-----PD--NCSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 155
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 156 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV-KWMALESLQTQK 212
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 213 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 268
Query: 231 SADCRH 236
              C H
Sbjct: 269 MLKCWH 274

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 5   YEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           ++ ++ +GSG FG    A+   D +T  +  VKY       +E  +RE+     L H NI
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYN------NEKAEREVKALAKLDHVNI 67
Query: 62  IRF----------------------------KEVLLTPTH-LAIVMEYAAGGELFARICS 92
           + +                            K    + T  L I ME+   G L   I  
Sbjct: 68  VHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 127
Query: 93  --AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS 150
               +  +  A   F+Q+  GV Y HS ++ HRDLK  N  L  + Q  +KI DFG   S
Sbjct: 128 RRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQ--VKIGDFGLVTS 185
Query: 151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML 195
                +   + GT  Y++PE ++ ++Y GK  D+++ G+ L  +L
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 229

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 174
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 175 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 231
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 232 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 287
Query: 231 SADCRH 236
              C H
Sbjct: 288 MLKCWH 293

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 2   EERYEPVKELGSGNFGVAR----LVRDKRTKELVAVKYIE--RGKKIDENVQREIINHRS 55
           E     +K LGSG FG       +   +  K  V +K IE   G++  + V   ++   S
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSY 114
           L H +I+R    L   + L +V +Y   G L   +    G         +  Q+  G+ Y
Sbjct: 72  LDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIA 168
                + HR+L   N LL    Q  +++ DFG +         LL+S+ K+ +    ++A
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEAKTPI---KWMA 185
Query: 169 PEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            E +   +Y  + SDVWS GVT++ +M  GA P+
Sbjct: 186 LESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 156
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 269
Query: 231 SADCRH 236
              C H
Sbjct: 270 MLKCWH 275

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 148
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 149 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 205
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 206 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 261
Query: 231 SADCRH 236
              C H
Sbjct: 262 MLKCWH 267

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 154
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 155 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 211
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 212 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 267
Query: 231 SADCRH 236
              C H
Sbjct: 268 MLKCWH 273

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 153
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 154 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 210
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 211 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 266
Query: 231 SADCRH 236
              C H
Sbjct: 267 MLKCWH 272

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 175
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 176 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 232
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 233 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 288
Query: 231 SADCRH 236
              C H
Sbjct: 289 MLKCWH 294

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 188
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 189 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 155
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 156 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 212
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 213 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 268
Query: 231 SADCRH 236
              C H
Sbjct: 269 MLKCWH 274

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 151
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 152 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 208
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 209 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 264
Query: 231 SADCRH 236
              C H
Sbjct: 265 MLKCWH 270

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ Y  S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKYLASKKFVH 156
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 269
Query: 231 SADCRH 236
              C H
Sbjct: 270 MLKCWH 275

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 35/210 (16%)
Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS-------LRH 58
           K LG G FG      L ++  T   VAVK +    K+D + QREI    S         H
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 59  PNIIRFKEVLLTPTHLAI-----VMEYAAGGEL-----FARICSAGRFSEDEARF-FFQQ 107
           PN+IR   V +  +   I     ++ +   G+L     ++R+ +  +    +    F   
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC--DFGYSK---SGLLHSQPKSTVG 162
           +  G+ Y  +    HRDL   N +L    +  + +C  DFG SK   SG  + Q +    
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCML----RDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
              +IA E LA + Y  K SDVW+ GVT++
Sbjct: 212 PVKWIAIESLADRVYTSK-SDVWAFGVTMW 240

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 33/221 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLRHPNII 62
           +ELG G FG   L     +   + K LVAVK ++       ++ QRE     +L+H +I+
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARIC--------------SAGRFSEDEARFFFQ 106
           +F  V      L +V EY   G+L  F R                + G     +      
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA- 165
           Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   ++S     VG    
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGAN--LLVKIGDFGMSRD--VYSTDYYRVGGHTM 196
Query: 166 ----YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
               ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 197 LPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 10  ELGSGNFGVARL-----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
           ELG G FG   L     +  ++ K LVAVK + E  +   ++ QRE      L+H +I+R
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 64  FKEVLLTPTHLAIVMEYAAGGELF---------ARICSAGR------FSEDEARFFFQQL 108
           F  V      L +V EY   G+L          A++ + G           +      Q+
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
            +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 139 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 194
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
             ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 195 IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 232

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 10  ELGSGNFGVARL-----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
           ELG G FG   L     +  ++ K LVAVK + E  +   ++ QRE      L+H +I+R
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 64  FKEVLLTPTHLAIVMEYAAGGELF---------ARICSAGR------FSEDEARFFFQQL 108
           F  V      L +V EY   G+L          A++ + G           +      Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
            +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 168 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 223
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
             ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 224 IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 135 LRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 190 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 84  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 143 LRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 197
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 198 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 239

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 215
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 216 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 272
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 273 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 328
Query: 231 SADCRH 236
              C H
Sbjct: 329 MLKCWH 334

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 10  ELGSGNFGVARL-----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNIIR 63
           ELG G FG   L     +  ++ K LVAVK + E  +   ++ QRE      L+H +I+R
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 64  FKEVLLTPTHLAIVMEYAAGGELF---------ARICSAGR------FSEDEARFFFQQL 108
           F  V      L +V EY   G+L          A++ + G           +      Q+
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--- 165
            +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 145 AAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 200
Query: 166 --YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
             ++ PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 201 IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 238

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 141 LRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 196 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 73  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 132 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 187 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 233

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 72  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 131 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 186 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 232

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 85  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 144 LRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 198
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 199 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 240

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 86  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 145 LRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 199
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 200 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 241

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 66  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 125 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 180 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 226

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 81  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 140 LRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 194
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 195 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 236

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 34/272 (12%)
Query: 2   EERYEPVKELGSGNFGVAR---LVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRS 55
           E+++   + LG G FG  R   L ++  +   VAVK ++       +++   RE    + 
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKE 81
Query: 56  LRHPNIIRFKEVLL-------TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
             HP++ +   V L        P  + +++ +   G+L A +  A R  E+      Q L
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPM-VILPFMKHGDLHAFLL-ASRIGENPFNLPLQTL 139
Query: 109 I-------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPK 158
           +        G+ Y  S    HRDL   N +L  +    + + DFG S+   SG  + Q  
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCML--AEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRI 217
           ++     ++A E LA   Y    SDVW+ GVT++ +M  G  P+   E+   +   I   
Sbjct: 198 ASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKR 249
           R  Q   P+ +    D   L+ Q + ADP +R
Sbjct: 257 RLKQP--PECMEEVYD---LMYQCWSADPKQR 283

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 161
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 162 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 218
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y
Sbjct: 219 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEY 266

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 136 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 191 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 237

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + V+ LG+G FG V     +  TK  VAVK +++G    +    E    + L+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE +  
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
             +  K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 156
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 269
Query: 231 SADCRH 236
              C H
Sbjct: 270 MLKCWH 275

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 157
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 158 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 214
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 215 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 270
Query: 231 SADCRH 236
              C H
Sbjct: 271 MLKCWH 276

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 23/232 (9%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 156
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 157 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 213
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y
Sbjct: 214 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEY 261

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 28/246 (11%)
Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
           +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 66  EVLL-TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
            + L +     +V+ Y   G+L  F R  +     +D   F  Q +  G+ +  S +  H
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ-VAKGMKFLASKKFVH 154
Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGL------LHSQPKSTVGTPAYIAPEVLARKE 176
           RDL   N +LD   +  +K+ DFG ++         +H++  + +    ++A E L  ++
Sbjct: 155 RDLAARNCMLD--EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQK 211
Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV-----RV 230
           +  K SDVWS GV L+ +M  GA P+ D      F  T+  ++  +   P+Y       V
Sbjct: 212 FTTK-SDVWSFGVLLWELMTRGAPPYPDVN---TFDITVYLLQGRRLLQPEYCPDPLYEV 267
Query: 231 SADCRH 236
              C H
Sbjct: 268 MLKCWH 273

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 39  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 98
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 99  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 153
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 209
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 210 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 246

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 187
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 188 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 186
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 20  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 79
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 80  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 134
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 190
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 191 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 227

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 187
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 188 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   +       +DK  + + VAVK ++     K + + V    +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 191
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 192 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 153 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 252

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 24  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 83
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 84  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 138
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 194
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 195 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K L SG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++M+    G L   +    R  +D   +++      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 191
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 192 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 187
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 188 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 150 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 249

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR       S D     E +  F+ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 148 SCTYQLARGMEYLASQKCIHRDLTARNVLV--TENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 247

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKST 160
           S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + + + +  + 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 161 VGTPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
              P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 68  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 122
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 178
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 179 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 215

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 70
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 71  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAE 125
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 181
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 182 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 218

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 43/277 (15%)
Query: 18  VARLVRDKRTKELVAVKYIERGKKIDENVQREI--INHRSLRHPNIIRFKEVLLTPTHLA 75
           V   V D RT  +++  ++ +       V REI  +NH    HPNI+  +++ +     A
Sbjct: 54  VFNTVSDGRTVNILSDSFLCK------RVLREIRLLNH--FHHPNILGLRDIFVHFEEPA 105
Query: 76  IVMEYAAGGEL---FARICSAGRF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
           +   Y     +    A++    R   S    ++F   ++ G+   H   + HRDL   N 
Sbjct: 106 MHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 131 LLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190
           LL  +    + ICDF  ++     +     V    Y APE++ + +   K+ D+WS G  
Sbjct: 166 LL--ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
Query: 191 LYVMLVGAYPFEDPEDPRNFRKTID-----RIRNVQYFLP----DYVRVS---------- 231
           +  M      F          K ++     +I +V  F      DY+R S          
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT 283
Query: 232 -----AD--CRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                AD     L++++   +P +RI   +  +HP+F
Sbjct: 284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 100/249 (40%), Gaps = 42/249 (16%)
Query: 3   ERYEPVKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL- 56
           E  E  K LGSG FG      A  +        VAVK ++  +K D + +  +++   + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMM 102
Query: 57  ----RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARF-------- 103
                H NI+           + ++ EY   G+L   + S   +FSEDE  +        
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 104 --------------FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
                         F  Q+  G+ +       HRDL   N L+  +    +KICDFG ++
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGKVVKICDFGLAR 220
Query: 150 SGLLHSQ--PKSTVGTPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPE 205
             +  S    +     P  ++APE L    Y  K SDVWS G+ L+ +  +G  P+    
Sbjct: 221 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 206 DPRNFRKTI 214
              NF K I
Sbjct: 280 VDANFYKLI 288

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 191
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 192 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARL-----VRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RH 58
           K LG G FG   +     +   + KE V V          E    ++++   +     +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSED-----EARFFFQQLI 109
            NII           L +++EYA+ G     L AR      +S D     E +  F+ L+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 110 S-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
           S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++    +    K+T 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K LGSG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 43/277 (15%)
Query: 18  VARLVRDKRTKELVAVKYIERGKKIDENVQREI--INHRSLRHPNIIRFKEVLLTPTHLA 75
           V   V D RT  +++  ++ +       V REI  +NH    HPNI+  +++ +     A
Sbjct: 54  VFNTVSDGRTVNILSDSFLCK------RVLREIRLLNH--FHHPNILGLRDIFVHFEEPA 105
Query: 76  IVMEYAAGGEL---FARICSAGRF--SEDEARFFFQQLISGVSYCHSMEICHRDLKLENT 130
           +   Y     +    A++    R   S    ++F   ++ G+   H   + HRDL   N 
Sbjct: 106 MHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI 165
Query: 131 LLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVT 190
           LL  +    + ICDF  ++     +     V    Y APE++ + +   K+ D+WS G  
Sbjct: 166 LL--ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223
Query: 191 LYVMLVGAYPFEDPEDPRNFRKTID-----RIRNVQYFLP----DYVRVS---------- 231
           +  M      F          K ++     +I +V  F      DY+R S          
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWT 283
Query: 232 -----AD--CRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                AD     L++++   +P +RI   +  +HP+F
Sbjct: 284 AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 140
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 227

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 -RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 160
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 161 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 220 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 247

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 140
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 227

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 141
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 142 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 201 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 228

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 59  PNIIRFKEVLL-----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           PNI++  +++      TP+   ++ EY    +      +    ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTDFKVLYPT---LTDYDIRYYIYELLKALD 139
Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           YCHS  I HRD+K  N ++D   + +L++ D+G ++      +    V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 174 R-KEYDGKISDVWSCGVTLYVMLVGAYPF 201
             ++YD  + D+WS G     M+    PF
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPF 226

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 67/276 (24%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PN- 60
           RY  +++LG G+F    L  D + K+ VA+K ++  +   E    EI   +S+R+  PN 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 61  ---------IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLI 109
                    +  FK   +  TH+ +V E   G  L   I  +          +   QQ++
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 110 SGVSYCHS-MEICHRDLKLENTLL-------------------DGSPQP----------- 138
            G+ Y H+   I H D+K EN LL                    G+P P           
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 139 -----------------RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 273
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
           +D+WS     + +  G Y FE P     + +  D I
Sbjct: 274 ADIWSTACMAFELATGDYLFE-PHSGEEYTRDEDHI 308

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKE 66
           V+ LG+G  G V     +  TK  VAVK +++G    +    E    + L+H  ++R   
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 67  VLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
           V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDG 179
           L+  N L+  S     KI DFG ++   L    + T    A     + APE +    +  
Sbjct: 135 LRAANILV--SDTLSCKIADFGLAR---LIEDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 180 KISDVWSCGVTLYVMLV-GAYPF---EDPEDPRNFRKTIDRIR 218
           K SDVWS G+ L  ++  G  P+    +PE  +N  +    +R
Sbjct: 190 K-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 54  RSLRHPNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLI 109
           R   HPN++       +P   H  ++  +   G L+  +     F  D+++   F   + 
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 110 SGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICD--FGYSKSGLLHSQPKSTVGTPA 165
            G+++ H++E  I    L   + ++D     R+ + D  F +   G +++        PA
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYA--------PA 173
Query: 166 YIAPEVLARKEYDG--KISDVWSCGVTLYVMLVGAYPFED 203
           ++APE L +K  D   + +D+WS  V L+ ++    PF D
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVAR--LVRDKRTKELVAVKYIERGKKIDENVQREIINHR----S 55
           E  ++ +K LGSG FG     L   +  K  + V  +E  +       +EI++      S
Sbjct: 48  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMAS 107
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 108 VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 162
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 218
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 219 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 255

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 102/277 (36%), Gaps = 65/277 (23%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----- 58
           RY  +++LG G+F    L  D + K  VA+K ++  +   E    EI   + +R      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 59  PN-------IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLI 109
           PN       I  FK   +   H+ +V E   G  L   I  +          +   +Q++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 110 SGVSYCHS-MEICHRDLKLENTLL-------------------DGSPQP----------- 138
            G+ Y HS  +I H D+K EN L+                    G+P P           
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 139 ---------------RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISD 183
                          R+KI D G   +  +H      + T  Y + EVL    Y    +D
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLG--NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTP-AD 267
Query: 184 VWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220
           +WS     + +  G Y FE P    ++ +  D I ++
Sbjct: 268 IWSTACMAFELATGDYLFE-PHSGEDYSRDEDHIAHI 303

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 36/236 (15%)
Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE------RGKKIDENVQREIINHR 54
           +   +  ++++G G FG   L +    K+  AVK +       R  KI+ ++ ++I  + 
Sbjct: 33  LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QND 91
Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC--SAGRFSEDEARFFFQQLISGV 112
            + + NI+++    +   H+ ++ E   G  L+  I   +   F  ++ + +  +++  +
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 113 SYCHSMEICHRDLKLENTLLDG-----------------------SPQPRLKICDFGYSK 149
           +Y   M + H DLK EN LLD                        +    +K+ DFG + 
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210
Query: 150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
                    S + T  Y APEV+    +D   SD+WS G  L  +  G+  F   E
Sbjct: 211 --FKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G +G   + R     E VAVK      +     + E+ N   LRH NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 71  PTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SM 118
             H    L ++  Y   G L+  +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEIFGTQGKP 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--------VGTPAYIAPE 170
            I HRDLK +N L+  + Q    I D G +   ++HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKNGQ--CCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 171 VLARK----EYDG-KISDVWSCGVTLYVM--------LVGAY--PFED--PEDP--RNFR 211
           VL        +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP   + R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 212 KTI------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           K +        I N  +  P    ++     L+ + +  +PS R+    IKK
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIKK 295

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 49/291 (16%)
Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           VK++G G +G   +   K   E VAVK     ++     + EI     +RH NI+ F   
Sbjct: 42  VKQIGKGRYGEVWM--GKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 68  LL----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM----- 118
            +    + T L ++ +Y   G L+  + S    ++   +  +   +SG+ + H+      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFSTQ 158
Query: 119 ---EICHRDLKLENTLLDGSPQPRLKICDFGY-----SKSGLLHSQPKSTVGTPAYIAPE 170
               I HRDLK +N L+  +      I D G      S +  +   P + VGT  Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 171 V----LARKEYDGKI-SDVWSCGVTLYVM--------LVGAY--PFED--PEDP--RNFR 211
           V    L R  +   I +D++S G+ L+ +        +V  Y  P+ D  P DP   + R
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276
Query: 212 KTIDRIRNVQYFLPDYVRVSAD-CRH----LLSQIFVADPSKRIPIPEIKK 257
           + +  I+ ++   P+  R S+D C      L+++ +  +P+ R+    +KK
Sbjct: 277 EIVC-IKKLRPSFPN--RWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/276 (23%), Positives = 103/276 (37%), Gaps = 67/276 (24%)
Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH--PN- 60
           RY  +++LG G+F    L  D + K+ VA+K ++  +   E    EI   +S+R+  PN 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 61  ---------IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLI 109
                    +  FK   +  TH+ +V E   G  L   I  +          +   QQ++
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 110 SGVSYCHS-MEICHRDLKLENTLL-------------------DGSPQP----------- 138
            G+ Y H+   I H D+K EN LL                    G+P P           
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 139 -----------------RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 257
Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI 217
           +D+WS     + +  G Y FE P     + +  D I
Sbjct: 258 ADIWSTACMAFELATGDYLFE-PHSGEEYTRDEDHI 292

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G +G   + R     E VAVK      +     + E+ N   LRH NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 71  PTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SM 118
             H    L ++  Y   G L+  +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEIFGTQGKP 132
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--------VGTPAYIAPE 170
            I HRDLK +N L+  + Q    I D G +   ++HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKNGQ--CCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 171 VLARK----EYDG-KISDVWSCGVTLYVM--------LVGAY--PFED--PEDP--RNFR 211
           VL        +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP   + R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 212 KTI------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           K +        I N  +  P    ++     L+ + +  +PS R+    IKK
Sbjct: 248 KVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIKK 295

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 119/292 (40%), Gaps = 57/292 (19%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT 70
           +G G +G   + R     E VAVK      +     + E+ N   LRH NI+ F    +T
Sbjct: 45  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 102
Query: 71  PTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SM 118
             H    L ++  Y   G L+  +      +    R     + SG+++ H          
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS-IASGLAHLHIEIFGTQGKP 161
Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--------VGTPAYIAPE 170
            I HRDLK +N L+  + Q    I D G +   ++HSQ  +         VGT  Y+APE
Sbjct: 162 AIAHRDLKSKNILVKKNGQ--CCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 171 VLARK----EYDG-KISDVWSCGVTLYVM--------LVGAY--PFED--PEDP--RNFR 211
           VL        +D  K  D+W+ G+ L+ +        +V  Y  PF D  P DP   + R
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 276
Query: 212 KTI------DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
           K +        I N  +  P    ++     L+ + +  +PS R+    IKK
Sbjct: 277 KVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIKK 324

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 91  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 150 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 206
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 207 SK-SDVWSFGVLMW 219

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K L SG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 14  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 184
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG--LLHSQPKSTV-GTPAYI 167
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK G  L  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVML 195
            PE   +     K SDV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 2   EERYEPVKELGSGNFGVA----RLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRS 55
           E  ++ +K L SG FG       +   ++ K  VA+K +      K ++ +  E     S
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDE--ARFFFQ---QLIS 110
           + +P++ R   + LT T + ++ +    G L   +    R  +D   +++      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA----- 165
           G++Y     + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K            
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 191
Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFE 202
           ++A E +  + Y  + SDVWS GVT++ +M  G+ P++
Sbjct: 192 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/88 (43%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG--LLHSQPKSTV-GTPAYI 167
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK G  L  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 168 APEVLARKEYDGKISDVWSCGVTLYVML 195
            PE   +     K SDV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 72/191 (37%), Gaps = 39/191 (20%)
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           N++  K       H+ I M Y    E F  I ++  F   E R +   L   +   H   
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSF--QEVREYMLNLFKALKRIHQFG 137
Query: 120 ICHRDLKLENTLLDGSPQPRLK---ICDFGY------SKSGLLH-----------SQPKS 159
           I HRD+K  N L +     RLK   + DFG       +K  LL            SQ K 
Sbjct: 138 IVHRDVKPSNFLYNR----RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC 193
Query: 160 TV------------GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
           ++            GTP + APEVL +        D+WS GV    +L G YPF    D 
Sbjct: 194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253
Query: 208 RNFRKTIDRIR 218
                 I  IR
Sbjct: 254 LTALAQIMTIR 264

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 198
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 199 SK-SDVWSFGVLMW 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 132 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 188
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 189 SK-SDVWSFGVLMW 201

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 130 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 186
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 187 SK-SDVWSFGVLMW 199

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 436 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 495 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 551
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 552 SK-SDVWSFGVLMW 564

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 15/194 (7%)
Query: 9   KELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPNIIR 63
           KELGSGNFG V +     +         I + +  D  ++ E++      + L +P I+R
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 435 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS-----GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           DL   N LL    Q   KI DFG SK+         +Q         Y APE +   ++ 
Sbjct: 494 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 550
Query: 179 GKISDVWSCGVTLY 192
            K SDVWS GV ++
Sbjct: 551 SK-SDVWSFGVLMW 563

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           LG G FG     R      LVAVK +  ER +  +   Q E+       H N++R +   
Sbjct: 46  LGRGGFGKVYKGR-LADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLIS-----GVSYCHSM---E 119
           +TPT   +V  Y A G + +  C   R  S+    +  +Q I+     G++Y H     +
Sbjct: 105 MTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 175
           I HRD+K  N LLD   +    + DFG +K  L+  +      +  GT  +IAPE L+  
Sbjct: 163 IIHRDVKAANILLDEEFEA--VVGDFGLAK--LMDYKDXHVXXAVRGTIGHIAPEYLSTG 218
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFE 202
           +   K +DV+  GV L  ++ G   F+
Sbjct: 219 KSSEK-TDVFGYGVMLLELITGQRAFD 244

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV+EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IVMEY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 106/256 (41%), Gaps = 23/256 (8%)
Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  + +K LG+G FG V     +  TK  VA+K ++ G    E+   E    + L+H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           ++   V+ +   + IV EY   G L  F +                 Q+ +G++Y   M 
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLAR 174
             HRDL+  N L+        KI DFG ++   L    + T    A     + APE    
Sbjct: 126 YIHRDLRSANILVGNGLI--CKIADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALY 180
Query: 175 KEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
             +  K SDVWS G+ L  ++  G  P+       N R+ ++++    Y +P        
Sbjct: 181 GRFTIK-SDVWSFGILLTELVTKGRVPYPG----MNNREVLEQVER-GYRMPCPQDCPIS 234
Query: 234 CRHLLSQIFVADPSKR 249
              L+   +  DP +R
Sbjct: 235 LHELMIHCWKKDPEER 250

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV+EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      FS + +    +QL S    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTV 161
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++    +    K+T 
Sbjct: 154 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 162 G-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 212 GRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 6   EPVKELGSGNFGVARLVRDK-----RTKELVAVKYI--ERGKKIDENVQREIINHRSLRH 58
           E V+++G G FG     R           +VAVK +  E    +  + QRE        +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGEL--FAR------ICSAGR--------------- 95
           PNI++   V      + ++ EY A G+L  F R      +CS                  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 96  -FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154
             S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S++ +  
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRN-IYS 226
Query: 155 SQPKSTVGTPA----YIAPEVLARKEYDGKISDVWSCGVTLY 192
           +      G  A    ++ PE +    Y  + SDVW+ GV L+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 11  LGSGNFGV---ARLVRD--------KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           +G GNFG    AR+ +D        KR KE     Y  +    D   + E++      HP
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----YASKDDHRDFAGELEVLCKLG-HHP 86
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-----ARI-----------CSAGRFSEDEARF 103
           NII          +L + +EYA  G L      +R+            +A   S  +   
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG- 162
           F   +  G+ Y    +  HRDL   N L+        KI DFG S+   ++   K T+G 
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVYV--KKTMGR 202
Query: 163 TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            P  ++A E L    Y    SDVWS GV L+ ++ +G  P+
Sbjct: 203 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 242

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 11  LGSGNFGV---ARLVRD--------KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           +G GNFG    AR+ +D        KR KE     Y  +    D   + E++      HP
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----YASKDDHRDFAGELEVLCKLG-HHP 76
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-----ARIC-----------SAGRFSEDEARF 103
           NII          +L + +EYA  G L      +R+            +A   S  +   
Sbjct: 77  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG- 162
           F   +  G+ Y    +  HRDL   N L+        KI DFG S+   ++   K T+G 
Sbjct: 137 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVYV--KKTMGR 192
Query: 163 TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            P  ++A E L    Y    SDVWS GV L+ ++ +G  P+
Sbjct: 193 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 15  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 72
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +  +       +      Q+ SG++Y   M   HRDL+ 
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 132
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 133 ANILV--GENLVCKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK-S 186
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 241
Query: 242 FVADPSKR 249
           +  +P +R
Sbjct: 242 WRKEPEER 249

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 16  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 73
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 133
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 134 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 187
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 188 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 242
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 243 WRKDPEER 250

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 26/212 (12%)
Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----PNIIRF 64
           K++G GNFG  RL ++  T E VA+K +E  K     +  E   ++ L      P +  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 65  KEVLLTPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
                   + A+V+E       +LF  +C    FS         QLIS + Y HS  + +
Sbjct: 74  GPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSKNLIY 128
Query: 123 RDLKLENTLLDGSP----QPRLKICDFGY--------SKSGLLHSQPKSTVGTPAYIAPE 170
           RD+K EN L+ G P    Q  + I DFG         +K  + + + KS  GT  Y++  
Sbjct: 129 RDVKPENFLI-GRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187
Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFE 202
               KE   +  D+ + G      L G+ P++
Sbjct: 188 THLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 14  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 71
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 131
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 132 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 185
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 186 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 240
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 241 WRKDPEER 248

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 192 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 249
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 309
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG    G L    + T    A     + APE      +  K S
Sbjct: 310 ANILV--GENLVCKVADFGL---GRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 363
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 364 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 418
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 419 WRKDPEER 426

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL  
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 18  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 75
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +  +       +      Q+ SG++Y   M   HRDL+ 
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 135
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 136 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 189
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 190 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 244
Query: 242 FVADPSKR 249
           +  +P +R
Sbjct: 245 WRKEPEER 252

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + +RH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 11  LGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           LG G FG     R      LVAVK +  ER +  +   Q E+       H N++R +   
Sbjct: 38  LGRGGFGKVYKGR-LADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 69  LTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLIS-----GVSYCHSM---E 119
           +TPT   +V  Y A G + +  C   R  S+    +  +Q I+     G++Y H     +
Sbjct: 97  MTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----PKSTVGTPAYIAPEVLARK 175
           I HRD+K  N LLD   +    + DFG +K  L+  +      +  G   +IAPE L+  
Sbjct: 155 IIHRDVKAANILLDEEFEA--VVGDFGLAK--LMDYKDXHVXXAVRGXIGHIAPEYLSTG 210
Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFE 202
           +   K +DV+  GV L  ++ G   F+
Sbjct: 211 KSSEK-TDVFGYGVMLLELITGQRAFD 236

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 25  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 82
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +          +      Q+ SG++Y   M   HRDL+ 
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 142
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 143 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 196
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 251
Query: 242 FVADPSKR 249
           +  DP +R
Sbjct: 252 WRKDPEER 259

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 146 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 201
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 245

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 91/221 (41%), Gaps = 41/221 (18%)
Query: 11  LGSGNFGV---ARLVRD--------KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP 59
           +G GNFG    AR+ +D        KR KE     Y  +    D   + E++      HP
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----YASKDDHRDFAGELEVLCKLG-HHP 83
Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF-----ARIC-----------SAGRFSEDEARF 103
           NII          +L + +EYA  G L      +R+            +A   S  +   
Sbjct: 84  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG- 162
           F   +  G+ Y    +  HR+L   N L+        KI DFG S+   ++   K T+G 
Sbjct: 144 FAADVARGMDYLSQKQFIHRNLAARNILV--GENYVAKIADFGLSRGQEVYV--KKTMGR 199
Query: 163 TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            P  ++A E L    Y    SDVWS GV L+ ++ +G  P+
Sbjct: 200 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 103/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 274 KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY + G L  F +  +       +      Q+ SG++Y   M   HRDL+ 
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 392 ANILV--GENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 445
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 500
Query: 242 FVADPSKR 249
           +  +P +R
Sbjct: 501 WRKEPEER 508

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTK-ELVAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 143 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 198
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 242

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 154 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 209
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 147 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 202
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 154 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 209
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 21/248 (8%)
Query: 10  ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V+ 
Sbjct: 22  KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 79
Query: 70  TPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKL 127
           +   + IV EY   G L  F +  +       +      Q+ SG++Y   M   HRDL+ 
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRA 139
Query: 128 ENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA-----YIAPEVLARKEYDGKIS 182
            N L+        K+ DFG ++   L    + T    A     + APE      +  K S
Sbjct: 140 ANILV--GENLVCKVADFGLAR---LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK-S 193
Query: 183 DVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           DVWS G+ L  +   G  P+    +    R+ +D++    Y +P           L+ Q 
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVN----REVLDQVER-GYRMPCPPECPESLHDLMCQC 248
Query: 242 FVADPSKR 249
           +  +P +R
Sbjct: 249 WRKEPEER 256

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 37/225 (16%)
Query: 9   KELGSGNFGVARLV------RDKRTKEL-VAVKYIERG---KKIDENVQREIINHRSLRH 58
           K LG G FG   L       +DK  +   VAVK ++     K + + +    +     +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLIS---- 110
            NII           L +++EYA+ G L     AR      +S + +    +QL S    
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 111 --------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKS 159
                   G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H      K+
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLARD--IHHIDYYKKT 250
Query: 160 TVG-TPA-YIAPEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           T G  P  ++APE L  + Y  + SDVWS GV L+ +  +G  P+
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 294
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	341
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-149
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-143
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-114
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-112
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-112
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-111
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-111
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-109
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-108
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-108
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-108
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-107
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-107
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-107
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-103
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-102
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-102
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-98
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-91
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-90
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-90
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-89
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-89
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-88
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-88
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-87
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-87
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-87
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-86
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-86
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-86
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-86
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-85
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-85
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-85
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-85
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-85
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-85
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-85
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-85
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-84
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-83
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-83
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-83
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-83
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-82
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-82
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-81
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-81
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-80
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-80
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-80
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-80
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-79
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-73
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-73
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-73
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-71
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-70
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-70
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-68
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-65
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-63
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-63
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-63
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-62
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-62
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-62
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-62
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-62
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-62
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-62
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-61
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-61
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-61
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-61
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-60
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-59
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-59
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-58
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-58
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-57
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-57
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-57
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-55
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-54
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-50
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-49
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-49
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-49
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-47
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-46
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-46
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-45
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-43
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-43
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-41
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-41
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-40
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-40
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-40
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-39
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-39
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-39
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-39
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-38
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-38
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-37
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-37
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-36
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-36
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-36
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-36
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-35
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-35
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-35
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-35
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-34
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-34
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-33
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-33
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-33
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-32
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-31
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-31
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-30
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-27
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-26
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-26
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-24
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-22
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-21
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-21
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-20
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-17
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-15
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-06

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  517 bits (1334), Expect = 0.0
 Identities = 238/339 (70%), Positives = 282/339 (83%), Gaps = 4/339 (1%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +RY+ VK++GSGNFGVARL+RDK TKELVAVKYIERG  IDENVQREIINHRSLRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
           RFKEV+LTPTHLAI+MEYA+GGEL+ RIC+AGRFSEDEARFFFQQL+SGVSYCHSM+ICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLKLENTLLDGSP PRLKICDFGYSKS +LHSQPKSTVGTPAYIAPEVL R+EYDGKI+
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           DVWSCGVTLYVMLVGAYPFEDPE+PR++RKTI RI +V+Y +PD +R+S +C HL+S+IF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMP 302
           VADP+ RI IPEIK H WFLKNLP +++    T  +    +QP QS++ IM+II EA +P
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319

Query: 303 GEATKVAGQGAAGASD----PDDMEGDIESEIDASGDYM 337
               +          D     DD + + E +ID+SG+ +
Sbjct: 320 AVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEIV 358

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  422 bits (1087), Expect = e-149
 Identities = 102/312 (32%), Positives = 166/312 (53%), Gaps = 16/312 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++        GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
             +  DVWSCG+ L  ML G  P++ P D  + +    ++    + +L  + ++ +    
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPLA 240

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI----IEIEKTNYKEAGRDQPTQSVEEI 292
           LL +I V +PS RI IP+IKK  W+ K L K      +     +   +G  +  QS  + 
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF 300

Query: 293 MRIIQEAKMPGE 304
             +   ++ PG 
Sbjct: 301 SPVNSASRTPGS 312

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  406 bits (1045), Expect = e-143
 Identities = 97/273 (35%), Positives = 153/273 (56%), Gaps = 12/273 (4%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++        GT  Y+APE+L R+E+
Sbjct: 127 THRDIKPENLLLDE--RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
             +  DVWSCG+ L  ML G  P++ P D  + +    ++    + +L  + ++ +    
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPLA 240

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           LL +I V +PS RI IP+IKK  W+ K L K  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  330 bits (849), Expect = e-114
 Identities = 110/272 (40%), Positives = 149/272 (54%), Gaps = 20/272 (7%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
            Y     LG G FG  ++   + T   VAVK + R K     +   ++REI N +  RHP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +II+  +V+ TPT   +VMEY +GGELF  IC  GR  E EAR  FQQ++S V YCH   
Sbjct: 72  HIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
           + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV++ +
Sbjct: 132 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVISGR 185

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y G   D+WSCGV LY +L G  PF+D   P  F+K    IR   +++P+Y  ++    
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVA 239

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
            LL  +   DP KR  I +I++H WF ++LP 
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  327 bits (841), Expect = e-112
 Identities = 103/293 (35%), Positives = 153/293 (52%), Gaps = 15/293 (5%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHRSLRHPN 60
            Y  +K +G GNF   +L R   T   VA+K I++ +    +   + RE+   + L HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I++  EV+ T   L ++MEYA+GGE+F  + + GR  E EAR  F+Q++S V YCH   I
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   K+YDG 
Sbjct: 136 VHRDLKAENLLLDA--DMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             DVWS GV LY ++ G+ PF+         +    +   +Y +P Y  +S DC +LL +
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLKR 247

Query: 241 IFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIM 293
             V +P KR  + +I K  W      ++ ++     + E   D   Q   +IM
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKP----FVEPELDISDQKRIDIM 296

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  332 bits (852), Expect = e-111
 Identities = 112/303 (36%), Positives = 160/303 (52%), Gaps = 20/303 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
            Y     LG G FG  ++ + + T   VAVK + R K     +   ++REI N +  RHP
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +II+  +V+ TP+ + +VMEY +GGELF  IC  GR  E E+R  FQQ++SGV YCH   
Sbjct: 77  HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
           + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV++ +
Sbjct: 137 VVHRDLKPENVLLDA--HMNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVISGR 190

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y G   D+WS GV LY +L G  PF+D   P  F+K    I +  ++ P Y  ++    
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVI 244

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRI 295
            LL  +   DP KR  I +I++H WF ++LPK +   + +       D+  + V E    
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFEC 304

Query: 296 IQE 298
            +E
Sbjct: 305 SEE 307

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  325 bits (834), Expect = e-111
 Identities = 118/284 (41%), Positives = 164/284 (57%), Gaps = 21/284 (7%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHP 59
            Y   + LG G+FG  +L    +T++ VA+K+I R       +   V+REI   + LRHP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +II+  +V+ TPT + +V+EYA GGELF  I    R +EDE R FFQQ+I  + YCH  +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAPEVLARK 175
           I HRDLK EN LLD +    +KI DFG S        L     ++ G+P Y APEV+  K
Sbjct: 129 IVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK----TSCGSPNYAAPEVINGK 182

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
            Y G   DVWSCG+ LYVMLVG  PF+D   P  F+K    + +  Y +PD+  +S   +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQ 236

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 279
            L+ ++ VADP +RI I EI++ PWF  NLP  +  +E+     
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  319 bits (821), Expect = e-109
 Identities = 82/273 (30%), Positives = 128/273 (46%), Gaps = 15/273 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
            RY   + LG G F     + D  TKE+ A K + +         E +  EI  HRSL H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            +++ F         + +V+E      L          +E EAR++ +Q++ G  Y H  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL++K +
Sbjct: 135 RVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWS G  +Y +LVG  PFE        ++T  RI+  +Y +P +  ++     L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKH--INPVAASL 245

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEI 269
           + ++   DP+ R  I E+    +F    +P  +
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  318 bits (817), Expect = e-108
 Identities = 88/281 (31%), Positives = 127/281 (45%), Gaps = 30/281 (10%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHRSLRH 58
           +Y     LG G++G  + V D  T    AVK +++ K       + NV++EI   R LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 59  PNIIRFKEVLL--TPTHLAIVMEYAAGG--ELFARICSAGRFSEDEARFFFQQLISGVSY 114
            N+I+  +VL       + +VMEY   G  E+   +    RF   +A  +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS-------KSGLLHSQPKSTVGTPAYI 167
            HS  I H+D+K  N LL       LKI   G +                 ++ G+PA+ 
Sbjct: 125 LHSQGIVHKDIKPGNLLLTT--GGTLKISALGVAEALHPFAADDTCR----TSQGSPAFQ 178

Query: 168 APEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
            PE+      + G   D+WS GVTLY +  G YPFE      N  K  + I    Y +P 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPG 234

Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
                     LL  +   +P+KR  I +I++H WF K  P 
Sbjct: 235 D--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  315 bits (810), Expect = e-108
 Identities = 90/279 (32%), Positives = 148/279 (53%), Gaps = 16/279 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
            + HRD+K EN LL       LKI DFG+S      S  ++ + GT  Y+ PE++  + +
Sbjct: 129 RVIHRDIKPENLLLGS--AGELKIADFGWSV--HAPSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVEFTFPDF--VTEGARDL 237

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN 276
           +S++   +PS+R  + E+ +HPW   N  K      K +
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKES 276

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  315 bits (810), Expect = e-108
 Identities = 80/275 (29%), Positives = 137/275 (49%), Gaps = 15/275 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           E ++    LG G+F          T   VA+K I++       + + VQ E+  H  L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS 117
           P+I+          ++ +V+E    GE+   + +    FSE+EAR F  Q+I+G+ Y HS
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
             I HRDL L N LL  +    +KI DFG +    +  +   T+ GTP YI+PE+  R  
Sbjct: 131 HGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           +  + SDVWS G   Y +L+G  PF+        + T++++    Y +P +  +S + + 
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTD----TVKNTLNKVVLADYEMPSF--LSIEAKD 241

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
           L+ Q+   +P+ R+ +  +  HP+  +N   +  +
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  315 bits (809), Expect = e-107
 Identities = 86/270 (31%), Positives = 143/270 (52%), Gaps = 16/270 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
           + ++  + LG G FG   L R+K+ K ++A+K + + +     ++  ++REI     LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R          + +++E+A  GEL+  +   GRF E  +  F ++L   + YCH  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
           ++ HRD+K EN L+    +  LKI DFG+S      S  + T+ GT  Y+ PE++  K +
Sbjct: 134 KVIHRDIKPENLLMGY--KGELKIADFGWSV--HAPSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
           D K+ D+W  GV  Y  LVG  PF+ P    +  +T  RI NV    P +  +S   + L
Sbjct: 190 DEKV-DLWCAGVLCYEFLVGMPPFDSP----SHTETHRRIVNVDLKFPPF--LSDGSKDL 242

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           +S++    P +R+P+  + +HPW   N  +
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  316 bits (812), Expect = e-107
 Identities = 82/273 (30%), Positives = 128/273 (46%), Gaps = 15/273 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH 58
            RY   + LG G F     + D  TKE+ A K + +         E +  EI  HRSL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            +++ F         + +V+E      L          +E EAR++ +Q++ G  Y H  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
            + HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL++K +
Sbjct: 161 RVIHRDLKLGNLFLN--EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWS G  +Y +LVG  PFE        ++T  RI+  +Y +P +  ++     L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPKH--INPVAASL 271

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEI 269
           + ++   DP+ R  I E+    +F    +P  +
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  314 bits (806), Expect = e-107
 Identities = 97/296 (32%), Positives = 143/296 (48%), Gaps = 47/296 (15%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------------------- 43
           +Y    E+G G++GV +L  ++      A+K + + K I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 44  -------ENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAG 94
                  E V +EI   + L HPN+++  EVL  P   HL +V E    G +   + +  
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 95  RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS-----K 149
             SED+ARF+FQ LI G+ Y H  +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE--DGHIKIADFGVSNEFKGS 190

Query: 150 SGLLHSQPKSTVGTPAYIAPEVLA--RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
             LL     +TVGTPA++APE L+  RK + GK  DVW+ GVTLY  + G  PF D    
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE--- 243

Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
                   +I++     PD   ++ D + L++++   +P  RI +PEIK HPW  +
Sbjct: 244 -RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  304 bits (781), Expect = e-103
 Identities = 84/284 (29%), Positives = 124/284 (43%), Gaps = 31/284 (10%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHRSL 56
           +Y+    LGSG FG             VA+K++E+ +  D         V  E++  + +
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103

Query: 57  RH--PNIIRFKEVLLTPTHLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVS 113
                 +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIAPE 170
           +CH+  + HRD+K EN L+D +    LK+ DFG     K  +         GT  Y  PE
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPPE 218

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
            +    Y G+ + VWS G+ LY M+ G  PFE            + I   Q F      V
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----------EEIIRGQVFFRQR--V 266

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIE 273
           S++C+HL+       PS R    EI+ HPW     LP+E  EI 
Sbjct: 267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  303 bits (777), Expect = e-102
 Identities = 81/332 (24%), Positives = 129/332 (38%), Gaps = 39/332 (11%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHR 54
           +Y  +  LGSG FG      DK   + V VK+I++ K              V  EI    
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISGVS 113
            + H NII+  ++        +VME    G +LFA I    R  E  A + F+QL+S V 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS----KSGLLHSQPKSTVGTPAYIAP 169
           Y    +I HRD+K EN ++       +K+ DFG +    +  L +    +  GT  Y AP
Sbjct: 145 YLRLKDIIHRDIKDENIVIAE--DFTIKLIDFGSAAYLERGKLFY----TFCGTIEYCAP 198

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
           EVL    Y G   ++WS GVTLY ++    PF +          ++         P    
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYL-- 246

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSV 289
           VS +   L+S +    P +R  + ++   PW  +        +   +Y      +  +  
Sbjct: 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP-------VNLADYTWEEVFRVNKPE 299

Query: 290 EEIMRIIQEAKMPGEATKVAGQGAAGASDPDD 321
             ++            + VA        +   
Sbjct: 300 SGVLSAASLEMGNRSLSDVAQAQELCGGEGHH 331

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  301 bits (773), Expect = e-102
 Identities = 76/288 (26%), Positives = 109/288 (37%), Gaps = 32/288 (11%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHRSL 56
            Y     LG G FG          +  VA+K I R + +             E+     +
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 57  R----HPNIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISG 111
                HP +IR  +   T     +V+E      +LF  I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS---KSGLLHSQPKSTVGTPAYIA 168
           + +CHS  + HRD+K EN L+D       K+ DFG                  GT  Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYSP 206

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           PE ++R +Y    + VWS G+ LY M+ G  PFE              I   +   P + 
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFPAH- 255

Query: 229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN 276
            VS DC  L+ +     PS R  + EI   PW         +   K  
Sbjct: 256 -VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  293 bits (752), Expect = 2e-98
 Identities = 61/328 (18%), Positives = 114/328 (34%), Gaps = 59/328 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------------------KIDE 44
             Y  ++ L  G F    L       +  A+K  E+                       +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 45  NVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG--------RF 96
           + + E+     +++   +  + ++     + I+ EY     +                  
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 97  SEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGL 152
                +   + +++  SY H+   ICHRD+K  N L+D     R+K+ DFG S+      
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKLSDFGESEYMVDKK 206

Query: 153 LHSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR 211
           +      + GT  ++ PE  + +  Y+G   D+WS G+ LYVM     PF       +  
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF---SLKISLV 259

Query: 212 KTIDRIRNVQYFLPDYVR-----------------VSADCRHLLSQIFVADPSKRIPIPE 254
           +  + IR      P                     +S +    L      +P++RI   +
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319

Query: 255 IKKHPWFLKNLPKEIIEIEKTNYKEAGR 282
             KH W      +++ E  K  YK+  +
Sbjct: 320 ALKHEWLADTNIEDLREFSKELYKKRKK 347

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  275 bits (705), Expect = 5e-92
 Identities = 91/275 (33%), Positives = 132/275 (48%), Gaps = 10/275 (3%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
            + Y     +G G++G  ++   K T+   A K I +    D +  ++EI   +SL HPN
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           IIR  E     T + +VME   GGELF R+     F E +A    + ++S V+YCH + +
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127

Query: 121 CHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
            HRDLK EN L    SP   LK+ DFG +         ++ VGTP Y++P+VL    Y  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGP 186

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 237
           +  D WS GV +YV+L G  PF  P D     K    IR   + F     + VS     L
Sbjct: 187 EC-DEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESL 241

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           + ++    P +RI   +  +H WF K L      +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  275 bits (704), Expect = 2e-91
 Identities = 64/304 (21%), Positives = 111/304 (36%), Gaps = 41/304 (13%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
              +     LG G        R K+T +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 60  NIIRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSY 114
           NI++   +    T  H  ++ME+   G L+  +          E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
                I HR++K  N +       Q   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 173 AR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF- 223
            R        K+Y   + D+WS GVT Y    G+ PF   E PR  ++ + +I   +   
Sbjct: 188 ERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 224 ------------------LPDYVRVSADCR----HLLSQIFVADPSKRIPIPEIKKHPWF 261
                             +P    +S   +     +L+ I  AD  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 262 LKNL 265
           + + 
Sbjct: 307 ILHR 310

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  274 bits (702), Expect = 5e-91
 Identities = 96/318 (30%), Positives = 138/318 (43%), Gaps = 18/318 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIIN 52
            + Y   K LGSG  G  +L  +++T + VA+K I + K             NV+ EI  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  V
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 113 SYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
            Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187

Query: 172 LARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 227
           L         +  D WS GV L++ L G  PF +     +     D+I + +Y F+P+  
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVW 244

Query: 228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQ 287
             VS     L+ ++ V DP  R    E  +HPW      K   +   +   E+       
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVL 304

Query: 288 SVEEIMRIIQEAKMPGEA 305
           +     R          A
Sbjct: 305 AQPSTSRKRPREGEAEGA 322

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  275 bits (706), Expect = 2e-90
 Identities = 93/285 (32%), Positives = 135/285 (47%), Gaps = 20/285 (7%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIIN 52
            + Y   K LGSG  G  +L  +++T + VA++ I + K             NV+ EI  
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 53  HRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            + L HP II+ K       +  IV+E   GGELF ++    R  E   + +F Q++  V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 113 SYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
            Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

Query: 172 LA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY 227
           L       Y+  + D WS GV L++ L G  PF +     + +   D+I + +Y F+P+ 
Sbjct: 313 LVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEV 368

Query: 228 -VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
              VS     L+ ++ V DP  R    E  +HPW      K   +
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  270 bits (694), Expect = 2e-90
 Identities = 87/271 (32%), Positives = 132/271 (48%), Gaps = 11/271 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
            + Y+  +ELG G F V R    K T    A K I   K   +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
             K  D+W+CGV LY++LVG  PF D +  R + +    I+   Y +       V+ + +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
            L+  +   +P KRI   +  K PW      
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRER 270

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  269 bits (689), Expect = 1e-89
 Identities = 81/268 (30%), Positives = 129/268 (48%), Gaps = 14/268 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KID-ENVQREIINHRSLRHP 59
           ++ +   ++LGSG FG   LV ++ +     +K I + + ++  E ++ EI   +SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYC 115
           NII+  EV     ++ IVME   GGEL  RI S        SE       +Q+++ ++Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 116 HSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
           HS  + H+DLK EN L    SP   +KI DFG ++         +  GT  Y+APEV  +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-K 199

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSAD 233
           ++   K  D+WS GV +Y +L G  PF         +K        +  +  +   ++  
Sbjct: 200 RDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWF 261
              LL Q+   DP +R    ++  H WF
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  269 bits (690), Expect = 2e-89
 Identities = 88/272 (32%), Positives = 139/272 (51%), Gaps = 12/272 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDE-NVQREIINHRSLRHPN 60
            + +  ++ LGSG F    LV+ + T +L A+K I++     + +++ EI   + ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+  +++  + TH  +VM+  +GGELF RI   G ++E +A    QQ++S V Y H   I
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 121 CHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEYD 178
            HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVLA+K Y 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRH 236
            K  D WS GV  Y++L G  PF +  + + F K    I+   Y F   +   +S   + 
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
            +  +   DP++R    +   HPW   N    
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  268 bits (686), Expect = 7e-89
 Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 39/300 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             +E +  LG G FG     R+       A+K I   ++    +  E++   SL H  ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 63  RFKEV-------------LLTPTHLAIVMEYAAGGELFARICSAGRF-SEDEARFFFQQL 108
           R+                +   + L I MEY   G L+  I S       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP----------- 157
           +  +SY HS  I HRDLK  N  +D S    +KI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 158 ----KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
                S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF            
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM---ERVNI 237

Query: 214 IDRIRNVQYFLPDYV--RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
           + ++R+V    P           + ++  +   DP+KR     +    W       E+I+
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIK 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  268 bits (688), Expect = 1e-88
 Identities = 75/329 (22%), Positives = 128/329 (38%), Gaps = 32/329 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
             Y  +K++GSG       V ++  K++ A+KY+   +  +   ++ + EI     L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 60  N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           +  IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
             I H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
                            SDVWS G  LY M  G  PF+      N    +  I +  + +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEI 240

Query: 225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LKNLPKEIIEIEKTNYK 278
                   D + +L      DP +RI IPE+  HP+       +  + K   E  K    
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300

Query: 279 EAGRDQPTQSVEEIMRIIQEAKMPGEATK 307
           +        S+ +  + + E    GE+  
Sbjct: 301 QLVGLNSPNSILKAAKTLYEHYSGGESHN 329

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  267 bits (685), Expect = 1e-88
 Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 27/295 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
             Y  +K++GSG       V ++  K++ A+KY+   +  +   ++ + EI     L+  
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 60  N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           +  IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
             I H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +  
Sbjct: 146 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
                            SDVWS G  LY M  G  PF+      N    +  I +  + +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---NQISKLHAIIDPNHEI 259

Query: 225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 279
                   D + +L      DP +RI IPE+  HP+        + ++ K   +E
Sbjct: 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ-THPVNQMAKGTTEE 313

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  265 bits (680), Expect = 3e-88
 Identities = 100/273 (36%), Positives = 139/273 (50%), Gaps = 12/273 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
            ERY  V  LG G+FG     +D+ T++  AVK I +     K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E+L   +   IV E   GGELF  I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
           D K  DVWS GV LY++L G  PF    +    ++    +   +Y F       +S D +
Sbjct: 200 DEKC-DVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
            L+ ++    PS RI   +  +HPW  K   +E
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  265 bits (679), Expect = 6e-88
 Identities = 89/286 (31%), Positives = 129/286 (45%), Gaps = 24/286 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----------KIDENVQREI- 50
            E YEP + LG G   V R    K T +  AVK I+             ++ E   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 51  INHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLIS 110
           I  +   HPNII+ K+   T T   +V +    GELF  +      SE E R   + L+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPE 170
            +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 171 VLARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL 224
           ++     D     GK  D+WS GV +Y +L G+ PF   +     R     I +  Y F 
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249

Query: 225 PDY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
                  S   + L+S+  V  P KR    E   HP+F + + +E+
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  267 bits (683), Expect = 3e-87
 Identities = 63/337 (18%), Positives = 117/337 (34%), Gaps = 41/337 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
              +     LG G        R K+T +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 60  NIIRFKEVL--LTPTHLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSY 114
           NI++   +    T  H  ++ME+   G L+  +          E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 115 CHSMEICHRDLKLENTLLDGSPQPR--LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
                I HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 173 AR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF- 223
            R        K+Y   + D+WS GVT Y    G+ PF   E PR  ++ + +I   +   
Sbjct: 188 ERAVLRKDHQKKYGATV-DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 224 ------------------LPDYVRVSADCR----HLLSQIFVADPSKRIPIPEIKKHPWF 261
                             +P    +S   +     +L+ I  AD  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 262 LKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
           + +     +   +             +      ++ +
Sbjct: 307 ILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYK 343

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  264 bits (678), Expect = 4e-87
 Identities = 89/267 (33%), Positives = 133/267 (49%), Gaps = 13/267 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
            + YE  +++G G++ V +    K T    AVK I++ K    +   EI I  R  +HPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYGQHPN 77

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           II  K+V     ++ +V E   GGEL  +I     FSE EA      +   V Y H+  +
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 121 CHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
            HRDLK  N L     G+P+  ++ICDFG++K     +    T   T  ++APEVL R+ 
Sbjct: 138 VHRDLKPSNILYVDESGNPES-IRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
           YD    D+WS GV LY ML G  PF +  D     + + RI + ++     Y   VS   
Sbjct: 197 YDAAC-DIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWF 261
           + L+S++   DP +R+    + +HPW 
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWI 281

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  264 bits (678), Expect = 7e-87
 Identities = 88/269 (32%), Positives = 132/269 (49%), Gaps = 11/269 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KID-ENVQREIINHRSLRH 58
            + Y+  +ELG G F V R    K T    A K I   K    D + ++RE    R L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R  + +   +   +V +   GGELF  I +   +SE +A    QQ++  ++YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
             K  D+W+CGV LY++LVG  PF D +  R + +    I+   Y +       V+ + +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            L+  +   +P KRI   +  K PW    
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNR 291

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  261 bits (670), Expect = 1e-86
 Identities = 92/279 (32%), Positives = 146/279 (52%), Gaps = 16/279 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
           E+ YE  +ELGSG F + R  R K T +  A K+I++ +          E ++RE+   R
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            +RHPNII   ++    T + +++E  +GGELF  +      +EDEA  F +Q++ GV Y
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            HS  I H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
             +   G  +D+WS GV  Y++L GA PF         ++T+  I  V Y F  +Y    
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNT 238

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           S   +  + ++ V DP +R+ I +  +H W      + +
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  265 bits (678), Expect = 2e-86
 Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 32/329 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
             Y  +K++GSG       V ++  K++ A+KY+   +  +   ++ + EI     L+  
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 60  N--IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           +  IIR  +  +T  ++ +VME     +L + +         E + +++ ++  V   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLAR 174
             I H DLK  N L+       LK+ DFG +             S VG   Y+ PE +  
Sbjct: 174 HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 175 KEYD----------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
                            SDVWS G  LY M  G  PF+   +  +    I    N +   
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-PNHEIEF 289

Query: 225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF------LKNLPKEIIEIEKTNYK 278
           PD      D + +L      DP +RI IPE+  HP+       +  + K   E  K    
Sbjct: 290 PDI--PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 347

Query: 279 EAGRDQPTQSVEEIMRIIQEAKMPGEATK 307
           +        S+ +  + + E    GE+  
Sbjct: 348 QLVGLNSPNSILKAAKTLYEHYSGGESHN 376

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  262 bits (672), Expect = 3e-86
 Identities = 81/321 (25%), Positives = 131/321 (40%), Gaps = 60/321 (18%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHRS 55
           +++Y     +G G++GV R+  + +T+ + A+K + + K         E ++ E+   + 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-------------------- 95
           L HPNI R  EV     ++ +VME   GG L  ++                         
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 96  --------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS 135
                                 E       +Q+ S + Y H+  ICHRD+K EN L   +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

Query: 136 PQPRLKICDFGYSKSGLLHSQP-----KSTVGTPAYIAPEVL--ARKEYDGKISDVWSCG 188
               +K+ DFG SK     +        +  GTP ++APEVL    + Y  K  D WS G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAG 263

Query: 189 VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLLSQIFVADP 246
           V L+++L+GA PF    D     +    + N +     P+Y  +S   R LLS +   + 
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319

Query: 247 SKRIPIPEIKKHPWFLKNLPK 267
            +R       +HPW  +   K
Sbjct: 320 DERFDAMRALQHPWISQFSDK 340

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  262 bits (671), Expect = 5e-86
 Identities = 96/272 (35%), Positives = 140/272 (51%), Gaps = 8/272 (2%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
            + +E   ELG G   +    + K T++  A+K +++     + V+ EI     L HPNI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNI 110

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           I+ KE+  TPT +++V+E   GGELF RI   G +SE +A    +Q++  V+Y H   I 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 122 HRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
           HRDLK EN L    +P   LKI DFG SK        K+  GTP Y APE+L    Y G 
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHLL 238
             D+WS G+  Y++L G  PF    D R  +    RI N +Y F+  +   VS + + L+
Sbjct: 230 EVDMWSVGIITYILLCGFEPF---YDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
            ++ V DP KR+   +  +HPW        + 
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  260 bits (666), Expect = 1e-85
 Identities = 91/274 (33%), Positives = 138/274 (50%), Gaps = 14/274 (5%)

Query: 2   EERYE---PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLR 57
            + Y+     K LG G+F + R    K++ +  AVK I   K+++ N Q+EI        
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEG 64

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI++  EV     H  +VME   GGELF RI     FSE EA +  ++L+S VS+ H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 118 MEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARK 175
           + + HRDLK EN L  D +    +KI DFG+++     +QP  T   T  Y APE+L + 
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI---DRIRNVQY-FLPDY-VRV 230
            YD    D+WS GV LY ML G  PF+  +        +    +I+   + F  +    V
Sbjct: 185 GYDESC-DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           S + + L+  +   DP+KR+ +  ++ + W    
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  261 bits (669), Expect = 2e-85
 Identities = 82/279 (29%), Positives = 129/279 (46%), Gaps = 23/279 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREI-I 51
            ++Y+P   +G G   V R    + T    AVK +E            ++ E  +RE  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 52  NHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
             +   HP+II   +   + + + +V +    GELF  +      SE E R   + L+  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           VS+ H+  I HRDLK EN LLD + Q  +++ DFG+S       + +   GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
           L     +     GK  D+W+CGV L+ +L G+ PF         R     I   QY F  
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326

Query: 226 DY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
                 S+  + L+S++   DP  R+   +  +HP+F +
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  270 bits (691), Expect = 2e-85
 Identities = 76/288 (26%), Positives = 108/288 (37%), Gaps = 31/288 (10%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNI 61
            +E  + LG+G FG       + T E VA+K   +    K  E    EI   + L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 62  IRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGV 112
           +  +EV      LA      + MEY  GG+L   +          E   R     + S +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 113 SYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
            Y H   I HRDLK EN +L  G  +   KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------- 223
           L +K+Y   + D WS G   +  + G  PF     P  +   +    N            
Sbjct: 195 LEQKKYTVTV-DYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 224 ------LPDYVRVS----ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                 LP    +S          L  + +    +R   P+      F
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  264 bits (677), Expect = 3e-85
 Identities = 100/273 (36%), Positives = 139/273 (50%), Gaps = 12/273 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRH 58
            ERY  V  LG G+FG     +D+ T++  AVK I +    +     + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  E+L   +   IV E   GGELF  I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY 199

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
           D K  DVWS GV LY++L G  PF      +N    + R+   +Y F       +S D +
Sbjct: 200 DEKC-DVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKYAFDLPQWRTISDDAK 254

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
            L+ ++    PS RI   +  +HPW  K   + 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  259 bits (663), Expect = 4e-85
 Identities = 92/280 (32%), Positives = 154/280 (55%), Gaps = 16/280 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
           ++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   +
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV Y
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 115 CHSMEICHRDLKLENTLL--DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
             +   G  +D+WS GV  Y++L GA PF         ++T+  +  V Y F  +Y    
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNT 244

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           SA  +  + ++ V DP KR+ I +  +HPW      ++ +
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQAL 284

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  258 bits (662), Expect = 5e-85
 Identities = 86/271 (31%), Positives = 143/271 (52%), Gaps = 16/271 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
           E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            + H N+I   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
             +   G  +D+WS GV  Y++L GA PF         ++T+  I +V Y F  ++    
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHT 245

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           S   +  + ++ V +  KR+ I E  +HPW 
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  263 bits (675), Expect = 7e-85
 Identities = 98/279 (35%), Positives = 141/279 (50%), Gaps = 12/279 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRH 58
            E Y+ VK+LGSG +G   L RDK T    A+K I +       +  +  E+   + L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI++  +      +  +VME   GGELF  I    +F+E +A    +Q++SGV+Y H  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            I HRDLK EN LL        +KI DFG S       + K  +GT  YIAPEVL RK+Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY 214

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
           D K  DVWS GV L+++L G  PF      +  ++ + ++   +Y F       VS   +
Sbjct: 215 DEKC-DVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 274
            L+ Q+   D  +RI   +  +HPW  +   K+   IE 
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIEL 308

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  259 bits (664), Expect = 7e-85
 Identities = 88/278 (31%), Positives = 146/278 (52%), Gaps = 16/278 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
           E+ Y+  +ELGSG F + +  R+K T    A K+I++ +          E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            + HPNII   +V    T + +++E  +GGELF  +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            H+ +I H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRV 230
             +   G  +D+WS GV  Y++L GA PF         ++T+  I  V Y F  ++  + 
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQT 245

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           S   +  + ++ V +  KR+ I E  +HPW      ++
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  263 bits (673), Expect = 1e-84
 Identities = 97/275 (35%), Positives = 139/275 (50%), Gaps = 13/275 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR 57
            +RY+  + LG G+FG   L +DK T +  AVK I + +       E++ RE+   + L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPNI++  E      +  +V E   GGELF  I S  RFSE +A    +Q++SG++Y H 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144

Query: 118 MEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
            +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGT 203

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
           YD K  DVWS GV LY++L G  PF       N    + ++   +Y F      +VS   
Sbjct: 204 YDEKC-DVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           + L+ ++    PS RI   +   H W      ++I
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  259 bits (663), Expect = 1e-83
 Identities = 90/270 (33%), Positives = 134/270 (49%), Gaps = 12/270 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRH 58
            E Y+  +ELG G F V R        +  A   I   K      + ++RE    R L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R  + +    H  ++ +   GGELF  I +   +SE +A    QQ++  V +CH M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 119 EICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKE 176
            + HR+LK EN LL        +K+ DFG +       Q      GTP Y++PEVL +  
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADC 234
           Y GK  D+W+CGV LY++LVG  PF D +  R +++    I+   Y F       V+ + 
Sbjct: 190 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEA 244

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           + L++++   +PSKRI   E  KHPW    
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHR 274

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  254 bits (652), Expect = 2e-83
 Identities = 66/277 (23%), Positives = 125/277 (45%), Gaps = 8/277 (2%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
            E+Y   ++LG G FG+     +  +K+    K+++        V++EI      RH NI
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEI 120
           +   E   +   L ++ E+ +G ++F RI ++    +E E   +  Q+   + + HS  I
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            H D++ EN +        +KI +FG ++        +     P Y APEV         
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHLL 238
            +D+WS G  +YV+L G  PF    +    ++ I+ I N +Y F  +    +S +    +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT 275
            ++ V +   R+   E  +HPW  + + +   ++ +T
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  256 bits (657), Expect = 2e-83
 Identities = 86/331 (25%), Positives = 143/331 (43%), Gaps = 18/331 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
            + Y+ ++ELGSG FGV     +K T  +   K+I     +D   V+ EI     L HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSME 119
           +I   +       + +++E+ +GGELF RI +   + SE E   + +Q   G+ + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I H D+K EN + +      +KI DFG +         K T  T  + APE++ R+   G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCRHL 237
             +D+W+ GV  YV+L G  PF   +D     +T+  ++   + F  D    VS + +  
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 238 LSQIFVADPSKRIPIPEIKKHPWF-------LKNLPKEIIEIEKTNYKEAGRDQPTQSVE 290
           +  +   +P KR+ + +  +HPW           +P       +   KE   D P     
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPA-PQP 343

Query: 291 EIMRIIQEAKMPGEATKVAGQGAAGASDPDD 321
            I RI   + +  +      Q      D  +
Sbjct: 344 AIGRIANFSSLR-KHRPQEYQIYDSYFDRKE 373

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  260 bits (666), Expect = 2e-83
 Identities = 92/284 (32%), Positives = 141/284 (49%), Gaps = 23/284 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQ 47
            E Y  V++LGSG +G   L ++K      A+K I++ +              K  E + 
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 48  REIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
            EI   +SL HPNII+  +V     +  +V E+  GGELF +I +  +F E +A    +Q
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 108 LISGVSYCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
           ++SG+ Y H   I HRD+K EN LL + +    +KI DFG S       + +  +GT  Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
           IAPEVL +K+Y+ K  DVWSCGV +Y++L G  PF      +N +  I ++   +Y F  
Sbjct: 215 IAPEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKYYFDF 268

Query: 226 DY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           +    +S + + L+  +   D +KR    E     W  K     
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  251 bits (643), Expect = 5e-82
 Identities = 79/284 (27%), Positives = 126/284 (44%), Gaps = 15/284 (5%)

Query: 2   EERYE-PVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREI-INHRSL 56
              Y    KELG G F V R    K T +  A K+++   RG+     +  EI +   + 
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSY 114
             P +I   EV    + + +++EYAAGGE+F+      A   SE++     +Q++ GV Y
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            H   I H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVS 231
                   +D+W+ G+  Y++L    PF   ++   +      I  V   +  +    VS
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKT 275
                 +  + V +P KR        H W  +   + +   E+T
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  251 bits (643), Expect = 8e-82
 Identities = 80/277 (28%), Positives = 130/277 (46%), Gaps = 20/277 (7%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID------ENVQREIINHRS 55
           E+ YE  + +G G F V R   ++ T +  AVK ++  K         E+++RE      
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
           L+HP+I+   E   +   L +V E+  G +L   I         +SE  A  + +Q++  
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142

Query: 112 VSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAP 169
           + YCH   I HRD+K    LL        +K+  FG +             VGTP ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY- 227
           EV+ R+ Y GK  DVW CGV L+++L G  PF   ++     +  + I   +Y   P   
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQW 256

Query: 228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
             +S   + L+ ++ + DP++RI + E   HPW  + 
Sbjct: 257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  250 bits (641), Expect = 4e-81
 Identities = 81/279 (29%), Positives = 128/279 (45%), Gaps = 11/279 (3%)

Query: 2   EERYE--PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRH 58
              Y     + LG G FG      +  T   +A K I+     D E V+ EI     L H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHS 117
            N+I+  +   +   + +VMEY  GGELF RI       +E +   F +Q+  G+ + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
           M I H DLK EN L       ++KI DFG ++      + K   GTP ++APEV+    +
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-F 264

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VRVSADCR 235
               +D+WS GV  Y++L G  PF    D     +T++ I   ++    +    +S + +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAK 320

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 274
             +S++ + + S RI   E  KHPW   +     +  +K
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQK 359

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  248 bits (636), Expect = 7e-81
 Identities = 84/275 (30%), Positives = 130/275 (47%), Gaps = 19/275 (6%)

Query: 2   EERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHP 59
            + Y+  K+ LG G  G       +RT +  A+K +    K     ++E+  + ++   P
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGP 82

Query: 60  NIIRFKEVLLTPTHLA----IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVS 113
           +I+   +V     H      I+ME   GGELF+RI   G   F+E EA    + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 114 YCHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEV 171
           + HS  I HRD+K EN L         LK+ DFG++K         ++   TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDY-VR 229
           L  ++YD    D+WS GV +Y++L G  PF              RIR  QY F       
Sbjct: 201 LGPEKYDKSC-DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           VS D + L+  +   DP++R+ I +   HPW  ++
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  246 bits (630), Expect = 8e-81
 Identities = 80/283 (28%), Positives = 136/283 (48%), Gaps = 27/283 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
           E YE +  +G+G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 60  NIIRFKE--VLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
           NI+R+ +  +  T T L IVMEY  GG+L + I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 114 YCHSM-----EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVGTPAY 166
            CH        + HRDLK  N  LDG     +K+ DFG ++  L H     K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARI-LNHDTSFAKTFVGTPYY 182

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP 225
           ++PE + R  Y+ K SD+WS G  LY +     PF       + ++   +IR  ++  +P
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIP 237

Query: 226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
              R S +   +++++       R  + EI ++P  L++    
Sbjct: 238 Y--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHH 278

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  249 bits (637), Expect = 3e-80
 Identities = 90/273 (32%), Positives = 139/273 (50%), Gaps = 15/273 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
           ++     + LG G  G    + +KRT+E  A+K ++   K     +RE+ ++ R+ + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 116

Query: 61  IIRFKEV----LLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
           I+R  +V          L IVME   GGELF+RI   G   F+E EA    + +   + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            HS+ I HRD+K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVS 231
            ++YD    D+WS GV +Y++L G  PF              RIR  QY  P+     VS
Sbjct: 237 PEKYDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            + + L+  +   +P++R+ I E   HPW +++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  247 bits (632), Expect = 4e-80
 Identities = 76/272 (27%), Positives = 135/272 (49%), Gaps = 16/272 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
           E+Y  ++++G G+FG A LV+         +K I   +      E  +RE+    +++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHS 117
           NI++++E       L IVM+Y  GG+LF RI +     F ED+   +F Q+   + + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKE 176
            +I HRD+K +N  L       +++ DFG ++         ++ +GTP Y++PE+   K 
Sbjct: 144 RKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSADCR 235
           Y+ K SD+W+ G  LY +    + FE      + +  + +I +  +  +      S D R
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDLR 254

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
            L+SQ+F  +P  R  +  I +  +  K + K
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK 286

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  253 bits (649), Expect = 4e-80
 Identities = 83/282 (29%), Positives = 138/282 (48%), Gaps = 10/282 (3%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
            + Y+  +ELG+G FGV   V ++ T    A K++    + D E V++EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSME 119
           ++   +       + ++ E+ +GGELF ++     + SEDEA  + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
             H DLK EN +        LK+ DFG +         K T GT  + APEV   K   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHL 237
             +D+WS GV  Y++L G  PF    D     +T+  +++  + + D  +  +S D +  
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYK 278
           + ++ +ADP+ R+ I +  +HPW    N P    +I  + Y 
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 432

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  246 bits (629), Expect = 4e-80
 Identities = 69/284 (24%), Positives = 109/284 (38%), Gaps = 26/284 (9%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
            + Y  +++LG G F    LV         A+K I   ++ D E  QRE   HR   HPN
Sbjct: 28  NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87

Query: 61  IIRFKEVLLTPT----HLAIVMEYAAGGELF----ARICSAGRFSEDEARFFFQQLISGV 112
           I+R     L          +++ +   G L+             +ED+  +    +  G+
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----------VG 162
              H+    HRDLK  N LL    QP   + D G      +H +                
Sbjct: 148 EAIHAKGYAHRDLKPTNILLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 163 TPAYIAPEVLARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV 220
           T +Y APE+ + + +    + +DVWS G  LY M+ G  P++      +           
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA---LAVQN 262

Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
           Q  +P   R S+    LL+ +   DP +R  IP +      L+ 
Sbjct: 263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  244 bits (625), Expect = 2e-79
 Identities = 77/296 (26%), Positives = 124/296 (41%), Gaps = 31/296 (10%)

Query: 2   EERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREI-INHRSLRH 58
           E+ Y+  ++ LG G     +   +  T +  AVK IE+        V RE+ + ++   H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            N++   E         +V E   GG + + I     F+E EA    Q + S + + H+ 
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 119 EICHRDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAP 169
            I HRDLK EN L    +    +KICDF            S +   +  +  G+  Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 170 EVL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI---------- 214
           EV+         YD K  D+WS GV LY++L G  PF                       
Sbjct: 191 EVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 215 -DRIRNVQY-FLPDY-VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
            + I+  +Y F       +S   + L+S++ V D  +R+   ++ +HPW     P+
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  242 bits (620), Expect = 4e-79
 Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 34/284 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             ++ ++ +GSG FG     + +   +   +K ++      E  +RE+     L H NI+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIV 67

Query: 63  RFKE----------------VLLTPTHLAIVMEYAAGGELFARI--CSAGRFSEDEARFF 104
            +                         L I ME+   G L   I      +  +  A   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
           F+Q+  GV Y HS ++ +RDLK  N  L  + Q  +KI DFG   S     +   + GT 
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL 224
            Y++PE ++ ++Y  +  D+++ G+ L  +L       +        K    +R+    +
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLRDGI--I 236

Query: 225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
            D        + LL ++    P  R    EI +     K  P++
Sbjct: 237 SD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  230 bits (588), Expect = 1e-73
 Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 39/316 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLR-HP 59
           E R    + L  G F      +D  +    A+K +   ++     + +E+   + L  HP
Sbjct: 27  ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86

Query: 60  NIIRF-------KEVLLTPTHLAIVMEYAAGGELFA---RICSAGRFSEDEARFFFQQLI 109
           NI++F       KE   T     +++     G+L     ++ S G  S D     F Q  
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 110 SGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST------- 160
             V + H  +  I HRDLK+EN LL        K+CDFG + +   +     +       
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTI--KLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 161 ------VGTPAYIAPEV--LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212
                   TP Y  PE+  L      G+  D+W+ G  LY++    +PFED         
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG-------- 256

Query: 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
              RI N +Y +P +         L+  +   +P +R+ I E+      +        + 
Sbjct: 257 AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316

Query: 273 EKTNYKEAGRDQPTQS 288
             T   E      + +
Sbjct: 317 PITELLEQNGGYGSAT 332

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  229 bits (585), Expect = 1e-73
 Identities = 83/273 (30%), Positives = 125/273 (45%), Gaps = 36/273 (13%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
           ++     + LG G  G    + +KRT+E  A+K ++   K     +RE+ ++ R+ + P+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 72

Query: 61  IIRFKEV----LLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
           I+R  +V          L IVME   GGELF+RI   G   F+E EA    + +   + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 115 CHSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            HS+ I HRD+K EN L     P   LK+ DFG                     A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETTG 172

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV--RVS 231
            K YD    D+WS GV +Y++L G  PF              RIR  QY  P+     VS
Sbjct: 173 EK-YDKSC-DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN 264
            + + L+  +   +P++R+ I E   HPW +++
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  228 bits (584), Expect = 2e-73
 Identities = 60/265 (22%), Positives = 104/265 (39%), Gaps = 17/265 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSL-R 57
           ++ ++ +  LG G++G    VR K    L AVK      RG K       E+ +H  + +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCH 116
           HP  +R ++       L +  E   G  L     + G    E +   + +  +  +++ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S  + H D+K  N  L   P+ R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y    +DV+S G+T+  +          E  +  R+                 +S++ R 
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPE-----FTAG--LSSELRS 283

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWF 261
           +L  +   DP  R     +   P  
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  227 bits (582), Expect = 4e-73
 Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 16/279 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
             +   K++G G F              VA+K ++    +D     +  +EI   + L H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVSY 114
           PN+I++    +    L IV+E A  G+L   I    +      E     +F QL S + +
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLA 173
            HS  + HRD+K  N  +  +    +K+ D G  +      +   S VGTP Y++PE + 
Sbjct: 152 MHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVRVSA 232
              Y+ K SD+WS G  LY M     PF    D  N      +I    Y  LP     S 
Sbjct: 210 ENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYSE 265

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
           + R L++     DP KR  +  +      +       +E
Sbjct: 266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  222 bits (567), Expect = 7e-71
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 26/272 (9%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVK-----YIERGKKIDE-NVQREIINHRSLRH 58
           ++  K LG G+F    L R+  T    A+K     +I +  K+     +R++++   L H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P  ++          L   + YA  GEL   I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARK 175
            I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L  K
Sbjct: 150 GIIHRDLKPENILLNE--DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
               K SD+W+ G  +Y ++ G  PF       N      +I  ++Y  P+        R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPEK--FFPKAR 260

Query: 236 HLLSQIFVADPSKRIPIP------EIKKHPWF 261
            L+ ++ V D +KR+          +K HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  225 bits (574), Expect = 2e-70
 Identities = 76/326 (23%), Positives = 122/326 (37%), Gaps = 48/326 (14%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHP 59
           ++      K LG G+ G     +       VAVK +       +    EI +   S  HP
Sbjct: 13  LKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDHP 69

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSED-------EARFFFQQLISGV 112
           N+IR+     T   L I +E      L   + S     E+             +Q+ SGV
Sbjct: 70  NVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQP-----------RLKICDFGYSK-----SGLLHSQ 156
           ++ HS++I HRDLK +N L+  S +            R+ I DFG  K          + 
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 157 PKSTVGTPAYIAPEVL-------ARKEYDGKISDVWSCGVTLYVMLVGAY-PFEDPEDPR 208
             +  GT  + APE+L        ++     I D++S G   Y +L     PF D     
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKYS-- 245

Query: 209 NFRKTIDRIRNVQYFLPDYVR-----VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
                   I    + L +        + A+   L+SQ+   DP KR    ++ +HP F  
Sbjct: 246 ----RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301

Query: 264 NLPKEIIEIEKTNYKEAGRDQPTQSV 289
              K    ++ ++  E     P  ++
Sbjct: 302 KSKKLEFLLKVSDRLEIENRDPPSAL 327

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  220 bits (562), Expect = 3e-70
 Identities = 68/304 (22%), Positives = 116/304 (38%), Gaps = 41/304 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
             +EP++ LG G FGV    ++K      A+K I     +   E V RE+     L HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 61  IIRFKEVLLT------------PTHLAIVMEYAAGGELFARI---CSAGRFSEDEARFFF 105
           I+R+    L               +L I M+      L   +   C+            F
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-------------SGL 152
            Q+   V + HS  + HRDLK  N          +K+ DFG                   
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK 212
            +++    VGT  Y++PE +    Y  K  D++S G+ L+ +L   YPF    +     +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMER---VR 235

Query: 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIE 271
           T+  +RN   F P + +       ++  +    P +R     I ++  F   + P + + 
Sbjct: 236 TLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

Query: 272 IEKT 275
            +++
Sbjct: 295 RQRS 298

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  218 bits (557), Expect = 5e-68
 Identities = 67/272 (24%), Positives = 100/272 (36%), Gaps = 19/272 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
           +  + P   LG G  G     R       VAVK I    +      RE+ +   S  HPN
Sbjct: 23  KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL--PECFSFADREVQLLRESDEHPN 79

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSME 119
           +IR+           I +E      L   +          E     QQ  SG+++ HS+ 
Sbjct: 80  VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138

Query: 120 ICHRDLKLENTLL---DGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVL 172
           I HRDLK  N L+   +   + +  I DFG  K         S+     GT  +IAPE+L
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 173 ARKEYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPDYVR 229
           +    +      D++S G   Y ++        P      R+    +       L     
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH---PFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                R L+ ++   DP KR     + KHP+F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  211 bits (537), Expect = 1e-65
 Identities = 41/308 (13%), Positives = 83/308 (26%), Gaps = 63/308 (20%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR------- 57
             LG  +        D+ T E   V      ++      + ++ E++  R LR       
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 58  ------------------HPNIIRFKEVLLTPTHLAIVMEYAA--------GGELFARIC 91
                                +IR +        L+    Y          G  L +   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 92  SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
           +              Q+I  ++  H   + H  L+  + +LD   +  + +  F +    
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRD 256

Query: 152 LLHSQPKSTVGTPAYIAPEVLA----------RKEYDGKISDVWSCGVTLYVMLVGAYPF 201
                   +  +  +  PE+ A          R+       D W+ G+ +Y +     P 
Sbjct: 257 ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 202 EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                           +N          +    R LL          R+   +  + P +
Sbjct: 314 TKDAALGGSEWIFRSCKN----------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

Query: 262 LKNLPKEI 269
            + L  E+
Sbjct: 364 -EQLRTEL 370

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  203 bits (520), Expect = 2e-63
 Identities = 88/262 (33%), Positives = 129/262 (49%), Gaps = 24/262 (9%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHPNI 61
           LG G+FG   L   K+T +  A+K +   KK D  +  + +            +  HP +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKAL---KK-DVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
                   T  +L  VMEY  GG+L   I S  +F    A F+  ++I G+ + HS  I 
Sbjct: 81  THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIV 140

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDGK 180
           +RDLKL+N LLD      +KI DFG  K  +L     +T  GTP YIAPE+L  ++Y   
Sbjct: 141 YRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 197

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             D WS GV LY ML+G  PF      ++  +    IR    F P +  +  + + LL +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAKDLLVK 251

Query: 241 IFVADPSKRI-PIPEIKKHPWF 261
           +FV +P KR+    +I++HP F
Sbjct: 252 LFVREPEKRLGVRGDIRQHPLF 273

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  204 bits (522), Expect = 3e-63
 Identities = 62/260 (23%), Positives = 116/260 (44%), Gaps = 12/260 (4%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRF 64
           + +G G+FG   +V+   TK++ A+KY+ + K ++ N  R +         L HP ++  
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
                    + +V++   GG+L   +     F E+  + F  +L+  + Y  +  I HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG--KIS 182
           +K +N LLD      + I DF  +      +Q  +  GT  Y+APE+ + ++  G     
Sbjct: 141 MKPDNILLDE--HGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAV 198

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF 242
           D WS GVT Y +L G  P+       + ++ +          P     S +   LL ++ 
Sbjct: 199 DWWSLGVTAYELLRGRRPYHI-RSSTSSKEIVHTFETTVVTYPSA--WSQEMVSLLKKLL 255

Query: 243 VADPSKRI-PIPEIKKHPWF 261
             +P +R   + +++  P+ 
Sbjct: 256 EPNPDQRFSQLSDVQNFPYM 275

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  203 bits (517), Expect = 9e-63
 Identities = 46/306 (15%), Positives = 84/306 (27%), Gaps = 45/306 (14%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHP 59
           + + V+ L  G+  V  LVRD    E  A+K    G +      E +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 60  NIIRFKEVL--------------------------LTPTHLAIVMEYAAG------GELF 87
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 88  ARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY 147
                 G            QLI   +   S  + H     +N  +   P  RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM--PDGRLMLGDVSA 240

Query: 148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYD-GKISDVWSCGVTLYVMLVGAYPFEDPED 206
                + ++  ++     Y   E L           + W  G+++Y +     PF     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 207 PRNF---RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
                  R ++               +    + L+ +    D  +R+   E  + P F  
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF-L 357

Query: 264 NLPKEI 269
            L  EI
Sbjct: 358 QLQNEI 363

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  202 bits (516), Expect = 1e-62
 Identities = 48/299 (16%), Positives = 95/299 (31%), Gaps = 41/299 (13%)

Query: 2   EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGKKIDENVQREIIN-HRS 55
            +       LG G F            D + K+   +K  +     +  +  +++   + 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-----FSEDEARFFFQQLIS 110
                 ++F    L      +V E  + G L   I            +     F  +++ 
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPR---------LKICDFGYSKSGLLHSQPKSTV 161
            +   H  EI H D+K +N +L      +         L + D G S    +   PK T+
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGTI 241

Query: 162 -----GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR 216
                 T  +   E+L+ K ++ +I D +    T+Y ML G Y     E      + + R
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300

Query: 217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP---WFLKNLPKEIIEI 272
               +    D              +        +P  ++ +      F ++   +I  +
Sbjct: 301 ----RLPHLDM------WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRAL 349

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  201 bits (513), Expect = 1e-62
 Identities = 76/269 (28%), Positives = 141/269 (52%), Gaps = 23/269 (8%)

Query: 6   EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRH 58
           E +K LG G+FG   + + +     ++L A+K + +   +    +      R     + H
Sbjct: 27  ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVEVNH 85

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P I++      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + HS+
Sbjct: 86  PFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEY 177
            I +RDLK EN LLD   +  +K+ DFG SK  + H +   +  GT  Y+APEV+ R+ +
Sbjct: 146 GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH 203

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             + +D WS GV ++ ML G  PF+     ++ ++T+  I   +  +P +  +S + + L
Sbjct: 204 -TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSL 256

Query: 238 LSQIFVADPSKRI-----PIPEIKKHPWF 261
           L  +F  +P+ R+      + EIK+H +F
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  200 bits (512), Expect = 1e-62
 Identities = 88/270 (32%), Positives = 138/270 (51%), Gaps = 28/270 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
           ++ ++ LG+G+FG   L+R +      A+K +    K +  V+ + + H          +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            HP IIR          + ++M+Y  GGELF+ +  + RF    A+F+  ++   + Y H
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKE 176
           S +I +RDLK EN LLD      +KI DFG++K   +     +  GTP YIAPEV++ K 
Sbjct: 124 SKDIIYRDLKPENILLDK--NGHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKP 179

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y  K  D WS G+ +Y ML G  PF D     N  KT ++I N +   P +   + D + 
Sbjct: 180 Y-NKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF--FNEDVKD 232

Query: 237 LLSQIFVADPSKRI-----PIPEIKKHPWF 261
           LLS++   D S+R+        ++K HPWF
Sbjct: 233 LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  202 bits (515), Expect = 2e-62
 Identities = 89/267 (33%), Positives = 128/267 (47%), Gaps = 27/267 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
           K +G G+FG   L R K  +   AVK +   +K    ++++   H         ++++HP
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVL---QK-KAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            ++       T   L  V++Y  GGELF  +     F E  ARF+  ++ S + Y HS+ 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLK EN LLD   Q  + + DFG  K  + H+   ST  GTP Y+APEVL ++ Y 
Sbjct: 160 IVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY- 216

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            +  D W  G  LY ML G  PF      RN  +  D I N    L     ++   RHLL
Sbjct: 217 DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKPN--ITNSARHLL 270

Query: 239 SQIFVADPSKRIPIP----EIKKHPWF 261
             +   D +KR+       EIK H +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  200 bits (512), Expect = 2e-62
 Identities = 87/267 (32%), Positives = 135/267 (50%), Gaps = 27/267 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSLRHPN 60
           K LG G FG   LVR+K T    A+K +   +K +  + ++ + H        ++ RHP 
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKIL---RK-EVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS ++
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYDG 179
            +RD+KLEN +LD      +KI DFG  K G+       T  GTP Y+APEVL   +Y G
Sbjct: 127 VYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           +  D W  GV +Y M+ G  PF +    ++  +  + I   +   P    +S + + LL+
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKSLLA 237

Query: 240 QIFVADPSKRI-----PIPEIKKHPWF 261
            +   DP +R+        E+ +H +F
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  201 bits (513), Expect = 3e-62
 Identities = 82/266 (30%), Positives = 142/266 (53%), Gaps = 20/266 (7%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPN 60
           ++ +K LG+G+FG   LV+ K +    A+K +++ K +        +N +    ++  P 
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+++
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            +RDLK EN L+D   Q  +++ DFG++K   +  +  +  GTP  +APE++  K Y  K
Sbjct: 163 IYRDLKPENLLIDQ--QGYIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSKGY-NK 217

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ 240
             D W+ GV +Y M  G  PF   + P    +  ++I + +   P +   S+D + LL  
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFA-DQP---IQIYEKIVSGKVRFPSH--FSSDLKDLLRN 271

Query: 241 IFVADPSKRI-----PIPEIKKHPWF 261
           +   D +KR       + +IK H WF
Sbjct: 272 LLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  200 bits (510), Expect = 7e-62
 Identities = 90/269 (33%), Positives = 127/269 (47%), Gaps = 29/269 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
           + LG G+FG   L R K T +L AVK +   KK D  +Q + +            +  HP
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVL---KK-DVILQDDDVECTMTEKRILSLARNHP 84

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + +      TP  L  VME+  GG+L   I  + RF E  ARF+  ++IS + + H   
Sbjct: 85  FLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
           I +RDLKL+N LLD   +   K+ DFG  K G+ +    +T  GTP YIAPE+L    Y 
Sbjct: 145 IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY- 201

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           G   D W+ GV LY ML G  PFE      N     + I N +   P +  +  D   +L
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPFEA----ENEDDLFEAILNDEVVYPTW--LHEDATGIL 255

Query: 239 SQIFVADPSKRI------PIPEIKKHPWF 261
                 +P+ R+          I +HP+F
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  197 bits (504), Expect = 1e-61
 Identities = 65/294 (22%), Positives = 110/294 (37%), Gaps = 40/294 (13%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIE---RGKKIDENVQREIINHRSL- 56
               +  ++++GSG FG       +    + A+K  +    G   ++N  RE+  H  L 
Sbjct: 9   YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG 68

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGV 112
           +H +++R+        H+ I  EY  GG L   I    R    F E E +    Q+  G+
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 113 SYCHSMEICHRDLKLENTLLD-----------------GSPQPRLKICDFGYSKSGLLHS 155
            Y HSM + H D+K  N  +                   S +   KI D G+       S
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---IS 185

Query: 156 QPKSTVGTPAYIAPEVLA-RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
            P+   G   ++A EVL     +  K +D+++  +T+           + +         
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQ-------W 237

Query: 215 DRIRNVQY-FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
             IR  +   +P    +S +   LL  +   DP +R     + KH   L    K
Sbjct: 238 HEIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  199 bits (509), Expect = 1e-61
 Identities = 86/268 (32%), Positives = 120/268 (44%), Gaps = 28/268 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
             LG G+FG   L   K T EL AVK +   KK D  +Q + +              + P
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + +      T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ +  S  
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLKL+N +LD   +  +KI DFG  K  +       T  GTP YIAPE++A + Y 
Sbjct: 142 IIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY- 198

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           GK  D W+ GV LY ML G  PFE      +  +    I       P    +S +   + 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEAVAIC 252

Query: 239 SQIFVADPSKRI-----PIPEIKKHPWF 261
             +    P KR+        +IK+H +F
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  199 bits (508), Expect = 1e-61
 Identities = 80/274 (29%), Positives = 126/274 (45%), Gaps = 30/274 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
           + +G G++    LVR K+T  + A+K +   KK +     E I+          ++  HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVV---KK-ELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLKL+N LLD   +  +K+ D+G  K GL      ST  GTP YIAPE+L  ++Y 
Sbjct: 131 IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 187

Query: 179 GKISDVWSCGVTLYVMLVGAYPF-----EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           G   D W+ GV ++ M+ G  PF      D  D          I   Q  +P    +S  
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 245

Query: 234 CRHLLSQIFVADPSKRI------PIPEIKKHPWF 261
              +L      DP +R+         +I+ HP+F
Sbjct: 246 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  196 bits (501), Expect = 8e-61
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 23/270 (8%)

Query: 6   EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQRE-IINHR----SLR 57
           E ++ LG G +G     R V    T ++ A+K +++   +            R     ++
Sbjct: 20  ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP I+       T   L +++EY +GGELF ++   G F ED A F+  ++   + + H 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKE 176
             I +RDLK EN +L+   Q  +K+ DFG  K  +       T  GT  Y+APE+L R  
Sbjct: 140 KGIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG 197

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           +  +  D WS G  +Y ML GA PF       N +KTID+I   +  LP Y  ++ + R 
Sbjct: 198 H-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LTQEARD 250

Query: 237 LLSQIFVADPSKRI-----PIPEIKKHPWF 261
           LL ++   + + R+        E++ HP+F
Sbjct: 251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  198 bits (505), Expect = 1e-60
 Identities = 79/274 (28%), Positives = 126/274 (45%), Gaps = 30/274 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RSLRHP 59
           + +G G++    LVR K+T  + A++ +   KK +     E I+          ++  HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVV---KK-ELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            ++       T + L  V+EY  GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLARKEYD 178
           I +RDLKL+N LLD   +  +K+ D+G  K GL      ST  GTP YIAPE+L  ++Y 
Sbjct: 174 IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230

Query: 179 GKISDVWSCGVTLYVMLVGAYPF-----EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           G   D W+ GV ++ M+ G  PF      D  D          I   Q  +P    +S  
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 288

Query: 234 CRHLLSQIFVADPSKRI------PIPEIKKHPWF 261
              +L      DP +R+         +I+ HP+F
Sbjct: 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  195 bits (497), Expect = 3e-59
 Identities = 88/275 (32%), Positives = 129/275 (46%), Gaps = 30/275 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
           YE VK +G G FG  +LVR K T+++ A+K +       E ++R                
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
             P +++         +L +VMEY  GG+L   + S     E  ARF+  +++  +   H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
           SM   HRD+K +N LLD      LK+ DFG           +    VGTP YI+PEVL  
Sbjct: 186 SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

Query: 175 KEYD---GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVR 229
           +  D   G+  D WS GV LY MLVG  PF       +   T  +I N +  L  PD   
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299

Query: 230 VSADCRHLLSQIFVADPSKRIP---IPEIKKHPWF 261
           +S + ++L+   F+ D   R+    + EIK+H +F
Sbjct: 300 ISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  196 bits (499), Expect = 3e-59
 Identities = 94/272 (34%), Positives = 136/272 (50%), Gaps = 28/272 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
           +E +K LG G FG   LV++K T    A+K +   KK +  V ++ + H        ++ 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KK-EVIVAKDEVAHTLTENRVLQNS 205

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           RHP +   K    T   L  VMEYA GGELF  +     FSED ARF+  +++S + Y H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265

Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLAR 174
           S   + +RDLKLEN +LD      +KI DFG  K G+       T  GTP Y+APEVL  
Sbjct: 266 SEKNVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
            +Y G+  D W  GV +Y M+ G  PF +    ++  K  + I   +   P    +  + 
Sbjct: 324 NDY-GRAVDWWGLGVVMYEMMCGRLPFYN----QDHEKLFELILMEEIRFPRT--LGPEA 376

Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           + LLS +   DP +R+        EI +H +F
Sbjct: 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  199 bits (507), Expect = 1e-58
 Identities = 86/272 (31%), Positives = 122/272 (44%), Gaps = 28/272 (10%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH---------RS 55
           +  +  LG G+FG   L   K T EL AVK +   KK D  +Q + +             
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KK-DVVIQDDDVECTMVEKRVLALP 398

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            + P + +      T   L  VMEY  GG+L   I   GRF E  A F+  ++  G+ + 
Sbjct: 399 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV-GTPAYIAPEVLAR 174
            S  I +RDLKL+N +LD   +  +KI DFG  K  +       T  GTP YIAPE++A 
Sbjct: 459 QSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY 516

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + Y GK  D W+ GV LY ML G  PFE      +  +    I       P    +S + 
Sbjct: 517 QPY-GKSVDWWAFGVLLYEMLAGQAPFEG----EDEDELFQSIMEHNVAYPKS--MSKEA 569

Query: 235 RHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
             +   +    P KR+        +IK+H +F
Sbjct: 570 VAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  191 bits (488), Expect = 1e-58
 Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 27/276 (9%)

Query: 6   EPVKELGSGNFG---VARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------- 53
           E +K LG+G +G   + R +    T +L A+K +   KK     + +   H         
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRTERQVLE 113

Query: 54  RSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
              + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  + 
Sbjct: 114 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 173

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
           + H + I +RD+KLEN LLD      + + DFG SK  +     ++    GT  Y+AP++
Sbjct: 174 HLHKLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231

Query: 172 LARKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
           +   +    K  D WS GV +Y +L GA PF    +  +  +   RI   +   P    +
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--M 289

Query: 231 SADCRHLLSQIFVADPSKRI-----PIPEIKKHPWF 261
           SA  + L+ ++ + DP KR+        EIK+H +F
Sbjct: 290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  191 bits (486), Expect = 2e-57
 Identities = 73/278 (26%), Positives = 121/278 (43%), Gaps = 32/278 (11%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
           +E +K +G G FG   +V+ K   ++ A+K +    K  E ++R              + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NK-WEMLKRAETACFREERDVLVNG 131

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYC 115
               I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +   
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLA 173
           H +   HRD+K +N L+D      +++ DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 174 RKEYD----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP---D 226
             E      G   D WS GV +Y ML G  PF       +  +T  +I N +        
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305

Query: 227 YVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
              VS + + L+ +  +     R+    I + KKHP+F
Sbjct: 306 VTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFF 342

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  189 bits (482), Expect = 4e-57
 Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 34/280 (12%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH--------RSL 56
           +E +K +G G F    +V+ K+T ++ A+K +    K  + ++R  ++          + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM---NK-WDMLKRGEVSCFREERDVLVNG 118

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYC 115
               I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  +   
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLA 173
           H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+L 
Sbjct: 179 HRLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 174 RKEYD------GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP-- 225
                      G   D W+ GV  Y M  G  PF       +  +T  +I + +  L   
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLP 292

Query: 226 -DYVRVSADCRHLLSQIFVADPSKRI---PIPEIKKHPWF 261
                V  + R  + +  +  P  R+      + + HP+F
Sbjct: 293 LVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  194 bits (495), Expect = 9e-57
 Identities = 69/265 (26%), Positives = 122/265 (46%), Gaps = 18/265 (6%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-------SLRHPNI 61
           + +G G FG     R   T ++ A+K +++ +   +  +   +N R       +   P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + H+  + 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +       
Sbjct: 315 YRDLKPANILLDE--HGHVRISDLGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSS 371

Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
           +D +S G  L+ +L G  PF      ++  +       +   LPD    S + R LL  +
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGL 428

Query: 242 FVADPSKRI-----PIPEIKKHPWF 261
              D ++R+        E+K+ P+F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFF 453

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  187 bits (476), Expect = 5e-55
 Identities = 69/265 (26%), Positives = 108/265 (40%), Gaps = 19/265 (7%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR----SLRHPNIIRFKE 66
           LG G FG     + K T +L A K + + +       +  +  +     +    I+    
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252

Query: 67  VLLTPTHLAIVMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICH 122
              T T L +VM    GG++   I +       F E  A F+  Q++SG+ + H   I +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIY 312

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDGKI 181
           RDLK EN LLD      ++I D G +              GTP ++APE+L  +EY    
Sbjct: 313 RDLKPENVLLDD--DGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369

Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI 241
            D ++ GVTLY M+    PF    +    ++   R+       PD    S   +     +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDFCEAL 427

Query: 242 FVADPSKRI-----PIPEIKKHPWF 261
              DP KR+         ++ HP F
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLF 452

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  186 bits (474), Expect = 2e-54
 Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 16/262 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS----LRHPNIIRFKE 66
           LG G FG     + + T ++ A K +E+ +      +   +N +     +    ++    
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251

Query: 67  VLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              T   L +V+    GG+L   I   G+  F E  A F+  ++  G+   H   I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDV 184
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+  + Y     D 
Sbjct: 312 LKPENILLDD--HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDW 368

Query: 185 WSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
           W+ G  LY M+ G  PF+  +      +    ++ V     +    S   R L SQ+   
Sbjct: 369 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARSLCSQLLCK 426

Query: 245 DPSKRI-----PIPEIKKHPWF 261
           DP++R+        E+K+HP F
Sbjct: 427 DPAERLGCRGGSAREVKEHPLF 448

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  180 bits (457), Expect = 2e-53
 Identities = 47/356 (13%), Positives = 95/356 (26%), Gaps = 79/356 (22%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR------- 57
             LG  +        D+ T E   V      ++      + ++ E++  R LR       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 58  ---------------HPNIIRFKEVLLTPTHLAIVMEYAA-----------GGELFARIC 91
                           P   +   V L    + ++  +             G  L +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 92  SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG 151
           +              Q+I  ++  H   + H  L+  + +LD   +  + +  F +    
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRD 261

Query: 152 LLHSQPKST--VGTPAYIAPEVLARKEYDGKI----SDVWSCGVTLYVMLVGAYPFEDPE 205
              +          P   A  +L   ++   +     D W+ G+ +Y +     P  D  
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321

Query: 206 DPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL 265
                       +           +    R LL          R+   +  + P +    
Sbjct: 322 ALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY---- 367

Query: 266 PKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGASDPDD 321
                                Q   E+   +   +  GE T+  G   +G S PD+
Sbjct: 368 --------------------EQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDE 403

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  176 bits (447), Expect = 9e-53
 Identities = 68/284 (23%), Positives = 107/284 (37%), Gaps = 15/284 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
                    +G G+FG    ++DK+T    AVK +     ++     E++    L  P I
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +     +     + I ME   GG L   I   G   ED A ++  Q + G+ Y H+  I 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPEVLARK 175
           H D+K +N LL      R  +CDFG++        G          GT  ++APEV+  K
Sbjct: 173 HGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
             D K  D+WS    +  ML G +P+          K I         +P     +    
Sbjct: 232 PCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-IASEPPPIREIPP--SCAPLTA 287

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKE 279
             + +    +P  R    E+++           +    K  YKE
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  168 bits (427), Expect = 6e-50
 Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 16/277 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREI-INHRSLRHP 59
              E + E+GSG  G    +R ++T  ++AVK +     K+ ++ +  ++ +  +S   P
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-M 118
            I++     +T T + I ME         +    G   E         ++  + Y     
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE- 176
            + HRD+K  N LLD   Q  +K+CDFG S   L+  + K    G  AY+APE +   + 
Sbjct: 145 GVIHRDVKPSNILLDERGQ--IKLCDFGISGR-LVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 177 ----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
               YD + +DVWS G++L  +  G +P+++ +        +  ++     LP ++  S 
Sbjct: 202 TKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGFSG 258

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           D +  +      D  KR    ++ +H +  +    E+
Sbjct: 259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEV 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  165 bits (420), Expect = 4e-49
 Identities = 70/260 (26%), Positives = 128/260 (49%), Gaps = 18/260 (6%)

Query: 11  LGSGNFGVARLVRDKRTKELVAVKYIE-RGKKIDENVQREIINHRSLRHPNIIRFKEVLL 69
           LG G +G+    RD   +  +A+K I  R  +  + +  EI  H+ L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 70  TPTHLAIVMEYAAGGELFARICSA--GRFSEDEA--RFFFQQLISGVSYCHSMEICHRDL 125
               + I ME   GG L + +  +  G   ++E    F+ +Q++ G+ Y H  +I HRD+
Sbjct: 90  ENGFIKIFMEQVPGGSL-SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148

Query: 126 KLENTLLDGSPQPRLKICDFGYSK-SGLLHSQPKSTVGTPAYIAPEVL--ARKEYDGKIS 182
           K +N L++ +    LKI DFG SK    ++   ++  GT  Y+APE++    + Y    +
Sbjct: 149 KGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-A 206

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSADCRHLLSQ 240
           D+WS G T+  M  G  PF +  +P   +  + ++   +    +P+   +SA+ +  + +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFKVHPEIPE--SMSAEAKAFILK 261

Query: 241 IFVADPSKRIPIPEIKKHPW 260
            F  DP KR    ++    +
Sbjct: 262 CFEPDPDKRACANDLLVDEF 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  167 bits (424), Expect = 4e-49
 Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 47/310 (15%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRH 58
           ++ +E + ELG+GN GV   V  K +  ++A K I    K      + RE+ + H     
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NS 90

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS- 117
           P I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEY 177
            +I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRGE--IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH- 236
             + SD+WS G++L  M VG YP   P+          ++       P   R      + 
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 237 -------------LLSQI-------------------FVA-----DPSKRIPIPEIKKHP 259
                        LL  I                   FV      +P++R  + ++  H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 260 WFLKNLPKEI 269
           +  ++  +E+
Sbjct: 327 FIKRSDAEEV 336

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  164 bits (418), Expect = 6e-49
 Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 19/273 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRHP 59
           +  EP+ ELG G +GV   +R   + +++AVK I       E   +  ++ I+ R++  P
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG--ELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
             + F   L     + I ME       + + ++        ED        ++  + + H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 117 S-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLA- 173
           S + + HRD+K  N L++   Q   K+CDFG S   L+    K    G   Y+APE +  
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQV--KMCDFGISGY-LVDDVAKDIDAGCKPYMAPERINP 183

Query: 174 ---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV 230
              +K Y  K SD+WS G+T+  + +  +P++    P  F++    +      LP   + 
Sbjct: 184 ELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLPA-DKF 239

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK 263
           SA+     SQ    +  +R   PE+ +HP+F  
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  159 bits (404), Expect = 8e-47
 Identities = 62/263 (23%), Positives = 111/263 (42%), Gaps = 18/263 (6%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQR---EIINHRSLRHPNIIRF- 64
            E+G G+F       D  T   VA   ++  K      QR   E    + L+HPNI+RF 
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 65  ---KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-- 119
              +  +     + +V E    G L   +           R + +Q++ G+ + H+    
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+   K YD 
Sbjct: 152 IIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMYEEK-YDE 208

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRN-FRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
              DV++ G+ +  M    YP+ + ++    +R+    ++              + + ++
Sbjct: 209 S-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDK--VAIPEVKEII 263

Query: 239 SQIFVADPSKRIPIPEIKKHPWF 261
                 +  +R  I ++  H +F
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  159 bits (403), Expect = 2e-46
 Identities = 77/273 (28%), Positives = 140/273 (51%), Gaps = 13/273 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
               +   ++G G+ G+  L R+K +   VAVK ++  K+   E +  E++  R  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           ++   +  L    L ++ME+  GG L   I S  R +E++     + ++  ++Y H+  +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
            HRD+K ++ LL  +   R+K+ DFG+    +    PK  S VGTP ++APEV++R  Y 
Sbjct: 163 IHRDIKSDSILL--TLDGRVKLSDFGFCAQ-ISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLPDYVRVSADCRHL 237
            ++ D+WS G+ +  M+ G  P+   + P    + + R+R +    L +  +VS   R  
Sbjct: 220 TEV-DIWSLGIMVIEMVDGEPPYFS-DSP---VQAMKRLRDSPPPKLKNSHKVSPVLRDF 274

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           L ++ V DP +R    E+  HP+ L+    E +
Sbjct: 275 LERMLVRDPQERATAQELLDHPFLLQTGLPECL 307

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  158 bits (401), Expect = 2e-46
 Identities = 75/273 (27%), Positives = 133/273 (48%), Gaps = 13/273 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
            HRD+K +N LL       +K+ DFG+    +   Q K  + VGTP ++APEV+ RK Y 
Sbjct: 138 IHRDIKSDNILL--GMDGSVKLTDFGFCAQ-ITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHL 237
            K+ D+WS G+    M+ G  P+ + E+P    + +  I  N    L +  ++SA  R  
Sbjct: 195 PKV-DIWSLGIMAIEMIEGEPPYLN-ENP---LRALYLIATNGTPELQNPEKLSAIFRDF 249

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEII 270
           L++    D  KR    E+ +H +     P   +
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSL 282

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  159 bits (403), Expect = 2e-46
 Identities = 70/282 (24%), Positives = 119/282 (42%), Gaps = 21/282 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN--VQREI-INHRSLRHP 59
           E  + + E+G G +G    +  K + +++AVK I       E   +  ++ +  RS   P
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGEL----FARICSAGRFSEDEARFFFQQLISGVSYC 115
            I++F   L       I ME  +        +          E+         +  +++ 
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 116 HS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLA 173
              ++I HRD+K  N LLD S    +K+CDFG S   L+ S  K+   G   Y+APE + 
Sbjct: 142 KENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERID 198

Query: 174 ----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
               R+ YD + SDVWS G+TLY +  G +P+       +    +  ++     L +   
Sbjct: 199 PSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNSEE 255

Query: 230 V--SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
              S    + ++     D SKR    E+ KHP+ L    + +
Sbjct: 256 REFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  158 bits (401), Expect = 3e-46
 Identities = 81/271 (29%), Positives = 131/271 (48%), Gaps = 16/271 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
           EE +  ++++G G+FG      D RT+++VA+K I  E  +   E++Q+EI        P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + ++    L  T L I+MEY  GG     +   G   E +     ++++ G+ Y HS +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLHSEK 139

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEY 177
             HRD+K  N LL    +  +K+ DFG +   L  +Q K  + VGTP ++APEV+ +  Y
Sbjct: 140 KIHRDIKAANVLLSEHGE--VKLADFGVAGQ-LTDTQIKRNTFVGTPFWMAPEVIKQSAY 196

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRH 236
           D K +D+WS G+T   +  G  P  +   P    K +  I +N    L      S   + 
Sbjct: 197 DSK-ADIWSLGITAIELARGEPPHSE-LHP---MKVLFLIPKNNPPTLEG--NYSKPLKE 249

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
            +      +PS R    E+ KH + L+N  K
Sbjct: 250 FVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  158 bits (401), Expect = 5e-46
 Identities = 46/238 (19%), Positives = 84/238 (35%), Gaps = 26/238 (10%)

Query: 40  KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI---CSAGRF 96
               +    +I         N +   +      +L I M+      L   +   CS    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 97  SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
                   F Q+   V + HS  + HRDLK  N          +K+ DFG   +     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEE 219

Query: 157 PKST-------------VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED 203
            ++              VGT  Y++PE +    Y  K  D++S G+ L+ +L   Y F  
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275

Query: 204 PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                   + I  +RN++ F   + +       ++  +    P++R    +I ++  F
Sbjct: 276 QM---ERVRIITDVRNLK-FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  155 bits (393), Expect = 5e-45
 Identities = 78/295 (26%), Positives = 130/295 (44%), Gaps = 15/295 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           EE ++ +++LG G++G       K T ++VA+K +     + E + +EI   +    P++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++       T L IVMEY   G +   I       +EDE     Q  + G+ Y H M  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKEYD 178
            HRD+K  N LL  + +   K+ DFG +   L  +  K  + +GTP ++APEV+    Y+
Sbjct: 147 IHRDIKAGNILL--NTEGHAKLADFGVAGQ-LTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVSADCRHL 237
              +D+WS G+T   M  G  P+ D   P    + I  I  N           S +    
Sbjct: 204 CV-ADIWSLGITAIEMAEGKPPYAD-IHP---MRAIFMIPTNPPPTFRKPELWSDNFTDF 258

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE--IEKTNYKEAGRDQPTQSVE 290
           + Q  V  P +R    ++ +HP+        I+   I +    +  R +  Q  E
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLKRQESQQREE 313

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (384), Expect = 1e-43
 Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 39/276 (14%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVL 68
           + +G G FGV  + + K   + VA+K I   +   +    E+     + HPNI++     
Sbjct: 14  EVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 69  LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI---SGVSYCHSME---ICH 122
           L P  + +VMEYA GG L+  +  A       A       +    GV+Y HSM+   + H
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKIS 182
           RDLK  N LL       LKICDFG +    + +   +  G+ A++APEV     Y  K  
Sbjct: 129 RDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGSNYSEK-C 184

Query: 183 DVWSCGVTLYVMLVGAYPFEDPEDP---------RNFRKTIDRIRNVQYFLPDYVRVSAD 233
           DV+S G+ L+ ++    PF++   P            R  +               +   
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL----------IKN--LPKP 232

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
              L+++ +  DPS+R  + EI K    + +L +  
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKI---MTHLMRYF 265

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  150 bits (381), Expect = 3e-43
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 27/295 (9%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
            + YE  + +GSG   V +       KE VA+K I  E+ +   + + +EI       HP
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELF--------ARICSAGRFSEDEARFFFQQLISG 111
           NI+ +    +    L +VM+  +GG +              +G   E       ++++ G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS------KSGLLHSQPKSTVGTPA 165
           + Y H     HRD+K  N LL       ++I DFG S           +   K+ VGTP 
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 166 YIAPEVLAR-KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTID----RIRN 219
           ++APEV+ + + YD K +D+WS G+T   +  GA P+     P +    T+      +  
Sbjct: 192 WMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLET 249

Query: 220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEK 274
                    +     R ++S     DP KR    E+ +H +F K   KE +  EK
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL-QEK 303

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  147 bits (372), Expect = 5e-42
 Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 18/293 (6%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
            E +E V ELG G FG     ++K T  L A K IE   + + E+   EI    +  HP 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSME 119
           I++          L I++E+  GG + A +       +E + +   +Q++  +++ HS  
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPEVLARKE- 176
           I HRDLK  N L+  + +  +++ DFG S +  L +  K  S +GTP ++APEV+  +  
Sbjct: 138 IIHRDLKAGNVLM--TLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 177 ----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-RNVQYFLPDYVRVS 231
               YD K +D+WS G+TL  M     P  +  +P    + + +I ++    L    + S
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP---MRVLLKIAKSDPPTLLTPSKWS 249

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQ 284
            + R  L      +P  R    ++ +HP+       + +       K    ++
Sbjct: 250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVMEE 302

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  144 bits (366), Expect = 2e-41
 Identities = 71/209 (33%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-----ENVQREIINHRSLRHPNIIR 63
           + +G G FG  ++ R     + VAVK        D     ENV++E      L+HPNII 
Sbjct: 13  EIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---EI 120
            + V L   +L +VME+A GG L  R+ S  R   D    +  Q+  G++Y H      I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLN-RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 121 CHRDLKLENTLLDGS------PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV+  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-WHRTTKMSAAGAYAWMAPEVIRA 188

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFED 203
             +    SDVWS GV L+ +L G  PF  
Sbjct: 189 SMFSKG-SDVWSYGVLLWELLTGEVPFRG 216

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 2e-41
 Identities = 79/312 (25%), Positives = 144/312 (46%), Gaps = 42/312 (13%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPN 60
              +E V+ +G+G +G     R  +T +L A+K ++     +E +++EI   +    H N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 61  IIRF------KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGV 112
           I  +      K        L +VME+   G +    +        E+   +  ++++ G+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK--STVGTPAYIAPE 170
           S+ H  ++ HRD+K +N LL  +    +K+ DFG S   L  +  +  + +GTP ++APE
Sbjct: 143 SHLHQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPE 199

Query: 171 VLARKE-----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--F---RKTIDRIRNV 220
           V+A  E     YD K SD+WS G+T   M  GA P  D   P    F   R    R+++ 
Sbjct: 200 VIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPAPRLKSK 257

Query: 221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK------EIIE-IE 273
           ++        S   +  +    V + S+R    ++ KHP F+++ P       ++ + I+
Sbjct: 258 KW--------SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNERQVRIQLKDHID 308

Query: 274 KTNYKEAGRDQP 285
           +T  K   +D+ 
Sbjct: 309 RTKKKRGEKDET 320

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  147 bits (372), Expect = 6e-41
 Identities = 79/298 (26%), Positives = 129/298 (43%), Gaps = 46/298 (15%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN 60
            E  Y   K +G+G+FGV    +   + ELVA+K + + K+  +N  RE+   R L H N
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FKN--RELQIMRKLDHCN 108

Query: 61  IIRFKEVLLTPT------HLAIVMEYAAGGELFARI----CSAGRFSEDEARFFFQQLIS 110
           I+R +    +        +L +V++Y     ++        +         + +  QL  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAP 169
            ++Y HS  ICHRD+K +N LLD      LK+CDFG +K  L+  +P  S + +  Y AP
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAP 225

Query: 170 EVLAR-KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFRKTID 215
           E++    +Y   I DVWS G  L  +L+G   +P +   D           P   R+ I 
Sbjct: 226 ELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIR 282

Query: 216 RI--RNVQYFLPDYV----------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            +     ++  P             R   +   L S++    P+ R+   E   H +F
Sbjct: 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  143 bits (362), Expect = 1e-40
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 28/274 (10%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +GSG+FG    V   +    VAVK +       + +Q    E+   R  RH NI+ F 
Sbjct: 30  QRIGSGSFGT---VYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86

Query: 66  EVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
               T   LAIV ++  G  L+  +  S  +F   +     +Q   G+ Y H+  I HRD
Sbjct: 87  GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRD 145

Query: 125 LKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARKE---YD 178
           LK  N  L       +KI DFG +          Q +   G+  ++APEV+  ++   Y 
Sbjct: 146 LKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC---- 234
            + SDV++ G+ LY ++ G  P+ +  +     + + R        PD  +V ++C    
Sbjct: 204 FQ-SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRM 258

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           + L+++       +R   P I      ++ L +E
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE---IEELARE 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  143 bits (362), Expect = 2e-40
 Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           +++G+G+FG   + R +     VAVK +       E V    RE+   + LRHPNI+ F 
Sbjct: 43  EKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100

Query: 66  EVLLTPTHLAIVMEYAAGGELFA---RICSAGRFSEDEARFFFQQLISGVSYCHSME--I 120
             +  P +L+IV EY + G L+    +  +  +  E         +  G++Y H+    I
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYIAPEVLARKEY 177
            HR+LK  N L+D      +K+CDFG S+  L  S     KS  GTP ++APEVL  +  
Sbjct: 161 VHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPS 216

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFED 203
           + K SDV+S GV L+ +     P+ +
Sbjct: 217 NEK-SDVYSFGVILWELATLQQPWGN 241

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  144 bits (365), Expect = 2e-40
 Identities = 81/313 (25%), Positives = 142/313 (45%), Gaps = 32/313 (10%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLR 57
           E+ +  ++E+G G+FG     RD R  E+VA+K +    ++  +  +++ +E+   + LR
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I+++   L      +VMEY  G              E E        + G++Y HS
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---R 174
             + HRD+K  N LL  S    +K+ DFG   + ++ +   S VGTP ++APEV+     
Sbjct: 173 HNMIHRDVKAGNILL--SEPGLVKLGDFGS--ASIM-APANSFVGTPYWMAPEVILAMDE 227

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN--F---RKTIDRIRNVQYFLPDYVR 229
            +YDGK  DVWS G+T   +     P  +  +  +  +   +     +++  +       
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHW------- 278

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE--IEKTNYKEAGRDQPTQ 287
            S   R+ +       P  R     + KH + L+  P  +I   I++   K+A R+    
Sbjct: 279 -SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQR--TKDAVRELDNL 335

Query: 288 SVEEIMRI-IQEA 299
              ++ +I  QEA
Sbjct: 336 QYRKMKKILFQEA 348

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  140 bits (354), Expect = 1e-39
 Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 21/211 (9%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV--------QREIINHRSLRHPN 60
           K++G G FG+    R  + K +VA+K +  G    E          QRE+    +L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++   ++  P    +VME+   G+L+ R+                  +  G+ Y  +  
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN 142

Query: 120 --ICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA- 173
             I HRDL+  N  L    +      K+ DFG S+           +G   ++APE +  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGA 200

Query: 174 -RKEYDGKISDVWSCGVTLYVMLVGAYPFED 203
             + Y  K +D +S  + LY +L G  PF++
Sbjct: 201 EEESYTEK-ADTYSFAMILYTILTGEGPFDE 230

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  142 bits (360), Expect = 2e-39
 Identities = 63/357 (17%), Positives = 114/357 (31%), Gaps = 70/357 (19%)

Query: 2   EERYEPVKELGSG--NFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSL 56
              YE +  +G G  +     L R K T E V V+ I       ++   +Q E+   +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELF--ARICSAGRFSEDEARFFFQQLISGVSY 114
            HPNI+ ++   +    L +V  + A G              +E    +  Q ++  + Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS--------KSGLLHSQPKSTVGTPAY 166
            H M   HR +K  + L+    +  + +     +        +  ++H  PK +V    +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 167 IAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED--------------------- 203
           ++PEVL +  + YD K SD++S G+T   +  G  PF+D                     
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260

Query: 204 -------------------PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVA 244
                                       T           P +   S    H + Q    
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320

Query: 245 DPSKRIPIPEIKKHPWF----------LKNLPKEIIEIEKTNYKEAGRDQPTQSVEE 291
           +P  R     +  H +F          L  L + +  I      ++        +  
Sbjct: 321 NPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVT 377

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  140 bits (356), Expect = 2e-39
 Identities = 84/313 (26%), Positives = 126/313 (40%), Gaps = 65/313 (20%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           +RY  + +LG G +G      D  T E VA+K I R +  +E V     RE+   + L+H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            NII  K V+     L ++ EYA   +L   +      S    + F  QLI+GV++CHS 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 119 EICHRDLKLENTLLDGSPQPR---LKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
              HRDLK +N LL  S       LKI DFG +++      P       + T  Y  PE+
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRPPEI 208

Query: 172 L-ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF----- 223
           L   + Y   + D+WS       ML+    +P +   D       + +I     F     
Sbjct: 209 LLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEID------QLFKI-----FEVLGL 256

Query: 224 -----------LPDYV-----------------RVSADCRHLLSQIFVADPSKRIPIPEI 255
                      LPD+                   +  +   LL+ +   DP KRI     
Sbjct: 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316

Query: 256 KKHPWFLKNLPKE 268
            +HP+F  +   +
Sbjct: 317 LEHPYF-SHNDFD 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  139 bits (353), Expect = 4e-39
 Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 68/314 (21%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSL 56
           M E+YE + ++G G++GV    R++ T ++VA+K      + D  ++    REI   + L
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQL 59

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYC 115
           +HPN++   EV      L +V EY     +   +    R   E   +    Q +  V++C
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-T--VGTPAYIAPEVL 172
           H     HRD+K EN L+       +K+CDFG+++   L          V T  Y +PE+L
Sbjct: 119 HKHNCIHRDVKPENILITKHSV--IKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELL 174

Query: 173 AR-KEYDGKISDVWSCGVTLYVMLVG---------------------------------- 197
               +Y   + DVW+ G     +L G                                  
Sbjct: 175 VGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 198 ----AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 253
                    DPED                    +  +S     LL      DP++R+   
Sbjct: 234 QYFSGVKIPDPEDMEPLELK-------------FPNISYPALGLLKGCLHMDPTERLTCE 280

Query: 254 EIKKHPWFLKNLPK 267
           ++  HP+F +N+ +
Sbjct: 281 QLLHHPYF-ENIRE 293

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  141 bits (357), Expect = 6e-39
 Identities = 77/299 (25%), Positives = 126/299 (42%), Gaps = 51/299 (17%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + E VA+K + + K+  +N  RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-FKN--RELQIMRIVKHPNV 94

Query: 62  IRFKEVLLTPTH------LAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISG 111
           +  K    +         L +V+EY     ++       +          + +  QL+  
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
           ++Y HS+ ICHRD+K +N LLD      LK+ DFG +K   L +   +   + +  Y AP
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRAP 210

Query: 170 EVLAR-KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-------------------- 206
           E++     Y   I D+WS G  +  ++ G   +P E   D                    
Sbjct: 211 ELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269

Query: 207 -PRNFRKTIDRIRNV---QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
            P        +IR     + F P   R   D   L+S++    PS R+   E   HP+F
Sbjct: 270 NPNYMEHKFPQIRPHPFSKVFRP---RTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  137 bits (347), Expect = 2e-38
 Identities = 82/319 (25%), Positives = 132/319 (41%), Gaps = 83/319 (26%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           ++YE ++++G G +G     +++ T E+VA+K + R    DE V     REI   + L+H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS----------AGRFSEDEARFFFQQL 108
            NI+R  +VL +   L +V E+          C            G    +  + F  QL
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEF----------CDQDLKKYFDSCNGDLDPEIVKSFLFQL 110

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
           + G+ +CHS  + HRDLK +N L++ + +  LK+ +FG +++      P       V T 
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARA---FGIPVRCYSAEVVTL 165

Query: 165 AYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNFRKTIDRIRNV 220
            Y  P+VL   K Y   I D+WS G     +     P     D +D       + RI   
Sbjct: 166 WYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDD------QLKRI--- 215

Query: 221 QYF----------------LPDYV----------------RVSADCRHLLSQIFVADPSK 248
             F                LPDY                 +++A  R LL  +   +P +
Sbjct: 216 --FRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273

Query: 249 RIPIPEIKKHPWFLKNLPK 267
           RI   E  +HP+F  +   
Sbjct: 274 RISAEEALQHPYF-SDFCP 291

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  137 bits (348), Expect = 2e-38
 Identities = 60/286 (20%), Positives = 118/286 (41%), Gaps = 47/286 (16%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNIIRFK 65
           + +G G FG    V   R    VA++ I+  +  ++ ++   RE++ +R  RH N++ F 
Sbjct: 39  ELIGKGRFGQ---VYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRD 124
              ++P HLAI+     G  L++ +  A      ++ R   Q+++ G+ Y H+  I H+D
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155

Query: 125 LKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPEVL------ 172
           LK +N   D     ++ I DFG         +G    + +   G   ++APE++      
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 173 ---ARKEYDGKISDVWSCGVTLYVMLVGAYPFED--PED-----PRNFRKTIDRIRNVQY 222
               +  +    SDV++ G   Y +    +PF+    E          +  + +I     
Sbjct: 213 TEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI----- 266

Query: 223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
                  +  +   +L   +  +  +R    ++      L+ LPK 
Sbjct: 267 ------GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLPKR 303

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  136 bits (344), Expect = 1e-37
 Identities = 69/299 (23%), Positives = 120/299 (40%), Gaps = 51/299 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLR-HP 59
           + Y+ V++LG G +       +    E V VK +   + KKI    +REI    +LR  P
Sbjct: 36  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI----KREIKILENLRGGP 91

Query: 60  NIIRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           NII   +++  P     A+V E+    +           ++ + RF+  +++  + YCHS
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS 148

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVL-AR 174
           M I HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L   
Sbjct: 149 MGIMHRDVKPHNVMIDHE-HRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDY 205

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPF------------------EDPEDPRNFRKTIDR 216
           + YD  + D+WS G  L  M+    PF                   +       +  I+ 
Sbjct: 206 QMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 217 IRNVQYFLPDYVR--------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                  L  + R              VS +    L ++   D   R+   E  +HP+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  134 bits (340), Expect = 1e-37
 Identities = 42/206 (20%), Positives = 81/206 (39%), Gaps = 19/206 (9%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFK 65
            +L   + G   L + +     + VK ++      +   +   E    R   HPN++   
Sbjct: 16  TKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 66  EVLLTP--THLAIVMEYAAGGELFARICSAGRFSEDEARF--FFQQLISGVSYCHSME-- 119
               +P   H  ++  +   G L+  +     F  D+++   F   +  G+++ H++E  
Sbjct: 74  GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I    L   + ++D       +I       S     Q    +  PA++APE L +K  D 
Sbjct: 134 IPRHALNSRSVMIDEDM--TARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDT 187

Query: 180 KI--SDVWSCGVTLYVMLVGAYPFED 203
               +D+WS  V L+ ++    PF D
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD 213

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  135 bits (343), Expect = 2e-37
 Identities = 74/301 (24%), Positives = 121/301 (40%), Gaps = 57/301 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
           E+YE +  +G G++G+    R+K T  +VA+K        D+ V     REI   + LRH
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQLRH 83

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            N++   EV        +V E+       +L               + +  Q+I+G+ +C
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFC 140

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS---TVGTPAYIAPEVL 172
           HS  I HRD+K EN L+  S    +K+CDFG++++  L +  +     V T  Y APE+L
Sbjct: 141 HSHNIIHRDIKPENILVSQSGV--VKLCDFGFART--LAAPGEVYDDEVATRWYRAPELL 196

Query: 173 AR-KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQ-------- 221
               +Y   + DVW+ G  +  M +G   +P +   D       +  I            
Sbjct: 197 VGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDID------QLYHIMMCLGNLIPRHQ 249

Query: 222 ---YFLPDYV------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                 P +                   ++S     L  +    DP KR    E+  H +
Sbjct: 250 ELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

Query: 261 F 261
           F
Sbjct: 310 F 310

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  135 bits (341), Expect = 2e-37
 Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 31/262 (11%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIER-GKKIDENVQREIINHRSLRHPNIIRFKEV 67
           + LG G FG A  V  + T E++ +K + R  ++      +E+   R L HPN+++F  V
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 68  LLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLK 126
           L     L  + EY  GG L   I S    +   +   F + + SG++Y HSM I HRDL 
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLN 135

Query: 127 LENTLLDGSPQPRLKICDFGYSK---------------SGLLHSQPKSTVGTPAYIAPEV 171
             N L+  +    + + DFG ++                     +  + VG P ++APE+
Sbjct: 136 SHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +  + YD K  DV+S G+ L  ++       D   PR     ++    +  + P      
Sbjct: 194 INGRSYDEK-VDVFSFGIVLCEIIGRVNADPDY-LPRTMDFGLNVRGFLDRYCPP----- 246

Query: 232 ADCRHLLSQIFV----ADPSKR 249
            +C      I V     DP KR
Sbjct: 247 -NCPPSFFPITVRCCDLDPEKR 267

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  135 bits (341), Expect = 3e-37
 Identities = 70/311 (22%), Positives = 124/311 (39%), Gaps = 59/311 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----ERGKKIDENVQREIINHRSLRH 58
            +++ +++LG+G +       +K T   VA+K +    E G        REI   + L+H
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKH 62

Query: 59  PNIIRFKEVLLTPTHLAIVMEY-----AAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
            NI+R  +V+ T   L +V E+         +      +      +  ++F  QL+ G++
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAP 169
           +CH  +I HRDLK +N L++   + +LK+ DFG +++      P +T    V T  Y AP
Sbjct: 123 FCHENKILHRDLKPQNLLIN--KRGQLKLGDFGLARA---FGIPVNTFSSEVVTLWYRAP 177

Query: 170 EVL-ARKEYDGKISDVWSCGVTLYVML--------------------------------V 196
           +VL   + Y   I D+WSCG  L  M+                                V
Sbjct: 178 DVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV 236

Query: 197 GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 256
              P  +P   +   + + ++            +  +    L  +   +P  R+   +  
Sbjct: 237 TKLPKYNPNIQQRPPRDLRQV----LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

Query: 257 KHPWFLKNLPK 267
            HPWF      
Sbjct: 293 HHPWF-AEYYH 302

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  135 bits (341), Expect = 4e-37
 Identities = 78/316 (24%), Positives = 131/316 (41%), Gaps = 62/316 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
           E Y  + +LG G +      + K T  LVA+K I  E  +       RE+   + L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I+   +++ T   L +V EY    +L   +   G   +    + F  QL+ G++YCH  +
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEVL-AR 174
           + HRDLK +N L++   +  LK+ DFG +++    S P  T    V T  Y  P++L   
Sbjct: 121 VLHRDLKPQNLLINERGE--LKLADFGLARA---KSIPTKTYDNEVVTLWYRPPDILLGS 175

Query: 175 KEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF--------- 223
            +Y  +I D+W  G   Y M  G   +P    E+       +  I     F         
Sbjct: 176 TDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEE------QLHFI-----FRILGTPTEE 223

Query: 224 -------LPDYV-----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHP 259
                    ++                  R+ +D   LL+++   +   RI   +  KHP
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283

Query: 260 WFLKNLPKEIIEIEKT 275
           +F  +L + I ++  T
Sbjct: 284 FF-LSLGERIHKLPDT 298

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  133 bits (337), Expect = 1e-36
 Identities = 81/321 (25%), Positives = 132/321 (41%), Gaps = 84/321 (26%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           E+Y+ ++++G G +GV    +D     +VA+K I R    DE +     REI   + L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARIC----------SAGRFSEDEARFFFQQL 108
           PNI+   +V+ +   L +V E+                     +     + + + +  QL
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEF----------MEKDLKKVLDENKTGLQDSQIKIYLYQL 128

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTP 164
           + GV++CH   I HRDLK +N L++      LK+ DFG +++      P  +    V T 
Sbjct: 129 LRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARA---FGIPVRSYTHEVVTL 183

Query: 165 AYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQ 221
            Y AP+VL   K+Y   + D+WS G     M+ G   +P    +D       + +I    
Sbjct: 184 WYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDD------QLPKI---- 232

Query: 222 YF----------------LPDYV-----------------RVSADCRHLLSQIFVADPSK 248
            F                LP +                      +   LLS +   DP+K
Sbjct: 233 -FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291

Query: 249 RIPIPEIKKHPWFLKNLPKEI 269
           RI   +   HP+F K+L  +I
Sbjct: 292 RISARDAMNHPYF-KDLDPQI 311

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (333), Expect = 4e-36
 Identities = 78/303 (25%), Positives = 109/303 (35%), Gaps = 48/303 (15%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
            RY  +K LG G  G+     D    + VA+K I        ++  REI   R L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 62  IRFKEVLLTPTHLA--------------IVMEYAAGGELFARICSAGRFSEDEARFFFQQ 107
           ++  E+L                     IV EY    +L A +   G   E+ AR F  Q
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLFMYQ 128

Query: 108 LISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGT 163
           L+ G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++    H   K      + T
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 164 PAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPFE------------------DP 204
             Y +P + L+   Y   I D+W+ G     ML G   F                     
Sbjct: 188 KWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246

Query: 205 ED----PRNFRKTIDRIRNV--QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
           ED           I        +        +S +    L QI    P  R+   E   H
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306

Query: 259 PWF 261
           P+ 
Sbjct: 307 PYM 309

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  132 bits (335), Expect = 4e-36
 Identities = 68/308 (22%), Positives = 122/308 (39%), Gaps = 59/308 (19%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRS 55
            +R++  +  G G FG  +L ++K T   VA+      KK+ ++ +      + + +   
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAI------KKVIQDPRFRNRELQIMQDLAV 75

Query: 56  LRHPNIIRFKEVLLTPTH-------LAIVMEYAAGGELFARICSAGR----FSEDEARFF 104
           L HPNI++ +    T          L +VMEY     L     +  R          + F
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 105 FQQLISGVSYCH--SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-- 160
             QLI  +   H  S+ +CHRD+K  N L++ +    LK+CDFG +K   L     +   
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK--LSPSEPNVAY 191

Query: 161 VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED----------- 206
           + +  Y APE+    + Y   + D+WS G     M++G   +  ++              
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250

Query: 207 ----------PRNFRKTIDRIRNV---QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 253
                     P +    +   + +     F    ++ + +   LLS +    P +R+   
Sbjct: 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310

Query: 254 EIKKHPWF 261
           E   HP+F
Sbjct: 311 EALCHPYF 318

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  130 bits (330), Expect = 6e-36
 Identities = 81/300 (27%), Positives = 133/300 (44%), Gaps = 58/300 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ----REIINHRSLRH 58
           E+Y  ++++G G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHS 117
            NI++  +V+ T   L +V E+    +L   +    G      A+ F  QL++G++YCH 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVL-ARK 175
             + HRDLK +N L++   +  LKI DFG +++  +  +  +  + T  Y AP+VL   K
Sbjct: 119 RRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 176 EYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIRNVQYF---------- 223
           +Y   I D+WS G     M+ G   +P     D       + RI     F          
Sbjct: 177 KYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRI-----FRILGTPNSKN 224

Query: 224 ------LPDYV----------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                 LP Y                  +      LLS++   DP++RI   +  +H +F
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  131 bits (333), Expect = 7e-36
 Identities = 88/352 (25%), Positives = 136/352 (38%), Gaps = 66/352 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENV----QREIINHRSL 56
           +RYE +  LG G F      RDK T ++VA+K I      +  + +     REI   + L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            HPNII   +     +++++V ++     E+  +  S    +    + +    + G+ Y 
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYL 128

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPAYIAPEV 171
           H   I HRDLK  N LLD +    LK+ DFG +KS      P       V T  Y APE+
Sbjct: 129 HQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS---FGSPNRAYTHQVVTRWYRAPEL 183

Query: 172 L-ARKEYDGKISDVWSCGVTLYVMLVGAYPF---EDPEDPRNFRKTIDRIRNVQYF---- 223
           L   + Y   + D+W+ G  L  +L+   PF   +   D       + RI     F    
Sbjct: 184 LFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLD------QLTRI-----FETLG 230

Query: 224 ------------LPDYV---------------RVSADCRHLLSQIFVADPSKRIPIPEIK 256
                       LPDYV                   D   L+  +F+ +P  RI   +  
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290

Query: 257 KHPWFL-KNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATK 307
           K  +F  +  P    ++ + N       + +     I R   EA   G   K
Sbjct: 291 KMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  130 bits (328), Expect = 4e-35
 Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 47/296 (15%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
           + Y     +GSG +G      DKR+ E VA+K + R    +I  +   RE++  + ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 60  NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           N+I   +V    + L       +VM +    +L   +    +FSE++ ++   Q++ G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGL--KFSEEKIQYLVYQMLKGLK 140

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
           Y HS  + HRDLK  N  ++   +  LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 172 -LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-- 214
            L+   Y+  + D+WS G  +  ML G   +  +D  D               F + +  
Sbjct: 195 ILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 215 DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
              ++    LP   R          S     LL ++   D  KR+   +   HP+F
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  130 bits (329), Expect = 4e-35
 Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 46/298 (15%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR 57
           + ERY+ +  +GSG +G      D +T   VAVK + R     I  +   RE+   + ++
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 58  HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
           H N+I   +V      L       +V     G +L   I    + ++D  +F   Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRG 144

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
           + Y HS +I HRDLK  N  ++   +  LKI DFG ++     +  + T  V T  Y AP
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARH----TADEMTGYVATRWYRAP 198

Query: 170 EV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI 214
           E+ L    Y+  + D+WS G  +  +L G   +P  D  D                 K I
Sbjct: 199 EIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257

Query: 215 --DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             +  RN    L    ++         +     LL ++ V D  KRI   +   H +F
Sbjct: 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  129 bits (327), Expect = 5e-35
 Identities = 82/311 (26%), Positives = 123/311 (39%), Gaps = 64/311 (20%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQ------REIINHR 54
             ++    LG G +GV      K T E+VA+K      KI+  +         REI   +
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKILK 64

Query: 55  SLRHPNIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLI 109
             +H NII    +    +        I+ E     +L  R+ S    S+D  ++F  Q +
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTL 122

Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKST----- 160
             V   H   + HRDLK  N L++ +    LK+CDFG      +S   +S+P        
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 161 --VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED--------- 206
             V T  Y APEV L   +Y   + DVWSCG  L  + +    +P  D            
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239

Query: 207 --PRNFRKTIDRIRN---VQYF--LPDYVRV---------SADCRHLLSQIFVADPSKRI 250
             P +    +  I +    +Y   LP Y            +     LL ++ V DP+KRI
Sbjct: 240 GTPHS-DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298

Query: 251 PIPEIKKHPWF 261
              E  +HP+ 
Sbjct: 299 TAKEALEHPYL 309

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  129 bits (327), Expect = 8e-35
 Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 46/298 (15%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR 57
           +   Y  ++ +GSG +G      D RT   VA+K + R    ++  +   RE+   + +R
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 58  HPNIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
           H N+I   +V      L       +VM +  G +L  ++    +  ED  +F   Q++ G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAP 169
           + Y H+  I HRDLK  N  ++   +  LKI DFG ++     +  + T  V T  Y AP
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ----ADSEMTGYVVTRWYRAP 194

Query: 170 EV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI 214
           EV L    Y   + D+WS G  +  M+ G   +   D  D            P  F + +
Sbjct: 195 EVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253

Query: 215 --DRIRNVQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
             D  +N    LP+  +          S    +LL ++ V D  +R+   E   HP+F
Sbjct: 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  129 bits (327), Expect = 1e-34
 Identities = 78/387 (20%), Positives = 130/387 (33%), Gaps = 67/387 (17%)

Query: 1   MEERYEPVKE-LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL 56
           +E+ +E     +G G +G    A+  +D +  +  A+K IE    I  +  REI   R L
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLREL 75

Query: 57  RHPNIIRFKEVLLTPTHLAI--VMEYA--------AGGELFARICSAGRFSEDEARFFFQ 106
           +HPN+I  ++V L+     +  + +YA                     +      +    
Sbjct: 76  KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPR--LKICDFG----YSKSGLLHSQPKST 160
           Q++ G+ Y H+  + HRDLK  N L+ G    R  +KI D G    ++      +     
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195

Query: 161 VGTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVML------------------------ 195
           V T  Y APE+L   + Y   I D+W+ G     +L                        
Sbjct: 196 VVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254

Query: 196 -----------------VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
                            +   P          R T      ++Y     V+  +   HLL
Sbjct: 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLL 314

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEII-EIEKTNYKEAGRDQPTQSVEEIMRIIQ 297
            ++   DP KRI   +  + P+F    P                R+  T+   +     +
Sbjct: 315 QKLLTMDPIKRITSEQAMQDPYF-LEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKK 373

Query: 298 EAKMPGEATKVAGQGAAGASDPDDMEG 324
             +         G G  G  D    +G
Sbjct: 374 NQQQQQGNNHTNGTGHPGNQDSSHTQG 400

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  127 bits (321), Expect = 2e-34
 Identities = 75/312 (24%), Positives = 113/312 (36%), Gaps = 61/312 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------REIINHRSL 56
            RYEPV E+G G +G     RD  +   VA+K +                 RE+   R L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 57  R---HPNIIRFKEVLLTPTH-----LAIVMEYAAGGEL----FARICSAGRFSEDEARFF 104
               HPN++R  +V  T        + +V E+    +     +           +  +  
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV---DQDLRTYLDKAPPPGLPAETIKDL 125

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK---STV 161
            +Q + G+ + H+  I HRDLK EN L+       +K+ DFG ++    +S        V
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARI---YSYQMALTPVV 180

Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--------------------YPF 201
            T  Y APEVL +  Y   + D+WS G     M                         P 
Sbjct: 181 VTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239

Query: 202 ED--PEDPR----NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI 255
           ED  P D       F       R VQ  +P    +      LL ++   +P KRI     
Sbjct: 240 EDDWPRDVSLPRGAFPPR--GPRPVQSVVP---EMEESGAQLLLEMLTFNPHKRISAFRA 294

Query: 256 KKHPWFLKNLPK 267
            +H +  K+   
Sbjct: 295 LQHSYLHKDEGN 306

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  129 bits (325), Expect = 2e-34
 Identities = 79/356 (22%), Positives = 129/356 (36%), Gaps = 82/356 (23%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
            ++Y   K LG+G+FG+   V D  + +  A+K + +  +      RE+   + L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNI 62

Query: 62  IRFKEVLLTPTH--------------------------------------LAIVMEYAAG 83
           I+  +   T                                         L ++MEY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-P 121

Query: 84  GELFARI----CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR 139
             L   +     S      +    +  QL   V + HS+ ICHRD+K +N L++      
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-T 180

Query: 140 LKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLV 196
           LK+CDFG +K   L     S   + +  Y APE+ L   EY   I D+WS G     +++
Sbjct: 181 LKLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELIL 237

Query: 197 GA--YPFEDPED-----------PRNFRKTIDRIRN--VQYFLPDYVRVS---------- 231
           G   +  E   D           P   ++ + R+     +   P                
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWF--LKNLPKEIIEIEKTNYKEAGRDQP 285
           +    LL QI   +P  RI   E   HP+F  L+N  +  ++          ++ P
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIP 351

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (318), Expect = 4e-34
 Identities = 66/296 (22%), Positives = 105/296 (35%), Gaps = 59/296 (19%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
           ++ +G G +G   + R     E VAVK      +     + E+ N   LRH NI+ F   
Sbjct: 13  LECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 65  -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME---- 119
                 + T L ++  Y   G L+  +                 + SG+++ H       
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129

Query: 120 ----ICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
               I HRDLK +N L+  +   +  I D G +      +  L       VGT  Y+APE
Sbjct: 130 GKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 171 VLARK------EYDGKISDVWSCGVTLYVMLVGAY----------PFED--PEDP----- 207
           VL         +   ++ D+W+ G+ L+ +               PF D  P DP     
Sbjct: 188 VLDETIQVDCFDSYKRV-DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 208 ------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
                    R  I         L    ++  +C +        +PS R+    IKK
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIKK 295

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  126 bits (318), Expect = 1e-33
 Identities = 83/304 (27%), Positives = 122/304 (40%), Gaps = 58/304 (19%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQ------REIINHR 54
            RY  +  +G G +G+     D   K  VA+K      KI   E+        REI    
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILL 80

Query: 55  SLRHPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLI 109
             RH NII   +++  PT      + IV +     +L  ++      S D   +F  Q++
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQIL 138

Query: 110 SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST----VGTPA 165
            G+ Y HS  + HRDLK  N LL+ +    LKICDFG ++               V T  
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 166 YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNFR 211
           Y APE+ L  K Y   I D+WS G  L  ML     +P +   D           P   +
Sbjct: 197 YRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS--Q 253

Query: 212 KTIDRIRN---VQYF--LPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEIKK 257
           + ++ I N     Y   LP   +V          +    LL ++   +P KRI + +   
Sbjct: 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313

Query: 258 HPWF 261
           HP+ 
Sbjct: 314 HPYL 317

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  125 bits (317), Expect = 2e-33
 Identities = 74/327 (22%), Positives = 130/327 (39%), Gaps = 59/327 (18%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
            +YE + ++G G FG     R ++T + VA+K +   +   E       REI   + L+H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKH 75

Query: 59  PNIIRFKEVLLTPTHLA--------IVMEYA----AGGELFARICSAGRFSEDEARFFFQ 106
            N++   E+  T             +V ++     AG  L + +    +F+  E +   Q
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRVMQ 131

Query: 107 QLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQP-KSTV 161
            L++G+ Y H  +I HRD+K  N L+       LK+ DFG    +S +         + V
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 162 GTPAYIAPEVL-ARKEYDGKISDVWSCGVTLYVMLVG----------------------- 197
            T  Y  PE+L   ++Y   I D+W  G  +  M                          
Sbjct: 190 VTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248

Query: 198 ---AYP-FEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIP 253
               +P  ++ E          + R V+  L  YVR       L+ ++ V DP++RI   
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPAQRIDSD 307

Query: 254 EIKKHPWFLKN-LPKEIIEIEKTNYKE 279
           +   H +F  + +P ++  +  T+   
Sbjct: 308 DALNHDFFWSDPMPSDLKGMLSTHLTS 334

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  125 bits (315), Expect = 4e-33
 Identities = 56/306 (18%), Positives = 104/306 (33%), Gaps = 54/306 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ------------REI 50
             Y   + + SG++G      D      VA+K +         V             REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 51  INHRSLRHPNIIRFKEVLLTPTH-----LAIVMEYAAGGELFARI-CSAGRFSEDEARFF 104
                  HPNI+  +++ +         L +V E     +L   I       S    ++F
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
              ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHR 197

Query: 165 AYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-----------PRNF 210
            Y APE+ +  K +   + D+WS G  +  M      +      +           P+  
Sbjct: 198 WYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK-- 254

Query: 211 RKTIDRIRN------VQYFLPDYVRV---------SADCRHLLSQIFVADPSKRIPIPEI 255
            + +    +      ++  L +                   L++++   +P +RI   + 
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314

Query: 256 KKHPWF 261
            +HP+F
Sbjct: 315 LRHPYF 320

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  124 bits (314), Expect = 6e-33
 Identities = 80/306 (26%), Positives = 120/306 (39%), Gaps = 55/306 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D   +  VA+K + R    +   +   RE++  + + H 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84

Query: 60  NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           NII    V      L       IVME      L   I        +   +   Q++ G+ 
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIK 141

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
           + HS  I HRDLK  N ++       LKI DFG +++    +    T  V T  Y APEV
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 197

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-DR 216
           +    Y   + D+WS G  +  M+ G   +P  D  D               F K +   
Sbjct: 198 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 217 IRNVQYFLPDYVRVS---------------------ADCRHLLSQIFVADPSKRIPIPEI 255
           +R      P Y   S                     +  R LLS++ V D SKRI + E 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 256 KKHPWF 261
            +HP+ 
Sbjct: 317 LQHPYI 322

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  121 bits (305), Expect = 3e-32
 Identities = 74/208 (35%), Positives = 101/208 (48%), Gaps = 13/208 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
           ERY+ V +LG G      L  D      VA+K I    +  E      +RE+ N   L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            NI+   +V        +VMEY  G  L   I S G  S D A  F  Q++ G+ + H M
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            I HRD+K +N L+D      LKI DFG     S++ L  +Q    +GT  Y +PE  A+
Sbjct: 131 RIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSL--TQTNHVLGTVQYFSPE-QAK 185

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFE 202
            E   + +D++S G+ LY MLVG  PF 
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFN 213

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  122 bits (307), Expect = 3e-32
 Identities = 70/307 (22%), Positives = 111/307 (36%), Gaps = 62/307 (20%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
            + +G G FG   + R K   E VAVK     ++     + EI     LRH NI+ F   
Sbjct: 47  QESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 65  -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------ 117
             +   T T L +V +Y   G LF  +      + +          SG+++ H       
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163

Query: 118 --MEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
               I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+APE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 171 VL------ARKEYDGKISDVWSCGVTLYVMLVG----------AYPFED--PEDP----- 207
           VL         E   +  D+++ G+  + +               P+ D  P DP     
Sbjct: 222 VLDDSINMKHFESFKRA-DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 208 ------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                 +  R  I         L    ++  +C +       A+ + R+    IKK    
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY-------ANGAARLTALRIKKT--- 330

Query: 262 LKNLPKE 268
           L  L ++
Sbjct: 331 LSQLSQQ 337

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  123 bits (311), Expect = 5e-32
 Identities = 77/306 (25%), Positives = 121/306 (39%), Gaps = 55/306 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R    +   +   RE++  + + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 60  NIIRFKEVLLTPTHLA------IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           NII    V      L       +VME      L   I        +   +   Q++ G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQM--ELDHERMSYLLYQMLCGIK 178

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEV 171
           + HS  I HRDLK  N ++       LKI DFG +++    +    T  V T  Y APEV
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 234

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED------------PRNFRKTI-DR 216
           +    Y   + D+WS G  +  M+     +P  D  D               F K +   
Sbjct: 235 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 217 IRNVQYFLPDYVRVS---------------------ADCRHLLSQIFVADPSKRIPIPEI 255
           +RN     P Y  ++                     +  R LLS++ V DP+KRI + + 
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 256 KKHPWF 261
            +HP+ 
Sbjct: 354 LQHPYI 359

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  120 bits (303), Expect = 1e-31
 Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 78/319 (24%)

Query: 3   ERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYIERGKKIDENVQ-------REI---I 51
           ++YE V E+G G +G     RD K     VA+K +    ++    +       RE+    
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLR 66

Query: 52  NHRSLRHPNIIRFKEVLLTP-----THLAIVMEYAAGGEL----FARICSAGRFSEDEAR 102
           +  +  HPN++R  +V         T L +V E+    +     +           +  +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV---DQDLTTYLDKVPEPGVPTETIK 123

Query: 103 FFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-- 160
               QL+ G+ + HS  + HRDLK +N L+  S Q  +K+ DFG ++      Q   T  
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARI--YSFQMALTSV 179

Query: 161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPEDPRNFRKTIDRIR 218
           V T  Y APEVL +  Y   + D+WS G     M      +      D       + +I 
Sbjct: 180 VVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKI- 231

Query: 219 NVQYF----------------LPDYV--------------RVSADCRHLLSQIFVADPSK 248
                                LP                  +    + LL +    +P+K
Sbjct: 232 ----LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287

Query: 249 RIPIPEIKKHPWFLKNLPK 267
           RI       HP+F ++L +
Sbjct: 288 RISAYSALSHPYF-QDLER 305

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  121 bits (305), Expect = 1e-31
 Identities = 72/352 (20%), Positives = 121/352 (34%), Gaps = 70/352 (19%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLRH 58
           RY  V++LG G+F    L +D      VA+K +   K   E  + EI     +N      
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 79

Query: 59  P------NIIRFKEVL----LTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQ 106
                  +I++  +          H+ +V E   G  L    +            +   +
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISK 138

Query: 107 QLISGVSYCHSME-ICHRDLKLENTLLDGSPQPR----LKICDFGYSKSGLLHSQPKSTV 161
           QL+ G+ Y H    I H D+K EN L++    P     +KI D G   +        +++
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSI 196

Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF----------- 210
            T  Y +PEVL    +     D+WS    ++ ++ G + F +P++  ++           
Sbjct: 197 QTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQII 254

Query: 211 -------RKTIDRIRNVQYF---------------------LPDYVRVSADCR----HLL 238
                     +   +  + F                     L +  + S D        L
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVE 290
           S +   DP KR     +  HPW    L  E I +       +G D P    E
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 366

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  120 bits (302), Expect = 2e-31
 Identities = 64/307 (20%), Positives = 111/307 (36%), Gaps = 62/307 (20%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF--- 64
           VK++G G +G   +   K   E VAVK     ++     + EI     +RH NI+ F   
Sbjct: 42  VKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 65  -KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS------ 117
             +   + T L ++ +Y   G L+  + S                +SG+ + H+      
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158

Query: 118 --MEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPE 170
               I HRDLK +N L+  +      I D G +      +  +   P + VGT  Y+ PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 171 VLA------RKEYDGKISDVWSCGVTLYVMLVG----------AYPFED--PEDP----- 207
           VL         +      D++S G+ L+ +               P+ D  P DP     
Sbjct: 217 VLDESLNRNHFQSYIMA-DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 208 ------RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                 +  R +     +    L    ++  +C          +P+ R+    +KK    
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA-------HNPASRLTALRVKKT--- 325

Query: 262 LKNLPKE 268
           L  + + 
Sbjct: 326 LAKMSES 332

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  121 bits (304), Expect = 3e-31
 Identities = 76/344 (22%), Positives = 124/344 (36%), Gaps = 89/344 (25%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
           + Y     +G G++G   L  DK T++ VA+K + R     ID + + REI     L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 60  NIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            IIR  ++++    L      IV+E A   +L     +    +E+  +     L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG---------------------YSKSGLL 153
            H   I HRDLK  N LL+      +K+CDFG                            
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 154 HSQPKST--VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG------------- 197
           + + + T  V T  Y APE+ L ++ Y   I D+WS G     +L               
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 198 -----------AYPFEDPEDPRNFRKTIDRIRNV------------------QYF--LPD 226
                                ++ R  ++ I N+                  +Y    P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 227 YVRV---------SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
              +         S D  +LL  +   +P+KRI I +   HP+ 
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (298), Expect = 4e-31
 Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 26/232 (11%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRHP 59
            Y   + +G G  G      D   + +VA+K +      D       QRE      L+ P
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +++   +       L + M    G +L A +   G  +   A    +Q+ S +   H+  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
             HRD+K EN L+  S      + DFG     +   L  +Q  +TVGT  Y+APE  +  
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSES 210

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPF-------------EDPEDPRNFRKTI 214
               + +D+++    LY  L G+ P+             +    P   R  I
Sbjct: 211 HATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGI 261

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  119 bits (300), Expect = 7e-31
 Identities = 78/329 (23%), Positives = 122/329 (37%), Gaps = 75/329 (22%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLR-H 58
            +YE VK+LG G +G+     D+RT E+VAVK I        D +   REI+    L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 59  PNIIRFKEVLLTPT--HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
            NI+    VL       + +V +Y    +L   +  A        ++   QLI  + Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---------------- 160
           S  + HRD+K  N LL+      +K+ DFG S+S +   +  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 161 ------VGTPAYIAPEV-LARKEYDGKISDVWSCGVTLYVMLVG---------------- 197
                 V T  Y APE+ L   +Y   I D+WS G  L  +L G                
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 198 -------------------------AYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
                                    +   +      N R    + +N+   +      + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +   LL ++   +P+KRI   +  KHP+ 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  119 bits (301), Expect = 1e-30
 Identities = 80/354 (22%), Positives = 125/354 (35%), Gaps = 101/354 (28%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER--GKKID-ENVQREIINHRSLRHP 59
           +RYE    +G+G++G      DK  K +VA+K I R     ID + + REI     L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 60  NIIRFKEVLLTPT-----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           ++++  ++++         L +V+E A   +      +    +E   +     L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA--------- 165
            HS  I HRDLK  N L++      +K+CDFG +++        S +             
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 166 -------------------YIAPEV-LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE 205
                              Y APE+ L ++ Y   I DVWS G     +L          
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENVAYH 288

Query: 206 DPRN--F----------------------------------------RKTIDRIRNVQYF 223
             R   F                                         + I+ +      
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK--ED 346

Query: 224 LPDYVR----------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
              Y+R                 SAD  HLL ++ V +P+KRI I E   HP+F
Sbjct: 347 AKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (294), Expect = 1e-30
 Identities = 70/238 (29%), Positives = 99/238 (41%), Gaps = 29/238 (12%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
           +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 59  PNIIR---FKEVLLTPTHLA-IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           P I+      E       L  IVMEY  G  L   + + G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG----YSKSGLLHSQPKSTVGTPAYIAPE 170
            H   I HRD+K  N ++  S    +K+ DFG     + SG   +Q  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPF--------------EDPEDPRNFRKTI 214
             AR +     SDV+S G  LY +L G  PF              EDP  P    + +
Sbjct: 190 -QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (291), Expect = 2e-29
 Identities = 75/330 (22%), Positives = 106/330 (32%), Gaps = 75/330 (22%)

Query: 4   RYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
           RYE +K +G G+FG V +   D +  + VA+K +   K+       EI   R L H    
Sbjct: 98  RYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEHLRKQ 153

Query: 59  -----PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISG 111
                 N+I   E      H+ +  E      L+  I       FS    R F   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPE 170
           +   H   I H DLK EN LL    +  +K+ DFG   S     Q   T + +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPE 269

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPF----------------------------- 201
           V+    Y   I D+WS G  L  +L G                                 
Sbjct: 270 VILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR 328

Query: 202 ----------------EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR--------HL 237
                               D           R      P+        +          
Sbjct: 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDF 388

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L Q    DP+ R+   +  +HPW  + LPK
Sbjct: 389 LKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (291), Expect = 9e-29
 Identities = 51/229 (22%), Positives = 81/229 (35%), Gaps = 38/229 (16%)

Query: 4   RYEPVKELGSGNFGVARLVRDKR-TKELVAVK---------YIERGKKIDENVQREIINH 53
           +YE    +  G  G   L  D+      V +K                       E    
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-------AMAERQFL 133

Query: 54  RSLRHPNIIR---FKEVLLTPTHLA--IVMEYAAGGELFARICSAGRFSEDEARFFFQQL 108
             + HP+I++   F E           IVMEY  G  L        +    EA  +  ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
           +  +SY HS+ + + DLK EN +L      +LK+ D G        +      GTP + A
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQA 245

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED------PEDPRNFR 211
           PE+  R       +D+++ G TL  + +             PED    +
Sbjct: 246 PEI-VRTGPTVA-TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK 292

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  110 bits (276), Expect = 8e-28
 Identities = 66/300 (22%), Positives = 104/300 (34%), Gaps = 60/300 (20%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           ++ +G G +G      L      +  VAVK      + +   ++ I     + H NI RF
Sbjct: 18  LELIGRGRYGAVYKGSL-----DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARF 72

Query: 65  -----KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
                +          +VMEY   G L   + S        +      +  G++Y H+  
Sbjct: 73  IVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131

Query: 120 ---------ICHRDLKLENTLLDGSPQPRLKICDFGYSK---------SGLLHSQPKSTV 161
                    I HRDL   N L+         I DFG S           G   +   S V
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKN--DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 162 GTPAYIAPEVL------ARKEYDGKISDVWSCGVTLYVML---VGAYPFEDPEDPRNFRK 212
           GT  Y+APEVL         E   K  D+++ G+  + +       +P E   +      
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE------ 243

Query: 213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPE-IKKHPWFLKNLPKEIIE 271
                    Y +     V         Q+ V+   +R   PE  K++   +++L KE IE
Sbjct: 244 ---------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KETIE 293

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (270), Expect = 4e-27
 Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 30/223 (13%)

Query: 8   VKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF-- 64
           ++    G FG V +          VAVK      K     + E+ +   ++H NI++F  
Sbjct: 29  LEVKARGRFGCVWKAQLLNEY---VAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIG 85

Query: 65  --KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--- 119
             K        L ++  +   G L   +  A   S +E     + +  G++Y H      
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGL 144

Query: 120 -------ICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAP 169
                  I HRD+K +N LL  +      I DFG +    +G         VGT  Y+AP
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

Query: 170 EVL-----ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP 207
           EVL      +++   +  D+++ G+ L+ +       + P D 
Sbjct: 203 EVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  105 bits (264), Expect = 7e-26
 Identities = 73/333 (21%), Positives = 112/333 (33%), Gaps = 74/333 (22%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--- 59
           +RYE    +G G+FG      D+  +E VA+K I+  K      Q E+     +      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 60  ---NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSY 114
               I+  K   +   HL +V E      L+  + +      S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEM-LSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 115 CHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEV 171
             + E  I H DLK EN LL    +  +KI DFG   S     Q     + +  Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVG---------------------------------- 197
           L    YD  I D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 198 ----------AYPFEDPEDPRN-----FRKTIDRIRNVQYFLPDYVRVSADCR------- 235
                      +  +  +D +        + +  I  V+   P   R             
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 236 --HLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
              L+ ++   DP  RI      +H +F K   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  104 bits (262), Expect = 8e-26
 Identities = 69/331 (20%), Positives = 110/331 (33%), Gaps = 70/331 (21%)

Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP-- 59
           ERYE V  LG G FG V   +   R K  VA+K I    K  E  + EI   + ++    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 60  ----NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVS 113
                 +   +      H+ I  E   G   F  +       +     R    QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 114 YCHSMEICHRDLKLENTLLDGSP-----------------QPRLKICDFGYSKSGLLHSQ 156
           + H  ++ H DLK EN L   S                     +++ DFG   S     +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 157 PKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFED---------- 203
             +T V T  Y  PEV+    +     DVWS G  L+    G   +   +          
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 204 --------------------------PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
                                      E+  + R   +  + ++ ++            L
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
           + ++   DP++RI + E   HP+F    P+E
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  102 bits (255), Expect = 1e-24
 Identities = 62/331 (18%), Positives = 115/331 (34%), Gaps = 78/331 (23%)

Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSL 56
             +  ++++G G FG V    +    K+  AVK +   KK   + + E      I +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSY 114
            + NI+++    +   H+ ++ E   G  L+  I       F  ++ + +  +++  ++Y
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 115 CHSMEICHRDLKLENTLLDGSP-----------------------QPRLKICDFGYSKSG 151
              M + H DLK EN LLD                             +K+ DFG     
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 152 LLHSQPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA--YPFEDPED-- 206
              S    + + T  Y APEV+    +D    D+WS G  L  +  G+  +   +  +  
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHL 268

Query: 207 ----------PRNFRKTIDRIRNVQYFLPDYVRVS------------------------- 231
                     P+N      +    +Y   D ++++                         
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 232 -ADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                  L  I   DP+ R    E+ KH + 
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  100 bits (251), Expect = 2e-24
 Identities = 83/333 (24%), Positives = 116/333 (34%), Gaps = 73/333 (21%)

Query: 3   ERYEPVKELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHR-- 54
            RYE V  LG G FG V   +  K     VAVK ++   +  E  + EI     +N    
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGV 112
           +      ++  E      H+ IV E   G   +  I   G   F  D  R    Q+   V
Sbjct: 74  NSTF-RCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 113 SYCHSMEICHRDLKLENTLLDGS-----------------PQPRLKICDFGYSKSGLLHS 155
           ++ HS ++ H DLK EN L   S                   P +K+ DFG   S     
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188

Query: 156 QPKST-VGTPAYIAPEVLARKEYDGKISDVWSCGVTLY---------------------V 193
           +  ST V T  Y APEV+    +     DVWS G  L                       
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 194 MLVGAYP------------FED-----PEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
            ++G  P            F        E     R      + ++ F+            
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
           L+ ++   DP+KRI + E  KHP+F   L K I
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF-DLLKKSI 339

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 4e-24
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 19/199 (9%)

Query: 8   VKELGSGNFGVARL----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
           +++LG GNFG   +         T E+VAVK +    ++   + +REI   +SL+H NI+
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 63  RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           ++K V  +     L ++MEY   G L  + +     R    +   +  Q+  G+ Y  + 
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK 164

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
              HRDL   N L+    + R+KI DFG +K  L   +    V  P        APE L 
Sbjct: 165 RYIHRDLATRNILV--ENENRVKIGDFGLTKV-LPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 174 RKEYDGKISDVWSCGVTLY 192
             ++    SDVWS GV LY
Sbjct: 222 ESKFSVA-SDVWSFGVVLY 239

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 98.9 bits (247), Expect = 4e-24
 Identities = 61/199 (30%), Positives = 93/199 (46%), Gaps = 19/199 (9%)

Query: 8   VKELGSGNFGVARL----VRDKRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
           +++LG GNFG   +         T E+VAVK +    ++   + +REI   +SL+H NI+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 63  RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           ++K V  +     L ++MEY   G L  + +     R    +   +  Q+  G+ Y  + 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK 133

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
              HRDL   N L+  +   R+KI DFG +K  L   +    V  P        APE L 
Sbjct: 134 RYIHRDLATRNILV-ENEN-RVKIGDFGLTKV-LPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 174 RKEYDGKISDVWSCGVTLY 192
             ++    SDVWS GV LY
Sbjct: 191 ESKFSVA-SDVWSFGVVLY 208

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (250), Expect = 6e-24
 Identities = 58/205 (28%), Positives = 84/205 (40%), Gaps = 14/205 (6%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIRFK 65
            +++G GNFG     R +    LVAVK        D   +  +E    +   HPNI+R  
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 66  EVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRD 124
            V      + IVME   GG+    + + G                +G+ Y  S    HRD
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARKEYDG 179
           L   N L+  + +  LKI DFG S+         +  G    +     APE L    Y  
Sbjct: 239 LAARNCLV--TEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294

Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
           + SDVWS G+ L+    +GA P+ +
Sbjct: 295 E-SDVWSFGILLWETFSLGASPYPN 318

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 9e-24
 Identities = 59/211 (27%), Positives = 82/211 (38%), Gaps = 21/211 (9%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRHPN 60
           +++LG G+FGV               VAVK ++           + I       SL H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ Y  S  
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLA 173
             HRDL   N LL  +    +KI DFG  +   L                    APE L 
Sbjct: 142 FIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            + +    SD W  GVTL+ +   G  P+  
Sbjct: 198 TRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 98.2 bits (245), Expect = 1e-23
 Identities = 64/214 (29%), Positives = 88/214 (41%), Gaps = 20/214 (9%)

Query: 8   VKELGSGNFGV---ARLVRD-KRTKELVAVKYI-ERGKKIDENVQREIINHRSLRHPNII 62
           + +LG GNFG     R       T  LVAVK +   G     + QREI   ++L    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 63  RFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           +++ V   P    L +VMEY   G L  F +     R        +  Q+  G+ Y  S 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR 146

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
              HRDL   N L+  S    +KI DFG +K  L   +    V  P        APE L+
Sbjct: 147 RCVHRDLAARNILV-ESEA-HVKIADFGLAKL-LPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPED 206
              +  + SDVWS GV LY +            +
Sbjct: 204 DNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAE 236

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 25/212 (11%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENVQREIINH----RSLRHP 59
           +K LGSG FG       + +    ++ VA+K +           +EI++      S+ +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNP 77

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           ++ R   + LT T + ++ +    G L  + R              +  Q+  G++Y   
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVL 172
             + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K        +     A E +
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 173 ARKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
             + Y  + SDVWS GVT++ +M  G+ P++ 
Sbjct: 192 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 22/201 (10%)

Query: 8   VKELGSGNFGV---ARLVRD-KRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG     R   +   T E VAVK +  E G     ++++EI   R+L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           +++K +        + ++ME+   G L  +       + +  +   +  Q+  G+ Y  S
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS 144

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYI-----APEV 171
            +  HRDL   N L++   + ++KI DFG +K   + +  +  TV           APE 
Sbjct: 145 RQYVHRDLAARNVLVES--EHQVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 172 LARKEYDGKISDVWSCGVTLY 192
           L + ++    SDVWS GVTL+
Sbjct: 201 LMQSKFYIA-SDVWSFGVTLH 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 22/200 (11%)

Query: 8   VKELGSGNFGVARL----VRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
           +++LG G+FG   L      +  T E+VAVK +  + G +     ++EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           I++K          L +VMEY   G L  +            +   F QQ+  G++Y H+
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVL 172
               HRDL   N LL  + +  +KI DFG +K+ +        V           APE L
Sbjct: 153 QHYIHRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 173 ARKEYDGKISDVWSCGVTLY 192
              ++    SDVWS GVTLY
Sbjct: 210 KEYKFYYA-SDVWSFGVTLY 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 97.9 bits (244), Expect = 7e-23
 Identities = 50/201 (24%), Positives = 81/201 (40%), Gaps = 8/201 (3%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
             +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                   I+ E+   G L  + R C+    S     +   Q+ S + Y       HR+L
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
              N L+       +K+ DFG S+     +              APE LA  ++  K SD
Sbjct: 345 AARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-SD 401

Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VW+ GV L+ +   G  P+  
Sbjct: 402 VWAFGVLLWEIATYGMSPYPG 422

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 92.5 bits (230), Expect = 8e-22
 Identities = 30/208 (14%), Positives = 54/208 (25%), Gaps = 35/208 (16%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRHP 59
           RY  +   G           D      VA+ +++    + ++         +    +  P
Sbjct: 32  RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP 91

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            + R  +V+ T     +V E+  GG L          S   A    Q L +     H   
Sbjct: 92  GVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAG 149

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           +           +       L                       PA +            
Sbjct: 150 VALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDANPQ------ 182

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDP 207
              D+   G +LY +LV  +P  +    
Sbjct: 183 --DDIRGIGASLYALLVNRWPLPEAGVR 208

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 69/364 (18%), Positives = 115/364 (31%), Gaps = 110/364 (30%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-----INHRSLR 57
            RY  +++LG G+F    L  D + K+ VA+K ++  +   E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 58  HPN--IIR-----FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQL 108
            PN  ++      FK   +  TH+ +V E   G  L  +    +         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 109 ISGVSYCHS-MEICHRDLKLENTLLD---------------------------------- 133
           + G+ Y H+   I H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 134 -------------GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
                         + + ++KI D G +     H      + T  Y + EVL    Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-------------------RNVQ 221
             D+WS     + +  G Y F +P     + +  D I                    + +
Sbjct: 274 A-DIWSTACMAFELATGDYLF-EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331

Query: 222 YF--------------------LPDYVRVSAD----CRHLLSQIFVADPSKRIPIPEIKK 257
           +F                    L +    S +        L  +    P KR    E  +
Sbjct: 332 FFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

Query: 258 HPWF 261
           HPW 
Sbjct: 392 HPWL 395

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 92.3 bits (230), Expect = 9e-22
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 10/202 (4%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
             +LG G +G       K+    VAVK ++      E   +E    + ++HPN+++   V
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
                   I+ E+   G L  + R C+    S     +   Q+ S + Y       HRDL
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPEVLARKEYDGKIS 182
              N L+       +K+ DFG S+  +      +  G   P  + APE LA  ++  K S
Sbjct: 138 AARNCLV--GENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK-S 193

Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
           DVW+ GV L+ +   G  P+  
Sbjct: 194 DVWAFGVLLWEIATYGMSPYPG 215

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 92.3 bits (230), Expect = 9e-22
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 18/207 (8%)

Query: 9   KELGSGNFGVAR--LVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIR 63
           KELGSGNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGT--P-AYIAPEVLARKEY 177
           DL   N LL  +     KI DFG SK   L +     K+      P  + APE +   ++
Sbjct: 142 DLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
             K SDVWS GV ++     G  P+  
Sbjct: 198 SSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENVQREIINH----RSLRHP 59
           +K LGSG FG       + +    ++ VA+K +           +EI++      S+ +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNP 77

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSM 118
           ++ R   + LT T + ++ +    G L   +              +  Q+  G++Y    
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLA 173
            + HRDL   N L+  +PQ  +KI DFG +K  LL ++ K        +     A E + 
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 174 RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            + Y  + SDVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 10/201 (4%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
             +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
            ++   + IV EY + G L  F +  +       +      Q+ SG++Y   M   HRDL
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 306

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
           +  N L+        K+ DFG ++    +               APE      +  K SD
Sbjct: 307 RAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 363

Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS G+ L  +   G  P+  
Sbjct: 364 VWSFGILLTELTTKGRVPYPG 384

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 21/210 (10%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKEL-VAVKYI--ERGKKIDENVQREIINHRSLRHPNI 61
           +K LGSG FG       + +  + ++ V +K I  + G++  + V   ++   SL H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           +R   +    + L +V +Y   G L    R    G         +  Q+  G+ Y     
Sbjct: 78  VRLLGLCPGSS-LQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLAR 174
           + HR+L   N LL  SP  ++++ DFG +   LL    K  + + A       A E +  
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
            +Y  + SDVWS GVT++ +M  GA P+  
Sbjct: 192 GKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 16/208 (7%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
            K +GSG+ G     RL    +    VA+K ++ G    +      E        HPNII
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           R + V+       IV EY   G L  F R    G+F+  +     + + +G+ Y   +  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---APEVLARKE 176
            HRDL   N L+        K+ DFG S+          +T G    I   APE +A + 
Sbjct: 173 VHRDLAARNVLV--DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +    SDVWS GV ++ V+  G  P+ +
Sbjct: 231 FSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 92.6 bits (230), Expect = 6e-21
 Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 10/201 (4%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
             +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  +++   V
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
            ++   + IV EY + G L  F +  +       +      Q+ SG++Y   M   HRDL
Sbjct: 331 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY--IAPEVLARKEYDGKISD 183
           +  N L+        K+ DFG ++    +               APE      +  K SD
Sbjct: 390 RAANILV--GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SD 446

Query: 184 VWSCGVTLY-VMLVGAYPFED 203
           VWS G+ L  +   G  P+  
Sbjct: 447 VWSFGILLTELTTKGRVPYPG 467

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 89.6 bits (223), Expect = 6e-21
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           V+E+GSG FG+            K+ VA+K I  G   +E+   E      L HP +++ 
Sbjct: 13  VQEIGSGQFGLVHLGYW----LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 65  KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             V L    + +V E+   G L  + R    G F+ +        +  G++Y     + H
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
           RDL   N L+       +K+ DFG ++  +L  Q  S+ GT   +   +PEV +   Y  
Sbjct: 128 RDLAARNCLV--GENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
           K SDVWS GV ++ V   G  P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
            K+LG+G FG   +    +  + VAVK ++ G    E    E    ++L+H  +++   V
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
            +T   + I+ E+ A G L  F +     +    +   F  Q+  G+++       HRDL
Sbjct: 252 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
           +  N L+  S     KI DFG ++  +  ++  +  G    I   APE +    +  K S
Sbjct: 311 RAANILV--SASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 366

Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
           DVWS G+ L  ++  G  P+  
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPG 388

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 20/210 (9%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPNII 62
            K +G+G FG     RL    + +  VA+K ++ G    +      E        HPNII
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           R + V+     + IV EY   G L  F R     +F+  +     + + SG+ Y   M  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLAR 174
            HRDL   N L+  +     K+ DFG  +  +L   P    +T G    I   +PE +A 
Sbjct: 169 VHRDLAARNILI--NSNLVCKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +++    SDVWS G+ L+ VM  G  P+ +
Sbjct: 225 RKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 18/206 (8%)

Query: 10  ELGSGNFG-VAR-LVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFK 65
           ELG GNFG V + + R ++ +  VA+K +++G  K   E + RE      L +P I+R  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 66  EVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
            V      + +VME A GG L  F                   Q+  G+ Y       HR
Sbjct: 77  GVCQAEALM-LVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARKEYD 178
           DL   N LL  +     KI DFG SK+ L       T  +         APE +  +++ 
Sbjct: 135 DLAARNVLL-VNRH-YAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 179 GKISDVWSCGVTLY-VMLVGAYPFED 203
            + SDVWS GVT++  +  G  P++ 
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKK 216

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 18/203 (8%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I+      +    E      LRH N+++   V
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 68  -LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
            +     L IV EY A G L  + R         D    F   +   + Y       HRD
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKI 181
           L   N L+  S     K+ DFG +K         +       +   APE L  K++  K 
Sbjct: 315 LAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTK- 366

Query: 182 SDVWSCGVTLY-VMLVGAYPFED 203
           SDVWS G+ L+ +   G  P+  
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPR 389

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 20/208 (9%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIR 63
            ELG GNFG          K+  + VA+K +++G  K   E + RE      L +P I+R
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
              V      + +VME A GG L   +                 Q+  G+ Y       H
Sbjct: 401 LIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP---KSTVGTPAYI---APEVLARKE 176
           R+L   N LL  +     KI DFG SK   L +      +       +   APE +  ++
Sbjct: 460 RNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +  + SDVWS GVT++  +  G  P++ 
Sbjct: 516 FSSR-SDVWSYGVTMWEALSYGQKPYKK 542

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 53/221 (23%), Positives = 88/221 (39%), Gaps = 35/221 (15%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
            + LG G FG    A+L ++  +   VAVK ++       +++   RE    +   HP++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 62  IRF------KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI---- 109
            +                  +++ +   G+L  F     A R  E+      Q L+    
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTLVRFMV 144

Query: 110 ---SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
               G+ Y  S    HRDL   N +L       + + DFG S+   ++S      G  + 
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQGCASK 200

Query: 167 I-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           +     A E LA   Y    SDVW+ GVT++ +M  G  P+
Sbjct: 201 LPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 1e-19
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           V+ LG+G FG   +       + VAVK +++G    +    E    + L+H  ++R   V
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 68  LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDL 125
            +T   + I+ EY   G L  F +  S  + + ++      Q+  G+++       HRDL
Sbjct: 77  -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135

Query: 126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKIS 182
           +  N L+  S     KI DFG ++  +  ++  +  G    I   APE +    +  K S
Sbjct: 136 RAANILV--SDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-S 191

Query: 183 DVWSCGVTLY-VMLVGAYPFED 203
           DVWS G+ L  ++  G  P+  
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPG 213

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           +KELGSG FGV    +     + +  VAVK I+ G   ++   +E      L HP +++F
Sbjct: 13  LKELGSGQFGVVKLGKW----KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 65  KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             V      + IV EY + G L  + R          +       +  G+++  S +  H
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
           RDL   N L+       +K+ DFG ++  +L  Q  S+VGT   +   APEV    +Y  
Sbjct: 128 RDLAARNCLV--DRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
           K SDVW+ G+ ++ V  +G  P++ 
Sbjct: 185 K-SDVWAFGILMWEVFSLGKMPYDL 208

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 86.1 bits (214), Expect = 1e-19
 Identities = 56/203 (27%), Positives = 80/203 (39%), Gaps = 18/203 (8%)

Query: 8   VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV 67
           ++ +G G FG   L   +  K  VAVK I+      +    E      LRH N+++   V
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 68  -LLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRD 124
            +     L IV EY A G L  + R         D    F   +   + Y       HRD
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142

Query: 125 LKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDGKI 181
           L   N L+  S     K+ DFG +K         +       +   APE L  K++  K 
Sbjct: 143 LAARNVLV--SEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTK- 194

Query: 182 SDVWSCGVTLY-VMLVGAYPFED 203
           SDVWS G+ L+ +   G  P+  
Sbjct: 195 SDVWSFGILLWEIYSFGRVPYPR 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKEL-VAVKYIERGKKIDENV--QREIINHRSLRHPNI 61
            K +G+G FG      L      KE+ VA+K ++ G    + V    E        H NI
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           IR + V+     + I+ EY   G L  F R    G FS  +     + + +G+ Y  +M 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANMN 167

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYI---APEVLARK 175
             HRDL   N L+  +     K+ DFG S+      +   +T G    I   APE ++ +
Sbjct: 168 YVHRDLAARNILV--NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           ++    SDVWS G+ ++ VM  G  P+ +
Sbjct: 226 KFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 85.4 bits (212), Expect = 3e-19
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRF 64
           +KELG+G FGV    +     R +  VA+K I+ G   ++    E     +L H  +++ 
Sbjct: 29  LKELGTGQFGVVKYGKW----RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 65  KEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             V      + I+ EY A G L  + R     RF   +     + +   + Y  S +  H
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 123 RDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEYDG 179
           RDL   N L+  + Q  +K+ DFG S+  +L  +  S+VG+   +    PEVL   ++  
Sbjct: 144 RDLAARNCLV--NDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 180 KISDVWSCGVTLY-VMLVGAYPFED 203
           K SD+W+ GV ++ +  +G  P+E 
Sbjct: 201 K-SDIWAFGVLMWEIYSLGKMPYER 224

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 54/220 (24%), Positives = 84/220 (38%), Gaps = 34/220 (15%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHPNI 61
            K LG G FG      L ++  T   VAVK ++        ++    E    +   HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 62  IR-----FKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI----- 109
           IR      +          +++ +   G+L  +       R          Q L+     
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLLKFMVD 155

Query: 110 --SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI 167
              G+ Y  +    HRDL   N +L       + + DFG SK   ++S      G  A +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQGRIAKM 211

Query: 168 -----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                A E LA + Y  K SDVW+ GVT++ +   G  P+
Sbjct: 212 PVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.4 bits (212), Expect = 4e-19
 Identities = 53/217 (24%), Positives = 80/217 (36%), Gaps = 28/217 (12%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
           ++ LG G FG         + +  +   VAVK +       + +    E +      H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
           I+R   V L      I+ME  AGG+L  F R           +      L+        G
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACG 152

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
             Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +   
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVK 210

Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
              PE      +  K +D WS GV L+ +  +G  P+
Sbjct: 211 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 52/217 (23%), Positives = 80/217 (36%), Gaps = 28/217 (12%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
           ++ LG G FG         + +  +   VAVK +       + +    E +      H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SG 111
           I+R   V L      I++E  AGG+L  F R           +      L+        G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPR--PSQPSSLAMLDLLHVARDIACG 193

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
             Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +   
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAMLPVK 251

Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
              PE      +  K +D WS GV L+ +  +G  P+
Sbjct: 252 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 84.2 bits (209), Expect = 6e-19
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 17/207 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
            + LG G FG          K  K  VAVK  ++   +D   +   E +  ++L HP+I+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   ++       I+ME    GEL  +    +           +  Q+   ++Y  S+  
Sbjct: 77  KLIGIIEEEPTW-IIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYLESINC 134

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI---APEVLARKEY 177
            HRD+ + N L+       +K+ DFG S+  +          T   I   +PE +  + +
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSRY-IEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
               SDVW   V ++ ++  G  PF  
Sbjct: 192 TTA-SDVWMFAVCMWEILSFGKQPFFW 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.8 bits (208), Expect = 1e-18
 Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 32/212 (15%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPNI 61
            +ELG G FG         +   + K LVAVK ++          QRE     +L+H +I
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICS-------AGRFSEDEARFFFQQLI--- 109
           ++F  V      L +V EY   G+L  F R           G+  + +      Q++   
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 110 ----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165
               SG+ Y  S    HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGHT 195

Query: 166 YI-----APEVLARKEYDGKISDVWSCGVTLY 192
            +      PE +  +++  + SDVWS GV L+
Sbjct: 196 MLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 50/207 (24%), Positives = 86/207 (41%), Gaps = 17/207 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
            + +G G FG       +  +     VA+K  +      + E   +E +  R   HP+I+
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   V+       I+ME    GEL  F +              +  QL + ++Y  S   
Sbjct: 80  KLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKRF 137

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT--PA-YIAPEVLARKEY 177
            HRD+   N L+  S    +K+ DFG S+  +  S          P  ++APE +  + +
Sbjct: 138 VHRDIAARNVLV--SSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 178 DGKISDVWSCGVTLY-VMLVGAYPFED 203
               SDVW  GV ++ +++ G  PF+ 
Sbjct: 195 TSA-SDVWMFGVCMWEILMHGVKPFQG 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 19/208 (9%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNII 62
            + +G G FG       +  +     VA+K  +      + E   +E +  R   HP+I+
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   V+       I+ME    GEL  F +              +  QL + ++Y  S   
Sbjct: 455 KLIGVITENPVW-IIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLESKRF 512

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP--KSTVG-TPA-YIAPEVLARKE 176
            HRD+   N L+  S    +K+ DFG S+   +      K++ G  P  ++APE +  + 
Sbjct: 513 VHRDIAARNVLV--SSNDCVKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 177 YDGKISDVWSCGVTLY-VMLVGAYPFED 203
           +    SDVW  GV ++ +++ G  PF+ 
Sbjct: 569 FTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 62/221 (28%), Positives = 91/221 (41%), Gaps = 32/221 (14%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDEN-VQREIINHRSLRHPNI 61
             ELG G FG         +  ++ K LVAVK ++   +      QRE      L+H +I
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGEL--FARICS------AGRFSEDEARFFFQQLI---- 109
           +RF  V      L +V EY   G+L  F R         AG            QL+    
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 110 ---SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAY 166
              +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG    
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRVGGRTM 221

Query: 167 I-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           +      PE +  +++  + SDVWS GV L+ +   G  P+
Sbjct: 222 LPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.0 bits (203), Expect = 7e-18
 Identities = 46/217 (21%), Positives = 86/217 (39%), Gaps = 28/217 (12%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
            +ELG G+FG     VA+ V     +  VA+K +     + E +    E    +     +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEAR--------FFFQQLIS 110
           ++R   V+       ++ME    G+L  + R       +                 ++  
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI--- 167
           G++Y ++ +  HRDL   N ++  +    +KI DFG ++   ++       G    +   
Sbjct: 150 GMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 205

Query: 168 --APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
             +PE L    +    SDVWS GV L+ +  +   P+
Sbjct: 206 WMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 18/207 (8%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
           + +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 64  FKEVLLTPTH-LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
              + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ +  S + 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASKKF 213

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLARK 175
            HRDL   N +LD      +K+ DFG ++             T A +     A E L  +
Sbjct: 214 VHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271

Query: 176 EYDGKISDVWSCGVTLY-VMLVGAYPF 201
           ++  K SDVWS GV L+ +M  GA P+
Sbjct: 272 KFTTK-SDVWSFGVLLWELMTRGAPPY 297

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 79.3 bits (196), Expect = 4e-17
 Identities = 37/217 (17%), Positives = 72/217 (33%), Gaps = 29/217 (13%)

Query: 8   VKELGSGNFGV-------ARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSL 56
            + LG G F               +  +  V +K +    K   N              L
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKL 69

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSY 114
            H +++    V +      +V E+   G L  + +  +    +        +QL + + +
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHF 128

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRL------KICDFGYSKSGLLHSQPKSTVGTPAYIA 168
                + H ++  +N LL      +       K+ D G S + L     +  +    ++ 
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVP 185

Query: 169 PEVLA-RKEYDGKISDVWSCGVTLY-VMLVGAYPFED 203
           PE +   K  +   +D WS G TL+ +   G  P   
Sbjct: 186 PECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 18/208 (8%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNII 62
            + +G G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 63  RFKEVLLTPTH-LAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
               + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ Y  S +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASKK 148

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI-----APEVLAR 174
             HRDL   N +LD      +K+ DFG ++             T A +     A E L  
Sbjct: 149 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206

Query: 175 KEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           +++  K SDVWS GV L+ +M  GA P+
Sbjct: 207 QKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.2 bits (191), Expect = 2e-16
 Identities = 45/223 (20%), Positives = 88/223 (39%), Gaps = 34/223 (15%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPN 60
           ++ELG   FG                + VA+K ++      + E  + E +    L+HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQLI-- 109
           ++    V+     L+++  Y + G+L          + + S       ++       +  
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 110 -----SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
                +G+ Y  S  + H+DL   N L+    +  +KI D G  +   +++     +   
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLGN 189

Query: 165 AYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           + +     APE +   ++    SD+WS GV L+ V   G  P+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 53/231 (22%), Positives = 85/231 (36%), Gaps = 42/231 (18%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
           V+++G G FG      A  +       +VAVK ++     D     QRE        +PN
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL-----------------FARICSAGRFSEDEARF 103
           I++   V      + ++ EY A G+L                       A   S      
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 104 FFQQLI-------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
              + +       +G++Y    +  HRDL   N L+       +KI DFG S++  ++S 
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYSA 227

Query: 157 PKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                     I      PE +    Y  + SDVW+ GV L+ +   G  P+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.7 bits (187), Expect = 8e-16
 Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 37/225 (16%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREI-INHRSLRHP 59
            K LG+G FG      A  +        VAVK ++    + E      E+ +      H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGEL-----------FARICSAGRFSEDEARFFFQQL 108
           NI+             ++ EY   G+L                S     +DE     + L
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
           +S       G+++  S    HRDL   N LL  +     KICDFG ++   + +     V
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL--THGRITKICDFGLAR--DIKNDSNYVV 203

Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
              A +     APE +    Y  + SDVWS G+ L+ +  +G+ P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 34/215 (15%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQ--REIINHRSLRHPNIIR 63
           + +G G+FGV      +   + +   A+K + R  ++ +     RE +  R L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 64  FKEVLLT--PTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLI-------SGV 112
              ++L        +++ Y   G+L  F R          +     + LI        G+
Sbjct: 87  LIGIMLPPEGLPH-VLLPYMCHGDLLQFIR--------SPQRNPTVKDLISFGLQVARGM 137

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYI----- 167
            Y    +  HRDL   N +LD S    +K+ DFG ++  L            A +     
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWT 195

Query: 168 APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
           A E L    +  K SDVWS GV L+ ++  GA P+
Sbjct: 196 ALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 56/223 (25%), Positives = 85/223 (38%), Gaps = 41/223 (18%)

Query: 8   VKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHP 59
              +G GNFG    AR+ +D    +  A+K ++      ++  R+      +      HP
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHP 86

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQQLI- 109
           NII          +L + +EYA  G L  F R         +    +   +    QQL+ 
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 110 ------SGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
                  G+ Y    +  HRDL   N L+        KI DFG S+   ++        T
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKIADFGLSRGQEVY-----VKKT 199

Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
              +     A E L    Y    SDVWS GV L+ ++ +G  P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 58/231 (25%), Positives = 90/231 (38%), Gaps = 42/231 (18%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENV--QREIINHRSLRHPN 60
            K LG G FG      A  ++ +     VAVK ++      E      E    + + HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGEL-----------------FARICSAGRFSEDEARF 103
           +I+          L +++EYA  G L                      S+     DE   
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 104 FFQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
               LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+   ++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSR--DVYEE 203

Query: 157 PKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
                 +   I     A E L    Y  + SDVWS GV L+ ++ +G  P+
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 73.1 bits (180), Expect = 9e-15
 Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 36/214 (16%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
            K LG+G FG      A  +  +     VAVK ++     DE  +  +++   +     +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQ 108

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FAR-----ICSAGRFSEDEARFFFQQLIS 110
           H NI+           + ++ EY   G+L  F R     + +   F+   +    + L+ 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 111 -------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
                  G+++  S    HRD+   N LL  +     KI DFG ++   + +     V  
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYIVKG 224

Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY 192
            A +     APE +    Y  + SDVWS G+ L+
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLW 257

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 37/225 (16%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENV--QREIINHRSL-R 57
            K LG G FG      A  +   + KE   VAVK ++      +      E+   + + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQL 108
           H NII           L +++EYA+ G L              S       E +  F+ L
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
           +S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++      
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKK 215

Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
            T   +     APE L  + Y  + SDVWS GV ++ +  +G  P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 37/226 (16%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENV--QREIINHRSL-R 57
            K LG G FG      A  +   + KE   VAVK ++      +      E+   + + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGEL---------FARICSAGRFSEDEARFFFQQL 108
           H NII           L +++EYA+ G L              S       E +  F+ L
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 109 IS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
           +S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++      
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYKK 261

Query: 162 GTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
            T   +     APE L  + Y  + SDVWS GV ++ +  +G  P+
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 55/218 (25%), Positives = 86/218 (39%), Gaps = 40/218 (18%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKE--LVAVKYIERGKKIDENVQREIINHRSL---- 56
            K LG G FG      A  +   +      VAVK ++      +    ++I+   +    
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMI 131

Query: 57  -RHPNIIRFKEVLLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQ 106
            +H NII           L +++EYA+ G L  + +         S       E +   +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 107 QLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS 159
            L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H     
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYY 247

Query: 160 TVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY 192
              T   +     APE L  + Y  + SDVWS GV L+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 57/227 (25%), Positives = 90/227 (39%), Gaps = 40/227 (17%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
            K LG G FG      A  +    T   VAVK ++ G    E   R +++   +      
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGH 89

Query: 58  HPNIIRFKEV-LLTPTHLAIVMEYAAGGEL--FARIC-------SAGRFSEDEARFFFQQ 107
           H N++            L +++E+   G L  + R                 +     + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 108 LIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST 160
           LI        G+ +  S +  HRDL   N LL  S +  +KICDFG ++   ++  P   
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILL--SEKNVVKICDFGLARD--IYKDPDYV 205

Query: 161 VGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPF 201
               A +     APE +  + Y  + SDVWS GV L+ +  +GA P+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 50/182 (27%), Positives = 75/182 (41%), Gaps = 27/182 (14%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH----P 59
            +   K++G GNFG  RL ++  T E VA+K +E  K     +  E   ++ L      P
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGG----ELFARICSAGRFSEDEARFFFQQLISGVSYC 115
            +  F        + A+V+E    G    +LF  +C    FS         QLIS + Y 
Sbjct: 69  QVYYFGP---CGKYNAMVLELL--GPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYV 121

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKIC---DFGYSK-----SGLLH---SQPKSTVGTP 164
           HS  + +RD+K EN L+        ++    DF  +K         H    + KS  GT 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 165 AY 166
            Y
Sbjct: 182 RY 183

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 56/288 (19%), Positives = 104/288 (36%), Gaps = 63/288 (21%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
             Y+  + +G G+FGV     +    + VA+K+ E  +     ++ E   ++ L      
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           PN+  F +      H  +V++   G    +L   +C   +FS        +Q+++ V   
Sbjct: 69  PNVYYFGQ---EGLHNVLVIDL-LGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSI 122

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLK---ICDFGYSK-----SGLLH---SQPKSTVGTP 164
           H   + +RD+K +N L+            + DFG  K         H    + K+  GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 165 AYIAPEVLARKEY---DGKISDVWSCGVTLYVMLVGAYPFE------------------- 202
            Y++      +E    D    D+ + G      L G+ P++                   
Sbjct: 183 RYMSINTHLGREQSRRD----DLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238

Query: 203 --DPED-----PRNFRKTIDRIRNVQYF-LPDYVRVSADCRHLLSQIF 242
                +     P  F K +   RN+ +   PDY       + L S++ 
Sbjct: 239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY----LQGLFSKVL 282

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 55/232 (23%), Positives = 83/232 (35%), Gaps = 46/232 (19%)

Query: 8   VKELGSGNFG-----VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----R 57
            K LGSG FG      A  +        VAVK ++      E  +  +++   +      
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGS 107

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGEL----------------FARICSAGRFSEDEA 101
           H NI+           + ++ EY   G+L                           ED  
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 102 RFFFQQLIS-------GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH 154
              F+ L+        G+ +       HRDL   N L+  +    +KICDFG ++   + 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGKVVKICDFGLARD--IM 223

Query: 155 SQPKSTVGTPAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYP 200
           S     V   A +     APE L    Y  K SDVWS G+ L+ +  +G  P
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 77/369 (20%), Positives = 123/369 (33%), Gaps = 66/369 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
            ++   +++GSG+FG   L  + +T E VA+K  E  K     +  E   +R L+     
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           PN+  F        +  +VM+   G    +LF   CS  + S         Q+I+ V + 
Sbjct: 66  PNVRWFGV---EGDYNVLVMDL-LGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFV 119

Query: 116 HSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSK-----SGLLH---SQPKSTVGTPAY 166
           HS    HRD+K +N L+  G    ++ I DFG +K     S   H    + K+  GT  Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

Query: 167 IAPEVLARKEY---DGKISDVWSCGVTLYVMLVGAYPFE--------------------- 202
            +       E    D    D+ S G  L   L G+ P++                     
Sbjct: 180 ASVNTHLGIEQSRRD----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235

Query: 203 DPED-----PRNFRKTIDRIRNVQYF-LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK 256
             E      P  F       R++++   PDY       + L   +F      R       
Sbjct: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSY----LKRLFRDLF-----IREGFQFDY 286

Query: 257 KHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGA 316
              W +    +  I          G      +   +    Q     G  +  +      A
Sbjct: 287 VFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPPALQNDRQSGVDEGRTSGWSSMDRRRA 346

Query: 317 SDPDDMEGD 325
             P    G 
Sbjct: 347 PPPIASVGT 355

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 23/180 (12%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH---- 58
            RY   +++GSG+FG   L  D    E VA+K  E  K     +  E   ++ ++     
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           P I           +  +VME   G    +LF   CS  +FS         Q+IS + Y 
Sbjct: 68  PTIRWCGA---EGDYNVMVMEL-LGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYI 121

Query: 116 HSMEICHRDLKLENTLL-DGSPQPRLKICDFGYSK-----SGLLH---SQPKSTVGTPAY 166
           HS    HRD+K +N L+  G     + I DFG +K         H    + K+  GT  Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.9 bits (157), Expect = 5e-12
 Identities = 50/332 (15%), Positives = 85/332 (25%), Gaps = 87/332 (26%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN---------VQREIIN 52
            E+ +  +++G G FG         T   VA+K I        N         +  EII 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 53  HRSL---------RHPNIIRFKEV------------------------------LLTPTH 73
            + L         R    I    V                                    
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 74  LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLENTLL 132
           L IV+E+  GG    ++ +    S   A+    QL + ++    S+   HRDL   N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 133 DGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLY 192
                   K+      K         ST+ +                 I D     +   
Sbjct: 196 K--KTSLKKLHYTLNGK--------SSTIPSCGLQVS-----------IIDYTLSRLERD 234

Query: 193 VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH----------LLSQIF 242
            ++V      D +    F    D   ++   +           H          L  ++ 
Sbjct: 235 GIVVFCDVSMDEDL---FTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML 291

Query: 243 VADPSKRIPIPEIKKHPWF-LKNLPKEIIEIE 273
                K        K     ++   + ++   
Sbjct: 292 KQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS 323

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 61.4 bits (150), Expect = 6e-11
 Identities = 40/149 (26%), Positives = 58/149 (38%), Gaps = 41/149 (27%)

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK------ST--VG 162
           G+++ H     HRD+K  N LLD +     KI DFG +++       K      ++  VG
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARAS-----EKFAQTVMTSRIVG 197

Query: 163 TPAYIAPEVLARKEY-DGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIR 218
           T AY+AP      E   G+I   SD++S GV L  ++ G                +D  R
Sbjct: 198 TTAYMAP------EALRGEITPKSDIYSFGVVLLEIITG-------------LPAVDEHR 238

Query: 219 NVQYFLPDYVRVSADCRHLLSQIFVADPS 247
             Q  L D      D    +      D  
Sbjct: 239 EPQL-LLDIKEEIEDEEKTIEDY--IDKK 264

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 7e-10
 Identities = 53/339 (15%), Positives = 112/339 (33%), Gaps = 80/339 (23%)

Query: 2   EERYEP-VKELGSGNFG--VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH 58
           EE  +  V+E+   N+   ++ +  ++R   ++   YIE+  ++  + Q     + S R 
Sbjct: 76  EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RL 134

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGE----LFARICSAGRFSEDEARFFFQQL-ISGVS 113
              ++ ++ LL       V+     G     +   +C + +    + +  F+   ++ + 
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190

Query: 114 YCHSME--------ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPA 165
            C+S E        + ++      +  D S   +L+I         LL S+P        
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----C 246

Query: 166 YIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE--DPRNFR-KTI--DRIRNV 220
            +   VL          +V                  + +  +  N   K +   R + V
Sbjct: 247 LL---VL-----L----NVQ-----------------NAKAWNAFNLSCKILLTTRFKQV 277

Query: 221 QYFLPDYVRV------------SADCRHLLSQIFVADPSKRIPIPEIKK-HPWFLKNLPK 267
             FL                    + + LL +     P   +P  E+   +P  L  + +
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD-LP-REVLTTNPRRLSIIAE 335

Query: 268 EIIEIEKT--NYKEAGRDQPTQSVEEIMRIIQEAKMPGE 304
            I +   T  N+K    D+    +  I+        P E
Sbjct: 336 SIRDGLATWDNWKHVNCDK----LTTIIESSLNVLEPAE 370

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 58.4 bits (142), Expect = 7e-10
 Identities = 42/105 (40%), Positives = 52/105 (49%), Gaps = 13/105 (12%)

Query: 111 GVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK-STV--GTPAYI 167
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK G    Q   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 168 APEVLARKEYDGKI---SDVWSCGVTLYVMLVGAYPFEDPEDPRN 209
            PE   +    G++   SDV+S GV L+ +L           PR 
Sbjct: 209 DPEYFIK----GRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 32/165 (19%), Positives = 60/165 (36%), Gaps = 20/165 (12%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
           ++   K++GSG FG+  L       E  A   ++   + +  +  E+  ++ +   + I+
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 64  FKEVLLTPTHLAI-------------------VMEYAAGGELFARICSAGRFSEDEARFF 104
                    +L I                   VME   G +L       G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156

Query: 105 FQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
             +++  + Y H  E  H D+K  N LL      ++ + D+G S 
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.7 bits (130), Expect = 2e-08
 Identities = 58/211 (27%), Positives = 86/211 (40%), Gaps = 53/211 (25%)

Query: 11  LGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDENVQRE------IINHRSLRHPNI 61
           LG G FG     RL  D     LVAVK ++  +   +  + +      +I+     H N+
Sbjct: 38  LGRGGFGKVYKGRL-ADGT---LVAVKRLKEERT--QGGELQFQTEVEMISM--AVHRNL 89

Query: 62  IRFKEVLL----TPTHLAIVMEYAAGGELFARI--CSAGRFSED-EARFFFQQLISGV-- 112
           +R    L     TPT   +V  Y A G + + +      +   D   R    ++  G   
Sbjct: 90  LR----LRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ---RIALGSAR 142

Query: 113 --SYCHSMEIC-----HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGT 163
             +Y H  + C     HRD+K  N LLD   +    + DFG +K         +T   GT
Sbjct: 143 GLAYLH--DHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 164 PAYIAPEVLARKEYDGKI---SDVWSCGVTL 191
             +IAPE L+     GK    +DV+  GV L
Sbjct: 199 IGHIAPEYLST----GKSSEKTDVFGYGVML 225

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 24/173 (13%), Positives = 57/173 (32%), Gaps = 31/173 (17%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRT--------KELVAVKYIERGKKIDENVQREIINHR 54
            +++        N G+        T        K+  ++K ++       N Q      R
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQR 98

Query: 55  SLRHPNIIRFKEVLLTPT---------------HLAIVMEYAAG---GELFARICSAGRF 96
           + +   + ++K++  TP                +  +V+    G         +      
Sbjct: 99  AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-DVSPKHVL 156

Query: 97  SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
           SE        +L+  + + H  E  H ++  EN  +D   Q ++ +  +G++ 
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.6 bits (126), Expect = 6e-08
 Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 11/117 (9%)

Query: 104 FFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGT 163
           +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++   ++  P      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253

Query: 164 PAYI-----APEVLARKEYDGKISDVWSCGVTLY-VMLVGAYPFEDPEDPRNFRKTI 214
            A +     APE +  + Y  + SDVWS GV L+ +  +GA P+   +    F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 27/170 (15%), Positives = 52/170 (30%), Gaps = 27/170 (15%)

Query: 4   RYEPVKELGSGNFGVARLVRDK-----RTKELVAVK---------------YIERGKKID 43
            ++    +G G FG   L          +     VK               Y    K   
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 44  ENVQREIINHRSLRHPNIIRF-KEVLLTPTHLAIVMEYAAG---GELFARICSAGRFSED 99
                     + L  P             ++  ++M+   G    +++    +  RFS  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY-EANA-KRFSRK 152

Query: 100 EARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK 149
                  +++  + Y H  E  H D+K  N LL+     ++ + D+G + 
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	341
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.51
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.92
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.78
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.53
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.47
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.04
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.92
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.87
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.86
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.65
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.6
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.52
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.52
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.49
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.37
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.7
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.52
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.65
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.76
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.13
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.71

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-68  Score=471.00  Aligned_cols=256  Identities=43%  Similarity=0.716  Sum_probs=212.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            58999999999999999999999999999999997643    23456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||| +|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.........
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC----------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccC
Confidence            999 6799999999999999999999999999999999999999999999999998776  9999999998655555556


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      +.+||+.|||||++.+..+++.++|||||||++|+|++|++||...+..    .....+......+|.  .+|+++.+||
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li  243 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFKNISNGVYTLPK--FLSPGAAGLI  243 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHTCCCCCT--TSCHHHHHHH
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence            7899999999999999888777799999999999999999999875433    233344444444554  6899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      .+||++||++|||++|+++||||+...|+
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~~p~  272 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVDLPE  272 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred             HHHccCChhHCcCHHHHHcCcccccCCCh
Confidence            99999999999999999999999777664

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.9e-68  Score=472.02  Aligned_cols=256  Identities=31%  Similarity=0.499  Sum_probs=224.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.|+|||||+++++|.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999999753    234467899999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---CC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HS  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---~~  155 (341)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+....   ..
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcc
Confidence            99999999999999999999999999999999999999999999999999999998877  99999999985432   22


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...+.+||+.|||||++.+..|+. ++|||||||++|+|++|.+||...+....    ...+....+.+|.  .+|++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~  262 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPE--KFFPKAR  262 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT--TCCHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--ccCHHHH
Confidence            345678999999999999888865 59999999999999999999987654333    3344444555554  6899999


Q ss_pred             HHHHHhcccCCCCCCChhH------HhcCCccCCCCCh
Q 019433          236 HLLSQIFVADPSKRIPIPE------IKKHPWFLKNLPK  267 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e------~l~hp~~~~~~~~  267 (341)
                      +||.+||++||++|||++|      +++||||......
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~  300 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  300 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence            9999999999999999998      5899999765443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.5e-67  Score=475.21  Aligned_cols=258  Identities=27%  Similarity=0.473  Sum_probs=224.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            57999999999999999999999999999999986543 33456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  160 (341)
                      +||+|.+++.+ .++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... ....+.
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCccccc
Confidence            99999998865 57999999999999999999999999999999999999998877  999999999854332 344567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      +||+.|||||++.+..|+. ++|||||||++|+|++|.+||...+....+..+..   .....++.+..+|+++.+||.+
T Consensus       231 ~GTp~YmAPEvl~~~~y~~-~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGP-EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHH
Confidence            9999999999998888865 49999999999999999999987655444333221   2233344556799999999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      ||++||++|||+.|+|+||||.+..++
T Consensus       307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          307 LLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            999999999999999999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-65  Score=475.80  Aligned_cols=258  Identities=27%  Similarity=0.478  Sum_probs=224.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            57999999999999999999999999999999997543 34456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~  160 (341)
                      +||+|.+++.. .++++..++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+..... ....+.
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCcccccc
Confidence            99999998864 56999999999999999999999999999999999999998877  999999999754332 334567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQ  240 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  240 (341)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|.+||...+....+..+..   .....++.+..+|+++.+||.+
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHH
Confidence            89999999999998888654 8999999999999999999987655444333221   2233344556799999999999


Q ss_pred             hcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          241 IFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       241 ~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      ||++||.+|||+.|+|+||||.+..+.
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            999999999999999999999876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.1e-67  Score=473.48  Aligned_cols=256  Identities=30%  Similarity=0.505  Sum_probs=214.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +||++++.||+|+||+||+|+++.+|+.||||++.....   ..+.+.+|+.+++.|+|||||+++++|.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            689999999999999999999999999999999976532   33568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-C
Q 019433           80 YAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-Q  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~  156 (341)
                      ||+||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+...... .
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHHH
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCccc
Confidence            999999999997543  5799999999999999999999999999999999999998877  9999999998543221 1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|||||++.+..|+. ++|||||||++|+|++|++||...+....+..    +....+ .+....+|+++.+
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~-~~~~~~~s~~~~~  255 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSF-PPVSLHYSYDLRS  255 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCC-CCCCTTSCHHHHH
T ss_pred             ccccCCCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCC-CCCCccCCHHHHH
Confidence            23467999999999999888865 49999999999999999999987655443333    222222 1233478999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ||.+||++||++|||+.|+|+||||.+...
T Consensus       256 li~~~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCHHhhcCCC
Confidence            999999999999999999999999976543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-65  Score=454.88  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=213.2

Q ss_pred             CCCc-cccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCE
Q 019433            2 EERY-EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTH   73 (341)
Q Consensus         2 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~----~~~   73 (341)
                      ++|| ++.++||+|+||+||+|.++.++..||+|++....   ...+.+.+|+.+++.|+|||||+++++|.+    +..
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            3566 67788999999999999999999999999987543   223468899999999999999999999875    356


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecC-CCCCCEEEeecCCccC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKS  150 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~  150 (341)
                      +|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+|||+++ ++.  +||+|||+|+.
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~  181 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL  181 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC--EEEEeCcCCEe
Confidence            8999999999999999999999999999999999999999999999  999999999999975 455  99999999975


Q ss_pred             CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .. .....+.+||+.|||||++.+ .|+ .++|||||||++|+|+||++||....+...+...   +.............
T Consensus       182 ~~-~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~~  255 (290)
T 3fpq_A          182 KR-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVA  255 (290)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCC
T ss_pred             CC-CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH---HHcCCCCCCCCccC
Confidence            32 234456789999999999875 465 4599999999999999999999876654443332   22222111122357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ++++.+||.+||++||++|||+.|+|+||||++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            899999999999999999999999999999964

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.1e-66  Score=460.25  Aligned_cols=254  Identities=30%  Similarity=0.543  Sum_probs=214.7

Q ss_pred             CCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ++|++++.||+|+||+||+|++.   .+++.||||++.+..   .....+.+|+.+++.++|||||+++++|.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            47999999999999999999984   578899999987642   223467889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~  155 (341)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999998877  99999999975332 33


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...+.+||+.|||||++.+..|+.+ +|||||||++|+|++|.+||...+....+    ..+......+|.  .+|+++.
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETM----TMILKAKLGMPQ--FLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCCC--cCCHHHH
Confidence            4556789999999999998888755 89999999999999999999876554333    333344444444  6899999


Q ss_pred             HHHHHhcccCCCCCCCh-----hHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIPI-----PEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~  265 (341)
                      +||++||++||++|||+     +|+++||||....
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            99999999999999984     7999999997643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.2e-64  Score=455.55  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=214.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.|+|||||+++++|.+++.+|||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            457888999999999999999999999999999976533    2479999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC------C
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS------Q  156 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~------~  156 (341)
                      ||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++. ++||+|||+|+......      .
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999999899999999999999999999999999999999999999987652 39999999997533221      1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|||||++.+..|+.+ +|||||||++|+|++|.+||........+..+...... ....  +..+|+++.+
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~--~~~~s~~~~~  288 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREI--PPSCAPLTAQ  288 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGS--CTTSCHHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhc--CccCCHHHHH
Confidence            234579999999999999888765 89999999999999999999876655444443322111 1112  2368999999


Q ss_pred             HHHHhcccCCCCCCChhHH-------------hcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIPEI-------------KKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~-------------l~hp~~~~~  264 (341)
                      ||.+||++||.+|||+.|+             |+|||+.+.
T Consensus       289 li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          289 AIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            9999999999999999997             579998654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-63  Score=461.73  Aligned_cols=263  Identities=27%  Similarity=0.410  Sum_probs=223.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEc------C
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT------P   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~------~   71 (341)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+++.|+|||||++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            35799999999999999999999999999999999976433   23467889999999999999999999864      3


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      +.+|||||||. |+|..++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~  208 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGL  208 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeec
Confidence            67999999996 689999998889999999999999999999999999999999999999998877  999999999753


Q ss_pred             CC-----CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc---
Q 019433          152 LL-----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF---  223 (341)
Q Consensus       152 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  223 (341)
                      ..     .....+.+||+.|||||++.+..+.+.++||||+||++|+|++|.+||.+.+....+..+..........   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            22     2234567999999999999887776677999999999999999999999877766666655443221110   


Q ss_pred             -------------CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          224 -------------LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       224 -------------~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                                   ++.         +..+|+++.+||.+||++||.+|||+.|+|+||||.+...
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                         111         1357899999999999999999999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-63  Score=455.18  Aligned_cols=338  Identities=70%  Similarity=1.175  Sum_probs=245.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+||++++.||+|+||+||+|+++.+++.||||++.......+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            47999999999999999999999999999999999887777788999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCcc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV  161 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  161 (341)
                      .+|+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++..++||+|||+++...........+
T Consensus        99 ~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  178 (361)
T 3uc3_A           99 SGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV  178 (361)
T ss_dssp             CSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCc
Confidence            99999999988889999999999999999999999999999999999999987776679999999998555555556678


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      ||+.|+|||++.+..+.++++|||||||++|+|++|..||........+...+..+.......|....+++++.+||.+|
T Consensus       179 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  258 (361)
T 3uc3_A          179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI  258 (361)
T ss_dssp             --CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHH
T ss_pred             CCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHH
Confidence            99999999999888887776899999999999999999998877766677777777777777777778999999999999


Q ss_pred             cccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCCHHHHHHHHHHhcCCCccccccCCCCCCC----C
Q 019433          242 FVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKMPGEATKVAGQGAAGA----S  317 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  317 (341)
                      |+.||.+|||+.++++||||.+..+.................++.++.+++++.+.++..+........+--...    +
T Consensus       259 L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~  338 (361)
T 3uc3_A          259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDD  338 (361)
T ss_dssp             SCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC-------------------
T ss_pred             ccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhcccccccccc
Confidence            999999999999999999998877665544333333333455677889999999988887765433222111111    1


Q ss_pred             CCCCCCCCcccccccCCccccC
Q 019433          318 DPDDMEGDIESEIDASGDYMSH  339 (341)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~  339 (341)
                      +.++++.+.+.|.|.+|++.++
T Consensus       339 ~~~~~d~~~~~d~d~~g~~~~~  360 (361)
T 3uc3_A          339 DMDDFDSESEIDIDSSGEIVYA  360 (361)
T ss_dssp             ----------------------
T ss_pred             ccccccchhhhccCCCCcEEec
Confidence            1122233344556666666553

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-62  Score=448.63  Aligned_cols=258  Identities=24%  Similarity=0.399  Sum_probs=208.9

Q ss_pred             CCCCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~i   76 (341)
                      |.++|++.++||+|+||+||+|+++   .+++.||||++.... ....+.+|+.+++.+ +|||||+++++|.+.+++|+
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            4689999999999999999999875   468899999987653 345688999999988 69999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--  154 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--  154 (341)
                      |||||+||+|.+++   +.+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.....  
T Consensus        98 vmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccc
Confidence            99999999999988   3599999999999999999999999999999999999998652 24999999999642211  


Q ss_pred             ---------------------------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh
Q 019433          155 ---------------------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP  207 (341)
Q Consensus       155 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~  207 (341)
                                                 ....+.+||+.|||||++.+...++.++||||+||++|+|++|+.||....+.
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                       11234579999999999988765566699999999999999999999665543


Q ss_pred             -hHHHHHHHHH----------------------------------hccc--------------ccCCCCCCCCHHHHHHH
Q 019433          208 -RNFRKTIDRI----------------------------------RNVQ--------------YFLPDYVRVSADCRHLL  238 (341)
Q Consensus       208 -~~~~~~~~~~----------------------------------~~~~--------------~~~~~~~~~s~~~~~li  238 (341)
                       ..+..+....                                  ....              ...+.+..+|+++.|||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence             2222221110                                  0000              01123456899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ++||++||++|||++|+|+||||++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-61  Score=432.97  Aligned_cols=252  Identities=25%  Similarity=0.393  Sum_probs=198.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--------
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPT--------   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--------   72 (341)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.....  ..+.+.+|+.+++.|+|||||+++++|...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            358999999999999999999999999999999875432  3356889999999999999999999997544        


Q ss_pred             ----EEEEEEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           73 ----HLAIVMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        73 ----~~~iv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                          .+|+|||||.||+|.+++.....   .++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccC
Confidence                47999999999999999987654   445678999999999999999999999999999999998876  999999


Q ss_pred             CCccCCCCCC-------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHH
Q 019433          146 GYSKSGLLHS-------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK  212 (341)
Q Consensus       146 g~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~  212 (341)
                      |+|+......             .....+||+.|||||++.+..|+.+ +|||||||++|+|++   ||....   ....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9997533221             1234579999999999998888654 899999999999996   886422   1122


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+..+....+ .+.+...++.+.+||++||++||.+|||+.|+++||||.+.
T Consensus       236 ~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            2333332221 12223467788999999999999999999999999999654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1e-60  Score=462.33  Aligned_cols=258  Identities=26%  Similarity=0.412  Sum_probs=218.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHH---HHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQR---EIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .......+   ++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999999999999999987532    12222333   456677889999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      +|||||+||+|..++.+.+.|++..++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+... ..
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~-~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFS-KK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS-SC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecC-CC
Confidence            99999999999999999999999999999999999999999999999999999999998887  9999999997543 33


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ...+.+||+.|||||++.++..++.++|||||||++|+|++|.+||....... ...+...+......+|.  .+|++++
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a~  422 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELR  422 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHHH
Confidence            45678999999999999754433455999999999999999999997643322 22344444444444554  6999999


Q ss_pred             HHHHHhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          236 HLLSQIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      +||.+||++||.+|++     ++|+++||||.....
T Consensus       423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW  458 (689)
T 3v5w_A          423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW  458 (689)
T ss_dssp             HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred             HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence            9999999999999998     799999999976543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-60  Score=461.88  Aligned_cols=258  Identities=29%  Similarity=0.558  Sum_probs=224.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.... ...+.+.+|+.+|+.|+|||||+++++|.++..+|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            68999999999999999999999999999999987643 23456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      .||+|.+++.. ...|++.+++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+...........
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~  316 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT  316 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence            99999999864 45799999999999999999999999999999999999998764456999999999876555555667


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCCCCCCHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLL  238 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li  238 (341)
                      +||+.|||||++.+..|+. ++|||||||++|+|++|.+||.+.+....+    ..+......+  +.+..+|+++.+||
T Consensus       317 ~GT~~y~APEv~~~~~y~~-~~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          317 TGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             CSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             EECccccCHHHhCCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHH
Confidence            8999999999999988864 589999999999999999999886654433    3333333332  33457999999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ++||++||.+|||+.|+|+||||....
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            999999999999999999999997643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=9.6e-59  Score=414.69  Aligned_cols=250  Identities=24%  Similarity=0.336  Sum_probs=200.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +++++.++||+|+||+||+|++..   .||||+++...   ...+.+.+|+.+++.++|||||++++++.. +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            467899999999999999998753   49999987533   233568899999999999999999998754 56899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---CC
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---~~  155 (341)
                      ||++|+|.+++... .++++..+..++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+....   ..
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcce
Confidence            99999999999764 57999999999999999999999999999999999999998776  99999999975322   12


Q ss_pred             CCCCccCCCCccccccccccc--cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .....+||+.|||||++.+..  ..+.++|||||||++|||+||+.||...++...+...+...............+|++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            234568999999999996532  234459999999999999999999988766544444332211111111123468899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+|+.+||+.||++|||+.+++++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999988654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.8e-59  Score=417.85  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=205.3

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ++|.+.++||+|+||+||+|++.     .++..||||++.... ...+.+.+|+.++++|+|||||++++++.+++.++|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46889999999999999999875     468899999997643 234578899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEe
Q 019433           77 VMEYAAGGELFARICSA-------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC  143 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~  143 (341)
                      |||||++|+|.+++...             ..+++.++..++.||++||.|||+++|+||||||+|||++.++.  +||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEEC
Confidence            99999999999999763             36999999999999999999999999999999999999998877  9999


Q ss_pred             ecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhc
Q 019433          144 DFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRN  219 (341)
Q Consensus       144 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  219 (341)
                      |||+|+......   ......||+.|||||++.+..++.+ +|||||||++|||+| |+.||...+..+.+..    +..
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQ  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHc
Confidence            999997432221   2234568999999999998888655 999999999999998 8999988665433332    222


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .. ..+....+|+++.+|+.+||+.||++|||+.++..
T Consensus       246 ~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~  282 (299)
T 4asz_A          246 GR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHT  282 (299)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            21 12233478999999999999999999999999943

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.1e-58  Score=417.64  Aligned_cols=248  Identities=25%  Similarity=0.356  Sum_probs=202.0

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +.|.+.++||+|+||+||+|++.     .+++.||||++.... ...+.+.+|+.+++.|+|||||++++++.+.+.+||
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            35778899999999999999864     468999999997643 334578999999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           77 VMEYAAGGELFARICSA---------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      |||||++|+|.+++...               .++++.++..++.||+.||.|||+++|+||||||+|||++.++.  +|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EE
Confidence            99999999999998653               35999999999999999999999999999999999999998776  99


Q ss_pred             EeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHH
Q 019433          142 ICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRI  217 (341)
Q Consensus       142 L~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~  217 (341)
                      |+|||+|+......   .....+||+.|||||++.+..++.+ +|||||||++|||+| |+.||........+..+    
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i----  273 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI----  273 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence            99999998533222   2234679999999999998888654 999999999999998 89999886654433322    


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ... ...+....+|+++.+|+.+||+.||++|||+.|++++
T Consensus       274 ~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            221 1223334789999999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.7e-58  Score=413.15  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=207.7

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ..++++++||+|+||+||+|...     .+++.||||++....  ...+.+.+|+.++++++|||||++++++..++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            35778899999999999999863     467899999986532  33467999999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           76 IVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      +|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++||||||||+|||+++++.  
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence            999999999999999643                35899999999999999999999999999999999999998877  


Q ss_pred             EEEeecCCccCCCCC---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHH
Q 019433          140 LKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID  215 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~  215 (341)
                      +||+|||+|+.....   ......+||+.|||||++.+..++.+ +|||||||++|||+| |..||...+.....    .
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~----~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVV----E  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHH----H
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHH----H
Confidence            999999999753222   22345689999999999998888655 999999999999998 89999886654333    2


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.... ..|....+|+++.+|+.+||+.||.+|||+.+++++
T Consensus       259 ~i~~~~-~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQ-VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            233222 233445789999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.2e-57  Score=409.69  Aligned_cols=255  Identities=38%  Similarity=0.662  Sum_probs=224.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            689999999999999999999999999999999876432   33467899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+++++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...........
T Consensus        95 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGGT
T ss_pred             CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCcccc
Confidence            9999999999998889999999999999999999999999999999999999988777  99999999975544445566


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+...    ....+.......|.  .+|+++.+||+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~  246 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRERVLRGKYRIPF--YMSTDCENLLK  246 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence            7899999999999988887677999999999999999999998755432    23333344444444  68999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +||+.||.+|||+.++++||||....
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999997643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-57  Score=412.18  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=207.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCC-CCeeeEEEEEEcC-CE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK--IDENVQREIINHRSLRH-PNIIRFKEVLLTP-TH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~-~~   73 (341)
                      ++|++.+.||+|+||+||+|.+..+     ++.||||++.....  ..+.+.+|+.+++.++| ||||+++++|... +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999997654     46899999876432  23568899999999965 9999999998764 67


Q ss_pred             EEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC
Q 019433           74 LAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ  137 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~  137 (341)
                      ++||||||++|+|.+++...                ..+++..+..++.||++||.|||+++||||||||+|||++.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999999753                34899999999999999999999999999999999999998877


Q ss_pred             CCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHH
Q 019433          138 PRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKT  213 (341)
Q Consensus       138 ~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~  213 (341)
                        +||+|||+|+......   .....+||+.|||||++.+..|+.+ +|||||||++|||+| |..||........+...
T Consensus       224 --vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          224 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              9999999998543222   1234578999999999998888654 999999999999998 99999876654444443


Q ss_pred             HHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       214 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +...  .....|  ..+++++.+|+.+||+.||.+|||+.++++|
T Consensus       301 i~~g--~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 LKEG--TRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHT--CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHcC--CCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            3321  122233  4689999999999999999999999999997

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.5e-56  Score=407.41  Aligned_cols=260  Identities=32%  Similarity=0.565  Sum_probs=224.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      +.++|++.+.||+|+||+||+|.++.+|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.....
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            45789999999999999999999999999999999876432       23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC--CCEEEeecCCccCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSG  151 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~--~~ikL~Dfg~a~~~  151 (341)
                      +++||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||++...
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999999999988889999999999999999999999999999999999999986652  25999999999865


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVR  229 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  229 (341)
                      .........+||+.|+|||++.+..++. ++|||||||++|+|++|.+||........+    ..+......++  .+..
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~  244 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETL----ANITAVSYDFDEEFFSQ  244 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTT
T ss_pred             CCCCccccCCCCccEECchHHcCCCCCc-cccHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhcCCCCCchhccC
Confidence            5545556678999999999998877754 489999999999999999999876543333    33333333332  2346


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +|+.+.+||.+||.+||.+|||+.++++||||....
T Consensus       245 ~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            899999999999999999999999999999997544

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-55  Score=397.31  Aligned_cols=257  Identities=35%  Similarity=0.593  Sum_probs=223.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            6899999999999999999999999999999998753    234457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~  157 (341)
                      ||++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... .....
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCcc
Confidence            99999999999998889999999999999999999999999999999999999998876  9999999997532 22334


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+..++.. +|||||||++|+|++|..||...+.....    ..+......+|.  .+++++.+|
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~l  235 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSL  235 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHH
T ss_pred             cccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHH
Confidence            56789999999999988877654 89999999999999999999875543332    223333344443  689999999


Q ss_pred             HHHhcccCCCCCC-----ChhHHhcCCccCCCCChh
Q 019433          238 LSQIFVADPSKRI-----PIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       238 i~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~  268 (341)
                      |.+||+.||.+||     ++.++++||||.......
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~  271 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD  271 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHH
Confidence            9999999999999     999999999997654443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-56  Score=404.33  Aligned_cols=259  Identities=24%  Similarity=0.465  Sum_probs=223.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      |.++|++.+.||+|+||+||+|.++.+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+++||||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            56899999999999999999999999999999999987655566788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+....+||+|||++...........
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  162 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence            99999999997654 79999999999999999999999999999999999999874444599999999976544444455


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  237 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..    +.......+  .+..+|+++.+|
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  237 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             ccCChhhcCcHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcCCCCCChhhhccCCHHHHHH
Confidence            67999999999998876654 59999999999999999999987655433333    333232222  234689999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |.+||..||.+|||+.|+|+||||.+.
T Consensus       238 i~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          238 VDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHcCCChhHCcCHHHHhcChhhccC
Confidence            999999999999999999999999654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-55  Score=401.99  Aligned_cols=256  Identities=45%  Similarity=0.789  Sum_probs=222.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.+.    ......+.+|+.+++.++||||+++++++.....+++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            6899999999999999999999999999999998653    233567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+ +|+|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTC
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccc
Confidence            999 6799999988889999999999999999999999999999999999999998776  9999999998655555566


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..+.+.++|||||||++|+|++|..||..........    .+.......|  ..+|+++.+||
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~li  239 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNSCVYVMP--DFLSPGAQSLI  239 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----CCCSSCCCCC--TTSCHHHHHHH
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----HHHcCCCCCc--ccCCHHHHHHH
Confidence            77899999999999988876667999999999999999999997654322111    1111222233  35899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      ++||+.||.+|||+.|+++||||....+.
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            99999999999999999999999776553

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.9e-55  Score=400.90  Aligned_cols=256  Identities=34%  Similarity=0.543  Sum_probs=218.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.    ....+.+.+|..+++.+ +||||+++++++.+.+.+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            6899999999999999999999999999999998753    23345677899999887 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      ||||.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ...
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC----
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCcc
Confidence            999999999999999889999999999999999999999999999999999999998877  99999999985332 233


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+    ..+......+|.  .+++++.+
T Consensus       181 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~  253 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQEMLYGP-AVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPT--WLHEDATG  253 (353)
T ss_dssp             -----CCGGGCCHHHHHHHHCTT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccCCCcCeEChhhcCCCCcCC-ccCCCcchHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHH
Confidence            45668999999999998887765 499999999999999999999876554333    333444444454  58999999


Q ss_pred             HHHHhcccCCCCCCCh------hHHhcCCccCCCCCh
Q 019433          237 LLSQIFVADPSKRIPI------PEIKKHPWFLKNLPK  267 (341)
Q Consensus       237 li~~~L~~dp~~R~s~------~e~l~hp~~~~~~~~  267 (341)
                      ||++||+.||.+||++      .++++||||......
T Consensus       254 li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~  290 (353)
T 3txo_A          254 ILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA  290 (353)
T ss_dssp             HHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred             HHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence            9999999999999999      899999999765443

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-54  Score=403.02  Aligned_cols=260  Identities=28%  Similarity=0.489  Sum_probs=220.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+..    .....+.+|..+++.+ +||||++++++|.+.+.+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57999999999999999999999999999999987643    2334577888888776 899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC-CCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG-LLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~-~~~~~  156 (341)
                      |||+.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.. .....
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~  209 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT  209 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCc
Confidence            999999999999998889999999999999999999999999999999999999998877  999999999853 23344


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----hHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|.+||......     .........+......+|.  .+|
T Consensus       210 ~~~~~gt~~Y~aPE~l~~~~~~~-~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s  286 (396)
T 4dc2_A          210 TSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS  286 (396)
T ss_dssp             BCCCCBCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSC
T ss_pred             cccccCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCC
Confidence            55678999999999999888765 489999999999999999999643211     1112233334444444554  689


Q ss_pred             HHHHHHHHHhcccCCCCCCCh------hHHhcCCccCCCCCh
Q 019433          232 ADCRHLLSQIFVADPSKRIPI------PEIKKHPWFLKNLPK  267 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~~~~~  267 (341)
                      +++.+||++||+.||.+||++      +++++||||......
T Consensus       287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred             HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence            999999999999999999995      799999999765443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-54  Score=385.94  Aligned_cols=258  Identities=28%  Similarity=0.436  Sum_probs=220.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+.+++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999999999999999999986543 3345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      +.+++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++...... .....
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCC
Confidence            9999999998664 6999999999999999999999999999999999999988776  999999998753322 22345


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|..||..............   ...........+++.+.+||.
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHH
Confidence            67999999999998888765 49999999999999999999987655443333222   122223334578999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +||+.||.+|||+.++++||||....+
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHccCChhHCcCHHHHhhChhhcccCc
Confidence            999999999999999999999976554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-54  Score=390.77  Aligned_cols=255  Identities=33%  Similarity=0.603  Sum_probs=222.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            58999999999999999999999999999999987532    34456788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..  .....
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~--~~~~~  161 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV--PDVTY  161 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEEC--SSCBC
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceec--CCccc
Confidence            99999999999998889999999999999999999999999999999999999988776  999999999743  23345


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..++.. +|||||||++|+|++|..||...+....+..    +......+|.  .+++++.+||
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~p~--~~~~~~~~li  234 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNEDVKDLL  234 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCC--CCCHHHHHHH
Confidence            6789999999999988877655 8999999999999999999987655433333    3333344443  6899999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCCChh
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~~~  268 (341)
                      .+||+.||.+||     +++++++||||.......
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHH
Confidence            999999999999     999999999997655443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-55  Score=395.90  Aligned_cols=260  Identities=33%  Similarity=0.618  Sum_probs=222.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            4689999999999999999999999999999999876432       245788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC--CCCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a~~~~  152 (341)
                      ++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ...+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998888899999999999999999999999999999999999998765  1249999999998655


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (341)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+..    +.......+  .+..+
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHTCCCCCHHHHTTS
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHhcCCCcCccccccC
Confidence            4455566789999999999987777554 8999999999999999999987554333322    222222222  12468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  280 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  280 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence            999999999999999999999999999999976543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.5e-54  Score=408.74  Aligned_cols=258  Identities=33%  Similarity=0.583  Sum_probs=218.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            4689999999999999999999999999999999876542   2346789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCCCCCC-C
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHS-Q  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~~~~~-~  156 (341)
                      |||.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. ....+||+|||++....... .
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            999999999999998999999999999999999999999999999999999999853 22459999999997543322 2


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..++. ++|||||||++|+|++|.+||........+..+...  ...+..+.+..+|+++.+
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~  246 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG--AYDFPSPEWDTVTPEAKD  246 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHH
T ss_pred             eecccCCcccCCHHHhcCCCCCC-ccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC--CCCCCccccccCCHHHHH
Confidence            34568999999999998877765 499999999999999999999876544333322211  223334455679999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ||.+||+.||.+|||+.++|+||||.
T Consensus       247 li~~~L~~dP~~Rpta~e~L~hp~~~  272 (444)
T 3soa_A          247 LINKMLTINPSKRITAAEALKHPWIS  272 (444)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHHSCTTH
T ss_pred             HHHHHcCCChhHCCCHHHHhcCcccc
Confidence            99999999999999999999999994

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-54  Score=400.37  Aligned_cols=257  Identities=34%  Similarity=0.604  Sum_probs=222.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3579999999999999999999999999999999976432   2346789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      ||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++.........
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            99999999999988888999999999999999999999999999999999999986542 45999999999865544445


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc--cCCCCCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  235 (341)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|.+||...+.....    ..+.....  ..+.+..+++++.
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHHH
Confidence            5678999999999998877765 489999999999999999999876543333    22333222  3344557899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +||.+||+.||.+|||+.++|+||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999953

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.3e-54  Score=384.12  Aligned_cols=262  Identities=25%  Similarity=0.435  Sum_probs=212.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            689999999999999999999999999999999875432   23568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~~  158 (341)
                      |+.++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.... ......
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence            9987444444444678999999999999999999999999999999999999998876  9999999997533 223344


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHHhcccc-c-------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRIRNVQY-F-------------  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~-~-------------  223 (341)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||....+. ..+............ .             
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            5688999999999987775556699999999999999888775444443 333333332211100 0             


Q ss_pred             ---------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          224 ---------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       224 ---------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                               ......+++.+.+||++||+.||++|||++|+++||||.+..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                     0011247899999999999999999999999999999976543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-54  Score=393.74  Aligned_cols=261  Identities=36%  Similarity=0.633  Sum_probs=221.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.++|++++.||+|+||+||+|.+..+++.||||++....  ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4589999999999999999999999999999999986543  23456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---CC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---HS  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---~~  155 (341)
                      |||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....   ..
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEEC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccc
Confidence            99999999999988888999999999999999999999999999999999999988776  99999999964321   12


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...........   .........+.+..+++.+.
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  239 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPL  239 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHH
Confidence            234568999999999998877766669999999999999999999987654322221   12222333444567899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +||.+||+.||.+|||+.|+++||||.+...
T Consensus       240 ~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          240 ALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            9999999999999999999999999976543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-54  Score=394.72  Aligned_cols=256  Identities=35%  Similarity=0.573  Sum_probs=220.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.    ......+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            6899999999999999999999999999999998764    23345677888888766 999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      |||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ...
T Consensus        97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCc
Confidence            999999999999998889999999999999999999999999999999999999998876  99999999975322 233


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+    ..+......+|.  .+++++.+
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~  247 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNPFYPR--WLEKEAKD  247 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccCCCCCcccCChhhhcCCCCCC-hhhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHhCCCCCCc--ccCHHHHH
Confidence            45678999999999998887755 489999999999999999999876543333    333333334443  58999999


Q ss_pred             HHHHhcccCCCCCCChh-HHhcCCccCCCCCh
Q 019433          237 LLSQIFVADPSKRIPIP-EIKKHPWFLKNLPK  267 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~-e~l~hp~~~~~~~~  267 (341)
                      ||.+||+.||.+||++. ++++||||......
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~  279 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWE  279 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence            99999999999999998 99999999765443

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-55  Score=393.42  Aligned_cols=253  Identities=23%  Similarity=0.259  Sum_probs=193.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----EEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----~~~i   76 (341)
                      |.++|.+.++||+|+||+||+|.+  +|+.||||++............|+..+..++|||||++++++..++    .+||
T Consensus         1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            568899999999999999999988  5899999999765433333445677777889999999999998653    6899


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------EICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      |||||++|+|.+++.. .++++..+..++.|++.||+|||++        +|+||||||+|||++.++.  +||+|||+|
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla  155 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCC
Confidence            9999999999999965 4699999999999999999999987        9999999999999998877  999999998


Q ss_pred             cCCCCCC-----CCCCccCCCCcccccccccccc-----CCCccchhhHHHHHHHHHhCCCCCCCCCCh-----------
Q 019433          149 KSGLLHS-----QPKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------  207 (341)
Q Consensus       149 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----------  207 (341)
                      +......     .....+||+.|||||++.+...     .+.++|||||||++|||+||.+||......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            7432221     2234589999999999976421     234589999999999999998776432211           


Q ss_pred             hHHHHHHHHHhccc--ccCCCC---CCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          208 RNFRKTIDRIRNVQ--YFLPDY---VRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       208 ~~~~~~~~~~~~~~--~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .........+....  ..+|..   ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11122222222111  112221   1123468899999999999999999999873

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.7e-54  Score=388.08  Aligned_cols=261  Identities=28%  Similarity=0.446  Sum_probs=214.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.++|++++.||+|+||+||+|.+. +++.||+|++.....   ....+.+|+.+++.++||||+++++++.....+++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4689999999999999999999996 589999999875432   235688999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HS  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~  155 (341)
                      |||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ..
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~  174 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVR  174 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcc
Confidence            999986 777777654 45999999999999999999999999999999999999988876  99999999975332 22


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc-CC---------
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-LP---------  225 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~---------  225 (341)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..||........+..+.......... ++         
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            33456789999999999875544556999999999999999999998877766666555433221100 00         


Q ss_pred             --------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          226 --------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       226 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                    ....+++++.+||.+||++||.+|||+.|+++||||.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                          0124788999999999999999999999999999997643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.9e-54  Score=391.58  Aligned_cols=259  Identities=29%  Similarity=0.495  Sum_probs=219.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+...    ..+.+.+|+.+++.+ +||||+++++++.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            579999999999999999999999999999999976432    233577899999887 899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      |||+.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... ....
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCc
Confidence            999999999999988889999999999999999999999999999999999999988776  9999999997532 2334


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----hHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----RNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||......     .........+......+|.  .++
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s  243 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS  243 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSC
T ss_pred             ccccCCCccccCccccCCCCCCh-HHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCC
Confidence            45678999999999998887754 599999999999999999999753211     1112223333344444444  689


Q ss_pred             HHHHHHHHHhcccCCCCCCCh------hHHhcCCccCCCCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPI------PEIKKHPWFLKNLP  266 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~------~e~l~hp~~~~~~~  266 (341)
                      +++.+||.+||+.||.+||++      .++++||||.....
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            999999999999999999996      79999999976543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-55  Score=413.52  Aligned_cols=294  Identities=26%  Similarity=0.392  Sum_probs=221.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .+||++++.||+|+||+||+|.+..+++.||||++.+..   ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999999999999999987632   3345678999999999999999999999654      4


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+||||+.+ +|...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~  215 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred             eEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence            68999999987 4656553  35999999999999999999999999999999999999998776  9999999998655


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----------  221 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (341)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+....+..++.......           
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            5445566789999999999998887655 8999999999999999999998776666665554332110           


Q ss_pred             ----ccCCCCCC---------------------CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhh
Q 019433          222 ----YFLPDYVR---------------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN  276 (341)
Q Consensus       222 ----~~~~~~~~---------------------~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~  276 (341)
                          ...+....                     .++++.+||.+||++||.+|||++|+|+||||...............
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~~  374 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ  374 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSCCC--
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccCCCCc
Confidence                00010000                     15679999999999999999999999999999865543322111111


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHhcC
Q 019433          277 YKEAGRDQPTQSVEEIMRIIQEAKM  301 (341)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~  301 (341)
                      ......+....+.+++++.+.+..+
T Consensus       375 ~~~~~~~~~~~~~~~~~~~~~~e~~  399 (464)
T 3ttj_A          375 IYDKQLDEREHTIEEWKELIYKEVM  399 (464)
T ss_dssp             ---------CCCHHHHHHHHHHHHH
T ss_pred             cCCcchhhccCCHHHHHHHHHHHHH
Confidence            1111223345567777777665543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-54  Score=402.32  Aligned_cols=294  Identities=27%  Similarity=0.344  Sum_probs=216.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCC--EEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLR-HPNIIRFKEVLLTPT--HLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~--~~~   75 (341)
                      -++|++++.||+|+||+||+|.+..+|+.||||++....   .......+|+.+++.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            368999999999999999999999999999999986532   23346778999999997 999999999997554  799


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC--
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL--  153 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~--  153 (341)
                      +|||||. ++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCcccccccccc
Confidence            9999997 488888865 57999999999999999999999999999999999999988776  99999999974321  


Q ss_pred             --------------------CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHH
Q 019433          154 --------------------HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT  213 (341)
Q Consensus       154 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~  213 (341)
                                          .......+||++|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                111234579999999999987554456699999999999999999999987766665555


Q ss_pred             HHHHhcccc-----------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCh
Q 019433          214 IDRIRNVQY-----------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPI  252 (341)
Q Consensus       214 ~~~~~~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~  252 (341)
                      +..+.....                                         .......+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            432211100                                         000112578999999999999999999999


Q ss_pred             hHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCCHHHHHHHHHHh
Q 019433          253 PEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA  299 (341)
Q Consensus       253 ~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (341)
                      .|+|+||||.....................+....+.+++...+.+.
T Consensus       324 ~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (388)
T 3oz6_A          324 NDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSE  370 (388)
T ss_dssp             HHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHH
T ss_pred             HHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHH
Confidence            99999999976544332111111111222223445677777666544

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.1e-54  Score=396.36  Aligned_cols=257  Identities=25%  Similarity=0.474  Sum_probs=222.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+.    ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            6899999999999999999999999999999998653    234467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~  172 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQIT  172 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBC
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCcee
Confidence            99999999999998889999999999999999999999999999999999999998877  9999999998655555566


Q ss_pred             CccCCCCcccccccccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          159 STVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ..+||+.|+|||++.+.   .++ .++|||||||++|+|++|..||...... ........+.......|.  .+++.+.
T Consensus       173 ~~~gt~~Y~aPE~~~~~~~~~~~-~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~p~--~~s~~~~  248 (384)
T 4fr4_A          173 TMAGTKPYMAPEMFSSRKGAGYS-FAVDWWSLGVTAYELLRGRRPYHIRSST-SSKEIVHTFETTVVTYPS--AWSQEMV  248 (384)
T ss_dssp             CCCSCGGGCCGGGTCCCSSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCCTTS-CHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccCCCccccCCeeeccCCCCCCC-ccceeechHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhhcccCCCC--cCCHHHH
Confidence            78899999999998742   344 4589999999999999999999754332 222333334444444443  6899999


Q ss_pred             HHHHHhcccCCCCCCC-hhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIP-IPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s-~~e~l~hp~~~~~~  265 (341)
                      +||.+||+.||.+||+ ++++++||||....
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            9999999999999998 89999999997644

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.4e-54  Score=392.37  Aligned_cols=253  Identities=32%  Similarity=0.573  Sum_probs=221.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+..    ...+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999986532    34467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...  ....
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~--~~~~  196 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTW  196 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBC
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceecc--CCcc
Confidence            99999999999998889999999999999999999999999999999999999988776  9999999997532  2345


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..++. ++|||||||++|+|++|..||........+    ..+......+|.  .+++++.+||
T Consensus       197 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li  269 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFPS--HFSSDLKDLL  269 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TCCHHHHHHH
T ss_pred             cccCCccccCHHHhcCCCCCC-cCCEecccHhHhHHhhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHH
Confidence            678999999999998887765 499999999999999999999876543333    333333444443  6899999999


Q ss_pred             HHhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          239 SQIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       239 ~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      .+||+.||.+||+     ++++++||||.....
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            9999999999998     999999999975543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.3e-54  Score=407.81  Aligned_cols=298  Identities=26%  Similarity=0.340  Sum_probs=213.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----CC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT-----PT   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----~~   72 (341)
                      +.++|++++.||+|+||+||+|.++.+++.||||++.+..   ...+.+.+|+.+++.++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4579999999999999999999999999999999986532   233568899999999999999999999954     36


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+||||+. ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~  207 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVD  207 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTT
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--Eeecccccchhcc
Confidence            7999999985 699999988888999999999999999999999999999999999999998876  9999999997533


Q ss_pred             CCC----------------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh--------
Q 019433          153 LHS----------------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV--------  196 (341)
Q Consensus       153 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~--------  196 (341)
                      ...                            .....+||++|+|||++......+.++|||||||++|+|++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            211                            22345789999999987554444556999999999999998        


Q ss_pred             ---CCCCCCCCCC--------------------hhHHHHHHHHHhccc----------------cc---------CCCCC
Q 019433          197 ---GAYPFEDPED--------------------PRNFRKTIDRIRNVQ----------------YF---------LPDYV  228 (341)
Q Consensus       197 ---g~~pf~~~~~--------------------~~~~~~~~~~~~~~~----------------~~---------~~~~~  228 (341)
                         |.++|.+...                    ...+..+...+....                ..         ...+.
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               6677755331                    111111111110000                00         01123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCCHHHHHHHHHHhcC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAKM  301 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (341)
                      .+++++.+||++||++||.+|||++|+|+||||.+...................+....+.+++...+.+...
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHT
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHH
Confidence            5699999999999999999999999999999998765544322111111112223345677788877665543

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-54  Score=404.31  Aligned_cols=297  Identities=26%  Similarity=0.331  Sum_probs=225.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----C
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----T   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~   72 (341)
                      +.++|++++.||+|+||+||+|.++.+++.||||++....   ...+.+.+|+.+++.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4689999999999999999999999999999999987642   2335688999999999999999999999766     6


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~  180 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTIN  180 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC-
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccc
Confidence            7999999996 499999988888999999999999999999999999999999999999988776  9999999997533


Q ss_pred             CCC-----------------------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-----------
Q 019433          153 LHS-----------------------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-----------  198 (341)
Q Consensus       153 ~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-----------  198 (341)
                      ...                       .....+||++|+|||++......+.++|||||||++|+|++|.           
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            221                       2356789999999999755554456699999999999999844           


Q ss_pred             CCCCCCCC-----------------hhHHHHHHHHHh--------------------cccccCC-----CCCCCCHHHHH
Q 019433          199 YPFEDPED-----------------PRNFRKTIDRIR--------------------NVQYFLP-----DYVRVSADCRH  236 (341)
Q Consensus       199 ~pf~~~~~-----------------~~~~~~~~~~~~--------------------~~~~~~~-----~~~~~s~~~~~  236 (341)
                      ++|.+...                 ..++..++..+.                    ......+     .+..+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            44433221                 111111111111                    1010000     11358999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCCHHHHHHHHHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEAK  300 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (341)
                      ||.+||++||.+|||++|+|+||||.....+...............+....+.+++..++.+..
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~  404 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEV  404 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHH
Confidence            9999999999999999999999999876655443333222222233445677888887766543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-53  Score=391.08  Aligned_cols=257  Identities=32%  Similarity=0.501  Sum_probs=221.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+.    ....+.+..|..++..+ +||||+++++++...+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            6899999999999999999999999999999998763    23445678899999887 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      |||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... ....
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcc
Confidence            999999999999998889999999999999999999999999999999999999998876  9999999997532 2233


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+    ..+......+|.  .+|+++.+
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~  250 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPK--SMSKEAVA  250 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHH
T ss_pred             cccccCCccccChhhhcCCCcCC-cccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHH
Confidence            45678999999999998887755 489999999999999999999876543333    333334444443  68999999


Q ss_pred             HHHHhcccCCCCCCC-----hhHHhcCCccCCCCChh
Q 019433          237 LLSQIFVADPSKRIP-----IPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       237 li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~~~  268 (341)
                      ||.+||+.||.+||+     +.++++||||.......
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHH
Confidence            999999999999995     69999999997654433

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.5e-54  Score=401.42  Aligned_cols=257  Identities=32%  Similarity=0.486  Sum_probs=220.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+.    ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998652    233456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--C
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~  156 (341)
                      |||+||+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......  .
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCccc
Confidence            99999999998865 47999999999999999999999999999999999999998877  9999999997533222  2


Q ss_pred             CCCccCCCCcccccccccccc---CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEY---DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ....+||+.|+|||++.+...   .+.++|||||||++|+|++|..||...+....+..+.....  ...+|....+|++
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~s~~  303 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN--SLTFPDDNDISKE  303 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCTTCCCCHH
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--cccCCCcccccHH
Confidence            346789999999999976541   23459999999999999999999987665555544443322  2345555679999


Q ss_pred             HHHHHHHhcccCCCC--CCChhHHhcCCccCCC
Q 019433          234 CRHLLSQIFVADPSK--RIPIPEIKKHPWFLKN  264 (341)
Q Consensus       234 ~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~  264 (341)
                      +.+||.+||+.+|.+  |++++++++||||...
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999988  9999999999999764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-53  Score=382.32  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=214.7

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcC---CCCCeeeEEEEEEcC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSL---RHPNIIRFKEVLLTP   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~~   71 (341)
                      +.+||++++.||+|+||+||+|.+..+++.||||++....      .......+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3689999999999999999999999999999999986422      2345677888887766   499999999999876


Q ss_pred             C-----EEEEEEeecCCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           72 T-----HLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        72 ~-----~~~iv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      .     .+++||||+.+ +|..++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|
T Consensus        87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~D  163 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLAD  163 (308)
T ss_dssp             CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECS
T ss_pred             CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEee
Confidence            5     58999999975 99999987654  999999999999999999999999999999999999988776  99999


Q ss_pred             cCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-c
Q 019433          145 FGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-F  223 (341)
Q Consensus       145 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~  223 (341)
                      ||++.............||+.|+|||++.+..++.+ +|||||||++|+|++|.+||........+..+......... .
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999986555555566789999999999988887655 89999999999999999999887766666555544322110 0


Q ss_pred             CCC--------------------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPD--------------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~--------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ++.                    ...+++.+.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            100                    12578999999999999999999999999999999654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.4e-54  Score=407.26  Aligned_cols=256  Identities=41%  Similarity=0.742  Sum_probs=225.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|.+.+.||+|+||+||+|.+..+|+.||||++.+..    .....+.+|+.+++.++||||+++++++...+.+++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            68999999999999999999999999999999987532    23457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~~  173 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLR  173 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCBC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhcccccccc
Confidence            99999999999988889999999999999999999999999999999999999988776  9999999998654444456


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..+.+.++|||||||++|+|++|..||........+.    .+.......|.  .+++++.+||
T Consensus       174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~Li  247 (476)
T 2y94_A          174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTPQ--YLNPSVISLL  247 (476)
T ss_dssp             CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCCT--TCCHHHHHHH
T ss_pred             ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCCc--cCCHHHHHHH
Confidence            67899999999999988776667999999999999999999998766543333    33333333343  6899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++||+.||.+|||+.++++||||.+..+
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            9999999999999999999999976543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-54  Score=398.49  Aligned_cols=259  Identities=27%  Similarity=0.513  Sum_probs=221.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||+||+|.++.+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            4689999999999999999999999999999999876432 334688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      +.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+....+||+|||++...........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            99999999987654 79999999999999999999999999999999999999865555699999999986544444445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc--cCCCCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  237 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..    +.....  ..+.+..+++++.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCH-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             eccCCCccCchhccCCCCCC-cccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHHHHH
Confidence            68999999999998877654 58999999999999999999987655433332    222222  222345789999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      |.+||+.||.+|||+.++++||||....
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999997653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-53  Score=377.06  Aligned_cols=262  Identities=33%  Similarity=0.581  Sum_probs=224.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.++|++.+.||+|+||.||+|.++.+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            57899999999999999999999999999999999876432   234677899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+.+++|...+.....+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++........
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988889999999999999999999999999999999999999976543 4599999999976555444


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..++. ++||||||+++|+|++|..||..............  .......+.+..+++++.+
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCc-ccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh--ccccCCchhhcccCHHHHH
Confidence            55678999999999998887755 48999999999999999999987654433322211  1222333444578999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||.+||+.||.+|||+.++++||||.+..
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            99999999999999999999999996543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-53  Score=379.84  Aligned_cols=257  Identities=27%  Similarity=0.433  Sum_probs=211.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||+||+|.+ .+++.||+|++....   .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            6899999999999999999999 579999999986543   234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCC
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~  157 (341)
                      |+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.... .....
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence            9986 888888764 57999999999999999999999999999999999999988776  9999999986422 12233


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cCC-----------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP-----------  225 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-----------  225 (341)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|..||........+............ .++           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            45678999999999977654456699999999999999999999887665555554443221100 000           


Q ss_pred             -----------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          226 -----------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       226 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                 ....+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                       01357899999999999999999999999999999965

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3e-53  Score=383.83  Aligned_cols=263  Identities=27%  Similarity=0.437  Sum_probs=205.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++++.||+|+||+||+|.++.+|+.||+|++....  .....+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            368999999999999999999999999999999987543  344678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           80 YAAGGELFARICSA------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        80 ~~~~~~L~~~l~~~------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      |+.+ +|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        84 ~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGI  160 (317)
T ss_dssp             CCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTS
T ss_pred             ecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCC
Confidence            9985 898888653      35999999999999999999999999999999999999988776  99999999975332


Q ss_pred             -CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc-------C-
Q 019433          154 -HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-------L-  224 (341)
Q Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~-  224 (341)
                       ........||+.|+|||++.+....+.++|||||||++|+|++|..||........+..+..........       . 
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence             2233456899999999999875544556999999999999999999998877665555544432211000       0 


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          225 --------------------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       225 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                                          .....+++++.+||.+||+.||.+|||+.++++||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                0012578899999999999999999999999999999765543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-53  Score=390.80  Aligned_cols=259  Identities=36%  Similarity=0.582  Sum_probs=205.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++.+.||+|+||+||+|.++.+++.||||++.... ..+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            468999999999999999999999999999999987653 3456788999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-CCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           82 AGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +....+||+|||+++...........
T Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  210 (349)
T 2w4o_A          131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV  210 (349)
T ss_dssp             CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence            99999999988888999999999999999999999999999999999999975 22334999999999754444444567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc--cCCCCCCCCHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCRHLL  238 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li  238 (341)
                      .||+.|+|||++.+..++. ++|||||||++|+|++|..||.........   ...+.....  ..+.+..++.++.+||
T Consensus       211 ~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          211 CGTPGYCAPEILRGCAYGP-EVDMWSVGIITYILLCGFEPFYDERGDQFM---FRRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             --CGGGSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCTTCHHHH---HHHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccCHHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCcccHHH---HHHHHhCCCccCCchhhhCCHHHHHHH
Confidence            8999999999998877755 499999999999999999999876554322   222222222  2233457899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ++||+.||.+|||+.++++||||....
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999997654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-53  Score=408.26  Aligned_cols=259  Identities=37%  Similarity=0.611  Sum_probs=220.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||+||+|.++.+++.||||++...   ......+.+|+.+++.++||||+++++++.....+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999998642   234567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||.+++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||++.........
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            9999999999998888999999999999999999999999999999999999996532 245999999999765444455


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+. ++ .++|||||||++|+|++|.+||........+.....  ....+..+.+..+|+++.+|
T Consensus       181 ~~~~gt~~y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~l  256 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRTISDDAKDL  256 (486)
T ss_dssp             -CCTTGGGGCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCSCSGGGGGSCHHHHHH
T ss_pred             CCCcCCCCCCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcccCCCCHHHHHH
Confidence            667899999999999764 44 459999999999999999999987665443333221  12233445666899999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |.+||+.||.+|||+.++|+||||.+.
T Consensus       257 i~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          257 IRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            999999999999999999999999653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-53  Score=381.91  Aligned_cols=253  Identities=36%  Similarity=0.610  Sum_probs=210.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---------------------------ccHHHHHHHHHHhc
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------------------------IDENVQREIINHRS   55 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~ei~~~~~   55 (341)
                      ++|++.+.||+|+||+||+|.+..+++.||||++.....                           ..+.+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            689999999999999999999999999999999865421                           12458899999999


Q ss_pred             CCCCCeeeEEEEEEc--CCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec
Q 019433           56 LRHPNIIRFKEVLLT--PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD  133 (341)
Q Consensus        56 l~hp~iv~l~~~~~~--~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~  133 (341)
                      ++||||+++++++..  ...+++||||+++++|..++ ...++++..++.++.||+.||.|||++||+||||||+|||++
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~  171 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG  171 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC
Confidence            999999999999987  57899999999999997754 345799999999999999999999999999999999999998


Q ss_pred             CCCCCCEEEeecCCccCCCCCC-CCCCccCCCCcccccccccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCChhHH
Q 019433          134 GSPQPRLKICDFGYSKSGLLHS-QPKSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF  210 (341)
Q Consensus       134 ~~~~~~ikL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~  210 (341)
                      .++.  +||+|||++....... ......||+.|+|||++.+...  .+.++|||||||++|+|++|..||......   
T Consensus       172 ~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---  246 (298)
T 2zv2_A          172 EDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM---  246 (298)
T ss_dssp             TTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             CCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH---
Confidence            8776  9999999987533222 2245679999999999976542  355689999999999999999999875432   


Q ss_pred             HHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          211 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                       .....+.......+....+++++.+||.+||+.||.+|||+.++++||||.
T Consensus       247 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          247 -CLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             -HHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             -HHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence             222333334444555567999999999999999999999999999999994

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-53  Score=407.91  Aligned_cols=258  Identities=36%  Similarity=0.600  Sum_probs=218.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||+||+|.++.++..||+|++...   ......+.+|+.+++.++||||+++++++.....+++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            45899999999999999999999999999999998764   234567899999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||.+|+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||++.........
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            9999999999998888999999999999999999999999999999999999997643 345999999999865555555


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+ .++ .++|||||||++|+|++|.+||........+..+...  ...+..+.+..+|+.+.+|
T Consensus       196 ~~~~gt~~y~aPE~l~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~l  271 (494)
T 3lij_A          196 KERLGTAYYIAPEVLRK-KYD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG--KYTFDSPEWKNVSEGAKDL  271 (494)
T ss_dssp             CCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCSGGGTTSCHHHHHH
T ss_pred             cccCCCcCeeCHHHHcc-cCC-CchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCchhcccCCHHHHHH
Confidence            66789999999999864 454 4599999999999999999999876654333322211  1223334556799999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      |++||+.||.+|||+.++|+||||.+
T Consensus       272 i~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          272 IKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHCCCChhhCccHHHHhcCccccc
Confidence            99999999999999999999999954

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-53  Score=399.67  Aligned_cols=263  Identities=26%  Similarity=0.479  Sum_probs=221.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+.    ......+.+|+.++..++||||++++++|.+.+.+|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999998752    22233488899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||.||+|..++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSC
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCC
Confidence            999999999999987 568999999999999999999999999999999999999998877  99999999975332222


Q ss_pred             --CCCccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC-C
Q 019433          157 --PKSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY-V  228 (341)
Q Consensus       157 --~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~  228 (341)
                        ....+||+.|+|||++.     +..++ .++|||||||++|+|++|..||...+....+..++.....  ..+|.. .
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~  307 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER--FQFPTQVT  307 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCCSSCC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc--ccCCcccc
Confidence              23468999999999987     33454 4599999999999999999999887665555554433222  233332 4


Q ss_pred             CCCHHHHHHHHHhcccCCCC--CCChhHHhcCCccCCCCChhH
Q 019433          229 RVSADCRHLLSQIFVADPSK--RIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~--R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      .+|+++.+||++||+.+|++  |++++++++||||.......+
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            68999999999999998888  999999999999987654443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-53  Score=408.59  Aligned_cols=259  Identities=34%  Similarity=0.610  Sum_probs=220.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--------------cccHHHHHHHHHHhcCCCCCeeeEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------------KIDENVQREIINHRSLRHPNIIRFKE   66 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~ei~~~~~l~hp~iv~l~~   66 (341)
                      |.++|++++.||+|+||+||+|.++.+++.||+|++....              ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4679999999999999999999999999999999987643              23457889999999999999999999


Q ss_pred             EEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeec
Q 019433           67 VLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDF  145 (341)
Q Consensus        67 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Df  145 (341)
                      ++.....+++|||||.+|+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+||
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  193 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF  193 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence            99999999999999999999999988889999999999999999999999999999999999999987653 35999999


Q ss_pred             CCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc--
Q 019433          146 GYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--  223 (341)
Q Consensus       146 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--  223 (341)
                      |++............+||+.|+|||++.+ .++ .++|||||||++|+|++|.+||........+    ..+......  
T Consensus       194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~  267 (504)
T 3q5i_A          194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYN-EKCDVWSCGVIMYILLCGYPPFGGQNDQDII----KKVEKGKYYFD  267 (504)
T ss_dssp             TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC
T ss_pred             CCCEEcCCCCccccccCCcCCCCHHHhcc-CCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC
Confidence            99986555555566789999999999874 454 4599999999999999999999876554333    233333322  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .+.+..+|+++.+||++||++||.+|||+.++|+||||.+..
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            233457899999999999999999999999999999996543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.9e-54  Score=393.00  Aligned_cols=256  Identities=30%  Similarity=0.564  Sum_probs=214.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++.+.||+|+||+||+|.++.+++.||||++....      ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999999999999999986421      23467889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccC
Q 019433           76 IVMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKS  150 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~  150 (341)
                      +|||||++++|...+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877543    35899999999999999999999999999999999999976542 4599999999975


Q ss_pred             CCCCC-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CC
Q 019433          151 GLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DY  227 (341)
Q Consensus       151 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  227 (341)
                      ..... .....+||+.|+|||++.+..++. ++|||||||++|+|++|..||.... .    .....+.......+  .+
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~-~----~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTK-E----RLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCSSH-H----HHHHHHHHTCCCCCHHHH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCc-hHhhHHHHHHHHHHHHCCCCCCCcH-H----HHHHHHHcCCCCCCcccc
Confidence            43322 234568999999999998877754 5999999999999999999998642 1    22222222222221  23


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            468999999999999999999999999999999953

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-53  Score=379.18  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=214.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      |-++|++++.||+|+||+||+|.+..+|+.||+|++......   .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            458999999999999999999999999999999998665432   34577899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      |||+.+++|..++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++..... ...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC-----
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccc
Confidence            999999999999888888999999999999999999999999999999999999988776  99999999875332 222


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------c
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------Q  221 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  221 (341)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|..||...................               .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            3456799999999999875544566999999999999999999998876655544333222110               0


Q ss_pred             ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          222 YFLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       222 ~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ...+.          ...+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            00111          135788999999999999999999999999999997654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-53  Score=391.77  Aligned_cols=293  Identities=26%  Similarity=0.380  Sum_probs=221.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP------   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------   71 (341)
                      +.++|++++.||+|+||+||+|.+..+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++...      
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            35799999999999999999999999999999999865322   234678999999999999999999999866      


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..+|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++..
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~  178 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA  178 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccc
Confidence            3469999999 7899988865 57999999999999999999999999999999999999998776  999999999853


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc---------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------  222 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  222 (341)
                      .  ......+||++|+|||++.+....+.++|||||||++|+|++|+.||...+....+..+.........         
T Consensus       179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          179 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            2  33456789999999999987443445599999999999999999999987766555554432211100         


Q ss_pred             -------cC---------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCC
Q 019433          223 -------FL---------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT  286 (341)
Q Consensus       223 -------~~---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (341)
                             .+         ......++.+.+||.+||+.||.+|||+.++|+||||............. .+. ...+...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~-~~~~~~~  334 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYD-DSFDDVD  334 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCC-CC-----
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCC-CChhhhc
Confidence                   00         01235789999999999999999999999999999997765433221111 111 1122234


Q ss_pred             CCHHHHHHHHHHhcC
Q 019433          287 QSVEEIMRIIQEAKM  301 (341)
Q Consensus       287 ~~~~~~~~~~~~~~~  301 (341)
                      .+.+++.+.+.+...
T Consensus       335 ~~~~~~~~~~~~~~~  349 (367)
T 1cm8_A          335 RTLDEWKRVTYKEVL  349 (367)
T ss_dssp             CCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHHH
Confidence            567777777665543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-53  Score=384.47  Aligned_cols=260  Identities=32%  Similarity=0.558  Sum_probs=222.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4689999999999999999999999999999999876432       245688999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC--CCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~--~~ikL~Dfg~a~~~~  152 (341)
                      ++||||+.+++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  ..+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            999999999999999988888999999999999999999999999999999999999987662  149999999997655


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC--CCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  230 (341)
                      .........||+.|+|||++.+..++. ++|||||||++|+|++|..||........+    ..+.......+.  +..+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETL----ANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTC
T ss_pred             ccccccccCCCCCccCcccccCCCCCC-ccccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccccChhhhccc
Confidence            444455678999999999998877755 489999999999999999999875543332    223333222221  2468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ++.+.+||.+||+.||.+|||+.++++||||.....
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            899999999999999999999999999999976543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-53  Score=376.81  Aligned_cols=257  Identities=31%  Similarity=0.534  Sum_probs=209.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +++|++.+.||+|+||+||+|.+..++..+|+|++....  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            578999999999999999999999999999999987643  234678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCCCCC
Q 019433           80 YAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~~~~  154 (341)
                      |+.+++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+||+++.+ ....+||+|||++......
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            9999999988854    3679999999999999999999999999999999999999542 2345999999999765444


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      .......||+.|+|||++.+ .+ +.++|||||||++|+|++|..||............. .  ...........+++.+
T Consensus       181 ~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~  255 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT-Y--KEPNYAVECRPLTPQA  255 (285)
T ss_dssp             ------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-H--CCCCCCC--CCCCHHH
T ss_pred             ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc-c--CCcccccccCcCCHHH
Confidence            44556789999999999864 34 455999999999999999999998755432222111 1  1111122233579999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      .+||.+||+.||.+|||+.|+++||||++
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999999965

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-53  Score=388.54  Aligned_cols=251  Identities=31%  Similarity=0.479  Sum_probs=218.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSLRHPNIIRFKEVLLTPT   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~   72 (341)
                      .++|++++.||+|+||+||+|.++.+++.||||++.....         ....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4689999999999999999999999999999999876532         2335778999999999999999999999999


Q ss_pred             EEEEEEeecCCC-chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           73 HLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        73 ~~~iv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      .+++||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~  180 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceEC
Confidence            999999999776 99999998889999999999999999999999999999999999999988776  999999999865


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      ..........||+.|+|||++.+..+.+.++|||||||++|+|++|..||.....            ...........++
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~~~~~~~~~~~~  248 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEAAIHPPYLVS  248 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------GTTTCCCCSSCCC
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------HHhhccCCCcccC
Confidence            5444455678999999999998888766668999999999999999999975321            0111122233589


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +++.+||.+||++||.+|||+.++++||||.+...
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            99999999999999999999999999999977543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-52  Score=382.03  Aligned_cols=256  Identities=30%  Similarity=0.499  Sum_probs=211.5

Q ss_pred             CCCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      .++|++++.||+|+||+||+|++.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            368999999999999999999985   689999999987642     233457789999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +|+||||+.+++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC-----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCccccccc
Confidence            9999999999999999998889999999999999999999999999999999999999988776  99999999874322


Q ss_pred             -CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          154 -HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       154 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                       .......+||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..    +......+|.  .+++
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~~p~--~~~~  246 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNR-AVDWWSLGALMYDMLTGAPPFTGENRKKTIDK----ILKCKLNLPP--YLTQ  246 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCCT--TSCH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCC-cccchhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCC--CCCH
Confidence             22334568999999999998877754 59999999999999999999987655433332    3333333443  6899


Q ss_pred             HHHHHHHHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          233 DCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      ++.+||.+||+.||.+||     ++.++++||||.....
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~  285 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW  285 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence            999999999999999999     8899999999976543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6e-53  Score=389.62  Aligned_cols=257  Identities=32%  Similarity=0.533  Sum_probs=213.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHH-HhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIIN-HRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~-~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+...    ....+.+|..+ ++.++||||++++++|.+.+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            589999999999999999999999999999999876432    22345566665 4678999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      |||+.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... ....
T Consensus       118 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCc
Confidence            999999999999998889999999999999999999999999999999999999998876  9999999997522 2334


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+.    .+......++.  .+++.+.+
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~  268 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLKP--NITNSARH  268 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH----HHHHSCCCCCS--SSCHHHHH
T ss_pred             cccccCCccccCHHHhCCCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcccCCCC--CCCHHHHH
Confidence            55678999999999998887765 4899999999999999999998765443333    33333333443  68999999


Q ss_pred             HHHHhcccCCCCCCCh----hHHhcCCccCCCCChh
Q 019433          237 LLSQIFVADPSKRIPI----PEIKKHPWFLKNLPKE  268 (341)
Q Consensus       237 li~~~L~~dp~~R~s~----~e~l~hp~~~~~~~~~  268 (341)
                      ||.+||+.||.+||++    .++++||||.......
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~  304 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD  304 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHH
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHH
Confidence            9999999999999997    6999999997655443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-53  Score=385.48  Aligned_cols=263  Identities=30%  Similarity=0.418  Sum_probs=211.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      -++|++++.||+|+||+||+|.+..+++.||||++.....   ....+.+|+.+++.++||||+++++++.....+++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            3689999999999999999999999999999999875432   2345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC---CCCEEEeecCCccCCC-CC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---QPRLKICDFGYSKSGL-LH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~---~~~ikL~Dfg~a~~~~-~~  154 (341)
                      ||+.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++   ...+||+|||++.... ..
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99985 9999999888999999999999999999999999999999999999995322   2349999999986422 22


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cC------CCC
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL------PDY  227 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------~~~  227 (341)
                      .......||+.|+|||++.+....+.++|||||||++|+|++|..||........+............ .+      +.+
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence            23345678999999999987664456699999999999999999999887766665555444321110 00      000


Q ss_pred             -----------------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          228 -----------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       228 -----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                       ..+++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                             11788999999999999999999999999999997653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-54  Score=409.79  Aligned_cols=258  Identities=37%  Similarity=0.596  Sum_probs=220.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++.+.||+|+||+||+|.++.+++.||||++...    ....+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46899999999999999999999999999999998653    23456788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.. ....+||+|||++........
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  184 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK  184 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence            9999999999999988899999999999999999999999999999999999999532 223599999999875444444


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+ .++ .++|||||||++|+|++|.+||........+..+..  ....+..+.+..+|+++.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG-TYD-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK--GKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT-CCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSGGGGGSCHHHHH
T ss_pred             cccCCCCccccCceeecC-CCC-CcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCCCcccccCCHHHHH
Confidence            455679999999999976 454 459999999999999999999988665443333221  1223344556689999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ||++||++||.+|||+.++|+||||..
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            999999999999999999999999964

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-53  Score=407.16  Aligned_cols=259  Identities=28%  Similarity=0.425  Sum_probs=222.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.+.    ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            6799999999999999999999999999999998653    233456789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           79 EYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||++||+|..++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCcc
Confidence            9999999999997754  4999999999999999999999999999999999999998776  99999999986544444


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++.. +|||||||++|+|++|..||...........+...+......++  ..+|+++.+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~d  418 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARS  418 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHH
Confidence            456789999999999988877654 89999999999999999999875443233333344444444444  368999999


Q ss_pred             HHHHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      ||.+||+.||.+||     ++.++++||||.....
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence            99999999999999     8999999999976543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.8e-53  Score=399.31  Aligned_cols=255  Identities=36%  Similarity=0.588  Sum_probs=211.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||.||+|.++.+|+.||||++...    ......+.+|+.+++.++||||+++++++...+.+++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            6799999999999999999999999999999998753    223346778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      ||+++++|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+++... ....
T Consensus       228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  305 (446)
T 4ejn_A          228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGAT  305 (446)
T ss_dssp             CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC----
T ss_pred             eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCcc
Confidence            999999999999988899999999999999999999998 99999999999999998776  9999999997532 2233


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||.........    ..+......+|.  .+++++.+
T Consensus       306 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~  378 (446)
T 4ejn_A          306 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLGPEAKS  378 (446)
T ss_dssp             -CCSSSCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHH
T ss_pred             cccccCCccccCHhhcCCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHHhCCCCCCc--cCCHHHHH
Confidence            45678999999999998887765 499999999999999999999876543333    223333333443  68999999


Q ss_pred             HHHHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      ||.+||++||.+||     |+.++++||||.....
T Consensus       379 li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~  413 (446)
T 4ejn_A          379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVW  413 (446)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCH
Confidence            99999999999999     9999999999976543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.1e-53  Score=374.71  Aligned_cols=254  Identities=34%  Similarity=0.600  Sum_probs=219.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +++|++.+.||+|+||.||+|.++.++..||+|++.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            578999999999999999999999999999999987643 3456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe---cCCCCCCEEEeecCCccCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili---~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      +++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||++   +.++.  ++|+|||++.........
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           88 CTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             CCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSCB
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCc--EEEEecccceeccCccch
Confidence            9999999999888899999999999999999999999999999999999999   44444  999999999765555555


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC--CCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~  235 (341)
                      ....||+.|+|||++.+. ++ .++|||||||++|+|++|..||...........    +.......+.  +..+++.+.
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YG-PECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHH
T ss_pred             hccCCCCCccChHHhccc-CC-chhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHHH
Confidence            667899999999998765 44 459999999999999999999987665433322    2222322222  236899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +||.+||+.||.+|||+.++++||||.+
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999999999943

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-53  Score=387.72  Aligned_cols=257  Identities=33%  Similarity=0.551  Sum_probs=215.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||+||+|.++.+++.||||++.+...   ...+|+.++..+ +||||+++++++.+...+|+||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            4689999999999999999999999999999999976543   234677777776 799999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC--CCEEEeecCCccCCCCC-CCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSGLLH-SQP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~--~~ikL~Dfg~a~~~~~~-~~~  157 (341)
                      |.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+.....  ..+||+|||+++..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            999999999998889999999999999999999999999999999999999854322  34999999999753322 234


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~  235 (341)
                      ...+||+.|+|||++.+..++. ++|||||||++|+|++|..||..... .........+....+..+  .+..+|+++.
T Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             CCSSCCSSCCCHHHHHHHHHHH-HHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             eccCCCccccCHHHhcCCCCCC-ccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHH
Confidence            4568999999999998777754 48999999999999999999976432 122333444444443332  3457899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +||++||..||.+|||+.++++||||..
T Consensus       256 ~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999999954

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.1e-52  Score=390.69  Aligned_cols=261  Identities=23%  Similarity=0.383  Sum_probs=212.9

Q ss_pred             CCCccccceeccc--CCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSG--NFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|++++.||+|  +||+||+|.++.+++.||||++.....   ..+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4789999999999  999999999999999999999876432   23467789999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC--
Q 019433           77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL--  152 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~--  152 (341)
                      |||||.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....  
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISH  181 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEET
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeeccc
Confidence            99999999999999875  67999999999999999999999999999999999999988776  9999999875321  


Q ss_pred             ------CCCCCCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc----
Q 019433          153 ------LHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV----  220 (341)
Q Consensus       153 ------~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----  220 (341)
                            ........+||+.|+|||++.+  ..++ .++|||||||++|+|++|..||........+..........    
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBC-THHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence                  1122334578999999999987  3454 45999999999999999999998766544443322111000    


Q ss_pred             ------------------------------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          221 ------------------------------------QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       221 ------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                                          ....+....+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                                                00011223578999999999999999999999999999999654


Q ss_pred             C
Q 019433          265 L  265 (341)
Q Consensus       265 ~  265 (341)
                      .
T Consensus       341 ~  341 (389)
T 3gni_B          341 K  341 (389)
T ss_dssp             -
T ss_pred             h
Confidence            3

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-52  Score=377.77  Aligned_cols=265  Identities=30%  Similarity=0.505  Sum_probs=213.0

Q ss_pred             CCCCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            1 MEERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         1 i~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      +.++|++. +.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.+ +||||+++++++...+.+++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            46789996 78999999999999999999999999997654 3346788999999885 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLLH--  154 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~~--  154 (341)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++......  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999999998889999999999999999999999999999999999999986553 35999999998643211  


Q ss_pred             ------CCCCCccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChh-----------HHHH
Q 019433          155 ------SQPKSTVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----------NFRK  212 (341)
Q Consensus       155 ------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~-----------~~~~  212 (341)
                            ......+||+.|+|||++.+     ..++ .++|||||||++|+|++|..||.......           ....
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence                  11234569999999999875     3444 45899999999999999999997654211           1122


Q ss_pred             HHHHHhcccccCCC--CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          213 TIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       213 ~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ....+......++.  +..+++.+.+||.+||+.||.+|||+.++++||||.+..+
T Consensus       249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            23333333333332  2468999999999999999999999999999999976543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.2e-53  Score=388.65  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=214.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----CCCeeeEEEEEEcCCEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----HPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----hp~iv~l~~~~~~~~~~~   75 (341)
                      ++++|++++.||+|+||+||+|.+..+++.||||++............|+.+++.+.     ||||+++++++...+..+
T Consensus        33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            468999999999999999999999999999999999876656667888999998886     999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC------------------
Q 019433           76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS------------------  135 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~------------------  135 (341)
                      +||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..                  
T Consensus       113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~  191 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI  191 (360)
T ss_dssp             EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence            999999 889999997754  59999999999999999999999999999999999999751                  


Q ss_pred             -----CCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHH
Q 019433          136 -----PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF  210 (341)
Q Consensus       136 -----~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~  210 (341)
                           ....+||+|||++...  ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+
T Consensus       192 ~~~~~~~~~~kl~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~  268 (360)
T 3llt_A          192 QIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHL  268 (360)
T ss_dssp             EEEEESCCCEEECCCTTCEET--TSCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cccccCCCCEEEEeccCceec--CCCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence                 1334999999999742  333456789999999999998887655 89999999999999999999876655444


Q ss_pred             HHHHHHHhccc----------------------ccCCCC------------------CCCCHHHHHHHHHhcccCCCCCC
Q 019433          211 RKTIDRIRNVQ----------------------YFLPDY------------------VRVSADCRHLLSQIFVADPSKRI  250 (341)
Q Consensus       211 ~~~~~~~~~~~----------------------~~~~~~------------------~~~s~~~~~li~~~L~~dp~~R~  250 (341)
                      ...........                      ..+|..                  ...++.+.+||.+||+.||.+||
T Consensus       269 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  348 (360)
T 3llt_A          269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRP  348 (360)
T ss_dssp             HHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCC
Confidence            33322111000                      001110                  01236788999999999999999


Q ss_pred             ChhHHhcCCccC
Q 019433          251 PIPEIKKHPWFL  262 (341)
Q Consensus       251 s~~e~l~hp~~~  262 (341)
                      |+.|+|+||||+
T Consensus       349 ta~elL~hp~f~  360 (360)
T 3llt_A          349 SPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHTTSGGGC
T ss_pred             CHHHHhcCcccC
Confidence            999999999994

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-53  Score=397.57  Aligned_cols=257  Identities=35%  Similarity=0.588  Sum_probs=204.6

Q ss_pred             CCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHH-hcCCCCCeeeEEEEEEc----CCEEEE
Q 019433            3 ERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLLT----PTHLAI   76 (341)
Q Consensus         3 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~----~~~~~i   76 (341)
                      ++|.+. +.||+|+||+||+|.++.+++.||||++..    .....+|+.++ +..+||||++++++|..    ...+|+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            467776 689999999999999999999999999864    34577888876 45689999999999875    567999


Q ss_pred             EEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCC
Q 019433           77 VMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL  153 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~  153 (341)
                      |||||.||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999997753  599999999999999999999999999999999999998732 23499999999986554


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--ccCCCCCCCC
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVS  231 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s  231 (341)
                      .......+||+.|+|||++.+..++. ++|||||||++|+|++|..||...............+....  +..+.+..++
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSS-HHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCCC-cccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            44556678999999999998877765 48999999999999999999976543221111112222222  2334456799


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +++.+||++||+.||.+|||+.++++||||.+.
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-53  Score=392.99  Aligned_cols=260  Identities=25%  Similarity=0.419  Sum_probs=217.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|..++..++||||++++++|.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987532    23345788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC-
Q 019433           79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ-  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~-  156 (341)
                      ||++||+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCcc
Confidence            999999999999875 47999999999999999999999999999999999999998877  99999999975433222 


Q ss_pred             -CCCccCCCCccccccccc-------cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC-C
Q 019433          157 -PKSTVGTPAYIAPEVLAR-------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-Y  227 (341)
Q Consensus       157 -~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~  227 (341)
                       ....+||+.|+|||++.+       ..++ .++|||||||++|+|++|..||...+....+..+......  ..+|. .
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~  295 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH--LSLPLVD  295 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--CCCC---
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--cCCCccc
Confidence             234689999999999873       3444 5599999999999999999999886655554444332221  22232 2


Q ss_pred             CCCCHHHHHHHHHhcccCCCCC---CChhHHhcCCccCCCCChh
Q 019433          228 VRVSADCRHLLSQIFVADPSKR---IPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R---~s~~e~l~hp~~~~~~~~~  268 (341)
                      ..+|+++.+||++||+ +|.+|   ++++++++||||.......
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~  338 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDG  338 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTT
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            4689999999999999 99998   5999999999997654443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-53  Score=390.82  Aligned_cols=259  Identities=30%  Similarity=0.495  Sum_probs=212.0

Q ss_pred             CCccc--cceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEP--VKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ..|++  .+.||+|+||.||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E  166 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME  166 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            34544  568999999999999999999999999987643 334578899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+....+||+|||+++.........
T Consensus       167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred             CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence            99999999888654 46999999999999999999999999999999999999954444459999999998655444455


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..+...  ......+.+..+++++.+||
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--RWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCSCSGGGTTSCHHHHHHH
T ss_pred             cccCCCcEeChhhccCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--cCCCChhhhccCCHHHHHHH
Confidence            668999999999998776654 589999999999999999999887655444433322  11111223357899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+||+.||.+|||+.++++||||...
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999999999543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.5e-53  Score=381.88  Aligned_cols=259  Identities=33%  Similarity=0.603  Sum_probs=198.6

Q ss_pred             CCcccc---ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPV---KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.   +.||+|+||+||+|.++.+++.||||++...  ......+|+.+++.+. ||||+++++++.+....|+||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            467765   7899999999999999999999999998754  3467789999999997 999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCccCCCC-CCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      ||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++.... ...
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            99999999999999889999999999999999999999999999999999999976542 2499999999974332 223


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHHHHHhcccccCCC--CCCCC
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFLPD--YVRVS  231 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~s  231 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||......   .........+.......+.  +..+|
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCCH-HHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            34567899999999998877765 489999999999999999999764331   1122334444443333322  24689


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-52  Score=394.91  Aligned_cols=262  Identities=26%  Similarity=0.371  Sum_probs=216.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC------CCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL------RHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l------~hp~iv~l~~~~~~~~~~~   75 (341)
                      ..||++++.||+|+||+||+|.+..+++.||||++.........+.+|+.+++.+      +|+||+++++++.....++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            5789999999999999999999999999999999987665566778888888766      6789999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||++...  
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~--  252 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--  252 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET--
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec--
Confidence            9999996 58988887654  499999999999999999999999999999999999999877656999999999742  


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc----------
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF----------  223 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------  223 (341)
                      .......+||+.|+|||++.+..++. ++|||||||++|+|++|.+||........+..+..........          
T Consensus       253 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~  331 (429)
T 3kvw_A          253 HQRVYTYIQSRFYRAPEVILGARYGM-PIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN  331 (429)
T ss_dssp             TCCCCSSCSCGGGCCHHHHHTBCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred             CCcccccCCCCCccChHHHhCCCCCc-hHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence            33445678999999999999888765 4999999999999999999998877666555544332111000          


Q ss_pred             ------CC-----------------------------C--------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCc
Q 019433          224 ------LP-----------------------------D--------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       224 ------~~-----------------------------~--------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  260 (341)
                            .|                             .        ....++.+.+||++||+.||.+|||+.|+|+|||
T Consensus       332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw  411 (429)
T 3kvw_A          332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPW  411 (429)
T ss_dssp             HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChh
Confidence                  00                             0        0123788999999999999999999999999999


Q ss_pred             cCCCCCh
Q 019433          261 FLKNLPK  267 (341)
Q Consensus       261 ~~~~~~~  267 (341)
                      |.+..++
T Consensus       412 ~~~~~~~  418 (429)
T 3kvw_A          412 LRRRLPK  418 (429)
T ss_dssp             TC-----
T ss_pred             hccCCCC
Confidence            9876554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.9e-52  Score=369.53  Aligned_cols=258  Identities=41%  Similarity=0.729  Sum_probs=214.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++.+.||+|+||.||+|.++.+++.||||++...    ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            37899999999999999999999999999999998653    23345788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence            999999999999988889999999999999999999999999999999999999988776  999999998765444444


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....||+.|+|||++.+..+.+.++||||||+++|+|++|..||........    ...+.......|.  .++..+.+|
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~l~~l  241 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----FKKIRGGVFYIPE--YLNRSVATL  241 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCcccCch--hcCHHHHHH
Confidence            5667999999999998877655669999999999999999999987543322    2233333333333  578999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      |.+||+.||.+|||+.++++||||.+..+.
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCchh
Confidence            999999999999999999999999776653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.6e-53  Score=382.33  Aligned_cols=259  Identities=26%  Similarity=0.447  Sum_probs=208.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||+||+|.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            689999999999999999999999999999999865432  122455799999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~  158 (341)
                      +.+ +|..++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... .....
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred             ccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence            975 8888877644 5999999999999999999999999999999999999988776  99999999874332 22234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cCC------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLP------------  225 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------  225 (341)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||..................... .++            
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            4578999999999987554456699999999999999999999887665555544443221110 000            


Q ss_pred             -----------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          226 -----------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       226 -----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                 ....+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence                       113578999999999999999999999999999999644

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.4e-52  Score=387.48  Aligned_cols=292  Identities=27%  Similarity=0.398  Sum_probs=216.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPT------   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------   72 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999999999999999999987643   22346789999999999999999999998765      


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+++||||+.+ +|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence            78999999975 7877775  45999999999999999999999999999999999999998776  9999999997544


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-----------  221 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  221 (341)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+..++.......           
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            4434456789999999999988777655 8999999999999999999988765544444332111000           


Q ss_pred             ----ccCCCCC---------------------CCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhh
Q 019433          222 ----YFLPDYV---------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTN  276 (341)
Q Consensus       222 ----~~~~~~~---------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~  276 (341)
                          ...+.+.                     ..++++.+||.+||+.||.+|||+.++|+||||...............
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~  337 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPK  337 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCC
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCCCCC
Confidence                0001000                     125678999999999999999999999999999766554322211111


Q ss_pred             hhhcCCCCCCCCHHHHHHHHHHh
Q 019433          277 YKEAGRDQPTQSVEEIMRIIQEA  299 (341)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~  299 (341)
                      ......+....+.+++.+++...
T Consensus       338 ~~~~~~~~~~~~~~~~~~~~~~~  360 (371)
T 2xrw_A          338 IPDKQLDEREHTIEEWKELIYKE  360 (371)
T ss_dssp             CCTTTTCCCCCCHHHHHHHHHHH
T ss_pred             CCChhhccccCcHHHHHHHHHHH
Confidence            12222334456677777665543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-52  Score=387.43  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=211.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----------   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----------   70 (341)
                      .++|++++.||+|+||+||+|.+..+|+.||||++......   ..+|+.+++.++||||++++++|..           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            57999999999999999999999999999999998765332   3479999999999999999999844           


Q ss_pred             ---------------------------CCEEEEEEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 019433           71 ---------------------------PTHLAIVMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSME  119 (341)
Q Consensus        71 ---------------------------~~~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~  119 (341)
                                                 ...+++||||+++ +|...+.    ....+++..++.++.||+.||.|||++|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                       3448999999985 6655553    4568999999999999999999999999


Q ss_pred             CeeCCCCCCCEEecC-CCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC
Q 019433          120 ICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA  198 (341)
Q Consensus       120 iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~  198 (341)
                      |+||||||+|||++. ++.  +||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|.
T Consensus       162 i~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  239 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK  239 (383)
T ss_dssp             EECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence            999999999999973 454  99999999986555556667789999999999987664455699999999999999999


Q ss_pred             CCCCCCCChhHHHHHHHHHhccc-------------ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHH
Q 019433          199 YPFEDPEDPRNFRKTIDRIRNVQ-------------YFLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEI  255 (341)
Q Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~  255 (341)
                      .||........+..++.......             ..++.          ...+++++.+||.+||+.||.+|||+.|+
T Consensus       240 ~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  319 (383)
T 3eb0_A          240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEA  319 (383)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            99998777666665554322110             01111          12478899999999999999999999999


Q ss_pred             hcCCccCC
Q 019433          256 KKHPWFLK  263 (341)
Q Consensus       256 l~hp~~~~  263 (341)
                      ++||||..
T Consensus       320 l~hp~f~~  327 (383)
T 3eb0_A          320 MAHPFFDH  327 (383)
T ss_dssp             HTSGGGHH
T ss_pred             hcCHHHHH
Confidence            99999953

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-52  Score=400.26  Aligned_cols=259  Identities=28%  Similarity=0.400  Sum_probs=220.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+|+.+++.++||||++++++|.....+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999986532    33456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCC
Confidence            999999999998764    36999999999999999999999999999999999999998877  999999999754333


Q ss_pred             CC-CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 SQ-PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      .. ....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...............+......+|  ..+|+.
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~~-~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~  419 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYDF-SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPA  419 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred             CcccccccCCccccChhhhcCCCCCh-HHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHH
Confidence            22 23458999999999999887765 489999999999999999999875433233334444444444444  368999


Q ss_pred             HHHHHHHhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          234 CRHLLSQIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      +.+||++||++||.+||+     +.++++||||.....
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence            999999999999999996     589999999976543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6e-52  Score=371.54  Aligned_cols=263  Identities=34%  Similarity=0.527  Sum_probs=220.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----------cccHHHHHHHHHHhcCC-CCCeeeEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----------KIDENVQREIINHRSLR-HPNIIRFKEVLL   69 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~   69 (341)
                      +.++|++.+.||+|+||.||+|.++.+++.||||++....          ...+.+.+|+.+++.+. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3579999999999999999999999999999999987542          12345778999999995 999999999999


Q ss_pred             cCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           70 TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        70 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      .....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~  172 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC  172 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchh
Confidence            99999999999999999999998889999999999999999999999999999999999999988776  9999999997


Q ss_pred             CCCCCCCCCCccCCCCccccccccc------cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLAR------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      ............||+.|+|||++.+      ..+ +.++|||||||++|+|++|..||...............  .....
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~  249 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFG  249 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCC
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC--CcccC
Confidence            6544444556789999999999852      233 44589999999999999999999876543333222211  12222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      .+.+..++..+.+||.+||+.||.+|||+.++++||||.+....+
T Consensus       250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            344457899999999999999999999999999999998765443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-52  Score=385.69  Aligned_cols=256  Identities=32%  Similarity=0.561  Sum_probs=216.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---------ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|++.+.||+|+||.||+|.++.+|+.||||++.....         ..+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999876432         134577899999998 7999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..++||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence            99999999999999999988889999999999999999999999999999999999999998776  9999999987655


Q ss_pred             CCCCCCCccCCCCcccccccccc------ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      .........||+.|+|||++.+.      .+ +.++|||||||++|+|++|..||........+..+...  ......+.
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  328 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEG--QYQFSSPE  328 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCHHH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCcc
Confidence            44455667899999999998643      34 34589999999999999999999875543333222111  11222233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +..+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       329 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          329 WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            4578999999999999999999999999999999963

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6e-52  Score=380.37  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=212.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc--------C
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT--------P   71 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--------~   71 (341)
                      ++|++++.||+|+||+||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            68999999999999999999999999999999986543   234578899999999999999999999987        4


Q ss_pred             CEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           72 THLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      +.+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~  173 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA  173 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEE
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhccc
Confidence            578999999986 66666654 357999999999999999999999999999999999999988776  99999999864


Q ss_pred             CC-----CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cC
Q 019433          151 GL-----LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL  224 (341)
Q Consensus       151 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  224 (341)
                      ..     .........||+.|+|||++.+....+.++|||||||++|+|++|.+||...........+......... .+
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            32     1222345678999999999987654456699999999999999999999887665554444333222111 11


Q ss_pred             CCCC-------------------------CCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          225 PDYV-------------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       225 ~~~~-------------------------~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +...                         ..++.+.+||.+||+.||.+|||+.|+|+||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            1110                         0267899999999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.5e-53  Score=389.02  Aligned_cols=290  Identities=23%  Similarity=0.388  Sum_probs=211.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------C
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP------T   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~   72 (341)
                      .+||++++.||+|+||+||+|.+..+|+.||||++....   .....+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            479999999999999999999999999999999987542   2335677999999999999999999999754      5


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+++|++++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~  183 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA  183 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence            689999999 6799888765 67999999999999999999999999999999999999998776  9999999997432


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc----------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY----------  222 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  222 (341)
                        ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+.........          
T Consensus       184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          184 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             --ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence              23455689999999999987444455699999999999999999999887766555554433211100          


Q ss_pred             ------cCCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCC
Q 019433          223 ------FLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQ  287 (341)
Q Consensus       223 ------~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (341)
                            .++.         +...++.+.+||.+||++||.+|||+.++|+||||.+...+....... .+.. .......
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~-~~~~-~~~~~~~  339 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYDQ-SLESRDL  339 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-CCCG-GGSSCCC
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-CCCc-chhhccC
Confidence                  0010         124688999999999999999999999999999998765443211111 1111 1122345


Q ss_pred             CHHHHHHHHHHh
Q 019433          288 SVEEIMRIIQEA  299 (341)
Q Consensus       288 ~~~~~~~~~~~~  299 (341)
                      ..+++.+++.+.
T Consensus       340 ~~~~~~~~~~~e  351 (367)
T 2fst_X          340 LIDEWKSLTYDE  351 (367)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHH
Confidence            677777776654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.8e-52  Score=367.43  Aligned_cols=259  Identities=37%  Similarity=0.640  Sum_probs=220.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            68999999999999999999999999999999986543  3346788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---CCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~~~  157 (341)
                      +++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence            999999999887778999999999999999999999999999999999999988776  999999998643211   223


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|..||...........   .........+.+..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHHH
Confidence            4567899999999998877655669999999999999999999987654322211   1222222334445789999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |.+||+.||.+|||+.++++||||.+...
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999999977654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.2e-53  Score=395.86  Aligned_cols=259  Identities=34%  Similarity=0.555  Sum_probs=206.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHRSLRHPNIIRFKEVLLTPT   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~   72 (341)
                      .++|++.+.||+|+||+||+|.+..+++.||||++....         .....+.+|+.+++.++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            478999999999999999999999999999999986532         112247899999999999999999999754 5


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSG  151 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~  151 (341)
                      ..++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5799999999999999998888999999999999999999999999999999999999997543 245999999999865


Q ss_pred             CCCCCCCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDY  227 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (341)
                      .........+||+.|+|||++.+  ....+.++|||||||++|+|++|..||........+...+.   ......  +.+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~  369 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVW  369 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHH
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhh
Confidence            54444556789999999999864  22223458999999999999999999987655434333322   222111  123


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            4689999999999999999999999999999999653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.2e-53  Score=386.87  Aligned_cols=260  Identities=30%  Similarity=0.539  Sum_probs=212.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC------ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG------KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      +++|++++.||+|+||+||+|.++.++..||+|++...      ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            57899999999999999999999999999999998653      233467889999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 019433           76 IVMEYAAGGELFARICS----------------------------------------AGRFSEDEARFFFQQLISGVSYC  115 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~aL~~L  115 (341)
                      +|||||++|+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998842                                        11246788999999999999999


Q ss_pred             HHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-----CCCCccCCCCccccccccc--cccCCCccchhhHH
Q 019433          116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCG  188 (341)
Q Consensus       116 H~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG  188 (341)
                      |++||+||||||+||+++.++...+||+|||++.......     ......||+.|+|||++.+  ..+ +.++||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG  263 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAG  263 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHHHH
Confidence            9999999999999999987765569999999987422111     2345679999999999875  344 4559999999


Q ss_pred             HHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          189 VTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       189 ~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |++|+|++|..||...............  ......+.+..+++.+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            9999999999999887665444333221  1222233444689999999999999999999999999999999654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5e-52  Score=368.81  Aligned_cols=251  Identities=34%  Similarity=0.635  Sum_probs=214.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            68999999999999999999999999999999986532    23456889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++.... .....
T Consensus        89 e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~-~~~~~  165 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRT  165 (279)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC-------
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCC-ccccc
Confidence            99999999999998889999999999999999999999999999999999999988776  9999999886432 22334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++.+ +||||||+++|+|++|..||........    ...+.......|.  .+++.+.+||
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li  238 (279)
T 3fdn_A          166 DLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQET----YKRISRVEFTFPD--FVTEGARDLI  238 (279)
T ss_dssp             --CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCCT--TSCHHHHHHH
T ss_pred             ccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHH----HHHHHhCCCCCCC--cCCHHHHHHH
Confidence            5679999999999988776554 8999999999999999999987554322    2333333333443  5899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      .+||+.||.+|||+.++++||||..
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HHHhccChhhCCCHHHHhhCccccC
Confidence            9999999999999999999999943

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.3e-52  Score=382.73  Aligned_cols=264  Identities=27%  Similarity=0.427  Sum_probs=217.9

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~   73 (341)
                      +.+||++++.||+|+||.||+|.+..+++.||||++....  .....+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            4579999999999999999999999999999999987533  2235688999999999999999999999765     46


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .++||||+.+ +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP  180 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCC
Confidence            8999999975 89888865 56999999999999999999999999999999999999988777  99999999974332


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-------
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------  222 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  222 (341)
                      ..    .....+||+.|+|||++.+....+.++|||||||++|+|++|..||........+..+.........       
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            21    1344589999999999776654455699999999999999999999887766666555432211100       


Q ss_pred             ---------cCCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          223 ---------FLPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       223 ---------~~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                               ..+.         ...+++++.+||.+||+.||.+|||+.++|+||||.+.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~  324 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  324 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcc
Confidence                     0010         135789999999999999999999999999999998775543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-52  Score=380.05  Aligned_cols=262  Identities=28%  Similarity=0.472  Sum_probs=215.2

Q ss_pred             CCCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +++|.+. +.||+|+||+||+|.++.+++.||+|++....   .....+.+|+.+++.+ .||||+++++++......++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            5688888 89999999999999999999999999987643   2345788999999988 56999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCC
Q 019433           77 VMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLL  153 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~  153 (341)
                      ||||+.+++|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++... ...+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999988553  5799999999999999999999999999999999999998621 23499999999986544


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ........||+.|+|||++.+..++. ++|||||||++|+|++|..||...............  ......+.+..+++.
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQL  263 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHH
Confidence            44455678999999999998877765 489999999999999999999876654433332211  222233344578999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +.+||.+||+.||.+|||+.++|+||||.+...
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            999999999999999999999999999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.9e-52  Score=374.12  Aligned_cols=256  Identities=34%  Similarity=0.610  Sum_probs=215.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            4689999999999999999999999999999999876532 345688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe---cCCCCCCEEEeecCCccCCCCCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili---~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      +++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||++   +.++  .+||+|||++.... ....
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~--~~kl~Dfg~~~~~~-~~~~  164 (304)
T 2jam_A           88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS--KIMITDFGLSKMEQ-NGIM  164 (304)
T ss_dssp             CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC--CEEBCSCSTTCCCC-CBTT
T ss_pred             CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC--CEEEccCCcceecC-CCcc
Confidence            9999999999888899999999999999999999999999999999999999   4444  49999999987432 2223


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc--cCCCCCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--FLPDYVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~  235 (341)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|..||...........    +.....  ..+.+..+++.+.
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          165 STACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             HHHHSCCCBCCTTTBSSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHCCCCCCTTTTTTSCHHHH
T ss_pred             ccccCCCCccChHHhccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCccccccCCHHHH
Confidence            3456999999999998777654 59999999999999999999987654333322    222222  2233357899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +||.+||+.||.+|||+.++++||||....
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999999996543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3e-51  Score=371.41  Aligned_cols=257  Identities=27%  Similarity=0.461  Sum_probs=216.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      .|...+.||+|+||+||+|.++.+|+.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            37788899999999999999999999999999876433 34568899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCCcc
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKSTV  161 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~~~  161 (341)
                      +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++...... .......
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence            9999998754 57999999999999999999999999999999999999988776  999999998753322 2234568


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      ||+.|+|||++.+..++. ++|||||||++|+|++|..||............. .  ...........+++.+.+||.+|
T Consensus       203 gt~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-D--SPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-H--SSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-c--CCCCCcCccccCCHHHHHHHHHH
Confidence            999999999998877765 4899999999999999999998765433322211 1  11112233346899999999999


Q ss_pred             cccCCCCCCChhHHhcCCccCCCCCh
Q 019433          242 FVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       242 L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      |+.||.+|||+.++++||||.+...+
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~~~  304 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTGLP  304 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCCCG
T ss_pred             ccCChhhCcCHHHHhcChhhccCCCc
Confidence            99999999999999999999776543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-52  Score=371.69  Aligned_cols=256  Identities=34%  Similarity=0.614  Sum_probs=214.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            5789999999999999999999999999999999875421       246788999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC--CCCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a~~~~  152 (341)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  ...+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998888999999999999999999999999999999999999998765  2259999999997544


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (341)
                      .........||+.|+|||++.+..++. ++||||||+++|+|++|..||.........    ..+.......+  ....+
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          164 AGNEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETL----TNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCHHHHTTC
T ss_pred             CCCcccccCCCcCccCcceecCCCCCc-chhhhhHHHHHHHHHHCCCCCCCcchHHHH----HHhHhcccCCcchhcccC
Confidence            444445567999999999998777755 489999999999999999999876543322    22222222221  12467


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ++.+.+||.+||+.||.+|||+.++++||||.
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  270 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIK  270 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHH
Confidence            89999999999999999999999999999993

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-51  Score=372.79  Aligned_cols=249  Identities=22%  Similarity=0.272  Sum_probs=199.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc---HHHHHHHHHHhc-CCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRS-LRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~~~~-l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|+++++||+|+||+||+|.+..+++.||||++.......   .....|+..+.. .+||||+++++++...+.+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999999999999999976543222   234445544444 48999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      ||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 55888877664 46999999999999999999999999999999999999988776  999999998765544455


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ....||+.|+|||++.+ .++ .++|||||||++|+|++|..||.....       ...+............+++++.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~-~~~DiwslG~il~el~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYG-TAADVFSLGLTILEVACNMELPHGGEG-------WQQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCS-THHHHHHHHHHHHHHHHTCCCCSSHHH-------HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CCC-chhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHhccCCCcccccCCCHHHHHH
Confidence            56679999999999876 454 459999999999999999766654221       111221111111123689999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      |.+||+.||.+|||+.++++||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-51  Score=405.51  Aligned_cols=256  Identities=32%  Similarity=0.496  Sum_probs=223.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|.++.+++.||||++.+.    ....+.+..|..++..+ +||+|++++++|.+.+.+|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            5799999999999999999999999999999998753    23456778899998887 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~  156 (341)
                      |||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... ....
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCC
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcc
Confidence            999999999999998889999999999999999999999999999999999999998877  9999999997532 2334


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|+|||++.+..++. ++|||||||++|+|++|.+||...+....    ...+......+|.  .+++++.+
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~-~~DvwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~  571 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGK-SVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVA  571 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBST-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHSSCCCCCT--TSCHHHHH
T ss_pred             cccccCCCcccCHhhhcCCCCCc-cceEechHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHH
Confidence            45678999999999998888865 48999999999999999999987654333    3344444445554  68999999


Q ss_pred             HHHHhcccCCCCCCCh-----hHHhcCCccCCCCCh
Q 019433          237 LLSQIFVADPSKRIPI-----PEIKKHPWFLKNLPK  267 (341)
Q Consensus       237 li~~~L~~dp~~R~s~-----~e~l~hp~~~~~~~~  267 (341)
                      ||++||+.||.+||++     +++++||||......
T Consensus       572 li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~  607 (674)
T 3pfq_A          572 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE  607 (674)
T ss_dssp             HHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred             HHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence            9999999999999998     999999999765443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-51  Score=378.12  Aligned_cols=260  Identities=28%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++++.||+|+||.||+|.+..+|+.||||++....      ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            478999999999999999999999999999999987532      12346789999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-
Q 019433           76 IVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-  153 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-  153 (341)
                      +||||+.+ +|...+.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++.... 
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCC
Confidence            99999986 8888776543 6999999999999999999999999999999999999988776  99999999975432 


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cCCC------
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FLPD------  226 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~------  226 (341)
                      ........||+.|+|||++.+....+.++|||||||++|+|++|.+||........+..+......... .++.      
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence            223445689999999999977654556699999999999999999999887766666655554322110 1111      


Q ss_pred             ---------------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          227 ---------------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       227 ---------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                     ...+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                           13467899999999999999999999999999999764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8e-52  Score=382.48  Aligned_cols=290  Identities=26%  Similarity=0.400  Sum_probs=222.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE---
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL---   74 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~---   74 (341)
                      +.++|++.+.||+|+||+||+|.++.+|+.||||++.....   ....+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            35799999999999999999999999999999999876432   235678999999999999999999999877654   


Q ss_pred             ---EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           75 ---AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        75 ---~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                         ++||||+. ++|...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus       120 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~  194 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHA  194 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC---
T ss_pred             eeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccc
Confidence               99999997 5887776  345999999999999999999999999999999999999998776  999999999743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc---------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------  222 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  222 (341)
                        ........||+.|+|||++.+....+.++|||||||++|+|++|..||...+....+............         
T Consensus       195 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 --DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             --ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence              233455688999999999987444445599999999999999999999887665555444332211000         


Q ss_pred             -------cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCC
Q 019433          223 -------FLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT  286 (341)
Q Consensus       223 -------~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (341)
                             ..+         ....+++.+.+||.+||+.||.+|||+.++|+||||.....+.........+.. ......
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~-~~~~~~  351 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDD-SLEHEK  351 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCC-TTSSCC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCc-chhhcc
Confidence                   000         013578999999999999999999999999999999765443221111111111 122334


Q ss_pred             CCHHHHHHHHHH
Q 019433          287 QSVEEIMRIIQE  298 (341)
Q Consensus       287 ~~~~~~~~~~~~  298 (341)
                      .+..++.+.+.+
T Consensus       352 ~~~~~~~~~~~~  363 (371)
T 4exu_A          352 LTVDEWKQHIYK  363 (371)
T ss_dssp             CCHHHHHHHHHH
T ss_pred             cchHHHHHHHHH
Confidence            456677666654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5e-52  Score=386.74  Aligned_cols=257  Identities=28%  Similarity=0.412  Sum_probs=209.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC------EEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT------HLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~------~~~   75 (341)
                      +.+|++++.||+|+||+||+|.+..+++ +|+|++......   ..+|+.+++.++||||++++++|....      .++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4689999999999999999999987766 888887654332   237999999999999999999996543      388


Q ss_pred             EEEeecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec-CCCCCCEEEeecCCccCC
Q 019433           76 IVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        76 iv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~-~~~~~~ikL~Dfg~a~~~  151 (341)
                      +||||+.++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.  +||+|||+++..
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~  192 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV--LKLIDFGSAKIL  192 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE--EEECCCTTCEEC
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc--EEEeeCCCcccc
Confidence            999999875443322   2356799999999999999999999999999999999999998 5555  999999999865


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----------  221 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------  221 (341)
                      ..........||+.|+|||++.+....+.++|||||||++|+|++|..||........+..++.......          
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            5555566778999999999998765445669999999999999999999998776666665554321110          


Q ss_pred             ---ccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          222 ---YFLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       222 ---~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                         ..++.          ...+++++.+||.+||++||.+|||+.++++||||...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence               01111          12478999999999999999999999999999999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-51  Score=373.94  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=214.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||.||+|.+..+|+.||||++......   .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            6899999999999999999999999999999998654332   3456789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~  158 (341)
                      |+.+++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... .....
T Consensus       105 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             CCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC-----------
T ss_pred             cCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccccC
Confidence            9999999888887888999999999999999999999999999999999999988776  99999999864322 22334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---------------ccc
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---------------QYF  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  223 (341)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||........+..........               ...
T Consensus       183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (331)
T 4aaa_A          183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR  262 (331)
T ss_dssp             -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCC
T ss_pred             CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccccc
Confidence            56799999999999876444566999999999999999999998877655554443322110               001


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+.          ...+++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          263 LPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             CccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            111          12578999999999999999999999999999999654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.2e-51  Score=372.17  Aligned_cols=258  Identities=23%  Similarity=0.400  Sum_probs=212.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEc--CCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLT--PTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~--~~~~~iv~   78 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++...  ..+.+.+|+.+++.++ ||||+++++++..  ....++||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            46899999999999999999999999999999998754  3567889999999997 9999999999987  67799999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+.+++|..++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++.........
T Consensus       113 e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             ECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCC
T ss_pred             eccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccc
Confidence            9999999988874   4899999999999999999999999999999999999986652 39999999997655555556


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-hHHHHHHHHH---------hccccc-----
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-RNFRKTIDRI---------RNVQYF-----  223 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-~~~~~~~~~~---------~~~~~~-----  223 (341)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||...... ..+.......         ......     
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            6789999999999987554456699999999999999999999654432 2222211111         000000     


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          224 -----------------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       224 -----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                       ......+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                             011123799999999999999999999999999999997654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=373.86  Aligned_cols=256  Identities=25%  Similarity=0.359  Sum_probs=210.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--EEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--~~~i   76 (341)
                      ++++|++.+.||+|+||+||+|.+..+++.||||++....  ...+.+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4689999999999999999999999999999999987543  33466789999999999999999999998765  7899


Q ss_pred             EEeecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe----cCCCCCCEEEeecCCcc
Q 019433           77 VMEYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL----DGSPQPRLKICDFGYSK  149 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili----~~~~~~~ikL~Dfg~a~  149 (341)
                      ||||+++++|..++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.  +||+|||+++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~--~kL~Dfg~a~  164 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAAR  164 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEE--EEECCCTTCE
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCce--EEEccCCCce
Confidence            9999999999999976543   9999999999999999999999999999999999998    54444  9999999998


Q ss_pred             CCCCCCCCCCccCCCCcccccccc--------ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLA--------RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ  221 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (341)
                      ............||+.|+|||++.        +..++ .++|||||||++|+|++|..||............+..+....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             ecCCCCceeecccCCCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            655555555678999999999986        34444 459999999999999999999976554443333333332211


Q ss_pred             c-------------------cCCCC----CCCCHHHHHHHHHhcccCCCCCCChhHHhcCC
Q 019433          222 Y-------------------FLPDY----VRVSADCRHLLSQIFVADPSKRIPIPEIKKHP  259 (341)
Q Consensus       222 ~-------------------~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  259 (341)
                      .                   ..+..    ..++..+.+||++||+.||++|||+.|+|+||
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            1                   11111    12446788999999999999999999999996

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-51  Score=364.56  Aligned_cols=250  Identities=33%  Similarity=0.645  Sum_probs=217.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            6899999999999999999999999999999998653    223457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++..... ....
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~  170 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRRR  170 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCBC
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-cccc
Confidence            99999999999998889999999999999999999999999999999999999988776  99999999864322 2334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...|++.|+|||++.+..++.. +||||||+++|+|++|..||.........    ..+......+|  ..++..+.+||
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li  243 (284)
T 2vgo_A          171 TMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKDLI  243 (284)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHHH
T ss_pred             cccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHHHH
Confidence            5679999999999988777654 89999999999999999999876543332    22333333333  36899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      .+||+.||.+|||+.++++||||.
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHHhhcCHhhCCCHHHHhhCHHHH
Confidence            999999999999999999999994

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.8e-52  Score=378.84  Aligned_cols=256  Identities=27%  Similarity=0.401  Sum_probs=213.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.+..+++.||||++......    .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4699999999999999999999999999999998754322    246789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      ||+.| +|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++....   ..
T Consensus       134 e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~---~~  207 (348)
T 1u5q_A          134 EYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PA  207 (348)
T ss_dssp             ECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SB
T ss_pred             ecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecC---CC
Confidence            99974 7777764 4567999999999999999999999999999999999999998776  9999999987532   23


Q ss_pred             CCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          158 KSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      ....||+.|+|||++.   +..++ .++|||||||++|+|++|..||........+....    ...........+++.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEYF  282 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCCCCCCTTSCHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCCCCCCHHH
Confidence            4568999999999985   34444 45999999999999999999998765543333222    1111112234689999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCChhH
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI  269 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~  269 (341)
                      .+||.+||+.||.+|||+.++++||||....++..
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~  317 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV  317 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTH
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChhhhccCCcch
Confidence            99999999999999999999999999977665543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.7e-52  Score=369.57  Aligned_cols=256  Identities=38%  Similarity=0.625  Sum_probs=218.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....   ...+.+.+|+.+++.++||||+++++++......++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            468999999999999999999999999999999986532   34567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      ||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||++.........
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~  180 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence            9999999999998888999999999999999999999999999999999999997644 345999999998754444444


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc--cccCCCCCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--QYFLPDYVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~  235 (341)
                      ....||+.|+|||++.+. ++ .++||||||+++|+|++|..||.........    ..+...  ....+.+..+++++.
T Consensus       181 ~~~~~~~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          181 KDRIGTAYYIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDIL----KRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             SCHHHHHTTCCHHHHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             ccccCcccccChHHhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCchhhhhcCHHHH
Confidence            556789999999998764 44 4589999999999999999999876543322    222222  223344567899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +||.+||+.||.+|||+.++++||||.+
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999999999953

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=364.17  Aligned_cols=254  Identities=31%  Similarity=0.535  Sum_probs=194.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....    ...+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            57999999999999999999999999999999986532    23467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CC
Q 019433           79 EYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~  156 (341)
                      ||+++++|..++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++...... ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC-----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCc
Confidence            999999999999775 57999999999999999999999999999999999999988776  999999998753322 22


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..+..+ +|||||||++|+|++|..||..........    .........|  ..++.++.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~  241 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEMP--SFLSIEAKD  241 (278)
T ss_dssp             -----------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCCC--TTSCHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCCc--cccCHHHHH
Confidence            334678999999999987776554 899999999999999999998755432221    1112222223  358999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||.+||+.||.+|||+.++++||||.+..
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999997653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-51  Score=386.05  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=209.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------CEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP------THLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~~~~i   76 (341)
                      .+|++++.||+|+||+||+|.++.+|+.||||++.....   ...+|+.+++.++||||++++++|...      ..+++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            479999999999999999999999999999999876432   234799999999999999999998542      24789


Q ss_pred             EEeecCCCchHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           77 VMEYAAGGELFARIC----SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        77 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ||||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcc
Confidence            9999986 5555443    3567999999999999999999999999999999999999985432 38999999998655


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc------------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------  220 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  220 (341)
                      ........+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+.+++..+...            
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            45555667899999999999776444556999999999999999999999877666666655432111            


Q ss_pred             -cccCCC----------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          221 -QYFLPD----------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       221 -~~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                       .+.+|.          ...+++++.+||.+||++||.+|||+.|+++||||..
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcc
Confidence             111121          1246899999999999999999999999999999954

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-51  Score=365.84  Aligned_cols=255  Identities=31%  Similarity=0.507  Sum_probs=219.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            578999999999999999999999999999999987643    2335678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      |||+.+++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++..... ...
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccc
Confidence            999999999999988889999999999999999999999999999999999999998776  99999999875332 223


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..++. ++||||||+++|+|++|..||........    ...+.......+.  .+++.+.+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~  244 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIPK--HINPVAAS  244 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCT--TSCHHHHH
T ss_pred             cccccCCCCcCCcchhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCCcc--ccCHHHHH
Confidence            34467999999999998777654 48999999999999999999987554332    2233333333343  68999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||.+||+.||.+|||+.++++||||....
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHcccChhhCcCHHHHhhChheecCC
Confidence            99999999999999999999999996553

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-51  Score=379.80  Aligned_cols=258  Identities=29%  Similarity=0.448  Sum_probs=214.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++++.||+|+||+||+|.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            578999999999999999999999999999999987642  234568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |+++++|.+++.....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.  +||+|||++.... .....
T Consensus       112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~-~~~~~  188 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMAN  188 (360)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHC--
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCcccc-ccccc
Confidence            999999999999888999999999999999999999996 9999999999999998776  9999999986321 12334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHH---------------------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR---------------------------  211 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~---------------------------  211 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|++|..||..........                           
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          189 SFVGTRSYMSPERLQGTHYSV-QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             --CCCCTTCCHHHHTTCCCSH-HHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             CCCCCCCeECHHHHcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            567999999999998877754 4899999999999999999997654322110                           


Q ss_pred             -----------HHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          212 -----------KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       212 -----------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                 .....+............++.++.+||.+||+.||.+|||+.++++||||.+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence                       1111111111111122357899999999999999999999999999999954

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-51  Score=378.73  Aligned_cols=259  Identities=31%  Similarity=0.522  Sum_probs=216.4

Q ss_pred             CCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc-----cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK-----KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~   73 (341)
                      ++|++++.||+|+||+||+|++.   .+++.||||++....     ...+.+.+|+.+++.+ +||||+++++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            68999999999999999999984   589999999986532     2345677899999998 69999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA  211 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeeccc
Confidence            9999999999999999998889999999999999999999999999999999999999988776  99999999874322


Q ss_pred             C--CCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          154 H--SQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       154 ~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .  ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...............+.......+  ..+
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  289 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEM  289 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTS
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--ccc
Confidence            1  1223457999999999998632 2345689999999999999999999765443333344444333333333  368


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      +..+.+||.+||+.||.+||     |+.++++||||....
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            99999999999999999999     999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-51  Score=373.90  Aligned_cols=255  Identities=31%  Similarity=0.514  Sum_probs=219.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999987643    2345678899999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      |||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++..... ...
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCccc
Confidence            999999999999988889999999999999999999999999999999999999998776  99999999875332 223


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..+.. ++|||||||++|+|++|..||.........    ..+.......+.  .+++.+.+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~  270 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSIPK--HINPVAAS  270 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCT-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCT--TSCHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHHHCcCCCCCCCHHHHH----HHHhcCCCCCCc--cCCHHHHH
Confidence            34567999999999998877654 489999999999999999999875543322    223333333443  68999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||.+||+.||.+|||+.++++||||....
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999999996654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8e-52  Score=375.81  Aligned_cols=251  Identities=24%  Similarity=0.360  Sum_probs=203.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--------
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--------   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--------   72 (341)
                      ++|++++.||+|+||+||+|.++.+|+.||||++....  ...+.+.+|+.+++.++||||++++++|....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            68999999999999999999999999999999987533  33467889999999999999999999986543        


Q ss_pred             -------------------------------------------------EEEEEEeecCCCchHHHHHhcCC---CCHHH
Q 019433           73 -------------------------------------------------HLAIVMEYAAGGELFARICSAGR---FSEDE  100 (341)
Q Consensus        73 -------------------------------------------------~~~iv~e~~~~~~L~~~l~~~~~---l~~~~  100 (341)
                                                                       ..++|||||++++|.+++.....   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987653   56667


Q ss_pred             HHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-------------CCCCCccCCCCcc
Q 019433          101 ARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-------------SQPKSTVGTPAYI  167 (341)
Q Consensus       101 ~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-------------~~~~~~~gt~~y~  167 (341)
                      ++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....             .......||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            9999999999999999999999999999999987776  999999998754332             1223457999999


Q ss_pred             ccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019433          168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPS  247 (341)
Q Consensus       168 aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~  247 (341)
                      |||++.+..++. ++|||||||++|+|++|..|+..      .............. ......++++.+||.+||+.||.
T Consensus       244 aPE~~~~~~~~~-~~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYSH-KVDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCCT-HHHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCcc-hhhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence            999998887755 48999999999999998766522      11222222222111 11234678899999999999999


Q ss_pred             CCCChhHHhcCCccCC
Q 019433          248 KRIPIPEIKKHPWFLK  263 (341)
Q Consensus       248 ~R~s~~e~l~hp~~~~  263 (341)
                      +|||+.++++||||.+
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999964

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.3e-51  Score=364.22  Aligned_cols=254  Identities=22%  Similarity=0.360  Sum_probs=211.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~----~~~~   74 (341)
                      +++|++.+.||+|+||+||+|.+..++..||+|++....   ...+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            356899999999999999999999999999999987543   233468899999999999999999999875    4668


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEec-CCCCCCEEEeecCCccCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLD-GSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~-~~~~~~ikL~Dfg~a~~~  151 (341)
                      ++||||+++++|.+++.....+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.  +||+|||++...
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~  182 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLK  182 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGC
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC--EEEeeCCCcccc
Confidence            999999999999999998889999999999999999999999999  99999999999997 4555  999999998643


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      . ........||+.|+|||++.+. ++ .++|||||||++|+|++|..||............   +.............+
T Consensus       183 ~-~~~~~~~~~t~~y~aPE~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~  256 (290)
T 1t4h_A          183 R-ASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAI  256 (290)
T ss_dssp             C-TTSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCC
T ss_pred             c-ccccccccCCcCcCCHHHHhcc-CC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH---HhccCCccccCCCCC
Confidence            2 2233456799999999988643 44 4599999999999999999999876654443322   222111111223577


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +++.+||.+||+.||.+|||+.++++||||.+
T Consensus       257 ~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            89999999999999999999999999999965

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-51  Score=378.60  Aligned_cols=260  Identities=24%  Similarity=0.377  Sum_probs=203.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-------EEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-------HLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-------~~~   75 (341)
                      ++|++.+.||+|+||+||+|.+..+++.||||++...........+++..++.++||||++++++|....       .++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            6899999999999999999999999999999999877666677888888889999999999999996543       389


Q ss_pred             EEEeecCCCchH---HHHHhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeeCCCCCCCEEecC-CCCCCEEEeecCCcc
Q 019433           76 IVMEYAAGGELF---ARICSAGRFSEDEARFFFQQLISGVSYCH--SMEICHRDLKLENTLLDG-SPQPRLKICDFGYSK  149 (341)
Q Consensus        76 iv~e~~~~~~L~---~~l~~~~~l~~~~~~~i~~qil~aL~~LH--~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~  149 (341)
                      +||||+.++.+.   ........+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.  +||+|||++.
T Consensus       103 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Dfg~a~  180 (360)
T 3e3p_A          103 VVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAK  180 (360)
T ss_dssp             EEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE--EEECCCTTCB
T ss_pred             EEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc--EEEeeCCCce
Confidence            999999875332   23334567999999999999999999999  999999999999999986 555  9999999998


Q ss_pred             CCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-------
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-------  222 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  222 (341)
                      ............||+.|+|||++.+....+.++|||||||++|+|++|..||........+............       
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence            6555555566789999999999977664456699999999999999999999987766555554433211100       


Q ss_pred             -------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          223 -------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       223 -------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                         ........++++.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                               000111256789999999999999999999999999999654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.7e-52  Score=374.89  Aligned_cols=258  Identities=35%  Similarity=0.583  Sum_probs=211.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---------KIDENVQREIINHRSLRHPNIIRFKEVLLTPT   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~   72 (341)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....         .....+.+|+.+++.++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            468999999999999999999999999999999986532         12235789999999999999999999987765


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSG  151 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~  151 (341)
                       .++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             899999999999999998888999999999999999999999999999999999999998654 245999999998754


Q ss_pred             CCCCCCCCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC-C-C
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-P-D  226 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~-~  226 (341)
                      ..........||+.|+|||++.   +..+ +.++|||||||++|+|++|..||........+...+..   ..... + .
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~  243 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEV  243 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHH
T ss_pred             ccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchh
Confidence            3222223456899999999974   2334 45599999999999999999999875544333333222   11111 1 1


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +..+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            23689999999999999999999999999999999654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.3e-51  Score=376.14  Aligned_cols=263  Identities=22%  Similarity=0.346  Sum_probs=206.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc------------cHHHHHHHHHHhcCCCCCeeeEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI------------DENVQREIINHRSLRHPNIIRFKEVL   68 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~ei~~~~~l~hp~iv~l~~~~   68 (341)
                      +.++|++.+.||+|+||.||+|.+.. ++.||||++......            .+.+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            46899999999999999999999975 999999998653211            26788999999999999999999998


Q ss_pred             Ec-----CCEEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEE
Q 019433           69 LT-----PTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI  142 (341)
Q Consensus        69 ~~-----~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL  142 (341)
                      ..     ...+++||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||
T Consensus        99 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl  175 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITI  175 (362)
T ss_dssp             EECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEE
T ss_pred             EeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEE
Confidence            53     3478999999985 777777654 37999999999999999999999999999999999999988776  999


Q ss_pred             eecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-
Q 019433          143 CDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-  221 (341)
Q Consensus       143 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-  221 (341)
                      +|||++.............||+.|+|||++.+....+.++|||||||++|+|++|..||........+........... 
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            9999997555445555678999999999988744445669999999999999999999988766555554443221110 


Q ss_pred             -------------------ccCC------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          222 -------------------YFLP------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       222 -------------------~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                                         ...+      .....++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                               0000      013568899999999999999999999999999999876544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-51  Score=365.16  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+..+..+ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            468999999999999999999999999999999987642   2345678899988888 999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-----------------
Q 019433           78 MEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-----------------  136 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-----------------  136 (341)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.++                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999765    6799999999999999999999999999999999999998543                 


Q ss_pred             CCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDR  216 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~  216 (341)
                      ...+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....   ..    .
T Consensus       170 ~~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~----~  239 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WH----E  239 (289)
T ss_dssp             CCCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HH----H
T ss_pred             ceEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HH----H
Confidence            23599999999875332   23456999999999998764544569999999999999999987754321   11    1


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +..... ......+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       240 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            222111 11223689999999999999999999999999999999654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=7.9e-52  Score=386.90  Aligned_cols=262  Identities=26%  Similarity=0.399  Sum_probs=194.4

Q ss_pred             CCCccc-cceecccCCeEEEEEEEc--CCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEE
Q 019433            2 EERYEP-VKELGSGNFGVARLVRDK--RTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAI   76 (341)
Q Consensus         2 ~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~i   76 (341)
                      .++|++ .++||+|+||+||+|.++  .+++.||||++.... ....+.+|+.+++.++||||+++++++..  ...+++
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            356777 457999999999999976  578999999997643 35678899999999999999999999954  678999


Q ss_pred             EEeecCCCchHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC--CCCCEEEeec
Q 019433           77 VMEYAAGGELFARICSA---------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS--PQPRLKICDF  145 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~--~~~~ikL~Df  145 (341)
                      ||||+.+ +|...+...         ..+++..++.++.||+.||.|||++||+||||||+|||+...  ....+||+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  176 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM  176 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence            9999975 777776532         249999999999999999999999999999999999999421  2234999999


Q ss_pred             CCccCCCCC----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---------hhHHHH
Q 019433          146 GYSKSGLLH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------PRNFRK  212 (341)
Q Consensus       146 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~---------~~~~~~  212 (341)
                      |+++.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.....         ...+..
T Consensus       177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~  256 (405)
T 3rgf_A          177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  256 (405)
T ss_dssp             TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred             CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence            999753321    2234568999999999998766556669999999999999999999976443         133333


Q ss_pred             HHHHHhccccc-C-------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCc
Q 019433          213 TIDRIRNVQYF-L-------------------------------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW  260 (341)
Q Consensus       213 ~~~~~~~~~~~-~-------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  260 (341)
                      ++..+...... +                               ......++.+.+||.+||++||.+|||+.|+|+|||
T Consensus       257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            33222111000 0                               000123778999999999999999999999999999


Q ss_pred             cCCCC
Q 019433          261 FLKNL  265 (341)
Q Consensus       261 ~~~~~  265 (341)
                      |....
T Consensus       337 f~~~~  341 (405)
T 3rgf_A          337 FLEDP  341 (405)
T ss_dssp             GTSSS
T ss_pred             hccCC
Confidence            97653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.6e-52  Score=375.68  Aligned_cols=256  Identities=25%  Similarity=0.344  Sum_probs=207.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPT----   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----   72 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++......    ...+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            468999999999999999999999999999999998764332    235788999999999999999999987653    


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~  167 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccc
Confidence            35999999999999999998889999999999999999999999999999999999999988776  9999999987432


Q ss_pred             CC----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          153 LH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ..    .......||+.|+|||++.+..++. ++|||||||++|+|++|..||...............  ..........
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  244 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE--DPIPPSARHE  244 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCHHHHST
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC--CCCCcccccC
Confidence            22    1223456899999999998877755 489999999999999999999876543332222111  0000011123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+++++.+||.+||+.||.+||++.+++.|+|+
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            589999999999999999999999999999998

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-51  Score=368.39  Aligned_cols=260  Identities=26%  Similarity=0.408  Sum_probs=212.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEc------CCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLT------PTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~------~~~~   74 (341)
                      .++|++++.||+|+||.||+|.+..+++.||||++.......+.+.+|+.+++.+ +||||+++++++..      ...+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~  102 (326)
T 2x7f_A           23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL  102 (326)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence            5799999999999999999999999999999999987766778899999999998 79999999999987      5689


Q ss_pred             EEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           75 AIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC---
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecC
Confidence            9999999999999999764  47999999999999999999999999999999999999987776  9999999987432


Q ss_pred             CC-CCCCCccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          153 LH-SQPKSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       153 ~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      .. .......||+.|+|||++.     +..++ .++|||||||++|+|++|..||...........    +.........
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~  255 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLK  255 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCS
T ss_pred             cCccccccccCCccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCC
Confidence            22 2234557999999999986     33444 458999999999999999999987654333222    1111111122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      ...+++.+.+||.+||..||.+|||+.++++||||.......
T Consensus       256 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  297 (326)
T 2x7f_A          256 SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER  297 (326)
T ss_dssp             CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTHH
T ss_pred             ccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcccc
Confidence            346899999999999999999999999999999997765543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-51  Score=371.92  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=205.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCC--CCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRH--PNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~h--p~iv~l~~~~~~~~~~~i   76 (341)
                      +++|++++.||+|+||+||+|.+. +++.||||++.....   ..+.+.+|+.+++.++|  |||+++++++.....+++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            578999999999999999999985 689999999875432   23467889999999976  999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.  +||+|||+++...... 
T Consensus        87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~--~kl~DFG~a~~~~~~~~  162 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM--LKLIDFGIANQMQPDTT  162 (343)
T ss_dssp             EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE--EEECCCSSSCCC-----
T ss_pred             EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc--EEEeecccccccCcccc
Confidence            999 56789999999988999999999999999999999999999999999999997 344  9999999997543222 


Q ss_pred             --CCCCccCCCCccccccccc----------cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          156 --QPKSTVGTPAYIAPEVLAR----------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                        .....+||+.|+|||++.+          ....+.++|||||||++|+|++|..||....+...  . ..........
T Consensus       163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~-~~~~~~~~~~  239 (343)
T 3dbq_A          163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--K-LHAIIDPNHE  239 (343)
T ss_dssp             -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H-HHHHHCTTSC
T ss_pred             cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--H-HHHHhcCCcc
Confidence              2235679999999999864          12234558999999999999999999976544211  1 1122222222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .......+.++.+||.+||+.||.+|||+.++++||||....
T Consensus       240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            222235678999999999999999999999999999997544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-50  Score=363.02  Aligned_cols=260  Identities=26%  Similarity=0.410  Sum_probs=215.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            578999999999999999999999999999999987653 4577899999999999999999999999999999999999


Q ss_pred             CCCchHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           82 AGGELFARIC-SAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~-~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      .+++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++...... .....
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCC
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCc
Confidence            9999999986 4567999999999999999999999999999999999999988776  999999998643222 22345


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||............   .............+++.+.+||.
T Consensus       185 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             cCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHH
Confidence            678999999999988777655 89999999999999999999876543332211   11222222233457899999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      +||..||.+|||+.++++||||.......
T Consensus       261 ~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~  289 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQHPFVRSAKGVS  289 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred             HHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence            99999999999999999999997765443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.6e-51  Score=365.61  Aligned_cols=255  Identities=30%  Similarity=0.390  Sum_probs=207.9

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +++||++++.||+|+||.||+|.+..+++.||+|++.....    ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            46899999999999999999999999999999999865432    23467889999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||||+++++|.+++...+++++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....... 
T Consensus        89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-----
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccc
Confidence            9999999999999998889999999999999999999999999999999999999988776  9999999997533222 


Q ss_pred             -CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc--CCCCCCCCH
Q 019433          156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--LPDYVRVSA  232 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~  232 (341)
                       ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||............   +......  ......+++
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  242 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---IQDSVPNVTTDVRKDIPQ  242 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH---HSSCCCCHHHHSCTTSCH
T ss_pred             cccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hhccCCCcchhcccCCCH
Confidence             2334579999999999988777554 89999999999999999999876543332221   1111110  011246899


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+.++|.+||+.||.+||+..+.+.+.|.
T Consensus       243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          243 SLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999999999966666665543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.9e-51  Score=371.52  Aligned_cols=259  Identities=29%  Similarity=0.397  Sum_probs=212.0

Q ss_pred             CCCCccccceecccCCeEEEEEEE-cCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC------CeeeEEEEEEcCCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRD-KRTKELVAVKYIERGKKIDENVQREIINHRSLRHP------NIIRFKEVLLTPTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp------~iv~l~~~~~~~~~   73 (341)
                      +.++|++++.||+|+||+||+|.+ ..+++.||||++.......+.+.+|+.+++.++|+      +++++++++...+.
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            368999999999999999999998 56899999999987665567788999998887654      59999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC---------------
Q 019433           74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP---------------  136 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~---------------  136 (341)
                      .++||||+ +++|.+++....  ++++..++.++.||+.||.|||++||+||||||+|||++..+               
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~  170 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT  170 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence            99999999 789999987765  689999999999999999999999999999999999998643               


Q ss_pred             --CCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH
Q 019433          137 --QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       137 --~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~  214 (341)
                        ...+||+|||++...  ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.............
T Consensus       171 ~~~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  247 (339)
T 1z57_A          171 LINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME  247 (339)
T ss_dssp             ESCCCEEECCCSSCEET--TSCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH
T ss_pred             ccCCCceEeeCcccccC--ccccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence              335999999998742  233456689999999999988777654 899999999999999999998766544333222


Q ss_pred             HHHhcccc--------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHh
Q 019433          215 DRIRNVQY--------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK  256 (341)
Q Consensus       215 ~~~~~~~~--------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l  256 (341)
                      ........                                      ........++.+.+||.+||+.||.+|||+.|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence            21110000                                      0000112356789999999999999999999999


Q ss_pred             cCCccCC
Q 019433          257 KHPWFLK  263 (341)
Q Consensus       257 ~hp~~~~  263 (341)
                      +||||..
T Consensus       328 ~hp~f~~  334 (339)
T 1z57_A          328 KHPFFDL  334 (339)
T ss_dssp             TSGGGGG
T ss_pred             cCHHHHH
Confidence            9999953

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=7.5e-51  Score=362.85  Aligned_cols=255  Identities=25%  Similarity=0.364  Sum_probs=195.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||+||+|.+..+++.||+|++.......   +.+..+...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999999999999999999987643222   23344455578889999999999999999999999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ||+.+ +|..++..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  +||+|||++.....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVD  162 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC--------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccc
Confidence            99975 77666543    56899999999999999999999998 9999999999999988776  99999999975544


Q ss_pred             CCCCCCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          154 HSQPKSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ........||+.|+|||++.   .....+.++|||||||++|+|++|..||.........  ............ ....+
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~-~~~~~  239 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPSPQL-PADKF  239 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HHHHHHSCCCCC-CTTTS
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HHHHhccCCCCc-ccccC
Confidence            44445568999999999972   2233345699999999999999999999864433221  112222222222 22468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ++++.+||.+||+.||.+|||+.++++||||.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~  271 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT  271 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccc
Confidence            99999999999999999999999999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-50  Score=371.26  Aligned_cols=262  Identities=28%  Similarity=0.407  Sum_probs=212.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~   73 (341)
                      +.++|++.+.||+|+||+||+|.+..+|+.||||++....  .....+.+|+.+++.++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            5689999999999999999999999999999999986533  2234677999999999999999999988754     67


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .++||||+. ++|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDE  164 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC-
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEeccccccccc
Confidence            999999997 589888865 57999999999999999999999999999999999999988776  99999999874322


Q ss_pred             CC-----------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          154 HS-----------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       154 ~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      ..           ......||+.|+|||++.+....+.++|||||||++|+|++|..||........+............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            11           1223578999999999876444456699999999999999999999886654444333222111000


Q ss_pred             -----------------cCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          223 -----------------FLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       223 -----------------~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                                       ..+         ....+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                             000         01368899999999999999999999999999999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-51  Score=383.98  Aligned_cols=258  Identities=26%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC--------CCCeeeEEEEEE---
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--------HPNIIRFKEVLL---   69 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~--------hp~iv~l~~~~~---   69 (341)
                      +.++|++++.||+|+||+||+|.+..+++.||||++.......+.+.+|+.+++.+.        ||||+++++++.   
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            358999999999999999999999999999999999876656677889999998885        788999999998   


Q ss_pred             -cCCEEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCC---------
Q 019433           70 -TPTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSP---------  136 (341)
Q Consensus        70 -~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~---------  136 (341)
                       ....+++||||+. ++|...+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++         
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~  193 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE  193 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence             5678999999995 5666665544  4699999999999999999999998 999999999999998654         


Q ss_pred             --------------------------------------CCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccC
Q 019433          137 --------------------------------------QPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD  178 (341)
Q Consensus       137 --------------------------------------~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  178 (341)
                                                            ...+||+|||++....  ......+||+.|+|||++.+..++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCC
T ss_pred             hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCC
Confidence                                                  1249999999997432  334556899999999999888776


Q ss_pred             CCccchhhHHHHHHHHHhCCCCCCCCCCh------hHHHHHHHHHhccc--------c----c-----------------
Q 019433          179 GKISDVWSCGVTLYVMLVGAYPFEDPEDP------RNFRKTIDRIRNVQ--------Y----F-----------------  223 (341)
Q Consensus       179 ~~~~DiwslG~vl~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~--------~----~-----------------  223 (341)
                      . ++|||||||++|+|++|..||......      ..+...........        .    .                 
T Consensus       272 ~-~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          272 T-PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             T-HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             c-HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            5 489999999999999999999765421      12222221111100        0    0                 


Q ss_pred             -------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          224 -------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       224 -------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                             .......++.+.+||.+||+.||.+|||+.|+|+||||.
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                   000112346688999999999999999999999999995

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.8e-51  Score=372.64  Aligned_cols=290  Identities=24%  Similarity=0.369  Sum_probs=221.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE-----
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTH-----   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~-----   73 (341)
                      .++|.+.+.||+|+||.||+|.++.+|+.||||++.....   ....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4789999999999999999999999999999999876432   23467889999999999999999999987654     


Q ss_pred             -EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           74 -LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        74 -~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                       +++||||+. ++|...+.  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~  177 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD  177 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred             eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence             599999997 48877763  35999999999999999999999999999999999999998776  9999999987432


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc------------
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV------------  220 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  220 (341)
                        .......||+.|+|||++.+....+.++|||||||++|+|++|..||........+..+.......            
T Consensus       178 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          178 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             --CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence              233456789999999998874444455999999999999999999998876554444433321110            


Q ss_pred             --------c----cc-CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCC
Q 019433          221 --------Q----YF-LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQ  287 (341)
Q Consensus       221 --------~----~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (341)
                              .    .. ......+++.+.+||.+||+.||.+|||+.++++||||...............+. ........
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~-~~~~~~~~  334 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFD-DSLEHEKL  334 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCC-CTTTTCCC
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCCCc-cchhhccC
Confidence                    0    00 0112357899999999999999999999999999999976544322111111111 12223445


Q ss_pred             CHHHHHHHHHHh
Q 019433          288 SVEEIMRIIQEA  299 (341)
Q Consensus       288 ~~~~~~~~~~~~  299 (341)
                      +++++++.+...
T Consensus       335 ~~~~~~~~~~~~  346 (353)
T 3coi_A          335 TVDEWKQHIYKE  346 (353)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHH
Confidence            677777766543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.4e-51  Score=372.81  Aligned_cols=263  Identities=22%  Similarity=0.399  Sum_probs=219.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----c--------------HHHHHHHHHHhcCCCCCeeeE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----D--------------ENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~--------------~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      ++|++++.||+|+||.||+|.+  +++.||||++......    .              +.+.+|+.+++.++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999999  8999999998653211    1              788999999999999999999


Q ss_pred             EEEEEcCCEEEEEEeecCCCchHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCC
Q 019433           65 KEVLLTPTHLAIVMEYAAGGELFAR------ICS--AGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGS  135 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~  135 (341)
                      ++++...+..++||||+++++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999888      655  5679999999999999999999999 999999999999999887


Q ss_pred             CCCCEEEeecCCccCCCCCCCCCCccCCCCcccccccccc-ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH
Q 019433          136 PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~  214 (341)
                      +.  +||+|||++...... ......||+.|+|||++.+. .+...++|||||||++|+|++|..||.........   .
T Consensus       189 ~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~  262 (348)
T 2pml_X          189 GR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL---F  262 (348)
T ss_dssp             SC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH---H
T ss_pred             Cc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---H
Confidence            76  999999998753222 34456799999999999877 55543699999999999999999999876653222   2


Q ss_pred             HHHhcccccCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHH
Q 019433          215 DRIRNVQYFLPDY-----------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE  273 (341)
Q Consensus       215 ~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~  273 (341)
                      ..+.......+..                 ..+++++.+||.+||+.||.+|||+.++++||||............
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~~~  338 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFS  338 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHHHH
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHHHH
Confidence            2333333333311                 4689999999999999999999999999999999877655554433

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-50  Score=374.76  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCC--CCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|.+.. ++.||||++.....   ..+.+.+|+.+++.++  ||||+++++++...+.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            569999999999999999999875 89999999876432   2356889999999996  59999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--  155 (341)
                      || +.+++|..++.....+++..++.++.||+.||.|||++||+||||||+|||+++ +.  +||+|||+++......  
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~--~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-SC--EEECCCSSSCCC------
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-Ce--EEEEecCccccccCCCcc
Confidence            99 668899999998889999999999999999999999999999999999999963 44  9999999997543222  


Q ss_pred             -CCCCccCCCCcccccccccc----------ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC
Q 019433          156 -QPKSTVGTPAYIAPEVLARK----------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (341)
                       .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|..||....+...   .+..+.......
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~~~~~~~~~~  287 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI  287 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHCTTSCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH---HHHHHhCccccC
Confidence             23456799999999998652          2234559999999999999999999976543211   122222222222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      +.....+.++.+||.+||+.||.+|||+.++++||||....
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            22234688999999999999999999999999999996543

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.7e-51  Score=376.67  Aligned_cols=259  Identities=27%  Similarity=0.366  Sum_probs=212.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CC-----CeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HP-----NIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp-----~iv~l~~~~~~~~~~~   75 (341)
                      .++|++.+.||+|+||+||+|.+..+++.||||++.........+..|+.+++.++ |+     +|+++++++...+..+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            47899999999999999999999999999999999876555567778888887774 44     4999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCH--SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH--~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      +||||+.+ +|.+++...  ..+++..++.++.|++.||.|||  ++||+||||||+|||++.+....+||+|||+++..
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            99999965 999988765  46999999999999999999999  57999999999999997544455999999999743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc---------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY---------  222 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  222 (341)
                        ........||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..+.........         
T Consensus       212 --~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 --GQRIYQYIQSRFYRSPEVLLGMPYDL-AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             --TCCCCSSCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             --ccccccccCCccccChHHHcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence              23345678999999999998887765 499999999999999999999987766655555443211100         


Q ss_pred             -----cCCC-------------------CCC-------------------------CCHHHHHHHHHhcccCCCCCCChh
Q 019433          223 -----FLPD-------------------YVR-------------------------VSADCRHLLSQIFVADPSKRIPIP  253 (341)
Q Consensus       223 -----~~~~-------------------~~~-------------------------~s~~~~~li~~~L~~dp~~R~s~~  253 (341)
                           .++.                   ...                         .++++.+||.+||+.||++|||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                 0000                   000                         013789999999999999999999


Q ss_pred             HHhcCCccCCC
Q 019433          254 EIKKHPWFLKN  264 (341)
Q Consensus       254 e~l~hp~~~~~  264 (341)
                      |+|+||||.+.
T Consensus       369 e~L~hp~f~~~  379 (382)
T 2vx3_A          369 YALQHSFFKKT  379 (382)
T ss_dssp             HHTTSGGGCC-
T ss_pred             HHhcCcccccC
Confidence            99999999764

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.3e-51  Score=367.24  Aligned_cols=264  Identities=27%  Similarity=0.384  Sum_probs=193.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            47899999999999999999999999999999998654  2334567899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           80 YAAGGELFARICS--------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        80 ~~~~~~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      |+++++|.+++..        ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~  171 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFL  171 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchhee
Confidence            9999999999864        446999999999999999999999999999999999999988776  999999988643


Q ss_pred             CCC------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc----
Q 019433          152 LLH------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ----  221 (341)
Q Consensus       152 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  221 (341)
                      ...      .......||+.|+|||++.+....+.++|||||||++|+|++|..||....................    
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV  251 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence            221      1123457999999999987643334569999999999999999999987665544332221110000    


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          222 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      ........+++++.+||.+||+.||.+|||+.++++||||.+...+
T Consensus       252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            0011124678999999999999999999999999999999765443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.6e-51  Score=375.43  Aligned_cols=258  Identities=32%  Similarity=0.541  Sum_probs=185.7

Q ss_pred             CCCCccccc-eecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHH-HHHhcCCCCCeeeEEEEEEc----CCEE
Q 019433            1 MEERYEPVK-ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPNIIRFKEVLLT----PTHL   74 (341)
Q Consensus         1 i~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei-~~~~~l~hp~iv~l~~~~~~----~~~~   74 (341)
                      +.++|++++ .||+|+||+||+|.++.+++.||||++.....    ..+|+ ..++.++||||+++++++..    ...+
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            357899976 59999999999999999999999999876432    23333 33566799999999999976    4568


Q ss_pred             EEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCC
Q 019433           75 AIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSG  151 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~  151 (341)
                      ++||||+.+|+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||++...
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~  181 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET  181 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence            99999999999999998754  699999999999999999999999999999999999997643 345999999998743


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc--ccccCCCCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN--VQYFLPDYVR  229 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  229 (341)
                      . ........||+.|+|||++.+..++. ++|||||||++|+|++|..||...............+..  .....+.+..
T Consensus       182 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (336)
T 3fhr_A          182 T-QNALQTPCYTPYYVAPEVLGPEKYDK-SCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE  259 (336)
T ss_dssp             -----------------------CHHHH-HHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTT
T ss_pred             c-ccccccCCCCcCccChhhhCCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhcc
Confidence            3 23344567899999999998777755 489999999999999999999765443222222222222  2223344457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       260 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            89999999999999999999999999999999653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=361.81  Aligned_cols=257  Identities=33%  Similarity=0.543  Sum_probs=210.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC-----ccccHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-----KKIDENVQREIINHRSLRHPNIIRFKEVLL--TPTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~--~~~~   73 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.||+|++...     ......+.+|+.+++.++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            457999999999999999999999999999999998653     233467889999999999999999999984  4567


Q ss_pred             EEEEEeecCCCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           74 LAIVMEYAAGGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      .++||||+.++ |...+..  ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~  159 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEAL  159 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeecccccccc
Confidence            89999999886 6666655  457999999999999999999999999999999999999988776  999999998743


Q ss_pred             CC---CCCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC
Q 019433          152 LL---HSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY  227 (341)
Q Consensus       152 ~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (341)
                      ..   ........||+.|+|||++.+.. ..+.++|||||||++|+|++|..||.......    ....+.......+  
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~~--  233 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAIP--  233 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCCC--
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCCC--
Confidence            22   11223456899999999987643 23456899999999999999999998754332    2333333333333  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ..+++.+.+||.+||+.||.+|||+.++++||||.+..+
T Consensus       234 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          234 GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            368999999999999999999999999999999976554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-50  Score=360.93  Aligned_cols=260  Identities=28%  Similarity=0.407  Sum_probs=211.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            578999999999999999999999999999999987543 3456788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCCC
Q 019433           81 AAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQPK  158 (341)
Q Consensus        81 ~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~~  158 (341)
                      +++++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++.... ......
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  175 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRD  175 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC--
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccc
Confidence            999999998876 457999999999999999999999999999999999999987776  9999999874211 111223


Q ss_pred             CccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          159 STVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ...||+.|+|||++.     +..+ +.++|||||||++|+|++|..||.............   ............++..
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          176 SFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             ---CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HSCCCCCSSGGGSCHH
T ss_pred             cccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh---ccCCcccCCccccCHH
Confidence            457899999999984     3344 445999999999999999999998765443332221   1111122233468899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCccCCCCCh
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK  267 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~  267 (341)
                      +.+||.+||+.||.+|||+.++++||||......
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            9999999999999999999999999999776544

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.3e-50  Score=365.43  Aligned_cols=253  Identities=32%  Similarity=0.531  Sum_probs=215.9

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCC--CCCeeeEEEEEEcC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLR--HPNIIRFKEVLLTP   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~   71 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....       ....+.+|+.+++.++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            46899999999999999999999999999999999876432       2245678999999886  59999999999999


Q ss_pred             CEEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec-CCCCCCEEEeecCCcc
Q 019433           72 THLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGYSK  149 (341)
Q Consensus        72 ~~~~iv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~-~~~~~~ikL~Dfg~a~  149 (341)
                      +..++|||++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.  +||+|||++.
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--~kL~Dfg~~~  198 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE--LKLIDFGSGA  198 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE--EEECCCTTCE
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC--EEEeeCcccc
Confidence            999999999976 89999999888999999999999999999999999999999999999998 4555  9999999987


Q ss_pred             CCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      ... ........||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .    ........+  ..
T Consensus       199 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~~~~--~~  265 (320)
T 3a99_A          199 LLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVFFR--QR  265 (320)
T ss_dssp             ECC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCCCS--SC
T ss_pred             ccc-cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhccccccc--cc
Confidence            533 2233456799999999999877776666899999999999999999997521      1    111222222  36


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      +++++.+||.+||+.||.+|||+.++++||||.+...+.
T Consensus       266 ~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            899999999999999999999999999999998876543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.1e-50  Score=361.67  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=207.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----------   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----------   70 (341)
                      .++|++++.||+|+||.||+|.+..+++.||||++.......+.+.+|+.+++.++||||+++++++..           
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            468999999999999999999999999999999997665556678899999999999999999998865           


Q ss_pred             --CCEEEEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           71 --PTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        71 --~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                        ....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~  162 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGL  162 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcc
Confidence              356899999999999999997644 6889999999999999999999999999999999999988776  99999999


Q ss_pred             ccCCCCC---------------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHH
Q 019433          148 SKSGLLH---------------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK  212 (341)
Q Consensus       148 a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~  212 (341)
                      +......               .......||+.|+|||++.+....+.++|||||||++|+|++   ||....+   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---~~~  236 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---RVN  236 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---HHH
Confidence            8743211               122345789999999999866444556999999999999998   6654222   122


Q ss_pred             HHHHHhcccccCCC--CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          213 TIDRIRNVQYFLPD--YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       213 ~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      ....+......+|.  ....++.+.+||.+||+.||.+|||+.++++||||......+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE  294 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHHH
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChHH
Confidence            33333333332222  235677899999999999999999999999999997665443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=8.9e-50  Score=361.90  Aligned_cols=260  Identities=28%  Similarity=0.403  Sum_probs=214.3

Q ss_pred             CCCccccceecccCCeEEEEEEEc-CCCcEEEEEEcccCc---cccHHHHHHHHHHhcC---CCCCeeeEEEEEE-----
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-RTKELVAVKYIERGK---KIDENVQREIINHRSL---RHPNIIRFKEVLL-----   69 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~-----   69 (341)
                      +++|++++.||+|+||.||+|.+. .+++.||+|++....   .....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            579999999999999999999995 678999999986532   2234566787777665   8999999999987     


Q ss_pred             cCCEEEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           70 TPTHLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        70 ~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      .....++||||+. ++|..++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~  166 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL  166 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcc
Confidence            5677999999998 59999987754  4999999999999999999999999999999999999988776  99999999


Q ss_pred             ccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCC-
Q 019433          148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLP-  225 (341)
Q Consensus       148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-  225 (341)
                      +.............||+.|+|||++.+..++. ++|||||||++|+|++|..||........+..+........ ..++ 
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCc-chhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            97544444445678999999999998877755 48999999999999999999998776655555544332110 0000 


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          226 -------------------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       226 -------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                         ....+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                               1135789999999999999999999999999999996543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.8e-50  Score=370.18  Aligned_cols=262  Identities=25%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCC-cEEEEEEcccCccccHHHHHHHHHHhcCCCCC------eeeEEEEEEcCCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTK-ELVAVKYIERGKKIDENVQREIINHRSLRHPN------IIRFKEVLLTPTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~------iv~l~~~~~~~~~   73 (341)
                      +.++|++++.||+|+||+||+|.+..++ +.||+|++.......+.+.+|+.+++.++|++      ++.+++++...+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4689999999999999999999998777 78999999876555677888999998886655      9999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC----------------
Q 019433           74 LAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS----------------  135 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~----------------  135 (341)
                      .++||||+ +++|...+....  .+++..++.++.||+.||.|||++||+||||||+|||++..                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~  175 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS  175 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence            99999999 556666665543  69999999999999999999999999999999999999432                


Q ss_pred             -CCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH
Q 019433          136 -PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       136 -~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~  214 (341)
                       ....+||+|||++...  ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+....
T Consensus       176 ~~~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  252 (355)
T 2eu9_A          176 VKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMME  252 (355)
T ss_dssp             ESCCCEEECCCTTCEET--TSCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cCCCcEEEeecCccccc--cccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence             1234999999999742  333456689999999999988777654 899999999999999999998766544433322


Q ss_pred             HHHhcccc--------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHh
Q 019433          215 DRIRNVQY--------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIK  256 (341)
Q Consensus       215 ~~~~~~~~--------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l  256 (341)
                      ........                                      ........+..+.+||.+||+.||.+|||+.+++
T Consensus       253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            22111000                                      0001112245789999999999999999999999


Q ss_pred             cCCccCCCCC
Q 019433          257 KHPWFLKNLP  266 (341)
Q Consensus       257 ~hp~~~~~~~  266 (341)
                      +||||....+
T Consensus       333 ~hp~f~~~~~  342 (355)
T 2eu9_A          333 LHPFFAGLTP  342 (355)
T ss_dssp             TSGGGGGCCH
T ss_pred             cChhhcCCCh
Confidence            9999976543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-50  Score=364.84  Aligned_cols=262  Identities=29%  Similarity=0.400  Sum_probs=206.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEE----------
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLL----------   69 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~----------   69 (341)
                      +.++|++++.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            4689999999999999999999999999999999987543 33456889999999999999999999874          


Q ss_pred             ----cCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           70 ----TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        70 ----~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                          .....++||||+. ++|.+++. ..++++..++.++.|++.||.|||++||+||||||+||+++..+ ..+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccC
Confidence                3478999999998 59988885 45799999999999999999999999999999999999997433 24999999


Q ss_pred             CCccCCCCC----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-
Q 019433          146 GYSKSGLLH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-  220 (341)
Q Consensus       146 g~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-  220 (341)
                      |++......    .......+|+.|+|||++.+....+.++|||||||++|+|++|..||................... 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH  245 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence            998753221    223345679999999998764444566999999999999999999998876655444433221100 


Q ss_pred             -----------------cccCC------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          221 -----------------QYFLP------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       221 -----------------~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                                       ....+      ....+++++.+||.+||+.||.+|||+.++++||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          246 EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence                             00000      0135899999999999999999999999999999996543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.7e-52  Score=382.73  Aligned_cols=244  Identities=14%  Similarity=0.146  Sum_probs=198.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHH---HHhcCCCCCeeeEE-------EE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREII---NHRSLRHPNIIRFK-------EV   67 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~---~~~~l~hp~iv~l~-------~~   67 (341)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++...    ....+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46899999999999999999999999999999998743    223457889994   55556899999998       77


Q ss_pred             EEcCCE-----------------EEEEEeecCCCchHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCeeC
Q 019433           68 LLTPTH-----------------LAIVMEYAAGGELFARICSAGRFSE-------DEARFFFQQLISGVSYCHSMEICHR  123 (341)
Q Consensus        68 ~~~~~~-----------------~~iv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~qil~aL~~LH~~~iiHr  123 (341)
                      +...+.                 .|+||||+ +|+|.+++...+.+++       ..++.++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            766542                 89999999 6799999987655655       7888899999999999999999999


Q ss_pred             CCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCcccccccccc-----------ccCCCccchhhHHHHHH
Q 019433          124 DLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK-----------EYDGKISDVWSCGVTLY  192 (341)
Q Consensus       124 Dikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~vl~  192 (341)
                      ||||+|||++.++.  +||+|||+++..  .......+| +.|+|||++.+.           .++ .++|||||||++|
T Consensus       231 Dikp~NIll~~~~~--~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~  304 (377)
T 3byv_A          231 YLRPVDIVLDQRGG--VFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIY  304 (377)
T ss_dssp             CCCGGGEEECTTCC--EEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCC--EEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHH
Confidence            99999999998776  999999999842  223345567 999999999877           554 5599999999999


Q ss_pred             HHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          193 VMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       193 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +|++|..||.........          ....+....+++++.+||.+||+.||.+|||+.++++||||.
T Consensus       305 elltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~  364 (377)
T 3byv_A          305 WIWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  364 (377)
T ss_dssp             HHHHSSCCC------CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred             HHHHCCCCCcccccccch----------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence            999999999764332111          111223357899999999999999999999999999999994

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-49  Score=357.06  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=215.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +++|++++.||+|+||.||+|.+..+++.||||++....  ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            578999999999999999999999999999999987543  344678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      |+++++|.+++.. .++++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....... ...
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBC
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccC
Confidence            9999999998854 57999999999999999999999999999999999999988776  9999999986433222 234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||............ ..  ......  ...++..+.+||
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~--~~~~~~--~~~~~~~l~~li  251 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLI-PK--NNPPTL--EGNYSKPLKEFV  251 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HH--SCCCCC--CSSCCHHHHHHH
T ss_pred             ccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hc--CCCCCC--ccccCHHHHHHH
Confidence            5678999999999988777654 89999999999999999999875543322211 11  111112  236899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+||+.||.+|||+.++++||||...
T Consensus       252 ~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          252 EACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHhhChhhhcC
Confidence            99999999999999999999999544

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-49  Score=356.74  Aligned_cols=247  Identities=28%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++.+.||+|+||+||+|.+  +++.||||++......   .+.+.+|+.+++.++||||+++++++.....+++||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            36899999999999999999987  5889999998765422   246788999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           79 EYAAGGELFARICSAGR---FSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~---l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ||+.+++|.+++.....   +++..++.++.||+.||.|||++|  |+||||||+||+++.++.  +||+|||+++....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKAS  191 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccc
Confidence            99999999999977553   999999999999999999999999  999999999999988776  99999999874322


Q ss_pred             C-CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          154 H-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      . .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.......+....+++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAA----VGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCH
T ss_pred             cccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCCCCCCCccCCH
Confidence            2 12345679999999999988877654 8999999999999999999987654333222    2111122222347899


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhc
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+.+||.+||+.||.+|||+.++++
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999999988

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=358.46  Aligned_cols=244  Identities=28%  Similarity=0.441  Sum_probs=205.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC-ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            6899999999999999999999999999999987653 334457889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC----
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ----  156 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~----  156 (341)
                      .+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++........    
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccc
Confidence            99999999987 567999999999999999999999999999999999999988776  99999999874322211    


Q ss_pred             -----------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChh-----HHHHHHHHHhcc
Q 019433          157 -----------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR-----NFRKTIDRIRNV  220 (341)
Q Consensus       157 -----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~  220 (341)
                                 .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......     ........    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----  242 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----  242 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----
Confidence                       114579999999999988777654 999999999999999999986533211     11111111    


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                        ..+  ..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       243 --~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 --YCP--PNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             --TCC--TTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --cCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence              112  367889999999999999999999999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-50  Score=361.41  Aligned_cols=250  Identities=30%  Similarity=0.493  Sum_probs=204.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcC----CCCCeeeEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSL----RHPNIIRFKEVLL   69 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l----~hp~iv~l~~~~~   69 (341)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++.....       ....+.+|+.+++.+    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            46799999999999999999999999999999999876432       123455788888887    8999999999999


Q ss_pred             cCCEEEEEEee-cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec-CCCCCCEEEeecCC
Q 019433           70 TPTHLAIVMEY-AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD-GSPQPRLKICDFGY  147 (341)
Q Consensus        70 ~~~~~~iv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~-~~~~~~ikL~Dfg~  147 (341)
                      ..+..++|||+ +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++ .++.  +||+|||+
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~dfg~  186 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGS  186 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE--EEECCCSS
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe--EEEEEcch
Confidence            99999999999 78999999999888999999999999999999999999999999999999998 5555  99999999


Q ss_pred             ccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC
Q 019433          148 SKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY  227 (341)
Q Consensus       148 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (341)
                      +..... .......||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .    .......++  
T Consensus       187 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~--  253 (312)
T 2iwi_A          187 GALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFP--  253 (312)
T ss_dssp             CEECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCC--
T ss_pred             hhhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCc--
Confidence            875332 234456799999999999877776656999999999999999999997521      1    111222233  


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            36899999999999999999999999999999997543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-50  Score=372.45  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----------CCCeeeEEEEEEc
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----------HPNIIRFKEVLLT   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----------hp~iv~l~~~~~~   70 (341)
                      .++|++++.||+|+||+||+|.+..+++.||||++.......+.+.+|+.+++.++           ||||+++++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            47999999999999999999999999999999999876655677889999988775           8999999999986


Q ss_pred             CC----EEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCC----CCC
Q 019433           71 PT----HLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSP----QPR  139 (341)
Q Consensus        71 ~~----~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~----~~~  139 (341)
                      ..    .+++||||+ +++|..++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ...
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence            54    789999999 88999998763  4599999999999999999999998 999999999999995432    225


Q ss_pred             EEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC------hhHHHHH
Q 019433          140 LKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED------PRNFRKT  213 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~------~~~~~~~  213 (341)
                      +||+|||++....  .......||+.|+|||++.+..++. ++|||||||++|+|++|..||.....      ...+..+
T Consensus       177 ~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          177 IKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             EEEcccccccccC--CCCCCCCCCccccCcHHHhCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            9999999997432  3345568999999999998887754 49999999999999999999976432      1222222


Q ss_pred             HHHHhcccc------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          214 IDRIRNVQY------------------------------------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       214 ~~~~~~~~~------------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .........                                    ........++++.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            221111000                                    00001134577899999999999999999999999


Q ss_pred             CCccCCCCC
Q 019433          258 HPWFLKNLP  266 (341)
Q Consensus       258 hp~~~~~~~  266 (341)
                      ||||.+...
T Consensus       334 hp~f~~~~~  342 (373)
T 1q8y_A          334 HPWLKDTLG  342 (373)
T ss_dssp             CGGGTTCTT
T ss_pred             ChhhhcccC
Confidence            999976543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1e-48  Score=349.90  Aligned_cols=257  Identities=28%  Similarity=0.433  Sum_probs=206.9

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +|.....||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            3455569999999999999999999999999987643 345678899999999999999999999999999999999999


Q ss_pred             CCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-CCCCCEEEeecCCccCCCC-CCCC
Q 019433           83 GGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        83 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      +++|..++....   .+++..++.++.|++.||.|||++||+||||||+||+++. ++.  +||+|||++..... ....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC--EEECCTTTCEESCC-----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC--EEEeecccccccCCCCCcc
Confidence            999999997653   5679999999999999999999999999999999999986 555  99999999874322 1223


Q ss_pred             CCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....||+.|+|||++.+.. ..+.++|||||||++|+|++|..||............. .........  ...+++++.+
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~  257 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVHPEI--PESMSAEAKA  257 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCCCCC--CTTSCHHHHH
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-ccccccccc--cccCCHHHHH
Confidence            4567899999999987643 23455999999999999999999997654432211111 111111122  2368999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ||.+||+.||.+|||+.++++||||....
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999996543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-49  Score=349.42  Aligned_cols=247  Identities=24%  Similarity=0.401  Sum_probs=209.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||+||+|.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            68999999999999999999997 57789999998877667889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--CCCCC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  159 (341)
                      +++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++......  .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccccccC
Confidence            99999999654 46999999999999999999999999999999999999987776  999999998742221  12334


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +... .........++.+.+++
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG-FRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTT-CCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCCc-hhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----HhcC-ccCCCCCcCCHHHHHHH
Confidence            55678899999998777654 4899999999999999 9999987655433322    2221 12222346799999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.||.+|||+.++++|
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.8e-50  Score=372.09  Aligned_cols=252  Identities=16%  Similarity=0.192  Sum_probs=188.6

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----ccHHHHHHH---HHHhcCCCCCeeeEE-------EEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----IDENVQREI---INHRSLRHPNIIRFK-------EVLL   69 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~ei---~~~~~l~hp~iv~l~-------~~~~   69 (341)
                      .|++.+.||+|+||+||+|.+..+++.||||++.....    ..+.+.+|+   .+++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            49999999999999999999999999999999987542    234566774   45555 799988866       4554


Q ss_pred             cC-----------------CEEEEEEeecCCCchHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeeCCC
Q 019433           70 TP-----------------THLAIVMEYAAGGELFARICSAG-RFSEDEA------RFFFQQLISGVSYCHSMEICHRDL  125 (341)
Q Consensus        70 ~~-----------------~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~------~~i~~qil~aL~~LH~~~iiHrDi  125 (341)
                      ..                 ..+|+|||||. ++|.+++.... .+++..+      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 79999997643 4555555      677799999999999999999999


Q ss_pred             CCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCC
Q 019433          126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFED  203 (341)
Q Consensus       126 kp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~  203 (341)
                      ||+|||++.++.  +||+|||+++...  .......+|+.|+|||++.+  ..++ .++|||||||++|+|++|..||..
T Consensus       221 kp~NIll~~~~~--~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFIMPDGR--LMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEECTTSC--EEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEECCCCC--EEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCC
Confidence            999999998776  9999999997432  22225667899999999976  4554 559999999999999999999977


Q ss_pred             CCChhH--HHH-HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          204 PEDPRN--FRK-TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       204 ~~~~~~--~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ......  +.. ............+....+++.+.+||.+||+.||.+|||+.++++||||.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~  357 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL  357 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHH
Confidence            532100  000 00000112233444557899999999999999999999999999999994

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.8e-49  Score=346.92  Aligned_cols=248  Identities=27%  Similarity=0.384  Sum_probs=210.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++++.||+|+||+||+|.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            478999999999999999999887 5778999999887766778999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        82 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      ++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......  ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  163 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSV  163 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhccc
Confidence            9999999997754 5999999999999999999999999999999999999988776  9999999987432221  122


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+|+.|+|||++.+..++.+ +||||||+++|+|++ |..||...........    +.... ........++.+.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQGH-RLYRPHLASDTIYQI  237 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTC-CCCCCTTSCHHHHHH
T ss_pred             CCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHcCC-CCCCCCcChHHHHHH
Confidence            3456778999999988777655 899999999999999 9999987655433322    22211 122223578999999


Q ss_pred             HHHhcccCCCCCCChhHHhcC
Q 019433          238 LSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~h  258 (341)
                      |.+||+.||.+|||+.+++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.7e-49  Score=358.48  Aligned_cols=258  Identities=24%  Similarity=0.357  Sum_probs=192.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc---EEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE-
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL-   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~-   74 (341)
                      .++|++.+.||+|+||+||+|.+..++.   .||||++....   ...+.+.+|+.+++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            5789999999999999999999987765   89999987642   2345788999999999999999999999887665 


Q ss_pred             -----EEEEeecCCCchHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEe
Q 019433           75 -----AIVMEYAAGGELFARICSAG------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC  143 (341)
Q Consensus        75 -----~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~  143 (341)
                           ++||||+.+++|..++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEe
Confidence                 99999999999999986543      5999999999999999999999999999999999999988776  9999


Q ss_pred             ecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhc
Q 019433          144 DFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRN  219 (341)
Q Consensus       144 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~  219 (341)
                      |||+++......   ......+++.|+|||++.+..++. ++|||||||++|+|++ |..||..............    
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~----  254 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTV-HSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG----  254 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCC-ccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc----
Confidence            999997432222   122345678899999998877654 5999999999999999 9999988766544433221    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCC-------hhHHhcCCccCCCCCh
Q 019433          220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIP-------IPEIKKHPWFLKNLPK  267 (341)
Q Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s-------~~e~l~hp~~~~~~~~  267 (341)
                      . ...+....+++++.+||.+||+.||.+|||       +++++.|||+......
T Consensus       255 ~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          255 G-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             T-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             C-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            1 112333478999999999999999999999       8888999999765443

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.4e-49  Score=358.50  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=206.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc---EEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|++.+.||+|+||+||+|.+..+++   .||||++....  ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            4689999999999999999999986554   59999987643  234568899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC---
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCc
Confidence            99999999999999654 57999999999999999999999999999999999999988776  9999999997533221


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                          ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +.. ....+....+
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~  279 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSS-ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VEE-GYRLPAPMGC  279 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HHT-TCCCCCCTTC
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HHc-CCCCCCCCCc
Confidence                112234577899999998777765 4899999999999999 9999987655433322    222 1223344578


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++.+.+||.+||..||.+|||+.++++.
T Consensus       280 ~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          280 PHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999873

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.9e-49  Score=360.26  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=185.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHH-HHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREII-NHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~-~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .++|++++.||+|+||.||+|.++.+|+.||||++.....  ....+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3789999999999999999999999999999999876432  2234555655 677789999999999999999999999


Q ss_pred             eecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           79 EYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        79 e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ||+.+ +|..++..     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.  +||+|||++....
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecc
Confidence            99986 77777653     56799999999999999999999998 9999999999999988776  9999999997544


Q ss_pred             CCCCCCCccCCCCcccccccc----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc---cccCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLA----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV---QYFLP  225 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~  225 (341)
                      .........||+.|+|||++.    +..++ .++|||||||++|+|++|..||........   ........   .....
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFD---QLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ----------------------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHHH---HHHHHhcCCCCCCCCc
Confidence            433444557999999999983    34444 458999999999999999999976432111   11111010   11111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ....+++.+.+||.+||+.||.+|||+.++++||||.
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            1235899999999999999999999999999999994

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-49  Score=352.38  Aligned_cols=256  Identities=30%  Similarity=0.494  Sum_probs=210.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLL--TPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~--~~~~~~i   76 (341)
                      .++|++++.||+|+||.||+|.++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            478999999999999999999999999999999987643   23346889999999999999999999885  4678999


Q ss_pred             EEeecCCCchHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           77 VMEYAAGGELFARICSA----GRFSEDEARFFFQQLISGVSYCHSME-----ICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qil~aL~~LH~~~-----iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+||+++.++.  +||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            99999999999998653    34999999999999999999999999     999999999999988776  99999999


Q ss_pred             ccCCCCCC-CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC
Q 019433          148 SKSGLLHS-QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD  226 (341)
Q Consensus       148 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  226 (341)
                      +....... ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.........    ..+...... +.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~~-~~  236 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFR-RI  236 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCC-CC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHH----HHHhhcccc-cC
Confidence            86432211 11234689999999999887765 4589999999999999999999876543222    222222211 12


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      ...+++++.++|.+||+.||.+|||+.++++|+|+....
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            236899999999999999999999999999999996553

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-48  Score=361.30  Aligned_cols=248  Identities=23%  Similarity=0.334  Sum_probs=206.2

Q ss_pred             CCccccceecccCCeEEEEEEEc-------CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|++.+.||+|+||+||+|.+.       .++..||||++.....  ..+.+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            58999999999999999999974       3567899999976432  234688999999999 8999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      .+|+||||+.+|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999997653                489999999999999999999999999999999999998877


Q ss_pred             CCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++......   ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........
T Consensus       241 ~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~  317 (370)
T 2psq_A          241 V--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL  317 (370)
T ss_dssp             C--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             C--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCc-HHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            6  9999999997432221   223345788999999998877654 4899999999999999 9999987654433322


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                          +... ...+....+++++.+||.+||+.||.+|||+.+++++
T Consensus       318 ----~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          318 ----LKEG-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ----HHTT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----HhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                2211 1122334689999999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3e-48  Score=350.50  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=191.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc---HHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.......   +.+..+..+++.++||||+++++++......++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            57899999999999999999999999999999987653222   223344556788899999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSM-EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~-~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  +||+|||++.........
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC---------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCccc
Confidence            99 5555555543 46799999999999999999999995 9999999999999988776  999999998754444444


Q ss_pred             CCccCCCCcccccccc-----ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          158 KSTVGTPAYIAPEVLA-----RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      ....||+.|+|||++.     +..+ +.++|||||||++|+|++|..||...........  ..........+....+++
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--KVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             -----CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--HHHHSCCCCCCSSSCCCH
T ss_pred             cccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--HHhccCCCCCCccCCCCH
Confidence            5567999999999985     2334 4458999999999999999999987544322221  112222333444456899


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ++.+||.+||+.||.+|||+.++++||||.
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            999999999999999999999999999994

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.2e-48  Score=347.51  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=207.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||+||+|.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            68999999999999999999887 67789999998877667889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--CCCCC
Q 019433           83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  159 (341)
                      +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++......  .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccC
Confidence            9999999976 457999999999999999999999999999999999999988776  999999998643211  12233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +... .........++.+.+||
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQG-LRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTT-CCCCCCTTCCHHHHHHH
T ss_pred             CccCcccCCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhcc-cCCCCCCcCCHHHHHHH
Confidence            45678899999998777654 5899999999999998 9999987665433322    2221 11222236789999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.||.+|||+.++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.7e-48  Score=343.49  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=204.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc--------cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI--------DENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      .++|++.+.||+|+||+||+|.+..+++.||+|++......        .+.+.+|+.+++.++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            57999999999999999999999999999999998653321        257889999999999999999999997766 


Q ss_pred             EEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCC---CCEEEeecCC
Q 019433           74 LAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQ---PRLKICDFGY  147 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~---~~ikL~Dfg~  147 (341)
                       ++||||+.+++|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+||+++.++.   ..+||+|||+
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~  175 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL  175 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence             6999999999998888654 47999999999999999999999999  999999999999976442   2489999999


Q ss_pred             ccCCCCCCCCCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          148 SKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       148 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                      +...  ........||+.|+|||++.+  ..+ +.++|||||||++|+|++|..||.........  .............
T Consensus       176 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~  250 (287)
T 4f0f_A          176 SQQS--VHSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPT  250 (287)
T ss_dssp             CBCC--SSCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCC
T ss_pred             cccc--cccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCC
Confidence            9743  233445679999999999843  333 44589999999999999999999875543321  1112222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ....+++.+.+||.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            33478999999999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=365.19  Aligned_cols=254  Identities=19%  Similarity=0.273  Sum_probs=208.3

Q ss_pred             CCCccccceecccCCeEEEEEE-----EcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++++.||+|+||+||+|.     +..++..||||++....  .....+.+|+.+++.++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            3689999999999999999999     55678899999986532  2334678899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecC
Q 019433           75 AIVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFG  146 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg  146 (341)
                      ++|||||.+|+|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG  229 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  229 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence            99999999999999997653       4899999999999999999999999999999999999985442 349999999


Q ss_pred             CccCC---CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSG---LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      +++..   ..........||+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.... 
T Consensus       230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DvwslG~il~ellt~g~~pf~~~~~~~~~~----~i~~~~-  303 (367)
T 3l9p_A          230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSGG-  303 (367)
T ss_dssp             HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTTC-
T ss_pred             cccccccccccccCCCcCCcccEECHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCC-
Confidence            98631   1122334467899999999998877755 4999999999999998 999998765433322    222221 


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..+....+++.+.+||.+||+.||.+|||+.++++|.++
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            122234689999999999999999999999999999776

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-48  Score=355.80  Aligned_cols=253  Identities=23%  Similarity=0.231  Sum_probs=206.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.+++.+ +||||+++++++......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4689999999999999999999999999999999987653 345688999999999 99999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC---CCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~---~~ikL~Dfg~a~~~~~~~  155 (341)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.   ..+||+|||+++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            99 8999999976 467999999999999999999999999999999999999986543   239999999997432222


Q ss_pred             C--------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCC-
Q 019433          156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD-  226 (341)
Q Consensus       156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  226 (341)
                      .        .....||+.|+|||++.+..++. ++|||||||++|+|++|..||........ ......+.......+. 
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~  242 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSR-RDDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIE  242 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHH
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCc-hhHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHH
Confidence            1        24568999999999998877754 58999999999999999999987543222 2222222211111111 


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          227 -YVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       227 -~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                       .....+++.++|.+||+.||.+||++.++++
T Consensus       243 ~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          243 VLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence             1112339999999999999999999999887

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.1e-49  Score=361.73  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=207.6

Q ss_pred             CCCccccceecccCCeEEEEEE-----EcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC-
Q 019433            2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT-   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~-   72 (341)
                      .++|++.+.||+|+||.||+|.     +..+++.||||++.....  ..+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            4789999999999999999999     566789999999976432  234688999999999 7899999999998765 


Q ss_pred             EEEEEEeecCCCchHHHHHhcCC---------------------------------------------------------
Q 019433           73 HLAIVMEYAAGGELFARICSAGR---------------------------------------------------------   95 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~---------------------------------------------------------   95 (341)
                      .+++|||||.+|+|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            48999999999999999976543                                                         


Q ss_pred             ---------CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---CCCCccCC
Q 019433           96 ---------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGT  163 (341)
Q Consensus        96 ---------l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt  163 (341)
                               +++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......   ......||
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCC
Confidence                     899999999999999999999999999999999999987776  9999999997432221   22345688


Q ss_pred             CCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhc
Q 019433          164 PAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIF  242 (341)
Q Consensus       164 ~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  242 (341)
                      +.|+|||++.+..++. ++|||||||++|+|++ |..||........+...+...  ..  .+....+++++.++|.+||
T Consensus       259 ~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~l~~li~~~l  333 (359)
T 3vhe_A          259 LKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG--TR--MRAPDYTTPEMYQTMLDCW  333 (359)
T ss_dssp             GGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT--CC--CCCCTTCCHHHHHHHHHHT
T ss_pred             ceeEChhhhcCCCCCc-hhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC--CC--CCCCCCCCHHHHHHHHHHc
Confidence            8999999998777754 5999999999999998 999998766554444333321  11  2223468999999999999


Q ss_pred             ccCCCCCCChhHHhcC
Q 019433          243 VADPSKRIPIPEIKKH  258 (341)
Q Consensus       243 ~~dp~~R~s~~e~l~h  258 (341)
                      +.||.+|||+.++++|
T Consensus       334 ~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          334 HGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCChhhCCCHHHHHHH
Confidence            9999999999999987

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.3e-48  Score=346.34  Aligned_cols=254  Identities=17%  Similarity=0.203  Sum_probs=208.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            3689999999999999999999999999999999986543 345688999999999 79999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC---CCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ---PRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~---~~ikL~Dfg~a~~~~~~~  155 (341)
                      |+ +++|.+++.... ++++..++.++.||+.||.|||++||+||||||+||+++.++.   ..+||+|||++.......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 899999998754 6999999999999999999999999999999999999976432   349999999987433221


Q ss_pred             --------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH---HHHHHHHHhcccccC
Q 019433          156 --------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN---FRKTIDRIRNVQYFL  224 (341)
Q Consensus       156 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  224 (341)
                              ......||+.|+|||++.+..++ .++|||||||++|+|++|..||........   +........... ..
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~  243 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LR  243 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HH
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HH
Confidence                    23456799999999999887765 459999999999999999999987543222   222211111111 00


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .....+++++.+|+.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            1123689999999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-48  Score=348.37  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=203.2

Q ss_pred             CCCccccceecccCCeEEEEEE----EcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEE
Q 019433            2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~   74 (341)
                      .++|++++.||+|+||+||+|.    +..+++.||||++.... ...+.+.+|+.+++.++||||+++++++...  ..+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            5799999999999999999999    66789999999987643 2335688999999999999999999998653  568


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ  166 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC----
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccC
Confidence            99999999999999997754 5999999999999999999999999999999999999998776  99999999975322


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh------------hHHHHHHHHH
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------------RNFRKTIDRI  217 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~------------~~~~~~~~~~  217 (341)
                      ..    ......+++.|+|||++.+..++. ++|||||||++|+|++|..||......            .........+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCCh-HHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            21    122345677899999998877754 589999999999999999998653210            0111112222


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      . .....+....+++++.+||.+||+.||.+|||+.++++.
T Consensus       246 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          246 K-NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             H-TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             h-ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            1 122233445789999999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-49  Score=367.94  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--EEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--~~~i   76 (341)
                      ++++|++.+.||+|+||+||+|.+..+++.||||++....  ...+.+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4689999999999999999999999999999999987543  33466789999999999999999999998765  7899


Q ss_pred             EEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe----cCCCCCCEEEeecCCcc
Q 019433           77 VMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL----DGSPQPRLKICDFGYSK  149 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili----~~~~~~~ikL~Dfg~a~  149 (341)
                      |||||.+++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++  .+||+|||+++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~  164 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAAR  164 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCE
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCce
Confidence            999999999999987644   39999999999999999999999999999999999998    4444  49999999998


Q ss_pred             CCCCCCCCCCccCCCCccccccccc--------cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLAR--------KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ  221 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (341)
                      ............||+.|+|||++.+        ..+ +.++|||||||++|+|++|..||............+..+....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             EccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            6555555556789999999999865        333 3458999999999999999999975443333233333322211


Q ss_pred             c-------------------cCCCCC----CCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          222 Y-------------------FLPDYV----RVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       222 ~-------------------~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .                   ..+...    .+++.+.+||++||+.||++|||+.+++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            0                   111111    244568899999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.3e-48  Score=347.65  Aligned_cols=248  Identities=21%  Similarity=0.291  Sum_probs=199.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......    .+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            6899999999999999999999999999999998764322    356889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--C
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--Q  156 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~  156 (341)
                      ||+++++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......  .
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC-----------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCcccccccccc
Confidence            99999999999998889999999999999999999999999999999999999988776  9999999986433221  2


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc-ccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ-YFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~  235 (341)
                      .....||+.|+|||++.+..++.+ +||||||+++|+|++|..||...... ...   ..+.... ........+++.+.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMG---AHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             -----CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHH---HHHHSCCCCGGGTSTTCCTHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHH---HHhccCCCCccccCCCCCHHHH
Confidence            234578999999999988777654 89999999999999999999864332 111   1111111 11112346899999


Q ss_pred             HHHHHhcccCCCCCC-ChhHHhc
Q 019433          236 HLLSQIFVADPSKRI-PIPEIKK  257 (341)
Q Consensus       236 ~li~~~L~~dp~~R~-s~~e~l~  257 (341)
                      ++|.+||+.||.+|| |++++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7887776

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.2e-48  Score=341.87  Aligned_cols=247  Identities=30%  Similarity=0.405  Sum_probs=196.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|.+.  ++.||+|++....     ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            68999999999999999999985  8899999987543     2235788999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeeCCCCCCCEEecCC------CCCCEEEeecCCc
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME---ICHRDLKLENTLLDGS------PQPRLKICDFGYS  148 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~---iiHrDikp~Nili~~~------~~~~ikL~Dfg~a  148 (341)
                      |||+++++|..++. ..++++..++.++.|++.||.|||++|   |+||||||+||+++..      ....+||+|||++
T Consensus        85 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~  163 (271)
T 3dtc_A           85 MEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA  163 (271)
T ss_dssp             EECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred             EEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence            99999999988874 567999999999999999999999999   8999999999999852      1334999999998


Q ss_pred             cCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ..... .......||+.|+|||++.+..++. ++||||||+++|+|++|..||..........    .........+...
T Consensus       164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~  237 (271)
T 3dtc_A          164 REWHR-TTKMSAAGAYAWMAPEVIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMNKLALPIPS  237 (271)
T ss_dssp             -------------CCGGGSCHHHHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTSCCCCCCCT
T ss_pred             ccccc-ccccCCCCccceeCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcCCCCCCCCc
Confidence            74322 2233567999999999998777654 5899999999999999999998765433322    2222222333345


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+++.+.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            789999999999999999999999999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-48  Score=346.69  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=212.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++.+.||+|+||+||+|.++.++..||+|++.......+.+.+|+.+++.++||||+++++++......++||||+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            46899999999999999999999999999999999877666778999999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           82 AGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      .+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++.......  ..
T Consensus        92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~  169 (288)
T 3kfa_A           92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAH  169 (288)
T ss_dssp             TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEE
T ss_pred             CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccccc
Confidence            999999999864  35999999999999999999999999999999999999987776  9999999987433222  12


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+|+.|+|||++.+..++. ++||||||+++|+|++ |..||.......... .+..    ....+....+++.+.+
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          170 AGAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEK----DYRMERPEGCPEKVYE  243 (288)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHT----TCCCCCCTTCCHHHHH
T ss_pred             cCCccccCcCChhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhc----cCCCCCCCCCCHHHHH
Confidence            2345678899999998777654 5899999999999999 999998765443322 2211    1222333478999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ||.+||..||.+|||+.++++.
T Consensus       244 li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCChhhCcCHHHHHHH
Confidence            9999999999999999999873

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4e-48  Score=349.38  Aligned_cols=256  Identities=26%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCC--CCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|++++.||+|+||.||+|.+. +++.||||++.....   ..+.+.+|+.+++.++  ||||+++++++......++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            468999999999999999999996 588999999865432   3356788999999997  5999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++++ +.  +||+|||++....... 
T Consensus       106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~--~kL~Dfg~~~~~~~~~~  181 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM--LKLIDFGIANQMQPDTT  181 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE--EEECCCSSSCC------
T ss_pred             EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce--EEEeeccccccccCccc
Confidence            999 567899999998889999999999999999999999999999999999999964 44  9999999987532221 


Q ss_pred             --CCCCccCCCCcccccccccc----------ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          156 --QPKSTVGTPAYIAPEVLARK----------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                        ......||+.|+|||++.+.          ...+.++|||||||++|+|++|..||........   ...........
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~  258 (313)
T 3cek_A          182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE  258 (313)
T ss_dssp             --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSC
T ss_pred             cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccc
Confidence              12345789999999998752          2234558999999999999999999976544221   11222222222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      .+.....+.++.+||.+||+.||.+|||+.++++||||....
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            222235688999999999999999999999999999996543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.1e-48  Score=345.84  Aligned_cols=247  Identities=24%  Similarity=0.350  Sum_probs=209.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----------   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----------   70 (341)
                      .++|++++.||+|+||.||+|.+..+++.||+|++....   +.+.+|+.+++.++||||+++++++..           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            468999999999999999999999999999999987643   467799999999999999999999864           


Q ss_pred             -----CCEEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEe
Q 019433           71 -----PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKIC  143 (341)
Q Consensus        71 -----~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~  143 (341)
                           ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~  164 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIG  164 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEEC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEEC
Confidence                 45589999999999999999754  57999999999999999999999999999999999999998776  9999


Q ss_pred             ecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc
Q 019433          144 DFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF  223 (341)
Q Consensus       144 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  223 (341)
                      |||++.............||+.|+|||++.+..++. ++|||||||++|+|++|..||...      ......+....  
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~--  235 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK-EVDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI--  235 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCT-HHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC--
T ss_pred             cchhheeccccccccccCCcccccChhhhccCCCcc-hhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc--
Confidence            999987654444455667999999999998877755 499999999999999999887431      11222222211  


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+  ..+++.+.+||.+||+.||.+|||+.++++|.+....
T Consensus       236 ~~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 IS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             CC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             cc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            22  3588999999999999999999999999999876443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.9e-48  Score=349.15  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=207.5

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|++....  ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            368999999999999999999983     456899999987643  2335688999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCE
Q 019433           75 AIVMEYAAGGELFARICSAGR------------------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT  130 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Ni  130 (341)
                      ++||||+.+++|.+++.....                        +++..++.++.||+.||.|||++||+||||||+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI  181 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI  181 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence            999999999999999987543                        89999999999999999999999999999999999


Q ss_pred             EecCCCCCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 019433          131 LLDGSPQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED  206 (341)
Q Consensus       131 li~~~~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~  206 (341)
                      +++.++.  +||+|||++.......   ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||.....
T Consensus       182 li~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          182 LVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             EEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             EEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCc-hhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9998776  9999999987432221   223445788899999998777654 4899999999999999 9999987655


Q ss_pred             hhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..... .+   ... ...+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~-~~---~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          259 ERLFN-LL---KTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GGHHH-HH---HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-Hh---hcC-CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            43322 22   111 1122334789999999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.5e-48  Score=351.19  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=206.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEE--EEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELV--AVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|.++.++..+  |+|.+...  ....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999999888866  99988653  23445688999999999 899999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           78 MEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      |||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EE
Confidence            99999999999997654                6999999999999999999999999999999999999988776  99


Q ss_pred             EeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      |+|||++.............+++.|+|||++.+..++. ++|||||||++|+|++ |..||........    ...+...
T Consensus       183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~~~  257 (327)
T 1fvr_A          183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEKLPQG  257 (327)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHGGGT
T ss_pred             EcccCcCccccccccccCCCCCccccChhhhccccCCc-hhcchHHHHHHHHHHcCCCCCCCCCcHHHH----HHHhhcC
Confidence            99999987543333344556788999999998777654 5899999999999998 9999987654322    2222221


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       ...+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       258 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             2223334789999999999999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.6e-48  Score=345.15  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             CCCccccceecccCCeEEEEEE----EcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CE
Q 019433            2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTP--TH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~   73 (341)
                      .++|++++.||+|+||.||+|.    +..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3579999999999999999999    67789999999987543  3346788999999999999999999999877  67


Q ss_pred             EEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           74 LAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      +++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECccccccccc
Confidence            8999999999999999954 457999999999999999999999999999999999999988776  9999999987543


Q ss_pred             CCC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCC-----------ChhHHHHHHHHH
Q 019433          153 LHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-----------DPRNFRKTIDRI  217 (341)
Q Consensus       153 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~-----------~~~~~~~~~~~~  217 (341)
                      ...    ......||+.|+|||++.+..++. ++|||||||++|+|++|..|+....           ............
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYI-ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCc-chhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            322    233456888899999998877764 4899999999999999998874321           111112222222


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      . .....+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       257 ~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          257 K-EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             H-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             h-ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2 22223334578999999999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-48  Score=357.29  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=207.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcC-------CCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP   71 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~   71 (341)
                      .++|++.+.||+|+||+||+|.+..       .+..||+|++.....  ....+.+|+.+++.+ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4789999999999999999999753       346799999876432  235688999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC
Q 019433           72 THLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~  135 (341)
                      +..++||||+.+++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  227 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence            99999999999999999997754                49999999999999999999999999999999999999887


Q ss_pred             CCCCEEEeecCCccCCCCC---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHH
Q 019433          136 PQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR  211 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~  211 (341)
                      +.  +||+|||+++.....   .......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||........  
T Consensus       228 ~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwslG~il~ellt~g~~p~~~~~~~~~--  302 (382)
T 3tt0_A          228 NV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--  302 (382)
T ss_dssp             CC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--
T ss_pred             Cc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            76  999999999743322   2233456788999999998877654 4899999999999999 9999987554322  


Q ss_pred             HHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                        ...+.... .......+++++.+||.+||+.||.+|||+.+++++
T Consensus       303 --~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 --FKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             --HHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHHHcCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              22222211 122234789999999999999999999999999985

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-48  Score=354.18  Aligned_cols=250  Identities=21%  Similarity=0.251  Sum_probs=198.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----EEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|.+.  ++.||||++...........+|+.+++.++||||+++++++....    .+++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            68999999999999999999885  789999999776555566777999999999999999999998743    479999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM----------EICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~----------~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      ||+++|+|.+++.. ..+++..++.++.|++.||.|||++          ||+||||||+|||++.++.  +||+|||++
T Consensus       102 e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTC
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcc
Confidence            99999999999965 4599999999999999999999999          9999999999999988776  999999999


Q ss_pred             cCCCCC---CCCCCccCCCCccccccccccc----cCCCccchhhHHHHHHHHHhCCCCCCCCCChh------------H
Q 019433          149 KSGLLH---SQPKSTVGTPAYIAPEVLARKE----YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR------------N  209 (341)
Q Consensus       149 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~------------~  209 (341)
                      +.....   .......||+.|+|||++.+..    ..+.++|||||||++|+|++|..||....+..            .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            642222   1233467999999999997632    22234799999999999999999997643211            1


Q ss_pred             HHHHHHHHhcccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          210 FRKTIDRIRNVQYFLPDY------VRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ............ ..+..      ...++.+.+||.+||+.||.+|||+.++++.
T Consensus       259 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          259 LEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111111111111 11111      1123459999999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=356.56  Aligned_cols=255  Identities=20%  Similarity=0.203  Sum_probs=200.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcC---CCcEEEEEEcccCcc------------ccHHHHHHHHHHhcCCCCCeeeEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKK------------IDENVQREIINHRSLRHPNIIRFKE   66 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~ei~~~~~l~hp~iv~l~~   66 (341)
                      .++|++.+.||+|+||+||+|.+..   ++..+|||++.....            ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            5789999999999999999999987   889999999876432            2234667888899999999999999


Q ss_pred             EEEc----CCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEE
Q 019433           67 VLLT----PTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKI  142 (341)
Q Consensus        67 ~~~~----~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL  142 (341)
                      ++..    ....++||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++...+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9988    78899999999 999999998877899999999999999999999999999999999999998777445999


Q ss_pred             eecCCccCCCCCC--------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCC-CChhHHHHH
Q 019433          143 CDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDP-EDPRNFRKT  213 (341)
Q Consensus       143 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~-~~~~~~~~~  213 (341)
                      +|||+++......        ......||+.|+|||++.+..++. ++|||||||++|+|++|..||... .+.......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSR-RSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999996432211        113457999999999998876654 599999999999999999999543 222222222


Q ss_pred             HHHHhcc-ccc---CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          214 IDRIRNV-QYF---LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       214 ~~~~~~~-~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....... ...   ......+++++.+||.+||+.||.+|||+.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            2221110 000   00112688999999999999999999999999874

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.6e-48  Score=348.54  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=209.9

Q ss_pred             CCCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~   73 (341)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36899999999999999999985     46788999999876532  335688999999999 99999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC
Q 019433           74 LAIVMEYAAGGELFARICSAG------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~  135 (341)
                      .++||||+++++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence            999999999999999997654                  48999999999999999999999999999999999999877


Q ss_pred             CCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHH
Q 019433          136 PQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR  211 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~  211 (341)
                      +.  +||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||..........
T Consensus       182 ~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          182 RI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             TE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             CC--EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            76  99999999875332221   2334577889999999877765 45899999999999998 999998766554444


Q ss_pred             HHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ......    ...+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          259 KMIKEG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhccC----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            433321    1222334689999999999999999999999999985

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.7e-48  Score=360.90  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=205.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ++|++.+.||+|+||.||+|.++.+++.||||++.....  ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            679999999999999999999999999999999875421  223577899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC---C
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS---Q  156 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~---~  156 (341)
                      +++|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++......   .
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeec
Confidence            99999999997654 6999999999999999999999999999999999999988776  9999999987432211   1


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....+++.|+|||++.+..++. ++|||||||++|+|++ |..||......... .   .+.. ....+....+++.+.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~el~t~g~~p~~~~~~~~~~-~---~~~~-~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSS-ESDVWSFGILLWETFSLGASPYPNLSNQQTR-E---FVEK-GGRLPCPELCPDAVF  345 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-H---HHHT-TCCCCCCTTCCHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H---HHHc-CCCCCCCCCCCHHHH
Confidence            11233567899999998777755 4899999999999998 99999876543222 1   1221 122333346889999


Q ss_pred             HHHHHhcccCCCCCCChhHHhc
Q 019433          236 HLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +||.+||+.||.+|||+.++++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-48  Score=343.69  Aligned_cols=248  Identities=24%  Similarity=0.367  Sum_probs=196.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|++.+.||+|+||.||+|.+..+   +..||+|++....  ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            47899999999999999999998654   5579999987542  23456889999999999999999999984 566899


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCccc
Confidence            999999999999997654 6999999999999999999999999999999999999998776  9999999987533222


Q ss_pred             C--CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          156 Q--PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                      .  .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||............    .... ..+....+++
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~~-~~~~~~~~~~  244 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGE-RLPMPPNCPP  244 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTC-CCCCCTTCCH
T ss_pred             ccccccCCCcccccChhhcccCCCCC-ccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcCC-CCCCCCCCCH
Confidence            1  22345678899999998777654 4899999999999996 99999876654433322    2211 1233347899


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.++|.+||+.||.+|||+.+++++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-47  Score=338.58  Aligned_cols=244  Identities=20%  Similarity=0.273  Sum_probs=205.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcC--CEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTP--THLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~--~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++....   ...+.+.+|+.+++.++||||+++++++...  ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            68999999999999999999985  8899999987643   2234688999999999999999999999887  788999


Q ss_pred             EeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           78 MEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      |||+++++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+||+++.++.  ++|+|||++..   
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~---  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS---  162 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT---
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee---
Confidence            99999999999998765  4899999999999999999999999  999999999999998776  89998887653   


Q ss_pred             CCCCCCccCCCCccccccccccccCCC--ccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGK--ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                       .......||+.|+|||++.+..+...  ++|||||||++|+|++|..||.............    ......+....++
T Consensus       163 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~  237 (271)
T 3kmu_A          163 -FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA----LEGLRPTIPPGIS  237 (271)
T ss_dssp             -TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH----HSCCCCCCCTTCC
T ss_pred             -ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH----hcCCCCCCCCCCC
Confidence             22345678999999999987665442  5899999999999999999998765543332222    1222222334689


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+.+||.+||+.||.+|||+.++++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          238 PHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2e-48  Score=349.01  Aligned_cols=250  Identities=25%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhc--CCCCCeeeEEEEEEc----CCEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLT----PTHL   74 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~--l~hp~iv~l~~~~~~----~~~~   74 (341)
                      +.++|++++.||+|+||+||+|.+  +++.||||++....  .....+|..++..  ++||||+++++++..    ...+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            468999999999999999999988  68999999987643  3444555555554  899999999998654    3568


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SMEICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      ++||||+++|+|.+++. ...+++..++.++.|++.||.|||        ++||+||||||+|||++.++.  +||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCT
T ss_pred             EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCC
Confidence            99999999999999984 457999999999999999999999        999999999999999988776  9999999


Q ss_pred             CccCCCCCC-----CCCCccCCCCccccccccccccC-----CCccchhhHHHHHHHHHhC----------CCCCCCCCC
Q 019433          147 YSKSGLLHS-----QPKSTVGTPAYIAPEVLARKEYD-----GKISDVWSCGVTLYVMLVG----------AYPFEDPED  206 (341)
Q Consensus       147 ~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~vl~~l~~g----------~~pf~~~~~  206 (341)
                      +++......     ......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            986322111     12345799999999999876322     1358999999999999999          888865432


Q ss_pred             hhHHHHHHHHHhcccccCCCC------CCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          207 PRNFRKTIDRIRNVQYFLPDY------VRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..................+..      ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            211112222211111111111      124577999999999999999999999987

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.9e-48  Score=346.11  Aligned_cols=247  Identities=17%  Similarity=0.197  Sum_probs=203.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCC-------cEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTK-------ELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      .++|++.+.||+|+||+||+|.+..++       ..||+|++.... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            579999999999999999999998877       479999986543 345678899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC------CEEEeecC
Q 019433           74 LAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP------RLKICDFG  146 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~------~ikL~Dfg  146 (341)
                      .++||||+.+++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++..      .+||+|||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9999999999999999987654 9999999999999999999999999999999999999876541      28999999


Q ss_pred             CccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-CCCCCCCChhHHHHHHHHHhcccccCC
Q 019433          147 YSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLP  225 (341)
Q Consensus       147 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  225 (341)
                      ++....   ......||+.|+|||++.+....+.++|||||||++|+|++|. +||.... ........    ......+
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~~~~~~~----~~~~~~~  238 (289)
T 4fvq_A          167 ISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-SQRKLQFY----EDRHQLP  238 (289)
T ss_dssp             SCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHH----HTTCCCC
T ss_pred             cccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-hHHHHHHh----hccCCCC
Confidence            986432   2234568999999999987444456699999999999999955 5554433 22222211    1122222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                        ...++++.+||.+||+.||.+|||+.++++|
T Consensus       239 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 --APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              2467889999999999999999999999997

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-48  Score=353.80  Aligned_cols=250  Identities=25%  Similarity=0.362  Sum_probs=207.3

Q ss_pred             CCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||.||+|.+     ..++..||+|++...  ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            5799999999999999999997     346778999998753  23456789999999999 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEE
Q 019433           75 AIVMEYAAGGELFARICSAG-----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL  131 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nil  131 (341)
                      ++||||+++|+|.+++....                       .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999997653                       3799999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCh
Q 019433          132 LDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP  207 (341)
Q Consensus       132 i~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~  207 (341)
                      ++.++.  +||+|||++........   .....||+.|+|||++.+..++. ++|||||||++|+|++ |..||......
T Consensus       205 l~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          205 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EcCCCc--EEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh-hHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            988776  99999999874322211   22345788999999998777654 5899999999999998 99999876655


Q ss_pred             hHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCC
Q 019433          208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP  259 (341)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  259 (341)
                      ..+...+..    ....+....+++++.+||.+||+.||.+|||+.++++|.
T Consensus       282 ~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          282 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            444433322    222233346899999999999999999999999999973

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-48  Score=339.27  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=209.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            68999999999999999999997 67889999998876667789999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--CCCCC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--~~~~~  159 (341)
                      +++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++......  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccccccc
Confidence            99999999765 46999999999999999999999999999999999999987776  999999998743211  12234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+++.|+|||++.+..++ .++||||||+++|+|++ |..||..........    .+... .........++.+.+++
T Consensus       165 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~i~~~-~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHHHHHHH
T ss_pred             ccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHH----HHhcC-CcCCCCccCcHHHHHHH
Confidence            5677889999999877765 45999999999999999 899998765433322    22221 11222336789999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.||.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.1e-48  Score=351.27  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcE----EEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKEL----VAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++++.||+|+||+||+|.+..+++.    ||+|.+...  ......+.+|+.+++.++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            57899999999999999999999888876    777776443  233456778999999999999999999886 45689


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcc
Confidence            999999999999998764 47999999999999999999999999999999999999988776  999999999753322


Q ss_pred             C---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 S---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .   ......||+.|+|||++.+..++. ++|||||||++|+|++ |..||.......... .   +... ...+.....
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~---~~~~-~~~~~~~~~  242 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTH-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-L---LEKG-ERLAQPQIC  242 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-H---HHTT-CBCCCCTTB
T ss_pred             cccccccCCCCcccccChHHhccCCCCh-hhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-H---HHcC-CCCCCCCcC
Confidence            2   223456788999999998777654 5999999999999999 999998765433222 2   2211 122223357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++++.+||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999997

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-48  Score=353.77  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=206.6

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++++.||+|+||.||+|.+.     .+++.||||++....  ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            368999999999999999999997     456899999987643  2345688999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCE
Q 019433           75 AIVMEYAAGGELFARICSA------------------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENT  130 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Ni  130 (341)
                      ++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI  205 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC  205 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence            9999999999999999763                        5699999999999999999999999999999999999


Q ss_pred             EecCCCCCCEEEeecCCccCCCCC---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCC
Q 019433          131 LLDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPED  206 (341)
Q Consensus       131 li~~~~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~  206 (341)
                      |++.++.  +||+|||++......   .......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||.....
T Consensus       206 l~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          206 LVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             EECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             EECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc-ccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            9988776  999999998632211   2233456889999999998777654 5999999999999999 9999987654


Q ss_pred             hhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          207 PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ....    ..+..... .+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       283 ~~~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          283 EEVI----YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHH----HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHH----HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            3322    22222221 12234689999999999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.3e-48  Score=351.49  Aligned_cols=248  Identities=23%  Similarity=0.347  Sum_probs=199.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEE----EEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELV----AVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      +++|++++.||+|+||+||+|.+..+++.+    |+|.+...  ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            478999999999999999999998887654    77776543  234567889999999999999999999998765 78


Q ss_pred             EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +|++|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCC
Confidence            89999999999999977 457999999999999999999999999999999999999998776  999999998642222


Q ss_pred             C---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 S---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .   ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||........ ...+..    ....+.....
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~----~~~~~~~~~~  244 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK----GERLPQPPIC  244 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHT----TCCCCCCTTB
T ss_pred             cccccccCCCccccccChHHhccCCCCc-hhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHHc----CCCCCCCccC
Confidence            1   122345688999999998877754 5999999999999999 9999987654332 222221    1223334468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.++.+++.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.7e-47  Score=352.62  Aligned_cols=253  Identities=16%  Similarity=0.222  Sum_probs=197.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC-----CcEEEEEEcccCcc------------ccHHHHHHHHHHhcCCCCCeeeE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT-----KELVAVKYIERGKK------------IDENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      .++|++.+.||+|+||+||+|.+..+     ++.||||++.....            .......|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            46899999999999999999999764     58899999876431            11234456666778899999999


Q ss_pred             EEEEEcC----CEEEEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           65 KEVLLTP----THLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        65 ~~~~~~~----~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      ++++...    ...++||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+....
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 99999999775 5799999999999999999999999999999999999998333345


Q ss_pred             EEEeecCCccCCCCCC--------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHH
Q 019433          140 LKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFR  211 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~  211 (341)
                      +||+|||+++......        ......||+.|+|||++.+..++. ++|||||||++|+|++|..||..........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR-RGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            9999999996432221        123445999999999998877654 5999999999999999999998643322222


Q ss_pred             HHHH-HHhcc-c----ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          212 KTID-RIRNV-Q----YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       212 ~~~~-~~~~~-~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .... ..... .    ..++ ...+++++.+|+..||+.||.+|||+.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            1111 11100 0    0111 1367999999999999999999999999987

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-47  Score=341.40  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=194.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +++|++.+.||+|+||+||+|.+..   .||+|++.....   ..+.+.+|+.+++.++||||++++++. .....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            5799999999999999999998753   499999875432   235688999999999999999999964 556689999


Q ss_pred             eecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---C
Q 019433           79 EYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---H  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---~  154 (341)
                      ||+.+++|..++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.....   .
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC-----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceecccccccccc
Confidence            99999999999854 446999999999999999999999999999999999999998776  99999999864322   2


Q ss_pred             CCCCCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          155 SQPKSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      .......||+.|+|||++.   +..+ +.++|||||||++|+|++|..||........+...................++
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             ccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence            2233457999999999986   3333 34589999999999999999999887766555444433221111111123688


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+.+||.+||+.||.+|||+.++++.
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999999999999999999999999873

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.8e-47  Score=342.43  Aligned_cols=251  Identities=26%  Similarity=0.366  Sum_probs=197.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++....    .....+.+|+.+++.++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            58999999999999999999999999999999987532    23346789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           79 EYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        79 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||+.+++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  189 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC---------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCC
Confidence            99999999998864    456999999999999999999999999999999999999988776  999999998643222


Q ss_pred             -CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          155 -SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                       .......|++.|+|||++.+..++. ++|||||||++|+|++|..||......  .......+............++++
T Consensus       190 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          190 TTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ---------CCSSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CccccccCCCeeEeChHHhCCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCHH
Confidence             1223457899999999998777654 489999999999999999999764321  112222333322222222468999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+||.+||..||.+|||+.+++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999984

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-48  Score=351.20  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=194.6

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHh--cCCCCCeeeEEEEEEcC----CEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR--SLRHPNIIRFKEVLLTP----THLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~--~l~hp~iv~l~~~~~~~----~~~~   75 (341)
                      .++|++++.||+|+||.||+|.+.  ++.||||++.....  ....+|..++.  .++||||+++++++...    ...+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            468999999999999999999985  89999999875433  33444555444  45999999999999887    7899


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------EICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      +||||+.+++|.+++.. ..+++..++.++.|++.||.|||++        ||+||||||+|||++.++.  +||+|||+
T Consensus       112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~  188 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL  188 (337)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTT
T ss_pred             EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCC
Confidence            99999999999999965 4799999999999999999999999        9999999999999988776  99999999


Q ss_pred             ccCCCCCCC-----CCCccCCCCccccccccccccCCC-----ccchhhHHHHHHHHHhC----------CCCCCCCCCh
Q 019433          148 SKSGLLHSQ-----PKSTVGTPAYIAPEVLARKEYDGK-----ISDVWSCGVTLYVMLVG----------AYPFEDPEDP  207 (341)
Q Consensus       148 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~vl~~l~~g----------~~pf~~~~~~  207 (341)
                      +........     .....||+.|+|||++.+......     ++|||||||++|+|++|          ..||......
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            864322221     234579999999999987665443     37999999999999999          7777653322


Q ss_pred             hHHHHHHHHHhccc---ccCCC---CCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          208 RNFRKTIDRIRNVQ---YFLPD---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       208 ~~~~~~~~~~~~~~---~~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..............   ...+.   ...+++.+.+||.+||+.||.+|||+.++++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            11111122211111   11111   11355679999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4e-47  Score=359.60  Aligned_cols=242  Identities=24%  Similarity=0.366  Sum_probs=204.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-EEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT-HLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-~~~iv~e~~   81 (341)
                      ++|++++.||+|+||.||+|.+.  ++.||||++.... ..+.+.+|+.+++.++||||+++++++.... .+++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            57999999999999999999985  7899999998654 5678999999999999999999999987665 799999999


Q ss_pred             CCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      .+|+|.+++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....  ....
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~--~~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCcccccc--cccC
Confidence            99999999987653  799999999999999999999999999999999999988776  99999999974322  2233


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+++.|+|||++.+..++. ++|||||||++|+|++ |..||............    .. ....+....+++.+.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~-~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EK-GYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----HT-TCCCCCCTTCCHHHHHHH
T ss_pred             CCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCcCCHHHHHHH
Confidence            46788999999998877765 4999999999999998 99999876654433322    11 122333347899999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||..||.+|||+.++++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9e-48  Score=352.85  Aligned_cols=251  Identities=14%  Similarity=0.167  Sum_probs=204.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC--------CcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeee----------
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT--------KELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR----------   63 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~----------   63 (341)
                      .++|++.+.||+|+||.||+|.+..+        ++.||||++...    ..+.+|+.+++.++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            47999999999999999999999874        889999998764    46889999999999999887          


Q ss_pred             -----EEEEEEc-CCEEEEEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC
Q 019433           64 -----FKEVLLT-PTHLAIVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        64 -----l~~~~~~-~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~  135 (341)
                           +++++.. ....++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                 6777765 78899999999 99999999876  689999999999999999999999999999999999999987


Q ss_pred             CCCCEEEeecCCccCCCCCC--------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCC-C
Q 019433          136 PQPRLKICDFGYSKSGLLHS--------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPE-D  206 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~-~  206 (341)
                      +...+||+|||+++......        ......||+.|+|||++.+..++. ++|||||||++|+|++|..||.... .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR-RSDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCc-hhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            62349999999996432221        123457999999999998877654 5999999999999999999998754 3


Q ss_pred             hhHHHHHHHHHhcccccC----CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          207 PRNFRKTIDRIRNVQYFL----PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ...+.............+    ..+..+++.+.+||.+||+.||.+|||+.++++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            333333333222221111    1123579999999999999999999999999873

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-47  Score=366.77  Aligned_cols=248  Identities=22%  Similarity=0.318  Sum_probs=211.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||+|.++.++..||||++.......+.+.+|+.+++.++||||+++++++.....+++||||+.
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46889999999999999999999999999999998776667889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecC
Confidence            99999999764  45999999999999999999999999999999999999987776  9999999997532211  122


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+++.|+|||++.+..++. ++|||||||++|+|++ |..||........... +   .. ....+....+++.+.+|
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~-~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~---~~-~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-L---EK-DYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H---HT-TCCCCCCTTCCHHHHHH
T ss_pred             CCcCCcceeCHhHHhcCCCCc-HHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-H---Hc-CCCCCCCCCCCHHHHHH
Confidence            344677899999998877755 4999999999999999 9999987665433322 2   11 22233344789999999


Q ss_pred             HHHhcccCCCCCCChhHHhcC
Q 019433          238 LSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~h  258 (341)
                      |.+||+.||.+|||+.++++.
T Consensus       452 i~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHHH
Confidence            999999999999999999873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.2e-48  Score=352.35  Aligned_cols=254  Identities=22%  Similarity=0.260  Sum_probs=204.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++.+.||+|+||+||+|.+. +++.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            479999999999999999999975 78999999987643 3345788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           81 AAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        81 ~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      +++++|.+++....    .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....... 
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  194 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQ  194 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccccc
Confidence            99999999886543    5899999999999999999999999999999999999988776  9999999987432211 


Q ss_pred             --CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHH--HH-HHHHHhcccc---cCCC-
Q 019433          156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF--RK-TIDRIRNVQY---FLPD-  226 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~--~~-~~~~~~~~~~---~~~~-  226 (341)
                        ......||+.|+|||++.+..++. ++|||||||++|+|++|..||.........  .. ..........   ..+. 
T Consensus       195 ~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (321)
T 2qkw_B          195 THLSTVVKGTLGYIDPEYFIKGRLTE-KSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL  273 (321)
T ss_dssp             CCCBCCCEEETTTCCHHHHHHCBCCT-HHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred             cccccccCCCccccCHHHhcCCCCCc-ccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhh
Confidence              223446899999999998777765 489999999999999999999764332111  11 0111111110   0010 


Q ss_pred             ----CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCC
Q 019433          227 ----YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP  259 (341)
Q Consensus       227 ----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  259 (341)
                          ....+..+.+++.+||+.||.+|||+.++++|.
T Consensus       274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                112456789999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.7e-47  Score=339.25  Aligned_cols=251  Identities=21%  Similarity=0.203  Sum_probs=202.3

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEE-EEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV-LLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~-~~~~~~~~iv~e   79 (341)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++..... .+.+.+|+.+++.++|++++..+.. +......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999999999999999999876543 4568899999999988775555554 467788999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEec---CCCCCCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLD---GSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~---~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++   .++.  +||+|||++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe--EEEeeCCCcccccccc
Confidence            99 8899999974 45799999999999999999999999999999999999994   5554  9999999987433222


Q ss_pred             C--------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCC---hhHHHHHHHHHhcccccC
Q 019433          156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---PRNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  224 (341)
                      .        .....||+.|+|||++.+..++. ++|||||||++|+|++|..||.....   ...+............ .
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~  240 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E  240 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H
T ss_pred             cccccccccccccccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-H
Confidence            1        24567999999999998877654 58999999999999999999986432   2222222222111110 0


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .....+|+++.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            011368899999999999999999999999987

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2e-47  Score=341.47  Aligned_cols=251  Identities=21%  Similarity=0.212  Sum_probs=197.9

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEE-EEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEV-LLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~-~~~~~~~~iv~e   79 (341)
                      +.++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+.. +......++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            46899999999999999999999999999999998765432 3468899999999987776655554 467788999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe---cCCCCCCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili---~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.  +||+|||++.......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe--EEEecCccceeccCcc
Confidence            99 8899999875 4579999999999999999999999999999999999999   55555  9999999997433221


Q ss_pred             --------CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh---hHHHHHHHHHhcccccC
Q 019433          156 --------QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP---RNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       156 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~  224 (341)
                              ......||+.|+|||++.+..++ .++|||||||++|+|++|..||......   ..+............ .
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~  240 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E  240 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-h
Confidence                    22356799999999999887765 4589999999999999999999764432   222222221111110 0


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .....+++++.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            011357899999999999999999999999987

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.3e-47  Score=348.11  Aligned_cols=253  Identities=26%  Similarity=0.410  Sum_probs=207.3

Q ss_pred             CCCccccceecccCCeEEEEEE----EcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEE--cCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLL--TPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~--~~~~~   74 (341)
                      .++|++++.||+|+||.||+|.    +..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            3689999999999999999999    57789999999987653 23346889999999999999999999987  45679


Q ss_pred             EEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCT
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceeccc
Confidence            999999999999999977 446999999999999999999999999999999999999988776  99999999874322


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----------hHHHHHHHHHh
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDRIR  218 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~  218 (341)
                      ..    ......||+.|+|||++.+..++. ++|||||||++|+|++|..||......           .........+.
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSR-QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCCh-HHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            22    223456888899999998877654 489999999999999999998653221           11112222222


Q ss_pred             cccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          219 NVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          259 -EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             122233445789999999999999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-48  Score=361.73  Aligned_cols=253  Identities=28%  Similarity=0.345  Sum_probs=194.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .+|++.+.||+|+||+||. ....+++.||||++....  ...+.+|+.+++.+ +||||+++++++.+....|+|||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            4699999999999999764 444589999999986543  33467899999998 7999999999999999999999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC---CCCCCEEEeecCCccCCCCC---
Q 019433           82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG---SPQPRLKICDFGYSKSGLLH---  154 (341)
Q Consensus        82 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~---~~~~~ikL~Dfg~a~~~~~~---  154 (341)
                      . |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++..++||+|||+++.....   
T Consensus       101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~  179 (432)
T 3p23_A          101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS  179 (432)
T ss_dssp             S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred             C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence            6 49999887654 4666678899999999999999999999999999999953   34445899999999754322   


Q ss_pred             -CCCCCccCCCCcccccccccc--ccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhccccc-CCCCCC
Q 019433          155 -SQPKSTVGTPAYIAPEVLARK--EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYF-LPDYVR  229 (341)
Q Consensus       155 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  229 (341)
                       .......||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||....... ...   ........ ......
T Consensus       180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~---~~~~~~~~~~~~~~~  255 (432)
T 3p23_A          180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANI---LLGACSLDCLHPEKH  255 (432)
T ss_dssp             ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHH---HTTCCCCTTSCTTCH
T ss_pred             eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHH---HhccCCccccCcccc
Confidence             223446799999999999742  222345899999999999999 999996543321 111   11111111 111123


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      .+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            4566899999999999999999999999999954

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.6e-48  Score=348.83  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=201.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEE----cCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLL----TPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~----~~~~~~i   76 (341)
                      .++|++++.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999999999999999999886532 34457889999999999999999999987    3457899


Q ss_pred             EEeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           77 VMEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      ||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcc
Confidence            9999999999998876    467999999999999999999999999999999999999988776  9999999886432


Q ss_pred             CCCCC----------CCccCCCCcccccccccccc--CCCccchhhHHHHHHHHHhCCCCCCCCCC-hhHHHHHHHHHhc
Q 019433          153 LHSQP----------KSTVGTPAYIAPEVLARKEY--DGKISDVWSCGVTLYVMLVGAYPFEDPED-PRNFRKTIDRIRN  219 (341)
Q Consensus       153 ~~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~vl~~l~~g~~pf~~~~~-~~~~~~~~~~~~~  219 (341)
                      .....          ....||+.|+|||++.+...  .+.++|||||||++|+|++|..||..... ......   ... 
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~-  261 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---AVQ-  261 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---HHH-
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---Hhh-
Confidence            11110          12357999999999875432  24459999999999999999999953110 001111   111 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          220 VQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            133345555789999999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-47  Score=345.79  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=206.8

Q ss_pred             CCCccccceecccCCeEEEEEEE-----cCCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC-
Q 019433            2 EERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT-   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~-   72 (341)
                      .++|++.+.||+|+||+||+|.+     ..+++.||||++.....  ..+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999985     45789999999876532  234688999999999 7999999999987754 


Q ss_pred             EEEEEEeecCCCchHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGR----------------FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      .+++||||+++++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence            58999999999999999987554                89999999999999999999999999999999999998777


Q ss_pred             CCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||++........   .....||+.|+|||++.+..++. ++|||||||++|+|++ |..||........+..
T Consensus       186 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~  262 (316)
T 2xir_A          186 V--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  262 (316)
T ss_dssp             C--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             C--EEECCCccccccccCccceeccCCCcceeecCchhhccccccc-hhHHHHHHHHHHHHHhCCCCCCcccchhHHHHH
Confidence            6  99999999875332221   22346788999999998777654 5899999999999998 9999987665444433


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+...  ..  .+....+++.+.++|.+||+.||.+|||+.++++|
T Consensus       263 ~~~~~--~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          263 RLKEG--TR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHT--CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhccC--cc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33221  11  22223589999999999999999999999999997

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1e-47  Score=348.81  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=204.6

Q ss_pred             CCCccccceecccCCeEEEEEE-----EcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVR-----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++++.||+|+||.||+|.     +..++..||||++....  .....+.+|+.+++.++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4799999999999999999999     56788999999986532  2334688899999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecC
Q 019433           75 AIVMEYAAGGELFARICSAG-------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFG  146 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg  146 (341)
                      ++||||+++++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence            99999999999999998753       489999999999999999999999999999999999998543 2359999999


Q ss_pred             CccCCC---CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccc
Q 019433          147 YSKSGL---LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQY  222 (341)
Q Consensus       147 ~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (341)
                      ++....   .........||+.|+|||++.+..++. ++|||||||++|+|++ |..||.........    ..+.... 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~-  262 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTS-KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----EFVTSGG-  262 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTTC-
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH----HHHhcCC-
Confidence            886321   112233456889999999998777654 5999999999999998 99999876543222    2222221 


Q ss_pred             cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ..+....+++.+.+||.+||+.||.+|||+.++++|.|+.
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1222346899999999999999999999999999998763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-47  Score=361.43  Aligned_cols=245  Identities=23%  Similarity=0.361  Sum_probs=206.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||+||+|.++ ++..||||++.......+.+.+|+.+++.++||||+++++++. ...+++||||+.
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            57999999999999999999997 5778999999877666788999999999999999999999986 567899999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--CCCC
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--~~~~  158 (341)
                      +|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....  ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceeccC
Confidence            99999999754  36899999999999999999999999999999999999988776  999999999743221  1123


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+|+.|+|||++.+..++. ++|||||||++|+|++ |..||............    .. ....+....+++++.+|
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ER-GYRMPRPENCPEELYNI  417 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HH-TCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHHHhccCCCCc-HHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHH
Confidence            345677899999998777654 5999999999999999 99999876654333322    11 22334445789999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      |.+||..||.+|||+.++++
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999976

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-47  Score=353.77  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=196.4

Q ss_pred             CCccccceecccCCeEEEEEEEc---CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK---RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||.||+|.++   .++..||||++....  ...+.+.+|+.+++.++||||+++++++......++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            58999999999999999999987   567789999987643  2345688999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCc
Confidence            99999999999997754 6999999999999999999999999999999999999988776  99999999875332211


Q ss_pred             ----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                          .....+++.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.. ....+....++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~----~i~~-~~~~~~~~~~~  276 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTS-ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK----AVDE-GYRLPPPMDCP  276 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHH----HHHT-TEECCCCTTCB
T ss_pred             cceeccCCCcCCCccChhhhccCCcCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCcccc
Confidence                11223567899999998777755 4899999999999998 999998765433222    2221 22234445788


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..+.+|+.+||+.||.+|||+.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-47  Score=337.10  Aligned_cols=246  Identities=21%  Similarity=0.343  Sum_probs=205.8

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      .++|++++.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            478999999999999999999986 57789999998776667789999999999999999999999864 4589999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QP  157 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~  157 (341)
                      .+++|.+++....  .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......  ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECC
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccccc
Confidence            9999999986543  6999999999999999999999999999999999999987776  9999999987533221  22


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+++.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +... ........+++.+.+
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERG-YRMVRPDNCPEELYQ  241 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTT-CCCCCCTTCCHHHHH
T ss_pred             cCCCCccCccChhhhccCCCCc-hhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hhcc-cCCCCcccccHHHHH
Confidence            3345678899999998777654 4899999999999999 9999987655433222    2221 122233478999999


Q ss_pred             HHHHhcccCCCCCCChhHHhc
Q 019433          237 LLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ||.+||..||.+|||+.++++
T Consensus       242 li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999987

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.9e-47  Score=338.23  Aligned_cols=246  Identities=23%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             CCccccc-eecccCCeEEEEEE--EcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVK-ELGSGNFGVARLVR--DKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ++|++.+ .||+|+||+||+|.  ...+++.||||++.....   ..+.+.+|+.+++.++||||+++++++ .....++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5799998 99999999999994  466789999999876432   245688999999999999999999999 5667899


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCC
Confidence            9999999999999998888999999999999999999999999999999999999998776  99999999874322211


Q ss_pred             ----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          157 ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       157 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                          .....+++.|+|||++.+..++. ++|||||||++|+|++ |..||.........    ..+.... ..+....++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~  246 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLEKGE-RMGCPAGCP  246 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTTC-CCCCCTTCC
T ss_pred             cccccccCCCCceeeChHHhccCCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCC-CCCCCCCCC
Confidence                12234678899999998777654 4899999999999999 99999876543222    2222211 122234689


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+.++|.+||+.||.+|||+.++++
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.8e-47  Score=346.19  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=204.9

Q ss_pred             CCCccccceecccCCeEEEEEEEc-------CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-------RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTP   71 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~   71 (341)
                      .++|++.+.||+|+||+||+|.+.       .++..||+|++.....  ....+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999999985       4678899999876432  334688999999999 899999999999999


Q ss_pred             CEEEEEEeecCCCchHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC
Q 019433           72 THLAIVMEYAAGGELFARICSAG----------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~  135 (341)
                      +.+++||||+.+++|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence            99999999999999999997654                38999999999999999999999999999999999999877


Q ss_pred             CCCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHH
Q 019433          136 PQPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFR  211 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~  211 (341)
                      +.  +||+|||++.......   ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||......... 
T Consensus       194 ~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  269 (334)
T 2pvf_A          194 NV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-  269 (334)
T ss_dssp             CC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-
T ss_pred             CC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcCh-HHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH-
Confidence            76  9999999987433221   223345788899999998777654 4899999999999999 99999875543222 


Q ss_pred             HHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          212 KTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .   .+.... ..+....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       270 ~---~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 K---LLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             H---HHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H---HHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2   222111 122334689999999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-47  Score=345.16  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=206.6

Q ss_pred             CCCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++.+.||+|+||.||+|.+.     .+++.||||++.....  ....+.+|+.+++.++||||+++++++...+..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            478999999999999999999886     4678999999876432  234578999999999999999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           75 AIVMEYAAGGELFARICSA----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      ++||||+.+++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~D  181 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGD  181 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECc
Confidence            9999999999999998653          45799999999999999999999999999999999999998776  99999


Q ss_pred             cCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||++.......   ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+...
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~  256 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR----FVMEG  256 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH----HHHTT
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCc-hhhHHHHHHHHHHHHhcCCCccccCCHHHHHH----HHHcC
Confidence            99987432211   122345688999999998777654 5899999999999999 899998765433222    22222


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      . ..+....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       257 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          257 G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1 122334789999999999999999999999999987

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.3e-47  Score=343.56  Aligned_cols=252  Identities=29%  Similarity=0.411  Sum_probs=203.0

Q ss_pred             CCCCc-cccceecccCCeEEEEEE----EcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEc--C
Q 019433            1 MEERY-EPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT--P   71 (341)
Q Consensus         1 i~~~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~   71 (341)
                      |++|| ++++.||+|+||+||++.    +..+++.||||++....  ...+.+.+|+.+++.++||||+++++++..  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            46777 999999999999998875    44589999999997653  234568899999999999999999999987  4


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..+++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++...
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~  184 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAV  184 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEEC
T ss_pred             ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccc
Confidence            6899999999999999998654 5999999999999999999999999999999999999988776  999999998753


Q ss_pred             CCCC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----------hHHHHHHHH
Q 019433          152 LLHS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RNFRKTIDR  216 (341)
Q Consensus       152 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----------~~~~~~~~~  216 (341)
                      ....    ......+|+.|+|||++.+..++. ++|||||||++|+|++|..||......           .........
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYY-ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCc-HHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            3221    233456788899999998877764 489999999999999999999753211           011111111


Q ss_pred             HhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          217 IRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      + ......+....+++.+.+||.+||+.||.+|||+.++++
T Consensus       264 ~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 L-ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H-hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            1 122233444578999999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-47  Score=362.08  Aligned_cols=253  Identities=28%  Similarity=0.333  Sum_probs=193.5

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.+.|.+.+.||+|+||+||.+. ..+|+.||||++....  .+.+.+|+.+++.+ +||||+++++++...+.+++|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            46778888999999999998754 4579999999986542  45678899999875 89999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-----------CCCEE
Q 019433           80 YAAGGELFARICSAGRF-------SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-----------QPRLK  141 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l-------~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-----------~~~ik  141 (341)
                      ||. |+|.+++......       ++..++.++.||+.||.|||++||+||||||+|||++.++           ...+|
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence            996 5999999765433       2334578999999999999999999999999999997542           34599


Q ss_pred             EeecCCccCCCCCC-----CCCCccCCCCcccccccccc------ccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhH
Q 019433          142 ICDFGYSKSGLLHS-----QPKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRN  209 (341)
Q Consensus       142 L~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~  209 (341)
                      |+|||+++......     ......||+.|+|||++.+.      ...+.++|||||||++|+|++ |..||....... 
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            99999997543221     12345799999999999751      233456999999999999998 999997654322 


Q ss_pred             HHHHHHHHhcccccCCC-----CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          210 FRKTIDRIRNVQYFLPD-----YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       210 ~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                       .....    .....+.     ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 -~~i~~----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNIIR----GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHHH----TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHhc----CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             11111    1111221     1234678999999999999999999999999999954

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.6e-47  Score=346.90  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=208.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCc-----EEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~   73 (341)
                      .++|++.+.||+|+||.||+|.+..+++     .||+|++.....  ..+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            3689999999999999999999987664     799999876432  345688999999999 89999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCC
Q 019433           74 LAIVMEYAAGGELFARICSA--------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPR  139 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~  139 (341)
                      .++||||+++|+|.+++...              ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--  202 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--  202 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--
Confidence            99999999999999998653              35899999999999999999999999999999999999988776  


Q ss_pred             EEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHH
Q 019433          140 LKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTID  215 (341)
Q Consensus       140 ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~  215 (341)
                      +||+|||++.......   ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||........+.....
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  281 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK  281 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence            9999999987432221   12334567889999999877765 45999999999999998 9999987665544444333


Q ss_pred             HHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .    ....+.....++.+.+||.+||+.||.+|||+.+++++
T Consensus       282 ~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          282 D----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            2    12222334678999999999999999999999999984

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=344.27  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=200.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEE----EEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELV----AVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++++.||+|+||+||+|.+..+++.+    |+|.+...  ....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            579999999999999999999998888765    66665432  334567899999999999999999999998765 78


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +|++|+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC-------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCc
Confidence            999999999999999774 57999999999999999999999999999999999999988776  999999999743222


Q ss_pred             CC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          155 SQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       155 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      ..   .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||......... ..+.    .....+....+
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~  244 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQPPIC  244 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHH----TTCCCCCCTTB
T ss_pred             cccccccCCCccccccCHHHHcCCCCCh-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH----cCCCCCCCccC
Confidence            21   22345677899999998877754 5899999999999999 99999876554332 2221    12223344568


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.++.+||.+||..||.+|||+.++++.
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999999984

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-47  Score=345.75  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=201.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++.+.||+|+||+||+|.+. +++.||||++....  .....+.+|+.+++.++||||+++++++......++|||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  107 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP  107 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred             hhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence            579999999999999999999865 68999999987643  223368899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           80 YAAGGELFARICSAG----RFSEDEARFFFQQLISGVSYCHSM---EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~----~l~~~~~~~i~~qil~aL~~LH~~---~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      |+.+++|..++....    .+++..++.++.|++.||.|||++   ||+||||||+|||++.++.  +||+|||++....
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~  185 (326)
T 3uim_A          108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMD  185 (326)
T ss_dssp             CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECC
T ss_pred             eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccC
Confidence            999999999997643    499999999999999999999999   9999999999999988776  9999999997433


Q ss_pred             CCC--CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCC----CCChhHHHHHHHHHhccc-c--c
Q 019433          153 LHS--QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFED----PEDPRNFRKTIDRIRNVQ-Y--F  223 (341)
Q Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~----~~~~~~~~~~~~~~~~~~-~--~  223 (341)
                      ...  ......||+.|+|||++.+..++. ++|||||||++|+|++|..||..    .................. .  .
T Consensus       186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (326)
T 3uim_A          186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSE-KTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL  264 (326)
T ss_dssp             SSSSCEECCCCSCGGGCCHHHHHHSEECH-HHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred             cccccccccccCCcCccCHHHhccCCCCc-cccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence            222  223445999999999998777754 58999999999999999999952    111111111111110000 0  0


Q ss_pred             ------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCC
Q 019433          224 ------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP  259 (341)
Q Consensus       224 ------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp  259 (341)
                            .......+..+.+|+.+||+.||.+|||+.++++|-
T Consensus       265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence                  000112336789999999999999999999999984

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-47  Score=342.67  Aligned_cols=237  Identities=35%  Similarity=0.593  Sum_probs=188.5

Q ss_pred             CCCcccc-ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHH-hcCCCCCeeeEEEEEEc----CCEEE
Q 019433            2 EERYEPV-KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH-RSLRHPNIIRFKEVLLT----PTHLA   75 (341)
Q Consensus         2 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~----~~~~~   75 (341)
                      -++|.++ +.||+|+||.||+|.++.+++.||+|++..    .....+|+.++ +.++||||+++++++..    ...++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678887 779999999999999999999999999865    35677888887 66799999999999987    67899


Q ss_pred             EEEeecCCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCC
Q 019433           76 IVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL  152 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~  152 (341)
                      +||||+++++|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++... ...+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998754  699999999999999999999999999999999999998732 2349999999886321


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (341)
                                           +..++ .++|||||||++|+|++|..||...............+.......+  .+..+
T Consensus       172 ---------------------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (299)
T 3m2w_A          172 ---------------------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  229 (299)
T ss_dssp             ---------------------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred             ---------------------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence                                 12333 4589999999999999999999764432111000000111111111  11468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ++++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            9999999999999999999999999999999553

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-47  Score=337.40  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=204.3

Q ss_pred             CCCccccc-eecccCCeEEEEEEEc--CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVK-ELGSGNFGVARLVRDK--RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|.+++ .||+|+||.||+|.+.  .++..||+|++....  ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            36788887 9999999999999864  578889999997643  2345688999999999999999999999 4556899


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADD  164 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCS
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCc
Confidence            99999999999998654 46999999999999999999999999999999999999998776  9999999987432221


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                          ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+.... ..+....+
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~i~~~~-~~~~~~~~  238 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGK-RMECPPEC  238 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECH-HHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTC-CCCCCTTC
T ss_pred             ceeeccccccccccccCHHHhccCCCCc-hhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHhcCC-cCCCCCCc
Confidence                123345688999999998777654 4899999999999998 999998766543332    222211 11223478


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHP  259 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp  259 (341)
                      ++.+.++|.+||+.||.+|||+.++++|.
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            99999999999999999999999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.5e-47  Score=334.93  Aligned_cols=242  Identities=24%  Similarity=0.373  Sum_probs=196.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-CEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP-THLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-~~~~iv~e~~   81 (341)
                      ++|++++.||+|+||+||+|.+.  |+.||+|++.... ..+.+.+|+.+++.++||||+++++++... +..++||||+
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            68999999999999999999884  8899999987653 456789999999999999999999997654 4789999999


Q ss_pred             CCCchHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~~--l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      ++++|.+++.....  +++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....  .....
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~--~~~~~  173 (278)
T 1byg_A           98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQDT  173 (278)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC------------
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccc--ccccC
Confidence            99999999976543  899999999999999999999999999999999999987776  9999999987432  22334


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+++.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +.. ....+....+++.+.++|
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li  247 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEK-GYKMDAPDGCPPAVYEVM  247 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HTT-TCCCCCCTTCCHHHHHHH
T ss_pred             CCccccccCHHHhCCCCCCc-hhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----Hhc-CCCCCCcccCCHHHHHHH
Confidence            56788999999998776654 5899999999999998 9999987654333222    211 112223347899999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||..||.+|||+.++++
T Consensus       248 ~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          248 KNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCChhhCCCHHHHHH
Confidence            9999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=343.08  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCC----cEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++|++.+.||+|+||+||+|.++.++    ..||||++.....  ....+.+|+.+++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            368999999999999999999987553    4599999876432  2346789999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++......
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccc
Confidence            999999999999999764 57999999999999999999999999999999999999988776  999999998743222


Q ss_pred             C----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          155 S----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       155 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .    ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||.........    ..+... ...+....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~~~-~~~~~~~~  274 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAINDG-FRLPTPMD  274 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTT-CCCCCCTT
T ss_pred             cccccccCCCCccccccCchhcccCCCCc-hhhhHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHCC-CcCCCccc
Confidence            1    112234577899999998777654 4899999999999998 99999876543322    222221 22334457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +++.+.+||.+||+.||.+|||+.+++++
T Consensus       275 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          275 CPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999999999885

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.4e-47  Score=335.83  Aligned_cols=248  Identities=23%  Similarity=0.281  Sum_probs=202.1

Q ss_pred             CCCccccceecccCCeEEEEEEEcC---CCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      .++|++.+.||+|+||+||+|.+..   ++..||+|++....  ...+.+.+|+.+++.++||||+++++++..+ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            3689999999999999999998653   34569999987643  2345688999999999999999999998654 4689


Q ss_pred             EEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC----
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCccccccc
Confidence            999999999999997654 5999999999999999999999999999999999999998776  9999999987533222


Q ss_pred             --CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCH
Q 019433          156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA  232 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  232 (341)
                        ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||........... +..    ....+....+++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~  241 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTT-ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEK----GDRLPKPDLCPP  241 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHH----TCCCCCCTTCCH
T ss_pred             ccccccCCCCcceeCchhhccCCCCc-hhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-Hhc----CCCCCCCCCCCH
Confidence              123345788899999998777654 5899999999999998 9999987655443322 211    112233346899


Q ss_pred             HHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          233 DCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       233 ~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+.++|.+||..||.+|||+.+++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.2e-46  Score=339.60  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcC---CCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC---
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR---TKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT---   72 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~---   72 (341)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++.....   ..+.+.+|+.+++.++||||+++++++....   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            3689999999999999999998865   566899999875432   2346889999999999999999999998765   


Q ss_pred             --EEEEEEeecCCCchHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           73 --HLAIVMEYAAGGELFARICS------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        73 --~~~iv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                        ..++||||+.+++|..++..      ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~D  190 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVAD  190 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECS
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEee
Confidence              35999999999999999843      356999999999999999999999999999999999999988776  99999


Q ss_pred             cCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcc
Q 019433          145 FGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       145 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      ||++.......   ......+++.|+|||++.+..++. ++|||||||++|+|++ |..||.............    ..
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~~  265 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----HG  265 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----TT
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----cC
Confidence            99987432221   223345788999999998777654 4899999999999999 999998766544433222    11


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       ...+....+++.+.+||.+||..||.+|||+.+++++
T Consensus       266 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          266 -HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             -CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             1122334689999999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=344.13  Aligned_cols=245  Identities=26%  Similarity=0.415  Sum_probs=184.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCC-CCCeeeEEEEEE--------cC
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLL--------TP   71 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~--------~~   71 (341)
                      +.+|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999999999999999999885543 33456789999999995 999999999994        34


Q ss_pred             CEEEEEEeecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecCCCCCCEEEeecC
Q 019433           72 THLAIVMEYAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDGSPQPRLKICDFG  146 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~~~~~~ikL~Dfg  146 (341)
                      ..+++||||+. |+|.+++..   ...+++..++.++.||+.||.|||++|  |+||||||+|||++.++.  +||+|||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg  183 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFG  183 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCc
Confidence            56899999996 588887754   457999999999999999999999999  999999999999998776  9999999


Q ss_pred             CccCCCCCCC-------------CCCccCCCCcccccccc---ccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHH
Q 019433          147 YSKSGLLHSQ-------------PKSTVGTPAYIAPEVLA---RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF  210 (341)
Q Consensus       147 ~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~  210 (341)
                      ++........             .....||+.|+|||++.   +..+ +.++|||||||++|+|++|..||........ 
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            9975332211             11456899999999983   4344 4459999999999999999999976443211 


Q ss_pred             HHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          211 RKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                             .......+.....+..+.+||.+||+.||.+|||+.++++|
T Consensus       262 -------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          262 -------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   11222233445678889999999999999999999999997

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=348.11  Aligned_cols=242  Identities=17%  Similarity=0.186  Sum_probs=196.6

Q ss_pred             CCCccccceecccCCeEEEEE-----EEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCE
Q 019433            2 EERYEPVKELGSGNFGVARLV-----RDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~   73 (341)
                      .++|++.+.||+|+||+||+|     .+..+++.||||++...  ....+.+|+.+++.++   |+||+++++++...+.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~  141 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG  141 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence            468999999999999999999     46778999999998764  3557788888888886   9999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecC-----------CCC
Q 019433           74 LAIVMEYAAGGELFARICS-----AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDG-----------SPQ  137 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~-----------~~~  137 (341)
                      .++|||||++|+|.+++..     ...+++..++.++.||+.||.|||++||+||||||+|||++.           ++.
T Consensus       142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCC
Confidence            9999999999999999974     457999999999999999999999999999999999999987           454


Q ss_pred             CCEEEeecCCccCC---CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH
Q 019433          138 PRLKICDFGYSKSG---LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI  214 (341)
Q Consensus       138 ~~ikL~Dfg~a~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~  214 (341)
                        +||+|||+|+..   .........+||+.|+|||++.+..++. ++|||||||++|+|++|..||........     
T Consensus       222 --~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~pf~~~~~~~~-----  293 (365)
T 3e7e_A          222 --LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVYCMLFGTYMKVKNEGGEC-----  293 (365)
T ss_dssp             --EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBST-HHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred             --EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCc-cccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence              999999999532   2222345567999999999999888765 49999999999999999999965332100     


Q ss_pred             HHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       215 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                          .....++.. ..++.+.+++..||..+|.+|++..+.+.+
T Consensus       294 ----~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          294 ----KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ----EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ----eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence                011111111 346778999999999999999766555554

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-46  Score=356.20  Aligned_cols=245  Identities=22%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||+|.++. +..||||++.......+.+.+|+.+++.++||||+++++++.. ...++||||+.
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            579999999999999999999974 4679999998766666789999999999999999999999876 67899999999


Q ss_pred             CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......  ...
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceeccc
Confidence            9999999964  356999999999999999999999999999999999999987776  9999999997532211  122


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+++.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +.. ....+....+++.+.+|
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~~-~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  413 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHhHHhcCCCCc-cccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            345678899999998777654 4999999999999999 9999987654333222    221 22233344789999999


Q ss_pred             HHHhcccCCCCCCChhHHhc
Q 019433          238 LSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~  257 (341)
                      |.+||+.||.+|||+.++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-46  Score=333.50  Aligned_cols=248  Identities=26%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             CccccceecccCCeEEEEEEEcCCCc---EEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE-EEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL-AIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~-~iv   77 (341)
                      +|++.+.||+|+||+||+|.+..++.   .||+|++.....  ..+.+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46677999999999999999765544   799999876432  335678999999999999999999999876655 999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC---
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL---  153 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~---  153 (341)
                      |||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.....   
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcc
Confidence            999999999999976 456899999999999999999999999999999999999988776  99999999874322   


Q ss_pred             --CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          154 --HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       154 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                        ........+|+.|+|||.+.+..++. ++|||||||++|+|++|..||....+.......+..    ....+....++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  254 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTT-KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPEYCP  254 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCTTCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCCh-hhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCccch
Confidence              12233456788999999998877754 489999999999999955554433333333332222    11223344689


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+.+||.+||+.||.+|||+.++++.
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=336.62  Aligned_cols=244  Identities=30%  Similarity=0.458  Sum_probs=195.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||+||+|.+.  ++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            58999999999999999999985  7889999987543 35678899999999999999999998764  4789999999


Q ss_pred             CCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           83 GGELFARICSAG---RFSEDEARFFFQQLISGVSYCHS---MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        83 ~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~---~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      +++|.+++....   .++...++.++.|++.||.|||+   +||+||||||+||+++.++. .+||+|||++....  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~--~~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ--TH  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc--cc
Confidence            999999997655   37899999999999999999999   89999999999999986654 37999999987432  22


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..++. ++|||||||++|+|++|..||........  ........ ....+....+++.+.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSE-KCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHN-GTRPPLIKNLPKPIES  235 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCT-HHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHT-TCCCCCBTTCCHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCc-HHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhc-CCCCCcccccCHHHHH
Confidence            34457999999999998877755 48999999999999999999976543221  11111111 1122333468999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ||.+||+.||.+|||+.+++++
T Consensus       236 li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999884

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1e-46  Score=336.24  Aligned_cols=249  Identities=28%  Similarity=0.410  Sum_probs=197.0

Q ss_pred             CCCccccceecccCCeEEEEEEEcC-CC--cEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR-TK--ELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      .++|++++.||+|+||+||+|.+.. ++  ..||+|++....    ...+.+.+|+.+++.++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4789999999999999999998643 33  369999987532    23457889999999999999999999998765 7


Q ss_pred             EEEEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++||||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQ  173 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccccc
Confidence            8999999999999998764 56999999999999999999999999999999999999988776  99999999875332


Q ss_pred             CC----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          154 HS----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       154 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ..    ......+|+.|+|||++.+..++. ++|||||||++|+|++ |..||........    ...+.......+...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~  248 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERLPRPE  248 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCCCCCT
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHHH----HHHHHccCCCCCCCc
Confidence            22    123345788899999998777654 4899999999999999 9999987654332    233333333344455


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+++.+.++|.+||..||.+|||+.+++++
T Consensus       249 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          249 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            789999999999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6e-48  Score=375.55  Aligned_cols=260  Identities=28%  Similarity=0.371  Sum_probs=206.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT------PTH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~------~~~   73 (341)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....  ...+.+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999999999999999999987542  234568889999999999999999999765      677


Q ss_pred             EEEEEeecCCCchHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC-CCEEEeecCCcc
Q 019433           74 LAIVMEYAAGGELFARICSAG---RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ-PRLKICDFGYSK  149 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~-~~ikL~Dfg~a~  149 (341)
                      .++|||||++++|..++....   .+++..++.++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999997754   5999999999999999999999999999999999999986653 348999999998


Q ss_pred             CCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHH-----HHHh-----c
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-----DRIR-----N  219 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~-----~~~~-----~  219 (341)
                      ............||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+....     ....     .
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            6555555566789999999999988877655 899999999999999999997643221110000     0000     0


Q ss_pred             ccc----cCCC----CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          220 VQY----FLPD----YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       220 ~~~----~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ...    ..+.    ...+++.+.+||.+||..||.+|||+.++++||||.
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHH
Confidence            000    0111    123568899999999999999999999999999994

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.1e-46  Score=337.59  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=203.6

Q ss_pred             CCCccccceecccCCeEEEEEE----EcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC--EE
Q 019433            2 EERYEPVKELGSGNFGVARLVR----DKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPT--HL   74 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~--~~   74 (341)
                      .++|++++.||+|+||.||+|.    +..+++.||||++.... ...+.+.+|+.+++.++||||+++++++....  .+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4679999999999999999999    46789999999987643 23456889999999999999999999987654  68


Q ss_pred             EEEEeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           75 AIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++.....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQ  197 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCS
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccc
Confidence            99999999999999998754 6999999999999999999999999999999999999988776  99999999875432


Q ss_pred             CCC----CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh-----------hH-HHHHHHHH
Q 019433          154 HSQ----PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------RN-FRKTIDRI  217 (341)
Q Consensus       154 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----------~~-~~~~~~~~  217 (341)
                      ...    .....++..|+|||++.+..++. ++|||||||++|+|++|..||......           .. .......+
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCc-hhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            221    23345677899999998777654 489999999999999999998642110           01 11111222


Q ss_pred             hcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          218 RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       218 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .. ....+....+++++.+||.+||+.||.+|||+.++++
T Consensus       277 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          277 KN-NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HT-TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hc-CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            11 1223334578999999999999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8e-46  Score=352.28  Aligned_cols=251  Identities=21%  Similarity=0.219  Sum_probs=203.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.|.| ++|+.+..++......++|||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999999999999999998776443 4468899999999976 667777777788899999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEe---cCCCCCCEEEeecCCccCCCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLL---DGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili---~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.  +||+|||+++......
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTC--EEECCCTTCEECBCTT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCe--EEEEeCCcceeccCCc
Confidence            99 8899999975 5579999999999999999999999999999999999999   45555  9999999997533222


Q ss_pred             C--------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHH---HHHHHHHhcccccC
Q 019433          156 Q--------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNF---RKTIDRIRNVQYFL  224 (341)
Q Consensus       156 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  224 (341)
                      .        .....||+.|+|||++.+..+.. ++|||||||++|+|++|..||.........   ......... ....
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~  238 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE  238 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence            1        22567999999999998887754 489999999999999999999875442222   111111110 0000


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .....++.++.+||.+||+.||.+||++.++++
T Consensus       239 ~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          239 ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            111367899999999999999999999998865

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1e-45  Score=332.58  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      |...+.||+|+||+||+|.+  +++.||+|++....     ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            45559999999999999987  58899999986532     234568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           80 YAAGGELFARICS---AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      |+++++|.+++..   ..++++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++....... 
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeecccccccccccc
Confidence            9999999999864   346999999999999999999999999999999999999987776  9999999987432211 


Q ss_pred             --CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc--------cCC
Q 019433          156 --QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY--------FLP  225 (341)
Q Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~  225 (341)
                        ......||+.|+|||++.+. ++ .++|||||||++|+|++|..||........+............        ..+
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~-~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGE-IT-PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTE-EC-THHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcCC-CC-ccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence              12345789999999998754 44 4589999999999999999999876544333333322221111        011


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          226 -DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       226 -~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       .....+..+.+++.+||+.||.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             112345678999999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.6e-46  Score=331.31  Aligned_cols=248  Identities=22%  Similarity=0.267  Sum_probs=198.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEE-cCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLL-TPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~-~~~~~~i   76 (341)
                      .+|++.+.||+|+||+||+|.+..+   ...+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4799999999999999999997543   34689999876432  3356889999999999999999999864 5567899


Q ss_pred             EEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      ||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccc
Confidence            9999999999999976 346899999999999999999999999999999999999988776  9999999997432211


Q ss_pred             -----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          156 -----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                           ......||+.|+|||++.+..++. ++|||||||++|+|++ |.+||..............   ...  ......
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~  256 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRR--LLQPEY  256 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---TCC--CCCCTT
T ss_pred             hhccccccCCCCCccccChHHhcCCCCCh-HHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---CCC--CCCCcc
Confidence                 223446788999999998777654 4899999999999999 6677766554433322211   111  122236


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +++.+.++|.+||+.||.+|||+.++++.
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88999999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=341.24  Aligned_cols=250  Identities=21%  Similarity=0.266  Sum_probs=186.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-----CCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-----PTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-----~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|..  +++.||||++............++..+..++||||+++++.+..     ...+++|
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            6899999999999999999977  68999999987654322333344544556899999999986542     3467999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM---------EICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~---------~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      ||||++|+|.+++... .+++..++.++.||+.||.|||++         ||+||||||+|||++.++.  +||+|||++
T Consensus        91 ~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a  167 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLS  167 (336)
T ss_dssp             ECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTC
T ss_pred             EecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeeccce
Confidence            9999999999998654 468999999999999999999999         9999999999999988776  999999999


Q ss_pred             cCCCCC---------CCCCCccCCCCcccccccccc------ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhH----
Q 019433          149 KSGLLH---------SQPKSTVGTPAYIAPEVLARK------EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRN----  209 (341)
Q Consensus       149 ~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~----  209 (341)
                      +.....         .......||+.|+|||++.+.      ...+.++|||||||++|+|++|..||........    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            643221         122345799999999999762      1223458999999999999999777643322110    


Q ss_pred             ----------HHHHHHHHhcc--cccCCC----CCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          210 ----------FRKTIDRIRNV--QYFLPD----YVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       210 ----------~~~~~~~~~~~--~~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                                ...........  ...++.    ....++.+.+||.+||+.||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                      01111111111  111111    1124457999999999999999999999955

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.5e-46  Score=358.29  Aligned_cols=246  Identities=22%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||.||+|.+.. +..||||++.......+.+.+|+.+++.++||||+++++++.. ..+++||||+.
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            579999999999999999999975 4679999998766666789999999999999999999999876 67899999999


Q ss_pred             CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC--CCCC
Q 019433           83 GGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH--SQPK  158 (341)
Q Consensus        83 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~--~~~~  158 (341)
                      +|+|.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceeccc
Confidence            9999999964  356999999999999999999999999999999999999987776  999999999743221  1122


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...++..|+|||++.+..++. ++|||||||++|+|++ |..||........+..    +.. ....+....++..+.+|
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~~-~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VER-GYRMPCPPECPESLHDL  496 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----HHT-TCCCCCCTTCCHHHHHH
T ss_pred             CCcCcccccCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHHHH
Confidence            345678899999998777654 4999999999999999 9999987654333322    222 22233344789999999


Q ss_pred             HHHhcccCCCCCCChhHHhcC
Q 019433          238 LSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~h  258 (341)
                      |.+||+.||.+|||+.++++.
T Consensus       497 i~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.2e-46  Score=338.37  Aligned_cols=250  Identities=23%  Similarity=0.296  Sum_probs=198.5

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhc--CCCCCeeeEEEEEEcCC----EEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRS--LRHPNIIRFKEVLLTPT----HLA   75 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~--l~hp~iv~l~~~~~~~~----~~~   75 (341)
                      .++|++.+.||+|+||+||+|.+  +++.||||++...  ....+.+|+.+++.  ++||||+++++++....    ..+
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            46899999999999999999998  5899999998654  24567778888776  79999999999998876    899


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeeCCCCCCCEEecCCCCCCEEEeecCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------SMEICHRDLKLENTLLDGSPQPRLKICDFGY  147 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~  147 (341)
                      +||||+.+++|.+++.+ .++++..++.++.|++.||.|||        ++||+||||||+|||++.++.  +||+|||+
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~  193 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL  193 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence            99999999999999965 46999999999999999999999        899999999999999988776  99999999


Q ss_pred             ccCCCCCC-----CCCCccCCCCccccccccccccCC-----CccchhhHHHHHHHHHhC----------CCCCCCCCCh
Q 019433          148 SKSGLLHS-----QPKSTVGTPAYIAPEVLARKEYDG-----KISDVWSCGVTLYVMLVG----------AYPFEDPEDP  207 (341)
Q Consensus       148 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~vl~~l~~g----------~~pf~~~~~~  207 (341)
                      +.......     ......||+.|+|||++.+.....     .++|||||||++|+|++|          ..||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            86432222     234567999999999987653221     458999999999999999          7888664321


Q ss_pred             h-HHHHHHHHHhcccc--cCCC---CCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          208 R-NFRKTIDRIRNVQY--FLPD---YVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       208 ~-~~~~~~~~~~~~~~--~~~~---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      . ........+.....  ..+.   ....+..+.+||.+||+.||.+|||+.++++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1 11222222221111  1111   01234578999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-46  Score=341.83  Aligned_cols=247  Identities=21%  Similarity=0.250  Sum_probs=192.9

Q ss_pred             CccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~iv   77 (341)
                      +|++.+.||+|+||+||+|.+..+   +..||+|.+....  ...+.+.+|+.+++.++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            578889999999999999997543   3468999987533  233568899999999999999999998754 5678999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      |||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeecccccccccccc
Confidence            99999999999997644 5899999999999999999999999999999999999988776  9999999997432211 


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                          ......+|+.|+|||++.+..++. ++|||||||++|+|++ |.+||............    .... ..+....+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~-~~~~p~~~  321 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEYC  321 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTC-CCCCCTTC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCc-HHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCC-CCCCCCCC
Confidence                122345778899999998777754 5999999999999999 78888776554333222    1111 12223468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-45  Score=359.64  Aligned_cols=240  Identities=24%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             ceecccCCeEEEEEEE--cCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            9 KELGSGNFGVARLVRD--KRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      +.||+|+||+||+|.+  +.+++.||||++....   ...+.+.+|+.+++.++|||||++++++.. ..+++|||||.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  5677899999987643   234678999999999999999999999875 457899999999


Q ss_pred             CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC----CCCC
Q 019433           84 GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS----QPKS  159 (341)
Q Consensus        84 ~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~----~~~~  159 (341)
                      |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccC
Confidence            999999998889999999999999999999999999999999999999998776  9999999987432221    1223


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+|+.|+|||++.+..++. ++|||||||++|+|++ |..||..........    .+... ...+....+++++.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~~~-~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKG-ERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcC-CCCCCCCCCCHHHHHHH
Confidence            34678899999998777765 4999999999999998 999998765543322    22221 12223346899999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||+.||.+|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1e-47  Score=350.16  Aligned_cols=243  Identities=18%  Similarity=0.220  Sum_probs=190.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---------ccHHHHHHHHHHhcCC---------CCCeeeE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---------IDENVQREIINHRSLR---------HPNIIRF   64 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~ei~~~~~l~---------hp~iv~l   64 (341)
                      ++|++++.||+|+||+||+|++  +|+.||||++.....         ..+.+.+|+.+++.++         ||||+++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            6899999999999999999998  689999999876432         2267889999888775         8888888


Q ss_pred             EEEEE------------------------------cCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 019433           65 KEVLL------------------------------TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY  114 (341)
Q Consensus        65 ~~~~~------------------------------~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~  114 (341)
                      .+++.                              ....+|+|||||.+|++...+.+ ..+++..++.++.||+.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            88753                              26789999999999977666643 678999999999999999999


Q ss_pred             HH-HcCCeeCCCCCCCEEecCCCC------------------CCEEEeecCCccCCCCCCCCCCccCCCCcccccccccc
Q 019433          115 CH-SMEICHRDLKLENTLLDGSPQ------------------PRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK  175 (341)
Q Consensus       115 LH-~~~iiHrDikp~Nili~~~~~------------------~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  175 (341)
                      || ++||+||||||+|||++.++.                  ..+||+|||+|+...    ....+||+.|+|||++.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~----~~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER----DGIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE----TTEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC----CCcEEEeecccChhhhcCC
Confidence            99 999999999999999987751                  149999999997432    2345899999999999876


Q ss_pred             ccCCCccchhhHHHH-HHHHHhCCCCCCCCCChhHHHHHHHHHh-cccccCC----CCCCCCHHHHHHHHHhcccCCCCC
Q 019433          176 EYDGKISDVWSCGVT-LYVMLVGAYPFEDPEDPRNFRKTIDRIR-NVQYFLP----DYVRVSADCRHLLSQIFVADPSKR  249 (341)
Q Consensus       176 ~~~~~~~DiwslG~v-l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~s~~~~~li~~~L~~dp~~R  249 (341)
                      .  +.++||||||++ .++++.|..||....   ........+. .......    ....+|+++.+||++||++|    
T Consensus       253 ~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          253 G--DYQFDIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             S--SHHHHHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             C--ccceehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            6  456999998877 667888999984311   0011111211 1111111    12247889999999999977    


Q ss_pred             CChhHHh-cCCccC
Q 019433          250 IPIPEIK-KHPWFL  262 (341)
Q Consensus       250 ~s~~e~l-~hp~~~  262 (341)
                       |+.|+| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999994

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=333.17  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++.+.||+|+||.||+|.+..   .+|+|++....   ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            689999999999999999999864   39999987532   233567789999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC------
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL------  152 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~------  152 (341)
                      |+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++ ++.  +||+|||++....      
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~--~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGK--VVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C--CEECCCSCCC---------
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCC--EEEeecCCccccccccccc
Confidence            999999999997655 699999999999999999999999999999999999998 444  9999999876421      


Q ss_pred             CCCCCCCccCCCCccccccccccc--------cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKE--------YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (341)
                      .........||+.|+|||++.+..        ..+.++|||||||++|+|++|..||..........    .+.......
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~  262 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMGTGMKPN  262 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHHTTCCCC
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhccCCCCC
Confidence            112223456899999999987522        23455899999999999999999998755433222    222222222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .....++.++.++|.+||..||.+|||+.++++.
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            2223588899999999999999999999999984

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=355.92  Aligned_cols=244  Identities=26%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             ccccc-eecccCCeEEEEEEEc--CCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            5 YEPVK-ELGSGNFGVARLVRDK--RTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         5 y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      |.+.+ .||+|+||+||+|.+.  .++..||||++....  ...+.+.+|+.+++.++|||||++++++.. +.+++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            44444 7999999999999875  456779999997643  345678999999999999999999999976 56899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--  156 (341)
                      ||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......  
T Consensus       416 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          416 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             CCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC------
T ss_pred             eCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCcee
Confidence            99999999998654 46999999999999999999999999999999999999998776  99999999975322211  


Q ss_pred             --CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 --PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                        .....+++.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +... ...+....++++
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~-~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~~-~~~~~p~~~~~~  567 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSS-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQG-KRMECPPECPPE  567 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHTT-CCCCCCTTCCHH
T ss_pred             eeccCCCCccceeCHhhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcC-CCCCCCCcCCHH
Confidence              11234568899999998777755 4899999999999998 9999988766543322    2221 122233468999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +.+||.+||..||.+|||+.++++
T Consensus       568 l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=5.7e-46  Score=347.92  Aligned_cols=242  Identities=15%  Similarity=0.133  Sum_probs=187.6

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHHHHHHHhcCCC-CC------------------
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQREIINHRSLRH-PN------------------   60 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~h-p~------------------   60 (341)
                      .|+..+.||+|+||+||+|.+..+|+.||||++....    ...+.+.+|+.+++.+.| +|                  
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            3778899999999999999999999999999987322    335678899999999876 21                  


Q ss_pred             ---eeeEEEEEEc-----CCEEEEEEeecCCCchHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCC
Q 019433           61 ---IIRFKEVLLT-----PTHLAIVMEYAAGGELFARICS-------AGRFSEDEARFFFQQLISGVSYCHSMEICHRDL  125 (341)
Q Consensus        61 ---iv~l~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDi  125 (341)
                         ...+..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence               1111111221     22467788876 5689888741       234788899999999999999999999999999


Q ss_pred             CCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccc----------cccccCCCccchhhHHHHHHHHH
Q 019433          126 KLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL----------ARKEYDGKISDVWSCGVTLYVML  195 (341)
Q Consensus       126 kp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~vl~~l~  195 (341)
                      ||+|||++.++.  +||+|||+++....  .....+| +.|+|||++          .+..++ .++|||||||++|+|+
T Consensus       238 Kp~NILl~~~~~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGG--VFLTGFEHLVRDGA--SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTE--EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCe--EEEEeccceeecCC--ccccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHH
Confidence            999999998877  99999999874322  2455678 999999999          333443 4599999999999999


Q ss_pred             hCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          196 VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       196 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      +|+.||........          ....++....+|+.+.+||.+||+.||.+|||+.++++||||.
T Consensus       312 tg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          312 CADLPNTDDAALGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             HSSCCCCTTGGGSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             HCCCCCCCcchhhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence            99999976543211          1112333447899999999999999999999999999999993

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.2e-44  Score=322.75  Aligned_cols=225  Identities=13%  Similarity=0.103  Sum_probs=183.8

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcccc----HHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +++||++.+.||+|+||.||+|.+..+++.||||++.......    +.+.+|+.+++.++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            4689999999999999999999999999999999998754433    578899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||++|++|.+++...  ....++..++.||+.||.|||++||+||||||+|||++.++.  +||++++          
T Consensus       109 v~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~----------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA----------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC----------
T ss_pred             EEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc----------
Confidence            99999999999998543  466678999999999999999999999999999999998876  8988543          


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCCCCCCHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADC  234 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~  234 (341)
                               |++|       + +.++|||||||++|+|++|..||........+....... ......  .....+++.+
T Consensus       175 ---------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          175 ---------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             ---------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCHHHHCTTSCHHH
T ss_pred             ---------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCChhhcccCCCHHH
Confidence                     3333       2 455899999999999999999998755422110000000 000000  0113689999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcC
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||.+||+.||.+| |+.++++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999884

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.3e-44  Score=352.66  Aligned_cols=247  Identities=25%  Similarity=0.375  Sum_probs=200.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|.+..+   +..||+|.+....  ...+.+.+|+.+++.++||||+++++++. ++..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            6799999999999999999998643   5679999987533  22356889999999999999999999985 4568999


Q ss_pred             EeecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      |||+.+|+|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcc
Confidence            99999999999997654 6999999999999999999999999999999999999998776  99999999975432221


Q ss_pred             --CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          157 --PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                        .....+|+.|+|||++.+..++. ++|||||||++|+|++ |..||...........    +.... ..+....+++.
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~-~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~----i~~~~-~~~~~~~~~~~  620 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGE-RLPMPPNCPPT  620 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHHTC-CCCCCTTCCHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCc-hhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHcCC-CCCCCccccHH
Confidence              22345678999999998777654 5899999999999997 9999987655433322    22211 12233468999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+||.+||..||.+|||+.++++.
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.7e-45  Score=362.80  Aligned_cols=238  Identities=22%  Similarity=0.263  Sum_probs=196.2

Q ss_pred             CCCccccceecccCCeEEEEEEEcC-CCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE-----
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKR-TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH-----   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~-----   73 (341)
                      .++|++++.||+|+||+||+|.+.. +++.||||++....  .....+.+|+.+++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            5799999999999999999999976 78999999986542  233467899999999999999999999987655     


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .|+||||++|++|..++..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .  +||+|||+++....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~--~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q--LKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C--EEECCCTTCEETTC
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c--EEEEecccchhccc
Confidence            7999999999999887754  79999999999999999999999999999999999999864 3  99999999975332


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                         .....||+.|+|||++.+..  +.++|||||||++|+|++|.+||.......           .. ........++.
T Consensus       234 ---~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~-~~~~~~~~~~~  296 (681)
T 2pzi_A          234 ---FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP-EDDPVLKTYDS  296 (681)
T ss_dssp             ---CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC-TTCHHHHHCHH
T ss_pred             ---CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc-----------cc-ccccccccCHH
Confidence               25567999999999987653  456999999999999999999886521100           00 00011124678


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      +.+||.+||++||.+||+..+.+.|+|+
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            9999999999999999999999999886

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.4e-36  Score=292.58  Aligned_cols=182  Identities=14%  Similarity=0.045  Sum_probs=133.8

Q ss_pred             eecccCCeEEEEEEEcCCCcEEEEEEcccCc-----------cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433           10 ELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------KIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus        10 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ..+.|+.|.+..++....|+.||+|++.+..           ...+.+.+|+.+|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567888888888888889999999987642           1234688999999999 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~  156 (341)
                      |||++|++|.+.+...+++++.   .|+.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+..... ..
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCcc
Confidence            9999999999999998889875   47899999999999999999999999999998876  999999999754332 23


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA  198 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~  198 (341)
                      ..+.+||+.|||||++.+...  ..+|+||+|++++.+.++.
T Consensus       396 ~~t~vGTp~YmAPE~l~g~~~--~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAENKS--WNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             ccCceechhhccHHHhCCCCC--Ccccccccccchhhhcccc
Confidence            445689999999999987532  3489999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=8.1e-31  Score=252.51  Aligned_cols=182  Identities=19%  Similarity=0.126  Sum_probs=139.2

Q ss_pred             cccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---------cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            6 EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         6 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ...+.||+|+||+||+|.  ..+..+++|........         .+.+.+|+.+++.++||||+++..++......|+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            345689999999999994  45788999986442211         2346899999999999999955555556667799


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||+++++|.+++..        +..++.|++.||.|||++||+||||||+|||++.    ++||+|||+++.......
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~  484 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDED  484 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccc
Confidence            9999999999998865        6789999999999999999999999999999987    499999999985432211


Q ss_pred             --------CCCccCCCCccccccccc--cccCCCccchhhHHHHHHHHHhCCCCCC
Q 019433          157 --------PKSTVGTPAYIAPEVLAR--KEYDGKISDVWSCGVTLYVMLVGAYPFE  202 (341)
Q Consensus       157 --------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~vl~~l~~g~~pf~  202 (341)
                              ....+||+.|||||++.+  ..|... +|+||..+-..+-+.++.+|.
T Consensus       485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence                    124579999999999976  455444 799999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=2.1e-27  Score=210.51  Aligned_cols=143  Identities=19%  Similarity=0.154  Sum_probs=115.1

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------------------ccHHHHHHHHHHhcCCCCCeeeE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------------------IDENVQREIINHRSLRHPNIIRF   64 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~ei~~~~~l~hp~iv~l   64 (341)
                      .|++.+.||+|+||.||+|.+ .+|+.||||+++....                   ....+.+|+.+++.++|   +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence            456679999999999999999 7899999999864321                   13457899999999984   445


Q ss_pred             EEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEee
Q 019433           65 KEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICD  144 (341)
Q Consensus        65 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~D  144 (341)
                      .+++.. +..++||||++|++|.. +.      ......++.|++.||.|||++||+||||||+|||++ ++.  +||+|
T Consensus       167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--vkl~D  235 (282)
T 1zar_A          167 PKVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--IWIID  235 (282)
T ss_dssp             CCEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--EEECC
T ss_pred             CeEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--EEEEE
Confidence            554433 44599999999999977 31      134567999999999999999999999999999999 665  99999


Q ss_pred             cCCccCCCCCCCCCCccCCCCcccccccc
Q 019433          145 FGYSKSGLLHSQPKSTVGTPAYIAPEVLA  173 (341)
Q Consensus       145 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~  173 (341)
                      ||+|+            .+..++|||.+.
T Consensus       236 FG~a~------------~~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSV------------EVGEEGWREILE  252 (282)
T ss_dssp             CTTCE------------ETTSTTHHHHHH
T ss_pred             CCCCe------------ECCCCCHHHHHH
Confidence            99986            244578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=1.5e-23  Score=183.56  Aligned_cols=135  Identities=14%  Similarity=0.091  Sum_probs=106.2

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcE--EEEEEcccCccc-------------------------cHHHHHHHHHHhcCC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGKKI-------------------------DENVQREIINHRSLR   57 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~ei~~~~~l~   57 (341)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++.....                         ...+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999778999  999987543111                         125788999999887


Q ss_pred             CCC--eeeEEEEEEcCCEEEEEEeecCC-C----chHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeeCCCCCCC
Q 019433           58 HPN--IIRFKEVLLTPTHLAIVMEYAAG-G----ELFARICSAGRFSEDEARFFFQQLISGVSYCH-SMEICHRDLKLEN  129 (341)
Q Consensus        58 hp~--iv~l~~~~~~~~~~~iv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH-~~~iiHrDikp~N  129 (341)
                      |++  ++.++..    ...++||||+.+ |    +|......   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            775  3444442    245899999942 3    66655432   345678899999999999999 9999999999999


Q ss_pred             EEecCCCCCCEEEeecCCccC
Q 019433          130 TLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       130 ili~~~~~~~ikL~Dfg~a~~  150 (341)
                      ||++.  .  ++|+|||+|..
T Consensus       202 ILl~~--~--~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID--K--VYFIDMGQAVT  218 (258)
T ss_dssp             EEESS--S--EEECCCTTCEE
T ss_pred             EEEcC--c--EEEEECccccc
Confidence            99986  3  99999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=7.1e-20  Score=167.05  Aligned_cols=134  Identities=16%  Similarity=0.119  Sum_probs=98.4

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc---------------cH--------HHHHHHHHHhcCCCCCe
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI---------------DE--------NVQREIINHRSLRHPNI   61 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~--------~~~~ei~~~~~l~hp~i   61 (341)
                      |++.++||.|++|.||+|.+. +|+.||||+++.....               ..        ...+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999986 6999999987542110               00        12356666666644433


Q ss_pred             --eeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCC-
Q 019433           62 --IRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQP-  138 (341)
Q Consensus        62 --v~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~-  138 (341)
                        ...+++  ..  .+|||||++|++|..+.      .......++.||+.+|.+||++|||||||||.|||++.++.. 
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence              222322  12  27999999998885432      223456788999999999999999999999999999876532 


Q ss_pred             -------CEEEeecCCcc
Q 019433          139 -------RLKICDFGYSK  149 (341)
Q Consensus       139 -------~ikL~Dfg~a~  149 (341)
                             .+.|+||+-+.
T Consensus       246 d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CTTSEEEEEEECCCTTCE
T ss_pred             cccccccceEEEEeCCcc
Confidence                   27899998765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.51  E-value=1.1e-13  Score=120.71  Aligned_cols=138  Identities=17%  Similarity=0.105  Sum_probs=110.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      ..|++...++.|+.+.||.+...  ++.+++|+..... .....+.+|+.+++.+. +..++++++++...+..|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            35888899999999999999864  6789999986522 22346889999998884 67788999999989999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  117 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------------  117 (341)
                      ++|.+|...+.     +......++.++..+|..||+                                           
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99999876521     223345788999999999998                                           


Q ss_pred             ----------------cCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          118 ----------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       118 ----------------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                                      ..++|+|++|.||+++++..  +.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEE--EEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcE--EEEEEchhcc
Confidence                            45899999999999975432  5699998664

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=3.7e-12  Score=110.56  Aligned_cols=132  Identities=13%  Similarity=0.119  Sum_probs=97.1

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC--eeeEEEEEEcCCEEEEEEeecC
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN--IIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~--iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      |.+....+.|..+.||++.. .+|..+++|+....  ....+.+|+.+++.+.+.+  +++++.++...+..++||||++
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            44433334566799999965 46778999997654  2356788998888875434  6678898888888999999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME-------------------------------------------  119 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~-------------------------------------------  119 (341)
                      |.+|.  .   ....   ...++.++...|..||+..                                           
T Consensus        99 G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A           99 GQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             SEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             CcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            98883  1   1122   2356777888888888643                                           


Q ss_pred             ---------------CeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          120 ---------------ICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       120 ---------------iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                                     ++|+|++|.||+++++..  +.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~--~~liD~~~a~  213 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRF--SGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEE--EEECCCTTCE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcE--EEEEcchhcc
Confidence                           999999999999976532  5699999765

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=6.4e-12  Score=114.69  Aligned_cols=140  Identities=16%  Similarity=0.234  Sum_probs=106.9

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcc--cCc--cccHHHHHHHHHHhcCC--CCCeeeEEEEEEcC---CEEEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIE--RGK--KIDENVQREIINHRSLR--HPNIIRFKEVLLTP---THLAIV   77 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~---~~~~iv   77 (341)
                      .++.|+.|.++.||++...  +..+++|+..  ...  .....+.+|+.+++.|.  +..+++++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4678999999999999875  4679999876  432  22456888999998886  45688899888766   457999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS----------------------------------------  117 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~----------------------------------------  117 (341)
                      |||++|..+...  ....++......++.+++.+|..||+                                        
T Consensus       120 me~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999999877431  12347888889999999999999997                                        


Q ss_pred             ------------------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433          118 ------------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus       118 ------------------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                                        ..++|+|++|.||+++.++...+.|+||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              358999999999999866533368999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.13  E-value=2.9e-11  Score=107.75  Aligned_cols=187  Identities=16%  Similarity=0.136  Sum_probs=120.9

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCC--eeeEEEEEEcCC---EEEEEEee
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPN--IIRFKEVLLTPT---HLAIVMEY   80 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~--iv~l~~~~~~~~---~~~iv~e~   80 (341)
                      .++.++.|....||++.     ..+++|+.... .....+.+|..+++.+. +..  +++++.......   ..|+||++
T Consensus        24 ~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           24 TIEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eeEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            35678999999999864     45999986543 23456888999987763 322  455555443333   34889999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-------------------------------------------  117 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-------------------------------------------  117 (341)
                      ++|.+|.....  ..++..+...++.++...|..||+                                           
T Consensus        98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99988865433  347888888899999999999996                                           


Q ss_pred             ---------------cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccc--cccCCC
Q 019433          118 ---------------MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR--KEYDGK  180 (341)
Q Consensus       118 ---------------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  180 (341)
                                     ..++|+|++|.||+++.+....+.|+||+.+..+..............-..|+....  ..|...
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~  255 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK  255 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence                           136999999999999874222378999998764322110000000000012221110  011111


Q ss_pred             -----------ccchhhHHHHHHHHHhCCCCC
Q 019433          181 -----------ISDVWSCGVTLYVMLVGAYPF  201 (341)
Q Consensus       181 -----------~~DiwslG~vl~~l~~g~~pf  201 (341)
                                 -.+.|++|.++|.+.+|..+|
T Consensus       256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                       148999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.78  E-value=5.6e-08  Score=86.49  Aligned_cols=135  Identities=19%  Similarity=0.130  Sum_probs=95.8

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC---CeeeEEEEEE-cCCEEEEEEeecC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP---NIIRFKEVLL-TPTHLAIVMEYAA   82 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp---~iv~l~~~~~-~~~~~~iv~e~~~   82 (341)
                      .++.++.|....||.+     +..+++|+... ......+.+|..+++.|.+.   .|.+.+.+.. ..+..++||++++
T Consensus        23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             CEEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            3567888998999998     46699998432 22345788999999988642   3666666664 4556789999999


Q ss_pred             CCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------------------------------------------
Q 019433           83 GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM--------------------------------------------  118 (341)
Q Consensus        83 ~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~--------------------------------------------  118 (341)
                      |.++.....  ..++......++.++...|..||+.                                            
T Consensus        97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            988866321  2355666666666666666666642                                            


Q ss_pred             ----------------CCeeCCCCCCCEEecC---CCCCCEEEeecCCccC
Q 019433          119 ----------------EICHRDLKLENTLLDG---SPQPRLKICDFGYSKS  150 (341)
Q Consensus       119 ----------------~iiHrDikp~Nili~~---~~~~~ikL~Dfg~a~~  150 (341)
                                      .++|+|++|.||+++.   ++. .+.|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~-~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTP-LTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCC-EEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCc-eEEEEehhhcCC
Confidence                            3589999999999986   232 247999997763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=2.3e-07  Score=80.75  Aligned_cols=132  Identities=17%  Similarity=0.200  Sum_probs=95.3

Q ss_pred             eecccCCe-EEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEeecCCCchH
Q 019433           10 ELGSGNFG-VARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGELF   87 (341)
Q Consensus        10 ~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~   87 (341)
                      .+..|..| .||.......+..+++|+-...  ....+.+|...++.|. +--|.+++.++.+.+..++||++++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445554 6899888877888999986543  2456778988888773 333778888888899999999999998876


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------------
Q 019433           88 ARICSAGRFSEDEARFFFQQLISGVSYCHSM-------------------------------------------------  118 (341)
Q Consensus        88 ~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~-------------------------------------------------  118 (341)
                      ......    ......+..++...|..||+.                                                 
T Consensus       109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            654332    223344566666666666621                                                 


Q ss_pred             ---------CCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          119 ---------EICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       119 ---------~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                               .++|+|+.+.||++++++.  +-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~~--~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGKL--IGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCeE--EEEEECcccc
Confidence                     2789999999999986543  5699998765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.53  E-value=2.7e-07  Score=85.12  Aligned_cols=77  Identities=16%  Similarity=0.085  Sum_probs=50.2

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--------cccHHHHHHHHHHhcCCC--C-CeeeEEEEEEcCCEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--------KIDENVQREIINHRSLRH--P-NIIRFKEVLLTPTHLA   75 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~ei~~~~~l~h--p-~iv~l~~~~~~~~~~~   75 (341)
                      .++.||.|..+.||++....+++.+++|......        ........|..+++.+..  | .+++++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3678999999999999876667889999754321        123456778888876632  3 45566654  344458


Q ss_pred             EEEeecCCCc
Q 019433           76 IVMEYAAGGE   85 (341)
Q Consensus        76 iv~e~~~~~~   85 (341)
                      +|||++++..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.31  E-value=4.8e-06  Score=74.70  Aligned_cols=74  Identities=18%  Similarity=0.253  Sum_probs=42.3

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC-----CCCCeeeEE-E--EEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL-----RHPNIIRFK-E--VLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l-----~hp~iv~l~-~--~~~~~~~~~iv~e   79 (341)
                      ++.|+.|..+.||++...  +..+++|+.....   ..+..|+.+++.|     ..|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            345666778899999864  3459999987632   3344455554443     234444310 0  1234677899999


Q ss_pred             ecCCCch
Q 019433           80 YAAGGEL   86 (341)
Q Consensus        80 ~~~~~~L   86 (341)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=9.9e-07  Score=79.96  Aligned_cols=79  Identities=9%  Similarity=0.074  Sum_probs=55.1

Q ss_pred             ccee-cccCCeEEEEEEEc--C----CCcEEEEEEcccCc---c-ccHHHHHHHHHHhcCC-C--CCeeeEEEEEEcC--
Q 019433            8 VKEL-GSGNFGVARLVRDK--R----TKELVAVKYIERGK---K-IDENVQREIINHRSLR-H--PNIIRFKEVLLTP--   71 (341)
Q Consensus         8 ~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~---~-~~~~~~~ei~~~~~l~-h--p~iv~l~~~~~~~--   71 (341)
                      ++.| +.|....+|++...  .    ++..+++|+.....   . ....+.+|+.+++.|. +  -.+.+++.+....  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88888999988753  1    15679999865533   1 1346778888887773 2  3577788877655  


Q ss_pred             -CEEEEEEeecCCCch
Q 019433           72 -THLAIVMEYAAGGEL   86 (341)
Q Consensus        72 -~~~~iv~e~~~~~~L   86 (341)
                       +..++|||+++|.++
T Consensus       105 ~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TSSCEEEEECCCCBCC
T ss_pred             cCCceEEEEecCCCCh
Confidence             346899999988654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.04  E-value=2e-05  Score=73.09  Aligned_cols=73  Identities=18%  Similarity=0.222  Sum_probs=45.3

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEccc-----Ccc-----ccHHHHHHHHHHh-cCCCCCeeeEEEEEEcCCEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIER-----GKK-----IDENVQREIINHR-SLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~-----~~~~~~~ei~~~~-~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      .++.||.|..+.||++..  ++..++||....     ...     ....+..|+..+. ......+++++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            467899999999999964  467899994221     111     1122333433322 12234577777765  45678


Q ss_pred             EEEeec-CC
Q 019433           76 IVMEYA-AG   83 (341)
Q Consensus        76 iv~e~~-~~   83 (341)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 76

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.92  E-value=9.6e-05  Score=65.59  Aligned_cols=76  Identities=20%  Similarity=0.116  Sum_probs=60.0

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCEEEEEEeecCC
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAIVMEYAAG   83 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~~~iv~e~~~~   83 (341)
                      -++.|+.|....+|++..  .+..+++|+....  ....+..|...++.|.   ...+++++.+....+..++|||+++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            356789999999999986  4678999987653  2456788888887773   35688888888888899999999998


Q ss_pred             Cch
Q 019433           84 GEL   86 (341)
Q Consensus        84 ~~L   86 (341)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.87  E-value=1.7e-05  Score=70.12  Aligned_cols=74  Identities=15%  Similarity=0.124  Sum_probs=45.7

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCe-eeEEEEEEcCCEEEEEEeec-C
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI-IRFKEVLLTPTHLAIVMEYA-A   82 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~i-v~l~~~~~~~~~~~iv~e~~-~   82 (341)
                      +.-++.|+.|....+|++      ..+++|+........-...+|+.+++.+...++ .+++.++  ...-+++++|+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            344788988999999999      459999876543222234567777665532122 4555543  33346899999 6


Q ss_pred             CCch
Q 019433           83 GGEL   86 (341)
Q Consensus        83 ~~~L   86 (341)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.86  E-value=0.00011  Score=60.82  Aligned_cols=122  Identities=12%  Similarity=0.041  Sum_probs=77.5

Q ss_pred             CchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCcc
Q 019433           84 GELFARICS-AGRFSEDEARFFFQQLISGVSYC-HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV  161 (341)
Q Consensus        84 ~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~L-H~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~~  161 (341)
                      .+|.+.+.. +.+++++++|.++.|.+.+|.-+ +.+.-..+=+.|..|++..+|.  |-..+ ..+.           .
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence            468888765 55899999999999999998876 2222234445678899988887  54442 1110           1


Q ss_pred             CCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHh
Q 019433          162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQI  241 (341)
Q Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  241 (341)
                      ....+.+||...  ...+.+.=|||||++||..+-...|=.                       ....+|+.+..||..|
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e~-----------------------eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKEN-----------------------EERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------EEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------cchhhCHHHHHHHHHH
Confidence            123466888763  222334679999999999875433211                       1126899999999999


Q ss_pred             ccc
Q 019433          242 FVA  244 (341)
Q Consensus       242 L~~  244 (341)
                      ..-
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.65  E-value=0.00012  Score=66.64  Aligned_cols=138  Identities=17%  Similarity=0.139  Sum_probs=81.7

Q ss_pred             cceecccCCeEEEEEEEcC-------CCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++.|..|-...+|++....       ++..+++|+............+|..+++.|. +.-..++++.+..    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4567668888899998752       3578999986443233456678988887773 3224666766543    39999


Q ss_pred             ecCCCchHH----------HH-------Hhc-----CCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 019433           80 YAAGGELFA----------RI-------CSA-----GRF--SEDEARFFFQQLIS-------------------GVSYCH  116 (341)
Q Consensus        80 ~~~~~~L~~----------~l-------~~~-----~~l--~~~~~~~i~~qil~-------------------aL~~LH  116 (341)
                      |++|.+|..          .+       ...     +..  ....+..++.++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998855421          11       111     111  24556666655432                   233332


Q ss_pred             ----H----cCCeeCCCCCCCEEecCCC--CCCEEEeecCCcc
Q 019433          117 ----S----MEICHRDLKLENTLLDGSP--QPRLKICDFGYSK  149 (341)
Q Consensus       117 ----~----~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a~  149 (341)
                          .    ..++|+|+.+.||+++.+.  ...+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2    2489999999999998651  1249999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.60  E-value=0.00026  Score=62.96  Aligned_cols=76  Identities=12%  Similarity=0.073  Sum_probs=48.6

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCC--CeeeEEEE-----EEcCCEEEEEEee
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHP--NIIRFKEV-----LLTPTHLAIVMEY   80 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp--~iv~l~~~-----~~~~~~~~iv~e~   80 (341)
                      +..|+ |....||++... +|+.+++|+..........+..|..+++.|...  .+++++..     ....+..+++|++
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34577 888899987653 466799999875433445667787777665311  13333332     1235567899999


Q ss_pred             cCCCc
Q 019433           81 AAGGE   85 (341)
Q Consensus        81 ~~~~~   85 (341)
                      ++|..
T Consensus       109 i~G~~  113 (328)
T 1zyl_A          109 VGGRQ  113 (328)
T ss_dssp             CCCEE
T ss_pred             cCCCC
Confidence            98854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.52  E-value=0.00021  Score=66.41  Aligned_cols=73  Identities=11%  Similarity=0.097  Sum_probs=49.7

Q ss_pred             cceecccCCeEEEEEEEcC-------CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++.|+.|....||++....       .+..+++|+.... .....+.+|..+++.|...+ .+++++.+..    .+|++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            5678888889999998753       3578999987432 11155668888888774222 3667766542    38999


Q ss_pred             ecCCCc
Q 019433           80 YAAGGE   85 (341)
Q Consensus        80 ~~~~~~   85 (341)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.52  E-value=0.00019  Score=65.19  Aligned_cols=74  Identities=15%  Similarity=0.048  Sum_probs=44.8

Q ss_pred             cceecccCCeEEEEEEEcC--------CCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEE
Q 019433            8 VKELGSGNFGVARLVRDKR--------TKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~   78 (341)
                      ++.|+.|....+|++....        .+..+++|+.............|..+++.|...+ +++++..+  .+  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            5677888888999998653        1368999987654322223457777777664223 45666554  22  6899


Q ss_pred             eecCCCc
Q 019433           79 EYAAGGE   85 (341)
Q Consensus        79 e~~~~~~   85 (341)
                      +|++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.00066  Score=60.59  Aligned_cols=138  Identities=14%  Similarity=0.085  Sum_probs=70.3

Q ss_pred             cceecccCCeE-EEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC--CCCeeeEEEEEEcCCEEEEEEeecCCC
Q 019433            8 VKELGSGNFGV-ARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus         8 ~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~~~~~iv~e~~~~~   84 (341)
                      ++.|+.|+... +|..... ++..+++|......  ...+..|+.+++.+.  .-.+++++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            44566565554 5666542 35678888655432  133445666665552  223566666544444  6899999776


Q ss_pred             chHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH---
Q 019433           85 ELFARICSA--------------------------GRFSEDEAR-------F-FF------------QQLISGVSYC---  115 (341)
Q Consensus        85 ~L~~~l~~~--------------------------~~l~~~~~~-------~-i~------------~qil~aL~~L---  115 (341)
                      .+...+...                          ..+......       . +.            ..+...+..|   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            664433210                          012221111       0 00            0111222233   


Q ss_pred             ---HHcCCeeCCCCCCCEEecCCC--CCCEEEeecCCccC
Q 019433          116 ---HSMEICHRDLKLENTLLDGSP--QPRLKICDFGYSKS  150 (341)
Q Consensus       116 ---H~~~iiHrDikp~Nili~~~~--~~~ikL~Dfg~a~~  150 (341)
                         +...++|||+.+.||+++.+.  ...+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence               124699999999999997641  12489999998763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.49  E-value=0.00021  Score=63.39  Aligned_cols=137  Identities=17%  Similarity=0.156  Sum_probs=75.0

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----CCCeeeEE-E--EEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----HPNIIRFK-E--VLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----hp~iv~l~-~--~~~~~~~~~iv~e   79 (341)
                      ++.|+.|....+|++... ++ .+++|+..... ....+..|+.+++.|.     -|.++... +  +....+..+++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            456777888899999864 23 68999887631 2345566777666552     23333210 0  1123466799999


Q ss_pred             ecCCCchH--------------HHHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH----
Q 019433           80 YAAGGELF--------------ARICSA-GRF--------SEDEARFF---------------FQQLISGVSYCHS----  117 (341)
Q Consensus        80 ~~~~~~L~--------------~~l~~~-~~l--------~~~~~~~i---------------~~qil~aL~~LH~----  117 (341)
                      +++|..+.              ..+... ..+        ........               ...+...+..+..    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99885431              111111 111        11100000               0113344555553    


Q ss_pred             ---cCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          118 ---MEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       118 ---~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                         .+++|+|+.+.||+++++..  +.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~--~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCce--EEEecchhcc
Confidence               46999999999999986532  4799998664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00053  Score=59.93  Aligned_cols=77  Identities=14%  Similarity=0.052  Sum_probs=54.4

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCC---CCeeeEEEEEEcCCEEEEEEe
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRH---PNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~h---p~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +..-++.+|.|..+.||++... +|+.|++|+..... .....+..|...|+.|..   --+++++.+.  .  -++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEE
Confidence            4456788999999999999875 68899999866433 233457789888887732   2355555542  2  378999


Q ss_pred             ecCCCc
Q 019433           80 YAAGGE   85 (341)
Q Consensus        80 ~~~~~~   85 (341)
                      ++.++.
T Consensus        91 ~l~~~~   96 (288)
T 3f7w_A           91 WVDERP   96 (288)
T ss_dssp             CCCCCC
T ss_pred             eecccC
Confidence            987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.37  E-value=0.0013  Score=61.44  Aligned_cols=75  Identities=15%  Similarity=0.095  Sum_probs=49.0

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEeecCCCch
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      ++.|+.|-...+|++.....+..+++|+........-...+|..+++.|...+ .+++++++.  +  ..|++|++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            56788888899999998654578999987543222212358888888775433 367777762  2  359999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.98  E-value=0.0075  Score=53.92  Aligned_cols=66  Identities=12%  Similarity=-0.055  Sum_probs=40.6

Q ss_pred             cCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcC---CCCCeeeEEEE------EEcCCEEEEEEeecCCC
Q 019433           14 GNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSL---RHPNIIRFKEV------LLTPTHLAIVMEYAAGG   84 (341)
Q Consensus        14 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l---~hp~iv~l~~~------~~~~~~~~iv~e~~~~~   84 (341)
                      |....||++... +| .+++|+......     ..|+..++.|   .-|++++.+..      ....+..+++|+|++|.
T Consensus        34 g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~  106 (339)
T 3i1a_A           34 DTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP  106 (339)
T ss_dssp             CSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred             ccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence            336789999864 34 899998766542     2444444443   22324444332      23357789999999986


Q ss_pred             ch
Q 019433           85 EL   86 (341)
Q Consensus        85 ~L   86 (341)
                      .+
T Consensus       107 ~~  108 (339)
T 3i1a_A          107 NG  108 (339)
T ss_dssp             BT
T ss_pred             cC
Confidence            55

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.70  E-value=0.0058  Score=56.44  Aligned_cols=75  Identities=16%  Similarity=0.062  Sum_probs=48.9

Q ss_pred             cceecccCCeEEEEEEEcCC-------CcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKRT-------KELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++.|..|-...+|++.....       +..+++++........-...+|..+++.|. +.-.+++++.+  .+  +.|++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            56677788889999987521       578999986554322223457888777763 22345566543  22  78999


Q ss_pred             ecCCCch
Q 019433           80 YAAGGEL   86 (341)
Q Consensus        80 ~~~~~~L   86 (341)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.65  E-value=0.26  Score=44.91  Aligned_cols=30  Identities=40%  Similarity=0.637  Sum_probs=23.3

Q ss_pred             CeeCCCCCCCEEecC----CCCCCEEEeecCCcc
Q 019433          120 ICHRDLKLENTLLDG----SPQPRLKICDFGYSK  149 (341)
Q Consensus       120 iiHrDikp~Nili~~----~~~~~ikL~Dfg~a~  149 (341)
                      ++|+|+.+.||++..    +....+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            679999999999943    122349999998775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.76  E-value=0.051  Score=50.75  Aligned_cols=60  Identities=8%  Similarity=0.037  Sum_probs=18.2

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEE------EEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEE
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAV------KYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLL   69 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~   69 (341)
                      +.+.||   ||.||++....+..+||+      |......   .....+.++..+++.++|||+++.+.+..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            456676   999999998766678888      6554322   22235667888888889999999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.13  E-value=2.9  Score=34.42  Aligned_cols=83  Identities=14%  Similarity=0.075  Sum_probs=60.8

Q ss_pred             CCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHcCCeeCCCCCCCEEecCC
Q 019433           57 RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS-YCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        57 ~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~-~LH~~~iiHrDikp~Nili~~~  135 (341)
                      .||++  --.+-.+++.+.+.++.-+++.-+..+   ..++..+.++++.+|+.... ++  ..-+|=-+.|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            68888  334447778888888776555445555   34788888998888877655 44  445788899999999988


Q ss_pred             CCCCEEEeecCCc
Q 019433          136 PQPRLKICDFGYS  148 (341)
Q Consensus       136 ~~~~ikL~Dfg~a  148 (341)
                      +.  +++.-.|+-
T Consensus       121 ~~--p~i~hRGi~  131 (219)
T 4ano_A          121 LE--PFFLHVGVK  131 (219)
T ss_dssp             CC--EEESCCEET
T ss_pred             Cc--EEEEEcCCc
Confidence            87  888887753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.71  E-value=1.1  Score=36.81  Aligned_cols=117  Identities=10%  Similarity=0.069  Sum_probs=77.5

Q ss_pred             CCCCCeeeEEEEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC
Q 019433           56 LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS  135 (341)
Q Consensus        56 l~hp~iv~l~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~  135 (341)
                      ..||+++.. .+-...+.+.+.++.-+.+.-+..+   +.++....++++.+|+....+++  .-+|=-+.|+||+++.+
T Consensus        42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred             ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence            378999977 5667777777777665433323333   34788999999999988775443  34788899999999988


Q ss_pred             CCCCEEEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCC
Q 019433          136 PQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFE  202 (341)
Q Consensus       136 ~~~~ikL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~  202 (341)
                      +.  +++.-.|+-..                ++|..+      +...=.-.+=|++..++.++..|.
T Consensus       116 ~~--p~i~~RGik~~----------------l~P~~~------~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GL--PIAKTRGLQNV----------------VDPLPV------SEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SC--EEESCCEETTT----------------BSCCCC------CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CC--EEEEEccCccC----------------CCCCCC------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence            77  88887775331                122211      111123356677888888877763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	341
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-84
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-81
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-79
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-79
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-77
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-76
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-76
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-75
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-72
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-68
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-68
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-65
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-64
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-62
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-61
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-61
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-60
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-60
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-59
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-55
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-53
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-52
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-51
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-49
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-49
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-43
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-41
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-15

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  253 bits (646), Expect = 7e-84
 Identities = 97/270 (35%), Positives = 151/270 (55%), Gaps = 10/270 (3%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID--ENVQREIINHRSLRHPN 60
           E ++ V+ LG G +G  +L  ++ T+E VAVK ++  + +D  EN+++EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +++F           + +EY +GGELF RI       E +A+ FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARKEY 177
            HRD+K EN LLD   +  LKI DFG +     +++ +      GT  Y+APE+L R+E+
Sbjct: 125 THRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
             +  DVWSCG+ L  ML G  P++ P D           +  + +L  + ++ +    L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL 239

Query: 238 LSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
           L +I V +PS RI IP+IKK  W+ K L K
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLKK 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 8e-81
 Identities = 89/266 (33%), Positives = 141/266 (53%), Gaps = 14/266 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENV----QREIINHRSLRH 58
           E +E  + LG G FG   L R+K++K ++A+K + + +     V    +RE+     LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            + HRD+K EN LL       LKI DFG+S      S+  +  GT  Y+ PE++  + +D
Sbjct: 126 RVIHRDIKPENLLLG--SAGELKIADFGWSVH-APSSRRTTLCGTLDYLPPEMIEGRMHD 182

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K  D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+  V+   R L+
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLI 235

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKN 264
           S++   +PS+R  + E+ +HPW   N
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITAN 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (620), Expect = 2e-79
 Identities = 70/318 (22%), Positives = 139/318 (43%), Gaps = 10/318 (3%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           E+Y   ++LG G FG+     +  +K+    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEIC 121
              E   +   L ++ E+ +G ++F RI ++    +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKI 181
           H D++ EN +        +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 182 SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLLS 239
           +D+WS G  +YV+L G  PF         ++ I+ I N +Y   +  +  +S +    + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 240 QIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQEA 299
           ++ V +   R+   E  +HPW  + + +   ++ +T      R   T   +++  ++  A
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR--RYYHTLIKKDLNMVVSAA 297

Query: 300 KMPGEATKVAGQGAAGAS 317
           ++       + +G + A 
Sbjct: 298 RISCGGAIRSQKGVSVAK 315

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  243 bits (622), Expect = 3e-79
 Identities = 75/306 (24%), Positives = 137/306 (44%), Gaps = 9/306 (2%)

Query: 1   MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHP 59
           + + Y+ ++ELGSG FGV     +K T  +   K+I     +D   V+ EI     L HP
Sbjct: 27  VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSM 118
            +I   +       + +++E+ +GGELF RI +   + SE E   + +Q   G+ + H  
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            I H D+K EN + +      +KI DFG +         K T  T  + APE++ R+   
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRH 236
              +D+W+ GV  YV+L G  PF   +D     +T+  ++   +   +  +  VS + + 
Sbjct: 207 -FYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKD 261

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRII 296
            +  +   +P KR+ + +  +HPW   +       I  + Y +  +    +  +      
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQP 321

Query: 297 QEAKMP 302
              ++ 
Sbjct: 322 AIGRIA 327

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  239 bits (611), Expect = 1e-77
 Identities = 82/282 (29%), Positives = 138/282 (48%), Gaps = 10/282 (3%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPNI 61
           + Y+  +ELG+G FGV   V ++ T    A K++    + D E V++EI     LRHP +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 62  IRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   +       + ++ E+ +GGELF ++     + SEDEA  + +Q+  G+ + H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGK 180
            H DLK EN +        LK+ DFG +         K T GT  + APEV   K     
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

Query: 181 ISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVSADCRHLL 238
            +D+WS GV  Y++L G  PF       N  +T+  +++  + + D  +  +S D +  +
Sbjct: 206 -TDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLK-NLPKEIIEIEKTNYKE 279
            ++ +ADP+ R+ I +  +HPW    N P    +I  + Y +
Sbjct: 261 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  237 bits (607), Expect = 2e-77
 Identities = 82/306 (26%), Positives = 132/306 (43%), Gaps = 18/306 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLR 57
           E+ +  ++E+G G+FG     RD R  E+VA+K +    K      +++ +E+   + LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HPN I+++   L      +VMEY  G              E E        + G++Y HS
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA---R 174
             + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+     
Sbjct: 134 HNMIHRDVKAGNILLS--EPGLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
            +YDGK  DVWS G+T   +     P  +     N    +  I   +         S   
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYF 243

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMR 294
           R+ +       P  R     + KH + L+  P  +I       K+A R+       ++ +
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303

Query: 295 II-QEA 299
           I+ QEA
Sbjct: 304 ILFQEA 309

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  235 bits (600), Expect = 2e-76
 Identities = 95/287 (33%), Positives = 144/287 (50%), Gaps = 16/287 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHP 59
            + Y+    LG+G F    L  DKRT++LVA+K I +      + +++ EI     ++HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+   ++  +  HL ++M+  +GGELF RI   G ++E +A     Q++  V Y H + 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 120 ICHRDLKLENTLLDGSPQP-RLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           I HRDLK EN L     +  ++ I DFG SK     S   +  GTP Y+APEVLA+K Y 
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRH 236
               D WS GV  Y++L G  PF D     N  K  ++I   +Y    P +  +S   + 
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 237 LLSQIFVADPSKRIPIPEIKKHPWFL------KNLPKEIIEIEKTNY 277
            +  +   DP KR    +  +HPW        KN+ + + E  K N+
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNF 289

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (600), Expect = 3e-76
 Identities = 78/309 (25%), Positives = 131/309 (42%), Gaps = 45/309 (14%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHP 59
           ++ +E + ELG+GN GV   V  K +  ++A K I  E    I   + RE+        P
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
            I+ F     +   ++I ME+  GG L   +  AGR  E         +I G++Y     
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 120 -ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            I HRD+K  N L++   +  +K+CDFG S   L+ S   S VGT +Y++PE L    Y 
Sbjct: 125 KIMHRDVKPSNILVN--SRGEIKLCDFGVSGQ-LIDSMANSFVGTRSYMSPERLQGTHYS 181

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPED-------------------------------- 206
            + SD+WS G++L  M VG YP   P+                                 
Sbjct: 182 VQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSY 240

Query: 207 ------PRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
                 P    + +D I N           S + +  +++  + +P++R  + ++  H +
Sbjct: 241 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300

Query: 261 FLKNLPKEI 269
             ++  +E+
Sbjct: 301 IKRSDAEEV 309

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 6e-76
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 12/278 (4%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
           E+ +E + ELG G FG     ++K T  L A K I+   + + E+   EI    S  HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-FSEDEARFFFQQLISGVSYCHSME 119
           I++  +      +L I++E+ AGG + A +    R  +E + +   +Q +  ++Y H  +
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYD 178
           I HRDLK  N L        +K+ DFG S       Q + + +GTP ++APEV+  +   
Sbjct: 131 IIHRDLKAGNILFT--LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 179 GKI----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
            +     +DVWS G+TL  M     P  +    R   K     ++    L    R S++ 
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---AKSEPPTLAQPSRWSSNF 245

Query: 235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEI 272
           +  L +    +   R    ++ +HP+   +  K I E+
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 1e-75
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 9/267 (3%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-ENVQREIINHRSLRHPN 60
           +++Y   +++G G  G      D  T + VA++ +   ++   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 61  IIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           I+ + +  L    L +VMEY AGG L   + +     E +     ++ +  + + HS ++
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEYDG 179
            HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV+ RK Y  
Sbjct: 138 IHRDIKSDNILLG--MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K  D+WS G+    M+ G  P+ +    R          N    L +  ++SA  R  L+
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLN 251

Query: 240 QIFVADPSKRIPIPEIKKHPWFLKNLP 266
           +    D  KR    E+ +H +     P
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKP 278

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  226 bits (578), Expect = 1e-73
 Identities = 89/275 (32%), Positives = 128/275 (46%), Gaps = 20/275 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI----------ERGKKIDENVQREIIN 52
           E YEP + LG G   V R    K T +  AVK I          E  +++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 53  HRSLR-HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
            R +  HPNII+ K+   T T   +V +    GELF  +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 172 LARKEYD-----GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD 226
           +     D     GK  D+WS GV +Y +L G+ PF   +     R  +    N Q+  P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS--GNYQFGSPE 238

Query: 227 YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           +   S   + L+S+  V  P KR    E   HP+F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 1e-72
 Identities = 95/317 (29%), Positives = 156/317 (49%), Gaps = 16/317 (5%)

Query: 3   ERYEPVKE-LGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREI-INHRSLRHPN 60
           + Y+   + LG G  G    + +KRT+E  A+K ++   K     +RE+ ++ R+ + P+
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66

Query: 61  IIRFKEVLLTP----THLAIVMEYAAGGELFARICSAG--RFSEDEARFFFQQLISGVSY 114
           I+R  +V          L IVME   GGELF+RI   G   F+E EA    + +   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 115 CHSMEICHRDLKLENTLLDG-SPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
            HS+ I HRD+K EN L     P   LK+ DFG++K    H+   +   TP Y+APEVL 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRVS 231
            ++YD    D+WS GV +Y++L G  PF              RIR  QY  P+  +  VS
Sbjct: 187 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEE 291
            + + L+  +   +P++R+ I E   HPW +++       +  +   +  +++     EE
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305

Query: 292 IMRIIQEAKMPGEATKV 308
           +   +   ++  E  K+
Sbjct: 306 MTSALATMRVDYEQIKI 322

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (572), Expect = 2e-72
 Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 22/272 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINH----RSLRH 58
           E ++  K LG G+F    L R+  T    A+K +E+   I EN    +         L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P  ++          L   + YA  GEL   I   G F E   RF+  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVLARK 175
            I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L  K
Sbjct: 128 GIIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
                 SD+W+ G  +Y ++ G  PF       N      +I  ++Y  P+  +     R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238

Query: 236 HLLSQIFVADPSKRIPI------PEIKKHPWF 261
            L+ ++ V D +KR+          +K HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 9e-72
 Identities = 90/271 (33%), Positives = 149/271 (54%), Gaps = 16/271 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID-------ENVQREIINHR 54
           ++ Y+  +ELGSG F V +  R+K T    A K+I++ +          E+++RE+   +
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
            ++HPN+I   EV    T + +++E  AGGELF  +      +E+EA  F +Q+++GV Y
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128

Query: 115 CHSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            HS++I H DLK EN +L     P+PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPD--YVRV 230
             +      +D+WS GV  Y++L GA PF         ++T+  +  V Y   D  +   
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNT 243

Query: 231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           SA  +  + ++ V DP KR+ I +  +HPW 
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-68
 Identities = 87/282 (30%), Positives = 128/282 (45%), Gaps = 25/282 (8%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-------VQREIINHR 54
           E +Y+    LGSG FG             VA+K++E+ +  D         V  E++  +
Sbjct: 3   ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62

Query: 55  SLR--HPNIIRFKEVLLTPTHLAIVMEYAAGG-ELFARICSAGRFSEDEARFFFQQLISG 111
            +      +IR  +    P    +++E      +LF  I   G   E+ AR FF Q++  
Sbjct: 63  KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEV 171
           V +CH+  + HRD+K EN L+D + +  LK+ DFG     L  +      GT  Y  PE 
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEW 180

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           +    Y G+ + VWS G+ LY M+ G  PFE  E+          I   Q F     RVS
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVS 228

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN-LPKEIIEI 272
           ++C+HL+       PS R    EI+ HPW     LP+E  EI
Sbjct: 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 3e-68
 Identities = 87/266 (32%), Positives = 136/266 (51%), Gaps = 16/266 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN-----VQREIINHRSLR 57
           E +   K LG G+FG   L   K+T +  A+K +++   + ++     +  + +   +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           HP +        T  +L  VMEY  GG+L   I S  +F    A F+  ++I G+ + HS
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 118 MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKE 176
             I +RDLKL+N LLD      +KI DFG  K  +L     +T  GTP YIAPE+L  ++
Sbjct: 122 KGIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           Y+    D WS GV LY ML+G  PF      ++  +    IR    F P +  +  + + 
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPRW--LEKEAKD 232

Query: 237 LLSQIFVADPSKRIPIP-EIKKHPWF 261
           LL ++FV +P KR+ +  +I++HP F
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLF 258

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 3e-68
 Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 23/273 (8%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
           E YE +  +G+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 60  NIIRFKEVLL--TPTHLAIVMEYAAGGELFARICSAGR----FSEDEARFFFQQLISGVS 113
           NI+R+ + ++  T T L IVMEY  GG+L + I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 114 YCH-----SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVG-TPAYI 167
            CH        + HRDLK  N  LDG     +K+ DFG ++     +        TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 168 APEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY 227
           +PE + R  Y+ K SD+WS G  LY +     PF       + ++   +IR  ++    Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236

Query: 228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPW 260
            R S +   +++++       R  + EI ++P 
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 5e-67
 Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 16/266 (6%)

Query: 5   YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHPNI 61
            +   E+G G+F       D  T   VA   ++  K      +  + E    + L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 62  IRFKEVLLTPT----HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS 117
           +RF +   +       + +V E    G L   +           R + +Q++ G+ + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 118 M--EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
               I HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+   +
Sbjct: 131 RTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAPEMY-EE 187

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
           +YD    DV++ G+ +  M    YP+ + ++     +   R+ +             + +
Sbjct: 188 KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243

Query: 236 HLLSQIFVADPSKRIPIPEIKKHPWF 261
            ++      +  +R  I ++  H +F
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 71/284 (25%), Positives = 132/284 (46%), Gaps = 19/284 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-------S 55
             +   + +G G FG     R   T ++ A+K +++ +   +  +   +N R       +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
              P I+       TP  L+ +++   GG+L   +   G FSE + RF+  ++I G+ + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARK 175
           H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL + 
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACD-FSKKKPHASVGTHGYMAPEVLQKG 180

Query: 176 EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR 235
                 +D +S G  L+ +L G  PF      ++  +       +   LPD    S + R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELR 237

Query: 236 HLLSQIFVADPSKRIPIP-----EIKKHPWFLKNLPKEIIEIEK 274
            LL  +   D ++R+        E+K+ P+F ++L  +++ ++K
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQK 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  205 bits (522), Expect = 1e-64
 Identities = 86/268 (32%), Positives = 140/268 (52%), Gaps = 20/268 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           + ++ ++ LG+G+FG   L+R +      A+K +++   +     E+   E +    + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P IIR          + ++M+Y  GGELF+ +  + RF    A+F+  ++   + Y HS 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           +I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV++ K Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
               D WS G+ +Y ML G  PF D     N  KT ++I N +   P +   + D + LL
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDS----NTMKTYEKILNAELRFPPF--FNEDVKDLL 232

Query: 239 SQIFVADPSKRIP-----IPEIKKHPWF 261
           S++   D S+R+        ++K HPWF
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  198 bits (504), Expect = 2e-62
 Identities = 64/268 (23%), Positives = 103/268 (38%), Gaps = 13/268 (4%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
           +RYE  + LG G      L RD R    VAVK +      D +     +RE  N  +L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 59  PNIIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           P I+   +     T       IVMEY  G  L   + + G  +   A          +++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFG--YSKSGLLHSQPKSTVGTPAYIAPEVL 172
            H   I HRD+K  N ++  +   ++         + SG   +Q  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
                D + SDV+S G  LY +L G  PF          + +    +       +  +SA
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSA 243

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPW 260
           D   ++ +    +P  R       +   
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 2e-61
 Identities = 86/269 (31%), Positives = 134/269 (49%), Gaps = 19/269 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDEN----VQREIINHRSLRH 58
             ++ +K LG G FG   LVR+K T    A+K + +   I ++       E    ++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +   K    T   L  VMEYA GGELF  +     F+E+ ARF+  +++S + Y HS 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP-KSTVGTPAYIAPEVLARKEY 177
           ++ +RD+KLEN +LD      +KI DFG  K G+      K+  GTP Y+APEVL   +Y
Sbjct: 125 DVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL 237
                D W  GV +Y M+ G  PF +    ++  +  + I   +   P    +S + + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPRT--LSPEAKSL 235

Query: 238 LSQIFVADPSKRIP-----IPEIKKHPWF 261
           L+ +   DP +R+        E+ +H +F
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-61
 Identities = 65/275 (23%), Positives = 110/275 (40%), Gaps = 16/275 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQ---REIINHRSLRHP 59
            +    + +GSG+FG     +       VAVK +       + +Q    E+   R  RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSM 118
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+ 
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVGTPAYIAPEVLARK 175
            I HRDLK  N  L        KI DFG +          Q +   G+  ++APEV+  +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTV--KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 176 EYD--GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD 233
           + +     SDV++ G+ LY ++ G  P+ +  +       + R                 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 234 CRHLLSQIFVADPSKRIPIPEIKKHPWFL-KNLPK 267
            + L+++       +R   P+I      L ++LPK
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 37/303 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNI 61
           E  Y   K +G+G+FGV    +   + ELVA+K + + K+      RE+   R L H NI
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI 75

Query: 62  IRFKEVLLTP------THLAIVMEYAAGG---ELFARICSAGRFSEDEARFFFQQLISGV 112
           +R +    +        +L +V++Y              +         + +  QL   +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
           +Y HS  ICHRD+K +N LLD       K+CDFG +K  +      S + +  Y APE++
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI-----RNVQYFLPDY 227
                     DVWS G  L  +L+G   F          + I  +       ++   P+Y
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 228 V------------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
                              R   +   L S++    P+ R+   E   H +F   L    
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-DELRDPN 313

Query: 270 IEI 272
           +++
Sbjct: 314 VKL 316

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-60
 Identities = 75/291 (25%), Positives = 115/291 (39%), Gaps = 32/291 (10%)

Query: 6   EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHP 59
           E +  LG G F      RDK T ++VA+K I+ G +      I+    REI   + L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NII   +     +++++V ++           ++   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           I HRDLK  N LLD      LK+ DFG +KS G  +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLD--ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------QYFLPDYV--- 228
           G   D+W+ G  L  +L+         D     +  + +             LPDYV   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 229 ------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
                           D   L+  +F+ +P  RI   +  K  +F  N P 
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (495), Expect = 3e-60
 Identities = 83/282 (29%), Positives = 144/282 (51%), Gaps = 21/282 (7%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHRSLRH 58
           ++++ +K LG+G+FG   LV+ K +    A+K +++ K +     E+   E    +++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 59  PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           P +++ +      ++L +VMEY AGGE+F+ +   GRFSE  ARF+  Q++    Y HS+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           ++ +RDLK EN L+D   Q  +++ DFG++K      +  +  GTP  +APE++  K Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
               D W+ GV +Y M  G  PF          +  ++I + +   P +   S+D + LL
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPSH--FSSDLKDLL 269

Query: 239 SQIFVADPSKRIP-----IPEIKKHPWFLKNLPKEIIEIEKT 275
             +   D +KR       + +IK H WF        I   K 
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF-ATTDWIAIYQRKV 310

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  191 bits (487), Expect = 3e-59
 Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 42/301 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNI 61
           + Y+ V++LG G +       +    E V VK ++  KK  + ++REI    +LR  PNI
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92

Query: 62  IRFKEVLLTPTH--LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           I   +++  P     A+V E+    +           ++ + RF+  +++  + YCHSM 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           I HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L   +   
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF---------------- 223
              D+WS G  L  M+    PF    D  +    I ++   +                  
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 224 ----------------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
                             +   VS +    L ++   D   R+   E  +HP+F   + K
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-YTVVK 327

Query: 268 E 268
           +
Sbjct: 328 D 328

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 1e-58
 Identities = 79/331 (23%), Positives = 137/331 (41%), Gaps = 42/331 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIER---GKKIDENVQREIINHRSLRH 58
              Y  ++ +GSG +G      D RT   VA+K + R    +   +   RE+   + +RH
Sbjct: 17  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76

Query: 59  PNIIRFKEV------LLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGV 112
            N+I   +V      L   T   +VM +   G    ++    +  ED  +F   Q++ G+
Sbjct: 77  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134

Query: 113 SYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVL 172
            Y H+  I HRDLK  N  ++      LKI DFG ++     S+    V T  Y APEV+
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVN--EDCELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVI 190

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI----------------DR 216
                  +  D+WS G  +  M+ G   F+  +     ++ +                D 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 217 IRNVQYFLPDYVR---------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
            +N    LP+  +          S    +LL ++ V D  +R+   E   HP+F ++L  
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLHD 309

Query: 268 EIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
              E +   Y ++  D   ++++E  R+  +
Sbjct: 310 TEDEPQVQKYDDS-FDDVDRTLDEWKRVTYK 339

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-58
 Identities = 77/295 (26%), Positives = 133/295 (45%), Gaps = 31/295 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
           E ++ V+++G G +GV    R+K T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 60  NIIRFKEVLLTPTHLAIVMEYAA-GGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
           NI++  +V+ T   L +V E+     + F    +         + +  QL+ G+++CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 119 EICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST-VGTPAYIAPEVLARKEY 177
            + HRDLK +N L++   +  +K+ DFG +++  +  +  +  V T  Y APE+L   +Y
Sbjct: 122 RVLHRDLKPQNLLIN--TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 178 DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI-------DRIRNVQYFLPDYV-- 228
                D+WS G     M+     F    +     +         + +      +PDY   
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEI 269
                          +  D R LLSQ+   DP+KRI       HP+F +++ K +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-58
 Identities = 74/331 (22%), Positives = 121/331 (36%), Gaps = 39/331 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI--ERGKKIDENVQREIINHRSLRHPN 60
            RY  +  +G G +G+     D   K  VA+K I     +   +   REI      RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 61  IIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH 116
           II   +++  PT        ++ +  G +L+ ++      S D   +F  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVL 172
           S  + HRDLK  N LL+      LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLN--TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI--------------- 217
              +   K  D+WS G  L  ML     F            +  +               
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 218 ----------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
                     +N   +   +    +    LL ++   +P KRI + +   HP+  +    
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL-EQYYD 303

Query: 268 EIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
              E       +   +      E++  +I E
Sbjct: 304 PSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-57
 Identities = 74/292 (25%), Positives = 128/292 (43%), Gaps = 30/292 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
           ++YE ++++G G +G     +++ T E+VA+K +   +  + +  +  REI   + L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI+R  +VL +   L +V E+             G    +  + F  QL+ G+ +CHS  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS-TVGTPAYIAPEVLARKEYD 178
           + HRDLK +N L++      LK+ +FG +++  +  +  S  V T  Y  P+VL   +  
Sbjct: 122 VLHRDLKPQNLLIN--RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV--------QYFLPDYV-- 228
               D+WS G     +     P     D  +  K I R+              LPDY   
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 229 --------------RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP 266
                         +++A  R LL  +   +P +RI   E  +HP+F    P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-57
 Identities = 66/311 (21%), Positives = 120/311 (38%), Gaps = 47/311 (15%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI---ERGKKIDENVQREIINHRSLRHP 59
            +YE + ++G G FG     R ++T + VA+K +      +       REI   + L+H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 60  NIIRFKEVLLTPT--------HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISG 111
           N++   E+  T           + +V ++              +F+  E +   Q L++G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 112 VSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAY 166
           + Y H  +I HRD+K  N L+       LK+ DFG ++          ++  + V T  Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT--RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 167 IAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF------------------------- 201
             PE+L  +   G   D+W  G  +  M   +                            
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 202 --EDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHP 259
             ++ E          + R V+  L  YVR       L+ ++ V DP++RI   +   H 
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVR-DPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 260 WFLKN-LPKEI 269
           +F  + +P ++
Sbjct: 307 FFWSDPMPSDL 317

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  183 bits (464), Expect = 2e-56
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 30/286 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHP 59
           E+Y  ++++G G +GV    ++    E  A+K I   K    I     REI   + L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 60  NIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME 119
           NI++  +V+ T   L +V E+             G      A+ F  QL++G++YCH   
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKS-GLLHSQPKSTVGTPAYIAPEVLARKEYD 178
           + HRDLK +N L++   +  LKI DFG +++ G+   +    + T  Y AP+VL   +  
Sbjct: 121 VLHRDLKPQNLLIN--REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-----------TIDRIRNVQYFLPDY 227
               D+WS G     M+ G   F    +     +               +  +  + P++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 228 VR------------VSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
                         +      LLS++   DP++RI   +  +H +F
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 3e-56
 Identities = 74/300 (24%), Positives = 117/300 (39%), Gaps = 38/300 (12%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYI---ERGKKIDENVQREIINHRSL- 56
           +++YE V E+G G +G     RD +     VA+K +      + +  +  RE+   R L 
Sbjct: 6   DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65

Query: 57  --RHPNIIRFKEVLLTP-----THLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQL 108
              HPN++R  +V         T L +V E+       +           +  +    QL
Sbjct: 66  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 109 ISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIA 168
           + G+ + HS  + HRDLK +N L+  S Q   K+ DFG ++         S V T  Y A
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 169 PEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRI----------- 217
           PEVL +  Y     D+WS G     M      F    D     K +D I           
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 218 ----------RNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPK 267
                     ++ Q        +    + LL +    +P+KRI       HP+F ++L +
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 5e-56
 Identities = 61/259 (23%), Positives = 99/259 (38%), Gaps = 15/259 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +  + ++ +G G FG   L   +  K  VAVK I +     +    E      LRH N++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLV 63

Query: 63  RFKEVLL-TPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSME 119
           +   V++     L IV EY A G L   + S GR     D    F   +   + Y     
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123

Query: 120 ICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
             HRDL   N L+        K+ DFG +K     S   +      + APE L  K++  
Sbjct: 124 FVHRDLAARNVLVSE--DNVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFST 179

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SDVWS G+ L+ +         P      +  + R+    Y +            ++ 
Sbjct: 180 K-SDVWSFGILLWEIYSFGRV---PYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMK 234

Query: 240 QIFVADPSKRIPIPEIKKH 258
             +  D + R    ++++ 
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 1e-55
 Identities = 59/260 (22%), Positives = 104/260 (40%), Gaps = 13/260 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           +    +KELG+G FGV +  +  R +  VA+K I+ G   ++    E     +L H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARI-CSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +   V      + I+ EY A G L   +     RF   +     + +   + Y  S +  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYDG 179
           HRDL   N L++   Q  +K+ DFG S+  L      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVND--QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           K SD+W+ GV ++ +  +G  P+E   +          +R     L      S     ++
Sbjct: 181 K-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-----LYRPHLASEKVYTIM 234

Query: 239 SQIFVADPSKRIPIPEIKKH 258
              +     +R     +  +
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-54
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 17/274 (6%)

Query: 3   ERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGK-----KIDENVQREIINHR 54
           E +E +K LG+G +G     R +    T +L A+K +++       K  E+ + E     
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 55  SLRH-PNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
            +R  P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           + H + I +RD+KLEN LLD +    L               +     GT  Y+AP+++ 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 174 RKEY-DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
             +    K  D WS GV +Y +L GA PF    +  +  +   RI   +   P    +SA
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSA 261

Query: 233 DCRHLLSQIFVADPSKRIP-----IPEIKKHPWF 261
             + L+ ++ + DP KR+        EIK+H +F
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-54
 Identities = 60/271 (22%), Positives = 104/271 (38%), Gaps = 15/271 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           E      +LG G FG   +     T   VA+K ++ G    E   +E    + LRH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           +   V+ +   + IV EY + G L  F +  +       +      Q+ SG++Y   M  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGENLVC--KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K SDVWS G+ L  +             R     ++R     Y +P           L+
Sbjct: 193 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLM 247

Query: 239 SQIFVADPSKRIPIPEIKK--HPWFLKNLPK 267
            Q +  +P +R     ++     +F    P+
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 3e-54
 Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 14/270 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
                  +LG G +G       K+    VAVK ++      E   +E    + ++HPN++
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSAGR--FSEDEARFFFQQLISGVSYCHSMEI 120
           +   V        I+ E+   G L   +    R   S     +   Q+ S + Y      
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYD 178
            HRDL   N L+  +     K+ DFG S+  +G  ++          + APE LA  ++ 
Sbjct: 137 IHRDLAARNCLVGENHLV--KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K SDVW+ GV L+ +           D     + +++     Y +            L+
Sbjct: 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELM 249

Query: 239 SQIFVADPSKRIPIPEIKKHPWFLKNLPKE 268
              +  +PS R    EI +     + + +E
Sbjct: 250 RACWQWNPSDRPSFAEIHQ---AFETMFQE 276

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-53
 Identities = 59/259 (22%), Positives = 105/259 (40%), Gaps = 11/259 (4%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
                V+E+GSG FG+  L      K+ VA+K I  G   +E+   E      L HP ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 63  RFKEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEIC 121
           +   V L    + +V E+   G L   + +  G F+ +        +  G++Y     + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSK--SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           HRDL   N L+  +     K+ DFG ++      ++    T     + +PEV +   Y  
Sbjct: 124 HRDLAARNCLVGENQVI--KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 180 KISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS 239
           K SDVWS GV ++ +         P + R+  + ++ I    + L      S     +++
Sbjct: 182 K-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDIST-GFRLYKPRLASTHVYQIMN 236

Query: 240 QIFVADPSKRIPIPEIKKH 258
             +   P  R     + + 
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 4e-53
 Identities = 70/270 (25%), Positives = 108/270 (40%), Gaps = 21/270 (7%)

Query: 2   EERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKID----ENVQREIINHR 54
           E+    +++LG G+FGV               VAVK ++          ++  RE+    
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 55  SLRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVS 113
           SL H N+IR   V+LTP  + +V E A  G L  R+    G F       +  Q+  G+ 
Sbjct: 67  SLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAP 169
           Y  S    HRDL   N LL    +  +KI DFG  +    +   +   +      A+ AP
Sbjct: 126 YLESKRFIHRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 170 EVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV 228
           E L  + +    SD W  GVTL+ M   G  P+       N  + + +I      LP   
Sbjct: 184 ESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPE 238

Query: 229 RVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
               D  +++ Q +   P  R     ++  
Sbjct: 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 2e-52
 Identities = 55/265 (20%), Positives = 101/265 (38%), Gaps = 15/265 (5%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
           E  + V+ LG+G FG   +       + VAVK +++G    +    E    + L+H  ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 63  RFKEVLLTPTHLAIVMEYAAGGEL--FARICSAGRFSEDEARFFFQQLISGVSYCHSMEI 120
           R   V+ T   + I+ EY   G L  F +  S  + + ++      Q+  G+++      
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 121 CHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLARKEYD 178
            HRDL+  N L+        KI DFG ++    +             + APE +    + 
Sbjct: 131 IHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 179 GKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
            K SDVWS G+ L  ++                + ++R     Y +        +   L+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLM 243

Query: 239 SQIFVADPSKRIPIPEIKK--HPWF 261
              +   P  R     ++     +F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-52
 Identities = 59/266 (22%), Positives = 102/266 (38%), Gaps = 22/266 (8%)

Query: 9   KELGSGNFGVARLV--RDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIR 63
           KELGSGNFG  +    + K+  + VAVK ++       + + +  E    + L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 64  FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHR 123
              +    + + +VME A  G L   +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSKS----GLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DL   N LL    Q   KI DFG SK+       +           + APE +   ++  
Sbjct: 132 DLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           K SDVWS GV ++     G  P+          +    +   +  +        +   L+
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLEKGER-MGCPAGCPREMYDLM 243

Query: 239 SQIFVADPSKRIPIPEIK---KHPWF 261
           +  +  D   R     ++   ++ ++
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYY 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 4e-52
 Identities = 53/280 (18%), Positives = 102/280 (36%), Gaps = 17/280 (6%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
           RY   +++GSG+FG   L  D    E VA+K +E  K     +  E   ++ ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 64  -FKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICH 122
             +       +  +VME             + +FS         Q+IS + Y HS    H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 123 RDLKLENTLL-DGSPQPRLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPEVLA 173
           RD+K +N L+  G     + I DFG +K          + + + K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR--VS 231
             E   +  D+ S G  L    +G+ P++  +     +K             + +     
Sbjct: 187 GIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 232 ADCRHLLSQIFVADPSKRIPIPEIK---KHPWFLKNLPKE 268
           ++    L+         +     ++   ++ +  +    +
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 8e-52
 Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 22/266 (8%)

Query: 9   KELGSGNFGVARLVRDKRTKE--LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRF 64
            ELG GNFG  R    +  K+   VA+K +++G  K   E + RE      L +P I+R 
Sbjct: 15  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 65  KEVLLTPTHLAIVMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHR 123
             V      L +VME A GG L   +                 Q+  G+ Y       HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 124 DLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEVLARKEYDG 179
           DL   N LL      +  I DFG SK        ++   +      + APE +  +++  
Sbjct: 134 DLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191

Query: 180 KISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL 238
           + SDVWS GVT++  L  G  P++         + +  I      +        +   L+
Sbjct: 192 R-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFIEQ-GKRMECPPECPPELYALM 245

Query: 239 SQIFVADPSKRIPIPEIK---KHPWF 261
           S  ++     R     ++   +  ++
Sbjct: 246 SDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 56/281 (19%), Positives = 100/281 (35%), Gaps = 16/281 (5%)

Query: 2   EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYI------ERGKKIDENVQREIINHRS 55
           E  ++ +K LGSG FG           E V +             K ++ +  E     S
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYC 115
           + +P++ R   + LT T   I      G  L                 +  Q+  G++Y 
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST---VGTPAYIAPEVL 172
               + HRDL   N L+       +KI DFG +K      +            ++A E +
Sbjct: 128 EDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 173 ARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSA 232
             + Y  + SDVWS GVT++ ++       D          +++       LP     + 
Sbjct: 186 LHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPICTI 240

Query: 233 DCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIE 273
           D   ++ + ++ D   R    E+      +   P+  + I+
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 2e-51
 Identities = 70/293 (23%), Positives = 122/293 (41%), Gaps = 40/293 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
           ERY+ +  +GSG +G      D +T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 60  NIIRFKEVLLTPTHLA-----IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSY 114
           N+I   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN-NIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 115 CHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLAR 174
            HS +I HRDLK  N  ++      LKI DFG ++      +    V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFED--------------------------PEDPR 208
             +  +  D+WS G  +  +L G   F                             E  R
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF 261
           N+ +++ ++  +  F   ++  +     LL ++ V D  KRI   +   H +F
Sbjct: 253 NYIQSLTQMPKMN-FANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (431), Expect = 3e-51
 Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 28/281 (9%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERG--KKIDENVQREIINHRSLR 57
              +  + +G+G FG       K   +    VA+K ++ G  +K   +   E        
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFA-RICSAGRFSEDEARFFFQQLISGVSYCH 116
           HPN+I  + V+   T + I+ E+   G L +    + G+F+  +     + + +G+ Y  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK------SGLLHSQPKSTVGTPAYIAPE 170
            M   HRDL   N L++ +     K+ DFG S+      S   ++          + APE
Sbjct: 146 DMNYVHRDLAARNILVNSNLVC--KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 171 VLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR 229
            +  +++    SDVWS G+ ++ ++  G  P+ D       +  I+ I    Y LP  + 
Sbjct: 204 AIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQDVINAIEQ-DYRLPPPMD 257

Query: 230 VSADCRHLLSQIFVADPSKRIPIPEI-------KKHPWFLK 263
             +    L+   +  D + R    +I        ++P  LK
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 4e-51
 Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 16/264 (6%)

Query: 3   ERYEPVKELGSGNFGV---ARLVRDKRTKELVAVKYIERG--KKIDENVQREIINHRSLR 57
           ER E  + +G G FG       +  +     VA+K  +      + E   +E +  R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCH 116
           HP+I++   V +T   + I+ME    GEL + +              +  QL + ++Y  
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 117 SMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST--VGTPAYIAPEVLAR 174
           S    HRD+   N L+       +K+ DFG S+     +  K++       ++APE +  
Sbjct: 126 SKRFVHRDIAARNVLVSS--NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 175 KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC 234
           + +    SDVW  GV ++ +L+       P         I RI N +  LP         
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPPTL 238

Query: 235 RHLLSQIFVADPSKRIPIPEIKKH 258
             L+++ +  DPS+R    E+K  
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-50
 Identities = 62/291 (21%), Positives = 100/291 (34%), Gaps = 42/291 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKEL-----VAVKYIERGKKIDE--NVQREIINHRS 55
           E  E  K LGSG FG           +      VAVK ++      E   +  E+     
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 56  L-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS---------------------- 92
           L  H NI+           + ++ EY   G+L   + S                      
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 93  -AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-- 149
                + ++   F  Q+  G+ +       HRDL   N L+      +  ICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVK--ICDFGLARDI 214

Query: 150 -SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVML-VGAYPFEDPEDP 207
            S   +    +      ++APE L    Y  K SDVWS G+ L+ +  +G  P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            NF K I       + +      + +   ++   +  D  KR   P +   
Sbjct: 274 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-50
 Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 51/341 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKID---ENVQREIINHRSLRHP 59
           +RY+ +K +GSG  G+     D      VA+K + R  +     +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 60  NIIRFKEVLLTP------THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
           NII    V            + +VME                   +   +   Q++ G+ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
           + HS  I HRDLK  N ++        KI DFG +++          V T  Y APEV+ 
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 174 RKEYDGKISDVWSCGVTLYVMLVGAYPFEDPED---------------PRNFRKTIDRIR 218
              Y   + D+WS G  +  M+     F   +                P   +K    +R
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 219 NVQYFLPDYVR---------------------VSADCRHLLSQIFVADPSKRIPIPEIKK 257
           N     P Y                        ++  R LLS++ V DP+KRI + +  +
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 258 HPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEIMRIIQE 298
           HP+         +E       +   D+   ++EE   +I +
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYK 351

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-49
 Identities = 64/299 (21%), Positives = 103/299 (34%), Gaps = 31/299 (10%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERGKKID--ENVQREIINHRSL-R 57
              +    +G GNFG     R K+       A+K ++     D   +   E+     L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 58  HPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----------------CSAGRFSEDEA 101
           HPNII          +L + +EYA  G L   +                 +A   S  + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 102 RFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTV 161
             F   +  G+ Y    +  HRDL   N L+        KI DFG S+   ++ +     
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 162 GTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ 221
               ++A E L    Y    SDVWS GV L+ ++        P       +  +++    
Sbjct: 188 LPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYCGMTCAELYEKLPQ-G 242

Query: 222 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE---IEKTNY 277
           Y L   +    +   L+ Q +   P +R    +I      +    K  +     EK  Y
Sbjct: 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTY 301

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  164 bits (415), Expect = 5e-49
 Identities = 42/270 (15%), Positives = 90/270 (33%), Gaps = 18/270 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
             Y+  + +G G+FGV     +    + VA+K+  R +     ++ E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 63  -RFKEVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 122 HRDLKLENTLLDGSPQP---RLKICDFGYSK--------SGLLHSQPKSTVGTPAYIAPE 170
           +RD+K +N L+          + + DFG  K          + + + K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 171 VLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR- 229
               +E   +  D+ + G      L G+ P+         ++  +RI   +   P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPW-QGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 230 --VSADCRHLLSQIFVADPSKRIPIPEIKK 257
                +    +                ++ 
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (409), Expect = 4e-48
 Identities = 61/289 (21%), Positives = 103/289 (35%), Gaps = 41/289 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYI--ERGKKIDENVQREIINHRS 55
              E V+++G G FG     R           +VAVK +  E    +  + QRE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGR-------------------- 95
             +PNI++   V      + ++ EY A G+L   + S                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 96  ----FSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK-- 149
                S  E     +Q+ +G++Y    +  HRDL   N L+  +     KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV--KIADFGLSRNI 190

Query: 150 -SGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPR 208
            S   +    +      ++ PE +    Y  + SDVW+ GV L+ +         P    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246

Query: 209 NFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK 257
              + I  +R+    L        +  +L+   +   P+ R     I +
Sbjct: 247 AHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-46
 Identities = 54/262 (20%), Positives = 98/262 (37%), Gaps = 19/262 (7%)

Query: 9   KELGSGNFGV---ARLVRDKRTKELVAVKYIERGKKIDE--NVQREIINHRSLRHPNIIR 63
           + +G G+FG      L+ +   K   AVK + R   I E      E I  +   HPN++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 64  FKEVLL-TPTHLAIVMEYAAGGELFA-RICSAGRFSEDEARFFFQQLISGVSYCHSMEIC 121
              + L +     +V+ Y   G+L           +  +   F  Q+  G+ +  S +  
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152

Query: 122 HRDLKLENTLLDGSPQPRLKICDFGYSK-----SGLLHSQPKSTVGTPAYIAPEVLARKE 176
           HRDL   N +LD       K+ DFG ++                     ++A E L  ++
Sbjct: 153 HRDLAARNCMLDEKFTV--KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK 210

Query: 177 YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH 236
           +  K SDVWS GV L+ ++    P     +  +    +  ++  +   P+Y         
Sbjct: 211 FTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGRRLLQPEY--CPDPLYE 265

Query: 237 LLSQIFVADPSKRIPIPEIKKH 258
           ++ + +      R    E+   
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (392), Expect = 9e-46
 Identities = 57/264 (21%), Positives = 102/264 (38%), Gaps = 18/264 (6%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERG--KKIDENVQREIINHRSL 56
                 K +G+G FG       K +       VA+K ++ G  +K   +   E       
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 57  RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYC 115
            H NIIR + V+     + I+ EY   G L   +    G FS  +     + + +G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 116 HSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK----SGLLHSQPKSTVGTPAYIAPEV 171
            +M   HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVC--KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 172 LARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS 231
           ++ +++    SDVWS G+ ++ ++                K I+      + LP  +   
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCP 239

Query: 232 ADCRHLLSQIFVADPSKRIPIPEI 255
           +    L+ Q +  + ++R    +I
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADI 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 9e-45
 Identities = 60/298 (20%), Positives = 99/298 (33%), Gaps = 41/298 (13%)

Query: 3   ERYEPVKELGSGNFGVARLVRD-----KRTKELVAVKYIERGKKID--ENVQREIINHRS 55
            R    K LG+G FG                  VAVK ++    +   E +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 56  L-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICS------------------AGRF 96
           L  H NI+             ++ EY   G+L   +                        
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 97  SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ 156
             ++   F  Q+  G+++  S    HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT--KICDFGLARDIKNDSN 200

Query: 157 PKST---VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT 213
                       ++APE +    Y  + SDVWS G+ L+ +                   
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP---YPGMPVDSK 256

Query: 214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE 271
             ++    + +       A+   ++   + ADP KR    +I      ++ + K+I E
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI------VQLIEKQISE 308

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 3e-43
 Identities = 53/283 (18%), Positives = 100/283 (35%), Gaps = 32/283 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKE-------LVAVKYI--ERGKKIDENVQREIINH 53
           +R    K LG G FG   L       +        VAVK +  +  +K   ++  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 54  RSL-RHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARI----------------CSAGRF 96
           + + +H NII           L +++EYA+ G L   +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 97  SEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRL-KICDFGYSKSGLLHS 155
           S  +      Q+  G+ Y  S +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTID 215
           +  +      ++APE L  + Y  + SDVWS GV L+ +         P       +   
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGS---PYPGVPVEELFK 248

Query: 216 RIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            ++   + +      + +   ++   + A PS+R    ++ + 
Sbjct: 249 LLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  149 bits (377), Expect = 7e-43
 Identities = 68/350 (19%), Positives = 117/350 (33%), Gaps = 63/350 (18%)

Query: 4   RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIR 63
           RY  V++LG G+F    L +D      VA+K +   K   E  + EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 64  ---------------FKEVLLTPTHLAIVMEYAAGGEL-FARICSAGRFSEDEARFFFQQ 107
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 108 LISGVSYC-HSMEICHRDLKLENTLLD--GSPQPRLKICDFGYSKSGLLHSQPKSTVGTP 164
           L+ G+ Y      I H D+K EN L++   SP+  ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 165 AYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPF--EDPEDPRNFRKTIDRIRNVQY 222
            Y +PEVL    +    +D+WS    ++ ++ G + F  ++          I +I  +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 223 FLPDYV----------------------------------------RVSADCRHLLSQIF 242
            LP Y+                                          + +    LS + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 243 VADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQSVEEI 292
             DP KR     +  HPW    L  E I +       +G D P    EE+
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF-EEV 361

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-42
 Identities = 62/293 (21%), Positives = 103/293 (35%), Gaps = 43/293 (14%)

Query: 3   ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62
                 + +G G FG     +     E VAVK     ++     + EI     LRH NI+
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 63  RFKEVL----LTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSM 118
            F         T T L +V +Y   G LF  + +    + +          SG+++ H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 119 E--------ICHRDLKLENTLLDGSPQPRLKICDFG-----YSKSGLLHSQPKSTVGTPA 165
                    I HRDLK +N L+         I D G      S +  +   P   VGT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKK--NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 166 YIAPEVLARKEYDGKI-----SDVWSCGVTLYVMLVGAYPFEDPEDPRNFR--------- 211
           Y+APEVL              +D+++ G+  + +          ED +            
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 212 -KTIDRIRNVQYFLPDYVRVSADC------RHLLSQIFVADPSKRIPIPEIKK 257
            + + ++   Q   P+       C        ++ + + A+ + R+    IKK
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 3e-41
 Identities = 59/284 (20%), Positives = 103/284 (36%), Gaps = 34/284 (11%)

Query: 3   ERYEPVKELGSGNFGV-----ARLVRDKRTKELVAVKYIERGKKIDEN---VQREIINHR 54
           +R +  K LG G FG      A  +    T   VAVK ++ G    E+   +    I   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 55  SLRHPNIIRFKEVLLTP-THLAIVMEYAAGGELFARICSAGR----------------FS 97
              H N++        P   L +++E+   G L   + S                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 98  EDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLH 154
            +    +  Q+  G+ +  S +  HRDL   N LL    +  +KICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS--EKNVVKICDFGLARDIYKDPDY 190

Query: 155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTI 214
            +         ++APE +  + Y  + SDVWS GV L+ +         P       +  
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDEEF 246

Query: 215 DRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH 258
            R       +      + +    +   +  +PS+R    E+ +H
Sbjct: 247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 3e-41
 Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 33/285 (11%)

Query: 3   ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKKIDE--NVQREIINHRS 55
           E+    +ELG G+FG+      K       +  VA+K +     + E      E    + 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 56  LRHPNIIRFKEVLLTPTHLAIVMEYAAGGELFARICSAGRF----------SEDEARFFF 105
               +++R   V+       ++ME    G+L + + S              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 106 QQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK---SGLLHSQPKSTVG 162
            ++  G++Y ++ +  HRDL   N ++       +KI DFG ++       + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA--EDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 163 TPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY 222
              +++PE L    +     DVWS GV L+ +   A     P    +  + +  +     
Sbjct: 198 PVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVME-GG 252

Query: 223 FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEI------KKHPWF 261
            L            L+   +  +P  R    EI      +  P F
Sbjct: 253 LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 71.7 bits (175), Expect = 1e-15
 Identities = 31/203 (15%), Positives = 55/203 (27%), Gaps = 49/203 (24%)

Query: 9   KELGSGNFGVARLVRDKRTKELVAVKYIERGK-----------KIDENVQREIINHRSLR 57
           K +G G          ++  E   VK+ + G              D +     I      
Sbjct: 6   KLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 58  HPNIIRFKEVLLTPTH----LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVS 113
              + + + + +   +     A++ME               R   +        ++  V+
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELI-------DAKELYRVRVENPDEVLDMILEEVA 117

Query: 114 YCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLA 173
             +   I H DL   N L+       + I DF  S            V        E+L 
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQS------------VEVGEEGWREILE 162

Query: 174 R----------KEYDGKISDVWS 186
           R          + Y     D+ S
Sbjct: 163 RDVRNIITYFSRTY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	341
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.21
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.36

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-67  Score=459.05  Aligned_cols=260  Identities=37%  Similarity=0.635  Sum_probs=223.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      .++|++++.||+|+||+||+|+++.+|+.||||++....  ...+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            478999999999999999999999999999999987543  234568899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---CC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---SQ  156 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~~  156 (341)
                      ||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.....   ..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCcccc
Confidence            9999999999988889999999999999999999999999999999999999988776  999999999753222   22


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      ....+||+.|||||++.+..+++.++|||||||++|+|++|++||....+.......   ........+.+..+|+++.+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHH
Confidence            345689999999999998888777799999999999999999999775543332222   22223334445678999999


Q ss_pred             HHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          237 LLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      ||.+||+.||++|||++|+|+||||++..+
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-65  Score=446.92  Aligned_cols=251  Identities=35%  Similarity=0.637  Sum_probs=221.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999998642    234567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |||++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+... .....
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~~  162 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRT  162 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCCE
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCccc
Confidence            99999999999999889999999999999999999999999999999999999998876  9999999997533 23345


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|||||++.+..++.+ +|||||||++|+|++|+.||...+..    .....+......+|.  .+|+++.+||
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~~li  235 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPD--FVTEGARDLI  235 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHHTTCCCCCT--TSCHHHHHHH
T ss_pred             ccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCCCCc--cCCHHHHHHH
Confidence            6789999999999998887654 89999999999999999999875443    233444455555554  6899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      .+||++||.+|||++|+|+||||..
T Consensus       236 ~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999953

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-64  Score=447.99  Aligned_cols=258  Identities=28%  Similarity=0.432  Sum_probs=222.3

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .+||+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            468999999999999999999999999999999987543 3345789999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      |+||+|..++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--Eeeccchhheeeccccccccc
Confidence            999999988765 57999999999999999999999999999999999999988776  999999999754332 33456


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLLS  239 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  239 (341)
                      .+||+.|+|||++.+..++. ++|||||||++|+|++|..||........+.....   ......+....+|+++++||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHH
Confidence            68999999999999888865 49999999999999999999987665444433222   222233444578999999999


Q ss_pred             HhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          240 QIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       240 ~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      +||++||.+|||+.|+|+||||+...+
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCCC
Confidence            999999999999999999999965443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-65  Score=454.10  Aligned_cols=259  Identities=34%  Similarity=0.615  Sum_probs=207.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      |.++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4578999999999999999999999999999999987643  22345778999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC-CCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS-PQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~-~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||+|+........
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            999999999999998899999999999999999999999999999999999999642 2345999999999865555555


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--ccCCCCCCCCHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--YFLPDYVRVSADCR  235 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~  235 (341)
                      ...+||+.|||||++.+..++.+ +|||||||++|+|++|.+||..........    .+....  ...+....+|+++.
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHTTCCCCCTTTTTTSCHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHhccCCCCCCccccCCCHHHH
Confidence            67789999999999998887654 999999999999999999998765443332    233222  23344457999999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +||.+||++||.+|||+.|+++||||.+.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-64  Score=444.44  Aligned_cols=263  Identities=29%  Similarity=0.423  Sum_probs=222.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC-ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG-KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      +.|++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+++.++|||||++++++.+++.+++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5799999999999999999999999999999998764 344567889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      ++|+|..++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence            99999998765 457999999999999999999999999999999999999998876  999999998643211 12345


Q ss_pred             ccCCCCccccccccc-----cccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHH
Q 019433          160 TVGTPAYIAPEVLAR-----KEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADC  234 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  234 (341)
                      .+||+.|+|||++.+     ..++ .++|||||||++|+|++|..||...+....+..+..   .....++....+|+++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~  245 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNF  245 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH---SCCCCCSSGGGSCHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCCCCCccccCCHHH
Confidence            689999999999853     3343 459999999999999999999988766555443322   1222233445789999


Q ss_pred             HHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHH
Q 019433          235 RHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIE  271 (341)
Q Consensus       235 ~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~  271 (341)
                      .+||.+||++||.+|||+.|+++||||.....+.+.+
T Consensus       246 ~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~p~~~  282 (288)
T d2jfla1         246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE  282 (288)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCHHHHH
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCcccCCCCCCCcHH
Confidence            9999999999999999999999999998776655443

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-64  Score=454.82  Aligned_cols=259  Identities=29%  Similarity=0.446  Sum_probs=215.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      .+++|+++++||+|+||+||+|+++.+|+.||+|++....  .....+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3689999999999999999999999999999999987543  33457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~  157 (341)
                      |||+||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.  +||+|||+|+... ....
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~-~~~~  160 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMA  160 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHH-HHTC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccC-CCcc
Confidence            999999999999988899999999999999999999997 59999999999999988876  9999999997432 2334


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHH-------------------------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRK-------------------------  212 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~-------------------------  212 (341)
                      .+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||...+.......                         
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            56789999999999999888765 8999999999999999999976543211100                         


Q ss_pred             -------------HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          213 -------------TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       213 -------------~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                                   .................+|+++.+||.+||++||.+|||++|+|+||||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                         000000000000011247899999999999999999999999999999953

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-64  Score=446.06  Aligned_cols=259  Identities=34%  Similarity=0.621  Sum_probs=225.0

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-------cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-------KIDENVQREIINHRSLRHPNIIRFKEVLLTPTH   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~   73 (341)
                      |+++|++++.||+|+||+||+|+++.+|+.||||++.+..       ...+.+.+|+.+++.++|||||+++++|.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            4689999999999999999999999999999999986532       234578899999999999999999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC--CCEEEeecCCccCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ--PRLKICDFGYSKSG  151 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~--~~ikL~Dfg~a~~~  151 (341)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  ..+||+|||+|...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            9999999999999999998889999999999999999999999999999999999999986653  35999999999876


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCC
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVR  229 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  229 (341)
                      ..........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+    ..+.......+  ....
T Consensus       168 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             TTSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCHHHHTT
T ss_pred             CCCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCCCCCchhcCC
Confidence            55556667889999999999988777654 89999999999999999999876544333    33333333222  2246


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      +|+++.+||++||++||.+|||++|+|+||||+..
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            89999999999999999999999999999999654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-63  Score=441.57  Aligned_cols=255  Identities=31%  Similarity=0.506  Sum_probs=219.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999999999999999998753    234467889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---C
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---S  155 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~  155 (341)
                      |||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999998877  999999999754322   2


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....+||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+    ..+......+|.  .+|+++.
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACK-SSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPE--KFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCT--TCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCCc-ccceehhhHHHHHHhhCCCCCCCcCHHHHH----HHHHcCCCCCCc--cCCHHHH
Confidence            234568999999999999888765 599999999999999999999876543333    334444444554  7899999


Q ss_pred             HHHHHhcccCCCCCCChhH------HhcCCccCCCCC
Q 019433          236 HLLSQIFVADPSKRIPIPE------IKKHPWFLKNLP  266 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e------~l~hp~~~~~~~  266 (341)
                      +||++||++||.+|||++|      +++||||.....
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w  275 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  275 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence            9999999999999999998      588999966433

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-63  Score=453.83  Aligned_cols=257  Identities=30%  Similarity=0.572  Sum_probs=222.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~   81 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            589999999999999999999999999999999876432 3456889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCCc
Q 019433           82 AGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKST  160 (341)
Q Consensus        82 ~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~~  160 (341)
                      +||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+...........
T Consensus       106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  185 (350)
T d1koaa2         106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT  185 (350)
T ss_dssp             CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccccee
Confidence            99999999854 45799999999999999999999999999999999999997654456999999999865555555567


Q ss_pred             cCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCCCCCCHHHHHHH
Q 019433          161 VGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHLL  238 (341)
Q Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li  238 (341)
                      .||+.|||||++.+..++. ++|||||||++|+|++|+.||.+.+....+..    +.......  +.+..+|+++.+||
T Consensus       186 ~gT~~Y~aPEv~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li  260 (350)
T d1koaa2         186 TGTAEFAAPEVAEGKPVGY-YTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFI  260 (350)
T ss_dssp             CSCTTTCCHHHHHTCCBCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred             cCcccccCHHHHcCCCCCh-hHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHH
Confidence            8999999999999888764 48999999999999999999987655433333    33333222  23346899999999


Q ss_pred             HHhcccCCCCCCChhHHhcCCccCCC
Q 019433          239 SQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+||++||.+|||++|+|+||||...
T Consensus       261 ~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         261 RKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-63  Score=453.28  Aligned_cols=258  Identities=28%  Similarity=0.522  Sum_probs=223.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..... ....+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3679999999999999999999999999999999876542 334678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+||+|.+.+.... ++++.+++.++.||+.||.|||++||+||||||+|||++....+++||+|||+|+..........
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            99999998876544 69999999999999999999999999999999999999855455699999999987655555566


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC--CCCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL--PDYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  237 (341)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+..    +.......  +.+..+|+++.+|
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHH
Confidence            789999999999998887654 8999999999999999999987665444333    33333322  2345799999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |++||++||.+|||+.|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-63  Score=443.53  Aligned_cols=256  Identities=27%  Similarity=0.388  Sum_probs=219.2

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|+++++||+|+||+||+|+++.+|+.||||++......    .+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3699999999999999999999999999999998765432    235789999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |||.+|+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|....   ...
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~---~~~  169 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMA---PAN  169 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSS---SBC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccC---CCC
Confidence            99999999888888889999999999999999999999999999999999999998776  9999999997532   234


Q ss_pred             CccCCCCcccccccccc---ccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          159 STVGTPAYIAPEVLARK---EYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ..+||+.|||||++.+.   .|+ .++|||||||++|+|++|..||........+....    ...........+|+++.
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~-~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~s~~~~  244 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEYFR  244 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCCCCSCTTSCHHHH
T ss_pred             ccccCccccCHHHHhccCCCCcC-chhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCCCHHHH
Confidence            57899999999998643   344 45899999999999999999998765544333322    22222223346899999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                      +||.+||++||.+|||++|+|+||||.+..+..
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~  277 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence            999999999999999999999999997765543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-62  Score=443.27  Aligned_cols=255  Identities=35%  Similarity=0.586  Sum_probs=224.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999999999999999998753    234567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQP  157 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~  157 (341)
                      |||+||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.... ....
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCB
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCccc
Confidence            99999999999999999999999999999999999999999999999999999998876  99999999986433 3344


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...+||+.|+|||++.+..|+.+ +|||||||++|+|++|.+||...+....    ...+......+|.  .+|+++.+|
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~dl  235 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKSL  235 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHH----HHHHhcCCCCCCc--cCCHHHHHH
Confidence            56789999999999999888654 8999999999999999999988654333    3333444444554  699999999


Q ss_pred             HHHhcccCCCCCCC-----hhHHhcCCccCCCCC
Q 019433          238 LSQIFVADPSKRIP-----IPEIKKHPWFLKNLP  266 (341)
Q Consensus       238 i~~~L~~dp~~R~s-----~~e~l~hp~~~~~~~  266 (341)
                      |++||++||.+|++     ++++++||||.+...
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~  269 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW  269 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence            99999999999994     899999999976543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-63  Score=434.05  Aligned_cols=253  Identities=23%  Similarity=0.388  Sum_probs=212.4

Q ss_pred             CCCc-cccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEc----CCE
Q 019433            2 EERY-EPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLT----PTH   73 (341)
Q Consensus         2 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~----~~~   73 (341)
                      ++|| ++.++||+|+||+||+|.++.+++.||+|++....   ...+.+.+|+.+++.++|||||+++++|.+    +..
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            5677 67778999999999999999999999999986543   223467899999999999999999999865    456


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeeCCCCCCCEEecC-CCCCCEEEeecCCccC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSME--ICHRDLKLENTLLDG-SPQPRLKICDFGYSKS  150 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~--iiHrDikp~Nili~~-~~~~~ikL~Dfg~a~~  150 (341)
                      +|+|||||++|+|.+++.+...+++..++.++.||+.||.|||++|  |+||||||+|||+++ ++.  +||+|||+|+.
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~  164 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATL  164 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGG
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC--EEEeecCccee
Confidence            8999999999999999999889999999999999999999999999  999999999999974 455  99999999975


Q ss_pred             CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .. .......+||+.|||||++.+ .++ .++|||||||++|+|++|+.||....+...+...   +.............
T Consensus       165 ~~-~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~~  238 (270)
T d1t4ha_         165 KR-ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVA  238 (270)
T ss_dssp             CC-TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCC
T ss_pred             cc-CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH---HHcCCCCcccCccC
Confidence            32 233456789999999999875 455 4599999999999999999999876655443332   22221111122357


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFL  262 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~  262 (341)
                      ++++.+||.+||++||++|||++|+|+||||+
T Consensus       239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            89999999999999999999999999999994

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=449.24  Aligned_cols=259  Identities=24%  Similarity=0.465  Sum_probs=226.5

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      |-+||++++.||+|+||+||+|.++.+|+.||||++.........+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            45899999999999999999999999999999999987665556788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           81 AAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      |+||+|.+++...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.++..++||+|||+++..........
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence            99999999997765 79999999999999999999999999999999999999876666799999999986555444556


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCCCHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRVSADCRHL  237 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  237 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|..||...+....+..    +......++  .+..+|+++.+|
T Consensus       163 ~~~t~~y~ape~~~~~~~~~-~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  237 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDF  237 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHH
T ss_pred             cccccccccchhccCCCCCc-hhhcccHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCChhhccCCCHHHHHH
Confidence            78999999999998888765 58999999999999999999987665433333    333333332  234689999999


Q ss_pred             HHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          238 LSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      |.+||++||.+|||+.|+++||||.+.
T Consensus       238 i~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         238 VDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999999654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.1e-62  Score=431.16  Aligned_cols=259  Identities=34%  Similarity=0.511  Sum_probs=223.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc----------ccHHHHHHHHHHhcCC-CCCeeeEEEEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK----------IDENVQREIINHRSLR-HPNIIRFKEVLL   69 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~ei~~~~~l~-hp~iv~l~~~~~   69 (341)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++.+...          ..+.+.+|+.+++.++ ||||++++++|.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            56899999999999999999999999999999999876432          1235778999999997 999999999999


Q ss_pred             cCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433           70 TPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus        70 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                      +++.+|+|||||++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~  158 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSC  158 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCE
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchhee
Confidence            99999999999999999999999899999999999999999999999999999999999999988777  9999999998


Q ss_pred             CCCCCCCCCCccCCCCcccccccccccc-----CCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC
Q 019433          150 SGLLHSQPKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL  224 (341)
Q Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  224 (341)
                      ............||+.|+|||++.+...     .+.++||||+||++|+|++|+.||...+.......+...  ......
T Consensus       159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~  236 (277)
T d1phka_         159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGS  236 (277)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCT
T ss_pred             EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCC
Confidence            6554545566789999999999874322     244589999999999999999999886654433332221  223334


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          225 PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      +....+|+++.+||.+||++||.+|||++|+|+||||++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            455689999999999999999999999999999999965

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.9e-62  Score=436.46  Aligned_cols=253  Identities=33%  Similarity=0.604  Sum_probs=222.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4699999999999999999999999999999998653    234567889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..  .....
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~--~~~~~  159 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYV--PDVTY  159 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEEC--SSCBC
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEe--ccccc
Confidence            99999999999999999999999999999999999999999999999999999998776  999999999853  33445


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+||+.|||||++.+..++.+ +|||||||++|+|++|+.||...+......    .+.......|.  .+|+++.++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~s~~~~~li  232 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFPP--FFNEDVKDLL  232 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHHH----HHHcCCCCCCC--CCCHHHHHHH
Confidence            6789999999999998888754 899999999999999999998765543333    33334444443  6899999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCCC
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNLP  266 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~~  266 (341)
                      .+||++||.+|+     |++++++||||.+...
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHHhhhCHHhccccchhhHHHHHcCcccccCCH
Confidence            999999999996     9999999999977544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-62  Score=429.19  Aligned_cols=251  Identities=30%  Similarity=0.489  Sum_probs=202.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEc--CCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT--PTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--~~~~~iv   77 (341)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.....   ..+.+.+|+.+++.++|||||++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            679999999999999999999999999999999876532   23457899999999999999999999865  4668999


Q ss_pred             EeecCCCchHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           78 MEYAAGGELFARICS----AGRFSEDEARFFFQQLISGVSYCHSME-----ICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qil~aL~~LH~~~-----iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      ||||++|+|.+++.+    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.  +||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccce
Confidence            999999999998854    457999999999999999999999976     999999999999998876  999999999


Q ss_pred             cCCCCC-CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCC
Q 019433          149 KSGLLH-SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDY  227 (341)
Q Consensus       149 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (341)
                      +..... ......+||+.|||||++.+..++. ++|||||||++|+|++|..||...+.....    ..+...... +..
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~i~~~~~~-~~~  235 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE-KSDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFR-RIP  235 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCCh-HHHHHhhCHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCC-CCC
Confidence            754322 2334578999999999998888764 599999999999999999999875543322    223332221 222


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          228 VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       228 ~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      ..+|+++.+||++||+.||.+|||+.|+++|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4789999999999999999999999999999995

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-61  Score=440.00  Aligned_cols=252  Identities=32%  Similarity=0.565  Sum_probs=221.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVM   78 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~   78 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||++++++.....+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999999999999999998643    234457889999999999999999999999999999999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      ||+.+|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+...  ....
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~--~~~~  196 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVK--GRTW  196 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECS--SCBC
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeecc--cccc
Confidence            99999999999999899999999999999999999999999999999999999988776  9999999998543  3445


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|||||++.+..++. ++|||||||++|+|++|..||...+....    ...+.......|  ..+|+++.+||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~li  269 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNK-AVDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFP--SHFSSDLKDLL  269 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTCCHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCCc-cccccchhHHHHHHHhCCCCCCCcCHHHH----HHHHhcCCCCCC--ccCCHHHHHHH
Confidence            678999999999999888865 48999999999999999999987554333    333333343344  37999999999


Q ss_pred             HHhcccCCCCCC-----ChhHHhcCCccCCCC
Q 019433          239 SQIFVADPSKRI-----PIPEIKKHPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~-----s~~e~l~hp~~~~~~  265 (341)
                      ++||++||.+|+     |++++++||||....
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            999999999995     999999999997653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.9e-61  Score=439.87  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=215.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc----cccHHHHH---HHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK----KIDENVQR---EIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~---ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    .....+.+   ++.+++.++|||||+++++|.+++.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999999999999999986432    12223333   467777889999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           76 IVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      +|||||+||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.... .
T Consensus        84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-~  160 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-K  160 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-S
T ss_pred             EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-C
Confidence            99999999999999999999999999999999999999999999999999999999998877  99999999985432 3


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||........ ..............  +..+|+++.
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~--~~~~s~~~~  237 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVEL--PDSFSPELR  237 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCCC--CSSSCHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCCC--CCCCCHHHH
Confidence            445678999999999997655445569999999999999999999987544322 22333322223333  347999999


Q ss_pred             HHHHHhcccCCCCCCC-----hhHHhcCCccCCCC
Q 019433          236 HLLSQIFVADPSKRIP-----IPEIKKHPWFLKNL  265 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s-----~~e~l~hp~~~~~~  265 (341)
                      +||.+||++||.+|||     ++++++||||.+..
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            9999999999999999     79999999997653

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-61  Score=427.78  Aligned_cols=252  Identities=32%  Similarity=0.526  Sum_probs=216.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------ccHHHHHHHHHHhcCC--CCCeeeEEEEEEcC
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------IDENVQREIINHRSLR--HPNIIRFKEVLLTP   71 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~   71 (341)
                      |++||++.+.||+|+||+||+|+++.+|+.||||++.+...       ....+.+|+.+++.++  |||||+++++|.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            68999999999999999999999999999999999875321       1234678999999886  89999999999999


Q ss_pred             CEEEEEEeecCC-CchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccC
Q 019433           72 THLAIVMEYAAG-GELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKS  150 (341)
Q Consensus        72 ~~~~iv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~  150 (341)
                      +..++||||+.+ +++..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.+. ..+||+|||+|+.
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~  160 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL  160 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEE
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECcccccee
Confidence            999999999976 68888888888999999999999999999999999999999999999998542 2399999999975


Q ss_pred             CCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          151 GLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                      .. ........||+.|+|||++.+..++++++|||||||++|+|++|..||...+          .+......++.  .+
T Consensus       161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~~--~~  227 (273)
T d1xwsa_         161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--RV  227 (273)
T ss_dssp             CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCSS--CC
T ss_pred             cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCCC--CC
Confidence            32 2334567899999999999888877777899999999999999999997521          12222333343  68


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                      |+++.+||++||++||++|||++|+++||||++...
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            999999999999999999999999999999987654

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-62  Score=442.60  Aligned_cols=259  Identities=34%  Similarity=0.571  Sum_probs=215.5

Q ss_pred             CCCccccc-eecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHh-cCCCCCeeeEEEEEEc----CCEEE
Q 019433            2 EERYEPVK-ELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHR-SLRHPNIIRFKEVLLT----PTHLA   75 (341)
Q Consensus         2 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~-~l~hp~iv~l~~~~~~----~~~~~   75 (341)
                      -++|+++. .||+|+||+||+|+++.+++.||||++..    ...+.+|+.++. .++|||||+++++|.+    +..+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            36899986 59999999999999999999999999865    356778998864 5589999999999975    46799


Q ss_pred             EEEeecCCCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCC
Q 019433           76 IVMEYAAGGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGL  152 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~  152 (341)
                      +|||||+||+|.+++.+.  .+|++.+++.++.||+.||+|||++||+||||||+|||++... ...+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            999999999999999774  3699999999999999999999999999999999999998643 3469999999998666


Q ss_pred             CCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCC--CCCCC
Q 019433          153 LHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLP--DYVRV  230 (341)
Q Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (341)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||...............+......+|  .+..+
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            6666677889999999999998888654 89999999999999999999776554444333333333333333  23468


Q ss_pred             CHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCC
Q 019433          231 SADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNL  265 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~  265 (341)
                      |+++.+||++||+.||++|||+.|+++||||.+..
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            99999999999999999999999999999996543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-61  Score=428.49  Aligned_cols=256  Identities=26%  Similarity=0.379  Sum_probs=214.4

Q ss_pred             ccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc------ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEee
Q 019433            7 PVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK------IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         7 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      .++.||+|+||+||+|+++.+|+.||||++.....      ..+.+.+|+.+++.++|||||++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999865432      234688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC-CCCCC
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH-SQPKS  159 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~-~~~~~  159 (341)
                      |.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence            999888877776778999999999999999999999999999999999999998777  999999999754332 23445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc-C--------------
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF-L--------------  224 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~--------------  224 (341)
                      .+||+.|+|||++.+....+.++|||||||++|+|++|.+||....+...+..+.......... +              
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            6899999999999776655667999999999999999999998877766666655443221100 0              


Q ss_pred             -CC------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          225 -PD------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       225 -~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                       +.      ...+++++.+||.+||++||++|||+.|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence             00      12568999999999999999999999999999999653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-60  Score=428.39  Aligned_cols=253  Identities=35%  Similarity=0.583  Sum_probs=218.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC----ccccHHHHHHHHHH-hcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG----KKIDENVQREIINH-RSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~ei~~~-~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++++.||+|+||+||+|.++.+|+.||||++.+.    ....+.+..|+.++ +.++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5699999999999999999999999999999999753    22334566666665 478999999999999999999999


Q ss_pred             EeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCC
Q 019433           78 MEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~  156 (341)
                      ||||++|+|..++.....+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ...
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence            999999999999999999999999999999999999999999999999999999998776  99999999975433 233


Q ss_pred             CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHH
Q 019433          157 PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRH  236 (341)
Q Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  236 (341)
                      .....||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+....    ...+......+|.  .+|+++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~d  232 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYPR--WLEKEAKD  232 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--cCCHHHHH
Confidence            44568999999999999988875 58999999999999999999987654333    3333344444443  68999999


Q ss_pred             HHHHhcccCCCCCCChh-HHhcCCccCCC
Q 019433          237 LLSQIFVADPSKRIPIP-EIKKHPWFLKN  264 (341)
Q Consensus       237 li~~~L~~dp~~R~s~~-e~l~hp~~~~~  264 (341)
                      ||++||++||.+|||+. ++++||||.+.
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            99999999999999996 89999999754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-60  Score=420.56  Aligned_cols=260  Identities=28%  Similarity=0.430  Sum_probs=216.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|+++++||+|+||+||+|.+..+|+.||||++....   ...+.+.+|+.+++.++|||||+++++|.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999986532   235678899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC-CCCCC
Q 019433           80 YAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL-LHSQP  157 (341)
Q Consensus        80 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~-~~~~~  157 (341)
                      ||.++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+... .....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence            9977544433333 457999999999999999999999999999999999999988776  9999999996432 23344


Q ss_pred             CCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc--------------
Q 019433          158 KSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------------  223 (341)
Q Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  223 (341)
                      ....||+.|+|||++....+.+.++|||||||++|+|++|+.||...+....+.............              
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            556899999999999888877778999999999999999999998876655555544433221110              


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          224 LPD---------YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       224 ~~~---------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      .+.         ...+|+++.+||++||++||++|||+.|+|+||||.+.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000         13578899999999999999999999999999999654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.5e-59  Score=415.51  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=215.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +||+++++||+|+||+||+|+++ +|+.||||++....   ...+.+.+|+.+++.++|||||+++++|..++..+++|+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            69999999999999999999996 78999999986542   335678999999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC-CCCCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL-HSQPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~-~~~~~  158 (341)
                      ++.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|..... .....
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence            9999888888777888999999999999999999999999999999999999998877  99999999864322 22334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccccc--------------C
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYF--------------L  224 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~  224 (341)
                      ...|++.|+|||++.+..+.+.++|||||||++|+|++|++||........+.............              .
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            55799999999999887776677999999999999999999998876665555544332211000              0


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          225 ---------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       225 ---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                               .....+++++.+||++||++||++|||+.|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     012357899999999999999999999999999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-59  Score=417.97  Aligned_cols=260  Identities=28%  Similarity=0.378  Sum_probs=214.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCC-CcEEEEEEcccC---ccccHHHHHHHHHHhcC---CCCCeeeEEEEEEc----
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRT-KELVAVKYIERG---KKIDENVQREIINHRSL---RHPNIIRFKEVLLT----   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l---~hp~iv~l~~~~~~----   70 (341)
                      ++||+++++||+|+||+||+|++..+ ++.||||++...   ......+.+|+.+++.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            58999999999999999999999765 677999998653   22334567888777665   79999999999853    


Q ss_pred             -CCEEEEEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           71 -PTHLAIVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        71 -~~~~~iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                       ...++++|||+.++++...... ...+++..++.++.|++.||+|||++||+||||||+|||++..+.  +||+|||++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~  163 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  163 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhh
Confidence             3578999999999877554433 456999999999999999999999999999999999999988777  999999999


Q ss_pred             cCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-cC---
Q 019433          149 KSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-FL---  224 (341)
Q Consensus       149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~---  224 (341)
                      +............||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+....+..+......... .+   
T Consensus       164 ~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         164 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            87666666677899999999999998888655 99999999999999999999987766666555443321100 00   


Q ss_pred             -----------------CCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          225 -----------------PDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       225 -----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                       .....+|+.+.+||++||++||++|||+.|+|+||||++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                             0123578999999999999999999999999999999653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-59  Score=422.88  Aligned_cols=291  Identities=25%  Similarity=0.376  Sum_probs=219.2

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPT-----   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----   72 (341)
                      +.+||+++++||+|+||+||+|.++.+|+.||||++.+...   ..+.+.+|+.+++.++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            46899999999999999999999999999999999976432   2346789999999999999999999997654     


Q ss_pred             -EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           73 -HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        73 -~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                       .+|+||||| +.+|...+ +..++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..
T Consensus        96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~  171 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA  171 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC
T ss_pred             ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc
Confidence             579999999 55676655 4567999999999999999999999999999999999999998877  999999999853


Q ss_pred             CCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-----------
Q 019433          152 LLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-----------  220 (341)
Q Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (341)
                        ........||+.|+|||++.+..+.+.++|||||||++|+|++|++||...+....+..........           
T Consensus       172 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 --DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             --CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             --CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence              3345667899999999999877666667999999999999999999998876554443333221110           


Q ss_pred             ----------ccc----CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCC
Q 019433          221 ----------QYF----LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPT  286 (341)
Q Consensus       221 ----------~~~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (341)
                                ...    ......+++++.+||.+||+.||.+|||+.|+|+||||.......... ..+ ......+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~-~~~-~~~~~~~~~~  327 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP-QVQ-KYDDSFDDVD  327 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------CCC-CCCCC-----
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc-cCC-CCCCchhhhh
Confidence                      000    011235789999999999999999999999999999997644322211 001 1111223344


Q ss_pred             CCHHHHHHHHHHh
Q 019433          287 QSVEEIMRIIQEA  299 (341)
Q Consensus       287 ~~~~~~~~~~~~~  299 (341)
                      .+.+++++++...
T Consensus       328 ~~~~e~k~~~~~e  340 (346)
T d1cm8a_         328 RTLDEWKRVTYKE  340 (346)
T ss_dssp             CCHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHH
Confidence            6677777776543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.2e-58  Score=409.22  Aligned_cols=256  Identities=25%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccc----cHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKI----DENVQREIINHRSLRHPNIIRFKEVLLTPT----   72 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----   72 (341)
                      |.+||++.+.||+|+||+||+|.+..+|+.||||++......    ...+.+|+.+++.++|||||++++++....    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            578999999999999999999999999999999999764332    335789999999999999999999997653    


Q ss_pred             EEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCC
Q 019433           73 HLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGL  152 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~  152 (341)
                      .+|+|||||+|++|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||.+....
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~  162 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIA  162 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC
T ss_pred             eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhc
Confidence            48999999999999999999999999999999999999999999999999999999999998877  9999999876432


Q ss_pred             CC----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCC
Q 019433          153 LH----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYV  228 (341)
Q Consensus       153 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (341)
                      ..    ......+||+.|+|||++.+..++. ++|||||||++|+|++|.+||...+....+...+...  .........
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~  239 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDA-RSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARHE  239 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCGGGTSS
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCc-ceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC--CCCCchhcc
Confidence            22    2334567999999999998887765 4999999999999999999998765544433332211  111112235


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHHhcCCcc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEIKKHPWF  261 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~  261 (341)
                      .+|+++.+||++||++||.+||+..+.+.|+|.
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            789999999999999999999955455555554

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=419.21  Aligned_cols=264  Identities=27%  Similarity=0.430  Sum_probs=211.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC-----E
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPT-----H   73 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~-----~   73 (341)
                      |+.||++++.||+|+||+||+|.++.+|+.||||++....  ...+.+.+|+.+++.++||||+++++++....     .
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            5689999999999999999999999999999999987543  22346789999999999999999999997643     3


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++++ +|+.+|+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....
T Consensus        86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~  161 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADP  161 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCG
T ss_pred             EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccC
Confidence            4555 55668999999865 47999999999999999999999999999999999999988776  99999999874322


Q ss_pred             C----CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhccc--------
Q 019433          154 H----SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQ--------  221 (341)
Q Consensus       154 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------  221 (341)
                      .    ......+||+.|+|||++......+.++||||+||++|+|++|+.||...+................        
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            2    2234567999999999987666656679999999999999999999987665444433322111100        


Q ss_pred             --------ccCC---------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChh
Q 019433          222 --------YFLP---------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKE  268 (341)
Q Consensus       222 --------~~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~  268 (341)
                              ...+         ....+|+++.+||.+||++||.+|||+.|+|+||||.+.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~  305 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS  305 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence                    0000         1235788999999999999999999999999999998665543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-58  Score=423.28  Aligned_cols=291  Identities=25%  Similarity=0.380  Sum_probs=216.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEc------CCE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLT------PTH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~------~~~   73 (341)
                      +||+++++||+|+||+||+|+++.+|+.||||++.+...   ....+.+|+.+++.++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            789999999999999999999999999999999976532   23457899999999999999999999964      478


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      +|+|||||.++++ ..+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +|++|||+++....
T Consensus        97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~  171 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred             eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence            9999999977544 444  356999999999999999999999999999999999999998777  99999999886666


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-------------
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------  220 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------  220 (341)
                      .......+||+.|+|||++.+..++.+ +||||+||++|+|++|++||...+........+......             
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            666667789999999999998877665 899999999999999999998776555444443322110             


Q ss_pred             -----ccc---------C-----CC----CCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhh
Q 019433          221 -----QYF---------L-----PD----YVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNY  277 (341)
Q Consensus       221 -----~~~---------~-----~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~  277 (341)
                           ...         .     +.    ...+|+++.+||++||++||++||||+|+|+||||.............+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~  330 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQI  330 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCC
Confidence                 000         0     00    012467899999999999999999999999999998765544333333333


Q ss_pred             hhcCCCCCCCCHHHHHHHHHHh
Q 019433          278 KEAGRDQPTQSVEEIMRIIQEA  299 (341)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~  299 (341)
                      .+...+....+++++++++...
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~~~  352 (355)
T d2b1pa1         331 YDKQLDEREHTIEEWKELIYKE  352 (355)
T ss_dssp             -----CCCCCCHHHHHHHHHHH
T ss_pred             CCcchhhhhcCHHHHHHHHHHH
Confidence            3334455677888887776543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-58  Score=417.67  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=211.5

Q ss_pred             CccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcC------CEEEEE
Q 019433            4 RYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTP------THLAIV   77 (341)
Q Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~------~~~~iv   77 (341)
                      +|+.+++||+|+||+||+|+++.+|+.||||++......   ..+|+.+++.++||||++++++|...      .++++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            699999999999999999999999999999999765432   34799999999999999999998543      458999


Q ss_pred             EeecCCCchHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           78 MEYAAGGELFAR---ICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        78 ~e~~~~~~L~~~---l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ||||+++.+...   ......+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence            999987643333   234557999999999999999999999999999999999999987652 3999999999876666


Q ss_pred             CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcc-------------c
Q 019433          155 SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNV-------------Q  221 (341)
Q Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~  221 (341)
                      ....+.+||+.|+|||++.+....+.++|||||||++|+|++|++||........+..+.......             .
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            666778999999999998776555566999999999999999999998877665555544322110             0


Q ss_pred             ccCC----------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCC
Q 019433          222 YFLP----------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLK  263 (341)
Q Consensus       222 ~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  263 (341)
                      ..++          ....+++++.+||.+||++||.+|||+.|+|+||||.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~  308 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE  308 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            0111          12357899999999999999999999999999999954

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-58  Score=408.96  Aligned_cols=248  Identities=22%  Similarity=0.287  Sum_probs=212.4

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||+||+|.++.+++.||||++..+....+.+.+|+.+++.++|||||+++++|.+++.+++|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            57899999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC--CC
Q 019433           83 GGELFARICSA--GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ--PK  158 (341)
Q Consensus        83 ~~~L~~~l~~~--~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~--~~  158 (341)
                      +|+|..++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.......  ..
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeec
Confidence            99999998764  46899999999999999999999999999999999999998876  99999999985332221  22


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|++|..||....+...+.+.+..    ....+....+|+++.+||
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~-k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSI-KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT----TCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccChHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc----CCCCCCCccchHHHHHHH
Confidence            345788999999998888765 599999999999999977776555554444333322    222333447899999999


Q ss_pred             HHhcccCCCCCCChhHHhc
Q 019433          239 SQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+||+.||.+|||+.++++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=404.15  Aligned_cols=262  Identities=26%  Similarity=0.445  Sum_probs=219.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      +||+++++||+|+||+||+|+++.+++.||||+++...   .....+.+|+.+++.++||||+++++++......++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            59999999999999999999999999999999986543   234578899999999999999999999999999999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-CCC
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-QPK  158 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-~~~  158 (341)
                      ++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||.|+...... ...
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence            9999999999888889999999999999999999999999999999999999988776  9999999997543322 334


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc----------------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY----------------  222 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  222 (341)
                      ...+++.|+|||++.+..+.+.++|||||||++|+|++|..||....+.......+........                
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            4567888999999988776667799999999999999999997665554443333222211100                


Q ss_pred             --------cCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCC
Q 019433          223 --------FLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLP  266 (341)
Q Consensus       223 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  266 (341)
                              .......+++.+.+||++||++||.+|||++|+|+||||.+-.+
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                    00112357889999999999999999999999999999976543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=409.59  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=211.5

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccC---ccccHHHHHHHHHHhcCCCCCeeeEEEEEEc--------C
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERG---KKIDENVQREIINHRSLRHPNIIRFKEVLLT--------P   71 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~--------~   71 (341)
                      +||+++++||+|+||+||+|+++.+|+.||||++...   ......+.+|+.+++.++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6999999999999999999999999999999998653   2345678899999999999999999999865        3


Q ss_pred             CEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCC
Q 019433           72 THLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSG  151 (341)
Q Consensus        72 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~  151 (341)
                      ..+++|||||.++++.........+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~  167 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAF  167 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeec
Confidence            468999999998887776666778999999999999999999999999999999999999998877  999999998642


Q ss_pred             CC-----CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccC-C
Q 019433          152 LL-----HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFL-P  225 (341)
Q Consensus       152 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~  225 (341)
                      ..     .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||....+.................. .
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            21     12334467999999999998775555669999999999999999999987665554444333322111100 0


Q ss_pred             CC-------------------------CCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          226 DY-------------------------VRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       226 ~~-------------------------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                      ..                         ...++++.+||.+||++||++|||++|+|+||||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            00                         0136788999999999999999999999999999754

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-57  Score=411.98  Aligned_cols=257  Identities=24%  Similarity=0.400  Sum_probs=213.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEc--CCEEEEEE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLT--PTHLAIVM   78 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~--~~~~~iv~   78 (341)
                      .++|+++++||+|+||+||+|+++.+|+.||||++...  ..+.+.+|+.+++.++ ||||++++++|..  ...+++||
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            36899999999999999999999999999999998764  3567889999999985 9999999999974  45699999


Q ss_pred             eecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCC
Q 019433           79 EYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPK  158 (341)
Q Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~  158 (341)
                      |||.+++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+.........
T Consensus       112 e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~  187 (328)
T d3bqca1         112 EHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYN  187 (328)
T ss_dssp             ECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCC
T ss_pred             eecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCccc
Confidence            99999998765   356999999999999999999999999999999999999986543 38999999998665556667


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc----------cc-------
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN----------VQ-------  221 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~~-------  221 (341)
                      ..+||+.|+|||++.+....+.++|||||||++|+|++|..||....+.......+.....          ..       
T Consensus       188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  267 (328)
T d3bqca1         188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  267 (328)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGG
T ss_pred             ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCccc
Confidence            7889999999999887765566799999999999999999999876654322221111100          00       


Q ss_pred             ---------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCC
Q 019433          222 ---------------YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKN  264 (341)
Q Consensus       222 ---------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  264 (341)
                                     ...+....+|+++.+||++||++||.+|||++|+|+||||...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             chhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                           0011123478999999999999999999999999999999653

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=400.08  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc---cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEe
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK---KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++|++.+.||+|+||+||+|+.+   ..||||+++...   ...+.+.+|+.+++.++|||||++++++.. ..+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            68999999999999999999864   359999987543   234578899999999999999999998654 56899999


Q ss_pred             ecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC---C
Q 019433           80 YAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH---S  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~---~  155 (341)
                      ||++|+|.+++... .++++..+..++.||++||+|||++||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcc
Confidence            99999999999764 56999999999999999999999999999999999999998776  999999999753321   2


Q ss_pred             CCCCccCCCCccccccccccc--cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKE--YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                      ......||+.|||||++.+..  ..+.++|||||||++|+|+||+.||........+...+...............+|++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            234567999999999987543  224558999999999999999999988776555544443322111111123468899


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-57  Score=395.72  Aligned_cols=247  Identities=24%  Similarity=0.400  Sum_probs=201.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||+||+|.++ +++.||||++.......+.+.+|+.+++.++|||||++++++..++.+++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            58999999999999999999987 57789999998877777889999999999999999999999999999999999999


Q ss_pred             CCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCCC
Q 019433           83 GGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~~  159 (341)
                      +|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++......  ....
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence            99999988654 46899999999999999999999999999999999999998877  9999999997533222  2234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|||+| |.+||........+ ..+   ... ...+.....++++.+|+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~~-k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~-~~i---~~~-~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-EDI---STG-FRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCCH-HHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH-HHH---HHT-CCCCCCTTSCHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCCc-hhhhcchHHHHHHHHHCCCCCCCCCCHHHHH-HHH---Hhc-CCCCCccccCHHHHHHH
Confidence            57899999999999888765 4999999999999999 56666554433222 222   221 11222346789999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      .+||+.||++|||++++++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-57  Score=397.90  Aligned_cols=249  Identities=21%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++++.||+|+||+||+|.++ +++.||||++.......+.+.+|+.+++.++|||||++++++.. +.+++|||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            57899999999999999999986 67889999998877677789999999999999999999998754 56789999999


Q ss_pred             CCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +|+|.+++....  ++++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccccc
Confidence            999998775433  6999999999999999999999999999999999999998776  9999999997543222  234


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-CCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHL  237 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  237 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|+||. +||..... ...   +..+... ...+....+++++.+|
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~-~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~---~~~i~~~-~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTI-KSDVWSFGILLTEIVTHGRIPYPGMTN-PEV---IQNLERG-YRMVRPDNCPEELYQL  242 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECH-HHHHHHHHHHHHHHHTTTCCSSTTCCH-HHH---HHHHHTT-CCCCCCTTCCHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCCc-hhhhhhhHHHHHHHHhCCCCCCCCCCH-HHH---HHHHHhc-CCCCCcccChHHHHHH
Confidence            567899999999998877764 599999999999999955 45544333 222   2222221 2223334789999999


Q ss_pred             HHHhcccCCCCCCChhHHhc--CCcc
Q 019433          238 LSQIFVADPSKRIPIPEIKK--HPWF  261 (341)
Q Consensus       238 i~~~L~~dp~~R~s~~e~l~--hp~~  261 (341)
                      +.+||+.||++|||+.++++  |+||
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            99999999999999999998  6776

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=391.44  Aligned_cols=247  Identities=22%  Similarity=0.341  Sum_probs=213.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      +.|+++++||+|+||+||+|+++ +++.||||++..+....+.+.+|+.+++.++||||+++++++..++.+++||||+.
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            57999999999999999999985 78899999999887778899999999999999999999999999999999999999


Q ss_pred             CCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCCC
Q 019433           83 GGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPKS  159 (341)
Q Consensus        83 ~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~~  159 (341)
                      +|+|..++.. ...+++..++.++.|+++||.|||++||+||||||+||+++.++.  +||+|||+++......  ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence            9999888655 457999999999999999999999999999999999999998776  9999999997433222  2234


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..||+.|+|||++.+..++. ++|||||||++|+|+| |+.||......+...    .+... ...+.....++.+.+||
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~-ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~----~i~~~-~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQG-LRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHHTT-CCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCCc-ceeecccchhhHhHHhcCCCCCCCCCHHHHHH----HHHhC-CCCCCcccccHHHHHHH
Confidence            56899999999999888765 5999999999999998 899998876543332    22222 22333457889999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++||+.||++|||++++++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-57  Score=414.43  Aligned_cols=291  Identities=23%  Similarity=0.378  Sum_probs=223.9

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcC-----CE
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTP-----TH   73 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~-----~~   73 (341)
                      .+||++++.||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+++.++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4799999999999999999999999999999999976432   234678999999999999999999999643     33


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      .+++++|+.+|+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.  +|++|||++...  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~--  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC--
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc--
Confidence            4666777889999998854 57999999999999999999999999999999999999998877  999999998743  


Q ss_pred             CCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccc-----------
Q 019433          154 HSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQY-----------  222 (341)
Q Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  222 (341)
                      ........||+.|+|||++.+..+.+.++|||||||++|+|++|.+||...+.......+.........           
T Consensus       172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence            334456789999999999888777667799999999999999999999887665554444332211100           


Q ss_pred             --------cCC------CCCCCCHHHHHHHHHhcccCCCCCCChhHHhcCCccCCCCChhHHHHHhhhhhhcCCCCCCCC
Q 019433          223 --------FLP------DYVRVSADCRHLLSQIFVADPSKRIPIPEIKKHPWFLKNLPKEIIEIEKTNYKEAGRDQPTQS  288 (341)
Q Consensus       223 --------~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (341)
                              ..+      ....+++++.+||++||++||.+|||+.|+|+||||.+........... ... .........
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~-~~~-~~~~~~~~~  329 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-PYD-QSFESRDLL  329 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC-CCC-CGGGGCCCC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC-CCC-CcccchhcC
Confidence                    000      0235789999999999999999999999999999998654322111110 000 111234556


Q ss_pred             HHHHHHHHHHh
Q 019433          289 VEEIMRIIQEA  299 (341)
Q Consensus       289 ~~~~~~~~~~~  299 (341)
                      ..++++++.+.
T Consensus       330 ~~~~k~~~~~e  340 (348)
T d2gfsa1         330 IDEWKSLTYDE  340 (348)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            77777766443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-57  Score=406.67  Aligned_cols=258  Identities=31%  Similarity=0.536  Sum_probs=219.2

Q ss_pred             CCccccceecccCCeEEEEEEE---cCCCcEEEEEEcccCc-----cccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCE
Q 019433            3 ERYEPVKELGSGNFGVARLVRD---KRTKELVAVKYIERGK-----KIDENVQREIINHRSLRH-PNIIRFKEVLLTPTH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-----~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~   73 (341)
                      ++|++++.||+|+||+||+|.+   +.+|+.||||++.+..     ...+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   4579999999986532     334568899999999976 899999999999999


Q ss_pred             EEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCC
Q 019433           74 LAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLL  153 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~  153 (341)
                      ++++|||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence            9999999999999999999999999999999999999999999999999999999999998776  99999999874322


Q ss_pred             --CCCCCCccCCCCccccccccccc-cCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCC
Q 019433          154 --HSQPKSTVGTPAYIAPEVLARKE-YDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRV  230 (341)
Q Consensus       154 --~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (341)
                        ........|++.|+|||.+.+.. +.+.++|||||||++|+|++|..||...........+...........|  ..+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~  259 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEM  259 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTS
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccC
Confidence              22334567999999999997654 3455699999999999999999999887665555555544443333333  368


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----ChhHHhcCCccCCC
Q 019433          231 SADCRHLLSQIFVADPSKRI-----PIPEIKKHPWFLKN  264 (341)
Q Consensus       231 s~~~~~li~~~L~~dp~~R~-----s~~e~l~hp~~~~~  264 (341)
                      |+++.+||.+||++||.+||     |++|+++||||++-
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            99999999999999999999     48999999999653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=406.83  Aligned_cols=249  Identities=25%  Similarity=0.368  Sum_probs=208.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc-----EEEEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE-----LVAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.+.||+|+||+||+|++..+++     .||+|.+...  ......+.+|+.+++.+ +|||||++++++.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            578999999999999999999876543     6999998653  33456788999999888 899999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEE
Q 019433           75 AIVMEYAAGGELFARICSAG-----------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL  131 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nil  131 (341)
                      ++|||||++|+|.+++....                       .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            99999999999999997542                       4899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCccCCCCCCC---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCCh
Q 019433          132 LDGSPQPRLKICDFGYSKSGLLHSQ---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDP  207 (341)
Q Consensus       132 i~~~~~~~ikL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~  207 (341)
                      ++.++.  +||+|||+|+.......   .....||+.|||||++.+..++. ++|||||||++|+|++ |.+||.+....
T Consensus       197 l~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         197 VTHGKV--VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI-KSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EETTTE--EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccCCe--EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc-ceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            998776  99999999975333222   22456899999999998888765 4899999999999997 89999876665


Q ss_pred             hHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..+.+.+..    ....+....+|+++.+||.+||+.||++|||++|+++|
T Consensus       274 ~~~~~~~~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhc----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555444332    22333445789999999999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-56  Score=399.09  Aligned_cols=248  Identities=23%  Similarity=0.372  Sum_probs=198.1

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc---EEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE---LVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|.++.+++   .||||.+....  ...+.+.+|+.+++.++|||||++++++..++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            578999999999999999999987665   58999886543  2345688999999999999999999999999999999


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCC
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQ  156 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~  156 (341)
                      ||||++|+|..++... +.+++.++..++.||++||.|||++||+||||||+|||++.++.  +||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence            9999999999988774 46999999999999999999999999999999999999998776  99999999975332221


Q ss_pred             ------CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          157 ------PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       157 ------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                            .....||+.|||||++.+..++.+ +|||||||++|||+| |..||.........    ..+.. ....+....
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----~~i~~-~~~~~~~~~  257 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVI----NAIEQ-DYRLPPPMD  257 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCCCCCCTT
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCcc
Confidence                  122457899999999988877654 899999999999998 89999876554332    22222 223344457


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +++.+.+|+.+||+.||.+|||+.+++++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            89999999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-57  Score=396.29  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             CCCcccc--ceecccCCeEEEEEEEc--CCCcEEEEEEcccCcc---ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEE
Q 019433            2 EERYEPV--KELGSGNFGVARLVRDK--RTKELVAVKYIERGKK---IDENVQREIINHRSLRHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         2 ~~~y~~~--~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~   74 (341)
                      ++++-.+  ++||+|+||+||+|.+.  .+++.||||++.....   ..+.+.+|+.+++.++|||||++++++..+ ..
T Consensus         4 d~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~   82 (277)
T d1xbba_           4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW   82 (277)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred             chhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence            3444444  36999999999999864  4568899999865432   235688999999999999999999998755 56


Q ss_pred             EEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           75 AIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      ++|||||++|+|..++.+..++++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus        83 ~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~  160 (277)
T d1xbba_          83 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRAD  160 (277)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccc
Confidence            899999999999999999899999999999999999999999999999999999999998877  999999999753322


Q ss_pred             C----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          155 S----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       155 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .    ......||+.|+|||++.+..++.+ +|||||||++|||++ |..||.........    ..+... ...+....
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~----~~i~~~-~~~~~p~~  234 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AMLEKG-ERMGCPAG  234 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHHTT-CCCCCCTT
T ss_pred             ccccccccccCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHH----HHHHcC-CCCCCCcc
Confidence            2    2234568999999999988877654 999999999999997 89999876543322    222221 12233347


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHh---cCCcc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIK---KHPWF  261 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l---~hp~~  261 (341)
                      +|+++.+||.+||+.||.+|||+.+++   +|+|+
T Consensus       235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            899999999999999999999999984   55554

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=390.35  Aligned_cols=254  Identities=22%  Similarity=0.286  Sum_probs=206.6

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEEEeecC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIVMEYAA   82 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv~e~~~   82 (341)
                      ++|++.+.||+|+||+||+|.++.+ +.||||++.......+.+.+|+.+++.++|||||++++++.. +.+++|||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            6799999999999999999999755 579999998777667789999999999999999999999854 56789999999


Q ss_pred             CCchHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC--CCC
Q 019433           83 GGELFARICS--AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS--QPK  158 (341)
Q Consensus        83 ~~~L~~~l~~--~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~--~~~  158 (341)
                      +|+|..++..  .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+......  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence            9999888754  357999999999999999999999999999999999999998876  9999999997532222  223


Q ss_pred             CccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          159 STVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ...||+.|+|||++.+..++. ++|||||||++|+|++|..||........+...   +.. ....+....+|+++.+||
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~-ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i~~-~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTI-KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VER-GYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHT-TCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccChHHHhCCCCCc-HHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HHh-cCCCCCCcccCHHHHHHH
Confidence            457899999999998888765 499999999999999966565544443333222   222 122334457899999999


Q ss_pred             HHhcccCCCCCCChhHHhc--CCccCCCC
Q 019433          239 SQIFVADPSKRIPIPEIKK--HPWFLKNL  265 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~--hp~~~~~~  265 (341)
                      .+||+.||++|||++++++  ++||....
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            9999999999999999988  88886543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=390.13  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=204.0

Q ss_pred             CCccccc-eecccCCeEEEEEEEcC--CCcEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVK-ELGSGNFGVARLVRDKR--TKELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|.+.+ +||+|+||+||+|.++.  ++..||||++....  ...+.+.+|+.+++.++|||||++++++..+ .+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            4577777 49999999999998753  45689999987643  2345788999999999999999999998754 57899


Q ss_pred             EeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           78 MEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+...... 
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccc
Confidence            9999999999987654 57999999999999999999999999999999999999998776  9999999997533222 


Q ss_pred             ---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          156 ---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       156 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                         ......||+.|+|||++.+..++.+ +|||||||++|||+| |..||......+...    .+.... ..+....+|
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~~~-~~~~p~~~~  238 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQGK-RMECPPECP  238 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHTTC-CCCCCTTCC
T ss_pred             ccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCC-CCCCCCcCC
Confidence               2234568999999999988877654 999999999999998 999998766543332    222221 122334789


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHH---hcCCcc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEI---KKHPWF  261 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~  261 (341)
                      +++.+||.+||+.||++|||+.++   |+|+|+
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999888   456654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-55  Score=384.01  Aligned_cols=247  Identities=24%  Similarity=0.363  Sum_probs=197.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCC---CcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRT---KELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.+.||+|+||+||+|.+..+   +..||||.+.....  ..+.+.+|+.+++.++|||||++++++. ++.+++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            6899999999999999999998654   45689998865432  2356889999999999999999999985 4678999


Q ss_pred             EeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-
Q 019433           78 MEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-  155 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-  155 (341)
                      ||||++|+|..++.. ...+++..++.++.||++||.|||++||+||||||+||++++++.  +||+|||+|+...... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence            999999999988765 447999999999999999999999999999999999999998877  9999999997533222 


Q ss_pred             -CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHH
Q 019433          156 -QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSAD  233 (341)
Q Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  233 (341)
                       ......||+.|+|||++.+..++. ++|||||||++|+|++ |.+||...........+    ... ...+.+..+|++
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~-~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~-~~~~~~~~~~~~  237 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCPPT  237 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT-CCCCCCTTCCHH
T ss_pred             eeccceecCcccchhhHhccCCCCC-ccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC-CCCCCCCCCCHH
Confidence             233456899999999998887765 4899999999999998 89999887665444332    221 122344579999


Q ss_pred             HHHHHHHhcccCCCCCCChhHHhcC
Q 019433          234 CRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       234 ~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-54  Score=381.36  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=198.0

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC----cEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK----ELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      ..|++.+.||+|+||+||+|.++.++    ..||||++.....  ....+.+|+.+++.++|||||++++++......++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46899999999999999999987654    4799999875432  23467899999999999999999999999999999


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      |||||.++++...+... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence            99999999998887655 57999999999999999999999999999999999999998876  9999999997532221


Q ss_pred             ----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          156 ----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       156 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                          ......||+.|||||++.+..++.+ +|||||||++|||++|..||........+...   +.. ....+....++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~---i~~-~~~~~~~~~~~  239 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---IND-GFRLPTPMDCP  239 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH---HHT-TCCCCCCTTCB
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH---Hhc-cCCCCCchhhH
Confidence                1223468999999999988877654 99999999999999965555444433333222   222 22234445789


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      ..+.+||.+||+.||++|||+.++++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-54  Score=375.00  Aligned_cols=243  Identities=24%  Similarity=0.367  Sum_probs=196.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEEEEEeec
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVMEYA   81 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~iv~e~~   81 (341)
                      ++|++++.||+|+||.||+|.++  |..||||+++.+. ..+.+.+|+.+++.++||||+++++++.. ++.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            57999999999999999999984  7899999997653 45779999999999999999999999865 46689999999


Q ss_pred             CCCchHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCCCCCC
Q 019433           82 AGGELFARICSAG--RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHSQPKS  159 (341)
Q Consensus        82 ~~~~L~~~l~~~~--~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~~~~~  159 (341)
                      ++|+|.+++....  .+++..++.++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++..  ......
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~--~~~~~~  159 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEA--SSTQDT  159 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC------------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--Eeecccccceec--CCCCcc
Confidence            9999999986543  5999999999999999999999999999999999999998877  999999999843  233445


Q ss_pred             ccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHHHHH
Q 019433          160 TVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCRHLL  238 (341)
Q Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  238 (341)
                      ..+|+.|+|||++.+..++. ++|||||||++|||+| |++||...........    +.. ....+....+++.+.+||
T Consensus       160 ~~~~~~y~aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~~~~li  233 (262)
T d1byga_         160 GKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VEK-GYKMDAPDGCPPAVYEVM  233 (262)
T ss_dssp             --CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HTT-TCCCCCCTTCCHHHHHHH
T ss_pred             ccccccCCChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHc-CCCCCCCccCCHHHHHHH
Confidence            67899999999998877754 5999999999999998 7888877654433322    222 112223346899999999


Q ss_pred             HHhcccCCCCCCChhHHhcC
Q 019433          239 SQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       239 ~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ++||+.||.+|||+.+++++
T Consensus       234 ~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         234 KNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=381.34  Aligned_cols=249  Identities=23%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             CCccccceecccCCeEEEEEEEcC-----CCcEEEEEEcccCc--cccHHHHHHHHHHhcC-CCCCeeeEEEEEEcC-CE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-----TKELVAVKYIERGK--KIDENVQREIINHRSL-RHPNIIRFKEVLLTP-TH   73 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~--~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~-~~   73 (341)
                      ++|++.++||+|+||+||+|.+..     +++.||||++....  ...+.+.+|+..+.++ +||||+.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            689999999999999999999754     45789999987543  2234566777776665 789999999988664 56


Q ss_pred             EEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCC
Q 019433           74 LAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQ  137 (341)
Q Consensus        74 ~~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~  137 (341)
                      +++|||||++|+|.+++...                ..+++..++.++.||++||.|||++||+||||||+|||++.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            89999999999999999653                24899999999999999999999999999999999999998776


Q ss_pred             CCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhC-CCCCCCCCChhHHHHH
Q 019433          138 PRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKT  213 (341)
Q Consensus       138 ~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g-~~pf~~~~~~~~~~~~  213 (341)
                        +||+|||+|+......   ......||+.|+|||++.+..++. ++|||||||++|+|++| .+||........+...
T Consensus       173 --~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         173 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             --EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCc-ccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              9999999997432222   233567999999999998877754 59999999999999986 5788776655554444


Q ss_pred             HHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          214 IDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       214 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +...  ..  .+....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       250 ~~~~--~~--~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LKEG--TR--MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHT--CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhcC--CC--CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3321  12  22234689999999999999999999999999997

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-53  Score=382.63  Aligned_cols=247  Identities=22%  Similarity=0.343  Sum_probs=200.3

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCc----EEEEEEcccC--ccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKE----LVAVKYIERG--KKIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~i   76 (341)
                      +.|++++.||+|+||+||+|.+..+|+    +||+|.+...  ....+.+.+|+.+++.++|||||++++++.++. .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            569999999999999999999988876    5888887643  334567999999999999999999999998754 577


Q ss_pred             EEeecCCCchHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC
Q 019433           77 VMEYAAGGELFARICSA-GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS  155 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~  155 (341)
                      +++++.+++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccc
Confidence            88999899998877664 57999999999999999999999999999999999999998876  9999999997533222


Q ss_pred             C---CCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCC
Q 019433          156 Q---PKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVS  231 (341)
Q Consensus       156 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  231 (341)
                      .   .....||+.|+|||++.+..++. ++|||||||++|+|+| |.+||........ ...+..    ....+....++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~-~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~----~~~~~~p~~~~  239 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEK----GERLPQPPICT  239 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHH----TCCCCCCTTBC
T ss_pred             ccccccccccCccccChHHHhcCCCCh-hhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHc----CCCCCCCcccC
Confidence            2   23346899999999998887754 5999999999999998 8899987654433 233222    12233344789


Q ss_pred             HHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          232 ADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       232 ~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +++.+|+.+||+.||.+|||+.++++|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=382.85  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=204.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcE--EEEEEcccC--ccccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEEEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKEL--VAVKYIERG--KKIDENVQREIINHRSL-RHPNIIRFKEVLLTPTHLAIV   77 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~--~~~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~~iv   77 (341)
                      ++|++.++||+|+||+||+|.++.+|..  ||||.+...  ....+.+.+|+.+++.+ +|||||++++++..++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5789999999999999999999988875  677776543  23445789999999998 799999999999999999999


Q ss_pred             EeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEE
Q 019433           78 MEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLK  141 (341)
Q Consensus        78 ~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ik  141 (341)
                      ||||++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.++.  +|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eE
Confidence            9999999999998654                56999999999999999999999999999999999999998876  99


Q ss_pred             EeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-CCCCCCCChhHHHHHHHHHhcc
Q 019433          142 ICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDPRNFRKTIDRIRNV  220 (341)
Q Consensus       142 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~  220 (341)
                      |+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|+|++|. +||...+...    ....+...
T Consensus       168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~~~  242 (309)
T d1fvra_         168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLPQG  242 (309)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGGGT
T ss_pred             EccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHHhc
Confidence            999999986555555556679999999999988887654 89999999999999965 5676544332    22233221


Q ss_pred             cccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          221 QYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       ...+....+++++.+||.+||+.||++|||+.++++|
T Consensus       243 -~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 -YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             -CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             2233345789999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-54  Score=376.95  Aligned_cols=247  Identities=28%  Similarity=0.408  Sum_probs=195.6

Q ss_pred             CCccccceecccCCeEEEEEEEcC-CC--cEEEEEEcccCc----cccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKR-TK--ELVAVKYIERGK----KIDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~----~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||+||+|+... ++  ..||||++.+..    ...+.+.+|+.+++.++||||+++++++.++ .++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            569999999999999999998653 33  468999987532    2335688999999999999999999999764 678


Q ss_pred             EEEeecCCCchHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCC
Q 019433           76 IVMEYAAGGELFARICS-AGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLH  154 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~  154 (341)
                      +|||||++|++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccC
Confidence            99999999999887655 457999999999999999999999999999999999999998776  999999999853222


Q ss_pred             C----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHHHHHHHhcccccCCCCCC
Q 019433          155 S----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVR  229 (341)
Q Consensus       155 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (341)
                      .    ......|+..|+|||++.+..++.+ +|||||||++|||++ |..||...+.....    ..+.......+....
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPED  239 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTT
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----HHHHhCCCCCCCccc
Confidence            2    1233457889999999998877654 899999999999998 89999876554333    334344444455567


Q ss_pred             CCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          230 VSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       230 ~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +|+++.+||.+||..||++|||+.++++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-53  Score=375.91  Aligned_cols=247  Identities=24%  Similarity=0.344  Sum_probs=200.7

Q ss_pred             CCccccceecccCCeEEEEEEEcCCC-------cEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCC
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTK-------ELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPT   72 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~   72 (341)
                      ++|++.+.||+|+||.||+|++..++       ..||||++.....  ....+.+|...+..+ +|||||++++++.++.
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999986554       4799999976543  335677888888777 7999999999999999


Q ss_pred             EEEEEEeecCCCchHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           73 HLAIVMEYAAGGELFARICSA----------------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        73 ~~~iv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      .+++|||||.+|+|.+++...                ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            999999999999999999654                3589999999999999999999999999999999999999887


Q ss_pred             CCCEEEeecCCccCCCCC---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++ |.+||........+  
T Consensus       173 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~--  247 (299)
T d1fgka_         173 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF--  247 (299)
T ss_dssp             C--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             C--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHHH--
Confidence            7  999999998743222   22344678999999999988887654 899999999999998 78999765543222  


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                        ..+.. ....+....+|+++.+||.+||+.||.+|||+.|+++
T Consensus       248 --~~i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 --KLLKE-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             --HHHHT-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHc-CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence              22222 2223334478999999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-52  Score=374.74  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=204.5

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++++.||+|+||+||+|+.+     .+++.||||++.....  ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999975     3568899999875432  2356899999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEE
Q 019433           76 IVMEYAAGGELFARICSAG------------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTL  131 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nil  131 (341)
                      ++|||+.+|+|.+++....                        .+++..+..++.|++.||+|||++||+||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999986532                        3889999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeecCCccCCCCC---CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCC-CCCCCCCCh
Q 019433          132 LDGSPQPRLKICDFGYSKSGLLH---SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGA-YPFEDPEDP  207 (341)
Q Consensus       132 i~~~~~~~ikL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~-~pf~~~~~~  207 (341)
                      ++.++.  +||+|||+|+.....   .......||+.|+|||++.+..++. ++|||||||++|||++|. +||......
T Consensus       173 ld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~-ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         173 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh-hhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            998776  999999998642222   2233567889999999999888765 599999999999999985 677766554


Q ss_pred             hHHHHHHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          208 RNFRKTIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      +..    ..+.... ..+....+++++.+||.+||+.||++|||+.|+++
T Consensus       250 e~~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHH----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            333    2233322 22233478999999999999999999999999966

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=374.86  Aligned_cols=259  Identities=19%  Similarity=0.156  Sum_probs=200.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-eeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-IIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-iv~l~~~~~~~~~~~iv~e   79 (341)
                      +++||+++++||+|+||+||+|++..+|+.||||++.... ....+..|+.+++.++|+| |+.+..++......++|||
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4689999999999999999999999999999999887643 3456889999999997665 5666677788899999999


Q ss_pred             ecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC-CCCEEEeecCCccCCCCCC---
Q 019433           80 YAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP-QPRLKICDFGYSKSGLLHS---  155 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~-~~~ikL~Dfg~a~~~~~~~---  155 (341)
                      |+.++.+.........+++..+..++.|++.||+|||++||+||||||+|||++..+ ...++|+|||+|+......   
T Consensus        84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            996644444444466899999999999999999999999999999999999986432 3459999999997533221   


Q ss_pred             -----CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhc-ccccCC-CCC
Q 019433          156 -----QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRN-VQYFLP-DYV  228 (341)
Q Consensus       156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-~~~  228 (341)
                           ......||+.|||||++.+..++. ++|||||||++|+|++|..||.................. .....+ ...
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  242 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCH-HHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCC-hhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhcc
Confidence                 233557999999999999887754 599999999999999999999875543333222111111 011001 123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCChhHH---hcCCcc
Q 019433          229 RVSADCRHLLSQIFVADPSKRIPIPEI---KKHPWF  261 (341)
Q Consensus       229 ~~s~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~  261 (341)
                      .+|+++.+||.+||+.||.+||++.++   |+|+|.
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            689999999999999999999998754   666654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=371.09  Aligned_cols=248  Identities=25%  Similarity=0.334  Sum_probs=207.1

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCcc--ccHHHHHHHHHHhcC-CCCCeeeEEEEEEcCCEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKK--IDENVQREIINHRSL-RHPNIIRFKEVLLTPTHL   74 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~ei~~~~~l-~hp~iv~l~~~~~~~~~~   74 (341)
                      ++|++.++||+|+||.||+|.+.     .+++.||||++.....  ....+.+|+.+++.+ +|||||++++++.....+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            68899999999999999999863     5678999999976432  334678899999988 699999999999999999


Q ss_pred             EEEEeecCCCchHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCC
Q 019433           75 AIVMEYAAGGELFARICSAG------------------RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSP  136 (341)
Q Consensus        75 ~iv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~  136 (341)
                      ++|||||++|+|..++....                  .+++..++.++.||+.||+|||++|++||||||+||+++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999987543                  589999999999999999999999999999999999998877


Q ss_pred             CCCEEEeecCCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHh-CCCCCCCCCChhHHHH
Q 019433          137 QPRLKICDFGYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLV-GAYPFEDPEDPRNFRK  212 (341)
Q Consensus       137 ~~~ikL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~-g~~pf~~~~~~~~~~~  212 (341)
                      .  +||+|||+++......   ......||+.|+|||++.+..++. ++|||||||++|+|+| |.+||........+.+
T Consensus       183 ~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             c--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCC-cccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            6  9999999997533221   223457899999999998777655 4999999999999998 6677766655555555


Q ss_pred             HHHHHhcccccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          213 TIDRIRNVQYFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      .+..    ....+....+|+++.+||.+||+.||.+|||+.++++
T Consensus       260 ~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4433    2222333468999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=370.71  Aligned_cols=248  Identities=21%  Similarity=0.293  Sum_probs=205.2

Q ss_pred             CCccccceecccCCeEEEEEEEc-----CCCcEEEEEEcccCccc--cHHHHHHHHHHhcCCCCCeeeEEEEEEcCCEEE
Q 019433            3 ERYEPVKELGSGNFGVARLVRDK-----RTKELVAVKYIERGKKI--DENVQREIINHRSLRHPNIIRFKEVLLTPTHLA   75 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~~~~   75 (341)
                      ++|++.+.||+|+||+||+|.++     .+++.||||++......  ...+.+|+.+++.++|||||++++++..+...+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            68999999999999999999885     24678999999764322  235789999999999999999999999999999


Q ss_pred             EEEeecCCCchHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           76 IVMEYAAGGELFARICSA----------GRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        76 iv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                      +|||||.+|+|..++...          ..+++..+..++.|+++||.|||+++|+||||||+|||++.++.  +||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeec
Confidence            999999999999988543          24789999999999999999999999999999999999998776  999999


Q ss_pred             CCccCCCCCC---CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhC-CCCCCCCCChhHHHHHHHHHhccc
Q 019433          146 GYSKSGLLHS---QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVG-AYPFEDPEDPRNFRKTIDRIRNVQ  221 (341)
Q Consensus       146 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~  221 (341)
                      |+|+......   ......||+.|+|||.+.+..++. ++|||||||++|+|++| .+||...+..+.+..    +....
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~-~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~~~~  252 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG  252 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH-HHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCc-ccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhCC
Confidence            9997432222   123346899999999998887765 48999999999999998 578876555443332    22222


Q ss_pred             ccCCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          222 YFLPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       222 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                       ..+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       253 -~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         253 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             223334789999999999999999999999999983

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-51  Score=361.34  Aligned_cols=254  Identities=18%  Similarity=0.192  Sum_probs=204.1

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCC-CCeeeEEEEEEcCCEEEEEEe
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRH-PNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~h-p~iv~l~~~~~~~~~~~iv~e   79 (341)
                      |++||++.+.||+|+||+||+|+++.+|+.||||++.... ....+.+|+..++.|+| +|++.+++++......++|||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4789999999999999999999999999999999886543 34567889999999965 899999999999999999999


Q ss_pred             ecCCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCC---CCCCEEEeecCCccCCCCC-
Q 019433           80 YAAGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGS---PQPRLKICDFGYSKSGLLH-  154 (341)
Q Consensus        80 ~~~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~---~~~~ikL~Dfg~a~~~~~~-  154 (341)
                      |+ +++|..++...+ .++...+..++.|++.||.|||++||+||||||+|||++..   ....+||+|||+|+..... 
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            99 679888887654 79999999999999999999999999999999999999742   2345999999999743211 


Q ss_pred             -------CCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHH--HHHHhcccccCC
Q 019433          155 -------SQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKT--IDRIRNVQYFLP  225 (341)
Q Consensus       155 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~  225 (341)
                             ......+||+.|||||++.+..++. ++|||||||++|+|++|..||............  +...........
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~-~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  239 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCCh-HHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence                   1233567999999999999887765 499999999999999999999765443222211  111111100000


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCChhHHhc
Q 019433          226 DYVRVSADCRHLLSQIFVADPSKRIPIPEIKK  257 (341)
Q Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  257 (341)
                      -...+|+++.+++..|+..+|.+||+.+.+.+
T Consensus       240 l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            12368899999999999999999999876654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-51  Score=364.09  Aligned_cols=244  Identities=20%  Similarity=0.244  Sum_probs=194.6

Q ss_pred             cceecccCCeEEEEEEEcCCC---cEEEEEEcccCc--cccHHHHHHHHHHhcCCCCCeeeEEEEEEc-CCEEEEEEeec
Q 019433            8 VKELGSGNFGVARLVRDKRTK---ELVAVKYIERGK--KIDENVQREIINHRSLRHPNIIRFKEVLLT-PTHLAIVMEYA   81 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~-~~~~~iv~e~~   81 (341)
                      -++||+|+||+||+|.+..++   ..||||++.+..  ...+.+.+|+.++++++||||+++++++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            568999999999999986543   369999987532  234578999999999999999999999765 56899999999


Q ss_pred             CCCchHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeecCCccCCCCCC-----
Q 019433           82 AGGELFARICSAG-RFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDFGYSKSGLLHS-----  155 (341)
Q Consensus        82 ~~~~L~~~l~~~~-~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~~~~~~~-----  155 (341)
                      ++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+++++.  +||+|||+++......     
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence            9999999887544 5788899999999999999999999999999999999988776  9999999997533222     


Q ss_pred             CCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCChhHHHHHHHHHhcccccCCCCCCCCHHHH
Q 019433          156 QPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDPRNFRKTIDRIRNVQYFLPDYVRVSADCR  235 (341)
Q Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  235 (341)
                      ......||+.|+|||.+.+..++. ++|||||||++|||++|..||....+...+..   .+.... ..+....+++++.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~-ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g~-~~~~p~~~~~~l~  264 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTT-KSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGR-RLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTTC-CCCCCTTCCHHHH
T ss_pred             ecccccccccccChHHHhcCCCCC-hhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCC-CCCCcccCcHHHH
Confidence            222346899999999998877754 48999999999999997777765433322222   222221 1222346889999


Q ss_pred             HHHHHhcccCCCCCCChhHHhcC
Q 019433          236 HLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       236 ~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      +||.+||+.||++|||+.|+++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-51  Score=363.40  Aligned_cols=253  Identities=23%  Similarity=0.265  Sum_probs=192.4

Q ss_pred             CCCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCCeeeEEEEEEcCC----EEEE
Q 019433            1 MEERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPNIIRFKEVLLTPT----HLAI   76 (341)
Q Consensus         1 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~iv~l~~~~~~~~----~~~i   76 (341)
                      |+++|.+.+.||+|+||+||+|+.  +|+.||||++............|+..++.++|||||++++++...+    .+++
T Consensus         1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            678999999999999999999987  6899999998765433333445566666789999999999997653    6899


Q ss_pred             EEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeeCCCCCCCEEecCCCCCCEEEeecCCc
Q 019433           77 VMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHS--------MEICHRDLKLENTLLDGSPQPRLKICDFGYS  148 (341)
Q Consensus        77 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~--------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a  148 (341)
                      |||||++|+|..++.+. ++++..+..++.|++.||.|||+        +||+||||||+||||+.++.  +||+|||++
T Consensus        79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~  155 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLA  155 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTC
T ss_pred             EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCcc
Confidence            99999999999999764 69999999999999999999996        59999999999999988776  999999998


Q ss_pred             cCCCCCC-----CCCCccCCCCcccccccccccc-----CCCccchhhHHHHHHHHHhCCCCCCCCCCh-----------
Q 019433          149 KSGLLHS-----QPKSTVGTPAYIAPEVLARKEY-----DGKISDVWSCGVTLYVMLVGAYPFEDPEDP-----------  207 (341)
Q Consensus       149 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~vl~~l~~g~~pf~~~~~~-----------  207 (341)
                      +......     ......||+.|+|||++.+...     .+.++|||||||++|+|+||..||......           
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            7432221     2345679999999999875431     133489999999999999998887432211           


Q ss_pred             hHHHHHHHHHhcccc--cCCCC---CCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          208 RNFRKTIDRIRNVQY--FLPDY---VRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       208 ~~~~~~~~~~~~~~~--~~~~~---~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ...............  .++..   ...+..+.+|+.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            111122222211111  11111   1122458899999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-51  Score=372.62  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=200.4

Q ss_pred             CCCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----------CCCeeeEEEEEEc
Q 019433            2 EERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----------HPNIIRFKEVLLT   70 (341)
Q Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----------hp~iv~l~~~~~~   70 (341)
                      ++||+++++||+|+||+||+|+++.+|+.||||++++.....+.+.+|+.+++.++           ||||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            46899999999999999999999999999999999876655667788998887764           5889999998864


Q ss_pred             --CCEEEEEEeecCCCchHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeeCCCCCCCEEecCCCC----CCE
Q 019433           71 --PTHLAIVMEYAAGGELFARI---CSAGRFSEDEARFFFQQLISGVSYCHS-MEICHRDLKLENTLLDGSPQ----PRL  140 (341)
Q Consensus        71 --~~~~~iv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~qil~aL~~LH~-~~iiHrDikp~Nili~~~~~----~~i  140 (341)
                        ....++++.++..+......   .....+++..++.++.||+.||.|||+ +||+||||||+|||++.++.    ..+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~  171 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  171 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence              46677777776554432222   234479999999999999999999998 89999999999999976543    238


Q ss_pred             EEeecCCccCCCCCCCCCCccCCCCccccccccccccCCCccchhhHHHHHHHHHhCCCCCCCCCCh------hHHHHHH
Q 019433          141 KICDFGYSKSGLLHSQPKSTVGTPAYIAPEVLARKEYDGKISDVWSCGVTLYVMLVGAYPFEDPEDP------RNFRKTI  214 (341)
Q Consensus       141 kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~vl~~l~~g~~pf~~~~~~------~~~~~~~  214 (341)
                      +|+|||.|...  .......+||+.|+|||++.+..++.+ +||||+||++++|++|+.||......      ..+...+
T Consensus       172 kl~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~  248 (362)
T d1q8ya_         172 KIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  248 (362)
T ss_dssp             EECCCTTCEET--TBCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             eEeeccccccc--ccccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHH
Confidence            99999998743  344567789999999999998888654 89999999999999999999754321      1111111


Q ss_pred             HHHhcc--------------------ccc----------------CCCCCCCCHHHHHHHHHhcccCCCCCCChhHHhcC
Q 019433          215 DRIRNV--------------------QYF----------------LPDYVRVSADCRHLLSQIFVADPSKRIPIPEIKKH  258 (341)
Q Consensus       215 ~~~~~~--------------------~~~----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  258 (341)
                      ..+...                    ...                .......++++.+||.+||++||.+|||++|+|+|
T Consensus       249 ~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            111000                    000                00012346779999999999999999999999999


Q ss_pred             CccCCCCC
Q 019433          259 PWFLKNLP  266 (341)
Q Consensus       259 p~~~~~~~  266 (341)
                      |||.+...
T Consensus       329 p~f~~~~~  336 (362)
T d1q8ya_         329 PWLKDTLG  336 (362)
T ss_dssp             GGGTTCTT
T ss_pred             cccCCCCC
Confidence            99975543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=4.4e-27  Score=194.61  Aligned_cols=131  Identities=19%  Similarity=0.164  Sum_probs=105.8

Q ss_pred             ccccceecccCCeEEEEEEEcCCCcEEEEEEcccCcc-------------------ccHHHHHHHHHHhcCCCCCeeeEE
Q 019433            5 YEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGKK-------------------IDENVQREIINHRSLRHPNIIRFK   65 (341)
Q Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~ei~~~~~l~hp~iv~l~   65 (341)
                      |.+.++||+|+||+||+|.+. +|+.||||+++.+..                   ......+|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999986 789999998753211                   012344678888899999999988


Q ss_pred             EEEEcCCEEEEEEeecCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeeCCCCCCCEEecCCCCCCEEEeec
Q 019433           66 EVLLTPTHLAIVMEYAAGGELFARICSAGRFSEDEARFFFQQLISGVSYCHSMEICHRDLKLENTLLDGSPQPRLKICDF  145 (341)
Q Consensus        66 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH~~~iiHrDikp~Nili~~~~~~~ikL~Df  145 (341)
                      ++..    .+++|||+++..+.       .++...+..++.|++.+|.|||++||+||||||+|||++.++   ++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence            7642    27999999886553       256666788999999999999999999999999999998543   899999


Q ss_pred             CCccC
Q 019433          146 GYSKS  150 (341)
Q Consensus       146 g~a~~  150 (341)
                      |+|..
T Consensus       147 G~a~~  151 (191)
T d1zara2         147 PQSVE  151 (191)
T ss_dssp             TTCEE
T ss_pred             CCccc
Confidence            99864

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=1.6e-07  Score=79.14  Aligned_cols=138  Identities=15%  Similarity=0.092  Sum_probs=90.8

Q ss_pred             CCccccceecccCCeEEEEEEEcCCCcEEEEEEcccCc-cccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEee
Q 019433            3 ERYEPVKELGSGNFGVARLVRDKRTKELVAVKYIERGK-KIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVMEY   80 (341)
Q Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e~   80 (341)
                      +.|+.++..+-++.+.||.+..  +++.+++|+..... .....+.+|...++.+. +--+.+++.+...++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            3566666655555678998864  46678888876533 23445778888877663 33367788888888999999999


Q ss_pred             cCCCchHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 019433           81 AAGGELFARICSAGRFSEDEARFFFQQLISGVSYCH--------------------------------------------  116 (341)
Q Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~i~~qil~aL~~LH--------------------------------------------  116 (341)
                      ++|.++.......     .....++.++...+..||                                            
T Consensus        92 l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          92 ADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            9998775443211     111223333334444444                                            


Q ss_pred             ---------H------cCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          117 ---------S------MEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       117 ---------~------~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                               .      ..++|+|+.|.||++++++.  +-|+||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~--~~lIDwe~a~  212 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV--SGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE--EEECCCTTCE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce--EEEeechhcc
Confidence                     1      12789999999999986543  4699998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.22  E-value=2.4e-06  Score=76.44  Aligned_cols=77  Identities=14%  Similarity=0.055  Sum_probs=49.2

Q ss_pred             cceecccCCeEEEEEEEcCCCcEEEEEEccc----C----ccccHHHHHHHHHHhcCC---CCCeeeEEEEEEcCCEEEE
Q 019433            8 VKELGSGNFGVARLVRDKRTKELVAVKYIER----G----KKIDENVQREIINHRSLR---HPNIIRFKEVLLTPTHLAI   76 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~----~~~~~~~~~ei~~~~~l~---hp~iv~l~~~~~~~~~~~i   76 (341)
                      .+.||.|....||.+.+..+++.+++|.-..    .    +........|...++.+.   ...+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5689999999999999887888999996322    1    112334566777776552   2346666654  3445578


Q ss_pred             EEeecCCCch
Q 019433           77 VMEYAAGGEL   86 (341)
Q Consensus        77 v~e~~~~~~L   86 (341)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.12  E-value=2.6e-06  Score=71.08  Aligned_cols=74  Identities=14%  Similarity=0.060  Sum_probs=52.7

Q ss_pred             eecccCC-eEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC--CCCeeeEEEEEEcCCEEEEEEeecCCCch
Q 019433           10 ELGSGNF-GVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR--HPNIIRFKEVLLTPTHLAIVMEYAAGGEL   86 (341)
Q Consensus        10 ~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~--hp~iv~l~~~~~~~~~~~iv~e~~~~~~L   86 (341)
                      .+..|.. +.||.+... .+..+++|......  ...+..|...++.+.  .-.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 678988864 56678999865543  345677877777663  23367788888888899999999988654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.37  E-value=0.00038  Score=59.95  Aligned_cols=67  Identities=13%  Similarity=0.147  Sum_probs=45.5

Q ss_pred             eEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCCCCC-----eeeE--EEEEEcCCEEEEEEeecCCC
Q 019433           17 GVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLRHPN-----IIRF--KEVLLTPTHLAIVMEYAAGG   84 (341)
Q Consensus        17 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~hp~-----iv~l--~~~~~~~~~~~iv~e~~~~~   84 (341)
                      -.||.+... +|+.|++|+.+.+....+.+..|...+..|...+     .+..  -..+......+.+++++.|.
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            479999885 6888999998877666677888888776653211     1111  11223467788999999873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.21  E-value=0.00059  Score=60.39  Aligned_cols=74  Identities=12%  Similarity=0.100  Sum_probs=51.0

Q ss_pred             cceecccCCeEEEEEEEcC-------CCcEEEEEEcccCccccHHHHHHHHHHhcCC-CCCeeeEEEEEEcCCEEEEEEe
Q 019433            8 VKELGSGNFGVARLVRDKR-------TKELVAVKYIERGKKIDENVQREIINHRSLR-HPNIIRFKEVLLTPTHLAIVME   79 (341)
Q Consensus         8 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-hp~iv~l~~~~~~~~~~~iv~e   79 (341)
                      ++.|+-|---.+|++....       .++.|.+++... ....-...+|..+++.+. +.-.+++++++..    ++|++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678778888999998753       346688887663 333445668888888774 4335577777643    68999


Q ss_pred             ecCCCch
Q 019433           80 YAAGGEL   86 (341)
Q Consensus        80 ~~~~~~L   86 (341)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.36  E-value=0.0032  Score=53.43  Aligned_cols=136  Identities=17%  Similarity=0.132  Sum_probs=69.4

Q ss_pred             ceecccCCeEEEEEEEcCCCcEEEEEEcccCccccHHHHHHHHHHhcCC-----CCCeeeEEE---EEEcCCEEEEEEee
Q 019433            9 KELGSGNFGVARLVRDKRTKELVAVKYIERGKKIDENVQREIINHRSLR-----HPNIIRFKE---VLLTPTHLAIVMEY   80 (341)
Q Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~ei~~~~~l~-----hp~iv~l~~---~~~~~~~~~iv~e~   80 (341)
                      +.|..|---+.|++... +| .+++|++.... ..+.+..|+.++..|.     -|..+...+   +.........++.+
T Consensus        24 ~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~  100 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  100 (316)
T ss_dssp             EEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             ecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeee
Confidence            44556666788998875 33 59999986542 3455666666665552     222221100   11224556666766


Q ss_pred             cCCCch--------------HHHHHhc-C--------CCC------------------HHHHHHHHHHHHHHHHHHH---
Q 019433           81 AAGGEL--------------FARICSA-G--------RFS------------------EDEARFFFQQLISGVSYCH---  116 (341)
Q Consensus        81 ~~~~~L--------------~~~l~~~-~--------~l~------------------~~~~~~i~~qil~aL~~LH---  116 (341)
                      ..+...              ...+... .        ...                  .......+..+...+...+   
T Consensus       101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  180 (316)
T d2ppqa1         101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  180 (316)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             cccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccc
Confidence            665322              0111000 0        000                  1111122223333333333   


Q ss_pred             -HcCCeeCCCCCCCEEecCCCCCCEEEeecCCcc
Q 019433          117 -SMEICHRDLKLENTLLDGSPQPRLKICDFGYSK  149 (341)
Q Consensus       117 -~~~iiHrDikp~Nili~~~~~~~ikL~Dfg~a~  149 (341)
                       ..|+||+|+.++||+++++..  .-++||+.+.
T Consensus       181 L~~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~  212 (316)
T d2ppqa1         181 LPAGVIHADLFQDNVFFLGDEL--SGLIDFYFAC  212 (316)
T ss_dssp             SCEEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred             cccccccCCcchhhhhcccccc--eeEecccccc
Confidence             357999999999999987653  5799999764